Citrus Sinensis ID: 008810
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 552 | 2.2.26 [Sep-21-2011] | |||||||
| Q6TGC6 | 507 | Serine/threonine-protein | N/A | no | 0.815 | 0.887 | 0.485 | 1e-123 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | yes | no | 0.780 | 0.928 | 0.5 | 1e-123 | |
| Q5R8M1 | 465 | Serine/threonine-protein | yes | no | 0.797 | 0.946 | 0.488 | 1e-122 | |
| Q15208 | 465 | Serine/threonine-protein | no | no | 0.797 | 0.946 | 0.488 | 1e-122 | |
| Q7TSE6 | 464 | Serine/threonine-protein | yes | no | 0.791 | 0.941 | 0.486 | 1e-121 | |
| A2VDV2 | 465 | Serine/threonine-protein | no | no | 0.797 | 0.946 | 0.486 | 1e-121 | |
| Q91VJ4 | 465 | Serine/threonine-protein | no | no | 0.797 | 0.946 | 0.486 | 1e-121 | |
| Q9NBK5 | 463 | Serine/threonine-protein | yes | no | 0.784 | 0.935 | 0.504 | 1e-121 | |
| Q2LZZ7 | 458 | Serine/threonine-protein | yes | no | 0.798 | 0.962 | 0.508 | 1e-121 | |
| Q54Y26 | 530 | Probable serine/threonine | yes | no | 0.829 | 0.864 | 0.459 | 1e-120 |
| >sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 223/459 (48%), Positives = 311/459 (67%), Gaps = 9/459 (1%)
Query: 37 DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLK 96
D + + T ++ A+ K +E+ YK ++ ER +RR E KLA SEE + L
Sbjct: 45 DASSFTKTTHERAASVKLKLEHLYKVTVEQTVERNQRRMDFEAKLAQDRGSEERKKRQLN 104
Query: 97 FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR 156
L +KE++++RL+R K+ +DF + +IGKGAFGEVR+ ++ TG +YAMK L KSEM +
Sbjct: 105 SLGQKESQFLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAMKTLLKSEMFK 164
Query: 157 RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED 216
+ Q+ HV+AER++LAE DS +V LY SFQD ++LYLIME+LPGGD+MT+L++ DT +ED
Sbjct: 165 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTMLIKYDTFSED 224
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC----KPLDCSTLQ 272
RFY+AE +LAIE++HK +IHRDIKPDN+L+DK GH++LSDFGL K D + Q
Sbjct: 225 VTRFYIAECILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGFHKTHDNAYYQ 284
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRT--QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ N S+QN+ T ++++ W+KNRR++AYSTVGTPDYIAPE+
Sbjct: 285 RLFESKINTSTSSTQNSLMVDTISLTMSSKDKIATWKKNRRIMAYSTVGTPDYIAPEIFT 344
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GYG ECDWWSLGAIM+E L+G+PPF S++ T RKI+NWR +L FPE+ LS EA+D
Sbjct: 345 QHGYGQECDWWSLGAIMFECLIGWPPFCSENAHETYRKIINWRENLYFPEDLHLSAEAED 404
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI KLL + +QRLG GA++IK+HP+F GV+W I ++ A FIP++ DT FE+ +
Sbjct: 405 LIRKLLTSADQRLGRYGANDIKLHPFFRGVNWDTIREINAPFIPQLKSITDTSYFEEIDT 464
Query: 451 SDNQTKTSSKTGPWRKMLSSKDIN--FVGYTYKNFEIVN 487
N T S K+ S D N FVGYTYK F+++
Sbjct: 465 IPNITMNSPPVLQ-NKIPSDVDQNLAFVGYTYKRFDMMT 502
|
Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating. Pneumocystis carinii (taxid: 4754) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 441 bits (1135), Expect = e-123, Method: Compositional matrix adjust.
Identities = 224/448 (50%), Positives = 301/448 (67%), Gaps = 17/448 (3%)
Query: 41 LSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEK 100
+SN T+++V AK +EN Y + +ER R+ LE + + +++E++ +
Sbjct: 13 MSNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHAR 72
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
KETE++RL+R ++G DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+KS+ML + QV
Sbjct: 73 KETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKSDMLEKEQV 132
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF 220
H+RAER++L E D +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTE+E +F
Sbjct: 133 AHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF 192
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
Y++ETVLAI++IH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E + +
Sbjct: 193 YISETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 252
Query: 281 N----LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
N + + N++R A + W+KNRR LAYSTVGTPDYIAPEV ++ GY
Sbjct: 253 NPPSDFSFQNMNSKRKA----------ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 302
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
CDWWSLG IMYEML+GYPPF S+ P T RK++NW+ L FP E +S +AKDLI +
Sbjct: 303 LCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC 362
Query: 397 CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTK 456
+ R+G G +EIK HP+F+GVDW I + AA E+ DT NF+ F ESD
Sbjct: 363 IDSENRIGNSGVEEIKGHPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDDFPESDILQP 422
Query: 457 TSSKTGPWRKMLSSKDINFVGYTYKNFE 484
+ T P K SKD F+ YTYK FE
Sbjct: 423 VPNTTEPDYK---SKDWVFLNYTYKRFE 447
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 222/454 (48%), Positives = 305/454 (67%), Gaps = 14/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKD
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKD 355
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F E
Sbjct: 356 LILRFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPE 415
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD T + + +KD F+ YTYK FE
Sbjct: 416 SDILKPTVATSNHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 222/454 (48%), Positives = 305/454 (67%), Gaps = 14/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKD
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKD 355
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F E
Sbjct: 356 LILRFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPE 415
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD T + + +KD F+ YTYK FE
Sbjct: 416 SDILKPTVATSNHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus GN=Stk38l PE=1 SV=2 | Back alignment and function description |
|---|
Score = 437 bits (1124), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/454 (48%), Positives = 303/454 (66%), Gaps = 17/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
+T +SN T+++V AK +EN Y + +ER R+ LE + + +++E++
Sbjct: 7 ATTTFPMSNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLR 66
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+K++M
Sbjct: 67 RSQHARKETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM 126
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E D +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 127 LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLT 186
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274
E+E +FY++ETVLAI++IH+ +IHRD+KPDNLLLD GH++LSDFGLC L + E
Sbjct: 187 EEETQFYISETVLAIDAIHQLGFIHRDVKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 246
Query: 275 DFTIGNN----LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ +N + + N++R A + W+KNRR LAYSTVGTPDYIAPEV +
Sbjct: 247 YRNLTHNPPSDFSFQNMNSKRKA----------ETWKKNRRQLAYSTVGTPDYIAPEVFM 296
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+G+PPF S+ P T RK+++W+ L FP E +S +AKD
Sbjct: 297 QTGYNKLCDWWSLGVIMYEMLIGFPPFCSETPQETYRKVMSWKETLAFPPEVPVSEKAKD 356
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + + R+G G +EIK HP+F+GVDW I + AA E+ DT NF+ F E
Sbjct: 357 LILRFCTDSENRIGNGGVEEIKGHPFFEGVDWGHIRERPAAIPIEIRSIDDTSNFDDFPE 416
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD + T P K SKD F+ YTYK FE
Sbjct: 417 SDILQPVPNTTEPDYK---SKDWVFLNYTYKRFE 447
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1123), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/454 (48%), Positives = 305/454 (67%), Gaps = 14/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++S+ TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSSHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKD
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKD 355
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F E
Sbjct: 356 LILRFCCEWEHRIGAPGVEEIKNNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPE 415
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD T + + +KD F+ YTYK FE
Sbjct: 416 SDILKPTVATSNHPDTDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91VJ4|STK38_MOUSE Serine/threonine-protein kinase 38 OS=Mus musculus GN=Stk38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1122), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/454 (48%), Positives = 304/454 (66%), Gaps = 14/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AK
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPVSEKAKG 355
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F E
Sbjct: 356 LILRFCCEWEHRIGAPGVEEIKNNLFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPE 415
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD T + + +KD F+ YTYK FE
Sbjct: 416 SDILKPTVTTSSHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 232/460 (50%), Positives = 302/460 (65%), Gaps = 27/460 (5%)
Query: 41 LSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEK 100
S+ T K AK +EN+Y + ER++R LE +L D +SE + +
Sbjct: 16 FSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLSEAQRQEKRLQHAQ 75
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
KETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 76 KETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQV 135
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF 220
HVRAER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM+KDTL+E+ +F
Sbjct: 136 AHVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQF 195
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL----------DCST 270
Y++ET LAI+SIHK +IHRDIKPDNLLLD GHL+LSDFGLC L D S
Sbjct: 196 YISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKSHRTDFYRDLSQ 255
Query: 271 LQEQDFTIGN--NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328
+ DF IG +L+ S +++R A + W++NRR LAYSTVGTPDYIAPEV
Sbjct: 256 AKPSDF-IGTCASLSCSPMDSKRRA----------ESWKRNRRALAYSTVGTPDYIAPEV 304
Query: 329 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
L+ GYG CDWWSLG IMYEML+GYPPF SD+P T RK++NWR L FP E +S EA
Sbjct: 305 FLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEA 364
Query: 389 KDLISKLLCNVNQRLGA-KGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEK 447
K+ I C ++RLG+ +G +++K P+F GVDW I + AA EV DT NF++
Sbjct: 365 KETIINFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDE 424
Query: 448 FEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVN 487
F D + S P + +KD F+ YTYK FE+ N
Sbjct: 425 F--PDVSLEIPSAPIPQGGEI-AKDWVFINYTYKRFEVRN 461
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1118), Expect = e-121, Method: Compositional matrix adjust.
Identities = 228/448 (50%), Positives = 299/448 (66%), Gaps = 7/448 (1%)
Query: 41 LSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEK 100
S+ T K AK +EN+Y + ER++R LE +L D ++E + +
Sbjct: 15 FSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTESQRQEKRLQHAQ 74
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
KETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 75 KETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQV 134
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF 220
HVRAER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM+KDTL+E+ +F
Sbjct: 135 AHVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQF 194
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
Y++ET LAI+SIHK +IHRDIKPDNLLLD GHL+LSDFGLC L S DF
Sbjct: 195 YISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKS--HRTDFYRDL 252
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ S A+P +++ + + W++NRR LAYSTVGTPDYIAPEV L+ GYG CDW
Sbjct: 253 SQAKPSDFIGTCASPMDSKR-RAESWKRNRRALAYSTVGTPDYIAPEVFLQTGYGPACDW 311
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVN 400
WSLG IMYEML+GYPPF SD+P T RK++NWR L FP E +S EAK+ I K C +
Sbjct: 312 WSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEAKETIIKFCCEAD 371
Query: 401 QRLGA-KGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSS 459
+RLG+ +G +++K P+F GVDW I + AA EV DT NF++F D + S
Sbjct: 372 RRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDEF--PDVSLEIPS 429
Query: 460 KTGPWRKMLSSKDINFVGYTYKNFEIVN 487
P + +KD F+ YTYK FE+ N
Sbjct: 430 APIPQGGEI-AKDWVFINYTYKRFEVRN 456
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y26|NDRA_DICDI Probable serine/threonine-protein kinase ndrA OS=Dictyostelium discoideum GN=ndrA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 232/505 (45%), Positives = 318/505 (62%), Gaps = 47/505 (9%)
Query: 19 GSGKKKEAGGNGSNEEST----DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERR 74
GS ++E N +EE T + LS T + AAK YIE +Y ++++ER +RR
Sbjct: 12 GSDDERE---NFEDEEDTTTVYSSDPLSRPTMDRSLAAKMYIEQYYINAQQSVKERGQRR 68
Query: 75 NILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV 134
LE KL + +S ++ N+L K L+KKE++YMR++R K+ DFE++ +IG+GAFGEV +
Sbjct: 69 KDLELKLENMKLSSKESNDLRKELDKKESDYMRIKRLKLKRSDFEVIRIIGRGAFGEVSL 128
Query: 135 CREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194
R + + +YAMK+LKKSEML++ Q HVRAER++LA ++N +VKLY SFQDD +LYLI
Sbjct: 129 VRHRESNDLYAMKRLKKSEMLKKEQAAHVRAERDVLASANTNWVVKLYYSFQDDNYLYLI 188
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
MEYLPGGDMM+LL++ D TE++ARFY+AET+LAIES+H YIHRDIKPDNLLLD GH
Sbjct: 189 MEYLPGGDMMSLLIKYDIFTENQARFYIAETILAIESVHTLGYIHRDIKPDNLLLDSKGH 248
Query: 255 LRLSDFGLCKPLDCSTLQEQDF---TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311
++L D GLC L +F +G+ + + E A TQ E++ W+K RR
Sbjct: 249 VKLCDLGLCTGF--HRLHSSEFYQMLVGDAMTIKMKLIE---ATPLTQTERIASWKKARR 303
Query: 312 MLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN 371
LAYS VGTPDY APEV L+ GY E DWWSLG I+YEM+VG+PPF SD+ TC KI+N
Sbjct: 304 ALAYSAVGTPDYTAPEVFLQIGYNKEVDWWSLGVILYEMVVGHPPFLSDNTTETCLKILN 363
Query: 372 WRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAA 431
+ L+ P + LS E DLI +L+C ++ K ADEIK+HP+F GV+W I A
Sbjct: 364 CKETLQIPTDMGLSKEVIDLIKRLVCEKDR---YKSADEIKLHPFFKGVNWDNIRNQSAP 420
Query: 432 FIPEVNDELDTQNFEKFEE----------------------SDNQTKTSSKTGPWRKM-- 467
F+PE+ DT NF+ +EE +DN + T P +K
Sbjct: 421 FVPELKSPTDTSNFDIYEEIPNDIDDDDNNNNNNSNNNINLNDNINSNCTYTTPTKKSNI 480
Query: 468 -----LSSKDINFVGYTYKNFEIVN 487
+ KD+ F+G+T+K F+ VN
Sbjct: 481 MGKGNIKDKDLAFIGFTFKGFDAVN 505
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 552 | ||||||
| 255577946 | 575 | serine/threonine-protein kinase, putativ | 0.985 | 0.946 | 0.852 | 0.0 | |
| 224082842 | 561 | predicted protein [Populus trichocarpa] | 0.985 | 0.969 | 0.861 | 0.0 | |
| 356545884 | 575 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.949 | 0.834 | 0.0 | |
| 7339534 | 564 | protein kinase MK6 [Mesembryanthemum cry | 0.996 | 0.975 | 0.835 | 0.0 | |
| 356537081 | 554 | PREDICTED: serine/threonine-protein kina | 0.981 | 0.978 | 0.832 | 0.0 | |
| 449462463 | 557 | PREDICTED: serine/threonine-protein kina | 0.967 | 0.958 | 0.852 | 0.0 | |
| 224066229 | 561 | predicted protein [Populus trichocarpa] | 0.998 | 0.982 | 0.821 | 0.0 | |
| 356503620 | 542 | PREDICTED: serine/threonine-protein kina | 0.952 | 0.970 | 0.845 | 0.0 | |
| 225438085 | 550 | PREDICTED: serine/threonine-protein kina | 0.976 | 0.98 | 0.851 | 0.0 | |
| 225433165 | 550 | PREDICTED: serine/threonine-protein kina | 0.974 | 0.978 | 0.821 | 0.0 |
| >gi|255577946|ref|XP_002529845.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223530673|gb|EEF32546.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 994 bits (2569), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/550 (85%), Positives = 509/550 (92%), Gaps = 6/550 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEE----STDEEALSNVTKQKVAAAKQYI 56
MDSARSW QK QPR+K+R + +KK+A SN E S D+E+LSN TKQKVAAAKQYI
Sbjct: 1 MDSARSWFQKFQPREKLRSTTRKKDASDESSNNEPKSPSEDDESLSNTTKQKVAAAKQYI 60
Query: 57 ENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGAD 116
ENHYKEQMKNLQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG D
Sbjct: 61 ENHYKEQMKNLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVD 120
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DFELLTMIGKGAFGEVRVCRE TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN
Sbjct: 121 DFELLTMIGKGAFGEVRVCRENTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 180
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
CIVKLYCSFQD+EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH+
Sbjct: 181 CIVKLYCSFQDEEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHN 240
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN-LNGSSQNNERPAAP 295
YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCST+QE DF++ NN +NG++QN ERPAAP
Sbjct: 241 YIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSTIQEGDFSVVNNSVNGTAQNEERPAAP 300
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KRTQQEQL+HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP
Sbjct: 301 KRTQQEQLKHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 360
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
PFYSDDPMSTCRKIVNWRTHLKFPEEA+LS EAKD+ISKLLCNVNQRLG KGADE+K HP
Sbjct: 361 PFYSDDPMSTCRKIVNWRTHLKFPEEARLSREAKDVISKLLCNVNQRLGTKGADELKAHP 420
Query: 416 WFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
WF+GV+W ++Y MEAAFIPEV D+LDTQNFEKFE+S+NQ +++++TGPWRKMLSSKD+NF
Sbjct: 421 WFNGVEWDKLYHMEAAFIPEVKDDLDTQNFEKFEDSENQNQSTTRTGPWRKMLSSKDLNF 480
Query: 476 VGYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGS 535
VGYTYKNFEIVNDYQVPGMA+LKK K KRPSVK+LFE++SETSESSDT SDQ GS
Sbjct: 481 VGYTYKNFEIVNDYQVPGMADLKKKTAKSKRPSVKSLFEADSETSESSDT-TSDQSVHGS 539
Query: 536 FTSLAPNQLD 545
F +L P QL+
Sbjct: 540 FLNLLPPQLE 549
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082842|ref|XP_002306862.1| predicted protein [Populus trichocarpa] gi|222856311|gb|EEE93858.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 978 bits (2528), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 473/549 (86%), Positives = 506/549 (92%), Gaps = 5/549 (0%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEES---TDEEALSNVTKQKVAAAKQYIE 57
MDSARSW QK QPR+K R S ++KE GG+ NE+S DEEALSNVTKQKVAAAKQYIE
Sbjct: 1 MDSARSWFQKFQPREKFRSSSRRKE-GGDEDNEDSKLEMDEEALSNVTKQKVAAAKQYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR LEKKLADADVSEEDQ+NLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKNLQERKERRTTLEKKLADADVSEEDQSNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI-GNNLNGSSQNNERPAAPK 296
IHRDIKPDNLLLD++GHLRLSDFGLCKPLDCST+QE DF++ NN N ++QN ERPAAPK
Sbjct: 240 IHRDIKPDNLLLDRHGHLRLSDFGLCKPLDCSTIQEGDFSVVNNNGNETTQNGERPAAPK 299
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP
Sbjct: 300 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 359
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
FYSDDPMSTCRKIVNWRTHLKFPEEAKLS EAKD+ISKLLCNV+ RLG GADEIK HPW
Sbjct: 360 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSPEAKDIISKLLCNVSHRLGTNGADEIKAHPW 419
Query: 417 FDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
FDGV+W ++YQMEAAFIPEV D+LDTQNFE FEES+NQT+T+SKTGPWRKMLSSKDINFV
Sbjct: 420 FDGVEWDKLYQMEAAFIPEVKDDLDTQNFENFEESENQTQTTSKTGPWRKMLSSKDINFV 479
Query: 477 GYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGSF 536
GYTYKNFEIVNDYQVPGMA+LKK + KPKRPSVK+LFE ESE SESSD D+ +QGSF
Sbjct: 480 GYTYKNFEIVNDYQVPGMADLKKKDTKPKRPSVKSLFEGESEASESSDIAPCDENAQGSF 539
Query: 537 TSLAPNQLD 545
+L P L+
Sbjct: 540 LNLLPPHLE 548
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545884|ref|XP_003541363.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 976 bits (2524), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/555 (83%), Positives = 508/555 (91%), Gaps = 9/555 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEES---TDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK R +GKKKE GNG N++S DE LS+VTKQKVAA KQYIE
Sbjct: 1 MDSARSWLQKFQPRDKTRAAGKKKEEDGNGGNQDSNEPVDEALLSSVTKQKVAATKQYIE 60
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 61 NHYKEQMKNLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVDD 120
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKT+ HVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVD NC
Sbjct: 121 FELLTMIGKGAFGEVRVCREKTSDHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDRNC 180
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 181 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 240
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLD+YGHL+LSDFGLCKPLDCS L+E+DF++G N+NGS+Q+ + PKR
Sbjct: 241 IHRDIKPDNLLLDRYGHLKLSDFGLCKPLDCSALEEKDFSVGQNVNGSTQS----STPKR 296
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+QQEQLQHWQ NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 297 SQQEQLQHWQMNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 356
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417
YSDDPM TCRKIVNW+T+LKFPEEA+LS EAKDLISKLLCNVNQRLG+KGADEIK HP+F
Sbjct: 357 YSDDPMLTCRKIVNWKTYLKFPEEARLSPEAKDLISKLLCNVNQRLGSKGADEIKAHPFF 416
Query: 418 DGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVG 477
GV+W ++YQMEAAFIPEVNDELDTQNFEKF+ESD+Q ++SS++GPWRKMLSSKD+NFVG
Sbjct: 417 KGVEWDKLYQMEAAFIPEVNDELDTQNFEKFDESDSQNQSSSRSGPWRKMLSSKDLNFVG 476
Query: 478 YTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESS--DTPASDQPSQGS 535
YTYKNFEIVNDYQVPG+AELKK +KPKRP++K+LF+ ESETSE S DT A+DQP+QGS
Sbjct: 477 YTYKNFEIVNDYQVPGIAELKKKQSKPKRPTIKSLFDCESETSEGSDTDTSANDQPAQGS 536
Query: 536 FTSLAPNQLDRSFSR 550
F L P QL+ S R
Sbjct: 537 FLKLLPPQLEVSPHR 551
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7339534|emb|CAB82852.1| protein kinase MK6 [Mesembryanthemum crystallinum] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2514), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/554 (83%), Positives = 505/554 (91%), Gaps = 4/554 (0%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEA--GGNGSNEESTDEEALSNVTKQKVAAAKQYIEN 58
MDSARSWL K QPRDK+R S KKK++ GG + ++DEE SNVTKQ+VAAAKQYIE
Sbjct: 6 MDSARSWLHKYQPRDKLRSSTKKKDSMMGGRDDSAPTSDEETPSNVTKQRVAAAKQYIEK 65
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYKEQMK+LQER+ERR+ILE+KL DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF
Sbjct: 66 HYKEQMKSLQERKERRSILERKLHDADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 125
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 126 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 185
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET+LAIESIHKH+YI
Sbjct: 186 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETILAIESIHKHNYI 245
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLDK+GHLRLSDFGLCKPLDCSTL+E+DF + NN NG S +NE P+RT
Sbjct: 246 HRDIKPDNLLLDKFGHLRLSDFGLCKPLDCSTLEEKDFEV-NNGNGGSPSNEGSTKPRRT 304
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY
Sbjct: 305 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 364
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418
SDDPMSTCRKIVNWRTHLKFPEEAKLS EAKDLISKLLCNV QRLG+ GA EIK+HPWF+
Sbjct: 365 SDDPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVTQRLGSNGAHEIKLHPWFN 424
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
G+DW RIYQMEAAFIPEVNDELDTQNFEKFEE+DN ++++SK GPWRKMLSSKD+NFVGY
Sbjct: 425 GIDWERIYQMEAAFIPEVNDELDTQNFEKFEEADNSSQSTSKAGPWRKMLSSKDLNFVGY 484
Query: 479 TYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGSFTS 538
TYKNFEIVNDYQVPG+AELKK + KPKRPS+K+LFE ES S + T + DQ QGSF +
Sbjct: 485 TYKNFEIVNDYQVPGIAELKKKDTKPKRPSIKSLFEDESSDSSEAAT-SGDQSVQGSFLN 543
Query: 539 LAPNQLDRSFSRAE 552
L P QL+ S ++ E
Sbjct: 544 LLPPQLEVSQTQTE 557
|
Source: Mesembryanthemum crystallinum Species: Mesembryanthemum crystallinum Genus: Mesembryanthemum Family: Aizoaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537081|ref|XP_003537059.1| PREDICTED: serine/threonine-protein kinase tricorner-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 964 bits (2492), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/554 (83%), Positives = 502/554 (90%), Gaps = 12/554 (2%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNE---ESTDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK R +GKKKE GNG N+ E+ DE LS+VTKQKVAAAKQYIE
Sbjct: 1 MDSARSWLQKFQPRDKTRAAGKKKEEDGNGGNQDSNEAIDEALLSSVTKQKVAAAKQYIE 60
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQ R ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG +D
Sbjct: 61 NHYKEQMKNLQVAYNSRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVED 120
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKT+GHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNC
Sbjct: 121 FELLTMIGKGAFGEVRVCREKTSGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 180
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE LYLIMEYLPGGDMMTLLMRKD LTEDEARFYV ETVLAIESIHKH+Y
Sbjct: 181 IVKLYCSFQDDEHLYLIMEYLPGGDMMTLLMRKDILTEDEARFYVGETVLAIESIHKHNY 240
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLD+YGHL+LSDFGLCKPLDCSTL+E DF++G N+NGS+Q+ + PKR
Sbjct: 241 IHRDIKPDNLLLDRYGHLKLSDFGLCKPLDCSTLEENDFSVGQNVNGSTQS----STPKR 296
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+QQEQLQHWQ NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 297 SQQEQLQHWQINRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 356
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417
YSDDPM TCRKIVNW+T+LKFPEEA+LS EAKDLISKLLCNVNQRLG+KGADEIK HP+F
Sbjct: 357 YSDDPMLTCRKIVNWKTYLKFPEEARLSPEAKDLISKLLCNVNQRLGSKGADEIKAHPFF 416
Query: 418 DGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFV 476
GV+W ++YQMEAAFIPEVNDELDTQNFEKF+ESD+QT++SS++GPWRKMLSS KD+NFV
Sbjct: 417 KGVEWNKLYQMEAAFIPEVNDELDTQNFEKFDESDSQTQSSSRSGPWRKMLSSKKDLNFV 476
Query: 477 GYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGSF 536
GYTYKNFEIVNDYQVPGMAELKK +KPKRP++K+LF ET E+SDT A+DQP+QGSF
Sbjct: 477 GYTYKNFEIVNDYQVPGMAELKKKQSKPKRPTIKSLF----ETPEASDTSANDQPAQGSF 532
Query: 537 TSLAPNQLDRSFSR 550
L P QL+ S R
Sbjct: 533 LKLLPPQLEVSPHR 546
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462463|ref|XP_004148960.1| PREDICTED: serine/threonine-protein kinase 38-like [Cucumis sativus] gi|449502113|ref|XP_004161547.1| PREDICTED: serine/threonine-protein kinase 38-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 951 bits (2459), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/544 (85%), Positives = 498/544 (91%), Gaps = 10/544 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST-----DEEALSNVTKQKVAAAKQY 55
MDSARSW Q RD++RGS KKK+ G NE+ST DEEALSN+TKQKVAAAKQY
Sbjct: 1 MDSARSWFN--QRRDRLRGSTKKKD-NSMGENEDSTATDQMDEEALSNITKQKVAAAKQY 57
Query: 56 IENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGA 115
IENHYKEQMKNLQER+ERRN+LEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG
Sbjct: 58 IENHYKEQMKNLQERKERRNVLEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGV 117
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDF+LLT+IGKGAFGEVRVCREKTTG VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS
Sbjct: 118 DDFDLLTIIGKGAFGEVRVCREKTTGQVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 177
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV E VLAIESIHKH
Sbjct: 178 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGEIVLAIESIHKH 237
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+YIHRDIKPDNLLLDK+GHLRLSDFGLCKPLDCS L+EQDF IG+ NG+ QN+ER A P
Sbjct: 238 NYIHRDIKPDNLLLDKFGHLRLSDFGLCKPLDCSILREQDFDIGSTRNGAGQNDERNATP 297
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP
Sbjct: 298 -RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
PFYSDDPMSTCRKIVNWRTHLKFP+EAKLS+ AKDLISKLLCNVNQRLG GADEIKVH
Sbjct: 357 PFYSDDPMSTCRKIVNWRTHLKFPDEAKLSLLAKDLISKLLCNVNQRLGTNGADEIKVHS 416
Query: 416 WFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
WF+G +W R+YQMEAAF+PEV DELDTQNFEKFEESD+Q+ TSSKTGPWRKMLSSKDINF
Sbjct: 417 WFEGTEWDRLYQMEAAFVPEVKDELDTQNFEKFEESDSQSSTSSKTGPWRKMLSSKDINF 476
Query: 476 VGYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPA-SDQPSQG 534
VGYTYKNFEIVNDYQ+PGMAELKK +KPKRPS+K+LF+ E E ++SDTP+ S Q + G
Sbjct: 477 VGYTYKNFEIVNDYQLPGMAELKKKCSKPKRPSIKSLFDGELEEGDASDTPSHSHQHTGG 536
Query: 535 SFTS 538
SF++
Sbjct: 537 SFSN 540
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066229|ref|XP_002302036.1| predicted protein [Populus trichocarpa] gi|222843762|gb|EEE81309.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/556 (82%), Positives = 503/556 (90%), Gaps = 5/556 (0%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST---DEEALSNVTKQKVAAAKQYIE 57
MDSARSW QK QPR+K R ++KE GG+ NE++ DEEA SNVTKQKVAAAK+YIE
Sbjct: 1 MDSARSWFQKFQPREKFRSPSRRKE-GGDEDNEDTISEMDEEAHSNVTKQKVAAAKRYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR LEKKLADADVSEEDQ+NLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKNLQERKERRTTLEKKLADADVSEEDQSNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVR+CREKTTG VYAMKKLKKSEMLRRGQVEHV+AERNLL EVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRICREKTTGQVYAMKKLKKSEMLRRGQVEHVKAERNLLTEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDD FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDGFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT-IGNNLNGSSQNNERPAAPK 296
IHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCST+QE DF+ + NN NG++QN ERPAAP+
Sbjct: 240 IHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSTIQEGDFSVVNNNSNGTTQNEERPAAPR 299
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
RTQQEQL+HWQKNRRMLA+STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP
Sbjct: 300 RTQQEQLEHWQKNRRMLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 359
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
FYSD+P+STC+KIVNWRTHLKFPEEAKLS AKDL SKLLCNV+QRLG GA+EIK HPW
Sbjct: 360 FYSDEPLSTCKKIVNWRTHLKFPEEAKLSPAAKDLTSKLLCNVDQRLGTNGAEEIKAHPW 419
Query: 417 FDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
F+GV+W ++YQMEAAFIPEV D+LDTQNF KFEES+NQ +T+SKTGPWRKMLSSKD+NFV
Sbjct: 420 FNGVEWDKLYQMEAAFIPEVKDDLDTQNFVKFEESENQPQTTSKTGPWRKMLSSKDVNFV 479
Query: 477 GYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGSF 536
GYTYKNFEIVNDYQVPGMA+LKK + K KRPS+K+LFE ESE ESS T D+ S+GSF
Sbjct: 480 GYTYKNFEIVNDYQVPGMADLKKKDTKLKRPSIKSLFEGESEAIESSVTAPGDETSRGSF 539
Query: 537 TSLAPNQLDRSFSRAE 552
+L P +L+ S ++ E
Sbjct: 540 LNLLPPRLEVSRNQNE 555
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503620|ref|XP_003520605.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2453), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 449/531 (84%), Positives = 488/531 (91%), Gaps = 5/531 (0%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNE---ESTDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK+R S + K+ NG+NE D+ +LSNVTKQKV AAKQYIE
Sbjct: 1 MDSARSWLQKFQPRDKLRASTRNKD-DTNGTNEIPNVPMDDTSLSNVTKQKVTAAKQYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMK+LQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKSLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVC+EK T HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRVCKEKATDHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL+E DFT G N NGS+QNNE APKR
Sbjct: 240 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLEETDFTTGQNANGSTQNNEH-VAPKR 298
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
TQQE+LQHWQKNRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 299 TQQEKLQHWQKNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417
YSDDPMSTCRKIVNW++HL+FPEEA+LS EAKDLISKLLC+VNQRLG+ GADEIK HP+F
Sbjct: 359 YSDDPMSTCRKIVNWKSHLRFPEEARLSPEAKDLISKLLCDVNQRLGSNGADEIKAHPFF 418
Query: 418 DGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVG 477
+GV+W ++YQMEAAFIPEVNDELDTQNFEKFEES++QT +SS+ PWRKM SSKD+NFVG
Sbjct: 419 NGVEWDKLYQMEAAFIPEVNDELDTQNFEKFEESESQTHSSSRVSPWRKMFSSKDLNFVG 478
Query: 478 YTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPAS 528
YTYKNFEIVNDYQVPGMAEL+K N+K K+PSVK+LF+ ESE E+S++ S
Sbjct: 479 YTYKNFEIVNDYQVPGMAELRKKNSKAKKPSVKSLFDGESEAFEASESTTS 529
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438085|ref|XP_002272501.1| PREDICTED: serine/threonine-protein kinase CBK1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 945 bits (2442), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/551 (85%), Positives = 501/551 (90%), Gaps = 12/551 (2%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEESTD----EEALSNVTKQKVAAAKQYI 56
MDSARSW QK QPR+++R S +KKE G G+ +E T +E SNVTKQKVAAAKQYI
Sbjct: 1 MDSARSWFQKFQPRERVRPSARKKE--GTGAEKEETGPTAGDETPSNVTKQKVAAAKQYI 58
Query: 57 ENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGAD 116
ENHYKEQMK+LQERRERRNILEKKLADADVSEEDQNNLLK LEKKETEYMRLQRHKMGAD
Sbjct: 59 ENHYKEQMKSLQERRERRNILEKKLADADVSEEDQNNLLKHLEKKETEYMRLQRHKMGAD 118
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DFELLTMIGKGAFGEVRVCREKTTG+VYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSN
Sbjct: 119 DFELLTMIGKGAFGEVRVCREKTTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSN 178
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+
Sbjct: 179 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHN 238
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL E+DFTI N+ NG Q + PAAPK
Sbjct: 239 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL-EEDFTIVNSPNGGHQGD--PAAPK 295
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
RTQQEQ QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP
Sbjct: 296 RTQQEQQQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 355
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
FYSDDPMSTCRKIVNWRTHLKFPEEA LS EAKDLISKLLCNV+QRLG+KGADEIKVHPW
Sbjct: 356 FYSDDPMSTCRKIVNWRTHLKFPEEASLSSEAKDLISKLLCNVSQRLGSKGADEIKVHPW 415
Query: 417 FDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
F+G +W R+Y MEAAFIPEV DELDTQNFEKFEES++ ++SSK+GPWRKMLSSKD+NFV
Sbjct: 416 FEGTEWDRLYLMEAAFIPEVRDELDTQNFEKFEESESLGQSSSKSGPWRKMLSSKDMNFV 475
Query: 477 GYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGSF 536
GYTYKNFEI+NDYQVPGMAELKK NKPKR S+K+LFE E S+ SDT A +QP QGSF
Sbjct: 476 GYTYKNFEIINDYQVPGMAELKKKTNKPKRASIKSLFEEE---SDGSDTVADNQPVQGSF 532
Query: 537 TSLAPNQLDRS 547
+L P QL+ S
Sbjct: 533 LNLLPPQLEVS 543
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433165|ref|XP_002285280.1| PREDICTED: serine/threonine-protein kinase tricorner [Vitis vinifera] gi|296083669|emb|CBI23658.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2439), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/549 (82%), Positives = 495/549 (90%), Gaps = 11/549 (2%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNG--SNEESTDEEALSNVTKQKVAAAKQYIEN 58
M S W KL+ RDK + S KKEA NG ++ T EEA SNVTKQKVAAAKQYIEN
Sbjct: 1 MKSIGCWFNKLKSRDKAKSS--KKEATNNGKEGSKAVTSEEAPSNVTKQKVAAAKQYIEN 58
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYKEQMKNLQER+ERRNILEKKLADA+VSEE+QNNLLK LEKKETEYMRLQRHKMGADDF
Sbjct: 59 HYKEQMKNLQERKERRNILEKKLADAEVSEEEQNNLLKHLEKKETEYMRLQRHKMGADDF 118
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVRVCREK TGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 119 EPLTMIGKGAFGEVRVCREKKTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 178
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+EFLYL+MEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+YI
Sbjct: 179 VKLYCSFQDEEFLYLVMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYI 238
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLD+YGH++LSDFGLCKPLDCS L E+DF++GNNL+G+ Q++ RPAAP+RT
Sbjct: 239 HRDIKPDNLLLDRYGHMKLSDFGLCKPLDCSNLHEKDFSLGNNLSGALQSDGRPAAPRRT 298
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQLQHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY
Sbjct: 299 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418
SD+PM+TCRKIVNWRTHLKFPEEAKLS EAKDLISKLLCNV+QRLG KGADEIK HPWF+
Sbjct: 359 SDEPMTTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVDQRLGTKGADEIKAHPWFE 418
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
GVDW ++YQ+EAAFIPEVNDELDTQNFEKFEE+D+Q +TSSK GPWRKMLSSKDINFVGY
Sbjct: 419 GVDWDKLYQIEAAFIPEVNDELDTQNFEKFEEADDQIQTSSKAGPWRKMLSSKDINFVGY 478
Query: 479 TYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGSFTS 538
TYKNFEIVND VPG+AELKK + K KRPS+K+LF+ ES A+++P QGSF +
Sbjct: 479 TYKNFEIVNDQPVPGIAELKKKSTKTKRPSIKSLFDDESGA-------AANEPVQGSFLN 531
Query: 539 LAPNQLDRS 547
L P +L+ S
Sbjct: 532 LLPPKLEVS 540
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 552 | ||||||
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.981 | 0.952 | 0.768 | 9.6e-231 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.971 | 0.972 | 0.762 | 2.9e-229 | |
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.971 | 0.943 | 0.749 | 9.2e-226 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.927 | 0.899 | 0.786 | 3.6e-224 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.978 | 0.960 | 0.649 | 2.9e-190 | |
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.856 | 0.911 | 0.668 | 2.1e-171 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.822 | 0.861 | 0.650 | 2.1e-164 | |
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.894 | 0.957 | 0.612 | 2.1e-164 | |
| UNIPROTKB|E1C8Z7 | 465 | STK38 "Uncharacterized protein | 0.795 | 0.944 | 0.496 | 3.5e-114 | |
| UNIPROTKB|Q15208 | 465 | STK38 "Serine/threonine-protei | 0.804 | 0.954 | 0.495 | 4.5e-114 |
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2226 (788.7 bits), Expect = 9.6e-231, P = 9.6e-231
Identities = 431/561 (76%), Positives = 477/561 (85%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSN---EE---STDEEALSNVTKQKVAAAKQ 54
MDSA+ W QK Q R R G AGG GSN +E TDEEA+SN TKQKVAAAKQ
Sbjct: 1 MDSAKGWFQKRQMRGGSRYKGASGGAGGGGSNGSADEHNVETDEEAVSNTTKQKVAAAKQ 60
Query: 55 YIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG 114
YIENHYKEQMK LQER+ERR++LE+KLADADVSEEDQNNLLKFLEKKETEYMRLQRHK+G
Sbjct: 61 YIENHYKEQMKILQERKERRSMLEQKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKLG 120
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DF+LLTMIGKGAFGEVRVCREKTTG VYAMKKLKK+EMLRRGQVEHVRAERNLLAEVD
Sbjct: 121 VADFDLLTMIGKGAFGEVRVCREKTTGQVYAMKKLKKAEMLRRGQVEHVRAERNLLAEVD 180
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
SN IVKLYCSFQDD+ LYL+MEYLPGGDMMTLLMRKDTLTE+EA+FYVAETVLAIESIH+
Sbjct: 181 SNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLLMRKDTLTEEEAKFYVAETVLAIESIHR 240
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H+YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCS + E DF+ NN NGS++ A
Sbjct: 241 HNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSAIGENDFS--NNSNGSTEQEAGSTA 298
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
PKRTQQEQL+HWQ+NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY
Sbjct: 299 PKRTQQEQLEHWQRNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 358
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVH 414
PPFYSDDPMSTCRKIVNW++HLKFPEEA LS EAKDLI+ LLC+V +RLG+KGADE+K H
Sbjct: 359 PPFYSDDPMSTCRKIVNWKSHLKFPEEAILSREAKDLINSLLCSVRRRLGSKGADELKAH 418
Query: 415 PWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN 474
WF+ VDW I+ M+AAF+PEVND+LDTQNFEKF+ES+++T+TSSK+GPWRKMLSSKDIN
Sbjct: 419 TWFETVDWDTIFDMDAAFVPEVNDDLDTQNFEKFDESESETQTSSKSGPWRKMLSSKDIN 478
Query: 475 FVGYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFXXXXXXXX-XXDT---PASDQ 530
FVGYTYKNFEIVNDYQVPGMAELKK K RP VK+LF +T P D+
Sbjct: 479 FVGYTYKNFEIVNDYQVPGMAELKK-KKKSTRPMVKSLFDNGSSETSDSSETTSRPPCDR 537
Query: 531 PS------QGSFTSLAPNQLD 545
P QGSF L P +L+
Sbjct: 538 PPPAPPVVQGSFLKLLPPELE 558
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2212 (783.7 bits), Expect = 2.9e-229, P = 2.9e-229
Identities = 417/547 (76%), Positives = 475/547 (86%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST--DEEALSNVTKQKVAAAKQYIEN 58
M++A++WL KL+ +DK++ S KKKEA N T EEALSN+TK+K AAAK YIEN
Sbjct: 1 METAKAWLSKLKSKDKVKSS-KKKEATSNVKEGPKTAGGEEALSNITKEKAAAAKLYIEN 59
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYK QM++LQER+ERR +LEKKLA A+VSEE+QNNLLK LE KETEYMR QRHKMGADDF
Sbjct: 60 HYKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLKDLEMKETEYMRRQRHKMGADDF 119
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVR+CREK TG+VYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 120 EPLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFY+ ETVLAIESIHKH+YI
Sbjct: 180 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYIGETVLAIESIHKHNYI 239
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLDK GH++LSDFGLCKPLDCS LQE+DFT+ N++G+ Q++ RP A +RT
Sbjct: 240 HRDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQEKDFTVARNVSGALQSDGRPVATRRT 299
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQL +WQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PPFY
Sbjct: 300 QQEQLLNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFY 359
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418
SDDPM+TCRKIVNWR +LKFP+E +LS EAKDLI +LLCNV QRLG KGADEIK HPWF
Sbjct: 360 SDDPMTTCRKIVNWRNYLKFPDEVRLSPEAKDLICRLLCNVEQRLGTKGADEIKGHPWFR 419
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
G +W ++YQM+AAFIP+VNDELDTQNFEKFEE+D Q S+K+GPWRKMLSSKDINFVGY
Sbjct: 420 GTEWGKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVPKSAKSGPWRKMLSSKDINFVGY 479
Query: 479 TYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFXXXXXXXXXXDTPASDQPSQGSFTS 538
TYKN EIVND Q+PG+AELKK +NKPKRPS+K+LF +T QGSF +
Sbjct: 480 TYKNVEIVNDDQIPGIAELKKKSNKPKRPSIKSLFED--------ETSGGTTTHQGSFLN 531
Query: 539 LAPNQLD 545
L P Q++
Sbjct: 532 LLPTQIE 538
|
|
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2179 (772.1 bits), Expect = 9.2e-226, P = 9.2e-226
Identities = 412/550 (74%), Positives = 475/550 (86%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST--DEEALSNVTKQKVAAAKQYIEN 58
MD+AR+WL+KL+ + K + S KK+ + GN T EEA+SNVTKQK AAAKQYIEN
Sbjct: 1 MDTARAWLKKLKSKGKEKSSNKKETSRGNVKEGSKTAGGEEAVSNVTKQKAAAAKQYIEN 60
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYK+Q+++ Q+R+ERR++LE KLA A+VSEE+Q NLLK LEKKETEYMR QRHKMG DDF
Sbjct: 61 HYKKQVQSQQQRKERRDMLENKLAAAEVSEEEQKNLLKDLEKKETEYMRRQRHKMGTDDF 120
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVR+CREKTTG+VYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 121 EPLTMIGKGAFGEVRICREKTTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 180
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+YI
Sbjct: 181 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYI 240
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLD+ GH++LSDFGLCKPLDCS LQE+DF + +NL+G+ Q++ RP AP+RT
Sbjct: 241 HRDIKPDNLLLDRSGHMKLSDFGLCKPLDCSILQEKDFVVAHNLSGALQSDGRPVAPRRT 300
Query: 299 --QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
Q EQLQ+WQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PP
Sbjct: 301 RSQMEQLQNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPP 360
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
FYSD+PM+TCRKIVNW+ +LKFP+E +LS EAKDLI +LLCNV QR+G KGA+EIK HPW
Sbjct: 361 FYSDEPMTTCRKIVNWKNYLKFPDEVRLSPEAKDLICRLLCNVEQRIGTKGANEIKEHPW 420
Query: 417 FDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
F GV+W ++YQM+AAFIP+VNDELDTQNFEKFEE+D Q + K+GPWRKMLSSKDINFV
Sbjct: 421 FSGVEWEKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVPKTPKSGPWRKMLSSKDINFV 480
Query: 477 GYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFXXXXXXXXXXDTPASDQPS-QGS 535
GYTYKN EIVN Q+PG+AELKK + KPKRPS+K+LF D AS S QGS
Sbjct: 481 GYTYKNVEIVNHDQLPGIAELKKKSTKPKRPSIKSLFE---------DESASSTTSHQGS 531
Query: 536 FTSLAPNQLD 545
F L P Q++
Sbjct: 532 FMKLLPTQIE 541
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2164 (766.8 bits), Expect = 3.6e-224, P = 3.6e-224
Identities = 406/516 (78%), Positives = 449/516 (87%)
Query: 37 DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLK 96
D EALSN TKQKVAAAKQYIENHYKEQMKNL ER+ERR LEKKLADADV EEDQ NL+K
Sbjct: 56 DGEALSNSTKQKVAAAKQYIENHYKEQMKNLNERKERRTTLEKKLADADVCEEDQTNLMK 115
Query: 97 FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR 156
FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV RE TGHV+AMKKLKKSEMLR
Sbjct: 116 FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVREINTGHVFAMKKLKKSEMLR 175
Query: 157 RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED 216
RGQVEHVRAERNLLAEVDSNCIVKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTL+ED
Sbjct: 176 RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEYLPGGDMMTLLMRKDTLSED 235
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
EA+FY+AE+VLAIESIH +YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCS + +DF
Sbjct: 236 EAKFYIAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSVIDGEDF 295
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
T+GN +G + PKR+QQEQL+HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM
Sbjct: 296 TVGNAGSGGGSESVS-TTPKRSQQEQLEHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 354
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
ECDWWSLGAIMYEMLVGYPPFY+DDPMSTCRKIVNW+THLKFPEE++LS A+DLI KLL
Sbjct: 355 ECDWWSLGAIMYEMLVGYPPFYADDPMSTCRKIVNWKTHLKFPEESRLSRGARDLIGKLL 414
Query: 397 CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTK 456
C+VNQRLG+ GA +IK HPWF+GV W +IYQMEAAFIPEVND+LDTQNFEKF+E DNQT+
Sbjct: 415 CSVNQRLGSTGASQIKAHPWFEGVQWEKIYQMEAAFIPEVNDDLDTQNFEKFDEEDNQTQ 474
Query: 457 TSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFXXX 516
S+TGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPG+AELKK +K KRPSVK+LF
Sbjct: 475 APSRTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGIAELKKKESKSKRPSVKSLFESE 534
Query: 517 XXXXXXXDTPASDQPSQGSFTSLAPNQLDRSFSRAE 552
+ Q S+++ P ++ + R +
Sbjct: 535 SDSSSSG---SEQQTINRSYSNPTPRGMEPNLRRLD 567
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1844 (654.2 bits), Expect = 2.9e-190, P = 2.9e-190
Identities = 361/556 (64%), Positives = 431/556 (77%)
Query: 2 DSARSWLQ-KLQPRDKMRGSGKKKEAGGNGSN-EESTDEEALSNVTKQKVAAAKQYIENH 59
+ RSW Q + Q DK S KK GN N +A SN TKQKVAAAKQYIENH
Sbjct: 4 EPTRSWFQIRQQKPDK--SSPTKKGQEGNVKNLGRPPMNDAPSNATKQKVAAAKQYIENH 61
Query: 60 YKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFE 119
YK Q K+LQER+ERR+ILE+ LADADV+ ED+ ++LK EKKE EYMRLQR KMG DDFE
Sbjct: 62 YKIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKKEMEYMRLQRQKMGVDDFE 121
Query: 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
LL++IG+GAFGEVR+C+EK+TG VYAMKKLKKSEMLRRGQVEHV+AERN+LAEVDS IV
Sbjct: 122 LLSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVEHVKAERNVLAEVDSPFIV 181
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
KL SFQDDE LYLIMEYLPGGDMMTLLMRKDTL EDE RFYVA+T+LAIESIHKH+Y+H
Sbjct: 182 KLCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFYVAQTILAIESIHKHNYVH 241
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER----PAAP 295
RDIKPDNLL+ + GH++LSDFGL K L+ + + + + ++R P+AP
Sbjct: 242 RDIKPDNLLITRNGHIKLSDFGLSKSLESKNFPDFKAELVDRSTKPAAEHDRLSKPPSAP 301
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+RTQQEQL HWQ+NRR LA+STVGTPDYIAPEVLLKKGYGMECDWWSLGAIM+EMLVG+P
Sbjct: 302 RRTQQEQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMFEMLVGFP 361
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
PFYS++P++TCRKIVNW+T LKFP+EAKLSIE KDLI +LLCNV QRLG KG EIK HP
Sbjct: 362 PFYSEEPLATCRKIVNWKTCLKFPDEAKLSIEVKDLIRRLLCNVEQRLGTKGVHEIKAHP 421
Query: 416 WFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
WF GV+W R+Y+ A +IP+V ELDTQNFEKF+E + +TSSK+ PWRKM+SSKD NF
Sbjct: 422 WFRGVEWERLYESNAPYIPQVKHELDTQNFEKFDEVPSTCQTSSKSSPWRKMISSKDANF 481
Query: 476 VGYTYKNFEIVNDYQVPGMAELKKTNNKPKRPSVKTLFXX------XXXXXXXXDTPASD 529
+GYT+KN EIV+++ +PGMAELK+ + +PS+KTLF D+P
Sbjct: 482 LGYTFKNLEIVDEHHIPGMAELKRKSKTANKPSLKTLFETPYPPSENQALKDLLDSPIYS 541
Query: 530 QPSQGSFTS--LAPNQ 543
+ S+GS S PNQ
Sbjct: 542 EGSRGSSGSPFSRPNQ 557
|
|
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1666 (591.5 bits), Expect = 2.1e-171, P = 2.1e-171
Identities = 326/488 (66%), Positives = 395/488 (80%)
Query: 33 EESTDEEAL-SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQ 91
E TDEE L S++T +KVAAAKQYIENHYK Q KN+QER+ERR ILE+KLA + V +E+Q
Sbjct: 8 ENGTDEEVLGSSLTMEKVAAAKQYIENHYKAQNKNIQERKERRWILERKLASSGVPKEEQ 67
Query: 92 NNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK 151
N++K LE+KETE+MRL+R+K+ DDFELLT+IG+GAFGEVR+CRE+ +G++YAMKKLKK
Sbjct: 68 INMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNIYAMKKLKK 127
Query: 152 SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD 211
SEM+ RGQVEHVRAERNLLAEV+S+ IVKLY SFQD E+LYLIMEYLPGGDMMTLLMR+D
Sbjct: 128 SEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMRED 187
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
TL ED ARFY+A++VLAIESIH+++YIHRDIKPDNLLLDK GH++LSDFGLCKPLDC L
Sbjct: 188 TLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNL 247
Query: 272 ---QEQDFTIGNNLNGSSQNNER--PAAPK----RTQQEQLQHWQKNRRMLAYSTVGTPD 322
QE T ++ + +R P R+ QEQLQHWQ NRR LA+STVGTPD
Sbjct: 248 PSIQENRATDDETMS-EPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPD 306
Query: 323 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA 382
YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY+DDP+STCRKIV+WR HLKFPE+A
Sbjct: 307 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPISTCRKIVHWRNHLKFPEDA 366
Query: 383 KLSIEAKDLISKLLCNVNQRLGAKG-ADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441
K S EAKDLI +LLCNV+ RLG G A +IK HPWF V W ++Y+MEAA+ PEVNDELD
Sbjct: 367 KFSSEAKDLICRLLCNVDHRLGTGGGAQQIKDHPWFKDVVWEKLYEMEAAYKPEVNDELD 426
Query: 442 TQNFEKFEESDNQTKTSSKTGPWRKML-SSKDINFVGYTYKNFEIVNDYQVPGMAELKKT 500
TQNF KF+E ++ +++G RKML + KD++FVGYTYKNF+ V + E+ +T
Sbjct: 427 TQNFMKFDEVNSPAPERTRSGLSRKMLLAPKDLSFVGYTYKNFDAVKGLR--HSLEMART 484
Query: 501 NNKPKRPS 508
+ + P+
Sbjct: 485 MSLDRSPA 492
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1600 (568.3 bits), Expect = 2.1e-164, P = 2.1e-164
Identities = 303/466 (65%), Positives = 381/466 (81%)
Query: 33 EESTDEEAL-SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQ 91
E++ ++E L SN T +KVAAAK+YIENHY +M+++Q+R+ERR +LE+K+A DVSE++Q
Sbjct: 19 EDNFEDEGLVSNSTLEKVAAAKKYIENHYNRRMRHIQQRKERRWVLEQKIASLDVSEKEQ 78
Query: 92 NNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK 151
LL+ L++KETEY RL R+++ DDF+LL++IG+GAFGEVR+CREK TG++YAMKKLKK
Sbjct: 79 LELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEVRLCREKKTGNIYAMKKLKK 138
Query: 152 SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD 211
SEML RGQVEHVRAERNLLAEV S+CIVKLY SFQD E+LYLIMEYL GGD+MTLLMR++
Sbjct: 139 SEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLYLIMEYLSGGDVMTLLMREE 198
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC--- 268
TLTE ARFY+A++VLAIESIHKH+Y+HRDIKPDNLLLDKYGH++LSDFGLCKPLDC
Sbjct: 199 TLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKYGHMKLSDFGLCKPLDCRNI 258
Query: 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ-----EQLQHWQKNRRMLAYSTVGTPDY 323
S + + N+N S +E + +R ++ EQLQHWQ NRR LAYSTVGTPDY
Sbjct: 259 SAMNVNEPLNDENINESIDGDENCSIGRRGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 318
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAK 383
IAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDP++TCRKIV+WRTHL FPE A+
Sbjct: 319 IAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVSWRTHLVFPEGAR 378
Query: 384 LSIEAKDLISKLLCNVNQRLGAKGA--DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441
L+ EA+DLI +LLC+ RLG+ GA ++IK H WF V+W ++Y+M+AAF P VN ELD
Sbjct: 379 LTPEARDLICRLLCDSEHRLGSHGAGAEQIKAHTWFKDVEWEKLYEMDAAFKPVVNGELD 438
Query: 442 TQNFEKFEESDNQTKTSSKTGP-WRKMLSSKDINFVGYTYKNFEIV 486
TQNF KF+E + + +GP W+ ++ ++INFVGYTY+NF+ V
Sbjct: 439 TQNFMKFDEVECPKPARTGSGPSWKVSITPQNINFVGYTYRNFDAV 484
|
|
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1600 (568.3 bits), Expect = 2.1e-164, P = 2.1e-164
Identities = 306/500 (61%), Positives = 380/500 (76%)
Query: 17 MRGS-GKKKEAGGNGSNEESTDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRN 75
M G+ G + G G E TD S VT+QK AAAKQ+IENHYK ++ L ER ERR
Sbjct: 1 MDGADGTVRVKPGRGFETE-TDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHERMERRR 59
Query: 76 ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVC 135
++K+ +A + E+Q+ +++ L ++ETEYMRLQR K+G DDFELLT+IGKGAFGEVR+C
Sbjct: 60 EFQRKVQEAQLPVEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLC 119
Query: 136 REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195
R ++T VYAMKKLKK+EML RGQVEHVR+ERNLLAEVDS IVKL+ SFQD E LYLIM
Sbjct: 120 RLRSTSEVYAMKKLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIM 179
Query: 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255
EYLPGGD+MTLLMR+D L+ED ARFY+AE++LAI SIH+H+Y+HRDIKPDNL+LDK GHL
Sbjct: 180 EYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHL 239
Query: 256 RLSDFGLCKPLD---CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRM 312
+LSDFGLCKPLD S L E D + + S ++ AP + +EQL W++NRR
Sbjct: 240 KLSDFGLCKPLDDKYSSLLLEDDEMLSQDSENQSGKSDADKAPWQMPKEQLLQWKRNRRA 299
Query: 313 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW 372
LAYSTVGT DY+APEVLLKKGYGMECDWWSLGAI+YEMLVGYPPF SDDP TCRKI+NW
Sbjct: 300 LAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKIINW 359
Query: 373 RTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAF 432
R LKFPEE K+S EA+DLI +LLC+V+ RLG +G +EIK HPWF G W ++Y MEAA+
Sbjct: 360 RVCLKFPEEPKISDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYDMEAAY 419
Query: 433 IPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVP 492
P V+ ELDTQNFEKF E + + + GPWRKML+SKD NF+G+T+K +I +
Sbjct: 420 RPIVDGELDTQNFEKFPEVEGSPSEAPQVGPWRKMLTSKDTNFIGFTFKKSDITRSMESS 479
Query: 493 GMAELKKTNNKPKRPSVKTL 512
G A++K +N + PS+ +L
Sbjct: 480 GSADMK-SNGSGEAPSLISL 498
|
|
| UNIPROTKB|E1C8Z7 STK38 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1126 (401.4 bits), Expect = 3.5e-114, P = 3.5e-114
Identities = 221/445 (49%), Positives = 301/445 (67%)
Query: 40 ALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLE 99
++SN TK++V K +EN Y + +ER R+ LE+ + + + +E++
Sbjct: 11 SMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEQMMEEEGLKDEEKRIRRSAHA 70
Query: 100 KKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ 159
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + Q
Sbjct: 71 QKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQ 130
Query: 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR 219
V H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTE+E +
Sbjct: 131 VGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQ 190
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L +F
Sbjct: 191 FYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL--KKAHRTEFY-- 246
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339
NLN S ++ + + + W++NRR LA+STVGTPDYIAPEV ++ GY CD
Sbjct: 247 RNLNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 304
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNV 399
WWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI + C
Sbjct: 305 WWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISDKAKDLILRFCCEW 364
Query: 400 NQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSS 459
R+GA G +EIK +P+F+GVDW I + AA E+ DT NF++F ESD T +
Sbjct: 365 EHRIGASGVEEIKSNPFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVA 424
Query: 460 KTGPWRKMLSSKDINFVGYTYKNFE 484
+ +KD F+ YTYK FE
Sbjct: 425 TSNHPETDYKNKDWVFINYTYKRFE 449
|
|
| UNIPROTKB|Q15208 STK38 "Serine/threonine-protein kinase 38" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1125 (401.1 bits), Expect = 4.5e-114, P = 4.5e-114
Identities = 223/450 (49%), Positives = 302/450 (67%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL--KKAHRT 243
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334
+F NLN S ++ + + + W++NRR LA+STVGTPDYIAPEV ++ GY
Sbjct: 244 EFY--RNLNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 299
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISK 394
CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI +
Sbjct: 300 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILR 359
Query: 395 LLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQ 454
C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F ESD
Sbjct: 360 FCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDIL 419
Query: 455 TKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
T + + +KD F+ YTYK FE
Sbjct: 420 KPTVATSNHPETDYKNKDWVFINYTYKRFE 449
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q54Y26 | NDRA_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.4594 | 0.8297 | 0.8641 | yes | no |
| Q2L6W9 | SAX1_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.4579 | 0.8025 | 0.9306 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.5089 | 0.7989 | 0.9628 | yes | no |
| Q9NBK5 | TRC_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.5043 | 0.7844 | 0.9352 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 552 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-177 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-156 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-137 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-136 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-135 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-118 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-118 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-117 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-114 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-111 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-110 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-110 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-105 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-104 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-102 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-100 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-96 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-94 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-94 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-91 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-88 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-87 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-85 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-85 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-84 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-79 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-77 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-73 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-73 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-73 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-70 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-69 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-69 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-68 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-68 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-67 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-67 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-65 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-64 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-59 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-58 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-58 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-57 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-56 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-56 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-55 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-55 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-54 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-52 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-52 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-51 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-51 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-49 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-48 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-46 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-46 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-45 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-45 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-44 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-44 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-43 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-42 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-41 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-40 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-40 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-40 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-39 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-38 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-36 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-35 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-35 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-34 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 5e-33 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-31 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-29 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-28 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 6e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-27 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-26 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-26 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-25 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-25 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-24 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-22 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-21 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-18 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 8e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 8e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-05 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 6e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 631 bits (1630), Expect = 0.0
Identities = 223/370 (60%), Positives = 270/370 (72%), Gaps = 7/370 (1%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE + +IG+GAFGEVR+ ++K TGH+YAMKKL+KSEML + QV HVRAER++LAE D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VKLY SFQD+ +LYLIMEYLPGGDMMTLLM+KDT TE+E RFY+AET+LAI+SIHK
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
YIHRDIKPDNLLLD GH++LSDFGLC L S E L+ + +N
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR----ILSHALPSNFLDFIS 176
Query: 296 K-RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
K + + + + W++NRR LAYSTVGTPDYIAPEV L+ GY ECDWWSLG IMYEMLVGY
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVH 414
PPF SD+P T RKI+NW+ L+FP+E LS EAKDLI +L C +RLG G +EIK H
Sbjct: 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296
Query: 415 PWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN 474
P+F GVDW I + A IPE+ DT NF+ FEE D TS GP R + SKD+
Sbjct: 297 PFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTS--PGPPRGKIKSKDLA 354
Query: 475 FVGYTYKNFE 484
F+GYTYK FE
Sbjct: 355 FIGYTYKRFE 364
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 504 bits (1299), Expect = e-177
Identities = 187/366 (51%), Positives = 253/366 (69%), Gaps = 16/366 (4%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE++ +IG+GAFGEV + R+K TG VYAMK L+KS+M++R Q+ HVRAER++LA+ DS
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IVKLY SFQD+E LYL+MEY+PGGD+M LL+RKD E+ ARFY+AE VLA++S+HK
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+IHRDIKPDN+L+D GH++L+DFGLCK ++ + +E N+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY------------LNDSHNLL 168
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
R + K RR+ A STVGTPDYIAPEVL YG+ECDWWSLG I+YEML G+P
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
PFYSD T KI+NW+ L+FP + +S EA DLI +LLC+ RLG+ +EIK HP
Sbjct: 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS--FEEIKSHP 286
Query: 416 WFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
+F G+DW + + + F+PE++ LDT NF+ FE D++ + + +K+ K + F
Sbjct: 287 FFKGIDWENLRETKPPFVPELSSPLDTSNFDDFE--DDKDLSDYLSQNSKKLNKGKQLAF 344
Query: 476 VGYTYK 481
VG+TYK
Sbjct: 345 VGFTYK 350
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 450 bits (1158), Expect = e-156
Identities = 189/377 (50%), Positives = 257/377 (68%), Gaps = 8/377 (2%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DF + +IGKGAFGEVR+ ++K TG +YAMK L KSEM ++ Q+ HV+AER++LAE DS
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V LY SFQD ++LYLIME+LPGGD+MT+L++ DT +ED RFY+AE VLAIE++HK
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCK---PLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+IHRDIKPDN+L+D+ GH++LSDFGL S ++ +N N N
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 293 AAP---KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ ++Q+ W+KNRR++AYSTVGTPDYIAPE+ L++GYG ECDWWSLGAIM+E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGAD 409
L+G+PPF S++ T RKI+NWR L FP++ LS+EA+DLI +L+ N RLG GA
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAH 300
Query: 410 EIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNF--EKFEESDNQTKTSSKTGPWRKM 467
EIK HP+F GVDW I Q+ A FIP++ DT F ++ E+ ++
Sbjct: 301 EIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEE 360
Query: 468 LSSKDINFVGYTYKNFE 484
D+ F+GYTYK F+
Sbjct: 361 SVELDLAFIGYTYKRFD 377
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 402 bits (1034), Expect = e-137
Identities = 198/371 (53%), Positives = 256/371 (69%), Gaps = 13/371 (3%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+K++ML + QV H+RAER++L E D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK++ SFQD LYLIME+LPGGDMMTLLM+KDTL+E+ +FY+AETVLAI++IH+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE--QDFTIGNNLNGSSQNNERPA 293
+IHRDIKPDNLLLD GH++LSDFGLC L + E ++ T + S QN
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN----- 175
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ + + W+KNRR LAYSTVGTPDYIAPEV ++ GY CDWWSLG IMYEML+G
Sbjct: 176 ---MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKV 413
YPPF S+ P T RK++NW+ L FP E +S +AKDLI + + R+G+ G +EIK
Sbjct: 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKS 292
Query: 414 HPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDI 473
HP+F+GVDW I + AA E+ DT NF++F ESD + P K SKD
Sbjct: 293 HPFFEGVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYK---SKDW 349
Query: 474 NFVGYTYKNFE 484
F+ YTYK FE
Sbjct: 350 VFLNYTYKRFE 360
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 399 bits (1026), Expect = e-136
Identities = 173/377 (45%), Positives = 244/377 (64%), Gaps = 15/377 (3%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + IG GAFGEV + R+ T +YAMK L+K+++L R Q HV+AER++LAE D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+VKLY SFQD + LY +M+Y+PGGDMM+LL+R ED ARFY+AE AIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQDFTIGNNLNGSSQNNERPA 293
IHRDIKPDN+L+D+ GH++L+DFGLC D Q+ D ++ S + +E +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD----HHRQDSMEPSEEWS 178
Query: 294 APKRTQQEQLQ--HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + + L+ ++++R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I+YEML
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEI 411
VG PPF +D P T K++NW T L P +AKLS EA DLI +L C RLG GADEI
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEI 298
Query: 412 KVHPWFDGVDWAR-IYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS 470
K HP+F G+D+A I + +A +IP++ DT NF+ + ++ S ++ P R + +
Sbjct: 299 KAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPN 358
Query: 471 K----DINFVGYTYKNF 483
+ F +T++ F
Sbjct: 359 NRKRTEHAFYEFTFRRF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 395 bits (1017), Expect = e-135
Identities = 200/379 (52%), Positives = 258/379 (68%), Gaps = 26/379 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV H+RAER++L E DS
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTE+E +FY+AETVLAI+SIH+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE----------QDFTIGNNLNGS 285
+IHRDIKPDNLLLD GH++LSDFGLC L + E DFT N
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN----- 175
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
N++R A + W++NRR LA+STVGTPDYIAPEV ++ GY CDWWSLG
Sbjct: 176 -MNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGA 405
IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI + C R+GA
Sbjct: 225 IMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGA 284
Query: 406 KGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWR 465
G +EIK +P+F+GVDW I + AA E+ DT NF++F +SD T + +
Sbjct: 285 PGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPE 344
Query: 466 KMLSSKDINFVGYTYKNFE 484
+KD F+ YTYK FE
Sbjct: 345 TDYKNKDWVFINYTYKRFE 363
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 351 bits (903), Expect = e-118
Identities = 134/338 (39%), Positives = 195/338 (57%), Gaps = 53/338 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE + +G G+FG V + R K +G YA+K L K+++++ QVEHV E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V LY SFQDD LYL+MEY+PGG++ + L + E ARFY A+ VLA+E +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+NLLLD G+++++DFG K +
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---------------------------- 152
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
RT Y+ GTP+Y+APE++L KGYG DWW+LG ++YEML GYP
Sbjct: 153 GRT----------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLG--AKGADEIK 412
PF+ D+P+ KI+ + ++FP + S +AKDLI LL ++ +RLG G ++IK
Sbjct: 197 PFFDDNPIQIYEKILEGK--VRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252
Query: 413 VHPWFDGVDWARIYQM--EAAFIPEVNDELDTQNFEKF 448
HPWF G+DW + Q EA FIP+V DT NF+ +
Sbjct: 253 NHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDDY 290
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 348 bits (895), Expect = e-118
Identities = 128/295 (43%), Positives = 180/295 (61%), Gaps = 46/295 (15%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG+FG+V + R+K TG +YAMK LKK ++++R +VEH ERN+L+ ++ IVKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
+FQ +E LYL++EY PGG++ + L ++ +E+ ARFY AE VLA+E +H I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+N+LLD GH++L+DFGL K L
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL------------------------------------- 143
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ + GTP+Y+APEVLL KGYG DWWSLG ++YEML G PPFY++D
Sbjct: 144 ----SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199
Query: 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
KI+ L+FPE LS EA+DLIS LL + +RLG+ GA+EIK HP+F
Sbjct: 200 EIYEKILKDP--LRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 349 bits (896), Expect = e-117
Identities = 165/375 (44%), Positives = 220/375 (58%), Gaps = 55/375 (14%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE+L +IG+GAFGEV V + K TG VYAMK L K EML+R + R ER++L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ LYL+M+Y GGD++TLL + +D L ED ARFY+AE VLAI+S+H+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HRDIKPDN+LLDK GH+RL+DFG C L +G+ Q+N
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL--------------LADGTVQSN----- 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
VGTPDYI+PE+L K YG ECDWWSLG MYE
Sbjct: 162 ---------------------VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFP-EEAKLSIEAKDLISKLLCNVNQRLGAKGA 408
ML G PFY++ + T KI+N + H +FP + +S EAKDLI +L+C+ RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGL 260
Query: 409 DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKT---SSKTGPWR 465
+ K HP+F+G+DW I A ++PEV+ DT NF+ ++ T++ SS
Sbjct: 261 QDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDLRNTESLPPSSHGAF-- 318
Query: 466 KMLSSKDINFVGYTY 480
S + FVG+TY
Sbjct: 319 ---SGNHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 343 bits (882), Expect = e-114
Identities = 157/396 (39%), Positives = 233/396 (58%), Gaps = 51/396 (12%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + E ++ + +M A+DF+++ +IG+GAFGEV++ R K++ VYAMK L K
Sbjct: 20 NIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S IV+L+ +FQDD++LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GHL+L+DFG C +D + +
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
G YG ECDWWS+G +YEMLVG PFY+D + T KI++ + L FP++ ++S +A
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278
Query: 389 KDLISKLLCNVNQRLGAKGADEIKVHPWF--DGVDWARIYQMEAAFIPEVNDELDTQNFE 446
KDLI L + RLG G DEIK HP+F D + I + A +PE++ ++DT NF+
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFD 338
Query: 447 KFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482
E+ D +T P K + + F+G+TY
Sbjct: 339 DIEDDDKNEETF----PLPKAFAGNQLPFIGFTYSK 370
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 335 bits (860), Expect = e-111
Identities = 169/381 (44%), Positives = 241/381 (63%), Gaps = 18/381 (4%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + +G GAFGEV + + T +YAMK L+K ++L R QV HV+AER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+VKLY SFQD + LY +M+Y+PGGDMM+LL+R + E ARFY+AE LAIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ---------N 288
IHRDIKPDN+L+D GH++L+DFGLC T + + G+++ S +
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRW-THNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
N R +T +++ ++++R LA+S VGTP+YIAPEVLL+KGY CDWWS+G I++
Sbjct: 182 NCRCGDRLKTLEQRAT--KQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGA 408
EMLVG PPF + P T K++NW L P + KLS EA DLI+KL C+ +RLG GA
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299
Query: 409 DEIKVHPWFDGVDWAR-IYQMEAAFIPEVNDELDTQNFEKF-EESDNQTKTSSKTGPWRK 466
D+IK HP+F VD++ I A ++P+++ +DT NF+ EES + T W
Sbjct: 300 DDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDT 359
Query: 467 MLSSKDIN----FVGYTYKNF 483
+ S + F +T++ F
Sbjct: 360 LCSPNGKHPEHAFYEFTFRRF 380
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 334 bits (857), Expect = e-110
Identities = 166/380 (43%), Positives = 237/380 (62%), Gaps = 15/380 (3%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + +G GAFGEV + R+ T +YAMK L+K ++L R QV HV+AER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+V+LY SFQD + LY +M+Y+PGGDMM+LL+R ED ARFY+AE A+ES+HK +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQDFTIGNNLNGSSQ--NNER 291
IHRDIKPDN+L+D+ GH++L+DFGLC D Q D ++++ S++ +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + + + ++++R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I+YEML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEI 411
VG PPF + P+ T K++NW+T L P +AKLS EA DLI KL RLG GADEI
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302
Query: 412 KVHPWFDGVDWAR-IYQMEAAFIPEVNDELDTQNFEKF-------EESDNQTKTSSKTGP 463
K HP+F +D++ + Q A +IP++ DT NF+ ++ + G
Sbjct: 303 KAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNG- 361
Query: 464 WRKMLSSKDINFVGYTYKNF 483
W K + F +T++ F
Sbjct: 362 WYKNGKHPEHAFYEFTFRRF 381
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 329 bits (846), Expect = e-110
Identities = 135/300 (45%), Positives = 189/300 (63%), Gaps = 36/300 (12%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
I KGA+G V + ++K+TG +YA+K +KK++M+R+ QV+ V ER++L++ S +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
SFQ + LYL+MEYLPGGD+ +LL +L ED AR Y+AE VLA+E +H + IHRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
PDN+L+D GHL+L+DFGL K +G L N +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSK-------------VG--LVRRQINLNDDEKEDKR----- 160
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
VGTPDYIAPEV+L +G+ DWWSLG I+YE LVG PPF+ + P
Sbjct: 161 -------------IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422
+ I+N + +++PE+ ++S EA DLISKLL + +RLGAK +EIK HP+F G+DW
Sbjct: 208 EIFQNILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 319 bits (818), Expect = e-105
Identities = 149/372 (40%), Positives = 213/372 (57%), Gaps = 50/372 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DF++ +++G+G FGEV+V REK TG +YAMK +KKS +L + V ER++L+ +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I +L +FQD + LYL+MEY PGGD+++LL R +D ED A+FY+AE VLAI S+H+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HRDIKP+N+L+D+ GH++L+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSLGAIMY 348
N+ + + VGTPDYIAPEVL K YG+ECDWWSLG I Y
Sbjct: 154 -------------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGA 408
EM+ G PF+ T I+N++ LKFPE+ K+S + DLI LLC +RLG +G
Sbjct: 201 EMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEG- 259
Query: 409 DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML 468
+ HP+F +DW I F+P + + DT NF++ E++ + SS T
Sbjct: 260 --LCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGF 317
Query: 469 SSKDINFVGYTY 480
S KD+ FVG+++
Sbjct: 318 SGKDLPFVGFSF 329
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 316 bits (812), Expect = e-104
Identities = 141/378 (37%), Positives = 209/378 (55%), Gaps = 60/378 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF++LT +G+G +G+V + ++K TG + A+K++KKS + + +V HV ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
+VKL +FQDDE+LYL MEY+PGGD TLL L+ED ARFY+AE A++++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
YIHRD+KP+N L+D GH++L+DFGL K +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK---------------GIVT------------- 153
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
A S VG+PDY+APEVL KGY D+WSLG ++YE L G+PP
Sbjct: 154 ----------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
Query: 357 FYSDDPMSTCRKIVNWRTHLKFP----EEAKLSIEAKDLISKLLCNVNQRLGAKGADEIK 412
F P T + W+ L+ P LS EA DLI+KL+ + ++R G+ ++IK
Sbjct: 198 FSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSL--EDIK 255
Query: 413 VHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQT---------KTSSKTGP 463
HP+F VDW + +++ F+PE+ E+DT F+ FE D+ K + K G
Sbjct: 256 NHPFFKEVDWNELRELKPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGGA 315
Query: 464 WRKMLSSKDINFVGYTYK 481
+ FVG+T++
Sbjct: 316 NGRD-PGNRRKFVGFTFR 332
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 308 bits (792), Expect = e-102
Identities = 113/301 (37%), Positives = 167/301 (55%), Gaps = 48/301 (15%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E+L +G+G+FG+V + R+K TG + A+K +KK ++ + E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV+LY F+D++ LYL+MEY GGD+ LL ++ L+EDEARFY+ + + A+E +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+KP+N+LLD+ GH++L+DFGL +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------- 145
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
Q + + VGTP+Y+APEVLL KGYG D WSLG I+YE+L G PPF
Sbjct: 146 ---------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF 196
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416
DD + K + P E +S EAKDLI KLL + +RL A+ E HP+
Sbjct: 197 PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE---EALQHPF 253
Query: 417 F 417
F
Sbjct: 254 F 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 305 bits (781), Expect = e-100
Identities = 163/375 (43%), Positives = 223/375 (59%), Gaps = 55/375 (14%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE++ +IG+GAFGEV V + K T +YAMK L K EML+R + R ERN+L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ +LYL+M+Y GGD++TLL + +D L ED ARFY+AE VLAI SIH+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
HY+HRDIKPDN+LLD GH+RL+DFG C ++ QD T+ +++
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN------QDGTVQSSV------------ 162
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--LKKG---YGMECDWWSLGAIMYE 349
VGTPDYI+PE+L ++ G YG ECDWWSLG MYE
Sbjct: 163 ----------------------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGA 408
ML G PFY++ + T KI+N +FP +S EAKDLI +L+C+ +RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGI 260
Query: 409 DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTK---TSSKTGPWR 465
++ K H +F+G+DW I +EA +IP+V+ DT NF+ ++ + SS TG
Sbjct: 261 EDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIAPPSSHTG--- 317
Query: 466 KMLSSKDINFVGYTY 480
S + FVG+TY
Sbjct: 318 --FSGLHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 297 bits (761), Expect = 3e-96
Identities = 153/394 (38%), Positives = 234/394 (59%), Gaps = 51/394 (12%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + E ++++ +M A+D++++ +IG+GAFGEV++ R K++ VYAMK L K
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S +V+L+C+FQDD++LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E A+FY AE VLA+++IH IHRD+KPDN+LLDK+GHL+L+DFG C +D + +
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
G YG ECDWWS+G ++EMLVG PFY+D + T KI++ + L FPE+ ++S A
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278
Query: 389 KDLISKLLCNVNQRLGAKGADEIKVHPWF--DGVDWARIYQMEAAFIPEVNDELDTQNFE 446
K+LI L + RLG G +EIK HP+F D +W I + A +PE++ ++D+ NF+
Sbjct: 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFD 338
Query: 447 KFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTY 480
E+ K +T P K + F+G+TY
Sbjct: 339 DIEDD----KGDVETFPIPKAFVGNQLPFIGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 293 bits (750), Expect = 1e-94
Identities = 155/394 (39%), Positives = 227/394 (57%), Gaps = 51/394 (12%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + + +++ +M A+D+E++ +IG+GAFGEV++ R K+T VYAMK L K
Sbjct: 20 NIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S +V+L+ +FQDD +LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GHL+L+DFG C ++ +
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
G YG ECDWWS+G +YEMLVG PFY+D + T KI+N + L FP++ +S EA
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278
Query: 389 KDLISKLLCNVNQRLGAKGADEIKVHPWF--DGVDWARIYQMEAAFIPEVNDELDTQNFE 446
K+LI L + RLG G +EIK H +F D W + A +P+++ ++DT NF+
Sbjct: 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 338
Query: 447 KFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTY 480
EE K +T P K + FVG+TY
Sbjct: 339 DIEED----KGEEETFPIPKAFVGNQLPFVGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 289 bits (741), Expect = 7e-94
Identities = 157/372 (42%), Positives = 218/372 (58%), Gaps = 49/372 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE+L +IG+GAFGEV V + K V+AMK L K EML+R + R ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ LYL+M+Y GGD++TLL + +D L ED ARFY+AE V+AI+S+H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
HY+HRDIKPDN+L+D GH+RL+DFG C L +D T+ +++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL------MEDGTVQSSV------------ 162
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
VGTPDYI+PE+L K YG ECDWWSLG MYE
Sbjct: 163 ----------------------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGA 408
ML G PFY++ + T KI+N + +FP + +S +AKDLI +L+C+ RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGI 260
Query: 409 DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML 468
++ K HP+F G+DW I EA +IPEV+ DT NF+ + D + + P
Sbjct: 261 EDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDV--DDDCLKNSETMPPPSHTAF 318
Query: 469 SSKDINFVGYTY 480
S + FVG+TY
Sbjct: 319 SGHHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 281 bits (722), Expect = 4e-91
Identities = 125/327 (38%), Positives = 182/327 (55%), Gaps = 18/327 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F+ + ++GKG G V + R K TG ++A+K L K EM++R +V+ V E+ +LA +D
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIH 233
+ LY SFQ + +L L+M+Y PGG++ LL R+ L+E+ ARFY AE +LA+E +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++RD+KP+N+LL + GH+ LSDF L K D + + R +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK---------ALRKGSRRS 171
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ E R S VGT +YIAPEV+ G+G DWW+LG ++YEML G
Sbjct: 172 SVNSIPSETFSEEPSFRSN---SFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEI 411
PF + T I+ + FP +S A+DLI KLL + ++RLG+K GA EI
Sbjct: 229 TTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVND 438
K HP+F GV+WA I IP +D
Sbjct: 287 KQHPFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 273 bits (701), Expect = 1e-88
Identities = 113/304 (37%), Positives = 165/304 (54%), Gaps = 49/304 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FG V + + K+ +A+K +KK ++ GQ EH+ +E+ +L E + IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
+F+D +++Y++MEY GG++ T+L + E ARFY+A VLA E +H I+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+NLLLD G+++L DFG K +L
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-------------------------------------KL 143
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD--D 361
+ QK ++ GTP+Y+APE++L KGY D+WSLG ++YE+L G PPF D D
Sbjct: 144 KSGQK-----TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFD 418
PM I+ L+FP + AKDLI +LL N +RLG G +IK H WF+
Sbjct: 199 PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
Query: 419 GVDW 422
G DW
Sbjct: 257 GFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 270 bits (692), Expect = 5e-87
Identities = 121/339 (35%), Positives = 181/339 (53%), Gaps = 53/339 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DD E + +G G FG V + R++ + H YA+K + E++R Q +HV E+ +L EV
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++L+ + D FLY++MEY+PGG++ + L + FY +E V A+E +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLDK GH++L+DFG K L T
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT------------------------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
++ GTP+Y+APEV+ KG+ DWW+LG ++YEMLVGYP
Sbjct: 156 -------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCN-VNQRLG--AKGADEIK 412
PF+ D+P KI+ + L+FP L AKDLI KLL +RLG GAD++K
Sbjct: 197 PFFDDNPFGIYEKILAGK--LEFPRHLDLY--AKDLIKKLLVVDRTRRLGNMKNGADDVK 252
Query: 413 VHPWFDGVDWARIYQM--EAAFIPEVNDELDTQNFEKFE 449
H WF VDW + Q + +P+V+ + DT NF+ +
Sbjct: 253 NHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDYP 291
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 3e-85
Identities = 131/361 (36%), Positives = 193/361 (53%), Gaps = 64/361 (17%)
Query: 98 LEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR 157
K +T +L DFE+ +G G+FG VR+ + K TG YA+K LKK E+L+
Sbjct: 7 FTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59
Query: 158 GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
QV+HV E+++L E+ IV + CSFQD+ +Y ++E++ GG++ T L + D
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
A+FY AE VLA E +H I+RD+KP+NLLLD GH++++DFG K +
Sbjct: 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----------- 168
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
P RT ++ GTP+Y+APEV+ KG+G
Sbjct: 169 -----------------PDRT----------------FTLCGTPEYLAPEVIQSKGHGKA 195
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKL 395
DWW++G ++YE + GYPPF+ D P KI+ R LKFP + + A+DL+ L
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGR----ARDLVKGL 249
Query: 396 L-CNVNQRLGA--KGADEIKVHPWFDGVDWARIYQME-AAFIP-EVNDELDTQNFEKFEE 450
L + +RLG G ++K HP+F G +W ++Y A IP V DT NFEK+ +
Sbjct: 250 LQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKYPD 309
Query: 451 S 451
S
Sbjct: 310 S 310
|
Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 266 bits (681), Expect = 4e-85
Identities = 130/333 (39%), Positives = 194/333 (58%), Gaps = 30/333 (9%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE + +I GA+G V + R K T +AMKK+ K ++ R Q++ V ER++L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V ++CSF+ L ++MEY+ GGD TLL L D AR Y AETVLA+E +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KPDNLL+ GH++L+DFGL K IG L + N
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSK-------------IG--LMSLTTNLYEGHIE 165
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K T++ + GTP+YIAPEV+L++GYG DWW++G I+YE LVG
Sbjct: 166 KDTREFLDKQ-----------VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKV 413
PF+ D P ++++ +++PE + L +A+DLIS+LL N +RLG GA E+K
Sbjct: 215 PFFGDTPEELFGQVIS--DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272
Query: 414 HPWFDGVDWARIYQMEAAFIPEVNDELDTQNFE 446
H +F G+DW + + +A FIP++ E DT F+
Sbjct: 273 HRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 262 bits (671), Expect = 3e-84
Identities = 126/306 (41%), Positives = 182/306 (59%), Gaps = 51/306 (16%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER-NLLAEVDSNCIV 179
L I KGAFG V + ++++TG +A+K LKKS+M+ + QV +V+AER ++ + +S +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
KLY SFQ ++LYL+MEYL GGD +L+ L ED A+ Y+AE VL +E +H+ IH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RDIKP+NLL+D+ GHL+L+DFGL S+N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGL-----------------------SRNGL--------- 148
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+N++ VGTPDY+APE +L G DWWSLG +++E L GYPPF++
Sbjct: 149 --------ENKKF-----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAK--LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416
+ P + I++ R + +PEE K S EA DLI++LLC + +RLGA G EIK HP+
Sbjct: 196 ETPDAVFDNILSRR--INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253
Query: 417 FDGVDW 422
F ++W
Sbjct: 254 FKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 250 bits (642), Expect = 1e-79
Identities = 116/305 (38%), Positives = 174/305 (57%), Gaps = 28/305 (9%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDF+ +IG+G+F V + +EK T YA+K L K ++++ +V++V+ E+ +L ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 176 N-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ I+KLY +FQD+E LY ++EY P G+++ + + +L E RFY AE +LA+E +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+KP+N+LLDK H++++DFG K LD N P +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD--------------------PNSSPES 160
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
K +KNRR A S VGT +Y++PE+L +K G D W+LG I+Y+ML G
Sbjct: 161 NKGDATNIDSQIEKNRRRFA-SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEIK 412
PPF + T +KI+ FP +AKDLI KLL + RLG G DE+K
Sbjct: 220 PPFRGSNEYLTFQKILK--LEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
Query: 413 VHPWF 417
HP+F
Sbjct: 276 AHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 249 bits (637), Expect = 4e-79
Identities = 106/305 (34%), Positives = 155/305 (50%), Gaps = 50/305 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ELL +G G+FG V + K TG + A+K LKK + R E +L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV+L +F+D + LYL+MEY GGD+ L R L+EDEA+ + + +E +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+KP+N+LLD+ G ++++DFGL K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--------------------------------- 146
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPP 356
+ + + + + VGTP Y+APEVLL GYG + D WSLG I+YE+L G PP
Sbjct: 147 ------KLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
Query: 357 FYSD---DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
F + D + R+I+ P+ + S EAKDLI K L + ++R A+ EI
Sbjct: 199 FSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAE---EIL 255
Query: 413 VHPWF 417
HPWF
Sbjct: 256 QHPWF 260
|
Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 2e-77
Identities = 134/371 (36%), Positives = 197/371 (53%), Gaps = 62/371 (16%)
Query: 121 LTMIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDSN 176
L ++GKG +G+V R TG ++AMK LKK+ ++R + H +AERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IV L +FQ LYLI+EYL GG++ L R+ ED A FY++E LA+E +H+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
I+RD+KP+N+LLD GH++L+DFGLCK ++ E T
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVT------------------- 157
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
++ GT +Y+APE+L++ G+G DWWSLGA+MY+ML G PP
Sbjct: 158 ------------------HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKV 413
F +++ T KI+ + L P L+ EA+DL+ KLL N + RLGA A E++
Sbjct: 200 FTAENRKKTIDKIL--KGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255
Query: 414 HPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFE-KFEESDNQTKTSSKTGPWRKMLSS 470
HP+F V+W + ++E F P + E D F+ KF T+ + P LS
Sbjct: 256 HPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKF------TRQTPVDSPDDSTLSE 309
Query: 471 KDIN-FVGYTY 480
F+G+TY
Sbjct: 310 SANQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 2e-73
Identities = 122/327 (37%), Positives = 183/327 (55%), Gaps = 48/327 (14%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IGKG+FG+V R++ T +YA+K ++K+ ++ R +V H AER +LA+V+ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
SFQ E LYL++ ++ GG++ L R+ ARFY AE + A+E++HK + I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+N+LLD GH+ L DFGLCK N+ + N
Sbjct: 121 PENILLDYQGHIALCDFGLCKL---------------NMKDDDKTN-------------- 151
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ GTP+Y+APE+LL GY DWW+LG ++YEML G PPFY ++
Sbjct: 152 ------------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199
Query: 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422
RKI+ + L+FP+ +AKDL+ LL + +RLG GA EIK HP+F + W
Sbjct: 200 EMYRKIL--QEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255
Query: 423 ARIY--QMEAAFIPEVNDELDTQNFEK 447
++ ++ F P V+ +DT NF++
Sbjct: 256 KKLLMKGIQPPFKPAVSSAIDTSNFDE 282
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 4e-73
Identities = 127/368 (34%), Positives = 187/368 (50%), Gaps = 55/368 (14%)
Query: 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVK 180
+IGKG+FG+V + + K G YA+K L+K +L++ + +H+ AERN LL V +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ SFQ + LY +++Y+ GG++ L R+ + E ARFY AE A+ +H + I+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP+N+LLD GH+ L+DFGLCK E K T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-------------------------EGIEHSKTT-- 153
Query: 301 EQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
ST GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 154 ---------------STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-DEIKVHPWF 417
D I+N LK +S+ A+ L+ LL + +RLGAK EIK H +F
Sbjct: 199 RDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
Query: 418 DGVDWARIYQ--MEAAFIPEVNDELDTQNFEKF---EESDNQTKTSSKTGPWRKMLSSKD 472
++W + + F P V+ +D ++F+ E N S + + D
Sbjct: 255 SSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD 314
Query: 473 INFVGYTY 480
F+G++Y
Sbjct: 315 DAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 232 bits (595), Expect = 4e-73
Identities = 108/307 (35%), Positives = 161/307 (52%), Gaps = 57/307 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELL +IGKGAFG+V + +++ T ++AMK + K + + +G V +V ER +L E++
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+V L+ SFQD+E +YL+++ L GGD+ L +K +E++ +F++ E VLA+E +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDN+LLD+ GH+ ++DF + A K
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNI-------------------------------ATKV 150
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
T ST GTP Y+APEVL ++GY + DWWSLG YE L G P+
Sbjct: 151 TPDTLTT-----------STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
Query: 358 YSDDPMSTCRKIVNWRTHLK------FPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADE 410
R I + + +P S EA D I+KLL + +RLG +
Sbjct: 200 RGHS-----RTIRDQIRAKQETADVLYPATW--STEAIDAINKLLERDPQKRLGDN-LKD 251
Query: 411 IKVHPWF 417
+K HP+F
Sbjct: 252 LKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 5e-70
Identities = 123/329 (37%), Positives = 179/329 (54%), Gaps = 52/329 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQV-EHVRAERNLLA 171
+FELL ++G GA+G+V + R K GH +YAMK LKK+ ++++ + EH R ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 172 EVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
V +V L+ +FQ D L+LI++Y+ GG++ T L +++ TE E R Y+AE VLA++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H+ I+RDIK +N+LLD GH+ L+DFGL K ++ E
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF------------------LAEEEE 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGAIMY 348
R AYS GT +Y+APEV+ G+ DWWSLG + +
Sbjct: 162 R----------------------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407
E+L G PF D ++ +I K P +S EA+D I KLL + +RLGA G
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 408 ADEIKVHPWFDGVDW--ARIYQMEAAFIP 434
ADEIK HP+F G+DW ++ A F P
Sbjct: 260 ADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 1e-69
Identities = 111/332 (33%), Positives = 169/332 (50%), Gaps = 51/332 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K T +YA+K LKK +L+ VE E+ +LA + + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ + L+ +MEY+ GGD+M + R E ARFY AE VL ++ +H+ I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++++DFG+CK L G + +
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKE--------------GILGGVTTS------------- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTPDYIAPE+L + YG DWW+LG ++YEML G PF DD
Sbjct: 155 --------------TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFD 418
+ I+ +P LS EAK ++ L N +RLG G +IK HP+F
Sbjct: 201 EDELFQSILEDEVR--YPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 419 GVDWARI--YQMEAAFIPEVNDELDTQNFEKF 448
+DW ++ +++ F P++ D NF+
Sbjct: 257 EIDWDKLERKEIKPPFKPKIKGRFDVSNFDDE 288
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 225 bits (575), Expect = 4e-69
Identities = 133/376 (35%), Positives = 194/376 (51%), Gaps = 65/376 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVDSNCIVK 180
IGKG FG+V R+K T +YAMK L K E++ + +V H ERN+L +S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L SFQ D LYL+ +Y+ GG++ L ++ +ED A+FY+AE VLA+E +HK+ ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP+N+LLD GH+ L DFGL K NL + N
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA---------------NLTDNKTTN----------- 154
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+ GT +Y+APEVLL +KGY D+WSLG +++EM G+ PFY+
Sbjct: 155 ---------------TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWF 417
+D R I + ++FP+ LS E + + LL N RLGA + A E+K HP+F
Sbjct: 200 EDTQQMYRNIAFGK--VRFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
Query: 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML------- 468
+DW + Q+ F P V+ + D NF+ E N + ++ PW +
Sbjct: 257 ADIDWDLLSKKQITPPFKPIVDSDEDVSNFDP--EFTNSSLLNAGIVPWEDVPGLPGANS 314
Query: 469 ----SSKDINFVGYTY 480
SS NF G+T+
Sbjct: 315 TPLSSSVQENFRGFTF 330
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 3e-68
Identities = 121/366 (33%), Positives = 177/366 (48%), Gaps = 51/366 (13%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK TG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
SFQ + L +MEY GG++ L R+ +ED ARFY AE V A+ +H ++RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K +NL+LDK GH++++DFGLCK + + G +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK---------EGISDGATMK------------------- 153
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ D
Sbjct: 154 -------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 363 MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD--EIKVHPWFDG 419
I+ ++FP LS EAK L++ LL + QRLG D EI H +F
Sbjct: 201 EKLFELIL--MEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256
Query: 420 VDWARIYQ--MEAAFIPEVNDELDTQNF-EKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
++W + Q +E F P+V E DT+ F E+F + + + +F
Sbjct: 257 INWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFP 316
Query: 477 GYTYKN 482
++Y
Sbjct: 317 QFSYSA 322
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 6e-68
Identities = 109/339 (32%), Positives = 175/339 (51%), Gaps = 56/339 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
F L ++G+G FG+V + K TG +YA+K LKK +++ R +VE + E+ + +S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 177 --CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+V L+ FQ ++ + +MEY GGD+M + + D +E A FY A VL ++ +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ ++RD+K DNLLLD G ++++DFGLCK
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK------------------------------ 149
Query: 295 PKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
E + + ST GTP+++APEVL + Y DWW LG ++YEMLVG
Sbjct: 150 ------EGMGFGDRT------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADE 410
PF DD IVN +++P LS EA ++ +LL N +RLG+ K A++
Sbjct: 198 ESPFPGDDEEEVFDSIVN--DEVRYPRF--LSREAISIMRRLLRRNPERRLGSGEKDAED 253
Query: 411 IKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNFEK 447
+K P+F ++W + ++ F+P + D NF++
Sbjct: 254 VKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDE 292
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 2e-67
Identities = 130/344 (37%), Positives = 197/344 (57%), Gaps = 52/344 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAE 172
+FELL ++G GA+G+V + R+ T TG +YAMK L+K+ ++++ + VEH R ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 173 V-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
V S +V L+ +FQ + L+LI++Y+ GG+M T L ++D +EDE RFY E +LA+E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HK ++RDIK +N+LLD GH+ L+DFGL K L E+
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEK---------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
+RT YS GT +Y+APE++ K G+G DWWSLG +++E+
Sbjct: 161 ----ERT----------------YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200
Query: 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KG 407
L G PF + +T ++ P + + EA+DL+ KLL + +RLGA +G
Sbjct: 201 LTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQG 260
Query: 408 ADEIKVHPWFDGVDWARI--YQMEAAFIPEVNDELDTQNF-EKF 448
A EIK HP+F G+DW + ++ F P + +ELD NF E+F
Sbjct: 261 ASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEF 304
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 4e-67
Identities = 130/365 (35%), Positives = 191/365 (52%), Gaps = 56/365 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K T +A+K LKK +L VE ER +LA + + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+C+FQ E L+ +MEYL GGD+M + E ARFY AE + ++ +HK I+RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLDK GH++++DFG+CK N+NG +
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCK---------------ENMNGEGK-------------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
A + GTPDYIAPE+L + Y DWWS G ++YEML+G PF+ +D
Sbjct: 153 ------------ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420
I+N R H FP +S EAKD +SKL + +RLG G +I+ HP+F G+
Sbjct: 201 EDELFDSILNDRPH--FPR--WISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGI 254
Query: 421 DWARI--YQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN-FVG 477
DW R+ ++ F P+V D NF++ E N+ S +K+L+S D F G
Sbjct: 255 DWERLEKREIPPPFKPKVKSPSDASNFDR--EFTNEKVRLSPVD--KKLLASMDQEQFRG 310
Query: 478 YTYKN 482
+++ N
Sbjct: 311 FSFTN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 215 bits (548), Expect = 3e-65
Identities = 128/351 (36%), Positives = 193/351 (54%), Gaps = 56/351 (15%)
Query: 121 LTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
L ++G+G+FG+V + R+ T G +YAMK LKK+ + R +V + ER++LAEV+
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKL+ +FQ + LYLI+++L GGD+ T L ++ TE++ +FY+AE LA++ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
I+RD+KP+N+LLD+ GH++L+DFGL K
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK--------------------------------- 146
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
E + H +K AYS GT +Y+APEV+ ++G+ DWWS G +M+EML G PF
Sbjct: 147 ---ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVH 414
D T I+ + L P+ LS EA+ L+ L N RLGA G +EIK H
Sbjct: 199 QGKDRKETMTMIL--KAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254
Query: 415 PWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGP 463
P+F +DW ++Y +++ F P V DT F+ E ++T S P
Sbjct: 255 PFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDP--EFTSRTPKDSPGIP 303
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 214 bits (545), Expect = 1e-64
Identities = 117/348 (33%), Positives = 187/348 (53%), Gaps = 54/348 (15%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAER 167
+++KM +DF + +G G+FG V + K A+K+ +KS+++++ QV+HV +ER
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L ++ V LY SF+D+ +LYL++E++ GG+ T L R D FY A+ VL
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
E + + ++RD+KP+NLLLDK G ++++DFG K +D T
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT----------------- 185
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
Y+ GTP+YIAPE+LL G+G DWW+LG +
Sbjct: 186 ---------------------------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG-- 404
YE+LVG PPFY+++P+ +KI+ + FP+ L K L+ KLL ++ +R G
Sbjct: 219 YEILVGCPPFYANEPLLIYQKILEGIIY--FPK--FLDNNCKHLMKKLLSHDLTKRYGNL 274
Query: 405 AKGADEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEE 450
KGA +K HPWF +DW + +E + P+ + D+ NFE+ +E
Sbjct: 275 KKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQE 322
|
Length = 340 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 8e-59
Identities = 114/374 (30%), Positives = 182/374 (48%), Gaps = 58/374 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS- 175
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK N+ G
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFG----------G 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K T+ + GTPDYIAPE++ + YG DWW+ G ++YEML G P
Sbjct: 156 KTTR----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEIK 412
PF +D + I+ ++ +P+ LS EA + LL + +RLG G +I+
Sbjct: 200 PFDGEDEDELFQSIME--HNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIR 255
Query: 413 VHPWFDGVDWARIYQME--AAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGP--WRKML 468
H +F +DW ++ + E F P+V +NF+KF T+ P +
Sbjct: 256 EHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKF-----FTREPPVLTPPDKLVIA 310
Query: 469 SSKDINFVGYTYKN 482
+ F G+++ N
Sbjct: 311 NIDQSEFQGFSFVN 324
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 126/365 (34%), Positives = 191/365 (52%), Gaps = 54/365 (14%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + + K+ G YA+K L+K +L++ + H+ AERN LL + +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ E LY +++Y+ GG++ L R+ E ARFY AE AI +H + I+RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK ++ ++ T
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETT------------------------ 153
Query: 302 QLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
ST GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 154 --------------STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
Query: 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD--EIKVHPWF 417
D I++ L+ P ++ A DL+ LL + +RLGAK AD EIK H +F
Sbjct: 200 DVSQMYDNILH--KPLQLP--GGKTVAACDLLVGLLHKDQRRRLGAK-ADFLEIKNHVFF 254
Query: 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
++W +Y ++ + P V D ++F+ + + + +T SS F
Sbjct: 255 SPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAF 314
Query: 476 VGYTY 480
+G++Y
Sbjct: 315 LGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 1e-58
Identities = 114/333 (34%), Positives = 171/333 (51%), Gaps = 53/333 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKL 181
++GKG+FG+V + K T VYA+K LKK +L+ V+ E+ +LA + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+C FQ + L+ +MEY+ GGD+M + R E +RFY AE LA+ +H+H I+RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH +L+DFG+CK LNG
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKE--------------GILNG----------------- 150
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ + GTPDYIAPE+L + YG DWW+LG +MYEM+ G PPF +D+
Sbjct: 151 ----------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA----DEIKVHPW 416
I++ + +P LS EA ++ + N N+RLG + D IK HP+
Sbjct: 201 EDDLFESILH--DDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
Query: 417 FDGVDWARIYQ--MEAAFIPEVNDELDTQNFEK 447
F +DW + Q ++ F P++ + D NF++
Sbjct: 257 FKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ 289
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 1e-57
Identities = 121/369 (32%), Positives = 183/369 (49%), Gaps = 59/369 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181
M+GKG+FG+V + K T +A+K LKK +L VE E+ +L+ + + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC+FQ E L+ +MEYL GGD+M + A FY AE + ++ +H ++RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++++DFG+CK N+ G ++
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK---------------ENMLGDAKTC------------ 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTPDYIAPE+LL + Y DWWS G ++YEML+G PF+ D
Sbjct: 155 --------------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420
+ I R L+ EAKD++ KL +RLG KG +I+ HP+F +
Sbjct: 201 EEELFQSI---RMDNPCYPRW-LTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREI 254
Query: 421 DWARI--YQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
DW+ + ++E F P+V D NF+K E N+ S T R +++S D N
Sbjct: 255 DWSALEEREIEPPFKPKVKSANDCSNFDK--EFLNEKPRLSVTD--RMLINSMDQNM--- 307
Query: 479 TYKNFEIVN 487
++NF +N
Sbjct: 308 -FENFSFIN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 3e-56
Identities = 123/366 (33%), Positives = 182/366 (49%), Gaps = 53/366 (14%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + + K G YA+K L+K +L R + +H+ AERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ E LY +++++ GG++ L R+ + E ARFY AE A+ +H + ++RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK G +Q++
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK------------------EGIAQSDT----------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTP+Y+APEV+ K+ Y DWW LGA++YEML G PPFY D
Sbjct: 153 ------------TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGA-DEIKVHPWFDG 419
I+ H S+ A ++ +LL + +RLGAK EI+ HP+F+
Sbjct: 201 VAEMYDNIL----HKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256
Query: 420 VDWARIYQ--MEAAFIPEVNDELDTQNFE-KFEESD--NQTKTSSKTGPWRKMLSSKDIN 474
+ W + Q + F P V D NF+ F E SS + D
Sbjct: 257 LSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDA 316
Query: 475 FVGYTY 480
FVG++Y
Sbjct: 317 FVGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 5e-56
Identities = 115/329 (34%), Positives = 168/329 (51%), Gaps = 50/329 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E +H ++RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K +NL+LDK GH++++DFGLCK + + G +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK---------EGISDGATMK------------------- 153
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ D
Sbjct: 154 -------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 363 MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGA--KGADEIKVHPWFDG 419
I+ ++FP LS EAK L++ LL + QRLG A E+ H +F
Sbjct: 201 ERLFELIL--MEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256
Query: 420 VDWARIYQ--MEAAFIPEVNDELDTQNFE 446
++W + Q + F P+V E+DT+ F+
Sbjct: 257 INWQDVVQKKLLPPFKPQVTSEVDTRYFD 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 7e-56
Identities = 88/299 (29%), Positives = 139/299 (46%), Gaps = 49/299 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++G+G+FG V + +K TG + A+K ++ S ++E + E +L+ + IV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 183 CSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
S +D+E L + +EY+ GG + +LL + L E R Y + + + +H + +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L+D G ++L+DFG K L E
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT------------------------- 160
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY-S 359
S GTP ++APEV+ + YG D WSLG + EM G PP+
Sbjct: 161 --------------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+PM+ KI + + PE LS EAKD + K L + +R ADE+ HP+
Sbjct: 207 GNPMAALYKIGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 1e-55
Identities = 107/331 (32%), Positives = 167/331 (50%), Gaps = 52/331 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + R K +G +YA+K LKK +L+ VE E+ +L+ ++ + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC FQ + L+ +ME++ GGD+M + + E ARFY AE A+ +H I+RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH +L+DFG+CK + F
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF------------------------- 156
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GTPDYIAPE+L + YG DWW++G ++YEML G+ PF +++
Sbjct: 157 ----------------CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWF 417
I+N + +P LS +A D++ + N RLG+ G + I HP+F
Sbjct: 201 EDDLFEAILN--DEVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
Query: 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFE 446
+DW ++ Q+E F P + D NF+
Sbjct: 257 KELDWEKLNRRQIEPPFRPRIKSREDVSNFD 287
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 2e-55
Identities = 123/342 (35%), Positives = 176/342 (51%), Gaps = 56/342 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK +G YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
SFQ + L +MEY+ GG++ L R+ +ED RFY AE V A++ +H ++RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKP--LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
K +NL+LDK GH++++DFGLCK D +T++
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMK---------------------------- 153
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 154 ---------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
Query: 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWF 417
D I+ +KFP LS +AK L+S LL + N+RLG A EI H +F
Sbjct: 199 DHEKLFELIL--MEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
Query: 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKT 457
GV+W +Y ++ F P+V E DT+ F+ EE QT T
Sbjct: 255 TGVNWQDVYDKKLVPPFKPQVTSETDTRYFD--EEFTAQTIT 294
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 4e-54
Identities = 122/367 (33%), Positives = 184/367 (50%), Gaps = 56/367 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + +EK TG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRD 241
SFQ + L +MEY GG++ L R+ +ED ARFY AE V A++ +H + + ++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKP--LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
+K +NL+LDK GH++++DFGLCK D +T++
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK--------------------------- 154
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 155 ----------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRL--GAKGADEIKVHPW 416
D I+ ++FP LS EAK L+S LL + QRL G A EI H +
Sbjct: 199 QDHEKLFELIL--MEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254
Query: 417 FDGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDI 473
F G+ W +Y+ + F P+V E DT+ F++ + T T + + + +
Sbjct: 255 FAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDNERRP 314
Query: 474 NFVGYTY 480
+F ++Y
Sbjct: 315 HFPQFSY 321
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 8e-54
Identities = 90/304 (29%), Positives = 130/304 (42%), Gaps = 55/304 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
FE+L IGKG FGEV R K TG A+K +K ++ E + E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IVK Y S+ + L+++ME+ GG D++ + TLTE + + E + +E +H
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLH 115
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRDIK N+LL G ++L DFGL
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------- 146
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
Q + + VGTP ++APEV+ K Y + D WSLG E+ G
Sbjct: 147 -------------QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
PP+ PM KI K S E KD + K L N +R A+ ++
Sbjct: 194 KPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAE---QLL 249
Query: 413 VHPW 416
HP+
Sbjct: 250 KHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 1e-53
Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 49/284 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+E++ IGKG+FG+V + R K+ G +Y +K++ S M + E E +L +++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIESI 232
I+K Y SF++ L ++MEY GGD+ + E++ + + LA++ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ L G ++L DFG+ K L ST+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVD-------------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
LA + VGTP Y++PE+ K Y + D WSLG ++YE+
Sbjct: 159 --------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
PF ++ + KI+ + P + S E ++L+S LL
Sbjct: 199 LKHPFEGENLLELALKILK-GQYPPIPS--QYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 1e-52
Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 46/230 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G+G FG V + R+K TG A+K +KK + +E + E +L +++ IVKLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
F+D+ LYL+MEY GG + LL + L+EDE + + + +E +H + IHRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 243 KPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
KP+N+LLD G ++L+DFGL K L
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT---------------------------------- 144
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
+ + L + VGTP Y+APEVLL K Y + D WSLG I+YE+
Sbjct: 145 -------SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 2e-52
Identities = 111/318 (34%), Positives = 173/318 (54%), Gaps = 54/318 (16%)
Query: 117 DFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQV-EHVRAERNLLAE 172
+FELL ++G GA+G+V + R+ + +G +YAMK LKK+ ++++ + EH R ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 173 V-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ S +V L+ +FQ D L+LI++Y+ GG++ T L +++ E E + Y E VLA+E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HK I+RDIK +N+LLD GH+ L+DFGL K ER
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF------------------HEDEVER 162
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSLGAIMYE 349
AYS GT +Y+AP+++ G+ DWWS+G +MYE
Sbjct: 163 ----------------------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKIVN--WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA- 405
+L G PF D ++ +I ++ +P+E +S AKD+I +LL + +RLG
Sbjct: 201 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCG 258
Query: 406 -KGADEIKVHPWFDGVDW 422
ADEIK HP+F ++W
Sbjct: 259 PSDADEIKKHPFFQKINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 2e-52
Identities = 119/367 (32%), Positives = 184/367 (50%), Gaps = 55/367 (14%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + R K YA+K L+K +L++ + +H+ +ERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ + LY +++Y+ GG++ L R+ E ARFY AE A+ +H + ++RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK N T
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK-----------------------ENIEHNGTTST--- 155
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS +
Sbjct: 156 ---------------FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-DEIKVHPWFDG 419
I+N LK ++ A+ L+ LL + +RLGAK EIK H +F
Sbjct: 201 TAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256
Query: 420 VDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN--- 474
++W + ++ F P V+ D ++F+ E ++ S P ++++
Sbjct: 257 INWDDLINKKITPPFNPNVSGPNDLRHFDP-EFTEEPVPNSIGQSPDSILVTASVKEAAE 315
Query: 475 -FVGYTY 480
F+G++Y
Sbjct: 316 AFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-51
Identities = 108/329 (32%), Positives = 166/329 (50%), Gaps = 51/329 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K G +A+K LKK +L VE E+ +LA N + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC+FQ E L+ +ME+L GGD+M + K A FY AE V ++ +H I+RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN++LD+ GH++++DFG+CK N+ G ++
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK---------------ENVFGDNR-------------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
A + GTPDYIAPE+L Y DWWS G ++YEML+G PF+ DD
Sbjct: 153 ------------ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGV 420
I H +P ++ E+KD++ KL + +RLG G I+ HP+F +
Sbjct: 201 EDELFESIRVDTPH--YPRW--ITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTI 254
Query: 421 DWARI--YQMEAAFIPEVNDELDTQNFEK 447
+W + +++ F P+V D NF++
Sbjct: 255 NWTALEKRELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 1e-51
Identities = 103/322 (31%), Positives = 158/322 (49%), Gaps = 55/322 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV C+ K TG +YA KKL K + +R + E+ +L +V S IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRD 241
+F+ + L L+M + GGD+ + E A FY A+ + +E +H+ ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD +G++R+SD GL + G + G
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA----------VELKGGKKIKGR---------------- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GTP Y+APEVL + Y DW++LG +YEM+ G PF
Sbjct: 155 ----------------AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF-RQR 197
Query: 362 PMSTCRKIVNWRT---HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG--ADEIKVHP 415
++ + RT +++P+ K S EAKDL LL + +RLG +G ADE++ HP
Sbjct: 198 KEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255
Query: 416 WFDGVDWARIY--QMEAAFIPE 435
F ++W R+ +E FIP+
Sbjct: 256 LFKDLNWRRLEAGMLEPPFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 5e-49
Identities = 103/341 (30%), Positives = 170/341 (49%), Gaps = 59/341 (17%)
Query: 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVK 180
+IG+G++ +V + K T +YAMK +KK + ++ V+ E+++ ++ +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ FQ + L+ ++E++ GGD+M + R+ L E+ ARFY AE LA+ +H+ I+R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+K DN+LLD GH++L+D+G+CK ++ D T
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTT----------------------- 153
Query: 301 EQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF-- 357
ST GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 154 ---------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
Query: 358 --YSDDPMSTCRKI---VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GA 408
SD+P V ++ P LS++A ++ L + +RLG G
Sbjct: 199 VGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGF 256
Query: 409 DEIKVHPWFDGVDWARIYQMEAA--FIPEVNDELDTQNFEK 447
+IK HP+F +DW + Q + + P + + D NF+
Sbjct: 257 RDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 105/338 (31%), Positives = 176/338 (52%), Gaps = 52/338 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA D
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 177 -CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E +A FY AE + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK + ++G
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------HMVDG----------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ + GTPDYIAPE++ + YG DWW+ G ++YEML G P
Sbjct: 156 ----------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNV-NQRLGA--KGADEIK 412
PF +D + I+ ++ +P+ LS EA + L+ ++RLG +G +I+
Sbjct: 200 PFDGEDEDELFQSIM--EHNVSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIR 255
Query: 413 VHPWFDGVDWARI--YQMEAAFIPEVNDELDTQNFEKF 448
H +F +DW ++ +++ F P+V + +NF+KF
Sbjct: 256 EHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-46
Identities = 103/338 (30%), Positives = 170/338 (50%), Gaps = 52/338 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDS 175
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK N +G +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------NMWDGVTTK------- 159
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ GTPDYIAPE++ + YG DWW+ G ++YEML G
Sbjct: 160 --------------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIK 412
PF +D + I+ ++ +P+ +S EA + L+ + +RLG +G +IK
Sbjct: 200 PFEGEDEDELFQSIM--EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 255
Query: 413 VHPWFDGVDWARI--YQMEAAFIPEVNDELDTQNFEKF 448
H +F +DW ++ +++ + P+ D +NF+KF
Sbjct: 256 EHAFFRYIDWEKLERKEVQPPYKPKACGR-DAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 104/336 (30%), Positives = 173/336 (51%), Gaps = 55/336 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
+IG+G++ +V + R K +YAMK +KK + ++ V+ E+++ + SN +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ L+L++EY+ GGD+M + R+ L E+ ARFY AE +A+ +H+ I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++L+D+G+CK P T
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK-----------------------EGLGPGDTTST--- 155
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF--YS 359
GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF +
Sbjct: 156 ---------------FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200
Query: 360 DDP-MSTCRKI--VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIK 412
D+P M+T + V ++ P LS++A ++ L + +RLG + G +IK
Sbjct: 201 DNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIK 258
Query: 413 VHPWFDGVDWARIYQMEAA--FIPEVNDELDTQNFE 446
H +F +DW + + + F P++ D+ +NF+
Sbjct: 259 SHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFD 294
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 2e-46
Identities = 85/302 (28%), Positives = 136/302 (45%), Gaps = 49/302 (16%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+++L +IG+GAFG V TG A+K++ + ++ ++ + E +LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IVK S + + LY+I+EY G + ++ + E YV + + + +H+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK N+L K G ++L+DFG+ LN S+++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA----------------TKLNDVSKDDA------ 157
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
S VGTP ++APEV+ G D WSLG + E+L G PP
Sbjct: 158 -------------------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
+Y +PM+ +IV H PE S E KD + + + N R AK ++ HP
Sbjct: 199 YYDLNPMAALFRIVQ-DDHPPLPEGI--SPELKDFLMQCFQKDPNLRPTAK---QLLKHP 252
Query: 416 WF 417
W
Sbjct: 253 WI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 51/302 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
++ L IG+GA GEV ++ TG A+KK++ LR+ E + E ++ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHH 236
IV Y S+ + L+++MEY+ GG + ++ + + E + + E + +E +H +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK DN+LL K G ++L+DFG L K
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT------------------------KEKSK 172
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
R S VGTP ++APEV+ +K YG + D WSLG + EM G PP
Sbjct: 173 RN-----------------SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
+ + P+ I K S E KD ++K L + +R A+E+ HP
Sbjct: 216 YLREPPLRALFLITTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKR---PSAEELLQHP 271
Query: 416 WF 417
+
Sbjct: 272 FL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 98/328 (29%), Positives = 154/328 (46%), Gaps = 62/328 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E+ A FY AE +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD YGH+R+SD GL + E
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEI--------------------PEGET---- 157
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ R VGT Y+APEV+ + Y DWW LG ++YEM+ G
Sbjct: 158 -----------IRGR-------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 356 PFYSDDPMSTCRKIVNW----RTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAK-- 406
PF ++ V R + EE K S A+ + +LL + RLG +
Sbjct: 200 PFRQR------KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGE 253
Query: 407 GADEIKVHPWFDGVDWARIYQMEAAFIP 434
GA+E+K HP+F ++ R +EA +
Sbjct: 254 GAEEVKAHPFFRTANFKR---LEAGMLE 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 161 bits (408), Expect = 5e-45
Identities = 105/338 (31%), Positives = 171/338 (50%), Gaps = 57/338 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
+IG+G++ +V + R K T +YAMK +KK + ++ V+ E+++ + ++ +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ + L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA+ +H+ I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++L+D+G+CK L+ D T
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTT------------------------ 153
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF---- 357
+ GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 154 -------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
Query: 358 YSDDPMSTCRKI---VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADE 410
SD+P V ++ P LS++A ++ L + +RLG G +
Sbjct: 201 SSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFAD 258
Query: 411 IKVHPWFDGVDWARIYQMEAA--FIPEVNDELDTQNFE 446
I+ HP+F VDW + Q + F P ++ E NF+
Sbjct: 259 IQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFD 296
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 161 bits (407), Expect = 2e-44
Identities = 103/328 (31%), Positives = 148/328 (45%), Gaps = 58/328 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS- 175
+ +L +G+G+FGEV + R++ + A+K L K + +VE E +LA ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESI 232
IVKLY FQD+ LYL+MEY+ GG + LL RK L+E EA F +A+ + A+E +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 233 HKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
H IHRDIKP+N+LLD+ G ++L DFGL K L
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI---------------- 161
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMY 348
L ++VGTP Y+APEVLL D WSLG +Y
Sbjct: 162 -------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE---------EAKLSIEAKDLISKLL-CN 398
E+L G PPF + S + + L P +S A DL+ KLL +
Sbjct: 203 ELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD 262
Query: 399 VNQRLGAKGA--DEIKVHPWFDGVDWAR 424
RL + ++ H D +
Sbjct: 263 PKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 5e-44
Identities = 103/315 (32%), Positives = 160/315 (50%), Gaps = 57/315 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NC--IV 179
+IG+G FGEV CR+ TG +YAMK L K + + ER +L+ V + +C IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
+ +F + L I++ + GGD+ L + +E E RFY AE +L +E +H ++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+KP N+LLD++GH+R+SD GL C DF+ ++P A
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----C------DFS-----------KKKPHA----- 154
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPF- 357
+VGT Y+APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 155 -----------------SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
Query: 358 --YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEIK 412
+ D R + ++ P+ S E + L+ LL +VN+RLG +GA E+K
Sbjct: 198 QHKTKDKHEIDRMTLT--MAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253
Query: 413 VHPWFDGVDWARIYQ 427
HP+F +DW ++
Sbjct: 254 EHPFFRSLDWQMVFL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 91/290 (31%), Positives = 137/290 (47%), Gaps = 50/290 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DFE+L IGKG+FG V K VYAMK++ S+M RR + E + E +LA++DS+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEA-RFYVAETVLAIESIH 233
I++ Y SF D L ++MEY GD+ LL R L ED+ RF++ + +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+HRDIK NL LD Y ++++ D G+ K L +T
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---------------------- 156
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
A + VGTP Y++PE+ K Y + D W+LG ++YE G
Sbjct: 157 -------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
PF +++ + KI+ P S + LI + L + QR
Sbjct: 198 KHPFDANNQGALILKIIRGVFP---PVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 4e-42
Identities = 94/320 (29%), Positives = 149/320 (46%), Gaps = 55/320 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV C+ + TG +YA KKL K + +R E E+ +LA+V S IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT----LTEDEARFYVAETVLAIESIHKHHYIH 239
+FQ L L+M + GGD+ + D E A FY A+ + +E +H+ I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+KP+N+LLD G++R+SD GL L Q+ + A
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELK-----------------DGQSKTKGYA----- 158
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
GTP ++APE+L + Y D+++LG +YEM+ PF +
Sbjct: 159 -------------------GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199
Query: 360 DDPMSTCRKIVNWRTH--LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA--DEIKVH 414
+++ + + +P+ K S +K LL + +RLG + D ++ H
Sbjct: 200 RGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257
Query: 415 PWFDGVDWARIYQMEAAFIP 434
P F ++W Q+EA +P
Sbjct: 258 PLFRDLNWR---QLEAGMLP 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 8e-41
Identities = 103/315 (32%), Positives = 167/315 (53%), Gaps = 59/315 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVDS-NC--I 178
+IG+G FGEV CR+ TG +YAMK L K + +++G+ + ER +L+ V + +C I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIMLSLVSTGDCPFI 59
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
V + +F + L I++ + GGD+ L + +E E RFY E +L +E +H +
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
+RD+KP N+LLD++GH+R+SD GL C DF+ ++P
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA----C------DFS-----------KKKP------ 152
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPF 357
+++VGT Y+APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 153 ----------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
Query: 358 Y---SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEI 411
+ D R + +++ P+ S E K L+ LL +V++RLG +GA E+
Sbjct: 197 RQHKTKDKHEIDRMTLT--VNVELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEV 252
Query: 412 KVHPWFDGVDWARIY 426
K H +F G+DW ++Y
Sbjct: 253 KEHVFFKGIDWQQVY 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 89/307 (28%), Positives = 139/307 (45%), Gaps = 58/307 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ F++L +G+G++G V K TG V A+K + + ++ + E ++L + DS
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PV--EEDLQEIIKEISILKQCDS 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
IVK Y S+ + L+++MEY G D+M + TLTE+E + +T+ +E +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + IHRDIK N+LL++ G +L+DFG+
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGV------------------------------ 145
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
QL R + +GTP ++APEV+ + GY + D WSLG EM
Sbjct: 146 -------SGQLTDTMAKRN----TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE 194
Query: 353 GYPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410
G PP+ PM I N L PE K S E D + K L + +R A +
Sbjct: 195 GKPPYSDIHPMRAIFMIPNKPPPTLSDPE--KWSPEFNDFVKKCLVKDPEERPSAI---Q 249
Query: 411 IKVHPWF 417
+ HP+
Sbjct: 250 LLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-40
Identities = 98/325 (30%), Positives = 160/325 (49%), Gaps = 49/325 (15%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA K+L+K + +R E+ +L +V+S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E+ A FY AE + +E +H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ ++RD+KP+N+LLD YGH+R+SD GL A
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGL-------------------------------AV 150
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K + E ++ VGT Y+APEVL + Y + D+W LG ++YEM+ G
Sbjct: 151 KIPEGESIR-----------GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIK 412
PF ++ + AK S EAK + LL + QRLG + GA E+K
Sbjct: 200 PFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK 259
Query: 413 VHPWFDGVDWARIYQ--MEAAFIPE 435
HP+F +++ R+ ++ F+P+
Sbjct: 260 RHPFFRNMNFKRLEAGMLDPPFVPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 1e-40
Identities = 103/327 (31%), Positives = 160/327 (48%), Gaps = 53/327 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M + E A FY AE +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD +GH+R+SD GL + + TI
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHV------PEGQTI----------------- 158
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K R VGT Y+APEV+ + Y DWW+LG ++YEM+ G
Sbjct: 159 ------------KGR-------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKG--ADE 410
PF R+ V R + EE K S +A+ L LLC + +RLG +G A E
Sbjct: 200 PF-QQRKKKIKREEVE-RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGARE 257
Query: 411 IKVHPWFDGVDWARIYQ--MEAAFIPE 435
+K HP F +++ R+ +E F P+
Sbjct: 258 VKEHPLFKQINFKRLEAGMLEPPFKPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 65/149 (43%), Positives = 99/149 (66%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++F ++ I +GAFG+V + R+K +YA+K +KK++M+ + V V+AER+ LA S
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV LY S Q +YL+MEYL GGD+ +LL E+ A Y++E LA++ +H+H
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
IHRD+KPDN+L+ GH++L+DFGL K
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 4e-39
Identities = 79/307 (25%), Positives = 130/307 (42%), Gaps = 55/307 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVD 174
D E + ++G+G+ G V R K TG +YA+KK+ + R Q+ E L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCE 57
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH- 233
S +VK Y +F + + +++EY+ GG + LL + + E + + + ++ +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
K H IHRDIKP NLL++ G ++++DFG+ K L+ + Q F
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF----------------- 160
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
VGT Y++PE + + Y D WSLG + E +G
Sbjct: 161 ------------------------VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196
Query: 354 YPPFYSD---DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
PF + I + + S E +D IS L + +R A
Sbjct: 197 KFPFLPPGQPSFFELMQAICD--GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAA--- 251
Query: 410 EIKVHPW 416
E+ HP+
Sbjct: 252 ELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 98/326 (30%), Positives = 152/326 (46%), Gaps = 51/326 (15%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E A FY AE +E + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD GH+R+SD GL
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAV------------------------------- 150
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
Q+ + R VGT Y+APEV+ + Y DWW LG ++YEM+ G
Sbjct: 151 ------QIPEGETVR-----GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEA-KLSIEAKDLISKLLC-NVNQRLGAK--GADEI 411
PF R+ V+ R E + K S +AK + LL N +RLG + GA +
Sbjct: 200 PFRKRKE-RVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258
Query: 412 KVHPWFDGVDWARIYQ--MEAAFIPE 435
K HP F +++ R+ +E F P+
Sbjct: 259 KQHPIFKNINFKRLEANMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 2e-38
Identities = 98/308 (31%), Positives = 138/308 (44%), Gaps = 62/308 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAEV 173
+ F LL IGKG+FGEV +K T V A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
S I K Y SF L++IMEY GG + LL + L E F + E +L +E +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRDIK N+LL + G ++L+DFG+ S
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGV------SG----------------------- 146
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
QL R + VGTP ++APEV+ + GY + D WSLG E+ G
Sbjct: 147 --------QLTSTMSKRN----TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
Query: 354 YPPFYSD-DPMSTCRKIVNWRTHLKFP---EEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
PP SD PM I P E K S KD +S L + +R AK
Sbjct: 195 EPP-LSDLHPMRVLFLIPK-----NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAK-- 246
Query: 409 DEIKVHPW 416
E+ H +
Sbjct: 247 -ELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-38
Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G+GAFG V +C + TG A+K++ + +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
Y +DDE L + MEY+PGG + L LTE R Y + + +E +H + +HR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L D G+++L DFG K L TI ++ G
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQ---------TICSSGTGMK-------------- 165
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
S GTP +++PEV+ +GYG + D WS+G + EML PP+
Sbjct: 166 ---------------SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
Query: 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+ M+ KI T+ + P +S +A++ + + N +R A+E+ H +
Sbjct: 211 EAMAAIFKIATQPTNPQLPSH--VSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-36
Identities = 94/330 (28%), Positives = 142/330 (43%), Gaps = 78/330 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDSN 176
+E L +G+G +G V R+K TG + A+KK++ + G +R E +LL E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKELKHP 58
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKH 235
IVKL + LYL+ EY D+ L R L+ + + + + + + H H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP N+L+++ G L+L+DFGL + F I P
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARA----------FGI----------------P 151
Query: 296 KRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
RT Y+ V T Y APE+LL K Y D WS+G I EM+ G
Sbjct: 152 LRT----------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
Query: 354 YPPFYSDDPMSTCRKI------------------VNWRTHL-KFPEEAKLSI------EA 388
P F D + KI +++ KFP + + E
Sbjct: 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG 255
Query: 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
DL+SK+L N +R+ AK A + HP+F
Sbjct: 256 IDLLSKMLQYNPAKRISAKEALK---HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 53/298 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G G+FG V G +A+K L + V+ + E LL+++ IV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
+ ++++ LY+ +E +PGG + LL + + E R Y + +L +E +H + +HR
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L+D G ++L+DFG+ K + E F
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAK-----QVVEFSF------------------------ 157
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPFYS 359
A S G+P ++APEV+ ++G YG+ D WSLG + EM G PP+
Sbjct: 158 -------------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAK--GADEIKVHP 415
+ ++ KI + P+ LS EAKD I K L QR + A E+ HP
Sbjct: 205 LEGVAAVFKIGRSKELPPIPDH--LSDEAKDFILKCL----QRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 72/253 (28%), Positives = 116/253 (45%), Gaps = 53/253 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D+E+L IGKG+FG VR R K+ G + K++ M + + + + +E N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 177 CIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIE 230
IV+ Y D ++ LY++MEY GGD+ L+ + + + E+ + + +LA+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 231 SIH-----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
H + +HRD+KP N+ LD +++L DFGL K L
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG------------------ 161
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ A + VGTP Y++PE L Y + D WSLG
Sbjct: 162 -----------------------HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198
Query: 346 IMYEMLVGYPPFY 358
++YE+ PPF
Sbjct: 199 LIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 81/305 (26%), Positives = 123/305 (40%), Gaps = 61/305 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG G FG+V TG + A+K+++ + ++ + E +L + +VK Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
E +Y+ MEY GG + LL L E R Y + + + +H H +HRDIK
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P N+ LD G ++L DFG L T E++
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKL--------------------------KNNTTTMGEEV 160
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
Q GTP Y+APEV+ KG+G D WSLG ++ EM G P+
Sbjct: 161 QSL-----------AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
Query: 361 DPMSTCRKIVNWRTHLK--------FPEEAKLSIEAKDLISK-LLCNVNQRLGAKGADEI 411
D ++ P+ +LS E KD + + L + +R A E+
Sbjct: 210 DN--------EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTAS---EL 258
Query: 412 KVHPW 416
HP+
Sbjct: 259 LQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 84/337 (24%), Positives = 125/337 (37%), Gaps = 88/337 (26%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRA-ERNLLAEV 173
+++L IG+GA G V +++ TG A+KK+ LRR G + + E L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQAC 56
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
+VKL F L+MEY+P L + L E + + Y+ + + +H
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +HRD+KP NLL+ G L+++DFGL + E P
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFS---------------------EEEPR 155
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 352
V T Y APE+L + Y D W++G I E+L
Sbjct: 156 LY-------------------SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN 196
Query: 353 GYPPFYSD-DPMSTCR-----------------------KIV-------NWRTHLKFPEE 381
G P F + D KI FP+
Sbjct: 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI--FPDA 254
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
S EA DL+ LL + ++RL A E HP+F
Sbjct: 255 ---SPEALDLLKGLLVYDPSKRLSAA---EALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 91/318 (28%), Positives = 143/318 (44%), Gaps = 54/318 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV + K TG +YA KKL K + ++ + E+ +L +V+S IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR--FYVAETVLAIESIHKHHYIHRD 241
+F+ L L+M + GGD+ + + R Y A+ I +H ++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD G+ RLSD GL E TQ+
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV-------------------------ELKDGKTITQR- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GT Y+APE+L ++ Y DW+++G +YEM+ G PF D
Sbjct: 155 ----------------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF-KDH 197
Query: 362 PMSTCRKIVNWRT---HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-DEIKVHPW 416
++ + RT +KF E + E+KD+ L RLG++ D+ + H +
Sbjct: 198 KEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEF 256
Query: 417 FDGVDWARIYQMEAAFIP 434
F +++ R +EA IP
Sbjct: 257 FKTINFPR---LEAGLIP 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 8e-34
Identities = 80/315 (25%), Positives = 127/315 (40%), Gaps = 61/315 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DD+EL+ +IG GA V A+K++ + + V+ +R E +++ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+VK Y SF + L+L+M YL GG D+M + L E + E + +E +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFG----LCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H + IHRDIK N+LL + G ++++DFG L D + + F
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF------------ 166
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIM 347
VGTP ++APEV+ GY + D WS G
Sbjct: 167 -----------------------------VGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA---KLSIEAKDLISKLLCNVNQRLG 404
E+ G P+ PM + A K S + +IS L Q+
Sbjct: 198 IELATGAAPYSKYPPMKVLMLTLQ-NDPPSLETGADYKKYSKSFRKMISLCL----QKDP 252
Query: 405 AK--GADEIKVHPWF 417
+K A+E+ H +F
Sbjct: 253 SKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 87/305 (28%), Positives = 147/305 (48%), Gaps = 56/305 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+ IG+G+ G V + +K+TG A+KK+ + RR E + E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHP 76
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKH 235
IV++Y S+ + L+++ME+L GG +T ++ + E++ V VL A+ +H
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIA-TVCLAVLKALSFLHAQ 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK D++LL G ++LSDFG C +Q ++ P
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC----------------------AQVSKE--VP 170
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+R S VGTP ++APEV+ + YG E D WSLG ++ EM+ G P
Sbjct: 171 RRK-----------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
Query: 356 PFYSDDPMSTCRKIVNWRTHL--KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
P++++ P+ ++I R +L K K+S + + ++L + QR A E+
Sbjct: 214 PYFNEPPLQAMKRI---RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAA---ELL 267
Query: 413 VHPWF 417
HP+
Sbjct: 268 NHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 85/332 (25%), Positives = 139/332 (41%), Gaps = 77/332 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E + IG+G +G+V R K TG + A+KK++ + +R E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 178 IVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
IV+L +Y++ EY+ D+ LL + TE + + Y+ + + ++ +H
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ +HRDIK N+L++ G L+L+DFGL +P + D+T
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYT----------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVG 353
NR V T Y PE+LL YG E D WS+G I+ E+ +G
Sbjct: 160 --------------NR-------VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
Query: 354 YPPFYSDDPMSTCRKI-----------------VNWRTHLKFPEEAK----------LSI 386
P F + KI + W +LK + K +
Sbjct: 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDP 258
Query: 387 EAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
A DL+ KLL + +R+ A A + H +F
Sbjct: 259 SALDLLDKLLTLDPKKRISADQALQ---HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 87/330 (26%), Positives = 136/330 (41%), Gaps = 77/330 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
++ L IG+G +G V R+K TG + A+KK+K + A R LL E++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL F+ LYL+ E++ + R+ L E + Y+ + + + H H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP+NLL++ G L+L+DFGL + +P
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFG--------------------------SP 151
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354
R V T Y APE+LL KGY D WS+G I E+L
Sbjct: 152 VRPYTHY---------------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
Query: 355 PPFYSDDPMSTCRKI---------VNWR--------THLKFPEEAKLSIE---------A 388
P F + KI W FP++A + + A
Sbjct: 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQA 256
Query: 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
DL+S++L + ++R+ A+ A HP+F
Sbjct: 257 LDLLSQMLHYDPHKRITAEQALA---HPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 7e-31
Identities = 98/334 (29%), Positives = 143/334 (42%), Gaps = 82/334 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS---EMLRRGQVEHVRAERNLLAEVD 174
+E+L ++G+GA+G V CR K TG + A+KK K+S E +++ + V+ R L E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-- 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIH 233
N IV L +F+ LYL+ EY+ ++ LL L D R Y+ + + AI H
Sbjct: 61 -N-IVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
H+ IHRDIKP+N+L+ + G L+L DFG + L T
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP--ASPLT---------------- 159
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLV 352
V T Y APE+L+ YG D W++G IM E+L
Sbjct: 160 ----------------------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197
Query: 353 GYPPFYSD---DPMSTCRKIV-------------NWRTH-LKFPE-----------EAKL 384
G P F D D + +K + N R + FPE K+
Sbjct: 198 GEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKV 257
Query: 385 SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
S A D + L + +RL DE+ HP+F
Sbjct: 258 SSPALDFLKACLRMDPKERL---TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 71/252 (28%), Positives = 115/252 (45%), Gaps = 48/252 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D+EL+ IG G +G+V R+ TG + A+K +K E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV + S+ + L+++MEY GG + + + L+E + + ET+ + +H+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRDIK N+LL + G ++L+DFG+ L +T+
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIA---------------------- 156
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLGAIMYEML 351
KR S +GTP ++APEV K GY +CD W+LG E+
Sbjct: 157 -KRK-----------------SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198
Query: 352 VGYPPFYSDDPM 363
PP + PM
Sbjct: 199 ELQPPMFDLHPM 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 87/338 (25%), Positives = 138/338 (40%), Gaps = 93/338 (27%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-----SEMLRRGQVEHVRAERNLLAE 172
++++ +G G FG V + R K TG + A+KK+KK E + + V++ R L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEH 57
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVL 227
IVKL F++++ LY + EY+ G L LM+ +E R + + +
Sbjct: 58 P---NIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ IHKH + HRD+KP+NLL+ ++++DFGL + + +T
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----PPYT---------- 156
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAI 346
Y V T Y APE+LL+ Y D W+LG I
Sbjct: 157 --------------------------DY--VSTRWYRAPEILLRSTSYSSPVDIWALGCI 188
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIV---------NW--------RTHLKFPEEAKLSI--- 386
M E+ P F + KI +W + +FP+ A S+
Sbjct: 189 MAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQL 248
Query: 387 ------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
EA DLI +L + +R A + HP+F
Sbjct: 249 IPNASPEAIDLIKDMLRWDPKKRPTAS---QALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 71/260 (27%), Positives = 113/260 (43%), Gaps = 47/260 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+F++ IGKG F V G V A+KK++ EM+ + E +LL ++D
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIES 231
++K SF ++ L +++E GD+ ++ +K + E Y + A+E
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H +HRDIKP N+ + G ++L D GL + T
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 161 --------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200
Query: 352 VGYPPFYSD--DPMSTCRKI 369
PFY D + S C+KI
Sbjct: 201 ALQSPFYGDKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 62/245 (25%), Positives = 111/245 (45%), Gaps = 48/245 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF++L +GKG++G V + + YA+K++ M ++ + + V R +LA V+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIESI 232
I+ +F D L ++MEY P GD+ + ++ + E E + + ++++
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ +HRD+K N+LL +++ D G+ K L
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-------------------------- 153
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ +A + +GTP Y+APEV + Y + D WSLG ++YEM
Sbjct: 154 -----------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
Query: 353 GYPPF 357
PPF
Sbjct: 197 FAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 87/296 (29%), Positives = 141/296 (47%), Gaps = 52/296 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ E + E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS----- 173
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 174 ------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 364 STCRKI-VNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
I N L+ PE KLS +D +++ L +V +R AK E+ HP+
Sbjct: 222 RALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 93/322 (28%), Positives = 140/322 (43%), Gaps = 72/322 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
FEL+ +IG+G +G+V R K TG + A+K + + + E ++ E N+L +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 175 S--NCIVKLYCSF-------QDDEFLYLIMEYLPGG---DMM-TLLMRKDTLTEDEARFY 221
+ N I Y +F DD+ L+L+ME GG D++ L + L E+ +
Sbjct: 61 NHPN-IATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ ET+ + +H++ IHRDIK N+LL K ++L DFG+ LD STL ++
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-STLGRRN------ 171
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGM 336
+ +GTP ++APEV+ Y
Sbjct: 172 ----------------------------------TFIGTPYWMAPEVIACDEQPDASYDA 197
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV-NWRTHLKFPEEAKLSIEAKDLISKL 395
D WSLG E+ G PP PM KI N LK PE S + D IS+
Sbjct: 198 RSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE--NWSKKFNDFISEC 255
Query: 396 LC-NVNQRLGAKGADEIKVHPW 416
L N QR +E+ HP+
Sbjct: 256 LIKNYEQR---PFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 5e-29
Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 48/282 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E++ IG+G+FG++ + + K+ +K++ ++M + + E + E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKH 235
IV + SFQ++ L+++MEY GGD+M + R+ +ED+ + + L ++ IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 236 HYIHRDIKPDNLLLDKYGHL-RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRDIK N+ L K G + +L DFG+ + L+ S
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM------------------------ 156
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
LAY+ VGTP Y++PE+ + Y + D WSLG ++YE+
Sbjct: 157 -----------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
PF ++ KI P S + + LIS+L
Sbjct: 200 HPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSLISQLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-29
Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 48/250 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---D 174
++ L +IG+GA+G V + TG V A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I K Y S+ L++IMEY GG + TL M+ + E + E ++A++ IHK
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRDIK N+L+ G+++L DFG+ L+ ++ + F
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF------------------ 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
VGTP ++APEV+ + K Y + D WSLG +YEM G
Sbjct: 162 -----------------------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
Query: 354 YPPFYSDDPM 363
PP+ D
Sbjct: 199 NPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 87/295 (29%), Positives = 142/295 (48%), Gaps = 50/295 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + REK +G A+K + + RR E + E ++ + +V++Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHQNVVEMYK 85
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKHHYIHRDI 242
S+ E L+++ME+L GG +T ++ + L E++ V E+VL A+ +H IHRDI
Sbjct: 86 SYLVGEELWVLMEFLQGG-ALTDIVSQTRLNEEQIA-TVCESVLQALCYLHSQGVIHRDI 143
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K D++LL G ++LSDFG C + PKR
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS------------------------KDVPKRK---- 175
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
S VGTP ++APEV+ + YG E D WSLG ++ EM+ G PP++SD P
Sbjct: 176 -------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
Query: 363 MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417
+ +++ + K K+S +D + ++L + A E+ HP+
Sbjct: 223 VQAMKRLRD-SPPPKLKNAHKISPVLRDFLERML--TREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 64/297 (21%)
Query: 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV--DSNCIVKLYCS 184
G FG+V V + K T ++ K +K ++ A ++ ++ D+ +KLY S
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKA---------KNFNAIEPMVHQLMKDNPNFIKLYYS 77
Query: 185 FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244
+ LIM+Y+ GD+ LL ++ L+E E + + + V A+ +HKH+ IH DIK
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137
Query: 245 DNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
+N+L D+ + L D+GLCK + + +
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------------------------------ 167
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF--YSDD 361
GT DY +PE + Y + DWW++G + YE+L G PF D+
Sbjct: 168 ---------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+ + + R K P +S A D + +L N+N RL +EI HP+
Sbjct: 213 ELDL--ESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRL--TNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 9e-28
Identities = 84/298 (28%), Positives = 133/298 (44%), Gaps = 47/298 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G+GAFG V +C + TG A K+++ +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 181 LYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
Y +D ++ L + MEY+PGG + L LTE R Y + + + +H + +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIK N+L D G+++L DFG K L TI + G
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQ---------TICMSGTGIR------------ 167
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
S GTP +++PEV+ +GYG + D WSLG + EML PP+
Sbjct: 168 -----------------SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
+ M+ KI T+ + P + +S A+D + + R A+E+ HP+
Sbjct: 211 EYEAMAAIFKIATQPTNPQLP--SHISEHARDFLGCIFVEARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 65/237 (27%), Positives = 113/237 (47%), Gaps = 46/237 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E + ++G+GAFG V +CR K + +K++ +M + + + E +L +
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAETVLAIESIHKH 235
I++ Y +F +D+ L ++MEY PGG + + L ED + + +LA+ +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 236 HYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+K N+LLDK+ +++ DFG+ K L SS++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL------------------SSKSK----- 157
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
AY+ VGTP YI+PE+ K Y + D W+LG ++YE+
Sbjct: 158 -------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 90/338 (26%), Positives = 138/338 (40%), Gaps = 92/338 (27%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-----------LRRGQVEHVRAE 166
+E +G+G + V R+K TG + A+KK+K E LR E
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR---------E 52
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAET 225
LL E+ I+ L F + L+ E++ D+ ++ K LT + + Y+ T
Sbjct: 53 IKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMT 111
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ +E +H + +HRD+KP+NLL+ G L+L+DFGL + F GS
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR----------SF-------GS 154
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLG 344
NR+M V T Y APE+L + YG+ D WS+G
Sbjct: 155 P----------------------NRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVG 190
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEAKLSI--------- 386
I E+L+ P D + KI NW P+ +
Sbjct: 191 CIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQI 250
Query: 387 ------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+A DL+ +LL N N+R+ A+ A E HP+F
Sbjct: 251 FPAASDDALDLLQRLLTLNPNKRITARQALE---HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 52/282 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERNLLAEVDS 175
+IGKG +G V + TTG + A+K+++ + + ++ V+ +R+E L ++D
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 176 NCIVKLYCSFQDDEFLYLI-MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV+ Y F+ E I +EY+PGG + + L E RF+ + + + +H
Sbjct: 68 LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+K DNLL+D G ++SDFG+ K D ++ + QN
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSD-------------DIYDNDQNM----- 168
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV--LLKKGYGMECDWWSLGAIMYEMLV 352
S G+ ++APEV +GY + D WSLG ++ EM
Sbjct: 169 ---------------------SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLI 392
G P+ ++ ++ K+ N R+ P + LS A D +
Sbjct: 208 GRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-27
Identities = 85/301 (28%), Positives = 138/301 (45%), Gaps = 48/301 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK------KSEMLRRGQVEHVRAERNLLAEVDSN 176
+IG G+FG V + ++G + A+K+++ S+ +R ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IV+ S D + L + +EY+PGG + LL E R +V + + + +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK N+L+D G +++SDFG+ K L+ N+L+ + N RP+
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLE-----------ANSLSTKT-NGARPS--- 171
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
LQ G+ ++APEV+ + Y + D WSLG ++ EML G P
Sbjct: 172 ------LQ--------------GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHP 415
F + KI + P S EA D + K + N+R A E+ HP
Sbjct: 212 FPDCTQLQAIFKI-GENASPEIPSNI--SSEAIDFLEKTFEIDHNKR---PTAAELLKHP 265
Query: 416 W 416
+
Sbjct: 266 F 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 83/302 (27%), Positives = 135/302 (44%), Gaps = 47/302 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVD 174
++ L ++G+GAFG V +C + TG A+K+++ +V + E LL +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 175 SNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
IV+ Y +D + L + ME++PGG + L LTE+ R Y + + + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + +HRDIK N+L D G+++L DFG K L TI L+G+
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ---------TIC--LSGTGMK---- 167
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
S GTP +++PEV+ +GYG + D WS+G + EML
Sbjct: 168 -----------------------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIK 412
PP+ + M+ KI T+ P +S +D + ++ R ADE+
Sbjct: 205 EKPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLR---PSADELL 259
Query: 413 VH 414
H
Sbjct: 260 RH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 73/246 (29%), Positives = 118/246 (47%), Gaps = 45/246 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + EK TG A+KK+ + RR E + E ++ + +V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHENVVDMYN 86
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++ME+L GG +T ++ + E++ + A+ +H IHRDIK
Sbjct: 87 SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
D++LL G ++LSDFG C + PKR
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVS------------------------KEVPKRK----- 176
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
S VGTP ++APEV+ + YG E D WSLG ++ EM+ G PP++++ P+
Sbjct: 177 ------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224
Query: 364 STCRKI 369
R+I
Sbjct: 225 QAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 57/131 (43%), Positives = 78/131 (59%), Gaps = 7/131 (5%)
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK 377
+GTPDY+APE+LL K +G DWW+LG ++E L G PPF + P + I+N +
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN--RDIP 598
Query: 378 FPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435
+PE E KLS+ A++ I LL + +R G K E+K HP F GVDW + FIP+
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLK---ELKQHPLFHGVDWENLQNQTMPFIPQ 655
Query: 436 VNDELDTQNFE 446
+DE DT FE
Sbjct: 656 PDDETDTSYFE 666
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 80/302 (26%), Positives = 129/302 (42%), Gaps = 48/302 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAEVDSNCIV 179
+G GAF R+ TG + A+K++ Q VE +R E L+A ++ I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
++ + +D L +E++ GG + LL + E Y + + + +H++ IH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 240 RDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
RD+K NLL+D G LR++DFG L +F
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF---------------------- 164
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
Q QL +GT ++APEVL + YG CD WS+G ++ EM PP+
Sbjct: 165 -QGQL--------------LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
Query: 359 SD---DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
++ + ++ KI + T PE LS +D+ L C Q + E+ HP
Sbjct: 210 AEKHSNHLALIFKIASATTAPSIPEH--LSPGLRDVT--LRCLELQPEDRPPSRELLKHP 265
Query: 416 WF 417
F
Sbjct: 266 VF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 76/283 (26%), Positives = 123/283 (43%), Gaps = 51/283 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ + ++GKGAFGE + R + K++ + + + + E +L+ +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDE-ARFYVAETVLAIESIHKH 235
I+ Y F DD L + MEY GG + ++R K L E+E +Y+ + V A+ IHK
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+ L K G ++L DFG+ K L
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS------------------------ 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+A + VGTP Y++PE+ Y + D W+LG ++YE+L
Sbjct: 157 -----------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
Query: 356 PFYSDDPMSTCRKIV--NWRTHLKFPEEAKLSIEAKDLISKLL 396
F + +P++ KIV N+ P + S E L+ LL
Sbjct: 200 TFDATNPLNLVVKIVQGNYT-----PVVSVYSSELISLVHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 74/245 (30%), Positives = 107/245 (43%), Gaps = 49/245 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ +L ++G+G+FG + + + YAMK +L KS VE R E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDTLTEDEARFYVAETVLAIESI 232
IV SF+ D LY++MEY GGD+M L R ED + + L ++ I
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ +HRDIK N+ L + G ++L DFG + L P
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-----------------------TSP 153
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A A + VGTP Y+ PE+ Y + D WSLG I+YE+
Sbjct: 154 GA------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
Query: 353 GYPPF 357
PF
Sbjct: 196 LKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 9e-26
Identities = 92/301 (30%), Positives = 145/301 (48%), Gaps = 62/301 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ + E + E ++ E+ + IV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTE---DEARFYVA--ETVLAIESIHKHHYI 238
SF + L+++MEYL GG + D +TE DEA+ E + A+E +H + I
Sbjct: 84 SFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEFLHANQVI 137
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIK DN+LL G ++L+DFG C + P KR+
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS 173
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+
Sbjct: 174 -----------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
Query: 359 SDDPMSTCRKI-VNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPW 416
+++P+ I N L+ PE KLS +D +++ L +V +R AK E+ HP+
Sbjct: 217 NENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMDVEKRGSAK---ELLQHPF 271
Query: 417 F 417
Sbjct: 272 L 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 85/296 (28%), Positives = 143/296 (48%), Gaps = 52/296 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ E + E ++ E + IV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A++ +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS----- 173
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 174 ------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 364 STCRKI-VNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
I N L+ PE +LS +D +++ L +V++R AK E+ HP+
Sbjct: 222 RALYLIATNGTPELQNPE--RLSAVFRDFLNRCLEMDVDRRGSAK---ELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 82/342 (23%), Positives = 128/342 (37%), Gaps = 97/342 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--------MLRRGQVEHVRAERNL 169
+E L IG+GA+G V R+ TG A+KK++ LR E L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR---------EIAL 51
Query: 170 LAEVDS-NC--IVKLY--CSFQDDE---FLYLIMEYLPGGDMMTLLMR--KDTLTEDEAR 219
L +++S IV+L C + L L+ E++ D+ T L + K L + +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK 110
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
+ + + ++ +H H +HRD+KP N+L+ G ++++DFGL +
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS------------ 158
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339
M S V T Y APEVLL+ Y D
Sbjct: 159 ------------------------------FEMALTSVVVTLWYRAPEVLLQSSYATPVD 188
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKI-----------------VNWRT-HLKFPEE 381
WS+G I E+ P F KI + + P
Sbjct: 189 MWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRS 248
Query: 382 AK-----LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
K + E DL+ K+L N ++R+ A A HP+F
Sbjct: 249 FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA---LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 81/277 (29%), Positives = 124/277 (44%), Gaps = 53/277 (19%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG +G V R+ +T A+K++ + + R Q H E L + + IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLH--EEIALHSYLKHRNIVQYL 71
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIH 239
S ++ F + ME +PGG + LL K E FY + + ++ +H + +H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 240 RDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
RDIK DN+L++ Y G +++SDFG K L + FT
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--------------------- 170
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 356
GT Y+APEV+ K +GYG D WSLG + EM G PP
Sbjct: 171 --------------------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 357 FYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLI 392
F +P + K+ ++ H + PE LS EAK+ I
Sbjct: 211 FIELGEPQAAMFKVGMFKIHPEIPES--LSAEAKNFI 245
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 81/298 (27%), Positives = 135/298 (45%), Gaps = 44/298 (14%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLR-RGQVEHVRAERNLLAEVDSNCIV 179
++GKGA+G V C G + A+K+ L S +L + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
+ + DD + + ME++PGG + ++L R L E Y + + + +H + +H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RDIK +N++L G ++L DFG + L L+G+ N
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWV-----------GLHGTHSN----------- 163
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
ML S GTP ++APEV+ + GYG + D WS+G ++EM G PP S
Sbjct: 164 ------------MLK-SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
Query: 360 DDPMSTCRKIVNWRTHL-KFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
D ++ I R + + P+ S A D ++ C + A ++ H +
Sbjct: 211 MDRLAAMFYIGAHRGLMPRLPD--SFSAAAIDFVT--SCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 4e-25
Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 44/236 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ + IG+G+FG+ + + K G Y +K++ S+M + + E R E +L+ +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+ SF+++ LY++M+Y GGD+ + R ED+ + + LA++ +H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+ L K G ++L DFG+ + L+ ST++
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVE----------------------- 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
LA + +GTP Y++PE+ + Y + D W+LG ++YEM
Sbjct: 157 -----------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 83/285 (29%), Positives = 136/285 (47%), Gaps = 49/285 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A++++ + ++ E + E ++ E + IV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 85 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRSTM--- 176
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 177 --------------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 364 STCRKI-VNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAK 406
I N L+ PE KLS +D +++ L +V +R AK
Sbjct: 223 RALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRGSAK 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 83/297 (27%), Positives = 143/297 (48%), Gaps = 54/297 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + K++G + A+KK+ + RR E + E ++ + +V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++ME+L GG +T ++ + E++ + A+ +H IHRDIK
Sbjct: 85 SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
D++LL G ++LSDFG C +Q ++ P+R
Sbjct: 144 SDSILLTHDGRVKLSDFGFC----------------------AQVSKE--VPRRK----- 174
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
S VGTP ++APE++ + YG E D WSLG ++ EM+ G PP++++ P+
Sbjct: 175 ------------SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
Query: 364 STCRKIVNWRTHL--KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+ I R +L K K+S K + +LL + QR A E+ HP+
Sbjct: 223 KAMKMI---RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR---ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 82/327 (25%), Positives = 128/327 (39%), Gaps = 84/327 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVD 174
DD E L +G G G V + TG + A+K + ++E A + +L E+D
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---------RLEINEAIQKQILRELD 51
Query: 175 ----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
N IV Y +F ++ + + MEY+ GG + +L + +A VL
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111
Query: 229 --IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
KH IHRD+KP N+L++ G ++L DFG+ L S
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----------------- 154
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
LA + VGT Y+APE + Y ++ D WSLG
Sbjct: 155 --------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLS 188
Query: 347 MYEMLVG-YP-PFYSDDPMST---CRKIVNWRTHLKFPEEA------KLSIEAKDLISKL 395
+ E+ G +P P +D P + IVN E K S + +D ++
Sbjct: 189 LIELATGRFPYPPENDPPDGIFELLQYIVN--------EPPPRLPSGKFSPDFQDFVNLC 240
Query: 396 LC-NVNQRLGAKGADEIKVHPWFDGVD 421
L + +R K E+ HP+ +
Sbjct: 241 LIKDPRERPSYK---ELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 44/246 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ K Y S+ L++IMEYL GG + LL R E + + E + ++ +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
Query: 358 YSDDPM 363
PM
Sbjct: 202 SDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 71/269 (26%), Positives = 120/269 (44%), Gaps = 58/269 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVY-AMKKLK-KSEMLRRGQVEHVRAERNLLAEVD- 174
+ +L +G GAFG V R+K G A+K++ + + + E ++ ++++EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 175 -------SNCIVKLYCSFQDDEFLYLIMEYLPGGDM----MTLLMRKDTLTEDEARFYVA 223
N IV+ Y +F +++ LY++M+ + G + +L +K TE+
Sbjct: 62 IKEQLRHPN-IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 224 ETVLAIESIHKHHYI-HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ VLA+ +HK I HRD+ P+N++L + + ++DFGL K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
QK S VGT Y PE++ + YG + D W+
Sbjct: 163 ------------------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWA 198
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVN 371
G I+Y+M PPFYS + +S KIV
Sbjct: 199 FGCILYQMCTLQPPFYSTNMLSLATKIVE 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 74/246 (30%), Positives = 112/246 (45%), Gaps = 44/246 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ K Y S+ D L++IMEYL GG + LL L E + + E + ++ +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL ++G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
Query: 358 YSDDPM 363
PM
Sbjct: 202 SELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 42/268 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL--KKSEMLRRGQVEHVRAERNLLAEVD 174
++ L ++G+GAFGEV +C + TG A+K++ +V + E LL +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 175 SNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ IV+ Y +D E L + +EY+PGG + L LTE+ R Y + + + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + +HRDIK N+L D G+++L DFG K + TI + G
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ---------TICMSGTGIK------ 167
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
S GTP +++PEV+ +GYG + D WS+ + EML
Sbjct: 168 -----------------------SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPE 380
PP+ + M+ KI T P+
Sbjct: 205 EKPPWAEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 44/246 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
I + Y S+ L++IMEYL GG + LL + L E + E + ++ +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
Query: 358 YSDDPM 363
PM
Sbjct: 202 SDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 86/338 (25%), Positives = 141/338 (41%), Gaps = 85/338 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++E L I +G +G V R+K TG + A+KKLK + + +R E N+L ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 176 NCIVKL----YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIE 230
IV + S D +Y++MEY+ D+ +L+ K + E + + + + +
Sbjct: 64 PNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H + +HRD+K NLLL+ G L++ DFGL
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLA--------------------------- 153
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYE 349
R L+ + + V T Y APE+LL K Y D WS+G I E
Sbjct: 154 ------REYGSPLKPYTQL--------VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAE 199
Query: 350 ML---------------------VGYP-----PFYSDDPMSTCRKIVN---WRTHLKFPE 380
+L +G P P +S+ P + + + KFP
Sbjct: 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFP- 258
Query: 381 EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
LS DL+++LL + +R+ A+ A + HP+F
Sbjct: 259 ALSLSDNGFDLLNRLLTYDPAKRISAEDALK---HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 80/312 (25%), Positives = 141/312 (45%), Gaps = 59/312 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
D +E++ +G GAFG+V + K TG A K +++ E ++E E ++L+E
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----ELEDFMVEIDILSE 58
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIES 231
IV LY ++ + L++++E+ GG + ++++ + LTE + R+ + + A+
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H H IHRD+K N+LL G ++L+DFG+ + STLQ++D
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGV-SAKNKSTLQKRD---------------- 161
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAI 346
+ +GTP ++APEV+ Y + D WSLG
Sbjct: 162 ------------------------TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGIT 197
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405
+ E+ PP + +PM KI+ + +K S D + L + + R
Sbjct: 198 LIELAQMEPPHHELNPMRVLLKILKSEPP-TLDQPSKWSSSFNDFLKSCLVKDPDDRP-- 254
Query: 406 KGADEIKVHPWF 417
A E+ HP+
Sbjct: 255 -TAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-23
Identities = 69/259 (26%), Positives = 112/259 (43%), Gaps = 47/259 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+F++ IG+G F EV A+KK++ EM+ + E +LL +++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESI 232
++K SF +D L +++E GD+ ++ +K + E Y + A+E +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ + G ++L D GL + T
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-------------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 163 ---------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
Query: 353 GYPPFYSD--DPMSTCRKI 369
PFY D + S C+KI
Sbjct: 202 LQSPFYGDKMNLFSLCQKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 88/343 (25%), Positives = 135/343 (39%), Gaps = 80/343 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
D+E+L +G+G FGEV R+ TG V A+KK+ M + A R +L ++
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILKKL 64
Query: 174 DSNCIVKLY---------CSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVA 223
+V L + Y++ Y+ D+ LL LTE + + Y+
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSV-YMVTPYM-DHDLSGLLENPSVKLTESQIKCYML 122
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ + I +H++H +HRDIK N+L+D G L+++DFGL +P D
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD---------------- 166
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY-STVGTPDYIAPEVLL-KKGYGMECDWW 341
G N + Y + V T Y PE+LL ++ Y D W
Sbjct: 167 GPPPNPKGGGGGGTR---------------KYTNLVVTRWYRPPELLLGERRYTTAVDIW 211
Query: 342 SLGAIMYEMLVGYPPFY------------------SDDPMSTCRKIVNWRTHLKFP---- 379
+G + EM P +++ R + F
Sbjct: 212 GIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR 271
Query: 380 --EE--AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
EE KL E DL+SKLL + +RL A A E HP+F
Sbjct: 272 TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE---HPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 92/340 (27%), Positives = 141/340 (41%), Gaps = 97/340 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNL 169
++ + IG+G +G V R+K TG + A+KK++ S +R E +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---------EISL 51
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMR---KDTLTEDEARFYVAET 225
L E++ IV+L + LYL+ E+L D+ + M L + Y+ +
Sbjct: 52 LKELNHPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ I H H +HRD+KP NLL+D+ G L+L+DFGL + F +
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA----------FGV------- 151
Query: 286 SQNNERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
P RT E + W Y APE+LL + Y D WS+
Sbjct: 152 ---------PVRTYTHEVVTLW----------------YRAPEILLGSRQYSTPVDIWSI 186
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKI---------VNWR--THL-----KFPEEAK---- 383
G I EM+ P F D + +I W T L FP+ A+
Sbjct: 187 GCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLS 246
Query: 384 -----LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L + DL+SK+L + +R+ AK A + HP+F
Sbjct: 247 KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 81/339 (23%), Positives = 134/339 (39%), Gaps = 81/339 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
+ELL IG GA+G V +K TG A+KK+ + ++ R R LL +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 176 NCIVKLYCSFQD---DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L + ++F +Y++ E + D+ ++ LT+D ++++ + + ++
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H + IHRD+KP N+L++ L++ DFGL + +D ++ T
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------------- 164
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349
V T Y APE+LL Y D WS+G I E
Sbjct: 165 -------------------------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAE 199
Query: 350 MLVGYPPF----Y----------------SDDPMSTCRKIVNWRTHLKFPEEAKL----- 384
+L P F Y D T K N+ L + L
Sbjct: 200 LLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP 259
Query: 385 --SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420
S EA DL+ K+L + +R+ A A HP+ +
Sbjct: 260 GASPEAIDLLEKMLVFDPKKRITADEALA---HPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 8e-23
Identities = 76/258 (29%), Positives = 120/258 (46%), Gaps = 44/258 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ FE+L ++G+GA+G V CR K T + A+KK K SE + +R E +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L +F+ LYL+ EY+ + L + + ++ R Y+ + + AI HK+
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIKP+NLL+ L+L DFG + L + G+N N +
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNL----------SEGSNANYTEY-------- 161
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
V T Y +PE+LL YG D WS+G I+ E+ G P
Sbjct: 162 ----------------------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199
Query: 356 PFYSD---DPMSTCRKIV 370
F + D + T +K++
Sbjct: 200 LFPGESEIDQLFTIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 53/299 (17%)
Query: 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHV 163
Y ++R + +E++ +G GAFG+V + K TG + A K ++ KSE ++E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDY 56
Query: 164 RAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYV 222
E +LA + IVKL +F D L++++E+ PGG + +++ D LTE + +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + A++ +H IHRD+K N+LL G ++L+DFG+ + TLQ +D
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRD------- 168
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGME 337
S +GTP ++APEV++ Y +
Sbjct: 169 ---------------------------------SFIGTPYWMAPEVVMCETMKDTPYDYK 195
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
D WSLG + EM PP + +PM KI + +K S+E +D + L
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKWSMEFRDFLKTAL 253
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 89/342 (26%), Positives = 143/342 (41%), Gaps = 102/342 (29%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAERNLLAEVD 174
+++L IG+G F EV + + TG YA+K +KK S QV ++R E L +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLR-EIQALRRLS 55
Query: 175 SNC-IVKLYCSFQDDEFLY--------LIMEYLPGGDM-MTLLM--RKDTLTEDEARFYV 222
+ I++L E L+ L+ E + DM + L+ RK L E + Y+
Sbjct: 56 PHPNILRL------IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYM 106
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + +++ +H++ HRDIKP+N+L+ L+L+DFG C + +T
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSC----RGIYSKPPYTE---- 157
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWW 341
Y + T Y APE LL G YG + D W
Sbjct: 158 --------------------------------Y--ISTRWYRAPECLLTDGYYGPKMDIW 183
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKI----------VNWRTH------LKFPEE---- 381
++G + +E+L +P F + + KI V + FP +
Sbjct: 184 AVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTG 243
Query: 382 -AKL----SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
KL S E DL+ KLL + ++R+ AK A HP+F
Sbjct: 244 LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR---HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 69/259 (26%), Positives = 112/259 (43%), Gaps = 47/259 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+F + IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESI 232
++K Y SF +D L +++E GD+ ++ +K + E Y + A+E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ + G ++L D GL + T
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-------------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 163 ---------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
Query: 353 GYPPFYSD--DPMSTCRKI 369
PFY D + S C+KI
Sbjct: 202 LQSPFYGDKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 73/258 (28%), Positives = 119/258 (46%), Gaps = 51/258 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAEVD 174
+E L ++G+G++G V C+ K TG + A+KK +SE M+++ + +R +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+V L F+ + LYL+ E++ + L + L E R Y+ + + IE H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H+ IHRDIKP+N+L+ + G ++L DFG + L AA
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL--------------------------AA 152
Query: 295 PKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 352
P Y+ V T Y APE+L+ YG D W++G ++ EML
Sbjct: 153 PGE----------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
Query: 353 GYPPFYSDDPMSTCRKIV 370
G P F D + I+
Sbjct: 197 GEPLFPGDSDIDQLYHII 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 92/340 (27%), Positives = 137/340 (40%), Gaps = 97/340 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSN 176
F+ + IG+G +G V R K TG V A+KK++ +E G E +LL E++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYL-----------PGGDMMTLLMRKDTLTEDEARFYVAET 225
IVKL + LYL+ E+L P + L++ Y+ +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YLFQL 109
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + H H +HRD+KP NLL++ G ++L+DFGL +
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------------------- 150
Query: 286 SQNNERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
P RT E + W Y APE+LL K Y D WSL
Sbjct: 151 -------GVPVRTYTHEVVTLW----------------YRAPEILLGCKYYSTAVDIWSL 187
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKI---------VNWR--THLK-----FPEEAK---- 383
G I EM+ F D + +I V W T L FP+ A+
Sbjct: 188 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFS 247
Query: 384 -----LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L + +DL+S++L + N+R+ AK A HP+F
Sbjct: 248 KVVPPLDEDGRDLLSQMLHYDPNKRISAKAA---LAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 2e-21
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 64/277 (23%)
Query: 118 FELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
EL +G+GAFGEV + E T V A+K LK+ + E E +++ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEE--EREEFLEEASIMKK 57
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAI 229
+ IV+L C+ E LY++ EY+PGGD++ L + LT + + +
Sbjct: 58 LSHPNIVRLLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
E + +++HRD+ N L+ + +++SDFGL + + E D
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR-----DIYEDD-------------- 156
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI-----APEVLLKKGYGMECDWWSLG 344
Y + APE L + + D WS G
Sbjct: 157 -------------------------YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 345 AIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPE 380
+++E+ +G P+ + + L PE
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLED-GYRLPRPE 227
|
Length = 258 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 4e-21
Identities = 70/281 (24%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+ ++GKG++GEV + R +T G Y +KKL RR + + E LL+++ IV
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIV 62
Query: 180 KLYCSFQ-DDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKHH 236
S++ +D LY++M + GGD+ L + L E++ + + +A++ +H+ H
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+K N+ L + +++ D G+ + L+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE----------------------------- 153
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
N+ +A + +GTP Y++PE+ K Y + D W+LG +YEM
Sbjct: 154 ------------NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397
F + D S +I+ + P S E +LI+ +L
Sbjct: 202 FNAKDMNSLVYRIIEGKLP---PMPKDYSPELGELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 49/252 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVD 174
+DFEL+ IG G +G+V R TG + A+K +K L G+ V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMKDCK 64
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ IV + S+ + L++ ME+ GG + + L+E + + ET+ + +H
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRDIK N+LL GH++L+DFG+ + + + + F
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF------------------ 166
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351
+GTP ++APEV K GY CD W++G E+
Sbjct: 167 -----------------------IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203
Query: 352 VGYPPFYSDDPM 363
PP + PM
Sbjct: 204 ELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 54/295 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL-KKSEMLRRGQVEHVRAERNLLAEVD 174
+ +E++ +G GAFG+V + K TG + A K + KSE ++E E ++LA D
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCD 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIH 233
IVKL +F + L++++E+ GG + +++ + LTE + R +T+ A+ +H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++ IHRD+K N+L G ++L+DFG+ + T+Q +D
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRD------------------ 161
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 348
S +GTP ++APEV++ + Y + D WSLG +
Sbjct: 162 ----------------------SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQR 402
EM PP + +PM KI + ++ S E KD + K L NV+ R
Sbjct: 200 EMAQIEPPHHELNPMRVLLKIAKSEPP-TLAQPSRWSSEFKDFLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 95/341 (27%), Positives = 137/341 (40%), Gaps = 84/341 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
D +E L IG+G +G+V R+K TG + A+KK + EM G E +LL + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 175 SNCIVKLYCSFQDDE-----FLYLIMEYLPGGDM---MTLLMRKDT--LTEDEARFYVAE 224
S IV+L +E LYL+ EYL D+ M R L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ + HKH +HRD+KP NLL+DK G L+++D GL + F+I
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----------AFSI----- 163
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWS 342
P K E + W Y APEVLL Y D WS
Sbjct: 164 --------PV--KSYTHEIVTLW----------------YRAPEVLLGSTHYSTPVDIWS 197
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIV------------------NWRTHLKFPEE--- 381
+G I EM P F D + I +W ++ +
Sbjct: 198 VGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLS 257
Query: 382 ---AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
LS E DL+ K+L + +R+ AK A HP+FD
Sbjct: 258 RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT---HPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 1e-20
Identities = 45/156 (28%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 119 ELLTMIGKGAFGEVRVCR-EKTTGHVY---AMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
L +G+GAFGEV + + G A+K LK+ Q+E E ++ ++D
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 175 SNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIES 231
+VKL C+ ++E LY++MEY+ GGD+++ L + L+ + + + +E
Sbjct: 60 HPNVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++IHRD+ N L+ + +++SDFGL + L
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 153
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 79/340 (23%), Positives = 140/340 (41%), Gaps = 86/340 (25%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSE--------------------MLRRGQVEHV 163
+G+G +G+V + TG + A+KK+K E LR ++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 164 RAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVA 223
N++ VD +Y +F+ L+M+ + D+ ++ RK LTE + + +
Sbjct: 77 IKHENIMGLVD------VYVE---GDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILL 126
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ + + +HK +++HRD+ P N+ ++ G +++DFGL +
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP-------------- 172
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWS 342
P + ++ E +Q RR S V T Y APE+L+ + Y D WS
Sbjct: 173 --------PYSDTLSKDETMQ-----RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWR---THLKFPEEAKL--------------- 384
+G I E+L G P F ++ + +I +P+ KL
Sbjct: 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK 279
Query: 385 ------SIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
S +A DL+ LL N +R+ AK A + H +F
Sbjct: 280 TIFPNASDDAIDLLQSLLKLNPLERISAKEALK---HEYF 316
|
Length = 335 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 70/261 (26%), Positives = 109/261 (41%), Gaps = 61/261 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
FEL+ ++G G +G+V R TG + A+K + +E + E ++ E N+L + +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 177 CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVL 227
I Y +F DD+ L+L+ME+ G + L+ + + L ED + E +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H H IHRDIK N+LL + ++L DFG+ LD + + F
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----------- 181
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342
+GTP ++APEV+ Y D WS
Sbjct: 182 ------------------------------IGTPYWMAPEVIACDENPDATYDYRSDIWS 211
Query: 343 LGAIMYEMLVGYPPFYSDDPM 363
LG EM G PP PM
Sbjct: 212 LGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 83/298 (27%), Positives = 126/298 (42%), Gaps = 63/298 (21%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEV 173
+D +E++ IGKG +G+V K G A+K L + E + AE N+L A
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALS 72
Query: 174 DSNCIVKLYCSF-----QDDEFLYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAE 224
D +VK Y + ++ + L+L++E GG + L L R + + E + + E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
++ ++ +H + IHRD+K +N+LL G ++L DFG+ L
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL------------------ 174
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
+ R+ ++VGTP ++APEV+ L Y CD
Sbjct: 175 -----------------------TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV-NWRTHLKFPEEAKLSIEAKDLISKLL 396
WSLG E+ G PP PM KI N L PE S E D I K L
Sbjct: 212 VWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE--LWSNEFNDFIRKCL 267
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 95/338 (28%), Positives = 147/338 (43%), Gaps = 86/338 (25%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
+E+L +GKGA+G V ++ T V A+KK+ + R + R R L E+
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQEL-G 64
Query: 176 NC--IVKLYCSF--QDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLA 228
+ IVKL ++D+ +YL+ EY M T L +R + L + R+ + + + A
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ IH + IHRD+KP N+LL+ ++L+DFGL + L +N
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE----------------LEEN 163
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
E P + Y V T Y APE+LL Y D WS+G I+
Sbjct: 164 PENPV------------------LTDY--VATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203
Query: 348 YEMLVGYPPFYSDDPMSTCRKIV------------------------NWRTHLKFPEEAK 383
EML+G P F ++ KI+ + + + P +
Sbjct: 204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL 263
Query: 384 L---SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L S +A DL+ KLL N N+RL A+ A E HP+
Sbjct: 264 LPKASDDALDLLKKLLVFNPNKRLTAEEALE---HPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 79/316 (25%), Positives = 133/316 (42%), Gaps = 67/316 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D+ E+L +GKG +G V + TG AMK+++ L + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESI 232
IV Y +F + +Y+ MEY+ G + L + + + ED R V ++ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 233 -HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H+ IHRD+KP N+L++ G ++L DFG + NL S
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG----------------VSGNLVAS------ 156
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------YGMECDWWSLGA 345
LA + +G Y+APE + G Y ++ D WSLG
Sbjct: 157 ---------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195
Query: 346 IMYEMLVG---YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQR 402
+ EM +G YPP + + IV+ P S +A+D ++K L +
Sbjct: 196 SILEMALGRYPYPPETYANIFAQLSAIVD-GDPPTLPSG--YSDDAQDFVAKCL----NK 248
Query: 403 LGAKGAD--EIKVHPW 416
+ + ++ HPW
Sbjct: 249 IPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-20
Identities = 86/305 (28%), Positives = 124/305 (40%), Gaps = 55/305 (18%)
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
N Y + ++ E EK AD D E + E +E R M
Sbjct: 17 NQYAKYFPHVLFTSEEA--FEKYCADLD--PEAYKKCVDLPEGEEVPESNNPREHM---- 68
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSN 176
+ L T++G+ V T G K + K ML Q + R+E + LA D
Sbjct: 69 YVLTTLVGRNPTTAAFVA---TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHF 125
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTL--TEDEARFYVAETVLAIESI 232
IVK + F+ D+ L LIMEY GGD+ + + K+ L E E + VLA++ +
Sbjct: 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRD+K N+ L G ++L DFG K
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---------------------------- 217
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
Q+ +A S GTP Y+APE+ +K Y + D WSLG I+YE+L
Sbjct: 218 -----------QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
Query: 353 GYPPF 357
+ PF
Sbjct: 267 LHRPF 271
|
Length = 478 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVY----AMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
L +G+GAFGEV K G A+K LK+ + Q+E E ++ ++D
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLD 59
Query: 175 SNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIE 230
IVKL C+ ++E L ++MEY+PGGD++ L R L+ + + + +E
Sbjct: 60 HPNIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++IHRD+ N L+ + +++SDFGL + L
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 95/336 (28%), Positives = 134/336 (39%), Gaps = 86/336 (25%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDS 175
D+ + IG+G +G V R K TG + AMKK++ +SE G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE------ARFYVAETVLAI 229
IV L + LYLI E+L M L D+L + + + Y+ + + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H +HRD+KP NLL+D G ++L+DFGL + F I
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA----------FGI----------- 153
Query: 290 ERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIM 347
P R E + W Y APEVLL Y D WS+G I
Sbjct: 154 -----PVRVYTHEVVTLW----------------YRAPEVLLGSPRYSTPVDIWSIGTIF 192
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVN---------WR--THLK-----FPEEAK-------- 383
EM P F+ D + +I W T L FP+ K
Sbjct: 193 AEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVK 252
Query: 384 -LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L + DL+ K+L + +R+ AK A HP+F
Sbjct: 253 NLDEDGLDLLEKMLIYDPAKRISAKKA---LNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-19
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 49/251 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDS 175
D+EL+ +G G +G+V R TG + A+K +K L G ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV + S+ E L++ MEY GG + + L+E + + ET+ + +H
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+LL G ++L+DFG+ + + + + F
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF------------------- 166
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGAIMYEMLV 352
+GTP ++APEV + GY CD W++G E+
Sbjct: 167 ----------------------IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE 204
Query: 353 GYPPFYSDDPM 363
PP + PM
Sbjct: 205 LQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 7e-19
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 60/270 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
D +E++ IGKG +G+V K G + A+K L E + AE N+L +
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLP 76
Query: 175 SN-CIVKLYCSF-QDDEF----LYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAE 224
++ +VK Y F + D+ L+L++E GG + L L+ L E + +
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+L ++ +H + IHRD+K +N+LL G ++L DFG+ L + L+
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN---------- 186
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
++VGTP ++APEV+ Y CD
Sbjct: 187 -------------------------------TSVGTPFWMAPEVIACEQQYDYSYDARCD 215
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKI 369
WSLG E+ G PP + P+ T KI
Sbjct: 216 VWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 70/255 (27%), Positives = 110/255 (43%), Gaps = 55/255 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--MLRRGQVEHVRAERNLLAEV 173
+ L+ +G+GA G V CR K TG ++A+K + L++ Q+ +R E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QI--LR-ELEINKSC 56
Query: 174 DSNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLL--MRKDT-LTEDEARFYVAETVL- 227
S IVK Y +F D+ + + MEY GG + ++ ++K ++ +AE+VL
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H IHRDIKP N+LL + G ++L DFG+ L S
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS------------------ 158
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
LA + GT Y+APE + K Y + D WSLG +
Sbjct: 159 -------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTL 193
Query: 348 YEMLVGYPPFYSDDP 362
E+ PF +
Sbjct: 194 LEVAQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-18
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 47/279 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK----SEMLRRGQVEHVRAERNLLAEV 173
++++ +IGKG GEV + + A+KK+++ + +L++ +R E + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLR-EAKIAADL 59
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM---RKDTLTEDEARFYVAETVLAI- 229
IV +Y D + +Y M Y+ G + +LL +K++L+++ A L+I
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 230 -------ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
E +H +HRD+KPDN+LL +G + + D+G E++ + ++
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI----FKKLEEEDLLDIDV 175
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ + P + VGTPDY+APE LL D ++
Sbjct: 176 DERNICYSSMTIPGK-------------------IVGTPDYMAPERLLGVPASESTDIYA 216
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381
LG I+Y+ML P+ RKI +R + P E
Sbjct: 217 LGVILYQMLTLSFPYRRKKG----RKIS-YRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 69/251 (27%), Positives = 114/251 (45%), Gaps = 51/251 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAE 172
+ +E L+ IG+G++G V CR + TG + A+KK +SE ++++ + +R +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ +V L F+ L+L+ EY + L + E + + +T+ A+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
HKH+ IHRD+KP+N+L+ K G ++L DFG + L T D+T
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYT--------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 351
V T Y APE+L+ YG D W++G + E+L
Sbjct: 159 -----------------------DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195
Query: 352 VGYP--PFYSD 360
G P P SD
Sbjct: 196 TGQPLWPGKSD 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 89/399 (22%), Positives = 153/399 (38%), Gaps = 111/399 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRA---ERNLLA 171
D ++ L+ +G GA+G+V + TG A+KKL R Q H + E LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-----SRPFQSAIHAKRTYRELRLLK 69
Query: 172 EVDSNCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
+D ++ L F L YL+ L G D+ + ++ L++D +F V +
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQI 127
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ ++ IH IHRD+KP N+ +++ L++ DFGL +
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--------------------- 166
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLG 344
+ M Y V T Y APE++L Y D WS+G
Sbjct: 167 ---------------------HTDDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVG 203
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNW-----------------RTHLK-FPEEAK--- 383
IM E+L G F D + ++I+N R +++ P+ K
Sbjct: 204 CIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDF 263
Query: 384 ------LSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEV 436
+ A DL+ K+L + ++R+ A A HP+ E
Sbjct: 264 KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA---HPYLA----------------EY 304
Query: 437 NDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
+D D +++S + W++++ + +NF
Sbjct: 305 HDPEDEPVAPPYDQSFESRDLTVDE--WKELVYKEIMNF 341
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 72/257 (28%), Positives = 113/257 (43%), Gaps = 48/257 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKL 181
+GKG+FG V + ++K +K LK+ + L + E LL+++D IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 182 YCSFQDDEFLYLIMEYLPGGDM----MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ SF + + +I EY G D+ L TL+E++ + + +L + +H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+K N+ L K L++ DFG+ S L L GS
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGV------SRL----------LMGSCD---------- 160
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
LA + GTP Y++PE L +GY + D WSLG I+YEM F
Sbjct: 161 ---------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205
Query: 358 YSDDPMSTCRKIVNWRT 374
+ +S +IV T
Sbjct: 206 EGQNFLSVVLRIVEGPT 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 67/257 (26%), Positives = 112/257 (43%), Gaps = 64/257 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK-------------LKKSEMLRRGQVE 161
++ L+ IG+GA+G V K TG A+KK L++ ++LRR + E
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
++ +++ + SF D +Y++ E + D+ L+ + L+ D +++
Sbjct: 64 NIIGILDIIRPPS-------FESFND---VYIVQELMET-DLYKLI-KTQHLSNDHIQYF 111
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ IH + +HRD+KP NLLL+ L++ DFGL + E D T
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR----IADPEHDHTGF-- 165
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
+ Y V T Y APE++L KGY D
Sbjct: 166 ------------------------------LTEY--VATRWYRAPEIMLNSKGYTKAIDI 193
Query: 341 WSLGAIMYEMLVGYPPF 357
WS+G I+ EML P F
Sbjct: 194 WSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 4e-18
Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 61/261 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
FEL+ ++G G +G+V R TG + A+K + + + E ++ E N+L + +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 177 CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVL 227
I Y +F DD+ L+L+ME+ G + L+ + +TL E+ + E +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQ-LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H+H IHRDIK N+LL + ++L DFG+ LD + + F
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----------- 171
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342
+GTP ++APEV+ Y + D WS
Sbjct: 172 ------------------------------IGTPYWMAPEVIACDENPDATYDFKSDLWS 201
Query: 343 LGAIMYEMLVGYPPFYSDDPM 363
LG EM G PP PM
Sbjct: 202 LGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 65/253 (25%), Positives = 106/253 (41%), Gaps = 69/253 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE L +G G G V + +G + A K + +++++R +V H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH------ 54
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L + + E+ + + +A
Sbjct: 55 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN----ILGKISIA 107
Query: 229 IES-----IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------- 153
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+A S VGT Y++PE L Y ++ D WSL
Sbjct: 154 -----------------------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSL 184
Query: 344 GAIMYEMLVG-YP 355
G + EM +G YP
Sbjct: 185 GLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 50/240 (20%), Positives = 96/240 (40%), Gaps = 55/240 (22%)
Query: 124 IGKGAFGEVRVCR---EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G+GAFGEV + + A+K LK+ + + E ++ ++ +V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVR 60
Query: 181 LY-CSFQDDEFLYLIMEYLPGGDMMTLL---------MRKDTLTEDEARFYVAETVLAIE 230
L +++ LYL++EY+ GGD++ L K TL+ + + + +E
Sbjct: 61 LLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ ++HRD+ N L+ + +++SDFGL + + + +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY--------------DDDYYRKKT 165
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
P R W M APE L + + D WS G +++E+
Sbjct: 166 GGKLPIR--------W-----M------------APESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 76/321 (23%), Positives = 129/321 (40%), Gaps = 72/321 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-----L 170
++ + IG GA+G V + +G A+KK+ + A+R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA------FDVPTLAKRTLRELKIL 58
Query: 171 AEVDSNCIVKLYCSFQ--DDEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ I+ + + +F +Y++M+ L D+ ++ LTE+ R+++ + +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH + IHRD+KP NLL+++ LR+ DFG+ + L S + + F
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF---------- 167
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
M Y V T Y APE+LL Y D WS+G
Sbjct: 168 -------------------------MTEY--VATRWYRAPELLLSLPEYTTAIDMWSVGC 200
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGA 405
I EML F + + + I+ + L P E L+ D + K + Q L
Sbjct: 201 IFAEMLGRRQLFPGKNYVHQLKLIL---SVLGSPSEEVLNRIGSDRVRKYI----QNLPR 253
Query: 406 KGADEIKVHPWFDGVDWARIY 426
K V W++I+
Sbjct: 254 KQP-----------VPWSKIF 263
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 72/257 (28%), Positives = 103/257 (40%), Gaps = 62/257 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKL----KKSEMLRRGQVEHVRAERNLLAEV 173
F L IG G+FG V R+ T V A+KK+ K+S + ++ VR + L
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL---R 73
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
N I C + + +L+MEY G L + K L E E + + +H
Sbjct: 74 HPNTIEYKGC-YLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFG---LCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
H IHRDIK N+LL + G ++L+DFG L P
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------------------------- 167
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIM 347
A S VGTP ++APEV+L + Y + D WSLG
Sbjct: 168 -----------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 348 YEMLVGYPPFYSDDPMS 364
E+ PP ++ + MS
Sbjct: 205 IELAERKPPLFNMNAMS 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 91/338 (26%), Positives = 137/338 (40%), Gaps = 86/338 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E + IG+G +G V R++ T A+KK++ E G E +LL E+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR------FYVAETVLAI 229
IV+L ++ LYL+ EYL + L D+ + D A+ Y+ + + I
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGI 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H +HRD+KP NLL+D+ + L+L+DFGL + F I
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA----------FGI---------- 155
Query: 289 NERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
P RT E + W Y APE+LL + Y D WS+G I
Sbjct: 156 ------PVRTFTHEVVTLW----------------YRAPEILLGSRHYSTPVDIWSVGCI 193
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVN---------WR----------THLKFPEE------ 381
EM+ P F D + KI W K+P +
Sbjct: 194 FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVV 253
Query: 382 AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
L DL+SK+L + ++R+ A+ A E H +F
Sbjct: 254 PTLEPAGVDLLSKMLRLDPSKRITARAALE---HEYFK 288
|
Length = 294 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 68/247 (27%), Positives = 109/247 (44%), Gaps = 51/247 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDS 175
+FE L IG+G +G V R+ T+G + A+KK++ + R G + +R E LL +
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLR-EITLLLNLRH 65
Query: 176 NCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
IV+L + ++L+MEY D+ +LL M +E + + + + + ++
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQY 123
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H++ IHRD+K NLLL G L+++DFGL +
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY-----------------------GL 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
PA P T V T Y APE+LL Y D W++G I+ E+
Sbjct: 161 PAKP-MT-----------------PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
Query: 351 LVGYPPF 357
L P
Sbjct: 203 LAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 62/263 (23%), Positives = 106/263 (40%), Gaps = 62/263 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL---KKSEMLRRGQVEHVRAERNLLA 171
+D E ++ +G G G V + TG V A K + KS + ++ + E ++
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMH 58
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA--I 229
E S IV Y +F ++ + + ME++ G + + + + + +A V+
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLT 117
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ H +HRDIKP N+L++ G ++L DFG+ L S
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-------------------- 157
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+A + VGT Y++PE + Y ++ D WSLG + E
Sbjct: 158 -----------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
Query: 350 MLVGYPPF--------YSDDPMS 364
+ +G PF DDPM
Sbjct: 195 LALGKFPFAFSNIDDDGQDDPMG 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 84/331 (25%), Positives = 130/331 (39%), Gaps = 79/331 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSN 176
F+ L +G+G + V R +TTG + A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDM---MTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IV+L+ + L L+ EY+ D+ M + L + + + + + I H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++ +HRD+KP NLL++K G L+L+DFGL + G +N S
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLAR------------AFGIPVNTFS------- 158
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 352
+ V T Y AP+VLL + Y D WS+G IM EM+
Sbjct: 159 ----------------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
Query: 353 GYPPFYSDDPMSTCRKIVN---------WRTHLKFPE----------------EAKLSIE 387
G P F + KI W + PE
Sbjct: 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPL 256
Query: 388 AKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
DL+ +LL N R+ A A + HPWF
Sbjct: 257 GIDLLHRLLQLNPELRISAHDALQ---HPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 69/270 (25%), Positives = 112/270 (41%), Gaps = 80/270 (29%)
Query: 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
A+D + L IG+GAFG V K +G + A+K++ +S + + Q + LL ++
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQ-------KRLLMDL 53
Query: 174 D-----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTED 216
D S+C IVK Y + + ++ ME +M + + K + E+
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEE 107
Query: 217 EARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
TV A+ + + IHRD+KP N+LLD+ G+++L DFG+ L S + +D
Sbjct: 108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD 167
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KK 332
G Y+APE + +
Sbjct: 168 ------------------------------------------AGCRPYMAPERIDPSARD 185
Query: 333 GYGMECDWWSLGAIMYEMLVG---YPPFYS 359
GY + D WSLG +YE+ G YP + S
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 54/264 (20%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K D F+++ IG+G +G+V R+K TG + A+KK++ + +R E +L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILR 61
Query: 172 EVDSNCIVKLYCSFQDD----EFL------YLIMEYLPGGDMMTLLMRK-DTLTEDEARF 220
+++ IV L D +F YL+ EY+ D+M LL +ED +
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKS 120
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
++ + + + HK +++HRDIK N+LL+ G ++L+DFGL +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR---------------- 164
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECD 339
+ + V T Y PE+LL ++ YG D
Sbjct: 165 ------------------------LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAID 200
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPM 363
WS G I+ E+ P F ++ +
Sbjct: 201 VWSCGCILGELFTKKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-16
Identities = 87/337 (25%), Positives = 131/337 (38%), Gaps = 91/337 (27%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNL 169
+E L IG+G +G V + + T + A+K+++ S LR E L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EICL 52
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
L E+ IV+LY D+ L L+ EY + + + ++ + + +
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H H+ +HRD+KP NLL++K G L+L+DFGL + F I
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA----------FGI----------- 151
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGAIM 347
P R YS V T Y P+VL K Y D WS G I
Sbjct: 152 -----PVR----------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 190
Query: 348 YEML-VGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEE---------------- 381
E+ G P F +D ++I +W K P+
Sbjct: 191 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVV 250
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
KL+ +DL+ LL CN QR+ A+ A + HP+F
Sbjct: 251 PKLNSTGRDLLQNLLVCNPVQRISAEEALQ---HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 81/291 (27%), Positives = 122/291 (41%), Gaps = 61/291 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAERNLLAE 172
D + L +G GA+G V ++ TG A+KKL + SE+ + +R LL
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKH 70
Query: 173 VDSNCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ ++ L F D L YL+M ++ G + LM+ + L+ED +F V + +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH IHRD+KP NL +++ L++ DFGL +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------------------- 166
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
Q + M Y V T Y APEV+L Y D WS+G
Sbjct: 167 --------------------QTDSEMTGY--VVTRWYRAPEVILNWMHYTQTVDIWSVGC 204
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL-SIEAKDLISKL 395
IM EML G P F D + +I+ KL S +AK+ + KL
Sbjct: 205 IMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 53/252 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEV 173
+E L IG+G FGEV R K T + A+KK+ M + + A R +L +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLL 68
Query: 174 DSNCIVKLY--CSFQDDEF------LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAE 224
+V L C + + YL+ E+ D+ LL K+ T E + +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + IH++ +HRD+K N+L+ K G L+L+DFGL + F++
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA----------FSL------ 171
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
++ + T NR V T Y PE+LL ++ YG D W
Sbjct: 172 ----SKNSKPNRYT----------NR-------VVTLWYRPPELLLGERDYGPPIDMWGA 210
Query: 344 GAIMYEMLVGYP 355
G IM EM P
Sbjct: 211 GCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 68/258 (26%), Positives = 108/258 (41%), Gaps = 79/258 (30%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE ++ +G G G V + K +G + A K + +++++R QV H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ 58
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L EA+ + E +L
Sbjct: 59 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--------KEAK-RIPEEILG 106
Query: 229 IESI----------HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
SI KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------- 157
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
+A S VGT Y++PE L Y ++
Sbjct: 158 ----------------------------------MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 339 DWWSLGAIMYEMLVG-YP 355
D WS+G + E+ +G YP
Sbjct: 184 DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 93/338 (27%), Positives = 136/338 (40%), Gaps = 96/338 (28%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEML-RRGQVE-----HVRAERNLLA 171
L +G GA+G V +K TG A+KKL + SE+ +R E H++ E N++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-NVIG 78
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAI 229
+D FQD YL+M Y M T L + L+ED+ ++ V + + +
Sbjct: 79 LLDVFTSAVSGDEFQD---FYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--------------------- 169
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
M Y V T Y APEV+L Y D WS+G IM
Sbjct: 170 ---------------------EMTGY--VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH---------------------LKFPEE------ 381
EML G F D + +I+ K+P +
Sbjct: 207 EMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF 266
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFD 418
K S +A DL+ K+L +V++RL A E HP+FD
Sbjct: 267 PKASPQAVDLLEKMLELDVDKRL---TATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 65/250 (26%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKK--------SEMLRRGQV-EHVRAERNLLAEVD 174
+G GAFG V R++ TG A+KK+ K R ++ +H+R E N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE-NII---- 72
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ ++ S +D +Y + E L G D+ LL + L + ++++ + + ++ +H
Sbjct: 73 --SLSDIFISPLED--IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHS 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+KP N+L+++ L++ DFGL + D
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLARIQD--------------------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
+M Y V T Y APE++L + Y +E D WS G I EML G
Sbjct: 160 ---------------PQMTGY--VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 354 YPPFYSDDPM 363
P F D +
Sbjct: 203 KPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-15
Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 55/295 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A + + ++G GA G V + + G +A+K + E + +AE L D
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCD 89
Query: 175 SNCIVKLYCSF-----QDDE---FLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYV 222
IVK + F ++ E + L+++Y GD+ + + T E EA
Sbjct: 90 FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ +LA+ +H H IHRDIK N+LL G ++L DFG K + +T+ + +G
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDD---VGRTF 205
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
G TP Y+APE+ +K Y + D +S
Sbjct: 206 CG-----------------------------------TPYYVAPEIWRRKPYSKKADMFS 230
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397
LG ++YE+L PF ++ K + R P +S E +++++ LL
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD---PLPPSISPEMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 65/257 (25%), Positives = 107/257 (41%), Gaps = 66/257 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE ++ +G G G V K +G + A K + +++++R QV H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ 58
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L + + E + ++
Sbjct: 59 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAV 112
Query: 229 IESI----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
I+ + KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------------- 157
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+A S VGT Y++PE L Y ++ D WS+G
Sbjct: 158 ----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 345 AIMYEMLVGYPPFYSDD 361
+ EM +G P D
Sbjct: 190 LSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 68/255 (26%), Positives = 103/255 (40%), Gaps = 48/255 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ T V A+KK+ S + + + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG + A+P
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG---------------------------SASIASP-- 177
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
A S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 178 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
Query: 355 PPFYSDDPMSTCRKI 369
PP ++ + MS I
Sbjct: 222 PPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 66/252 (26%), Positives = 100/252 (39%), Gaps = 48/252 (19%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L IG G+FG V T V A+KK+ S + + + E L ++ ++
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
+ + +L+MEY G L + K L E E + + +H H+ IHR
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+LL + G ++L+DFG S + PA
Sbjct: 146 DIKAGNILLTEPGQVKLADFG------------------------SASKSSPAN------ 175
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGYPPF 357
S VGTP ++APEV+L + Y + D WSLG E+ PP
Sbjct: 176 ---------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
Query: 358 YSDDPMSTCRKI 369
++ + MS I
Sbjct: 221 FNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 75/265 (28%), Positives = 110/265 (41%), Gaps = 70/265 (26%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q++ +D E L IG G G+V R K TGHV A+K+++++ + E+ R +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMD 63
Query: 169 L---LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMT----LLMR-KDTLTEDEARF 220
L L D IVK Y F D +++ ME M T LL R + + ED
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICMEL-----MSTCLDKLLKRIQGPIPEDILG- 117
Query: 221 YVAETVLAIESIH----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
TV ++++H KH IHRD+KP N+LLD G+++L DFG+ L
Sbjct: 118 --KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV--------- 166
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKK 332
S+ R A G Y+APE +
Sbjct: 167 --------DSKAKTRSA-------------------------GCAAYMAPERIDPPDPNP 193
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPF 357
Y + D WSLG + E+ G P+
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 67/272 (24%), Positives = 101/272 (37%), Gaps = 59/272 (21%)
Query: 120 LLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +G+G FG+V +CR TG A+K L S E R+ E +L
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS------GEEQHRSDFEREIEILR 61
Query: 172 EVDSNCIVKL-YCSFQDDEF-LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLA 228
+D IVK + L LIMEYLP G + L R +D + + ++
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + YIHRD+ N+L++ +++SDFGL K L +++D+
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP----EDKDYYYVKEP------ 171
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
E P W Y APE L + D WS G +Y
Sbjct: 172 GESPI-----------FW--------Y---------APECLRTSKFSSASDVWSFGVTLY 203
Query: 349 EMLVGYPPFYSDDP----MSTCRKIVNWRTHL 376
E+ P S M + T L
Sbjct: 204 ELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 65/255 (25%), Positives = 100/255 (39%), Gaps = 48/255 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+K N+LL + G ++L DFG + AP
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG---------------------------SASIMAP-- 167
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
A VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 168 ----------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 355 PPFYSDDPMSTCRKI 369
PP ++ + MS I
Sbjct: 212 PPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 71/265 (26%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKK--------------LKKSEMLRRGQVEHVRAERNL 169
IG+GA+G V + T A+KK L++ ++LR H+ E N+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR-----HLDHE-NV 66
Query: 170 LAEVDSNCIVKLYC--SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+A D I+ +F D +Y++ E L D+ ++ TL++D ++++ + +
Sbjct: 67 IAIKD---IMPPPHREAFND---VYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ IH + +HRD+KP NLLL+ L++ DFGL + T ++ DF
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----TSEKGDF----------- 164
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346
M Y V T Y APE+LL Y D WS+G I
Sbjct: 165 ------------------------MTEY--VVTRWYRAPELLLNCSEYTTAIDVWSVGCI 198
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVN 371
E+L P F D + + I
Sbjct: 199 FAELLGRKPLFPGKDYVHQLKLITE 223
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 51/244 (20%)
Query: 124 IGKGAFGEVRV-CREKT---TGHVYAMKKLKK--SEMLRRGQVEHVRAERNLLAEVDSNC 177
+G+G FG+V + C + TG + A+K LK+ + G + E N+L +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK----EINILKTLYHEN 67
Query: 178 IVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IVK CS Q + L LIMEY+P G + L K L + + + + +H
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HYIHRD+ N+LLD +++ DFGL K + G+ ++ + P
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----------PEGHEYYRVREDGDSPVF- 175
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ A E L + + D WS G +YE+L
Sbjct: 176 ---------------------------WYAVECLKENKFSYASDVWSFGVTLYELLTHCD 208
Query: 356 PFYS 359
S
Sbjct: 209 SKQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 62/294 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTT--GHVYAMKKL----KKSEMLRRGQVE-----HVRAE 166
+EL+ +G+GA+G V R T A+KK+ K + +R E H R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+N+ D + IV +F + LYL E L D+ ++ LT+ + ++ + +
Sbjct: 62 KNITCLYDMD-IV-FPGNFNE---LYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH + +HRD+KP NLL++ L++ DFGL + G S
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-------------------GFS 156
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
+N E M Y V T Y APE++L + Y D WS+G
Sbjct: 157 EN----------PGENAGF------MTEY--VATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL----SIEAKDLISKL 395
I+ E+L P F D + +I+ L P+E L S +A++ I L
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQ---VLGTPDEETLSRIGSPKAQNYIRSL 249
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 64/245 (26%), Positives = 100/245 (40%), Gaps = 64/245 (26%)
Query: 121 LTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVR---AERNLLAEV 173
+ +GKG FG V +CR + TG V A+KKL+ S EH+R E +L +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS------TAEHLRDFEREIEILKSL 62
Query: 174 DSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIE 230
+ IVK C L L+MEYLP G + L + ++ L + Y ++ +E
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME 122
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ Y+HRD+ N+L++ +++ DFGL K L Q+ E
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL-------------------PQDKE 163
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPD-----YIAPEVLLKKGYGMECDWWSLGA 345
Y V P + APE L + + + D WS G
Sbjct: 164 ------------------------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGV 199
Query: 346 IMYEM 350
++YE+
Sbjct: 200 VLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 7e-13
Identities = 60/254 (23%), Positives = 108/254 (42%), Gaps = 49/254 (19%)
Query: 124 IGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+G+G FG+V +CR TG A+K LK + ++ E +L + IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 180 KL--YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHH 236
K C+ + LIME+LP G + L R K+ + + Y + ++ +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
Y+HRD+ N+L++ +++ DFGL K ++ ++ +T+ ++L+
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDLD------------- 173
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
S V + APE L++ + + D WS G +YE+L
Sbjct: 174 -------------------SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211
Query: 357 FYSDDPMSTCRKIV 370
S PM+ K++
Sbjct: 212 ESS--PMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 79/302 (26%), Positives = 125/302 (41%), Gaps = 78/302 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD- 174
DD E++ +G+GA+G V R TG + A+K++ R V + ++ LL ++D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52
Query: 175 ----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------MRKDTLTEDEARF 220
+C V Y + + +++ ME M T L + T+ ED
Sbjct: 53 SMRSVDCPYTVTFYGALFREGDVWICMEV-----MDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 221 YVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
V A+E +H K IHRD+KP N+L+++ G ++L DFG+ L S + D
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID---- 163
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE----VLLKKGYG 335
G Y+APE L +KGY
Sbjct: 164 --------------------------------------AGCKPYMAPERINPELNQKGYD 185
Query: 336 MECDWWSLGAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISK 394
++ D WSLG M E+ G P+ S P +++V + P E K S E +D ++K
Sbjct: 186 VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAE-KFSPEFQDFVNK 243
Query: 395 LL 396
L
Sbjct: 244 CL 245
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 46/245 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
AD +E L +G+G++ V + K G + A+K ++ E G E +LL +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLK 61
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV L+ E L L+ EY+ + L + + ++ + + + IH+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ +HRD+KP NLL+ G L+L+DFGL + +
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARA--------------------------KSV 155
Query: 295 PKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC-DWWSLGAIMYEMLV 352
P T E + W Y P+VLL C D W +G I EM+
Sbjct: 156 PSHTYSNEVVTLW----------------YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199
Query: 353 GYPPF 357
G F
Sbjct: 200 GVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 56/248 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL--KKSEMLRRGQVEHVRAERNLLAEVD 174
+ E + IG GA G V + TG +YA+K + + +RR + E +L +V+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEILRDVN 130
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+VK + F + + +++E++ GG + + + D AR + + I +H+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHR 186
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRDIKP NLL++ +++++DFG+ + L Q D P
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMD----------------PCN 226
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGY--GMECDWWSLGAIMYE 349
S+VGT Y++PE + L G G D WSLG + E
Sbjct: 227 ---------------------SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
Query: 350 MLVGYPPF 357
+G PF
Sbjct: 266 FYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 32/135 (23%), Positives = 70/135 (51%), Gaps = 8/135 (5%)
Query: 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186
G +V + + T + +K L+KS R ER + +V L+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246
++ ++L++++ GG + + + + + E+ + + AE V+A++++H+ + RD+ P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 247 LLLDKYGHLRLSDFG 261
+LLD GH++L+ F
Sbjct: 116 ILLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 48/249 (19%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ E +R E +LL + IV
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIR-LEHEEGAPCTAIR-EVSLLKNLKHANIVT 67
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ + L L+ EYL L + ++ + ++ + + + HK +HR
Sbjct: 68 LHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPT-------------------------KTYSN 162
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
E + W Y P+VLL Y D W +G I+YEM G P F
Sbjct: 163 EVVTLW----------------YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-- 204
Query: 360 DDPMSTCRK 368
P ST ++
Sbjct: 205 --PGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 66/265 (24%), Positives = 110/265 (41%), Gaps = 60/265 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---------KSEMLRRGQVEHVRAE 166
+ ++ L+ +G GA+G V + TG A+KKL K ++H++ E
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
N++ +D + F D +YL+ +L G D+ ++ + LT+D +F + + +
Sbjct: 77 -NVIGLLDVFTPARSLEEFND---VYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQIL 130
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD------------------- 171
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
M Y V T Y APE++L Y D WS+G
Sbjct: 172 -----------------------DEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIV 370
IM E+L G F D + + I+
Sbjct: 207 IMAELLTGRTLFPGTDHIDQLKLIL 231
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 82/350 (23%), Positives = 132/350 (37%), Gaps = 104/350 (29%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D E IG GAFG V + G A+KK+ + + V R R L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFREL------- 50
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDM--------MTLLMRKD---------TLTEDEAR 219
K+ C F+ D L + + L + +T LM+ D L+ D +
Sbjct: 51 ---KMLCFFKHDNVLSAL-DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK 106
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
++ + + ++ +H +HRDIKP NLL++ L++ DFGL + ++E D
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR------VEEPD---- 156
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMEC 338
S++ TQ+ V T Y APE+L+ + Y
Sbjct: 157 -----ESKH--------MTQE-----------------VVTQYYRAPEILMGSRHYTSAV 186
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW----------------RTHL-----K 377
D WS+G I E+L F + P+ I + R H+ K
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK 246
Query: 378 FPEEAKL-------SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
P L + EA L+ ++L + ++R+ A A HP+ D
Sbjct: 247 PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA---LAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 40/99 (40%), Positives = 53/99 (53%), Gaps = 13/99 (13%)
Query: 323 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKI-VNWRTHLKFPEE 381
Y APEV CDWWSLGAI++E+L G + C +N T L PE
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTG-------KTLVECHPSGINTHTTLNIPEW 200
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGA--DEIKVHPWF 417
+S EA+ L+ +LL N +RLGA A ++IK HP+F
Sbjct: 201 --VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ G E +LL ++ IV
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ D+ L L+ EYL + + ++ + ++ + + + H+ +HR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPT-------------------------KTYSN 163
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPF 357
E + W Y P+VLL Y + D W +G I +EM G P F
Sbjct: 164 EVVTLW----------------YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 64/285 (22%)
Query: 118 FELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLAEV 173
+E + IG+GA+G+V R+ K G A+K+++ E + + V R+L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 174 DSNCIVKLY----CSFQDDEF-LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETV 226
N +V+L+ S D E L L+ E++ D+ T L + + + + + + + +
Sbjct: 63 HPN-VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ +H H +HRD+KP N+L+ G ++L+DFGL +
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---------------------- 158
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ +Q M S V T Y APEVLL+ Y D WS+G I
Sbjct: 159 ----------------IYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEA 382
EM P F + KI+ +W + P +A
Sbjct: 199 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 49/268 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+++E++ IG G FGEV + + K T + K + + R + + V E N++ E+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELKH 71
Query: 176 NCIVKLYCSF--QDDEFLYLIMEYLPGGDMMTLLMRKDTL---TEDEARFYVAETVL-AI 229
IV+ F + ++ LY++ME+ GD+ + + + E+ A + +L A+
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 230 ESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
H +HRD+KP N+ L G+ + + T Q NNL
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLST---------GI-RHIGKITAQ------ANNL 175
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRM----LAYSTVGTPDYIAPEVLL--KKGYGM 336
NG RP A ++ + ++ + +A+S VGTP Y +PE+LL K Y
Sbjct: 176 NG------RPIA-------KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD 222
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMS 364
+ D W+LG I+YE+ G PF+ + S
Sbjct: 223 KSDMWALGCIIYELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 59/242 (24%), Positives = 90/242 (37%), Gaps = 52/242 (21%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
L +G+G++ V + G + A+K +K E + + E +LL + I
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANI 65
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
V L+ E L + EY+ ++ L R ++ + + + IH H +
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLC--KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
HRD+KP NLL+ G L+L+DFGL K + T + T+
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL------------------ 167
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYP 355
W Y P+VLL Y D W G I EML G P
Sbjct: 168 ---------W----------------YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202
Query: 356 PF 357
F
Sbjct: 203 AF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 66/262 (25%), Positives = 105/262 (40%), Gaps = 54/262 (20%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLAEVD 174
+E + IG GA+G V R+ +GH A+K ++ + L V V + L D
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL-EAFD 60
Query: 175 SNCIVKLY----CSFQDDEF-LYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVL 227
IV+L S D E + L+ E++ D+ T L + L + + + + +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ +H + +HRD+KP+N+L+ G ++L+DFGL + C
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC------------------- 160
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+M V T Y APEVLL+ Y D WS+G I
Sbjct: 161 -----------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197
Query: 348 YEMLVGYPPFYSDDPMSTCRKI 369
EM P F + KI
Sbjct: 198 AEMFRRKPLFCGNSEADQLGKI 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 43/227 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IGKG FG+V K V A+K + L E +L + D IVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+ +Y++ME +PGG ++T L + K+ LT + + +E + + IHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ + L++SDFG+ + E++ I +G Q P +
Sbjct: 120 AARNCLVGENNVLKISDFGMSR--------EEEGGIYTVSDGLKQ------IPIK----- 160
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ APE L Y E D WS G +++E
Sbjct: 161 --------------------WTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 83/354 (23%), Positives = 126/354 (35%), Gaps = 117/354 (33%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAE 166
+ ++ L +G+G++ V R K TG + A+K+++ +EH +R E
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR-E 53
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL-----------PGGDMMTLLMRKDTLTE 215
+LL ++ IV L+ + L L+ EYL GG L+
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----------LSM 102
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
R ++ + + + H+ +HRD+KP NLL+ + G L+L+DFGL +
Sbjct: 103 HNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA---------- 152
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKG 333
+ P +T YS V T Y P+VLL
Sbjct: 153 ----------------KSVPSKT----------------YSNEVVTLWYRPPDVLLGSTE 180
Query: 334 YGMECDWWSLGAIMYEMLVGYPPFY-SDDPMSTCRKIV---------NWRTHLKFPEEAK 383
Y D W +G I YEM G P F S D KI W PE
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240
Query: 384 LS-------------------IEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
S ++L K L +R+ A E HP+F
Sbjct: 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ G E +LL ++ IV
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ ++ L L+ EYL L +++ + ++ + + + H+ +HR
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPT-------------------------KTYSN 163
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPF 357
E + W Y P++LL Y + D W +G I YEM G P F
Sbjct: 164 EVVTLW----------------YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 5e-11
Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 53/243 (21%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVD 174
D + ++G G G V T + A+K L + L++ + +E +L + D
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCD 57
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S I+ Y +F + + + E++ GG +L + + R VA V + +
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGG---SLDVYRKIPEHVLGRIAVA-VVKGLTYLWS 113
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------------------------- 148
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
+A + VGT Y+APE + + YG+ D WSLG E+ +G
Sbjct: 149 ------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
Query: 355 PPF 357
P+
Sbjct: 191 FPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 57/259 (22%), Positives = 112/259 (43%), Gaps = 51/259 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + + V A+K LK M V+ E NL+ +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+ +V+LY +E +Y+I EY+ G ++ L + + + + A+ + I
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +YIHRD++ N+L+ + +++DFGL + +++ ++T E
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLAR-----VIEDNEYTA----------REGAK 165
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-- 351
P + + APE + + ++ D WS G ++YE++
Sbjct: 166 FPIK-------------------------WTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200
Query: 352 --VGYPPFYSDDPMSTCRK 368
+ YP + D MS ++
Sbjct: 201 GKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 8e-11
Identities = 40/146 (27%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 124 IGKGAFGEVR--VCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G G FG V V K+ V A+K LK+ + G+ E +R E +++A++D CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLR-EASVMAQLDHPCIVR 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L + + + L+ME P G ++ L ++ + + + + + + + H++HR
Sbjct: 61 LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPL 266
D+ N+LL ++SDFG+ + L
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 64/263 (24%), Positives = 111/263 (42%), Gaps = 60/263 (22%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM----LRRGQVE-----HVRAERN 168
++ LT +G GA+G V + A+KKL + RR E H++ E N
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE-N 75
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
++ +D + S ++ +YL+ L G D+ ++ + L+++ +F + + +
Sbjct: 76 VIGLLD---VFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRG 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ IH IHRD+KP N+ +++ LR+ DFGL +
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------ 166
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
Q + M Y V T Y APE++L Y D WS+G IM
Sbjct: 167 ------------------QADDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206
Query: 348 YEMLVGYPPFYSDDPMSTCRKIV 370
E+L G F +D + ++I+
Sbjct: 207 AELLKGKALFPGNDYIDQLKRIM 229
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 70/261 (26%), Positives = 103/261 (39%), Gaps = 56/261 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL--LAEVDS 175
++ L IG GA G V + G A+KKL + + Q RA R L L V+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNH 79
Query: 176 NCIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F +EF +YL+ME + + M D + + + + + I
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD---HERMSYLLYQMLCGI 136
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------------- 170
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
R A N M Y V T Y APEV+L GY D WS+G IM E
Sbjct: 171 -RTAC-------------TNFMMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 350 MLVGYPPFYSDDPMSTCRKIV 370
++ G F D + K++
Sbjct: 215 LVKGSVIFQGTDHIDQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 64/254 (25%), Positives = 102/254 (40%), Gaps = 61/254 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---- 173
+++ +IGKG++G V + TG A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLR 54
Query: 174 -----DSNCIVKLYCSFQDDEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
D I + EF +Y++ E L D+ ++ D LT + +F++ + +
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLL 113
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
A++ IH + HRD+KP N+L + L++ DFGL +
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------------------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV---LLKKGYGMECDWWSL 343
N+ P A + V T Y APE+ K Y D WS+
Sbjct: 153 AFNDTPTA-----------------IFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSI 194
Query: 344 GAIMYEMLVGYPPF 357
G I E+L G P F
Sbjct: 195 GCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 59/258 (22%), Positives = 99/258 (38%), Gaps = 55/258 (21%)
Query: 119 ELLTMIGKGAFGE--VRVCREKTTGHVYAMKKL----KKSEMLRRGQVEHVRAERNLLAE 172
ELLT+IGK V + + K T + A+KK+ E L+ Q E +
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ-----QEIITSRQ 55
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIE 230
+ I+ SF D LY++ + G LL + L E F + + + A++
Sbjct: 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALD 115
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH +IHR +K ++LL G + LS
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGL------------------------------ 145
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAY---STVGTPDYIAPEVLLK--KGYGMECDWWSLGA 345
R ++H ++ R + + S P +++PEVL + +GY + D +S+G
Sbjct: 146 ------RYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGI 198
Query: 346 IMYEMLVGYPPFYSDDPM 363
E+ G+ PF
Sbjct: 199 TACELANGHVPFKDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 123 MIGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++GKG FGEV ++KT V K+ E+ + +E +L + D IVK
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIH 239
L + +Y++ME +PGGD ++ L + KD L + + + + + + IH
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+ N L+ + L++SDFG+ + QE D + SS + P
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-------QEDD-----GIYSSSGLKQIPI------ 158
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
+ APE L Y E D WS G +++E +G P+
Sbjct: 159 ----------------------KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 74/260 (28%), Positives = 104/260 (40%), Gaps = 60/260 (23%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHV-RAERN--LLAEVDSN 176
L IG GA G V + TG A+KKL R Q V H RA R L+ V+
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 177 CIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L F +EF +YL+ME + + M D + + + + + I+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD---HERMSYLLYQMLCGIK 132
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H IHRD+KP N+++ L++ DFGL + T G +
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSF-------- 172
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
M Y V T Y APEV+L GY D WS+G IM EM
Sbjct: 173 --------------------MMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
Query: 351 LVGYPPFYSDDPMSTCRKIV 370
+ G F D + KI+
Sbjct: 211 IRGTVLFPGTDHIDQWNKII 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 60/254 (23%)
Query: 123 MIGKGAFGEVRVCREKT-----TGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+G GAFGEV +G + A+K L+K + + E + E +L++ +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFL-KEAHLMSNFNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-LAIE----- 230
IVKL +E Y+IME + GGD+++ L + E + + ++
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 231 -SIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + H+IHRD+ N L+ + G+ +++ DFGL + + S
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----------- 168
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
K + W +APE LL + + D WS G
Sbjct: 169 -----------KEGEGLLPVRW-----------------MAPESLLDGKFTTQSDVWSFG 200
Query: 345 AIMYEML-VGYPPF 357
+M+E+L +G P+
Sbjct: 201 VLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M E AE NL+ ++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYVAETVLA 228
+V+LY + E +Y+I EY+ G ++ L + + L + A+ +AE +
Sbjct: 61 PRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ--IAEGMAF 117
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
IE + +YIHRD++ N+L+ + +++DFGL +
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 54/220 (24%), Positives = 80/220 (36%), Gaps = 38/220 (17%)
Query: 140 TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFLYLIMEYL 198
TGH A+K L+ Q R E L A + IV L S + L+ + EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HL 255
PG + +L L E + + + A+ H +HRD+KP N+++ + G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY 315
++ DFG IG L G +
Sbjct: 122 KVLDFG----------------IGTLLPGVRDADVA------------------TLTRTT 147
Query: 316 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+GTP Y APE L + D ++ G I E L G
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 63/293 (21%)
Query: 86 VSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYA 145
+S ++N +E ++ + L+R ++ L IG GA G V + A
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAILERNVA 53
Query: 146 MKKLKKSEMLRRGQVEHVRAERNL--LAEVDSNCIVKLYCSFQD----DEF--LYLIMEY 197
+KKL + + Q RA R L + V+ I+ L F +EF +Y++ME
Sbjct: 54 IKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257
+ + M D + + + + + I+ +H IHRD+KP N+++ L++
Sbjct: 111 MDANLCQVIQMELD---HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST 317
DFGL + S +
Sbjct: 168 LDFGLARTAGTSFMMTPY------------------------------------------ 185
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV 370
V T Y APEV+L GY D WS+G IM EM+ G F D + K++
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 75/283 (26%), Positives = 114/283 (40%), Gaps = 67/283 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKL------KKSEMLRRGQVEHVRAERNLLA 171
++L +IG G+FG V T A+KK+ K E+L + H+ N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NIIF 123
Query: 172 EVD---SNCIVKLYCSFQDDEFLYLIMEYLPGG--DMMTLLMRKD-TLTEDEARFYVAET 225
D + C K + + FL ++ME++P M R + L + Y +
Sbjct: 124 LKDYYYTECFKK----NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
A+ IH HRD+KP NLL+D H L+L DFG K N L G
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---------------NLLAG 224
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
+R ++Y + + Y APE++L Y D WSL
Sbjct: 225 -------------------------QRSVSY--ICSRFYRAPELMLGATNYTTHIDLWSL 257
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSI 386
G I+ EM++GYP F + +I+ L P E +L
Sbjct: 258 GCIIAEMILGYPIFSGQSSVDQLVRIIQV---LGTPTEDQLKE 297
|
Length = 440 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-08
Identities = 12/50 (24%), Positives = 20/50 (40%), Gaps = 3/50 (6%)
Query: 435 EVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
+V DT NF+ S+ + + S + F G++Y N E
Sbjct: 1 KVKSPTDTSNFDPEFTSEPPKLSP---PDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 6/143 (4%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G +GEV K A+K LK+ M +VE E ++ E+ +V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETV-LAIESIHKHHYIHRD 241
+ Y+I E++ G+++ L + Y+A + A+E + K ++IHRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 242 IKPDNLLLDKYGHLRLSDFGLCK 264
+ N L+ + ++++DFGL +
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 58/296 (19%), Positives = 112/296 (37%), Gaps = 62/296 (20%)
Query: 83 DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH 142
A S++D ++ L ++K E + +G + ++ + G+ G V V +
Sbjct: 40 SASESDDDDDDGLIPTKQKAREVV----ASLG---YTVIKTLTPGSEGRVFVATKPGQ-- 90
Query: 143 VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD 202
+L+ GQ E LL V+ ++++ + +++ + D
Sbjct: 91 -------PDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSD 142
Query: 203 MMTLLMRKDTLTEDEARFYVAETVL-AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
+ T L ++ + + + +L + +H IHRD+K +N+ ++ + + D G
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG 202
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
+ F + AP GT
Sbjct: 203 AAQ-----------FPV--------------VAPA-----------------FLGLAGTV 220
Query: 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV-NWRTHL 376
+ APEVL + Y + D WS G +++EML YP +DP ST + V + +HL
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IGKG FG+V + + G A+K LK + A + LAE
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAEASVM 54
Query: 175 -----SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVL 227
N + L Q + LY++ EY+ G ++ L + +T + + +
Sbjct: 55 TTLRHPNLVQLLGVVLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+E + + +++HRD+ N+L+ + ++SDFGL K
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 43/236 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G FGEV R + A+K + E L E +L + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA-IESIHKHHYIHRDI 242
+ +Y++ME + GGD +T L + + + + E A +E + H IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ + L++SDFG+ + +E+D +S + K T
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-------EEEDGVY------ASTGGMKQIPVKWT---- 163
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
APE L Y E D WS G +++E +G P+
Sbjct: 164 ----------------------APEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 60/248 (24%), Positives = 97/248 (39%), Gaps = 58/248 (23%)
Query: 118 FELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
F +L GA G C + KT HV +++ GQ E ++L ++
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHV----------VIKAGQRGGTATEAHILRAINHP 143
Query: 177 CIVKLYCSFQDDEFLYLIMEYLP--GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I++L +F ++F LI LP D+ L K + + + AI+ +H+
Sbjct: 144 SIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFG-LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRDIK +N+ ++ G + L DFG C P+D +
Sbjct: 201 NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN------------------------ 236
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
N+ Y GT APE+L + YG D WS G +++EM
Sbjct: 237 --------------ANKY---YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
Query: 354 YPPFYSDD 361
+ + D
Sbjct: 280 HDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 63/242 (26%), Positives = 95/242 (39%), Gaps = 56/242 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL--LAEVDS 175
++ L IG GA G V + A+KKL + + Q RA R L + V+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNH 75
Query: 176 NCIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F +EF +YL+ME + + M D + + + + + I
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGI 132
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL + S +
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM------------------ 174
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
M Y V T Y APEV+L GY D WS+G IM E
Sbjct: 175 ----------------------MTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 350 ML 351
M+
Sbjct: 211 MV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERNLLAEVD 174
+G G FG V+ V + + A+K LK + EM+R ++ H ++D
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLD 53
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIH 233
+ IV++ + E L L+ME GG + L +KD +T + + + ++ +
Sbjct: 54 NPYIVRM-IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+++HRD+ N+LL + ++SDFGL K L
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 55/249 (22%), Positives = 94/249 (37%), Gaps = 60/249 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--- 174
+ +L+ + G+ GEV VC T H +K + V+ V + E+D
Sbjct: 94 YNILSSLTPGSEGEVFVC----TKHGDEQRK--------KVIVKAVTGGKTPGREIDILK 141
Query: 175 --SNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIE 230
S+ I+ L +++ + ++M D+ T + R L ++A + +L A+
Sbjct: 142 TISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALA 199
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H IHRD+K +N+ LD+ + L DFG LD Q
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC--------------- 244
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
Y GT + +PE+L Y + D WS G +++EM
Sbjct: 245 ------------------------YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
Query: 351 LVGYPPFYS 359
V +
Sbjct: 281 SVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 64/269 (23%), Positives = 107/269 (39%), Gaps = 57/269 (21%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D L +G G FG V+ + + V A+K +K+ M +E + L E
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEK--- 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTED--EARFYVAETVLAIESI 232
+V+LY +Y++ EY+ G ++ L K E V E + +ES
Sbjct: 61 -LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES- 118
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+IHRD+ N L+D G +++SDFGL + + + ++T SS ++ P
Sbjct: 119 --KQFIHRDLAARNCLVDDQGCVKVSDFGLSR-----YVLDDEYT-------SSVGSKFP 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML- 351
W PEVLL + + D W+ G +M+E+
Sbjct: 165 V-----------RWS-----------------PPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
Query: 352 VGYPPFYSDDPMSTCRKIVN----WRTHL 376
+G P+ + T K+ +R HL
Sbjct: 197 LGKMPYERFNNSETVEKVSQGLRLYRPHL 225
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 21/167 (12%)
Query: 115 ADDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + + A+K LK E + E L
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAEL 61
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--------------TLTE 215
L IVK Y + + ++ EY+ GD+ L LT
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + + + H++HRD+ N L+ +++ DFG+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 5e-07
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNLLAEV 173
+G G FG V+ + + K + A+K LK K E+LR E N++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---------EANVMQQL 53
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
D+ IV++ + E L+ME G + L + +TE V + + ++ +
Sbjct: 54 DNPYIVRM-IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ +++HRD+ N+LL + ++SDFGL K L
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FG V + + + V A+K + + M +E E ++ ++ +V+LY
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+ LY++ E++ G ++ L R+ L++D + +E + ++ +IHRD+
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ G +++SDFG+ + + + ++T SS + P
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR-----YVLDDEYT-------SSSGAKFPV--------- 165
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359
+ PEV Y + D WS G +M+E+ G PF
Sbjct: 166 -------------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 60/250 (24%), Positives = 96/250 (38%), Gaps = 63/250 (25%)
Query: 123 MIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+IG G FGEV R K G A+K LK + Q +E +++ + D I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNII 68
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI------- 232
L + + ++ EY+ G + L + D +F V + V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
Y+HRD+ N+L++ ++SDFGL + L E D P
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL------EDD----------------P 160
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTP---DYIAPEVLLKKGYGMECDWWSLGAIMYE 349
A AY+T G + APE + + + D WS G +M+E
Sbjct: 161 EA-------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201
Query: 350 -MLVGYPPFY 358
M G P++
Sbjct: 202 VMSYGERPYW 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 55/251 (21%), Positives = 106/251 (42%), Gaps = 60/251 (23%)
Query: 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ + +LL IGKG FG+V + + G+ A+K +K + AE +++ +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 173 VDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAI 229
+ + +V+L ++ LY++ EY+ G ++ L + L D + + A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
E + ++++HRD+ N+L+ + ++SDFGL K + S+ Q+
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD---------------- 157
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP-DYIAPEVLLKKGYGMECDWWSLGAIMY 348
T P + APE L +K + + D WS G +++
Sbjct: 158 ---------------------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 190
Query: 349 EML----VGYP 355
E+ V YP
Sbjct: 191 EIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+L +G G FGEV + T V A+K LK M E E ++ ++ +
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-----------VAETV 226
+V+LY ++E +Y++ EY+ G ++ D L E + +AE +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLL------DFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ES +YIHRD+ N+L+ + +++DFGL
Sbjct: 117 AYLES---RNYIHRDLAARNILVGENLVCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 37/148 (25%), Positives = 68/148 (45%), Gaps = 7/148 (4%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
+LL +G G FGEV T V A+K LK M + AE ++ ++ +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLRHPKL 63
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH 236
++LY +E +Y++ E + G ++ L L + A+ + + +
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
YIHRD+ N+L+ + +++DFGL +
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 46/235 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+ L +G G FG V + + + V A+K +++ M +E + L
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKLSHPN--- 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKH 235
+V+LY ++++ EY+ G ++ L + E + V A+E + +
Sbjct: 61 -LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+IHRD+ N L+ + +++SDFGL + L +Q +T SSQ + P
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLAR----YVLDDQ-YT-------SSQGTKFPV-- 165
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
W PEV + + D WS G +M+E+
Sbjct: 166 ---------KWA-----------------PPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FGEV + V A+K +K M VE AE N++ + + +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 67
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF--YVAETVLAIESIHKHHYIHRD 241
+ E +Y+I E++ G ++ L + + + + A+ + I + +YIHRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLD 267
++ N+L+ +++DFGL + ++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE 153
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 44/253 (17%), Positives = 95/253 (37%), Gaps = 60/253 (23%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G+G+FG V V + + V A+K + ++ +R + E ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRV-AIKTVNENASMR--ERIEFLNEASV 62
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-------- 221
+ E + + +V+L + ++ME + GD+ + L R +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKF 121
Query: 222 ---VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
AE + + ++HRD+ N ++ + +++ DFG+ + + E D+
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYY- 175
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
R + +L ++APE L + +
Sbjct: 176 ------------RKGG---------------KGLLPVR------WMAPESLKDGVFTTKS 202
Query: 339 DWWSLGAIMYEML 351
D WS G +++EM
Sbjct: 203 DVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 56/231 (24%)
Query: 149 LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY-------CSFQDD-----EF--LYLI 194
+KK + V+H E ++ +D + IVK+Y +D E +Y++
Sbjct: 35 VKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIV 94
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
EY+ + ++ + L+E+ AR ++ + + ++ IH + +HRD+KP N+ ++
Sbjct: 95 QEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152
Query: 255 -LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRML 313
L++ DFGL + +D H+ ++ L
Sbjct: 153 VLKIGDFGLARIVD------------------------------------PHYS-HKGYL 175
Query: 314 AYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ V T Y +P +LL Y D W+ G I EML G P F +
Sbjct: 176 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 59/268 (22%), Positives = 97/268 (36%), Gaps = 67/268 (25%)
Query: 107 RLQRHKMGADDFELLTMIGKGAFGEVRVC--------REKTTGHVYAMKKLKKSEML--- 155
+L+ F ++ + GAFG++ +C E G + K E L
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198
Query: 156 --RRGQVEHVRAERNLLA--EVDSNCIVKLYCSFQDDEFLYLIME--------YLPGGDM 203
+ G ++ E +LA ++ I+K+ + + Y+I + ++
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA- 257
Query: 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263
KD + R + + + A+E IH IHRDIK +N+ L+ G + L DFG
Sbjct: 258 ---FDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323
P ++K R Y VGT
Sbjct: 315 MP----------------------------------------FEKEREAFDYGWVGTVAT 334
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEML 351
+PE+L GY D WS G I+ +ML
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 38/151 (25%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK M +E E ++ ++
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+ +V+LY + +E +Y++ EY+ G ++ L + L A+ + I
Sbjct: 61 DKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ +YIHRD++ N+L+ +++DFGL +
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 55/270 (20%), Positives = 103/270 (38%), Gaps = 75/270 (27%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVY-----------AMKKLKKSEMLRRGQVEHVRA 165
L +G+GAFG+V G + A+K LK++ + + R
Sbjct: 6 AVRFLEELGEGAFGKV------YKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQ 57
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR---------------- 209
E L++++ IV L ++ ++ EYL GD+ L+R
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
K +L + + +E + HH++HRD+ N L+ + +++SDFGL +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----- 172
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ S + R +++ +L ++ PE +
Sbjct: 173 -------------DIYSADYYR---------------VQSKSLLPVR------WMPPEAI 198
Query: 330 LKKGYGMECDWWSLGAIMYEML-VGYPPFY 358
L + E D WS G +++E+ G P+Y
Sbjct: 199 LYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 25/128 (19%), Positives = 48/128 (37%), Gaps = 11/128 (8%)
Query: 138 KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV--KLYCSFQDDEFLYLIM 195
T Y +K E + E +L + + K+ S + D + YL+M
Sbjct: 18 GTKDEDYVLKINPSRE-----KGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72
Query: 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255
E++ G L +++ +AE + + + H D+ P N+L+D L
Sbjct: 73 EWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKIL 128
Query: 256 RLSDFGLC 263
+ D+
Sbjct: 129 GIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY----------AMKKLKKSEMLRRGQVEHVRA 165
+D L IG+G FG+V VY A+K K E
Sbjct: 6 EDITLGRCIGEGQFGDVYQ-------GVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQ 56
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMRKDTLTEDEARFYVAE 224
E ++ + D IVKL ++ ++++ME P G++ L + K +L Y +
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
A+ + ++HRDI N+L+ ++L DFGL + L+
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 38/154 (24%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M+ ++ E ++ ++
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIH 233
+ +V LY + +E +Y++ E++ G ++ L D L + A+ + I
Sbjct: 61 DKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ +YIHRD++ N+L+ +++DFGL + ++
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 58/274 (21%), Positives = 102/274 (37%), Gaps = 73/274 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHV-------YAMKKLKKSEMLRRGQVEHVRAERN 168
++ E + IG+GAFG RV + + G + A+K LK+ Q + R E
Sbjct: 5 NNIEYVRDIGQGAFG--RVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADFQR-EAA 60
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------------------- 207
L+AE D IVKL + + L+ EY+ GD+ L
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 208 -MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ L+ E + + + + ++HRD+ N L+ + ++++DFGL +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-- 178
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
+ D+ +E A P R ++ P
Sbjct: 179 ---NIYSADYYKA---------SENDAIPIR-------------------------WMPP 201
Query: 327 EVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYS 359
E + Y E D W+ G +++E+ G P+Y
Sbjct: 202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 40/174 (22%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+D + +IG+G FG+V R K G A+K++K+ + +H R+ E+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDH----RDFAGEL 58
Query: 174 DSNC-------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK---------------- 210
+ C I+ L + + +LYL +EY P G+++ L +
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 211 DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
TL+ + + A+ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 55/240 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDS 175
+F L +G G FGEV K V A+K LK ++L++ + V+A + L +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKH-- 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-----VAETVLAIE 230
++ L+ E +Y+I E + G ++ L + A VAE + +E
Sbjct: 64 --LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ IHRD+ N+L+ + +++DFGL + L ++D + ++
Sbjct: 122 E---QNSIHRDLAARNILVGEDLVCKVADFGLAR------LIKEDVYLSSDKK------- 165
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
P + + APE + + D WS G ++YEM
Sbjct: 166 ---IPYK-------------------------WTAPEAASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 34/162 (20%), Positives = 72/162 (44%), Gaps = 24/162 (14%)
Query: 121 LTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHV----RAERNLLA 171
+T +G+G FGEV + + E+ + +K L+K++ E++ R E ++
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------DENLQSEFRRELDMFR 63
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--------RKDTLTEDEARFYVA 223
++ +V+L ++ E Y+I+EY GD+ L K + + +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 224 ETV-LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ L ++ + ++HRD+ N L+ +++S L K
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLLAEV-DS 175
F++L+++G+G FG+V ++ A+K ++ + R ++E E+ A+ D
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
++K+ FQ++ I+ G ++ +M+ + + +T +A++ H
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250
Query: 236 -HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP+N+L++ SD +D T N P
Sbjct: 251 LHLMHTDLKPENILMET------SD----TVVDPVT-----------------NRALPPD 283
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
P R + L R + V T Y +PEV+L G+ D WS+G I+YE+ G
Sbjct: 284 PCRVRICDLGGCCDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 54/263 (20%), Positives = 105/263 (39%), Gaps = 75/263 (28%)
Query: 124 IGKGAFGEVRVCREKTTGHVY----------AMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+G+ AFG++ GH+Y A+K LK ++ Q + E +L+AE+
Sbjct: 13 LGECAFGKI------YKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMT-LLMR----------------KDTLTED 216
IV L ++ + ++ EYL GD+ L+MR K +L
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + +E + H ++H+D+ N+L+ + H+++SD GL + + + D+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA-----DY 179
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
R Q + L + ++ PE ++ +
Sbjct: 180 Y-------------------RVQPKSLLPIR---------------WMPPEAIMYGKFSS 205
Query: 337 ECDWWSLGAIMYEML-VGYPPFY 358
+ D WS G +++E+ G P+Y
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 63/255 (24%)
Query: 124 IGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+G+GAFG+V +C E+ V A+K LK + R H AE LL +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILV-AVKTLKDASDNARKDF-HREAE--LLTNLQHEH 68
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-------------DTLTEDEARFYVAE 224
IVK Y + + L ++ EY+ GD+ L LT+ + +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + H++HRD+ N L+ + +++ DFG+ + + + + +G +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY----YRVGGH--- 181
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
P R ++ PE ++ + + E D WSLG
Sbjct: 182 -------TMLPIR-------------------------WMPPESIMYRKFTTESDVWSLG 209
Query: 345 AIMYEMLV-GYPPFY 358
+++E+ G P+Y
Sbjct: 210 VVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 19/165 (11%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D LL +G GAFGEV R A+K L E E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIM 63
Query: 171 AEVDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYV 222
++ + IV+L SF+ ++++E + GGD+ + L R +LT + F
Sbjct: 64 SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR---LSDFGLCK 264
+ + + ++H+IHRDI N LL G R ++DFG+ +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 63/251 (25%)
Query: 123 MIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVR----AERNLLAEVDS 175
+IG G FGEV R K G A+K LK G E R +E +++ + D
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS------GYTEKQRRDFLSEASIMGQFDH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI--- 232
I+ L + +I E++ G + + L + D +F V + V + I
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAG 118
Query: 233 ----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ +Y+HRD+ N+L++ ++SDFGL + L+ T D T ++L G
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT---SDPTYTSSLGGK--- 172
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
P R + APE + + + D WS G +M+
Sbjct: 173 -----IPIR-------------------------WTAPEAIAYRKFTSASDVWSYGIVMW 202
Query: 349 E-MLVGYPPFY 358
E M G P++
Sbjct: 203 EVMSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 5e-05
Identities = 38/159 (23%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYVAETVLA 228
+V+LY + +E +Y++ EY+ G ++ L +R L + A+
Sbjct: 61 EKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASG 114
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + + +Y+HRD++ N+L+ + +++DFGL + ++
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 6e-05
Identities = 14/67 (20%), Positives = 27/67 (40%), Gaps = 5/67 (7%)
Query: 418 DGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
G+DW ++ +E F+P++ DT NF+ + T + + F
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEP---F 57
Query: 476 VGYTYKN 482
G++Y
Sbjct: 58 RGFSYVF 64
|
Length = 64 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 38/171 (22%), Positives = 74/171 (43%), Gaps = 32/171 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKS--------EMLRRGQVEHVR----AERNLLA 171
+G+G FGEV +C + + +MLR + R E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV----- 226
+ + I++L D+ L +I EY+ GD+ L ++ E E+ F A +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR----EIESTFTHANNIPSVSI 128
Query: 227 -------LAIESIHKH----HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ I S K+ +++HRD+ N L+ + ++++DFG+ + L
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 37/166 (22%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC----- 177
+IG+G FG+V R K G ++ + ++ + R+ E++ C
Sbjct: 2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHH 55
Query: 178 --IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEA----------------- 218
I+ L + + +LYL +EY P G+++ L + L D A
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
F A+ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 116 HF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 39/166 (23%), Positives = 71/166 (42%), Gaps = 24/166 (14%)
Query: 124 IGKGAFGEVRVCREKT-TGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G G+FG VR T G V A+K LK ++ ++ E ++ +D +++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIR 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL--------AIESI 232
LY L ++ E P G ++ D L +D ++ T+ + +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLL------DRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQ 274
+IHRD+ N+LL +++ DFGL + L D ++E
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 38/172 (22%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D + +IG+G FG+V K G +K +ML+ E+ R+ E++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASEN--DHRDFAGELEV 55
Query: 176 NC-------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DT 212
C I+ L + ++ +LY+ +EY P G+++ L + T
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
LT + + ++ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 54/279 (19%), Positives = 98/279 (35%), Gaps = 64/279 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
D L +G+GAFG+V + + A+K LK + R + E LL
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----------------MRKDTLTE 215
+ IVK Y D + L ++ EY+ GD+ L K L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+ ++ + + H++HRD+ N L+ +++ DFG+ + + +
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---- 178
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335
+ +G + P R ++ PE ++ + +
Sbjct: 179 YRVGGH----------TMLPIR-------------------------WMPPESIMYRKFT 203
Query: 336 MECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWR 373
E D WS G I++E+ G P++ I R
Sbjct: 204 TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 77/274 (28%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHV--------YAMKKLKKSEMLRRGQVEHVRAERN 168
+ L +G+G FG+V + T + A+K LK++ ++ + +E N
Sbjct: 1 NLVLGKTLGEGEFGKVV---KATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFN 55
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--RK--------------DT 212
LL +V+ ++KLY + D L LI+EY G + + L RK
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 213 LTEDEARFYVAETVLA--------IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
L + R +++ ++ + + +HRD+ N+L+ + +++SDFGL +
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324
+ E+D + KR++ W +
Sbjct: 176 -----DVYEED-----------------SYVKRSKGRIPVKW-----------------M 196
Query: 325 APEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
A E L Y + D WS G +++E++ +G P+
Sbjct: 197 AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKK--SEMLRRGQVEHVRAERNL 169
+ +IG G FGEV R K G A+K LK S+ R + E ++
Sbjct: 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL----TEASI 58
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ + D I++L + +I EY+ G + L D +F V + V +
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGML 112
Query: 230 ESI-------HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
I + +Y+HRD+ N+L++ ++SDFGL + L+ S
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 10/156 (6%)
Query: 118 FELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
E + ++G GAFG V EK V A+K L++ + E + E ++A
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPV-AIKVLREETS-PKANKEILD-EAYVMAS 65
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIES 231
VD +V+L + LI + +P G ++ + KD + + + +
Sbjct: 66 VDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +HRD+ N+L+ H++++DFGL K LD
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 47/248 (18%)
Query: 119 ELLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
ELLT+IG+G V + R K TG ++++ E V ++ E ++ +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHK 234
IV +F D L+++ ++ G L+ D ++E + + + A++ IH
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HR +K ++L+ G + LS GL
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLS--GL-------------------------------- 145
Query: 295 PKRTQQEQLQHWQKNRRML---AYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349
R+ + H Q+ R + YS P +++PEVL + +GY + D +S+G E
Sbjct: 146 --RSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACE 202
Query: 350 MLVGYPPF 357
+ G+ PF
Sbjct: 203 LANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 58/259 (22%), Positives = 106/259 (40%), Gaps = 55/259 (21%)
Query: 116 DDFELLTMIGKGAFGEVR------VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ +G GAFG+V + + V A+K LK + + E + +E +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTA--HSSEREALMSELKI 91
Query: 170 LAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETV 226
++ + ++ IV L + + +I EY GD++ L RK LT ++ + +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHL-RLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + + IHRD+ N+LL +G + ++ DFGL + I N+ N
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLAR------------DIMNDSNYV 198
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ N R P + ++APE + Y E D WS G
Sbjct: 199 VKGNAR--LPVK-------------------------WMAPESIFNCVYTFESDVWSYGI 231
Query: 346 IMYEML-VGYPPFYSDDPM 363
+++E+ +G P Y P+
Sbjct: 232 LLWEIFSLGSNP-YPGMPV 249
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 40/139 (28%), Positives = 53/139 (38%), Gaps = 40/139 (28%)
Query: 222 VAETVL-AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
VA +L AI+ IH IHRDIK +N+L++ + L DFG C F G+
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA----C-------FARGS 313
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ P Y GT D APEVL Y D
Sbjct: 314 W-----------STP-----------------FHYGIAGTVDTNAPEVLAGDPYTPSVDI 345
Query: 341 WSLGAIMYEMLVGYPPFYS 359
WS G +++E V +S
Sbjct: 346 WSAGLVIFEAAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 118 FELLTMIGKGAFGEVR---VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
F L M+GKG FG VR + E + A+K LK +++ +E E + E D
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 175 SNCIVKLY-CSFQDDEFLYL-----IMEYLPGGDMMTLLMRKD------TLTEDEARFYV 222
++KL S + L I+ ++ GD+ T L+ TL ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ +E + ++IHRD+ N +L++ + ++DFGL K
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 34/163 (20%), Positives = 71/163 (43%), Gaps = 18/163 (11%)
Query: 118 FELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+L ++G+G FG V + + + V A+K +K ++E +E + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYS-EIEEFLSEAACMKDF 58
Query: 174 DSNCIVKLY-CSFQDDEFLYL-----IMEYLPGGDMMTLLMRKDT------LTEDEARFY 221
D ++KL F+ + I+ ++ GD+ + L+ L +
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ + L +E + ++IHRD+ N +L + + ++DFGL K
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 38/175 (21%), Positives = 70/175 (40%), Gaps = 39/175 (22%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--------VEHVRAERN------L 169
+G+G FGEV +C M+K + V+ +R + N
Sbjct: 13 LGEGQFGEVHLCE------AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 170 LAEV-------DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-----------KD 211
L E+ D N I++L + L +I EY+ GD+ L R
Sbjct: 67 LKEIKIMSRLKDPN-IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
T++ F + ++ + +++HRD+ N L+ K ++++DFG+ + L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 55/248 (22%), Positives = 97/248 (39%), Gaps = 59/248 (23%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVR----AERNLLAEVDSNCI 178
+IG G FGEV K G +K L+ G E R +E +++ + + I
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKT---LKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--- 235
++L + +I EY+ G + L D + + + + + I + K+
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSD 125
Query: 236 -HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+Y+HRD+ N+L++ ++SDFGL + L +D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVL-------EDD------------------ 160
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTP---DYIAPEVLLKKGYGMECDWWSLGAIMYE-M 350
P+ T Y+T G + APE + + + D WS G +M+E M
Sbjct: 161 PEGT----------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
Query: 351 LVGYPPFY 358
G P++
Sbjct: 205 SFGERPYW 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 50/259 (19%), Positives = 96/259 (37%), Gaps = 69/259 (26%)
Query: 124 IGKGAFGEVRVC--------REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+G+GAFG+V + ++K V A+K+ +S + E LL +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ------DFQREAELLTVLQH 66
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEAR------------FY 221
IV+ Y + L ++ EY+ GD+ L D
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 222 VAETVLA-IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+A + + + + H++HRD+ N L+ + +++ DFG+ + + + + +G
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY----YRVGG 182
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
R P R ++ PE +L + + E D
Sbjct: 183 ----------RTMLPIR-------------------------WMPPESILYRKFTTESDI 207
Query: 341 WSLGAIMYEMLV-GYPPFY 358
WS G +++E+ G P+Y
Sbjct: 208 WSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 62/236 (26%)
Query: 145 AMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203
A+K LK K+E R E + E + + + IV L ++ L +I Y D+
Sbjct: 39 AIKTLKDKAEGPLR---EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 204 MT-LLMR---------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247
L+MR K TL + V + +E + HH +H+D+ N+
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV 155
Query: 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQ 307
L+ ++++SD GL + + + + +GN+L P R
Sbjct: 156 LVFDKLNVKISDLGLFREVYAADYYK---LMGNSL-----------LPIR---------- 191
Query: 308 KNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF--YSD 360
+++PE ++ + ++ D WS G +++E+ G P+ YS+
Sbjct: 192 ---------------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 552 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.58 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.46 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.64 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.36 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.36 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.32 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.17 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.09 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.83 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.76 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.74 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.67 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.64 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.59 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.59 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.57 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 97.54 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.46 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.32 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.9 | |
| PLN02236 | 344 | choline kinase | 96.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.84 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.79 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.77 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.75 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.58 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.38 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.2 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 96.08 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.87 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.82 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.81 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.71 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.58 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.29 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.09 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.55 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.44 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.36 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.13 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-117 Score=915.02 Aligned_cols=458 Identities=67% Similarity=1.036 Sum_probs=420.4
Q ss_pred chhccCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCHHHHHHHHHHHHhhhhhhhhhhccccCCC
Q 008810 37 DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGAD 116 (552)
Q Consensus 37 ~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~r~~~~e~~l~~~~~~~e~~~~~~~~~~~~e~~~~~~~~~~~~~~ 116 (552)
.+.+.++.|++++++++.||+++|..+++.+++|++|+..+++.++..+++++++.+.++.+..++++|+|++|.++..+
T Consensus 62 ~~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~~~ 141 (550)
T KOG0605|consen 62 YEFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLSLD 141 (550)
T ss_pred cccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCCcc
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
||+++++||+||||+||+|+.+.||++||||+|+|+.+...+|++|+++|++||...++||||+|||+|||.+++|||||
T Consensus 142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME 221 (550)
T KOG0605|consen 142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME 221 (550)
T ss_pred cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc--
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ-- 274 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~-- 274 (552)
|+||||++++|++.+.|+|+.++||++|+++||+.||++|||||||||+|+|||..|||||+|||||+.+.+......
T Consensus 222 ylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 222 YLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred ecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 999999999999999999999999999999999999999999999999999999999999999999988766432210
Q ss_pred -cccccCCCCCCCCCCCC---CCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 275 -DFTIGNNLNGSSQNNER---PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 275 -~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
+.....+...+...+.. .....+...+++.+|+++|+.+++++||||+|||||||.+++|+..|||||||||||||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 00011111111111111 11233447889999999999999999999999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhcCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEA 430 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~ 430 (552)
|+|+|||+++++.++|++|++|+..+.+|.+..+|++|+|||.+|||||.+|+|+.|++||+.||||++|+|+.|++++|
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~a 461 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLREMPA 461 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhhcCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCcccCcCccccccccccccCCCCCCccccccc-------ccCCcccCceecCcccccCCCCCch
Q 008810 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLS-------SKDINFVGYTYKNFEIVNDYQVPGM 494 (552)
Q Consensus 431 pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~f~g~~~~~~~~~~~~~~~~~ 494 (552)
||+|.+++++||+||++|++++...+++...++|+++.. +++.+|+||||++++.++....+.+
T Consensus 462 pfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~~~~~~~~~~~ 532 (550)
T KOG0605|consen 462 PFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFDGLNKANSLLI 532 (550)
T ss_pred CCCCCCCCcccccccccCcccccCcccccccccchhhhhcccccCCcccccccceeeeccccccccccccc
Confidence 999999999999999999999888888888888887655 5678899999999999988777643
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-87 Score=699.94 Aligned_cols=438 Identities=43% Similarity=0.778 Sum_probs=379.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCHHHHHHHHHHHHhhhhhhhhhhccccCCCCeeEEeeeeecCC
Q 008810 50 AAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAF 129 (552)
Q Consensus 50 ~~~k~~~~~~~~~~~~~~~~~~~r~~~~e~~l~~~~~~~e~~~~~~~~~~~~e~~~~~~~~~~~~~~~f~~~~~IG~G~f 129 (552)
.+-|.|+|+|..+.++..++|..|+..||++|...++++..+....+.+.++|..|+||+|.++...-|..++.||-|+|
T Consensus 563 qafkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGAF 642 (1034)
T KOG0608|consen 563 QAFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGAF 642 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeeccccc
Confidence 35678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCchhhHHhh
Q 008810 130 GEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR 209 (552)
Q Consensus 130 G~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~ 209 (552)
|+|+||+..+|...||||.|+|..++.++++.|+++|++||++.+++|||+||++|||.++||+||+|++||||+.+|.+
T Consensus 643 GeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr 722 (1034)
T KOG0608|consen 643 GEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR 722 (1034)
T ss_pred ceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC----CcccccccccCCCCCC
Q 008810 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS----TLQEQDFTIGNNLNGS 285 (552)
Q Consensus 210 ~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~----~~~~~~~~~~~~~~~~ 285 (552)
.+.|.|+.|+||++++.+|++++|+.|+|||||||+|||||.+|||||+|||||..+... .++..+....++....
T Consensus 723 mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~ 802 (1034)
T KOG0608|consen 723 MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPS 802 (1034)
T ss_pred hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCc
Confidence 999999999999999999999999999999999999999999999999999999876432 1121111111111000
Q ss_pred CCCCCCCCCCccchHHHHHH--HhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChh
Q 008810 286 SQNNERPAAPKRTQQEQLQH--WQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (552)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~--~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~ 363 (552)
.....-..+ -..+.. .+..+|.++.+.|||+.|+|||||...+|+..|||||.|||||||++|.+||..+++.
T Consensus 803 ~e~~d~~~~-----lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 803 PEWADISKC-----LKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred hhhcccccc-----chHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence 000000011 112222 2566788999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccccCCcccCc
Q 008810 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQ 443 (552)
Q Consensus 364 ~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~~~~~~d~~ 443 (552)
++..+|++|+..+.+|....+|.+|.+||.+|+|+++.|+|..|+++|++||||++|||..|++..+||||.+..+.||+
T Consensus 878 ~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTS 957 (1034)
T KOG0608|consen 878 ETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTS 957 (1034)
T ss_pred cceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccCCCccc
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccccccccccCCCCCCcccccccccCCcccCceecCcccccCCCCCch
Q 008810 444 NFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGM 494 (552)
Q Consensus 444 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~~~~~~~ 494 (552)
|||.++.+......+...+-|......-+-.|..|||..|- ++.+.|.+
T Consensus 958 NFdpvdpeklwnddses~~~~~~~nkhpehaFyEFTfRrFF--Ddng~P~~ 1006 (1034)
T KOG0608|consen 958 NFDPVDPEKLWNDDSESPNVRDTLNKHPEHAFYEFTFRRFF--DDNGYPSL 1006 (1034)
T ss_pred cCCcCCccccccccccCCCcccccccCCccceeEeeeehhc--cCCCCccc
Confidence 99999875433322222222322222233579999999874 34444543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-81 Score=624.28 Aligned_cols=292 Identities=48% Similarity=0.863 Sum_probs=271.9
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+..++|+++++||+|+||+||+|+.++|++.||||+|+|..+...+.++|+++|++||..++||+||+|+++||+.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|||+||++||+|+.+|.+.+.|+|..++||++||++||.|||++|||||||||||||||.+|||+|+|||||+..-....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999995322110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
...++|||+.|||||++.+.+|+.+||||||||++||||
T Consensus 181 -----------------------------------------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML 219 (357)
T KOG0598|consen 181 -----------------------------------------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEML 219 (357)
T ss_pred -----------------------------------------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHh
Confidence 122589999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC-CChhhhhcCCCcCCCChhhhhh--
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIYQ-- 427 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~-~~a~eil~HpfF~~i~w~~l~~-- 427 (552)
+|.+||++.+...++.+|...+ +..+. ..+|.+++|||++||. ||++|+|. .++++|++||||++|||+.+.+
T Consensus 220 ~G~pPF~~~~~~~~~~~I~~~k--~~~~p-~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~ 296 (357)
T KOG0598|consen 220 TGKPPFYAEDVKKMYDKILKGK--LPLPP-GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKK 296 (357)
T ss_pred hCCCCCcCccHHHHHHHHhcCc--CCCCC-ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcC
Confidence 9999999999999999999743 33333 2599999999999999 99999984 4699999999999999999985
Q ss_pred cCCCCccccCCcccCcCccc
Q 008810 428 MEAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 428 ~~~pf~P~~~~~~d~~~f~~ 447 (552)
+.|||+|.+.+..|++||+.
T Consensus 297 l~PpF~P~~~~~~~~~~Fd~ 316 (357)
T KOG0598|consen 297 LSPPFKPNVTGLEDTSNFDN 316 (357)
T ss_pred CCCCeecCCCCccccccccH
Confidence 88999999999999999997
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-81 Score=685.78 Aligned_cols=345 Identities=48% Similarity=0.859 Sum_probs=306.3
Q ss_pred HHHHhhhhhhhhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC
Q 008810 96 KFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175 (552)
Q Consensus 96 ~~~~~~e~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h 175 (552)
.++...+.-...+...++..+||+++++||+|+||+|.+|+++.|+++||||+++|-.|.++.....|+.|++||...++
T Consensus 55 ~fl~~~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns 134 (1317)
T KOG0612|consen 55 EFLNRYKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNS 134 (1317)
T ss_pred HHHHHhHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCc
Confidence 34444444444566677889999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcE
Q 008810 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255 (552)
Q Consensus 176 p~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~i 255 (552)
+|||.|+++|||+.++||||||+|||||.++|.+.+.++|+.|+||+++|+.||..||+.|+|||||||+|||||..|||
T Consensus 135 ~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 135 EWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred HHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcE
Confidence 99999999999999999999999999999999998999999999999999999999999999999999999999999999
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc----
Q 008810 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---- 331 (552)
Q Consensus 256 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---- 331 (552)
||+|||-|-.++.... ..+...||||+|++||+|..
T Consensus 215 kLADFGsClkm~~dG~----------------------------------------V~s~~aVGTPDYISPEvLqs~~~~ 254 (1317)
T KOG0612|consen 215 KLADFGSCLKMDADGT----------------------------------------VRSSVAVGTPDYISPEVLQSQGDG 254 (1317)
T ss_pred eeccchhHHhcCCCCc----------------------------------------EEeccccCCCCccCHHHHHhhcCC
Confidence 9999999988763321 12346799999999999983
Q ss_pred -CCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhh
Q 008810 332 -KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADE 410 (552)
Q Consensus 332 -~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~e 410 (552)
+.||..||||||||+|||||+|..|||+++-.+||.+|++.+..+.||+...+|++++|||.+|||+|+.|+|+.|+++
T Consensus 255 ~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngied 334 (1317)
T KOG0612|consen 255 KGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIED 334 (1317)
T ss_pred ccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHHH
Confidence 4599999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred hhcCCCcCCCChhhhhhcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecC
Q 008810 411 IKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (552)
Q Consensus 411 il~HpfF~~i~w~~l~~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (552)
|+.||||.|++|+.|+...|||+|+++++.||+||+-.++......+... ...+.....++.|+||||..
T Consensus 335 ik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~e~~p~--~~~~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 335 IKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDAETFPP--RIPKAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred HHhCccccCCChhhhhhcCCCCCCcCCCCCccccccccccccchhhccCC--CCCCCCcCCcCCeeeeeecc
Confidence 99999999999999999999999999999999999643322211111110 11123445778999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-78 Score=588.46 Aligned_cols=292 Identities=46% Similarity=0.920 Sum_probs=279.4
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
...+||++++.||.|+||.|.+++++.+|..||||+|.|..+.+..|++|+.+|+.+|+.+.||++++|+++|+|..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 77899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
|||||++||.|+.+|.+.++|+|..|+||++||++||+|||+++||||||||||||||.+||+||+|||+||.+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999976421
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
+++.||||+|+|||++..++|+.++|||||||++|||+.
T Consensus 198 -----------------------------------------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla 236 (355)
T KOG0616|consen 198 -----------------------------------------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA 236 (355)
T ss_pred -----------------------------------------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc
Confidence 457999999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh--
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ-- 427 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~-- 427 (552)
|++||++.++..++.+|+. ..+.||. .+|++++|||++||+ |-.+|.|. .|..+|++||||++++|..+.+
T Consensus 237 G~pPF~~~~~~~iY~KI~~--~~v~fP~--~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ 312 (355)
T KOG0616|consen 237 GYPPFYDDNPIQIYEKILE--GKVKFPS--YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRK 312 (355)
T ss_pred CCCCCcCCChHHHHHHHHh--CcccCCc--ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhcc
Confidence 9999999999999999998 6789996 899999999999999 99999885 4799999999999999999985
Q ss_pred cCCCCcc-ccCCcccCcCcccccccc
Q 008810 428 MEAAFIP-EVNDELDTQNFEKFEESD 452 (552)
Q Consensus 428 ~~~pf~P-~~~~~~d~~~f~~~~~~~ 452 (552)
++|||+| .+..+.|++||+.+.+++
T Consensus 313 ie~P~~pp~~~~~gdtsnfd~y~e~~ 338 (355)
T KOG0616|consen 313 IEPPFEPPNIHGPGDTSNFDDYEEED 338 (355)
T ss_pred ccCCCCCccccCCccccccccccccc
Confidence 8999998 899999999999987664
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-75 Score=615.08 Aligned_cols=323 Identities=37% Similarity=0.701 Sum_probs=290.5
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
.+++.++|.++++||+|+||+|+++..+.+++.||||+++|..++.+..++.++.|..|+... +||+++.||++||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 478899999999999999999999999999999999999999999999999999999999887 5999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
++|+||||+.||| +.+++..+.|+|..++||+|+|++||.|||++||||||||.+|||||.+||+||+||||||.....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999999 555567789999999999999999999999999999999999999999999999999999964311
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ..+.++||||+|||||++.+..|+.++|||||||+|||
T Consensus 522 g-----------------------------------------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlye 560 (694)
T KOG0694|consen 522 G-----------------------------------------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYE 560 (694)
T ss_pred C-----------------------------------------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHH
Confidence 1 12347999999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhh
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~ 426 (552)
||+|.+||.|++..+.+..|++ ....+|. .+|.|+.+++++||. +|++|+|+ .++++|+.||||++|||+.|+
T Consensus 561 ML~Gq~PF~gddEee~FdsI~~--d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~ 636 (694)
T KOG0694|consen 561 MLVGESPFPGDDEEEVFDSIVN--DEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL 636 (694)
T ss_pred HHcCCCCCCCCCHHHHHHHHhc--CCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHh
Confidence 9999999999999999999998 5667775 899999999999999 99999997 579999999999999999998
Q ss_pred h--cCCCCccccCCcccCcCccccccccccccCCCCCCcccccccc-cCCcccCceecCc
Q 008810 427 Q--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTYKNF 483 (552)
Q Consensus 427 ~--~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~~~ 483 (552)
+ ++|||+|.++++.|.+|||+....+.+..+..... .+.. ....|.||+|.+.
T Consensus 637 ~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~----~l~~~~q~~F~~Fs~~~~ 692 (694)
T KOG0694|consen 637 NRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPR----PLTEEEQEAFRDFSFVAE 692 (694)
T ss_pred hccCCCCCCcccCChhhhcccchhhhcCCCccCCCCcc----ccchhhHHHhcCccccCC
Confidence 5 89999999999999999998555555555432221 2222 4468999999874
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-72 Score=547.33 Aligned_cols=330 Identities=39% Similarity=0.684 Sum_probs=292.1
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
-.+.++..++|+.+++||+|.||+|.+|+.+.+|+.||||+++|..++.+.++.|...|-.+|+..+||++..|-|+||+
T Consensus 160 ~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 160 KRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred cccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 34677899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+.+|+||||+.||+|+.+|.+...|+|+.++||-++|++||.|||+.+||+||||.+|+|||.+|||||+||||||.-.
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999532
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
... ....++||||.|+|||++....|+.++|||.+||+|
T Consensus 320 ~~g-----------------------------------------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVM 358 (516)
T KOG0690|consen 320 KYG-----------------------------------------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVM 358 (516)
T ss_pred ccc-----------------------------------------ceeccccCChhhcCchhhccccccceeehhhhhHHH
Confidence 110 012378999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~ 424 (552)
|||++|+.||++.+....+..|+. ..+.||. .+|++|+.|+..||. ||.+|+|.+ +|.||..|+||.+|||..
T Consensus 359 YEMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~ 434 (516)
T KOG0690|consen 359 YEMMCGRLPFYNKDHEKLFELILM--EDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEA 434 (516)
T ss_pred HHHHhccCcccccchhHHHHHHHh--hhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHH
Confidence 999999999999999999999987 6889996 899999999999998 999999853 599999999999999999
Q ss_pred hhh--cCCCCccccCCcccCcCccccccccccccCC-CCCCcccccccccCCcccCceecC
Q 008810 425 IYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTS-SKTGPWRKMLSSKDINFVGYTYKN 482 (552)
Q Consensus 425 l~~--~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~f~g~~~~~ 482 (552)
++. +.|||+|++.++.|+++||+.........++ ...++...+-.....+|--|+|.+
T Consensus 435 ~~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~ 495 (516)
T KOG0690|consen 435 TYRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSA 495 (516)
T ss_pred HHHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccchhhhhccCCcceeeec
Confidence 884 8999999999999999999743333222222 222232222223345788887765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-70 Score=550.36 Aligned_cols=327 Identities=36% Similarity=0.640 Sum_probs=272.9
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
+...+..++|++++.||+|.-|+||+|+.+.++..+|||+|.|..+..++...++..|++||+.++||+++.||..|+++
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 45667888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
++.|||||||+||||..+++++ +.|++..++||++|++.||+|||.+||||||||||||||.++|||.|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999765 68999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccc--cccccCCCCCCCCCCCCCCC-------CccchHHHHHH--------HhhhccccccccccCCCCCChhhh
Q 008810 267 DCSTLQEQ--DFTIGNNLNGSSQNNERPAA-------PKRTQQEQLQH--------WQKNRRMLAYSTVGTPDYIAPEVL 329 (552)
Q Consensus 267 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~--------~~~~r~~~~~s~~GT~~Y~APEvl 329 (552)
........ ....... . ......++.+ .....+..... ..........++|||-+|+|||++
T Consensus 230 ~~~Pt~~~s~~~~~~~~-~-~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGS-Q-PSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred CCCCeeeccCCCCCCCC-C-cccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 33211000 0000000 0 0000000000 00000000000 001112345689999999999999
Q ss_pred hcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC-CC
Q 008810 330 LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KG 407 (552)
Q Consensus 330 ~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~-~~ 407 (552)
.+.+++.++|||+|||++||||.|..||.|.+..+++.+|+. ..+.||..+.+|..|+|||++||. ||.+|+|+ .|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccc
Confidence 999999999999999999999999999999999999999997 788999988999999999999998 99999995 68
Q ss_pred hhhhhcCCCcCCCChhhhhhcCCCCccccCCc
Q 008810 408 ADEIKVHPWFDGVDWARIYQMEAAFIPEVNDE 439 (552)
Q Consensus 408 a~eil~HpfF~~i~w~~l~~~~~pf~P~~~~~ 439 (552)
|+||++||||++|+|.-++...||++|...+.
T Consensus 386 A~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~ 417 (459)
T KOG0610|consen 386 AAEIKRHPFFEGVNWALIRCARPPEIPKPVDG 417 (459)
T ss_pred hHHhhcCccccCCChhheeccCCCcCCCcccc
Confidence 99999999999999997778999999987554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-68 Score=547.53 Aligned_cols=285 Identities=39% Similarity=0.725 Sum_probs=259.6
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCce
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 190 (552)
+....||.+.+.||.|+|++|++|+.+.+++.|||||+.|..+.+...+..+..|+++|..+ +||.||+||+.|||+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 56789999999999999999999999999999999999999999999999999999999999 99999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
||+|+||+++|+|.++|.+.+.|+|..+++|++||+.||+|||++|||||||||||||||.+||+||+|||-|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999887653
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
....... .+..+ ...+.++|||..|.+||+|.....+..||+|+||||+|+|
T Consensus 229 ~~~~~~~----------------~~~~a------------~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQm 280 (604)
T KOG0592|consen 229 KSQENPV----------------DPNQA------------SSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQM 280 (604)
T ss_pred ccccCcc----------------Ccccc------------cCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHH
Confidence 2211000 00000 0012479999999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhcC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQME 429 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~ 429 (552)
|.|.|||.+.++.-++++|+. ..+.||+ .+++.++|||.+||. ||.+|++ +++|++||||.+|||+.|.+.+
T Consensus 281 laG~PPFra~NeyliFqkI~~--l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nlw~~~ 353 (604)
T KOG0592|consen 281 LAGQPPFRAANEYLIFQKIQA--LDYEFPE--GFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENLWQQT 353 (604)
T ss_pred hcCCCCCccccHHHHHHHHHH--hcccCCC--CCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhhhhcC
Confidence 999999999999999999997 5667776 799999999999998 9999999 8999999999999999999876
Q ss_pred CC
Q 008810 430 AA 431 (552)
Q Consensus 430 ~p 431 (552)
||
T Consensus 354 PP 355 (604)
T KOG0592|consen 354 PP 355 (604)
T ss_pred CC
Confidence 54
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-69 Score=536.66 Aligned_cols=331 Identities=35% Similarity=0.663 Sum_probs=296.8
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCC
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD 188 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~ 188 (552)
+..+...||.++.+||+|+||+|.++..+.|.+.||||+++|..++....++..+.|..+|+.. +-|++|+|+.+||+-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 3457788999999999999999999999999999999999999999999999999999999987 568999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+.+|+||||+.||||+.++++-+.|.|..|.||+++|+.||-+||++|||+||||.+|||||.+|||||+|||+|+.-..
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999995322
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. ..+.++||||+|||||++..++|+.++||||+||+||
T Consensus 503 ~~-----------------------------------------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLy 541 (683)
T KOG0696|consen 503 DG-----------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 541 (683)
T ss_pred CC-----------------------------------------cceeeecCCCcccccceEEecccccchhHHHHHHHHH
Confidence 11 1134789999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l 425 (552)
|||.|.+||.+++..+.++.|.. ....+|. .+|.||.+++..+|. .|.+|+|+. +-.+|..||||+.|||+++
T Consensus 542 EmlaGQpPFdGeDE~elF~aI~e--hnvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~ 617 (683)
T KOG0696|consen 542 EMLAGQPPFDGEDEDELFQAIME--HNVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL 617 (683)
T ss_pred HHHcCCCCCCCCCHHHHHHHHHH--ccCcCcc--cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence 99999999999999999999997 5778886 899999999999998 999999974 5678999999999999999
Q ss_pred h--hcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCcccccC
Q 008810 426 Y--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVND 488 (552)
Q Consensus 426 ~--~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~ 488 (552)
. +++|||.|.++-.-|++|||+|........++.. +.-|.+-+...|.||+|.|++.+..
T Consensus 618 E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD---~~v~~nldq~eF~gFsfvNpefv~~ 679 (683)
T KOG0696|consen 618 ERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPD---KLVMMNLDQSEFEGFSFVNPEFVKP 679 (683)
T ss_pred hhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCch---HHHHhcCchhhcCceeeeChhhcCC
Confidence 8 4899999999999999999997766554444322 2224444567899999999877643
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-66 Score=525.80 Aligned_cols=316 Identities=35% Similarity=0.679 Sum_probs=280.2
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
++.+.++.+.|...++||+||||+||-|+.+.||+.||+|++.|..+..+.......+|+.||.++++++||.|-|+|++
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 55678899999999999999999999999999999999999999998888888889999999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+.+||||..|.||||..+|.+.+ .|+|..++||++||++||++||..+||+|||||+|||||+.|||+|+|+|||..
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999999999997765 899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
+..... ..+.|||.+|||||++.+..|+..+|||||||
T Consensus 337 i~~g~~------------------------------------------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGC 374 (591)
T KOG0986|consen 337 IPEGKP------------------------------------------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGC 374 (591)
T ss_pred cCCCCc------------------------------------------cccccCcccccCHHHHcCCcccCCccHHHHHh
Confidence 753321 12569999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCCh----hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcC
Q 008810 346 IMYEMLVGYPPFYSDDP----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFD 418 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~ 418 (552)
++|||+.|+.||..... .+.-+.++. ....+|+ .+|+++++|++.||+ ||.+|+|+. |++++++||||+
T Consensus 375 llYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~--kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk 450 (591)
T KOG0986|consen 375 LLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSD--KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK 450 (591)
T ss_pred HHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhccc--ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence 99999999999976432 344555554 5667775 899999999999999 999999975 699999999999
Q ss_pred CCChhhhhh--cCCCCcccc-----CCcccCcCcccc-----ccccc----cccCCCCCCcccc-ccc
Q 008810 419 GVDWARIYQ--MEAAFIPEV-----NDELDTQNFEKF-----EESDN----QTKTSSKTGPWRK-MLS 469 (552)
Q Consensus 419 ~i~w~~l~~--~~~pf~P~~-----~~~~d~~~f~~~-----~~~~~----~~~~~~~~~~~~~-~~~ 469 (552)
++||.+|.. ++|||+|.. ++.+|+.+|++. ++.+. ...+.+.+.||++ |+.
T Consensus 451 ~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VKGV~ld~~D~~fy~~F~tg~vsipWQnE~~E 518 (591)
T KOG0986|consen 451 DLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVKGVKLDDTDTDFYKNFATGSVSIPWQNEMIE 518 (591)
T ss_pred cCCHhHHhccCCCCCCCCCccccchhhhhhhhhcccccceecccccHHHHHhccCCcccchHHHHHHH
Confidence 999999984 899999986 577899999853 22221 3567788899987 443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-62 Score=516.29 Aligned_cols=364 Identities=61% Similarity=1.040 Sum_probs=303.9
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||+||+|+++.+|+.||||++.+..+.......++.+|+.+|..++||||++++++|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999999877666677788999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||+||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999865432111000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
........... ................|...++...++.+||+.|+|||++.+.+|+.++|||||||++|||++|.+
T Consensus 161 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 161 RILSHALPSNF---LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccccc---cccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 00000000000 000000011112234566666667778899999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccc
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~ 435 (552)
||.+.+..+.+.+++.|...+.+|....+|+++++||.+||++|.+|+++.++.+++.||||++++|+.+....+|++|.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 99999999999999998888888877678999999999999999999988889999999999999999999899999999
Q ss_pred cCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCcc
Q 008810 436 VNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484 (552)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 484 (552)
+.+..|.++|+.+++.+.....+. .+.+....+++..|+||+|++|+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 318 LKSITDTSNFDDFEEIDLDVPTSP--GPPRGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred CCCchhhhhccccccccccccCCC--ccccccccccCCCCCCCeeeCCC
Confidence 999999999998876654433322 22233345789999999999985
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-62 Score=512.79 Aligned_cols=361 Identities=54% Similarity=0.939 Sum_probs=291.7
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||+||+|+++.+|+.||||++.+..........+++.|+.++..++||||++++++|++...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999999877666677788999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||+||+|.+++.+.+.+++..++.|+.|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~-- 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE-- 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc--
Confidence 999999999999988999999999999999999999999999999999999999999999999999998654321000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
+..........+.... ..........|..++.....+.+||+.|+|||++.+.+|+.++|||||||++|||++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 159 FYRNLNHSLPSDFTFQ----NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccc----ccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 0000000000000000 000001112344444445567899999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccc
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~ 435 (552)
||.+.+..+.+.+|..|...+.+|....+++++++||.+|+++|.+|+++.+++||++||||++++|+.+....++..+.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 314 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIE 314 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCcc
Confidence 99999999999999998888888876678999999999999999999888889999999999999999998776666667
Q ss_pred cCCcccCcCccccccccccccCCCC-CCcccccccccCCcccCceecCc
Q 008810 436 VNDELDTQNFEKFEESDNQTKTSSK-TGPWRKMLSSKDINFVGYTYKNF 483 (552)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~f~g~~~~~~ 483 (552)
+....|+++|+.+...+....+... ..| .......+..|.||||+.|
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 362 (363)
T cd05628 315 IKSIDDTSNFDEFPDSDILKPTVATSNHP-ETDYKNKDWVFINYTYKRF 362 (363)
T ss_pred CCCcchhhccCCCCccccccccccccCCc-ccccCcCCcccCCceeecC
Confidence 8888899999988765432221111 111 1122334567999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-63 Score=500.16 Aligned_cols=264 Identities=32% Similarity=0.542 Sum_probs=236.8
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh----hhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR----RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
..+.|.+.+.||+|+||.|.+|..+.||+.||||++++..... ......+.+|++||++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4566889999999999999999999999999999999876543 223445789999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC---CcEEEccccccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPL 266 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~---g~iKL~DFGlak~~ 266 (552)
+.||||||+.||+|++.+..++.+.|+..+.|+.|++.||.|||++||+||||||||||+..+ -++||+||||||..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999866 78999999999976
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC---CCccchhhh
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY---GMECDWWSL 343 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y---~~~~DiWSl 343 (552)
.... ...+.||||.|.||||+.++++ ..++|+|||
T Consensus 330 g~~s------------------------------------------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl 367 (475)
T KOG0615|consen 330 GEGS------------------------------------------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL 367 (475)
T ss_pred ccce------------------------------------------ehhhhcCCccccChhheecCCeecccchheeeec
Confidence 4221 2347899999999999998764 557899999
Q ss_pred hHHHHHHhhCCCCCCCCChhh-HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
|||+|-||+|++||.+..... ..+.|..++..+.-|.+..+|.++.+||.+||. ||++|++ ++|+|+||||+.++
T Consensus 368 GcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 368 GCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAP 444 (475)
T ss_pred cceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhccc
Confidence 999999999999998876555 778888877777777788999999999999999 9999999 99999999999876
Q ss_pred h
Q 008810 422 W 422 (552)
Q Consensus 422 w 422 (552)
-
T Consensus 445 ~ 445 (475)
T KOG0615|consen 445 C 445 (475)
T ss_pred c
Confidence 3
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-63 Score=510.29 Aligned_cols=298 Identities=38% Similarity=0.742 Sum_probs=281.1
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+...+++.+..||-||||.|=+++.+.....+|+|+++|..+....|.+|+..|++||..+++||||+||-.|.|+.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45677888999999999999999998877667999999999999999999999999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+.||-|-||+|++.|..++.|.+..++||++.++.|++|||.+|||||||||||+||+.+|.+||.|||+||.+..+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999875431
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.+.++||||.|.|||++++++++.++|+||||+++||||
T Consensus 575 -----------------------------------------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL 613 (732)
T KOG0614|consen 575 -----------------------------------------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELL 613 (732)
T ss_pred -----------------------------------------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHH
Confidence 234799999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCC--CCChhhhhcCCCcCCCChhhhhh-
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEIKVHPWFDGVDWARIYQ- 427 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~--~~~a~eil~HpfF~~i~w~~l~~- 427 (552)
+|.|||.+.+++.+|..|+.+-..+.||. .++..+.+||++|.. +|.+|+| ..|+.+|+.|-||.+.||+.|..
T Consensus 614 ~G~pPFs~~dpmktYn~ILkGid~i~~Pr--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~ 691 (732)
T KOG0614|consen 614 TGSPPFSGVDPMKTYNLILKGIDKIEFPR--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSR 691 (732)
T ss_pred cCCCCCCCCchHHHHHHHHhhhhhhhccc--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhc
Confidence 99999999999999999999888889995 899999999999998 9999999 68899999999999999999984
Q ss_pred -cCCCCccccCCcccCcCccccccccc
Q 008810 428 -MEAAFIPEVNDELDTQNFEKFEESDN 453 (552)
Q Consensus 428 -~~~pf~P~~~~~~d~~~f~~~~~~~~ 453 (552)
++|||+|.+.++.|++||+.|.....
T Consensus 692 ~L~pPi~~~va~ptD~s~Fd~~p~dnd 718 (732)
T KOG0614|consen 692 TLPPPIIPSVANPTDVSNFDNFPPDND 718 (732)
T ss_pred cCCCCccccCCCcccchhccCCCcccC
Confidence 89999999999999999999876544
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-61 Score=505.78 Aligned_cols=369 Identities=51% Similarity=0.924 Sum_probs=294.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|.+++.||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|..++|||||+++++|++..++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc--
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE-- 273 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~-- 273 (552)
|||+||+|..++.....+++..+++++.|++.||+|||+.||+||||||+|||++.+|++||+|||+|+.+.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999997542211000
Q ss_pred ccccccCCCC----CCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 274 QDFTIGNNLN----GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 274 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.....+.... +.....................|...+.....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 0000000000 000000000000011122334455555555567899999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhcC
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQME 429 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~ 429 (552)
|++|.+||.+.+..+.+.+|..|...+.+|....++.++++||.+||++|.+|+++.++.+++.||||++++|+.+..+.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~ 320 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIR 320 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHHHccCC
Confidence 99999999999988889999988888888876678999999999999999999988889999999999999999999999
Q ss_pred CCCccccCCcccCcCccccccccccccCCCCC-Ccc-cccccccCCcccCceecCcc
Q 008810 430 AAFIPEVNDELDTQNFEKFEESDNQTKTSSKT-GPW-RKMLSSKDINFVGYTYKNFE 484 (552)
Q Consensus 430 ~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~f~g~~~~~~~ 484 (552)
+|++|.+....|+.+|................ .+. .....+.+..|.||||+.|+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (377)
T cd05629 321 APFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRFD 377 (377)
T ss_pred CCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCCC
Confidence 99999999999999887643322221111111 110 11223466899999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-61 Score=506.19 Aligned_cols=365 Identities=45% Similarity=0.808 Sum_probs=288.6
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++++.||+|+||.||+|+++.+++.||||++.+.......+..++.+|+.+|+.++|||||+++++|++.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999998777667788899999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
||+||+|.+++.+.+.+++..++++++||+.||.|||++|||||||||+|||++.+|++||+|||+|..+....... .+
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~-~~ 160 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK-YY 160 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc-cc
Confidence 99999999999888899999999999999999999999999999999999999999999999999987543211000 00
Q ss_pred cccCCCCCCCC-CCCCCCCC------cc-chHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 277 TIGNNLNGSSQ-NNERPAAP------KR-TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 277 ~~~~~~~~~~~-~~~~~~~~------~~-~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
..+........ .......+ .. ...+.... ....+....+.+||+.|+|||++.+.+|+.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAA-RQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhc-cccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHH
Confidence 00000000000 00000000 00 00000000 011122334678999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhh-hh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARI-YQ 427 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l-~~ 427 (552)
||++|++||.+.++.+...++++|...+.+|....+++++++||.+|+.+|.+|+++.++++|+.||||++++|... .+
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~ 319 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQ 319 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHHHHhc
Confidence 99999999999999999999998888888887778999999999998779999999888999999999999999874 46
Q ss_pred cCCCCccccCCcccCcCccccccccccccC------CCCCCcccccccccCCcccCceecCc
Q 008810 428 MEAAFIPEVNDELDTQNFEKFEESDNQTKT------SSKTGPWRKMLSSKDINFVGYTYKNF 483 (552)
Q Consensus 428 ~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~f~g~~~~~~ 483 (552)
..+|++|.+..+.|+++|+.++..+..... .....-|......++..|.||||+.|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (382)
T cd05625 320 QSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHPEHAFYEFTFRRF 381 (382)
T ss_pred CCCCccCcCCCcchhhhcCCCCccccccccccccccccccccccccccccCcccccceeccc
Confidence 789999999999999999986543321110 00111133333446789999999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-62 Score=476.77 Aligned_cols=325 Identities=34% Similarity=0.662 Sum_probs=278.0
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
..+...||.++++||+|+|.+|.+++.+.|.+.||||+++|.-......+.-++.|..+.... +||++|-|+.+||++.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 457789999999999999999999999999999999999998777777888899999998775 8999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+++|.||++||||+.++++...|+|+.|+||.++|++||.|||+.|||+||||.+|+|||..|||||+|+|+||.--..
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999953211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ..+.++||||.|+|||++.+..|++.+|||+|||+|||
T Consensus 405 g-----------------------------------------d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfe 443 (593)
T KOG0695|consen 405 G-----------------------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 443 (593)
T ss_pred C-----------------------------------------cccccccCCCcccchhhhcccccCceehHHHHHHHHHH
Confidence 0 01236899999999999999999999999999999999
Q ss_pred HhhCCCCCCC---CC-----hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC---ChhhhhcCCCc
Q 008810 350 MLVGYPPFYS---DD-----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIKVHPWF 417 (552)
Q Consensus 350 mltG~~PF~~---~~-----~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~---~a~eil~HpfF 417 (552)
|+.|+.||.- ++ ..-.++-|+. ..+.+|. .+|-.|..+++..|. ||.+|+|+. |..+|+.||||
T Consensus 444 mmagrspfdivgm~n~d~ntedylfqvile--kqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ff 519 (593)
T KOG0695|consen 444 MMAGRSPFDIVGMDNPDMNTEDYLFQVILE--KQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFF 519 (593)
T ss_pred HHcCCCCcceecCCCcccchhHHHHHHHhh--hcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhh
Confidence 9999999952 12 2223444554 5677775 789999999999998 999999974 78999999999
Q ss_pred CCCChhhhhh--cCCCCccccCCcccCcCccccccccccccCCCCCCcccccccc-cCCcccCceecCcc
Q 008810 418 DGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTYKNFE 484 (552)
Q Consensus 418 ~~i~w~~l~~--~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~~~~ 484 (552)
+.|||+.+.+ +-|||.|.+.++.+..||+.-...+..+.++... ..+.. .+..|.||.|.|+-
T Consensus 520 r~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~----d~i~ridqsefegfeyinpl 585 (593)
T KOG0695|consen 520 RSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDE----DAIKRIDQSEFEGFEYINPL 585 (593)
T ss_pred hhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCH----HHHHhcchhhcCcceecchh
Confidence 9999999985 7899999999999999999733333333322221 12222 33579999998863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-61 Score=505.14 Aligned_cols=255 Identities=38% Similarity=0.614 Sum_probs=242.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
.+|...+.||+|||+.||.+++..+|+.||+|++.|+.+.+..+.+.+.+|++|.+.++|||||++|.+|+|.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|+|..|+|+.++.+++.|+|.+|++|+.||+.||.|||+++|||||||..|++|+++.+|||+|||||..+....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~----- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG----- 172 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999998775321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
...++.||||.|+||||+.+.++++++||||+|||||-||+|+|
T Consensus 173 ------------------------------------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~P 216 (592)
T KOG0575|consen 173 ------------------------------------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRP 216 (592)
T ss_pred ------------------------------------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCC
Confidence 01247899999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
||...+-.+++.+|.. ....+|. .+|.+|+|||.+||. ||.+||+ +++|+.|+||+
T Consensus 217 PFetk~vkety~~Ik~--~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 217 PFETKTVKETYNKIKL--NEYSMPS--HLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFK 273 (592)
T ss_pred CcccchHHHHHHHHHh--cCccccc--ccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhh
Confidence 9999999999999997 5677886 899999999999999 9999999 99999999993
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-60 Score=498.08 Aligned_cols=360 Identities=54% Similarity=0.936 Sum_probs=292.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+|+.||||++.+..........+++.|+.++..++||||++++++|++.+++||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999999877666677888999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||+||+|.+++.+.+.+++..+++|++|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~- 159 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF- 159 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc-
Confidence 9999999999998888999999999999999999999999999999999999999999999999999986543210000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
+... ............. ........|..++....++.+||+.|+|||++.+.+|+.++|||||||++|||++|++
T Consensus 160 ~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 160 YRNL-THNPPSDFSFQNM----NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccc-ccCCccccccccc----ccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 0000 0000000000000 0001112233444555667899999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccc
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~ 435 (552)
||.+.++...+.++..|...+.+|....+++++++||.+|+.||.+|+++.++++|+.||||++++|..+....++..+.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 314 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIE 314 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCcc
Confidence 99999999999999988777888876678999999999977799999998889999999999999999998766555566
Q ss_pred cCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCcc
Q 008810 436 VNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484 (552)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 484 (552)
+....|+++|+.+.+........... ..-..+++..|.+|+|+.++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 315 IKSIDDTSNFDEFPESDILQPAENTI---EPDYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred CCCcchhhhcCCCCcccccCCCcccc---ccccCcCCcccCCceeecCC
Confidence 78888999999876654332222111 12235577789999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-59 Score=494.31 Aligned_cols=366 Identities=45% Similarity=0.818 Sum_probs=281.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|++++.||+|+||+||+|+++.+++.||||++.+..........++.+|+.+|..++|||||+++++|.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 68999999999999999999999999999999998877777778899999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
||+||+|.+++.+...+++..++++++||+.||.|||+.|||||||||+||||+.+|++||+|||+|+.+....... .+
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~-~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK-YY 160 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc-cc
Confidence 99999999999988899999999999999999999999999999999999999999999999999987543211000 00
Q ss_pred cccCCCCCCCCC------CCCC-CCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 277 TIGNNLNGSSQN------NERP-AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 277 ~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
..+......... .... ....+...-............+.+.+||+.|+|||++.+.+|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000000000000 0000 000000000000000111223456799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhh-hc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIY-QM 428 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~-~~ 428 (552)
|++|.+||.+.++.+...+++.|...+.+|....+++++++||.+||+.+.+|.++.++++|+.||||.+++|.... ..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~~~~~ 320 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQ 320 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHHhhcC
Confidence 99999999999888888888888777888876679999999999998844444444449999999999999998755 46
Q ss_pred CCCCccccCCcccCcCccccccccccccCCCC-CCccccccc----ccCCcccCceecCc
Q 008810 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSK-TGPWRKMLS----SKDINFVGYTYKNF 483 (552)
Q Consensus 429 ~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~f~g~~~~~~ 483 (552)
.+|++|.+..+.|+++|+.+.+.......... ...|....+ .....|.||||+.|
T Consensus 321 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (381)
T cd05626 321 PAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRRF 380 (381)
T ss_pred CCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeecc
Confidence 78999999999999999886554322111111 112222211 12468999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-57 Score=480.01 Aligned_cols=366 Identities=46% Similarity=0.824 Sum_probs=284.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|..++||||+++++.|++.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc--
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE-- 273 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~-- 273 (552)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987543211000
Q ss_pred --ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 274 --QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 274 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.....................+..... ........+....+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLE--RRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccchh--hhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 000000000000000000000000000 0000000112233578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhh-hcCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIY-QMEA 430 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~-~~~~ 430 (552)
+|++||.+.++.+...++..|...+.+|....+++++.+||.+|+++|.+|++..++.++++||||++++|..+. .+.+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~ 318 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKA 318 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCC
Confidence 999999999988888888888777777776679999999999987899999976569999999999999999984 5789
Q ss_pred CCccccCCcccCcCccccccccccccCCCCCCcccc----cccccCCcccCceecCc
Q 008810 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRK----MLSSKDINFVGYTYKNF 483 (552)
Q Consensus 431 pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~f~g~~~~~~ 483 (552)
|++|.+..+.|+++|+....+...........++.. ........|.-|+|.+|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (376)
T cd05598 319 PYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFRRF 375 (376)
T ss_pred CCCCcCCCcchhhhcCCCCcccccccccccccccccccccccccCCcccccceeccc
Confidence 999999999999999876554433222221111111 11224457788888776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-57 Score=477.21 Aligned_cols=329 Identities=44% Similarity=0.879 Sum_probs=276.8
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+.+..+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.++||||++++++|.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 34455677899999999999999999999999999999999988766555666778899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
+..+|+|||||+||+|.+++.. ..+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999999998854 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC----CCCccchhhh
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSL 343 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~----y~~~~DiWSl 343 (552)
.... ....+.+||+.|+|||++.+.+ |+.++|||||
T Consensus 194 ~~~~----------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05621 194 ETGM----------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred cCCc----------------------------------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEee
Confidence 2110 0112468999999999998643 7899999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCCh-
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDW- 422 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w- 422 (552)
||++|||++|.+||.+.+....+.+|+.....+.+|....++..+++||.+||+++.+|+++.+++|+++||||++.+|
T Consensus 234 G~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 234 GVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 9999999999999999998889999987666677887667899999999999997777777777999999999998655
Q ss_pred -hhhhhcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceec
Q 008810 423 -ARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (552)
Q Consensus 423 -~~l~~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (552)
..+....+|++|.+....|.++|+.++.......+. ..| .........|.||+|.
T Consensus 314 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~ 369 (370)
T cd05621 314 WDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETF--PIP--KAFVGNQLPFIGFTYY 369 (370)
T ss_pred hHhcCCCCCCcCCCCCCcchhhhcCCccccccccccC--CCC--ccccccccccCCCEec
Confidence 455567899999999999999998765443222111 111 1111235789999884
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-57 Score=473.37 Aligned_cols=350 Identities=53% Similarity=0.962 Sum_probs=286.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+|+.||||++++...........+..|+.+|..++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999999887666677888999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876433210000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
...... ....... .........+.......+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 161 ~~~~~~---~~~~~~~---------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 161 LNDSHN---LLFRDNV---------LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cccccc---ccccccc---------cccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 000000 0000000 0000000111122345689999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccc
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~ 435 (552)
||.+.+....+.++..|...+.+|....+++++++||.+||+||.+|++. +++|++||||++++|+.+....+|++|.
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s--~~~ll~hp~~~~~~~~~~~~~~~~~~~~ 306 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS--FEEIKSHPFFKGIDWENLRETKPPFVPE 306 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCC--HHHHhcCCCcCCCCHHHHhhCCCCcCCC
Confidence 99999999999999998888888877678999999999999999999874 8999999999999999999889999999
Q ss_pred cCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceec
Q 008810 436 VNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (552)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (552)
+....|+.+|+..+......... ..............|.||+|+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 350 (350)
T cd05573 307 LSSPLDTSNFDDFEDDKDLSDYL--SQNSKKLNKGKQLAFVGFTYK 350 (350)
T ss_pred CCCchhhhhcCCCCccccccccc--ccccccccccccCccCCCccC
Confidence 99999999999876654322110 111111223355789999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-57 Score=474.31 Aligned_cols=330 Identities=45% Similarity=0.859 Sum_probs=279.7
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.++||||++++++|.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45566778999999999999999999999999999999999988766666666778899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
..++|+|||||+||+|..++.. ..+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999999998854 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC----CCCccchhhh
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSL 343 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~----y~~~~DiWSl 343 (552)
..... .....+||+.|+|||++.+.+ |+.++|||||
T Consensus 194 ~~~~~----------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSl 233 (371)
T cd05622 194 KEGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (371)
T ss_pred cCCcc----------------------------------------cccCcccCccccCHHHHhccCCCccCCCccceeeh
Confidence 21100 012468999999999998643 8899999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCC--
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVD-- 421 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~-- 421 (552)
||++|||++|.+||.+.+....+.+|+.....+.+|....++.++++||.+||.+|..|+++.++++|++||||++.+
T Consensus 234 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 234 GVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 999999999999999999988999998766667788767899999999999999888888888899999999999855
Q ss_pred hhhhhhcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecC
Q 008810 422 WARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (552)
Q Consensus 422 w~~l~~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (552)
|..+....+|++|.+....++++|++.........+. +........+..|.||+|.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 370 (371)
T cd05622 314 WETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETF----PIPKAFVGNQLPFVGFTYYS 370 (371)
T ss_pred HHhcCCCCCCCCCCCCCcchhhhcCCCcccccccccC----CCCccccccccccCCCeecC
Confidence 4566678899999999999999998765433211111 11122233358999999853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-57 Score=465.35 Aligned_cols=316 Identities=37% Similarity=0.672 Sum_probs=264.9
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG 201 (552)
++||+|+||.||+|+++.+|+.||||++++..........++.+|..+|+.++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999876666667778899999999999999999999999999999999999999
Q ss_pred chhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCC
Q 008810 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (552)
Q Consensus 202 ~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~ 281 (552)
+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---------- 150 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC----------
Confidence 9999998889999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCC
Q 008810 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (552)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~ 361 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -------------------------------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 0124689999999999999999999999999999999999999999988
Q ss_pred hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhh--hcCCCCcccc
Q 008810 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--QMEAAFIPEV 436 (552)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~--~~~~pf~P~~ 436 (552)
.......+.. ....+|. .+++++++||.+||+ ||.+|++.. .+.+|++||||.+++|..+. .+.||+.|.+
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05571 200 HEKLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQV 275 (323)
T ss_pred HHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 8877777765 3456664 789999999999999 999999532 49999999999999999987 4778999999
Q ss_pred CCcccCcCccc-cccccccccCCCCCCcccccccccCCcccCceecC
Q 008810 437 NDELDTQNFEK-FEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (552)
Q Consensus 437 ~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (552)
....|+++|+. +..............+......+....|.+|+|..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05571 276 TSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSYSA 322 (323)
T ss_pred CCcchhhhcCcccccCCcccCCCCcccccccccccccccCCCCeeeC
Confidence 99999999975 33222111111111110001123456899998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-56 Score=465.44 Aligned_cols=293 Identities=42% Similarity=0.821 Sum_probs=264.7
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..+..++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+++.+|+.+|..++|||||+++++|.+++.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 44567899999999999999999999999999999999998776666677889999999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
....+||+.|+|||++.+..++.++|||||||++|||
T Consensus 172 -------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 208 (329)
T PTZ00263 172 -------------------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208 (329)
T ss_pred -------------------------------------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHH
Confidence 1145799999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~ 427 (552)
++|.+||.+.++...+.+|.. ..+.+|. .++.++++||.+||. ||.+|+++ ..+++|+.||||++++|..+..
T Consensus 209 ltg~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~ 284 (329)
T PTZ00263 209 IAGYPPFFDDTPFRIYEKILA--GRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYA 284 (329)
T ss_pred HcCCCCCCCCCHHHHHHHHhc--CCcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 999999999998888888876 4456664 689999999999999 99999985 4589999999999999999874
Q ss_pred --cCCCCccccCCcccCcCccccccc
Q 008810 428 --MEAAFIPEVNDELDTQNFEKFEES 451 (552)
Q Consensus 428 --~~~pf~P~~~~~~d~~~f~~~~~~ 451 (552)
..+|+.+.+....++.+|..+.++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~s 310 (329)
T PTZ00263 285 RYYPAPIPVRVKSPGDTSNFEKYPDS 310 (329)
T ss_pred CCCCCCcCCCCCCcccchhccCCccc
Confidence 677888888888999999877543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-57 Score=466.36 Aligned_cols=322 Identities=46% Similarity=0.829 Sum_probs=277.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|.+.+.||+|+||+||+|+++.+|+.||||++++...........+..|+.++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999999876555566777899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||++||+|..++.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|..+......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-- 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence 999999999999776 78999999999999999999999999999999999999999999999999999865322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh------cCCCCCccchhhhhHHHH
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~------~~~y~~~~DiWSlGvily 348 (552)
.....+||+.|+|||++. +..|+.++|||||||++|
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 200 (330)
T cd05601 159 --------------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200 (330)
T ss_pred --------------------------------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence 011357999999999997 456889999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhc
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~ 428 (552)
||++|..||.+.+....+.+|++....+.+|....+++++++||.+||++|.+|++ +++++.||||..++|..+...
T Consensus 201 el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~t---~~~l~~h~~~~~~~~~~~~~~ 277 (330)
T cd05601 201 EMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLG---YEGLCCHPFFSKIDWNNIRNS 277 (330)
T ss_pred eeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCCC---HHHHhCCCCcCCCCHHHHhhC
Confidence 99999999999988888889887766677887678999999999999999999999 999999999999999999988
Q ss_pred CCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCcee
Q 008810 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTY 480 (552)
Q Consensus 429 ~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~ 480 (552)
.||++|.+....|+++|+...........+..........+.+++.|+||+|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (330)
T cd05601 278 LPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSF 329 (330)
T ss_pred CCCccCcCCCcchhhhcCCCccccccccccccccCCCcCCCCCCCCccCcee
Confidence 8999999999999999987544432222111111111223457889999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-56 Score=468.34 Aligned_cols=327 Identities=46% Similarity=0.878 Sum_probs=273.2
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
....+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+..|+.+|+.++||||++++++|.+.
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34456788999999999999999999999999999999999887666666667788999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+|||||+||+|..++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.+..
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998854 5689999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC----CCCCccchhhhh
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK----GYGMECDWWSLG 344 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~----~y~~~~DiWSlG 344 (552)
.... .....+||+.|+|||++.+. .++.++||||||
T Consensus 195 ~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlG 234 (370)
T cd05596 195 NGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (370)
T ss_pred CCcc----------------------------------------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehh
Confidence 1100 01246899999999999764 388999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
|++|||++|.+||.+.+....+.+|+.....+.+|....+|.++++||.+||. +|. |+++.++++|+.||||++.+|.
T Consensus 235 vilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~-r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 235 VFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREV-RLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhh-ccCCCCHHHHhcCcccCCCChh
Confidence 99999999999999999888999998766677888777799999999999999 664 4444449999999999998886
Q ss_pred h--hhhcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceec
Q 008810 424 R--IYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (552)
Q Consensus 424 ~--l~~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (552)
. +....+|++|.+....|+++|++.........+- ..| .........|.||+|.
T Consensus 314 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~ 369 (370)
T cd05596 314 FDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEETF--PLP--KAFAGNQLPFIGFTYS 369 (370)
T ss_pred hHHhcCCCcCccCcCCCcchhhhcCCccccccccccC--CCc--cccccccCccCCCeec
Confidence 5 4456789999999999999998765543211110 011 1122235579999884
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-56 Score=460.04 Aligned_cols=289 Identities=45% Similarity=0.849 Sum_probs=262.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+|+.||||++++..........++..|+.+|..++||||++++++|++.+++||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999999876555566778999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ 154 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 155 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 155 --------------------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred --------------------------------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence 124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCccc----ccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhcCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEA----KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEA 430 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~----~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~ 430 (552)
||.+.+..+.+..+..|...+..|... .++.++++||.+||. +|.+|++ +.+|+.||||.+++|..+....|
T Consensus 197 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~~~~~~~ 273 (333)
T cd05600 197 PFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNELRELKP 273 (333)
T ss_pred CCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHHHhhCCC
Confidence 999999988888888876655555432 579999999999999 8888888 99999999999999999999999
Q ss_pred CCccccCCcccCcCccccccc
Q 008810 431 AFIPEVNDELDTQNFEKFEES 451 (552)
Q Consensus 431 pf~P~~~~~~d~~~f~~~~~~ 451 (552)
||+|.+....|..+|+.+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~ 294 (333)
T cd05600 274 PFVPELESEIDTGYFDDFENE 294 (333)
T ss_pred CCCCCCCCcchhhhccCCCCc
Confidence 999999999999998876544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-56 Score=462.54 Aligned_cols=294 Identities=39% Similarity=0.824 Sum_probs=263.4
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
...+..++|++++.||+|+||.||+|.++.++ ..||+|++.+.........+.+.+|+.+|..++|||||+++++|.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 35567889999999999999999999977655 78999999887766666778899999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+||||++||+|..++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+..
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
. ..+.+||+.|+|||++.+..++.++|||||||++|
T Consensus 184 ~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 219 (340)
T PTZ00426 184 R--------------------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIY 219 (340)
T ss_pred C--------------------------------------------cceecCChhhcCHHHHhCCCCCccccccchhhHHH
Confidence 1 12468999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l 425 (552)
||++|.+||.+.++...+.++.. ....+|. .+++++++||++||. ||.+|++. .++++|+.||||.+++|..+
T Consensus 220 ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~ 295 (340)
T PTZ00426 220 EILVGCPPFYANEPLLIYQKILE--GIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295 (340)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 99999999999998888888876 3455664 689999999999999 99999853 35999999999999999988
Q ss_pred h--hcCCCCccccCCcccCcCccccccc
Q 008810 426 Y--QMEAAFIPEVNDELDTQNFEKFEES 451 (552)
Q Consensus 426 ~--~~~~pf~P~~~~~~d~~~f~~~~~~ 451 (552)
. .+.+|++|......+.++|+.+.+.
T Consensus 296 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (340)
T PTZ00426 296 LHKNVEVPYKPKYKNVFDSSNFERVQED 323 (340)
T ss_pred HhCCCCCCcCCCCCCCcchhhcCCCccc
Confidence 7 4789999999999999998765443
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=454.75 Aligned_cols=317 Identities=34% Similarity=0.663 Sum_probs=268.7
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CceEEEeeeecCCceEEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lylVm 195 (552)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|+.++..+.| ++|++++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999998766556667788899999999976 56889999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC----
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++
T Consensus 157 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (324)
T cd05587 157 -------------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199 (324)
T ss_pred -------------------------------------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 0124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~ 430 (552)
||.+.+..+.+..+.. ....+|. .+++++++||.+||. ||.+|++.. ..++++.||||++++|..+.. +.+
T Consensus 200 pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~ 275 (324)
T cd05587 200 PFDGEDEDELFQSIME--HNVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275 (324)
T ss_pred CCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCC
Confidence 9999988888888876 3445554 689999999999999 999999853 358999999999999998864 678
Q ss_pred CCccccCCcccCcCccccccccccccCCCCCCcccccc-cccCCcccCceecC
Q 008810 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML-SSKDINFVGYTYKN 482 (552)
Q Consensus 431 pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~g~~~~~ 482 (552)
|+.|.+....++++|+.+........++. -+..+ ......|.+|+|.|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 276 PFKPKVKGRRSAENFDKFFTREPPVLTPP----DKLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred CccCcCCCcchhhhcCcccccCccccCCC----CccccccccccccCCCcccC
Confidence 99999998899999998765443322211 11122 23445788887764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-55 Score=454.28 Aligned_cols=317 Identities=33% Similarity=0.651 Sum_probs=267.8
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+....|..++..+ +||+|++++++|.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999987655556667778888888877 5899999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|..++.....+++..+.+++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC----
Confidence 9999999999998888999999999999999999999999999999999999999999999999999975321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 199 (323)
T cd05616 157 -------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199 (323)
T ss_pred -------------------------------------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence 0124689999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~ 430 (552)
||.+.+....+..|.. ....+|. .++.++++||.+||. ||.+|++.. ...+|+.||||+.++|..+.. +.|
T Consensus 200 Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05616 200 PFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQP 275 (323)
T ss_pred CCCCCCHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCC
Confidence 9999988888888876 4455664 689999999999999 999999853 468999999999999999874 789
Q ss_pred CCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecC
Q 008810 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (552)
Q Consensus 431 pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (552)
|+.|.... .|..+|+.|.....+..++. +...+.......|.||+|.|
T Consensus 276 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 276 PYKPKACG-RDAENFDKFFTRHPPVLTPP---DQEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred CcCCcCCC-chhhhcCchhccCCccCCCC---CccccccccccccCCCcccC
Confidence 99998754 78889988766432222211 11122233346788888764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-56 Score=449.81 Aligned_cols=259 Identities=33% Similarity=0.590 Sum_probs=236.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
...+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ ....++.+..|+.||+.++|||||.|++++.+++++||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 36789999999999999999999999999999999998765 45667889999999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC------CcEEEcccccccccC
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY------GHLRLSDFGLCKPLD 267 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~------g~iKL~DFGlak~~~ 267 (552)
|||||.||||..+|.+++.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+.
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999999999999999999999999999999999999999999999999999865 468999999999875
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
.. .++.+.||||-||||||+..+.|+.++|+||+|+|+
T Consensus 167 ~~------------------------------------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Il 204 (429)
T KOG0595|consen 167 PG------------------------------------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTIL 204 (429)
T ss_pred ch------------------------------------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHH
Confidence 33 234578999999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|+|++|++||...++.+.+..|-......+.+. ..++....+|+..+|+ +|.+|.+ .++-..|||...
T Consensus 205 yq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 205 YQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAA 273 (429)
T ss_pred HHHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccCc---hHHhhhhhhccc
Confidence 999999999999999999998877665555554 3688888899999998 9999998 888899998865
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=455.22 Aligned_cols=292 Identities=51% Similarity=0.933 Sum_probs=259.3
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|+.++..++|+||++++++|++.+++|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998876666666777899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||++||+|..++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-- 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--
Confidence 99999999999977 468999999999999999999999999999999999999999999999999999865322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCCCCccchhhhhHHHHH
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvilyE 349 (552)
.....+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~e 200 (331)
T cd05624 159 --------------------------------------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200 (331)
T ss_pred --------------------------------------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhh
Confidence 0113579999999999976 468899999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcc-cccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~ 428 (552)
|++|++||.+.+..+.+.++......+.+|.. ..++.++++||.+||+.+.+|+++.+++++++||||++++|..+...
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~ 280 (331)
T cd05624 201 MLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNL 280 (331)
T ss_pred hhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhC
Confidence 99999999999988888888876555666653 35799999999999996667877777999999999999999999999
Q ss_pred CCCCccccCCcccCcCccc
Q 008810 429 EAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 429 ~~pf~P~~~~~~d~~~f~~ 447 (552)
.+|++|....+.+..+|+.
T Consensus 281 ~~~~~p~~~~~~~~~~~~~ 299 (331)
T cd05624 281 EAPYIPDVSSPSDTSNFDV 299 (331)
T ss_pred CCCccCCCCCcchhhhcCC
Confidence 9999999998888888874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-55 Score=454.31 Aligned_cols=324 Identities=48% Similarity=0.879 Sum_probs=271.6
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+.+.+++.||+|++.+...........+..|+.++..++|+||++++++|++...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998776666666677899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~--- 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT--- 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc---
Confidence 99999999999976 46799999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccchhhhhHHHHH
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSlGvilyE 349 (552)
......+||+.|+|||++. ...|+.++|||||||++||
T Consensus 158 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 158 -------------------------------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred -------------------------------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHH
Confidence 0011357999999999997 3468999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcc-cccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~ 428 (552)
|++|++||.+.+..+.+.+|........+|.. ..+++++++||.+||+.+.+|+++.++++++.||||.+++|+.+...
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~~ 280 (332)
T cd05623 201 MLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNC 280 (332)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhhC
Confidence 99999999999999999998876555556643 36899999999999996677877777999999999999999999999
Q ss_pred CCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceec
Q 008810 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (552)
Q Consensus 429 ~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (552)
.+|++|...++.++++++...+......+.. .|...........|.||||.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 331 (332)
T cd05623 281 EAPYIPEVSSPTDTSNFDVDDDCLKNSETMP--PPSHTAFSGHHLPFVGFTYT 331 (332)
T ss_pred CCCccCCCCCCcccccCCCCcccccccCCCC--CCCccccccCCCCcCCeeec
Confidence 9999999999999998865432221111111 11111223346789999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-55 Score=454.04 Aligned_cols=324 Identities=49% Similarity=0.878 Sum_probs=272.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|+.++..++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999999877666677778999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-- 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998765322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCCCCccchhhhhHHHHH
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvilyE 349 (552)
.....+||+.|+|||++.. ..++.++|||||||++||
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (331)
T cd05597 159 --------------------------------------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200 (331)
T ss_pred --------------------------------------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHH
Confidence 0112479999999999973 457899999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcc-cccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCChhhhhhc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~ 428 (552)
|++|+.||.+.+..+.+.+|......+.+|.. ..++.++++||.+||+.|.+|+++.++++++.||||.+++|..+...
T Consensus 201 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~ 280 (331)
T cd05597 201 MLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNS 280 (331)
T ss_pred HhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhhC
Confidence 99999999999888888888876555555542 35899999999999997788887777999999999999999999988
Q ss_pred CCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceec
Q 008810 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (552)
Q Consensus 429 ~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (552)
.+|++|......++.+|+..........+ ...+...........+.||+|.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 331 (331)
T cd05597 281 TAPYVPEVSSPTDTSNFDVDDDDLRNTES--LPPSSHGAFSGNHLPFVGFTYT 331 (331)
T ss_pred CCCccCcCCCcchhhhcCCcccccccccc--cCCCCcCcCCcCCCCCCceeeC
Confidence 89999999999999999764432211111 1111111233455678888884
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=449.18 Aligned_cols=285 Identities=42% Similarity=0.865 Sum_probs=257.7
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+|+.||||++.+.......+.+.+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998766555556778999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------ 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754311
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 155 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 155 --------------------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred --------------------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 113579999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~ 430 (552)
||.+.+....+..+.. ....+|. .+++.+++||.+||. ||.+|++.. .+++++.||||..++|..+.. ..|
T Consensus 197 pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~ 272 (291)
T cd05612 197 PFFDDNPFGIYEKILA--GKLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKP 272 (291)
T ss_pred CCCCCCHHHHHHHHHh--CCcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCC
Confidence 9999998888888876 3455664 679999999999999 999999743 599999999999999998874 678
Q ss_pred CCccccCCcccCcCcccc
Q 008810 431 AFIPEVNDELDTQNFEKF 448 (552)
Q Consensus 431 pf~P~~~~~~d~~~f~~~ 448 (552)
|++|.+....|+.||+..
T Consensus 273 ~~~p~~~~~~~~~~~~~~ 290 (291)
T cd05612 273 PIVPKVSHDGDTSNFDDY 290 (291)
T ss_pred CEeCCCCCccccccccCC
Confidence 999999999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-56 Score=445.39 Aligned_cols=258 Identities=29% Similarity=0.494 Sum_probs=232.9
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce-E
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF-L 191 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~-l 191 (552)
+..++.+.++.||+|+.|+||+|+++.|++.||+|++.-. .+......+.+|++||..++||+||..|++|.++.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 5567888899999999999999999999999999999432 234455678999999999999999999999999984 9
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|+||||.||+|..++...+.++|.....++.+++.||.|||. ++||||||||+|||++..|.|||||||.++.+..+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999988999999999999999999999995 99999999999999999999999999999876432
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
++.+++||..|||||.+.+..|+.++||||||+.++||
T Consensus 233 ------------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 233 ------------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLEL 270 (364)
T ss_pred ------------------------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHH
Confidence 35689999999999999999999999999999999999
Q ss_pred hhCCCCCCCC-----ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 351 LVGYPPFYSD-----DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 351 ltG~~PF~~~-----~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
++|+.||... +..+.+..|+.. ....+|.. .+|+++++||..||. ||.+|++ +.|+++|||++..
T Consensus 271 a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 271 AIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEG-EFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKF 341 (364)
T ss_pred hhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcc-cCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhc
Confidence 9999999874 566778888863 45566653 699999999999999 9999999 9999999999754
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-55 Score=451.65 Aligned_cols=283 Identities=37% Similarity=0.708 Sum_probs=251.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999987665566677788899998876 799999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.+...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--------- 151 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--------- 151 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 152 --------------------------------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred --------------------------------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 012457999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC---ChhhhhcCCCcCCCChhhhhh--cCCCCcc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIKVHPWFDGVDWARIYQ--MEAAFIP 434 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~---~a~eil~HpfF~~i~w~~l~~--~~~pf~P 434 (552)
+..+.+..|.. ....+|. .++.++++||.+||. ||.+|+++. +.++++.||||.+++|+.+.. +.|||.|
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 275 (320)
T cd05590 200 NEDDLFEAILN--DEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRP 275 (320)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 98888888876 3445554 689999999999999 999999953 348999999999999999874 7899999
Q ss_pred ccCCcccCcCccccc
Q 008810 435 EVNDELDTQNFEKFE 449 (552)
Q Consensus 435 ~~~~~~d~~~f~~~~ 449 (552)
.+....|.+||+...
T Consensus 276 ~~~~~~~~~~~~~~~ 290 (320)
T cd05590 276 RIKSREDVSNFDPDF 290 (320)
T ss_pred CCCCcchhhhcCccc
Confidence 999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-55 Score=449.28 Aligned_cols=279 Identities=43% Similarity=0.818 Sum_probs=252.4
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCch
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L 203 (552)
||+|+||.||+|+++.+++.||+|++.+..........++.+|+.+|..++|||||+++++|.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999887666666778889999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCC
Q 008810 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (552)
Q Consensus 204 ~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~ 283 (552)
..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------------ 148 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------------ 148 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------------
Confidence 99998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChh
Q 008810 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (552)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~ 363 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 149 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~ 199 (312)
T cd05585 149 -----------------------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199 (312)
T ss_pred -----------------------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH
Confidence 012468999999999999999999999999999999999999999998888
Q ss_pred hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh--hcCCCCccccCCcc
Q 008810 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDEL 440 (552)
Q Consensus 364 ~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~--~~~~pf~P~~~~~~ 440 (552)
+.+.++.. ..+.+|. .+++++++||.+||. ||.+|++..++.+++.||||..++|..+. .+.+++.|.+.+..
T Consensus 200 ~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (312)
T cd05585 200 EMYRKILQ--EPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAI 275 (312)
T ss_pred HHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 88888875 4556664 689999999999999 99999988789999999999999998876 37789999999999
Q ss_pred cCcCccc
Q 008810 441 DTQNFEK 447 (552)
Q Consensus 441 d~~~f~~ 447 (552)
|+++|+.
T Consensus 276 ~~~~~~~ 282 (312)
T cd05585 276 DTSNFDE 282 (312)
T ss_pred chhhcCc
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-54 Score=446.43 Aligned_cols=316 Identities=35% Similarity=0.691 Sum_probs=265.0
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVm 195 (552)
+|+++++||+|+||.||+|+++.+|+.||||++.+.........+.+..|..++..+. ||+|++++++|++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999999876655666777888999998885 578889999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc----
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (323)
T cd05615 157 -------------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199 (323)
T ss_pred -------------------------------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCC
Confidence 0124679999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~ 430 (552)
||.+.+....+..+.. ....+|. .++.++++||.+||. +|.+|++.. ..++++.||||.+++|..+.. +.+
T Consensus 200 pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~ 275 (323)
T cd05615 200 PFDGEDEDELFQSIME--HNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQP 275 (323)
T ss_pred CCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCc
Confidence 9999988888888876 4455664 689999999999999 999999864 478999999999999999875 679
Q ss_pred CCccccCCcccCcCccccccccccccCCCCCCcccccccccC-CcccCceecC
Q 008810 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKD-INFVGYTYKN 482 (552)
Q Consensus 431 pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~f~g~~~~~ 482 (552)
||.|..... +.++|+++.......... |....+...+ .-|.||+|.|
T Consensus 276 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 276 PFKPKVCGK-GAENFDKFFTRGQPVLTP----PDQLVIANIDQADFEGFSYVN 323 (323)
T ss_pred CccCccCCC-chhhcCccccccCCCCCC----CcccccccccccccCCCcccC
Confidence 999987654 588888876543322211 1111222233 3678887754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=446.19 Aligned_cols=281 Identities=40% Similarity=0.746 Sum_probs=249.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||.||+|+++.+|+.||||++++.........+.+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999987665566677788899999866 899999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--------- 151 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 152 --------------------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred --------------------------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 012467999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC----ChhhhhcCCCcCCCChhhhhh--cCCCCc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK----GADEIKVHPWFDGVDWARIYQ--MEAAFI 433 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~----~a~eil~HpfF~~i~w~~l~~--~~~pf~ 433 (552)
+....+..+.. ....+|. .++.++.+||.+||. ||.+|+++. .+++++.||||.+++|..+.. +.+||.
T Consensus 200 ~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~ 275 (321)
T cd05591 200 NEDDLFESILH--DDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFK 275 (321)
T ss_pred CHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCC
Confidence 99888888886 3445554 689999999999999 999999642 489999999999999999874 678999
Q ss_pred cccCCcccCcCccc
Q 008810 434 PEVNDELDTQNFEK 447 (552)
Q Consensus 434 P~~~~~~d~~~f~~ 447 (552)
|......+..+|+.
T Consensus 276 ~~~~~~~~~~~~~~ 289 (321)
T cd05591 276 PKIKTKRDVNNFDQ 289 (321)
T ss_pred CCCCCcchhhhcCC
Confidence 99988888888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-54 Score=446.59 Aligned_cols=282 Identities=40% Similarity=0.723 Sum_probs=251.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG 201 (552)
++||+|+||.||+|+++.+|+.||+|++++..........++.+|..+|+.++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999876655666778889999999999999999999999999999999999999
Q ss_pred chhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCC
Q 008810 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (552)
Q Consensus 202 ~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~ 281 (552)
+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------- 150 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCC
Q 008810 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (552)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~ 361 (552)
.....+||+.|+|||++.+..|+.++|+|||||++|||++|..||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -------------------------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 0114579999999999999999999999999999999999999999988
Q ss_pred hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh--cCCCCcccc
Q 008810 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (552)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~--~~~pf~P~~ 436 (552)
.......+.. ....+|. .+++++++||.+||. ||.+|++. ..+.+++.||||.+++|..+.+ +.||+.|.+
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05595 200 HERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 275 (323)
T ss_pred HHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 8887777765 3455664 689999999999999 99999953 2599999999999999998874 668999999
Q ss_pred CCcccCcCcccc
Q 008810 437 NDELDTQNFEKF 448 (552)
Q Consensus 437 ~~~~d~~~f~~~ 448 (552)
..+.+++.|+..
T Consensus 276 ~~~~~~~~~~~~ 287 (323)
T cd05595 276 TSEVDTRYFDDE 287 (323)
T ss_pred CChhhhhhcCcc
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-54 Score=443.06 Aligned_cols=310 Identities=39% Similarity=0.723 Sum_probs=259.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||+||+|+++.+++.||||++++.........+....|+.++... +||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999987655555566667788887654 899999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--------- 151 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999975421110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 152 --------------------------------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 012468999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh--hcCCCCccccC
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY--QMEAAFIPEVN 437 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~--~~~~pf~P~~~ 437 (552)
+..+.+..+.. ....+|. .++.++.+||.+||. ||.+|++. +.+++.||||..++|..+. .+.|||.|...
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd05592 200 DEDELFDSILN--DRPHFPR--WISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVK 273 (316)
T ss_pred CHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCC
Confidence 88888877765 3334453 689999999999999 99999983 4589999999999999886 37889999999
Q ss_pred CcccCcCccccccccccccCCCCCCcccccccc-cCCcccCceecC
Q 008810 438 DELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTYKN 482 (552)
Q Consensus 438 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~~ 482 (552)
...+..+|+..........+... .....+ ....|.||.|.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05592 274 SPSDASNFDREFTNEKVRLSPVD----KKLLASMDQEQFRGFSFTN 315 (316)
T ss_pred CcchhhhcCcccccccccCCCcc----ccccccccccccCCCcccC
Confidence 99999999864433332222211 122222 346899998876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-54 Score=446.15 Aligned_cols=281 Identities=41% Similarity=0.761 Sum_probs=250.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG 201 (552)
++||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++||||++++++|++.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999876656666778899999999999999999999999999999999999999
Q ss_pred chhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCC
Q 008810 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (552)
Q Consensus 202 ~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~ 281 (552)
+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---------- 150 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---------- 150 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCC
Q 008810 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (552)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~ 361 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred -------------------------------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 0124689999999999999999999999999999999999999999888
Q ss_pred hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh--cCCCCcccc
Q 008810 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (552)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~--~~~pf~P~~ 436 (552)
..+....+.. ....+|. .+++++.+||.+||+ ||.+|++. ..+.+|++||||.+++|..+.. +.+|+.|.+
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~ 275 (328)
T cd05593 200 HEKLFELILM--EDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQV 275 (328)
T ss_pred HHHHHHHhcc--CCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence 8777777664 4456664 689999999999999 99999853 3599999999999999998874 678999999
Q ss_pred CCcccCcCccc
Q 008810 437 NDELDTQNFEK 447 (552)
Q Consensus 437 ~~~~d~~~f~~ 447 (552)
..+.++.+|+.
T Consensus 276 ~~~~~~~~~~~ 286 (328)
T cd05593 276 TSETDTRYFDE 286 (328)
T ss_pred CCcchhhhcCc
Confidence 99999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-54 Score=444.19 Aligned_cols=316 Identities=35% Similarity=0.675 Sum_probs=263.9
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH---hcCCCceEEEeeeecCCceEEEE
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA---EVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
|++++.||+|+||.||+|+++.+|+.||||++++.........+.+..|+.++. .++||||++++++|.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999999876555666777888887764 56899999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++||+|..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~---- 155 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG---- 155 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC----
Confidence 99999999998875 4679999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
......+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 156 -------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~ 198 (324)
T cd05589 156 -------------------------------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198 (324)
T ss_pred -------------------------------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence 0012468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhh--hcC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--QME 429 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~--~~~ 429 (552)
+||.+.+..+.+..+.. ....+|. .+++++.+||.+||. ||.+||++. .+.+++.||||++++|..+. .+.
T Consensus 199 ~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~ 274 (324)
T cd05589 199 SPFPGDDEEEVFDSIVN--DEVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274 (324)
T ss_pred CCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCC
Confidence 99999988888888776 3344554 689999999999999 999999753 48999999999999999876 377
Q ss_pred CCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceec
Q 008810 430 AAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (552)
Q Consensus 430 ~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (552)
+|++|.+....|.++|+.-.....+..+++. +.+....+....|.+|+|.
T Consensus 275 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05589 275 PPFVPTIKGPEDVSNFDEEFTSEAPVLTPPR--EPRLLTEEEQELFRGFDYV 324 (324)
T ss_pred cCccCCCCCcchhhhcCccccccccccCCCc--cccccchhhhcccCCcccC
Confidence 9999999999999998754333322222221 1112333455678888773
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=454.68 Aligned_cols=258 Identities=37% Similarity=0.642 Sum_probs=234.9
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh--hHHHHHHHHHHHHHhcC-CCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~ 189 (552)
.....|.+.+.||+|+||+|++|++..+|..||+|++.+...... ...+.+.+|+.+|+.+. ||||++++.++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456789999999999999999999999999999998887643322 34567889999999999 999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC-CcEEEcccccccccC-
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLD- 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~-g~iKL~DFGlak~~~- 267 (552)
.+|+|||||.||+|++++...+.++|.++++|+.|++.||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998663
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-C-CCccchhhhhH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-Y-GMECDWWSLGA 345 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-y-~~~~DiWSlGv 345 (552)
.. ....+.||||.|+|||++.+.+ | +.++|+||+||
T Consensus 174 ~~------------------------------------------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GV 211 (370)
T KOG0583|consen 174 ED------------------------------------------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGV 211 (370)
T ss_pred CC------------------------------------------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHH
Confidence 11 1223689999999999999988 8 58999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccccccCCccccc-ChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL-SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~-s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||-|++|+.||...+...++.+|.. ..+.+|. .+ |+++++||++||. ||.+|++ +.+|+.||||+.
T Consensus 212 iLy~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 212 ILYVLLCGRLPFDDSNVPNLYRKIRK--GEFKIPS--YLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQK 280 (370)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHhc--CCccCCC--CcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhcc
Confidence 99999999999999999999999886 6788886 56 9999999999999 9999999 999999999985
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-54 Score=443.98 Aligned_cols=283 Identities=34% Similarity=0.667 Sum_probs=245.0
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||+||+|+.+.+++.||+|++++...........+..|+.++..+ +||+|+.++++|++.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999987665666777899999999888 699999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--------- 151 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 152 --------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred --------------------------------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 012468999999999999999999999999999999999999999642
Q ss_pred C-------hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC---CChhhhhcCCCcCCCChhhhhh--
Q 008810 361 D-------PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARIYQ-- 427 (552)
Q Consensus 361 ~-------~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~---~~a~eil~HpfF~~i~w~~l~~-- 427 (552)
. .......+.. ....+|. .++..+++||.+||. ||.+|++. .++++|+.||||++++|+.+..
T Consensus 200 ~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~ 275 (327)
T cd05617 200 TDNPDMNTEDYLFQVILE--KPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQ 275 (327)
T ss_pred CCCcccccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCC
Confidence 2 1223333433 3445664 689999999999999 99999985 3578999999999999999874
Q ss_pred cCCCCccccCCcccCcCccccc
Q 008810 428 MEAAFIPEVNDELDTQNFEKFE 449 (552)
Q Consensus 428 ~~~pf~P~~~~~~d~~~f~~~~ 449 (552)
..+||.|.+.+..+.++|+...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~ 297 (327)
T cd05617 276 VTPPFKPQITDDYGLENFDTQF 297 (327)
T ss_pred CCCCccCCCCCCcchhhcCCcc
Confidence 6789999999998999998643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-54 Score=444.21 Aligned_cols=315 Identities=38% Similarity=0.700 Sum_probs=260.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHH-HHhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||+||+|+++.+|+.||||++.+..........++..|+.+ ++.++|||||+++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999987765555555666666664 5779999999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--------- 151 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 152 --------------------------------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred --------------------------------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 012457999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC-ChhhhhcCCCcCCCChhhhhh--cCCCCcccc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~-~a~eil~HpfF~~i~w~~l~~--~~~pf~P~~ 436 (552)
+..+.+..+... .+.++. .+++++.+||.+||+ ||.+|++.. .+.+++.||||..++|..+.. +.+|+.|.+
T Consensus 200 ~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05575 200 DTAEMYDNILNK--PLRLKP--NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNV 275 (323)
T ss_pred CHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCC
Confidence 888888888763 344443 679999999999999 999999953 468999999999999999874 789999999
Q ss_pred CCcccCcCccc-cccccccccCCCC--CCcccccccccCCcccCceec
Q 008810 437 NDELDTQNFEK-FEESDNQTKTSSK--TGPWRKMLSSKDINFVGYTYK 481 (552)
Q Consensus 437 ~~~~d~~~f~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~f~g~~~~ 481 (552)
....+.++|+. +.+...+...... ...........+..|.||+|.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05575 276 SGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEADDAFLGFSYA 323 (323)
T ss_pred CCcchhhhcCccccccccccccCCCcccccccccccccccccCCCccC
Confidence 99989998875 3322221111111 111111233456789999883
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-54 Score=443.78 Aligned_cols=282 Identities=34% Similarity=0.675 Sum_probs=243.3
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||.||+|+++.+++.||||++++...........+..|+.++..+ +||||++++++|.+...+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999987655556677789999999888 799999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---------- 150 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---------- 150 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987421110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
......+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 151 -------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred -------------------------------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence 0012468999999999999999999999999999999999999999632
Q ss_pred C---------hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC---CChhhhhcCCCcCCCChhhhhh
Q 008810 361 D---------PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 361 ~---------~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~---~~a~eil~HpfF~~i~w~~l~~ 427 (552)
. .......+.. ..+.+|. .++.++++||.+||+ ||.+|+++ .++++++.||||..++|+.+..
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~ 275 (329)
T cd05588 200 GMSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ 275 (329)
T ss_pred cccccccccchHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence 1 1123333443 3455664 689999999999999 99999985 3589999999999999998874
Q ss_pred --cCCCCccccCCcccCcCcccc
Q 008810 428 --MEAAFIPEVNDELDTQNFEKF 448 (552)
Q Consensus 428 --~~~pf~P~~~~~~d~~~f~~~ 448 (552)
..||+.|.+....+..+|+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~ 298 (329)
T cd05588 276 KQVLPPYKPNIESDRDLDNFDPQ 298 (329)
T ss_pred CCCCCCccccCCCcchhhhcCCc
Confidence 678999999888888888864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-54 Score=441.40 Aligned_cols=310 Identities=35% Similarity=0.668 Sum_probs=257.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||.||+|+++.+|+.||||++++..............|+.++.. .+||+|++++++|.+.+++|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999998765445556677888888875 4999999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---------- 150 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---------- 150 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----------
Confidence 9999999888899999999999999999999999999999999999999999999999999987432110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 151 -------------------------------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred -------------------------------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 0012468999999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh--hcCCCCccccC
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY--QMEAAFIPEVN 437 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~--~~~~pf~P~~~ 437 (552)
+..+....+.. ....+|. .++.++++||.+||. ||.+|++. +++++.||||++++|..+. .+.+|+.|...
T Consensus 200 ~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd05620 200 DEDELFESIRV--DTPHYPR--WITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVK 273 (316)
T ss_pred CHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 88877777765 3344554 689999999999999 99999983 3689999999999999876 46789999999
Q ss_pred CcccCcCccccccccccccCCCCCCccccccc-ccCCcccCceecC
Q 008810 438 DELDTQNFEKFEESDNQTKTSSKTGPWRKMLS-SKDINFVGYTYKN 482 (552)
Q Consensus 438 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~ 482 (552)
.+.+..+|+.-..+..+....+. ...+. ..+..|.||.|.+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05620 274 SPSDYSNFDREFLSEKPRLSYSD----KNLIDSMDQSAFAGFSFIN 315 (316)
T ss_pred CcchhhhcCccccccCcccCCCc----ccccccccccCcCCCcccC
Confidence 99999998763222211111111 11112 2345888888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-54 Score=443.44 Aligned_cols=316 Identities=37% Similarity=0.665 Sum_probs=261.4
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHH-HHhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||+||+|+++.+|+.||||++.+...........+..|+.+ ++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987755555555666667654 6779999999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--------- 151 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--------- 151 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 152 --------------------------------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred --------------------------------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 012467999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC-ChhhhhcCCCcCCCChhhhhh--cCCCCcccc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~-~a~eil~HpfF~~i~w~~l~~--~~~pf~P~~ 436 (552)
+..+.+.++... .+.++. .++.++.+||.+||. +|.+|++.. .+.+|+.||||++++|..+.+ +.+|+.|.+
T Consensus 200 ~~~~~~~~~~~~--~~~~~~--~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05604 200 DVAEMYDNILHK--PLVLRP--GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNV 275 (325)
T ss_pred CHHHHHHHHHcC--CccCCC--CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence 888888888763 334433 589999999999999 999999953 578999999999999998874 678999999
Q ss_pred CCcccCcCccc-cccccccccCCCCCCc--ccccccccCCcccCceecC
Q 008810 437 NDELDTQNFEK-FEESDNQTKTSSKTGP--WRKMLSSKDINFVGYTYKN 482 (552)
Q Consensus 437 ~~~~d~~~f~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~f~g~~~~~ 482 (552)
....|.++|+. +.++.........+++ ........+..|.||+|..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (325)
T cd05604 276 EGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAP 324 (325)
T ss_pred CCcchhhhcCCccccCCcccCcccccccccccccccccccccCCCEecC
Confidence 99999999986 3333222111111111 1112234577899999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=415.88 Aligned_cols=259 Identities=38% Similarity=0.625 Sum_probs=240.3
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
.....+||++.+.||+|-||.||+|+.+.++-.||+|++.|+.+....-...+++|++|...++||||+++|++|.|+..
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 45778999999999999999999999999999999999999998776666679999999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 191 LYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.||++||.++|+|...|. +...|+|..+..|+.|++.||.|+|..+||||||||+|+|++..|.+||+|||.+...++
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 677899999999999999999999999999999999999999999999999998865331
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
. + ..+.|||.+|.+||+..+.+++..+|+|++||+.|
T Consensus 177 ~----------------------------------------k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 177 N----------------------------------------K---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCY 213 (281)
T ss_pred C----------------------------------------C---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHH
Confidence 1 1 12689999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|+|+|.+||.+.+..+++++|.. ..+.+|. .+|.+|+|||.+||. +|.+|+. ..|++.|||...
T Consensus 214 eflvg~ppFes~~~~etYkrI~k--~~~~~p~--~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRK--VDLKFPS--TISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHH--ccccCCc--ccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 99999999999999999999987 5677774 899999999999998 9999998 999999999853
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=439.60 Aligned_cols=309 Identities=36% Similarity=0.669 Sum_probs=257.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
+.||+|+||+||+|+++.+++.||||++++..............|..++.. .+||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999988755444556667778888876 4999999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|+|||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 152 --------------------------------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred --------------------------------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 012467999999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCCh-hhhhcCCCcCCCChhhhh--hcCCCCcccc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-DEIKVHPWFDGVDWARIY--QMEAAFIPEV 436 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a-~eil~HpfF~~i~w~~l~--~~~~pf~P~~ 436 (552)
+..+....+... ...+|. .++.++++||.+||+ ||.+|++ + ++++.||||+.++|..+. .+++|+.|.+
T Consensus 200 ~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~ 272 (316)
T cd05619 200 DEEELFQSIRMD--NPCYPR--WLTREAKDILVKLFVREPERRLG---VKGDIRQHPFFREIDWSALEEREIEPPFKPKV 272 (316)
T ss_pred CHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHhccCHhhcCC---ChHHHHcCcccCCCCHHHHHhCCCCCCcCCCC
Confidence 888777777643 334553 689999999999999 9999999 5 489999999999999886 4789999999
Q ss_pred CCcccCcCccccccccccccCCCCCCcccccccccCCc-ccCceecC
Q 008810 437 NDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN-FVGYTYKN 482 (552)
Q Consensus 437 ~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-f~g~~~~~ 482 (552)
.+..|.++|++............ ....+.+.+.+ |.||.|.+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 315 (316)
T cd05619 273 KSANDCSNFDKEFLNEKPRLSVT----DRMLINSMDQNMFENFSFIN 315 (316)
T ss_pred CCccchhhcChhhhcCCcccCCC----cccccccccccccCCCcccC
Confidence 99999999987433322221111 11233444444 77776654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=433.49 Aligned_cols=275 Identities=33% Similarity=0.641 Sum_probs=235.9
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+|..++|++|++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987765544555668899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++||+|..++.. ...+++..+.+++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC----
Confidence 9999999988754 3469999999999999999999999999999999999999999999999999997643211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 157 --------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 198 (285)
T cd05631 157 --------------------------------------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198 (285)
T ss_pred --------------------------------------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhc--cccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh--
Q 008810 355 PPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ-- 427 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~-- 427 (552)
+||.+.+.......+... .....++ ..+++++.+||.+||. ||.+|++. .+++++++||||.+++|+.+.+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~ 276 (285)
T cd05631 199 SPFRKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANM 276 (285)
T ss_pred CCCCCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCc
Confidence 999886653332222211 1223344 3689999999999999 99999985 3589999999999999999985
Q ss_pred cCCCCccc
Q 008810 428 MEAAFIPE 435 (552)
Q Consensus 428 ~~~pf~P~ 435 (552)
++|||+|.
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05631 277 LEPPFCPD 284 (285)
T ss_pred CCcCCCCC
Confidence 68999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-53 Score=439.50 Aligned_cols=311 Identities=37% Similarity=0.701 Sum_probs=260.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||+||+|+++.+++.||||++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999987665666677788899999887 799999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--------- 151 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|+|||||++|+|++|..||.+.
T Consensus 152 --------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 152 --------------------------------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred --------------------------------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 012457999999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCCCCccc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEAAFIPE 435 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~pf~P~ 435 (552)
+....+..+.. ....+|. .++.++++||.+||. ||.+|+++. ...+++.||||+.++|..+.. +.||+.|.
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (318)
T cd05570 200 DEDELFQSILE--DEVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPK 275 (318)
T ss_pred CHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 88888777775 3445554 689999999999999 999999931 129999999999999988764 78999999
Q ss_pred cCCcccCcCccc-cccccccccCCCCCCcccccccccCCcccCceec
Q 008810 436 VNDELDTQNFEK-FEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (552)
Q Consensus 436 ~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (552)
+....|.++|+. |.... ...++... . .+..-....|.||+|.
T Consensus 276 ~~~~~~~~~~~~~~~~~~-~~~~~~~~-~--~~~~~~~~~~~~~~~~ 318 (318)
T cd05570 276 IKGRFDVSNFDDEFTKEK-PVLTPPDE-A--IIRNIDQEEFRGFSYI 318 (318)
T ss_pred CCCcchhhhcCchhccCc-ccCCCCcc-c--ccccccccccCCCCCC
Confidence 999999999975 33222 21111111 1 1222244689999883
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-54 Score=455.85 Aligned_cols=261 Identities=30% Similarity=0.572 Sum_probs=240.6
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
...-|++.+.||+|+-|.|.+|++..||+..|||++.+.......+...+.+|+-||+.+.||||++||+++.+..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 45668999999999999999999999999999999998865666677789999999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|+||++||.|+++|.++++|+|.+++.|+.||+.|+.|+|..+|+||||||+|+|||..+.|||+|||+|..-..+.
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--- 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--- 166 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999997543221
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEmlt 352 (552)
+..+.||+|+|.|||++.|.+| |.++||||.|||||.|||
T Consensus 167 ---------------------------------------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt 207 (786)
T KOG0588|consen 167 ---------------------------------------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT 207 (786)
T ss_pred ---------------------------------------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh
Confidence 2336799999999999999998 789999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
|+.||.+++....+.|+.. +.+.+|. .+|++|+|||++||. ||..|++ .+||+.|||+.+..=.
T Consensus 208 G~LPFdDdNir~LLlKV~~--G~f~MPs--~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 208 GKLPFDDDNIRVLLLKVQR--GVFEMPS--NISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYTSL 272 (786)
T ss_pred CCCCCCCccHHHHHHHHHc--CcccCCC--cCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCCCC
Confidence 9999999999999999986 6778885 899999999999998 9999999 9999999999886543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-53 Score=439.01 Aligned_cols=287 Identities=44% Similarity=0.788 Sum_probs=244.2
Q ss_pred CeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceE
Q 008810 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~l 191 (552)
+|++++.||+|+||.||+|+.. .+|+.||+|++.+..... ....+++..|+.+|..+ +||+|++++++|.+.+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 578999999998765432 34456788999999999 599999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||++||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999875422110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEm 350 (552)
......+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 161 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 200 (332)
T cd05614 161 ----------------------------------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200 (332)
T ss_pred ----------------------------------------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhh
Confidence 011246899999999999875 589999999999999999
Q ss_pred hhCCCCCCCCCh----hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChh
Q 008810 351 LVGYPPFYSDDP----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWA 423 (552)
Q Consensus 351 ltG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~ 423 (552)
++|..||..... ......+.. ....+|. .+++.+++||.+||. ||.+|+++. .++++++||||++++|.
T Consensus 201 ltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 201 LTGASPFTLEGERNTQSEVSRRILK--CDPPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred hcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999975432 233334443 2334443 689999999999999 999999765 69999999999999999
Q ss_pred hhh--hcCCCCccccCCcccCcCccc
Q 008810 424 RIY--QMEAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 424 ~l~--~~~~pf~P~~~~~~d~~~f~~ 447 (552)
.+. .+.+||.|......|..+|..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (332)
T cd05614 277 ALALRKVNPPFRPSIRNELDVGNFAE 302 (332)
T ss_pred HHHhCCCCCCcCCCCCCcchhhhcCc
Confidence 876 378899999999999988864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=439.57 Aligned_cols=281 Identities=35% Similarity=0.689 Sum_probs=241.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +|||||+++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999987655555667788999998776 899999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--------- 151 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--------- 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (329)
T cd05618 152 --------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccC
Confidence 012468999999999999999999999999999999999999999531
Q ss_pred C---------hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC---CChhhhhcCCCcCCCChhhhhh
Q 008810 361 D---------PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 361 ~---------~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~---~~a~eil~HpfF~~i~w~~l~~ 427 (552)
. .......+.. ....+|. .++.++++||.+||. ||.+|+++ .++++|++||||++++|+.+..
T Consensus 200 ~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~ 275 (329)
T cd05618 200 GSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ 275 (329)
T ss_pred CCcCCcccccHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc
Confidence 1 1122333443 3455664 689999999999999 99999985 2578999999999999998864
Q ss_pred --cCCCCccccCCcccCcCccc
Q 008810 428 --MEAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 428 --~~~pf~P~~~~~~d~~~f~~ 447 (552)
+.||+.|.+.+..+..+|+.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
T cd05618 276 KQVVPPFKPNISGEFGLDNFDA 297 (329)
T ss_pred CCCCcCccCCCCCcccchhcCc
Confidence 78999999988888888875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-53 Score=435.56 Aligned_cols=281 Identities=39% Similarity=0.717 Sum_probs=244.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHH-HHHhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
+.||+|+||.||+|+++.+++.||+|++.+..........++..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998766544444455555554 56788999999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--------- 151 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--------- 151 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 152 --------------------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred --------------------------------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 012468999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC-ChhhhhcCCCcCCCChhhhhh--cCCCCcccc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~-~a~eil~HpfF~~i~w~~l~~--~~~pf~P~~ 436 (552)
+..+.+..+... ...++ ..++.++++||.+||. ||.+|++.. ...++++||||..++|+.+.. ..+|+.|.+
T Consensus 200 ~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05602 200 NTAEMYDNILNK--PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNV 275 (325)
T ss_pred CHHHHHHHHHhC--CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCC
Confidence 888888888763 33443 3689999999999999 999999964 467999999999999999874 678899999
Q ss_pred CCcccCcCccc
Q 008810 437 NDELDTQNFEK 447 (552)
Q Consensus 437 ~~~~d~~~f~~ 447 (552)
....++.+|+.
T Consensus 276 ~~~~~~~~~~~ 286 (325)
T cd05602 276 SGPNDLRHFDP 286 (325)
T ss_pred CCcchhhhcCC
Confidence 98888888874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=433.85 Aligned_cols=282 Identities=40% Similarity=0.730 Sum_probs=245.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHH-HHHhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
++||+|+||.||+|+++.+|+.||+|++.+...........+..|+. +++.++|||||+++++|.+.+.+|+|||||+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998876554455556666665 57889999999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|...+.+...+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--------- 151 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874311100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 152 --------------------------------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred --------------------------------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 012457999999999999999999999999999999999999999999
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC-CChhhhhcCCCcCCCChhhhhh--cCCCCcccc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~-~~a~eil~HpfF~~i~w~~l~~--~~~pf~P~~ 436 (552)
+....+..+.. ..+.+|. ..+.++.+||.+||. ||.+|+++ .++.+++.||||..++|..+.. +.+|+.|..
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T cd05603 200 DVSQMYDNILH--KPLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNV 275 (321)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCC
Confidence 88888888876 3455554 678899999999999 99999985 3577999999999999999874 678999998
Q ss_pred CCcccCcCcccc
Q 008810 437 NDELDTQNFEKF 448 (552)
Q Consensus 437 ~~~~d~~~f~~~ 448 (552)
....++..|+..
T Consensus 276 ~~~~~~~~~~~~ 287 (321)
T cd05603 276 AGPADLRHFDPE 287 (321)
T ss_pred CCcchhhhcCCc
Confidence 888888888753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=436.41 Aligned_cols=266 Identities=37% Similarity=0.658 Sum_probs=230.8
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh-----------hhHHHHHHHHHHHHHhcCCCceEE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----------RGQVEHVRAERNLLAEVDSNCIVK 180 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~-----------~~~~~~~~~E~~iL~~l~hp~Iv~ 180 (552)
....+.|++++.||+|.||+|.+|++..+++.||||++.|..... ...++.+++|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 456788999999999999999999999999999999998865432 223578999999999999999999
Q ss_pred EeeeecCC--ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEc
Q 008810 181 LYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (552)
Q Consensus 181 l~~~f~d~--~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~ 258 (552)
|+.+..|. +++|||+|||..|.+...=.....|++.+|+.|+.+++.||+|||.+|||||||||.|+||+.+|+|||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99999865 5899999999999887654333339999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC----C
Q 008810 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----Y 334 (552)
Q Consensus 259 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~----y 334 (552)
|||.|-....+..... .+++ ..++|||.|||||.+.+.. -
T Consensus 253 DFGVs~~~~~~~~~~~-------------------------d~~L-----------~~tvGTPAF~APE~c~~~~~~~~~ 296 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGS-------------------------DDQL-----------SRTVGTPAFFAPELCSGGNSFSYS 296 (576)
T ss_pred ccceeeecccCCcccc-------------------------HHHH-----------hhcCCCccccchHhhcCCCCcccc
Confidence 9999876533211000 0111 1279999999999998732 3
Q ss_pred CCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+++.|||||||.||.|+.|..||.++...+++.+|++ ..+.||..+.+.++++|||.+||+ ||++|++ +.+|+.
T Consensus 297 g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~---l~~ik~ 371 (576)
T KOG0585|consen 297 GFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRIT---LPDIKL 371 (576)
T ss_pred chhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhheee---hhhhee
Confidence 7899999999999999999999999999999999998 789999988899999999999999 9999999 999999
Q ss_pred CCCcC
Q 008810 414 HPWFD 418 (552)
Q Consensus 414 HpfF~ 418 (552)
|||..
T Consensus 372 Hpwvt 376 (576)
T KOG0585|consen 372 HPWVT 376 (576)
T ss_pred cceec
Confidence 99974
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-53 Score=435.52 Aligned_cols=281 Identities=41% Similarity=0.741 Sum_probs=248.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG 201 (552)
+.||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999876555566777889999999999999999999999999999999999999
Q ss_pred chhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 202 ~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
+|..++.+...+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--------- 151 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---------
Confidence 999999888899999999999999999999997 7999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 152 --------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred --------------------------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 011357999999999999999999999999999999999999999998
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh--cCCCCccc
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPE 435 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~--~~~pf~P~ 435 (552)
+.......+.. ....+|. .+++++.+||.+||+ ||.+|++. ..+.+|+.||||.+++|..+.. ..||+.|.
T Consensus 200 ~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05594 200 DHEKLFELILM--EEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQ 275 (325)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 88777777765 4555664 689999999999999 99999853 2499999999999999998874 66899999
Q ss_pred cCCcccCcCccc
Q 008810 436 VNDELDTQNFEK 447 (552)
Q Consensus 436 ~~~~~d~~~f~~ 447 (552)
...+.|+.+|+.
T Consensus 276 ~~~~~~~~~~~~ 287 (325)
T cd05594 276 VTSETDTRYFDE 287 (325)
T ss_pred CCCcchhhhcCc
Confidence 998999998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-55 Score=414.01 Aligned_cols=260 Identities=33% Similarity=0.595 Sum_probs=238.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.+.|++-.+||+|+|+.||.|.++.||+.||+|++.......+ ..+.+.+|..|-..++|||||+|..+++...+.|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4568888899999999999999999999999999987655443 667899999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGlak~~~~~~~ 271 (552)
+|+|.||+|..-+-.+-.++|..+..|+.||+.||.|+|.+||||||+||+|+||.. ..-+||+|||+|..+...
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-- 166 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-- 166 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc--
Confidence 999999999999888888999999999999999999999999999999999999964 336999999999977521
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
..+..++|||.|||||++...+|+..+|||+-|||||-||
T Consensus 167 ----------------------------------------~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 167 ----------------------------------------EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred ----------------------------------------cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 1234689999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
.|++||++.+....++.|+......+-|.++.+|++|++||++||. ||.+|++ +.|.|+|||+.+-
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNR 273 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcch
Confidence 9999999999999999999987777777889999999999999999 9999999 9999999999864
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=432.32 Aligned_cols=282 Identities=43% Similarity=0.790 Sum_probs=246.0
Q ss_pred EeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 121 LTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
++.||+|+||.||+|+.. .+++.||||++++..... .....++.+|+.+|+.++||||++++++|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999863 578999999998765432 3445678899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~------ 154 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG------ 154 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC------
Confidence 99999999999988999999999999999999999999999999999999999999999999999987432110
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
......+||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 155 -----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~p 199 (323)
T cd05584 155 -----------------------------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199 (323)
T ss_pred -----------------------------------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCC
Confidence 001245799999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh--cCCC
Q 008810 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAA 431 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~--~~~p 431 (552)
|.+.+....+..+.. ....+|. .+++++++||.+||. ||.+|++. ..+++++.||||...+|..+.. ..+|
T Consensus 200 f~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05584 200 FTAENRKKTIDKILK--GKLNLPP--YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPP 275 (323)
T ss_pred CCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCC
Confidence 999888888888876 3445554 689999999999999 99999953 2489999999999999998874 6788
Q ss_pred CccccCCcccCcCccc
Q 008810 432 FIPEVNDELDTQNFEK 447 (552)
Q Consensus 432 f~P~~~~~~d~~~f~~ 447 (552)
+.|......|.+.|+.
T Consensus 276 ~~~~~~~~~~~~~~~~ 291 (323)
T cd05584 276 FKPLLQSEEDVSQFDS 291 (323)
T ss_pred cCCCCCCcchhhhcCc
Confidence 9998888888888774
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-53 Score=437.33 Aligned_cols=280 Identities=42% Similarity=0.763 Sum_probs=245.3
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
||+|+||+||+|+++.+|+.||||++.+..........+...|..++... +||+|++++.+|.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999887665555666677788888765 799999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~---------- 150 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN---------- 150 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----------
Confidence 9999999888999999999999999999999999999999999999999999999999999987532110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYS 359 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~~PF~~ 359 (552)
......+||+.|+|||++.+. .|+.++|+|||||++|||++|..||.+
T Consensus 151 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 151 -------------------------------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred -------------------------------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 001246899999999999764 589999999999999999999999999
Q ss_pred CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC-ChhhhhcCCCcCCCChhhhhh--cCCCCccc
Q 008810 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEIKVHPWFDGVDWARIYQ--MEAAFIPE 435 (552)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~-~a~eil~HpfF~~i~w~~l~~--~~~pf~P~ 435 (552)
.+..+.+.++.. ....+|. ..+++++++||.+||+ ||.+|+++. ++++++.||||.+++|+.+.. +.+|+.|.
T Consensus 200 ~~~~~~~~~i~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 276 (330)
T cd05586 200 EDTQQMYRNIAF--GKVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPI 276 (330)
T ss_pred CCHHHHHHHHHc--CCCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCC
Confidence 988888887765 3445554 2589999999999999 999999753 599999999999999998874 77899999
Q ss_pred cCCcccCcCccc
Q 008810 436 VNDELDTQNFEK 447 (552)
Q Consensus 436 ~~~~~d~~~f~~ 447 (552)
+....+.++|+.
T Consensus 277 ~~~~~~~~~~~~ 288 (330)
T cd05586 277 VDSDEDVSNFDP 288 (330)
T ss_pred CCCCcchhhcCc
Confidence 999999998874
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-55 Score=420.76 Aligned_cols=249 Identities=33% Similarity=0.572 Sum_probs=222.3
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEee-eecCCce
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC-SFQDDEF 190 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~-~f~d~~~ 190 (552)
.....+|+++++||+|+||+||+|++..+|+.+|.|.+.- .+.+......+..|+.+|++++|||||+.|. .|.++..
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f-~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF-GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch-hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 4456789999999999999999999999999999999984 4455566677889999999999999999998 7776665
Q ss_pred -EEEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--CcccccCCCCccccCCCcEEEcccc
Q 008810 191 -LYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHK--HH--YIHRDIKPDNLLLDKYGHLRLSDFG 261 (552)
Q Consensus 191 -lylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~--~g--iiHrDLKPeNILl~~~g~iKL~DFG 261 (552)
++||||||.+|||..+++. +..++|..+..|+.|++.||+++|. .. |+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999999864 4679999999999999999999998 44 9999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchh
Q 008810 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341 (552)
Q Consensus 262 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiW 341 (552)
|++.+.... ..+.+.||||.||+||++...+|++++|||
T Consensus 174 L~r~l~s~~-----------------------------------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiW 212 (375)
T KOG0591|consen 174 LGRFLSSKT-----------------------------------------TFAHSLVGTPYYMSPERIHESGYNFKSDIW 212 (375)
T ss_pred hHhHhcchh-----------------------------------------HHHHhhcCCCcccCHHHHhcCCCCcchhHH
Confidence 999875432 235589999999999999999999999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCC
Q 008810 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 342 SlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
||||++|||+.-.+||++++-.+.+.+|.+. ...+.|. ...|.++..||..||+ ||+.||+
T Consensus 213 slGCllyEMcaL~~PF~g~n~~~L~~KI~qg-d~~~~p~-~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 213 SLGCLLYEMCALQSPFYGDNLLSLCKKIEQG-DYPPLPD-EHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred HHHHHHHHHHhcCCCcccccHHHHHHHHHcC-CCCCCcH-HHhhhHHHHHHHHHccCCcccCCC
Confidence 9999999999999999999999999999985 2223553 3789999999999999 9999998
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=442.92 Aligned_cols=254 Identities=34% Similarity=0.609 Sum_probs=233.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|-+...||+|+||.||+|+.|.|.++||||.+.|.. ....++..+++|++|++.++|||||.++.+|++..++++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 57888999999999999999999999999999998865 33456788999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||.| +|+++|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+.+|++||||||+|+.+...+
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99977 999999999999999999999999999999999999999999999999999999999999999764321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.+..+.-|||-|||||++.+.+|+..+|.||||||+|||.+|+|
T Consensus 155 ------------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 155 ------------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred ------------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 12346789999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||+.....+..+.|.. .....|. .+|.+++.||..||. ||.+|++ ..+++.|||.++
T Consensus 199 PF~a~si~~Lv~~I~~--d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 199 PFYARSITQLVKSILK--DPVKPPS--TASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKG 256 (808)
T ss_pred CchHHHHHHHHHHHhc--CCCCCcc--cccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhh
Confidence 9999998888888886 4555554 899999999999998 9999999 999999999876
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-54 Score=412.35 Aligned_cols=261 Identities=33% Similarity=0.595 Sum_probs=235.6
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----hhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
..|+..++||+|..+.|..|.++.+|+.+|+|++.-.... -..-.+..+.|+.||+++ .||+|++|.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3466677899999999999999999999999999643211 122345577899999987 8999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+++|+|.|+.|.|+++|...-.++|.+++.++.|++.|++|||.++||||||||+|||+|++..|||+|||+|+.+..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc------CCCCCccchhhh
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWWSL 343 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~------~~y~~~~DiWSl 343 (552)
.. ....||||+|+|||.+.. .||+.++|+||+
T Consensus 177 ek------------------------------------------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 177 EK------------------------------------------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC 214 (411)
T ss_pred hh------------------------------------------HHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence 21 125799999999999973 689999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
|||||-||.|.|||+.....-+++.|+.++..+.-|++.++|.+++|||++||+ ||.+|++ ++|+|+||||..+-
T Consensus 215 GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~~ 290 (411)
T KOG0599|consen 215 GVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQIA 290 (411)
T ss_pred HHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHHH
Confidence 999999999999999999999999999998899999999999999999999999 9999999 99999999996543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=428.20 Aligned_cols=281 Identities=42% Similarity=0.738 Sum_probs=245.0
Q ss_pred EeeeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 121 LTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~---k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
++.||+|+||.||+|+. +.+|+.||+|++.+.... ......+..|+.+|..++||||++++++|.+...+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 467899999999876532 23345677899999999999999999999999999999999
Q ss_pred CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccc
Q 008810 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (552)
Q Consensus 198 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~ 277 (552)
++||+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~------- 152 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE------- 152 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-------
Confidence 9999999999888889999999999999999999999999999999999999999999999999987542210
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCC
Q 008810 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (552)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF 357 (552)
....+.+||+.|+|||++.+..++.++|+|||||++|||++|..||
T Consensus 153 ----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 198 (318)
T cd05582 153 ----------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198 (318)
T ss_pred ----------------------------------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence 0122468999999999999999999999999999999999999999
Q ss_pred CCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC--hhhhhcCCCcCCCChhhhhh--cCCCC
Q 008810 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG--ADEIKVHPWFDGVDWARIYQ--MEAAF 432 (552)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~--a~eil~HpfF~~i~w~~l~~--~~~pf 432 (552)
.+.+..+....+.. ....+|. .+++++++||.+||. ||.+|+++.. +++++.||||..++|..+.. ..+|+
T Consensus 199 ~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (318)
T cd05582 199 QGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPF 274 (318)
T ss_pred CCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCc
Confidence 99888888877765 3445554 689999999999999 9999999766 88999999999999998874 67889
Q ss_pred ccccCCcccCcCccc
Q 008810 433 IPEVNDELDTQNFEK 447 (552)
Q Consensus 433 ~P~~~~~~d~~~f~~ 447 (552)
.|......+..+|+.
T Consensus 275 ~~~~~~~~~~~~~~~ 289 (318)
T cd05582 275 KPAVGRPDDTFYFDP 289 (318)
T ss_pred CCCCCCcchhhhcCc
Confidence 998877777777654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-53 Score=410.71 Aligned_cols=259 Identities=30% Similarity=0.490 Sum_probs=220.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+.|+.+..+|+|+||.||+|+++.||+.||||++.-++- +..--+-..+|+.+|++++|||+|.|..+|.-...+|||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 468889999999999999999999999999999976531 1112234789999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||...-|..+-.....++++.++.|+.|++.|+.|+|++++||||||||||||+.+|.+||||||+|+.+.....
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd---- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD---- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc----
Confidence 9997755555544557899999999999999999999999999999999999999999999999999997752210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG~ 354 (552)
..+..|.|.||+|||.+.+ ..|+..+||||+||++.||++|.
T Consensus 157 -------------------------------------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~ 199 (396)
T KOG0593|consen 157 -------------------------------------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE 199 (396)
T ss_pred -------------------------------------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence 0124689999999999998 78999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccc-----------------cccCCcc----------cccChhHHHHHHHHhh-CccccCCCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRT-----------------HLKFPEE----------AKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~----------~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
|.|.|.+..+.+..|...-+ -+.+|+. +.++.-+.||+.+||. ||.+|++
T Consensus 200 pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s-- 277 (396)
T KOG0593|consen 200 PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS-- 277 (396)
T ss_pred cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc--
Confidence 99999988887766653111 1122321 3678889999999999 9999999
Q ss_pred ChhhhhcCCCcCC
Q 008810 407 GADEIKVHPWFDG 419 (552)
Q Consensus 407 ~a~eil~HpfF~~ 419 (552)
.++++.||||.+
T Consensus 278 -c~qll~H~yFd~ 289 (396)
T KOG0593|consen 278 -CEQLLHHPYFDG 289 (396)
T ss_pred -HHHHhcChHHHH
Confidence 999999999954
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-52 Score=433.49 Aligned_cols=260 Identities=35% Similarity=0.612 Sum_probs=239.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lyl 193 (552)
.+.|++.+.||+|.||.||+|+.+.||+.||+|++.|..+......+.+.+|+.||+.+. |||||.++++|.+...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456999999999999999999999999999999999988766666788999999999998 9999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC----CCcEEEcccccccccCCC
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK----YGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~----~g~iKL~DFGlak~~~~~ 269 (552)
|||+|.||+|++.+... .++|..+..++.|++.|+.|||+.||+||||||||+|+.. ++.+|++|||+++.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999877 5999999999999999999999999999999999999963 358999999999876431
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
......||||.|+|||++...+|+..+|+||+||++|.
T Consensus 193 ------------------------------------------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yi 230 (382)
T KOG0032|consen 193 ------------------------------------------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYI 230 (382)
T ss_pred ------------------------------------------ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHH
Confidence 11236899999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
||+|.+||.+.+...++.+|......+..+.+..+|..|+|||++||. ||..|++ |.+++.|||+.+.
T Consensus 231 LL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 231 LLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSI 299 (382)
T ss_pred HhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCC
Confidence 999999999999999999999876666777778999999999999999 9999999 9999999998765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-52 Score=425.43 Aligned_cols=274 Identities=30% Similarity=0.473 Sum_probs=234.1
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--c
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--E 189 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~ 189 (552)
....+.|+.++.||+|+||.||+|++..||+.||+|++..... +.+......+|+.||++++|||||+|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 3456789999999999999999999999999999999987642 455566788999999999999999999988766 6
Q ss_pred eEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|||+|||+ -||..++... -.|++.+++.|+.||+.||+|||.+||+|||||..|||||.+|.+||+|||||+.++.
T Consensus 192 siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 8999999995 5899998764 4799999999999999999999999999999999999999999999999999997754
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
.... ..++.|-|.||+|||+|+| ..|+.++|+||+||||
T Consensus 271 ~~~~----------------------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl 310 (560)
T KOG0600|consen 271 SGSA----------------------------------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCIL 310 (560)
T ss_pred CCCc----------------------------------------ccccceEEeeccChHHhcCCcccccceeehhhhHHH
Confidence 3211 1236789999999999998 6799999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhh---------ccccccCCc-----------------ccccChhHHHHHHHHhh-Ccc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVN---------WRTHLKFPE-----------------EAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~---------~~~~~~~p~-----------------~~~~s~e~~dLI~~lL~-dp~ 400 (552)
.||++|+|.|.|.+..+.+.+|.+ |. ...+|. ...+++.+.+|+..||+ ||.
T Consensus 311 ~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~ 389 (560)
T KOG0600|consen 311 AELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPD 389 (560)
T ss_pred HHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcc
Confidence 999999999999999999999875 44 223331 12578899999999999 999
Q ss_pred ccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccc
Q 008810 401 QRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~ 435 (552)
+|.+ |.++|.|+||... ....+|+.+|.
T Consensus 390 kR~t---A~~aL~seyF~t~----p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 390 KRGT---ASSALQSEYFTTE----PLPCDPSSLPK 417 (560)
T ss_pred cccc---HHHHhcCcccccC----CCCCCcccCCC
Confidence 9999 9999999999432 22344555554
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=410.14 Aligned_cols=275 Identities=33% Similarity=0.665 Sum_probs=234.7
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|+++++||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.|.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999987655444445567889999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+|||++..+....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC----
Confidence 99999999888653 469999999999999999999999999999999999999999999999999987543110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 157 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 157 --------------------------------------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred --------------------------------------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhc--cccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--
Q 008810 355 PPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ-- 427 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~-- 427 (552)
.||.+.+.......+... .....+| ..++..+.+||.+||. ||.+|++.. ++++++.||||...+|.++.+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05605 199 SPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276 (285)
T ss_pred CCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCC
Confidence 999887654433333221 1222333 3689999999999999 999999654 599999999999999999875
Q ss_pred cCCCCccc
Q 008810 428 MEAAFIPE 435 (552)
Q Consensus 428 ~~~pf~P~ 435 (552)
+.|||.|.
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05605 277 LEPPFCPD 284 (285)
T ss_pred CCCCCCCC
Confidence 67899884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=410.34 Aligned_cols=266 Identities=34% Similarity=0.652 Sum_probs=227.2
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCch
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L 203 (552)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+|+.++||||++++++|.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999877655555567788999999999999999999999999999999999999999
Q ss_pred hhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccccc
Q 008810 204 MTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (552)
Q Consensus 204 ~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~ 279 (552)
..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-------- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-------- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--------
Confidence 888743 35699999999999999999999999999999999999999999999999999976532210
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCC
Q 008810 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (552)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~ 359 (552)
......||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 153 ---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 153 ---------------------------------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred ---------------------------------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 01135799999999999999999999999999999999999999987
Q ss_pred CChhh----HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCC
Q 008810 360 DDPMS----TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (552)
Q Consensus 360 ~~~~~----~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~ 430 (552)
.+... ....+.. ....+|. .+++++.+||.+||. ||.+|++.. .++++++||||++++|..+.. +++
T Consensus 200 ~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~ 275 (280)
T cd05608 200 RGEKVENKELKQRILN--DSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPP 275 (280)
T ss_pred CCcchhHHHHHHhhcc--cCCCCcc--cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCC
Confidence 54322 2223322 2334443 689999999999998 999999642 489999999999999998864 678
Q ss_pred CCcc
Q 008810 431 AFIP 434 (552)
Q Consensus 431 pf~P 434 (552)
||.|
T Consensus 276 ~~~~ 279 (280)
T cd05608 276 PFVP 279 (280)
T ss_pred CCCC
Confidence 8877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=405.92 Aligned_cols=285 Identities=46% Similarity=0.926 Sum_probs=257.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|.+..+++.||||++.+.........+.+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998877666667788999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|.+++.+...+++..+..++.||+.||.|||+.||+||||+|.|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999988899999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
....+|++.|+|||.+.+..++.++|+|||||++|+|++|.+
T Consensus 155 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 196 (290)
T cd05580 155 --------------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196 (290)
T ss_pred --------------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 113578999999999998889999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~ 430 (552)
||...+......++.. ....+|. .++..++++|.+||+ ||.+|++.. .++|++.||||+.++|..+.. +.+
T Consensus 197 p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 272 (290)
T cd05580 197 PFFDDNPIQIYEKILE--GKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEA 272 (290)
T ss_pred CCCCCCHHHHHHHHhc--CCccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCC
Confidence 9998887777777774 4455664 579999999999999 999999643 599999999999999999874 789
Q ss_pred CCccccCCcccCcCcccc
Q 008810 431 AFIPEVNDELDTQNFEKF 448 (552)
Q Consensus 431 pf~P~~~~~~d~~~f~~~ 448 (552)
|+.|...++.|.+.|+++
T Consensus 273 ~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05580 273 PFIPKVKGPGDTSNFDDY 290 (290)
T ss_pred CccCCCCCccccccccCC
Confidence 999999999999988763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-51 Score=427.90 Aligned_cols=254 Identities=32% Similarity=0.555 Sum_probs=226.6
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
..|.....||+|+-|.||.|+...+++.||||.+....... .+-+.+|+.+|+..+|+|||.++.+|.-.+.+++||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 45788889999999999999999999999999998765332 345899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||.||+|.+.+.. -.++|.+++.++.+++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.....
T Consensus 350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---- 424 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---- 424 (550)
T ss_pred eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC----
Confidence 99999998888744 5699999999999999999999999999999999999999999999999999997754321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
+ ..+.||||.|||||++..+.|+.++||||||++++||+-|.|
T Consensus 425 --------------------K-----------------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 425 --------------------K-----------------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred --------------------c-----------------cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCC
Confidence 1 126899999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
||..+++...+..|... +...+.....+|++++||+.+||+ |+.+|++ |.|+|.||||+
T Consensus 468 PYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~ 527 (550)
T KOG0578|consen 468 PYLNENPLRALYLIATN-GTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLK 527 (550)
T ss_pred CccCCChHHHHHHHhhc-CCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhh
Confidence 99999988877777652 344444445999999999999999 9999999 99999999994
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-51 Score=421.93 Aligned_cols=257 Identities=30% Similarity=0.528 Sum_probs=222.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCc-eEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE-FLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~-~ly 192 (552)
.++|.+++.||.|+||.||+|+.+.+|..||||.|++.... -+...-.+|+..|++++ |||||+|+.++.|.+ .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 46799999999999999999999999999999999876432 22223457888999998 999999999999988 999
Q ss_pred EEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
+||||| ..+|..++.. ++.|+|..++.|+.||+.||.|+|++|+.||||||||||+.....|||+|||||+.+....-
T Consensus 87 fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 999999 5689998854 56899999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEm 350 (552)
-+..|.|.||+|||+|+. .-|+.++|+||+||||+|+
T Consensus 166 ------------------------------------------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl 203 (538)
T KOG0661|consen 166 ------------------------------------------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAEL 203 (538)
T ss_pred ------------------------------------------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHH
Confidence 124789999999999997 4589999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhh---------cc--------ccccCCcc---------cccChhHHHHHHHHhh-CccccC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVN---------WR--------THLKFPEE---------AKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~---------~~--------~~~~~p~~---------~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
.+-+|.|.|.+..+.+.+|+. |. -.+.||.- +.+++++.+||.+||. ||.+||
T Consensus 204 ~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp 283 (538)
T KOG0661|consen 204 YSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP 283 (538)
T ss_pred HHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence 999999999999998888874 11 12344431 3478999999999999 999999
Q ss_pred CCCChhhhhcCCCcCC
Q 008810 404 GAKGADEIKVHPWFDG 419 (552)
Q Consensus 404 ~~~~a~eil~HpfF~~ 419 (552)
+ |.++++||||+.
T Consensus 284 T---A~~al~~pffq~ 296 (538)
T KOG0661|consen 284 T---ASQALQHPFFQV 296 (538)
T ss_pred c---HHHHhcCccccc
Confidence 9 999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=411.15 Aligned_cols=260 Identities=32% Similarity=0.519 Sum_probs=220.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc--eEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--FLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~--~ly 192 (552)
..++...+.||+|+||.||++.++.+|..+|||.+.... ....+.+.+|+.+|.+++|||||+.++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888899999999999999999999999999987652 222667899999999999999999999755444 699
Q ss_pred EEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-CCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-~g~iKL~DFGlak~~~~~~ 270 (552)
+.|||++||+|.+++.+.+ .|+|..++.|..||+.||.|||++|||||||||+|||++. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998877 7999999999999999999999999999999999999999 7999999999998765310
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyE 349 (552)
... ....+..|||.|||||++... .-+.++|||||||++.|
T Consensus 173 ~~~--------------------------------------~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 173 TKS--------------------------------------DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred ccc--------------------------------------cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 000 012257899999999999962 23359999999999999
Q ss_pred HhhCCCCCCC-CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 350 MLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 350 mltG~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|+||.+||.. ....+.+.+|........+|. .+|.++++||.+|+. ||.+||+ |+++|.|||....
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~--~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLPEIPD--SLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQN 282 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcc
Confidence 9999999987 566666666665443446665 799999999999999 9999999 9999999999753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-51 Score=408.17 Aligned_cols=253 Identities=29% Similarity=0.587 Sum_probs=234.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
..+|++.+.||+|+||+|-+|.....|+.||||.++|..+......-|+++|++||..++||||+.+|.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46799999999999999999999999999999999999998888899999999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||..||+|.+++...+.|+|.+++.++.||+.|+.|+|+++++|||||.+|||||.++++||+||||+..+....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---- 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---- 207 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998764332
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEmltG 353 (552)
+..++||+|-|.+||++.+.+| +.++|-|||||+||-|+.|
T Consensus 208 --------------------------------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 208 --------------------------------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred --------------------------------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 2337899999999999999998 7899999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
..||.|.+.....+.|..+ .+.-| .-+.+|.-||+.||. ||++|.+ +++|..|=|.
T Consensus 250 tMPFDG~Dhk~lvrQIs~G--aYrEP---~~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWv 306 (668)
T KOG0611|consen 250 TMPFDGRDHKRLVRQISRG--AYREP---ETPSDASGLIRWMLMVNPERRAT---IEDIASHWWV 306 (668)
T ss_pred ccccCCchHHHHHHHhhcc--cccCC---CCCchHHHHHHHHHhcCcccchh---HHHHhhhhee
Confidence 9999999999998888864 33344 346789999999998 9999998 9999999884
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=401.83 Aligned_cols=274 Identities=34% Similarity=0.675 Sum_probs=232.4
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|++.++||+|+||.||+|.++.+++.||+|.+.+...........+..|+.+|+.++|++|+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987655444445667889999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 99999999988543 469999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 157 --------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred --------------------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCChh---hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh-
Q 008810 355 PPFYSDDPM---STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ- 427 (552)
Q Consensus 355 ~PF~~~~~~---~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~- 427 (552)
+||.+.... .....+... ....++ ..+++++++||.+||+ ||.+|++.. +++|+++||||+.++|..+..
T Consensus 199 ~Pf~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05630 199 SPFQQRKKKIKREEVERLVKE-VQEEYS--EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAG 275 (285)
T ss_pred CCCCCCCccchHHHHHhhhhh-hhhhcC--ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcC
Confidence 999875432 222222211 112233 2688999999999999 999999853 489999999999999998875
Q ss_pred -cCCCCccc
Q 008810 428 -MEAAFIPE 435 (552)
Q Consensus 428 -~~~pf~P~ 435 (552)
+.|||+|.
T Consensus 276 ~~~~~~~~~ 284 (285)
T cd05630 276 MLEPPFKPD 284 (285)
T ss_pred CCCCCCCCC
Confidence 77899985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=399.82 Aligned_cols=267 Identities=31% Similarity=0.592 Sum_probs=224.4
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCch
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L 203 (552)
||+|+||.||+|+.+.+|+.||+|++.+...........+..|+++|..++||||++++++|.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999876554444455567799999999999999999999999999999999999999
Q ss_pred hhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCC
Q 008810 204 MTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (552)
Q Consensus 204 ~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~ 281 (552)
..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---------- 150 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---------- 150 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----------
Confidence 9888553 3589999999999999999999999999999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCC
Q 008810 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (552)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~ 361 (552)
.....||+.|+|||++.+..++.++|+|||||++|||++|.+||.+..
T Consensus 151 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 151 --------------------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred --------------------------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 113468999999999999889999999999999999999999997653
Q ss_pred hh----hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC-hhhhhcCCCcCCCChhhhhh--cCCCCc
Q 008810 362 PM----STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG-ADEIKVHPWFDGVDWARIYQ--MEAAFI 433 (552)
Q Consensus 362 ~~----~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~-a~eil~HpfF~~i~w~~l~~--~~~pf~ 433 (552)
.. +....+.. ....++. ..+++++++||.+||. ||.+|+++.+ .++++.||||++++|..+.. .+|||+
T Consensus 199 ~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~ 275 (277)
T cd05607 199 EKVAKEELKRRTLE--DEVKFEH-QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFV 275 (277)
T ss_pred chhhHHHHHHHhhc--ccccccc-ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCC
Confidence 32 23333332 2223322 3689999999999999 9999999532 47899999999999999984 678887
Q ss_pred cc
Q 008810 434 PE 435 (552)
Q Consensus 434 P~ 435 (552)
|.
T Consensus 276 ~~ 277 (277)
T cd05607 276 PD 277 (277)
T ss_pred CC
Confidence 73
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=401.68 Aligned_cols=269 Identities=29% Similarity=0.496 Sum_probs=233.3
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
+..+..++|++..+||.|.-+.||+|++..++..||||++.-.... ..++.+++|+..|..++|||||+.|++|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 4567789999999999999999999999999999999999877643 33788999999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|+||.||.+|++.+++.. ...|.|..++.++.+++.||.|||++|.||||||+.||||+.+|.|||+|||.+-.+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999999965 3679999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGA 345 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGv 345 (552)
.+. . +.+-.. .+++|||.|||||++.. .||++++||||||+
T Consensus 178 ~~G-~-----------------------------------R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGI 220 (516)
T KOG0582|consen 178 DSG-D-----------------------------------RQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGI 220 (516)
T ss_pred ccC-c-----------------------------------eeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhH
Confidence 321 0 111111 57899999999999764 78999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhcccc------ccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTH------LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~~------~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
...||.+|..||....+...+..-++...+ +.......++...+.+|..||. ||.+||+ |+++++|+||+
T Consensus 221 TA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk 297 (516)
T KOG0582|consen 221 TACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFK 297 (516)
T ss_pred HHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHh
Confidence 999999999999999998877666653221 1112234677889999999999 9999999 99999999998
Q ss_pred CC
Q 008810 419 GV 420 (552)
Q Consensus 419 ~i 420 (552)
..
T Consensus 298 ~~ 299 (516)
T KOG0582|consen 298 KA 299 (516)
T ss_pred hc
Confidence 75
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=380.73 Aligned_cols=259 Identities=31% Similarity=0.545 Sum_probs=223.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|..++.||+|+||.||+|++..||+.||||+++.... +.+-.....+|+.+|++++|+||+.|.++|.+.+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 467888899999999999999999999999999987643 2333345788999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||+ .||...+..+ -.|+..+++.|+.+++.||+|||.+.|+||||||.|+||+.+|.+||+|||||+.+......
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 9995 5898888654 57999999999999999999999999999999999999999999999999999977533210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG 353 (552)
.. ..|-|.+|+|||.+.| ..|+..+|+||+|||+.||+-|
T Consensus 158 --------------------------------------~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 158 --------------------------------------QT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred --------------------------------------cc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc
Confidence 11 2378999999999997 6799999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhh---------ccccccCCcc---------------cccChhHHHHHHHHhh-CccccCCCCCh
Q 008810 354 YPPFYSDDPMSTCRKIVN---------WRTHLKFPEE---------------AKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~---------~~~~~~~p~~---------------~~~s~e~~dLI~~lL~-dp~~Rl~~~~a 408 (552)
.|-|.|+++.+.+..|.. |..-..+|+. +..+.++.||+.+||. ||.+|++ |
T Consensus 199 ~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a 275 (318)
T KOG0659|consen 199 VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---A 275 (318)
T ss_pred CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---H
Confidence 999999999998888874 4332222221 2468899999999999 9999999 9
Q ss_pred hhhhcCCCcCCC
Q 008810 409 DEIKVHPWFDGV 420 (552)
Q Consensus 409 ~eil~HpfF~~i 420 (552)
.|++.||||+..
T Consensus 276 ~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 276 SQALKHPYFKSL 287 (318)
T ss_pred HHHhcchhhhcC
Confidence 999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=392.42 Aligned_cols=261 Identities=29% Similarity=0.471 Sum_probs=223.4
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec--CCceE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFL 191 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~l 191 (552)
..++|+.+..|++|+||.||+|+++.|+++||+|+++... .+.+.---..+|+++|.+++|||||.+-.+.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 4578999999999999999999999999999999998654 22333334678999999999999999987776 34579
Q ss_pred EEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|||||||. .||..++..-. +|...+++.++.|++.||.|||.+.|+||||||+|+|++..|.+||+|||||+.+....
T Consensus 153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99999995 59999997654 89999999999999999999999999999999999999999999999999999875331
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 349 (552)
. ..+..|-|.+|+|||+|++ ..|+.++|+||+|||+.|
T Consensus 232 k-----------------------------------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE 270 (419)
T KOG0663|consen 232 K-----------------------------------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAE 270 (419)
T ss_pred c-----------------------------------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHH
Confidence 0 1235789999999999998 569999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhh---------cccccc--------CCcc-----------cccChhHHHHHHHHhh-Ccc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVN---------WRTHLK--------FPEE-----------AKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~---------~~~~~~--------~p~~-----------~~~s~e~~dLI~~lL~-dp~ 400 (552)
||++.|.|.|....+.+.+|+. |.+.-. ||.. ..+|..+.||+..||+ ||.
T Consensus 271 ~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~ 350 (419)
T KOG0663|consen 271 LLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPG 350 (419)
T ss_pred HHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcc
Confidence 9999999999999999988875 333222 2211 1267999999999999 999
Q ss_pred ccCCCCChhhhhcCCCcCCC
Q 008810 401 QRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF~~i 420 (552)
+|++ |+|.|.|+||.+.
T Consensus 351 kR~t---A~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 351 KRIT---AEDGLKHEYFRET 367 (419)
T ss_pred cccc---HHHhhcccccccC
Confidence 9999 9999999999875
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-48 Score=395.56 Aligned_cols=303 Identities=43% Similarity=0.783 Sum_probs=254.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|.++.+++.||+|.+.+...........+.+|+++++.++||||++++++|.+..++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998775544555677889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|..++...+.+++..+..++.+++.||.|||+.||+||||||+|||++.+|.+||+|||+++......... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~-~ 159 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN-L 159 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc-c
Confidence 999999999999888889999999999999999999999999999999999999999999999999987432111000 0
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
+. .. .... ..........|++.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 160 ~~------~~--------~~~~-----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 160 YE------GH--------IEKD-----------TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred cc------cc--------cccc-----------hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 00 00 0000 00001113568999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcc-cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCc
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFI 433 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~ 433 (552)
||.+.+..+....+... ....|.. ..++.++++||.+||. ||.+||++.++.+++.||||...+|..+.....+++
T Consensus 215 pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~ 292 (305)
T cd05609 215 PFFGDTPEELFGQVISD--DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFI 292 (305)
T ss_pred CCCCCCHHHHHHHHHhc--ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCC
Confidence 99998888777777653 2233322 2578999999999999 999999988899999999999999999888778999
Q ss_pred cccCCcccCcCcc
Q 008810 434 PEVNDELDTQNFE 446 (552)
Q Consensus 434 P~~~~~~d~~~f~ 446 (552)
|.+....|+++|+
T Consensus 293 ~~~~~~~~~~~~~ 305 (305)
T cd05609 293 PQLESEDDTSYFD 305 (305)
T ss_pred CCCCCccccccCC
Confidence 9998888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=407.56 Aligned_cols=258 Identities=32% Similarity=0.577 Sum_probs=234.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
.-|.+.+.||+|-|..|-+|++.-||..||||++.|..+ ......|+..|+..|+.++|||||+||.+..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 458889999999999999999999999999999998765 3445678999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc-cCCCcEEEcccccccccCCCCccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl-~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|+-.||||++++++. ..+.|+.++.|++||+.||.|+|+..+||||||||||.+ ..-|-|||+|||++..+.++.
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--- 173 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--- 173 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc---
Confidence 999999999999885 579999999999999999999999999999999999877 567999999999998765432
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCC-CccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvilyEmlt 352 (552)
...+.||+..|-|||+|++..|+ +++||||||||||-|++
T Consensus 174 ---------------------------------------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 174 ---------------------------------------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC 214 (864)
T ss_pred ---------------------------------------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh
Confidence 12368999999999999999996 68999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
|.+||...+..+++..|+.. .+..|. .+|.+++|||..||. ||.+|.+ .++|..|+|++.+|-.
T Consensus 215 Gq~PFqeANDSETLTmImDC--KYtvPs--hvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 215 GQPPFQEANDSETLTMIMDC--KYTVPS--HVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDRG 279 (864)
T ss_pred CCCccccccchhhhhhhhcc--cccCch--hhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCCC
Confidence 99999999999999999974 445564 899999999999998 9999998 9999999999998753
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=393.18 Aligned_cols=275 Identities=35% Similarity=0.666 Sum_probs=234.4
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|+..+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+|..++|++|+.+++.|.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999987665444445567889999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---- 156 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC----
Confidence 99999999888543 469999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
......||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 157 --------------------------------------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred --------------------------------------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhc--cccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhh--h
Q 008810 355 PPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--Q 427 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~--~ 427 (552)
+||.+.........+... .....++ ..+++++.+||.+||. ||.+|+++. .+.+++.||||+.++|+++. +
T Consensus 199 ~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05632 199 SPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276 (285)
T ss_pred CCCCCCCHHHHHHHHHHhhhccccccC--ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCc
Confidence 999887665444333221 1122333 3688999999999999 999999864 47899999999999999886 4
Q ss_pred cCCCCccc
Q 008810 428 MEAAFIPE 435 (552)
Q Consensus 428 ~~~pf~P~ 435 (552)
+.|||+|.
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05632 277 LDPPFVPD 284 (285)
T ss_pred CCCCCCCC
Confidence 78999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=396.18 Aligned_cols=258 Identities=33% Similarity=0.488 Sum_probs=216.9
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+++.||||++..... .....+.+.+|+.++..++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999986532 2334567888999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+.+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--- 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc---
Confidence 99999877766655678999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.....+||+.|+|||++.+..++.++|+|||||++|||++|++
T Consensus 157 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 157 -------------------------------------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred -------------------------------------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence 0113579999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhcccc-----------------ccCCcc-----------cccChhHHHHHHHHhh-CccccCCCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTH-----------------LKFPEE-----------AKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~-----------------~~~p~~-----------~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
||.+.+..+....+...... ..+|.. ..+|.++++||.+||. ||.+|++
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s-- 277 (287)
T cd07848 200 LFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL-- 277 (287)
T ss_pred CCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC--
Confidence 99987765544433321110 111110 1378899999999999 9999999
Q ss_pred ChhhhhcCCCc
Q 008810 407 GADEIKVHPWF 417 (552)
Q Consensus 407 ~a~eil~HpfF 417 (552)
+++++.||||
T Consensus 278 -~~~~l~hp~f 287 (287)
T cd07848 278 -TEQCLNHPAF 287 (287)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=395.24 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=215.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||.|+||.||+|+++.++..||+|+++.... ......+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5689999999999999999999999999999999975432 22344677899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||++| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 999975 898888654 4589999999999999999999999999999999999999999999999999975432110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 199 (288)
T cd07871 159 ---------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199 (288)
T ss_pred ---------------------------------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh
Confidence 0113578999999999976 568999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccc-----------------cccCCc---------ccccChhHHHHHHHHhh-CccccCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
|++||.+.+..+....+..... ...+|. ...++++++|||++||+ ||.+|++
T Consensus 200 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t- 278 (288)
T cd07871 200 GRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS- 278 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC-
Confidence 9999999887776655543110 011111 12578899999999999 9999999
Q ss_pred CChhhhhcCCCc
Q 008810 406 KGADEIKVHPWF 417 (552)
Q Consensus 406 ~~a~eil~HpfF 417 (552)
++|+++||||
T Consensus 279 --~~~~l~hp~f 288 (288)
T cd07871 279 --AEAALRHSYF 288 (288)
T ss_pred --HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-49 Score=393.46 Aligned_cols=261 Identities=31% Similarity=0.485 Sum_probs=221.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-----Cce
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-----DEF 190 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-----~~~ 190 (552)
..|..++.||+|+||.|+.+.++.||+.||||++... ....-..++..+|+.+|+.++|+||+.+++++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4466689999999999999999999999999998743 2334456778999999999999999999999876 246
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|+|+|+| +.||...+.....|+++.+++++.||+.||.|+|+.||+||||||.|+|++.+..+||+|||||+..+..
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 99999999 8899999988888999999999999999999999999999999999999999999999999999976532
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 349 (552)
... ...+..|-|.+|.|||++.. ..|+.++||||+|||+.|
T Consensus 179 -~~~-------------------------------------~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AE 220 (359)
T KOG0660|consen 179 -FED-------------------------------------GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAE 220 (359)
T ss_pred -Ccc-------------------------------------cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHH
Confidence 000 01235789999999999986 789999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccc---------------------cccCCc------ccccChhHHHHHHHHhh-Cccc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRT---------------------HLKFPE------EAKLSIEAKDLISKLLC-NVNQ 401 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~---------------------~~~~p~------~~~~s~e~~dLI~~lL~-dp~~ 401 (552)
||+|++-|.|.+....+..|+.--+ ....|. -+.++++|.||+.+||. ||.+
T Consensus 221 mL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~k 300 (359)
T KOG0660|consen 221 MLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKK 300 (359)
T ss_pred HHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccc
Confidence 9999999999987776666653110 001111 13679999999999999 9999
Q ss_pred cCCCCChhhhhcCCCcCCC
Q 008810 402 RLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 402 Rl~~~~a~eil~HpfF~~i 420 (552)
|++ |+|++.||||...
T Consensus 301 Rit---a~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 301 RIT---AEEALAHPYLAPY 316 (359)
T ss_pred cCC---HHHHhcChhhhhh
Confidence 999 9999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=397.54 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=212.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999975432 22234577899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||++ |+|..++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 99995 577777654 46799999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 199 (303)
T cd07869 159 ---------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199 (303)
T ss_pred ---------------------------------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 0123578999999999876 468999999999999999999
Q ss_pred CCCCCCCCChh-hHHHHHhh---------cccccc------------CCc-------ccccChhHHHHHHHHhh-Ccccc
Q 008810 353 GYPPFYSDDPM-STCRKIVN---------WRTHLK------------FPE-------EAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 353 G~~PF~~~~~~-~~~~~i~~---------~~~~~~------------~p~-------~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|.+||.+.... .....+.. |..... .|. ...+++++++||.+||+ ||.+|
T Consensus 200 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R 279 (303)
T cd07869 200 GVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNR 279 (303)
T ss_pred CCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhc
Confidence 99999875432 33333221 000000 010 01245789999999999 99999
Q ss_pred CCCCChhhhhcCCCcCCCCh
Q 008810 403 LGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 403 l~~~~a~eil~HpfF~~i~w 422 (552)
++ +.|+++||||+++++
T Consensus 280 ~s---~~~~l~h~~f~~~~~ 296 (303)
T cd07869 280 LS---AQAALSHEYFSDLPP 296 (303)
T ss_pred cC---HHHHhcCcccccCCh
Confidence 99 999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=385.73 Aligned_cols=253 Identities=35% Similarity=0.571 Sum_probs=219.3
Q ss_pred CCCeeEE-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeec----CC
Q 008810 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ----DD 188 (552)
Q Consensus 115 ~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~----d~ 188 (552)
.+||.+- ++||-|-.|+|..|.++.||+.+|+|++..+. ..++|+++.-.. .|||||.++++|. ..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 5677764 58999999999999999999999999986442 367788876444 7999999998775 45
Q ss_pred ceEEEEEecCCCCchhhHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEcccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGla 263 (552)
..+.+|||.|.||+|+..++.++. |+|.+|..++.||..|+.|||+.+|.||||||||+|... +..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 689999999999999999987765 999999999999999999999999999999999999975 447999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
|.-.... ...+.|-||.|.|||++....|+..||+||+
T Consensus 212 K~t~~~~------------------------------------------~L~TPc~TPyYvaPevlg~eKydkscdmwSl 249 (400)
T KOG0604|consen 212 KETQEPG------------------------------------------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_pred cccCCCc------------------------------------------cccCCcccccccCHHHhCchhcCCCCCccch
Confidence 9643211 1225789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCCh----hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 344 GAIMYEMLVGYPPFYSDDP----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
|||||-||+|+||||+..- ..+..+|......++-|++..+|.+++|||++||. +|.+|++ +++++.|||+.
T Consensus 250 gVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi~ 326 (400)
T KOG0604|consen 250 GVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWIN 326 (400)
T ss_pred hHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchhc
Confidence 9999999999999998653 35677888866666667788999999999999998 9999999 99999999997
Q ss_pred CC
Q 008810 419 GV 420 (552)
Q Consensus 419 ~i 420 (552)
..
T Consensus 327 ~~ 328 (400)
T KOG0604|consen 327 QY 328 (400)
T ss_pred cc
Confidence 64
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=392.75 Aligned_cols=310 Identities=39% Similarity=0.704 Sum_probs=250.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||+|+||.||+|....+++.||||.+.+...........+..|+.+|..++||+|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998776554456677999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 196 EYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||+.|++|.+++.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 579999999999999999999999999999999999999999999999999998654321110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
.... ... .... ....+ ................+||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~--~~~--~~~~--~~~~~------~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 161 SKAL--RKG--SRRS--SVNSI------PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred cccc--ccc--cccc--ccccc------chhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 0000 000 0000 00000 0000000111122346899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC-CChhhhhcCCCcCCCChhhhhhcCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIYQMEAA 431 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~-~~a~eil~HpfF~~i~w~~l~~~~~p 431 (552)
..||.+.+....+.++.. ....+|....++.++++||.+||+ ||.+|++. .++++++.||||++++|..+....+|
T Consensus 229 ~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~ 306 (316)
T cd05574 229 TTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPP 306 (316)
T ss_pred CCCCCCCchHHHHHHHhc--CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCC
Confidence 999999888888877775 344555544589999999999999 99999984 45899999999999999999988888
Q ss_pred CccccCCc
Q 008810 432 FIPEVNDE 439 (552)
Q Consensus 432 f~P~~~~~ 439 (552)
-+|.+...
T Consensus 307 ~~~~~~~~ 314 (316)
T cd05574 307 IIPRPDDG 314 (316)
T ss_pred CCCCcccc
Confidence 88876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=387.04 Aligned_cols=260 Identities=32% Similarity=0.504 Sum_probs=220.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc-eEEEeeeecCCc----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDE---- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~---- 189 (552)
...|+.++.||+|+||+||+|+.+.+|+.||+|++.-.... ++--....+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34577778899999999999999999999999999865321 223344688999999999999 999999999887
Q ss_pred --eEEEEEecCCCCchhhHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 190 --FLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 190 --~lylVmEy~~gG~L~~~L~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
.+|||+||+ .-||..++.... .++...++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 569999997654 6888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 342 (552)
+...-.. + ...+-++|.+|.|||++.+. .|+..+|+||
T Consensus 168 ra~~ip~--------------------------~---------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs 206 (323)
T KOG0594|consen 168 RAFSIPM--------------------------R---------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWS 206 (323)
T ss_pred HHhcCCc--------------------------c---------------cccccEEEeeccCHHHhcCCCcCCCCcchHh
Confidence 8543110 0 01246899999999999985 7999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHHHHhh---------ccccc-------cCCcc----------cccChhHHHHHHHHh
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------WRTHL-------KFPEE----------AKLSIEAKDLISKLL 396 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~~i~~---------~~~~~-------~~p~~----------~~~s~e~~dLI~~lL 396 (552)
+|||++||+++.+.|.+....+...+|.. |+... .||.. +..++++.||+.+||
T Consensus 207 ~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L 286 (323)
T KOG0594|consen 207 LGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLL 286 (323)
T ss_pred HHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHh
Confidence 99999999999999999999888888864 43322 22221 234568999999999
Q ss_pred h-CccccCCCCChhhhhcCCCcCCC
Q 008810 397 C-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 397 ~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+ +|.+|.+ |..++.||||..+
T Consensus 287 ~y~p~~R~S---a~~al~h~yf~~~ 308 (323)
T KOG0594|consen 287 QYDPAKRIS---AKGALTHPYFSEL 308 (323)
T ss_pred ccCcccCcC---HHHHhcChhhccc
Confidence 9 9999999 9999999999887
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-49 Score=383.41 Aligned_cols=259 Identities=33% Similarity=0.596 Sum_probs=218.6
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
.+||+|+|+.|--|....||..||||++.|... ....++.+|++++..+ .|+||+.|+.+|+|+..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 469999999999999999999999999988643 3345688999999988 799999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc---EEEcccccccccCCCCccccccc
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTLQEQDFT 277 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~---iKL~DFGlak~~~~~~~~~~~~~ 277 (552)
|.|..++.++..|+|.+|..++.+|+.||.|||.+||.||||||+|||-..-.+ ||||||.|...+...+..
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~----- 235 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC----- 235 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC-----
Confidence 999999999999999999999999999999999999999999999999976655 799999987654321100
Q ss_pred ccCCCCCCCCCCCCCC-CCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccchhhhhHHHHHHh
Q 008810 278 IGNNLNGSSQNNERPA-APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 278 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSlGvilyEml 351 (552)
.++ .|. ..+.||+..|||||++. ..-|+..||.||||||+|-||
T Consensus 236 -------------spastP~-----------------L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL 285 (463)
T KOG0607|consen 236 -------------SPASTPE-----------------LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML 285 (463)
T ss_pred -------------CCCCCcc-----------------ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHH
Confidence 000 010 13679999999999986 246999999999999999999
Q ss_pred hCCCCCCCC-------C--------hhhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 352 VGYPPFYSD-------D--------PMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 352 tG~~PF~~~-------~--------~~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.|++||.|. + ....+..|.. +.+.||+ +..+|.+++|||+.||. |+.+|++ +.++++
T Consensus 286 sGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE--GkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vln 360 (463)
T KOG0607|consen 286 SGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE--GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLN 360 (463)
T ss_pred hCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc--cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccC
Confidence 999999652 1 2334555665 4566665 67899999999999998 9999999 999999
Q ss_pred CCCcCCCChh
Q 008810 414 HPWFDGVDWA 423 (552)
Q Consensus 414 HpfF~~i~w~ 423 (552)
|||++.+--+
T Consensus 361 hPw~~~~~~e 370 (463)
T KOG0607|consen 361 HPWVQRCAPE 370 (463)
T ss_pred Cccccccchh
Confidence 9999987543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=395.29 Aligned_cols=263 Identities=26% Similarity=0.416 Sum_probs=213.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----ceE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----EFL 191 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~~l 191 (552)
+|++.+.||+|+||.||+|+++.+|..||||++.... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 1223345688999999999999999999887533 358
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||| +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 578999998888999999999999999999999999999999999999999999999999999985422110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyE 349 (552)
.. ......+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 159 ~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~e 200 (338)
T cd07859 159 TA--------------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 200 (338)
T ss_pred cc--------------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHH
Confidence 00 01124689999999999976 678999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhc--------------------------cccccCCc-ccccChhHHHHHHHHhh-Cccc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNW--------------------------RTHLKFPE-EAKLSIEAKDLISKLLC-NVNQ 401 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~--------------------------~~~~~~p~-~~~~s~e~~dLI~~lL~-dp~~ 401 (552)
|++|++||.+.+.......+... .....+.. .+.+++++.+||.+||+ ||.+
T Consensus 201 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 280 (338)
T cd07859 201 VLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD 280 (338)
T ss_pred HHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCccc
Confidence 99999999877654333222110 00011100 12468899999999999 9999
Q ss_pred cCCCCChhhhhcCCCcCCCCh
Q 008810 402 RLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 402 Rl~~~~a~eil~HpfF~~i~w 422 (552)
||+ ++||++||||+++..
T Consensus 281 Rpt---~~e~l~hp~f~~~~~ 298 (338)
T cd07859 281 RPT---AEEALADPYFKGLAK 298 (338)
T ss_pred CCC---HHHHhcCchhhhcCc
Confidence 999 999999999988654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=393.35 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=220.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++++.||+|+||.||+|+++.+|..||+|++.... .......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45689999999999999999999999999999999997542 2334567899999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|++||+|||+++.+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999999998888899999999999999999999985 69999999999999999999999999987542110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 196 (331)
T cd06649 159 ------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196 (331)
T ss_pred ------------------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 11357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhcc----------------------------------------------ccccCCcccccC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWR----------------------------------------------THLKFPEEAKLS 385 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~----------------------------------------------~~~~~p~~~~~s 385 (552)
+|+.||...+..+... ++... .....+ ...++
T Consensus 197 tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 274 (331)
T cd06649 197 IGRYPIPPPDAKELEA-IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFT 274 (331)
T ss_pred hCCCCCCCCCHHHHHH-HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC-Ccccc
Confidence 9999997765543322 11100 001111 12478
Q ss_pred hhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 386 IEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 386 ~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
+++++||.+||. ||++||+ +.+|+.||||+...
T Consensus 275 ~~l~~li~~~L~~~P~~Rpt---~~ell~h~~~~~~~ 308 (331)
T cd06649 275 PDFQEFVNKCLIKNPAERAD---LKMLMNHTFIKRSE 308 (331)
T ss_pred HHHHHHHHHHccCCcccCCC---HHHHhcChHHhhcc
Confidence 899999999999 9999999 99999999998654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=409.48 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=210.5
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC----
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD---- 188 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~---- 188 (552)
....+|++++.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34568999999999999999999999999999999986532 1245699999999999999998876432
Q ss_pred ----ceEEEEEecCCCCchhhHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEcc
Q 008810 189 ----EFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSD 259 (552)
Q Consensus 189 ----~~lylVmEy~~gG~L~~~L~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~D 259 (552)
.++|+||||+++ +|..++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 368899999976 5655553 356799999999999999999999999999999999999999665 699999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCcc
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 338 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~ 338 (552)
||+|+.+.... ...+.+||+.|+|||++.+ ..|+.++
T Consensus 215 FGla~~~~~~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~ 252 (440)
T PTZ00036 215 FGSAKNLLAGQ------------------------------------------RSVSYICSRFYRAPELMLGATNYTTHI 252 (440)
T ss_pred cccchhccCCC------------------------------------------CcccCCCCcCccCHHHhcCCCCCCcHH
Confidence 99998653211 0124678999999999876 4699999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccc---------------cccCCc----------ccccChhHHHHHH
Q 008810 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT---------------HLKFPE----------EAKLSIEAKDLIS 393 (552)
Q Consensus 339 DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~e~~dLI~ 393 (552)
|||||||++|||++|++||.+.+..+.+.+++.... .+.+|. ....++++++||.
T Consensus 253 DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~ 332 (440)
T PTZ00036 253 DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFIS 332 (440)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHH
Confidence 999999999999999999999887777666654211 111221 0146789999999
Q ss_pred HHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 394 KLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 394 ~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
+||+ ||.+|++ +.|++.||||.++..
T Consensus 333 ~~L~~dP~~R~t---a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 333 QFLKYEPLKRLN---PIEALADPFFDDLRD 359 (440)
T ss_pred HHCCCChhHCcC---HHHHhCChhHHhhhc
Confidence 9999 9999999 999999999987654
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=381.74 Aligned_cols=268 Identities=37% Similarity=0.686 Sum_probs=225.9
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCch
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L 203 (552)
||+|+||+||+|.++.+|+.||+|++.+...........+..|+.+|+.++||+|++++++|.+.+.+|+||||++||+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876554455556678899999999999999999999999999999999999999
Q ss_pred hhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCC
Q 008810 204 MTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (552)
Q Consensus 204 ~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~ 281 (552)
.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~----------- 149 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK----------- 149 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-----------
Confidence 99997765 79999999999999999999999999999999999999999999999999987542110
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCC
Q 008810 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (552)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~ 361 (552)
......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.+..
T Consensus 150 -------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 150 -------------------------------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred -------------------------------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 0113468899999999998889999999999999999999999998765
Q ss_pred hhhHHHHHhhcc--ccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCCCCcc
Q 008810 362 PMSTCRKIVNWR--THLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEAAFIP 434 (552)
Q Consensus 362 ~~~~~~~i~~~~--~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~pf~P 434 (552)
.......+.... ....+| ..+++++.+||.+||. ||.+|++.. ++.+++.||||..++|..+.. +.|||+|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 199 EKVEKEELKRRTLEMAVEYP--DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred ccccHHHHHhccccccccCC--ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 422222222211 122333 3679999999999998 999999532 388999999999999999874 6788887
Q ss_pred c
Q 008810 435 E 435 (552)
Q Consensus 435 ~ 435 (552)
+
T Consensus 277 ~ 277 (277)
T cd05577 277 D 277 (277)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=383.97 Aligned_cols=251 Identities=32% Similarity=0.538 Sum_probs=213.1
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----ceE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----EFL 191 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~~l 191 (552)
.|+-.++||.|+||.||.|....+++.||||+.....-. -.+|..||..++|||||+|.++|... -++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 588899999999999999999999999999998755321 24689999999999999999888622 267
Q ss_pred EEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC-CcEEEccccccccc
Q 008810 192 YLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPL 266 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~-g~iKL~DFGlak~~ 266 (552)
.|||||||. +|...+.. +..++.-.++.|..||+.||.|||+.||+||||||.|||+|.+ |.+||||||.||.+
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 799999975 78888863 5789999999999999999999999999999999999999966 89999999999987
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 345 (552)
..... ..+...|..|+|||.+.+ ..|+.+.||||.||
T Consensus 177 ~~~ep------------------------------------------niSYicSRyYRaPELifga~~Yt~~IDiWSaGC 214 (364)
T KOG0658|consen 177 VKGEP------------------------------------------NISYICSRYYRAPELIFGATEYTTSIDIWSAGC 214 (364)
T ss_pred ccCCC------------------------------------------ceeEEEeccccCHHHHcCccccCceeEEhhhhH
Confidence 54321 125678999999999998 67999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhcc---------------ccccCCc----------ccccChhHHHHHHHHhh-Cc
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWR---------------THLKFPE----------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~e~~dLI~~lL~-dp 399 (552)
||.||+-|+|-|.|++...++..|++-- ....+|. ...+++++.||+.++|. +|
T Consensus 215 V~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P 294 (364)
T KOG0658|consen 215 VMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSP 294 (364)
T ss_pred HHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccCh
Confidence 9999999999999999888877776410 0122222 13578999999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCC
Q 008810 400 NQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+|++ +.|++.||||..+
T Consensus 295 ~~R~~---~~~~l~h~fFdel 312 (364)
T KOG0658|consen 295 SKRLS---ALEALAHPFFDEL 312 (364)
T ss_pred hhcCC---HHHHhcchhhHHh
Confidence 99999 9999999999764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=380.78 Aligned_cols=255 Identities=28% Similarity=0.457 Sum_probs=209.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCceEEEeeeec-----
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQ----- 186 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~-tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~----- 186 (552)
.+|++++.||+|+||+||+|++.. +|..||+|+++..... ......+.+|..+++.+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 5788999998764322 22334456677777665 6999999999875
Q ss_pred CCceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
....+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 6898888653 458999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
...... ......||+.|+|||++.+..++.++|+||||
T Consensus 159 ~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 196 (290)
T cd07862 159 IYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 196 (290)
T ss_pred eccCCc------------------------------------------ccccccccccccChHHHhCCCCCCccchHHHH
Confidence 543210 01245799999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhccc---------cccCCc--------------ccccChhHHHHHHHHhh-Ccc
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRT---------HLKFPE--------------EAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~---------~~~~p~--------------~~~~s~e~~dLI~~lL~-dp~ 400 (552)
|++|||++|.+||.+.+..+.+.+|+.... ...++. .+.+++.+++||.+||+ ||+
T Consensus 197 ~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 197 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 999999999999999888887777764211 000110 02478889999999999 999
Q ss_pred ccCCCCChhhhhcCCCc
Q 008810 401 QRLGAKGADEIKVHPWF 417 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF 417 (552)
+||+ +.|+++||||
T Consensus 277 ~R~s---~~~~l~hp~f 290 (290)
T cd07862 277 KRIS---AYSALSHPYF 290 (290)
T ss_pred hcCC---HHHHhcCCCC
Confidence 9999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=392.77 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=217.1
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcE-EEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE- 189 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~-~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~- 189 (552)
.+...++.+...||+|+||+||.+.++. .. ||+|++......... .+.+.+|+.+|.+++|||||++++++.+..
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3445556666779999999999998774 46 999999876543333 678999999999999999999999999887
Q ss_pred eEEEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccccCCCCccccCCC-cEEEcccccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHH-YIHRDIKPDNLLLDKYG-HLRLSDFGLCKP 265 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHrDLKPeNILl~~~g-~iKL~DFGlak~ 265 (552)
.++|||||+++|+|..+|.+ +..|+...+..++.+|+.|++|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999987 689999999999999999999999999 99999999999999998 999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh--cCCCCCccchhhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSL 343 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~--~~~y~~~~DiWSl 343 (552)
..... ....+..||+.|||||++. +..|+.++|+|||
T Consensus 194 ~~~~~-----------------------------------------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySF 232 (362)
T KOG0192|consen 194 KVISK-----------------------------------------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSF 232 (362)
T ss_pred ecccc-----------------------------------------ccccCCCCCccccChhhhcCCCCcCCccchhhhH
Confidence 54221 0012368999999999999 6699999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
||+||||+||..||.+..+.+....++.......+|. .+++.+..||.+|+. ||..||+ ..+|.
T Consensus 233 gIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP~---f~ei~ 297 (362)
T KOG0192|consen 233 GIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRPS---FLEIV 297 (362)
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCCC---HHHHH
Confidence 9999999999999999998777777776555556665 489999999999998 9999999 55554
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=396.64 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=218.0
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----eE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----FL 191 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-----~l 191 (552)
+|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 12234456889999999999999999999998877 89
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||+. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999995 68888888888999999999999999999999999999999999999999999999999999985432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEm 350 (552)
. .....+||+.|+|||++.+. .|+.++||||||||+|||
T Consensus 159 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 198 (372)
T cd07853 159 K----------------------------------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198 (372)
T ss_pred c----------------------------------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHH
Confidence 0 01134789999999999874 589999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccc---------------------cccCC-------cccccChhHHHHHHHHhh-Cccc
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRT---------------------HLKFP-------EEAKLSIEAKDLISKLLC-NVNQ 401 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~---------------------~~~~p-------~~~~~s~e~~dLI~~lL~-dp~~ 401 (552)
++|++||.+.++......|..... ....| ....+++++.+||.+||+ ||.+
T Consensus 199 ~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 278 (372)
T cd07853 199 LGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDK 278 (372)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhh
Confidence 999999998887766655543110 00111 112468899999999999 9999
Q ss_pred cCCCCChhhhhcCCCcCCCCh
Q 008810 402 RLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 402 Rl~~~~a~eil~HpfF~~i~w 422 (552)
||+ +.|++.||||.+..+
T Consensus 279 R~t---~~e~l~hp~~~~~~~ 296 (372)
T cd07853 279 RIS---AADALAHPYLDEGRL 296 (372)
T ss_pred CcC---HHHHhcCHhhCCCcc
Confidence 999 999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=400.93 Aligned_cols=256 Identities=24% Similarity=0.350 Sum_probs=211.3
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+...+|++++.||+|+||.||+|+++.+++.||||+... ..+.+|+.+|+.++|||||+++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999999999999997532 2467899999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+|||++ +++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9999999 578999998888899999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 238 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 277 (391)
T PHA03212 238 ----------------------------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277 (391)
T ss_pred ----------------------------------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 0112468999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-------hhHHHHHhhccc------------------------cc----cCCcc---cccChhHHHHHH
Q 008810 352 VGYPPFYSDDP-------MSTCRKIVNWRT------------------------HL----KFPEE---AKLSIEAKDLIS 393 (552)
Q Consensus 352 tG~~PF~~~~~-------~~~~~~i~~~~~------------------------~~----~~p~~---~~~s~e~~dLI~ 393 (552)
+|..||...+. ...+..++.... .. ..|.. ..++.++.+||.
T Consensus 278 tg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~ 357 (391)
T PHA03212 278 TCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLIC 357 (391)
T ss_pred HCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHH
Confidence 99988865321 111222221000 00 01110 135678999999
Q ss_pred HHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 394 KLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 394 ~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+||+ ||.+||+ |+|++.||||+.+
T Consensus 358 ~mL~~dP~~Rpt---a~elL~hp~f~~~ 382 (391)
T PHA03212 358 KMLAFDAHHRPS---AEALLDFAAFQDI 382 (391)
T ss_pred HHhcCChhhCCC---HHHHhcChhhccC
Confidence 9999 9999999 9999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=397.00 Aligned_cols=257 Identities=31% Similarity=0.502 Sum_probs=231.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce-EEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF-LYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~-lyl 193 (552)
.++|+.+++||+|+||.+++++++..++.||+|.+.-.....+ ..+....|..+++++.|||||..+++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4689999999999999999999999999999999987654333 33468899999999999999999999998887 999
Q ss_pred EEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 194 IMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||+||.||+|...|.+. ..|+|+.+..|+.|++.||.|||+.+|+|||||+.||+++.++.|||+|||+||.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 99999999999999664 469999999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.++.+.+|||.||.||++.+.+|+.++|||||||++|||+
T Consensus 161 ----------------------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 161 ----------------------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred ----------------------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 1345789999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+-+++|.+.+......+|.... ..|.....|.+++.||..||. +|..||+ |.+++.+|....
T Consensus 201 ~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 201 TLKPAFKASNMSELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLLR 263 (426)
T ss_pred hcccccCccchHHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhhh
Confidence 9999999999999999998643 334445789999999999998 9999999 999999998864
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=373.63 Aligned_cols=257 Identities=46% Similarity=0.823 Sum_probs=221.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH-HhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
+.||.|+||.||+|.++.+|+.||||++.+...........+..|..++ ...+||||++++++|.+.+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999876554444444556666555 445899999999999999999999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|..++.....+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----------- 150 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----------- 150 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-----------
Confidence 999999988889999999999999999999999999999999999999999999999999998743210
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
....|++.|+|||.+.+..++.++|||||||++|+|++|.+||...
T Consensus 151 ----------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 151 ----------------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ----------------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 1346899999999999888999999999999999999999999988
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
+....+..+..............+++++.++|.+||. +|.+|+++.+++|++.||||++++|+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 197 TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 8877777665432222211223578999999999998 99999998889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=378.30 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=208.7
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCceEEEeeeecC-----C
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQD-----D 188 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d-----~ 188 (552)
+|++++.||+|+||.||+|+++.+|+.||+|+++.... .......+.+|+.+++.+ +||||++++++|.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 48999999999999999999999999999999976432 122223455677777655 79999999998864 3
Q ss_pred ceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
..+|+||||+++ +|..++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999974 888888653 45999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
..... ....+||+.|+|||++.+..++.++|||||||+
T Consensus 159 ~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 196 (288)
T cd07863 159 SCQMA------------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196 (288)
T ss_pred cCccc------------------------------------------CCCccccccccCchHhhCCCCCCcchhhhHHHH
Confidence 32110 113578999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHhhcc---------ccccCCc--------------ccccChhHHHHHHHHhh-Ccccc
Q 008810 347 MYEMLVGYPPFYSDDPMSTCRKIVNWR---------THLKFPE--------------EAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 347 lyEmltG~~PF~~~~~~~~~~~i~~~~---------~~~~~p~--------------~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
+|+|++|.+||.+......+.++.... .....+. .+.++.++++||.+||+ ||.+|
T Consensus 197 l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (288)
T cd07863 197 FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKR 276 (288)
T ss_pred HHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccC
Confidence 999999999999888777766665421 1111110 02467889999999999 99999
Q ss_pred CCCCChhhhhcCCCc
Q 008810 403 LGAKGADEIKVHPWF 417 (552)
Q Consensus 403 l~~~~a~eil~HpfF 417 (552)
|+ +.|++.||||
T Consensus 277 ~t---~~~~l~hp~f 288 (288)
T cd07863 277 IS---AFRALQHPFF 288 (288)
T ss_pred CC---HHHHhcCCCC
Confidence 99 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=419.78 Aligned_cols=152 Identities=43% Similarity=0.736 Sum_probs=143.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|.+++.||+|+||.||+|.+..+++.||||++++...........+..|+.++..++|||||++++++.+..++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999887666666667899999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
|||++||+|..++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.+|++||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=396.33 Aligned_cols=257 Identities=31% Similarity=0.499 Sum_probs=227.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
...|..+..||+|+||.||+|.+..+++.||||++.-.. ...+++.+..|+.+|..++++||.+.|++|..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 456888899999999999999999999999999998664 356678899999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||||.||++.++|.....+.|..+..++.+++.||.|||.++.||||||+.|||+..+|.+||+|||++-.+....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~---- 165 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV---- 165 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechh----
Confidence 9999999999999888888999999999999999999999999999999999999999999999999987654221
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.+..+++|||.||||||+.+.+|+.++||||||++.|||++|.
T Consensus 166 -------------------------------------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge 208 (467)
T KOG0201|consen 166 -------------------------------------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE 208 (467)
T ss_pred -------------------------------------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCC
Confidence 1124799999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
||+....++.....|-+. .+..+ ...+|+.+++||..||. ||+.||+ |.++++|+|++..
T Consensus 209 PP~s~~hPmrvlflIpk~-~PP~L--~~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 209 PPHSKLHPMRVLFLIPKS-APPRL--DGDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKRA 269 (467)
T ss_pred CCCcccCcceEEEeccCC-CCCcc--ccccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHhc
Confidence 999998886554444321 11122 23789999999999999 9999999 9999999999863
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=375.12 Aligned_cols=266 Identities=36% Similarity=0.686 Sum_probs=215.1
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH---hcCCCceEEEeeeecCCceEEEEEecCC
Q 008810 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA---EVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~---~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
+||+|+||.||+|.+..+|+.||+|++.+.............+|..++. ..+||+|+.++++|.+.+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998765433333333444544443 3479999999999999999999999999
Q ss_pred CCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccccc
Q 008810 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (552)
Q Consensus 200 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~ 279 (552)
||+|..++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--------- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---------
Confidence 99999999888899999999999999999999999999999999999999999999999999987542110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-cCCCCCccchhhhhHHHHHHhhCCCCCC
Q 008810 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (552)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvilyEmltG~~PF~ 358 (552)
.....||+.|+|||++. +..++.++|+|||||++|+|++|..||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 152 ----------------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred ----------------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 01246899999999987 4668999999999999999999999997
Q ss_pred CCChhh--HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--cCCC
Q 008810 359 SDDPMS--TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEAA 431 (552)
Q Consensus 359 ~~~~~~--~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~--~~~p 431 (552)
...... ...... ......+|. .+++++++||.+||. ||.+|+++. ++.++++||||++++|..+.. ..+|
T Consensus 198 ~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~ 274 (279)
T cd05633 198 QHKTKDKHEIDRMT-LTVNVELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPP 274 (279)
T ss_pred CCCCcCHHHHHHHh-hcCCcCCcc--ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCC
Confidence 653221 111111 112333443 689999999999999 999999632 499999999999999988763 4455
Q ss_pred Ccc
Q 008810 432 FIP 434 (552)
Q Consensus 432 f~P 434 (552)
-+|
T Consensus 275 ~~~ 277 (279)
T cd05633 275 LIP 277 (279)
T ss_pred CCC
Confidence 444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=405.41 Aligned_cols=255 Identities=24% Similarity=0.440 Sum_probs=206.8
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC------CceEEEeeeec
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS------NCIVKLYCSFQ 186 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~Iv~l~~~f~ 186 (552)
+..++|++++.||+|+||+||+|.+..+++.||||++++.. ........|+.++..+.| ++|++++.+|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 45678999999999999999999999999999999997532 122345667777776644 46899999887
Q ss_pred CC-ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCC-----------
Q 008810 187 DD-EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYG----------- 253 (552)
Q Consensus 187 d~-~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g----------- 253 (552)
.. .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 5789999998 88999999888899999999999999999999998 5999999999999998766
Q ss_pred -----cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhh
Q 008810 254 -----HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328 (552)
Q Consensus 254 -----~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEv 328 (552)
.+||+|||++...... ....+||+.|+|||+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~--------------------------------------------~~~~~gt~~Y~APE~ 316 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS--------------------------------------------RTAIVSTRHYRSPEV 316 (467)
T ss_pred CCCCceEEECCCCccccCccc--------------------------------------------cccccCCccccCcHH
Confidence 4999999987532110 124689999999999
Q ss_pred hhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccccc--------------------------CCc--
Q 008810 329 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK--------------------------FPE-- 380 (552)
Q Consensus 329 l~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~--------------------------~p~-- 380 (552)
+.+..|+.++|||||||++|||++|++||.+.+..+....+....+.++ .|.
T Consensus 317 ~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (467)
T PTZ00284 317 VLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHL 396 (467)
T ss_pred hhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHH
Confidence 9999999999999999999999999999998876655544432111000 000
Q ss_pred ----------ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 381 ----------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 381 ----------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
....++.+.|||.+||+ ||.+|++ ++||+.||||..
T Consensus 397 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~ 443 (467)
T PTZ00284 397 ARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLK 443 (467)
T ss_pred HhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC---HHHHhcCccccc
Confidence 00124567899999999 9999999 999999999975
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=369.24 Aligned_cols=259 Identities=32% Similarity=0.542 Sum_probs=225.6
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
++|.+.+.||+|+||.||+|....+++.||||++...... ...+...+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998765322 22345678899999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||||++|++|.+++.....+++..++.++.|++.||.|||+.||+||||+|+||+++.+|.++|+|||+++.+.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999987653211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
.......|++.|+|||++.+..++.++|+|||||++|||++|
T Consensus 162 --------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 162 --------------------------------------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred --------------------------------------ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 000135688999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.+||.+.+......++..+.....+|. .++.++.+||.+||. +|.+||+ +.+|+.||||
T Consensus 204 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 204 KPPWAEFEAMAAIFKIATQPTNPQLPS--HVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred CCCccccchHHHHHHHhccCCCCCCCc--cCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 999988877777666665545555554 689999999999999 9999999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=390.83 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=212.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 188 (552)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999997543 2233455678899999999999999999988654
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+||||+++ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 357999999965 6666664 3588999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 179 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 179 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216 (364)
T ss_pred CC------------------------------------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHH
Confidence 11 012457999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhcccc----------------------------------ccCCc----ccccChhHHH
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH----------------------------------LKFPE----EAKLSIEAKD 390 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~----------------------------------~~~p~----~~~~s~e~~d 390 (552)
||++|.+||.+.+..+.+.+++..... ..+|. ....+.++++
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 296 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHH
Confidence 999999999998877776666531100 00010 0123567999
Q ss_pred HHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 391 LI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||.+||+ ||.+||+ ++|++.||||..
T Consensus 297 ll~~mL~~dP~~R~t---~~e~L~hp~~~~ 323 (364)
T cd07875 297 LLSKMLVIDASKRIS---VDEALQHPYINV 323 (364)
T ss_pred HHHHhcCcCcccCCC---HHHHhcCccccc
Confidence 9999999 9999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=388.26 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=209.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
.++|++++.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999997653 22334556788999999999999999999987543
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999965 5655553 3589999999999999999999999999999999999999999999999999875321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 176 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 213 (359)
T cd07876 176 NF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213 (359)
T ss_pred Cc------------------------------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHH
Confidence 10 012357899999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccc--------------------ccc--------------CCc----ccccChhHHH
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRT--------------------HLK--------------FPE----EAKLSIEAKD 390 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~--------------------~~~--------------~p~----~~~~s~e~~d 390 (552)
+|++|.+||.+.+....+..++.... ... +|. ....++++++
T Consensus 214 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 99999999998775544333321100 000 110 0124678999
Q ss_pred HHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 391 LI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||.+||+ ||.+||+ +.|++.||||..
T Consensus 294 li~~mL~~dP~~R~t---~~e~l~hp~~~~ 320 (359)
T cd07876 294 LLSKMLVIDPDKRIS---VDEALRHPYITV 320 (359)
T ss_pred HHHHHhccCcccCCC---HHHHhcCchhhh
Confidence 9999999 9999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=371.99 Aligned_cols=259 Identities=37% Similarity=0.677 Sum_probs=213.8
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHH---HHhcCCCceEEEeeeecCCceEEEEEecCC
Q 008810 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL---LAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~i---L~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
+||+|+||.||+|++..+|+.||||++.+..............|..+ +...+||+|+.+++.|.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987644322222233444443 444589999999999999999999999999
Q ss_pred CCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccccc
Q 008810 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (552)
Q Consensus 200 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~ 279 (552)
||+|..++.+.+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--------- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---------
Confidence 99999999888899999999999999999999999999999999999999999999999999987542110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhCCCCCC
Q 008810 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFY 358 (552)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG~~PF~ 358 (552)
....+||+.|+|||++.+ ..++.++|+||+||++|||++|..||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 152 ----------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred ----------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 113579999999999975 468999999999999999999999998
Q ss_pred CCC---hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhhc
Q 008810 359 SDD---PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQM 428 (552)
Q Consensus 359 ~~~---~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~~ 428 (552)
+.. .......+.. ....+|. .+|.++.+||.+||. +|.+|+... .+.+++.||||++++|..+...
T Consensus 198 ~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 198 QHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred CCCccchHHHHHHhhc--cCCCCCC--cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 763 2222222222 2334443 579999999999999 999999544 5999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=385.25 Aligned_cols=258 Identities=28% Similarity=0.436 Sum_probs=217.8
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++.+.||.|+||.||+|.++.+|..+|+|++.... .......+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45688999999999999999999999999999999987542 2334566889999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
+||||++||+|.+++...+.+++..+..++.+++.||.|||+. +|+||||||+|||++.+|.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999999998888899999999999999999999974 79999999999999999999999999987542110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 159 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 196 (333)
T cd06650 159 ------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196 (333)
T ss_pred ------------------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 11357999999999999989999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHH--------------------------------------------hhccccccCCcccccChh
Q 008810 352 VGYPPFYSDDPMSTCRKI--------------------------------------------VNWRTHLKFPEEAKLSIE 387 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i--------------------------------------------~~~~~~~~~p~~~~~s~e 387 (552)
+|+.||...........+ .+. ....++. ..++.+
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~ 274 (333)
T cd06650 197 IGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLPS-GVFGAE 274 (333)
T ss_pred HCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC-CCccCCC-CCcCHH
Confidence 999999765543322111 100 0111111 136789
Q ss_pred HHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 388 AKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 388 ~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+++||.+||+ ||.+||+ +.||+.||||+..
T Consensus 275 ~~~li~~~L~~~P~~Rpt---~~ell~h~~~~~~ 305 (333)
T cd06650 275 FQDFVNKCLIKNPAERAD---LKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHHHhccCCcccCcC---HHHHhhCHHHhcC
Confidence 9999999999 9999999 9999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=390.05 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=208.5
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+|+.++|+|||+++++|.+.+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 4567888999999999999999999999999999996542 22344668899999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||||.||+|... ..+.+..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+.....
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999999998653 3467888889999999999999999999999999999999999999999999986532100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCCCCccchhhhhHHHH
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMY 348 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvily 348 (552)
.....+||+.|+|||++.. ..++.++|||||||++|
T Consensus 224 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~ 264 (353)
T PLN00034 224 ---------------------------------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264 (353)
T ss_pred ---------------------------------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHH
Confidence 0124579999999999853 23467899999999999
Q ss_pred HHhhCCCCCCCCChhhH---HHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 349 EMLVGYPPFYSDDPMST---CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~---~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
||++|..||........ ...+.. ......+ ..++.++++||.+||. ||.+||+ +.||+.||||.+-
T Consensus 265 el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~ 334 (353)
T PLN00034 265 EFYLGRFPFGVGRQGDWASLMCAICM-SQPPEAP--ATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRA 334 (353)
T ss_pred HHHhCCCCCCCCCCccHHHHHHHHhc-cCCCCCC--CccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccC
Confidence 99999999974332221 122211 1122222 3688999999999999 9999999 9999999999763
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=379.77 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=215.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|.+++.||+|+||.||+|+++.+++.||+|+++.... ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999975432 22334567899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-- 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence 999975 787777554 4689999999999999999999999999999999999999999999999999875422110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 160 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t 200 (309)
T cd07872 160 ---------------------------------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200 (309)
T ss_pred ---------------------------------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 0113468999999999876 568999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccc-----------------cccCCc---------ccccChhHHHHHHHHhh-CccccCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
|.+||.+.+..+....+..... ...+|. ...+++++++||.+||+ ||.+|++
T Consensus 201 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t- 279 (309)
T cd07872 201 GRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS- 279 (309)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC-
Confidence 9999998876655544432100 011111 12578899999999999 9999999
Q ss_pred CChhhhhcCCCcCCC
Q 008810 406 KGADEIKVHPWFDGV 420 (552)
Q Consensus 406 ~~a~eil~HpfF~~i 420 (552)
+.|++.||||+++
T Consensus 280 --~~e~l~h~~~~~~ 292 (309)
T cd07872 280 --AEEAMKHAYFRSL 292 (309)
T ss_pred --HHHHhcChhhhhc
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=401.84 Aligned_cols=257 Identities=30% Similarity=0.439 Sum_probs=221.9
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCC-CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTT-GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~t-g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
..|.+.+.||+|+||.||+|....+ +..||+|.+.... ......+++|+.+|+.++|||||++++.|.+.+.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3499999999999999999998777 7889999765432 34456688899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 195 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|||++||+|.++|.. ...+++..+..++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999988753 3569999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.. ....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 224 ~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 264 (478)
T PTZ00267 224 SL---------------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264 (478)
T ss_pred cc---------------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHH
Confidence 00 011246899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
++|++||.+.+..+.+..+.... ...+| ..++.++++||.+||. ||.+||+ +++++.|||++.+
T Consensus 265 ~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~--~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~~ 329 (478)
T PTZ00267 265 LTLHRPFKGPSQREIMQQVLYGK-YDPFP--CPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKYV 329 (478)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCC-CCCCC--ccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHHH
Confidence 99999999988888887777532 22333 3689999999999999 9999999 9999999999754
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=366.74 Aligned_cols=256 Identities=43% Similarity=0.841 Sum_probs=227.6
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCch
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L 203 (552)
||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||||++||+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999877655555667899999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCC
Q 008810 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (552)
Q Consensus 204 ~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~ 283 (552)
.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.+|.++|+|||+++.+....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999888889999999999999999999999999999999999999999999999999988653211
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCC--
Q 008810 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD-- 361 (552)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~-- 361 (552)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.+||...+
T Consensus 148 -----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 198 (262)
T cd05572 148 -----------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198 (262)
T ss_pred -----------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC
Confidence 0124578999999999998899999999999999999999999998877
Q ss_pred hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChh
Q 008810 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~ 423 (552)
+...+.++........+|. .+++++++||.+||+ +|.+|++. ..+.|+++||||++.+|+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 199 PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 6667777775445566665 458999999999998 99999983 458999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=402.12 Aligned_cols=263 Identities=28% Similarity=0.458 Sum_probs=224.9
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc--
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-- 189 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-- 189 (552)
+...++|++.+.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|..++|++|++++..|....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3456799999999999999999999999999999999976543 3345567889999999999999999988775332
Q ss_pred ------eEEEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcc
Q 008810 190 ------FLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (552)
Q Consensus 190 ------~lylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~D 259 (552)
.+++||||++||+|.++|.. ...+++..+..++.|++.||.|||+.|||||||||+|||++.+|++||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 47899999999999999864 24799999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccc
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 339 (552)
||+++.+...... ......+||+.|+|||++.+..|+.++|
T Consensus 187 FGls~~~~~~~~~---------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 187 FGFSKMYAATVSD---------------------------------------DVGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred cccCeeccccccc---------------------------------------cccccccCCcceeCHHHhCCCCCCcHHH
Confidence 9999865321100 0012468999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 340 iWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
||||||++|||++|..||.+.+..+.+.++..... ..+| ..+++++.+||.+||+ ||.+||+ +.+++.|||++
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~ 301 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-DPLP--PSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICK 301 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHH
Confidence 99999999999999999999888888777775322 2334 3789999999999999 9999999 99999999997
Q ss_pred CC
Q 008810 419 GV 420 (552)
Q Consensus 419 ~i 420 (552)
..
T Consensus 302 ~~ 303 (496)
T PTZ00283 302 LF 303 (496)
T ss_pred Hh
Confidence 64
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=391.21 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=216.7
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
...+|++++.||+|+||.||+|... .++..||+|.+.+.. ...+|+.+|+.++|||||+++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3567999999999999999999764 356789999886532 245799999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||+. ++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.+.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999995 78999987788999999999999999999999999999999999999999999999999999976532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
. ......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 241 ~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 281 (392)
T PHA03207 241 T---------------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281 (392)
T ss_pred c---------------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 0 0112468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChh---hHHHHHhhcc--cccc-------------------------CCc---ccccChhHHHHHHHHhh-
Q 008810 352 VGYPPFYSDDPM---STCRKIVNWR--THLK-------------------------FPE---EAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 352 tG~~PF~~~~~~---~~~~~i~~~~--~~~~-------------------------~p~---~~~~s~e~~dLI~~lL~- 397 (552)
+|..||.+.... ..+..|+... .... .|. ...++.++++||.+||+
T Consensus 282 ~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~ 361 (392)
T PHA03207 282 VKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTF 361 (392)
T ss_pred HCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhcc
Confidence 999999876432 2222222100 0111 111 02356789999999999
Q ss_pred CccccCCCCChhhhhcCCCcCCCChhhhhh
Q 008810 398 NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~ 427 (552)
||.+||+ +.||+.||||...+|+.+.-
T Consensus 362 dp~~Rps---a~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 362 DQEFRPS---AQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred ChhhCCC---HHHHhhCchhhccchhhhcC
Confidence 9999999 99999999999999988753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=366.24 Aligned_cols=255 Identities=36% Similarity=0.615 Sum_probs=215.1
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|++++.||+|+||.||+|+...+++.||+|++......... ......|..++..++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999987543332 22345599999999999999999999999999999999
Q ss_pred CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccc
Q 008810 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (552)
Q Consensus 198 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~ 277 (552)
+++++|.+++.....+++..+..++.||+.||.+||+.||+||||||+|||++.+|.++|+|||++..+....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~------- 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN------- 152 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999888999999999999999999999999999999999999999999999999999997541110
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-cCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
......+||+.|+|||++. +..++.++||||||+++|+|++|..|
T Consensus 153 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 153 ----------------------------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp ----------------------------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred ----------------------------------cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 0112467899999999998 78899999999999999999999999
Q ss_pred CCCCC---hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 357 FYSDD---PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 357 F~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|.... ......++...............+.++.+||.+||. ||.+||+ +.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 199 FEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp STTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred cccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 99873 333333333321111222111234899999999999 9999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=383.26 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=209.7
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 188 (552)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 578999999999999999999999999999999997543 2233445678899999999999999999988654
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+||||+++ +|...+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 357999999965 5666654 3589999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. .....+||+.|+|||++.+..|+.++|+|||||++|
T Consensus 172 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 209 (355)
T cd07874 172 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_pred cc------------------------------------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHH
Confidence 11 012457999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccc-------------------------cccCC---------c----ccccChhHHH
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRT-------------------------HLKFP---------E----EAKLSIEAKD 390 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~-------------------------~~~~p---------~----~~~~s~e~~d 390 (552)
+|++|..||.+.+..+.+..++..-. .+.+| . ....+.++++
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T cd07874 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHH
Confidence 99999999998776555444332100 00000 0 0124568899
Q ss_pred HHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 391 LI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||.+||. ||.+||+ +.||+.||||..
T Consensus 290 li~~mL~~dP~~Rps---~~ell~hp~~~~ 316 (355)
T cd07874 290 LLSKMLVIDPAKRIS---VDEALQHPYINV 316 (355)
T ss_pred HHHHHhcCCchhcCC---HHHHhcCcchhc
Confidence 9999999 9999999 999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=381.09 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=208.1
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 185 (552)
.+..++|++.+.||+|+||.||+|.+ +.++..||||+++... .......+.+|+.+|..+ +|||||+++++|
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45667899999999999999999975 3456789999997542 233456788999999999 899999999988
Q ss_pred cCC-ceEEEEEecCCCCchhhHHhhc------------------------------------------------------
Q 008810 186 QDD-EFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (552)
Q Consensus 186 ~d~-~~lylVmEy~~gG~L~~~L~~~------------------------------------------------------ 210 (552)
.+. ..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 754 4689999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCC
Q 008810 211 --------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282 (552)
Q Consensus 211 --------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~ 282 (552)
..+++..+..++.||+.||.|||+.|||||||||+|||++.++.+||+|||+++.+......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~---------- 230 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---------- 230 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch----------
Confidence 24788899999999999999999999999999999999999999999999999864321000
Q ss_pred CCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCC
Q 008810 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDD 361 (552)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~ 361 (552)
....+..+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+..
T Consensus 231 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 231 -----------------------------VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred -----------------------------hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 00113456789999999999999999999999999999997 999998866
Q ss_pred hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
..+.+...+........| ..+++++++||.+||. ||.+||+ +.+|+.
T Consensus 282 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~el~~ 329 (338)
T cd05102 282 INEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPT---FSALVE 329 (338)
T ss_pred ccHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 544444444332333344 3688999999999999 9999999 777754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=370.21 Aligned_cols=266 Identities=29% Similarity=0.478 Sum_probs=225.5
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..+.|++++.||.|+||.||+|++..+++.||+|++.... ......+..|+.+++.++||||++++++|..+..+|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3467999999999999999999999999999999997542 3456678889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++........
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 9999999999888754 46799999999999999999999999999999999999999999999999999875321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccchhhhhHHH
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIM 347 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSlGvil 347 (552)
......|++.|+|||++. ...++.++|||||||++
T Consensus 166 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 166 ----------------------------------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred ----------------------------------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 011356899999999985 34578899999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~ 426 (552)
|||++|.+||...+......++..... ...+....++.++.+||.+||. +|.+||+ +++|+.||||..++|.+..
T Consensus 206 ~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 206 IEMAQIEPPHHELNPMRVLLKIAKSEP-PTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred HHHhcCCCCCccccHHHHHHHHhcCCC-ccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchhH
Confidence 999999999988877666666554211 1222223688899999999999 9999999 9999999999999998755
Q ss_pred h
Q 008810 427 Q 427 (552)
Q Consensus 427 ~ 427 (552)
+
T Consensus 282 ~ 282 (292)
T cd06644 282 R 282 (292)
T ss_pred H
Confidence 3
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=383.42 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=212.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 188 (552)
.++|++++.||+|+||.||+|.+..+++.||||++.+... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4679999999999999999999999999999999976432 223445677899999999999999999988643
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+|||++ |++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 3579999998 888987764 46799999999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
. ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 171 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (343)
T cd07878 171 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred C--------------------------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHH
Confidence 1 113579999999999987 5789999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccc---------------------cCCc------ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~e~~dLI~~lL~-dp 399 (552)
|+|++|++||.+.+.......+....... ..|. ...+++.+.+||.+||. ||
T Consensus 207 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp 286 (343)
T cd07878 207 AELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDS 286 (343)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCCh
Confidence 99999999998877665555543311100 0110 01356789999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCC
Q 008810 400 NQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+|++ +.|++.||||...
T Consensus 287 ~~R~s---~~ell~hp~~~~~ 304 (343)
T cd07878 287 DKRIS---ASEALAHPYFSQY 304 (343)
T ss_pred hhCCC---HHHHhcCcchhcc
Confidence 99999 9999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=361.64 Aligned_cols=260 Identities=31% Similarity=0.529 Sum_probs=220.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--ceE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~l 191 (552)
.+|++.+.||+|+||.||+|.+..+|..||||++..... ....++..+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864321 1234567889999999999999999999998764 578
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.++|+|||++..+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999886532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
... ......||..|+|||++.+..++.++|+|||||++|||+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 203 (265)
T cd06652 162 SGT--------------------------------------GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203 (265)
T ss_pred ccc--------------------------------------ccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence 000 011356899999999999989999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~ 418 (552)
+|.+||...+......++.........| ..++..+.++|++|+.+|.+||+ +++|+.|||+.
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 204 TEKPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred hCCCCCCccchHHHHHHHhcCCCCCCCc--hhhCHHHHHHHHHHhcChhhCCC---HHHHhcCcccC
Confidence 9999998876666665555332223334 36788999999999999999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=368.47 Aligned_cols=274 Identities=43% Similarity=0.772 Sum_probs=228.2
Q ss_pred CeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceE
Q 008810 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~l 191 (552)
+|++.+.||+|+||.||+|+.. .++..||||++++..... .....++.+|..++..+ +||+|++++++|.+...+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467899999998764432 23456788999999999 699999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||++||+|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC--CCCccchhhhhHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYE 349 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvilyE 349 (552)
. .....+|++.|+|||++.+.. ++.++|+||||+++||
T Consensus 161 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~e 200 (288)
T cd05583 161 E----------------------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200 (288)
T ss_pred c----------------------------------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHH
Confidence 0 012357899999999987654 7899999999999999
Q ss_pred HhhCCCCCCCCChh----hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 350 MLVGYPPFYSDDPM----STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 350 mltG~~PF~~~~~~----~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
|++|..||...+.. +....+.. .....| ..++.++.+||.+||. ||++||+..++.++++||||+.++|+.
T Consensus 201 l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 201 LLTGASPFTVDGEQNSQSEISRRILK--SKPPFP--KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred HHhCCCCcccCcccchHHHHHHHHHc--cCCCCC--cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 99999999754332 22233332 222333 3688999999999998 999999988899999999999999998
Q ss_pred hhh--cCCCCcc
Q 008810 425 IYQ--MEAAFIP 434 (552)
Q Consensus 425 l~~--~~~pf~P 434 (552)
+.. +.|||.|
T Consensus 277 ~~~~~~~~~~~~ 288 (288)
T cd05583 277 LAAKRIPAPFKP 288 (288)
T ss_pred HhhhccCCCCCC
Confidence 864 5566654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=384.52 Aligned_cols=257 Identities=34% Similarity=0.627 Sum_probs=224.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG 201 (552)
++||.|-||+||-|+++.+|+.||||++.|-... .++...+++|+.||.++.||.||.|-+-|++.+.+++|||-+ .|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp-~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP-TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCC-CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 5899999999999999999999999999987654 445588999999999999999999999999999999999999 56
Q ss_pred chhhHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cEEEcccccccccCCCCcccccc
Q 008810 202 DMMTLLM--RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 202 ~L~~~L~--~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|+..++. .++.|+|...+|++.||+.||.|||-+||+|+|||||||||.... .+||||||+|+.+....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks------ 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS------ 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh------
Confidence 7777663 368999999999999999999999999999999999999997543 79999999999875331
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
...++||||.|+|||+|.+++|+..-|+||+|||+|--|.|..|
T Consensus 722 ------------------------------------FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 722 ------------------------------------FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred ------------------------------------hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEeccccc
Confidence 12278999999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC-ChhhhhhcC
Q 008810 357 FYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV-DWARIYQME 429 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i-~w~~l~~~~ 429 (552)
|..+. ++-..|.+ ..+-+|. +..+|++|.|||..||+ .-.+|.+ ++..+.|||+++. -|-.|+.++
T Consensus 766 FNEdE--dIndQIQN--AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~DLRelE 835 (888)
T KOG4236|consen 766 FNEDE--DINDQIQN--AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWLDLRELE 835 (888)
T ss_pred CCCcc--chhHHhhc--cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHHHHHHHH
Confidence 96543 34455665 3445554 56799999999999999 9999999 9999999999885 588887644
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=370.69 Aligned_cols=261 Identities=27% Similarity=0.476 Sum_probs=216.3
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||.|+||.||+|+++.+++.||+|.+..... ......+.+|+.+++.++||||++++++|.+...+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875432 2233457789999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++ ++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 999997 588888765 45789999999999999999999999999999999999999999999999999875422110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml 351 (552)
......+++.|+|||++.+ ..++.++|||||||++|||+
T Consensus 160 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 199 (301)
T cd07873 160 ----------------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199 (301)
T ss_pred ----------------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHH
Confidence 0113467899999999876 45889999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccc-----------------cccCCc---------ccccChhHHHHHHHHhh-CccccCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
+|++||.+.+..+....+..... ...+|. ...+++++++||.+||+ ||.+|++
T Consensus 200 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t 279 (301)
T cd07873 200 TGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS 279 (301)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 99999998876655544432100 011121 12578899999999999 9999999
Q ss_pred CCChhhhhcCCCcCCCC
Q 008810 405 AKGADEIKVHPWFDGVD 421 (552)
Q Consensus 405 ~~~a~eil~HpfF~~i~ 421 (552)
++||+.||||+.+-
T Consensus 280 ---~~eil~h~~f~~~~ 293 (301)
T cd07873 280 ---AEEAMKHPYFHCLG 293 (301)
T ss_pred ---HHHHhcCccccccc
Confidence 99999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=361.81 Aligned_cols=264 Identities=50% Similarity=0.891 Sum_probs=227.9
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCch
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L 203 (552)
||.|+||.||+|++..+|+.||+|++.+.........+.+.+|++++..++||||+++++.+.+...+|+||||++||+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 69999999999999999999999999877655556677899999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCC
Q 008810 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (552)
Q Consensus 204 ~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~ 283 (552)
..++.+.+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99998878999999999999999999999999999999999999999999999999999875432110000
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChh
Q 008810 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (552)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~ 363 (552)
... .......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 152 ----~~~--------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 152 ----NDD--------------------EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred ----ccc--------------------cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 000 00012357899999999999888999999999999999999999999988888
Q ss_pred hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 364 ~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
+....+.. ....+|....++.++.+||.+||+ +|.+||+..++.+++.||||++++|
T Consensus 208 ~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 208 EIFQNILN--GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHHHhc--CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 87777765 344555544459999999999999 9999999767799999999999999
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=388.02 Aligned_cols=259 Identities=29% Similarity=0.566 Sum_probs=234.3
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
......|.+++.||+|.|++|.+|++..||..||||++.|.... .....++.+|+++|+.++|||||+||.+......+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34567899999999999999999999999999999999988643 33345588999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||+.||+++++|.+.+.+.+..++.++.|++.|++|||+++|||||||.+||||+.+..+||+|||++..++....
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999988764321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEm 350 (552)
..+.||++.|.|||++.+..| +.++|+||+|+++|-|
T Consensus 211 ------------------------------------------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 211 ------------------------------------------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred ------------------------------------------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence 236899999999999999887 7899999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+.|..||.+.+-.+...+++..+..+++ .+|.++++||+++|. +|.+|++ .++|..|.|....
T Consensus 249 V~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 249 VEGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRNDL 312 (596)
T ss_pred eecccccCCcccccccchheeeeecccc----eeechhHHHHHHhhccCccccCC---HHHhhhhcccchh
Confidence 9999999999888888888765444444 589999999999998 9999999 9999999998653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=374.47 Aligned_cols=250 Identities=25% Similarity=0.439 Sum_probs=194.5
Q ss_pred EeeeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--CceEEEEEe
Q 008810 121 LTMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLYLIME 196 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~lylVmE 196 (552)
.+.||+|+||.||+|+++. +++.||+|++..... ...+.+|+.+|+.++|||||+++++|.+ ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 3579999999999999764 678999999875432 2346789999999999999999999853 567899999
Q ss_pred cCCCCchhhHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc----cCCCcEEEcccccc
Q 008810 197 YLPGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (552)
Q Consensus 197 y~~gG~L~~~L~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl----~~~g~iKL~DFGla 263 (552)
|+. ++|..++... ..+++..++.++.||+.||.|||+.|||||||||+|||+ +.+|.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5788776432 258999999999999999999999999999999999999 46689999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 342 (552)
+.+....... ......+||+.|+|||++.+ ..|+.++||||
T Consensus 160 ~~~~~~~~~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 201 (317)
T cd07868 160 RLFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred eccCCCCccc--------------------------------------cccCCccccccccCCHHHcCCCCcCchhhHHH
Confidence 8653221000 00124679999999999987 45899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChh---------hHHHHHhh---------ccccccCCc------------------------
Q 008810 343 LGAIMYEMLVGYPPFYSDDPM---------STCRKIVN---------WRTHLKFPE------------------------ 380 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~---------~~~~~i~~---------~~~~~~~p~------------------------ 380 (552)
|||++|||++|.+||.+.... ..+.++.. |.....+|.
T Consensus 202 lG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (317)
T cd07868 202 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 281 (317)
T ss_pred HHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHh
Confidence 999999999999999754321 12222221 000000000
Q ss_pred -ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 381 -EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 381 -~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
....+.++.|||.+||+ ||.+|++ ++|+++||||
T Consensus 282 ~~~~~~~~~~dli~~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 282 HKVKPDSKAFHLLQKLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred cCCCCChHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 01235679999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=366.00 Aligned_cols=275 Identities=40% Similarity=0.737 Sum_probs=225.8
Q ss_pred CeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceE
Q 008810 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~l 191 (552)
+|++.+.||.|+||.||+|+.. .+|..||+|++.+..... ....+++.+|+.+|..+ +||+|+.++++|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 478999999998754332 23456788999999999 699999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||++||+|.+++.....+++..+..++.|++.||.|||+.|++||||||+|||++.++++||+|||+++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyE 349 (552)
. .....+|+..|+|||++.+ ..++.++|+|||||++|+
T Consensus 161 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ 200 (290)
T cd05613 161 E----------------------------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200 (290)
T ss_pred c----------------------------------------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHH
Confidence 0 0124578999999999975 357889999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhc--cccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhh
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~ 424 (552)
|++|..||...........+... .....+| ..+++.+.+||.+||. ||.+|+++ ..+++++.||||..++|+.
T Consensus 201 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 201 LLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred HhcCCCCCCcCCccccHHHHHHHhhccCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 99999999754433222222211 1222334 3688999999999999 99999864 3599999999999999988
Q ss_pred hhh--cCCCCc
Q 008810 425 IYQ--MEAAFI 433 (552)
Q Consensus 425 l~~--~~~pf~ 433 (552)
+.. .++||.
T Consensus 279 ~~~~~~~~~~~ 289 (290)
T cd05613 279 LAAKKVPAPFK 289 (290)
T ss_pred HhhccCCCCCC
Confidence 753 444554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=363.95 Aligned_cols=256 Identities=29% Similarity=0.500 Sum_probs=215.7
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|.+.+.||+|+||.||+|++..+++.||+|+++... ......+.+|..+++.++||||+++++++.+.+.+|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3457889999999999999999999999999999997553 2334567889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++..+.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-- 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999875532100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhhhHHHHHH
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEm 350 (552)
.....+||+.|+|||++. ...++.++|+|||||++|+|
T Consensus 162 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l 202 (267)
T cd06645 162 ---------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred ---------------------------------------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHH
Confidence 011357999999999985 45689999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhcccc-ccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
++|.+||....+......+...... ........++..+.+||.+||. +|++||+ +++|+.|||
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 203 AELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred hcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 9999999876655444333321111 1111123578899999999999 9999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=367.18 Aligned_cols=248 Identities=21% Similarity=0.264 Sum_probs=213.6
Q ss_pred CCCeeEE--eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC----C
Q 008810 115 ADDFELL--TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----D 188 (552)
Q Consensus 115 ~~~f~~~--~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~ 188 (552)
.++++.. ..||+|++|.||+|.. +|+.||||++++.........+.+.+|+.+|.+++|||||+++++|.+ .
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence 3344444 6799999999999986 688999999987644334446778899999999999999999999876 4
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
..+|+||||++||+|.+++.....+++..+..++.+++.||.|||+ .+++||||||+|||++.+|.+||+|||+++.+.
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 5789999999999999999888899999999999999999999998 599999999999999999999999999988543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGA 345 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGv 345 (552)
... ...+||+.|+|||++.+ ..|+.++|||||||
T Consensus 175 ~~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGv 210 (283)
T PHA02988 175 SPP--------------------------------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV 210 (283)
T ss_pred ccc--------------------------------------------ccccCcccccCHHHhhhccccccchhhhhHHHH
Confidence 210 13468999999999986 68999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++|||++|..||.+.+..+.+..++.....+.+|. .+++++++||.+||. ||.+||+ +.+|+.
T Consensus 211 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rps---~~ell~ 274 (283)
T PHA02988 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPL--DCPLEIKCIVEACTSHDSIKRPN---IKEILY 274 (283)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCC--cCcHHHHHHHHHHhcCCcccCcC---HHHHHH
Confidence 99999999999999888888888876545555553 689999999999999 9999999 777764
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=360.77 Aligned_cols=259 Identities=31% Similarity=0.542 Sum_probs=218.7
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--CceE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFL 191 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~l 191 (552)
.+|+..+.||+|+||.||+|.+..+|..||+|++..... ........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999999875432 123456678999999999999999999999875 3678
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++++||+|||+++.+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999886532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
... ......|+..|+|||++.+..++.++|+|||||++|||+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 162 SGT--------------------------------------GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred cCC--------------------------------------ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 000 001346899999999999989999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
+|.+||...+......++........+|. .+++.+++||+ ||. +|.+||+ ++||+.||||+
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~-~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 204 TEKPPWAEYEAMAAIFKIATQPTNPQLPS--HISEHARDFLG-CIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HCCCCccccchHHHHHHHhcCCCCCCCch--hcCHHHHHHHH-HhcCChhhCcC---HHHHhcCcccc
Confidence 99999988776666666554433344443 67899999995 555 9999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=370.15 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=215.7
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||+|+||.||+|.+..+|..||+|.+.... .......+.+|++++..++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999987542 2334456888999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ .|++||||||+|||++.+|.+||+|||++..+....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999999999888899999999999999999999997 699999999999999999999999999986542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
....+|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 155 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 195 (308)
T cd06615 155 ---------------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195 (308)
T ss_pred ---------------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence 11457899999999998888999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhcc-----------------------------------ccccCCcccccChhHHHHHHHHhh-C
Q 008810 355 PPFYSDDPMSTCRKIVNWR-----------------------------------THLKFPEEAKLSIEAKDLISKLLC-N 398 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~-----------------------------------~~~~~p~~~~~s~e~~dLI~~lL~-d 398 (552)
.||...+.......+.... .....|. ..++.++++||.+||. |
T Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~ 274 (308)
T cd06615 196 YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKN 274 (308)
T ss_pred CCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCC
Confidence 9998765433322221100 0011111 1367899999999998 9
Q ss_pred ccccCCCCChhhhhcCCCcCC
Q 008810 399 VNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 399 p~~Rl~~~~a~eil~HpfF~~ 419 (552)
|.+||+ +.+|+.||||.+
T Consensus 275 P~~Rpt---~~~ll~~~~~~~ 292 (308)
T cd06615 275 PKERAD---LKELTKHPFIKR 292 (308)
T ss_pred hhhCcC---HHHHhcChhhhh
Confidence 999999 999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=364.44 Aligned_cols=252 Identities=24% Similarity=0.393 Sum_probs=211.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|+++++||+|+||.||+|.+..+++.||||++.+.. .......+.+|+.+|+.++||||++++++|.+.+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47889999999999999999999999999999997642 2334456889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|..+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..+....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----- 149 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----- 149 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----
Confidence 99999998654 357899999999999999999999999999999999999999999999999997553210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
....+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 150 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 191 (279)
T cd06619 150 --------------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191 (279)
T ss_pred --------------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 113579999999999999999999999999999999999999
Q ss_pred CCCCCChh-------hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 356 PFYSDDPM-------STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 356 PF~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
||...... .....+... .....+ ....++++++||.+||+ +|.+||+ +++++.||||...+
T Consensus 192 pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~ 260 (279)
T cd06619 192 PYPQIQKNQGSLMPLQLLQCIVDE-DPPVLP-VGQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYN 260 (279)
T ss_pred CchhhcccccccchHHHHHHHhcc-CCCCCC-CCcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCccccccc
Confidence 99753321 222222221 111222 23578899999999999 9999999 99999999997654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=368.86 Aligned_cols=274 Identities=29% Similarity=0.479 Sum_probs=230.5
Q ss_pred hhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh----hhhhHHHHHHHHHHHHHhcCCCceEEEe
Q 008810 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM----LRRGQVEHVRAERNLLAEVDSNCIVKLY 182 (552)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 182 (552)
.+..++...++|-++.+||+|||++||+|.+...+++||+|+-.-... .+.+...|..+|.+|.+.++||.||++|
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 356677788899999999999999999999999999999998754322 2345678899999999999999999999
Q ss_pred eeec-CCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccccCCCCcccc---CCCcEE
Q 008810 183 CSFQ-DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--HYIHRDIKPDNLLLD---KYGHLR 256 (552)
Q Consensus 183 ~~f~-d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~--giiHrDLKPeNILl~---~~g~iK 256 (552)
++|. |.+.+|-|+|||+|.||..+|.....++|.+|+.++.||+.||.||... .|||-||||.||||- ..|.||
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence 9997 6778999999999999999999999999999999999999999999975 699999999999995 568899
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc----C
Q 008810 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----K 332 (552)
Q Consensus 257 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~----~ 332 (552)
|+||||++.++...+...+ | ..++....||.||++||++.- .
T Consensus 614 ITDFGLSKIMdddSy~~vd--------G--------------------------meLTSQgAGTYWYLPPEcFvVgkePP 659 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVD--------G--------------------------MELTSQGAGTYWYLPPECFVVGKEPP 659 (775)
T ss_pred eeecchhhhccCCccCccc--------c--------------------------eeeecccCceeeecCcceeecCCCCC
Confidence 9999999998765332110 0 012234689999999999873 3
Q ss_pred CCCCccchhhhhHHHHHHhhCCCCCCCCChhh-HH--HHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCCh
Q 008810 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMS-TC--RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (552)
Q Consensus 333 ~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~-~~--~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a 408 (552)
..+.++|+||+|||+|.+|.|+.||..+-... ++ .-|++ ...+.||..+.+|++|++||++||+ .-++|.. +
T Consensus 660 KIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk-AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D---V 735 (775)
T KOG1151|consen 660 KISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK-ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID---V 735 (775)
T ss_pred ccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc-ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh---H
Confidence 46899999999999999999999997754332 22 22333 3567899888999999999999999 8888887 9
Q ss_pred hhhhcCCCcC
Q 008810 409 DEIKVHPWFD 418 (552)
Q Consensus 409 ~eil~HpfF~ 418 (552)
.++..||||.
T Consensus 736 ~qLA~dpyll 745 (775)
T KOG1151|consen 736 QQLACDPYLL 745 (775)
T ss_pred HHHccCcccc
Confidence 9999999984
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=354.14 Aligned_cols=253 Identities=28% Similarity=0.539 Sum_probs=216.6
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-CceEEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEFLYLIM 195 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-~~~lylVm 195 (552)
.|++++.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.+++.++||||+++++.|.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999976432 23445668899999999999999999998874 45789999
Q ss_pred ecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 196 EYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 196 Ey~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||++|++|.+++.. ...+++.++..++.+++.||.+||+.||+||||||+||+++.+++++|+|||+++.+.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 99999999999865 34689999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 158 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 158 ---------------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred ---------------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence 01135689999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
..||.+.+.......+..... ...| ..+++++.+||.+||+ ||.+||+ +.+|+.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 199 KHAFNAKDMNSLVYRIIEGKL-PPMP--KDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcCC-CCCc--cccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 999988777666655554211 1223 3688999999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=408.74 Aligned_cols=264 Identities=27% Similarity=0.457 Sum_probs=219.7
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD- 187 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d- 187 (552)
.......++|++++.||+|+||.||+|+++.++..||+|++..... .......+..|+.+|..++|||||+++++|.+
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3455667899999999999999999999999999999999976543 23445678899999999999999999998854
Q ss_pred -CceEEEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CCcccccCCCCccccC----
Q 008810 188 -DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-------HYIHRDIKPDNLLLDK---- 251 (552)
Q Consensus 188 -~~~lylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-------giiHrDLKPeNILl~~---- 251 (552)
...+|||||||++|+|..+|.. ...|++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 4679999999999999999865 35799999999999999999999985 4999999999999964
Q ss_pred -------------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccc
Q 008810 252 -------------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (552)
Q Consensus 252 -------------~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~ 318 (552)
.+.+||+|||+++.+.... .....+
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------------------------------------------~~~s~v 202 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES------------------------------------------MAHSCV 202 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccccc------------------------------------------cccccC
Confidence 3459999999998653211 012457
Q ss_pred cCCCCCChhhhhc--CCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHh
Q 008810 319 GTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396 (552)
Q Consensus 319 GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL 396 (552)
||+.|+|||++.+ ..|+.++||||||||||||++|.+||...+....+..++.... .+|. ...+.++.+||.+||
T Consensus 203 GTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p--~lpi-~~~S~eL~dLI~~~L 279 (1021)
T PTZ00266 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP--DLPI-KGKSKELNILIKNLL 279 (1021)
T ss_pred CCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC--CCCc-CCCCHHHHHHHHHHh
Confidence 9999999999975 4589999999999999999999999987665555444443222 2222 257899999999999
Q ss_pred h-CccccCCCCChhhhhcCCCcCCCC
Q 008810 397 C-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 397 ~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
. +|.+||+ +.|++.||||+.+.
T Consensus 280 ~~dPeeRPS---a~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 280 NLSAKERPS---ALQCLGYQIIKNVG 302 (1021)
T ss_pred cCChhHCcC---HHHHhccHHHhhcC
Confidence 9 9999999 99999999998764
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=386.17 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=215.1
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-C-----CceEEEeeeecCCc
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-S-----NCIVKLYCSFQDDE 189 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h-----p~Iv~l~~~f~d~~ 189 (552)
-+|+++++||+|+||.|-+|.+..|++.||||+++... ........|+.||..++ | -|||+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 37899999999999999999999999999999998753 33455677999999986 3 38999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC--cEEEcccccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG--HLRLSDFGLCKP 265 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g--~iKL~DFGlak~ 265 (552)
++|||+|.+ +-+|.++|..+ ..|+...++.++.||+.||.+||++||||+|||||||||..-+ .|||+|||.|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 77999999765 5799999999999999999999999999999999999997544 799999999875
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
.... .++.+-+..|+|||||+|.+|+.++|+|||||
T Consensus 341 ~~q~--------------------------------------------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGC 376 (586)
T KOG0667|consen 341 ESQR--------------------------------------------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGC 376 (586)
T ss_pred cCCc--------------------------------------------ceeeeeccccccchhhccCCCCCccceeehhh
Confidence 4321 23678889999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccc--------------------------------------------------c
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRT--------------------------------------------------H 375 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~--------------------------------------------------~ 375 (552)
|+.||++|.|.|.|++..+.+..|+.-.+ .
T Consensus 377 IlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~ 456 (586)
T KOG0667|consen 377 ILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLE 456 (586)
T ss_pred hHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhccc
Confidence 99999999999999999988888864100 0
Q ss_pred ccCC-ccc--------ccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 376 LKFP-EEA--------KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 376 ~~~p-~~~--------~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
...| ... .-.....|||.+||. ||.+|++ +.++++||||.+.
T Consensus 457 ~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 457 RRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTGT 508 (586)
T ss_pred ccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC---HHHHhcCcccccc
Confidence 0011 000 011246999999999 9999999 9999999999865
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=358.89 Aligned_cols=255 Identities=42% Similarity=0.759 Sum_probs=220.9
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++.++||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.|.+...+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999988765555667889999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|++|++|..++.....+++..+..++.|++.||.|||.+||+|+||+|+||+++.+|.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence 999999999998878999999999999999999999999999999999999999999999999999875432110
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 156 -------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 156 -------------------------------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred -------------------------------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 1134688999999999998899999999999999999999999
Q ss_pred CCCCCh--hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 357 FYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 357 F~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|...+. ...+...... ....+|. .++.++.++|.+||. ||.+|++.. ..|++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 199 YRGHSRTIRDQIRAKQET-ADVLYPA--TWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred CCCCCccHHHHHHHHhcc-ccccCcc--cCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 988764 2222222221 2334443 688999999999999 999999932 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=389.85 Aligned_cols=261 Identities=30% Similarity=0.479 Sum_probs=228.6
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+.|+|+..||.|+||+||+|..+.++-..|-|++... .....+.+.-|++||+.++||+||+|++.|.-++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 4478888999999999999999999999999998643 3567788999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||+||-...++.. ...|++.+++.++++++.||.|||+++|||||||..|||++.+|.|+|+|||.+-.....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----- 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----- 183 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-----
Confidence 99999999887654 568999999999999999999999999999999999999999999999999987543110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCCCCccchhhhhHHHHH
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvilyE 349 (552)
+....+++|||.||||||+.. .+|++++||||||+.|.|
T Consensus 184 ------------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIE 227 (1187)
T KOG0579|consen 184 ------------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIE 227 (1187)
T ss_pred ------------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHH
Confidence 111237899999999999873 689999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
|.-+.||-...+++..+.+|.... +..+-....+|..+.||+.+||. ||..||+ +.+|+.||||.+++-.+
T Consensus 228 MAqiEPPHhelnpMRVllKiaKSe-PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 228 MAQIEPPHHELNPMRVLLKIAKSE-PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred HhccCCCccccchHHHHHHHhhcC-CCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCCcch
Confidence 999999999999999999988642 22222335889999999999998 9999999 99999999999886654
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=359.64 Aligned_cols=256 Identities=27% Similarity=0.471 Sum_probs=215.4
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||+|+||.||+|+.+.+|+.||+|++.... ......+.+|+.++..++||||++++++|.+...+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3568999999999999999999999999999999997542 2334568889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||||+++|+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-- 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhhhHHHHHH
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEm 350 (552)
......|++.|+|||++. ...++.++|+|||||++|||
T Consensus 162 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el 202 (267)
T cd06646 162 ---------------------------------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred ---------------------------------------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHH
Confidence 011357899999999985 35578899999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccc-cCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHL-KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~-~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
++|.+||...++......+....... ..+....++.++.+||++||+ +|.+||+ +++|+.|+|
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 203 AELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred HhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 99999998766554443332211111 111123578899999999999 9999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=362.27 Aligned_cols=260 Identities=28% Similarity=0.476 Sum_probs=221.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||.|+||.||+|....++..||+|++.... ....+.+..|+.+++.++||||+++++.|.+...+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 457999999999999999999999899999999987542 34556788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||++||+|..++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999998664 5799999999999999999999999999999999999999999999999999865421100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCCCCccchhhhhHHHH
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMY 348 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiWSlGvily 348 (552)
......||+.|+|||++.. ..++.++|+|||||++|
T Consensus 159 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 159 ---------------------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred ---------------------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 0113578999999999863 45788999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
+|++|.+||.+.+......++.... ...+.....++.++.+||.+||. +|.+||+ +++|++||||.....
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~~ 270 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILKSE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQSD 270 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhcCC-CCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhcccch
Confidence 9999999999887777666665421 11222223688999999999998 9999999 999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=361.85 Aligned_cols=255 Identities=32% Similarity=0.493 Sum_probs=209.9
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++++.||.|+||.||+|+++.+|..||||++.... ........+.+|+.++..++||||++++++|.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999987543 223334568889999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 197 YLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 197 y~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 997 5788887542 5699999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
......|++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 157 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 157 ---------------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred ---------------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 0113467899999999876 457999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhcccc----------------ccCC---------cccccChhHHHHHHHHhh-CccccCCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTH----------------LKFP---------EEAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~----------------~~~p---------~~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
|.+||.+.+.......+...... ..++ ....+++++++||.+||+ ||.+||+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt-- 275 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS-- 275 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC--
Confidence 99999987654433332210000 0000 012478999999999999 9999999
Q ss_pred ChhhhhcCCCc
Q 008810 407 GADEIKVHPWF 417 (552)
Q Consensus 407 ~a~eil~HpfF 417 (552)
+.+|+.||||
T Consensus 276 -~~~ll~~~~~ 285 (285)
T cd07861 276 -AKKALNHPYF 285 (285)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=361.50 Aligned_cols=255 Identities=31% Similarity=0.509 Sum_probs=216.9
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|++++.||.|+||.||+|++..++..+|+|.+.... ......+.+|+.+++.++||||++++++|.+....|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 577889999999999999999999999999986543 34456788899999999999999999999999999999999
Q ss_pred CCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 198 ~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
++||+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-----
Confidence 999999988765 46799999999999999999999999999999999999999999999999999875421100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccchhhhhHHHHHHh
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSlGvilyEml 351 (552)
......||+.|+|||++. +..++.++|+|||||++|||+
T Consensus 159 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 159 ------------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred ------------------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 011357899999999984 355788999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+|.+||...++.+...++..... ...+....++.++++||.+||. ||.+||+ +++|++||||...
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 268 (282)
T cd06643 203 QIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVN 268 (282)
T ss_pred cCCCCccccCHHHHHHHHhhcCC-CCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEecc
Confidence 99999998887776666654321 1222223688999999999998 9999999 9999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.86 Aligned_cols=253 Identities=34% Similarity=0.550 Sum_probs=220.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|.+.+.||+|+||.||+|..+.+|+.||+|.+...... ......+..|+.+++.++||||++++++|.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999999765433 3445678899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++|++|.+++... ..+++..+..++.+++.||.|||+.||+||||||+||+++.+++++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--- 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--- 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc---
Confidence 99999999998764 5789999999999999999999999999999999999999999999999999986542210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 198 (256)
T cd08529 157 --------------------------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198 (256)
T ss_pred --------------------------------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence 011356899999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.||...+......++.... ...++. .++.++.++|.+||+ +|++||+ +.+|+.|||+
T Consensus 199 ~p~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 199 HPFDANNQGALILKIIRGV-FPPVSQ--MYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred CCCCCCCHHHHHHHHHcCC-CCCCcc--ccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 9999888777666666421 222332 678899999999999 9999999 9999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=358.46 Aligned_cols=253 Identities=31% Similarity=0.524 Sum_probs=211.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD------ 187 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d------ 187 (552)
.+.|++.+.||+|+||.||+|..+.+++.||+|++.... .....+..|+.++..+ +||||++++++|.+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456888899999999999999999999999999997542 2345678899999988 79999999999875
Q ss_pred CceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...+|+||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 34689999999999999998763 4689999999999999999999999999999999999999999999999999886
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccch
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 340 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Di 340 (552)
...... ......||+.|+|||++. +..|+.++|+
T Consensus 161 ~~~~~~-----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv 199 (272)
T cd06637 161 LDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 199 (272)
T ss_pred cccccc-----------------------------------------cCCcccccccccCHhHhccccCcCCCCCchhhH
Confidence 532110 011357999999999997 3468899999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|||||++|||++|.+||....+......+.. ..........++.++.+||.+||. ||.+||+ +.+|+.||||
T Consensus 200 ~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 200 WSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHHHhCCCCccccCHHHHHHHHhc--CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 9999999999999999987766555544432 111112223678899999999998 9999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=354.15 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=221.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||.|+||.||+|....++..+|+|++....... ....+.+|+.+|+.++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999999999999999997654322 5677899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 196 EYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||++|++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 46999999999999999999999999999999999999999999999999999866432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEml 351 (552)
. +......+|++.|+|||++... .++.++|+|||||++|+|+
T Consensus 159 ~-------------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 159 T-------------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201 (267)
T ss_pred c-------------------------------------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence 0 0011245799999999999876 7899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcc---cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEE---AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~---~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
+|..||...+....+.++.... ...++.. ..+++++++||.+||+ ||.+||+ +.+|+.||||
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred hCCCCccccChhhhHHHHhcCC-CCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 9999999887776666665431 2222221 3678999999999999 9999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=355.65 Aligned_cols=260 Identities=30% Similarity=0.510 Sum_probs=220.1
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh------hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML------RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.++..++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999999999999999998754322 22345678899999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
.|+||||++|++|..++.+.+.+++..+..++.|++.||.|||+.|++||||+|+|||++.++.+||+|||+++.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998664221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.... . ........|++.|+|||++.+..++.++|+|||||++|+|
T Consensus 161 ~~~~---------------~--------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l 205 (267)
T cd06628 161 LSTK---------------T--------------------NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205 (267)
T ss_pred ccCC---------------c--------------------cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHH
Confidence 1000 0 0001135689999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
++|..||.+.+......++... ....+|. .++.++.+||.+||. ||.+||+ +.+|+.||||
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 206 LTGKHPFPDCTQLQAIFKIGEN-ASPEIPS--NISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred hhCCCCCCCccHHHHHHHHhcc-CCCcCCc--ccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 9999999887766665555442 1223333 688999999999999 9999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=358.15 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=215.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875432 1223345788999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++++.|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.+|++||+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--- 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc---
Confidence 99999999888877778999999999999999999999999999999999999999999999999999865322100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 157 --------------------------------------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred --------------------------------------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 012457899999999876 55899999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccc-----------------cccCCc----------ccccChhHHHHHHHHhh-CccccCCCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRT-----------------HLKFPE----------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~----------~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
+||.+.+..+....+..... ....|. ...++..+.+||.+||+ +|.+||+
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-- 276 (286)
T cd07847 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS-- 276 (286)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC--
Confidence 99988776554443322100 011111 12468899999999999 9999999
Q ss_pred ChhhhhcCCCc
Q 008810 407 GADEIKVHPWF 417 (552)
Q Consensus 407 ~a~eil~HpfF 417 (552)
+.|++.||||
T Consensus 277 -~~eil~~~~f 286 (286)
T cd07847 277 -CEELLEHPYF 286 (286)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=370.23 Aligned_cols=264 Identities=21% Similarity=0.335 Sum_probs=210.2
Q ss_pred EEeeeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 120 LLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 120 ~~~~IG~G--~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
++++||+| +||+||+|+.+.+|+.||||++..... .....+.+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999976532 234456788899999999999999999999999999999999
Q ss_pred CCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 198 LPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 198 ~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
+++|+|.+++.. ...+++..++.++.|++.||.|||++|||||||||+|||++.++.++|+|||.+............
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999865 356999999999999999999999999999999999999999999999999876543211000000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhHHHHHHhhC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEmltG 353 (552)
. .......+++..|+|||++.+ .+|+.++|||||||++|||++|
T Consensus 161 --------------~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 161 --------------V--------------------HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred --------------c--------------------ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence 0 000112467888999999986 4699999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccc------------------------------------------cCCcccccChhHHHH
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHL------------------------------------------KFPEEAKLSIEAKDL 391 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~------------------------------------------~~p~~~~~s~e~~dL 391 (552)
++||................... ..|....+++++++|
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 99998655444333322210000 001112457889999
Q ss_pred HHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 392 ISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 392 I~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
|.+||+ ||.+||+ ++++++||||+.+.
T Consensus 287 i~~~l~~dP~~Rpt---~~ell~~p~f~~~~ 314 (327)
T cd08227 287 VEQCLQRNPDARPS---ASTLLNHSFFKQIK 314 (327)
T ss_pred HHHHHhhCchhcCC---HHHHhcChhhhhcc
Confidence 999999 9999999 99999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.01 Aligned_cols=260 Identities=28% Similarity=0.494 Sum_probs=217.9
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechh---hhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~---~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
+|.+.+.||+|+||.||+|.. .+|..+|+|.+.... .........+.+|+++|+.++|+||++++++|.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999975 578899999987532 1223445678999999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.+|.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999988653211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
. . ........||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 160 ~---------------~--------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 160 T---------------H--------------------SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred c---------------c--------------------cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence 0 0 0011245799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccc-cCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHL-KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~-~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.+||...+.......+....... .+| ..++.++.+||.+||. +|.+||+ +.+++.||||
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLP--DSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCC--CCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 99998876665554444321211 233 3688999999999998 9999998 9999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=359.61 Aligned_cols=264 Identities=19% Similarity=0.297 Sum_probs=217.6
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
.+..++|++.+.||+|+||.||+|..+. .+..||+|.+..... ......+.+|..+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3567789999999999999999997653 355899999865432 223345788999999999999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEE
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iK 256 (552)
+....|+||||++||+|.+++.+. ..++...+..++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999999653 2346778899999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCC
Q 008810 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (552)
Q Consensus 257 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~ 336 (552)
|+|||+++.+....... ......++..|+|||.+.+..++.
T Consensus 160 L~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~ 200 (288)
T cd05061 160 IGDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMAPESLKDGVFTT 200 (288)
T ss_pred ECcCCcccccccccccc---------------------------------------ccCCCcccccccCHHHhccCCCCh
Confidence 99999988653211000 001234678899999999999999
Q ss_pred ccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc-
Q 008810 337 ECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV- 413 (552)
Q Consensus 337 ~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~- 413 (552)
++|+|||||++|||++ |.+||.+.+..+....+... ....+|. .+++++++||.+||+ ||.+||+ +.++++
T Consensus 201 ~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~ 274 (288)
T cd05061 201 SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYLDQPD--NCPERVTDLMRMCWQFNPKMRPT---FLEIVNL 274 (288)
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 9999999999999998 89999988777766666542 2233443 578899999999999 9999999 666655
Q ss_pred -----CCCcCCCCh
Q 008810 414 -----HPWFDGVDW 422 (552)
Q Consensus 414 -----HpfF~~i~w 422 (552)
||||.+++|
T Consensus 275 l~~~~~~~~~~~~~ 288 (288)
T cd05061 275 LKDDLHPSFPEVSF 288 (288)
T ss_pred HHhhcCCCCCCCCC
Confidence 999999999
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=358.48 Aligned_cols=246 Identities=32% Similarity=0.545 Sum_probs=202.4
Q ss_pred CeeEEeee--eecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCceEEEeeeecCCceEEE
Q 008810 117 DFELLTMI--GKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 117 ~f~~~~~I--G~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lyl 193 (552)
+|++.+.+ |.|+||.||+|+.+.+|..||+|++.+..... .|..+... .+||||++++++|.+.+.+|+
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 45555555 99999999999999999999999997653211 12222222 279999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~~~~~~~ 272 (552)
||||++||+|..++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999999999999998878999999999999999999999999999999999999999998 9999999998754321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 164 ------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 201 (267)
T PHA03390 164 ------------------------------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201 (267)
T ss_pred ------------------------------------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 02468999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhc--cccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|..||............... ......+ ..+|+.+++||.+||+ +|.+|+++ +++|++||||++
T Consensus 202 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~--~~~~l~h~~~~~ 267 (267)
T PHA03390 202 GKHPFKEDEDEELDLESLLKRQQKKLPFI--KNVSKNANDFVQSMLKYNINYRLTN--YNEIIKHPFLKI 267 (267)
T ss_pred CCCCCCCCCcchhhHHHHHHhhcccCCcc--cccCHHHHHHHHHHhccChhhCCch--HHHHhcCCcccC
Confidence 99999865443321111111 1222222 3689999999999999 99999962 699999999974
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=358.05 Aligned_cols=257 Identities=35% Similarity=0.534 Sum_probs=222.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||.|+||.||+|++..+|+.||+|++.... .......+.+|+.+++.++||||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999997653 2344567889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|.+++... .+++..+..++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||+++.+.....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~---- 153 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS---- 153 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc----
Confidence 999999999998654 899999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 154 -------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 154 -------------------------------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred -------------------------------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0113578999999999999889999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
||.+.++......+... .....+. ..+++++.++|.+||+ +|.+||+ +++++.||||.+..
T Consensus 197 p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~ 258 (274)
T cd06609 197 PLSDLHPMRVLFLIPKN-NPPSLEG-NKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAK 258 (274)
T ss_pred CcccCchHHHHHHhhhc-CCCCCcc-cccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCC
Confidence 99887776666555542 1222222 2378999999999998 9999999 99999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=361.23 Aligned_cols=255 Identities=29% Similarity=0.496 Sum_probs=207.8
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++++.||+|+||.||+|+++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999976432 23334567789999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 197 y~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|++ |+|..++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+++.+.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~---- 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR---- 154 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC----
Confidence 996 577777754 56799999999999999999999999999999999999999999999999999975432110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~ 354 (552)
......+|+.|+|||++.+. .++.++|+|||||++|||++|.
T Consensus 155 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 155 -------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred -------------------------------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 00134678999999999774 4799999999999999999988
Q ss_pred CCCC-CCChhhHHHHHhhcc---------------ccccCCc----------ccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 355 PPFY-SDDPMSTCRKIVNWR---------------THLKFPE----------EAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 355 ~PF~-~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
.||. +.+..+.+..+...- ....++. ...+++++++||.+||. ||.+||+
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t--- 274 (284)
T cd07839 198 RPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS--- 274 (284)
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---
Confidence 8754 444444444332100 0000110 12478999999999999 9999999
Q ss_pred hhhhhcCCCc
Q 008810 408 ADEIKVHPWF 417 (552)
Q Consensus 408 a~eil~HpfF 417 (552)
+++|+.||||
T Consensus 275 ~~~il~h~~f 284 (284)
T cd07839 275 AEEALQHPYF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=376.32 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=203.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+...+|++++.||+|+||.||+|++..++..||+|+..+.. ...|..+|+.++|||||+++++|.+....|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 34457999999999999999999999999999999865432 346889999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
+||||+. |+|..++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++......
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 9999995 578887754 4679999999999999999999999999999999999999999999999999987432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
......||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 212 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell 250 (357)
T PHA03209 212 -----------------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250 (357)
T ss_pred -----------------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHH
Confidence 012457999999999999999999999999999999999
Q ss_pred hCCCC-CCCCChh---------hHHHHHhhc--cccccCC----------------------------cccccChhHHHH
Q 008810 352 VGYPP-FYSDDPM---------STCRKIVNW--RTHLKFP----------------------------EEAKLSIEAKDL 391 (552)
Q Consensus 352 tG~~P-F~~~~~~---------~~~~~i~~~--~~~~~~p----------------------------~~~~~s~e~~dL 391 (552)
++..| |...... ..+.+++.. .....+| ....++.++.+|
T Consensus 251 ~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 330 (357)
T PHA03209 251 AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFL 330 (357)
T ss_pred HcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHH
Confidence 85544 4432111 111111110 0011111 012467788999
Q ss_pred HHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 392 ISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 392 I~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|.+||+ ||.+||+ +.||++||||+.+
T Consensus 331 i~~mL~~dP~~Rpt---a~e~l~hp~f~~~ 357 (357)
T PHA03209 331 VHKMLTFDAAMRPS---AEEILNYPMFAQL 357 (357)
T ss_pred HHHHHcCCcccCcC---HHHHhcCchhccC
Confidence 999999 9999999 9999999999864
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=362.82 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=214.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|++..+|+.||+|.+.... .......+.+|+.++..++||||++++++|.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999999999999987532 2334567889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 196 EYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||++|++|..++... ..+++..+..++.+++.||.|||. .||+||||||+|||++.++.+||+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999888653 379999999999999999999996 699999999999999999999999999987542110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC------CCCCccchhhhhH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK------GYGMECDWWSLGA 345 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~------~y~~~~DiWSlGv 345 (552)
....+|++.|+|||++.+. .++.++|+|||||
T Consensus 158 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 195 (286)
T cd06622 158 ------------------------------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195 (286)
T ss_pred ------------------------------------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHH
Confidence 1134688999999998653 3588999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHH---HhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRK---IVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~---i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
++|+|++|..||...+....... +... ....+|. .++.++.+||.+||. +|.+||+ +++++.||||...
T Consensus 196 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~ 268 (286)
T cd06622 196 SILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPS--GYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCCc--ccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhc
Confidence 99999999999987665544433 3321 2233443 589999999999998 9999999 9999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=360.77 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=218.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
..+|++++.||+|+||.||+|.++.++..||+|.+..... ...+.+.+|+.+++.++||||+++++.|.+...+|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4589999999999999999999999999999999976542 2346688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++||+|..++. ...+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 96 ~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--- 171 (296)
T cd06654 96 MEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (296)
T ss_pred ecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc---
Confidence 99999999999885 45689999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus 172 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~ 213 (296)
T cd06654 172 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (296)
T ss_pred --------------------------------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 011347899999999999988999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+||...++......+... .....+....++..+.+||.+||. +|.+||+ +.+|+.||||..
T Consensus 214 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~ 275 (296)
T cd06654 214 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (296)
T ss_pred CCCCCCCHHHhHHHHhcC-CCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhc
Confidence 999988765544333321 111222223688999999999999 9999999 999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=354.14 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=216.9
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh---hhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR---RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
+|+..+.||+|+||.||+|.++.+|+.||+|++....... ......+.+|+.+|+.++||||++++++|.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999999999999999997543211 2235678999999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~~~~~~~ 272 (552)
||||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888999999999999999999999999999999999999998877 4999999998866422100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.. ......+||..|+|||++.+..++.++|+|||||++|+|++
T Consensus 161 ~~-------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 161 AG-------------------------------------EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred CC-------------------------------------ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh
Confidence 00 00113578999999999998899999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhh---ccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 353 GYPPFYSDDPMSTCRKIVN---WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~---~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
|.+||...+.......+.. ......+| ..+++++.++|.+||. +|.+||+ +.++++||||+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASATTAPSIP--EHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhccCCCCCCc--hhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 9999976554333333322 11222333 3688999999999998 9999999 99999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=353.35 Aligned_cols=259 Identities=29% Similarity=0.499 Sum_probs=217.8
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
.|.+.+.||.|+||.||+|....+|+.||+|.++..... .....+.+..|..+++.++||||+++++++.+.+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999999999999999998643211 1223467889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||++||+|.+++.+.+.+++..++.++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998754311
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC--CCCccchhhhhHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIM 347 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil 347 (552)
... .......|+..|+|||++.... ++.++|+|||||++
T Consensus 162 ~~~---------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l 202 (272)
T cd06629 162 YDN---------------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202 (272)
T ss_pred ccc---------------------------------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence 000 0011356899999999998754 89999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcc--cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|+|++|..||...+......++........+|.. ..++.++++||.+||. +|.+||+ +++|++||||
T Consensus 203 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 203 LEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred HHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 9999999999876666555554433333344432 2568999999999999 9999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=359.70 Aligned_cols=256 Identities=32% Similarity=0.541 Sum_probs=220.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
..+|++++.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|.+...+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 356999999999999999999999999999999987543 23456688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++||+|..++.. ..+++.++..++.+++.||.|||+.|++||||||+||+++.+|.+||+|||++..+.....
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--- 170 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--- 170 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc---
Confidence 999999999998854 5699999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus 171 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~ 212 (296)
T cd06655 171 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (296)
T ss_pred --------------------------------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 011346899999999999989999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhc-cccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 355 PPFYSDDPMSTCRKIVNW-RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~-~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+||.+.++......+... ...+..| ..+++.+++||.+||. ||.+||+ +.+|+.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~ 275 (296)
T cd06655 213 PPYLNENPLRALYLIATNGTPELQNP--EKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLA 275 (296)
T ss_pred CCCCCCCHHHHHHHHHhcCCcccCCc--ccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhc
Confidence 999988776655554432 1122233 3689999999999999 9999999 9999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=349.12 Aligned_cols=253 Identities=33% Similarity=0.535 Sum_probs=217.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++.+.||.|+||.||+|..+.+++.||+|.+..... .+.+.+|+.+++.++||||+++++.|.+...+|+|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3679999999999999999999999999999999976532 56788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.+|.+||+|||++..+.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999865 46789999999999999999999999999999999999999999999999999886532210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
......|+..|+|||++.+..++.++|+||||||+|+|++|
T Consensus 155 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g 195 (256)
T cd06612 155 ---------------------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195 (256)
T ss_pred ---------------------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC
Confidence 01134689999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.+||...++......+.... ...+.....++.++.+||.+||. ||.+||+ +.||+.||||
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 196 KPPYSDIHPMRAIFMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred CCCCCCcchhhhhhhhccCC-CCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 99998876655444443321 11122223678899999999998 9999999 9999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.52 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=217.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
..+|++++.||.|+||.||+|.++.+|+.||||.+..... ...+.+.+|+.+++.++||||+++++.|.+...+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3679999999999999999999999999999999975432 2346688899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++||+|..++.+ ..+++..+..++.+++.||.|||+.||+||||||+|||++.+|.++|+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 170 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc---
Confidence 999999999998854 5689999999999999999999999999999999999999999999999999875432210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
......|++.|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 171 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~ 212 (297)
T cd06656 171 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (297)
T ss_pred --------------------------------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 001346899999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhc-cccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 355 PPFYSDDPMSTCRKIVNW-RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~-~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+||.+.++......+... ...+..| ..++..+++||.+||. +|.+||+ +.+|+.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 275 (297)
T cd06656 213 PPYLNENPLRALYLIATNGTPELQNP--ERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLA 275 (297)
T ss_pred CCCCCCCcchheeeeccCCCCCCCCc--cccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhccc
Confidence 999887664433322221 1112222 3678899999999999 9999999 9999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=346.79 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=221.3
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|+++++||.|+||.||+++...+++.+|+|.+..... .......+.+|+.+|+.++|+||++++++|.+...+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999876542 23445668899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++||+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999764 5689999999999999999999999999999999999999999999999999986532210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
......||+.|+|||++.+..++.++|+|||||++|||++|.
T Consensus 157 --------------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08221 157 --------------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198 (256)
T ss_pred --------------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCC
Confidence 012357899999999999888999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.||...+..+....+...... ..+ ..++.++.++|.+||+ +|.+||+ +.+++.|||+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 199 RTFDATNPLNLVVKIVQGNYT-PVV--SVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred CCCCCCCHHHHHHHHHcCCCC-CCc--cccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 999998888888777653211 122 4678999999999998 9999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.10 Aligned_cols=257 Identities=31% Similarity=0.512 Sum_probs=216.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|.++.+|+.||||++.+.... ....+.+.+|+.+|+.++||||++++++|.++..+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998765432 234456888999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++++.|..+......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc----
Confidence 9999999988877767799999999999999999999999999999999999999999999999999886532110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+|+..|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 156 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~ 198 (286)
T cd07846 156 -------------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198 (286)
T ss_pred -------------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence 0113468999999999976 45789999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccc-----------------cCCc----------ccccChhHHHHHHHHhh-CccccCCCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHL-----------------KFPE----------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~-----------------~~p~----------~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
+||.+.+..+....+..+...+ ..|. .+.++..+.+||.+||. +|.+||+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~-- 276 (286)
T cd07846 199 PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS-- 276 (286)
T ss_pred CCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh--
Confidence 9998877655555544321111 1110 12568899999999998 9999999
Q ss_pred ChhhhhcCCCc
Q 008810 407 GADEIKVHPWF 417 (552)
Q Consensus 407 ~a~eil~HpfF 417 (552)
+.+|+.||||
T Consensus 277 -~~~il~~~~~ 286 (286)
T cd07846 277 -SSQLLHHEFF 286 (286)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=349.03 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=218.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+|..+++.++||||+++++++.+...+|+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999997653 22556788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||++|++|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++..+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999999998776 7899999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC---CCCCccchhhhhHHHHHH
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~---~y~~~~DiWSlGvilyEm 350 (552)
.....+|+..|+|||++.+. .++.++|+|||||++|||
T Consensus 157 ---------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 157 ---------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197 (262)
T ss_pred ---------------------------------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHH
Confidence 01135789999999999877 889999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhcccc-ccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
++|.+||...++......+...... ........++.++++||.+||+ +|.+||+ +.+|+.|||
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 198 AELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 9999999887766655544432111 1111123567899999999998 9999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=374.85 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=210.8
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 184 (552)
..+..++|++.+.||+|+||.||+|++..+ +..||||+++.... ....+.+.+|+.+|+.+ +|||||+++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 345567899999999999999999986544 45899999976432 23456788999999999 89999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhhc------------------------------------------------------
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~~------------------------------------------------------ 210 (552)
|.+...+|+|||||++|+|.+++...
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 99999999999999999999998542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 211 ----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 211 ----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-- 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-- 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--
Confidence 24788899999999999999999999999999999999999999999999999865321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-C
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-G 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G 353 (552)
.......+++.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 269 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G 311 (374)
T cd05106 269 -------------------------------------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 311 (374)
T ss_pred -------------------------------------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 00012345678999999999999999999999999999997 9
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.+||.+......+.+++........| ..+++++++||.+||+ ||.+||+ +.+|.+
T Consensus 312 ~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~~l~~ 367 (374)
T cd05106 312 KSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERPT---FSQISQ 367 (374)
T ss_pred CCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 99998876655555555433333334 3578999999999999 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=391.33 Aligned_cols=285 Identities=25% Similarity=0.355 Sum_probs=211.5
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCC-cEEEEE--------------EeechhhhhhhHHHHHHHHHHHHHhcCCCce
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTG-HVYAMK--------------KLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg-~~~AiK--------------~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 178 (552)
..++|++++.||+|+||+||+|..+... ..++.| ++.+...........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 3568999999999999999999875432 222222 1111111122234568899999999999999
Q ss_pred EEEeeeecCCceEEEEEecCCCCchhhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC
Q 008810 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (552)
Q Consensus 179 v~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g 253 (552)
|++++++.+.+..|+|||++ +++|..++... .......++.++.||+.||.|||++|||||||||+||||+.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999999999999999999 45777766432 2345677889999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC
Q 008810 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (552)
Q Consensus 254 ~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~ 333 (552)
.+||+|||+++.+..... ......+||+.|+|||++.+..
T Consensus 305 ~vkL~DFGla~~~~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 344 (501)
T PHA03210 305 KIVLGDFGTAMPFEKERE----------------------------------------AFDYGWVGTVATNSPEILAGDG 344 (501)
T ss_pred CEEEEeCCCceecCcccc----------------------------------------cccccccCCcCCCCchhhcCCC
Confidence 999999999986532110 0112468999999999999999
Q ss_pred CCCccchhhhhHHHHHHhhCCCCCCC-C--ChhhHHHHHhhccc--cccCCc--------------------------cc
Q 008810 334 YGMECDWWSLGAIMYEMLVGYPPFYS-D--DPMSTCRKIVNWRT--HLKFPE--------------------------EA 382 (552)
Q Consensus 334 y~~~~DiWSlGvilyEmltG~~PF~~-~--~~~~~~~~i~~~~~--~~~~p~--------------------------~~ 382 (552)
|+.++|||||||++|||++|..|+.+ . ++...+.+++.... ...+|. ..
T Consensus 345 ~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 424 (501)
T PHA03210 345 YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL 424 (501)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc
Confidence 99999999999999999998754433 2 22233333322100 001111 11
Q ss_pred ccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhc---------CCCCccccCCcccC
Q 008810 383 KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQM---------EAAFIPEVNDELDT 442 (552)
Q Consensus 383 ~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~---------~~pf~P~~~~~~d~ 442 (552)
.++.++.++|.+||+ ||.+||+ +.|++.||||.+.++..+..+ -.|+.|.+..+.|+
T Consensus 425 ~~~~~~~~li~kmL~~DP~~Rps---a~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 491 (501)
T PHA03210 425 GLPADFEYPLVKMLTFDWHLRPG---AAELLALPLFSAEEEEEILFIHGLKSGAAHFKPIKPACRIESDT 491 (501)
T ss_pred CCChHHHHHHHHHhccCcccCcC---HHHHhhChhhhcCCchHHHHHHhhhccccccccCCchheecccc
Confidence 356788999999999 9999999 999999999999887766432 23566665555444
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=354.16 Aligned_cols=259 Identities=30% Similarity=0.502 Sum_probs=213.0
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeee---
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF--- 185 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f--- 185 (552)
......++|++++.||+|+||.||+|.++.+++.||+|++.... .....+.+|..++..+ +||||++++++|
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34456789999999999999999999999999999999986532 1234577899999998 799999999987
Q ss_pred --cCCceEEEEEecCCCCchhhHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcc
Q 008810 186 --QDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (552)
Q Consensus 186 --~d~~~lylVmEy~~gG~L~~~L~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~D 259 (552)
.+...+|+||||++||+|..++. ....+++..+..++.+++.||.|||+.+|+||||||+||+++.+|.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 35568999999999999998874 235789999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCC
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGY 334 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y 334 (552)
||+++.+..... .....+||+.|+|||++.. ..|
T Consensus 168 fg~~~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~ 206 (286)
T cd06638 168 FGVSAQLTSTRL-----------------------------------------RRNTSVGTPFWMAPEVIACEQQLDSTY 206 (286)
T ss_pred CCceeecccCCC-----------------------------------------ccccccCCCcccChhhhchhhhccccc
Confidence 999886532110 0113479999999999853 458
Q ss_pred CCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+.++|||||||++|||++|.+||...++.....++.... .........++.++.+||.+||. ||.+||+ +.||+.
T Consensus 207 ~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~ 282 (286)
T cd06638 207 DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQ 282 (286)
T ss_pred cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-CCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhh
Confidence 999999999999999999999998877655544433221 11111122567899999999998 9999999 999999
Q ss_pred CCCc
Q 008810 414 HPWF 417 (552)
Q Consensus 414 HpfF 417 (552)
||||
T Consensus 283 ~~~~ 286 (286)
T cd06638 283 HVFI 286 (286)
T ss_pred cccC
Confidence 9997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=349.40 Aligned_cols=259 Identities=30% Similarity=0.531 Sum_probs=220.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechh--hhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--ceE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~l 191 (552)
.+|++.+.||+|+||.||+|.++.+|+.||||++.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999986432 11234556789999999999999999999998764 568
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
++||||++|++|.+++.....+++..++.++.+++.||.|||+.||+||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999986532100
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.. .......||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 ~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 203 (264)
T cd06653 162 SG--------------------------------------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203 (264)
T ss_pred cC--------------------------------------ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence 00 0001356899999999999988999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCc
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF 417 (552)
+|.+||..........++........+|. .+++++.++|.+||.+|..||+ +.+++.|||.
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~~i~~~l~~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 204 TEKPPWAEYEAMAAIFKIATQPTKPMLPD--GVSDACRDFLKQIFVEEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred hCCCCCCccCHHHHHHHHHcCCCCCCCCc--ccCHHHHHHHHHHhcCcccCcc---HHHHhcCCCC
Confidence 99999988776666666554333334554 7899999999999998899999 8999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=359.58 Aligned_cols=261 Identities=28% Similarity=0.445 Sum_probs=216.0
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--ceE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~l 191 (552)
..++|++++.||+|+||.||+|.++.+|+.||+|+++.... .......+.+|+.++..++|+||+++++++.+. +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999975432 222233466799999999999999999998755 578
Q ss_pred EEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|+||||+. ++|..++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.+|.+||+|||++..+....
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 478888765 4679999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 349 (552)
. ......+++.|+|||++.+ ..++.++|+|||||++||
T Consensus 163 ~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 163 K-----------------------------------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred C-----------------------------------------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHH
Confidence 0 0012356889999999876 568999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccc-----------------cccCCcc---------cccChhHHHHHHHHhh-Ccccc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRT-----------------HLKFPEE---------AKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~---------~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|++|.+||.+.+..+.+..+..... .+.++.. ..+++++.+||.+||+ ||.+|
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhC
Confidence 9999999999888888777765211 0111110 1358899999999999 99999
Q ss_pred CCCCChhhhhcCCCcCCC
Q 008810 403 LGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 403 l~~~~a~eil~HpfF~~i 420 (552)
|+ +++|+.||||++.
T Consensus 282 ~t---~~~il~h~~f~~~ 296 (309)
T cd07845 282 AT---AEEALESSYFKEK 296 (309)
T ss_pred cC---HHHHhcChhhccC
Confidence 99 9999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=357.66 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=217.3
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.++..++||||++++++|.+...+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999999999999987542 23345678899999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++||+|..++...+.+++..+..++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999999999888889999999999999999999997 699999999999999999999999999986432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
....+||..|+|||++.+..++.++|+|||||++|+|++
T Consensus 159 -----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t 197 (284)
T cd06620 159 -----------------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197 (284)
T ss_pred -----------------------------------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh
Confidence 113579999999999998899999999999999999999
Q ss_pred CCCCCCCCChh-----------hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 353 GYPPFYSDDPM-----------STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 353 G~~PF~~~~~~-----------~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|..||...... +....+... ....++. ..++.++.+||.+||. ||.+||+ +.||++||||..
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~ 271 (284)
T cd06620 198 GKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPS-SDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQ 271 (284)
T ss_pred CCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCCc-hhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccc
Confidence 99999875542 222333321 1122222 2478899999999999 9999999 999999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=354.25 Aligned_cols=255 Identities=31% Similarity=0.507 Sum_probs=212.4
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecC----
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD---- 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d---- 187 (552)
...+.|++.+.||.|+||.||+|+++.+++.||+|++.... .....+..|+.++..+ +||||++++++|..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34578999999999999999999999999999999986542 2345678899999888 79999999999853
Q ss_pred --CceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 188 --DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 188 --~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
...+|+||||+++|+|..++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 46899999999999999998653 45899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCcc
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMEC 338 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~ 338 (552)
........ .....+|++.|+|||++. +..|+.++
T Consensus 169 ~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~ 207 (282)
T cd06636 169 AQLDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDYRS 207 (282)
T ss_pred hhhhcccc-----------------------------------------CCCcccccccccCHhhcCcccCcCcCCCccc
Confidence 75421100 012457999999999986 35688999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 339 DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|+|||||++|||++|.+||....+......+... ...... ...++.++.+||.+||. ||.+||+ +.||+.||||
T Consensus 208 DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 208 DIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLK-SKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred chhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC-CCCCCc-ccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 9999999999999999999877665555444331 111111 23578999999999998 9999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=353.59 Aligned_cols=257 Identities=31% Similarity=0.531 Sum_probs=214.5
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCC--
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD-- 188 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~-- 188 (552)
....++|.+.+.||+|+||.||+|..+.+++.||+|++.... .....+.+|..++..+ +||||++++++|...
T Consensus 18 ~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 18 GDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred CCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 334788999999999999999999999999999999987542 2234577899999988 899999999988643
Q ss_pred ---ceEEEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccc
Q 008810 189 ---EFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (552)
Q Consensus 189 ---~~lylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFG 261 (552)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg 173 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG 173 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecc
Confidence 468999999999999998753 4579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-----CCCC
Q 008810 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-----GYGM 336 (552)
Q Consensus 262 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-----~y~~ 336 (552)
++..+...... ....+|++.|+|||++... .++.
T Consensus 174 ~~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 212 (291)
T cd06639 174 VSAQLTSTRLR-----------------------------------------RNTSVGTPFWMAPEVIACEQQYDYSYDA 212 (291)
T ss_pred cchhccccccc-----------------------------------------ccCccCCccccChhhhcCCCCcccccCC
Confidence 98865321100 1134689999999998643 3689
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccc-cccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 337 ~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~-~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
++|||||||++|||++|++||...++......+..+.. .+..| ..++.++++||.+||. +|.+||+ +.+|+.|
T Consensus 213 ~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~ 287 (291)
T cd06639 213 RCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHP--EKWCRSFNHFISQCLIKDFEARPS---VTHLLEH 287 (291)
T ss_pred ccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCcc--cccCHHHHHHHHHHhhcChhhCcC---HHHHhcC
Confidence 99999999999999999999998877666666554321 12223 3577899999999998 9999999 9999999
Q ss_pred CCcC
Q 008810 415 PWFD 418 (552)
Q Consensus 415 pfF~ 418 (552)
|||+
T Consensus 288 ~~~~ 291 (291)
T cd06639 288 PFIK 291 (291)
T ss_pred cccC
Confidence 9995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=361.75 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=192.4
Q ss_pred eeeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec--CCceEEEEEec
Q 008810 122 TMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFLYLIMEY 197 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~lylVmEy 197 (552)
..||+|+||.||+|+.+. ++..||+|.+..... ...+.+|+.+|+.++||||++++++|. ++..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999764 668999999875432 234678999999999999999999884 45689999999
Q ss_pred CCCCchhhHHhh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc----cCCCcEEEccccccc
Q 008810 198 LPGGDMMTLLMR---------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCK 264 (552)
Q Consensus 198 ~~gG~L~~~L~~---------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl----~~~g~iKL~DFGlak 264 (552)
++ ++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+|+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 96 577777642 1358999999999999999999999999999999999999 567899999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSl 343 (552)
.+....... ......+||+.|+|||++.+ ..++.++|||||
T Consensus 161 ~~~~~~~~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 161 LFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred ccCCCcccc--------------------------------------cccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 654221000 00124579999999999987 458999999999
Q ss_pred hHHHHHHhhCCCCCCCCChh---------hHHHHHhh---------ccc---cccCC----------------------c
Q 008810 344 GAIMYEMLVGYPPFYSDDPM---------STCRKIVN---------WRT---HLKFP----------------------E 380 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~---------~~~~~i~~---------~~~---~~~~p----------------------~ 380 (552)
||++|||++|.+||...... ....++.. |.. ...++ .
T Consensus 203 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (317)
T cd07867 203 GCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKH 282 (317)
T ss_pred HHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcc
Confidence 99999999999999754321 11111110 000 00000 0
Q ss_pred ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 381 EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 381 ~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
....+..+.+||.+||+ ||.+||+ ++|++.||||
T Consensus 283 ~~~~~~~~~~ll~~~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 283 KVKPDSKVFLLLQKLLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred cCCCChHHHHHHHHHhccCcccccC---HHHHhcCCCC
Confidence 01235678999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=353.33 Aligned_cols=274 Identities=40% Similarity=0.725 Sum_probs=228.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylV 194 (552)
++|.+.+.||+|+||.||+|..+.+|+.||+|++.+...........+..|..++..+. ||||++++++|.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998866555555677889999999998 99999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++|++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.+|+++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986643321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.... .. .... ... .........+|+..|+|||++....++.++|+|||||++|+|++|.
T Consensus 161 ~~~~-----~~--~~~~--~~~------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~ 219 (280)
T cd05581 161 NKGD-----AT--NIDS--QIE------------KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219 (280)
T ss_pred CCCC-----Cc--cccc--ccc------------ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 0000 00 0000 000 0001123467899999999999888999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCCh----hhhhcCCCc
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA----DEIKVHPWF 417 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a----~eil~HpfF 417 (552)
+||...+....+..+.. ....+|. .+++.+.+||.+||. +|.+||+ + +++++||||
T Consensus 220 ~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~---~~~~~~~ll~~~~~ 280 (280)
T cd05581 220 PPFRGSNEYLTFQKILK--LEYSFPP--NFPPDAKDLIEKLLVLDPQDRLG---VNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccHHHHHHHHHh--cCCCCCC--ccCHHHHHHHHHHhcCCHhhCCC---cccCHHHHhcCCCC
Confidence 99998887777766663 3444553 678999999999998 9999999 7 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=347.64 Aligned_cols=260 Identities=30% Similarity=0.468 Sum_probs=221.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|.+.+.||+|+||.||+|....+++.||+|+++..... ......+..|+.+++.++|++|+++++.+.+.+.+|+|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 488899999999999999999999999999999876432 4567889999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|+++++|.+++.....+++..+..++.+++.||.|||+.||+||||+|+||+++.++.+||+|||++...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~-- 157 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG-- 157 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccc--
Confidence 999999999998877899999999999999999999999999999999999999999999999999986543211000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC---CCCccchhhhhHHHHHHhhC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~---y~~~~DiWSlGvilyEmltG 353 (552)
.......|++.|+|||++.+.. ++.++|+|||||++|+|++|
T Consensus 158 -----------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g 202 (264)
T cd06626 158 -----------------------------------EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202 (264)
T ss_pred -----------------------------------ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhC
Confidence 0011356889999999998766 89999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
+.||.+.+........+.......+|....+++.+.+||.+||. +|.+||+ +.+|+.|||+
T Consensus 203 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 203 KRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred CCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 99997664333332222223445566655679999999999998 9999999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=380.68 Aligned_cols=253 Identities=24% Similarity=0.285 Sum_probs=205.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.++|||||++++++......|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2356799999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||++ +|+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence 9999 46888887653 57999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
......+||+.|+|||++.+..|+.++||||||||||||++|
T Consensus 317 --------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g 358 (461)
T PHA03211 317 --------------------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH 358 (461)
T ss_pred --------------------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHc
Confidence 001246799999999999999999999999999999999998
Q ss_pred CCCCCCCCh-------hhHHHHHhhcccc--ccCC--------------------------c---ccccChhHHHHHHHH
Q 008810 354 YPPFYSDDP-------MSTCRKIVNWRTH--LKFP--------------------------E---EAKLSIEAKDLISKL 395 (552)
Q Consensus 354 ~~PF~~~~~-------~~~~~~i~~~~~~--~~~p--------------------------~---~~~~s~e~~dLI~~l 395 (552)
..|+.+... .....+++..... ..+| . ...++.++.+||.+|
T Consensus 359 ~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 438 (461)
T PHA03211 359 TASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA 438 (461)
T ss_pred CCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHH
Confidence 877654321 1222233221110 0111 0 114567899999999
Q ss_pred hh-CccccCCCCChhhhhcCCCcCC
Q 008810 396 LC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 396 L~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|. ||.+||+ +.|||+||||+.
T Consensus 439 L~~DP~~RPs---a~elL~hp~f~~ 460 (461)
T PHA03211 439 LTFDGARRPS---AAELLRLPLFQS 460 (461)
T ss_pred cccChhhCcC---HHHHhhCcccCC
Confidence 99 9999999 999999999974
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=357.96 Aligned_cols=259 Identities=31% Similarity=0.477 Sum_probs=216.6
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
+|++++.||+|+||.||+|.++.+|+.||||++...... .......+..|+.+++.++|+||++++++|.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999999999999999876543 122345577899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||+ +|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-- 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR-- 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--
Confidence 9999 999999997766 899999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
......+++.|+|||++.+ ..++.++|+|||||++|||++
T Consensus 158 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 158 ---------------------------------------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred ---------------------------------------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc
Confidence 0012357889999999865 567999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhcccc------------------c---cCCc---ccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTH------------------L---KFPE---EAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~------------------~---~~p~---~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
|.+||.+.+....+.++...... . ..+. ...++.++.+||.+||. ||.+||+
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s--- 275 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT--- 275 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---
Confidence 99999888776666555431100 0 0000 02457889999999999 9999999
Q ss_pred hhhhhcCCCcCCC
Q 008810 408 ADEIKVHPWFDGV 420 (552)
Q Consensus 408 a~eil~HpfF~~i 420 (552)
+.||+.||||.+.
T Consensus 276 ~~e~l~~~~~~~~ 288 (298)
T cd07841 276 ARQALEHPYFSND 288 (298)
T ss_pred HHHHhhCccccCC
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=346.11 Aligned_cols=254 Identities=31% Similarity=0.549 Sum_probs=217.8
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
+|+..+.||+|+||+||+|..+.++..||+|++..... ........+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36777899999999999999998999999999876432 1233456788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++|++|.+++.+...+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---- 156 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc----
Confidence 9999999999999888889999999999999999999999999999999999999999999999999987653211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-CCCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEmltG 353 (552)
......|++.|+|||.+.... ++.++|+|||||++|+|++|
T Consensus 157 --------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g 198 (258)
T cd06632 157 --------------------------------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198 (258)
T ss_pred --------------------------------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 011356899999999998776 99999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.+||..........++........+| ..+++++++||.+||. +|.+||+ +.+++.|||+
T Consensus 199 ~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 199 KPPWSQLEGVAAVFKIGRSKELPPIP--DHLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred CCCcccCcHHHHHHHHHhcccCCCcC--CCcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 99998776555554544322223333 3688999999999998 9999999 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=352.78 Aligned_cols=258 Identities=29% Similarity=0.479 Sum_probs=209.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHH-HHhcCCCceEEEeeeecCCceEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
++|++++.||+|+||.||+|+++.+|+.||||++++... ...+. .+..|..+ ++..+|||||++++++.++..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999976532 12222 34445554 6677999999999999999999999
Q ss_pred EecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 195 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
|||++ |+|..++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 677776643 35799999999999999999999997 9999999999999999999999999998754211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc----CCCCCccchhhhhH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----KGYGMECDWWSLGA 345 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~----~~y~~~~DiWSlGv 345 (552)
. ......||..|+|||++.+ .+++.++|+|||||
T Consensus 158 ~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 195 (283)
T cd06617 158 V------------------------------------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195 (283)
T ss_pred c------------------------------------------ccccccCCccccChhhcCCcccccccCccccchhhHH
Confidence 0 0012468999999999865 56789999999999
Q ss_pred HHHHHhhCCCCCCCC-ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 346 IMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 346 ilyEmltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
++|+|++|..||... ...+.+..+... ....+|. ..+|.++.+||.+||. +|.+||+ +.+|+.||||....+.
T Consensus 196 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 270 (283)
T cd06617 196 TMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPA-EKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCCc-cccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccc
Confidence 999999999999753 233344444431 2233333 2588999999999998 9999999 9999999999876654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=366.56 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=211.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 188 (552)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 467999999999999999999999999999999987542 1233445677899999999999999999988744
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+||||+. |+|...+... +++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999995 5788877543 99999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. ......||+.|+|||++.+..++.++|||||||++|
T Consensus 171 ~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 208 (353)
T cd07850 171 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (353)
T ss_pred CC------------------------------------------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHH
Confidence 11 011356899999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhcccc----------------------------------ccCCc-----ccccChhHH
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH----------------------------------LKFPE-----EAKLSIEAK 389 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~----------------------------------~~~p~-----~~~~s~e~~ 389 (552)
+|++|+.||.+.+....+.+++..-.. ..+|. ....+.+++
T Consensus 209 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
T cd07850 209 EMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288 (353)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHH
Confidence 999999999988766655555421000 00110 012466789
Q ss_pred HHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 390 dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+||.+||+ ||.+||+ +.||+.||||+.
T Consensus 289 ~li~~~L~~dP~~R~t---~~eiL~~~~~~~ 316 (353)
T cd07850 289 DLLSKMLVIDPEKRIS---VDDALQHPYINV 316 (353)
T ss_pred HHHHHHcCCChhhCcC---HHHHhcChhHhh
Confidence 99999999 9999999 999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=381.10 Aligned_cols=242 Identities=38% Similarity=0.625 Sum_probs=210.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCceEEEeeeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lyl 193 (552)
.+.|++...||.|+||.|..|.++.+++.+|+|++.+..- ...+|..++.. -+||||+++++.|.+..+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 5678899999999999999999999999999999987621 23446655544 489999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc-cCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl-~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
|||++.||.|.+.+.....+. .++..++++|+.|+.|||.+|||||||||+|||+ +..||++|+|||.++.....
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--- 469 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence 999999999999987777666 8888999999999999999999999999999999 69999999999999865322
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
+.+-|-|..|.|||++...+|+.+|||||||++||+||+
T Consensus 470 -----------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~ 508 (612)
T KOG0603|consen 470 -----------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLT 508 (612)
T ss_pred -----------------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHh
Confidence 123477899999999999999999999999999999999
Q ss_pred CCCCCCCCChh-hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 353 GYPPFYSDDPM-STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 353 G~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|++||.+.... ++..+|.. .++. ..+|.+|+|||++||+ ||.+||+ +.+|+.||||
T Consensus 509 G~tp~~~~P~~~ei~~~i~~----~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~---~~~i~~h~w~ 566 (612)
T KOG0603|consen 509 GRTLFAAHPAGIEIHTRIQM----PKFS--ECVSDEAKDLLQQLLQVDPALRLG---ADEIGAHPWF 566 (612)
T ss_pred CCCccccCCchHHHHHhhcC----Cccc--cccCHHHHHHHHHhccCChhhCcC---hhhhccCcch
Confidence 99999876655 44444432 2333 4899999999999999 9999999 9999999999
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=344.96 Aligned_cols=253 Identities=28% Similarity=0.520 Sum_probs=220.0
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++++.||+|+||.||+++...+|+.||+|.+...... ......+.+|+.+++.++||||++++++|.+.+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999999765432 3345678899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++|++|..++... ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--- 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence 99999999998654 3589999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
......|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08218 157 --------------------------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198 (256)
T ss_pred --------------------------------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCC
Confidence 011346899999999999888999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.||...+..+....++... ....| ..++.++.+||.+||. +|.+||+ +.+|+.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 199 HAFEAGNMKNLVLKIIRGS-YPPVS--SHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred CCccCCCHHHHHHHHhcCC-CCCCc--ccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 9999888877777776532 22233 3688999999999998 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=350.51 Aligned_cols=253 Identities=17% Similarity=0.279 Sum_probs=211.5
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
+...+|++.+.||+|+||.||+|..+ ..+..||+|+++... .......+.+|..+|..++|||||++++++.+.+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 45678999999999999999999875 356789999997642 2334567889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999764 5799999999999999999999999999999999999999999999999998764321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.... ......+++.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 199 (266)
T cd05064 160 EAIY----------------------------------------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMW 199 (266)
T ss_pred cchh----------------------------------------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHH
Confidence 1000 001234577899999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||++ |.+||.+.+..+....+... ...|....++..+.++|.+||. +|.+||+ +++|+.
T Consensus 200 ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~RP~---~~~i~~ 260 (266)
T cd05064 200 EVMSYGERPYWDMSGQDVIKAVEDG---FRLPAPRNCPNLLHQLMLDCWQKERGERPR---FSQIHS 260 (266)
T ss_pred HHhcCCCCCcCcCCHHHHHHHHHCC---CCCCCCCCCCHHHHHHHHHHcCCCchhCCC---HHHHHH
Confidence 9775 99999988877776666542 2223334688999999999999 9999999 777754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=386.96 Aligned_cols=305 Identities=36% Similarity=0.621 Sum_probs=262.7
Q ss_pred eeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEEEecC
Q 008810 123 MIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYL 198 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~---k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmEy~ 198 (552)
++|.|+||.|++|+. .+.|+.||||++++.....+... +.+.|+.++..++ ||++|++++.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999999875 45688999999998876655555 8899999999997 999999999999999999999999
Q ss_pred CCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccc
Q 008810 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (552)
Q Consensus 199 ~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~ 278 (552)
.||+|...+.....+++...++|.+++++|++++|+.||||||+|++||+++.+||+++.|||+++..-...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------- 151 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh--------
Confidence 999999999999999999999999999999999999999999999999999999999999999998653210
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCC
Q 008810 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (552)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~ 358 (552)
..|||..|||||++. ++...+||||||+++|||++|..||.
T Consensus 152 -------------------------------------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 152 -------------------------------------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred -------------------------------------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 139999999999998 88999999999999999999999998
Q ss_pred CCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhh--hcCCCCc
Q 008810 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFI 433 (552)
Q Consensus 359 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~--~~~~pf~ 433 (552)
+ ++...|.. ..+.+|. .++.++++++..|+. +|..|+++ .++.||++|+||..|+|+.+. ...|||+
T Consensus 193 ~----~~~~~Il~--~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fk 264 (612)
T KOG0603|consen 193 G----DTMKRILK--AELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFK 264 (612)
T ss_pred h----HHHHHHhh--hccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCC
Confidence 8 66777775 4566665 799999999999998 99999997 489999999999999999887 4789999
Q ss_pred cccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCcccccC
Q 008810 434 PEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVND 488 (552)
Q Consensus 434 P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~ 488 (552)
|.+..+.|+.+|+.+.....+...+...+ ..+...-|.||+|..+.++.+
T Consensus 265 p~~~~e~~~~~fd~eft~~~P~dsp~~~~-----~~s~~~if~g~sfva~~il~~ 314 (612)
T KOG0603|consen 265 PGSITERDVAQFDPEFTSQVPADSPLLSA-----SGSDHTIFSGPSFVAPGVLED 314 (612)
T ss_pred CcccchhhhhhcCchhccCCcccCCCCCC-----CccccchhcCCCccChHHhhc
Confidence 99999999999998443332222111111 122336899999998877655
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=357.17 Aligned_cols=256 Identities=29% Similarity=0.508 Sum_probs=220.9
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
-|.++..||+|+||.||+|.++.+|+++|||.+.-. .....+..|+.||.++++|+||+.|++|.....+++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 377888999999999999999999999999987643 345678899999999999999999999999999999999
Q ss_pred cCCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 197 YLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 197 y~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||..|+..+.+. ++.+|+|+++..++...+.||+|||...-||||||..||||+.+||.||+|||.|-.+...
T Consensus 109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT------ 182 (502)
T KOG0574|consen 109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT------ 182 (502)
T ss_pred hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh------
Confidence 999999999985 4678999999999999999999999999999999999999999999999999998754311
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.. ..+++.|||-||||||+..-+|+..+||||||+...||..|+|
T Consensus 183 -------------------------------MA----KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~P 227 (502)
T KOG0574|consen 183 -------------------------------MA----KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRP 227 (502)
T ss_pred -------------------------------HH----hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCC
Confidence 11 1236899999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
||..-.++..+-.|-. ..+..|-.....|.+..|||++||. +|++|-+ |.++++|||.++-.-
T Consensus 228 PYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 228 PYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNAPG 291 (502)
T ss_pred CcccccccceeEeccC-CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCCCc
Confidence 9987777654333322 1222333334689999999999998 9999998 999999999987543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=353.01 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=216.2
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++.+.||.|+||.||+|.++.+|..||+|++..... .......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999986542 23345678899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 197 y~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|+ |++|..++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.+|.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---- 154 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC----
Confidence 99 9999999864 46799999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~ 354 (552)
.......||..|+|||++.+. .++.++|||||||++|||++|.
T Consensus 155 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (286)
T cd07832 155 ------------------------------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198 (286)
T ss_pred ------------------------------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence 001135789999999998754 4699999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccc-----------------cccCCcc---------cccChhHHHHHHHHhh-CccccCCCCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRT-----------------HLKFPEE---------AKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~---------~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
+||.+.+....+..++..-. .+.++.. ..++.++++||.+||. +|.+||+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--- 275 (286)
T cd07832 199 PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS--- 275 (286)
T ss_pred cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---
Confidence 99988877666665543111 1111110 2457899999999999 9999999
Q ss_pred hhhhhcCCCcC
Q 008810 408 ADEIKVHPWFD 418 (552)
Q Consensus 408 a~eil~HpfF~ 418 (552)
+++++.||||.
T Consensus 276 ~~~~l~h~~~~ 286 (286)
T cd07832 276 AAEALRHPYFT 286 (286)
T ss_pred HHHHhhCcCcC
Confidence 99999999993
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=355.52 Aligned_cols=256 Identities=17% Similarity=0.318 Sum_probs=206.3
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcC----------------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKT----------------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~----------------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp 176 (552)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|..++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence 345789999999999999999998532 34579999987542 233456688999999999999
Q ss_pred ceEEEeeeecCCceEEEEEecCCCCchhhHHhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 008810 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-------------------DTLTEDEARFYVAETVLAIESIHKHHY 237 (552)
Q Consensus 177 ~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~-------------------~~l~e~~~~~~~~qi~~aL~~LH~~gi 237 (552)
|||+++++|.+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999999999999999999999999998543 236778899999999999999999999
Q ss_pred cccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccc
Q 008810 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST 317 (552)
Q Consensus 238 iHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~ 317 (552)
+||||||+|||++.+|.+||+|||+++.+....... .....
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~---------------------------------------~~~~~ 200 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR---------------------------------------IQGRA 200 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeE---------------------------------------ecCcC
Confidence 999999999999999999999999998653221000 01124
Q ss_pred ccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh--CCCCCCCCChhhHHHHHhhcc----ccccCCcccccChhHHHH
Q 008810 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKIVNWR----THLKFPEEAKLSIEAKDL 391 (552)
Q Consensus 318 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt--G~~PF~~~~~~~~~~~i~~~~----~~~~~p~~~~~s~e~~dL 391 (552)
.+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ..........++..+.+|
T Consensus 201 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (304)
T cd05096 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYEL 280 (304)
T ss_pred CCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHH
Confidence 56889999999999899999999999999999986 678898877666555443210 111111123678899999
Q ss_pred HHHHhh-CccccCCCCChhhhh
Q 008810 392 ISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 392 I~~lL~-dp~~Rl~~~~a~eil 412 (552)
|.+||. ||.+||+ +.+|.
T Consensus 281 i~~cl~~~p~~RPs---~~~i~ 299 (304)
T cd05096 281 MLQCWSRDCRERPS---FSDIH 299 (304)
T ss_pred HHHHccCCchhCcC---HHHHH
Confidence 999999 9999999 77773
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=353.45 Aligned_cols=255 Identities=22% Similarity=0.388 Sum_probs=215.4
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCC-----cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTG-----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+..++|++++.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.+|..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 44578999999999999999999986655 689999987543 23334568899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK 251 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~ 251 (552)
....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45888999999999999999999999999999999999999
Q ss_pred CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc
Q 008810 252 YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (552)
Q Consensus 252 ~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~ 331 (552)
++.+||+|||+++........ .......+|+.|+|||++.+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYY---------------------------------------RVQSKSLLPVRWMPPEAILY 200 (283)
T ss_pred CCcEEECCCcceeeccccccc---------------------------------------cccCCCcccccccCHHHhcc
Confidence 999999999999865322100 00113467899999999999
Q ss_pred CCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChh
Q 008810 332 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (552)
Q Consensus 332 ~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ 409 (552)
..++.++|||||||++|||++ |..||.+.+..+....|... .....| ..+++++.+||.+||. ||.+||+ +.
T Consensus 201 ~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~l~~~c~~~~p~~Rp~---~~ 274 (283)
T cd05048 201 GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSR-QLLPCP--EDCPARVYALMIECWNEIPARRPR---FK 274 (283)
T ss_pred CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCc--ccCCHHHHHHHHHHccCChhhCcC---HH
Confidence 999999999999999999998 99999998888877776642 222333 3789999999999999 9999999 88
Q ss_pred hhhcC
Q 008810 410 EIKVH 414 (552)
Q Consensus 410 eil~H 414 (552)
+|++|
T Consensus 275 ~i~~~ 279 (283)
T cd05048 275 DIHTR 279 (283)
T ss_pred HHHHH
Confidence 88764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=370.61 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=208.7
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 185 (552)
.+..++|++.+.||+|+||.||+|.. ..++..||+|+++.... ....+.+.+|+.+|..+ +|||||+++++|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 44566899999999999999999974 34677999999975432 23446788999999999 899999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhcC------------------------------------------------------
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRKD------------------------------------------------------ 211 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~~------------------------------------------------------ 211 (552)
.+....|+|||||+||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986422
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 212 ---------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 212 ---------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47888899999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.. .......+++.|+|||++.+..|+.++|||||||++|||
T Consensus 269 ~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~el 309 (375)
T cd05104 269 NY---------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309 (375)
T ss_pred cc---------------------------------------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHH
Confidence 00 000123456789999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++ |.+||.+........+++........| ...+.++++||.+||. ||.+||+ +.+|++
T Consensus 310 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 369 (375)
T cd05104 310 FSLGSSPYPGMPVDSKFYKMIKEGYRMLSP--ECAPSEMYDIMKSCWDADPLKRPT---FKQIVQ 369 (375)
T ss_pred HhcCCCCCCCCCchHHHHHHHHhCccCCCC--CCCCHHHHHHHHHHccCChhHCcC---HHHHHH
Confidence 97 999998766554444444322222233 3568899999999999 9999999 777765
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=347.85 Aligned_cols=255 Identities=32% Similarity=0.510 Sum_probs=214.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCC----
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD---- 188 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~---- 188 (552)
..++|++.+.||.|+||.||+|.++.+++.||+|++..... ....+.+|+.++..+ +||||++++++|.+.
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 35789999999999999999999999999999999876532 345688999999998 799999999999654
Q ss_pred --ceEEEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 189 --EFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 189 --~~lylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
..+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++++||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 458999999999999998865 35799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCCCCc
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGME 337 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y~~~ 337 (552)
+........ ......||+.|+|||++.. ..++.+
T Consensus 160 ~~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 198 (275)
T cd06608 160 SAQLDSTLG-----------------------------------------RRNTFIGTPYWMAPEVIACDEQPDASYDAR 198 (275)
T ss_pred ceecccchh-----------------------------------------hhcCccccccccCHhHhcccccccCCcccc
Confidence 875432110 0113568999999999864 357889
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 338 ~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
+|+|||||+||+|++|++||...........+.... ....+....++.++++||.+||. ||.+||+ +.+|+.|||
T Consensus 199 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~ 274 (275)
T cd06608 199 SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPF 274 (275)
T ss_pred ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCC
Confidence 999999999999999999998776666665555421 22222223578899999999998 9999999 999999999
Q ss_pred c
Q 008810 417 F 417 (552)
Q Consensus 417 F 417 (552)
+
T Consensus 275 ~ 275 (275)
T cd06608 275 I 275 (275)
T ss_pred C
Confidence 6
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=344.46 Aligned_cols=248 Identities=31% Similarity=0.537 Sum_probs=214.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++.+.||.|+||.||+|+++.+++.||+|.++.... ....+.+..|..+++.++||||++++++|.+...+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999875432 3345678889999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++||+|..++.. ...+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 9999999998864 34689999999999999999999999999999999999999999999999999875532110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
......|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 156 --------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~ 197 (255)
T cd08219 156 --------------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197 (255)
T ss_pred --------------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhcc
Confidence 011357899999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+||.+.+.......+.... ...+| ..++..+++||.+||. ||.+||+ +.+|+.
T Consensus 198 ~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~ 251 (255)
T cd08219 198 HPFQANSWKNLILKVCQGS-YKPLP--SHYSYELRSLIKQMFKRNPRSRPS---ATTILS 251 (255)
T ss_pred CCCCCCCHHHHHHHHhcCC-CCCCC--cccCHHHHHHHHHHHhCCcccCCC---HHHHhh
Confidence 9999888777766665421 22233 3688999999999999 9999999 888875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.21 Aligned_cols=257 Identities=33% Similarity=0.508 Sum_probs=210.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCce----
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEF---- 190 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~---- 190 (552)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999987542 22333456788999999995 6999999999987665
Q ss_pred -EEEEEecCCCCchhhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-CCcEEEcccccc
Q 008810 191 -LYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLC 263 (552)
Q Consensus 191 -lylVmEy~~gG~L~~~L~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-~g~iKL~DFGla 263 (552)
+|+||||+++ +|..++... ..+++..++.++.||+.||.|||..||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999985 788887542 35899999999999999999999999999999999999998 899999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 342 (552)
+.+..... ......+++.|+|||++.+ ..++.++||||
T Consensus 159 ~~~~~~~~-----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 197 (295)
T cd07837 159 RAFSIPVK-----------------------------------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197 (295)
T ss_pred eecCCCcc-----------------------------------------ccCCcccccCCCChHHhhCCCCCCchHHHHH
Confidence 75532100 0112367899999999875 56899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHHHHhhcccc---c------------cCCc---------ccccChhHHHHHHHHhh-
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH---L------------KFPE---------EAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~---~------------~~p~---------~~~~s~e~~dLI~~lL~- 397 (552)
|||++|+|++|.+||.+.+....+.++...... . .+|. ...+++++.+||.+||.
T Consensus 198 lG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 277 (295)
T cd07837 198 VGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY 277 (295)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccC
Confidence 999999999999999988877766655432100 0 0110 02578999999999999
Q ss_pred CccccCCCCChhhhhcCCCcC
Q 008810 398 NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~HpfF~ 418 (552)
||.+||+ +.||+.||||+
T Consensus 278 ~P~~R~~---~~eil~~~~~~ 295 (295)
T cd07837 278 DPAKRIS---AKAALTHPYFD 295 (295)
T ss_pred ChhhcCC---HHHHhcCCCcC
Confidence 9999999 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.76 Aligned_cols=252 Identities=29% Similarity=0.554 Sum_probs=218.7
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++++.||+|+||.||+|....+++.||+|.+....+ .......+.+|+.+|+.++||||+++++.+.....+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999986543 33456778999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEcccccccccCCCCccc
Q 008810 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 197 y~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~~~~~~~~ 273 (552)
|++|++|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999763 4589999999999999999999999999999999999998654 579999999986532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
....+|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~ 197 (256)
T cd08220 158 ----------------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL 197 (256)
T ss_pred ----------------------------------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence 1135689999999999988899999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
..||.+.+.......+... ....+|. .+++++++||.+||. +|.+||+ +.||++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 198 KRAFEAANLPALVLKIMSG-TFAPISD--RYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred CCCcccCchHHHHHHHHhc-CCCCCCC--CcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 9999988877776666542 2223343 689999999999998 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=351.86 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=207.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++.+.||.|+||.||+|..+.+++.||||.+..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875431 22233467899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||+++ +|.+++.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 999975 899888654 5789999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
.....++++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 159 ---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 159 ---------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred ---------------------------------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 0012357889999999876 568999999999999999999
Q ss_pred CCCCCCCCC-hhhHHHHHhhccc-----------------cccC----Cc-----ccccC--hhHHHHHHHHhh-Ccccc
Q 008810 353 GYPPFYSDD-PMSTCRKIVNWRT-----------------HLKF----PE-----EAKLS--IEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 353 G~~PF~~~~-~~~~~~~i~~~~~-----------------~~~~----p~-----~~~~s--~e~~dLI~~lL~-dp~~R 402 (552)
|++||.+.. ..+....+..... ...+ +. ...++ .++.+||.+||+ +|.+|
T Consensus 200 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 279 (291)
T cd07844 200 GRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKR 279 (291)
T ss_pred CCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccc
Confidence 999997665 2222222211000 0000 00 01344 889999999999 99999
Q ss_pred CCCCChhhhhcCCCc
Q 008810 403 LGAKGADEIKVHPWF 417 (552)
Q Consensus 403 l~~~~a~eil~HpfF 417 (552)
|+ +.+++.||||
T Consensus 280 ps---~~e~l~~~~f 291 (291)
T cd07844 280 IS---AAEAMKHPYF 291 (291)
T ss_pred cC---HHHHhcCCCC
Confidence 99 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=345.19 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=221.9
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||.|+||.||+|.++.+|+.||+|++...... .....+.+|+.++..++||||++++++|.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4799999999999999999999999999999999765421 44567889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.+|.++|+|||++..+......
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 999999999999888899999999999999999999999 99999999999999999999999999998865322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....|+..|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 157 ---------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~ 197 (264)
T cd06623 157 ---------------------------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197 (264)
T ss_pred ---------------------------------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 11356899999999999999999999999999999999999
Q ss_pred CCCCCCC---hhhHHHHHhhccccccCCcccc-cChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 355 PPFYSDD---PMSTCRKIVNWRTHLKFPEEAK-LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 355 ~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~-~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
+||...+ ..+....+.. ......+ .. ++..+.+||.+||. +|.+||+ +.+++.||||+.++
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 198 FPFLPPGQPSFFELMQAICD-GPPPSLP--AEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred CCCccccccCHHHHHHHHhc-CCCCCCC--cccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 9998774 3344444442 1222233 24 78999999999998 9999999 99999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=353.52 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=211.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++++.||.|+||.||+|+++.+|+.||||++.... ........+.+|+++++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999987543 222334568889999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|++ ++|..++.. ...+++..+..++.+++.||.|||..|++||||+|+||+++.+|.+||+|||++..+.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 996 688888754 45789999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-CCCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEmltG 353 (552)
......+++.|+|||++.+.. ++.++|+|||||++|||++|
T Consensus 156 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 156 --------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred --------------------------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 011245789999999987644 68899999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccc----------------cCCc---------ccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHL----------------KFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~----------------~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
..||.+.+......++....... .++. ...+++++++||.+||+ ||.+||+
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt--- 274 (284)
T cd07860 198 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS--- 274 (284)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---
Confidence 99999887665555444321100 1110 12478899999999999 9999999
Q ss_pred hhhhhcCCCc
Q 008810 408 ADEIKVHPWF 417 (552)
Q Consensus 408 a~eil~HpfF 417 (552)
+++++.||||
T Consensus 275 ~~~~l~~~~f 284 (284)
T cd07860 275 AKAALAHPFF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=354.77 Aligned_cols=263 Identities=25% Similarity=0.414 Sum_probs=212.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lyl 193 (552)
.++|+.++.||+|+||.||++.+..+|+.||||++.+.... .....+..|+.++.++. |||||++++++.++...|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 45677788999999999999999999999999999765322 34456888999999985 9999999999999999999
Q ss_pred EEecCCCCchhhHH---h--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 194 IMEYLPGGDMMTLL---M--RKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 194 VmEy~~gG~L~~~L---~--~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
||||+.+ ++..+. . ....+++..+..++.+++.||.|||+ .||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999864 444432 2 24679999999999999999999997 599999999999999999999999999997543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC---CCCCccchhhhh
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLG 344 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~---~y~~~~DiWSlG 344 (552)
.... .....||+.|+|||++.+. .++.++||||||
T Consensus 160 ~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG 197 (288)
T cd06616 160 DSIA------------------------------------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG 197 (288)
T ss_pred cCCc------------------------------------------cccccCccCccCHHHhccccccCCcchhhhhHHH
Confidence 2110 1134689999999999876 689999999999
Q ss_pred HHHHHHhhCCCCCCCCCh-hhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 345 AIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|++|||++|.+||..... .+...++... ....++. ...++.++.+||.+||. ||.+||+ +++|+.||||+..
T Consensus 198 ~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~ 273 (288)
T cd06616 198 ITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDY 273 (288)
T ss_pred HHHHHHHhCCCCchhcchHHHHHhhhcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhch
Confidence 999999999999976542 1222233221 1111221 23588999999999999 9999999 9999999999988
Q ss_pred Chhhhh
Q 008810 421 DWARIY 426 (552)
Q Consensus 421 ~w~~l~ 426 (552)
.|.+.+
T Consensus 274 ~~~~~~ 279 (288)
T cd06616 274 EERNVD 279 (288)
T ss_pred hhcchh
Confidence 776654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=352.77 Aligned_cols=260 Identities=30% Similarity=0.474 Sum_probs=213.7
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999876532 2234456788999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-CCcEEEcccccccccCCCCcc
Q 008810 196 EYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-~g~iKL~DFGlak~~~~~~~~ 272 (552)
||++ ++|..++.... .+++..+..++.||+.||.|||++||+||||+|+||+++. ++.+||+|||++........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 9995 57887775543 3588899999999999999999999999999999999985 56799999999975432100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml 351 (552)
.....+|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 159 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~ 198 (294)
T PLN00009 159 ----------------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198 (294)
T ss_pred ----------------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 0113468899999999876 45899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccc-------------------cCCc------ccccChhHHHHHHHHhh-CccccCCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHL-------------------KFPE------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~-------------------~~p~------~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
+|.+||.+.+..+...++....... .++. ...+++++++||.+||. +|.+||+
T Consensus 199 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps- 277 (294)
T PLN00009 199 NQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT- 277 (294)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC-
Confidence 9999999887776666654321100 0000 12578899999999999 9999999
Q ss_pred CChhhhhcCCCcCCCC
Q 008810 406 KGADEIKVHPWFDGVD 421 (552)
Q Consensus 406 ~~a~eil~HpfF~~i~ 421 (552)
+.+++.||||.+++
T Consensus 278 --~~~~l~~~~~~~~~ 291 (294)
T PLN00009 278 --ARAALEHEYFKDLG 291 (294)
T ss_pred --HHHHhcCchHhHHh
Confidence 99999999998764
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.14 Aligned_cols=258 Identities=35% Similarity=0.558 Sum_probs=216.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||+|+||.||+|.++.+++.||+|+++.... .......+.+|+.+++.++|+||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 469999999999999999999999999999999876432 2334467889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++++.+..++.+...+++..+..++.+|+.||.|||..|++||||+|+||+++.+|.+||+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---- 155 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---- 155 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc----
Confidence 9999988877777777899999999999999999999999999999999999999999999999999886543210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~ 354 (552)
......+|++.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus 156 ------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 199 (288)
T cd07833 156 ------------------------------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199 (288)
T ss_pred ------------------------------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 001235789999999999987 8999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhcccc-----------------ccCCc-----------ccccChhHHHHHHHHhh-CccccCCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTH-----------------LKFPE-----------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~-----------~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
+||.+.+..+....+...... ..++. ...++.++++||.+||. +|.+||+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps- 278 (288)
T cd07833 200 PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT- 278 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc-
Confidence 999877655544333221000 01110 01358899999999998 9999999
Q ss_pred CChhhhhcCCCc
Q 008810 406 KGADEIKVHPWF 417 (552)
Q Consensus 406 ~~a~eil~HpfF 417 (552)
+++|+.||||
T Consensus 279 --~~~il~~~~f 288 (288)
T cd07833 279 --CDELLQHPYF 288 (288)
T ss_pred --HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=350.46 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=217.1
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||.|+||.||+|.++.+++.+|+|++..... ......+.+|+++++.++||||+++++.|.+...+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468889999999999999999999999999999976532 234556888999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||++|++|.+++... ..+++..+..++.+++.||.|||+ .|++||||||+||+++.+|.++|+|||++..+....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999775 789999999999999999999999 999999999999999999999999999987542110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
.....|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 156 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 156 ----------------------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred ----------------------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 0125789999999999999999999999999999999999
Q ss_pred CCCCCCCC-----hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 354 YPPFYSDD-----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 354 ~~PF~~~~-----~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
..||...+ ..+....+... .....|.. .++.++++||.+||. ||.+||+ +.+++.||||+.
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~ 262 (265)
T cd06605 196 RFPYPPENDPPDGIFELLQYIVNE-PPPRLPSG-KFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKK 262 (265)
T ss_pred CCCCCccccccccHHHHHHHHhcC-CCCCCChh-hcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhc
Confidence 99997652 23333444432 22233332 288999999999998 9999999 999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=354.91 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=215.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
...|++++.||+|+||.||+|....+|+.||||++.............+.+|+.+++.++||||++++++|.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35589999999999999999999999999999999765444445556788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||++| +|.+++. ....+++..+..++.|++.||.|||+.||+||||+|+||+++.+|.+||+|||++......
T Consensus 94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 999974 6666654 3567999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhhhHHHHHH
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEm 350 (552)
....|++.|+|||++. ...++.++|||||||++|||
T Consensus 169 -----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 169 -----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred -----------------------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 1346889999999985 35688999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
++|.+||.+.+.......+... ....++. ..++.++++||.+||. +|.+||+ +.+|+.||||..
T Consensus 208 ~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 272 (307)
T cd06607 208 AERKPPLFNMNAMSALYHIAQN-DSPTLSS-NDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLR 272 (307)
T ss_pred HcCCCCCCCccHHHHHHHHhcC-CCCCCCc-hhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcc
Confidence 9999999988776665555432 1222221 2578899999999999 9999999 999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=367.41 Aligned_cols=264 Identities=29% Similarity=0.494 Sum_probs=214.7
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCC
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD 188 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~ 188 (552)
..++....|++++.||+||.++||+|..-+ ...||+|++.-. ..+..-+.-+++|+.+|.++ .|.+||+||++-..+
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 345777889999999999999999998544 346677665432 23344567799999999999 689999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCC-CHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTL-TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l-~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
+++||||||- ..||..+|.++... +...+++|..||++|+.++|.+||||-||||.|+|+-. |.+||+|||+|+.+.
T Consensus 433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9999999975 67999999876543 43689999999999999999999999999999999976 999999999999876
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-----------CCC
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-----------YGM 336 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-----------y~~ 336 (552)
.++.. ....+.|||+.||+||.+.... .+.
T Consensus 511 ~DTTs---------------------------------------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r 551 (677)
T KOG0596|consen 511 PDTTS---------------------------------------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISR 551 (677)
T ss_pred ccccc---------------------------------------eeeccccCcccccCHHHHhhccccccCCCcceeecC
Confidence 55322 1234789999999999997433 468
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCC-hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 337 ECDWWSLGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 337 ~~DiWSlGvilyEmltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
++||||||||||+|+.|++||..-. ...-+..|..-...+.||..+. ..++.++++.||. ||.+|++ +.++|+|
T Consensus 552 ~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~s---i~eLLqh 627 (677)
T KOG0596|consen 552 KSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWS---IPELLQH 627 (677)
T ss_pred ccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCC---cHHHhcC
Confidence 8999999999999999999997643 3444555665445567775321 2349999999999 9999999 9999999
Q ss_pred CCcCCC
Q 008810 415 PWFDGV 420 (552)
Q Consensus 415 pfF~~i 420 (552)
||...+
T Consensus 628 pFl~~~ 633 (677)
T KOG0596|consen 628 PFLQIQ 633 (677)
T ss_pred cccccc
Confidence 999753
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=357.10 Aligned_cols=255 Identities=30% Similarity=0.543 Sum_probs=216.6
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|.....||.|+||.||++.+..++..||||++.... ....+.+.+|+.++..++||||+++++.|.+.+..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3455677999999999999999999999999986543 2344568899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|++|++|..++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~----- 173 (292)
T cd06658 100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----- 173 (292)
T ss_pred CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-----
Confidence 999999999874 45799999999999999999999999999999999999999999999999999875421100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
.....+||+.|+|||++.+..++.++|+|||||++|||++|+.|
T Consensus 174 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p 217 (292)
T cd06658 174 ------------------------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217 (292)
T ss_pred ------------------------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 01135789999999999988999999999999999999999999
Q ss_pred CCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|.+.+.......+... ....++....++..+.+||.+||+ ||.+||+ +++|+.||||+..
T Consensus 218 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~ 278 (292)
T cd06658 218 YFNEPPLQAMRRIRDN-LPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLA 278 (292)
T ss_pred CCCCCHHHHHHHHHhc-CCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhcc
Confidence 9988776665554432 122223334678899999999999 9999999 9999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=354.56 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=209.5
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~--~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
+..++|++.+.||+|+||.||+|.++.+|.. +|+|.++.. ........+.+|+.++.++ +||||++++++|.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4567899999999999999999999888765 466666532 2334556788899999999 8999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g 253 (552)
.+|+||||++||+|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999996542 578999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC
Q 008810 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (552)
Q Consensus 254 ~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~ 333 (552)
.+||+|||+++...... ......++..|+|||++.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 162 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred cEEeCccccCcccchhh------------------------------------------hcccCCCcccccCHHHHhccC
Confidence 99999999986321000 000123467899999998888
Q ss_pred CCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 334 y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
++.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. +|.+||+ ++++
T Consensus 200 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~i 273 (303)
T cd05088 200 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERPS---FAQI 273 (303)
T ss_pred CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHH
Confidence 9999999999999999998 99999988777766655431 122233 3578899999999999 9999999 8888
Q ss_pred hcC
Q 008810 412 KVH 414 (552)
Q Consensus 412 l~H 414 (552)
+.+
T Consensus 274 l~~ 276 (303)
T cd05088 274 LVS 276 (303)
T ss_pred HHH
Confidence 876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=342.37 Aligned_cols=253 Identities=32% Similarity=0.588 Sum_probs=217.0
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec--CCceEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFLYLI 194 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~lylV 194 (552)
+|++++.||.|+||.||+|.+..+|..||+|++..... .....+.+..|+.+++.++||||+++++.+. ....+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999976543 3444567889999999999999999998775 34578999
Q ss_pred EecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIH-----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 195 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH-----~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
|||+++|+|.+++.. ...+++..+..++.+|+.||.||| +.+|+||||||+||+++.+|++||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 367999999999999999999999 88999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
...... ......|++.|+|||++.+..++.++|+|||||
T Consensus 160 ~~~~~~-----------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~ 198 (265)
T cd08217 160 LGHDSS-----------------------------------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198 (265)
T ss_pred ccCCcc-----------------------------------------cccccccCCCccChhhhcCCCCCchhHHHHHHH
Confidence 542210 011356899999999999888999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
++|+|++|..||...+.......+... ....+| ..++.++.+||.+||. +|.+||+ +.+|+.|||+
T Consensus 199 il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 199 LIYELCALSPPFTARNQLQLASKIKEG-KFRRIP--YRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred HHHHHHHCCCcccCcCHHHHHHHHhcC-CCCCCc--cccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 999999999999988766665555542 222333 3678999999999998 9999999 9999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=348.54 Aligned_cols=251 Identities=30% Similarity=0.509 Sum_probs=205.8
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCC--ceEEEE
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD--EFLYLI 194 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~--~~lylV 194 (552)
|++++.||+|+||.||+|.++.+++.||+|++++... ...+ .....|..++..+ +||||++++++|.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999876431 1222 2345688888888 499999999999988 899999
Q ss_pred EecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||++| +|.+.+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++. |.+||+|||+++.+.....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 999974 77777765 467999999999999999999999999999999999999999 9999999999986532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
.....||+.|+|||++.. ..++.++|||||||++|||++
T Consensus 155 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 155 ----------------------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred ----------------------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 012468899999998765 457899999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhcc----------------ccccCCc---------ccccChhHHHHHHHHhh-CccccCCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWR----------------THLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~----------------~~~~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
|.+||.+.+..+....+.... ....+|. ...++.++++||.+||. +|.+||+
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~-- 272 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT-- 272 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC--
Confidence 999999887766655554211 1112221 12468999999999999 9999999
Q ss_pred ChhhhhcCCCc
Q 008810 407 GADEIKVHPWF 417 (552)
Q Consensus 407 ~a~eil~HpfF 417 (552)
+++|+.||||
T Consensus 273 -~~~~l~~~~~ 282 (282)
T cd07831 273 -AKQALRHPYF 282 (282)
T ss_pred -HHHHhhCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=360.74 Aligned_cols=256 Identities=31% Similarity=0.500 Sum_probs=213.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
.++|++++.||+|+||.||+|.+..+|..||||++.+.. ........+.+|+.+|+.++||||++++++|.+..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 567999999999999999999999999999999986542 22233456789999999999999999999998654
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|+||||+ |++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 458999999 788988775 46799999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
. .....|++.|+|||++.+ ..++.++|+|||||++
T Consensus 171 ~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll 206 (343)
T cd07880 171 E--------------------------------------------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206 (343)
T ss_pred C--------------------------------------------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 1 013467999999999986 4589999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccc------------------cCCc---------ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL------------------KFPE---------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~------------------~~p~---------~~~~s~e~~dLI~~lL~-dp 399 (552)
|+|++|.+||.+.+....+.+++...... ..|. ...+++++.+||.+||+ ||
T Consensus 207 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 286 (343)
T cd07880 207 AEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDA 286 (343)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCCh
Confidence 99999999999887666655554321110 0000 12578899999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCC
Q 008810 400 NQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+||+ +.+++.||||+..
T Consensus 287 ~~R~t---~~~~l~~~~~~~~ 304 (343)
T cd07880 287 ESRIT---AAEALAHPYFEEF 304 (343)
T ss_pred hhCCC---HHHHhcCccHhhh
Confidence 99999 9999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=376.05 Aligned_cols=249 Identities=32% Similarity=0.565 Sum_probs=219.8
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCc
Q 008810 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD 202 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~ 202 (552)
+||+|+||+||.|+++.|....|||-+.... ...+.-+..|+.+.+.+.|.|||+..+++..+.++-|.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 7999999999999999999999999986432 4455668899999999999999999999999999999999999999
Q ss_pred hhhHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc-CCCcEEEcccccccccCCCCcccccccc
Q 008810 203 MMTLLMRK-DTL--TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (552)
Q Consensus 203 L~~~L~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~-~~g~iKL~DFGlak~~~~~~~~~~~~~~ 278 (552)
|..+|..+ +++ .|...-||..||+.||.|||.+.|||||||-+|||++ -.|.+||+|||-||.+..-+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP------- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP------- 731 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-------
Confidence 99999765 778 8899999999999999999999999999999999997 579999999999998743221
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhHHHHHHhhCCCC
Q 008810 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
.+.++.||..|||||++.. .||+.++|||||||.+.||.||+||
T Consensus 732 ----------------------------------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP 777 (1226)
T KOG4279|consen 732 ----------------------------------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP 777 (1226)
T ss_pred ----------------------------------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence 1236789999999999985 5799999999999999999999999
Q ss_pred CCCC-ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 357 FYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 357 F~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|... +++...-++--.+.+.++|+ .+|.+|+.||.+|.. ||..||+ |.+++..||++.-
T Consensus 778 F~ElgspqAAMFkVGmyKvHP~iPe--elsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 778 FVELGSPQAAMFKVGMYKVHPPIPE--ELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHN 838 (1226)
T ss_pred eeecCChhHhhhhhcceecCCCCcH--HHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccC
Confidence 9864 45555566666667778886 799999999999999 9999999 9999999999754
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=349.36 Aligned_cols=257 Identities=31% Similarity=0.473 Sum_probs=219.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
..|+.++.||.|+||.||+|.++.++..||+|++..... ......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 357788899999999999999999999999999876532 334567889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|.+++. .+.+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---- 156 (277)
T cd06640 82 EYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI---- 156 (277)
T ss_pred ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc----
Confidence 9999999999885 46799999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
......|+..|+|||++.+..++.++|+|||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~ 199 (277)
T cd06640 157 -------------------------------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred -------------------------------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCC
Confidence 0113468899999999998889999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
||...++......+... ....++ ..++..+.+||.+||. +|.+||+ +.+|+.||||.....
T Consensus 200 p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06640 200 PNSDMHPMRVLFLIPKN-NPPTLT--GEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKNAK 261 (277)
T ss_pred CCCCcChHhHhhhhhcC-CCCCCc--hhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhcch
Confidence 99887776655544321 122222 2578899999999998 9999999 999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=348.22 Aligned_cols=254 Identities=30% Similarity=0.507 Sum_probs=212.4
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++++.||.|+||.||+|+++.+|..||||+++.... ......+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2334557789999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 197 YLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 197 y~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|++| +|..++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-- 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--
Confidence 9975 888887553 4689999999999999999999999999999999999999999999999999975432100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 156 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 156 ---------------------------------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred ---------------------------------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 0013468899999999876 457999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccc----------------cccCCc---------ccccChhHHHHHHHHhh-CccccCCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRT----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~----------------~~~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
|.+||.+.+..+.+.++..... ...+|. ...++++++++|.+||+ ||.+||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~-- 274 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS-- 274 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC--
Confidence 9999998887776666543210 001110 02468899999999998 9999999
Q ss_pred ChhhhhcCCCc
Q 008810 407 GADEIKVHPWF 417 (552)
Q Consensus 407 ~a~eil~HpfF 417 (552)
+.+|+.||||
T Consensus 275 -~~~~l~~~~f 284 (284)
T cd07836 275 -AHDALQHPWF 284 (284)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=360.50 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=214.9
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec----CCceE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ----DDEFL 191 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~----d~~~l 191 (552)
++|++.+.||.|+||.||+|..+.+|+.||+|++.+... .......+.+|+.+|+.++||||++++++|. +...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999976432 2234566788999999999999999998886 34578
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||+. |+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999998888899999999999999999999999999999999999999999999999999986532211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEm 350 (552)
.. .......+||..|+|||++.+ ..++.++|+|||||++|||
T Consensus 163 ~~-------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el 205 (334)
T cd07855 163 EH-------------------------------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205 (334)
T ss_pred CC-------------------------------------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHH
Confidence 00 001123579999999999876 5689999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhc------------------------cccccCCc---ccccChhHHHHHHHHhh-Ccccc
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNW------------------------RTHLKFPE---EAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~------------------------~~~~~~p~---~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
++|++||.+.+.......+... ......+. ...++.++++||.+||+ +|.+|
T Consensus 206 ~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred HcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence 9999999887655443333221 00001110 12468999999999999 99999
Q ss_pred CCCCChhhhhcCCCcCCC
Q 008810 403 LGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 403 l~~~~a~eil~HpfF~~i 420 (552)
|+ +.+++.||||+..
T Consensus 286 pt---~~~~l~~~~~~~~ 300 (334)
T cd07855 286 IT---VEQALQHPFLAQY 300 (334)
T ss_pred cC---HHHHHhChhhhhc
Confidence 99 9999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=348.95 Aligned_cols=256 Identities=28% Similarity=0.433 Sum_probs=205.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|.+++.||+|+||.||+|.++.+|+.||||++..... ......+.+|+.+|+.++|+||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999975432 22233567899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||++ ++|...+.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence 99996 566666544 46789999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
.....++++.|+|||++.+ ..++.++|+|||||++|||++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 199 (291)
T cd07870 159 ---------------------------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199 (291)
T ss_pred ---------------------------------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh
Confidence 0113467999999999876 458999999999999999999
Q ss_pred CCCCCCCCChh-hHHHHHhhccc---------------------cccCCc-------ccccChhHHHHHHHHhh-Ccccc
Q 008810 353 GYPPFYSDDPM-STCRKIVNWRT---------------------HLKFPE-------EAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 353 G~~PF~~~~~~-~~~~~i~~~~~---------------------~~~~p~-------~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|.+||.+.+.. +.+.++..... ....+. ....++++.+||.+||+ ||.+|
T Consensus 200 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R 279 (291)
T cd07870 200 GQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDR 279 (291)
T ss_pred CCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccC
Confidence 99999865432 22222211000 000000 01235789999999999 99999
Q ss_pred CCCCChhhhhcCCCc
Q 008810 403 LGAKGADEIKVHPWF 417 (552)
Q Consensus 403 l~~~~a~eil~HpfF 417 (552)
|+ +.|++.||||
T Consensus 280 ~t---~~~~l~h~~~ 291 (291)
T cd07870 280 IS---AQDALLHPYF 291 (291)
T ss_pred cC---HHHHhcCCCC
Confidence 99 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=343.54 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=209.8
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..+.+.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++.+.+..|+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3445555668999999999999999999999999987543 2345678899999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-CCcEEEcccccccccCCC
Q 008810 194 IMEYLPGGDMMTLLMRK-DTL--TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-~g~iKL~DFGlak~~~~~ 269 (552)
||||++|++|..++... ..+ ++..+.+++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++..+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999999999999764 456 88999999999999999999999999999999999986 689999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC--CCCCccchhhhhHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGAIM 347 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil 347 (552)
.. ......|++.|+|||++.+. .++.++|+|||||++
T Consensus 163 ~~-----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl 201 (268)
T cd06624 163 NP-----------------------------------------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTI 201 (268)
T ss_pred CC-----------------------------------------ccccCCCCccccChhhhccccccCCchhhhHHHHHHH
Confidence 10 01124589999999999764 488999999999999
Q ss_pred HHHhhCCCCCCCCChh-hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 348 YEMLVGYPPFYSDDPM-STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 348 yEmltG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|+|++|.+||...... .....+........+|. .+++++++||.+||. +|.+||+ +.+|+.||||
T Consensus 202 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 202 VEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE--SLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred HHHHhCCCCCccccChhhhHhhhhhhccCCCCCc--ccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 9999999999764432 22222221122333443 688999999999998 9999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=353.98 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=207.3
Q ss_pred CeeEEeeeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--ceEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLY 192 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~ly 192 (552)
.|++++.||+|+||.||+|..+. ++..||+|++.+...........+.+|+.++..++||||++++++|.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999875433344456678899999999999999999999988 8899
Q ss_pred EEEecCCCCchhhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC----CCcEEEcccccc
Q 008810 193 LIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK----YGHLRLSDFGLC 263 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~----~g~iKL~DFGla 263 (552)
+||||+++ +|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999965 676666321 36899999999999999999999999999999999999999 999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 342 (552)
+.+....... ......+||+.|+|||++.+ ..++.++|+||
T Consensus 160 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 201 (316)
T cd07842 160 RLFNAPLKPL--------------------------------------ADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201 (316)
T ss_pred cccCCCcccc--------------------------------------cccCCccccccccCHHHHhCCCCCCcHHHHHH
Confidence 8653221000 00123578999999999876 46899999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhh---------HHHHHhh------------------------ccccccCCc---------
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMS---------TCRKIVN------------------------WRTHLKFPE--------- 380 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~---------~~~~i~~------------------------~~~~~~~p~--------- 380 (552)
|||++|+|++|++||.+.+... .+..++. ......++.
T Consensus 202 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (316)
T cd07842 202 IGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281 (316)
T ss_pred HHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHh
Confidence 9999999999999998755432 1111111 000111110
Q ss_pred ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 381 EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 381 ~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
....+.++.+||.+||. ||.+||+ +.||+.||||
T Consensus 282 ~~~~~~~~~~~i~~~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 282 HKKPDSQGFDLLRKLLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred ccCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCCCC
Confidence 01467789999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=343.82 Aligned_cols=253 Identities=30% Similarity=0.497 Sum_probs=212.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||+|+||.||+|+.+.+|+.||||++.............+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 68999999999999999999999999999999987655555556667889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 196 Ey~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||+++|+|..++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988853 34589999999999999999999999999999999999999999999999999886532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
......|++.|+|||++.+..++.++|+|||||++|||+
T Consensus 162 -----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 011356899999999999999999999999999999999
Q ss_pred hCCCCCCCCCh--hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 352 VGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 352 tG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+|..||..... ......+.. ......+. ..++..+.+||.+||+ +|.+||+ +.+|++.
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rp~---~~~vl~~ 261 (267)
T cd08228 201 ALQSPFYGDKMNLFSLCQKIEQ-CDYPPLPT-EHYSEKLRELVSMCIYPDPDQRPD---IGYVHQI 261 (267)
T ss_pred cCCCCCccccccHHHHHHHHhc-CCCCCCCh-hhcCHHHHHHHHHHCCCCcccCcC---HHHHHHH
Confidence 99999976543 233333322 11112221 2577899999999999 9999999 8888753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=348.83 Aligned_cols=253 Identities=21% Similarity=0.360 Sum_probs=212.0
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
..++|.+++.||+|+||.||+|.... ++..||||+++... .......+.+|+++|+.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 45678999999999999999998753 46789999987543 222456789999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK--------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~ 254 (552)
..+|+||||++||+|..++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999999654 34889999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC
Q 008810 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (552)
Q Consensus 255 iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y 334 (552)
+||+|||+++.+....... ......+++.|+|||++.+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYR---------------------------------------VGGHTMLPIRWMPPESIMYRKF 201 (280)
T ss_pred EEECCcccceecccCccee---------------------------------------cCCCCcccceecChhhhccCCc
Confidence 9999999987543211000 0012456889999999999999
Q ss_pred CCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 335 GMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
+.++|||||||++|||++ |..||.+.+..+....+... ....+ ...++.++++||.+||+ ||.+||+ +.||+
T Consensus 202 ~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~---~~eil 275 (280)
T cd05049 202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG--RLLQR-PRTCPSEVYDIMLGCWKRDPQQRIN---IKDIH 275 (280)
T ss_pred chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CcCCC-CCCCCHHHHHHHHHHcCCCcccCCC---HHHHH
Confidence 999999999999999998 99999988877777666642 22222 13688999999999999 9999999 77776
Q ss_pred c
Q 008810 413 V 413 (552)
Q Consensus 413 ~ 413 (552)
.
T Consensus 276 ~ 276 (280)
T cd05049 276 E 276 (280)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=349.02 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=211.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+..++|.+.+.||+|+||+||+|... .++..||+|.+.+.. ......+.+|+.+|.+++||+|++++++|.+
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 45678999999999999999999853 345679999987542 3345668899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKD-------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~ 254 (552)
.+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.+++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999986543 4899999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC
Q 008810 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (552)
Q Consensus 255 iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y 334 (552)
+||+|||+++.+...... .......|++.|+|||++.+..+
T Consensus 159 ~kl~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYY---------------------------------------RVGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred EEeccCCccccccCCcee---------------------------------------ecCCCCCccccccCHHHhccCCC
Confidence 999999999855321100 00112456889999999999999
Q ss_pred CCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 335 GMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
+.++|+|||||++|+|++ |.+||.+.+.......+.... ....+ ..++.++.+||.+||. ||.+||+ +.+++
T Consensus 200 ~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt---~~~v~ 273 (288)
T cd05093 200 TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP--RTCPKEVYDLMLGCWQREPHMRLN---IKEIH 273 (288)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHccCChhhCCC---HHHHH
Confidence 999999999999999998 999999888877777776532 12233 3678999999999999 9999999 66664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=354.60 Aligned_cols=253 Identities=31% Similarity=0.552 Sum_probs=214.3
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|+....||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++..++||||++++++|...+..|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 3445579999999999999999999999999975432 2345688899999999999999999999999999999999
Q ss_pred CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccc
Q 008810 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (552)
Q Consensus 198 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~ 277 (552)
++|++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~------ 172 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------ 172 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc------
Confidence 999999987744 6799999999999999999999999999999999999999999999999999875432110
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCC
Q 008810 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (552)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF 357 (552)
.....+|++.|+|||++.+..++.++|+|||||++|||++|++||
T Consensus 173 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 173 -----------------------------------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred -----------------------------------cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 011357999999999999989999999999999999999999999
Q ss_pred CCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
...+..+....+.... .........++.++.++|.+||+ +|.+||+ +.+|+.||||..
T Consensus 218 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~ 276 (297)
T cd06659 218 FSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQ 276 (297)
T ss_pred CCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhcc
Confidence 9887766665554321 11112223678899999999999 9999999 999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=347.42 Aligned_cols=255 Identities=30% Similarity=0.545 Sum_probs=217.7
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|...+.||.|++|.||++.++.+++.||+|++.... ....+.+.+|+.++..++||||++++++|...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 3555679999999999999999999999999986432 2334568899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|++|++|.+++.. ..+++..+..++.+++.||.|||++||+||||+|+||+++.+|.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~----- 170 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP----- 170 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-----
Confidence 9999999999876 6799999999999999999999999999999999999999999999999998875421100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
......|++.|+|||++.+..++.++|+|||||++|||++|..|
T Consensus 171 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p 214 (285)
T cd06648 171 ------------------------------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214 (285)
T ss_pred ------------------------------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 01135689999999999988899999999999999999999999
Q ss_pred CCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|.+.++.....++... .....+....++..+.+||.+||. +|.+||+ +.+|+.||||+..
T Consensus 215 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 275 (285)
T cd06648 215 YFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKA 275 (285)
T ss_pred CcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccC
Confidence 9988887777766643 111222223478999999999999 9999998 9999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=358.77 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=208.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----c
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 189 (552)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... .......+..|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 468999999999999999999999999999999986422 223445678899999999999999999876543 3
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||++ ++|..++ ....+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 82 ~~~lv~e~~~-~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999996 5888777 4467999999999999999999999999999999999999999999999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvily 348 (552)
.... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 160 ~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~ 201 (336)
T cd07849 160 HDHT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILA 201 (336)
T ss_pred cccc--------------------------------------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHH
Confidence 1000 00123578999999999765 56899999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccc--------------------cc----cCCc---ccccChhHHHHHHHHhh-Ccc
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRT--------------------HL----KFPE---EAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~--------------------~~----~~p~---~~~~s~e~~dLI~~lL~-dp~ 400 (552)
+|++|++||.+.+.......+..... .. ..+. .+.+++++.+||.+||+ ||.
T Consensus 202 el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 281 (336)
T cd07849 202 EMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH 281 (336)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChh
Confidence 99999999987654333322211000 00 0000 12468899999999999 999
Q ss_pred ccCCCCChhhhhcCCCcCCC
Q 008810 401 QRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF~~i 420 (552)
+||+ +.+++.||||+.+
T Consensus 282 ~Rpt---~~e~l~hp~~~~~ 298 (336)
T cd07849 282 KRIT---VEEALAHPYLEQY 298 (336)
T ss_pred hCcC---HHHHhcCcccccc
Confidence 9999 9999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=340.43 Aligned_cols=253 Identities=31% Similarity=0.576 Sum_probs=216.6
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|.+.+.||+|+||.||+|..+.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999976543 22345668899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc-EEEcccccccccCCCCccc
Q 008810 197 YLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 197 y~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~-iKL~DFGlak~~~~~~~~~ 273 (552)
|++|++|.+++.+.. .+++..+..++.+++.||.|||+.|++||||||+||+++.++. +||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 999999999987643 5899999999999999999999999999999999999998865 69999999876532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
......|++.|+|||++.+..++.++|+|||||++|||++|
T Consensus 158 ---------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 158 ---------------------------------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred ---------------------------------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 01134689999999999988899999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
..||.+.+.......+.... + .+....++.+++++|.+||. +|.+||+ +.+|+.||||
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 199 KHPFEGNNLHQLVLKICQGY--F-APISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred CCCCCCccHHHHHHHHhccc--C-CCCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 99998887776666655421 1 11123678899999999998 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=351.34 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=213.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--ceEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~ly 192 (552)
.++|++.+.||.|+||.||+|.++.+++.||+|.++..... ......+.+|+.++..++||||+++++++.+. ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999765432 33334567899999999999999999998877 8999
Q ss_pred EEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 193 LIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
+||||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999997 4898888664 4599999999999999999999999999999999999999999999999999886532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEm 350 (552)
......|++.|+|||++.+. .++.++|+|||||++|+|
T Consensus 162 -----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 200 (293)
T cd07843 162 -----------------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200 (293)
T ss_pred -----------------------------------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHH
Confidence 01134678999999999764 468999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhcccc-----------------------------ccCCcccccChhHHHHHHHHhh-Ccc
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTH-----------------------------LKFPEEAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~-----------------------------~~~p~~~~~s~e~~dLI~~lL~-dp~ 400 (552)
++|.+||.+.+....+.++...-.. -.+|. ..+++.+++||.+||+ +|+
T Consensus 201 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 201 LTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc-cCCChHHHHHHHHHhccCcc
Confidence 9999999988877766665431100 01111 0158889999999999 999
Q ss_pred ccCCCCChhhhhcCCCc
Q 008810 401 QRLGAKGADEIKVHPWF 417 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF 417 (552)
+||+ +.|++.||||
T Consensus 280 ~R~t---~~ell~~~~f 293 (293)
T cd07843 280 KRIS---AEDALKHPYF 293 (293)
T ss_pred ccCC---HHHHhcCCCC
Confidence 9999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=352.49 Aligned_cols=257 Identities=30% Similarity=0.522 Sum_probs=218.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|.+++.||.|+||.||+|....+++.||+|.+.... ....+.+.+|+.+++.++||||++++++|.+.+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 468999999999999999999998899999999986443 23346688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++||+|..++.+ ..+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--- 170 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 170 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc---
Confidence 999999999999854 4689999999999999999999999999999999999999999999999999875432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
......|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 171 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~ 212 (293)
T cd06647 171 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (293)
T ss_pred --------------------------------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 011346899999999999888999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+||.+.+.......+..+ ....++....++..+++||.+||. +|.+||+ +.+|+.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~ 275 (293)
T cd06647 213 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIA 275 (293)
T ss_pred CCCCCCChhhheeehhcC-CCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcC
Confidence 999887665443333322 222333334678899999999998 9999998 9999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=345.46 Aligned_cols=255 Identities=17% Similarity=0.249 Sum_probs=210.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+..++|++.+.||+|+||.||+|.++ .++..||+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45678999999999999999999864 2457899999865432 2234568899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEE
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL 257 (552)
....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999998653 23577889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCc
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~ 337 (552)
+|||+++.+....... ......+++.|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05062 161 GDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMSPESLKDGVFTTY 201 (277)
T ss_pred CCCCCccccCCcceee---------------------------------------cCCCCccCHhhcChhHhhcCCcCch
Confidence 9999988653221100 0012356788999999999999999
Q ss_pred cchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 338 ~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+|+|||||++|||++ |.+||.+.+.......+... ....+| ..++..+++||.+||+ ||.+||+ +.|++.+
T Consensus 202 ~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~ 274 (277)
T cd05062 202 SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GLLDKP--DNCPDMLFELMRMCWQYNPKMRPS---FLEIISS 274 (277)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 999999999999999 79999988877776666542 222333 3678899999999999 9999999 8887754
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=346.96 Aligned_cols=254 Identities=19% Similarity=0.373 Sum_probs=211.7
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
..++|++.+.||+|+||.||+|... .++..||+|.+.... .......+.+|..+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 456789999997532 2334567889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK-----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~-----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~ 252 (552)
..|+||||+++|+|.+++... ..+++..+..++.+++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 247889999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC
Q 008810 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (552)
Q Consensus 253 g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~ 332 (552)
+.+||+|||+++.+....... ......++..|+|||++.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYR---------------------------------------VQPKSLLPIRWMPPEAIMYG 201 (283)
T ss_pred CcEEeccccccccccCCccee---------------------------------------cccCCCccceecChHHhccC
Confidence 999999999998653221000 01134567889999999988
Q ss_pred CCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhh
Q 008810 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (552)
Q Consensus 333 ~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~e 410 (552)
.++.++|+|||||++|||++ |.+||.+.+.......+... ..+..| ..+++++++||.+||+ ||.+||+ +.+
T Consensus 202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~ 275 (283)
T cd05090 202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCS--EDCPPRMYSLMTECWQEGPSRRPR---FKD 275 (283)
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCcC---HHH
Confidence 89999999999999999998 99999988776666555542 233333 3689999999999999 9999999 777
Q ss_pred hhcC
Q 008810 411 IKVH 414 (552)
Q Consensus 411 il~H 414 (552)
|+++
T Consensus 276 i~~~ 279 (283)
T cd05090 276 IHTR 279 (283)
T ss_pred HHHH
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=358.59 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=213.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----c
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 189 (552)
..+|.+++.||+|+||.||+|++..+|+.||||.+.+.. ........+..|+.+|..++||||+++++++.+. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357999999999999999999999999999999987642 2233445677899999999999999999888654 3
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||+. ++|..++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||+++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 789999888889999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvily 348 (552)
.. .....+||..|+|||++.+ ..++.++|+|||||++|
T Consensus 162 ~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 162 GD-----------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred cc-----------------------------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 10 0113568999999999875 56899999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhcccc-----------------------ccCC----cccccChhHHHHHHHHhh-Ccc
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH-----------------------LKFP----EEAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~-----------------------~~~p----~~~~~s~e~~dLI~~lL~-dp~ 400 (552)
+|++|++||.+.+.......+...... ...+ ....+++++++||.+||+ +|.
T Consensus 201 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 280 (337)
T cd07858 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS 280 (337)
T ss_pred HHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh
Confidence 999999999877654444333211000 0000 013578999999999999 999
Q ss_pred ccCCCCChhhhhcCCCcCCC
Q 008810 401 QRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF~~i 420 (552)
+||+ +++++.||||+.+
T Consensus 281 ~Rps---~~ell~h~~~~~~ 297 (337)
T cd07858 281 KRIT---VEEALAHPYLASL 297 (337)
T ss_pred hccC---HHHHHcCcchhhh
Confidence 9999 9999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=342.47 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=213.2
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+...+|.+.+.||+|+||.||+|..+.+++.||+|++.+.. .....+.+|+.+|..++||||+++++++..+..+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45667999999999999999999999999999999987542 23456888999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999998653 468999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
... .....+++.|+|||++.+..++.++|||||||++|||
T Consensus 159 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 198 (263)
T cd05052 159 YTA----------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198 (263)
T ss_pred eec----------------------------------------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 100 0022356789999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++ |.+||.+.+..+....+... ....+| ..++.++.+||.+||. ||.+||+ +.++++
T Consensus 199 ~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~l~~ 257 (263)
T cd05052 199 ATYGMSPYPGIDLSQVYELLEKG-YRMERP--EGCPPKVYELMRACWQWNPSDRPS---FAEIHQ 257 (263)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHccCCcccCCC---HHHHHH
Confidence 98 99999988877776666542 223333 3689999999999999 9999999 666653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=345.95 Aligned_cols=256 Identities=30% Similarity=0.479 Sum_probs=212.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--ceEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYL 193 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~lyl 193 (552)
++|+.++.||.|+||.||+|.+..+++.||+|.+.+... ......+.+|+++++.++||||++++++|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999976432 23456688999999999999999999988654 47999
Q ss_pred EEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 194 IMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
||||++||+|.+++.. ...+++..+..++.||+.||.|||..|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999888643 356899999999999999999999999999999999999999999999999998754211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 159 ~-------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~ 195 (287)
T cd06621 159 L-------------------------------------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195 (287)
T ss_pred c-------------------------------------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 0 012457889999999999999999999999999999
Q ss_pred HhhCCCCCCCCC-----hhhHHHHHhhccccccCCc----ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 350 MLVGYPPFYSDD-----PMSTCRKIVNWRTHLKFPE----EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 350 mltG~~PF~~~~-----~~~~~~~i~~~~~~~~~p~----~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|++|..||.... ..+....+.... ...++. ...+++++.+||.+||. +|.+||+ +.||+.||||+.
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~ 271 (287)
T cd06621 196 VAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKA 271 (287)
T ss_pred HHhCCCCCCcccCCCCChHHHHHHHhcCC-chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCccccc
Confidence 999999998662 233333333321 111111 12456789999999998 9999999 999999999976
Q ss_pred C
Q 008810 420 V 420 (552)
Q Consensus 420 i 420 (552)
.
T Consensus 272 ~ 272 (287)
T cd06621 272 Q 272 (287)
T ss_pred c
Confidence 4
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=341.23 Aligned_cols=249 Identities=22% Similarity=0.407 Sum_probs=211.0
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++++.||+|+||.||+|... ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 56788999999999999999999864 556799999875432 3467889999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+||||++||+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999998653 568899999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.. ......++..|+|||++.+..++.++|||||||++|+|
T Consensus 158 ~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 197 (261)
T cd05072 158 YT----------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEI 197 (261)
T ss_pred ee----------------------------------------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHH
Confidence 00 00123467789999999988899999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
++ |..||.+.+.......+.. ....|....++.++.+||.+||. +|++||+ +++|.
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~ 255 (261)
T cd05072 198 VTYGKIPYPGMSNSDVMSALQR---GYRMPRMENCPDELYDIMKTCWKEKAEERPT---FDYLQ 255 (261)
T ss_pred HccCCCCCCCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHccCCcccCcC---HHHHH
Confidence 98 9999998887777666654 22334334688999999999999 9999999 66654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=345.75 Aligned_cols=256 Identities=31% Similarity=0.531 Sum_probs=215.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCceEEEeeeecCCceEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d~~~lyl 193 (552)
.|++++.||.|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.+. ||||++++++|.+....|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4788899999999999999999999999999987542 2344567888999999986 9999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||||++|++|.+++.. ..+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.++|+|||++..+......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 9999999999998855 58999999999999999999999999999999999999999999999999999865422100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt 352 (552)
....+|++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~ 197 (277)
T cd06917 158 ----------------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT 197 (277)
T ss_pred ----------------------------------------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh
Confidence 113478999999999875 457899999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
|.+||.+.+.......+... ....++. ..++.++.+||.+||. ||.+||+ +.+++.||||+...
T Consensus 198 g~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~ 262 (277)
T cd06917 198 GNPPYSDVDAFRAMMLIPKS-KPPRLED-NGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHS 262 (277)
T ss_pred CCCCCCCCChhhhhhccccC-CCCCCCc-ccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccc
Confidence 99999887665544333321 1122222 2378899999999998 9999999 99999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=339.40 Aligned_cols=249 Identities=51% Similarity=0.921 Sum_probs=221.0
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCch
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L 203 (552)
||.|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+.++...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887766666778899999999999999999999999999999999999999999
Q ss_pred hhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCC
Q 008810 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (552)
Q Consensus 204 ~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~ 283 (552)
.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------------ 148 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------------ 148 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------------
Confidence 99998888899999999999999999999999999999999999999999999999999876532210
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChh
Q 008810 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (552)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~ 363 (552)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+..
T Consensus 149 -----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 199 (250)
T cd05123 149 -----------------------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199 (250)
T ss_pred -----------------------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 011356899999999999888999999999999999999999999888776
Q ss_pred hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 364 ~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.....+.. ..+.+|. .++.++.+||.+||+ ||.+||++..+++++.||||
T Consensus 200 ~~~~~~~~--~~~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 200 EIYEKILK--DPLRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 77777665 4455554 678999999999999 99999994334999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=349.65 Aligned_cols=261 Identities=30% Similarity=0.420 Sum_probs=207.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
.++|++++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4679999999999999999999999999999999865432 2223345678999999999999999999887553
Q ss_pred ---eEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 190 ---FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 190 ---~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
..|+||||+. ++|..++... ..+++..++.++.|++.||.|||++|++||||||+|||++.+|.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4699999995 5788777654 3799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 344 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlG 344 (552)
+....... .......+|+..|+|||++.+. .++.++|+||||
T Consensus 169 ~~~~~~~~-------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 169 FSLSKNSK-------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred ccCCcccC-------------------------------------CCCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 54221000 0001134688999999998764 478999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhcccc-----------------ccCCcc-----------cccChhHHHHHHHHh
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH-----------------LKFPEE-----------AKLSIEAKDLISKLL 396 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~~-----------~~~s~e~~dLI~~lL 396 (552)
|++|||++|++||.+.+.......+..-... +.+|.. ...+..+++||.+||
T Consensus 212 ~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l 291 (310)
T cd07865 212 CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291 (310)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHh
Confidence 9999999999999887765544333221000 111110 023567899999999
Q ss_pred h-CccccCCCCChhhhhcCCCc
Q 008810 397 C-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 397 ~-dp~~Rl~~~~a~eil~HpfF 417 (552)
+ ||.+||+ +++++.||||
T Consensus 292 ~~~P~~R~t---~~e~l~h~~f 310 (310)
T cd07865 292 VLDPAKRID---ADTALNHDFF 310 (310)
T ss_pred cCChhhccC---HHHHhcCCCC
Confidence 9 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=345.92 Aligned_cols=252 Identities=32% Similarity=0.500 Sum_probs=216.2
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.++..++||||++++++|.++..+|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 7788899999999999999999999999999875432 23456788999999999999999999999999999999999
Q ss_pred CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccc
Q 008810 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (552)
Q Consensus 198 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~ 277 (552)
++||+|..++.. ..+++..+..++.+++.||.+||+.|++|+||||+||+++.+|.++|+|||++..+.....
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~------ 156 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI------ 156 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh------
Confidence 999999988854 5789999999999999999999999999999999999999999999999999876532110
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCC
Q 008810 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (552)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF 357 (552)
......|+..|+|||++.+..++.++|+|||||++|+|++|.+||
T Consensus 157 -----------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (277)
T cd06641 157 -----------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201 (277)
T ss_pred -----------------------------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 001346899999999999888999999999999999999999999
Q ss_pred CCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
...+.......+... ....++ ..++.++.++|.+||. +|.+||+ +.+++.||||..
T Consensus 202 ~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~ 258 (277)
T cd06641 202 SELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVR 258 (277)
T ss_pred CccchHHHHHHHhcC-CCCCCC--cccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhh
Confidence 877766555554332 122222 2578899999999998 9999999 999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=340.49 Aligned_cols=249 Identities=20% Similarity=0.364 Sum_probs=209.7
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||+|+||.||+|+.+. +..+|+|.+.+... ....+.+|+.+|+.++||||++++++|.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 35679999999999999999998754 56799999875432 23457889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++||+|.+++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999999999865 356899999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
. .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~ 196 (256)
T cd05114 157 S----------------------------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196 (256)
T ss_pred c----------------------------------------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHc
Confidence 0 012345678999999998999999999999999999999
Q ss_pred -CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|++||...+..+....+.... ....|. ..+.++.+||.+||+ +|.+||+ +++|+.
T Consensus 197 ~g~~p~~~~~~~~~~~~i~~~~-~~~~~~--~~~~~~~~li~~c~~~~p~~Rps---~~~l~~ 253 (256)
T cd05114 197 EGKMPFEKKSNYEVVEMISRGF-RLYRPK--LASMTVYEVMYSCWHEKPEGRPT---FAELLR 253 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHCCC-CCCCCC--CCCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 999999888888877776532 222332 568899999999999 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=359.26 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=208.6
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 185 (552)
.+..++|++.+.||.|+||.||+|... .+++.||+|+++... .......+..|+.++..+ +||||++++++|
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 345668999999999999999999754 346799999987542 223445678899999999 899999999987
Q ss_pred cC-CceEEEEEecCCCCchhhHHhhc------------------------------------------------------
Q 008810 186 QD-DEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (552)
Q Consensus 186 ~d-~~~lylVmEy~~gG~L~~~L~~~------------------------------------------------------ 210 (552)
.. +..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 46789999999999999988542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCC
Q 008810 211 -------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (552)
Q Consensus 211 -------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~ 283 (552)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+++.+.......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---------- 230 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---------- 230 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----------
Confidence 268899999999999999999999999999999999999999999999999998653221000
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCCh
Q 008810 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDP 362 (552)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~ 362 (552)
......|+..|+|||++.+..|+.++|||||||++|||++ |.+||.+...
T Consensus 231 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 231 -----------------------------RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred -----------------------------hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 0113456788999999999999999999999999999997 9999987655
Q ss_pred hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 363 MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 363 ~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
.+.+...+........| ..+++++.+||.+||+ +|.+||+ +++|++|
T Consensus 282 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~p~~RPs---~~ell~~ 329 (337)
T cd05054 282 DEEFCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRPT---FSELVEI 329 (337)
T ss_pred cHHHHHHHhccCCCCCC--ccCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 55444444322233333 3678999999999999 9999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=346.57 Aligned_cols=256 Identities=20% Similarity=0.347 Sum_probs=213.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCC----------------cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTG----------------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg----------------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~ 177 (552)
...+|++++.||+|+||.||+|....++ ..||+|++..... ....+.+.+|+.+|..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999876543 5689999876532 245667899999999999999
Q ss_pred eEEEeeeecCCceEEEEEecCCCCchhhHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCC
Q 008810 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (552)
Q Consensus 178 Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeN 246 (552)
|++++++|.++..+++||||+++++|..++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997765 68999999999999999999999999999999999
Q ss_pred ccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCCh
Q 008810 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (552)
Q Consensus 247 ILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~AP 326 (552)
||++.++.++|+|||+++.+....... ......+|+.|+||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aP 201 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYR---------------------------------------VQGRAPLPIRWMAW 201 (296)
T ss_pred eeecCCCceEEccccceeecccCccee---------------------------------------ecCcCCCCceecCH
Confidence 999999999999999987653221100 01134578899999
Q ss_pred hhhhcCCCCCccchhhhhHHHHHHhh--CCCCCCCCChhhHHHHHhhc----cccccCCcccccChhHHHHHHHHhh-Cc
Q 008810 327 EVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKIVNW----RTHLKFPEEAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 327 Evl~~~~y~~~~DiWSlGvilyEmlt--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~e~~dLI~~lL~-dp 399 (552)
|++.+..++.++|+|||||++|||++ |..||...+....+..+... ......+....++.++.+||.+||. ||
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccCh
Confidence 99998889999999999999999998 78999887777776666542 1122222233678899999999999 99
Q ss_pred cccCCCCChhhhhc
Q 008810 400 NQRLGAKGADEIKV 413 (552)
Q Consensus 400 ~~Rl~~~~a~eil~ 413 (552)
.+||+ +.+|+.
T Consensus 282 ~~Rpt---~~el~~ 292 (296)
T cd05051 282 EDRPT---FREIHL 292 (296)
T ss_pred hcCCC---HHHHHH
Confidence 99999 777753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=351.13 Aligned_cols=256 Identities=31% Similarity=0.478 Sum_probs=216.2
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|+.++.||+|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 46677889999999999999999999999999875532 2345678899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|++||+|..++. ...+++..++.++.+++.||.|||+.|++|+||+|+||+++.+|.++|+|||++..+.....
T Consensus 83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~----- 156 (277)
T cd06642 83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI----- 156 (277)
T ss_pred ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-----
Confidence 999999999885 46799999999999999999999999999999999999999999999999999876532110
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
......|+..|+|||++.+..++.++|+|||||++|||++|.+|
T Consensus 157 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06642 157 ------------------------------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred ------------------------------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCC
Confidence 00134689999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
|....+......+... ....++ ..++.++.+||.+||. +|.+||+ +.+|+.||||....+
T Consensus 201 ~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06642 201 NSDLHPMRVLFLIPKN-SPPTLE--GQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYTK 261 (277)
T ss_pred CcccchhhHHhhhhcC-CCCCCC--cccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHhh
Confidence 9876665544433321 111222 2578899999999998 9999999 999999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=342.12 Aligned_cols=254 Identities=19% Similarity=0.301 Sum_probs=213.4
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+..++|++.+.||+|+||.||+|..+.. +..||+|.+.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999998654 4789999986543 22345568899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEE
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL 257 (552)
....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999998643 24788899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCc
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~ 337 (552)
+|||+++.+....... ......||..|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05032 161 GDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMAPESLKDGVFTTK 201 (277)
T ss_pred CCcccchhhccCcccc---------------------------------------cCCCCCccccccCHHHHhcCCCCcc
Confidence 9999998653221000 0112457889999999998889999
Q ss_pred cchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 338 ~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+|+|||||++|||++ |.+||.+.+..+....+.. .....+|. .++.++.+||.+||+ +|.+||+ +.+|+.
T Consensus 202 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt---~~~l~~ 273 (277)
T cd05032 202 SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGHLDLPE--NCPDKLLELMRMCWQYNPKMRPT---FLEIVS 273 (277)
T ss_pred cchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHcCCChhhCCC---HHHHHH
Confidence 999999999999998 9999998887777666653 33444554 578999999999999 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=334.64 Aligned_cols=253 Identities=32% Similarity=0.559 Sum_probs=222.1
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++.+.||+|+||.||+|.++.+++.||+|.+.+.... ......+.+|++++..++||+|+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999999999999999876532 3456789999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|++|++|.+++.....+++..+..++.+++.||.+||+.||+||||||+||+++.+|.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999999999988889999999999999999999999999999999999999999999999999999866432100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|.+|
T Consensus 156 -------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p 198 (254)
T cd06627 156 -------------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198 (254)
T ss_pred -------------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 1135689999999999888899999999999999999999999
Q ss_pred CCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|...+......++... ....+| ..++.+++++|.+||. +|++||+ +.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 199 YYDLNPMAALFRIVQD-DHPPLP--EGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred CCCccHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 9887766655555432 233344 3688999999999998 9999999 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=385.86 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=207.1
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|+++++||+|+||.||+|++..+|+.||||++.+..........++.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999998654333344567889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccc
Q 008810 196 EYLPGGDMMTLLMRK-----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
||++||+|.+++.+. ..++...+..++.||+.||.|||+.|||||||||+|||++.+|.+||+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998641 234566778899999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
............... ...... .........+||+.|+|||++.+..++.++||||||
T Consensus 162 ~i~~~~~~~~~l~~~----------~~~s~~-------------s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLG 218 (932)
T PRK13184 162 FKKLEEEDLLDIDVD----------ERNICY-------------SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG 218 (932)
T ss_pred ecccccccccccccc----------cccccc-------------cccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHH
Confidence 763211000000000 000000 000011246899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
|++|||++|.+||.+.+.......... ......+....+++.+.++|.+||. ||.+|+++
T Consensus 219 VILyELLTG~~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 219 VILYQMLTLSFPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred HHHHHHHHCCCCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999999999987654433222111 1111222224688999999999999 99999883
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=356.90 Aligned_cols=261 Identities=29% Similarity=0.445 Sum_probs=220.2
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----eE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----FL 191 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-----~l 191 (552)
+|++.+.||.|+||.||+|+...+|+.||||++.+.. ........+..|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999999999999999997642 12344567889999999999999999999998875 79
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||++ ++|..++.+...+++..+..++.+|+.||.|||+.||+||||||+|||++.+|+++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 58999998878999999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEm 350 (552)
. ........||+.|+|||++.+. .++.++|+|||||++|+|
T Consensus 159 ~--------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l 200 (330)
T cd07834 159 E--------------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200 (330)
T ss_pred c--------------------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence 0 0001235689999999999987 899999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccC------------------C---------cccccChhHHHHHHHHhh-Ccccc
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKF------------------P---------EEAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~------------------p---------~~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
++|.+||.+.+..+.+..+......... + ....+++++.+||.+||+ +|.+|
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 280 (330)
T cd07834 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR 280 (330)
T ss_pred HcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhC
Confidence 9999999998887777766652211000 0 002368899999999999 99999
Q ss_pred CCCCChhhhhcCCCcCCC
Q 008810 403 LGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 403 l~~~~a~eil~HpfF~~i 420 (552)
|+ +++++.||||+++
T Consensus 281 pt---~~~ll~~~~~~~~ 295 (330)
T cd07834 281 IT---ADEALAHPYLAQL 295 (330)
T ss_pred CC---HHHHHhCccHHhh
Confidence 99 9999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.75 Aligned_cols=261 Identities=31% Similarity=0.518 Sum_probs=224.5
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.++..++|+||++++++|.+....|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 35568899999999999999999998999999999976532 45668889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++|++|.+++.... .+++..+..++.+++.||.|||+.||+|+||+|+||+++.+|+++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence 999999999999998776 899999999999999999999999999999999999999999999999999865432100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
......|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 172 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~ 211 (286)
T cd06614 172 ----------------------------------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE 211 (286)
T ss_pred ----------------------------------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh
Confidence 0013458899999999998889999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
|..||...++......+... ....++....++.++++||.+||. +|.+||+ +.+|+.||||....|.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~ 279 (286)
T cd06614 212 GEPPYLREPPLRALFLITTK-GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPK 279 (286)
T ss_pred CCCCCCCCCHHHHHHHHHhc-CCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCch
Confidence 99999887776665555442 222333333488999999999999 9999999 9999999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.06 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=210.5
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCceEEEeeeecCCce----
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEF---- 190 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d~~~---- 190 (552)
|++.+.||+|+||.||+|+++.+++.||+|+++.... .......+.+|+.++..+ +||||++++++|.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999998999999999975432 223344566788877666 69999999999998776
Q ss_pred -EEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 191 -LYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 191 -lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
+|+||||+++ +|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+|||++.++++||+|||++..+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999974 7888886643 59999999999999999999999999999999999999999999999999987653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
.... ....+|++.|+|||++.+..++.++|+|||||++
T Consensus 159 ~~~~------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 159 FEMA------------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred CCcc------------------------------------------cccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 2210 0134688999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccc---cccCC-----------c---------ccccChhHHHHHHHHhh-CccccC
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRT---HLKFP-----------E---------EAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~---~~~~p-----------~---------~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
|||++|.+||.+.+..+.+.++...-. ...+| . ...+++++.+||.+||+ ||.+||
T Consensus 197 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 999999999999888777777654210 00000 0 02457889999999999 999999
Q ss_pred CCCChhhhhcCCCc
Q 008810 404 GAKGADEIKVHPWF 417 (552)
Q Consensus 404 ~~~~a~eil~HpfF 417 (552)
+ +.+++.||||
T Consensus 277 ~---~~~il~~~~~ 287 (287)
T cd07838 277 S---AFEALQHPYF 287 (287)
T ss_pred C---HHHHhcCcCC
Confidence 9 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=366.39 Aligned_cols=251 Identities=28% Similarity=0.420 Sum_probs=221.0
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|.-++.||.|+||.||-|++..+..+||||++.-+..........+..|+..|..+.|||+|..-++|--+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55677899999999999999999999999999876655556667799999999999999999999999999999999999
Q ss_pred CCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 198 LPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 198 ~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|-| +-.++|. .+.+|.|.++..++.+.+.||.|||+++.||||||..||||++.|.|||+|||.|..+.+
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------- 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------- 178 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence 954 5555553 357899999999999999999999999999999999999999999999999999876532
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhhHHHHHHhhC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvilyEmltG 353 (552)
+.++||||.||||||++. +.|+-++|||||||...||...
T Consensus 179 -------------------------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 179 -------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred -------------------------------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence 358999999999999984 6799999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+||+.+.+.+..+..|... ....++. ..+|..++.||..||. -|.+||+ .++++.|+|...
T Consensus 222 kPPlFnMNAMSALYHIAQN-esPtLqs-~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~R 283 (948)
T KOG0577|consen 222 KPPLFNMNAMSALYHIAQN-ESPTLQS-NEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVLR 283 (948)
T ss_pred CCCccCchHHHHHHHHHhc-CCCCCCC-chhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhcc
Confidence 9999999999888888753 2333332 3689999999999999 8999999 899999999854
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=349.99 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=215.0
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|..++.||+|+||.||+|++..+|..||+|++.+...........+..|+.+++.++|||||++++++.++...|+|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 47888999999999999999999999999999986544444455678899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 197 y~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|++| +|.+++.. ...+++..+..++.+++.||.|||+.||+||||+|+||+++.++++||+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------ 178 (317)
T cd06635 106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------ 178 (317)
T ss_pred CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc------
Confidence 9975 67666643 567999999999999999999999999999999999999999999999999998643211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhhhHHHHHHhh
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEmlt 352 (552)
....|++.|+|||++. ...++.++|+|||||++|||++
T Consensus 179 ---------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~ 219 (317)
T cd06635 179 ---------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 219 (317)
T ss_pred ---------------------------------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh
Confidence 1346899999999985 3568999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|.+||...+.......+..... ...+ ...+++.+++||.+||. +|.+||+ +.+|+.|||+..
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~ 282 (317)
T cd06635 220 RKPPLFNMNAMSALYHIAQNES-PTLQ-SNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLR 282 (317)
T ss_pred CCCCCCCccHHHHHHHHHhccC-CCCC-CccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhc
Confidence 9999998877776666665321 1121 23578899999999998 9999999 999999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=363.71 Aligned_cols=254 Identities=23% Similarity=0.325 Sum_probs=207.8
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYC 183 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~ 183 (552)
+..+..++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+.+. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5566788899999999999999999987433 3579999997542 2334567899999999996 999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhc-----------------------------------------------------
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------------------------------------------------- 210 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~----------------------------------------------------- 210 (552)
+|.+...+|||||||+||+|.++|...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCc
Q 008810 211 -------------------------------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (552)
Q Consensus 211 -------------------------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNI 247 (552)
..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2478888999999999999999999999999999999
Q ss_pred cccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChh
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APE 327 (552)
|++.++.+||+|||+++.+...... .......|++.|+|||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE 309 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY---------------------------------------VSKGSTFLPVKWMAPE 309 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc---------------------------------------cccCCcCCCcceEChh
Confidence 9999999999999999865321100 0011346788999999
Q ss_pred hhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 328 vl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
++.+..++.++|||||||++|||++ |..||.+..........+........| ..++.++.+||.+||. ||.+||+.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHCccCHhHCcCH
Confidence 9999999999999999999999997 999998765544444444322233333 4688999999999999 99999993
Q ss_pred C
Q 008810 406 K 406 (552)
Q Consensus 406 ~ 406 (552)
.
T Consensus 388 ~ 388 (400)
T cd05105 388 L 388 (400)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=356.23 Aligned_cols=257 Identities=32% Similarity=0.508 Sum_probs=211.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 188 (552)
.++|.+.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.++||||++++++|...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3579999999999999999999999999999999976432 222345678899999999999999999998754
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+||||+. ++|..++ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 35699999995 4676654 34699999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
. ....+||+.|+|||++.+ ..++.++|+|||||++
T Consensus 170 ~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil 205 (342)
T cd07879 170 E--------------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM 205 (342)
T ss_pred C--------------------------------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHH
Confidence 1 013468999999999976 4689999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccc---------------------cccCCc------ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRT---------------------HLKFPE------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~---------------------~~~~p~------~~~~s~e~~dLI~~lL~-dp 399 (552)
|||++|+.||.+.+....+..++.... ...++. .+.+++++++||.+||+ ||
T Consensus 206 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 285 (342)
T cd07879 206 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDV 285 (342)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCCh
Confidence 999999999998876666555543110 000111 12467889999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCCCh
Q 008810 400 NQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
.+||+ +++++.||||+++.+
T Consensus 286 ~~R~~---~~e~l~h~~f~~~~~ 305 (342)
T cd07879 286 DKRLT---ATEALEHPYFDSFRD 305 (342)
T ss_pred hhCcC---HHHHhcCcchhhccc
Confidence 99999 999999999988754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=350.94 Aligned_cols=254 Identities=20% Similarity=0.353 Sum_probs=209.3
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
+...+|++++.||+|+||.||+|++..+|.. ||||+++... .......+..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4567899999999999999999998776664 8999986432 233445688899999999999999999998765
Q ss_pred ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
..++|+||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999764 468999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... ......+++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l 201 (316)
T cd05108 161 ADEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201 (316)
T ss_pred CCCcce---------------------------------------eccCCccceeecChHHhccCCCCchhhhHHHHHHH
Confidence 221000 01123457789999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++ |.+||.+....+. ..++.....+ |....++.++.+||.+||. +|.+||+ +.+|+.+
T Consensus 202 ~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~l~~~ 264 (316)
T cd05108 202 WELMTFGSKPYDGIPASEI-SSILEKGERL--PQPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 264 (316)
T ss_pred HHHHcCCCCCCCCCCHHHH-HHHHhCCCCC--CCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 99997 9999987765544 3444433333 3334688999999999998 9999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=341.75 Aligned_cols=251 Identities=29% Similarity=0.515 Sum_probs=211.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||+|+||.||+|+.+.+|+.||||.+.+...........+.+|+.+++.++||||++++++|.+.+.+|+||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57889999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 196 Ey~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||++|++|.+++.. ...+++..+..++.+++.||.|||++|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 35689999999999999999999999999999999999999999999999999875532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.....+|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 200 (267)
T cd08229 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence 011357899999999999999999999999999999999
Q ss_pred hCCCCCCCCCh--hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 352 VGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 352 tG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
+|..||.+... ......+... .....+ ...+++++++||.+||. ||.+||+ +.+|+
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt---~~~i~ 259 (267)
T cd08229 201 ALQSPFYGDKMNLYSLCKKIEQC-DYPPLP-SDHYSEELRQLVNMCINPDPEKRPD---ITYVY 259 (267)
T ss_pred hCCCCcccccchHHHHhhhhhcC-CCCCCC-cccccHHHHHHHHHhcCCCcccCCC---HHHHH
Confidence 99999976543 2333333321 111122 13578899999999998 9999999 77654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=354.17 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=210.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 188 (552)
..+|++.+.||.|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 368999999999999999999999999999999987654 24556788999999999999999999776543
Q ss_pred --------ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc-CCCcEEEcc
Q 008810 189 --------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSD 259 (552)
Q Consensus 189 --------~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~-~~g~iKL~D 259 (552)
..+|+||||++ ++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 46899999996 58888774 45799999999999999999999999999999999999998 456789999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCcc
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 338 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~ 338 (552)
||+++.+....... ......+||..|+|||++.+ ..++.++
T Consensus 159 fg~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 159 FGLARIVDPHYSHK--------------------------------------GYLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred cccceecCCccccc--------------------------------------cccccccccccccCHHHHhCccccCchh
Confidence 99997653211000 00012368999999998765 5688999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcc-----------------------ccccCCc---ccccChhHHHHH
Q 008810 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWR-----------------------THLKFPE---EAKLSIEAKDLI 392 (552)
Q Consensus 339 DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~-----------------------~~~~~p~---~~~~s~e~~dLI 392 (552)
|+|||||++|+|++|..||.+.++......+.... .....|. ...++.++++||
T Consensus 201 DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 280 (342)
T cd07854 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFL 280 (342)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHH
Confidence 99999999999999999998877666555443210 0000010 024788999999
Q ss_pred HHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 393 SKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 393 ~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+||+ ||.+||+ +.+|+.||||+.+
T Consensus 281 ~~~L~~dP~~R~t---~~ell~h~~~~~~ 306 (342)
T cd07854 281 EQILTFNPMDRLT---AEEALMHPYMSCY 306 (342)
T ss_pred HHHhCCCchhccC---HHHHhCCCccccc
Confidence 99999 9999999 9999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.11 Aligned_cols=255 Identities=21% Similarity=0.343 Sum_probs=212.3
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+..++|.+.+.||+|+||.||+|.++. ++..||+|.+.... .......+..|+.+++.++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345679999999999999999999987 77899999886432 23334568889999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cEEE
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRL 257 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~iKL 257 (552)
....|+||||++||+|.+++.+.. .+++..+..++.||+.||.|||+.|++||||||+|||++.+| .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999997653 589999999999999999999999999999999999998765 6999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCc
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~ 337 (552)
+|||+++.+....... ......+++.|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05036 161 ADFGMARDIYRASYYR---------------------------------------KGGRAMLPIKWMPPEAFLDGIFTSK 201 (277)
T ss_pred ccCccccccCCcccee---------------------------------------cCCCCCccHhhCCHHHHhcCCcCch
Confidence 9999998653221000 0001234568999999999999999
Q ss_pred cchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 338 ~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+|||||||++|||++ |..||.+.+.......+... ....+| ..++.++.+||.+||+ +|.+||+ +.+|++|
T Consensus 202 ~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~cl~~~p~~Rps---~~~vl~~ 274 (277)
T cd05036 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPP--KGCPGPVYRIMTDCWQHTPEDRPN---FATILER 274 (277)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 999999999999997 99999988777766655432 233344 3688999999999999 9999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=345.41 Aligned_cols=254 Identities=31% Similarity=0.512 Sum_probs=211.9
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++||+|+++++++.+....|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999976532 233445678899999999999999999999999999999999
Q ss_pred CCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 198 LPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 198 ~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
++ ++|..++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.+|.++|+|||++..+.....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 95 68999987665 799999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+|++.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus 155 -------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 197 (283)
T cd07835 155 -------------------------------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197 (283)
T ss_pred -------------------------------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence 00124678999999998764 5789999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccc----------------cCCc---------ccccChhHHHHHHHHhh-CccccCCCCCh
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHL----------------KFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~----------------~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a 408 (552)
+||.+.+......++..+.... .++. ...++.++.+||.+||+ ||.+||+ +
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~ 274 (283)
T cd07835 198 PLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---A 274 (283)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---H
Confidence 9999887766555544321000 0110 13577899999999999 9999999 9
Q ss_pred hhhhcCCCc
Q 008810 409 DEIKVHPWF 417 (552)
Q Consensus 409 ~eil~HpfF 417 (552)
+||+.||||
T Consensus 275 ~~il~~~~~ 283 (283)
T cd07835 275 KAALQHPYF 283 (283)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.12 Aligned_cols=250 Identities=19% Similarity=0.330 Sum_probs=209.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
...+|++.+.||+|+||.||+|+++ ++..+|+|++.+... ....+..|+.+++.++||||+++++++.+....|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence 3457899999999999999999876 466899999875432 22357789999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++|++|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+||+++.+|++||+|||+++........
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 77 VTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred EEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999999999865 357899999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
. .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~ 196 (256)
T cd05059 157 S----------------------------------------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196 (256)
T ss_pred c----------------------------------------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhc
Confidence 0 001234567999999999999999999999999999999
Q ss_pred -CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|.+||...+..+....+... .....| ..++.++.+||.+||+ +|.+||+ +.+++..
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt---~~~~l~~ 254 (256)
T cd05059 197 EGKMPYERFSNSEVVESVSAG-YRLYRP--KLAPTEVYTIMYSCWHEKPEDRPA---FKKLLSQ 254 (256)
T ss_pred cCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHhcCChhhCcC---HHHHHHH
Confidence 89999888877777666542 222333 3689999999999998 9999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=336.59 Aligned_cols=251 Identities=31% Similarity=0.524 Sum_probs=211.9
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||+|+||.||+|....+|+.||+|.++........+.+.+.+|+.+++.++|++|++++++|.+.+..|+||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999998765555556778999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 196 Ey~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||++||+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999999854 34589999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 012356899999999999999999999999999999999
Q ss_pred hCCCCCCCCCh--hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 352 VGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 352 tG~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
+|..||..... ......+... .....|. ..++.++.++|.+||. +|.+||+ +.+|+
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp~---~~~il 259 (267)
T cd08224 201 ALQSPFYGDKMNLYSLCKKIEKC-DYPPLPA-DHYSEELRDLVSRCINPDPEKRPD---ISYVL 259 (267)
T ss_pred HCCCCcccCCccHHHHHhhhhcC-CCCCCCh-hhcCHHHHHHHHHHcCCCcccCCC---HHHHH
Confidence 99999976542 2233333321 1122332 2678899999999998 9999999 66655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=348.14 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=214.0
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|..++.||+|+||+||+|++..+|..||||++.............+.+|+.+++.++||||++++++|.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999999999999999999865444445556788899999999999999999999999999999999
Q ss_pred CCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 198 ~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
++ |+|..++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.+|.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence 96 567776654 46799999999999999999999999999999999999999999999999998753210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhhhHHHHHHhhC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEmltG 353 (552)
.....|++.|+|||++. ...++.++|+|||||++|+|++|
T Consensus 174 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 174 -------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred -------------------------------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 01356899999999985 35688999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
.+||.+.+......++..... ...+ ...++..+++||.+||. +|.+||+ +.+++.||||...+
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~ 280 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDS-PTLQ-SNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDR 280 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCC-CCCC-ccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 999998877666666553211 1111 23567889999999998 9999999 99999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=356.46 Aligned_cols=261 Identities=20% Similarity=0.304 Sum_probs=207.1
Q ss_pred eeeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCC
Q 008810 122 TMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 122 ~~IG~G--~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
..||+| +||+||+|+++.+|+.||||++...... ....+.+.+|+.+++.++|||||+++++|++...+|+||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 9999999999999999999998765332 3445778999999999999999999999999999999999999
Q ss_pred CCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccc
Q 008810 200 GGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (552)
Q Consensus 200 gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~ 277 (552)
+|+|..++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++++|||.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~--- 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK--- 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence 99999998764 4589999999999999999999999999999999999999999999999987643321100000
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhHHHHHHhhCCC
Q 008810 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
. .........++..|+|||++.+ .+|+.++|+|||||++|||++|.+
T Consensus 160 ------------~-------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 160 ------------V-------------------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred ------------c-------------------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 0 0000001245678999999986 458899999999999999999999
Q ss_pred CCCCCChhhHHHHHhhcccc-------------------------------------------ccCCcccccChhHHHHH
Q 008810 356 PFYSDDPMSTCRKIVNWRTH-------------------------------------------LKFPEEAKLSIEAKDLI 392 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~-------------------------------------------~~~p~~~~~s~e~~dLI 392 (552)
||.+.........++..... +..+....+++.+++||
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 288 (328)
T cd08226 209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288 (328)
T ss_pred CCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence 99887655554444321110 01111224677899999
Q ss_pred HHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 393 SKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 393 ~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
++||+ ||.+||+ +.|+++||||+.+
T Consensus 289 ~~~l~~dP~~Rpt---a~e~l~~~~~~~~ 314 (328)
T cd08226 289 ELCLQQDPEKRPS---ASSLLSHAFFKQV 314 (328)
T ss_pred HHHccCCcccCCC---HHHHhhCHHHHHH
Confidence 99999 9999999 9999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=331.93 Aligned_cols=256 Identities=34% Similarity=0.535 Sum_probs=220.0
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--ceEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYLI 194 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~lylV 194 (552)
+|.+.+.||+|+||.||+|....+++.|++|++...... ....+.+.+|+.+++.++||||+++++.+.+. ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 478899999999999999999999999999999765432 45567889999999999999999999999988 899999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++|++|.+++.....+++..+..++.+++.||.|||+.|++|+||+|+||+++.+|.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-- 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG-- 157 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--
Confidence 999999999999988889999999999999999999999999999999999999999999999999999866432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.......++..|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 158 -------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 158 -------------------------------------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred -------------------------------------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 0011356899999999999888999999999999999999999
Q ss_pred CCCCCCC-hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 355 PPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 355 ~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
.||...+ .......+........+|. .++.++++||.+||. +|.+||+ +.+++.||||
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 201 PPWSELGNPMAALYKIGSSGEPPEIPE--HLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred CCCCCCCchHHHHHhccccCCCcCCCc--ccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 9998765 3333333333223334443 678999999999999 9999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=330.38 Aligned_cols=251 Identities=36% Similarity=0.559 Sum_probs=217.4
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++.+.||+|+||.||+|....+++.||+|++..... .....+.+|..+++.++||+|+++++.|.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999976542 355678899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 197 YLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 197 y~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|++|++|.+++... ..+++..+..++.+++.||.+||..|++||||+|+||+++.+|.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999998775 6899999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.....|+..|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 154 --------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 195 (253)
T cd05122 154 --------------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195 (253)
T ss_pred --------------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 013578999999999998889999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
||...+.......+.. .....++....++.++.++|.+||. ||.+||+ +.+++.|||
T Consensus 196 p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 196 PYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred CCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 9988765555444433 2223334333458899999999998 9999999 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=338.47 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=203.7
Q ss_pred eeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 123 MIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~--k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
.||+|+||.||+|.. +.++..||||+++... ......+.+.+|+.+++.++||||+++++.+.+ +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 5678899999987543 233456678999999999999999999998864 567899999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~------- 152 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY------- 152 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-------
Confidence 9999999888889999999999999999999999999999999999999999999999999998653221000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~ 359 (552)
.......+++.|+|||++.+..++.++|+|||||++|||++ |.+||.+
T Consensus 153 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 153 -------------------------------KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred -------------------------------eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 00012345689999999988889999999999999999998 9999998
Q ss_pred CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
.+..+....+... .....|. .+++++++||.+||+ ||.+||+ +++|.
T Consensus 202 ~~~~~~~~~i~~~-~~~~~~~--~~~~~l~~li~~~~~~~p~~Rp~---~~~i~ 249 (257)
T cd05116 202 MKGNEVTQMIESG-ERMECPQ--RCPPEMYDLMKLCWTYGVDERPG---FAVVE 249 (257)
T ss_pred CCHHHHHHHHHCC-CCCCCCC--CCCHHHHHHHHHHhccCchhCcC---HHHHH
Confidence 8877777766543 2334443 689999999999999 9999999 55553
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=334.73 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=213.2
Q ss_pred eeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecC
Q 008810 122 TMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~ 198 (552)
+.||+|+||.||+|..... +..||+|++....... ....+.+|+.++..++|++|+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 8999999998664322 5677899999999999999999999999999999999999
Q ss_pred CCCchhhHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 199 PGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 199 ~gG~L~~~L~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
+||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999866432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
... .......+++.|+|||++....++.++|+|||||++||
T Consensus 159 ~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 199 (262)
T cd00192 159 DYY---------------------------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199 (262)
T ss_pred ccc---------------------------------------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHH
Confidence 100 00123568899999999998899999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|++ |..||...+..+....+.. ......|. .+++++.++|.+||+ +|.+||+ +.+++.|
T Consensus 200 l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~l~~~ 260 (262)
T cd00192 200 IFTLGATPYPGLSNEEVLEYLRK-GYRLPKPE--YCPDELYELMLSCWQLDPEDRPT---FSELVER 260 (262)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCc--cCChHHHHHHHHHccCCcccCcC---HHHHHHh
Confidence 999 6999999888777777765 22334443 679999999999999 9999999 8888865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=343.57 Aligned_cols=257 Identities=20% Similarity=0.349 Sum_probs=214.2
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 184 (552)
..+..++|++.+.||+|+||.||++..+.. ...+|+|++.... .......+.+|+.++..+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 346677899999999999999999998644 3789999987542 233456688999999999 89999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcc
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMR----------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLL 248 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~----------------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNIL 248 (552)
|.+...+|+||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 9999999999999999999999854 246889999999999999999999999999999999999
Q ss_pred ccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhh
Q 008810 249 LDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328 (552)
Q Consensus 249 l~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEv 328 (552)
++.++.+||+|||+++.+....... ......+++.|+|||+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~ 205 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR---------------------------------------KTTNGRLPVKWMAPEA 205 (293)
T ss_pred EcCCCeEEeCcccccccccccccee---------------------------------------ccCCCCCCccccCHHH
Confidence 9999999999999998654321100 0011235678999999
Q ss_pred hhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC
Q 008810 329 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 329 l~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
+.+..++.++|||||||++|||++ |..||.+....+.+..+... .....| ..++.++.+||.+||. ||.+||+
T Consensus 206 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps-- 280 (293)
T cd05053 206 LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRMEKP--QNCTQELYHLMRDCWHEVPSQRPT-- 280 (293)
T ss_pred hccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCcC--
Confidence 999999999999999999999997 99999988877777666542 222333 3678899999999999 9999999
Q ss_pred ChhhhhcC
Q 008810 407 GADEIKVH 414 (552)
Q Consensus 407 ~a~eil~H 414 (552)
+.+|+.+
T Consensus 281 -~~eil~~ 287 (293)
T cd05053 281 -FKQLVED 287 (293)
T ss_pred -HHHHHHH
Confidence 8888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=336.35 Aligned_cols=244 Identities=24% Similarity=0.354 Sum_probs=203.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG 201 (552)
+.||+|+||.||+|.++.+|+.||+|.+.+.. .......+.+|..+|+.++||||++++++|.+...+|+||||++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36999999999999999999999999986432 2334567889999999999999999999999999999999999999
Q ss_pred chhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 202 DMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 202 ~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence 999999664 468999999999999999999999999999999999999999999999999987543211000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~ 359 (552)
......++..|+|||++.+..++.++|+|||||++|||++ |.+||..
T Consensus 152 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 152 --------------------------------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred --------------------------------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 0001123567999999999899999999999999999997 9999987
Q ss_pred CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
.........+... ....+| ..++..+.+||.+||+ +|.+||+ +.+|+
T Consensus 200 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~~~ 247 (252)
T cd05084 200 LSNQQTREAIEQG-VRLPCP--ELCPDAVYRLMERCWEYDPGQRPS---FSTVH 247 (252)
T ss_pred cCHHHHHHHHHcC-CCCCCc--ccCCHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 7776665555432 223333 3678999999999999 9999999 77765
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=342.86 Aligned_cols=253 Identities=22% Similarity=0.386 Sum_probs=212.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+...+|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|++++..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 45568899999999999999999753 356789999987543 3445678999999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKD---------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~---------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~ 252 (552)
....|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999987643 48899999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC
Q 008810 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (552)
Q Consensus 253 g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~ 332 (552)
+++||+|||+++.+...... .......+++.|+|||++.+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~ 199 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYY---------------------------------------RVGGRTMLPIRWMPPESILYR 199 (280)
T ss_pred CCEEECCCCceeEcCCCcee---------------------------------------ecCCCccccccccCHHHhccC
Confidence 99999999998755321100 001124567899999999999
Q ss_pred CCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhh
Q 008810 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (552)
Q Consensus 333 ~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~e 410 (552)
.++.++|+|||||++|||++ |.+||...........+..+. ....| ..+++.+.+||.+||+ ||.+||+ +.+
T Consensus 200 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~P~~Rp~---~~~ 273 (280)
T cd05092 200 KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERP--RTCPPEVYAIMQGCWQREPQQRMV---IKD 273 (280)
T ss_pred CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCC--CCCCHHHHHHHHHHccCChhhCCC---HHH
Confidence 99999999999999999998 999998888777777776532 23333 3688999999999999 9999999 777
Q ss_pred hhc
Q 008810 411 IKV 413 (552)
Q Consensus 411 il~ 413 (552)
|+.
T Consensus 274 l~~ 276 (280)
T cd05092 274 IHS 276 (280)
T ss_pred HHH
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.48 Aligned_cols=247 Identities=22% Similarity=0.390 Sum_probs=210.8
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..+..+.+.+++.||+|-||+||+|.++.+ ..||+|.++...+ ..+.+.+|++||+++.|++||+||+++..++.
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 344455567788999999999999998643 3789999986533 23457899999999999999999999999889
Q ss_pred EEEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 191 LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+|||||||+.|+|.++|.. ...+...+...+++||+.|++||+++++|||||-..|||+++++.+||+|||||+.+..
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999999986 56799999999999999999999999999999999999999999999999999996543
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
+.+... ...--..-|.|||.+....++.++|||||||+||
T Consensus 356 ~~Y~~~----------------------------------------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~ 395 (468)
T KOG0197|consen 356 DEYTAS----------------------------------------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLW 395 (468)
T ss_pred Cceeec----------------------------------------CCCCCCceecCHHHHhhCCcccccceeehhhhHH
Confidence 322110 0011234699999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
||+| |+.||.+.+..+....+-.+ ..+|....+|+++-+|+..|+. +|++||+.
T Consensus 396 E~fT~G~~py~~msn~ev~~~le~G---yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 396 ELFTYGRVPYPGMSNEEVLELLERG---YRLPRPEGCPDEVYELMKSCWHEDPEDRPTF 451 (468)
T ss_pred HHhccCCCCCCCCCHHHHHHHHhcc---CcCCCCCCCCHHHHHHHHHHhhCCcccCCCH
Confidence 9998 99999999999998888753 3444445899999999999999 99999993
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=346.65 Aligned_cols=268 Identities=30% Similarity=0.475 Sum_probs=211.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 187 (552)
.++|++++.||.|+||.||+|.++.+++.||||++...... ......+.+|+.+++.++||||+++++.+.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 57899999999999999999999999999999998765321 2223456789999999999999999987743
Q ss_pred -CceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 188 -DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 188 -~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...+|+||||+.+ +|...+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 3457999999965 67766654 45799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 344 (552)
.......... .... ........+||+.|+|||++.+ ..++.++|+||||
T Consensus 165 ~~~~~~~~~~--------------~~~~----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 214 (311)
T cd07866 165 YDGPPPNPKG--------------GGGG----------------GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG 214 (311)
T ss_pred ccCCCccccc--------------CCcc----------------cccccccceeccCcCChHHhhCCCccCchhHhHHHH
Confidence 5432110000 0000 0001224678999999999876 4589999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhccccc---------------------cCCc-----ccccChhHHHHHHHHhh-
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE-----EAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~-----~~~~s~e~~dLI~~lL~- 397 (552)
|++|||++|++||.+.+.......+....... ..|. ...+++++.+||.+||.
T Consensus 215 ~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 294 (311)
T cd07866 215 CVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294 (311)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHccc
Confidence 99999999999999888776666554321110 0010 02355789999999999
Q ss_pred CccccCCCCChhhhhcCCCc
Q 008810 398 NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~HpfF 417 (552)
||.+||+ +.+++.||||
T Consensus 295 ~p~~R~t---~~ell~~~~f 311 (311)
T cd07866 295 DPYKRLT---ASDALEHPYF 311 (311)
T ss_pred CcccCcC---HHHHhcCCCC
Confidence 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=340.57 Aligned_cols=253 Identities=19% Similarity=0.306 Sum_probs=208.8
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
+..++|++++.||+|+||.||+|++..+|+ .||+|+++... .......+.+|+.++..++||||+++++++.+.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 567889999999999999999999887776 48999987543 233345688899999999999999999998754
Q ss_pred ceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
..++||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||+++.+.
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 57899999999999999976 4579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... ......+++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05109 161 IDETEY---------------------------------------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTV 201 (279)
T ss_pred ccccee---------------------------------------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHH
Confidence 221000 00122456789999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++ |.+||...........+... ..... ...++.++.+||.+||. ||.+||+ +.+++.
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~dp~~Rp~---~~~l~~ 263 (279)
T cd05109 202 WELMTFGAKPYDGIPAREIPDLLEKG-ERLPQ--PPICTIDVYMIMVKCWMIDSECRPR---FRELVD 263 (279)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHCC-CcCCC--CccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 99998 99999877665555444432 22222 34688999999999998 9999999 777774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=337.50 Aligned_cols=254 Identities=21% Similarity=0.323 Sum_probs=213.0
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..++|++.+.||+|+||.||+|+.+.+ ...||||+++... .......+.+|+.++..++||||+++++++.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 457899999999999999999998654 4589999987543 23345568889999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.|+||||++||+|.+++... +.+++..+..++.+++.||.|||+.||+||||||+|||++.++++||+|||+++.+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999998664 57999999999999999999999999999999999999999999999999999876411
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
... .......+++.|+|||.+.+..++.++|+|||||++|+
T Consensus 160 ~~~---------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~ 200 (266)
T cd05033 160 EAT---------------------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200 (266)
T ss_pred ccc---------------------------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHH
Confidence 100 00112345788999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|++ |..||...........+... ...|....++..+.+||.+||. +|.+||+ +.+|++|
T Consensus 201 l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~---~~ei~~~ 261 (266)
T cd05033 201 VMSYGERPYWDMSNQDVIKAVEDG---YRLPPPMDCPSALYQLMLDCWQKDRNERPT---FSQIVST 261 (266)
T ss_pred HHccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 998 99999887777777666542 1223234688999999999999 9999999 8887754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.43 Aligned_cols=255 Identities=20% Similarity=0.324 Sum_probs=212.9
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+...+|++++.||+|+||.||+|....+ ++.||||+++... .....+.+..|..++..++|||||++++++.+
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 3456788899999999999999987543 5789999997542 22334668899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMR----------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK 251 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~----------------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~ 251 (552)
...+++++||+++++|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 9999999999999999999853 235888899999999999999999999999999999999999
Q ss_pred CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc
Q 008810 252 YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (552)
Q Consensus 252 ~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~ 331 (552)
++.+||+|||+++.+...... .......+++.|+|||++.+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYY---------------------------------------KLMGNSLLPIRWMSPEAIMY 200 (283)
T ss_pred CCceEecccccccccccchhe---------------------------------------eeccCccCCccccCHHHHhc
Confidence 999999999998865321100 00113456889999999998
Q ss_pred CCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChh
Q 008810 332 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (552)
Q Consensus 332 ~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ 409 (552)
..++.++|||||||++|||++ |.+||.+....+....+.... ...+| ..++.++.+||.+||. +|.+||+ +.
T Consensus 201 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~RP~---~~ 274 (283)
T cd05091 201 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCP--DDCPAWVYTLMLECWNEFPSRRPR---FK 274 (283)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHhCCCcccCCC---HH
Confidence 899999999999999999998 999999888887777776532 23334 3689999999999998 9999999 88
Q ss_pred hhhcC
Q 008810 410 EIKVH 414 (552)
Q Consensus 410 eil~H 414 (552)
+|+..
T Consensus 275 ~i~~~ 279 (283)
T cd05091 275 DIHSR 279 (283)
T ss_pred HHHHH
Confidence 88753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.45 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=207.7
Q ss_pred eeEEeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 118 FELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
|.+.+.||+|+||.||+|.... ++..||||+++... ........+.+|+.+|+.++||||+++++.+.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5678899999999999998765 34789999987543 23345667899999999999999999998876544
Q ss_pred -eEEEEEecCCCCchhhHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
..++||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 379999999999999998432 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
++.+....... ......++..|+|||++.+..++.++||||
T Consensus 160 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~S 200 (273)
T cd05035 160 SKKIYSGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRVYTSKSDVWA 200 (273)
T ss_pred eeecccccccc---------------------------------------ccccccCCccccCHhhcccCCCCcccchHH
Confidence 98653221100 001123567899999998899999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 343 lGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++|||++ |.+||.+.+..+.+..+... .....|. .++.++.+||.+||. ||.+||+ +.+++.+
T Consensus 201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~---~~e~~~~ 268 (273)
T cd05035 201 FGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQPE--DCLDELYDLMYSCWRADPKDRPT---FTKLREV 268 (273)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCc--CCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 9999999999 99999988887777766653 2334443 689999999999999 9999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=345.69 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=212.6
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 184 (552)
.++..++|.+.+.||+|+||.||+|.+ ..++..||+|++++.. .....+.+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 456677899999999999999999975 3356689999987543 233456789999999999 89999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
|.+.+.+|+||||+++|+|..++.+.. .+++..+..++.+++.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997543 389999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
++.+...... .......+++.|+|||++.+..++.++||||
T Consensus 188 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 228 (302)
T cd05055 188 ARDIMNDSNY---------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWS 228 (302)
T ss_pred cccccCCCce---------------------------------------eecCCCCcccccCCHhhhccCCCCcHhHHHH
Confidence 9855321100 0001235678999999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 343 lGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++|||++ |.+||.+........+.+........| ..+++++.+||.+||. +|.+||+ +.||+.
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt---~~ell~ 296 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP--EHAPAEIYDIMKTCWDADPLKRPT---FKQIVQ 296 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC--CCCCHHHHHHHHHHcCCCchhCcC---HHHHHH
Confidence 9999999998 999998877666655555422222222 3678999999999998 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.65 Aligned_cols=274 Identities=26% Similarity=0.437 Sum_probs=216.9
Q ss_pred CCeeE-EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhh-----------HHHHHHHHHHHHHhcCCCceEEEee
Q 008810 116 DDFEL-LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-----------QVEHVRAERNLLAEVDSNCIVKLYC 183 (552)
Q Consensus 116 ~~f~~-~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~-----------~~~~~~~E~~iL~~l~hp~Iv~l~~ 183 (552)
++|.. .+.||.|+||.||+|.++.+|+.||+|++......... ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 47799999999999999999999999999765432210 0124678999999999999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
+|...+.+|+||||+. |+|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 689999988888999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 342 (552)
............. ..... .. +.......+++.|+|||++.+. .++.++|+||
T Consensus 167 ~~~~~~~~~~~~~-----------~~~~~---------------~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 219 (335)
T PTZ00024 167 RRYGYPPYSDTLS-----------KDETM---------------QR-REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219 (335)
T ss_pred eeccccccccccc-----------ccccc---------------cc-cccccccccccCCCCChhcccCCCCCcHHHHHH
Confidence 8764332110000 00000 00 0011234689999999999764 4799999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHHHHhhcccc---------ccCC----------c-----ccccChhHHHHHHHHhh-
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH---------LKFP----------E-----EAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~---------~~~p----------~-----~~~~s~e~~dLI~~lL~- 397 (552)
|||++|||++|.+||.+.+..+.+..+...... ...| . ...++.++.+||.+||.
T Consensus 220 lG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 999999999999999998887777666542110 0000 0 02457889999999999
Q ss_pred CccccCCCCChhhhhcCCCcCCC
Q 008810 398 NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+|.+||+ ++|++.||||++.
T Consensus 300 ~P~~R~s---~~~~l~~~~~~~~ 319 (335)
T PTZ00024 300 NPLERIS---AKEALKHEYFKSD 319 (335)
T ss_pred CchhccC---HHHHhcCcccCCC
Confidence 9999999 9999999999864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=331.36 Aligned_cols=253 Identities=32% Similarity=0.599 Sum_probs=220.6
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|.+.+.||.|+||.||+|.+..+++.||+|++..... .......+..|+++++.++|||++++++.+.+....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999999999999999976542 23445568899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 197 YLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 197 y~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
|++|++|..++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999999763 789999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
......+|++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 158 ---------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 158 ---------------------------------------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred ---------------------------------------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc
Confidence 01123578999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|..||...+.......+... ....+|. .++.++.++|.+||. +|.+||+ +.+++.||||
T Consensus 199 g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 199 LKHPFEGENLLELALKILKG-QYPPIPS--QYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcC-CCCCCCC--CCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 99999888777666666542 2223333 688999999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.73 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=214.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF---- 190 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~---- 190 (552)
.++|++.+.||+|+||.||+|++..+++.||||++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 568999999999999999999999999999999987542 223345667889999999999999999988876654
Q ss_pred --EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 191 --LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 191 --lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+|+||||+ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 7799888864 5799999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
. ....+||+.|+|||++.+ ..++.++|+|||||++
T Consensus 171 ~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l 206 (343)
T cd07851 171 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred c--------------------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHH
Confidence 1 013468899999999876 4688999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhcccccc--------------------------CCc-ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLK--------------------------FPE-EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~--------------------------~p~-~~~~s~e~~dLI~~lL~-dp 399 (552)
|||++|++||.+.+....+..+.+...... ++. ...+++++.+||.+||+ ||
T Consensus 207 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P 286 (343)
T cd07851 207 AELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDP 286 (343)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCCh
Confidence 999999999998887777666654211100 000 02368899999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCC
Q 008810 400 NQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+||+ +.+|+.||||...
T Consensus 287 ~~Rpt---~~ell~h~~~~~~ 304 (343)
T cd07851 287 DKRIT---AAEALAHPYLAEY 304 (343)
T ss_pred hhCCC---HHHHhcCCCcccc
Confidence 99999 9999999999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.34 Aligned_cols=255 Identities=31% Similarity=0.516 Sum_probs=212.7
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--ceEEEEE
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYLIM 195 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~~lylVm 195 (552)
|++++.||.|+||.||+|....+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++.+. ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999998764 2334456688899999999999999999999988 8999999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||+++ +|..++.+. ..+++..+..++.||+.||.|||+.|++|+||||+|||++.+|.+||+|||++.........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 99974 888888665 58999999999999999999999999999999999999999999999999999865322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG 353 (552)
......++..|+|||.+.+ ..++.++|+|||||++|||++|
T Consensus 157 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 157 --------------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred --------------------------------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC
Confidence 0112467889999998775 4689999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccc---cCCcc-----------------------cc-cChhHHHHHHHHhh-CccccCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHL---KFPEE-----------------------AK-LSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~---~~p~~-----------------------~~-~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
++||...+.......+....... .+|.. .. ++.++.++|.+||+ +|.+||+
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~- 277 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS- 277 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC-
Confidence 99999888776666655321100 00000 11 38899999999999 9999999
Q ss_pred CChhhhhcCCCc
Q 008810 406 KGADEIKVHPWF 417 (552)
Q Consensus 406 ~~a~eil~HpfF 417 (552)
+.+++.||||
T Consensus 278 --~~~~l~~~~~ 287 (287)
T cd07840 278 --ADQALQHEYF 287 (287)
T ss_pred --HHHHhhCcCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.17 Aligned_cols=249 Identities=20% Similarity=0.330 Sum_probs=212.6
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
...+|++++.||.|+||.||+|..+. +..+|+|++.+... .....+..|+.+|+.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 34579999999999999999999987 88999999976542 234468889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 194 IMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+++|+|.+++... ..+++..+..++.+|+.||.|||+.||+||||||+|||++.++.+||+|||++..+.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999753 4689999999999999999999999999999999999999999999999999976532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
. ..+..+++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 160 ~-----------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~ 198 (261)
T cd05148 160 L-----------------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMF 198 (261)
T ss_pred c-----------------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 0 01234677899999999889999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 352 t-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+ |..||.+.+..+++..+... ...|....+++++.++|.+||+ ||.+||+ +.+|.+
T Consensus 199 ~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~l~~ 256 (261)
T cd05148 199 TYGQVPYPGMNNHEVYDQITAG---YRMPCPAKCPQEIYKIMLECWAAEPEDRPS---FKALRE 256 (261)
T ss_pred cCCCCCCCcCCHHHHHHHHHhC---CcCCCCCCCCHHHHHHHHHHcCCCchhCcC---HHHHHH
Confidence 8 89999988888887777642 2223334789999999999999 9999999 666653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=351.95 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=210.8
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD----- 188 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~----- 188 (552)
..++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.++..++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 35789999999999999999999999999999999976421 223345678899999999999999999988643
Q ss_pred -ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 -EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 -~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
...|+|++++ |++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++...
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3578999987 8899887754 569999999999999999999999999999999999999999999999999987532
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvi 346 (552)
.. .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 172 ~~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i 207 (345)
T cd07877 172 DE--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207 (345)
T ss_pred cc--------------------------------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHH
Confidence 11 013468999999999876 578999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHhhcccc---------------------ccCCc------ccccChhHHHHHHHHhh-C
Q 008810 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTH---------------------LKFPE------EAKLSIEAKDLISKLLC-N 398 (552)
Q Consensus 347 lyEmltG~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~e~~dLI~~lL~-d 398 (552)
+|||++|.+||.+.+.......++..... ...|. ....++++++||.+||+ |
T Consensus 208 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 287 (345)
T cd07877 208 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 287 (345)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCC
Confidence 99999999999887765555444331110 00111 01357889999999999 9
Q ss_pred ccccCCCCChhhhhcCCCcCC
Q 008810 399 VNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 399 p~~Rl~~~~a~eil~HpfF~~ 419 (552)
|.+|++ +.+++.||||+.
T Consensus 288 p~~R~t---~~e~l~h~~f~~ 305 (345)
T cd07877 288 SDKRIT---AAQALAHAYFAQ 305 (345)
T ss_pred hhhcCC---HHHHhcChhhhh
Confidence 999999 999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=337.58 Aligned_cols=254 Identities=21% Similarity=0.338 Sum_probs=211.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
...+|++.+.||+|+||.||+|.++.++. .+|+|.++... .......+.+|+.+|..++||||+++++++.+++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35689999999999999999999875543 79999987543 23345678899999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999764 56899999999999999999999999999999999999999999999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.... .......++..|+|||++.+..++.++|+|||||++||
T Consensus 160 ~~~~--------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~e 201 (267)
T cd05066 160 PEAA--------------------------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201 (267)
T ss_pred ccee--------------------------------------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHH
Confidence 1000 00011234678999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|++ |..||...+..+....+... ...|....+++.+.+||.+||+ +|.+||+ +.+|+.
T Consensus 202 ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~~ 261 (267)
T cd05066 202 VMSYGERPYWEMSNQDVIKAIEEG---YRLPAPMDCPAALHQLMLDCWQKDRNERPK---FEQIVS 261 (267)
T ss_pred HhcCCCCCcccCCHHHHHHHHhCC---CcCCCCCCCCHHHHHHHHHHcccCchhCCC---HHHHHH
Confidence 886 99999888777776666642 2334334688999999999998 9999999 666653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=312.72 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=217.2
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|..++.||+|+||+||+|+.+.+++.||+|.++-..- ..+--....+|+-+|++++|.|||+|++....+..+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 35556789999999999999999999999999976532 22333457889999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 197 y~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|| ..+|..+... ++.++.+.++.++.|++.||.++|+++++||||||.|+||+.+|.+||+|||+++.+....
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----- 155 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----- 155 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-----
Confidence 99 5678877755 5789999999999999999999999999999999999999999999999999999764321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccc-ccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhh-
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY-STVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV- 352 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~-s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmlt- 352 (552)
.++ .-+-|.+|.+|.++.+ +-|+...|+||.|||+.|+..
T Consensus 156 -------------------------------------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelana 198 (292)
T KOG0662|consen 156 -------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_pred -------------------------------------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhc
Confidence 122 2478999999999998 559999999999999999995
Q ss_pred CCCCCCCCChhhHHHHHhh---------ccccccCCcc----------------cccChhHHHHHHHHhh-CccccCCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVN---------WRTHLKFPEE----------------AKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~---------~~~~~~~p~~----------------~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
|+|.|.+.+..+.+.+|.. |...-++|+. +.++...+||+.+||. +|.+|++
T Consensus 199 grplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris-- 276 (292)
T KOG0662|consen 199 GRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS-- 276 (292)
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC--
Confidence 9999999999888888864 4332222221 2456678999999996 9999999
Q ss_pred ChhhhhcCCCcCCC
Q 008810 407 GADEIKVHPWFDGV 420 (552)
Q Consensus 407 ~a~eil~HpfF~~i 420 (552)
|++.++||||.+.
T Consensus 277 -aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 277 -AEAALQHPYFSDF 289 (292)
T ss_pred -HHHHhcCcccccc
Confidence 9999999999764
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=334.76 Aligned_cols=249 Identities=20% Similarity=0.344 Sum_probs=209.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++.+.||+|+||.||+|... +++.||||.++.... ..+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 55678999999999999999999865 456899999876532 2345788999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+||||++||+|.+++.... .+++..+..++.+++.||.|||+.||+||||||+|||++.+|.+||+|||+++.+....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997644 79999999999999999999999999999999999999999999999999998764211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
... .....++..|+|||++.+..++.++|+|||||++|||
T Consensus 158 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 197 (261)
T cd05068 158 YEA----------------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197 (261)
T ss_pred ccc----------------------------------------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHH
Confidence 000 0012234689999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
++ |.+||.+.+.......+... ..+..+ ..++..+.+||.+||. +|.+||+ +.+|.
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~P~~Rp~---~~~l~ 255 (261)
T cd05068 198 VTYGRMPYPGMTNAEVLQQVDQG-YRMPCP--PGCPKELYDIMLDCWKEDPDDRPT---FETLQ 255 (261)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHhhcCcccCCC---HHHHH
Confidence 99 99999988877777766542 222233 3678999999999998 9999999 66654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=361.26 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=208.3
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..+...-+.-||.|+.|.||+|+.+ ++.||||+++.- -..++.-|++++||||+.+.++|...-.+|
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 33334444667999999999999876 669999987522 123555688999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||||+.|-|..+|.....++......+..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||-++.....
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--- 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--- 265 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998865321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
....+++||..|||||++.+.+.+.++|||||||+||||||
T Consensus 266 ---------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT 306 (904)
T KOG4721|consen 266 ---------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT 306 (904)
T ss_pred ---------------------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh
Confidence 11347999999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|..||..-+...++.-+-. ..+.+|-...++.-++=||++||. .|.+||+ +.+|+.|
T Consensus 307 ~EiPYkdVdssAIIwGVGs--NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPS---Frqil~H 364 (904)
T KOG4721|consen 307 GEIPYKDVDSSAIIWGVGS--NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPS---FRQILLH 364 (904)
T ss_pred cCCCccccchheeEEeccC--CcccccCcccCchHHHHHHHHHHhcCCCCCcc---HHHHHHH
Confidence 9999988776655444433 344444445899999999999998 9999999 8889888
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.48 Aligned_cols=231 Identities=31% Similarity=0.509 Sum_probs=195.8
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCchhhH
Q 008810 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206 (552)
Q Consensus 127 G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~ 206 (552)
|.||+||+|+++.+|+.||+|++.+... ...|+..+....||||+++++++++.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 23345555566799999999999999999999999999999999
Q ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCC
Q 008810 207 LMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286 (552)
Q Consensus 207 L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~ 286 (552)
+.+...+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++..+...
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------------- 138 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------------- 138 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------------
Confidence 988888999999999999999999999999999999999999999999999999987654211
Q ss_pred CCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHH
Q 008810 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTC 366 (552)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~ 366 (552)
.....++..|+|||.+.+..++.++|+||+||++|||++|++||......
T Consensus 139 ---------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--- 188 (237)
T cd05576 139 ---------------------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--- 188 (237)
T ss_pred ---------------------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---
Confidence 01245678899999998888999999999999999999999998643211
Q ss_pred HHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCc
Q 008810 367 RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWF 417 (552)
Q Consensus 367 ~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF 417 (552)
......+.+|. .+++.+++||.+||+ ||.+|+++ .++++++.||||
T Consensus 189 ---~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 189 ---INTHTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ---cccccccCCcc--cCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 11112334553 689999999999998 99999985 346999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=343.17 Aligned_cols=249 Identities=22% Similarity=0.377 Sum_probs=207.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCc--EEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ly 192 (552)
++|++.++||+|+||.||+|..+.++. .+|+|.++.. ......+.+.+|+.++.++ +||||+++++++.+...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999887765 4688887632 2233456688899999998 7999999999999999999
Q ss_pred EEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEE
Q 008810 193 LIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iK 256 (552)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999999653 2488999999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCC
Q 008810 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (552)
Q Consensus 257 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~ 336 (552)
|+|||++........ .....++..|+|||++.+..++.
T Consensus 160 l~dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ 197 (297)
T cd05089 160 IADFGLSRGEEVYVK------------------------------------------KTMGRLPVRWMAIESLNYSVYTT 197 (297)
T ss_pred ECCcCCCccccceec------------------------------------------cCCCCcCccccCchhhccCCCCc
Confidence 999999863211000 00122355799999999999999
Q ss_pred ccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 337 ECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 337 ~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
++|||||||++|||++ |.+||.+.+......++... .....| ..++.++++||.+||. +|.+||+ +++|+..
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~~~ 271 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKP--RNCDDEVYELMRQCWRDRPYERPP---FAQISVQ 271 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 9999999999999997 99999998887777776542 122233 3688999999999999 9999999 8887654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=335.05 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=212.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
+..++|+..+.||+|+||.||+|+.+.++. .+|||++.... .....+.+..|+.++..++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456789999999999999999999876665 79999986542 2234556889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..|+||||+++|+|..++... +.+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999998653 6799999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
..... . ......+++.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~--~------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ 201 (268)
T cd05063 160 DPEGT--Y------------------------------------TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201 (268)
T ss_pred ccccc--e------------------------------------eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHH
Confidence 21000 0 000123456799999999989999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||++ |..||...+.......+... ...|....++.++.+||.+||. +|.+||+ +.+|++
T Consensus 202 ell~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~---~~~i~~ 262 (268)
T cd05063 202 EVMSFGERPYWDMSNHEVMKAINDG---FRLPAPMDCPSAVYQLMLQCWQQDRARRPR---FVDIVN 262 (268)
T ss_pred HHHhCCCCCCCcCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHHH
Confidence 9997 99999888877777666542 2333334688999999999998 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.82 Aligned_cols=259 Identities=20% Similarity=0.336 Sum_probs=211.3
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEE
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVK 180 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~ 180 (552)
.+..+..++|.+.+.||+|+||.||+|++.. ++..||+|++.... .......+..|+.++..+ +||||++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 3445666889999999999999999998643 23579999997542 223345688899999999 8999999
Q ss_pred EeeeecCCceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCC
Q 008810 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244 (552)
Q Consensus 181 l~~~f~d~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKP 244 (552)
++++|.+.+.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 999999999999999999999999999754 2488899999999999999999999999999999
Q ss_pred CCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCC
Q 008810 245 DNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324 (552)
Q Consensus 245 eNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~ 324 (552)
+|||++.++++||+|||+++.+....... ......+++.|+
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~ 209 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWM 209 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhh---------------------------------------ccccCCCcccee
Confidence 99999999999999999987553211000 000123457899
Q ss_pred ChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-Ccccc
Q 008810 325 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 325 APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|||++.+..++.++|+|||||++|||++ |.+||.+.+..+....+.. ......| ..++.++++||.+||. +|.+|
T Consensus 210 aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~R 286 (307)
T cd05098 210 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GHRMDKP--SNCTNELYMMMRDCWHAVPSQR 286 (307)
T ss_pred ChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc-CCCCCCC--CcCCHHHHHHHHHHcccChhhC
Confidence 9999999999999999999999999998 9999988776666555543 2223344 3688999999999998 99999
Q ss_pred CCCCChhhhhcC
Q 008810 403 LGAKGADEIKVH 414 (552)
Q Consensus 403 l~~~~a~eil~H 414 (552)
|+ +.+|+.+
T Consensus 287 ps---~~evl~~ 295 (307)
T cd05098 287 PT---FKQLVED 295 (307)
T ss_pred cC---HHHHHHH
Confidence 99 7777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=344.78 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=212.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|..++.||+|+||.||+|+++.++..||+|.+.............+..|+.+++.++||||+++++++.+....|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 47778889999999999999999999999999875433334445668889999999999999999999999999999999
Q ss_pred cCCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 197 YLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 197 y~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|+. |+|..++. ....+++..+..++.+++.||.|||+.|++||||||+|||++.+|.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------ 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc------
Confidence 996 57777664 4567999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhhHHHHHHhh
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvilyEmlt 352 (552)
....||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 169 ---------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 209 (308)
T cd06634 169 ---------------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (308)
T ss_pred ---------------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence 13468999999999863 457889999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|..||...+.......+.... ........++..+++||.+||. +|.+||+ +++++.||||...
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~ 273 (308)
T cd06634 210 RKPPLFNMNAMSALYHIAQNE--SPALQSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 273 (308)
T ss_pred CCCCCccccHHHHHHHHhhcC--CCCcCcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCcccccc
Confidence 999998877665555554321 1111123678899999999998 9999999 9999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=331.22 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=218.1
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+|++.+.||.|+||.||+|+++.+|+.||||++.+.... ......+..|..+++.++||||++++++|.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 588999999999999999999999999999999876542 3445567789999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 197 YLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 197 y~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
|++|++|..++.+ ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999999999866 3678999999999999999999999999999999999999999999999999997653210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.....|++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 158 -----------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 158 -----------------------------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -----------------------------------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh
Confidence 113468899999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|++||...+.......+... .....+ ..++.+++++|.+||. +|.+||+ +.++++||+.
T Consensus 197 g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRG-KYPPIP--PIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcC-CCCCCc--hhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 99999988876666555432 112233 3688999999999998 9999999 9999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=342.69 Aligned_cols=260 Identities=29% Similarity=0.503 Sum_probs=212.0
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc---
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--- 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~--- 189 (552)
...++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456789999999999999999999999999999999976432 2233356778999999999999999999987655
Q ss_pred -------eEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccc
Q 008810 190 -------FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (552)
Q Consensus 190 -------~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFG 261 (552)
.+|+||||+++ ++..++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999976 66666654 3579999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccch
Q 008810 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340 (552)
Q Consensus 262 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 340 (552)
++..+...... ......+++.|+|||++.+ ..++.++||
T Consensus 162 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 201 (302)
T cd07864 162 LARLYNSEESR----------------------------------------PYTNKVITLWYRPPELLLGEERYGPAIDV 201 (302)
T ss_pred ccccccCCccc----------------------------------------ccccceeccCccChHHhcCCCCCCchhHH
Confidence 99865422100 0012356889999999875 457899999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccc---ccCC-----------------------cccccChhHHHHHHH
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH---LKFP-----------------------EEAKLSIEAKDLISK 394 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~---~~~p-----------------------~~~~~s~e~~dLI~~ 394 (552)
|||||++|||++|++||...+..+....+...... ..+| ....++..+.+||.+
T Consensus 202 ~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 281 (302)
T cd07864 202 WSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDH 281 (302)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHH
Confidence 99999999999999999987776666555432110 0000 012468899999999
Q ss_pred Hhh-CccccCCCCChhhhhcCCCc
Q 008810 395 LLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 395 lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
||. ||.+||+ +.+|+.||||
T Consensus 282 ~l~~~P~~Rp~---~~~il~~~~~ 302 (302)
T cd07864 282 MLTLDPSKRCT---AEEALNSPWL 302 (302)
T ss_pred HccCChhhCCC---HHHHhcCCCC
Confidence 999 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=342.17 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=210.9
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
..+..++|++.+.||+|+||.||+|.++.+|+.||||++++... ......+..|+.++... +||||++++++|.+..
T Consensus 10 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred ccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 34667899999999999999999999999999999999986532 22234455566666555 5999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|+||||++ +.|..++.. ...+++..+..++.+++.||.|||+ .||+||||+|+||+++.++.+||+|||++..+.
T Consensus 88 ~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 88 DVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9999999985 577777654 4579999999999999999999997 699999999999999999999999999987543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC----CCCccchhhh
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSL 343 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~----y~~~~DiWSl 343 (552)
.... .....|++.|+|||++.+.. ++.++|||||
T Consensus 167 ~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl 204 (296)
T cd06618 167 DSKA------------------------------------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL 204 (296)
T ss_pred CCCc------------------------------------------ccCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence 2110 01235788999999997653 8899999999
Q ss_pred hHHHHHHhhCCCCCCCCCh-hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 344 GAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||++|+|++|+.||..... .+.+..++... ....+....++.++.+||.+||. ||.+||+ +++|+.||||..
T Consensus 205 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 278 (296)
T cd06618 205 GISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhc
Confidence 9999999999999976433 34455555422 22333333578899999999998 9999999 999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=336.82 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=205.7
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCc--EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------c
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------E 189 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------~ 189 (552)
|.+.+.||+|+||.||+|+...++. .||||.++... ......+.+..|..+|+.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3467889999999999999887775 59999987643 2345567889999999999999999999876321 2
Q ss_pred eEEEEEecCCCCchhhHHhh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMR------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
..++||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++++||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 235899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+.+....... ......+++.|+|||++.+..++.++|||||
T Consensus 160 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 160 KKIYNGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred cccCccccee---------------------------------------cCCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 8653221000 0012346788999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 344 GAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 344 GvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
||++|||++ |.+||.+.........+.... ....+ ..++..+++||.+||+ ||.+||+ +.+|+.+
T Consensus 201 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~l~~~ 267 (272)
T cd05075 201 GVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQP--PDCLDGLYSLMSSCWLLNPKDRPS---FETLRCE 267 (272)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 999999999 899998887777777666532 22333 3688899999999999 9999999 8887653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=333.92 Aligned_cols=250 Identities=20% Similarity=0.359 Sum_probs=209.9
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|.+++.||+|+||.||+|+... +..||+|.+..... ..+.+.+|..++..++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 35679999999999999999998754 44699999875432 23458889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999998763 47899999999999999999999999999999999999999999999999998755321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
. .....++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 157 ~----------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~ 196 (256)
T cd05113 157 S----------------------------------------SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196 (256)
T ss_pred e----------------------------------------cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhc
Confidence 0 012346678999999998889999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|..||...+.......+.+... ...| ...+..+++||.+||. ||.+||+ +.+|+.+
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~ll~~ 254 (256)
T cd05113 197 LGKMPYERFNNSETVEKVSQGLR-LYRP--HLASEKVYAIMYSCWHEKAEERPT---FQQLLSS 254 (256)
T ss_pred CCCCCcCcCCHHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcCCCcccCCC---HHHHHHh
Confidence 9999988887777777765322 2223 3568899999999998 9999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=331.27 Aligned_cols=262 Identities=26% Similarity=0.438 Sum_probs=221.8
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCC
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD 188 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~ 188 (552)
+.....++.+.+..||.|+.|.|++++.+.+|...|||.+.+.. +..+..++....+++... ++|+||+.|++|..+
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n 163 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN 163 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence 44566777888889999999999999999999999999998764 344556677777766555 599999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
..+++.||.| +..+..+|.+ .++++|..+-.+..-++.||.||.. +||||||+||+|||+|..|.|||||||++-.+
T Consensus 164 ~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 164 TDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred chHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 9999999998 4455566644 5789999999999999999999985 79999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhh
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSL 343 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSl 343 (552)
..+..+ .-..|-+.|||||.+.- ..|+..+|+|||
T Consensus 243 vdSkAh------------------------------------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSl 280 (391)
T KOG0983|consen 243 VDSKAH------------------------------------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSL 280 (391)
T ss_pred eccccc------------------------------------------ccccCCccccCccccCCCCCCccchhhhhhhh
Confidence 433211 02369999999999974 569999999999
Q ss_pred hHHHHHHhhCCCCCCCC-ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 344 GAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 344 GvilyEmltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
||.++||.||..||.+. ...+++.+|++. .+..+|....+|+...+|+..||+ |+.+||. -.++++|||+...
T Consensus 281 GITlveLaTg~yPy~~c~tdFe~ltkvln~-ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 281 GITLVELATGQYPYKGCKTDFEVLTKVLNE-EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKRY 355 (391)
T ss_pred ccchhhhhcccCCCCCCCccHHHHHHHHhc-CCCCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceeec
Confidence 99999999999999885 466788888883 455666666799999999999999 9999999 8899999999764
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=340.48 Aligned_cols=252 Identities=23% Similarity=0.398 Sum_probs=209.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+...+|.+.+.||+|+||.||+|+.. .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGD 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence 34567999999999999999999864 3456799999865432 233568889999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK 251 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~ 251 (552)
...+++||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence 99999999999999999998653 24899999999999999999999999999999999999999
Q ss_pred CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc
Q 008810 252 YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (552)
Q Consensus 252 ~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~ 331 (552)
++.+||+|||+++........ .......|++.|+|||++.+
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~ 199 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYY---------------------------------------RVGGHTMLPIRWMPPESIMY 199 (291)
T ss_pred CCcEEECCCCcccccCCCcee---------------------------------------ecCCCCCcceeecChHHhcc
Confidence 999999999999754321100 00113467889999999999
Q ss_pred CCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChh
Q 008810 332 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (552)
Q Consensus 332 ~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ 409 (552)
..++.++|+|||||++|||++ |.+||...+..+....+.... ....+ ..++.++.+||.+||. ||.+||+ +.
T Consensus 200 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt---~~ 273 (291)
T cd05094 200 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLERP--RVCPKEVYDIMLGCWQREPQQRLN---IK 273 (291)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-CCCCC--ccCCHHHHHHHHHHcccChhhCcC---HH
Confidence 999999999999999999998 999998888777666655421 11222 3578899999999999 9999999 66
Q ss_pred hhh
Q 008810 410 EIK 412 (552)
Q Consensus 410 eil 412 (552)
+|+
T Consensus 274 ~v~ 276 (291)
T cd05094 274 EIY 276 (291)
T ss_pred HHH
Confidence 664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=394.53 Aligned_cols=256 Identities=30% Similarity=0.490 Sum_probs=221.1
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecC
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~ 198 (552)
.-...||.|.||.||-|....||...|||-++-.... ......+.+|..+|..++|||+|+.|++-.+.+.+||.||||
T Consensus 1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred ccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 3445799999999999999999999999998765543 444566889999999999999999999999999999999999
Q ss_pred CCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccc
Q 008810 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (552)
Q Consensus 199 ~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~ 278 (552)
.||+|.+++...+..+|...+.|..|++.||.|||++|||||||||+||||+.+|-||++|||.|..+......
T Consensus 1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~------ 1390 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT------ 1390 (1509)
T ss_pred ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc------
Confidence 99999999999899999999999999999999999999999999999999999999999999999977543100
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhhHHHHHHhhCCC
Q 008810 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.+ .. ..+.+|||.|||||++.+ +|.+.+.|||||||++.||+||+.
T Consensus 1391 ---------------~~-----~e-----------l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1391 ---------------MP-----GE-----------LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred ---------------CC-----HH-----------HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 00 00 125789999999999986 678999999999999999999999
Q ss_pred CCCCCCh-hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 356 PFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 356 PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
||...+. -.+..++.. ....++|+ .+|++.+|||.+||. ||.+|.. +.||+.|.|=+
T Consensus 1440 PW~~~dne~aIMy~V~~-gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1440 PWAELDNEWAIMYHVAA-GHKPQIPE--RLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGK 1498 (1509)
T ss_pred chhhccchhHHHhHHhc-cCCCCCch--hhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhccc
Confidence 9987554 344444443 34667887 599999999999998 9999998 88999998864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=346.27 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=205.8
Q ss_pred eeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 123 MIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 123 ~IG~G--~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
+||+| ++|.||+++.+.+|+.||||++.+.. ........+..|+.+|+.++||||++++++|.+.+.+|+||||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 45554 56777777888899999999998653 2345667899999999999999999999999999999999999999
Q ss_pred CchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccc
Q 008810 201 GDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (552)
Q Consensus 201 G~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~ 278 (552)
|+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||.+..+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~---- 159 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR---- 159 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc----
Confidence 9999998753 5689999999999999999999999999999999999999999999999999876532211000
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhHHHHHHhhCCCC
Q 008810 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
..........++..|+|||++.+ .+|+.++|+|||||++|||++|.+|
T Consensus 160 ------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~p 209 (314)
T cd08216 160 ------------------------------VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209 (314)
T ss_pred ------------------------------ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 00001123568889999999976 4689999999999999999999999
Q ss_pred CCCCChhhHHHHHhhccc------------------------------cccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 357 FYSDDPMSTCRKIVNWRT------------------------------HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~------------------------------~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
|................. ....+....++.++.+||.+||+ ||.+||+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt- 288 (314)
T cd08216 210 FKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS- 288 (314)
T ss_pred CCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC-
Confidence 987654443322111000 00001112356789999999999 9999999
Q ss_pred CChhhhhcCCCcCCC
Q 008810 406 KGADEIKVHPWFDGV 420 (552)
Q Consensus 406 ~~a~eil~HpfF~~i 420 (552)
+++++.||||+.+
T Consensus 289 --~~~ll~~p~~~~~ 301 (314)
T cd08216 289 --ASQLLNHSFFKQC 301 (314)
T ss_pred --HHHHhcCchHhhh
Confidence 9999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=343.36 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=211.1
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEee
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 183 (552)
.+..++|.+.+.||+|+||.||+|++.. .+..||+|+++... .......+..|+.++..+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 4556789999999999999999998642 34579999987542 234466788999999999 6999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNI 247 (552)
+|.+...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999653 3488999999999999999999999999999999999
Q ss_pred cccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChh
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APE 327 (552)
|++.++.+||+|||+++.+....... ......+++.|+|||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE 206 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK---------------------------------------KTSNGRLPVKWMAPE 206 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc---------------------------------------ccccCCCCccccCHH
Confidence 99999999999999998653211000 000123456899999
Q ss_pred hhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 328 vl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
++.+..++.++|||||||++|||++ |..||.+.+..+.+..+... ....+| ..++.++++||.+||. +|.+||+
T Consensus 207 ~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps- 282 (314)
T cd05099 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG-HRMDKP--SNCTHELYMLMRECWHAVPTQRPT- 282 (314)
T ss_pred HHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCcccCcC-
Confidence 9999999999999999999999999 99999988877777766643 223334 3678899999999998 9999999
Q ss_pred CChhhhhc
Q 008810 406 KGADEIKV 413 (552)
Q Consensus 406 ~~a~eil~ 413 (552)
+.+++.
T Consensus 283 --~~~ll~ 288 (314)
T cd05099 283 --FKQLVE 288 (314)
T ss_pred --HHHHHH
Confidence 777664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=334.38 Aligned_cols=248 Identities=21% Similarity=0.361 Sum_probs=206.2
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++.+.||+|+||.||+|++..++ .||+|++.+... ..+.+.+|+.++..++||||+++++.+.+ ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 34567999999999999999999887664 599999986432 22457889999999999999999998754 5689
Q ss_pred EEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+||||+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999753 458999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.. ......|+..|+|||++.+..++.++|+|||||++|||
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~el 196 (262)
T cd05071 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (262)
T ss_pred cc----------------------------------------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHH
Confidence 00 00123567889999999989999999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
++ |.+||.+....+....+... . ..+....++..+.+||.+||. ||.+||+ +.+++
T Consensus 197 lt~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~~~ 254 (262)
T cd05071 197 TTKGRVPYPGMVNREVLDQVERG-Y--RMPCPPECPESLHDLMCQCWRKEPEERPT---FEYLQ 254 (262)
T ss_pred HcCCCCCCCCCChHHHHHHHhcC-C--CCCCccccCHHHHHHHHHHccCCcccCCC---HHHHH
Confidence 99 99999988877777766542 1 222234688999999999999 9999999 65554
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=343.05 Aligned_cols=252 Identities=30% Similarity=0.539 Sum_probs=212.2
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCC
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
....||+|+||.||++..+.+|+.||||++.... ......+.+|+.++..++||||+++++.|.+.+..|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3467999999999999999999999999985332 2334568889999999999999999999999999999999999
Q ss_pred CCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccccc
Q 008810 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (552)
Q Consensus 200 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~ 279 (552)
+++|.+++. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.+|+++|+|||++..+.....
T Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-------- 171 (292)
T cd06657 101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-------- 171 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--------
Confidence 999998774 45789999999999999999999999999999999999999999999999999875422100
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCC
Q 008810 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (552)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~ 359 (552)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+
T Consensus 172 ---------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 172 ---------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ---------------------------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 01135689999999999888899999999999999999999999998
Q ss_pred CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+.......+... ....++....+++++.++|.+||. +|.+|++ +.+|+.||||...
T Consensus 219 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~ 276 (292)
T cd06657 219 EPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 276 (292)
T ss_pred CCHHHHHHHHHhh-CCcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhcc
Confidence 7766555444321 112222223678999999999999 9999999 9999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=346.25 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=210.9
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-CceEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEFLY 192 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-~~~ly 192 (552)
..++|++++.||.|+||.||+|.++.+|+.||||++.+.. .......++..|+.++..++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4678999999999999999999999999999999987543 223345678899999999999999999999875 56899
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
+||||+ +++|..++. ...+++..+..++.|++.||.|||+.||+||||+|.|||++.+|++||+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999999 668887774 457899999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEml 351 (552)
....+|++.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 162 -----------------------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred -----------------------------------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 013467899999999876 67899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhcc------------------------ccccCCc---ccccChhHHHHHHHHhh-CccccC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWR------------------------THLKFPE---EAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~------------------------~~~~~p~---~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
+|.+||.+.+.......+...- .....|. ...++.++.++|.+||+ +|.+||
T Consensus 201 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 280 (328)
T cd07856 201 EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280 (328)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC
Confidence 9999998776544332222110 0011111 12468899999999999 999999
Q ss_pred CCCChhhhhcCCCcCC
Q 008810 404 GAKGADEIKVHPWFDG 419 (552)
Q Consensus 404 ~~~~a~eil~HpfF~~ 419 (552)
+ +++++.||||..
T Consensus 281 t---~~ell~~~~~~~ 293 (328)
T cd07856 281 S---AAEALAHPYLAP 293 (328)
T ss_pred C---HHHHhcCCcccc
Confidence 9 999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=336.16 Aligned_cols=254 Identities=21% Similarity=0.383 Sum_probs=212.2
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
..++|++++.||+|+||.||+|+.+. +.+.||+|.+.... .......+.+|+.+|+.++||||+++++.|.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA 80 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC
Confidence 34789999999999999999999764 35689999886543 122456788999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKD---------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~D 259 (552)
...|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999999997655 799999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccc
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 339 (552)
||+++........ ......+++.|+|||.+.+..++.++|
T Consensus 161 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~D 200 (275)
T cd05046 161 LSLSKDVYNSEYY----------------------------------------KLRNALIPLRWLAPEAVQEDDFSTKSD 200 (275)
T ss_pred cccccccCccccc----------------------------------------ccCCceeEEeecChhhhccCCCCchhh
Confidence 9998743211000 011346778899999999888999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 340 WWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 340 iWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
||||||++|+|++ |..||...........+... .+.++....++..+.++|.+||. +|.+||+ +.+++.+
T Consensus 201 i~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~~l~~ 272 (275)
T cd05046 201 VWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLELPVPEGCPSRLYKLMTRCWAVNPKDRPS---FSELVSA 272 (275)
T ss_pred HHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcCCCCCCCCCHHHHHHHHHHcCCCcccCCC---HHHHHHH
Confidence 9999999999998 89999877766666666542 22333334688999999999999 9999998 8888754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.19 Aligned_cols=249 Identities=22% Similarity=0.380 Sum_probs=207.4
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|+++++||+|+||.||+|..+ +++.||+|.+.+... ....+.+|+.+++.++||||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999864 567899999976542 2356888999999999999999998875 45789
Q ss_pred EEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 468999999999999999999999999999999999999999999999999997654211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
... .....++..|+|||++.+..++.++|+|||||++|||
T Consensus 157 ~~~----------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05067 157 YTA----------------------------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196 (260)
T ss_pred ccc----------------------------------------ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHH
Confidence 000 0123567889999999988999999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++ |++||.+.+..+....+... ...+....++.++.+||.+||. +|.+||+ +++|+.
T Consensus 197 ~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~ 255 (260)
T cd05067 197 VTYGRIPYPGMTNPEVIQNLERG---YRMPRPDNCPEELYELMRLCWKEKPEERPT---FEYLRS 255 (260)
T ss_pred HhCCCCCCCCCChHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHHH
Confidence 98 99999988776666655432 2223223678899999999998 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=332.42 Aligned_cols=248 Identities=21% Similarity=0.387 Sum_probs=206.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++++.||+|+||.||+|... .+..+|+|.+..... ..+.+.+|+.+++.++||+|+++++.+.+ ...|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 44578999999999999999999865 556799999976432 23458899999999999999999998864 5689
Q ss_pred EEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999998753 458999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.. ......|+..|+|||++.+..++.++|+|||||++|+|
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 196 (260)
T cd05070 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred cc----------------------------------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHH
Confidence 00 00123456789999999988899999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
++ |.+||.+.+..+....+... .....| ...+.++.+||.+||. +|.+||+ +.++.
T Consensus 197 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt---~~~l~ 254 (260)
T cd05070 197 VTKGRVPYPGMNNREVLEQVERG-YRMPCP--QDCPISLHELMLQCWKKDPEERPT---FEYLQ 254 (260)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcccCcccCcC---HHHHH
Confidence 99 99999988877777766542 222333 4678999999999999 9999999 66654
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=342.02 Aligned_cols=258 Identities=20% Similarity=0.351 Sum_probs=214.2
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEE
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-------~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 181 (552)
+..+..++|.+.+.||+|+||.||+|+.. .++..||+|++.... .......+.+|+.++..+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 45577889999999999999999999753 234579999987542 234456788999999999 89999999
Q ss_pred eeeecCCceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 008810 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (552)
Q Consensus 182 ~~~f~d~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPe 245 (552)
+++|.+...+|+||||+++|+|..++.+. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999999653 24778889999999999999999999999999999
Q ss_pred CccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 246 NILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
|||++.+|.+||+|||+++.+....... ......+++.|+|
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 207 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYK---------------------------------------KTTNGRLPVKWMA 207 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccc---------------------------------------cccCCCCCceeeC
Confidence 9999999999999999998653221000 0112356788999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccC
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
||++.+..|+.++|||||||++|+|++ |..||.+.+..+....+... .....| ..++.++++||.+||. +|.+||
T Consensus 208 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccChhhCC
Confidence 999999999999999999999999998 89999988887777766542 222333 3688999999999998 999999
Q ss_pred CCCChhhhhcC
Q 008810 404 GAKGADEIKVH 414 (552)
Q Consensus 404 ~~~~a~eil~H 414 (552)
+ +.+|+..
T Consensus 285 s---~~e~l~~ 292 (304)
T cd05101 285 T---FKQLVED 292 (304)
T ss_pred C---HHHHHHH
Confidence 8 7777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.31 Aligned_cols=244 Identities=21% Similarity=0.342 Sum_probs=202.0
Q ss_pred eeeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecC
Q 008810 122 TMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~ 198 (552)
+.||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++|||||++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 46999999999999876554 78999999866543 345568899999999999999999998764 4679999999
Q ss_pred CCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccc
Q 008810 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (552)
Q Consensus 199 ~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~ 278 (552)
++|+|.+++.+...+++..+..++.|++.||.|||..|++||||||+|||++.++.+||+|||+++.+....... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~---~- 153 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY---R- 153 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc---c-
Confidence 999999999888889999999999999999999999999999999999999999999999999998653221000 0
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCC
Q 008810 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPF 357 (552)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF 357 (552)
......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||
T Consensus 154 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 154 ----------------------------------ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred ----------------------------------cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 0001234578999999999999999999999999999998 99999
Q ss_pred CCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
...+..+....+... .....| ..++..+++||.+||. +|.+||+ +.+|+
T Consensus 200 ~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~---~~~l~ 249 (257)
T cd05060 200 GEMKGAEVIAMLESG-ERLPRP--EECPQEIYSIMLSCWKYRPEDRPT---FSELE 249 (257)
T ss_pred ccCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHhcCChhhCcC---HHHHH
Confidence 887776665555442 222333 4688999999999999 9999999 66654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.78 Aligned_cols=250 Identities=20% Similarity=0.358 Sum_probs=210.7
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
++..++|++.+.||+|+||.||+|... .++.||||.+..... ....+.+|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356789999999999999999999875 457899999976542 235688899999999999999999999998999
Q ss_pred EEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
|+||||++|++|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++.+||+|||+++.+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999764 36899999999999999999999999999999999999999999999999998765321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.... .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 157 ~~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~ 196 (261)
T cd05034 157 EYTA----------------------------------------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTE 196 (261)
T ss_pred hhhh----------------------------------------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHH
Confidence 1000 002235678999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
|++ |++||.+.+......++... ...+....++.++.++|.+||+ +|.+||+ ++++.
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~l~ 255 (261)
T cd05034 197 IVTYGRVPYPGMTNREVLEQVERG---YRMPRPPNCPEELYDLMLQCWDKDPEERPT---FEYLQ 255 (261)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcccCcccCCC---HHHHH
Confidence 998 99999988877777776542 2222223568899999999999 9999999 66665
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=368.34 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=211.3
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecC--
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD-- 187 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d-- 187 (552)
..+...++++.++|.+|||+.||+|+....|..||+|++-.. +....+.+++|+++|+.|. |+|||.++++...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 346667788999999999999999999988899999998654 4566778999999999996 9999999994321
Q ss_pred -----CceEEEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCccccCCCcEEEc
Q 008810 188 -----DEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLS 258 (552)
Q Consensus 188 -----~~~lylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~~~g~iKL~ 258 (552)
.-.++|.||||.||.|.+++.. ...|+|.++..|+.+++.|+.+||.+. |||||||-|||||+.+|+.|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 1257899999999999999964 356999999999999999999999987 9999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCC
Q 008810 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYG 335 (552)
Q Consensus 259 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~ 335 (552)
|||.|...... +... ..+.-.+.+- ...-|+.|+|||++. +.+.+
T Consensus 189 DFGSatt~~~~-------------------------~~~~--~e~~~ve~eI-----~k~TTp~YRsPEMIDlysg~pI~ 236 (738)
T KOG1989|consen 189 DFGSATTKILS-------------------------PTSA--QEVNYVEEEI-----EKYTTPQYRSPEMIDLYSGLPIG 236 (738)
T ss_pred cccccccccCC-------------------------CccH--HHHHHHHHHH-----HhhCCccccChHHHhhhcCCCCc
Confidence 99988643211 0000 0111111110 124599999999986 67789
Q ss_pred CccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 336 ~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.++|||+|||+||-|+....||..... ..|++ ..+.||..+..|..+++||+.||. ||.+||. +-+++.
T Consensus 237 eKsDIWALGclLYkLCy~t~PFe~sg~----laIln--g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPn---I~Qv~~ 306 (738)
T KOG1989|consen 237 EKSDIWALGCLLYKLCYFTTPFEESGK----LAILN--GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPN---IYQVLE 306 (738)
T ss_pred chhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe--ccccCCCCccHHHHHHHHHHHHhccCcccCCC---HHHHHH
Confidence 999999999999999999999976543 24666 567788777899999999999999 9999999 666664
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=360.81 Aligned_cols=253 Identities=24% Similarity=0.438 Sum_probs=221.4
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce--EEEEE
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF--LYLIM 195 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~--lylVm 195 (552)
+...+||+|+|-+||+|.+..+|..||.-.++-.++. ...+.+++..|+.+|+.++|||||++|++|.+..+ +-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4456899999999999999999999998776655443 34567889999999999999999999999997765 88999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCcccccCCCCcccc-CCCcEEEcccccccccCCCCcc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--HYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~--giiHrDLKPeNILl~-~~g~iKL~DFGlak~~~~~~~~ 272 (552)
|++.+|+|+.++.+.+.++...++.|+.||+.||.|||++ .|||||||-+||+|+ .-|.|||+|+|||..+..+
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 9999999999999999999999999999999999999998 599999999999998 4589999999999876422
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.+.+.+|||.|||||++. ..|+..+||||||++|.||+|
T Consensus 200 ----------------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT 238 (632)
T KOG0584|consen 200 ----------------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVT 238 (632)
T ss_pred ----------------------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHh
Confidence 244789999999999997 899999999999999999999
Q ss_pred CCCCCCC-CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCC
Q 008810 353 GYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 353 G~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+..||.- .++.++|+++..+..+-.|-. .-.+++++||.+||.-..+||+ |.|+|.||||..-
T Consensus 239 ~eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~fIekCl~~~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 239 SEYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREFIEKCLATKSERLS---AKELLKDPFFDED 302 (632)
T ss_pred ccCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHHHHHHhcCchhccC---HHHHhhChhhccc
Confidence 9999964 578889999987544333322 2368999999999988899999 9999999999764
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=336.68 Aligned_cols=254 Identities=33% Similarity=0.532 Sum_probs=213.4
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|++.+.||+|+||.||+|+...+++.||+|++.... ........+..|+.+++.++|+||+++++++.+...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998764 2233456678899999999999999999999999999999999
Q ss_pred CCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 198 LPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 198 ~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
++ ++|.+++.+. ..+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.+||+|||+++.......
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----- 153 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR----- 153 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-----
Confidence 97 5899999776 5899999999999999999999999999999999999999999999999999986532210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~~ 355 (552)
......++..|+|||++.+. .++.++|+|||||++|||++|.+
T Consensus 154 ------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 197 (282)
T cd07829 154 ------------------------------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197 (282)
T ss_pred ------------------------------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence 00123567889999999876 88999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccc----------------cccCCc---------ccccChhHHHHHHHHhh-CccccCCCCChh
Q 008810 356 PFYSDDPMSTCRKIVNWRT----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~----------------~~~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ 409 (552)
||.+.+....+.++...-. ...+|. .+.++.++.++|.+||. ||.+||+ ++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~ 274 (282)
T cd07829 198 LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AK 274 (282)
T ss_pred CCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HH
Confidence 9998877666655543100 001111 01357889999999999 9999999 99
Q ss_pred hhhcCCCc
Q 008810 410 EIKVHPWF 417 (552)
Q Consensus 410 eil~HpfF 417 (552)
+++.||||
T Consensus 275 ~~l~~p~~ 282 (282)
T cd07829 275 EALKHPYF 282 (282)
T ss_pred HHhhCcCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=348.53 Aligned_cols=264 Identities=33% Similarity=0.489 Sum_probs=213.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCC--ceE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD--EFL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~--~~l 191 (552)
.++|++.+.||+|+||.||+|.+..+|+.||||++.+.. ........+..|+.++..+ +||||++++++|... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467999999999999999999999999999999986532 2223445677899999999 999999999988643 478
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||++ ++|..++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999997 5898888665 889999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEm 350 (552)
.. . .......+||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 163 ~~----------------~--------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el 206 (337)
T cd07852 163 NP----------------E--------------------NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206 (337)
T ss_pred cc----------------c--------------------CcchhcccccccccCceeeeccccccccchHHHHHHHHHHH
Confidence 00 0 000113579999999998865 5688999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhcccc--------------------------ccCCc-ccccChhHHHHHHHHhh-Ccccc
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTH--------------------------LKFPE-EAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~--------------------------~~~p~-~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
++|++||.+........++...... ..+.. ...++.++.+||.+||. ||.+|
T Consensus 207 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 286 (337)
T cd07852 207 LLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR 286 (337)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccc
Confidence 9999999887766555544332110 00000 12368899999999999 99999
Q ss_pred CCCCChhhhhcCCCcCCC
Q 008810 403 LGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 403 l~~~~a~eil~HpfF~~i 420 (552)
|+ +.+++.||||+.+
T Consensus 287 ps---~~~il~~~~~~~~ 301 (337)
T cd07852 287 LT---AEEALEHPYVAQF 301 (337)
T ss_pred cC---HHHHhhChhhhhh
Confidence 99 9999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.85 Aligned_cols=243 Identities=23% Similarity=0.344 Sum_probs=199.3
Q ss_pred eeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 123 MIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
.||+|+||.||+|..+ .++..||+|++.... .....+.+.+|+.+|+.++||||++++++++. ..+|+||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999765 456679999987542 23345678899999999999999999998864 578999999999
Q ss_pred CchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccccc
Q 008810 201 GDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (552)
Q Consensus 201 G~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~ 279 (552)
|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~----- 153 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----- 153 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee-----
Confidence 999999864 46799999999999999999999999999999999999999999999999999985532211000
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCC
Q 008810 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 358 (552)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~ 358 (552)
......+++.|+|||++.+..++.++|+|||||++|||++ |.+||.
T Consensus 154 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 154 ---------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred ---------------------------------ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 0001234678999999998899999999999999999996 999999
Q ss_pred CCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 359 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
+....+....+... ....+| ..+++++.+||.+||. +|.+||+ +.+|+
T Consensus 201 ~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~c~~~~~~~Rp~---~~~i~ 249 (257)
T cd05115 201 KMKGPEVMSFIEQG-KRLDCP--AECPPEMYALMKDCWIYKWEDRPN---FAKVE 249 (257)
T ss_pred cCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 88877766666543 223344 3678999999999999 9999999 55543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=345.09 Aligned_cols=261 Identities=27% Similarity=0.408 Sum_probs=209.2
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCC--CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeec----CCc
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTT--GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ----DDE 189 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~t--g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~----d~~ 189 (552)
+|++.+.||+|+||.||+|++..+ +..||||++.... ........+.+|+.++..+ +|||||++++.+. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 9999999987532 1222345678899999998 6999999998643 235
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|++|||+. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6899999995 689999988889999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvily 348 (552)
.... .......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 159 ~~~~-------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~ 201 (332)
T cd07857 159 PGEN-------------------------------------AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201 (332)
T ss_pred cccc-------------------------------------cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHH
Confidence 1100 000123579999999999876 57899999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccc--------------------------cccCCc-ccccChhHHHHHHHHhh-Ccc
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRT--------------------------HLKFPE-EAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~--------------------------~~~~p~-~~~~s~e~~dLI~~lL~-dp~ 400 (552)
+|++|.+||.+.+.......++...+ ...++. ...++.++.+||.+||+ ||.
T Consensus 202 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 281 (332)
T cd07857 202 ELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT 281 (332)
T ss_pred HHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc
Confidence 99999999988765444433332110 011111 12467899999999999 999
Q ss_pred ccCCCCChhhhhcCCCcCC
Q 008810 401 QRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF~~ 419 (552)
+||+ +.+++.||||..
T Consensus 282 ~R~t---~~~ll~~~~~~~ 297 (332)
T cd07857 282 KRIS---VEEALEHPYLAI 297 (332)
T ss_pred cCCC---HHHHhcChhhhh
Confidence 9999 999999999954
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=328.76 Aligned_cols=245 Identities=21% Similarity=0.368 Sum_probs=209.5
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++.+.||.|+||.||+|... |+.||+|.+..... ...++.+|..++..++|+||+++++.+.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999864 78999999976532 4567889999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997765 79999999999999999999999999999999999999999999999999998652110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
....++..|+|||++....++.++|+|||||++|||
T Consensus 157 --------------------------------------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l 192 (256)
T cd05039 157 --------------------------------------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred --------------------------------------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHH
Confidence 012345679999999888899999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++ |..||...+.......+... .....| ..+++++.+||.+||. +|.+||+ +.+++.
T Consensus 193 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~ 251 (256)
T cd05039 193 YSFGRVPYPRIPLKDVVPHVEKG-YRMEAP--EGCPPEVYKVMKDCWELDPAKRPT---FKQLRE 251 (256)
T ss_pred HhcCCCCCCCCCHHHHHHHHhcC-CCCCCc--cCCCHHHHHHHHHHhccChhhCcC---HHHHHH
Confidence 97 99999888766655554431 222333 3678999999999999 9999999 777664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=332.28 Aligned_cols=256 Identities=21% Similarity=0.340 Sum_probs=211.6
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
...+|++.+.||+|+||.||+|..+.+++ .||||++.+.. .......+..|+.+++.++||||+++++++.++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 34678999999999999999999887765 69999987542 24455678999999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
+|+||||++||+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999999999875 456899999999999999999999999999999999999999999999999998755322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.... .+ .......++..|+|||++.+..++.++|+|||||++||
T Consensus 160 ~~~~-~~-----------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e 203 (269)
T cd05065 160 TSDP-TY-----------------------------------TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 203 (269)
T ss_pred cccc-cc-----------------------------------ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHH
Confidence 1000 00 00001123457999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|++ |.+||.+.+.......+.. ....|....++.++.++|.+||. +|.+||+ +.+|+.
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~~ 263 (269)
T cd05065 204 VMSYGERPYWDMSNQDVINAIEQ---DYRLPPPMDCPTALHQLMLDCWQKDRNARPK---FGQIVS 263 (269)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHc---CCcCCCcccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 886 9999998887777666643 22333334688999999999998 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=329.79 Aligned_cols=244 Identities=22% Similarity=0.397 Sum_probs=204.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee-cCCceE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF-QDDEFL 191 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~d~~~l 191 (552)
+...+|.+.+.||+|+||.||+|... |..||+|.++... ....+.+|+.+++.++|++|+++++++ .+....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 34568999999999999999999764 7789999986432 245688999999999999999999865 566789
Q ss_pred EEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
|+||||+++|+|.+++.... .+++..+..++.+++.||.|||++||+||||||+||+++.+|.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999987643 4899999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ....++..|+|||++.+..++.++|||||||++||
T Consensus 156 ~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~ 191 (256)
T cd05082 156 Q--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191 (256)
T ss_pred C--------------------------------------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHH
Confidence 0 02345678999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|++ |.+||...+..+....+... .....+ ..+++.+++||.+||. +|.+||+ +.+++.
T Consensus 192 l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt---~~~l~~ 251 (256)
T cd05082 192 IYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPVVYDVMKQCWHLDAATRPS---FLQLRE 251 (256)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 997 99999887776666665432 122233 3688999999999999 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=349.27 Aligned_cols=257 Identities=22% Similarity=0.345 Sum_probs=206.6
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 185 (552)
.+..++|++.+.||+|+||.||+|.+ ..+++.||||+++... .......+.+|+.+|..+ +|||||++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 34567899999999999999999984 3567899999997542 233456788999999999 689999999887
Q ss_pred cC-CceEEEEEecCCCCchhhHHhhc------------------------------------------------------
Q 008810 186 QD-DEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (552)
Q Consensus 186 ~d-~~~lylVmEy~~gG~L~~~L~~~------------------------------------------------------ 210 (552)
.. ...+|+|||||+||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 64 45789999999999999998642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccc
Q 008810 211 -------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (552)
Q Consensus 211 -------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~ 277 (552)
..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----- 235 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----- 235 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch-----
Confidence 23678888999999999999999999999999999999999999999999998764221100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCC
Q 008810 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPP 356 (552)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~P 356 (552)
.......+++.|+|||++.+..|+.++|||||||++|+|++ |..|
T Consensus 236 ----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 281 (343)
T cd05103 236 ----------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281 (343)
T ss_pred ----------------------------------hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 00012346778999999999999999999999999999997 9999
Q ss_pred CCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|.+..........+........|. .+++++.++|.+||. ||.+||+ +.+|++|
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~cl~~~p~~Rps---~~eil~~ 335 (343)
T cd05103 282 YPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 335 (343)
T ss_pred CCCccccHHHHHHHhccCCCCCCC--CCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 987654433333333222333443 578899999999998 9999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.35 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=209.5
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+..++|++++.||+|+||.||+|++.. ++..||||++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 346789999999999999999998753 678999999875431 2334568889999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK----------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~----------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPe 245 (552)
...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||..|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999999643 24788889999999999999999999999999999
Q ss_pred CccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 246 NILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
|||++.++.++|+|||++..+....... ......+++.|+|
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 200 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYK---------------------------------------ASENDAIPIRWMP 200 (288)
T ss_pred heEecCCCceEECccccceecccCcccc---------------------------------------ccCCCccChhhcC
Confidence 9999999999999999987553221000 0002235678999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccC
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
||++.+..++.++|+|||||++|||++ |..||.+.+..+....+.... ....| ..++.++.+||.+||+ ||.+||
T Consensus 201 PE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp 277 (288)
T cd05050 201 PESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VLSCP--DNCPLELYNLMRLCWSKLPSDRP 277 (288)
T ss_pred HHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcccCcccCC
Confidence 999999999999999999999999997 999999888877777665422 22233 3678999999999999 999999
Q ss_pred CCCChhhhh
Q 008810 404 GAKGADEIK 412 (552)
Q Consensus 404 ~~~~a~eil 412 (552)
+ +.||+
T Consensus 278 t---~~el~ 283 (288)
T cd05050 278 S---FASIN 283 (288)
T ss_pred C---HHHHH
Confidence 9 66654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=332.08 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=213.0
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
+|.+.+.||+|+||.||+|.+..++..+++|+++..... ......++..|..+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 488999999999999999999888888888887754322 223344577899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 195 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|||+++++|..++.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++. +.+||+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 457999999999999999999999999999999999999975 679999999987653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
. ......|++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 160 ~-----------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 160 D-----------------------------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred c-----------------------------------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 0 01134688999999999888899999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
++|..||.+.+......++... ....+| ..++.++.+||.+||. +|.+||+ +.+|+.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 199 CCLAHAFEGQNFLSVVLRIVEG-PTPSLP--ETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HhCCCCCCCccHHHHHHHHHcC-CCCCCc--chhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 9999999877776666666542 112223 3678899999999998 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=338.96 Aligned_cols=256 Identities=17% Similarity=0.344 Sum_probs=206.2
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCC--------------cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTG--------------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg--------------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv 179 (552)
...+|++.+.||+|+||.||+|++..++ ..||+|+++... .......+.+|+++|..++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3568999999999999999999875432 359999987542 233456788999999999999999
Q ss_pred EEeeeecCCceEEEEEecCCCCchhhHHhhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCc
Q 008810 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (552)
Q Consensus 180 ~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNI 247 (552)
+++++|.+...+|+||||++|++|.+++.... .+++..+..++.+++.||.|||+.|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 468889999999999999999999999999999999
Q ss_pred cccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChh
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APE 327 (552)
|++.++.+||+|||++..+...... .......+++.|+|||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE 201 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYY---------------------------------------RIQGRAVLPIRWMAWE 201 (295)
T ss_pred EEcCCCcEEecccccccccccCcce---------------------------------------eccCcCcCceeecChh
Confidence 9999999999999998754321100 0011235678999999
Q ss_pred hhhcCCCCCccchhhhhHHHHHHhh--CCCCCCCCChhhHHHHHhhc---c-ccccCCcccccChhHHHHHHHHhh-Ccc
Q 008810 328 VLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKIVNW---R-THLKFPEEAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 328 vl~~~~y~~~~DiWSlGvilyEmlt--G~~PF~~~~~~~~~~~i~~~---~-~~~~~p~~~~~s~e~~dLI~~lL~-dp~ 400 (552)
++.+..++.++|+|||||++|+|++ |..||...+..+....+... . .....+....+++.+++||.+||. ||.
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCch
Confidence 9999999999999999999999988 77899887766655554321 0 111112223578899999999999 999
Q ss_pred ccCCCCChhhhhc
Q 008810 401 QRLGAKGADEIKV 413 (552)
Q Consensus 401 ~Rl~~~~a~eil~ 413 (552)
+||+ +++|++
T Consensus 282 ~RPs---~~~i~~ 291 (295)
T cd05097 282 DRPT---FNKIHH 291 (295)
T ss_pred hCcC---HHHHHH
Confidence 9999 777643
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.70 Aligned_cols=242 Identities=24% Similarity=0.402 Sum_probs=199.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEEecC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYL 198 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~--~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVmEy~ 198 (552)
++||+|+||.||+|+.+.+|.. +|+|.++.. ......+.+.+|+.++.++ +||||++++++|.....+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 3689999999999999888764 688887642 2234456788999999999 8999999999999999999999999
Q ss_pred CCCchhhHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 199 PGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 199 ~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
++|+|.+++.... .+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999986543 478999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
+....... ......+++.|+|||++.+..++.++|+||
T Consensus 159 ~~~~~~~~------------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 196 (270)
T cd05047 159 SRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWS 196 (270)
T ss_pred ccccchhh------------------------------------------hccCCCCccccCChHHHccCCCCchhhHHH
Confidence 86321100 000123466799999999899999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 343 lGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++|||++ |..||.+.+.......+... .....| ..++.++.+||.+||. ||.+||+ +.+|+.
T Consensus 197 lG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 263 (270)
T cd05047 197 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERPS---FAQILV 263 (270)
T ss_pred HHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCC--CcCCHHHHHHHHHHcccChhhCCC---HHHHHH
Confidence 9999999997 99999888777766666431 222333 3578899999999999 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=354.39 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=211.2
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCS 184 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~ 184 (552)
..+..++|.+.+.||+|+||.||+|+++ .+++.||+|+++... .......+..|+.+|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4566678899999999999999999864 356789999997542 2333456889999999997 9999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhhcC-----------------------------------------------------
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD----------------------------------------------------- 211 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~~~----------------------------------------------------- 211 (552)
|.+...+|+|||||+||+|.++|.+..
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986431
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCC
Q 008810 212 ---------------------------------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (552)
Q Consensus 212 ---------------------------------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeN 246 (552)
.+++..+..|+.||+.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 36777888999999999999999999999999999
Q ss_pred ccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCCh
Q 008810 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (552)
Q Consensus 247 ILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~AP 326 (552)
||++.++.+||+|||+++.+...... ....+.+|++.|+||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aP 310 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNY---------------------------------------ISKGSTFLPLKWMAP 310 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccccc---------------------------------------ccCCCcCCCCceeCh
Confidence 99999999999999999854221100 001135678999999
Q ss_pred hhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCC
Q 008810 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 327 Evl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
|++.+..++.++|||||||++|||++ |..||......+.....+.....+..| ..++.++.+||.+||+ +|.+||+
T Consensus 311 E~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 311 ESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP--AHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred HHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHcCCChhHCcC
Confidence 99999899999999999999999998 899998766555544444332233344 3689999999999999 9999999
Q ss_pred CCChhhhhcC
Q 008810 405 AKGADEIKVH 414 (552)
Q Consensus 405 ~~~a~eil~H 414 (552)
+.+|+..
T Consensus 389 ---~~ell~~ 395 (401)
T cd05107 389 ---FSQLVHL 395 (401)
T ss_pred ---HHHHHHH
Confidence 7777653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=322.55 Aligned_cols=263 Identities=26% Similarity=0.423 Sum_probs=218.1
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc--
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-- 189 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-- 189 (552)
.+..++|++.+.||.|||+-||+|+...+++.||+|++.... ..+.+..++|++..++++||||+++++....+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 356788999999999999999999999999999999998764 456778999999999999999999997765443
Q ss_pred ---eEEEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCccccCCCcEEEccc
Q 008810 190 ---FLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDF 260 (552)
Q Consensus 190 ---~lylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~~~g~iKL~DF 260 (552)
..||++.|...|+|.+.+.+ ...++|.++..|+.+++.||++||... ++||||||.|||+++.|.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 49999999999999999854 347999999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCc
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGME 337 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~ 337 (552)
|.+....-. ...+++.-+++.|-.. ..|..|.|||.+.- ...+.+
T Consensus 174 GS~~~a~i~------------------------i~~~~~a~~lQe~a~e--------~Ct~pyRAPELf~vk~~~ti~er 221 (302)
T KOG2345|consen 174 GSATQAPIQ------------------------IEGSRQALRLQEWAEE--------RCTIPYRAPELFNVKSHCTITER 221 (302)
T ss_pred cCccccceE------------------------eechHHHHHHHHHHHH--------hCCCcccCchheecccCcccccc
Confidence 998764321 1223344456667543 35889999999974 345889
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChh--hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 338 CDWWSLGAIMYEMLVGYPPFYSDDPM--STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 338 ~DiWSlGvilyEmltG~~PF~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+|||||||++|+|+.|..||...-.. .....+.+ .++.+|.....|..+..||..||+ ||.+||+ +.+++.+
T Consensus 222 tDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~---i~~ll~~ 296 (302)
T KOG2345|consen 222 TDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRPT---IPELLSK 296 (302)
T ss_pred cchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCCC---HHHHHHH
Confidence 99999999999999999999532111 11112332 467788877899999999999999 9999999 8887764
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=327.96 Aligned_cols=246 Identities=21% Similarity=0.352 Sum_probs=206.6
Q ss_pred eeeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecC
Q 008810 122 TMIGKGAFGEVRVCREKT-TGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~-tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~ 198 (552)
++||+|+||.||+|.+.. .+. .||||.+...... .....+..|+.++..++|||||++++.+.+ ..+|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999999876543 556778999999999999999999999998 8999999999
Q ss_pred CCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 199 PGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 199 ~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++.+...... +
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~ 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---Y 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc---e
Confidence 9999999997654 6899999999999999999999999999999999999999999999999999865321100 0
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 355 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~ 355 (552)
.......|+..|+|||++.+..++.++|+|||||++|||++ |.+
T Consensus 155 -----------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 199 (257)
T cd05040 155 -----------------------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199 (257)
T ss_pred -----------------------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence 00012457889999999999999999999999999999998 999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||...+..+....+.........| ..++..+.+||.+||+ +|.+||+ +.+|+.
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~~~~ 253 (257)
T cd05040 200 PWAGLSGSQILKKIDKEGERLERP--EACPQDIYNVMLQCWAHNPADRPT---FAALRE 253 (257)
T ss_pred CCCCCCHHHHHHHHHhcCCcCCCC--ccCCHHHHHHHHHHCCCCcccCCC---HHHHHH
Confidence 998888777776666433333334 3678999999999999 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.05 Aligned_cols=258 Identities=19% Similarity=0.336 Sum_probs=212.1
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEE
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 181 (552)
...+...+|++.+.||+|+||.||+|++... +..||+|+++... .......+.+|+.++..+ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3455667899999999999999999986432 2379999887532 233456788999999999 89999999
Q ss_pred eeeecCCceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 008810 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (552)
Q Consensus 182 ~~~f~d~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPe 245 (552)
+++|.+...+|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||.+||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 99999999999999999999999999753 24778889999999999999999999999999999
Q ss_pred CccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 246 NILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
|||++.++.+||+|||+++.+....... ......++..|+|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 204 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYK---------------------------------------KTTNGRLPVKWMA 204 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccc---------------------------------------cccCCCcCceEcC
Confidence 9999999999999999998653211000 0012235678999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccC
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
||++.+..++.++|||||||++|||++ |.+||.+.+..+....+... .....| ..++.++.+||.+||. +|.+||
T Consensus 205 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp 281 (334)
T cd05100 205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTHELYMIMRECWHAVPSQRP 281 (334)
T ss_pred HHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccChhhCc
Confidence 999999999999999999999999998 99999988877777666542 222333 3678899999999999 999999
Q ss_pred CCCChhhhhcC
Q 008810 404 GAKGADEIKVH 414 (552)
Q Consensus 404 ~~~~a~eil~H 414 (552)
+ +.+|+.+
T Consensus 282 s---~~ell~~ 289 (334)
T cd05100 282 T---FKQLVED 289 (334)
T ss_pred C---HHHHHHH
Confidence 9 8888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.13 Aligned_cols=252 Identities=31% Similarity=0.525 Sum_probs=208.5
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEEEe
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmE 196 (552)
|.+.+.||.|+||+||+|....+++.||||++.+.... .......+|...+..+. ||||++++++|.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 67889999999999999999999999999998754321 12223456888999998 9999999999999999999999
Q ss_pred cCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|+ +|+|..++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 889999887764 789999999999999999999999999999999999999999999999999876532210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG 353 (552)
....+|+..|+|||++.+ ..++.++|+|||||++|||++|
T Consensus 155 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 155 ---------------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred ---------------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 113468899999998864 5689999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccc-----------------cCCc---------ccccChhHHHHHHHHhh-CccccCCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHL-----------------KFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~-----------------~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
++||.+.+..+.+.++...-... .+|. ....+.++++||.+||+ ||.+||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt-- 273 (283)
T cd07830 196 RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT-- 273 (283)
T ss_pred CCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC--
Confidence 99998887766665554311110 0000 01236789999999999 9999999
Q ss_pred ChhhhhcCCCc
Q 008810 407 GADEIKVHPWF 417 (552)
Q Consensus 407 ~a~eil~HpfF 417 (552)
+.||+.||||
T Consensus 274 -~~ei~~~~~~ 283 (283)
T cd07830 274 -ASQALQHPYF 283 (283)
T ss_pred -HHHHhhCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=328.32 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=205.5
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++...||+|+||.||+|.+..++ .+|+|++..... ..+.+.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 34567999999999999999999876554 589998865432 2345788999999999999999998885 45689
Q ss_pred EEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.++|+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999999754 348999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.. ......++..|+|||++.+..++.++|+|||||++|||
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05069 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred cc----------------------------------------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHH
Confidence 00 00123467889999999988899999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++ |.+||.+....+....+... .....| ..++..+++||.+||. ||.+||+ +++|+.
T Consensus 197 ~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~~ 255 (260)
T cd05069 197 VTKGRVPYPGMVNREVLEQVERG-YRMPCP--QGCPESLHELMKLCWKKDPDERPT---FEYIQS 255 (260)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 99 99999988877777666542 222333 3688999999999999 9999999 666653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=336.01 Aligned_cols=254 Identities=19% Similarity=0.364 Sum_probs=205.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcC----------------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCce
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKT----------------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~----------------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 178 (552)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999986543 34579999987542 23345678899999999999999
Q ss_pred EEEeeeecCCceEEEEEecCCCCchhhHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCc
Q 008810 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (552)
Q Consensus 179 v~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNI 247 (552)
+++++++.+.+.+|+||||++||+|..++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999986542 467789999999999999999999999999999999
Q ss_pred cccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChh
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APE 327 (552)
|++.++.++|+|||+++.+....... ......+++.|+|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe 202 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR---------------------------------------IQGRAVLPIRWMSWE 202 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee---------------------------------------ccCcCcCccccCCHH
Confidence 99999999999999988653221000 001234578899999
Q ss_pred hhhcCCCCCccchhhhhHHHHHHhh--CCCCCCCCChhhHHHHHhhc----cccccCCcccccChhHHHHHHHHhh-Ccc
Q 008810 328 VLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKIVNW----RTHLKFPEEAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 328 vl~~~~y~~~~DiWSlGvilyEmlt--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~e~~dLI~~lL~-dp~ 400 (552)
++.+..++.++|+|||||++|||++ |..||...+..+...+...+ .....+|....+++.+.+||.+||. ||.
T Consensus 203 ~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 282 (296)
T cd05095 203 SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAK 282 (296)
T ss_pred HHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 9998899999999999999999998 78999887766655443221 0112233334678999999999999 999
Q ss_pred ccCCCCChhhhh
Q 008810 401 QRLGAKGADEIK 412 (552)
Q Consensus 401 ~Rl~~~~a~eil 412 (552)
+||+ +.+|.
T Consensus 283 ~Rp~---~~~i~ 291 (296)
T cd05095 283 ERPS---FQEIH 291 (296)
T ss_pred cCCC---HHHHH
Confidence 9999 66654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=326.15 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=211.6
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
|++.+.||.|+||.||+|++..++ ..||+|++..... ......+..|+.+|..++||||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 8999999975532 2256778999999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 194 IMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||++|++|.+++..... +++..+..++.|++.||.+||+.|++||||||+||+++.+++++|+|||+++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.. .....+++.|+|||.+.+..++.++|+|||||++|+|+
T Consensus 159 ~~----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~ 198 (258)
T smart00219 159 YK----------------------------------------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198 (258)
T ss_pred cc----------------------------------------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHH
Confidence 00 00123788999999998888999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 352 t-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+ |.+||.+.+.......+.... ....| ..++.++.++|.+||. ||.+||+ +.+++.
T Consensus 199 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~ 256 (258)
T smart00219 199 TLGESPYPGMSNEEVLEYLKKGY-RLPKP--ENCPPEIYKLMLQCWAEDPEDRPT---FSELVE 256 (258)
T ss_pred hCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHCcCChhhCcC---HHHHHh
Confidence 8 899999888777777776532 23333 3589999999999999 9999999 888764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.92 Aligned_cols=249 Identities=21% Similarity=0.359 Sum_probs=206.4
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+..++|++.+.||+|+||.||+|... .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 356788999999999999999999854 45679999887543 234568889999999999999999999988 778
Q ss_pred EEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
|+||||+++|+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999763 45788899999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
... ......++..|+|||++....++.++|+|||||++|+
T Consensus 156 ~~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 195 (260)
T cd05073 156 EYT----------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 195 (260)
T ss_pred Ccc----------------------------------------cccCCcccccccCHhHhccCCcCccccchHHHHHHHH
Confidence 100 0012346678999999998889999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
|++ |.+||.+.+.......+... ...+....++.++.++|.+||+ +|.+||+ +.+++
T Consensus 196 l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~l~ 254 (260)
T cd05073 196 IVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERPT---FEYIQ 254 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCC---CCCCCcccCCHHHHHHHHHHcccCcccCcC---HHHHH
Confidence 998 99999988776666655532 2223234688999999999999 9999999 55554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=331.37 Aligned_cols=254 Identities=18% Similarity=0.293 Sum_probs=210.8
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcC----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKT----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD- 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d- 187 (552)
+..++|.+.++||+|+||.||+|.+.. ++..||+|++... ....+...+.+|..+|+.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 567889999999999999999999876 3688999998643 234556778999999999999999999987654
Q ss_pred CceEEEEEecCCCCchhhHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK--------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~D 259 (552)
....++++||+++|+|..++... ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57889999999999999998653 4589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccc
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 339 (552)
||+++.+....... ......++..|+|||++.+..++.++|
T Consensus 161 ~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~D 201 (280)
T cd05043 161 NALSRDLFPMDYHC---------------------------------------LGDNENRPVKWMALESLVNKEYSSASD 201 (280)
T ss_pred CCCcccccCCceEE---------------------------------------eCCCCCcchhccCHHHHhcCCCCchhh
Confidence 99998653321110 001234567899999999999999999
Q ss_pred hhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 340 WWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 340 iWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||||||++|||++ |.+||...++.+....+.. ...++....+++++.++|.+||+ ||++||+ +.+++.
T Consensus 202 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~~~ 271 (280)
T cd05043 202 VWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD---GYRLAQPINCPDELFAVMACCWALDPEERPS---FSQLVQ 271 (280)
T ss_pred HHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHc---CCCCCCCCcCCHHHHHHHHHHcCCChhhCCC---HHHHHH
Confidence 9999999999999 9999998887776655543 22223334678999999999999 9999999 777653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=325.02 Aligned_cols=244 Identities=25% Similarity=0.343 Sum_probs=205.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG 201 (552)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 369999999999999877 999999998765432 34567899999999999999999999999999999999999999
Q ss_pred chhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 202 DMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 202 ~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
+|.+++.. ...+++..+..++.+++.||.|||++|++||||||+|||++.++++||+|||+++.........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV------- 150 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-------
Confidence 99999965 3568999999999999999999999999999999999999999999999999997653211000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~ 359 (552)
......++..|+|||++.+..++.++|+|||||++|||++ |.+||.+
T Consensus 151 --------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 151 --------------------------------SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred --------------------------------ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 0001234677999999998899999999999999999999 8999988
Q ss_pred CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.........+... ..+..| ..++.++.+||.+||+ +|.+||+ +.|++.
T Consensus 199 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~ell~ 247 (251)
T cd05041 199 MSNQQTRERIESG-YRMPAP--QLCPEEIYRLMLQCWAYDPENRPS---FSEIYN 247 (251)
T ss_pred CCHHHHHHHHhcC-CCCCCC--ccCCHHHHHHHHHHhccChhhCcC---HHHHHH
Confidence 8776666665431 223333 3688999999999998 9999999 888775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=331.54 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=197.3
Q ss_pred eeEEeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--CceE
Q 008810 118 FELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFL 191 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~l 191 (552)
|.+++.||+|+||+||++.. ..++..||+|+++.... ......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48899999999999988763 35788999999875421 2334567889999999999999999998765 3468
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999999865 4699999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.. .......++..|+|||++.+..++.++|||||||++|||+
T Consensus 163 ~~--------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~ 204 (283)
T cd05080 163 YY--------------------------------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204 (283)
T ss_pred hh--------------------------------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence 00 0001234567799999999888999999999999999999
Q ss_pred hCCCCCCCCChhh--------------HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 352 VGYPPFYSDDPMS--------------TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 352 tG~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+|..||....... .....+........| ..++.++.+||.+||. +|.+||+ +++|+.
T Consensus 205 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps---~~~i~~ 276 (283)
T cd05080 205 THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP--KNCPQEVYILMKNCWETEAKFRPT---FRSLIP 276 (283)
T ss_pred hCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 9999986543210 011111111111222 3678999999999999 9999999 777664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=332.04 Aligned_cols=253 Identities=20% Similarity=0.326 Sum_probs=203.9
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
+..++|++++.||+|+||+||+|....+|.. +|+|.+.... .......+..|..+++.++|||||++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 4567899999999999999999999888775 5666654221 12234567778888999999999999998764
Q ss_pred ceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
..+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 567899999999999999975 4579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... .......|+..|+|||++.+..|+.++|+|||||++
T Consensus 161 ~~~~~---------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il 201 (279)
T cd05111 161 PDDKK---------------------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201 (279)
T ss_pred CCCcc---------------------------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHH
Confidence 21100 001124577889999999988999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++ |..||.+..+......+.. ......| ..++.++.++|.+|+. ||.+||+ +.|++.
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~c~~~~p~~Rps---~~el~~ 263 (279)
T cd05111 202 WEMMSYGAEPYAGMRPHEVPDLLEK-GERLAQP--QICTIDVYMVMVKCWMIDENVRPT---FKELAN 263 (279)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCC--CCCCHHHHHHHHHHcCCCcccCcC---HHHHHH
Confidence 99998 9999988876655444432 2222223 3567889999999998 9999999 777754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=325.11 Aligned_cols=250 Identities=19% Similarity=0.298 Sum_probs=208.7
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
...+|++.+.||.|+||.||+|.+. ++..+|+|++..... ....+.+|+.++..++||+|+++++++.+....|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3568999999999999999999875 467899999875432 12457889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++||+|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||+++.++++||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999998754 56899999999999999999999999999999999999999999999999998754221100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
. .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~----------------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~ 196 (256)
T cd05112 157 S----------------------------------------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196 (256)
T ss_pred c----------------------------------------cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHc
Confidence 0 012345678999999998899999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|++||...........+... .....| ...+.++.+||.+||+ +|.+||+ +.+++++
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp~---~~~~l~~ 254 (256)
T cd05112 197 EGKTPYENRSNSEVVETINAG-FRLYKP--RLASQSVYELMQHCWKERPEDRPS---FSLLLHQ 254 (256)
T ss_pred CCCCCCCcCCHHHHHHHHhCC-CCCCCC--CCCCHHHHHHHHHHcccChhhCCC---HHHHHHh
Confidence 99999887777666665432 122223 2568899999999999 9999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=330.49 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=210.8
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
+...+|++++.||+|+||.||+|..+.+|. .+|+|++.+... ......+.+|..+|+.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 456789999999999999999999877765 589998876532 3445678899999999999999999999987
Q ss_pred ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7889999999999999999764 579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... ......+++.|+|||.+....++.++|+|||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05057 161 VDEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTV 201 (279)
T ss_pred Ccccce---------------------------------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHH
Confidence 221000 00012346789999999988999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
|||++ |.+||.+....+....+... ..+..| ..++.++.++|.+||. ||.+||+ +.+++
T Consensus 202 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp~---~~~l~ 262 (279)
T cd05057 202 WELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQP--PICTIDVYMVLVKCWMIDAESRPT---FKELI 262 (279)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHhCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCCC---HHHHH
Confidence 99998 99999998877776666643 233333 3678899999999998 9999999 55554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=333.48 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=205.1
Q ss_pred CeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
+|++.+.||+|+||.||+|.... ....+|+|++.+... ......+.+|+.+|+.++||||+++++.|...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 57889999999999999998753 335799998875432 23456788999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRK------------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNI 247 (552)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998542 3478899999999999999999999999999999999
Q ss_pred cccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChh
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APE 327 (552)
|++.++.+||+|||+++......... ......++..|+|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~apE 199 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV---------------------------------------KRSKGRIPVKWMAIE 199 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh---------------------------------------cccCCCCCccccCHH
Confidence 99999999999999987543211000 001234677899999
Q ss_pred hhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 328 vl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
++.+..++.++|+|||||++|||++ |.+||.+..+......+.. ....+....++.++.+||.+||. +|.+||+
T Consensus 200 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~- 275 (290)
T cd05045 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT---GYRMERPENCSEEMYNLMLTCWKQEPDKRPT- 275 (290)
T ss_pred HHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCCCCCCHHHHHHHHHHccCCcccCCC-
Confidence 9999999999999999999999998 9999988877766554442 12222224688999999999998 9999999
Q ss_pred CChhhhhc
Q 008810 406 KGADEIKV 413 (552)
Q Consensus 406 ~~a~eil~ 413 (552)
+.+|+.
T Consensus 276 --~~~i~~ 281 (290)
T cd05045 276 --FADISK 281 (290)
T ss_pred --HHHHHH
Confidence 776653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.14 Aligned_cols=258 Identities=26% Similarity=0.402 Sum_probs=220.1
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCc---E-EEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeee
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH---V-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~-~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 184 (552)
+.+.+..++-.+.++||+|+||+||+|+.+..+. . ||+|..+.+....+.++..+.+|.++|..++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3345566777788999999999999999876433 3 89999986555667888899999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
..+..-+|||||+|+||+|.++|.+.+ .++..+...|+.+.+.||+|||++++|||||-..|+|++.++.+||+||||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999998876 5999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+....-.. . .....-...|+|||.+...-|+.++|||||
T Consensus 310 ~~~~~~~~-------~----------------------------------~~~~klPirWLAPEtl~~~~~s~kTDV~sf 348 (474)
T KOG0194|consen 310 RAGSQYVM-------K----------------------------------KFLKKLPIRWLAPETLNTGIFSFKTDVWSF 348 (474)
T ss_pred cCCcceee-------c----------------------------------cccccCcceecChhhhccCccccccchhhe
Confidence 75321000 0 000112457999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 344 GAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 344 GvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
||++||+.+ |..||.+....+...+|+......+.|. ..+.+...++.+|+. +|++|++ +.+|.
T Consensus 349 GV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p~~~~~~~~~c~~~~p~~R~t---m~~i~ 414 (474)
T KOG0194|consen 349 GVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTPKELAKVMKQCWKKDPEDRPT---MSTIK 414 (474)
T ss_pred eeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCHHHHHHHHHHhccCChhhccC---HHHHH
Confidence 999999998 8999999999999999966444555554 778899999999998 9999999 55554
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.42 Aligned_cols=262 Identities=27% Similarity=0.424 Sum_probs=210.3
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-Cce
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEF 190 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-~~~ 190 (552)
..|++++.||+|+||.||+|..+.++ +.||||+++...- ..+-.....+|+.++++++|||||.|..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 45889999999999999999655443 3799999976532 12223457889999999999999999999987 889
Q ss_pred EEEEEecCCCCchhhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC----CcEEEcccc
Q 008810 191 LYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFG 261 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~----g~iKL~DFG 261 (552)
++||+||.+ -||...+.- ...++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999995 588888843 2468999999999999999999999999999999999999887 899999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccch
Q 008810 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340 (552)
Q Consensus 262 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~Di 340 (552)
+++.+...-..-- ....+|-|.+|+|||.|++ ..|+.++|+
T Consensus 182 laR~~~~plkpl~--------------------------------------s~d~VVVTiWYRAPELLLGa~hYT~AiDv 223 (438)
T KOG0666|consen 182 LARLFNNPLKPLA--------------------------------------SLDPVVVTIWYRAPELLLGARHYTKAIDV 223 (438)
T ss_pred HHHHhhccccccc--------------------------------------cCCceEEEEEecChHHhcccccccchhhh
Confidence 9998754321100 0114788999999999998 679999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCCh---------hhHHHHHhh---------ccccccCCccc--------------------
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDP---------MSTCRKIVN---------WRTHLKFPEEA-------------------- 382 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~---------~~~~~~i~~---------~~~~~~~p~~~-------------------- 382 (552)
||+|||+.|||+-.|.|.+... .....+|++ |..-..+|+..
T Consensus 224 WAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~ 303 (438)
T KOG0666|consen 224 WAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYY 303 (438)
T ss_pred HHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHH
Confidence 9999999999999999987532 233455553 33333344320
Q ss_pred ----ccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 383 ----KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 383 ----~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
.-++.+.+|+.+||. ||.+|.+ +++.++|+||..-
T Consensus 304 ~~~k~k~~~a~~LL~klL~yDP~kRIt---a~qAleh~yF~~d 343 (438)
T KOG0666|consen 304 HKHKVKDPSALDLLQKLLTYDPIKRIT---AEQALEHPYFTED 343 (438)
T ss_pred HHhcCCCchHHHHHHHHhccCchhhcc---HHHHhcccccccC
Confidence 125569999999999 9999999 9999999999754
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=323.43 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=202.0
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG 201 (552)
++||+|+||.||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++.+.+....|+||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36999999999999864 68899999987542 1223346889999999999999999999999999999999999999
Q ss_pred chhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccC
Q 008810 202 DMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (552)
Q Consensus 202 ~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~ 280 (552)
+|.+++.. ...+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------- 150 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc-------
Confidence 99999865 3568999999999999999999999999999999999999999999999999987543221100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCC
Q 008810 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (552)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~ 359 (552)
.....+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+
T Consensus 151 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 151 ---------------------------------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred ---------------------------------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 001234678999999998889999999999999999998 9999988
Q ss_pred CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.........+... ....+| ..++.++.+||.+||. +|.+||+ +.++++
T Consensus 198 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~ 246 (250)
T cd05085 198 MTNQQAREQVEKG-YRMSCP--QKCPDDVYKVMQRCWDYKPENRPK---FSELQK 246 (250)
T ss_pred CCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCCC---HHHHHH
Confidence 8777766666532 222333 3688999999999999 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=331.76 Aligned_cols=254 Identities=33% Similarity=0.529 Sum_probs=212.4
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|++.+.||.|++|.||+|....+|+.+|+|.+..... .......+..|..+|+.++||+|+++++++.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5678899999999999999999999999999876542 223456688899999999999999999999999999999999
Q ss_pred CCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 198 ~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
+++ +|..++.. ...+++..+..++.+++.||.|||+.||+|+||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence 975 88887766 46899999999999999999999999999999999999999999999999999876532210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~~ 355 (552)
......++..|+|||.+.+. .++.++|+|||||++|+|++|++
T Consensus 154 ------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 197 (283)
T cd05118 154 ------------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197 (283)
T ss_pred ------------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 00124688899999999876 78999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhcccc-----------------ccCCc---------ccccChhHHHHHHHHhh-CccccCCCCCh
Q 008810 356 PFYSDDPMSTCRKIVNWRTH-----------------LKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a 408 (552)
||.+.+..+...++...-.. ..+|. ...++.++++||.+||. ||.+||+ +
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~ 274 (283)
T cd05118 198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---A 274 (283)
T ss_pred CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---H
Confidence 99888776665555431000 01110 12468899999999999 9999999 9
Q ss_pred hhhhcCCCc
Q 008810 409 DEIKVHPWF 417 (552)
Q Consensus 409 ~eil~HpfF 417 (552)
.+|+.||||
T Consensus 275 ~~ll~~~~~ 283 (283)
T cd05118 275 EQALAHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=328.07 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=208.2
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
+..++|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN- 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence 4567799999999999999999987654 4479999886543 133456788999999999999999999998764
Q ss_pred eEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..|+||||+++|+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999999764 4689999999999999999999999999999999999999999999999999886532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
..... .....+++.|+|||++....++.++|+|||||++|
T Consensus 160 ~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 199 (270)
T cd05056 160 ESYYK----------------------------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199 (270)
T ss_pred cccee----------------------------------------cCCCCccccccChhhhccCCCCchhhhHHHHHHHH
Confidence 21000 01223567899999999899999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||++ |.+||.+.+..+....+.+. ..+..| ..++.++++||.+|+. +|.+||+ +.+++.
T Consensus 200 el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt---~~~~~~ 260 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSKRPR---FTELKA 260 (270)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9996 99999888776666655542 233344 3789999999999998 9999998 777664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=331.91 Aligned_cols=254 Identities=22% Similarity=0.385 Sum_probs=202.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--c
Q 008810 116 DDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--E 189 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~--~ 189 (552)
..|++++.||+|+||.||+|+. +.++..||+|.++... .......+.+|+.+|+.++||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3478899999999999999984 4578899999986442 233456789999999999999999999998875 6
Q ss_pred eEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..|+||||++||+|.+++.+. ..+++..+..++.+++.||.|||+.||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 789999999999999998654 4689999999999999999999999999999999999999999999999999886532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
..... .......|+..|+|||++.+..++.++|+|||||++|
T Consensus 162 ~~~~~--------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 162 DKEYY--------------------------------------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred Cccce--------------------------------------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 21000 0011345778899999999889999999999999999
Q ss_pred HHhhCCCCCCCCCh--------------hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 349 EMLVGYPPFYSDDP--------------MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 349 EmltG~~PF~~~~~--------------~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||++|..|+..... .......++. ....|....++.++.+||.+||+ +|.+||+ +.+|+.
T Consensus 204 ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 278 (284)
T cd05079 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE--GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT---FQNLIE 278 (284)
T ss_pred hhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc--CccCCCCCCCCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 99998877643210 1111112221 11223334689999999999999 9999999 888875
Q ss_pred C
Q 008810 414 H 414 (552)
Q Consensus 414 H 414 (552)
+
T Consensus 279 ~ 279 (284)
T cd05079 279 G 279 (284)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=328.77 Aligned_cols=246 Identities=19% Similarity=0.271 Sum_probs=193.7
Q ss_pred eeeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCC
Q 008810 122 TMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.|.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 358999999999997533 34578888775432 22334567889999999999999999999999999999999999
Q ss_pred CCchhhHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 200 GGDMMTLLMRKD-----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 200 gG~L~~~L~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 999999986542 35678889999999999999999999999999999999999999999999987532111000
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-------CCCCCccchhhhhHHH
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-------KGYGMECDWWSLGAIM 347 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-------~~y~~~~DiWSlGvil 347 (552)
......+++.|+|||++.. ..++.++|||||||++
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 158 --------------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred --------------------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence 0012456788999999853 3568899999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCc---ccccChhHHHHHHHHhhCccccCCCCChhhhh
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPE---EAKLSIEAKDLISKLLCNVNQRLGAKGADEIK 412 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~---~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil 412 (552)
|||++ |.+||....+.+...+++.. ....+|. ...++....+++..|+.||.+||+ +++|+
T Consensus 200 ~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt---~~~v~ 264 (269)
T cd05042 200 WELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPT---AEEVH 264 (269)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhhc-cCccCCCCcccccCCHHHHHHHHHHhcCcccccC---HHHHH
Confidence 99999 88999887776666665542 2222222 236788899999988889999999 55544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.69 Aligned_cols=253 Identities=24% Similarity=0.410 Sum_probs=200.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec--CC
Q 008810 115 ADDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DD 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~ 188 (552)
..+|++++.||+|+||.||+|.. ..++..||||++.... ......+.+|+.+|..++||||+++++++. +.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35799999999999999999984 4578899999987543 344567889999999999999999998764 34
Q ss_pred ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
..+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||+++.+.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 5789999999999999999764 568999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... .......++..|+|||++.+..++.++|||||||++
T Consensus 160 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 201 (284)
T cd05081 160 QDKEYY--------------------------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201 (284)
T ss_pred CCCcce--------------------------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHH
Confidence 221000 000012345569999999988999999999999999
Q ss_pred HHHhhCCCCCCCCChhh---------------HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 348 YEMLVGYPPFYSDDPMS---------------TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~---------------~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
|||++|..|+....... ....++.. ...+|....++.++.+||.+||. +|++||+ +.+|
T Consensus 202 ~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei 276 (284)
T cd05081 202 YELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN--NGRLPAPPGCPAEIYAIMKECWNNDPSQRPS---FSEL 276 (284)
T ss_pred HHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc--CCcCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHH
Confidence 99999988765432110 01112221 12233334688999999999999 9999999 7777
Q ss_pred hc
Q 008810 412 KV 413 (552)
Q Consensus 412 l~ 413 (552)
+.
T Consensus 277 ~~ 278 (284)
T cd05081 277 AL 278 (284)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=330.96 Aligned_cols=236 Identities=18% Similarity=0.267 Sum_probs=193.8
Q ss_pred eeeecCCeEEEEEEEcCCCc-------EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 123 MIGKGAFGEVRVCREKTTGH-------VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~tg~-------~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
.||+|+||.||+|..+.++. .||+|.+.+.. ....+.+..|..+|+.++|||||+++++|.+....|+||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 68999999999999866544 48888876543 334556888999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc--------EEEccccccccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--------LRLSDFGLCKPL 266 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~--------iKL~DFGlak~~ 266 (552)
||+++|+|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999999764 46899999999999999999999999999999999999987765 688999887643
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 345 (552)
... ....|++.|+|||++.+ ..++.++|||||||
T Consensus 159 ~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 193 (258)
T cd05078 159 LPK---------------------------------------------EILLERIPWVPPECIENPQNLSLAADKWSFGT 193 (258)
T ss_pred CCc---------------------------------------------hhccccCCccCchhccCCCCCCchhhHHHHHH
Confidence 210 12468899999999987 45899999999999
Q ss_pred HHHHHhhC-CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 346 IMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 346 ilyEmltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
++|||++| .+||...++..... +.. ....+|. ..+.++.+||.+||. ||.+||+ +++|++.
T Consensus 194 ~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~il~~ 256 (258)
T cd05078 194 TLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPA--PKWTELANLINQCMDYEPDFRPS---FRAIIRD 256 (258)
T ss_pred HHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCC--CCcHHHHHHHHHHhccChhhCCC---HHHHHHh
Confidence 99999998 57776665544332 222 2334453 467889999999999 9999999 8888753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.40 Aligned_cols=246 Identities=22% Similarity=0.276 Sum_probs=194.6
Q ss_pred eeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCC
Q 008810 122 TMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 3567899999875432 2233468889999999999999999999999999999999999
Q ss_pred CCchhhHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 200 GGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 200 gG~L~~~L~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||+|.+++... ..+++..++.++.|++.||.|||+.|++||||||+|||++.++++||+|||+++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 99999998643 24567788899999999999999999999999999999999999999999998743211100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-------CCCCccchhhhhHHH
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-------GYGMECDWWSLGAIM 347 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-------~y~~~~DiWSlGvil 347 (552)
.......|++.|+|||++.+. .++.++|+|||||++
T Consensus 157 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05087 157 -------------------------------------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199 (269)
T ss_pred -------------------------------------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence 001134678899999998642 368899999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcc---cccChhHHHHHHHHhhCccccCCCCChhhhh
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEE---AKLSIEAKDLISKLLCNVNQRLGAKGADEIK 412 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~---~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil 412 (552)
|||++ |.+||...+..+....++.. ....++.. ..++..+.+||.+|+.+|.+||+ +++|.
T Consensus 200 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rpt---~~~l~ 264 (269)
T cd05087 200 WELFELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPS---AEEVH 264 (269)
T ss_pred HHHHhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccCCCCChHHHHHHHHHhcCcccCCC---HHHHH
Confidence 99996 99999877666554443332 22222221 24678899999999889999999 66665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=333.34 Aligned_cols=254 Identities=18% Similarity=0.293 Sum_probs=206.4
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
+..++|+.++.||+|+||.||+|.++.+|. .+|+|++..... ......+.+|..+++.++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999999988776 468888765432 22334578899999999999999999998764
Q ss_pred ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 467999999999999998764 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... ......++..|+|||++.+..++.++|+|||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l 201 (303)
T cd05110 161 GDEKEY---------------------------------------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201 (303)
T ss_pred Cccccc---------------------------------------ccCCCccccccCCHHHhccCCCChHHHHHHHHHHH
Confidence 221000 01123567899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++ |..||.+........ ++.....+.. ...++..+.++|.+|+. +|.+||+ +.+++..
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~li~~c~~~~p~~Rp~---~~~l~~~ 264 (303)
T cd05110 202 WELMTFGGKPYDGIPTREIPD-LLEKGERLPQ--PPICTIDVYMVMVKCWMIDADSRPK---FKELAAE 264 (303)
T ss_pred HHHHhCCCCCCCCCCHHHHHH-HHHCCCCCCC--CCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99997 999998776554443 3332223333 34678899999999998 9999999 7777664
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.37 Aligned_cols=248 Identities=31% Similarity=0.475 Sum_probs=203.3
Q ss_pred eEEeeeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 119 ELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.+.+.||.|+||.||+|... ..+..||||+++.. ......+.+.+|.++|..++||||+++++++.....+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 45678999999542 2233467789999999999999999999999988889999
Q ss_pred EecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 195 MEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++|+|.++|... ..+++.....++.||+.||.|||+.+|||+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999876 78999999999999999999999999999999999999999999999999999876221100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
. ......+...|+|||++.+..++.++||||||+++|||++
T Consensus 160 ~---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 160 K---------------------------------------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp E---------------------------------------ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred c---------------------------------------cccccccccccccccccccccccccccccccccccccccc
Confidence 0 0113456778999999999999999999999999999999
Q ss_pred -CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|..||...+..+...++.. .....+| ..++..+.+||.+||. ||.+||+ +.+|++
T Consensus 201 ~~~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~C~~~~p~~RPs---~~~i~~ 257 (259)
T PF07714_consen 201 LGKFPFSDYDNEEIIEKLKQ-GQRLPIP--DNCPKDIYSLIQQCWSHDPEKRPS---FQEILQ 257 (259)
T ss_dssp TSSGTTTTSCHHHHHHHHHT-TEETTSB--TTSBHHHHHHHHHHT-SSGGGS-----HHHHHH
T ss_pred cccccccccccccccccccc-cccceec--cchhHHHHHHHHHHcCCChhhCcC---HHHHHh
Confidence 7899998888887777744 2333344 3689999999999998 9999999 887763
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.98 Aligned_cols=242 Identities=20% Similarity=0.351 Sum_probs=202.2
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++.+.||+|+||.||++. .+++.||+|+++... ....+.+|+.++..++||||+++++++..+ .+|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34679999999999999999986 478899999986532 235688999999999999999999998765 4799
Q ss_pred EEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 194 IMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||++||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.+|.+||+|||+++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999999997643 58999999999999999999999999999999999999999999999999987532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....++..|+|||++.+..++.++|+|||||++|||+
T Consensus 155 -------------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 155 -------------------------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred -------------------------------------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 0123456799999999889999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 352 t-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+ |++||...+..+....+... .....+ ..++.++.+||.+||. +|.+||+ +.+|+.
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~ 249 (254)
T cd05083 192 SYGRAPYPKMSLKEVKECVEKG-YRMEPP--EGCPADVYVLMTSCWETEPKKRPS---FHKLRE 249 (254)
T ss_pred hCCCCCCccCCHHHHHHHHhCC-CCCCCC--CcCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 7 99999988877666555432 222222 3688999999999998 9999999 666653
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=321.73 Aligned_cols=247 Identities=18% Similarity=0.281 Sum_probs=198.4
Q ss_pred eeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec-CCceEEEEEec
Q 008810 122 TMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFLYLIMEY 197 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-d~~~lylVmEy 197 (552)
+.||+|+||.||+|.... .+..||+|.+.... .....+.+..|..+++.++||||+++++.+. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 34579999985421 2344567888999999999999999999765 55678999999
Q ss_pred CCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 198 LPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 198 ~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
+++|+|..++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~-- 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-- 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence 9999999998664 4567888889999999999999999999999999999999999999999999986532110000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 355 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~ 355 (552)
.......+++.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 157 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 157 -----------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred -----------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence 00012356788999999999999999999999999999999 577
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||...+.......+..+ .....| ..++..+.+||.+||. +|.+||+ +.+|+.
T Consensus 202 ~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~il~ 254 (262)
T cd05058 202 PYPDVDSFDITVYLLQG-RRLLQP--EYCPDPLYEVMLSCWHPKPEMRPT---FSELVS 254 (262)
T ss_pred CCCCCCHHHHHHHHhcC-CCCCCC--CcCCHHHHHHHHHHcCCChhhCCC---HHHHHH
Confidence 88877776666666543 222333 3578899999999999 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=324.71 Aligned_cols=245 Identities=25% Similarity=0.385 Sum_probs=201.6
Q ss_pred eeeeecCCeEEEEEEEcCCC------cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 122 TMIGKGAFGEVRVCREKTTG------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+.||+|+||.||+|+.+..+ ..||||.+.+... ......+.+|..+|+.++||||++++++|.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 6899999865421 233456888999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-----cEEEcccccc
Q 008810 196 EYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-----HLRLSDFGLC 263 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-----~iKL~DFGla 263 (552)
||++||+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+|||++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 3478899999999999999999999999999999999999888 8999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+.+....... ......++..|+|||++.+..++.++|+|||
T Consensus 159 ~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 199 (269)
T cd05044 159 RDIYKSDYYR---------------------------------------KEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199 (269)
T ss_pred cccccccccc---------------------------------------cCcccCCCccccCHHHHccCCcccchhHHHH
Confidence 8653221000 0012356788999999999999999999999
Q ss_pred hHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 344 GAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 344 GvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||++|||++ |..||...+..+....+... ..+..+ ..++..+.+||.+||. +|.+||+ +.+|+.
T Consensus 200 G~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~~ 265 (269)
T cd05044 200 GVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKP--ENCPDKIYQLMTNCWAQDPSERPT---FDRIQE 265 (269)
T ss_pred HHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCc--ccchHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 999999998 99999887777766665431 223333 3688999999999999 9999999 777653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=323.21 Aligned_cols=236 Identities=20% Similarity=0.247 Sum_probs=191.0
Q ss_pred eeeecCCeEEEEEEEcC------------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 123 MIGKGAFGEVRVCREKT------------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~------------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
.||+|+||.||+|.... ....+|+|++.... ......+..|..++..++|||||++++++.+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 68999999999998532 22358888876542 2334567888999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc-------EEEccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-------LRLSDFGL 262 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~-------iKL~DFGl 262 (552)
.++||||+++|+|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|. +||+|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999999988865 457999999999999999999999999999999999999987664 89999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-cCCCCCccchh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWW 341 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiW 341 (552)
+...... ...+||..|+|||++. +..++.++|||
T Consensus 159 ~~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Diw 193 (262)
T cd05077 159 PITVLSR---------------------------------------------QECVERIPWIAPECVEDSKNLSIAADKW 193 (262)
T ss_pred CccccCc---------------------------------------------ccccccccccChhhhcCCCCCCchhHHH
Confidence 8644211 1346888999999987 46799999999
Q ss_pred hhhHHHHHHh-hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 342 SLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 342 SlGvilyEml-tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
||||++|||+ .|.+||......+.. ++.. ...... ...+.++.+||.+||. ||.+||+ +.+|+.+
T Consensus 194 slG~~l~el~~~~~~p~~~~~~~~~~-~~~~--~~~~~~--~~~~~~~~~li~~cl~~dp~~Rp~---~~~il~~ 260 (262)
T cd05077 194 SFGTTLWEICYNGEIPLKDKTLAEKE-RFYE--GQCMLV--TPSCKELADLMTHCMNYDPNQRPF---FRAIMRD 260 (262)
T ss_pred HHHHHHHHHHhCCCCCCCCcchhHHH-HHHh--cCccCC--CCChHHHHHHHHHHcCCChhhCcC---HHHHHHh
Confidence 9999999998 589999876544432 2222 112221 2346789999999999 9999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=326.20 Aligned_cols=236 Identities=20% Similarity=0.250 Sum_probs=192.1
Q ss_pred eeeecCCeEEEEEEEcCC------------------------CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCce
Q 008810 123 MIGKGAFGEVRVCREKTT------------------------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~t------------------------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I 178 (552)
.||+|+||.||+|....+ ...+|+|++.... ......+..|..+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999975322 2358999986543 2334567888999999999999
Q ss_pred EEEeeeecCCceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC----
Q 008810 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---- 253 (552)
Q Consensus 179 v~l~~~f~d~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---- 253 (552)
+++++++.+....|+||||++||+|..++.+ .+.+++..+..++.||+.||.|||+.||+||||||+|||++..|
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999865 46789999999999999999999999999999999999998654
Q ss_pred ---cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh
Q 008810 254 ---HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (552)
Q Consensus 254 ---~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~ 330 (552)
.+||+|||++...... ....|++.|+|||++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---------------------------------------------~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---------------------------------------------EERVERIPWIAPECVP 193 (274)
T ss_pred ccceeeecCCccccccccc---------------------------------------------cccccCCcccCchhhc
Confidence 4899999987643110 1235788899999997
Q ss_pred c-CCCCCccchhhhhHHHHHHh-hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 331 K-KGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 331 ~-~~y~~~~DiWSlGvilyEml-tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
+ ..++.++|+|||||++|||+ +|.+||.+..+.+... +.. ....+|. ..++++.+||.+||+ +|.+||+
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps--- 265 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE--KKHRLPE--PSCKELATLISQCLTYEPTQRPS--- 265 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH--hccCCCC--CCChHHHHHHHHHcccChhhCcC---
Confidence 6 56899999999999999995 6999998876654432 222 2223443 356789999999999 9999998
Q ss_pred hhhhhcC
Q 008810 408 ADEIKVH 414 (552)
Q Consensus 408 a~eil~H 414 (552)
+.+|+.+
T Consensus 266 ~~~il~~ 272 (274)
T cd05076 266 FRTILRD 272 (274)
T ss_pred HHHHHHh
Confidence 8888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=368.25 Aligned_cols=270 Identities=31% Similarity=0.490 Sum_probs=207.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 187 (552)
..||+.+.+||+||||.||+|+.+-+|..||||++.-.. .......+.+|+.+|++++|||||+.|.+|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 467999999999999999999999999999999997653 44556678999999999999999999977621
Q ss_pred --------------------------------------------------------------------------------
Q 008810 188 -------------------------------------------------------------------------------- 187 (552)
Q Consensus 188 -------------------------------------------------------------------------------- 187 (552)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------ceEEEEEecCCCCchhhHHhhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 008810 188 ------------------------D--------EFLYLIMEYLPGGDMMTLLMRKDTL-TEDEARFYVAETVLAIESIHK 234 (552)
Q Consensus 188 ------------------------~--------~~lylVmEy~~gG~L~~~L~~~~~l-~e~~~~~~~~qi~~aL~~LH~ 234 (552)
+ ..+||-||||+...|.+++.++... ....+..+++||+.||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1379999999887777777665544 478889999999999999999
Q ss_pred CCCcccccCCCCccccCCCcEEEcccccccccCC-CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccc
Q 008810 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC-STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRML 313 (552)
Q Consensus 235 ~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~ 313 (552)
.|||||||||.||+||.+++|||+|||+|+.... ..........+++..++...+
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~------------------------ 771 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGD------------------------ 771 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcc------------------------
Confidence 9999999999999999999999999999986321 111111111122222222211
Q ss_pred ccccccCCCCCChhhhhcCC---CCCccchhhhhHHHHHHhhCCCCCCCC-ChhhHHHHHhhccccccCCcc--cccChh
Q 008810 314 AYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEE--AKLSIE 387 (552)
Q Consensus 314 ~~s~~GT~~Y~APEvl~~~~---y~~~~DiWSlGvilyEmltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~~--~~~s~e 387 (552)
.++.+||.-|+|||++.+.. |+.++|+||||||+|||+ .||... ....++.++. ...+++|.. ..--+.
T Consensus 772 ~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~ 846 (1351)
T KOG1035|consen 772 LTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLR--KGSIPEPADFFDPEHPE 846 (1351)
T ss_pred cccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcc--cCCCCCCcccccccchH
Confidence 13679999999999998754 999999999999999998 357532 2233333333 244555511 122346
Q ss_pred HHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 388 AKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 388 ~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
...+|+.||. ||.+||+ |.|+|++-||-
T Consensus 847 e~slI~~Ll~hdP~kRPt---A~eLL~s~llp 875 (1351)
T KOG1035|consen 847 EASLIRWLLSHDPSKRPT---ATELLNSELLP 875 (1351)
T ss_pred HHHHHHHHhcCCCccCCC---HHHHhhccCCC
Confidence 7789999999 9999999 99999999997
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=322.22 Aligned_cols=251 Identities=29% Similarity=0.519 Sum_probs=208.1
Q ss_pred CeeEEeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhh-------hhhhHHHHHHHHHHHHHh-cCCCceEEEeeeecC
Q 008810 117 DFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEM-------LRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQD 187 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~-tg~~~AiK~l~k~~~-------~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d 187 (552)
+|++.+.||+|+||.||+|.++. +++.+|+|.+..... ........+..|..++.+ ++||||+++++.|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 788999999864321 223345567788888865 799999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||. .|++||||+|+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3579999999999999999999996 7899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
+....... ......|+..|+|||++.+..++.++|+||
T Consensus 161 ~~~~~~~~------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s 198 (269)
T cd08528 161 AKQKQPES------------------------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWA 198 (269)
T ss_pred eeeccccc------------------------------------------ccccccCcccCcChhhhcCCCCchHHHHHH
Confidence 97643210 011356899999999999888999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++|+|++|.+||...+.......+...... ..+ ...+++++.+||.+||. ||.+||+ +.|+..+
T Consensus 199 lG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~l~~li~~cl~~~p~~Rp~---~~e~~~~ 266 (269)
T cd08528 199 FGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLP-EGMYSEDVTDVITSCLTPDAEARPD---IIQVSAM 266 (269)
T ss_pred HHHHHHHHHhCCCcccccCHHHHHHHHhhccCC-cCC-cccCCHHHHHHHHHHCCCCCccCCC---HHHHHHH
Confidence 999999999999999888777666666542211 122 23678999999999998 9999999 7776543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.12 Aligned_cols=260 Identities=25% Similarity=0.434 Sum_probs=211.2
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--C----ceEEEe
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--N----CIVKLY 182 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p----~Iv~l~ 182 (552)
+...+-..+|.+++.+|+|+||+|..|.+..++..||||+++.-. ...+..+-|+++|.++.+ | .+|.+.
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 334455788999999999999999999999999999999997532 233457789999999832 2 489999
Q ss_pred eeecCCceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---------
Q 008810 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--------- 251 (552)
Q Consensus 183 ~~f~d~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~--------- 251 (552)
++|.-.++.|||+|.+ |-+++++|..+ .+|+...++.+++|++.++.+||+.+++|.||||||||+.+
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEecc
Confidence 9999999999999998 77999999765 46999999999999999999999999999999999999932
Q ss_pred -----------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccC
Q 008810 252 -----------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (552)
Q Consensus 252 -----------~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT 320 (552)
+-+|||+|||.|..-... ..+.|.|
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------------------------------------------hs~iVsT 272 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH--------------------------------------------HSTIVST 272 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccC--------------------------------------------cceeeec
Confidence 236899999988754321 1367899
Q ss_pred CCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhh---HHHHHhhc----------------cccccCCcc
Q 008810 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMS---TCRKIVNW----------------RTHLKFPEE 381 (552)
Q Consensus 321 ~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~---~~~~i~~~----------------~~~~~~p~~ 381 (552)
..|.||||+++-|++..||+||+||||+|+.+|...|+..+..+ +.++|+.- ...+..|+.
T Consensus 273 RHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~ 352 (415)
T KOG0671|consen 273 RHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEV 352 (415)
T ss_pred cccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccc
Confidence 99999999999999999999999999999999999999877554 44444420 001111110
Q ss_pred -----------------------cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 382 -----------------------AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 382 -----------------------~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
..--.++.|||.+||. ||.+|++ +.|++.||||+..
T Consensus 353 ~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 353 SSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARL 412 (415)
T ss_pred cccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcC
Confidence 0011257899999999 9999999 9999999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=324.03 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=205.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--C
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--D 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~ 188 (552)
..+|++++.||+|+||.||+|+.. .+++.||+|++...... .....+.+|+.+++.+.||||+++++++.+ .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 457888999999999999999864 35889999999865432 356679999999999999999999998877 6
Q ss_pred ceEEEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
...|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999997654 69999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... . ......++..|+|||.+.+..++.++|+|||||++
T Consensus 161 ~~~~~~---~-----------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 202 (284)
T cd05038 161 EDKDYY---Y-----------------------------------VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202 (284)
T ss_pred cCCcce---e-----------------------------------ccCCCCCcccccCcHHHccCCCCcccchHHHhhhh
Confidence 221000 0 00012456679999999988999999999999999
Q ss_pred HHHhhCCCCCCCCChhh--------------HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 348 YEMLVGYPPFYSDDPMS--------------TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
|||++|..||....... ....++.. ...++....++.++.+||.+||. +|.+||+ +.||+
T Consensus 203 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~ 277 (284)
T cd05038 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPS---FADLI 277 (284)
T ss_pred heeeccCCCcccccchhccccccccccccHHHHHHHHHc--CCcCCCCccCCHHHHHHHHHHhccChhhCCC---HHHHH
Confidence 99999999987643221 11222222 22333334678899999999999 9999999 77766
Q ss_pred c
Q 008810 413 V 413 (552)
Q Consensus 413 ~ 413 (552)
.
T Consensus 278 ~ 278 (284)
T cd05038 278 L 278 (284)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=320.05 Aligned_cols=234 Identities=19% Similarity=0.274 Sum_probs=193.4
Q ss_pred eeeeecCCeEEEEEEEcCCC----------cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 122 TMIGKGAFGEVRVCREKTTG----------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg----------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
+.||+|+||.||+|.++.++ ..+|+|++..... ....+.+|..+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998777 3478887764431 15678889999999999999999999988 778
Q ss_pred EEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-------cEEEcccccc
Q 008810 192 YLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-------HLRLSDFGLC 263 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-------~iKL~DFGla 263 (552)
|+||||+++|+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999997765 799999999999999999999999999999999999999888 8999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC--CCCCccchh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWW 341 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~--~y~~~~DiW 341 (552)
...... ...+|+..|+|||++.+. .++.++|+|
T Consensus 156 ~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~ 190 (259)
T cd05037 156 ITVLSR---------------------------------------------EERVERIPWIAPECIRNGQASLTIAADKW 190 (259)
T ss_pred cccccc---------------------------------------------cccccCCCccChhhhcCCCCCcchhhHHH
Confidence 754311 124577889999999876 789999999
Q ss_pred hhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 342 SLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 342 SlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||||++|||++ |..||...+......... +......| .+..+.+||.+||. +|.+||+ +.+|+.
T Consensus 191 slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 256 (259)
T cd05037 191 SFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP----DCAELANLINQCWTYDPTKRPS---FRAILR 256 (259)
T ss_pred HHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC----CchHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 99999999999 688887776443333222 22222232 23789999999999 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=350.15 Aligned_cols=241 Identities=32% Similarity=0.497 Sum_probs=195.1
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc------e
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------F 190 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~------~ 190 (552)
.+..-+.||+||||.||+++++.||..||||.+++.. ....++...+|+++|++++|||||+++++-.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3556678999999999999999999999999998754 3445677889999999999999999998876544 3
Q ss_pred EEEEEecCCCCchhhHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc--CCCc--EEEcccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMR---KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYGH--LRLSDFGLC 263 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~--~~g~--iKL~DFGla 263 (552)
-.+|||||.||||+..|.+ ...|+|.+...++..++.||.|||.+|||||||||+||++- .+|. -||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 5799999999999999965 35799999999999999999999999999999999999995 3343 599999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWS 342 (552)
|.++... ...|++||+.|.+||++.. +.|+..||.||
T Consensus 172 rel~d~s------------------------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS 209 (732)
T KOG4250|consen 172 RELDDNS------------------------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWS 209 (732)
T ss_pred ccCCCCC------------------------------------------eeeeecCchhhcChHHHhhccCcCceeehhh
Confidence 9876442 2448999999999999995 88999999999
Q ss_pred hhHHHHHHhhCCCCCCCCCh----hhHHHHHh-------------------hccccccCCcccccChhHHHHHHH----H
Q 008810 343 LGAIMYEMLVGYPPFYSDDP----MSTCRKIV-------------------NWRTHLKFPEEAKLSIEAKDLISK----L 395 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~----~~~~~~i~-------------------~~~~~~~~p~~~~~s~e~~dLI~~----l 395 (552)
|||++|+++||..||..... .++...++ .|...+++| ..+++.....+.+ +
T Consensus 210 ~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p--~~Ls~~l~~~~~kwLa~~ 287 (732)
T KOG4250|consen 210 FGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQP--NHLSRGLATRLTKWLASM 287 (732)
T ss_pred hhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCc--ccccHHHHhhhhHHHHHH
Confidence 99999999999999964321 22333332 144444554 3566655544444 4
Q ss_pred hh-CccccC
Q 008810 396 LC-NVNQRL 403 (552)
Q Consensus 396 L~-dp~~Rl 403 (552)
|. +|.+|-
T Consensus 288 L~~~~~~~~ 296 (732)
T KOG4250|consen 288 LEWNPRKRG 296 (732)
T ss_pred HhhhHHHhC
Confidence 44 899987
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=321.36 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=204.4
Q ss_pred eeEEeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 118 FELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
|.+.++||+|+||.||+|..+. +++.||||++.... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998653 57899999997543 33445667889999999999999999999886432
Q ss_pred -eEEEEEecCCCCchhhHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
..++++||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998887432 2578999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
++.+....... ......+++.|++||.+.+..++.++||||
T Consensus 160 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~s 200 (273)
T cd05074 160 SKKIYSGDYYR---------------------------------------QGCASKLPVKWLALESLADNVYTTHSDVWA 200 (273)
T ss_pred cccccCCccee---------------------------------------cCCCccCchhhcCHhHHhcCccchhhhhHH
Confidence 88653221000 001234567899999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 343 lGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++|||++ |.+||.+.+....+..+..+. .+..+ ..++..+.+||.+||. +|.+||+ +.+++.
T Consensus 201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rps---~~~~~~ 267 (273)
T cd05074 201 FGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQP--PDCLEDVYELMCQCWSPEPKCRPS---FQHLRD 267 (273)
T ss_pred HHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9999999999 999999888877777776532 22333 3678899999999998 9999999 777765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=321.94 Aligned_cols=262 Identities=29% Similarity=0.418 Sum_probs=212.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 187 (552)
.+.|+-+..||+|.||+||+|+.+.+|+.||+|++--.. .+.+.-....+|+.+|..++|+|++.|+..|.+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 455777789999999999999999999999998754321 123333456789999999999999999877753
Q ss_pred -CceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 188 -DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 188 -~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...+||||.+|. .||..+|... ..|+..+++.++.+++.||.|+|...|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 235999999995 5899999654 6899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 344 (552)
+..+... .+. .....|-|.+|++||.+++ ..|+.+.|+|..|
T Consensus 174 fs~~~n~---------------------~kp----------------rytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 174 FSTSKNV---------------------VKP----------------RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred eeccccc---------------------CCC----------------CcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 6432110 000 0124678999999999998 6799999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhh---------ccccccCCccc----------------------ccChhHHHHHH
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVN---------WRTHLKFPEEA----------------------KLSIEAKDLIS 393 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~---------~~~~~~~p~~~----------------------~~s~e~~dLI~ 393 (552)
|||.||.+|.|-|.+++...++..|.. |+....+|-.. .-.+++.||+.
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 999999999999999998887766643 33221221110 11458999999
Q ss_pred HHhh-CccccCCCCChhhhhcCCCcC
Q 008810 394 KLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 394 ~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
+||. ||.+|+. ++++++|-||.
T Consensus 297 ~ll~~DP~kR~~---ad~alnh~~F~ 319 (376)
T KOG0669|consen 297 KLLKLDPTKRID---ADQALNHDFFW 319 (376)
T ss_pred HHhccCcccCcc---hHhhhchhhhh
Confidence 9999 9999999 99999999995
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=324.14 Aligned_cols=258 Identities=16% Similarity=0.152 Sum_probs=191.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhhhhHH--------HHHHHHHHHHHhcCCCceEEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQV--------EHVRAERNLLAEVDSNCIVKL 181 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~~AiK~l~k~~~~~~~~~--------~~~~~E~~iL~~l~hp~Iv~l 181 (552)
+....|.+.++||+|+||.||+|++..+ +..+|+|+..........+. .....+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4567899999999999999999998887 67788886542211000000 111223334556789999999
Q ss_pred eeeecCCc----eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEE
Q 008810 182 YCSFQDDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (552)
Q Consensus 182 ~~~f~d~~----~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL 257 (552)
++++.... ..|++||++. .++...+.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 4588999884 466677766566789999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCc
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~ 337 (552)
+|||+|+.+........ .........+||+.|+|||++.+..|+.+
T Consensus 168 ~DFGla~~~~~~~~~~~----------------------------------~~~~~~~~~~gt~~y~ape~~~~~~~~~~ 213 (294)
T PHA02882 168 IDYGIASHFIIHGKHIE----------------------------------YSKEQKDLHRGTLYYAGLDAHNGACVTRR 213 (294)
T ss_pred EEcCCceeeccCCcccc----------------------------------cccccccccCCCccccCHHHhCCCCCCcH
Confidence 99999987642210000 00000123579999999999999999999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhhH-H--------HHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 338 CDWWSLGAIMYEMLVGYPPFYSDDPMST-C--------RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 338 ~DiWSlGvilyEmltG~~PF~~~~~~~~-~--------~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
+|||||||++|||++|.+||.+...... . .++.. ..+.++ .++.++.+++..|+. +|++||+
T Consensus 214 ~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~--- 285 (294)
T PHA02882 214 GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE--GKIKIK---NANKFIYDFIECVTKLSYEEKPD--- 285 (294)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh--hhhccC---CCCHHHHHHHHHHHhCCCCCCCC---
Confidence 9999999999999999999987743221 1 12221 122232 568899999999998 9999999
Q ss_pred hhhhhc
Q 008810 408 ADEIKV 413 (552)
Q Consensus 408 a~eil~ 413 (552)
.++|++
T Consensus 286 ~~~l~~ 291 (294)
T PHA02882 286 YDALIK 291 (294)
T ss_pred HHHHHH
Confidence 777654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=344.18 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=209.8
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
..+.+..+.+.+...||+|.||+||+|++.. .||||+++-... ...+.+.|++|+.+|++-+|-||+-+.++|..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4566777888899999999999999999865 499999987654 455889999999999999999999999999877
Q ss_pred ceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.. .||..+|.|.+|..+|.- +-.|.....+.|+.||++|+.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 899999999999999954 4568999999999999999999999999999999999999999999999999986321
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhh
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLG 344 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlG 344 (552)
.- .+. .-....-|...|||||++.. .+|++.+||||||
T Consensus 540 ~w-------------~g~--------------------------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFG 580 (678)
T KOG0193|consen 540 RW-------------SGE--------------------------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFG 580 (678)
T ss_pred ee-------------ccc--------------------------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhh
Confidence 00 000 00112357889999999984 5799999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCc----ccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE----EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~----~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|++|||++|..||...+..+++-.+-. +.+ .|+ ...++.++++|+..|+. ++++||. +.+|+.
T Consensus 581 iV~YELltg~lPysi~~~dqIifmVGr--G~l-~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~---F~~il~ 648 (678)
T KOG0193|consen 581 IVWYELLTGELPYSIQNRDQIIFMVGR--GYL-MPDLSKIRSNCPKAMKRLLSDCWKFDREERPL---FPQLLS 648 (678)
T ss_pred HHHHHHHhCcCCcCCCChhheEEEecc--ccc-CccchhhhccCHHHHHHHHHHHHhcCcccCcc---HHHHHH
Confidence 999999999999996666655444332 211 121 23567799999999999 9999999 666664
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=318.75 Aligned_cols=247 Identities=17% Similarity=0.231 Sum_probs=193.6
Q ss_pred eeeecCCeEEEEEEEcCC--CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCC
Q 008810 123 MIGKGAFGEVRVCREKTT--GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~t--g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
.||+|+||.||+|+.... ...+++|.+.... .....+.+.+|..+++.++||||+++++.|.+...+|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999976433 2345666665432 123456788999999999999999999999999999999999999
Q ss_pred CchhhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 201 GDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 201 G~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|+|.+++.+. ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++++||+|||++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~---- 155 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---- 155 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh----
Confidence 9999999753 34677788899999999999999999999999999999999999999999998642111000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-------CCCCCccchhhhhHHHHH
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-------KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-------~~y~~~~DiWSlGvilyE 349 (552)
......+|++.|+|||++.. ..++.++|||||||++||
T Consensus 156 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (268)
T cd05086 156 -----------------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200 (268)
T ss_pred -----------------------------------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHH
Confidence 00113578999999999853 345789999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccc-cccCCc-ccccChhHHHHHHHHhhCccccCCCCChhhhhc
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRT-HLKFPE-EAKLSIEAKDLISKLLCNVNQRLGAKGADEIKV 413 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~-~~~~p~-~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~ 413 (552)
|++ |.+||...+..+.+.+++.... .+..|. ...+++.+.++|..|+.+|.+||+ +++|+.
T Consensus 201 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp~---~~~i~~ 264 (268)
T cd05086 201 LFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRAT---AEEVHR 264 (268)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccCCC---HHHHHH
Confidence 997 6789988777777776654321 111121 125788999999999989999999 777753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=334.43 Aligned_cols=202 Identities=27% Similarity=0.371 Sum_probs=174.9
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-eE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-FL 191 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-~l 191 (552)
-.+++|.--.+||+|+||.||+|..... ..||||++....... ...|.+|+.+|..++|||+|+|+++|.+.+ ..
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 3457888889999999999999987544 899999887543211 344999999999999999999999999888 59
Q ss_pred EEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcccccCCCCccccCCCcEEEccccccccc
Q 008810 192 YLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH---YIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
+||+|||++|+|.++|.... .|+|.....|+.+++.||+|||... ||||||||.|||||.++..||+|||||+..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 99999999999999997765 8999999999999999999999853 999999999999999999999999999754
Q ss_pred CC-CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccc-ccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 267 DC-STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 267 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~-~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
.. ... ..+. .||.+|+|||++..+..+.++||||||
T Consensus 228 ~~~~~~------------------------------------------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFG 265 (361)
T KOG1187|consen 228 PEGDTS------------------------------------------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFG 265 (361)
T ss_pred Cccccc------------------------------------------eeeecCCCCccCChhhhccCCcCcccccccch
Confidence 32 110 0122 799999999999998999999999999
Q ss_pred HHHHHHhhCCCCCCCC
Q 008810 345 AIMYEMLVGYPPFYSD 360 (552)
Q Consensus 345 vilyEmltG~~PF~~~ 360 (552)
|+|.||++|+.|....
T Consensus 266 VvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 266 VVLLELITGRKAVDQS 281 (361)
T ss_pred HHHHHHHhCCcccCCC
Confidence 9999999999888743
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=351.11 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=217.6
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEe
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 182 (552)
.....+...+.++.+.||+|+||+||+|+.-. ....||||.++... .......|++|+++|+.++|||||+|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 34455677888999999999999999998632 34579999998654 233556799999999999999999999
Q ss_pred eeecCCceEEEEEecCCCCchhhHHhhc----------C----CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcc
Q 008810 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRK----------D----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLL 248 (552)
Q Consensus 183 ~~f~d~~~lylVmEy~~gG~L~~~L~~~----------~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNIL 248 (552)
++|..++-+|||+|||..|||..+|... . .|+..+...++.||+.|++||-++.+|||||-..|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 9999999999999999999999999642 1 2888999999999999999999999999999999999
Q ss_pred ccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhh
Q 008810 249 LDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328 (552)
Q Consensus 249 l~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEv 328 (552)
|.++-.|||+||||++.+-..++.. .+ + ...-...|||||.
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk----~~----------~-------------------------~t~lPIRWMppEs 676 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYK----VR----------G-------------------------NTLLPIRWMPPES 676 (774)
T ss_pred eccceEEEecccccchhhhhhhhhc----cc----------C-------------------------CceeeeecCCHHH
Confidence 9999999999999999764332211 00 0 1122457999999
Q ss_pred hhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC
Q 008810 329 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 329 l~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
|+...|+.++||||+||+|||+.+ |..|+++...++.+..|.+.+- +.-|+ .++.++.+|+..|+. +|.+||+..
T Consensus 677 Ily~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe--~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 677 ILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPE--NCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred hhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCC--CCCHHHHHHHHHHhhcCcccCCCHH
Confidence 999999999999999999999997 9999999999999999987543 66665 899999999999999 999999933
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=349.25 Aligned_cols=264 Identities=21% Similarity=0.330 Sum_probs=185.5
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCC----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeee-
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS- 184 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~- 184 (552)
+..+..++|++.+.||+|+||.||+|++..+ +..||+|++.... ..+....++ +....+.+++.+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~--l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER--VRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH--HHhhchhhHHHHHHhh
Confidence 4456788999999999999999999999988 9999999876432 111111221 112222222222222
Q ss_pred -----ecCCceEEEEEecCCCCchhhHHhhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 008810 185 -----FQDDEFLYLIMEYLPGGDMMTLLMRKDT--------------------LTEDEARFYVAETVLAIESIHKHHYIH 239 (552)
Q Consensus 185 -----f~d~~~lylVmEy~~gG~L~~~L~~~~~--------------------l~e~~~~~~~~qi~~aL~~LH~~giiH 239 (552)
..+...++|||||+++|+|.+++..... ..+..++.++.||+.||.|||++||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456689999999999999999864321 123456789999999999999999999
Q ss_pred cccCCCCccccC-CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccc
Q 008810 240 RDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (552)
Q Consensus 240 rDLKPeNILl~~-~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~ 318 (552)
|||||+|||++. ++++||+|||+|+.+..... ......+
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~----------------------------------------~~~~~~~ 318 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----------------------------------------YIPKEFL 318 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCccccccccc----------------------------------------cCCcccc
Confidence 999999999985 68999999999986532110 0012468
Q ss_pred cCCCCCChhhhhcC----------------------CCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhh-----
Q 008810 319 GTPDYIAPEVLLKK----------------------GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN----- 371 (552)
Q Consensus 319 GT~~Y~APEvl~~~----------------------~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~----- 371 (552)
||+.|||||++... .++.++||||||||+|||+++..|+. +....+.+++.
T Consensus 319 ~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~ 396 (566)
T PLN03225 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD 396 (566)
T ss_pred cCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc
Confidence 99999999977532 24456799999999999998665543 33223322221
Q ss_pred ---cccccc--CCc--------ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 372 ---WRTHLK--FPE--------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 372 ---~~~~~~--~p~--------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
|..... .+. ....+..++|||.+||+ ||.+||+ +.++++||||.+.++..+
T Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 397 LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCcccc
Confidence 111000 000 01123456799999999 9999999 999999999999887544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=344.18 Aligned_cols=261 Identities=31% Similarity=0.507 Sum_probs=222.9
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeec--
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ-- 186 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~-- 186 (552)
......+.|++..+||.|.+|+||+++++.+|+..|+|++.... ...+.+..|.+||+.. +|||++.+||+|.
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 33455678999999999999999999999999999999987543 3335577889998776 8999999999886
Q ss_pred ---CCceEEEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccc
Q 008810 187 ---DDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (552)
Q Consensus 187 ---d~~~lylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFG 261 (552)
.++.++||||||.||+.-+++.. ...+.|+.+..++.+++.||.+||...+||||||-.|||++.+|.|||+|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 35689999999999999999865 4679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCCCC
Q 008810 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGM 336 (552)
Q Consensus 262 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y~~ 336 (552)
++..++.. +....+.+|||.|||||++.. ..|+.
T Consensus 169 vSaQldsT-----------------------------------------~grRnT~iGtP~WMAPEViac~e~~d~tyd~ 207 (953)
T KOG0587|consen 169 VSAQLDST-----------------------------------------VGRRNTFIGTPYWMAPEVIACDESPDATYDY 207 (953)
T ss_pred eeeeeecc-----------------------------------------cccccCcCCCcccccceeeecccCCCCCccc
Confidence 99876532 112347899999999999974 34889
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCC
Q 008810 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415 (552)
Q Consensus 337 ~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hp 415 (552)
.||+||||++..||.-|.||+....+...+-+|-.. .+..+-.+...+.+..|||+.||. |-++||. ..+++.||
T Consensus 208 R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~hp 283 (953)
T KOG0587|consen 208 RSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKHP 283 (953)
T ss_pred ccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccCC
Confidence 999999999999999999999999888877666542 222332234789999999999998 9999999 99999999
Q ss_pred CcCC
Q 008810 416 WFDG 419 (552)
Q Consensus 416 fF~~ 419 (552)
|...
T Consensus 284 Fi~e 287 (953)
T KOG0587|consen 284 FITE 287 (953)
T ss_pred cccc
Confidence 9974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=357.47 Aligned_cols=268 Identities=40% Similarity=0.725 Sum_probs=223.0
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..-..++|+.+|.|-.|+||.||+++++.+.+.+|| +++|..++-++ ||....+|++|
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn----------ilt~a~npfvv----------- 135 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN----------ILTFAGNPFVV----------- 135 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc----------cccccCCccee-----------
Confidence 344568999999999999999999999999999999 55554433222 66677888877
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
||-.+++..-+.++.+. +.|++|||+-||+|||+||+|+||+.-||+|++||||++..-...
T Consensus 136 ----------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 78888887777777654 889999999999999999999999999999999999998643221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhh-ccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKN-RRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.. +. ...++.+. +......+||||.|+||||+..++|+..+|||++|+|+||
T Consensus 198 at--------nl-------------------~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlye 250 (1205)
T KOG0606|consen 198 AT--------NL-------------------KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 250 (1205)
T ss_pred cc--------hh-------------------hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHH
Confidence 00 00 00011111 1112235799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCc-ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhh
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~ 427 (552)
.|.|+.||.++++.+.+..++. ..+.+|+ ...+.+|++++|.+||. +|..|++..++-++++|+||+.+||..|..
T Consensus 251 FLVgcvpffGdtpeelfg~vis--d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llR 328 (1205)
T KOG0606|consen 251 FLVGCVPFFGDTPEELFGQVIS--DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLR 328 (1205)
T ss_pred HheeeeeccCCCHHHHHhhhhh--hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhh
Confidence 9999999999999999999887 4555665 34688999999999998 999999999999999999999999999999
Q ss_pred cCCCCccccCCcccCcCccc
Q 008810 428 MEAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 428 ~~~pf~P~~~~~~d~~~f~~ 447 (552)
.+++|+|.+..+.|+.+|++
T Consensus 329 qkaefvpql~~eddtsyfdT 348 (1205)
T KOG0606|consen 329 QKAEFVPQLESEDDTSYFDT 348 (1205)
T ss_pred hhccccccccccccchhhcc
Confidence 99999999999999999985
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=316.60 Aligned_cols=268 Identities=28% Similarity=0.458 Sum_probs=220.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
..+|.-++.+|.|+- .|..+-+.-+++.||+|++... ........+..+|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 356788899999999 7888888889999999998765 333444567888999999999999999999997443
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|+||||| .++|...+. -.++-+.+++++.|+++|+.|||+.||+||||||+||++..++.+||.|||+|+..+.
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 589999999 568887775 4578889999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
. .+....+.|..|.|||++.+.+|...+||||+|||+.
T Consensus 171 ~------------------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 171 D------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (369)
T ss_pred c------------------------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHH
Confidence 1 1123578999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhcccc-----------------------------ccCCcc---------cccChhHHH
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH-----------------------------LKFPEE---------AKLSIEAKD 390 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~-----------------------------~~~p~~---------~~~s~e~~d 390 (552)
||++|...|.|.+..+.+.+|+..-++ -.||+. ..-+..|+|
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ard 288 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARD 288 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHH
Confidence 999999999999988887777641111 112211 112346999
Q ss_pred HHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCcc
Q 008810 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIP 434 (552)
Q Consensus 391 LI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P 434 (552)
|+.+||. ||++|.+ ++++|+||||+ -|-.-.++++|..|
T Consensus 289 ll~~MLvi~pe~Ris---v~daL~HPY~~--vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 289 LLSKMLVIDPEKRIS---VDDALRHPYIK--VWYDPDEVEAPPPE 328 (369)
T ss_pred HHHHhhccChhhccc---HHHHhcCCeee--eecccccccCCCCc
Confidence 9999998 9999999 99999999999 57555556666555
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=350.18 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=216.0
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCC-Cc----EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTT-GH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t-g~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+.....++.+.||+|+||+||.|..... |. .||||.+++. .+..++..|.+|..+|++++|||||+|++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4466788999999999999999998653 32 4899998764 356778889999999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DF 260 (552)
....+||+|||.||||..+|... ..|+......++.+|+.|.+||+++++|||||-..|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999764 46899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccch
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 340 (552)
|||+.+....+-. +.- ...--..|||||.+....++.++||
T Consensus 847 GlArDiy~~~yyr----------------------------------~~~-----~a~lPvkWm~PEsl~d~iFtskSDv 887 (1025)
T KOG1095|consen 847 GLARDIYDKDYYR----------------------------------KHG-----EAMLPVKWMPPESLKDGIFTSKSDV 887 (1025)
T ss_pred chhHhhhhchhee----------------------------------ccC-----ccccceecCCHHHHhhcccccccch
Confidence 9999543221110 000 0011246999999999999999999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 341 WSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||||+|||+++ |..||.+.+..++..-++.. +.+..| ..++..+.+|+.+|+. +|++||+ +..|+.
T Consensus 888 WsFGVllWEifslG~~PY~~~~n~~v~~~~~~g-gRL~~P--~~CP~~ly~lM~~CW~~~pe~RP~---F~~i~~ 956 (1025)
T KOG1095|consen 888 WSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG-GRLDPP--SYCPEKLYQLMLQCWKHDPEDRPS---FRTIVE 956 (1025)
T ss_pred hhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC-CccCCC--CCCChHHHHHHHHHccCChhhCcc---HHHHHh
Confidence 999999999998 99999999998888777764 355555 4899999999999999 9999999 666665
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=300.01 Aligned_cols=253 Identities=31% Similarity=0.493 Sum_probs=208.9
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCc--e
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE--F 190 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~--~ 190 (552)
..++|++++.+|+|.|++||.|....+++.++||+++.-. ...+++|+.||..+. ||||++|+++..|.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 4678999999999999999999999999999999997532 245889999999995 999999999998764 4
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC-CcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~-g~iKL~DFGlak~~~~~ 269 (552)
..||+||+.+.|...+. ..|+.-.+++|+.|++.||.|+|+.||+|||+||.|++||.. ..++|+|+|||....+.
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 67999999998887775 578999999999999999999999999999999999999954 57999999999877543
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvily 348 (552)
.. -+-.|.+..|--||.+.. ..|+..-|+|||||++.
T Consensus 187 ~e------------------------------------------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA 224 (338)
T KOG0668|consen 187 KE------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224 (338)
T ss_pred ce------------------------------------------eeeeeehhhcCCchheeechhccccHHHHHHHHHHH
Confidence 10 113467788999999986 67999999999999999
Q ss_pred HHhhCCCCC-CCCChhhHHHHHhhc-----------cccccCC---------------------cc-cccChhHHHHHHH
Q 008810 349 EMLVGYPPF-YSDDPMSTCRKIVNW-----------RTHLKFP---------------------EE-AKLSIEAKDLISK 394 (552)
Q Consensus 349 EmltG~~PF-~~~~~~~~~~~i~~~-----------~~~~~~p---------------------~~-~~~s~e~~dLI~~ 394 (552)
.|++.+-|| .|.+..+.+-+|..- +..+.++ +. .-++++|.|||.+
T Consensus 225 ~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldk 304 (338)
T KOG0668|consen 225 SMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDK 304 (338)
T ss_pred HHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHH
Confidence 999988887 455555555555420 1111111 11 2357999999999
Q ss_pred Hhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 395 LLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 395 lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
||. |-.+||+ |.|++.||||..+
T Consensus 305 lLrYDHqeRlT---akEam~HpyF~~~ 328 (338)
T KOG0668|consen 305 LLRYDHQERLT---AKEAMAHPYFAPV 328 (338)
T ss_pred HHhhccccccc---hHHHhcCchHHHH
Confidence 999 9999999 9999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=333.09 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=192.3
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEc----------------CCCcEEEEEEeechhhhh-----------hhHHHH
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREK----------------TTGHVYAMKKLKKSEMLR-----------RGQVEH 162 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k----------------~tg~~~AiK~l~k~~~~~-----------~~~~~~ 162 (552)
+.++..++|++.++||+|+||.||+|... ..++.||||.+....... ....+.
T Consensus 139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~ 218 (507)
T PLN03224 139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET 218 (507)
T ss_pred CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence 34567899999999999999999999642 345689999986432110 111223
Q ss_pred HHHHHHHHHhcCCCce-----EEEeeeec--------CCceEEEEEecCCCCchhhHHhhc-------------------
Q 008810 163 VRAERNLLAEVDSNCI-----VKLYCSFQ--------DDEFLYLIMEYLPGGDMMTLLMRK------------------- 210 (552)
Q Consensus 163 ~~~E~~iL~~l~hp~I-----v~l~~~f~--------d~~~lylVmEy~~gG~L~~~L~~~------------------- 210 (552)
...|..++.++.|+++ ++++++|. +....||||||+++|+|.++|...
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 4457777777777654 55655553 235689999999999999988632
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCC
Q 008810 211 -----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285 (552)
Q Consensus 211 -----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~ 285 (552)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.+......
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~------------- 365 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF------------- 365 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-------------
Confidence 12456778899999999999999999999999999999999999999999999754321100
Q ss_pred CCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC--------------------CC--Cccchhhh
Q 008810 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--------------------YG--MECDWWSL 343 (552)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~--------------------y~--~~~DiWSl 343 (552)
......+|+.|+|||++.... |+ ..+|+||+
T Consensus 366 ---------------------------~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSl 418 (507)
T PLN03224 366 ---------------------------NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTA 418 (507)
T ss_pred ---------------------------CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhH
Confidence 001234589999999986422 22 34799999
Q ss_pred hHHHHHHhhCCC-CCCCCChh----hHHHHHh-hc----cccccCCcccccChhHHHHHHHHhh-Cc---cccCCCCChh
Q 008810 344 GAIMYEMLVGYP-PFYSDDPM----STCRKIV-NW----RTHLKFPEEAKLSIEAKDLISKLLC-NV---NQRLGAKGAD 409 (552)
Q Consensus 344 GvilyEmltG~~-PF~~~~~~----~~~~~i~-~~----~~~~~~p~~~~~s~e~~dLI~~lL~-dp---~~Rl~~~~a~ 409 (552)
|||+|+|++|.. ||.+.... ..+.... .| .....++....+++.++|||.+||+ +| .+|++ ++
T Consensus 419 Gvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~ 495 (507)
T PLN03224 419 GVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLS---VG 495 (507)
T ss_pred HHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCC---HH
Confidence 999999999875 77542211 1111111 11 1334555555789999999999998 55 57888 99
Q ss_pred hhhcCCCcC
Q 008810 410 EIKVHPWFD 418 (552)
Q Consensus 410 eil~HpfF~ 418 (552)
|+|+||||.
T Consensus 496 eaL~Hp~f~ 504 (507)
T PLN03224 496 QALSHRFFL 504 (507)
T ss_pred HHhCCCCcC
Confidence 999999995
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=310.72 Aligned_cols=262 Identities=28% Similarity=0.483 Sum_probs=212.8
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH-HhcCCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f~d~~ 189 (552)
+.+..++.+-+..||.|+||+|++..++.+|+..|||.++.... .....+++.|.+.. +.-+.||||++|++...+.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 45666777778899999999999999999999999999986654 33445677777764 5568999999999999999
Q ss_pred eEEEEEecCCCCchhhHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLM-----RKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~-----~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
..++.||+| .-+|..+.+ ++..++|...-.+..-++.||+||-. +.||||||||+||||+..|.|||||||+|
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 999999999 445554432 35789999999999999999999986 68999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWW 341 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiW 341 (552)
-.+..+... .--+|...|||||.+.. .+|+..+|+|
T Consensus 216 GqLv~SiAk------------------------------------------T~daGCrpYmAPERi~p~~~gyDiRSDvW 253 (361)
T KOG1006|consen 216 GQLVDSIAK------------------------------------------TVDAGCRPYMAPERIDPSDKGYDIRSDVW 253 (361)
T ss_pred HhHHHHHHh------------------------------------------hhccCCccccChhccCCccCCcchhhhhh
Confidence 765432100 02368899999999974 6799999999
Q ss_pred hhhHHHHHHhhCCCCCCCCCh-hhHHHHHhhcccc-ccCCcc-cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 342 SLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTH-LKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 342 SlGvilyEmltG~~PF~~~~~-~~~~~~i~~~~~~-~~~p~~-~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|||+.|||+.||..|+.+-+. .+.+..++.+..+ +.++.+ ...|...+.+|.-||. |-..||. ..+++.|||+
T Consensus 254 SLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fy 330 (361)
T KOG1006|consen 254 SLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFY 330 (361)
T ss_pred hhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchh
Confidence 999999999999999988654 3445555554332 233322 4589999999999998 9999999 8899999999
Q ss_pred CCC
Q 008810 418 DGV 420 (552)
Q Consensus 418 ~~i 420 (552)
+..
T Consensus 331 r~y 333 (361)
T KOG1006|consen 331 RMY 333 (361)
T ss_pred hhh
Confidence 753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=295.15 Aligned_cols=241 Identities=47% Similarity=0.809 Sum_probs=205.4
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCchhhHH
Q 008810 128 AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL 207 (552)
Q Consensus 128 ~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L 207 (552)
+||.||+|....+|+.+|+|++........ ...+.+|+.+++.++|++|+++++.+.+....++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999976543221 567899999999999999999999999999999999999999999999
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCC
Q 008810 208 MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287 (552)
Q Consensus 208 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~ 287 (552)
.....+++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------- 141 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------- 141 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------
Confidence 776669999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCC-CChhhHH
Q 008810 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPMSTC 366 (552)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~-~~~~~~~ 366 (552)
......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.. .+.....
T Consensus 142 -------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 196 (244)
T smart00220 142 -------------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF 196 (244)
T ss_pred -------------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 01135789999999999988899999999999999999999999988 4444444
Q ss_pred HHHhhccccccCCcc-cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 367 RKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 367 ~~i~~~~~~~~~p~~-~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
..+... ....+.. ..++.++.++|.+||. +|.+||+ +.++++||||
T Consensus 197 ~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 197 KKIGKP--KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred HHHhcc--CCCCccccccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 444331 2222211 1288899999999999 9999998 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.20 Aligned_cols=264 Identities=25% Similarity=0.444 Sum_probs=214.2
Q ss_pred hhhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC------Cce
Q 008810 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS------NCI 178 (552)
Q Consensus 105 ~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h------p~I 178 (552)
|++.+..++...+|.+....|+|-||.|..|++...|..||||+|...++.-. .=+.|++||++++. -++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHH
Confidence 33444556677889999999999999999999999999999999987764322 23579999999842 478
Q ss_pred EEEeeeecCCceEEEEEecCCCCchhhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-c
Q 008810 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-H 254 (552)
Q Consensus 179 v~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~ 254 (552)
++|+-.|...++||||+|-+ ..+|..+|.+. -.|....++.|+.|++.||..|-.+||+|.||||+|||++..- .
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcce
Confidence 99999999999999999988 67999999764 3688999999999999999999999999999999999998654 6
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC
Q 008810 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (552)
Q Consensus 255 iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y 334 (552)
+||||||.|.......+ ....-+.-|.|||+++|.+|
T Consensus 576 LKLCDfGSA~~~~enei-------------------------------------------tPYLVSRFYRaPEIiLG~~y 612 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI-------------------------------------------TPYLVSRFYRAPEIILGLPY 612 (752)
T ss_pred eeeccCccccccccccc-------------------------------------------cHHHHHHhccCcceeecCcc
Confidence 79999999875532211 12344567999999999999
Q ss_pred CCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccccc-------------------------------------
Q 008810 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK------------------------------------- 377 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~------------------------------------- 377 (552)
+...|+||+||.||||.||+..|.|.+...++...+..++.++
T Consensus 613 d~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm 692 (752)
T KOG0670|consen 613 DYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVM 692 (752)
T ss_pred cCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEe
Confidence 9999999999999999999999999887777655543211100
Q ss_pred ------------------CCc-ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 378 ------------------FPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 378 ------------------~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|. ...+-..++||+.+||. ||.+|++ +.++|.||||.+
T Consensus 693 ~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 693 VNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITE 751 (752)
T ss_pred cccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccC
Confidence 000 00112358999999999 9999999 999999999964
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=317.15 Aligned_cols=203 Identities=32% Similarity=0.539 Sum_probs=183.9
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHH-----HHHHHHHHHHhcC---CCceEEEeeee
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE-----HVRAERNLLAEVD---SNCIVKLYCSF 185 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~-----~~~~E~~iL~~l~---hp~Iv~l~~~f 185 (552)
...+|..++.+|.|+||.|++|.++.+...|+||.+.|+.++-...++ .+-.|+.||..++ |+||++|.++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 456899999999999999999999999999999999998876544433 4668999999997 99999999999
Q ss_pred cCCceEEEEEecC-CCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccc
Q 008810 186 QDDEFLYLIMEYL-PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 186 ~d~~~lylVmEy~-~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
+|++++||+||-- +|-||++++..+..++|.+++.++.|++.|+++||+.||||||||-|||.++.+|-+||+|||.|.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999976 678999999999999999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSL 343 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSl 343 (552)
....+. .-.++||.+|.|||++.+..| +..-|||+|
T Consensus 719 ~~ksgp-------------------------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 719 YTKSGP-------------------------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred hhcCCC-------------------------------------------cceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 554321 125899999999999999888 889999999
Q ss_pred hHHHHHHhhCCCCCCC
Q 008810 344 GAIMYEMLVGYPPFYS 359 (552)
Q Consensus 344 GvilyEmltG~~PF~~ 359 (552)
|++||-++....|||.
T Consensus 756 gillytivykenpyyn 771 (772)
T KOG1152|consen 756 GILLYTIVYKENPYYN 771 (772)
T ss_pred hheeeEEEeccCCCcC
Confidence 9999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.13 Aligned_cols=270 Identities=28% Similarity=0.458 Sum_probs=209.6
Q ss_pred eeEEeeeeecCCeE-EEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEEE
Q 008810 118 FELLTMIGKGAFGE-VRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 118 f~~~~~IG~G~fG~-V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylVm 195 (552)
|.--+++|.|+-|+ ||+|.. .|+.||||.+-.. ....+.+|+.+|... +|||||+.||.-++..++||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34446889999875 788875 5779999987533 345678999999887 6999999999999999999999
Q ss_pred ecCCCCchhhHHhhc--C--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CC--cEEEccccccccc
Q 008810 196 EYLPGGDMMTLLMRK--D--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YG--HLRLSDFGLCKPL 266 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~--~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g--~iKL~DFGlak~~ 266 (552)
|.| ..+|.+++... + .......+..+.|++.||.|||+.+||||||||.||||+. +| .++|+|||+||.+
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 67999999763 1 1111456788999999999999999999999999999986 34 6899999999988
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
+.+...- +| ..+..||-+|+|||++....-+.++||+|||||
T Consensus 662 ~~~~sS~------------------------------------~r--~s~~sGt~GW~APE~L~~~~~~~avDiFslGCv 703 (903)
T KOG1027|consen 662 AGGKSSF------------------------------------SR--LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCV 703 (903)
T ss_pred CCCcchh------------------------------------hc--ccCCCCcccccCHHHHhccccCcccchhhcCce
Confidence 6542110 01 235679999999999999888889999999999
Q ss_pred HHHHhhC-CCCCCCCChhhHHHHHhhcccccc-CCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 347 MYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLK-FPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 347 lyEmltG-~~PF~~~~~~~~~~~i~~~~~~~~-~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
+|..++| ..||...- +...+|+.....+. +.....+ +|+|||.+||. +|..||+ |.+|+.|||| |+
T Consensus 704 fyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPs---a~~VL~HPlF----W~ 772 (903)
T KOG1027|consen 704 FYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPS---ATDVLNHPLF----WD 772 (903)
T ss_pred EEEEecCCccCCCchH--HhhhhhhcCccceeeeccCchH--HHHHHHHHhcCCCcccCCC---HHHHhCCCcc----CC
Confidence 9999985 99997543 33446776544332 2111122 99999999999 9999999 9999999999 43
Q ss_pred hhhhcCCCCccccCCcccCcCccc
Q 008810 424 RIYQMEAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 424 ~l~~~~~pf~P~~~~~~d~~~f~~ 447 (552)
.-.++ .|.-++.+..+..+++.
T Consensus 773 ~ekrL--~Fl~dvSDRvE~e~r~~ 794 (903)
T KOG1027|consen 773 SEKRL--SFLRDVSDRVEKENRDS 794 (903)
T ss_pred hHHHH--HHHHhhhhhhhhhhccC
Confidence 32222 36666777777766654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=294.55 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=213.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----e
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----F 190 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-----~ 190 (552)
.|.+.-+.||.|+||.||.+.+..+|+.||+|++..- ..+-...+.+.+|..+|.-++|.|++.+.++.|-.. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3555667899999999999999999999999998643 223334567889999999999999999998887553 5
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|+|.|+| ..||...+-....|+.+.++-++.||+.||.|||+.||+||||||.|+|++.+..+|||||||++.-+...
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 78999999 56999999888999999999999999999999999999999999999999999999999999998643221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 349 (552)
. + -...-|-|-.|.|||++.+ ..|+.++||||+|||+.|
T Consensus 211 ~---------------------------------------~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 211 R---------------------------------------L-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred h---------------------------------------h-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 0 0 0113467889999999998 579999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhc---------------------cccccCCcc---------cccChhHHHHHHHHhh-C
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNW---------------------RTHLKFPEE---------AKLSIEAKDLISKLLC-N 398 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~---------------------~~~~~~p~~---------~~~s~e~~dLI~~lL~-d 398 (552)
+|-.+..|...++.+.+..|... +...+-|.- ..-..++.+++.+||. |
T Consensus 251 LLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d 330 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD 330 (449)
T ss_pred HHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC
Confidence 99999999999988887776531 111122211 1224478999999998 9
Q ss_pred ccccCCCCChhhhhcCCCcCCC
Q 008810 399 VNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 399 p~~Rl~~~~a~eil~HpfF~~i 420 (552)
|..|.+ .++.+.|++....
T Consensus 331 ~dkris---~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 331 PDKRIS---VEEALQHRYLEEG 349 (449)
T ss_pred Cccccc---Hhhhccccccccc
Confidence 999998 8999999998764
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.15 Aligned_cols=245 Identities=24% Similarity=0.367 Sum_probs=205.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCC----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTT----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~t----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
.+...+.++||.|-||.||.|....- .--||||..++... ....+.|..|.-+|++++||+||+|+++|.+ .-
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 33444567999999999999987432 33589999887543 3447789999999999999999999999975 46
Q ss_pred EEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+||||+++-|.|+.+|+.+ ..|+......|+.||+.||.|||+..+|||||-..|||+.....|||+||||++-+...
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence 78999999999999999764 67999999999999999999999999999999999999999999999999999987544
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.+-. +....-..-|||||.+.-..++.++|+|-|||+|||
T Consensus 545 ~yYk----------------------------------------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWE 584 (974)
T KOG4257|consen 545 AYYK----------------------------------------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWE 584 (974)
T ss_pred chhh----------------------------------------ccccccceeecCccccchhcccchhhHHHHHHHHHH
Confidence 2211 001122457999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
+|. |.-||.+-...+.+..|-++ ..++.| +.|++.+..|.++|+. +|.+||..
T Consensus 585 Il~lGvkPfqgvkNsDVI~~iEnG-eRlP~P--~nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 585 ILSLGVKPFQGVKNSDVIGHIENG-ERLPCP--PNCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred HHHhcCCccccccccceEEEecCC-CCCCCC--CCCChHHHHHHHHHhccCcccCCcH
Confidence 996 99999998877776666653 445555 4899999999999999 99999984
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=304.33 Aligned_cols=258 Identities=21% Similarity=0.340 Sum_probs=219.2
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
..+++...+......||-|-||+||.|.++.-.-.||||.++...| .++.|..|..+|+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 3455666777788899999999999999999888999999986543 678899999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
--+|||.|||..|+|.++|.+.+ .++.-....++.||..|++||.++++|||||-..|+|+..+..||++||||++.+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999997653 4666677788899999999999999999999999999999999999999999988
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
..+++... ...--..-|.|||-|....++.++|+|+|||+
T Consensus 416 tgDTYTAH----------------------------------------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVL 455 (1157)
T KOG4278|consen 416 TGDTYTAH----------------------------------------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVL 455 (1157)
T ss_pred cCCceecc----------------------------------------cCccCcccccCcccccccccccchhhHHHHHH
Confidence 65543210 01122457999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 347 lyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||+.| |-.||.+-+..+.|..+-+ .....-|+ .|++.+..|++.|+. .|.+||+..++.+.+.
T Consensus 456 LWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~Pe--GCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 456 LWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGPE--GCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred HHHHHhcCCCCCCCccHHHHHHHHhc-cccccCCC--CCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 999997 9999999998888876654 34455565 899999999999999 9999999544433333
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=341.70 Aligned_cols=239 Identities=18% Similarity=0.277 Sum_probs=186.3
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|...++||+|+||.||+|+.+.+|..||||++...... ...|+.+|++++|||||+++++|.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 355667899999999999999999999999998654311 1345788999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH---KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|++||+|.+++. .+++..+..++.+++.||.||| +.+||||||||+|||++.++..++. ||.......
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 999999999995 4899999999999999999999 6699999999999999999888775 665432210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
....+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 835 ----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 835 ----------------------------------------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred ----------------------------------------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence 0124689999999999999999999999999999999999
Q ss_pred CCCCCCCChh--hH--HHHH-h------hccc-cc--cCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 354 YPPFYSDDPM--ST--CRKI-V------NWRT-HL--KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 354 ~~PF~~~~~~--~~--~~~i-~------~~~~-~~--~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+.||...... .. +.+. . .|.. .+ ..+.......++.+|+.+|+. ||.+||+ +.||++.
T Consensus 875 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt---~~evl~~ 947 (968)
T PLN00113 875 KSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC---ANDVLKT 947 (968)
T ss_pred CCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcC---HHHHHHH
Confidence 9999543211 11 0000 0 0000 00 001111223467899999998 9999999 7777653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=272.26 Aligned_cols=230 Identities=28% Similarity=0.488 Sum_probs=187.0
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH-hcCCCceEEEeeeecCC
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~d~ 188 (552)
...+..++...+..||+|+||.|-+.++..+|...|+|.+...- ......+..+|.++.. ...+|++|.+|+.+.+.
T Consensus 40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 34566677777889999999999999999999999999997542 3444556777888754 45899999999999999
Q ss_pred ceEEEEEecCCCCchhhH----HhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccc
Q 008810 189 EFLYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~----L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
..+++.||.| .-+|..+ +.+.+.++|...-.++..++.||+|||+ ..+||||+||.||||+.+|++|+||||++
T Consensus 118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs 196 (282)
T KOG0984|consen 118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGIS 196 (282)
T ss_pred ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccc
Confidence 9999999999 3455444 4456889999999999999999999997 58999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccc-cccCCCCCChhhhhc----CCCCCcc
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYS-TVGTPDYIAPEVLLK----KGYGMEC 338 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s-~~GT~~Y~APEvl~~----~~y~~~~ 338 (552)
-.+..+. +.+ -.|.-.|||||.+.. .+|+-++
T Consensus 197 G~L~dSi-------------------------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vks 233 (282)
T KOG0984|consen 197 GYLVDSI-------------------------------------------AKTMDAGCKPYMAPERINPELNQKGYSVKS 233 (282)
T ss_pred eeehhhh-------------------------------------------HHHHhcCCCccCChhhcCcccCcccceeeh
Confidence 7654321 112 468889999999873 5899999
Q ss_pred chhhhhHHHHHHhhCCCCCCC-CChhhHHHHHhhccccccCCcccccChh
Q 008810 339 DWWSLGAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIE 387 (552)
Q Consensus 339 DiWSlGvilyEmltG~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~e 387 (552)
||||||+.|+||.+++.||.. .++.+.+..++.. ....+|.. .+|++
T Consensus 234 DvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp~~-~FS~e 281 (282)
T KOG0984|consen 234 DVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLPAD-TFSPE 281 (282)
T ss_pred hhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCccc-ccCCC
Confidence 999999999999999999976 4677778888763 34445543 35543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=312.52 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=223.9
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
..++......+-++||.|.||+||.|+.+..|+ .||||.|+... ...+...|..|..||.+++||||++|-++..
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT 700 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence 345777888899999999999999999988774 69999998543 4566778999999999999999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...-+.||.|||++|.|..+|..+ +.|+..+..-+++.|+.|+.||-+.|+|||||-..|||++.+-.+|++||||++.
T Consensus 701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRv 780 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 780 (996)
T ss_pred cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceee
Confidence 999999999999999999999765 6799999999999999999999999999999999999999999999999999997
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccc---CCCCCChhhhhcCCCCCccchhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG---TPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~G---T~~Y~APEvl~~~~y~~~~DiWS 342 (552)
+..+. .. +++..| ...|.|||.+...+++.++|+||
T Consensus 781 ledd~--~~---------------------------------------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWS 819 (996)
T KOG0196|consen 781 LEDDP--EA---------------------------------------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWS 819 (996)
T ss_pred cccCC--Cc---------------------------------------cccccCCccceeecChhHhhhcccCchhhccc
Confidence 74332 10 112222 25799999999999999999999
Q ss_pred hhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 343 lGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+||+|||.++ |..||...+.++.+..|.. .+.+|....++..+..|+..|++ |-.+||. +.+|.++
T Consensus 820 yGIVmWEVmSyGERPYWdmSNQdVIkaIe~---gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~---F~qiV~~ 887 (996)
T KOG0196|consen 820 YGIVMWEVMSYGERPYWDMSNQDVIKAIEQ---GYRLPPPMDCPAALYQLMLDCWQKDRNRRPK---FAQIVST 887 (996)
T ss_pred cceEEEEecccCCCcccccchHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCC---HHHHHHH
Confidence 9999999875 9999999999999988874 45666667999999999999999 9999999 8888765
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=303.08 Aligned_cols=247 Identities=21% Similarity=0.361 Sum_probs=211.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKT-TGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~-tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..++..+.++||+|+||.|+.|.++. +|+ .||||+++..... .....|++|..+|.+++||++|+||++..+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 34556778899999999999999865 444 5899999865432 256779999999999999999999999988 67
Q ss_pred EEEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 191 LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+.||||++++|+|.+.|.+ +..|.......|+.||+.|+.||..+++|||||-..||||-....|||+||||.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 8899999999999999976 56799999999999999999999999999999999999999999999999999997753
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. +.|. ++...--...|+|||.|....++.++|+|++||.+|
T Consensus 265 ne---d~Yv-----------------------------------m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiW 306 (1039)
T KOG0199|consen 265 NE---DMYV-----------------------------------MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIW 306 (1039)
T ss_pred CC---cceE-----------------------------------ecCCCcCcccccCHhHhccccccccchhhhhhhhHH
Confidence 31 1111 011122346799999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCC
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
||++ |.-||.|....+++++|- ....+.-|. .||.+..+++..|+. +|.+||+
T Consensus 307 EMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk--~csedIY~imk~cWah~paDRpt 361 (1039)
T KOG0199|consen 307 EMFTYGEEPWVGCRGIQILKNID-AGERLPRPK--YCSEDIYQIMKNCWAHNPADRPT 361 (1039)
T ss_pred hhhccCCCCCCCCCHHHHHHhcc-ccccCCCCC--CChHHHHHHHHHhccCCcccccc
Confidence 9997 899999999999999887 345566664 899999999999999 9999999
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.23 Aligned_cols=255 Identities=18% Similarity=0.314 Sum_probs=207.3
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..+...+.+.||+|-||+|.+|... .+..||+|+++.... ......|..|+.+|.+++|||||.|+++|..++.++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 44455678899999999999999854 367999999986542 333467999999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|||||..|||..+|+.. ..+.-.....++.||+.|+.||.+.+||||||-+.|+|++.++++||+|||+++.+-...
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999999887 333445666799999999999999999999999999999999999999999999664432
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
+..- -.-.|-...|||||.+..++++.++|+|+|||.|||+
T Consensus 692 yy~v---------------------------------------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~ 732 (807)
T KOG1094|consen 692 YYRV---------------------------------------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEV 732 (807)
T ss_pred ceee---------------------------------------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHH
Confidence 2110 0023556789999999999999999999999999998
Q ss_pred hh--CCCCCCCCChhhHHHHHhhc---cc-cccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 351 LV--GYPPFYSDDPMSTCRKIVNW---RT-HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 351 lt--G~~PF~~~~~~~~~~~i~~~---~~-~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
++ ...||...+..+..++.... .. ....+...-++..+..||.+|+. |..+||+ ++++-
T Consensus 733 ~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPs---Fe~lh 798 (807)
T KOG1094|consen 733 FMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPS---FEQLH 798 (807)
T ss_pred HHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCC---HHHHH
Confidence 75 78899887776666554321 11 11222234788999999999998 9999999 77764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.51 Aligned_cols=260 Identities=28% Similarity=0.488 Sum_probs=223.5
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
-.+||+++..||.|+||.||+++++.+++..|+|+++-.. ...+.-+..|+-+++.++|||||.+++++.-.+.+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 4689999999999999999999999999999999997543 3445567789999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
+||||.||+|.+.-.-.++++|.++.+.+++.+.||.|||+.|-+|||||-.|||+++.|.+||+|||.+-.+....
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--- 166 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--- 166 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh---
Confidence 99999999999998889999999999999999999999999999999999999999999999999999876542110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhhhHHHHHH
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEm 350 (552)
....++.|||.|||||+-. ..+|+..||+|++|+...|+
T Consensus 167 --------------------------------------~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 167 --------------------------------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred --------------------------------------hhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 0123789999999999875 57899999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhc-cccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNW-RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~-~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
---.+|-...-++....-.-.. .......+....++-+-+|++.+|. +|.+||+ ++-++.|||...-
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT 277 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc
Confidence 9999998877776655433321 1122233345789999999999998 9999999 8889999998653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=289.13 Aligned_cols=134 Identities=22% Similarity=0.427 Sum_probs=117.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-----C---CceEEEeee
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----S---NCIVKLYCS 184 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----h---p~Iv~l~~~ 184 (552)
+...+|-+.+.||.|-|++||||.+..+.+.||||+.+.... ..+....|+.+|+.+. | .+||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 445889999999999999999999999999999999986643 3455788999998872 3 479999999
Q ss_pred ecC----CceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccC
Q 008810 185 FQD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDK 251 (552)
Q Consensus 185 f~d----~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~ 251 (552)
|.. ..++|||+|++ |.+|..+|.+. +.++...++.|+.||+.||.|||. +||||.||||+||||..
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 974 46899999999 88999999764 679999999999999999999996 69999999999999943
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=291.18 Aligned_cols=292 Identities=25% Similarity=0.447 Sum_probs=209.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCce
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 190 (552)
...|.++.+||.|+|+.||++.+.. .++.||+|.+.... ...++.+|.++|..+ .+.||+++.++|..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4568889999999999999999877 78899999987543 234588999999988 68999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc-CCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~-~~g~iKL~DFGlak~~~~~ 269 (552)
..+||||++..+..+++. .++-.+++.|+..++.||.++|+.|||||||||.|+|.+ ..++-.|+|||||...+..
T Consensus 110 v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred eEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999999999888874 467899999999999999999999999999999999998 4578899999999843221
Q ss_pred Cccccccc----ccCCCCCCC---CCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchh
Q 008810 270 TLQEQDFT----IGNNLNGSS---QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWW 341 (552)
Q Consensus 270 ~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiW 341 (552)
......-. ......|.. ........|... .-.-...++....+..||++|.|||++.+. ..+.++|+|
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~----~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGY----YRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCc----eeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 10000000 000000000 000000000000 000012234445678999999999999974 478999999
Q ss_pred hhhHHHHHHhhCCCCCCCCC-hhhHHHHHh-------------------hcc-cc-------------cc----CC----
Q 008810 342 SLGAIMYEMLVGYPPFYSDD-PMSTCRKIV-------------------NWR-TH-------------LK----FP---- 379 (552)
Q Consensus 342 SlGvilyEmltG~~PF~~~~-~~~~~~~i~-------------------~~~-~~-------------~~----~p---- 379 (552)
|.|||+.-++++..||.... ....+..|+ -|. .. +. .+
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 99999999999999986432 111111111 111 00 00 00
Q ss_pred ------cccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 380 ------EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 380 ------~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
.....+..+.||+.+||. ||.+|.+ |++.|.||||...+
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEAD 388 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcchh
Confidence 001245589999999999 9999999 99999999998543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=257.57 Aligned_cols=212 Identities=42% Similarity=0.676 Sum_probs=182.6
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
|.+.+.||.|++|.||+|....+++.+|||.+...... .....+.+|+..+..++|+||+++++.+......|+||||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999988999999999865432 2456788999999999999999999999999999999999
Q ss_pred CCCCchhhHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 198 LPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 198 ~~gG~L~~~L~~~~~-l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
+++++|..++..... +++..+..++.+++.+|.+||+.|++|+||+|.||+++.++.++|+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~---- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA---- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----
Confidence 999999999987666 899999999999999999999999999999999999999999999999998865322100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhh-hcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl-~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
......|+..|++||++ ....++.++|+||||+++|+|++|++
T Consensus 155 ------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~ 198 (225)
T smart00221 155 ------------------------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE 198 (225)
T ss_pred ------------------------------------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 00135788999999999 66778889999999999999999999
Q ss_pred CCCC-CChh-hHHHHHhh
Q 008810 356 PFYS-DDPM-STCRKIVN 371 (552)
Q Consensus 356 PF~~-~~~~-~~~~~i~~ 371 (552)
||.+ .++. .....|..
T Consensus 199 pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 199 PFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred CccccchhHHHHHHHHhc
Confidence 9988 4444 45555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=297.23 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=207.4
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcC---C----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEe
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKT---T----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~---t----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 182 (552)
.++..++..+.+.||.|+||.|++|..+. . ...||||.++.... ..+.+.+..|+++|+.+ .|||||.|.
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 44555556677799999999999997531 1 45799999986543 36677899999999998 699999999
Q ss_pred eeecCCceEEEEEecCCCCchhhHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCC
Q 008810 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (552)
Q Consensus 183 ~~f~d~~~lylVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeN 246 (552)
+++.....+++|+||+..|+|..+|...+ .|+......++.||+.|++||++.++|||||-..|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999997655 48899999999999999999999999999999999
Q ss_pred ccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccC--CCCC
Q 008810 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT--PDYI 324 (552)
Q Consensus 247 ILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT--~~Y~ 324 (552)
||+..+..+||+|||||+......... .....|| ..||
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~----------------------------------------~~~~~~~LP~kWm 488 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYR----------------------------------------TKSSAGTLPVKWM 488 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceE----------------------------------------ecCCCCccceeec
Confidence 999999999999999999653321110 0011222 3499
Q ss_pred ChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCC-hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-Cccc
Q 008810 325 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401 (552)
Q Consensus 325 APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~ 401 (552)
|||.+....|+.++|+||+||+||||.+ |.+||.+-. ..+.+..+.. ......|. .++++..+++..|+. +|++
T Consensus 489 ApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~-G~r~~~P~--~c~~eiY~iM~~CW~~~p~~ 565 (609)
T KOG0200|consen 489 APESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE-GNRMEQPE--HCSDEIYDLMKSCWNADPED 565 (609)
T ss_pred CHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHhCCCccc
Confidence 9999999999999999999999999998 999998855 4455554443 23455564 789999999999998 9999
Q ss_pred cCCCCChhhhh
Q 008810 402 RLGAKGADEIK 412 (552)
Q Consensus 402 Rl~~~~a~eil 412 (552)
||+ +.++.
T Consensus 566 RP~---F~~~~ 573 (609)
T KOG0200|consen 566 RPT---FSECV 573 (609)
T ss_pred CCC---HHHHH
Confidence 999 54444
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=277.05 Aligned_cols=244 Identities=22% Similarity=0.332 Sum_probs=193.7
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh--cCCCceEEEeeeecCCc---
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQDDE--- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~d~~--- 189 (552)
....+++.+||+|.||.||+|+.. ++.||||++.-. +.+.+.+|++|... ++|+||++++++-.-..
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 556778889999999999999865 589999998643 45669999999876 48999999998765333
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCCcccccCCCCccccCCCcEEEcc
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------HHYIHRDIKPDNLLLDKYGHLRLSD 259 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~---------~giiHrDLKPeNILl~~~g~iKL~D 259 (552)
.++||+||.+.|+|.++|.. ..+++.....++.-++.||.|||. -+|+|||||..|||+-.++...|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 78999999999999999954 689999999999999999999995 2599999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCC---
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYG--- 335 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~--- 335 (552)
||||..+....... -+...|||..|||||+|.+. .+.
T Consensus 360 FGLAl~~~p~~~~~---------------------------------------d~~~qVGT~RYMAPEvLEgainl~d~~ 400 (534)
T KOG3653|consen 360 FGLALRLEPGKPQG---------------------------------------DTHGQVGTRRYMAPEVLEGAINLQDRD 400 (534)
T ss_pred cceeEEecCCCCCc---------------------------------------chhhhhhhhhhcCHHHHhhhcccccHH
Confidence 99999876332110 01246999999999999873 222
Q ss_pred --CccchhhhhHHHHHHhhCCC------------CCC---C--CChhhHHHHHhhccccccCCccc---ccChhHHHHHH
Q 008810 336 --MECDWWSLGAIMYEMLVGYP------------PFY---S--DDPMSTCRKIVNWRTHLKFPEEA---KLSIEAKDLIS 393 (552)
Q Consensus 336 --~~~DiWSlGvilyEmltG~~------------PF~---~--~~~~~~~~~i~~~~~~~~~p~~~---~~s~e~~dLI~ 393 (552)
...|+||+|.|||||++... ||. | .+-.++...++..+....+|+.- .--.-+++.|.
T Consensus 401 Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~E 480 (534)
T KOG3653|consen 401 AFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIE 480 (534)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHH
Confidence 45899999999999998643 332 1 22345566677767777777631 12335788899
Q ss_pred HHhh-CccccCCCC
Q 008810 394 KLLC-NVNQRLGAK 406 (552)
Q Consensus 394 ~lL~-dp~~Rl~~~ 406 (552)
.|+. |++-|+++.
T Consensus 481 eCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 481 ECWDHDAEARLTAG 494 (534)
T ss_pred HHcCCchhhhhhhH
Confidence 9998 999999954
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=247.59 Aligned_cols=211 Identities=43% Similarity=0.705 Sum_probs=186.7
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCch
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L 203 (552)
||.|++|.||+|....+|+.+++|++....... ....+.+|+.+++.+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999998654221 346789999999999999999999999999999999999999999
Q ss_pred hhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-CCcEEEcccccccccCCCCcccccccccCC
Q 008810 204 MTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (552)
Q Consensus 204 ~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-~g~iKL~DFGlak~~~~~~~~~~~~~~~~~ 281 (552)
..++... ..+++..+..++.+++.+|.+||+.|++|+||+|.||+++. +++++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9999765 57999999999999999999999999999999999999999 89999999999986543210
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCCCCCCCC
Q 008810 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (552)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~~PF~~~ 360 (552)
......++..|++||.+... .++.+.|+|+||+++|+|
T Consensus 149 -------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------- 187 (215)
T cd00180 149 -------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------- 187 (215)
T ss_pred -------------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------
Confidence 01134678899999999887 889999999999999999
Q ss_pred ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCC
Q 008810 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415 (552)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hp 415 (552)
..+.++|.+||+ +|.+||+ +.+++.|+
T Consensus 188 -------------------------~~~~~~l~~~l~~~p~~R~~---~~~l~~~~ 215 (215)
T cd00180 188 -------------------------PELKDLIRKMLQKDPEKRPS---AKEILEHL 215 (215)
T ss_pred -------------------------HHHHHHHHHHhhCCcccCcC---HHHHhhCC
Confidence 578999999998 9999999 89999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=270.68 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=189.8
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc--CCCceEEEeeeecCC
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV--DSNCIVKLYCSFQDD 188 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~d~ 188 (552)
++....+..+.+.||+|-||+||+|+++ |+.||||++... +.....+|.+|.+.+ +|+||+.++.+-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 3445678899999999999999999876 779999999643 345678899998764 999999998775533
Q ss_pred ----ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccccCCCCccccCCCcEE
Q 008810 189 ----EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------HYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 189 ----~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------giiHrDLKPeNILl~~~g~iK 256 (552)
..++||.+|.+.|+|+++|.+ ..++.+....++..++.||.|||.. .|.|||||..|||+.++|..-
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 269999999999999999977 7899999999999999999999952 499999999999999999999
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC---
Q 008810 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--- 333 (552)
Q Consensus 257 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~--- 333 (552)
|+|+|||...+..+. ...++ .+..|||-.|||||+|...-
T Consensus 357 IADLGLAv~h~~~t~---~idi~----------------------------------~N~rVGTKRYMAPEvLdetin~~ 399 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTD---TIDIP----------------------------------PNPRVGTKRYMAPEVLDETINMK 399 (513)
T ss_pred EeeceeeEEecccCC---cccCC----------------------------------CCCccceeeccChHHhhhhcChh
Confidence 999999987654421 11111 12579999999999997522
Q ss_pred -C--CCccchhhhhHHHHHHhhC----------CCCCCCC----ChhhHHHHHhh-ccccccCCcccccChh----HHHH
Q 008810 334 -Y--GMECDWWSLGAIMYEMLVG----------YPPFYSD----DPMSTCRKIVN-WRTHLKFPEEAKLSIE----AKDL 391 (552)
Q Consensus 334 -y--~~~~DiWSlGvilyEmltG----------~~PF~~~----~~~~~~~~i~~-~~~~~~~p~~~~~s~e----~~dL 391 (552)
+ -..+||||||.||||++.. .+||++- ...+..++++- .+....+|.. +-|.+ .-.|
T Consensus 400 ~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr-W~s~~~l~~m~kl 478 (513)
T KOG2052|consen 400 HFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR-WKSDPALRVMAKL 478 (513)
T ss_pred hhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcc-cccCHHHHHHHHH
Confidence 1 2357999999999999853 4899763 23344455442 2233344432 33333 3456
Q ss_pred HHHHhh-CccccCC
Q 008810 392 ISKLLC-NVNQRLG 404 (552)
Q Consensus 392 I~~lL~-dp~~Rl~ 404 (552)
++.|+. +|.-|++
T Consensus 479 MkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 479 MKECWYANPAARLT 492 (513)
T ss_pred HHHhhcCCchhhhH
Confidence 677776 9999998
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=285.18 Aligned_cols=243 Identities=19% Similarity=0.296 Sum_probs=201.7
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
....++||.|+||+||+|.+...|+ +||||++...... .....+..|.-+|..++|||+++|+++++... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456799999999999999865554 6899998765432 33456889999999999999999999999776 789
Q ss_pred EEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
|++|||+|.|.++++. ++.+-......|..||+.|+.|||.+++|||||-..|||+..-.|+||+|||+++.+......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999965 467888999999999999999999999999999999999999999999999999987544211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
- . +....-.+-|||-|.+....|+.++|+|||||.+||++|
T Consensus 855 y---~------------------------------------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmT 895 (1177)
T KOG1025|consen 855 Y---S------------------------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMT 895 (1177)
T ss_pred c---c------------------------------------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHh
Confidence 0 0 001122457999999999999999999999999999997
Q ss_pred -CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
|..|+.+....++- +++.....+.-| +.++.++.-++.+||. |+..||++
T Consensus 896 FGa~Py~gi~~~eI~-dlle~geRLsqP--piCtiDVy~~mvkCwmid~~~rp~f 947 (1177)
T KOG1025|consen 896 FGAKPYDGIPAEEIP-DLLEKGERLSQP--PICTIDVYMVMVKCWMIDADSRPTF 947 (1177)
T ss_pred cCCCccCCCCHHHhh-HHHhccccCCCC--CCccHHHHHHHHHHhccCcccCccH
Confidence 99999888766554 444433445444 4899999999999998 99999984
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=292.78 Aligned_cols=324 Identities=34% Similarity=0.565 Sum_probs=269.9
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
+...++|.+.+-+-+|++|.++.+....+|...++|+..+..++...+.+..+.+.+++-...||.++..++.|.-...+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45788999999999999999999999999999999999999888888888899999999889999999999998888899
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
+|||+|+.||+|...|...++.+++-++.++..+++++++||...++|||++|.|+|+..+||.+++|||+......-..
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999996654432211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.. +.. |....+........ .+..++..- .- ......+||+.|.|||.+.+...+..+|||++|++++|.+
T Consensus 960 ~~-~~s-g~~~~~~~~~~~~~-----~~~~~l~~~-~~--~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 960 TT-DLS-GPSSSGTPRRLSRS-----ERRPQLSAD-EA--RRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cC-Ccc-cccccCcccccccc-----ccccccccc-hh--hccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 00 000 11111111100000 000011100 00 1124678999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcc-cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhcC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQME 429 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~ 429 (552)
+|.+||....++.++++|.+. ....|.. ...+++++++|.++|. +|.+|+++.++.+++.||||++++|+.|....
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~--~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNR--DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred cCCCCCCCcchhhhhhccccC--CCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccccc
Confidence 999999999999999999974 3444432 3689999999999998 99999999888999999999999999999999
Q ss_pred CCCccccCCcccCcCccc
Q 008810 430 AAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 430 ~pf~P~~~~~~d~~~f~~ 447 (552)
.+|+|...+..|+++|..
T Consensus 1108 ~~~~p~~~s~~dtS~~~~ 1125 (1205)
T KOG0606|consen 1108 AEFVPQPESTQDTSYFES 1125 (1205)
T ss_pred CccCCCCCCCCccchhhc
Confidence 999999999999999976
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=304.08 Aligned_cols=225 Identities=13% Similarity=0.172 Sum_probs=154.8
Q ss_pred CceEEEeeee-------cCCceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCc
Q 008810 176 NCIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (552)
Q Consensus 176 p~Iv~l~~~f-------~d~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNI 247 (552)
+||++++++| .....++++|||+ +++|..+|.. ...+++.+++.|+.||+.||.|||++|||||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 5777788777 2335688999988 6799999965 45699999999999999999999999999999999999
Q ss_pred cccCCCcEEEcccccccccCCCC---cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhh-ccccccccccCCCC
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCST---LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKN-RRMLAYSTVGTPDY 323 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-r~~~~~s~~GT~~Y 323 (552)
||+..|.+|++|||+|....... ....++........ .+.+.. ......... ........+||+.|
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~---------~~~~~~-~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEI---------LSERRI-EKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCccccccccccccccc---------ccccch-hhhhccccCCCcccccccCCCcce
Confidence 99988889988888886542210 00001100000000 000000 000000000 00001135799999
Q ss_pred CChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCc-ccccChhHHHHHHHHhh-Cccc
Q 008810 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQ 401 (552)
Q Consensus 324 ~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~e~~dLI~~lL~-dp~~ 401 (552)
||||++.+..|+.++||||||||||||++|.+||.... .....+... .+|. .....+++.+++.+||. +|.+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~L~~~P~~ 255 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR----VLPPQILLNWPKEASFCLWLLHPEPSC 255 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh----hcChhhhhcCHHHHHHHHHhCCCChhh
Confidence 99999999999999999999999999999999986432 222222211 1121 11235567899999999 9999
Q ss_pred cCCCCChhhhhcCCCcCCC
Q 008810 402 RLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 402 Rl~~~~a~eil~HpfF~~i 420 (552)
||+ +.||+.||||...
T Consensus 256 Rps---~~eil~h~~~~~~ 271 (793)
T PLN00181 256 RPS---MSELLQSEFINEP 271 (793)
T ss_pred CcC---hHHHhhchhhhhh
Confidence 999 9999999999763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=251.30 Aligned_cols=239 Identities=22% Similarity=0.390 Sum_probs=187.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEe-eeecCCceEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY-CSFQDDEFLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~-~~f~d~~~ly 192 (552)
.+.|.+.+.||.|-||++.+|+++.++..+|+|.+.+... ....|.+|..---.+ .|.+|+.-| ..||+.+...
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 3568999999999999999999999999999999987643 233455565543333 688999988 5689999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc--CCCcEEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~--~~g~iKL~DFGlak~~~~~~ 270 (552)
++|||+|-|||..-+.. ..+-|...+.+++|++.||+|+|+.++||||||.+||||- +...|||||||+.+..+...
T Consensus 99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 99999999999988744 5689999999999999999999999999999999999994 34589999999987543210
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-----CCCCccchhhhhH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-----GYGMECDWWSLGA 345 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-----~y~~~~DiWSlGv 345 (552)
+ -.--+..|.+||+.... ...+..|+|.||+
T Consensus 178 ------------------------------~--------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGI 213 (378)
T KOG1345|consen 178 ------------------------------K--------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGI 213 (378)
T ss_pred ------------------------------h--------------hhhhhcccCCcHHHhhccccceEecccccchheee
Confidence 0 01235579999988642 2477899999999
Q ss_pred HHHHHhhCCCCCCCCChh-hHHHHHhhccc--cccCCcc-cccChhHHHHHHHHhh-Ccccc
Q 008810 346 IMYEMLVGYPPFYSDDPM-STCRKIVNWRT--HLKFPEE-AKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~-~~~~~i~~~~~--~~~~p~~-~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|+|.+|+|.+||...... .-|.+-+.|.. ....|.. ..+|+.|..+.++-|. ++++|
T Consensus 214 i~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 214 IFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred eeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 999999999999854322 23444455533 2344432 4689999999999998 88888
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-27 Score=239.03 Aligned_cols=261 Identities=39% Similarity=0.605 Sum_probs=207.4
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC-ceEEEeeeecCCceEEEEEe
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~d~~~lylVmE 196 (552)
|.+...||.|+||.||++.+. ..+|+|.+.+...........+.+|..++..+.|+ +|++++..+......++|++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788899999999999999987 78999999877654444567789999999999988 79999999988888999999
Q ss_pred cCCCCchhhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEcccccccccCCCCcc
Q 008810 197 YLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 197 y~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~~~~~~~ 272 (552)
|+.|+++..++.... .+++..+..++.|++.+|.|+|..|++||||||+|||++..+ .++++|||+++.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776654 799999999999999999999999999999999999999998 7999999999854322110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhhHHHHH
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvilyE 349 (552)
.... ......+||+.|+|||++.+ ..++...|+||+|+++++
T Consensus 159 ~~~~-----------------------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~ 203 (384)
T COG0515 159 SSIP-----------------------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203 (384)
T ss_pred cccc-----------------------------------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHH
Confidence 0000 01235789999999999998 578999999999999999
Q ss_pred HhhCCCCCCCCCh----hhHHHHHhhcccc-ccCCccccc----ChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 350 MLVGYPPFYSDDP----MSTCRKIVNWRTH-LKFPEEAKL----SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 350 mltG~~PF~~~~~----~~~~~~i~~~~~~-~~~p~~~~~----s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+++|..||..... ......+...... ...+..... ...+.+++.+++. +|..|.+ ..+...++|...
T Consensus 204 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~~ 280 (384)
T COG0515 204 LLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLAH 280 (384)
T ss_pred HHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhhC
Confidence 9999999887764 3444444332211 111111111 2578999999998 9999998 666666655543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=230.64 Aligned_cols=161 Identities=21% Similarity=0.236 Sum_probs=130.3
Q ss_pred CchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccccc
Q 008810 201 GDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (552)
Q Consensus 201 G~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~ 279 (552)
|+|.+++.. ...|++..++.++.|++.||.|||+.+ ||+|||++.++++|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 789999976 456999999999999999999999998 999999999999999 9998754311
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCC
Q 008810 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (552)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~ 359 (552)
...||+.|||||++.+..|+.++|||||||++|||++|.+||..
T Consensus 63 ------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 63 ------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ------------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 23689999999999999999999999999999999999999976
Q ss_pred CChh-hHHHHHhhcccccc---CCcccccCh--hHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 360 DDPM-STCRKIVNWRTHLK---FPEEAKLSI--EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 360 ~~~~-~~~~~i~~~~~~~~---~p~~~~~s~--e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
.... .....+........ .+....++. ++++||.+||. +|.+||+ +.+++.|+|+.
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~ 169 (176)
T smart00750 107 ERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRAL 169 (176)
T ss_pred cchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHH
Confidence 5443 33333332111110 011123444 79999999999 9999999 99999999974
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-29 Score=274.02 Aligned_cols=264 Identities=24% Similarity=0.383 Sum_probs=205.1
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeech---hhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS---EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~---~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
....++|.|+||.|+.+......+.++.|..... ..........+..|.-+-..+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999999999888777777777765521 1111111222555666667789999998888888777777779
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||++ ||+.++++...++..++..++.|++.|+.|||..||.||||||+|+|++.+|.+||+|||.+..+......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~--- 476 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEK--- 476 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcch---
Confidence 99999 99999999889999999999999999999999999999999999999999999999999998765332100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCC-CccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvilyEmltG~ 354 (552)
+ -.....++|+..|+|||++.+..|. ..+|+||.|+|++.|++|+
T Consensus 477 ---------------------------------~-~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 477 ---------------------------------N-IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred ---------------------------------h-hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 0 0123468999999999999999996 5689999999999999999
Q ss_pred CCCCCCChhhHH---HHHhhccccccCC--cccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 355 PPFYSDDPMSTC---RKIVNWRTHLKFP--EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 355 ~PF~~~~~~~~~---~~i~~~~~~~~~p--~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
.||......+.. .+-..|.....-| -...++.+.+.+|.+||+ ||.+|.+ +++|++.+||+.|+=.
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIECC 594 (601)
T ss_pred CccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcceE
Confidence 999765433221 1111111111111 124678899999999999 9999999 9999999999988643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=244.84 Aligned_cols=145 Identities=17% Similarity=0.149 Sum_probs=117.7
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCceEE-EeeeecC
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVK-LYCSFQD 187 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-tg~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~-l~~~f~d 187 (552)
....++|.+.+.||+|+||+||+|+++. ++..||||++..... ......+.+.+|+.+|+.++|+|||. ++. +
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-T-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE-c--
Confidence 3456789999999999999999999876 788899998753311 12233456899999999999999985 544 2
Q ss_pred CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccc-CCCCccccCCCcEEEccccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI-KPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDL-KPeNILl~~~g~iKL~DFGlak~~ 266 (552)
...|||||||+|++|.. +.. .. ...++.+++.||.|||+.||||||| ||+|||++.+|.+||+|||+|+.+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 35799999999999963 211 11 1467899999999999999999999 999999999999999999999976
Q ss_pred C
Q 008810 267 D 267 (552)
Q Consensus 267 ~ 267 (552)
.
T Consensus 163 ~ 163 (365)
T PRK09188 163 R 163 (365)
T ss_pred c
Confidence 4
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=233.07 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=209.4
Q ss_pred hhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCC-----cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEE
Q 008810 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTG-----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181 (552)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l 181 (552)
|++...+..+++++..++-+|.||.||.|.++... +.+-+|.++.. .+.-|+..+..|--+|..+.|||+..+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 34445566677899999999999999999776432 23445555432 245677888999999999999999999
Q ss_pred eeeec-CCceEEEEEecCCCCchhhHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC
Q 008810 182 YCSFQ-DDEFLYLIMEYLPGGDMMTLLMR--------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (552)
Q Consensus 182 ~~~f~-d~~~lylVmEy~~gG~L~~~L~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~ 252 (552)
.++.. +...-+.++.++.-|+|..+|.. ...++..+...++.|++.|++|||++||||.||-..|.+||+.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 88776 44567788899999999999972 2357788899999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC
Q 008810 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (552)
Q Consensus 253 g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~ 332 (552)
-.+||+|=.|++.+-+..++- .|++ -.-...||+||.+.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhc----LGDn-----------------------------------EnRPvkWMslEal~n~ 473 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHC----LGDN-----------------------------------ENRPVKWMSLEALQNS 473 (563)
T ss_pred eeEEeccchhccccCcccccc----cCCC-----------------------------------CCCcccccCHHHHhhh
Confidence 999999999999765443321 1111 1123569999999999
Q ss_pred CCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhh
Q 008810 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (552)
Q Consensus 333 ~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~e 410 (552)
.|+.++|+|||||+||||+| |+.|+..-+|.++...+..+ ..+.-|- .++.++..++--|+. +|++||+ .+|
T Consensus 474 ~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-yRlaQP~--NCPDeLf~vMacCWallpeeRPs---f~Q 547 (563)
T KOG1024|consen 474 HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-YRLAQPF--NCPDELFTVMACCWALLPEERPS---FSQ 547 (563)
T ss_pred hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-ceecCCC--CCcHHHHHHHHHHHhcCcccCCC---HHH
Confidence 99999999999999999998 99999999999998887753 4455553 899999999999999 9999999 665
Q ss_pred hh
Q 008810 411 IK 412 (552)
Q Consensus 411 il 412 (552)
+.
T Consensus 548 lv 549 (563)
T KOG1024|consen 548 LV 549 (563)
T ss_pred HH
Confidence 43
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=228.39 Aligned_cols=217 Identities=26% Similarity=0.345 Sum_probs=172.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC----CCceEEEeeee-cCCce
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD----SNCIVKLYCSF-QDDEF 190 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~----hp~Iv~l~~~f-~d~~~ 190 (552)
.|.+.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|+.+|..+. .+++..++..+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987774 68999998765322211 4777888888886 36899999998 58889
Q ss_pred EEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC-----CcEEEcccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-----GHLRLSDFGLC 263 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~-----g~iKL~DFGla 263 (552)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.||++||+.|+|||||||+|+++... -.+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 89999988543 689999999999999999999999999999999999999865 36999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+......... ....+. +.....+.||..|+++.+..+...+..-|+||+
T Consensus 175 r~~~~~~~~~-----------------~~~~~~--------------r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~ 223 (322)
T KOG1164|consen 175 RRFKYVGDSG-----------------GNLRPP--------------RPQKGLFRGTLRYASINVHLGIEQGRRDDLESL 223 (322)
T ss_pred ccccccCCCC-----------------cccccC--------------CCCccCCCCccccccHHHhCCCccCCchhhhhH
Confidence 8332110000 000000 000124679999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHH
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRK 368 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~ 368 (552)
+.++.||+.|..||.+........+
T Consensus 224 ~Y~l~el~~g~LPW~~~~~~~~~~~ 248 (322)
T KOG1164|consen 224 FYMLLELLKGSLPWEALEMTDLKSK 248 (322)
T ss_pred HHHHHHHhcCCCCCccccccchHHH
Confidence 9999999999999977654333333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=210.20 Aligned_cols=244 Identities=21% Similarity=0.269 Sum_probs=190.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CceEEEeeeecCCceE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFL 191 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~l 191 (552)
+....|.+++.||.|+||.+|+|....+|..||||+-.+.. .-.++.-|..+...+.+ ..|..+..++....+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45788999999999999999999999999999999976432 11246678888888865 6788888888889999
Q ss_pred EEEEecCCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cEEEcccccccccC
Q 008810 192 YLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLD 267 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~iKL~DFGlak~~~ 267 (552)
.|||+++ |-+|.+++. ....|+...+..++-|++.-|+|+|.+++|||||||+|+|..-+- .+.|+||||||.+-
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 889988884 467899999999999999999999999999999999999997554 47899999999874
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... ...|.|. .....||..|.+--...+...+..-|+=|+|.+|
T Consensus 166 d~~t~-------------------~HIpyre---------------~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 166 DIRTR-------------------QHIPYRE---------------DRNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred ccccc-------------------ccCcccc---------------CCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 32111 0111111 1256899999998888888889999999999999
Q ss_pred HHHhhCCCCCCCCC---hhhHHHHHhhccccccCCc-ccccChhHHHHHHHHh
Q 008810 348 YEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLL 396 (552)
Q Consensus 348 yEmltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~e~~dLI~~lL 396 (552)
....-|..||.+.. ..+-+++|...+....... ...++.|..-.+.-|-
T Consensus 212 mYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R 264 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCR 264 (341)
T ss_pred eeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHh
Confidence 99999999998854 4456777776433322111 1244556655555543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=210.25 Aligned_cols=143 Identities=19% Similarity=0.199 Sum_probs=112.8
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhH-----------------------HHHHHHHHHHHHhcCCCc
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-----------------------VEHVRAERNLLAEVDSNC 177 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~-----------------------~~~~~~E~~iL~~l~hp~ 177 (552)
...||+|+||.||+|... +|+.||||+++......... ......|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 89999999998653211110 123456999999998776
Q ss_pred eEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccccCCCCccccCCCcEE
Q 008810 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI-HKHHYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 178 Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~L-H~~giiHrDLKPeNILl~~~g~iK 256 (552)
|...+..... . .||||||++|+++...+.....+++..+..++.|++.+|.+| |+.|||||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 5333222222 2 389999999988876655567899999999999999999999 799999999999999998 58999
Q ss_pred EcccccccccC
Q 008810 257 LSDFGLCKPLD 267 (552)
Q Consensus 257 L~DFGlak~~~ 267 (552)
|+|||+|...+
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=214.37 Aligned_cols=220 Identities=22% Similarity=0.334 Sum_probs=183.0
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~l 191 (552)
+..-.|.+.+.||+|+||+.++|...-++++||||.-... ...-.++.|-...+.+ ..+.|...|++-+...+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4566899999999999999999999999999999986432 2234577788887777 568999999999999999
Q ss_pred EEEEecCCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-----cEEEcccccccc
Q 008810 192 YLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-----HLRLSDFGLCKP 265 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-----~iKL~DFGlak~ 265 (552)
.||||++ |-+|.+++. ..+.|+...+..++.|++.-++|+|.+.+|+|||||+|+||..-| .|-|+|||+||.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 888888875 456899999999999999999999999999999999999997544 489999999998
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
+....... ..|.|. ..+..||..||+--..++...+..-|+=|||-
T Consensus 179 YrDp~Tkq-------------------HIPYrE---------------~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 179 YRDPKTKQ-------------------HIPYRE---------------HKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred hcCccccc-------------------cCcccc---------------ccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 74432110 112111 23678999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCC---ChhhHHHHHhhc
Q 008810 346 IMYEMLVGYPPFYSD---DPMSTCRKIVNW 372 (552)
Q Consensus 346 ilyEmltG~~PF~~~---~~~~~~~~i~~~ 372 (552)
+++..|-|..||.|. +..+.+++|-..
T Consensus 225 vFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 225 VFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhhhccCCCccccccCcchHHHHHHhccc
Confidence 999999999999874 566778888653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=201.76 Aligned_cols=144 Identities=19% Similarity=0.162 Sum_probs=114.6
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh-----------------------hHHHHHHHHHHHHHhcCCCc
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-----------------------GQVEHVRAERNLLAEVDSNC 177 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~-----------------------~~~~~~~~E~~iL~~l~hp~ 177 (552)
++.||+|+||.||+|.+. +|+.||||+++....... .....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 899999999986521100 00223467889999999988
Q ss_pred eEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEE
Q 008810 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 178 Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iK 256 (552)
|.......... .||||||++|+++...+.....+++..+..++.+++.+|.+||+ .||+||||||+|||++ +|.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 74433322222 38999999998665544455678899999999999999999999 9999999999999999 89999
Q ss_pred EcccccccccCC
Q 008810 257 LSDFGLCKPLDC 268 (552)
Q Consensus 257 L~DFGlak~~~~ 268 (552)
|+|||+|+.++.
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-24 Score=207.27 Aligned_cols=143 Identities=17% Similarity=0.194 Sum_probs=116.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHH------HHHHHHHHHhcCCCceEEEeeeec
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH------VRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~------~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
+...+|+++++||.|+||.||++.. ++..||+|++............. +.+|...+.++.||+|..+...+.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4467899999999999999999755 46689999997654333333333 578888999999999999888766
Q ss_pred CC--------ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEc
Q 008810 187 DD--------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (552)
Q Consensus 187 d~--------~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~ 258 (552)
+. ...||||||++|.+|.++. .+++. ...+++.+|..||..|++||||||.|||++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 43 3579999999999998773 23432 456999999999999999999999999999999 9999
Q ss_pred cccccccc
Q 008810 259 DFGLCKPL 266 (552)
Q Consensus 259 DFGlak~~ 266 (552)
|||.++..
T Consensus 177 Dfg~~~~~ 184 (232)
T PRK10359 177 DLSGKRCT 184 (232)
T ss_pred ECCCcccc
Confidence 99987643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=198.37 Aligned_cols=203 Identities=19% Similarity=0.229 Sum_probs=147.1
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhH-HHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEEEe
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~-~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.+...||+|+||+|+++.. .+..++.+.+.-.....+.- -..+.+|+++|+++. |++|++++++ ...|+|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998764 67788888776654432221 224789999999995 4789999875 34699999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccc-CCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI-KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDL-KPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|+.|.+|...+.. . ...++.|++.+|.++|.+||||||| ||+|||++.+|+++|+|||+|+.........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~-- 149 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM-- 149 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH--
Confidence 9999998754321 1 2357889999999999999999999 7999999999999999999998543211000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCC-CccchhhhhHHHHHHhhC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYG-MECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~-~~~DiWSlGvilyEmltG 353 (552)
.--...-+.+..+.. ...+++|++|+.-.-. ..+ ...+|++.|+-+|.++||
T Consensus 150 --------------------r~L~~rDl~~llk~~------~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~ 203 (218)
T PRK12274 150 --------------------RLLAREDLRHLLKHK------RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTR 203 (218)
T ss_pred --------------------HHHHHHHHHHHHHHH------HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhc
Confidence 000001112221211 2368999999876532 233 567999999999999999
Q ss_pred CCCCCCCCh
Q 008810 354 YPPFYSDDP 362 (552)
Q Consensus 354 ~~PF~~~~~ 362 (552)
..|+.+++.
T Consensus 204 ~~~~~~~~~ 212 (218)
T PRK12274 204 RVLHWEDNE 212 (218)
T ss_pred cCCccccCC
Confidence 999988764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=209.67 Aligned_cols=274 Identities=25% Similarity=0.325 Sum_probs=189.4
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCC-----------------------------------cEEEEEEeechh
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTG-----------------------------------HVYAMKKLKKSE 153 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-----------------------------------~~~AiK~l~k~~ 153 (552)
...++..++|++...||+|.-..||.++....| =+.|||.|-.-+
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 346788999999999999999999998765421 134666653322
Q ss_pred hhhhhHHHHHH----HHH------HH-----------H-----HhcCCCceEEEeeeecCC-------------------
Q 008810 154 MLRRGQVEHVR----AER------NL-----------L-----AEVDSNCIVKLYCSFQDD------------------- 188 (552)
Q Consensus 154 ~~~~~~~~~~~----~E~------~i-----------L-----~~l~hp~Iv~l~~~f~d~------------------- 188 (552)
..+ ...++. +|. .. + ...+|||||+++.+|.|.
T Consensus 230 ~~s--~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~ 307 (598)
T KOG4158|consen 230 HDS--GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARW 307 (598)
T ss_pred cCC--chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCccccccee
Confidence 111 111111 111 00 1 013699999999998663
Q ss_pred --------ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc--CCC--cEE
Q 008810 189 --------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYG--HLR 256 (552)
Q Consensus 189 --------~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~--~~g--~iK 256 (552)
..+|+||.-.+ .+|+.+|.. ...+....+.+++|++.|+.|||++||.|||||.+||||. +++ .+.
T Consensus 308 ~p~g~g~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LV 385 (598)
T KOG4158|consen 308 YPSGAGEPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLV 385 (598)
T ss_pred cccccCCCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEE
Confidence 35899999874 588888854 4567788899999999999999999999999999999994 444 589
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC---
Q 008810 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--- 333 (552)
Q Consensus 257 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~--- 333 (552)
|+|||.|---+...++-. .. +| .-+.-|...-||||+....+
T Consensus 386 vaDFGCcLAd~~hGlqlp---------y~-------------------S~-------~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 386 VADFGCCLADDNHGLQLP---------YE-------------------SD-------EVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred Ecccceeeeccccccccc---------cc-------------------cc-------cccCCCcceecchhhhhcCCCCc
Confidence 999998754332211110 00 00 01345778899999997422
Q ss_pred --C-CCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChh
Q 008810 334 --Y-GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (552)
Q Consensus 334 --y-~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ 409 (552)
. -.++|.|+.|.+.||++....|||+....-.-..-.....-..+| ..+++.+++||..+|. ||.+|++..-|.
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp--~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP--SRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc--ccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 1 236899999999999999999999855432211111111222344 3799999999999999 999999977677
Q ss_pred hhhcCCCcCCCChh
Q 008810 410 EIKVHPWFDGVDWA 423 (552)
Q Consensus 410 eil~HpfF~~i~w~ 423 (552)
.+++--.|..-+|-
T Consensus 509 Nvl~LsLw~~~~~v 522 (598)
T KOG4158|consen 509 NVLNLSLWRMGEDV 522 (598)
T ss_pred hHHHHHHhcCchHH
Confidence 77776666555553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=203.33 Aligned_cols=232 Identities=24% Similarity=0.328 Sum_probs=151.7
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-----------CceEEEee---
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-----------NCIVKLYC--- 183 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-----------p~Iv~l~~--- 183 (552)
+.....||.|+||.||.|.+..||+.+|+|++.-.........+.+++|.-....+.+ .+++.+--
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 4567799999999999999999999999999876554455567777777655444322 12222210
Q ss_pred -----eecCC---c-----eEEEEEecCCCCchhhHHh---hcCCC---CHHHHHHH-HHHHHHHHHHHHhCCCcccccC
Q 008810 184 -----SFQDD---E-----FLYLIMEYLPGGDMMTLLM---RKDTL---TEDEARFY-VAETVLAIESIHKHHYIHRDIK 243 (552)
Q Consensus 184 -----~f~d~---~-----~lylVmEy~~gG~L~~~L~---~~~~l---~e~~~~~~-~~qi~~aL~~LH~~giiHrDLK 243 (552)
++... . +.+++|+-+ -+||..++. ..... ....|+.+ ..|++..+.+||..|+||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 01111 1 347788877 668877753 22222 22344444 4899999999999999999999
Q ss_pred CCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCC
Q 008810 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323 (552)
Q Consensus 244 PeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y 323 (552)
|+|++++.+|.++|+||+........ ......+..|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~--------------------------------------------~~~~~~~~~~ 208 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR--------------------------------------------YRCSEFPVAF 208 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE--------------------------------------------EEGGGS-TTT
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce--------------------------------------------eeccCCCccc
Confidence 99999999999999999987654211 0012345789
Q ss_pred CChhhhhcC--------CCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHH
Q 008810 324 IAPEVLLKK--------GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKL 395 (552)
Q Consensus 324 ~APEvl~~~--------~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~l 395 (552)
.+||+.... .|+.+.|.|+||+++|.|.+|..||....+...... .|.....++...++||.+|
T Consensus 209 ~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~l 280 (288)
T PF14531_consen 209 TPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGL 280 (288)
T ss_dssp S-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHH
T ss_pred CChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHH
Confidence 999988642 478999999999999999999999986654322111 2222225778999999999
Q ss_pred hh-Ccccc
Q 008810 396 LC-NVNQR 402 (552)
Q Consensus 396 L~-dp~~R 402 (552)
|. ||.+|
T Consensus 281 L~~~~~~R 288 (288)
T PF14531_consen 281 LQRNPEDR 288 (288)
T ss_dssp T-SSGGGS
T ss_pred ccCCcccC
Confidence 99 99887
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-23 Score=229.76 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=182.5
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechh-hhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~-~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+|...+.||.+-|=+|.+|++.. | .|+||++-+.. ...-....+-..|+. ....++||++.+--+-.++...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68888999999999999998654 3 59999997754 222222233333333 66679999999888777888899999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
+|+ ..+|.+.|..+.-|..-+.++|+.|++.||.-+|..||+|+|||.|||||+.-.-+.|+||.--|+.-.......+
T Consensus 101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999 5689999988888999999999999999999999999999999999999999999999999877654222111111
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-----------CCCccchhhhh
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-----------YGMECDWWSLG 344 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-----------y~~~~DiWSlG 344 (552)
|+.-- -+..--..|+|||.+...+ .+++.||||+|
T Consensus 180 f~fFF----------------------------------DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G 225 (1431)
T KOG1240|consen 180 FTFFF----------------------------------DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG 225 (1431)
T ss_pred ceEEE----------------------------------ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence 11000 0001124699999997532 56789999999
Q ss_pred HHHHHHhh-CCCCCCC-----------CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 345 AIMYEMLV-GYPPFYS-----------DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 345 vilyEmlt-G~~PF~~-----------~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
|+++||++ |.|||.- .++...+++| -+...+.||..||+ ||.+|++ |++.
T Consensus 226 CViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlS---Aedy 288 (1431)
T KOG1240|consen 226 CVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLS---AEDY 288 (1431)
T ss_pred HHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC--------------cCccHHHHHHHHHccCchhccC---HHHH
Confidence 99999997 8999931 1111122211 13368999999999 9999999 8888
Q ss_pred hcC
Q 008810 412 KVH 414 (552)
Q Consensus 412 l~H 414 (552)
|+-
T Consensus 289 L~~ 291 (1431)
T KOG1240|consen 289 LQK 291 (1431)
T ss_pred HHh
Confidence 875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-21 Score=190.43 Aligned_cols=136 Identities=15% Similarity=0.236 Sum_probs=109.5
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-----CCCceEEEeeeecCCc---eEE
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-----DSNCIVKLYCSFQDDE---FLY 192 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~f~d~~---~ly 192 (552)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ +||||+++|++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 6666655 699887543 22345689999999999 6799999999999874 444
Q ss_pred -EEEec--CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCcccccCCCCccccCC----CcEEEccccccc
Q 008810 193 -LIMEY--LPGGDMMTLLMRKDTLTEDEARFYVAETVLAI-ESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFGLCK 264 (552)
Q Consensus 193 -lVmEy--~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL-~~LH~~giiHrDLKPeNILl~~~----g~iKL~DFGlak 264 (552)
+|||| +++|+|.+++.+ ..+++. ..++.+++.++ +|||+++||||||||+|||++.. +.++|+||+.++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 668999999965 457766 36688888888 99999999999999999999743 489999955444
Q ss_pred c
Q 008810 265 P 265 (552)
Q Consensus 265 ~ 265 (552)
.
T Consensus 158 ~ 158 (210)
T PRK10345 158 T 158 (210)
T ss_pred c
Confidence 3
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-21 Score=216.43 Aligned_cols=199 Identities=23% Similarity=0.328 Sum_probs=158.3
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCceEEEeeeecC
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSFQD 187 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d 187 (552)
.++..+.|.|-+.||+|+||+||+|.... |+.||+|+-+......--- =.+++.+++ -+.|+.++.++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI------~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI------CLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee------hHHHHHhhchhhhcchHHHHHHHcc
Confidence 45677899999999999999999999877 9999999977654322111 112333333 2456666655555
Q ss_pred CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-------CCcEEEccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------YGHLRLSDF 260 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-------~g~iKL~DF 260 (552)
.+.-+||+||.+.|+|.+++...+.++|..+.+++.|++.-+++||..+|||+||||+|+||.. .--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 5666899999999999999998999999999999999999999999999999999999999952 235899999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccch
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 340 (552)
|-+-.+..- ... ......++|-.+-.+|+..|.++++.+|.
T Consensus 846 G~siDm~lf--p~~-------------------------------------~~F~~~~~td~f~C~EM~~grpWtYq~Dy 886 (974)
T KOG1166|consen 846 GRSIDMKLF--PDG-------------------------------------TKFKAVWHTDLFDCIEMREGRPWTYQIDY 886 (974)
T ss_pred ccceeeeEc--CCC-------------------------------------cEEeeeeccccchhHHHhcCCCCchhhhh
Confidence 988644211 000 01225688999999999999999999999
Q ss_pred hhhhHHHHHHhhCCC
Q 008810 341 WSLGAIMYEMLVGYP 355 (552)
Q Consensus 341 WSlGvilyEmltG~~ 355 (552)
|.|..+++-||+|..
T Consensus 887 fGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 887 FGLAATVHVMLFGKY 901 (974)
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999999963
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-22 Score=222.24 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=212.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k-~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~ly 192 (552)
...|.+.+.||+|+|+.|.++... .+...+|+|.+.... .......+...|..+-+.+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 567889999999999999998763 445567888776543 33455667777888888886 999999999999999999
Q ss_pred EEEecCCCCchhhHH-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCcccccCCCCccccCCC-cEEEcccccccccCC
Q 008810 193 LIMEYLPGGDMMTLL-MRKD-TLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDC 268 (552)
Q Consensus 193 lVmEy~~gG~L~~~L-~~~~-~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~~~ 268 (552)
++++|..||+++..+ .... ..+...+.+|+.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 5554 7888999999999999999999 99999999999999999999 999999999986543
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccc-CCCCCChhhhhcCC-CCCccchhhhhHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG-TPDYIAPEVLLKKG-YGMECDWWSLGAI 346 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~G-T~~Y~APEvl~~~~-y~~~~DiWSlGvi 346 (552)
.. .........+| ++.|+|||.+.+.. .+...|+||.|++
T Consensus 178 ~~--------------------------------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~ 219 (601)
T KOG0590|consen 178 KN--------------------------------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIV 219 (601)
T ss_pred cC--------------------------------------CcceeeecccCCCCCCCCcccccchhhcCCCccccccccc
Confidence 10 00112235688 99999999999854 4788999999999
Q ss_pred HHHHhhCCCCCCCCChhhH-HHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 347 MYEMLVGYPPFYSDDPMST-CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 347 lyEmltG~~PF~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+.-|++|..|+........ +......+..+....+..++..+.+++.++|+ +|..|.+ .+++..+||+..
T Consensus 220 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 220 LSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred ccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 9999999999875443321 12222222222334456899999999999997 9999999 999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=187.21 Aligned_cols=146 Identities=16% Similarity=0.132 Sum_probs=116.8
Q ss_pred CeeEEeeeeecCCeEEEEEE-EcCCCcEEEEEEeechhhhh-------------------h-h-HHHHHHHHHHHHHhcC
Q 008810 117 DFELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLKKSEMLR-------------------R-G-QVEHVRAERNLLAEVD 174 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~-~k~tg~~~AiK~l~k~~~~~-------------------~-~-~~~~~~~E~~iL~~l~ 174 (552)
.|.+.+.||+|+||.||+|. +..+|+.||||+++...... . . ....+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 67799999999997542100 0 0 1123578999999997
Q ss_pred CCc--eEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC-CcccccCCCCccccC
Q 008810 175 SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH-YIHRDIKPDNLLLDK 251 (552)
Q Consensus 175 hp~--Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~g-iiHrDLKPeNILl~~ 251 (552)
+.+ +.+.+.. ...||||||++|++|...+.....+.+..+..++.|++.+|.+||..| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 4455542 234899999999888776655566777788899999999999999999 99999999999999
Q ss_pred CCcEEEcccccccccC
Q 008810 252 YGHLRLSDFGLCKPLD 267 (552)
Q Consensus 252 ~g~iKL~DFGlak~~~ 267 (552)
++.++|+|||+|....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8999999999998654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=182.51 Aligned_cols=137 Identities=23% Similarity=0.297 Sum_probs=113.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-----hhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-----LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+.||+|++|.||+|+. .|..+++|+...... ........+.+|..++..+.|++|+....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999986 677899998653321 111223457889999999999988776666667778899999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
|++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||+++.
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865332 7788999999999999999999999999999999 79999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.8e-20 Score=174.91 Aligned_cols=134 Identities=22% Similarity=0.269 Sum_probs=106.4
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEec
Q 008810 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy 197 (552)
.||+|+||.||+|. .+|..+++|+....... ......++.+|..++..+.|+++......+.+....++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 45788999986543211 122346678899999999887654333334455667899999
Q ss_pred CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 198 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
++|++|..++..... .++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||+++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988754321 7899999999999999999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=173.04 Aligned_cols=139 Identities=20% Similarity=0.182 Sum_probs=109.4
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh-------------------hHHHHHHHHHHHHHhcCCC--
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-------------------GQVEHVRAERNLLAEVDSN-- 176 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~-------------------~~~~~~~~E~~iL~~l~hp-- 176 (552)
|.+.+.||+|+||.||+|... +|+.||||++........ ........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777889999999999999874 799999999875321000 0112366788889888776
Q ss_pred ceEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEE
Q 008810 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 177 ~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iK 256 (552)
.++..+. ....|+||||++|++|..+... ..+..++.+++.++.++|..||+||||||+|||++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 3444443 2345899999999998765431 34667889999999999999999999999999999999999
Q ss_pred EcccccccccC
Q 008810 257 LSDFGLCKPLD 267 (552)
Q Consensus 257 L~DFGlak~~~ 267 (552)
|+|||+|....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-19 Score=167.64 Aligned_cols=140 Identities=16% Similarity=0.204 Sum_probs=101.4
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHH---------------------HHHHHHHHHHhcCCCc--
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE---------------------HVRAERNLLAEVDSNC-- 177 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~---------------------~~~~E~~iL~~l~hp~-- 177 (552)
.+.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 8999999998764321111111 1135566666664432
Q ss_pred eEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEE
Q 008810 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 178 Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iK 256 (552)
+.+.++. ...++||||++||.+........... ..++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4444443 23589999999965543221111111 6788999999999999999 9999999999999999 89999
Q ss_pred EcccccccccC
Q 008810 257 LSDFGLCKPLD 267 (552)
Q Consensus 257 L~DFGlak~~~ 267 (552)
|+|||.+....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-19 Score=173.57 Aligned_cols=239 Identities=18% Similarity=0.255 Sum_probs=189.8
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+...+..++..|...-.|+.|+|++.. .-++.|+++-.+... ...+.|..|.-.|+-+.||||+.+++.|+...++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 444566678889999999999998764 467778887554322 22345777888888889999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-Ccc-cccCCCCccccCCCcEEEc--cccccccc
Q 008810 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH-YIH-RDIKPDNLLLDKYGHLRLS--DFGLCKPL 266 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g-iiH-rDLKPeNILl~~~g~iKL~--DFGlak~~ 266 (552)
++..|||.|+|+.+|.... ..+..++..++.+++.|+.|||+.. +|- --|....++||++-..+|+ |--++-.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq- 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ- 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-
Confidence 9999999999999997653 3677899999999999999999974 443 3577888999988776654 2221110
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC---CCccchhhh
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY---GMECDWWSL 343 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y---~~~~DiWSl 343 (552)
. ....-.|.||+||.+..++- -.++|+|||
T Consensus 343 -----------------------------------------e------~gr~y~pawmspealqrkped~n~raadmwsf 375 (448)
T KOG0195|consen 343 -----------------------------------------E------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSF 375 (448)
T ss_pred -----------------------------------------c------cccccCcccCCHHHHhcCchhcchhhhhHHHH
Confidence 0 01234689999999987654 357999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
.+++||+.|...||....+++.-.+|.-..-...+|. .+|.....|+.-|+. ||-+||.
T Consensus 376 aillwel~trevpfadlspmecgmkialeglrv~ipp--gis~hm~klm~icmnedpgkrpk 435 (448)
T KOG0195|consen 376 AILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP--GISRHMNKLMNICMNEDPGKRPK 435 (448)
T ss_pred HHHHHHhhccccccccCCchhhhhhhhhccccccCCC--CccHHHHHHHHHHhcCCCCcCCC
Confidence 9999999999999999999988888876445566664 899999999999998 9999998
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.7e-19 Score=193.35 Aligned_cols=139 Identities=26% Similarity=0.280 Sum_probs=112.0
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechh-----hhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-----MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
|...+.||+|+||.||+|..... .+++|+..... .......+++.+|..++..++|++|+..+.++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 45578999999999999986543 44444432211 111223456889999999999999988777777777789
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
+||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+|+..+
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 9999999999999885 456789999999999999999999999999999 67899999999998643
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=183.15 Aligned_cols=181 Identities=27% Similarity=0.394 Sum_probs=136.6
Q ss_pred ceEEEEEecCCCCchhhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.++||.|++|.-++|.++|.++. ..+......++.|++.|++| +|.+|||+||.||.+..+..+||.||||...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36999999999999999997543 35667788899999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
...... ..++... ....+||..||+||.|.+..|+.++||||||+
T Consensus 406 ~~~~~~------------------~~~~~a~-----------------~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGl 450 (516)
T KOG1033|consen 406 QDKDET------------------VAPAAAS-----------------HTQQVGTLLYMSPEQIRGQQYSEKVDIYALGL 450 (516)
T ss_pred cccCCc------------------ccchhhh-----------------hhhcccccccCCHHHHhhhhhhhhcchhhHHH
Confidence 543210 0000000 12458999999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcc-cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 346 ilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
|+||+++ -..+|.. ..+...|- ...+|+. ..=-++..+|+.+||. .|.+||. +.+.-.|+|.
T Consensus 451 il~EL~~~f~T~~er---~~t~~d~r----~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 451 ILAELLIQFSTQFER---IATLTDIR----DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred HHHHHHHHhccHHHH---HHhhhhhh----cCCCChHHhhcCcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 9999997 4444432 12222232 2234421 1123466799999998 9999996 7777777764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.5e-17 Score=159.67 Aligned_cols=138 Identities=20% Similarity=0.290 Sum_probs=105.8
Q ss_pred eeee-ecCCeEEEEEEEcCCCcEEEEEEeechhh----hh------hhHHHHHHHHHHHHHhcCCCce--EEEeeeecCC
Q 008810 122 TMIG-KGAFGEVRVCREKTTGHVYAMKKLKKSEM----LR------RGQVEHVRAERNLLAEVDSNCI--VKLYCSFQDD 188 (552)
Q Consensus 122 ~~IG-~G~fG~V~l~~~k~tg~~~AiK~l~k~~~----~~------~~~~~~~~~E~~iL~~l~hp~I--v~l~~~f~d~ 188 (552)
.+|| .||.|+||.+... +..+|||.+....+ .. ......+.+|..++..+.|++| +..+......
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 8888899988653 77899998865322 11 1223567889999999988774 6666554332
Q ss_pred -ce---EEEEEecCCC-CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 189 -EF---LYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 189 -~~---lylVmEy~~g-G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
.. .++||||++| .+|..++.. ..+++.. +.+++.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999998 688888754 4566653 568999999999999999999999999999999999999998
Q ss_pred ccc
Q 008810 264 KPL 266 (552)
Q Consensus 264 k~~ 266 (552)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.9e-17 Score=146.26 Aligned_cols=133 Identities=20% Similarity=0.273 Sum_probs=113.9
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--CceEEEeeeecCCceEEEEEec
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~~~lylVmEy 197 (552)
+++.||.|.++.||++.... ..+++|....... ...+..|..++..+.+ +++++++.++...+..|+||||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999998753 6899999865432 3568889999999976 5899999998888899999999
Q ss_pred CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCcccccCCCCccccCCCcEEEccccccccc
Q 008810 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 198 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++|+|||++...
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999888654 5566778899999999999985 7999999999999999999999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=167.48 Aligned_cols=197 Identities=23% Similarity=0.271 Sum_probs=151.6
Q ss_pred HHhcCCCceEEEeeeecCCceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCC-cccccCCCCc
Q 008810 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHY-IHRDIKPDNL 247 (552)
Q Consensus 170 L~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~gi-iHrDLKPeNI 247 (552)
|+.+.|.|+.++++.+.+...+++|.+||.-|+|.+.+.. .-.+++.-...++.+|+.||.|||...| .|+.|++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3567899999999999999999999999999999999976 4567777888889999999999998765 9999999999
Q ss_pred cccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChh
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APE 327 (552)
++|....+||+|||+........ . . .. .....-..-|.|||
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~-~-----------------~--~~-------------------~~~~~~~~lw~aPe 121 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETA-E-----------------P--EA-------------------HHPIRKALLWTAPE 121 (484)
T ss_pred eeeeeEEEEechhhhcccccccc-c-----------------c--cc-------------------cchhHHHHhccCHH
Confidence 99999999999999976542100 0 0 00 00011234689999
Q ss_pred hhhcCC-------CCCccchhhhhHHHHHHhhCCCCCCCC----ChhhHHHHHhhccccccCCcc---cccChhHHHHHH
Q 008810 328 VLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYSD----DPMSTCRKIVNWRTHLKFPEE---AKLSIEAKDLIS 393 (552)
Q Consensus 328 vl~~~~-------y~~~~DiWSlGvilyEmltG~~PF~~~----~~~~~~~~i~~~~~~~~~p~~---~~~s~e~~dLI~ 393 (552)
++.... -+.+.|+||+|+|+||+++..-||... ++.++..++.+.......|.- ..+.+++..++.
T Consensus 122 llr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~ 201 (484)
T KOG1023|consen 122 LLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVA 201 (484)
T ss_pred HhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHH
Confidence 998632 366799999999999999999999763 233455555541222233321 145668999999
Q ss_pred HHhh-CccccCCC
Q 008810 394 KLLC-NVNQRLGA 405 (552)
Q Consensus 394 ~lL~-dp~~Rl~~ 405 (552)
.|+. +|.+||+.
T Consensus 202 ~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 202 RCWEEIPEKRPSI 214 (484)
T ss_pred HhcccChhhCccH
Confidence 9998 99999993
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.2e-15 Score=166.49 Aligned_cols=143 Identities=20% Similarity=0.344 Sum_probs=99.3
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------------------------------hhhHHHHHH
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------------------------------RRGQVEHVR 164 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-------------------------------~~~~~~~~~ 164 (552)
.+|+. +.||.|++|.||.|+.+.+|+.||||++++.-.. -....+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999988999999999753100 001123345
Q ss_pred HHHHHHHhcCCCceEEEeeeecCC-------------ceEEEEEecCCCCchhhH--HhhcC----CCCHHHHHHHHHHH
Q 008810 165 AERNLLAEVDSNCIVKLYCSFQDD-------------EFLYLIMEYLPGGDMMTL--LMRKD----TLTEDEARFYVAET 225 (552)
Q Consensus 165 ~E~~iL~~l~hp~Iv~l~~~f~d~-------------~~lylVmEy~~gG~L~~~--L~~~~----~l~e~~~~~~~~qi 225 (552)
+|.+++.+. .|+.++...|.+. ...+|||||+.|+.+.++ +...+ .+.+..+..|+.|+
T Consensus 199 ~ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 199 DELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HhhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 555555443 2333333333222 234699999999999764 33333 25555555566665
Q ss_pred HHHHHHHHhCCCcccccCCCCccccCCC----cEEEcccccccccCC
Q 008810 226 VLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDC 268 (552)
Q Consensus 226 ~~aL~~LH~~giiHrDLKPeNILl~~~g----~iKL~DFGlak~~~~ 268 (552)
+ ..|++|+|+||.||+++.+| .++++|||++..++.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4 58999999999999999988 999999999987753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=4.8e-14 Score=151.73 Aligned_cols=140 Identities=18% Similarity=0.265 Sum_probs=95.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--hh-------------------------h----HHH------HHH
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RR-------------------------G----QVE------HVR 164 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~--~~-------------------------~----~~~------~~~ 164 (552)
+.||.|++|.||+|+.+ +|+.||||+.+..-.. .. . ... .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999865 7899999998643100 00 0 001 133
Q ss_pred HHHHHHHhc-----CCCce--EEEeeeecCCceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 008810 165 AERNLLAEV-----DSNCI--VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVL-AIESIHKH 235 (552)
Q Consensus 165 ~E~~iL~~l-----~hp~I--v~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~-aL~~LH~~ 235 (552)
+|...+.++ ++++| .+.|..+ ....+|||||++|++|.+++... ..++ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 344444443 23443 2333322 23458999999999998876432 1222 2334444544 47889999
Q ss_pred CCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 236 giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
|++|+|+||.||+++.+|.++|+|||++..++
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=1e-14 Score=155.89 Aligned_cols=264 Identities=19% Similarity=0.217 Sum_probs=192.6
Q ss_pred CCeeEEeeeee--cCCeEEEEEEE--cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCce
Q 008810 116 DDFELLTMIGK--GAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 116 ~~f~~~~~IG~--G~fG~V~l~~~--k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 190 (552)
..|.+...+|. |.+|.||.++. ..++..+|+|.=+... .....-.+-.+|..-...+ .|++.|+.+..+.+.+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence 44677888999 99999999998 8899999999843211 1111112233454445555 58999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCCcccccCCCCccccCC-CcEEEccccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVL----AIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCK 264 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~-l~e~~~~~~~~qi~~----aL~~LH~~giiHrDLKPeNILl~~~-g~iKL~DFGlak 264 (552)
+|+-+|+| |.+|..+...... +++..+..+..+... ||.++|..+++|-|+||+||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 6788888765544 888889999999988 9999999999999999999999999 789999999999
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
.+........- . .....-|..-|++||++ +.-++...|++|||
T Consensus 272 ~i~~~~~~~~~-----------------------------------~-~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ 314 (524)
T KOG0601|consen 272 KISDGNFSSVF-----------------------------------K-VSKRPEGDCIYAAKELL-NGLATFASDIFSLG 314 (524)
T ss_pred EccCCccccce-----------------------------------e-eeecCCCCceEeChhhh-ccccchHhhhcchh
Confidence 87654322100 0 00122577789999988 45689999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
.++.+-.+|..++..... ..+..+-++..+..+- ...+.++...+..|+. +|..|++ +..+++|++......-
T Consensus 315 ev~l~~~l~~~~~~~g~~-~~W~~~r~~~ip~e~~--~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~~~~ 388 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKN-SSWSQLRQGYIPLEFC--EGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSKLFV 388 (524)
T ss_pred hhhHhhHhhcccccCCCC-CCccccccccCchhhh--cCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccchhhh
Confidence 999999998777644310 0011111111111111 2456667778888888 9999998 8999999999865443
Q ss_pred h
Q 008810 424 R 424 (552)
Q Consensus 424 ~ 424 (552)
+
T Consensus 389 ~ 389 (524)
T KOG0601|consen 389 H 389 (524)
T ss_pred c
Confidence 3
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-13 Score=128.41 Aligned_cols=129 Identities=18% Similarity=0.194 Sum_probs=96.8
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc-eEEEeeeecCCceEEEEEecCC
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
++.|+.|.++.||+++.. |..|++|+...... .......|..++..+.+.. +.++++.+.+ ..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecC
Confidence 467899999999998854 77899999765421 1123567888888875443 4455555432 3479999999
Q ss_pred CCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----cccccCCCCccccCCCcEEEccccccccc
Q 008810 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY-----IHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 200 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~gi-----iHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+...
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 9887643 11123457899999999999885 9999999999999 678999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=9.3e-13 Score=126.11 Aligned_cols=141 Identities=13% Similarity=0.150 Sum_probs=103.0
Q ss_pred eeeeecCCeEEEEEEEcC------CCcEEEEEEeechhh--------h-----------hhhHHHH----HHHHHHHHHh
Q 008810 122 TMIGKGAFGEVRVCREKT------TGHVYAMKKLKKSEM--------L-----------RRGQVEH----VRAERNLLAE 172 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~------tg~~~AiK~l~k~~~--------~-----------~~~~~~~----~~~E~~iL~~ 172 (552)
..||.|-=+.||.|.... .+..+|||+.+.+.. . +.+.... .++|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997543 357999999863210 0 1111222 3388888888
Q ss_pred cCC--CceEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCcccccCCCCccc
Q 008810 173 VDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI-HKHHYIHRDIKPDNLLL 249 (552)
Q Consensus 173 l~h--p~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~L-H~~giiHrDLKPeNILl 249 (552)
+.. -.+...+.+ ..-+|||||+.|+.+..-..+...+++..+..+..+++.+|..| |+.||||+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 743 345555553 34579999997765544333444567777778889999999999 89999999999999999
Q ss_pred cCCCcEEEcccccccccC
Q 008810 250 DKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 250 ~~~g~iKL~DFGlak~~~ 267 (552)
+ +|.+.|+|||.|...+
T Consensus 159 ~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 H-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred E-CCcEEEEECCCceeCC
Confidence 7 4789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.5e-13 Score=147.06 Aligned_cols=250 Identities=23% Similarity=0.253 Sum_probs=185.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCce
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k-~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 190 (552)
....+|..+..||.|.|+.|+.+..+ .++..||+|.+.+.......++.. ..|.-+...+ -|.+++..+..|.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34678999999999999999998876 678899999987765443333333 3455555554 58899999999988888
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC-CcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~-g~iKL~DFGlak~~~~~ 269 (552)
.|+=.|||.|+++...+.-...+.+...+....|++.|+.++|+..++|+|+||+||++..+ +-.++.|||..+.+.-.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 99999999999988777666778999999999999999999999999999999999999986 77899999988753211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCC--ChhhhhcCCCCCccchhhhhHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI--APEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~--APEvl~~~~y~~~~DiWSlGvil 347 (552)
. ....++-.+. +|..+....+..+.|++|||.-+
T Consensus 421 ~--------------------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~ 456 (524)
T KOG0601|consen 421 S--------------------------------------------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSV 456 (524)
T ss_pred c--------------------------------------------ccccccccccccchhhccccccccccccccccccc
Confidence 0 0112223333 55555567899999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
+|.++|.+--..... ...|.. + ..|.....+.++..+...++. ++..|+. +.++..|+=|
T Consensus 457 ~e~~~~~~ls~~~~~---~~~i~~--~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~ 517 (524)
T KOG0601|consen 457 DEAITGSPLSESGVQ---SLTIRS--G--DTPNLPGLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEF 517 (524)
T ss_pred cccccCcccCccccc---ceeeec--c--cccCCCchHHhhhhhhhhhcCCccccchh---hhhhcccchh
Confidence 999998764332221 112222 1 122222344777888888887 8888877 6677666555
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.1e-12 Score=136.67 Aligned_cols=169 Identities=19% Similarity=0.277 Sum_probs=130.8
Q ss_pred EEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCC
Q 008810 134 VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTL 213 (552)
Q Consensus 134 l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l 213 (552)
.|..+.++.+|.|.+.+.+.- ...+.+++-..-|+.++||||++++.++..+..+|||+|-+. -|..++.. +
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---L 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---h
Confidence 456678899999999876542 445567778888999999999999999999999999999883 45556644 3
Q ss_pred CHHHHHHHHHHHHHHHHHHH-hCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCC
Q 008810 214 TEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292 (552)
Q Consensus 214 ~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (552)
+...+..-+.||+.||.||| +.+++|++|.-+-|+++..|+.||++|-++......+.
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------------------- 160 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------------------- 160 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---------------------
Confidence 47788888999999999998 67899999999999999999999999998864321110
Q ss_pred CCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 293 ~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
+ +....---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 161 --~------------------~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 --P------------------AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --c------------------cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 0 00111122366776654333 567999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.5e-12 Score=127.11 Aligned_cols=214 Identities=19% Similarity=0.235 Sum_probs=152.7
Q ss_pred HHHHHHhcCCCceEEEeeeecCCc-----eEEEEEecCCCCchhhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC-
Q 008810 166 ERNLLAEVDSNCIVKLYCSFQDDE-----FLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKH- 235 (552)
Q Consensus 166 E~~iL~~l~hp~Iv~l~~~f~d~~-----~lylVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~LH~~- 235 (552)
-.+-|-.+.|.|||+++.++.|.. ...++.|||..|+|..+|++. ..+.....+.++-||+.||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 334455667889999998887655 478999999999999999753 4688888999999999999999987
Q ss_pred -CCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 008810 236 -HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLA 314 (552)
Q Consensus 236 -giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~ 314 (552)
-|||+++..+-|.+..+|-||+.--.-.... .+ ....++ .++
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h-~s-----------------------~~~~~~-------~Ek------ 239 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-PS-----------------------VNSTRE-------AEK------ 239 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccc-hh-----------------------hhhhhH-------hhh------
Confidence 5999999999999999998887532111000 00 000000 000
Q ss_pred cccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC-CCCCChhhHHHHHhhccccccCCcccccChhHHHHHH
Q 008810 315 YSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP-FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLIS 393 (552)
Q Consensus 315 ~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P-F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~ 393 (552)
.--.|-++|.|||.=.....+.++|||++|+...||..|..- =.+....+....|.+-...+. ..--+++|.
T Consensus 240 ~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~ 312 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSIT 312 (458)
T ss_pred hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccCcCc
Confidence 012467889999987667778899999999999999998754 333333333333332111111 123478999
Q ss_pred HHhh-CccccCCCCChhhhhcCCCcCCCChhhhh
Q 008810 394 KLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 394 ~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~ 426 (552)
+||. .|..||+ +.+++.||..-++.-.++.
T Consensus 313 kcl~~eP~~rp~---ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 313 KCLEGEPNGRPD---ARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred ccccCCCCCCcc---hhhhhcCceeeecchHHHH
Confidence 9999 9999999 8999999999877665554
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.1e-11 Score=118.29 Aligned_cols=141 Identities=16% Similarity=0.242 Sum_probs=108.0
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--CceEEEeeeecCC---ceEEEEE
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDD---EFLYLIM 195 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~---~~lylVm 195 (552)
++.||.|.++.||++.... |+.|++|+....... .....+..|..++..+.+ ..+.+++.+.... +..|+||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3578999999999998643 678999998654321 123457889999999865 3456677666553 2668999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK----------------------------------------- 234 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~----------------------------------------- 234 (552)
||++|+++...+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999988876542 457777777788888888888873
Q ss_pred ---------------CCCcccccCCCCccccC--CCcEEEcccccccc
Q 008810 235 ---------------HHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKP 265 (552)
Q Consensus 235 ---------------~giiHrDLKPeNILl~~--~g~iKL~DFGlak~ 265 (552)
..+||+|+.|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 67789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.6e-11 Score=109.30 Aligned_cols=134 Identities=20% Similarity=0.220 Sum_probs=95.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechh-----hhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-----MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
..|++|+=+.|+.+... |..+.+|.=.+.. +-.+--.++.++|..+|..+.--.|..-+-++.|.....||||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35889999999998664 4355666432211 1111123457788888888754433333333445666679999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
|++|-.|.+.|... ...++.++-.-+.-||..||||+||.+.||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999998888665 245667777778889999999999999999998755 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=8.4e-09 Score=108.93 Aligned_cols=210 Identities=17% Similarity=0.229 Sum_probs=152.7
Q ss_pred CeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC----CceEEEEEecCCC-Cch
Q 008810 129 FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEFLYLIMEYLPG-GDM 203 (552)
Q Consensus 129 fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~~lylVmEy~~g-G~L 203 (552)
-.+.|+|....+|..|++|.++.......+. ...-.++++++.|+|||++..+|.+ +..++||++|.|+ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3578999999999999999995544333322 2334668899999999999999983 4579999999987 566
Q ss_pred hhHHhh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 204 MTLLMR---------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 204 ~~~L~~---------------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.++-.. ....+|...+.|+.|+..||.++|+.|+.-+-|-|.+||++.+-.|+|+..|+...+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 665421 23467899999999999999999999999999999999999988999999888765532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
... +-+.. -..-|.=.||.+++
T Consensus 446 d~~-------------------------------------------------------~~le~---~Qq~D~~~lG~ll~ 467 (655)
T KOG3741|consen 446 DPT-------------------------------------------------------EPLES---QQQNDLRDLGLLLL 467 (655)
T ss_pred CCC-------------------------------------------------------cchhH---HhhhhHHHHHHHHH
Confidence 210 00110 12357788999999
Q ss_pred HHhhCCCCC-CCCChhhH-HHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 349 EMLVGYPPF-YSDDPMST-CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 349 EmltG~~PF-~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
.|.+|..-= ..+..++. ...|. ...|.+++++|.-|.. ++++ .+ +.+++.|
T Consensus 468 aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~-ks---I~~llp~ 521 (655)
T KOG3741|consen 468 ALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFRE-KS---IQDLLPM 521 (655)
T ss_pred HHhhcccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCccc-cc---HHHHHHH
Confidence 999996542 22222222 22222 2578899999988887 6664 33 6777655
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.4e-09 Score=99.64 Aligned_cols=144 Identities=24% Similarity=0.280 Sum_probs=101.3
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEee-c----hhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-K----SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~-k----~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.+.+|-+|+=+.|+++.. .|+.+.||.=- | ..+-..-...+.++|..+|.++.--.|.--.-+|.|...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 577899999999998864 58888888532 1 1111122234578899999887543333222334556666799
Q ss_pred EecCCC-CchhhHHhhc-CCCCHHH-HHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cEEEcccccccc
Q 008810 195 MEYLPG-GDMMTLLMRK-DTLTEDE-ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKP 265 (552)
Q Consensus 195 mEy~~g-G~L~~~L~~~-~~l~e~~-~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~iKL~DFGlak~ 265 (552)
|||++| -.+.+++... ..-.++. ...++..|-..|.-||..+|||+||..+||||..+| .+.|+||||+..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4667776543 2222333 367888888999999999999999999999997666 358999999763
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.3e-10 Score=124.45 Aligned_cols=166 Identities=19% Similarity=0.353 Sum_probs=122.2
Q ss_pred HHHHHHHHHHhC-CCcccccCCCCccccCCCcEEEcccccccccCCCC-cccccccccCCCCCCCCCCCCCCCCccchHH
Q 008810 224 ETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST-LQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301 (552)
Q Consensus 224 qi~~aL~~LH~~-giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (552)
+++.||.|+|.. ++||++|-|++|.++.+|.+||+.|++|....... +.-..| .+..|
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~y--------------d~~lp------ 166 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEY--------------DPPLP------ 166 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccC--------------CCCCC------
Confidence 444899999975 89999999999999999999999999987554321 110000 01111
Q ss_pred HHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh-hCCCCCCCCChhhHHHHHhhcc--ccccC
Q 008810 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWR--THLKF 378 (552)
Q Consensus 302 ~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml-tG~~PF~~~~~~~~~~~i~~~~--~~~~~ 378 (552)
....-...|.|||++.+...+.++|++||||++|-+. .|++-|.+.+....+..-.+.. ....+
T Consensus 167 -------------~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~ 233 (700)
T KOG2137|consen 167 -------------LLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGY 233 (700)
T ss_pred -------------hhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccc
Confidence 1123467899999999988899999999999999999 6777776665444443333211 12222
Q ss_pred CcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhh
Q 008810 379 PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 379 p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~ 427 (552)
+ ..+++++++=+.++|. ++.-||+ +.+++.-|||.+.--..|..
T Consensus 234 s--~~~p~el~~~l~k~l~~~~~~rp~---~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 234 S--NNLPSELRESLKKLLNGDSAVRPT---LDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred c--ccCcHHHHHHHHHHhcCCcccCcc---hhhhhcccccCCchhhhhhh
Confidence 3 4789999999999998 9999996 89999999999876555544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=5e-09 Score=99.94 Aligned_cols=129 Identities=22% Similarity=0.246 Sum_probs=83.4
Q ss_pred EEEEEEEcCCCcEEEEEEeechhh-----------------------hhhhHHHHHHHHHHHHHhcCCC--ceEEEeeee
Q 008810 131 EVRVCREKTTGHVYAMKKLKKSEM-----------------------LRRGQVEHVRAERNLLAEVDSN--CIVKLYCSF 185 (552)
Q Consensus 131 ~V~l~~~k~tg~~~AiK~l~k~~~-----------------------~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f 185 (552)
.||.|.. ..|..+|||+.+.... .........++|...|..+..- ++.+++..-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888875 4677999999863210 0011124578899999999665 456666442
Q ss_pred cCCceEEEEEecCC--CCchhhHHhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 186 QDDEFLYLIMEYLP--GGDMMTLLMRKDTLTEDEARFYVAETVLAIES-IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 186 ~d~~~lylVmEy~~--gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~-LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
.-+|||||++ |..+..+... .++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2369999998 6555544322 22245667778888886655 579999999999999999986 999999999
Q ss_pred ccccC
Q 008810 263 CKPLD 267 (552)
Q Consensus 263 ak~~~ 267 (552)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.1e-09 Score=104.08 Aligned_cols=132 Identities=14% Similarity=0.096 Sum_probs=91.4
Q ss_pred EEEEEEcCCCcEEEEEEeechhh---hhh-----hHHHHHHHHHHHHHhcC-----CCceEEEeeeecC--CceEEEEEe
Q 008810 132 VRVCREKTTGHVYAMKKLKKSEM---LRR-----GQVEHVRAERNLLAEVD-----SNCIVKLYCSFQD--DEFLYLIME 196 (552)
Q Consensus 132 V~l~~~k~tg~~~AiK~l~k~~~---~~~-----~~~~~~~~E~~iL~~l~-----hp~Iv~l~~~f~d--~~~lylVmE 196 (552)
|..+. -.|+.|.||....... .+. .-...+.+|...+..+. .|-+|-+...-.+ ...-|||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44443 3567899997643321 111 11124677887776663 3333333211111 235689999
Q ss_pred cCCCC-chhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-------CCcEEEcccccccc
Q 008810 197 YLPGG-DMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------YGHLRLSDFGLCKP 265 (552)
Q Consensus 197 y~~gG-~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-------~g~iKL~DFGlak~ 265 (552)
+++|- +|.+++.. ....++.....++.+++..+.-||..||+|+|++|.|||++. ++.+.|+||+.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99886 78888753 345667788899999999999999999999999999999985 46899999998863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=4e-10 Score=121.30 Aligned_cols=241 Identities=20% Similarity=0.237 Sum_probs=161.5
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc-eEEEeeeecCCceEEEEEe
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~~lylVmE 196 (552)
+....-+++|+++++++.+...+.... .+.+... ...+-++++|.+++||| .|..++.++.+.++.++|+
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 555667899999999988766554444 5555432 33566899999999999 7888888888899999999
Q ss_pred cCCCC-c-hhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 197 YLPGG-D-MMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 197 y~~gG-~-L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|+.+| + ........-.|.+-+.......-+.+|+++|+.--+||| |||..+ +..|+.|||....+....
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---- 385 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---- 385 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc----
Confidence 99888 2 111111122344444555667777899999998889999 888776 778999999876553221
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
...+..+|+.++|||+.....+....|.||+|+-..+|.-|-
T Consensus 386 --------------------------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~ 427 (829)
T KOG0576|consen 386 --------------------------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGL 427 (829)
T ss_pred --------------------------------------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCC
Confidence 123578999999999999999999999999999888888888
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccCh-hHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSI-EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~-e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|-.+ +......+-+......+-.....++ .-.++...|+. .|.-|+. ....+.|.+|++
T Consensus 428 pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfng 489 (829)
T KOG0576|consen 428 PPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNG 489 (829)
T ss_pred CCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhcc
Confidence 88654 2111111111111111111001111 11235556666 6666665 555677777765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.1e-07 Score=98.37 Aligned_cols=233 Identities=16% Similarity=0.182 Sum_probs=151.8
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEE--------EeeeecCCce
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVK--------LYCSFQDDEF 190 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~--------l~~~f~d~~~ 190 (552)
..+.||+|+-+.+|-.-... -.+-|+..+...... ..-+..|... +||-+-. ||+. .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 45679999999999653322 234588776542111 1122334433 5664322 2221 11223
Q ss_pred EEEEEecCCCCchhhHHh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 191 LYLIMEYLPGGDMMTLLM-------RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~-------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
.-+.|..++|-.=-..+. ....+.+..+...+.+++.|...||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 678899888753222221 1245778899999999999999999999999999999999999999999874321
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCcc
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMEC 338 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~ 338 (552)
.....+ .....-||.++|.+||.-. +.+-+...
T Consensus 165 qi~~ng------------------------------------------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~h 202 (637)
T COG4248 165 QINANG------------------------------------------TLHLCPVGVSEFTPPELQTLPSFVGFERTANH 202 (637)
T ss_pred eeccCC------------------------------------------ceEecccCccccCCHHHhccccccccCCCccc
Confidence 111111 0122468999999999865 34557789
Q ss_pred chhhhhHHHHHHhhC-CCCCCCC-------ChhhHHHHHhhcc---------ccccC---CcccccChhHHHHHHHHhh-
Q 008810 339 DWWSLGAIMYEMLVG-YPPFYSD-------DPMSTCRKIVNWR---------THLKF---PEEAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 339 DiWSlGvilyEmltG-~~PF~~~-------~~~~~~~~i~~~~---------~~~~~---p~~~~~s~e~~dLI~~lL~- 397 (552)
|-|.|||++|++|.| +.||.|- ++.++ .|.+.. ...+- +...-+++++..|..++..
T Consensus 203 D~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~ 280 (637)
T COG4248 203 DNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTE 280 (637)
T ss_pred cchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcc
Confidence 999999999999986 9999763 22222 233211 11111 1124578999999999997
Q ss_pred --CccccCCCC
Q 008810 398 --NVNQRLGAK 406 (552)
Q Consensus 398 --dp~~Rl~~~ 406 (552)
++.-||++.
T Consensus 281 ~~~~~~RP~a~ 291 (637)
T COG4248 281 SGVATPRPTAK 291 (637)
T ss_pred cCCCCCCCCHH
Confidence 356888853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.9e-08 Score=94.15 Aligned_cols=127 Identities=23% Similarity=0.249 Sum_probs=89.7
Q ss_pred CCcEEEEEEeechh----hhhhhHHHHHHHHHHHHHhcC-----CCceEEEeeeecC-CceEEEEEecCCCC-chhhHHh
Q 008810 140 TGHVYAMKKLKKSE----MLRRGQVEHVRAERNLLAEVD-----SNCIVKLYCSFQD-DEFLYLIMEYLPGG-DMMTLLM 208 (552)
Q Consensus 140 tg~~~AiK~l~k~~----~~~~~~~~~~~~E~~iL~~l~-----hp~Iv~l~~~f~d-~~~lylVmEy~~gG-~L~~~L~ 208 (552)
.++.|-+|.+...- ....-......+|...+..+. -|-+|-+...-.. ...-|||||+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45566666543321 111122334667777666553 2333332221111 13458999999985 7999987
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cEEEccccccccc
Q 008810 209 RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPL 266 (552)
Q Consensus 209 ~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~iKL~DFGlak~~ 266 (552)
....++......++.+++..+.-||..||+|+|++|.|||++.++ .+.|+||+-++..
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 755578888899999999999999999999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.64 E-value=3e-07 Score=89.04 Aligned_cols=141 Identities=20% Similarity=0.326 Sum_probs=92.4
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHH------HHHHHHHHHhc---CCCceEEEee
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH------VRAERNLLAEV---DSNCIVKLYC 183 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~------~~~E~~iL~~l---~hp~Iv~l~~ 183 (552)
+...+|.+++++-......|.+.. -.|+.|.+|..+............ ..++...+..+ .-..++.+|.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 456789999999888888887765 457899999986543211111111 12222222222 2223333222
Q ss_pred e-----ecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEc
Q 008810 184 S-----FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (552)
Q Consensus 184 ~-----f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~ 258 (552)
+ +.-....+|||||++|..|.++.. +++. +...++.+|.-||+.|++|+|..|.|++++.++ ++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 2 222334568999999988876642 3332 445677889999999999999999999999655 9999
Q ss_pred cccccc
Q 008810 259 DFGLCK 264 (552)
Q Consensus 259 DFGlak 264 (552)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.3e-07 Score=90.63 Aligned_cols=138 Identities=19% Similarity=0.227 Sum_probs=100.2
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh------hh-------------hHHHHHHHHHHHHHhcCCC--c
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML------RR-------------GQVEHVRAERNLLAEVDSN--C 177 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~------~~-------------~~~~~~~~E~~iL~~l~hp--~ 177 (552)
.+...||-|-=+.||.|... .|..+|||.-+-.... .+ -.....++|..+|..+... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45679999999999999764 7889999975421100 00 0123467788888888544 4
Q ss_pred eEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEE
Q 008810 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (552)
Q Consensus 178 Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL 257 (552)
|.+.++ -+.-.+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+=|||++.+|.+.+
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 554443 34567999999997765442 245556666666776666666899999999999999999999999
Q ss_pred ccccccccc
Q 008810 258 SDFGLCKPL 266 (552)
Q Consensus 258 ~DFGlak~~ 266 (552)
+||--|...
T Consensus 244 IDwPQ~v~~ 252 (304)
T COG0478 244 IDWPQAVPI 252 (304)
T ss_pred EeCcccccC
Confidence 999887754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.7e-06 Score=94.48 Aligned_cols=142 Identities=20% Similarity=0.306 Sum_probs=91.0
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--------------------hh-----------hhHHHHH------H
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--------------------LR-----------RGQVEHV------R 164 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~--------------------~~-----------~~~~~~~------~ 164 (552)
+.|+.++-|.||.|+.+. |+.||||+.+..-. .. ..-.+.+ +
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 578999999999999765 99999999863110 00 0001122 2
Q ss_pred HHHHHHHhc-----CCCce--EEEeeeecCCceEEEEEecCCCCchhhHH-hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008810 165 AERNLLAEV-----DSNCI--VKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKHH 236 (552)
Q Consensus 165 ~E~~iL~~l-----~hp~I--v~l~~~f~d~~~lylVmEy~~gG~L~~~L-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g 236 (552)
+|..-+.++ +.|+| .++|.-+. ..-.|+|||+.|-.+.+.. .+...++...+.....++. +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t--~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT--TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc--CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 333333333 23433 34443332 3346999999999888884 2334555333222222221 33344589
Q ss_pred CcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 237 iiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
++|.|..|.||+++.+|++.+.|||+...++.
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.1e-06 Score=92.33 Aligned_cols=141 Identities=21% Similarity=0.279 Sum_probs=90.8
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh----h------------------------hhHHHHHHHHHH-----
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML----R------------------------RGQVEHVRAERN----- 168 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~----~------------------------~~~~~~~~~E~~----- 168 (552)
+.||.-+.|.|++|+.+. |+.||||+-+..--. + ....+.+-.|.+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 468999999999999876 999999997532100 0 000111222222
Q ss_pred -----HHHhcCCCc------eEEEeeeecCCceEEEEEecCCCCchhhHH-hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008810 169 -----LLAEVDSNC------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKHH 236 (552)
Q Consensus 169 -----iL~~l~hp~------Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g 236 (552)
+.+.+.|-. |.++|..+.+ .-.|+||||+|..+.++. .....++...+...+.++. ++-|-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 223333444 5566655433 346999999998887764 2334555554443333322 23344578
Q ss_pred CcccccCCCCccccC----CCcEEEcccccccccC
Q 008810 237 YIHRDIKPDNLLLDK----YGHLRLSDFGLCKPLD 267 (552)
Q Consensus 237 iiHrDLKPeNILl~~----~g~iKL~DFGlak~~~ 267 (552)
++|.|=.|.|||++. ++.+.|-|||+...+.
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999994 6689999999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.3e-06 Score=95.49 Aligned_cols=201 Identities=19% Similarity=0.220 Sum_probs=145.8
Q ss_pred HHHHHHHHHHHhcCCCceEEEeeeecCCc----eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 008810 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236 (552)
Q Consensus 161 ~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~g 236 (552)
....-|...+.+..|+|++.++.+-.... .+.+..|+|++-+++..+...+.++.+.++.|..+++.||.|+|+..
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 33455667778889999999876544332 23455689999999999999999999999999999999999999997
Q ss_pred CcccccCCC---CccccCCCcEEEc--ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 008810 237 YIHRDIKPD---NLLLDKYGHLRLS--DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311 (552)
Q Consensus 237 iiHrDLKPe---NILl~~~g~iKL~--DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~ 311 (552)
..|.=|--. +...+..+++.++ ||+..+.+......
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--------------------------------------- 347 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--------------------------------------- 347 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccc---------------------------------------
Confidence 766666555 5556677777777 99988765432111
Q ss_pred ccccccccCCCCCChhhhhcCCCCCc--cchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccCh-hH
Q 008810 312 MLAYSTVGTPDYIAPEVLLKKGYGME--CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSI-EA 388 (552)
Q Consensus 312 ~~~~s~~GT~~Y~APEvl~~~~y~~~--~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~-e~ 388 (552)
.+..-+..+.|||.+....+..+ .|+|.+|.+...+..|..+-... .....++ + ..+. +.
T Consensus 348 ---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l--------~---~~~~~~~ 410 (1351)
T KOG1035|consen 348 ---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLL--------D---VLSTSEL 410 (1351)
T ss_pred ---hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhh--------c---cccchhh
Confidence 12344566888888887666555 69999999999999876542111 0111111 1 1121 67
Q ss_pred HHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 389 ~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
.++..+|+. ++++|++ +.+++.|||.+--
T Consensus 411 ~d~~~~~~~~~~~~Rl~---~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 411 LDALPKCLDEDSEERLS---ALELLTHPFLRFP 440 (1351)
T ss_pred hhhhhhhcchhhhhccc---hhhhhhchhcccc
Confidence 888889987 8999999 9999999998753
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.6e-06 Score=81.32 Aligned_cols=139 Identities=11% Similarity=0.147 Sum_probs=99.1
Q ss_pred eecCCeEEEEEEEcCCCcEEEEEEeech---hhhhhhHHHHHHHHHHHHHhcCCCc--eEEEeeeec--C--CceEEEEE
Q 008810 125 GKGAFGEVRVCREKTTGHVYAMKKLKKS---EMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSFQ--D--DEFLYLIM 195 (552)
Q Consensus 125 G~G~fG~V~l~~~k~tg~~~AiK~l~k~---~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~--d--~~~lylVm 195 (552)
|+||-+-|+..... |+.|=+|.-... .+.-......+.+|...|..+..-. +.+....-. . .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 77999999976543 446778876421 1111334456889999888774321 333332211 1 12467999
Q ss_pred ecCCC-CchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc--EEEcccccccc
Q 008810 196 EYLPG-GDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKP 265 (552)
Q Consensus 196 Ey~~g-G~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~--iKL~DFGlak~ 265 (552)
|-++| -+|.+++... ...++.....++.+++.+|.-||..|+.|+|+-+.|||++.+|. |+++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 5787777552 34577778899999999999999999999999999999997777 99999987764
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.4e-06 Score=84.12 Aligned_cols=133 Identities=20% Similarity=0.170 Sum_probs=83.1
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc--eEEEeeeecCCceEEEEEecCC
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
..||.|..+.||++ .|..+++|...... ....+.+|.+++..+..-. +.+.+.+..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999974 25567888876422 2234688999998875322 4666777777777889999999
Q ss_pred CCc-hhhHH---------------------hhc--C--CCCHHHHHHHHH----------HHHH-HHHHHHh----CCCc
Q 008810 200 GGD-MMTLL---------------------MRK--D--TLTEDEARFYVA----------ETVL-AIESIHK----HHYI 238 (552)
Q Consensus 200 gG~-L~~~L---------------------~~~--~--~l~e~~~~~~~~----------qi~~-aL~~LH~----~gii 238 (552)
|.+ +...+ ..- . .++... ..+.. .+.. ...+|.. ..++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 864 11111 000 0 111100 00100 0111 1222221 2478
Q ss_pred ccccCCCCccccCCCcEEEcccccccc
Q 008810 239 HRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 239 HrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
|+|+.|.||+++.+| +.|+||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999988 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.5e-06 Score=79.14 Aligned_cols=138 Identities=21% Similarity=0.329 Sum_probs=82.1
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC--ceEEEeeeec---CCceEEEEE
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSFQ---DDEFLYLIM 195 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f~---d~~~lylVm 195 (552)
++.|+.|..+.||++.... ..|++|+.... .....+..|..++..+... -+.+++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998654 48999997644 2344567788888776322 2455555332 233579999
Q ss_pred ecCCCCchhh----------------HHh---hc----CCCCHHH---H---HHH---------------HHHHHH-HHH
Q 008810 196 EYLPGGDMMT----------------LLM---RK----DTLTEDE---A---RFY---------------VAETVL-AIE 230 (552)
Q Consensus 196 Ey~~gG~L~~----------------~L~---~~----~~l~e~~---~---~~~---------------~~qi~~-aL~ 230 (552)
++++|..+.. .|. .. ..+.... . ... +..+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988877 111 11 0111000 0 000 111222 333
Q ss_pred HHHh-------CCCcccccCCCCcccc-CCCcEEEcccccccc
Q 008810 231 SIHK-------HHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKP 265 (552)
Q Consensus 231 ~LH~-------~giiHrDLKPeNILl~-~~g~iKL~DFGlak~ 265 (552)
.++. ..++|+|+.|.|||++ .+|.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 4699999999999999 677778999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.5e-06 Score=80.37 Aligned_cols=141 Identities=18% Similarity=0.182 Sum_probs=94.8
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhh-------------------HH--HHHHHHHHHHHhcC--CCc
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-------------------QV--EHVRAERNLLAEVD--SNC 177 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~-------------------~~--~~~~~E~~iL~~l~--hp~ 177 (552)
...|..|--+.||+|.. .++..+|+|+++......+. ++ .-.+.|..-|.++. +=.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999864 56789999999754321111 11 12445555555542 222
Q ss_pred eEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEE
Q 008810 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 178 Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iK 256 (552)
+.+-+.++ .-.|||||++..-+..=..+.-.+..+++..+..+++..+.-|-. .|+||+||..=|||+. +|.+.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 33344433 235999999543121111222334455788889999999999877 8999999999999999 89999
Q ss_pred EcccccccccC
Q 008810 257 LSDFGLCKPLD 267 (552)
Q Consensus 257 L~DFGlak~~~ 267 (552)
|+|||-|...+
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999988664
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.17 E-value=3.9e-05 Score=73.67 Aligned_cols=130 Identities=21% Similarity=0.327 Sum_probs=90.0
Q ss_pred CCCCeeEEeeeeecCC-eEEEEEEEcCCCcEEEEEEeechhh---------hhh---------hHHHHHHHHHHHHHh--
Q 008810 114 GADDFELLTMIGKGAF-GEVRVCREKTTGHVYAMKKLKKSEM---------LRR---------GQVEHVRAERNLLAE-- 172 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~f-G~V~l~~~k~tg~~~AiK~l~k~~~---------~~~---------~~~~~~~~E~~iL~~-- 172 (552)
...+++.++.||.|+- |.||+++. .|+.||+|+++.-.. ... ....-+..|-....+
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3479999999999999 99999975 477999999432100 000 122335666665544
Q ss_pred -cCCCce--EEEeeeecCC------------------ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHH
Q 008810 173 -VDSNCI--VKLYCSFQDD------------------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231 (552)
Q Consensus 173 -l~hp~I--v~l~~~f~d~------------------~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~ 231 (552)
+.+..+ |+.|+++.-. ....||.||++... .++. .-+.+|..-|..
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHH
Confidence 455555 8888877311 12468888887654 2222 335677788889
Q ss_pred HHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 232 LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
+|+.||+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999987 2389999854
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.5e-07 Score=106.59 Aligned_cols=256 Identities=14% Similarity=0.065 Sum_probs=164.0
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--Cc
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DE 189 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~--~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~ 189 (552)
...++++.=-||-|.+++--.-+.+.. -+-+|+.+.-.. ..+...+....|++.+++..|++++..+.-..+ ..
T Consensus 1227 ~~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred HhhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 345666665666666654322222222 234555443221 223344567778888888899998887755543 34
Q ss_pred eEEEEEecCCCCchhhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCCCccccCCCcEEEccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHH-----YIHRDIKPDNLLLDKYGHLRLSDF 260 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKPeNILl~~~g~iKL~DF 260 (552)
..|.+|+||.+|++++.|.+. ..+.+.-+-....+.+++..-+|... .+|++||+-|.+|..+..+|+.++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 578999999999999999763 33444444444445588888888642 789999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccch
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 340 (552)
|+.|..... .......++++.|++|++...-.++.+.|+
T Consensus 1385 gLdKIknp~-----------------------------------------~sf~Gl~l~sp~~v~qli~N~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1385 GLDKIKNPV-----------------------------------------LSFFGLELCSPIYVLQLIKNEIKFTKRSDI 1423 (2724)
T ss_pred ccccccCch-----------------------------------------HhhhhhhhCCHHHHHHHHHHHHhhhhHHHH
Confidence 999832211 011235688999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
|+.|+-+|+...|.+||..-.... ...++........+. --|.++-.++..+|- .-..||+ ...++.-+.|.
T Consensus 1424 lr~s~~ly~rs~~n~~fi~flq~~-Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~---q~isls~d~~a 1496 (2724)
T KOG1826|consen 1424 LRRSLSLYLRSDGNAYFIFFLQPA-LKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPG---QYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHHHHhcccHHHHHHHHHH-HcCcccccccccccc--cCCCcccHHHHHHHHHHhhhcch---hhhhccccccc
Confidence 999999999999999984322111 111221111222221 112333333333333 4556777 55666666663
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.4e-05 Score=79.19 Aligned_cols=135 Identities=16% Similarity=0.086 Sum_probs=82.2
Q ss_pred eeeecCC-eEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEEEecCCC
Q 008810 123 MIGKGAF-GEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 123 ~IG~G~f-G~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
.|-.|.. ..||++... +..+.+|+..... ...+.+|..++..+. +--+.+++++..+.+.-++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 789988643 4578888875432 234667888887773 33456777777766678899999999
Q ss_pred CchhhHHh-------------------hcC----CCCHH------HHHHHHH----------------HHHHHHHHH---
Q 008810 201 GDMMTLLM-------------------RKD----TLTED------EARFYVA----------------ETVLAIESI--- 232 (552)
Q Consensus 201 G~L~~~L~-------------------~~~----~l~e~------~~~~~~~----------------qi~~aL~~L--- 232 (552)
..|..... .-. .+... .....+. .+...+..|
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 77664320 000 11100 0000000 011111222
Q ss_pred ----HhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 233 ----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 233 ----H~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.3e-05 Score=91.39 Aligned_cols=146 Identities=21% Similarity=0.360 Sum_probs=91.2
Q ss_pred EEeeeeecCCeEEEEEEEcCCC--cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCce--EEEeeeecCC---ceE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTG--HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCI--VKLYCSFQDD---EFL 191 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg--~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~I--v~l~~~f~d~---~~l 191 (552)
.++.|+.|.++.+|+......+ ..|++|+........ ....+.+|..+|+.+. |++| .++++.+.+. ...
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3678899999999998765432 467777754332211 1235778999999885 6654 7778877765 467
Q ss_pred EEEEecCCCCchhh--------------------HHh---hcC----CC---------CHHHHHHHHH------------
Q 008810 192 YLIMEYLPGGDMMT--------------------LLM---RKD----TL---------TEDEARFYVA------------ 223 (552)
Q Consensus 192 ylVmEy~~gG~L~~--------------------~L~---~~~----~l---------~e~~~~~~~~------------ 223 (552)
|+||||++|..+.+ .|. .-. .+ ...++..+..
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998864321 110 100 01 0112221111
Q ss_pred ---HHHHHHHHHHh-----------CCCcccccCCCCccccC-CCc-EEEcccccccccC
Q 008810 224 ---ETVLAIESIHK-----------HHYIHRDIKPDNLLLDK-YGH-LRLSDFGLCKPLD 267 (552)
Q Consensus 224 ---qi~~aL~~LH~-----------~giiHrDLKPeNILl~~-~g~-iKL~DFGlak~~~ 267 (552)
.+...+.+|.. ..+||+|++|.|||++. ++. +-|.||++|..-+
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 12233556632 25999999999999985 334 5799999987644
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.84 E-value=9.9e-05 Score=72.59 Aligned_cols=137 Identities=14% Similarity=0.196 Sum_probs=81.8
Q ss_pred EeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEEEecC
Q 008810 121 LTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYL 198 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~-tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmEy~ 198 (552)
++.|..|-...||++.... .++.|++|+...... . .-...+|..++..+. +...+++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888889999986443 356889998754311 1 112346888888773 3445566665542 3799999
Q ss_pred CCCchhhH--------------Hh---hcC-CC----------C-HHHHHHHHHH----------------------HH-
Q 008810 199 PGGDMMTL--------------LM---RKD-TL----------T-EDEARFYVAE----------------------TV- 226 (552)
Q Consensus 199 ~gG~L~~~--------------L~---~~~-~l----------~-e~~~~~~~~q----------------------i~- 226 (552)
+|-.+... |. ... .. . ...+..|... +.
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665321 10 000 11 1 1122222111 11
Q ss_pred --HHHHH-HH----hCCCcccccCCCCccccC-CCcEEEcccccccc
Q 008810 227 --LAIES-IH----KHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKP 265 (552)
Q Consensus 227 --~aL~~-LH----~~giiHrDLKPeNILl~~-~g~iKL~DFGlak~ 265 (552)
..|.. +- ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 11111 11 236999999999999998 57899999998863
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.83 E-value=6.5e-05 Score=74.20 Aligned_cols=74 Identities=11% Similarity=0.160 Sum_probs=45.5
Q ss_pred EeeeeecCCe-EEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC---ceEEEeeeecCC---ceEEE
Q 008810 121 LTMIGKGAFG-EVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN---CIVKLYCSFQDD---EFLYL 193 (552)
Q Consensus 121 ~~~IG~G~fG-~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~f~d~---~~lyl 193 (552)
+..|+.|+.. .||++ +..+++|+..... ....+.+|..+|..+... -+.+.++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567877776 59976 2357778754321 234688899888777421 234444443332 24589
Q ss_pred EEecCCCCchh
Q 008810 194 IMEYLPGGDMM 204 (552)
Q Consensus 194 VmEy~~gG~L~ 204 (552)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999997664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.0001 Score=68.86 Aligned_cols=128 Identities=16% Similarity=0.211 Sum_probs=89.5
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceE-EEeeeecCCceEEEEEec
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV-KLYCSFQDDEFLYLIMEY 197 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv-~l~~~f~d~~~lylVmEy 197 (552)
+..+.||+|.+|.||+|.++ |..+|+|+-+... ....+..|..+|..+..-++- ++|.+-. -.++|||
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~ 93 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY 93 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence 34568999999999999865 6699999865432 334578899999888766554 3443321 2356999
Q ss_pred CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccC-CCCccccCCCcEEEccccccc
Q 008810 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK-PDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 198 ~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLK-PeNILl~~~g~iKL~DFGlak 264 (552)
+.|-.|...-... + +.-+..++.+-.-|-..||-|..|. |..++|..++.+.|+||.-|+
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9998887665321 1 2233445555445667899999986 666666666799999999887
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00038 Score=67.12 Aligned_cols=133 Identities=20% Similarity=0.282 Sum_probs=90.5
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------------hhhHHHHHHHHHHHHHhcC------CCceEEEe
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------------RRGQVEHVRAERNLLAEVD------SNCIVKLY 182 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-------------~~~~~~~~~~E~~iL~~l~------hp~Iv~l~ 182 (552)
..||+|+.=.||.- ....-..||++...... ........++|..-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46999999999943 23345678998766500 0112334555665554444 78899999
Q ss_pred eeecCCceEEEEEecCCC------CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC--C-
Q 008810 183 CSFQDDEFLYLIMEYLPG------GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY--G- 253 (552)
Q Consensus 183 ~~f~d~~~lylVmEy~~g------G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~--g- 253 (552)
+..+++.-+-+|+|.+-. -+|.+++ ..+.+++ ..+.. +-.-..||-.++|+.+||+|.||++... |
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998743 2566666 4455666 33333 3344567788999999999999999633 2
Q ss_pred -cEEEcc-ccc
Q 008810 254 -HLRLSD-FGL 262 (552)
Q Consensus 254 -~iKL~D-FGl 262 (552)
.+.|+| ||-
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 577777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00078 Score=71.73 Aligned_cols=81 Identities=20% Similarity=0.214 Sum_probs=55.0
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--h--hhHHHHHHHHHHHHHhc---CCCceEEEeeeecCCceEE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--R--RGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~--~--~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d~~~ly 192 (552)
-.+.||.|.++.||++.....++.+.||.-...... . .-..++...|.+.|..+ ....++++|++ +.+..+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 356899999999999987644458999974311100 0 12345677788888775 23467777776 445578
Q ss_pred EEEecCCCCc
Q 008810 193 LIMEYLPGGD 202 (552)
Q Consensus 193 lVmEy~~gG~ 202 (552)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998743
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00011 Score=70.15 Aligned_cols=99 Identities=19% Similarity=0.250 Sum_probs=79.3
Q ss_pred HHHHHHHHhcCC-CceEEEeeeecCCceEEEEEecCCCCchhhH---HhhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 008810 164 RAERNLLAEVDS-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL---LMRKDTLTEDEARFYVAETVLAIESIHK---HH 236 (552)
Q Consensus 164 ~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~---L~~~~~l~e~~~~~~~~qi~~aL~~LH~---~g 236 (552)
..|.-+|..+.+ +++++++|+|-+ ++|.||++.+++... +..-..-++..+..++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347778888865 689999999843 579999988766532 2222356899999999999999999997 34
Q ss_pred CcccccCCCCccccCCCcEEEccccccccc
Q 008810 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 237 iiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
+.-.|++|+|+-++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 677999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00021 Score=71.54 Aligned_cols=133 Identities=16% Similarity=0.165 Sum_probs=77.4
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC-ceEEEeeeecCCceEEEEEecCCCCc
Q 008810 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGD 202 (552)
Q Consensus 124 IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~d~~~lylVmEy~~gG~ 202 (552)
+..|-.+.+|++. .+|+.|++|+....... -.+ ...+|..+|+.+..- ...++++.+. -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4568888999886 45678889876543210 001 246688888877432 2344454432 268999999866
Q ss_pred hhhH--------------Hh---hc----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCCcccccC
Q 008810 203 MMTL--------------LM---RK----DTLTE-DEARFYVAET---------VLAIESIHK--------HHYIHRDIK 243 (552)
Q Consensus 203 L~~~--------------L~---~~----~~l~e-~~~~~~~~qi---------~~aL~~LH~--------~giiHrDLK 243 (552)
+... |. .. ..++. ..+..|..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5321 11 11 11111 1222332222 111222211 258999999
Q ss_pred CCCccccCCCcEEEccccccccc
Q 008810 244 PDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 244 PeNILl~~~g~iKL~DFGlak~~ 266 (552)
|.|||++.+| +.|+||+.|..-
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcC
Confidence 9999999877 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00072 Score=69.41 Aligned_cols=77 Identities=10% Similarity=0.027 Sum_probs=53.3
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC---CceEEEeeeecC---CceEEE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS---NCIVKLYCSFQD---DEFLYL 193 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~f~d---~~~lyl 193 (552)
-.+.||.|..+.||..... +..+.+|..+. . .....+..|...|+.+.. -.+.++++.+.+ .+.-||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS--QGNPMPLMARS-F----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC--CCCEEEEEecc-c----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3567999999999987532 23466777432 1 112457889998887742 357778877654 356899
Q ss_pred EEecCCCCch
Q 008810 194 IMEYLPGGDM 203 (552)
Q Consensus 194 VmEy~~gG~L 203 (552)
|||+++|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998755
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00033 Score=71.79 Aligned_cols=137 Identities=18% Similarity=0.173 Sum_probs=82.6
Q ss_pred EeeeeecCCeEEEEEEEcC------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CceEEEeeeecCCceEEE
Q 008810 121 LTMIGKGAFGEVRVCREKT------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lyl 193 (552)
++.|..|--..||++.... +++.|++|+..... .......+|..++..+.. ....++++++.+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566777778999887543 36789999976532 112235678878877743 234566666653 26
Q ss_pred EEecCCCCchhhHH-----------------hhcC-CC--------C--HHHHHH-------------------------
Q 008810 194 IMEYLPGGDMMTLL-----------------MRKD-TL--------T--EDEARF------------------------- 220 (552)
Q Consensus 194 VmEy~~gG~L~~~L-----------------~~~~-~l--------~--e~~~~~------------------------- 220 (552)
||||++|..+.... .+.. .. + +.....
T Consensus 75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (302)
T cd05156 75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS 154 (302)
T ss_pred hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence 89999987664311 0000 00 0 001100
Q ss_pred -HHHHHHHHHHHHHh---------CCCcccccCCCCccccCC----CcEEEcccccccc
Q 008810 221 -YVAETVLAIESIHK---------HHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKP 265 (552)
Q Consensus 221 -~~~qi~~aL~~LH~---------~giiHrDLKPeNILl~~~----g~iKL~DFGlak~ 265 (552)
...++...+..|-. .+++|+|+.|.|||++.+ +.+.|+||..|..
T Consensus 155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 11122223334432 358999999999999985 8899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=97.54 E-value=8.3e-05 Score=57.71 Aligned_cols=59 Identities=27% Similarity=0.631 Sum_probs=39.7
Q ss_pred CCCChhhhh--hcCCCCccccCCcccCcCccc-cccccccccCCCCCCcccccccc-cCCcccCceec
Q 008810 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEK-FEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTYK 481 (552)
Q Consensus 418 ~~i~w~~l~--~~~~pf~P~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~ 481 (552)
++|||+.|. ++.|||+|.+.+..|++||+. |...... .+... + .+... ....|.||+|.
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~~~-~s~~~--~--~~~~~~~~~~F~gfsy~ 63 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEETPV-LTPVD--S--PASGGSQQEPFRGFSYV 63 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCCCC-CCCCC--c--cccccccccccCCCccc
Confidence 479999997 589999999999999999997 5544322 11110 1 11111 13589999985
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0012 Score=67.35 Aligned_cols=138 Identities=14% Similarity=0.084 Sum_probs=82.4
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC--ceEEEeee------ecCCceE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCS------FQDDEFL 191 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~------f~d~~~l 191 (552)
-++.|..|.-..||++.. .+..|++|+.... ....+..|..++..+.+. .+++.+.. ....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 356788888899998864 3457899987641 123455677777666322 24444432 1233467
Q ss_pred EEEEecCCCCchhh----HH----------hhc-CCC----------CHHHH--H--------HHHHHHHHHHHHHHh--
Q 008810 192 YLIMEYLPGGDMMT----LL----------MRK-DTL----------TEDEA--R--------FYVAETVLAIESIHK-- 234 (552)
Q Consensus 192 ylVmEy~~gG~L~~----~L----------~~~-~~l----------~e~~~--~--------~~~~qi~~aL~~LH~-- 234 (552)
++||+|++|..+.. .+ ... ..+ .+... . .....+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999999976532 00 000 000 00000 0 011112234444443
Q ss_pred -----CCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 235 -----HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 235 -----~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.++||+|+.|.|||++.++.+.|+||+.|..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987789999998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0014 Score=67.52 Aligned_cols=142 Identities=19% Similarity=0.147 Sum_probs=83.1
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC--ceEEEeeee------cC
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSF------QD 187 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f------~d 187 (552)
+....++.|+.|.-..||++.. . +..|++|+..... ..+.+..|..++..+... .+++.+... ..
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEe-C-CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 3345577888888889998863 3 3367889875421 122345566666665321 134443321 22
Q ss_pred CceEEEEEecCCCCchhh-----------HH---hh-cCCCC---------HH--H--HH----------HHHHHHHHHH
Q 008810 188 DEFLYLIMEYLPGGDMMT-----------LL---MR-KDTLT---------ED--E--AR----------FYVAETVLAI 229 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~-----------~L---~~-~~~l~---------e~--~--~~----------~~~~qi~~aL 229 (552)
.+..++||+|++|..+.. .| .. ...++ .. . .. .....+..++
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 456789999999854321 01 10 01110 00 0 00 0011233355
Q ss_pred HHHHh-------CCCcccccCCCCccccCCCcEEEccccccc
Q 008810 230 ESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 230 ~~LH~-------~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
+++.. .++||+|+.+.||+++.++.+.|+||+.|.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 55542 589999999999999998877999999886
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0023 Score=66.00 Aligned_cols=31 Identities=26% Similarity=0.288 Sum_probs=26.6
Q ss_pred CCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 235 ~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.|+||+|+.|.|||++.+..+-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3899999999999999665568999998863
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0063 Score=63.75 Aligned_cols=84 Identities=15% Similarity=0.137 Sum_probs=52.5
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhh----hhhHHHHHHHHHHHHHhcC--CC-ceEEEeeeecCCceEEEEE
Q 008810 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML----RRGQVEHVRAERNLLAEVD--SN-CIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~----~~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~f~d~~~lylVm 195 (552)
.||-|...-||++.....++-++||.-..-.-. -.-..++.+-|...|.... .| .++++|++ |.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997544467888864321110 1233456677888886653 24 45555543 455556999
Q ss_pred ecCCCC-chhhHHh
Q 008810 196 EYLPGG-DMMTLLM 208 (552)
Q Consensus 196 Ey~~gG-~L~~~L~ 208 (552)
|+++.. .|+..|.
T Consensus 80 EdL~~~~ilR~~Li 93 (370)
T TIGR01767 80 EDLSHHKIARKGLI 93 (370)
T ss_pred hhCccchHHHHHHH
Confidence 999553 3444443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0057 Score=64.16 Aligned_cols=141 Identities=14% Similarity=0.185 Sum_probs=82.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcC----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CceEEEeeeecCCce
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKT----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEF 190 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~ 190 (552)
+...+. .|-.|--..||++.... +++.|++|+..... ...+. -.+|..+++.+.. .--.++++.|...
T Consensus 37 ~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 344444 55458888999987532 34689999886532 11222 2568888877743 3334566766443
Q ss_pred EEEEEecCCCCchhhH--------------H---hhcC------CCCHHHHHHHHHHH-----------------HHHHH
Q 008810 191 LYLIMEYLPGGDMMTL--------------L---MRKD------TLTEDEARFYVAET-----------------VLAIE 230 (552)
Q Consensus 191 lylVmEy~~gG~L~~~--------------L---~~~~------~l~e~~~~~~~~qi-----------------~~aL~ 230 (552)
.|++|++|-.|... | .... ....+.+..+..++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 58999987665421 0 0000 11122333332211 11111
Q ss_pred HH----H----hCCCcccccCCCCccccC-CCcEEEcccccccc
Q 008810 231 SI----H----KHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKP 265 (552)
Q Consensus 231 ~L----H----~~giiHrDLKPeNILl~~-~g~iKL~DFGlak~ 265 (552)
.| . ...++|+|+++.|||++. ++.+.|+||..|..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22 1 236899999999999986 47899999998864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0087 Score=62.18 Aligned_cols=139 Identities=21% Similarity=0.266 Sum_probs=94.3
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---------------------hHHHH--HHHHHHHHHhcCC-
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---------------------GQVEH--VRAERNLLAEVDS- 175 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---------------------~~~~~--~~~E~~iL~~l~h- 175 (552)
+-..|..|-=+.||.|. ..+|..+|||+++.+-+.-. ...-. ...|+.-|+++..
T Consensus 148 inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44578889999999986 45788899999875422111 11111 2334445655532
Q ss_pred ----CceEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccccCCCCcccc
Q 008810 176 ----NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLD 250 (552)
Q Consensus 176 ----p~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKPeNILl~ 250 (552)
|--+-| ..-.|||+|+.+...-.-..+.-.++...++.+-.+++.-+.-|- .++.||.||.-=|+|+.
T Consensus 227 GIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 221211 123599999954433333345567888889988888888888774 57999999999999987
Q ss_pred CCCcEEEcccccccccC
Q 008810 251 KYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 251 ~~g~iKL~DFGlak~~~ 267 (552)
. |++.|+|.+-+...+
T Consensus 300 d-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEHD 315 (520)
T ss_pred C-CEEEEEEccccccCC
Confidence 5 899999999877554
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.014 Score=59.74 Aligned_cols=29 Identities=28% Similarity=0.591 Sum_probs=26.1
Q ss_pred CCCcccccCCCCccccCCCcEEEccccccc
Q 008810 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 235 ~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
.++||+|+.+.|||++. +.+.|+||+.|.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999998 778999999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.001 Score=67.87 Aligned_cols=137 Identities=15% Similarity=0.177 Sum_probs=92.7
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh------h------hH-----H--HHHHHHHHHHHhcC-CCc
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR------R------GQ-----V--EHVRAERNLLAEVD-SNC 177 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~------~------~~-----~--~~~~~E~~iL~~l~-hp~ 177 (552)
+.+...||-|-=+-||++-+ ..|.++++|.-+-....- + .. . -....|...|+.+. |.+
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 55778999999999999875 468899999753211100 0 00 0 12345666666652 332
Q ss_pred -eEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEE
Q 008810 178 -IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 178 -Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iK 256 (552)
|.+.+ |-+..++|||++.|-.|...-.- ..+..+...+..-|--|-.+|+||+|..-=||+++++++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 22222 34567899999999887655321 22334455566667788899999999999999999999999
Q ss_pred Ecccccccc
Q 008810 257 LSDFGLCKP 265 (552)
Q Consensus 257 L~DFGlak~ 265 (552)
++||--+..
T Consensus 243 vIDFPQmvS 251 (465)
T KOG2268|consen 243 VIDFPQMVS 251 (465)
T ss_pred EeechHhhc
Confidence 999987653
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.011 Score=60.04 Aligned_cols=32 Identities=28% Similarity=0.453 Sum_probs=26.7
Q ss_pred CCcccccCCCCccccCCCc-EEEcccccccccC
Q 008810 236 HYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLD 267 (552)
Q Consensus 236 giiHrDLKPeNILl~~~g~-iKL~DFGlak~~~ 267 (552)
.+||+|+.|.|||++.+|. .-|+||+.+..-+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 4899999999999997565 4699999887543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.016 Score=60.35 Aligned_cols=142 Identities=15% Similarity=0.184 Sum_probs=80.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc-eEEEeeeecCCce
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEF 190 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~~ 190 (552)
.+++.+..+.| |=-..+|++..... +..|.+|+..... ...+ .-.+|..+++.+..-. -.++++.+...
T Consensus 14 ~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~G-- 86 (330)
T PLN02421 14 DSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFGNG-- 86 (330)
T ss_pred cCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeCCc--
Confidence 34555554444 77788998865432 3478899876432 1111 1346777887774433 34666666432
Q ss_pred EEEEEecCCCCchhhH----------H----h---hcC-----CC-CHHHHHHHHHHH----------------------
Q 008810 191 LYLIMEYLPGGDMMTL----------L----M---RKD-----TL-TEDEARFYVAET---------------------- 225 (552)
Q Consensus 191 lylVmEy~~gG~L~~~----------L----~---~~~-----~l-~e~~~~~~~~qi---------------------- 225 (552)
+|.+|++|-.|... + . ... .+ ....+..|..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 58999987654211 1 0 101 01 122333333222
Q ss_pred HHHHHH---HH-hC----CCcccccCCCCccccC-CCcEEEcccccccc
Q 008810 226 VLAIES---IH-KH----HYIHRDIKPDNLLLDK-YGHLRLSDFGLCKP 265 (552)
Q Consensus 226 ~~aL~~---LH-~~----giiHrDLKPeNILl~~-~g~iKL~DFGlak~ 265 (552)
..-+.. +. .. -++|.||.|.|||++. ++.++|+||..|-.
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 111111 21 11 2799999999999974 57899999998864
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.031 Score=59.61 Aligned_cols=84 Identities=15% Similarity=0.089 Sum_probs=54.3
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh----hHHHHHHHHHHHHHhcC---CCceEEEeeeecCCceEE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR----GQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~----~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d~~~ly 192 (552)
..+.||.|....||++... +..|+||.-........ ....+...|...|..+. ...+.++|+++.+. -+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM--AL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CE
Confidence 4678999999999998863 45688887542111011 13445556677776553 24788888887644 46
Q ss_pred EEEecCCC--CchhhHH
Q 008810 193 LIMEYLPG--GDMMTLL 207 (552)
Q Consensus 193 lVmEy~~g--G~L~~~L 207 (552)
+||||+++ -.+++-|
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 89999977 2454444
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.035 Score=57.16 Aligned_cols=30 Identities=13% Similarity=0.153 Sum_probs=27.9
Q ss_pred CCcccccCCCCccccCCCcEEEcccccccc
Q 008810 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 236 giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
++||+|+.++|||++.+|.+.++||..|..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.0029 Score=46.32 Aligned_cols=46 Identities=37% Similarity=0.490 Sum_probs=24.1
Q ss_pred ccCCcccCcCccc-cccccccccCCCCCCcccccccccCCcccCceecCc
Q 008810 435 EVNDELDTQNFEK-FEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNF 483 (552)
Q Consensus 435 ~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~ 483 (552)
.|+++.|++|||. |+... ...+.. ..+..+....+.+|.||||+++
T Consensus 1 ~v~~~~DtsnFD~eFt~~~-~~~t~~--~~~~~~~~~~~~~F~GFTy~~~ 47 (48)
T PF00433_consen 1 KVKSETDTSNFDPEFTEEP-PVDTPP--SDPSPLSSSMQENFQGFTYVNP 47 (48)
T ss_dssp S-SSTT-GTTSCHHHHTSS-SSS--S----HHHHCTSSGGGGTT-CEETC
T ss_pred CCCchhhhhhcCcccccCC-CCCCCc--ccCCcccccccCcCCCCeecCC
Confidence 3678999999998 55433 222211 1122223344556999999875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.072 Score=55.04 Aligned_cols=148 Identities=15% Similarity=0.167 Sum_probs=84.8
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC--ceEEEeeeecCCc--eEE
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSFQDDE--FLY 192 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~f~d~~--~ly 192 (552)
...++..+-.|.--.+|... .+++.+++. ... ............+|..+|+.+..- -+...++.|.++. ..|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~--~~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLG--DTGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEe--cCCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 34455555444444444443 337788887 221 122233445566787888776431 2445667776665 678
Q ss_pred EEEecCCCCchhhHHhhc--------------------------------CCCCHHHHHHHHHHH--------------H
Q 008810 193 LIMEYLPGGDMMTLLMRK--------------------------------DTLTEDEARFYVAET--------------V 226 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--------------------------------~~l~e~~~~~~~~qi--------------~ 226 (552)
.||+|+.|..+.+.+... +.+...+...+..+. .
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 999999984332222100 000111122222222 1
Q ss_pred HHHHHHHhC--------CCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 227 LAIESIHKH--------HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 227 ~aL~~LH~~--------giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.-..+|+.+ .++|+|+.+.||||+.++-+=+.||+++..-++
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 223445432 589999999999999999999999999986554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.023 Score=59.07 Aligned_cols=73 Identities=23% Similarity=0.444 Sum_probs=55.8
Q ss_pred CCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...++|++|++- |+.+.-. ..-..+++..++.+.+..|.-+... .+-|||+.-+||||+ +|.|.|+||-+|+.
T Consensus 297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 345789999986 5555321 2234667777777777777666653 789999999999999 99999999999984
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.044 Score=58.30 Aligned_cols=84 Identities=19% Similarity=0.194 Sum_probs=46.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCC-CcEEEEEE-eechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTT-GHVYAMKK-LKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~t-g~~~AiK~-l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~ly 192 (552)
+++++. .|..|--+.+|+|..... +..+.+|. +...........-.-.+|..+++.+. +..-.++++.|.. +
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 344444 555588899999975432 22333331 11110000111112356788888874 4455677888753 5
Q ss_pred EEEecCCCCchh
Q 008810 193 LIMEYLPGGDMM 204 (552)
Q Consensus 193 lVmEy~~gG~L~ 204 (552)
+|.||++|-.|.
T Consensus 126 ~l~efIeGr~l~ 137 (383)
T PTZ00384 126 TIQEWVEGNTMG 137 (383)
T ss_pred EEEEEeccccCC
Confidence 999999987654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.062 Score=57.09 Aligned_cols=86 Identities=19% Similarity=0.225 Sum_probs=55.9
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh---hhHHHHHHHHHHHHHhcC--CC-ceEEEeeeecCCceEEEE
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR---RGQVEHVRAERNLLAEVD--SN-CIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~---~~~~~~~~~E~~iL~~l~--hp-~Iv~l~~~f~d~~~lylV 194 (552)
++.||-|.-.-||++.....++-++||.-..---.. .-..++.+-|.++|+... .| .++++|++ |.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 778999999999999874445678888643211110 233567777888887663 24 56666654 55566799
Q ss_pred EecCCCC-chhhHHh
Q 008810 195 MEYLPGG-DMMTLLM 208 (552)
Q Consensus 195 mEy~~gG-~L~~~L~ 208 (552)
||+++.. .|+..|.
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 9999653 3444444
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.095 Score=53.57 Aligned_cols=75 Identities=20% Similarity=0.235 Sum_probs=46.3
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCceEEEeeeecCCceEEEEE
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+-.+.||.|....+|... .+++.|.+|+-.... ...+..|..-|+.+ ..-.+++.+.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 446678999999999876 778899999876321 23467787777776 3345777777776666669999
Q ss_pred ecCCCC
Q 008810 196 EYLPGG 201 (552)
Q Consensus 196 Ey~~gG 201 (552)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.039 Score=53.38 Aligned_cols=31 Identities=32% Similarity=0.638 Sum_probs=22.2
Q ss_pred CCCcccccCCCCccc-cCCCcEEEcccccccc
Q 008810 235 HHYIHRDIKPDNLLL-DKYGHLRLSDFGLCKP 265 (552)
Q Consensus 235 ~giiHrDLKPeNILl-~~~g~iKL~DFGlak~ 265 (552)
..++|.||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8899999999998874
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.33 Score=58.21 Aligned_cols=31 Identities=32% Similarity=0.455 Sum_probs=26.6
Q ss_pred CCCcccccCCCCccccCCC--cEE-Ecccccccc
Q 008810 235 HHYIHRDIKPDNLLLDKYG--HLR-LSDFGLCKP 265 (552)
Q Consensus 235 ~giiHrDLKPeNILl~~~g--~iK-L~DFGlak~ 265 (552)
.++||.|+.+.|||++.++ ++. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999876 565 999998753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.55 E-value=0.39 Score=50.03 Aligned_cols=135 Identities=21% Similarity=0.214 Sum_probs=77.7
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCceEE---Ee----eeecCCceE
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVK---LY----CSFQDDEFL 191 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~---l~----~~f~d~~~l 191 (552)
..|.. .-..||++... +..|++|+.... .... .+.-|..+|..+ ..+-.+. +- ..+....+.
T Consensus 32 ~~l~s-~eN~~f~~~~~--~g~~iLki~~~~--~~~~---~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~ 103 (331)
T COG2334 32 RGLNS-EENSNFRVQTE--DGRYILKIYRPG--WTRA---EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRP 103 (331)
T ss_pred ccccc-ccCceEEEEec--CCCeEEEEecCC--CCHH---HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCcee
Confidence 34454 55678987643 334589988765 2233 344566666555 2222222 22 222222377
Q ss_pred EEEEecCCCCchhh-H-----------H---hh---------cC---CCCHH----HHH---------HHHHHHHHHHHH
Q 008810 192 YLIMEYLPGGDMMT-L-----------L---MR---------KD---TLTED----EAR---------FYVAETVLAIES 231 (552)
Q Consensus 192 ylVmEy~~gG~L~~-~-----------L---~~---------~~---~l~e~----~~~---------~~~~qi~~aL~~ 231 (552)
+-|.+|++|..+.. . | .. .. ...+. ... ...+++...+..
T Consensus 104 a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~ 183 (331)
T COG2334 104 AALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDR 183 (331)
T ss_pred EEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHH
Confidence 88999999987772 1 0 00 00 11121 111 123344455555
Q ss_pred HHh--------CC--CcccccCCCCccccCCCc-EEEccccccc
Q 008810 232 IHK--------HH--YIHRDIKPDNLLLDKYGH-LRLSDFGLCK 264 (552)
Q Consensus 232 LH~--------~g--iiHrDLKPeNILl~~~g~-iKL~DFGlak 264 (552)
+.. .+ +||+|+.|+|||++.+.. +.++|||-|.
T Consensus 184 ~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 184 LLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 543 24 999999999999998885 8999999876
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.11 Score=56.47 Aligned_cols=79 Identities=20% Similarity=0.166 Sum_probs=55.4
Q ss_pred CccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcc-----------cccChhHHHHHHHHhh-CccccC
Q 008810 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-----------AKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 336 ~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-----------~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
+++||||+|.++.|+..|...+......+....|... ...+.. ..++.-..++..+|+- .|..|+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~---~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY---YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh---ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 3899999999999999999888766655555444431 111110 1245556777778887 899998
Q ss_pred CCCChhhhhcCCCcCCC
Q 008810 404 GAKGADEIKVHPWFDGV 420 (552)
Q Consensus 404 ~~~~a~eil~HpfF~~i 420 (552)
. ..++..|+-|..+
T Consensus 187 l---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 L---PMELSKRCSFTEV 200 (725)
T ss_pred c---hhHHhcCccHHHH
Confidence 6 7788888888765
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.15 Score=49.86 Aligned_cols=101 Identities=22% Similarity=0.286 Sum_probs=64.6
Q ss_pred EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHH
Q 008810 143 VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222 (552)
Q Consensus 143 ~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~ 222 (552)
+..+|++......- ....++++..+++++. .|++|..- +.-..-+++|+|-.-.. ...-++.
T Consensus 87 ~L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------------~~~N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------------NFSNFIT 148 (308)
T ss_pred hhhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------------chhHHHH
Confidence 44556655433220 1233677888888774 47777732 33356689999843211 1112222
Q ss_pred HHHHHHHHHHHh--CCCcccccCCCCccccCCCcEEEccccc
Q 008810 223 AETVLAIESIHK--HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 223 ~qi~~aL~~LH~--~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
+ =+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 149 a-gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 A-GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred H-hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 2 2456777884 4799999999999999999999999763
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.42 Score=51.90 Aligned_cols=81 Identities=17% Similarity=0.127 Sum_probs=48.3
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcC--------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCce-EEEeee
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKT--------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCS 184 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~--------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-v~l~~~ 184 (552)
..++. -++.|..|--..+|++.... .++.|.+++.-... ..-+ .-..|..++..+..-.| .++++.
T Consensus 104 ~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~ 178 (442)
T PTZ00296 104 TEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNT 178 (442)
T ss_pred CcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEE
Confidence 34455 56677778888899987542 25678899875431 1111 23446666666643222 355666
Q ss_pred ecCCceEEEEEecCCCCch
Q 008810 185 FQDDEFLYLIMEYLPGGDM 203 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L 203 (552)
|.. +.|.||++|-.|
T Consensus 179 f~g----g~I~efi~g~~l 193 (442)
T PTZ00296 179 FSG----GRIEEWLYGDPL 193 (442)
T ss_pred eCC----CEEEEeeCCccC
Confidence 642 368999988643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 552 | ||||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-81 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-80 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-78 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-78 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-78 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-77 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-77 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-73 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-64 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-64 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-64 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-64 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-64 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-64 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-64 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-64 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-64 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-64 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-64 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-64 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-64 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-63 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-63 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-63 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-63 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-63 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-63 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-63 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-63 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-63 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-63 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-63 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-63 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-63 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-63 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-63 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-63 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-63 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-63 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-63 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-62 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-62 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-62 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-62 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-62 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-62 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-62 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-62 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-62 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-62 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-62 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-62 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-62 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-62 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-62 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-62 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-62 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-62 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-61 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-61 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-58 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-53 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-53 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-52 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-50 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-50 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-50 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-50 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-50 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-49 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-49 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-49 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-49 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-49 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-49 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-49 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-49 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-49 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-49 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-48 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-48 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-48 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-48 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-48 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-45 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-44 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-44 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-44 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-43 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-43 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-43 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-43 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-43 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-43 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-43 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-43 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-43 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-43 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-43 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-43 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-43 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-43 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-43 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-43 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-43 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-42 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-42 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-42 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-42 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-42 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-39 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-38 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-37 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-37 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-36 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-36 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-36 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-35 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-35 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-34 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-34 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-34 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-34 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-33 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-33 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-33 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-33 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-33 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-32 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-32 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-32 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-32 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-32 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-32 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-32 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-32 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-32 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-32 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-32 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-32 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-32 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-32 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-32 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-32 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-32 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-31 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-31 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-31 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-31 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-31 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-31 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-31 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-31 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-31 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-31 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-31 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-31 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-31 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-31 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-31 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-31 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-31 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-31 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-31 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-31 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-31 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-31 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-31 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-30 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-30 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-30 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-30 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-30 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-30 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-29 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-29 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-28 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-28 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-28 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-28 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-28 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-28 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-28 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-28 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-28 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-28 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-28 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-28 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-28 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-28 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-28 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-28 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-28 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-28 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-28 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-28 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-27 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-27 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-27 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-27 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-27 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-27 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-27 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-26 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-26 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-26 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-26 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-26 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-26 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-26 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-26 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-26 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-26 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-26 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-26 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-26 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-26 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-26 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-26 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-26 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-26 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-26 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-26 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-26 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-25 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-25 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-25 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-25 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-25 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-25 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-25 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-25 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-24 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-24 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-24 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-24 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-24 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-24 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-23 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-23 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-22 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-22 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-21 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-21 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-21 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-20 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-20 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-20 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-17 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-17 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-17 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-09 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 4e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 5e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 6e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 7e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 8e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 9e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-05 | ||
| 4ax8_A | 569 | Medium Resolution Structure Of The Bifunctional Kin | 7e-05 | ||
| 4azs_A | 569 | High Resolution (2.2 A) Crystal Structure Of Wbdd. | 8e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-04 | ||
| 4azw_A | 471 | Crystal Structure Of Monomeric Wbdd Length = 471 | 2e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-04 |
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4AX8|A Chain A, Medium Resolution Structure Of The Bifunctional Kinase- Methyltransferase Wbdd Length = 569 | Back alignment and structure |
|
| >pdb|4AZS|A Chain A, High Resolution (2.2 A) Crystal Structure Of Wbdd. Length = 569 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4AZW|A Chain A, Crystal Structure Of Monomeric Wbdd Length = 471 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 486 bits (1252), Expect = e-170
Identities = 154/413 (37%), Positives = 224/413 (54%), Gaps = 53/413 (12%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
+ FL+ E +RL+ ++ DDFE+L +IG+GAF EV V + K TG VYAMK + K
Sbjct: 38 YVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW 97
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-D 211
+ML+RG+V R ER++L D I +L+ +FQD+ +LYL+MEY GGD++TLL + +
Sbjct: 98 DMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE 157
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
+ + ARFY+AE V+AI+S+H+ Y+HRDIKPDN+LLD+ GH+RL+DFG C L
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL----- 212
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
+G+ + + VGTPDY++PE+L
Sbjct: 213 ---------RADGTVR--------------------------SLVAVGTPDYLSPEILQA 237
Query: 332 KG-------YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAK- 383
G YG ECDWW+LG YEM G PFY+D T KIV+++ HL P +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 384 LSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQ 443
+ EA+D I +LLC RLG GA + + HP+F G+DW + F P+ DT
Sbjct: 298 VPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTC 357
Query: 444 NFEKFEESDNQTKT---SSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPG 493
NF+ E+ + + + + FVGY+Y + + +VPG
Sbjct: 358 NFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALRDS-EVPG 409
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-166
Identities = 161/429 (37%), Positives = 237/429 (55%), Gaps = 49/429 (11%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
+ N+L++LE + ++++ ++ +DFE+L +IG+GAFGEV V + K V+AM
Sbjct: 45 PLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAM 104
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206
K L K EML+R + R ER++L DS I L+ +FQDD LYL+M+Y GGD++TL
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 207 LMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265
L + +D L E+ ARFY+AE V+AI+S+H+ HY+HRDIKPDN+L+D GH+RL+DFG C
Sbjct: 165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325
L ++ + + VGTPDYI+
Sbjct: 225 LM----------------------------------------EDGTVQSSVAVGTPDYIS 244
Query: 326 PEVLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE 380
PE+L K YG ECDWWSLG MYEML G PFY++ + T KI+N + +FP
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 381 E-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDE 439
+ +S AKDLI +L+C+ RLG G ++ K HP+F G+DW I EA +IPEV+
Sbjct: 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSP 364
Query: 440 LDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGMAELKK 499
DT NF+ ++ + + P S + FVG+TY + +++D +
Sbjct: 365 TDTSNFDVDDDC--LKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVLSDRSCLRVTAGPT 422
Query: 500 TNNKPKRPS 508
+ S
Sbjct: 423 SAENLYFQS 431
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 476 bits (1226), Expect = e-166
Identities = 158/414 (38%), Positives = 234/414 (56%), Gaps = 52/414 (12%)
Query: 76 ILEKKLADADVSEEDQN-NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV 134
L+ + D D +N N+ FL + + +++ +M A+D+E++ +IG+GAFGEV++
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL 87
Query: 135 CREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194
R K+T VYAMK L K EM++R ER+++A +S +V+L+ +FQDD +LY++
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
MEY+PGGD++ L+ D + E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GH
Sbjct: 148 MEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH 206
Query: 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLA 314
L+L+DFG C ++ K +
Sbjct: 207 LKLADFGTCMKMN----------------------------------------KEGMVRC 226
Query: 315 YSTVGTPDYIAPEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV 370
+ VGTPDYI+PEVL +G YG ECDWWS+G +YEMLVG PFY+D + T KI+
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
Query: 371 NWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQ--M 428
N + L FP++ +S EAK+LI L + RLG G +EIK H +F WA
Sbjct: 287 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT 346
Query: 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482
A +P+++ ++DT NF+ EE + +T P K + FVG+TY +
Sbjct: 347 VAPVVPDLSSDIDTSNFDDLEEDKGEEETF----PIPKAFVGNQLPFVGFTYYS 396
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-135
Identities = 124/347 (35%), Positives = 187/347 (53%), Gaps = 54/347 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K DF++L +G G+FG V + R + G YAMK LKK ++R QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
V I++++ +FQD + +++IM+Y+ GG++ +LL + A+FY AE LA+E
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H I+RD+KP+N+LLDK GH++++DFG K + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--------------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
Y+ GTPDYIAPEV+ K Y DWWS G ++YEML
Sbjct: 161 -----------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGA 408
GY PFY + M T KI+N L+FP + + KDL+S+L+ +++QRLG G
Sbjct: 198 AGYTPFYDSNTMKTYEKILNAE--LRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGT 253
Query: 409 DEIKVHPWFDGVDWARIYQ--MEAAFIPEV-NDELDTQNFEKFEESD 452
+++K HPWF V W ++ +E + P + + DT F+K+ E D
Sbjct: 254 EDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED 300
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 392 bits (1008), Expect = e-133
Identities = 128/381 (33%), Positives = 202/381 (53%), Gaps = 53/381 (13%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
E + L K E ++ ++ D F+ + +G G+FG V + + K +G+ YAM
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206
K L K ++++ Q+EH E+ +L V+ +VKL SF+D+ LY++MEY+ GG+M +
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131
Query: 207 LMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
L R +E ARFY A+ VL E +H I+RD+KP+NLL+D+ G+++++DFG K +
Sbjct: 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
T ++ GTP+ +AP
Sbjct: 192 KGRT--------------------------------------------WTLCGTPEALAP 207
Query: 327 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSI 386
E++L KGY DWW+LG ++YEM GYPPF++D P+ KIV+ + ++FP + S
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFP--SHFSS 263
Query: 387 EAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELD 441
+ KDL+ LL ++ +R G G ++IK H WF DW IYQ +EA FIP+ D
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGD 323
Query: 442 TQNFEKFEESDNQTKTSSKTG 462
T NF+ +EE + + + K G
Sbjct: 324 TSNFDDYEEEEIRVSINEKCG 344
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 375 bits (966), Expect = e-128
Identities = 101/337 (29%), Positives = 167/337 (49%), Gaps = 47/337 (13%)
Query: 102 ETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE 161
+ Q K +DF+ ++G+G+F V + RE T YA+K L+K +++ +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
+V ER++++ +D VKLY +FQDDE LY + Y G+++ + + + E RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
AE V A+E +H IHRD+KP+N+LL++ H++++DFG K L
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------------- 181
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ R S VGT Y++PE+L +K D W
Sbjct: 182 ---------PESKQARA----------------NSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVN 400
+LG I+Y+++ G PPF + + +KI+ FPE+ +A+DL+ KLL +
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEK--FFPKARDLVEKLLVLDAT 272
Query: 401 QRLGAK---GADEIKVHPWFDGVDWARIYQMEAAFIP 434
+RLG + G +K HP+F+ V W ++Q +
Sbjct: 273 KRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 309
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-122
Identities = 119/404 (29%), Positives = 191/404 (47%), Gaps = 53/404 (13%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
+ N ++ DF L +IGKG+FG+V + R K YA+
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAV 68
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMT 205
K L+K +L++ + +H+ +ERN+L + + +V L+ SFQ + LY +++Y+ GG++
Sbjct: 69 KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 128
Query: 206 LLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265
L R+ E ARFY AE A+ +H + ++RD+KP+N+LLD GH+ L+DFGLCK
Sbjct: 129 HLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK- 187
Query: 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325
E ++H + GTP+Y+A
Sbjct: 188 -----------------------------------ENIEHNST-----TSTFCGTPEYLA 207
Query: 326 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLS 385
PEVL K+ Y DWW LGA++YEML G PPFYS + I+N L+ ++
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPN--IT 263
Query: 386 IEAKDLISKLLC-NVNQRLGAK-GADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELD 441
A+ L+ LL + +RLGAK EIK H +F ++W + ++ F P V+ D
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPND 323
Query: 442 TQNFEKF---EESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482
++F+ E N + + + F+G++Y
Sbjct: 324 LRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAP 367
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-122
Identities = 123/356 (34%), Positives = 183/356 (51%), Gaps = 54/356 (15%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRR 157
+ K+ + FELL ++GKG +G+V R+ TG ++AMK LKK+ ++R
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 158 G-QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED 216
H +AERN+L EV IV L +FQ LYLI+EYL GG++ L R+ ED
Sbjct: 62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
A FY+AE +A+ +H+ I+RD+KP+N++L+ GH++L+DFGLCK
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------------ 169
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
E + ++ GT +Y+APE+L++ G+
Sbjct: 170 ------------------------ESIHDGTV-----THTFCGTIEYMAPEILMRSGHNR 200
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
DWWSLGA+MY+ML G PPF ++ T KI+ L P L+ EA+DL+ KLL
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPY--LTQEARDLLKKLL 256
Query: 397 C-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNFEK 447
N RLGA A E++ HP+F ++W + +E F P + E D F+
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDS 312
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-121
Identities = 121/387 (31%), Positives = 182/387 (47%), Gaps = 59/387 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K+ +DF+ L ++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ L +FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H ++RDIK +NL+LDK GH++++DFGLCK + +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATM-------------- 162
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GTP+Y+APEVL YG DWW LG +MYEM+
Sbjct: 163 -----------------------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGA 408
G PFY+ D I+ ++FP LS EAK L++ LL + QRLG A
Sbjct: 200 CGRLPFYNQDHERLFELILM--EEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 409 DEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKF----EESDNQTKTSSKTG 462
E+ H +F ++W + ++ F P+V E+DT+ F+ + G
Sbjct: 256 KEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLG 315
Query: 463 PWRKMLSSKDINFVGYTYKNFEIVNDY 489
+ F + Y + D+
Sbjct: 316 LLELDQREEQEMFEDFDY-----IADW 337
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-121
Identities = 123/353 (34%), Positives = 188/353 (53%), Gaps = 54/353 (15%)
Query: 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQ 159
T +++ K FELL ++G+G+FG+V + ++ +YAMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR 219
V + ER++L EV+ IVKL+ +FQ + LYLI+++L GGD+ T L ++ TE++ +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
FY+AE LA++ +H I+RD+KP+N+LLD+ GH++L+DFGL K
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 174
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339
E + H +K AYS GT +Y+APEV+ ++G+ D
Sbjct: 175 ---------------------ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSAD 208
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398
WWS G +M+EML G PF D T I+ L P+ LS EA+ L+ L N
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQF--LSPEAQSLLRMLFKRN 264
Query: 399 VNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEK 447
RLGA G +EIK H +F +DW ++Y ++ F P DT F+
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDP 317
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-119
Identities = 117/378 (30%), Positives = 181/378 (47%), Gaps = 54/378 (14%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+ K+ +DF L M+GKG+FG+V + K T +A+K LKK +L VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 169 LLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L+ + + ++C+FQ E L+ +MEYL GGD+M + A FY AE +L
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ +H ++RD+K DN+LLDK GH++++DFG+CK
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------- 166
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
E + K + GTPDYIAPE+LL + Y DWWS G ++
Sbjct: 167 -------------ENMLGDAK-----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 208
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
YEML+G PF+ D I + +P L EAKDL+ KL +RLG +
Sbjct: 209 YEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVR 264
Query: 407 GADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPW 464
G +I+ HP F ++W + +++ F P+V D NF+ +E N+ S
Sbjct: 265 G--DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFD--KEFLNEKPRLSFADR- 319
Query: 465 RKMLSSKDINFVGYTYKN 482
+ S F +++ N
Sbjct: 320 ALINSMDQNMFRNFSFMN 337
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 353 bits (909), Expect = e-119
Identities = 126/373 (33%), Positives = 194/373 (52%), Gaps = 56/373 (15%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHV 143
+ LL + T + K+G ++FELL ++G GA+G+V + R+ TG +
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 144 YAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGG 201
YAMK LKK+ ++++ EH R ER +L + + +V L+ +FQ + L+LI++Y+ GG
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144
Query: 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
++ T L +++ TE E + YV E VLA+E +HK I+RDIK +N+LLD GH+ L+DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
L K + ER AY GT
Sbjct: 205 LSKE------------------FVADETER----------------------AYDFCGTI 224
Query: 322 DYIAPEVLL--KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH--LK 377
+Y+AP+++ G+ DWWSLG +MYE+L G PF D ++ +I
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 378 FPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAF 432
+P+E +S AKDLI +LL + +RLG + ADEIK H +F ++W + ++ A F
Sbjct: 285 YPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPF 342
Query: 433 IPEVNDELDTQNF 445
P + DELD NF
Sbjct: 343 KPVIRDELDVSNF 355
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-118
Identities = 115/386 (29%), Positives = 185/386 (47%), Gaps = 65/386 (16%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+++G D+FE + ++GKG+FG+V + R K TG +YA+K LKK +L+ VE E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 169 LLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L+ ++ + +L+C FQ + L+ +ME++ GGD+M + + E ARFY AE +
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
A+ +H I+RD+K DN+LLD GH +L+DFG+CK + T
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE----GICNGVTT---------- 181
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+ GTPDYIAPE+L + YG DWW++G ++
Sbjct: 182 ---------------------------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
YEML G+ PF +++ I+N + +P L +A ++ + N RLG+
Sbjct: 215 YEMLCGHAPFEAENEDDLFEAILN--DEVVYPTW--LHEDATGILKSFMTKNPTMRLGSL 270
Query: 407 ---GADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEK-FEESDNQTKTSSK 460
G I HP+F +DWA++ Q+E F P + D NF+ F +
Sbjct: 271 TQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDF--------IKEE 322
Query: 461 ---TGPWRKMLSSKD-INFVGYTYKN 482
T L + F + Y +
Sbjct: 323 PVLTPIDEGHLPMINQDEFRNFEYVS 348
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 352 bits (904), Expect = e-117
Identities = 90/346 (26%), Positives = 158/346 (45%), Gaps = 61/346 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+ + D FE+L IGKG+FG+V + ++ T +YAMK + K + + R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
++ ++ +V L+ SFQD+E ++++++ L GGD+ L + E+ + ++ E V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + IHRD+KPDN+LLD++GH+ ++DF +
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------------ 163
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGA 345
+ + + GT Y+APE+ + GY DWWSLG
Sbjct: 164 ----------------MLPRETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGV 205
Query: 346 IMYEMLVGYPPFY---SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
YE+L G P++ S T + +P S E L+ KLL N +Q
Sbjct: 206 TAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSA--WSQEMVSLLKKLLEPNPDQ 261
Query: 402 RLGAKGADEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNF 445
R +++ P+ + ++W ++Q + FIP N
Sbjct: 262 RFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK----GRLNC 301
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-117
Identities = 104/386 (26%), Positives = 180/386 (46%), Gaps = 55/386 (14%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R +M DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 169 LLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+LA + +L+ FQ + LY +MEY+ GGD+M + + E A FY AE +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ + I+RD+K DN++LD GH++++DFG+CK
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------------------- 169
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
E + + GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 170 -------------ENIWDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 211
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA- 405
YEML G PF +D + I+ ++ +P+ +S EA + L+ + +RLG
Sbjct: 212 YEMLAGQAPFEGEDEDELFQSIME--HNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCG 267
Query: 406 -KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTG 462
+G +IK H +F +DW ++ +++ + P+ + +NF++ +
Sbjct: 268 PEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDR--FFTRHPPVLTPPD 324
Query: 463 PWRKMLSSKDINFVGYTYKNFEIVND 488
+ + F G+++ N E +
Sbjct: 325 Q-EVIRNIDQSEFEGFSFVNSEFLKP 349
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-114
Identities = 114/388 (29%), Positives = 187/388 (48%), Gaps = 66/388 (17%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+G DF+LL +IG+G++ +V + R K T +YAMK +KK + ++ V+ E+++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 172 EVDSNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ SN +V L+ FQ + L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA+
Sbjct: 65 QA-SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H+ I+RD+K DN+LLD GH++L+D+G+CK L+ D T
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE----GLRPGDTT------------ 167
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ GTP+YIAPE+L + YG DWW+LG +M+E
Sbjct: 168 -------------------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 350 MLVGYPPF---------YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NV 399
M+ G PF + + I+ ++ P LS++A ++ L +
Sbjct: 203 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS--LSVKAASVLKSFLNKDP 258
Query: 400 NQRLGA---KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQ 454
+RLG G +I+ HP+F VDW + Q+ F P ++ E NF+ + N+
Sbjct: 259 KERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS--QFTNE 316
Query: 455 TKTSSKTGPWRKMLSSKDINFVGYTYKN 482
+ + F G+ Y N
Sbjct: 317 PVQLTPDDD-DIVRKIDQSEFEGFEYIN 343
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-114
Identities = 125/393 (31%), Positives = 189/393 (48%), Gaps = 55/393 (13%)
Query: 61 KEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFEL 120
+E +Q + D N+ + +E + +H++ ++FE
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAK----PKHRVTMNEFEY 152
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L ++GKG FG+V + +EK TG YAMK LKK ++ + +V H E +L +
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH-YIH 239
L SFQ + L +MEY GG++ L R+ +ED ARFY AE V A++ +H ++
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+K +NL+LDK GH++++DFGLCK
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCK----------------------------------- 297
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
E ++ + GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 298 -EGIKDGAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPW 416
D I+ ++FP L EAK L+S LL + QRLG + A EI H +
Sbjct: 352 QDHEKLFELILM--EEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
Query: 417 FDGVDWARIY--QMEAAFIPEVNDELDTQNFEK 447
F G+ W +Y ++ F P+V E DT+ F++
Sbjct: 408 FAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 440
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 338 bits (870), Expect = e-112
Identities = 112/400 (28%), Positives = 188/400 (47%), Gaps = 64/400 (16%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
E T +G DF+LL +IG+G++ +V + R K T +YAM+ +KK +
Sbjct: 35 EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE 94
Query: 159 QVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
++ V+ E+++ + ++ +V L+ FQ + L+ ++EY+ GGD+M + R+ L E+
Sbjct: 95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
ARFY AE LA+ +H+ I+RD+K DN+LLD GH++L+D+G+CK
Sbjct: 155 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------------- 201
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
E L+ + GTP+YIAPE+L + YG
Sbjct: 202 -----------------------EGLRPGDT-----TSTFCGTPNYIAPEILRGEDYGFS 233
Query: 338 CDWWSLGAIMYEMLVGYPPF---------YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
DWW+LG +M+EM+ G PF + + I+ ++ P LS++A
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS--LSVKA 289
Query: 389 KDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDT 442
++ L + +RLG G +I+ HP+F VDW + Q+ F P ++ E
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 349
Query: 443 QNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482
NF+ + N+ + + F G+ Y N
Sbjct: 350 DNFDS--QFTNEPVQLTPDDD-DIVRKIDQSEFEGFEYIN 386
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-111
Identities = 127/533 (23%), Positives = 221/533 (41%), Gaps = 101/533 (18%)
Query: 34 ESTDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNN 93
T + + V +Q V Q +E + + R + AD S
Sbjct: 111 SHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIY---- 166
Query: 94 LLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE 153
+ ++ L+R + + F ++GKG FGEV C+ + TG +YA KKL+K
Sbjct: 167 -----FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 221
Query: 154 MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKD 211
+ +R E+ +L +V+S +V L +++ + L L++ + GGD+ + M +
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA 281
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
E A FY AE +E +H+ ++RD+KP+N+LLD +GH+R+SD GL
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV------- 334
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
G + G VGT Y+APEV+
Sbjct: 335 ---HVPEGQTIKGR--------------------------------VGTVGYMAPEVVKN 359
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTC----RKIVNWRTHLKFPEEAKLSIE 387
+ Y DWW+LG ++YEM+ G PF R + ++ E + S +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSE--RFSPQ 415
Query: 388 AKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDE--L 440
A+ L S+LLC + +RLG + A E+K HP F +++ R+ +E F P+
Sbjct: 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCK 475
Query: 441 DTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN-FVGYTYKN--------------FEI 485
D + E+F S+ G L D + + + + F+
Sbjct: 476 DVLDIEQF---------STVKGV---ELEPTDQDFYQKFATGSVPIPWQNEMVETECFQE 523
Query: 486 VNDYQVPG-----MAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQ 533
+N + + G + + PK+ ++ LF S ++S +S + P++
Sbjct: 524 LNVFGLDGSVPPDLDWKGQPPAPPKKGLLQRLF-SRQDSSGNSSDSEEELPTR 575
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 340 bits (873), Expect = e-111
Identities = 99/371 (26%), Positives = 165/371 (44%), Gaps = 63/371 (16%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
+ ++ L+ MG D F ++G+G FGEV C+ K TG +YA KKL K + +R
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 159 QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMM----TLLMRKDTLT 214
+ E+ +LA+V S IV L +F+ L L+M + GGD+ +
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274
E A FY A+ V +E +H+ + I+RD+KP+N+LLD G++R+SD GL
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV---------- 337
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334
E A +T+ GTP ++APE+LL + Y
Sbjct: 338 ---------------ELKAGQTKTK----------------GYAGTPGFMAPELLLGEEY 366
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTC----RKIVNWRTHLKFPEEAKLSIEAKD 390
D+++LG +YEM+ PF + ++++ + +P+ K S +KD
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPD--KFSPASKD 422
Query: 391 LISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--QMEAAFIPEVN-----DEL 440
LL + +RLG + D ++ HP F + W ++ + F+P+ +
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQ 482
Query: 441 DTQNFEKFEES 451
D F +
Sbjct: 483 DVGAFSTVKGV 493
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 340 bits (873), Expect = e-109
Identities = 112/415 (26%), Positives = 194/415 (46%), Gaps = 61/415 (14%)
Query: 83 DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH 142
A + + + K R +M DF L ++GKG+FG+V + K T
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 143 VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGG 201
+YA+K LKK +++ VE E+ +LA + +L+ FQ + LY +MEY+ GG
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
D+M + + E A FY AE + + + I+RD+K DN++LD GH++++DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
+CK E T + GTP
Sbjct: 488 MCK-------------------------ENIWDGVTT----------------KTFCGTP 506
Query: 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381
DYIAPE++ + YG DWW+ G ++YEML G PF +D + I+ ++ +P+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKS 564
Query: 382 AKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFIPEV 436
+S EA + L+ + +RLG +G +IK H +F +DW ++ +++ + P+
Sbjct: 565 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 622
Query: 437 NDELDTQNFEK-FEESDNQTKTSSK-TGPWRKMLSSKD-INFVGYTYKNFEIVND 488
+ + +NF++ F T+ T P ++++ + D F G+++ N E +
Sbjct: 623 SGR-NAENFDRFF------TRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFLKP 670
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-107
Identities = 116/470 (24%), Positives = 196/470 (41%), Gaps = 82/470 (17%)
Query: 88 EEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK 147
+ + +F + K E + +DF + +IG+G FGEV CR+ TG +YAMK
Sbjct: 165 FIESDKFTRFCQWKNVE----LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 148 KLKKSEMLRRGQVEHVRAERNLLAEVDSNC---IVKLYCSFQDDEFLYLIMEYLPGGDMM 204
L K + + ER +L+ V + IV + +F + L I++ + GGD+
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 205 TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
L + +E + RFY AE +L +E +H ++RD+KP N+LLD++GH+R+SD GL
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340
Query: 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324
+ K + +++VGT Y+
Sbjct: 341 ----------------------------------------DFSKKK---PHASVGTHGYM 357
Query: 325 APEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST---CRKIVNWRTHLKFPE 380
APEVL K Y DW+SLG +++++L G+ PF R + ++ P+
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD 415
Query: 381 EAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFIPE 435
S E + L+ LL +VN+RLG +GA E+K P+F +DW ++ + IP
Sbjct: 416 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 473
Query: 436 VN-----DELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQ 490
D D +F++ + TK K+L S + + E
Sbjct: 474 RGEVNAADAFDIGSFDEED-----TKGI-------KLLDSDQELYRNFPLTISERWQQEV 521
Query: 491 VPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGSFTSLA 540
+ N + R + +++ E D G + +
Sbjct: 522 AETV--FDTINAETDRLEARKKTKNKQLGHEEDYALGKDCIMHGYMSKMG 569
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = 2e-99
Identities = 97/316 (30%), Positives = 144/316 (45%), Gaps = 51/316 (16%)
Query: 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH 162
T + + K DDF++ +GKG FG V + REK + A+K L KS++ + G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 163 VRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+R E + + + I+++Y F D + +YL++E+ P G++ L + E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
E A+ H+ IHRDIKP+NLL+ G L+++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
H RR + GT DY+ PE++ K + + D W
Sbjct: 163 ----------------------HAPSLRR---RTMCGTLDYLPPEMIEGKTHDEKVDLWC 197
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
G + YE LVG PPF S T R+IV LKFP LS +KDLISKLL + Q
Sbjct: 198 AGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPP--FLSDGSKDLISKLLRYHPPQ 253
Query: 402 RLGAKGADEIKVHPWF 417
RL + HPW
Sbjct: 254 RL---PLKGVMEHPWV 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = 9e-99
Identities = 94/310 (30%), Positives = 143/310 (46%), Gaps = 51/310 (16%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
++ + +DFE+ +GKG FG V + REK + + A+K L K+++ + G +R E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+ + + I++LY F D +YLI+EY P G + L + E Y+ E A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ H IHRDIKP+NLLL G L+++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------------------ 157
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
H +RR GT DY+ PE++ + + + D WSLG + Y
Sbjct: 158 ----------------HAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407
E LVG PPF ++ T ++I R FP+ ++ A+DLIS+LL N +QR
Sbjct: 199 EFLVGKPPFEANTYQETYKRIS--RVEFTFPD--FVTEGARDLISRLLKHNPSQRP---M 251
Query: 408 ADEIKVHPWF 417
E+ HPW
Sbjct: 252 LREVLEHPWI 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 5e-84
Identities = 89/304 (29%), Positives = 148/304 (48%), Gaps = 50/304 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DF++ ++GKG+F V TG A+K + K M + G V+ V+ E + ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
I++LY F+D ++YL++E G+M L + +E+EAR ++ + + + +H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+ NLLL + +++++DFGL +T + +E+
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGL------ATQLKMP-------------HEK--- 168
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
T GTP+YI+PE+ + +G+E D WSLG + Y +L+G
Sbjct: 169 -HYT------------------LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413
PPF +D +T K+V + P LSIEAKDLI +LL N RL +
Sbjct: 210 PPFDTDTVKNTLNKVV--LADYEMPSF--LSIEAKDLIHQLLRRNPADRL---SLSSVLD 262
Query: 414 HPWF 417
HP+
Sbjct: 263 HPFM 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 260 bits (667), Expect = 2e-83
Identities = 87/303 (28%), Positives = 142/303 (46%), Gaps = 49/303 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +GKG F + + T V+A K + KS +L+ Q E + E ++ +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V + F+D++F+++++E ++ L R+ LTE EAR+Y+ + VL + +H++
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRD+K NL L++ +++ DFGL +T E D ER
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYD-------------GER---- 171
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K+ GTP+YIAPEVL KKG+ E D WS+G IMY +LVG P
Sbjct: 172 KKV------------------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
PF + T +I + P+ ++ A LI K+L + R +E+
Sbjct: 214 PFETSCLKETYLRIK--KNEYSIPKH--INPVAASLIQKMLQTDPTARP---TINELLND 266
Query: 415 PWF 417
+F
Sbjct: 267 EFF 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 1e-82
Identities = 87/303 (28%), Positives = 142/303 (46%), Gaps = 49/303 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +GKG F + + T V+A K + KS +L+ Q E + E ++ +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V + F+D++F+++++E ++ L R+ LTE EAR+Y+ + VL + +H++
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRD+K NL L++ +++ DFGL +T E D ER
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYD-------------GER---- 197
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K+ GTP+YIAPEVL KKG+ E D WS+G IMY +LVG P
Sbjct: 198 KKV------------------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
PF + T +I + P+ ++ A LI K+L + R +E+
Sbjct: 240 PFETSCLKETYLRIK--KNEYSIPKH--INPVAASLIQKMLQTDPTARP---TINELLND 292
Query: 415 PWF 417
+F
Sbjct: 293 EFF 295
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 4e-82
Identities = 77/319 (24%), Positives = 136/319 (42%), Gaps = 52/319 (16%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A DFE + ++G+GAFG+V R YA+KK++ +E ++ + +E LLA ++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLN 60
Query: 175 SNCIVKLYCSFQDDE-------------FLYLIMEYLPGGDMMTLLM-RKDTLTEDEARF 220
+V+ Y ++ + L++ MEY G + L+ DE
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ + A+ IH IHRD+KP N+ +D+ ++++ DFGL K
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK---------------- 164
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECD 339
N++ S + + + L S +GT Y+A EVL G Y + D
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLT-----------SAIGTAMYVATEVLDGTGHYNEKID 213
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398
+SLG I +EM+ YP + ++ +K+ + + K +I L+ +
Sbjct: 214 MYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 399 VNQRLGAKGADEIKVHPWF 417
N+R GA+ + W
Sbjct: 272 PNKRPGAR---TLLNSGWL 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 2e-79
Identities = 67/320 (20%), Positives = 115/320 (35%), Gaps = 56/320 (17%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
+ Y + F+ L+ +G G++GEV R K G +YA+K+ +
Sbjct: 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DR 100
Query: 161 EHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEA 218
AE +V C V+L ++++ LYL E G + +L E +
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV 159
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
Y+ +T+LA+ +H +H D+KP N+ L G +L DFGL L
Sbjct: 160 WGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL------------ 207
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
G P Y+APE+ L+ YG
Sbjct: 208 ------------------------------GTAGAGEVQEGDPRYMAPEL-LQGSYGTAA 236
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC- 397
D +SLG + E+ + + +++ +F LS E + ++ +L
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTA--GLSSELRSVLVMMLEP 291
Query: 398 NVNQRLGAKGADEIKVHPWF 417
+ R A+ + P
Sbjct: 292 DPKLRATAE---ALLALPVL 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 1e-76
Identities = 58/366 (15%), Positives = 125/366 (34%), Gaps = 94/366 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR--------------RGQVE 161
+D+ ++ + +G F ++ +C + YA+KK +KS + + + + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------MRKDTL 213
+ E ++ ++ + + + + +Y+I EY+ ++ +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 214 TEDEARFYVAETVLAIESIHKHHYI-HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ + + + IH I HRD+KP N+L+DK G ++LSDFG +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE-------- 200
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
+ + + GT +++ PE +
Sbjct: 201 --------------------------------YMVDKKI---KGSRGTYEFMPPEFFSNE 225
Query: 333 G--YGMECDWWSLGAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEEAK------ 383
G + D WSLG +Y M PF + I ++++P +
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT--KNIEYPLDRNHFLYPL 283
Query: 384 -----------LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAA 431
LS E D + L N +R+ +++ H W + + +
Sbjct: 284 TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIEDLREFSKE 340
Query: 432 FIPEVN 437
+
Sbjct: 341 LYKKRK 346
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 1e-73
Identities = 75/332 (22%), Positives = 134/332 (40%), Gaps = 63/332 (18%)
Query: 102 ETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE 161
TE + Q + + +L IG G +V + +YA+K + E ++
Sbjct: 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLD 71
Query: 162 HVRAERNLLAEVD--SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR 219
R E L ++ S+ I++LY D+++Y++ME D+ + L +K ++ E +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 130
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
Y + A+ +IH+H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT--------- 180
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--------- 330
++ S VGT +Y+ PE +
Sbjct: 181 ------------------------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 331 --KKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIE 387
K + D WSLG I+Y M G PF + +S I++ ++FP+ +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKD 268
Query: 388 AKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
+D++ L + QR+ E+ HP+
Sbjct: 269 LQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 297
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 4e-73
Identities = 82/308 (26%), Positives = 140/308 (45%), Gaps = 54/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++++ +GKGAF VR C KTTG +A K + ++ R + + E + ++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S Q++ F YL+ + + GG++ ++ ++ +E +A + + + +I H +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---------------------------- 156
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y++PEVL K Y D W+ G I+Y +LV
Sbjct: 157 ------------EVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF+ +D +I +P ++ EAK LI +L N +R+ AD
Sbjct: 203 GYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TAD 257
Query: 410 EIKVHPWF 417
+ PW
Sbjct: 258 QALKVPWI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 3e-72
Identities = 72/305 (23%), Positives = 130/305 (42%), Gaps = 51/305 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + L IG+G+FG+ + + G Y +K++ S M + + E R E +LA +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKH 82
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIH 233
IV+ SF+++ LY++M+Y GGD+ + ED+ + + LA++ +H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+HRDIK N+ L K G ++L DFG+ + L+ +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV----------------------- 179
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
LA + +GTP Y++PE+ K Y + D W+LG ++YE+
Sbjct: 180 ------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
F + + KI++ + S + + L+S+L N R + I
Sbjct: 222 KHAFEAGSMKNLVLKIIS-GSFPPVSL--HYSYDLRSLVSQLFKRNPRDRP---SVNSIL 275
Query: 413 VHPWF 417
+
Sbjct: 276 EKGFI 280
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 1e-71
Identities = 80/376 (21%), Positives = 143/376 (38%), Gaps = 68/376 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IG G +V + +YA+K + E ++ R E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S+ I++LY D+++Y++ME D+ + L +K ++ E + Y + A+ +IH+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT------------------------ 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWSL 343
++ S VGT +Y+ PE + K + D WSL
Sbjct: 162 ---------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 344 GAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
G I+Y M G PF + +S I++ ++FP+ + +D++ L + Q
Sbjct: 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQ 264
Query: 402 RLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDT----QNFEKFEESDNQTKT 457
R+ E+ HP+ + + QM E+ L + ++
Sbjct: 265 RI---SIPELLAHPYVQ-IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 320
Query: 458 SSKTGPWRKMLSSKDI 473
G SSK
Sbjct: 321 HYSGGESHNSSSSKTF 336
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-71
Identities = 85/324 (26%), Positives = 134/324 (41%), Gaps = 63/324 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD- 174
+++E ++G+G VR C K T YA+K + + E L EVD
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 175 ------SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
I++L +++ + F +L+ + + G++ L K TL+E E R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
I ++HK + +HRD+KP+N+LLD +++L+DFG LD +
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD----PGEKLR----------- 181
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGMECDWWS 342
GTP Y+APE++ GYG E D WS
Sbjct: 182 ---------------------------EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NV 399
G IMY +L G PPF+ M R I+ + +F S KDL+S+ L
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQMLMLRMIM--SGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 400 NQRLGAKGADEIKVHPWFDGVDWA 423
+R A+E HP+F
Sbjct: 273 QKRY---TAEEALAHPFFQQYVVE 293
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-71
Identities = 86/308 (27%), Positives = 145/308 (47%), Gaps = 55/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + ++ M+GKG+FGEV C+++ T YA+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL+ +D Y++ E GG++ ++++ +E +A + + I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+N+LL +K +++ DFGL
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST---------------------------- 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+Q+N +M +GT YIAPEV L+ Y +CD WS G I+Y +L
Sbjct: 173 ------------CFQQNTKM--KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLS 217
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PPFY + +++ F +S +AKDLI K+L + + R+ A
Sbjct: 218 GTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
Query: 410 EIKVHPWF 417
E HPW
Sbjct: 276 E---HPWI 280
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-70
Identities = 83/310 (26%), Positives = 139/310 (44%), Gaps = 57/310 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F + ++G GAF EV + +++ TG ++A+K +KKS + + E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV L ++ YL+M+ + GG++ ++ + TE +A + + + A++ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL ++ + ++DFGL K +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST------------------- 166
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
GTP Y+APEVL +K Y D WS+G I Y +L
Sbjct: 167 ------------------------ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPFY + KI + +F +S AKD I LL + N+R +
Sbjct: 203 GYPPFYEETESKLFEKIK--EGYYEFESPFWDDISESAKDFICHLLEKDPNERY---TCE 257
Query: 410 EIKVHPWFDG 419
+ HPW DG
Sbjct: 258 KALSHPWIDG 267
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-70
Identities = 85/326 (26%), Positives = 142/326 (43%), Gaps = 57/326 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEHVRAERNLLAE 172
D +E+ +G G F VR CR+K TG YA K +KK + R E + E N+L E
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ I+ L+ F++ + LI+E + GG++ L K++LTEDEA ++ + + + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L ++L DFG+ ++ +F
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE----AGNEFK----------- 169
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 170 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGA 405
+L G PF + T I + F EE S AKD I +LL + +R+
Sbjct: 203 ILLSGASPFLGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTI 260
Query: 406 KGADEIKVHPWFDGVDWARIYQMEAA 431
+ E H W + + ++
Sbjct: 261 AQSLE---HSWIKAIRRRNVRGEDSG 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 4e-70
Identities = 73/311 (23%), Positives = 132/311 (42%), Gaps = 59/311 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D F +G GAFG+V + E+++G +K + K + +E + AE +L +D
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGD----MMTLLMRKDTLTEDEARFYVAETVLAIES 231
I+K++ F+D +Y++ME GG+ +++ R L+E + + + A+
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 232 IHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H +H+D+KP+N+L + +++ DFGL +
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE------------------------ 175
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
++ + + GT Y+APEV K+ +CD WS G +MY
Sbjct: 176 ----------------LFKSDEHS--TNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMY 216
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAK 406
+L G PF +K + E L+ +A DL+ ++L + +R A
Sbjct: 217 FLLTGCLPFTGTSLEEVQQKAT--YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAA 274
Query: 407 GADEIKVHPWF 417
++ H WF
Sbjct: 275 ---QVLHHEWF 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-70
Identities = 81/308 (26%), Positives = 139/308 (45%), Gaps = 54/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++++ +GKGAF VR C KTTG +A K + ++ R + + E + ++
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 87
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S Q++ F YL+ + + GG++ ++ ++ +E +A + + + +I H +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---------------------------- 179
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y++PEVL K Y D W+ G I+Y +LV
Sbjct: 180 ------------EVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF+ +D +I +P ++ EAK LI +L N +R+ A
Sbjct: 226 GYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITAD--- 280
Query: 410 EIKVHPWF 417
+ PW
Sbjct: 281 QALKVPWI 288
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 7e-70
Identities = 89/343 (25%), Positives = 150/343 (43%), Gaps = 64/343 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAE 172
D +++ +G G F V+ CREK+TG YA K +KK + + E + E ++L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
V + ++ L+ +++ + LI+E + GG++ L +K++L+E+EA ++ + + + +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L H++L DFGL ++ +F
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----DGVEFK----------- 176
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 177 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGA 405
+L G PF D T I F EE S AKD I KLL +RL
Sbjct: 210 ILLSGASPFLGDTKQETLANIT--SVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTI 267
Query: 406 KGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKF 448
+ A HPW VD + ++ +NF K
Sbjct: 268 QEALR---HPWITPVD-------NQQAMVRRESVVNLENFRKQ 300
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-69
Identities = 87/308 (28%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L IG+G++GEV++ +K T A KK+ K + V+ + E ++ +D
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++LY +F+D+ +YL+ME GG++ ++ K E +A + + + A+ HK
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ HRD+KP+N L L+L DFGL
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---------------------------- 157
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ + M + VGTP Y++P+V L+ YG ECD WS G +MY +L
Sbjct: 158 ------------RFKPGKMM--RTKVGTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLC 202
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF + KI FPE+ +S +A+ LI +LL + QR+ +
Sbjct: 203 GYPPFSAPTDSEVMLKIR--EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL--- 257
Query: 410 EIKVHPWF 417
+ H WF
Sbjct: 258 QALEHEWF 265
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 3e-69
Identities = 82/349 (23%), Positives = 134/349 (38%), Gaps = 87/349 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEV 173
+ L IG+G++G VRV E T + A+K + K+++ + VE ++ E L+ ++
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGD------------------------------- 202
I +LY ++D++++ L+ME GG
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 203 ---------MMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL--DK 251
E + + A+ +H HRDIKP+N L +K
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 252 YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311
++L DFGL K E
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGM---------------------------------- 231
Query: 312 MLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKI 369
+ GTP ++APEVL + YG +CD WS G +++ +L+G PF + T ++
Sbjct: 232 ---TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV 288
Query: 370 VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+N + + P LS A+DL+S LL NV++R A HPW
Sbjct: 289 LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM---RALQHPWI 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 3e-69
Identities = 87/321 (27%), Positives = 139/321 (43%), Gaps = 63/321 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
D++ + +G GA GEV++ E+ T A+K K +V E +L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+++ CI+K+ F D E Y+++E + GG++ ++ L E + Y + +LA++
Sbjct: 70 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 231 SIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H++ IHRD+KP+N+LL ++ ++++DFG K L E
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLM---------- 173
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLG 344
+ GTP Y+APEVL GY D WSLG
Sbjct: 174 ---------------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 345 AIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVN 400
I++ L GYPPF +S +I F E A++S +A DL+ KLL +
Sbjct: 207 VILFICLSGYPPFSEHRTQVSLKDQIT--SGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 401 QRLGAKGADEIKVHPWFDGVD 421
R +E HPW D
Sbjct: 265 ARF---TTEEALRHPWLQDED 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-69
Identities = 90/308 (29%), Positives = 148/308 (48%), Gaps = 54/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D ++ ++GKG+FGEV +C++K TG A+K + K ++ ++ E + E LL ++D
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KLY F+D + YL+ E GG++ ++ + +E +A + + + I +HK+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLLL K ++R+ DFGL
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLST---------------------------- 177
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
H++ +++M +GT YIAPEV L Y +CD WS G I+Y +L
Sbjct: 178 ------------HFEASKKM--KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLS 222
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PPF + +K+ + F K+S AKDLI K+L + R+ A+
Sbjct: 223 GCPPFNGANEYDILKKVE--KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISAR--- 277
Query: 410 EIKVHPWF 417
+ H W
Sbjct: 278 DALDHEWI 285
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 8e-69
Identities = 94/402 (23%), Positives = 161/402 (40%), Gaps = 82/402 (20%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEH 162
M + + D +++ +G G F V+ CREK+TG YA K +KK + R E
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 163 VRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+ E ++L +V I+ L+ +++ + LI+E + GG++ L +K++L+E+EA ++
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ + + +H H D+KP+N++L H++L DFGL ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----------- 170
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
+ + + GTP+++APE++ + G+E
Sbjct: 171 --------------------DGVEFK-----------NIFGTPEFVAPEIVNYEPLGLEA 199
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLL 396
D WS+G I Y +L G PF D T I F EE + S AKD I KLL
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANIT--AVSYDFDEEFFSQTSELAKDFIRKLL 257
Query: 397 C-NVNQRLGAKGADEIKVHPWFDGVD-------------------------WARIYQMEA 430
+RL + A HPW VD W + + +
Sbjct: 258 VKETRKRLTIQEALR---HPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVS 314
Query: 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKD 472
+ + E+ N + + RK L +
Sbjct: 315 LCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRR 356
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-68
Identities = 84/319 (26%), Positives = 140/319 (43%), Gaps = 59/319 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
D++ + +G GA GEV++ E+ T A++ K +V E +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+++ CI+K+ F D E Y+++E + GG++ ++ L E + Y + +LA++
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 231 SIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H++ IHRD+KP+N+LL ++ ++++DFG K L E
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLM---------- 298
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLG 344
+ GTP Y+APEVL GY D WSLG
Sbjct: 299 ---------------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 345 AIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
I++ L GYPPF +S +I + + + A++S +A DL+ KLL + R
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391
Query: 403 LGAKGADEIKVHPWFDGVD 421
+E HPW D
Sbjct: 392 F---TTEEALRHPWLQDED 407
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-68
Identities = 85/317 (26%), Positives = 136/317 (42%), Gaps = 62/317 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
++ +IG+G VR C + TGH +A+K + S E R E ++L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 171 AEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+V I+ L S++ F++L+ + + G++ L K L+E E R + + A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H ++ +HRD+KP+N+LLD +RLSDFG
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC------------------------- 248
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGMECDWWSL 343
H + ++ GTP Y+APE+L GYG E D W+
Sbjct: 249 ---------------HLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVN 400
G I++ +L G PPF+ + R I+ +F S KDLIS+LL +
Sbjct: 292 GVILFTLLAGSPPFWHRRQILMLRMIM--EGQYQFSSPEWDDRSSTVKDLISRLLQVDPE 349
Query: 401 QRLGAKGADEIKVHPWF 417
RL A++ HP+F
Sbjct: 350 ARL---TAEQALQHPFF 363
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 2e-68
Identities = 79/376 (21%), Positives = 142/376 (37%), Gaps = 68/376 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IG G +V + +YA+K + E ++ R E L ++
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 114
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S+ I++LY D+++Y++ME D+ + L +K ++ E + Y + A+ +IH+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT------------------------ 208
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWSL 343
++ S VG +Y+ PE + K + D WSL
Sbjct: 209 ---------------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 344 GAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
G I+Y M G PF + +S I++ ++FP+ + +D++ L + Q
Sbjct: 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQ 311
Query: 402 RLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDT----QNFEKFEESDNQTKT 457
R+ E+ HP+ + + QM E+ L + ++
Sbjct: 312 RI---SIPELLAHPYVQ-IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 367
Query: 458 SSKTGPWRKMLSSKDI 473
G SSK
Sbjct: 368 HYSGGESHNSSSSKTF 383
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-68
Identities = 86/336 (25%), Positives = 150/336 (44%), Gaps = 57/336 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + ++ M+GKG+FGEV C+++ T YA+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL+ +D Y++ E GG++ ++++ +E +A + + I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+N+LL +K +++ DFGL
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST---------------------------- 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+Q+N +M +GT YIAPEV L+ Y +CD WS G I+Y +L
Sbjct: 173 ------------CFQQNTKM--KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLS 217
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PPFY + +++ F +S +AKDLI K+L + + R+ A
Sbjct: 218 GTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT--- 272
Query: 410 EIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNF 445
+ HPW + + + + F
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPSLESAMTNI--RQF 306
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 5e-68
Identities = 80/316 (25%), Positives = 141/316 (44%), Gaps = 57/316 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAE 172
D ++ +G G F V+ CREK+TG YA K +KK + E + E ++L E
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ ++ L+ +++ + LI+E + GG++ L K++LTE+EA ++ + + + +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L +++ DFGL +D +F
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFK----------- 175
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 176 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGA 405
+L G PF D T + + +F +E S AKD I +LL + +R+
Sbjct: 209 ILLSGASPFLGDTKQETLANVS--AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 406 KGADEIKVHPWFDGVD 421
+ + + HPW D
Sbjct: 267 QDSLQ---HPWIKPKD 279
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 6e-68
Identities = 78/314 (24%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--VEHVRAERNLLAEV 173
D +EL +IGKG F VR C + TG +A+K + ++ E ++ E ++ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAI 229
IV+L ++ D LY++ E++ G D+ ++++ +E A Y+ + + A+
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 230 ESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
H ++ IHRD+KP +LL + ++L FG+ L S G G
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES---------GLVAGG-- 192
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
VGTP ++APEV+ ++ YG D W G I
Sbjct: 193 ------------------------------RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRL 403
++ +L G PFY I+ + K + +S AKDL+ ++L + +R+
Sbjct: 223 LFILLSGCLPFYGTKER-LFEGII--KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI 279
Query: 404 GAKGADEIKVHPWF 417
A HPW
Sbjct: 280 TVYEALN---HPWL 290
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-67
Identities = 73/309 (23%), Positives = 131/309 (42%), Gaps = 57/309 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLY 182
+G+G F VR C K+TG YA K LKK + + E +L S ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHR 240
+++ + LI+EY GG++ +L + + ++E++ + + + + +H+++ +H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 241 DIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
D+KP N+LL G +++ DFG+ + +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG------------------------------ 185
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+L+ +GTP+Y+APE+L D W++G I Y +L PF
Sbjct: 186 -HACELR-----------EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
+D T I + ++ + EE +S A D I LL N +R A+ H
Sbjct: 234 VGEDNQETYLNIS--QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS---H 288
Query: 415 PWFDGVDWA 423
W D+
Sbjct: 289 SWLQQWDFE 297
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 4e-67
Identities = 83/308 (26%), Positives = 142/308 (46%), Gaps = 53/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++++L +GKGAF VR C + G YA + L + + E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKH 69
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S ++ YLI + + GG++ ++ ++ +E +A + + + A+ H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL ++
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE------------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + + GTP Y++PEVL K YG D W+ G I+Y +LV
Sbjct: 165 --------------GEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF+ +D ++I FP ++ EAKDLI+K+L N ++R+ A A
Sbjct: 209 GYPPFWDEDQHRLYQQIK--AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 410 EIKVHPWF 417
+ HPW
Sbjct: 267 K---HPWI 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 5e-67
Identities = 87/309 (28%), Positives = 131/309 (42%), Gaps = 68/309 (22%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKL 181
+G+G+F R C K + +A+K + K + + E L + N IVKL
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPN-IVKL 71
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ F D +L+ME L GG++ + +K +E EA + + + V A+ +H +HRD
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 242 IKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
+KP+NLL + +++ DFG A K
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGF------------------------------ARLKPP 161
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
+ L+ + T Y APE+L + GY CD WSLG I+Y ML G PF
Sbjct: 162 DNQPLK-----------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
Query: 359 SDDPMSTC-------RKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGA 408
S D TC +KI + F E +S EAKDLI LL + N+RL
Sbjct: 211 SHDRSLTCTSAVEIMKKIK--KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS-- 266
Query: 409 DEIKVHPWF 417
++ + W
Sbjct: 267 -GLRYNEWL 274
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 5e-66
Identities = 80/314 (25%), Positives = 137/314 (43%), Gaps = 60/314 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D+E+L IG G++G + R K+ G + K+L M + + + +E NLL E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 176 NCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAI 229
IV+ Y D + LY++MEY GGD+ +++ + + L E+ + + LA+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 230 ESIHKHHY-----IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ H+ +HRD+KP N+ LD +++L DFGL + L+ T
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------------- 170
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
A + VGTP Y++PE + + Y + D WSLG
Sbjct: 171 ---------------------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403
++YE+ PPF + KI + P + S E ++I+++L R
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPY--RYSDELNEIITRMLNLKDYHRP 260
Query: 404 GAKGADEIKVHPWF 417
+EI +P
Sbjct: 261 ---SVEEILENPLI 271
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 5e-66
Identities = 88/336 (26%), Positives = 154/336 (45%), Gaps = 57/336 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++ + +G GA+GEV +CR+K T A+K ++K+ + + E +L +D
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDH 95
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KLY F+D YL+ME GG++ ++ + E +A + + + + +HKH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+NLLL +K +++ DFGL
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA---------------------------- 187
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ ++M +GT YIAPEV L+K Y +CD WS+G I++ +L
Sbjct: 188 ------------VFENQKKM--KERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLA 232
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF RK+ + F +S AKDLI ++L + +R+ A+
Sbjct: 233 GYPPFGGQTDQEILRKVE--KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ--- 287
Query: 410 EIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNF 445
+ HPW + + +E + + + + F
Sbjct: 288 QALEHPWIKEMCSKKESGIELPSLANAIENM--RKF 321
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 6e-66
Identities = 85/362 (23%), Positives = 156/362 (43%), Gaps = 58/362 (16%)
Query: 64 MKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTM 123
M+ + + K +++ D+ + + KK + D +++L
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDK--FYEDIWKKYVPQPVEVKQGSVYDYYDILEE 58
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G GAFG V C EK TG V+ K + V+ E +++ ++ ++ L+
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+F+D + LI+E+L GG++ + +D ++E E Y+ + ++ +H+H +H DI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 243 KPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
KP+N++ K +++ DFGL L+ ++ +
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLN----PDEIVKV---------------------- 209
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
T T ++ APE++ ++ G D W++G + Y +L G PF +
Sbjct: 210 ----------------TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253
Query: 361 DPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
D + T + + R +F E+A +S EAKD I LL +RL A E HPW
Sbjct: 254 DDLETLQNVK--RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE---HPWL 308
Query: 418 DG 419
G
Sbjct: 309 KG 310
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 6e-66
Identities = 74/308 (24%), Positives = 124/308 (40%), Gaps = 57/308 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + + +G+G FG V C E ++ Y K +K + V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMM-TLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I+ L+ SF+ E L +I E++ G D+ + L E E YV + A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 235 HHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ H DI+P+N++ + +++ +FG + L +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRL-------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
P+Y APEV D WSLG ++Y +L
Sbjct: 163 ------------------------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PF ++ I+ F EEA ++SIEA D + +LL R+ A A
Sbjct: 199 GINPFLAETNQQIIENIM--NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256
Query: 410 EIKVHPWF 417
+ HPW
Sbjct: 257 Q---HPWL 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 1e-65
Identities = 89/318 (27%), Positives = 145/318 (45%), Gaps = 64/318 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM----------LRRGQVEHVRA 165
+ + + +G GA+GEV +C+EK A+K +KKS+ E +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E +LL +D I+KL+ F+D ++ YL+ E+ GG++ ++ + E +A + +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 226 VLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ I +HKH+ +HRDIKP+N+LL + ++++ DFGL
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS------------------ 197
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ K+ ++ +GT YIAPEV LKK Y +CD WS
Sbjct: 198 ----------------------FFSKDYKL--RDRLGTAYYIAPEV-LKKKYNEKCDVWS 232
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NV 399
G IMY +L GYPPF + +K+ + F +S EAK+LI +L +
Sbjct: 233 CGVIMYILLCGYPPFGGQNDQDIIKKVE--KGKYYFDFNDWKNISDEAKELIKLMLTYDY 290
Query: 400 NQRLGAKGADEIKVHPWF 417
N+R A+ E W
Sbjct: 291 NKRCTAE---EALNSRWI 305
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-65
Identities = 65/323 (20%), Positives = 109/323 (33%), Gaps = 81/323 (25%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DF+ + +IG G FG+V + + G Y +K++K + E E LA++D
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62
Query: 175 SNCIVKLYCSFQDDE----------------FLYLIMEYLPGGDMMTLL--MRKDTLTED 216
IV + + L++ ME+ G + + R + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
A + ++ IH I+RD+KP N+ L +++ DFGL L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---------- 172
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
+ GT Y++PE + + YG
Sbjct: 173 --------------------------------KNDGKRTRSKGTLRYMSPEQISSQDYGK 200
Query: 337 ECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKL 395
E D ++LG I+ E+L V F + + R + + K L+ KL
Sbjct: 201 EVDLYALGLILAELLHVCDTAFETSKFFTDLRDG-------IISD--IFDKKEKTLLQKL 251
Query: 396 LC-NVNQRLGAKGADEIKVHPWF 417
L R EI
Sbjct: 252 LSKKPEDRP---NTSEILRTLTV 271
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-65
Identities = 87/358 (24%), Positives = 149/358 (41%), Gaps = 58/358 (16%)
Query: 68 QERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG--ADDFELLTMIG 125
++RR ++ E+ N + + Y + K D +++ +G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 126 KGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185
GAFG V E+ TG+ +A K + E VR E ++ + +V L+ +F
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 186 QDDEFLYLIMEYLPGGDMM-TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244
+DD + +I E++ GG++ + + ++EDEA Y+ + + +H+++Y+H D+KP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 245 DNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
+N++ + L+L DFGL LD +Q +
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLD----PKQSVKV------------------------ 315
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
T GT ++ APEV K G D WS+G + Y +L G PF ++
Sbjct: 316 --------------TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 363 MSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
T R + + A +S + KD I KLL + N R+ A E HPW
Sbjct: 362 DETLRNVK--SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE---HPWL 414
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-65
Identities = 83/316 (26%), Positives = 134/316 (42%), Gaps = 62/316 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E+ IG G++ + C K T +A+K + KS+ ++E LL
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------LLRYGQH 75
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+ L + D +++Y++ E + GG+++ ++R+ +E EA + +E +H
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 236 HYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HRD+KP N+L +R+ DFG K L
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL------------------------- 170
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + L + T +++APEVL ++GY CD WSLG ++Y ML
Sbjct: 171 -----RAENGLL-----------MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
Query: 352 VGYPPFYS---DDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGA 405
GY PF + D P +I +S AKDL+SK+L + +QRL
Sbjct: 215 TGYTPFANGPDDTPEEILARIG--SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL-- 270
Query: 406 KGADEIKVHPWFDGVD 421
A + HPW D
Sbjct: 271 -TAALVLRHPWIVHWD 285
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-65
Identities = 88/311 (28%), Positives = 140/311 (45%), Gaps = 59/311 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D FE+ + +G+GA V C++K T YA+K LKK+ + VR E +L +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSH 107
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL F+ + L++E + GG++ ++ K +E +A V + + A+ +H++
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL L+++DFGL K
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---------------------------- 199
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ M + GTP Y APE+L YG E D WS+G I Y +L
Sbjct: 200 ------------IVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245
Query: 353 GYPPFYSD-DPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGA 408
G+ PFY + R+I+ F ++S+ AKDL+ KL+ + +RL A
Sbjct: 246 GFEPFYDERGDQFMFRRIL--NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
Query: 409 DEIKVHPWFDG 419
+ HPW G
Sbjct: 304 LQ---HPWVTG 311
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-64
Identities = 89/317 (28%), Positives = 136/317 (42%), Gaps = 68/317 (21%)
Query: 116 DDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD++L ++G G G+V C + TG A+K L S R+ +V+H
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-EVDH------HWQASG 80
Query: 175 SNCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLA 228
IV + +++ L +IME + GG++ + + + TE EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 229 IESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
I+ +H H+ HRD+KP+NLL +K L+L+DFG K + LQ
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ------------- 187
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ TP Y+APEVL + Y CD WSLG
Sbjct: 188 ------------------------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVN--WRTHLKFPEE--AKLSIEAKDLISKLLC-NVN 400
IMY +L G+PPFYS+ + + FP +++S +AK LI LL +
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPT 277
Query: 401 QRLGAKGADEIKVHPWF 417
+RL + HPW
Sbjct: 278 ERL---TITQFMNHPWI 291
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 4e-64
Identities = 77/307 (25%), Positives = 134/307 (43%), Gaps = 56/307 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
++G G FG+V C E TG A K +K M + E V+ E +++ ++D
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKH 235
+++LY +F+ + L+MEY+ GG++ ++ + LTE + ++ + I +H+
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 236 HYIHRDIKPDNLLL-DKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +H D+KP+N+L ++ +++ DFGL +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-------------------------- 240
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
++ GTP+++APEV+ D WS+G I Y +L G
Sbjct: 241 --------------PREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGADE 410
PF D+ T I+ +E +S EAK+ ISKLL + R+ A A +
Sbjct: 285 LSPFLGDNDAETLNNIL--ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 411 IKVHPWF 417
HPW
Sbjct: 343 ---HPWL 346
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 5e-64
Identities = 67/349 (19%), Positives = 117/349 (33%), Gaps = 90/349 (25%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ L ++G+GA V R K TG ++A+K LR V+ E +L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLK 62
Query: 172 EVDSNCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETV 226
+++ IVKL+ ++ LIME+ P G + T+L L E E + + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 227 LAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ +HR+IKP N++ D +L+DFG + L+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------------ 170
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--------LKKGY 334
S GT +Y+ P++ +K Y
Sbjct: 171 ------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------------------WR 373
G D WS+G Y G PF + ++++
Sbjct: 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260
Query: 374 THLKFPEEAKLSIEAKDLISKLL-----CNVNQRLGAKGADEIKVHPWF 417
P LS + L++ +L + + G D+
Sbjct: 261 WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETSD 306
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 1e-63
Identities = 79/323 (24%), Positives = 131/323 (40%), Gaps = 67/323 (20%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVK 180
++G+GA V+ C T YA+K ++K R V E +L + +++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQC-QGHRNVLE 75
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L F++++ YL+ E + GG +++ + ++ E EA V + A++ +H HR
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 241 DIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
D+KP+N+L ++ +++ DF L +
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIK------------------------------ 165
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYEMLV 352
+ + G+ +Y+APEV+ Y CD WSLG I+Y +L
Sbjct: 166 --LNGDCSPISTPEL--LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
Query: 353 GYPPFYSDDPMSTCRKIVNWRT-------------HLKFPEE--AKLSIEAKDLISKLLC 397
GYPPF +FP++ A +S AKDLISKLL
Sbjct: 222 GYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLV 281
Query: 398 -NVNQRLGAKGADEIKVHPWFDG 419
+ QRL A ++ HPW G
Sbjct: 282 RDAKQRL---SAAQVLQHPWVQG 301
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 3e-63
Identities = 88/329 (26%), Positives = 140/329 (42%), Gaps = 76/329 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ L IGKG++G V++ + YAMK L K +++R+ R
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 178 -----------------------IVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDT 212
+VKL D ++ LY++ E + G +M +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKP 133
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
L+ED+ARFY + + IE +H IHRDIKP NLL+ + GH++++DFG+
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--------- 184
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--L 330
+ K L +TVGTP ++APE L
Sbjct: 185 --------------------------------NEFKGSDALLSNTVGTPAFMAPESLSET 212
Query: 331 KKGY-GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAK 389
+K + G D W++G +Y + G PF + M KI L+FP++ ++ + K
Sbjct: 213 RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK--SQALEFPDQPDIAEDLK 270
Query: 390 DLISKLLC-NVNQRLGAKGADEIKVHPWF 417
DLI+++L N R+ EIK+HPW
Sbjct: 271 DLITRMLDKNPESRI---VVPEIKLHPWV 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-63
Identities = 69/323 (21%), Positives = 126/323 (39%), Gaps = 57/323 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DFE + +G+G FG V + K YA+K+++ E V E LA+++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 176 NCIVKLYCSFQDDE------------FLYLIMEYLPGGDMMTLLMRKDTLTEDEARF--- 220
IV+ + ++ + +LY+ M+ ++ + + T+ E E
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ A+E +H +HRD+KP N+ +++ DFGL +D
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD------------- 169
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ ++EQ VGT Y++PE + Y + D
Sbjct: 170 ----------------QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-N 398
+SLG I++E+L YP + + T + N LKFP + ++ +L +
Sbjct: 214 FSLGLILFELL--YPFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPS 267
Query: 399 VNQRLGAKGADEIKVHPWFDGVD 421
+R A I + F+ +D
Sbjct: 268 PMERP---EAINIIENAVFEDLD 287
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-62
Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 53/289 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+F + IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIES 231
++K Y SF +D L +++E GD+ ++ +K + E Y + A+E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H +HRDIKP N+ + G ++L D GL + T
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 190
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 191 --------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 352 VGYPPFYSDD--PMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLL 396
PFY D S C+KI +P S E + L++ +
Sbjct: 231 ALQSPFYGDKMNLYSLCKKIEQ----CDYPPLPSDHYSEELRQLVNMCI 275
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-62
Identities = 91/322 (28%), Positives = 132/322 (40%), Gaps = 77/322 (23%)
Query: 116 DDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD+++ + ++G G G+V K T +A+K L+ RR E L
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA- 111
Query: 175 SNC--IVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVA 223
S C IV++ +++ + L ++ME L GG+ L R TE EA +
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMK 168
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
AI+ +H + HRD+KP+NLL L+L+DFG
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------ 210
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
A + T L + TP Y+APEVL + Y CD
Sbjct: 211 -------------AKETTSHNSLT-----------TPCYTPYYVAPEVLGPEKYDKSCDM 246
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN--WRTHLKFPEE--AKLSIEAKDLISKLL 396
WSLG IMY +L GYPPFYS+ ++ + +FP +++S E K LI LL
Sbjct: 247 WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 306
Query: 397 C-NVNQRLGAKGADEIKVHPWF 417
QR+ E HPW
Sbjct: 307 KTEPTQRMTIT---EFMNHPWI 325
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-62
Identities = 71/307 (23%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA-----------------------------TVF 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
+ +E+L + GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 156 RYNNRERLLN----------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 355 PPFYSDDPMSTC---RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410
P+ D P +C K+ L+ K+L N + R+ +
Sbjct: 206 LPW--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPD 258
Query: 411 IKVHPWF 417
IK W+
Sbjct: 259 IKKDRWY 265
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 4e-62
Identities = 65/331 (19%), Positives = 115/331 (34%), Gaps = 55/331 (16%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
+E Y + + + + +G+G F V + GH YA+K++ E
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDR 70
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEF----LYLIMEYLPGGD----MMTLLMRKDT 212
E + E ++ + I++L + +L++ + G + L + +
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
LTED+ + + +E+IH Y HRD+KP N+LL G L D G
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA------ 184
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
Q LQ W + T Y APE+ +
Sbjct: 185 ------------------CIHVEGSRQALTLQDW--------AAQRCTISYRAPELFSVQ 218
Query: 333 GY---GMECDWWSLGAIMYEMLVGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIE 387
+ D WSLG ++Y M+ G P+ S + N L P+ + S
Sbjct: 219 SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---QLSIPQSPRHSSA 275
Query: 388 AKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L++ ++ + +QR +
Sbjct: 276 LWQLLNSMMTVDPHQRP---HIPLLLSQLEA 303
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-61
Identities = 37/357 (10%), Positives = 96/357 (26%), Gaps = 106/357 (29%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--------------- 167
++G+ ++ TG + + +E ++ ++ E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 168 ----------NLLAEVDSNCIVKLYCSFQDDEFL--YLIME------YLPGGDMMTLLMR 209
+L+ + ++++ +D L + + G +++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+L + + + S+H + +H ++P +++LD+ G + L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ + + PE+
Sbjct: 260 V---------------------------------------------VSSVSRGFEPPELE 274
Query: 330 L-----------KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKF 378
+ D W+LG ++Y + P D + I F
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--------F 326
Query: 379 PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIP 434
+ + L+ L RL + P ++ + +A +P
Sbjct: 327 RSCKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLR-----TELSAALP 375
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-61
Identities = 75/354 (21%), Positives = 131/354 (37%), Gaps = 65/354 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLLA 171
+ ++ +G GAFG V +K +K K+ + + ++ V E +L+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIME-YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
V+ I+K+ F++ F L+ME + G D+ + R L E A + + V A+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ IHRDIK +N+++ + ++L DFG G
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY----------LERGKLFY------- 187
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYE 349
+ GT +Y APEVL+ Y G E + WSLG +Y
Sbjct: 188 -------------------------TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
++ PF + V + P +S E L+S LL +R
Sbjct: 223 LVFEENPFCEL------EETV--EAAIHPPY--LVSKELMSLVSGLLQPVPERRT---TL 269
Query: 409 DEIKVHPWF-DGVDWARIYQMEAAFIPEV-NDELDTQNFEKFEESDNQTKTSSK 460
+++ PW V+ A E + + + L + E S + + +
Sbjct: 270 EKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-61
Identities = 75/313 (23%), Positives = 125/313 (39%), Gaps = 67/313 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE---HVRAERNLLAE 172
++ L ++GKG FG V T A+K + ++ +L + E LL +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 173 VDSNC----IVKLYCSFQDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
V + +++L F+ E L++E LP D+ + K L E +R + + V
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
AI+ H +HRDIK +N+L+D + G +L DFG + L ++ +T
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS-----GALLHDEPYT--------- 196
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 345
GT Y PE + + Y + WSLG
Sbjct: 197 -----------------------------DFDGTRVYSPPEWISRHQYHALPATVWSLGI 227
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404
++Y+M+ G PF D ++I+ L FP +S + LI + L + R
Sbjct: 228 LLYDMVCGDIPFERD------QEILEAE--LHFPA--HVSPDCCALIRRCLAPKPSSRP- 276
Query: 405 AKGADEIKVHPWF 417
+EI + PW
Sbjct: 277 --SLEEILLDPWM 287
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 5e-61
Identities = 82/311 (26%), Positives = 136/311 (43%), Gaps = 53/311 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R K+G + L +G G FG+V++ + TGH A+K L + ++ V ++ E
Sbjct: 6 GRVKIG--HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L I+KLY +++MEY+ GG++ + + + E EAR + + A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ H+H +HRD+KP+N+LLD + + +++DFGL N
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------N 159
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
RT + G+P+Y APEV+ + Y G E D WS G I+
Sbjct: 160 MMSDGEFLRT------------------SCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
Y +L G PF + + +KI PE L+ L+ +L + +R
Sbjct: 202 YALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEY--LNRSVATLLMHMLQVDPLKRA--- 254
Query: 407 GADEIKVHPWF 417
+I+ H WF
Sbjct: 255 TIKDIREHEWF 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 8e-61
Identities = 90/355 (25%), Positives = 139/355 (39%), Gaps = 57/355 (16%)
Query: 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
H ++ + IG G FG R+ R+K T + A+K +++ + E+V+ E
Sbjct: 17 HDSD--RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINH 70
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+ IV+ L +IMEY GG++ + +EDEARF+ + + +
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 231 SIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H HRD+K +N LLD L++ DFG S
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY------SKSSVLH------------- 171
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
Q + STVGTP YIAPEVLL++ Y G D WS G +
Sbjct: 172 ------------SQPK-----------STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404
Y MLVG PF + RK + P++ ++S E LIS++ + R+
Sbjct: 209 YVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRIS 268
Query: 405 AKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSS 459
EIK H WF A + E Q+ + + ++ +
Sbjct: 269 IP---EIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPA 320
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-60
Identities = 71/307 (23%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA-----------------------------TVF 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
+ +E+L + GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 156 RYNNRERLLN----------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 355 PPFYSDDPMSTC---RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410
P+ D P +C K+ L+ K+L N + R+ +
Sbjct: 206 LPW--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPD 258
Query: 411 IKVHPWF 417
IK W+
Sbjct: 259 IKKDRWY 265
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 9e-60
Identities = 68/334 (20%), Positives = 117/334 (35%), Gaps = 87/334 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L ++G+GA V R K TG ++A+K LR V+ E +L +++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 176 NCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIE 230
IVKL+ ++ LIME+ P G + T+L L E E + + V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 231 SIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ ++ +HR+IKP N++ D +L+DFG + L+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------------------- 167
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--------LKKGYGMEC 338
EQ S GT +Y+ P++ +K YG
Sbjct: 168 ------------DDEQFV-----------SLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------------------WRTHLK 377
D WS+G Y G PF + ++++
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
Query: 378 FPEEAKLSIEAKDLISKLL-----CNVNQRLGAK 406
P LS + L++ +L + + G
Sbjct: 265 MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 8e-59
Identities = 73/311 (23%), Positives = 124/311 (39%), Gaps = 65/311 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH---VRAERNLLAE 172
+++ ++G G FG V + A+K ++K + G++ + V E LL +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 173 VDSNC--IVKLYCSFQDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
V S +++L F+ + LI+E P D+ + + L E+ AR + + + A+
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 230 ESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H +HRDIK +N+L+D G L+L DFG L
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-----------------AL------ 199
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
+ + GT Y PE + Y G WSLG ++
Sbjct: 200 ---------LKDTVYTDF-----------DGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
Y+M+ G PF D +I+ + + F + ++S E + LI L + R
Sbjct: 240 YDMVCGDIPFEHD------EEIIRGQ--VFFRQ--RVSSECQHLIRWCLALRPSDRP--- 286
Query: 407 GADEIKVHPWF 417
+EI+ HPW
Sbjct: 287 TFEEIQNHPWM 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-58
Identities = 78/394 (19%), Positives = 137/394 (34%), Gaps = 85/394 (21%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+G F ++G GA G + V R A+K++ E LL
Sbjct: 20 IVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPE------CFSFADREVQLLR 72
Query: 172 EVDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
E D N +++ +C+ +D +F Y+ +E + + +KD E + +T
Sbjct: 73 ESDEHPN-VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ +H + +HRD+KP N+L+ +SDFGLCK L
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA---------------V 175
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDW 340
G + R GT +IAPE+L K+ D
Sbjct: 176 GRHSFSRR-----------------------SGVPGTEGWIAPEMLSEDCKENPTYTVDI 212
Query: 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC- 397
+S G + Y ++ G PF I+ L E + A++LI K++
Sbjct: 213 FSAGCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAM 270
Query: 398 NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDEL-----DTQNFEKFEESD 452
+ +R A + HP+F + + F +V+D + D ++ E
Sbjct: 271 DPQKRP---SAKHVLKHPFF------WSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGG 321
Query: 453 NQTKTSSKTGPWRKMLSSKDINFVG----YTYKN 482
WR+ ++ + Y +
Sbjct: 322 RAV----VKMDWRENITVPLQTDLRKFRTYKGGS 351
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-58
Identities = 81/303 (26%), Positives = 138/303 (45%), Gaps = 52/303 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
++ LL IGKG F +V++ R TG A+K + K++ L ++ + E ++ ++
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHP 74
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IVKL+ + ++ LYLIMEY GG++ L+ + E EAR + V A++ H+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+K +NLLLD +++++DFG +FT+G L+
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFS----------NEFTVGGKLDAF----------- 173
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYP 355
G P Y APE+ K Y G E D WSLG I+Y ++ G
Sbjct: 174 ---------------------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
PF + +++ K+ +S + ++L+ + L N +R ++I
Sbjct: 213 PFDGQNLKELRERVLR----GKYRIPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKD 265
Query: 415 PWF 417
W
Sbjct: 266 RWI 268
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 4e-58
Identities = 88/355 (24%), Positives = 156/355 (43%), Gaps = 54/355 (15%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA 165
M + + +G + + +G+G+FG+V++ T A+K + + + + V
Sbjct: 1 MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E + L + I+KLY + +++EY GG++ ++ K +TEDE R + +
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ AIE H+H +HRD+KP+NLLLD +++++DFGL
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS---------------------- 155
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLG 344
N +T + G+P+Y APEV+ K Y G E D WS G
Sbjct: 156 --NIMTDGNFLKT------------------SCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403
++Y MLVG PF + + +K+ P+ LS A+ LI +++ + QR+
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVN--SCVYVMPDF--LSPGAQSLIRRMIVADPMQRI 251
Query: 404 GAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTS 458
EI+ PWF+ + ME + + ++ E S++ +
Sbjct: 252 ---TIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEA 303
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-58
Identities = 82/408 (20%), Positives = 139/408 (34%), Gaps = 97/408 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++G G+ G V V + G A+K++ + E LL E D
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67
Query: 176 -NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVL 227
+++ YCS D FLY+ +E ++ L+ K+ E + +
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-------------KYGHLRLSDFGLCKPLDCSTLQEQ 274
+ +H IHRD+KP N+L+ + + +SDFGLCK L
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK-----KLDSG 181
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---- 330
+ NLN GT + APE+L
Sbjct: 182 QSSFRTNLNNP--------------------------------SGTSGWRAPELLEESNN 209
Query: 331 ---KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWR---THLKFPEEAK 383
K+ D +S+G + Y +L G PF + I+ +K +
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRS 267
Query: 384 LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDT 442
L EA DLIS+++ + +R A ++ HP F + F+ +V+D L+
Sbjct: 268 LIAEATDLISQMIDHDPLKRPTAM---KVLRHPLF------WPKSKKLEFLLKVSDRLEI 318
Query: 443 QNFEKFEESDNQTKTSSKT----GPWRKMLSSKDI----NFVGYTYKN 482
+N + + S G W + + Y
Sbjct: 319 ENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSK 366
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-57
Identities = 91/353 (25%), Positives = 154/353 (43%), Gaps = 54/353 (15%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R K+G + L +G G FG+V+V + + TGH A+K L + ++ V +R E
Sbjct: 11 GRVKIG--HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L I+KLY ++++MEY+ GG++ + + L E E+R + +
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ H+H +HRD+KP+N+LLD + + +++DFGL N
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------N 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
RT + G+P+Y APEV+ + Y G E D WS G I+
Sbjct: 165 MMSDGEFLRT------------------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
Y +L G PF D + +KI P+ L+ L+ +L + +R K
Sbjct: 207 YALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQY--LNPSVISLLKHMLQVDPMKRATIK 262
Query: 407 GADEIKVHPWF-DGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTS 458
+I+ H WF + + + ++DE + EKFE S+ + +
Sbjct: 263 ---DIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSC 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 7e-56
Identities = 38/335 (11%), Positives = 89/335 (26%), Gaps = 90/335 (26%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE---------- 172
++G+ ++ TG + + +E ++ ++ E L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 173 ------------VDSNCIVKLYCSFQDDEFLYLIMEYLP-----------GGDMMTLLMR 209
V K+ D+ ++++ + G +++
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+L + + + S+H + +H ++P +++LD+ G + L+ F S
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ + P+ A +L
Sbjct: 265 AV-----SPIG-----------------------------------RGFAPPETTAERML 284
Query: 330 L-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL 384
D W+LG +Y + P D + I F +
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--------FRSCKNI 336
Query: 385 SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
+ L+ L RL + P ++
Sbjct: 337 PQPVRALLEGFLRYPKEDRL---LPLQAMETPEYE 368
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 8e-56
Identities = 73/380 (19%), Positives = 126/380 (33%), Gaps = 80/380 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E+ +G G FG V + TG A+K+ ++ L E E ++ +++
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNH 71
Query: 176 NCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETV 226
+V + L L MEY GGD+ L + + L E R +++
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
A+ +H++ IHRD+KP+N++L ++ D G K LD
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---------------- 175
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
Q E VGT Y+APE+L +K Y + D+WS
Sbjct: 176 ---------------QGELCT-----------EFVGTLQYLAPELLEQKKYTVTVDYWSF 209
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIV----------------NWRTHLKFPEEAKLSIE 387
G + +E + G+ PF + V + P LS
Sbjct: 210 GTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGI 269
Query: 388 AKDLISKLL-----CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDT 442
+ + L + QR + F +D ++ +
Sbjct: 270 LAGKLERWLQCMLMWHQRQRG---TDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTY 326
Query: 443 QNFEKFEESDNQTKTSSKTG 462
E + ++ TG
Sbjct: 327 PVTENENLQNLKSWLQQDTG 346
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-55
Identities = 66/308 (21%), Positives = 122/308 (39%), Gaps = 55/308 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE-HVRAERNLLAEVDSN 176
+ + ++G+G++G+V+ + T A+K LKK ++ R E +V+ E LL +
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 177 CIVKLY--CSFQDDEFLYLIMEYLPGG--DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+++L ++ + +Y++MEY G +M+ + K +A Y + + +E +
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYL 125
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +H+DIKP NLLL G L++S G+
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVA----------------------------- 156
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGY-GMECDWWSLGAIMYEM 350
A + ++ G+P + PE+ + G + D WS G +Y +
Sbjct: 157 EALHPFAADDTCR----------TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206
Query: 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PF D+ I + P + DL+ +L +R
Sbjct: 207 TTGLYPFEGDNIYKLFENIG--KGSYAIPGD--CGPPLSDLLKGMLEYEPAKRF---SIR 259
Query: 410 EIKVHPWF 417
+I+ H WF
Sbjct: 260 QIRQHSWF 267
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-54
Identities = 52/312 (16%), Positives = 101/312 (32%), Gaps = 49/312 (15%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+F L IG G FG V C ++ G +YA+K+ KK + +R
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIE 230
+ +V+ + ++ +D+ + + EY GG + + E E + + + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ---DFTIGNNLNGSSQ 287
IH +H DIKP N+ + + + + S D ++
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--- 186
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
G ++A EVL + + D ++L
Sbjct: 187 --------------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALT 220
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLG 404
+ P + D +I + P LS E +L+ ++ + +R
Sbjct: 221 VVCAAGAEPLPRNGDQW---HEIRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273
Query: 405 AKGADEIKVHPW 416
A + H
Sbjct: 274 AM---ALVKHSV 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-54
Identities = 45/342 (13%), Positives = 79/342 (23%), Gaps = 89/342 (26%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+L+ + G V + R+ +A+K R ++E + A +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 177 CIVKLYCSFQ--------------------------DDEFLYLIMEYLPGGDMMTLL--- 207
+ + L+M D+ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 208 ----MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263
+ + A+ + ++ +H PDNL + G L L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323
+ ++ Y
Sbjct: 242 WKVGTRG--------------------------------------------PASSVPVTY 257
Query: 324 IAPEVLLKKG--YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW-----RTHL 376
E L + + W LG +Y + + PF P L
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317
Query: 377 KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
F L K LI + L + +RL E P F
Sbjct: 318 AFGSCTPLPDFVKTLIGRFLNFDRRRRL---LPLEAMETPEF 356
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-54
Identities = 73/334 (21%), Positives = 120/334 (35%), Gaps = 56/334 (16%)
Query: 85 DVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVY 144
+ + + L + L+ + EY + +G+G+FGEV ++K TG
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEY------REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 145 AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMM 204
A+KK++ E A + S IV LY + ++ ++ + ME L GG +
Sbjct: 87 AVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 205 TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLC 263
L+ + L ED A +Y+ + + +E +H +H D+K DN+LL G L DFG
Sbjct: 139 QLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323
L L + GT +
Sbjct: 199 LCLQPDGL------------------------------------GKSLLTGDYIPGTETH 222
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAK 383
+APEV++ K + D WS +M ML G P+ C KI +
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPIREIPPS 281
Query: 384 LSIEAKDLISK-LLCNVNQRLGAKGADEIKVHPW 416
+ I + L R A E++
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAM---ELRRKVG 312
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 2e-54
Identities = 49/330 (14%), Positives = 96/330 (29%), Gaps = 74/330 (22%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAE 166
++G+ + ++G+GAF +V + + +K K + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFY 221
L + +K Y + L+ E G ++ + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLL-----------DKYGHLRLSDFGLCKPLDCST 270
+ IE +H IH DIKPDN +L D L L D G
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI------ 231
Query: 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
++ + K + T + E+L
Sbjct: 232 -------------------------------DMKLFPKGTIF--TAKCETSGFQCVEMLS 258
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
K + + D++ + A +Y ML G ++ + F L + +
Sbjct: 259 NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------CKPEGLFRRLPHLDM-WNE 310
Query: 391 LISKLLCNVNQ--RLGAKGADEIKVHPWFD 418
+L N+ L + K+ F
Sbjct: 311 FFHVML-NIPDCHHLPSLDLLRQKLKKVFQ 339
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 6e-50
Identities = 87/307 (28%), Positives = 132/307 (42%), Gaps = 57/307 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
+ F L IGKG+FGEV + T V A+K L+++E ++E ++ E +L++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQ 76
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
DS + K Y S+ D L++IMEYL GG + L + L E + + E + ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYL 135
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRDIK N+LL ++G ++L+DFG+ L T
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQI-------------------- 174
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
KR + VGTP ++APEV+ + Y + D WSLG E+
Sbjct: 175 ---KRN-----------------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410
G PP PM I P E S K+ + L + R AK E
Sbjct: 215 GEPPHSELHPMKVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAK---E 267
Query: 411 IKVHPWF 417
+ H +
Sbjct: 268 LLKHKFI 274
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 8e-50
Identities = 83/293 (28%), Positives = 138/293 (47%), Gaps = 49/293 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+GA G V + TG A++++ + ++ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV S+ + L+++MEYL GG + T ++ + + E + E + A+E +H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK DN+LL G ++L+DFG C + P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------------------------PEQS 171
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KR+ + VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 172 KRS-----------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 356 PFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
P+ +++P+ I T L+ PE KLS +D +++ L +V +R AK
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSAK 265
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 49/293 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+G+ G V + REK +G A+K + + RR E + E ++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQH 101
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V++Y S+ E L+++ME+L GG + T ++ + L E++ + A+ +H
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK D++LL G ++LSDFG C + P
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS------------------------KDVP 196
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KR S VGTP ++APEV+ + Y E D WSLG ++ EM+ G P
Sbjct: 197 KRK-----------------SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 356 PFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
P++SD P+ +++ + LK K+S +D + ++L + +R A+
Sbjct: 240 PYFSDSPVQAMKRLRDSPPPKLKNSH--KVSPVLRDFLERMLVRDPQERATAQ 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-48
Identities = 75/321 (23%), Positives = 127/321 (39%), Gaps = 61/321 (19%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
DD+EL +IG GA V+ A+K L+K + ++ + E +++
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQ 69
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKD-----TLTEDEARFYVAE 224
IV Y SF + L+L+M+ L GG D++ ++ K L E + E
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ +E +HK+ IHRD+K N+LL + G ++++DFG+ L
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL------------------ 171
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
+ + R + VGTP ++APEV+ + +GY + D WS
Sbjct: 172 -ATGGDITRNKVRK-----------------TFVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT------HLKFPEEAKLSIEAKDLISKLLC 397
G E+ G P++ PM + K + +IS L
Sbjct: 214 GITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ 273
Query: 398 -NVNQRLGAKGADEIKVHPWF 417
+ +R A E+ H +F
Sbjct: 274 KDPEKRPTAA---ELLRHKFF 291
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-48
Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 61/304 (20%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++GKG +G V R+ + A+K + S + + E L + IV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQ 83
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHY 237
SF ++ F+ + ME +PGG + LL K E FY + + ++ +H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 238 IHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRDIK DN+L++ Y G L++SDFG K
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSK-------------------------------- 171
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGY 354
+L + GT Y+APE++ K +GYG D WSLG + EM G
Sbjct: 172 -----RLAGINPCTE----TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
Query: 355 PPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISK-LLCNVNQRLGAKGADEIK 412
PPFY +P + K+ ++ H + PE +S EAK I K + ++R A ++
Sbjct: 223 PPFYELGEPQAAMFKVGMFKVHPEIPES--MSAEAKAFILKCFEPDPDKRACAN---DLL 277
Query: 413 VHPW 416
V +
Sbjct: 278 VDEF 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-47
Identities = 83/296 (28%), Positives = 129/296 (43%), Gaps = 55/296 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ F++L +G+G++G V K TG + A+K++ ++ + E +++ + DS
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+VK Y S+ + L+++MEY G D++ L R TLTEDE + T+ +E +
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYL 141
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRDIK N+LL+ GH +L+DFG+ L
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT------------------------D 177
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
KR + +GTP ++APEV+ + GY D WSLG EM
Sbjct: 178 TMAKRN-----------------TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 353 GYPPFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
G PP+ PM I + PE S D + + L + QR A
Sbjct: 221 GKPPYADIHPMRAIFMIPTNPPPTFRKPE--LWSDNFTDFVKQCLVKSPEQRATAT 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 9e-47
Identities = 66/325 (20%), Positives = 120/325 (36%), Gaps = 58/325 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q ++G + ++ +G F V ++ +G YA+K+L +E + + E
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVC 77
Query: 169 LLAEVDSN-CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLLMR---KDTLTEDE 217
+ ++ + IV+ + + +L++ L G ++ L + + L+ D
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 218 ARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+T A++ +H+ IHRD+K +NLLL G ++L DFG +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI--------- 188
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKK 332
+ P Q+ L + R TP Y PE++
Sbjct: 189 -------------SHYPDYSWSAQRRALVEEEITR-------NTTPMYRTPEIIDLYSNF 228
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLI 392
G + D W+LG I+Y + PF + +IVN + P LI
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGK--YSIPPHDTQYTVFHSLI 282
Query: 393 SKLLC-NVNQRLGAKGADEIKVHPW 416
+L N +RL E+
Sbjct: 283 RAMLQVNPEERL---SIAEVVHQLQ 304
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-46
Identities = 90/329 (27%), Positives = 141/329 (42%), Gaps = 61/329 (18%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
+K EY ++R + +E++ +G GAFG+V + K TG + A K ++
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EE 58
Query: 159 QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTE 215
++E E +LA D IVKL ++ D L++++E+ PGG +M L LTE
Sbjct: 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTE 116
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+ + + + A+ +H IHRD+K N+L+ G +RL+DFG+ TLQ
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQ--- 172
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL----- 330
KR S +GTP ++APEV++
Sbjct: 173 --------------------KRD-----------------SFIGTPYWMAPEVVMCETMK 195
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAK 389
Y + D WSLG + EM PP + +PM KI L P K S+E +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--KWSVEFR 253
Query: 390 DLISKLLC-NVNQRLGAKGADEIKVHPWF 417
D + L N R A ++ HP+
Sbjct: 254 DFLKIALDKNPETRPSAA---QLLEHPFV 279
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 74/355 (20%), Positives = 126/355 (35%), Gaps = 61/355 (17%)
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
++Y + + N+ + D + +L K+ + L
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSL------KDPDVAELFFKDDPEKL 55
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+K N+LL + G ++L DFG S +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGS-----ASIMA-----------------------PA 207
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 208 N-----------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFP--EEAKLSIEAKDLISKLLC-NVNQRLGAK 406
PP ++ + MS I + P + S ++ + L R ++
Sbjct: 251 PPLFNMNAMSALYHIAQNES----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 301
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-44
Identities = 51/256 (19%), Positives = 94/256 (36%), Gaps = 43/256 (16%)
Query: 115 ADDFELLTMIGKGA--FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ELLT+IGKG V + R K TG ++++ E V ++ E ++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKL 82
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ IV +F D L+++ ++ G D++ D + E + + + A+
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKAL 141
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ IH Y+HR +K ++L+ G + LS
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN-------------------------- 175
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGAIM 347
Q+ +V +++PEVL +GY + D +S+G
Sbjct: 176 --------LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA 227
Query: 348 YEMLVGYPPFYSDDPM 363
E+ G+ PF
Sbjct: 228 CELANGHVPFKDMPAT 243
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 67/320 (20%), Positives = 122/320 (38%), Gaps = 61/320 (19%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRA 165
QR++ +D E L +G G G+V R + TGHV A+K+++ E +R ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL--- 74
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
+L D IV+ + +F + +++ ME + + + E
Sbjct: 75 -DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 226 VLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
V A+ + KH IHRD+KP N+LLD+ G ++L DFG+ G ++
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS---------------GRLVDD 178
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
+++ + G Y+APE + K Y + D
Sbjct: 179 KAKDR---------------------------SAGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 340 WWSLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC- 397
WSLG + E+ G P+ + K++ P S + + + L
Sbjct: 212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 398 NVNQRLGAKGADEIKVHPWF 417
+ +R ++ H +
Sbjct: 271 DHRKRPKYN---KLLEHSFI 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-43
Identities = 60/362 (16%), Positives = 115/362 (31%), Gaps = 98/362 (27%)
Query: 116 DDFELLTMIGKGAFGEV---------------------------RVCRE----------- 137
DFE + +G+G FG V +V RE
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 138 -----------------KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+ ++ + + ++ + + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE---ARFYVAETVLAIESIHKHHY 237
+LY+ M+ ++ + R+ +L + E + A+E +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+KP N+ +++ DFGL +D + + PA
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMD------------QDEEEQTVLTPMPAYATH 233
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
T VGT Y++PE + Y + D +SLG I++E+L Y
Sbjct: 234 T-----------------GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSFS 274
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
+ + + N LKFP + + ++ +L + +R A +I +
Sbjct: 275 TQMERVRIITDVRN----LKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENA 327
Query: 416 WF 417
F
Sbjct: 328 IF 329
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-43
Identities = 69/324 (21%), Positives = 128/324 (39%), Gaps = 64/324 (19%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRA 165
Q A+D + L IG+GA+G V K +G + A+K+++ + ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--- 71
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG--DMMTLLM--RKDTLTEDEARFY 221
++ D IV+ Y + + ++ ME + + D + E+
Sbjct: 72 -DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 222 VAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
TV A+ + IHRDIKP N+LLD+ G+++L DFG+ G
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---------------GQ 175
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGM 336
++ ++ G Y+APE + ++GY +
Sbjct: 176 LVDSIAKTR---------------------------DAGCRPYMAPERIDPSASRQGYDV 208
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPM-STCRKIVNWRT-HLKFPEEAKLSIEAKDLISK 394
D WSLG +YE+ G P+ + + ++V L EE + S + ++
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNL 268
Query: 395 LLC-NVNQRLGAKGADEIKVHPWF 417
L + ++R K E+ HP+
Sbjct: 269 CLTKDESKRPKYK---ELLKHPFI 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-43
Identities = 75/317 (23%), Positives = 129/317 (40%), Gaps = 66/317 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLA 171
ADD E + +G+GA+G V R +G + A+K+++ S+ +R ++ +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----DISMR 61
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLA 228
VD V Y + + +++ ME + ++ + T+ ED V A
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 229 IESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+E +H K IHRD+KP N+L++ G +++ DFG+ L
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------------------ 163
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL----KKGYGMECDWWS 342
+A G Y+APE + +KGY ++ D WS
Sbjct: 164 -------------------------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 343 LGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVN 400
LG M E+ + P+ S P +++V + + P + K S E D S+ L N
Sbjct: 199 LGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPAD-KFSAEFVDFTSQCLKKNSK 256
Query: 401 QRLGAKGADEIKVHPWF 417
+R E+ HP+F
Sbjct: 257 ERPTYP---ELMQHPFF 270
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-42
Identities = 87/361 (24%), Positives = 146/361 (40%), Gaps = 75/361 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV- 173
A FEL+ ++G G +G+V R TG + A+K + + + E ++ E N+L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYS 78
Query: 174 DSNCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
I Y +F D+ L+L+ME+ G + L+ + +TL E+ + E
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + +H+H IHRDIK N+LL + ++L DFG+ LD T+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVG------------- 184
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-----GYGMECDW 340
+R + +GTP ++APEV+ Y + D
Sbjct: 185 ----------RRN-----------------TFIGTPYWMAPEVIACDENPDATYDFKSDL 217
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFP--EEAKLSIEAKDLISKLLC- 397
WSLG EM G PP PM I P + K S + + I L
Sbjct: 218 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA----PRLKSKKWSKKFQSFIESCLVK 273
Query: 398 NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKT 457
N +QR + ++ HP+ R E ++ D +D ++ E+ + + +
Sbjct: 274 NHSQRPATE---QLMKHPFI------RDQPNERQVRIQLKDHIDRTKKKRGEKDETEYEY 324
Query: 458 S 458
S
Sbjct: 325 S 325
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-42
Identities = 58/302 (19%), Positives = 114/302 (37%), Gaps = 57/302 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+F V + T A +L+ + L + + + + E +L + IV+ Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 184 SFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY-- 237
S++ + + L+ E + G + T L R + R + + + ++ +H
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 238 IHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRD+K DN+ + G +++ D GL S
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-------------------------- 186
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
A + +GTP+++APE+ ++ Y D ++ G M EM P
Sbjct: 187 -----------------AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
+ + + V ++ E K++I + N ++R K ++ H
Sbjct: 229 YSECQNAAQIYRRVTSGVKPASFDK-VAIPEVKEIIEGCIRQNKDERYSIK---DLLNHA 284
Query: 416 WF 417
+F
Sbjct: 285 FF 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 8e-42
Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 56/287 (19%)
Query: 79 KKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREK 138
KKL + ++ E+ + L FL +K+ + ++ DDFE ++ +G G G V K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQ------KVGELKDDDFEKISELGAGNGGVVFKVSHK 55
Query: 139 TTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196
+G V A K L+ +R + E +L E +S IV Y +F D + + ME
Sbjct: 56 PSGLVMARKLIHLEIKPAIRN----QIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHL 255
++ GG + +L + + E + + + KH +HRD+KP N+L++ G +
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
Query: 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY 315
+L DFG+ L S +A
Sbjct: 172 KLCDFGVSGQLIDS-------------------------------------------MAN 188
Query: 316 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
S VGT Y++PE L Y ++ D WS+G + EM VG P D
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 74/341 (21%), Positives = 131/341 (38%), Gaps = 86/341 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +E + IG+G++G V CR + TG + A+KK +SE ++ E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRMLK 57
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIE 230
++ +V L F+ L+L+ EY ++ L + + E + +T+ A+
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
HKH+ IHRD+KP+N+L+ K+ ++L DFG + L
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL------------------------ 152
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
P Y V T Y +PE+L+ YG D W++G +
Sbjct: 153 --TGPSDY----------------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 349 EMLVGYPPFYSDDPMSTCRKIV---------NW--------RTHLKFPEE---------- 381
E+L G P + + I + + +K P+
Sbjct: 195 ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF 254
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVD 421
+S A L+ L + +RL + HP+F+ +
Sbjct: 255 PNISYPALGLLKGCLHMDPTERLTCEQLLH---HPYFENIR 292
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 79/348 (22%), Positives = 130/348 (37%), Gaps = 97/348 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSE-------MLRRGQVEHVRAER 167
D + +T +G+G +GEV + T A+K+++ + E +R E
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---------EV 84
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+LL E+ I++L + L+LI EY D+ + + ++ + ++ + +
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-----KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ H +HRD+KP NLLL + L++ DFGL + F I
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----------FGI---- 189
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDW 340
P R ++ + T Y PE+LL + Y D
Sbjct: 190 ------------PIRQ----------------FTHEIITLWYRPPEILLGSRHYSTSVDI 221
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKI---------VNWRTHLKFPE----------- 380
WS+ I EML+ P F D + KI W P+
Sbjct: 222 WSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGK 281
Query: 381 ------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421
A L E DL++ +L + +R+ AK A E HP+F D
Sbjct: 282 TLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE---HPYFSHND 326
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 82/349 (23%), Positives = 137/349 (39%), Gaps = 86/349 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +E L ++G+G++G V CR K TG + A+KK +S+ + V+ E LL
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKLLK 79
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIE 230
++ +V L + + YL+ E++ ++ L + + L + Y+ + + I
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
H H+ IHRDIKP+N+L+ + G ++L DFG + L
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------------------------ 174
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 348
AAP Y V T Y APE+L+ YG D W++G ++
Sbjct: 175 --AAPGEV----------------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT 216
Query: 349 EMLVGYPPFYSDDPMSTCRKIV---------NWRTH--------LKFPEE---------- 381
EM +G P F D + I+ + ++ PE
Sbjct: 217 EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY 276
Query: 382 AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQME 429
KLS DL K L + ++R H +F +A + E
Sbjct: 277 PKLSEVVIDLAKKCLHIDPDKRPFCAELLH---HDFFQMDGFAERFSQE 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-36
Identities = 82/351 (23%), Positives = 131/351 (37%), Gaps = 103/351 (29%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAE 166
+ F+ L +G G + V KTTG A+K++K ++ +R E
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR-E 53
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL------MRKDTLTEDEARF 220
+L+ E+ IV+LY + L L+ E++ D+ + L + ++
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ + + + H++ +HRD+KP NLL++K G L+L DFGL + F I
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA----------FGI-- 160
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMEC 338
P T +S+ V T Y AP+VL+ + Y
Sbjct: 161 --------------PVNT----------------FSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKI----------------------------- 369
D WS G I+ EM+ G P F + + I
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250
Query: 370 -VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
+ R L+ + L D + LL N + RL AK A HPWF
Sbjct: 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH---HPWFA 298
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-36
Identities = 77/344 (22%), Positives = 130/344 (37%), Gaps = 94/344 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAER 167
+ + L +G+G + V + K T ++ A+K+++ +EH +R E
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-EV 51
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
+LL ++ IV L+ ++ L L+ EYL D+ L + + + ++ + +
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ H+ +HRD+KP NLL+++ G L+L+DFGL + +I
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA----------KSI-------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P +T Y V T Y P++LL Y + D W +G
Sbjct: 153 --------PTKT----------------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 188
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKI---------VNWRTHLKFPEEAK------------ 383
I YEM G P F I W L E
Sbjct: 189 CIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALL 248
Query: 384 -----LSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVD 421
L + DL++KLL R+ A+ A + HP+F +
Sbjct: 249 SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK---HPFFLSLG 289
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 87/343 (25%), Positives = 137/343 (39%), Gaps = 93/343 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAER 167
+ + L IG+G +G V + G +A+KK++ + E +R E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR---------EI 51
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
++L E+ + IVKLY + L L+ E+L D+ LL + + L A+ ++ + +
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
I H +HRD+KP NLL+++ G L+++DFGL + F I
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA----------FGI-------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P R Y+ + T Y AP+VL+ K Y D WS+G
Sbjct: 153 --------PVRK----------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKI---------VNWRTHLKFPE--------------- 380
I EM+ G P F +I NW + P+
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248
Query: 381 -EAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVD 421
L DL+SK+L + NQR+ AK A E H +F +
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALE---HAYFKENN 288
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 70/344 (20%), Positives = 125/344 (36%), Gaps = 86/344 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH----VRAERNLLA 171
+E + IG GA+G V R+ +GH A+K ++ G VR E LL
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVALLR 66
Query: 172 EVDSNC---IVKLYCSFQDDEF-----LYLIMEYLPGGDMMTLL--MRKDTLTEDEARFY 221
+++ +V+L + L+ E++ D+ T L L + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ +H + +HRD+KP+N+L+ G ++L+DFGL + ++
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI----------YSY--- 172
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ W Y APEVLL+ Y D W
Sbjct: 173 -------------QMALTPVVVTLW----------------YRAPEVLLQSTYATPVDMW 203
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEA---------- 382
S+G I EM P F + KI +W + P A
Sbjct: 204 SVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQ 263
Query: 383 ----KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421
++ L+ ++L N ++R+ A A + H + +
Sbjct: 264 SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ---HSYLHKDE 304
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 84/344 (24%), Positives = 136/344 (39%), Gaps = 94/344 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAER 167
+ ++ L +G+G +G V ++ G + A+K+++ +E +R E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIR---------EI 70
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
+LL E+ IV L + L L+ E++ D+ +L K L + + + Y+ + +
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ H+H +HRD+KP NLL++ G L+L+DFGL + F I
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA----------FGI-------- 171
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P R+ Y+ V T Y AP+VL+ K Y D WS+G
Sbjct: 172 --------PVRS----------------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKI---------VNWRTH--------LKFPEEAK---- 383
I EM+ G P F KI W F K
Sbjct: 208 CIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWS 267
Query: 384 -----LSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVD 421
E DL+S +L + N+R+ A+ A HP+F +D
Sbjct: 268 SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN---HPYFKDLD 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 81/341 (23%), Positives = 133/341 (39%), Gaps = 93/341 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAER 167
+E L IG+G +G V + + T + A+K+++ + LR E
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EI 52
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
LL E+ IV+L+ D+ L L+ E+ D+ L + + ++ + +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ H + +HRD+KP NLL+++ G L+L++FGL + F I
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA----------FGI-------- 153
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P R YS V T Y P+VL K Y D WS G
Sbjct: 154 --------PVRC----------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189
Query: 345 AIMYEML-VGYPPFYSDDPMSTCRKIV------------------NWRTHLKFPEE---- 381
I E+ G P F +D ++I +++ + +P
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249
Query: 382 ---AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFD 418
KL+ +DL+ LL CN QR+ A+ A + HP+F
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ---HPYFS 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 83/338 (24%), Positives = 133/338 (39%), Gaps = 84/338 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH------VRAERN 168
A +E L +G+G F V R+K T + A+KK+K + R + + +R E
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALR-EIK 64
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVL 227
LL E+ I+ L +F + L+ +++ D+ ++ LT + Y+ T+
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+E +H+H +HRD+KP+NLLLD+ G L+L+DFGL K F
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGS--------- 164
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGA 345
P R Y+ V T Y APE+L + YG+ D W++G
Sbjct: 165 -------PNRA----------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 201
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEA-------------- 382
I+ E+L+ P D + +I W P+
Sbjct: 202 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 261
Query: 383 -KLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFD 418
+ DLI L N R+ A A + +F
Sbjct: 262 SAAGDDLLDLIQGLFLFNPCARITATQALK---MKYFS 296
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 76/370 (20%), Positives = 140/370 (37%), Gaps = 98/370 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAE 166
+E + IG+GA+G+V R+ K G A+K+++ ++ +R E
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---------E 61
Query: 167 RNLLAEVDSNC---IVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTED 216
+L +++ +V+L+ + L L+ E++ D+ T L + + + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + + + ++ +H H +HRD+KP N+L+ G ++L+DFGL + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI----------Y 170
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
+ + W Y APEVLL+ Y
Sbjct: 171 SF----------------QMALTSVVVTLW----------------YRAPEVLLQSSYAT 198
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEA----- 382
D WS+G I EM P F + KI+ +W + P +A
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 258
Query: 383 ---------KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAF 432
+ KDL+ K L N +R+ A A HP+F ++ +
Sbjct: 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS---HPYFQDLERCKENLDSHLP 315
Query: 433 IPEVNDELDT 442
+ EL+T
Sbjct: 316 PSQNTSELNT 325
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 76/348 (21%), Positives = 126/348 (36%), Gaps = 98/348 (28%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
DD++L+ +G+G + EV T +K LK V+ + +R +L +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENL 87
Query: 174 -DSNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L +D L+ E++ D L TLT+ + RFY+ E + A++
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD 144
Query: 231 SIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H +HRD+KP N+++D ++ LRL D+GL
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-------------------------- 178
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
P + V + + PE+L+ + Y D WSLG ++
Sbjct: 179 -EFYHP-------------GQEYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 349 EMLVGYPPFY-----------------SDDPMSTCRKI-----------------VNWRT 374
M+ PF+ ++D K W
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 282
Query: 375 HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421
+ + +S EA D + KLL + RL A+ A E HP+F V
Sbjct: 283 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME---HPYFYTVV 327
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 90/380 (23%), Positives = 138/380 (36%), Gaps = 107/380 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + +G + A+KK+ K R E ++ ++D
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---------ELQIMRKLDH 106
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTL--LMR-----KDTLTEDEARFYV 222
IV+L F +D+ +L L+++Y+P T+ + R K TL + Y+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ ++ IH HRDIKP NLLLD L+L DFG K L
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------- 208
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
+ ++Y + + Y APE++ Y D
Sbjct: 209 --------------------------RGEPNVSY--ICSRYYRAPELIFGATDYTSSIDV 240
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------WR------THLKFPE----- 380
WS G ++ E+L+G P F D + +I+ R T KFP+
Sbjct: 241 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 300
Query: 381 -----EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIP 434
+ EA L S+LL RL E H +FD + +P
Sbjct: 301 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPL---EACAHSFFDE------LRDPNVKLP 351
Query: 435 EVNDELDTQNFEKFEESDNQ 454
D NF E S N
Sbjct: 352 NGRDTPALFNFTTQELSSNP 371
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 78/376 (20%), Positives = 122/376 (32%), Gaps = 113/376 (30%)
Query: 94 LLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--- 150
+ K + E + +E L IG+G FGEV R + TG A+KK+
Sbjct: 1 MAKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN 54
Query: 151 -----KSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY--------CSFQDDEFLYLIMEY 197
LR E +L + +V L + +YL+ ++
Sbjct: 55 EKEGFPITALR---------EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF 105
Query: 198 LPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256
D+ LL T E + + + + IH++ +HRD+K N+L+ + G L+
Sbjct: 106 CEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164
Query: 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQH-----WQKNRR 311
L+DFGL + K +Q + + W
Sbjct: 165 LADFGLARAFS--------------------------LAKNSQPNRYTNRVVTLW----- 193
Query: 312 MLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV 370
Y PE+LL ++ YG D W G IM EM P + I
Sbjct: 194 -----------YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 371 N-----------------WRTHLKFPEEAK-----------LSIEAKDLISKLLC-NVNQ 401
L+ + K A DLI KLL + Q
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 402 RLGAKGADEIKVHPWF 417
R+ + A H +F
Sbjct: 303 RIDSDDALN---HDFF 315
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 7e-32
Identities = 90/377 (23%), Positives = 138/377 (36%), Gaps = 108/377 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + + V A+KK+ K R E ++ V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR---------ELQIMRIVKH 91
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTL--LMR-----KDTLTEDEARFYV 222
+V L F +D+ FL L++EY+P T+ R K T+ + Y+
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + ++ IH HRDIKP NLLLD G L+L DFG K L
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-------------- 193
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
++Y + + Y APE++ Y D
Sbjct: 194 --------------------------AGEPNVSY--ICSRYYRAPELIFGATNYTTNIDI 225
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------WR------THLKFPE----- 380
WS G +M E++ G P F + + +I+ + KFP+
Sbjct: 226 WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP 285
Query: 381 -----EAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIP 434
+ +A DLIS+LL + RL A E HP+FD + A +P
Sbjct: 286 FSKVFRPRTPPDAIDLISRLLEYTPSARLTAI---EALCHPFFDE------LRTGEARMP 336
Query: 435 EVNDELDTQNFEKFEES 451
+ N+ K E S
Sbjct: 337 NGRELPPLFNWTKEELS 353
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
++++ +G G V + + A+K + + ++ E + +++
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV + ++D+ YL+MEY+ G + + L+ D A + + + I+ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRDIKP N+L+D L++ DFG+ K L ++L
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-------------------------- 166
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
TQ +GT Y +PE + D +S+G ++YEMLVG PPF
Sbjct: 167 TQTN--------------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 358 YSDDPMS 364
+ +S
Sbjct: 213 NGETAVS 219
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 63/288 (21%), Positives = 106/288 (36%), Gaps = 65/288 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ E+ ++G+GAFG V C+ K A+K+++ + E L+ V+
Sbjct: 8 KEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNH 60
Query: 176 NCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIES 231
IVKLY + L+MEY GG + +L + T A + + +
Sbjct: 61 PNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 232 IHKHHY---IHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H IHRD+KP NLLL L++ DFG + + T
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT------ACDIQTHMT---------- 161
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+ G+ ++APEV Y +CD +S G I+
Sbjct: 162 ----------------------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 348 YEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISK 394
+E++ PF P V+ T + I + L+++
Sbjct: 194 WEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--ESLMTR 239
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 53/244 (21%), Positives = 92/244 (37%), Gaps = 42/244 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSN 176
+ L ++G+G G+V + + A+K + + ++ E +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
+V ++ + D LY+ M + G D+ +L R+ L A V + A+++ H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
HRD+KP+N+L+ L DFG+ L
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL------------------------- 189
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
TQ +TVGT Y+APE + D ++L ++YE L G PP
Sbjct: 190 -TQ--------------LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 357 FYSD 360
+ D
Sbjct: 235 YQGD 238
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 57/250 (22%), Positives = 105/250 (42%), Gaps = 33/250 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLLAEVD 174
D ++GKG FG+ + TG V MK+L + E +R E ++ ++
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR----TFLKEVKVMRCLE 65
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-LAIESIH 233
++K D+ L I EY+ GG + ++ D+ R A+ + + +H
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRD+ N L+ + ++ ++DFGL + L +
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGL------ARLMVDE------------------ 161
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+TQ E L+ +K R Y+ VG P ++APE++ + Y + D +S G ++ E++
Sbjct: 162 ---KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218
Query: 354 YPPFYSDDPM 363
P
Sbjct: 219 VNADPDYLPR 228
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 66/284 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK----SEMLRRGQVEHVRAERNLLA 171
++ E IGKG FG V R V A+K L E + + + E +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVA-ETVLA 228
++ IVKLY ++ME++P GD+ L+ K + + + + L
Sbjct: 79 NLNHPNIVKLYGLMH----NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 229 IESIHKHHY--IHRDIKPDNLLLDKYG-----HLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
IE + + +HRD++ N+ L +++DFGL S +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------SQQSVHSVS---- 184
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECD 339
+G ++APE + + Y + D
Sbjct: 185 ----------------------------------GLLGNFQWMAPETIGAEEESYTEKAD 210
Query: 340 WWSLGAIMYEMLVGYPPF--YSDDPMSTCRKIVNWRTHLKFPEE 381
+S I+Y +L G PF YS + I PE+
Sbjct: 211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 116 DDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD+++ ++G G G+V K T +A+K L+ RR E L
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRAS 68
Query: 175 S--NCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVA 223
+ IV++ +++ + L ++ME L GG+ L R TE EA +
Sbjct: 69 QCPH-IVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMK 124
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGL 262
AI+ +H + HRD+KP+NLL L+L+DFG
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN--WRTHLKFPEE 381
A E + Y CD WSLG IMY +L GYPPFYS+ ++ + +FP
Sbjct: 166 FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 382 --AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+++S E K LI LL QR+ E HPW
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMTIT---EFMNHPWIMQ 262
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 59/273 (21%), Positives = 101/273 (36%), Gaps = 53/273 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + IG G+FG V R + G A+K L + + +V E ++ +
Sbjct: 37 CDLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRH 93
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIE 230
IV + + L ++ EYL G + LL + L E + +
Sbjct: 94 PNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 231 SIHKHHY--IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+H + +HR++K NLL+DK +++ DFGL S L+ F
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL------SRLKASTFLSSK-------- 197
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
S GTP+++APEVL + + D +S G I++
Sbjct: 198 ---------------------------SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381
E+ P+ + +P + L+ P
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 58/252 (23%), Positives = 106/252 (42%), Gaps = 44/252 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDSN 176
+EL ++G G EV + R+ A+K L+ +++ R R E A ++
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 177 CIVKLYCSFQDDEFL----YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
IV +Y + + + Y++MEY+ G + ++ + +T A +A+ A+
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H++ IHRD+KP N+++ +++ DFG+ + + S T +
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAV---------- 179
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+GT Y++PE D +SLG ++YE+L
Sbjct: 180 -------------------------IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 353 GYPPFYSDDPMS 364
G PPF D P+S
Sbjct: 215 GEPPFTGDSPVS 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 83/350 (23%), Positives = 129/350 (36%), Gaps = 98/350 (28%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAE 172
D F++ M G+G FG V++ +EK+TG A+KK R Q LA
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ------IMQDLAV 75
Query: 173 VDSNCIVKLYCSF-------QDDEFLYLIMEYLPGGD----MMTLLMRKDTLTEDEARFY 221
+ IV+L F + D +L ++MEY+P R+ + +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134
Query: 222 VAETVLAIESIHKHHY--IHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ + + +I +H HRDIKP N+L+++ G L+L DFG K L
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS----------- 183
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 337
+ +AY + + Y APE++ + Y
Sbjct: 184 -----------------------------PSEPNVAY--ICSRYYRAPELIFGNQHYTTA 212
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPM---------------STCRKIVNWRTHLKFP--- 379
D WS+G I EM++G P F D+ RK+ T +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSK 272
Query: 380 ----------EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
K + EA DL+S LL +R+ E HP+FD
Sbjct: 273 GIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY---EALCHPYFD 319
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 41/274 (14%), Positives = 80/274 (29%), Gaps = 58/274 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
LT + + GE+ + + G+ +K LK + R + E L
Sbjct: 10 KQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFSH 66
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEA-RFYVA-ETVLAIES 231
++ + C LI ++P G + +L D++ A + +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 232 IHKHHY--IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H + ++++D+ R+S +
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADV--------------------------- 159
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME---CDWWSLGAI 346
K + Q + P ++APE L KK D WS +
Sbjct: 160 ------KFSFQSP-------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE 380
++E++ PF M K+ P
Sbjct: 201 LWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 60/278 (21%), Positives = 101/278 (36%), Gaps = 58/278 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVD 174
+ L +IG G FG+V R G A+K + +E+VR E L A +
Sbjct: 7 AELTLEEIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I+ L + L L+ME+ GG + +L + D + + + +H
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 235 HHY---IHRDIKPDNLLLDKYGH--------LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
IHRD+K N+L+ + L+++DFGL +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------------------- 164
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
W + +M S G ++APEV+ + D WS
Sbjct: 165 ---------------------EWHRTTKM---SAAGAYAWMAPEVIRASMFSKGSDVWSY 200
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381
G +++E+L G PF D ++ + + L P
Sbjct: 201 GVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 54/266 (20%), Positives = 95/266 (35%), Gaps = 65/266 (24%)
Query: 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLKKS---EMLRRGQVEH 162
+L + A +E+ I G G + + G +K L S E
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----- 125
Query: 163 VRAERNLLAEVDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
AER LAEV IV+++ D Y++MEY+ G + L E
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
A Y+ E + A+ +H ++ D+KP+N++L + L+L D G
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLG---------------- 226
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV-GTPDYIAPEVLLKKGYGM 336
A R+ ++ + GTP + APE+ ++ G +
Sbjct: 227 ---------------AV---------------SRINSFGYLYGTPGFQAPEI-VRTGPTV 255
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G + + + P
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYV 281
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 52/255 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG G+FG V + K G V A+K L + + Q++ + E +L +
Sbjct: 24 GQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 79
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVA-ETVLAIESI 232
I+ + L ++ ++ G + L +T E + +A +T ++ +
Sbjct: 80 VNILLFMGYST---APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRD+K +N+ L + +++ DFGL +T + +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSR------------------ 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYE 349
W + + G+ ++APEV+ + Y + D ++ G ++YE
Sbjct: 173 -------------WSGSHQFEQ--LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217
Query: 350 MLVGYPPFYSDDPMS 364
++ G P+ + +
Sbjct: 218 LMTGQLPYSNINNRD 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 60/250 (24%), Positives = 108/250 (43%), Gaps = 38/250 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK--------SEMLRRGQVEHVRAER 167
D +E+ +IG G++G V +K V A+KK+ + +LR E
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR---------EI 103
Query: 168 NLLAEVDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+L ++ + +VK+ + + LY+++E D L LTE + +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
++ ++ +H +HRD+KP N L+++ +++ DFGL + T+
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR------------TVDYPE 210
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWW 341
NG+SQ P R++ + V T Y APE++L ++ Y D W
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH--VVTRWYRAPELILLQENYTEAIDVW 268
Query: 342 SLGAIMYEML 351
S+G I E+L
Sbjct: 269 SIGCIFAELL 278
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 49/258 (18%), Positives = 92/258 (35%), Gaps = 51/258 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ E+ +IGKG FG+V + G V A++ + Q++ + E +
Sbjct: 33 EQLEIGELIGKGRFGQV--YHGRWHGEV-AIRLIDIERDNED-QLKAFKREVMAYRQTRH 88
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHK 234
+V + L +I G + +++ K L ++ R E V + +H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+H+D+K N+ D G + ++DFGL F+I L + ++
Sbjct: 149 KGILHKDLKSKNVFYDN-GKVVITDFGL-------------FSISGVLQAGRREDKLRIQ 194
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---------LKKGYGMECDWWSLGA 345
G ++APE++ K + D ++LG
Sbjct: 195 N-----------------------GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 346 IMYEMLVGYPPFYSDDPM 363
I YE+ PF +
Sbjct: 232 IWYELHAREWPFKTQPAE 249
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 69/367 (18%), Positives = 123/367 (33%), Gaps = 109/367 (29%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL------------------------- 149
+ + L +G G+FG V + +G +A+KK+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 150 ------KKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD- 202
E + Q + +N + + +++L +IMEY+P
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124
Query: 203 ---MMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLS 258
+ + + ++ + Y+ + A+ IH HRDIKP NLL++ K L+L
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318
DFG K L + +AY +
Sbjct: 185 DFGSAKKLI----------------------------------------PSEPSVAY--I 202
Query: 319 GTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM-------------- 363
+ Y APE++L Y D WS+G + E+++G P F + +
Sbjct: 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT 262
Query: 364 -STCRKIVNWRTHLKFPEEAKLSI----------EAKDLISKLLC-NVNQRLGAKGADEI 411
++ T ++FP A DL+ ++L + R+ E
Sbjct: 263 KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEA 319
Query: 412 KVHPWFD 418
HP+FD
Sbjct: 320 MAHPFFD 326
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 81/345 (23%), Positives = 140/345 (40%), Gaps = 83/345 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAE 172
+ DF+L +++G+GA+G V K TG + A+KK++ + R R +L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL----RTLREIKILKH 65
Query: 173 VDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAE 224
I+ ++ SF++ +Y+I E M T L + L++D ++++ +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
T+ A++ +H + IHRD+KP NLL++ L++ DFGL + +D S + T
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT------- 173
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
+ M+ + V T Y APEV+L Y D WS
Sbjct: 174 ----------------------GQQSGMVEF--VATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIV------------------NWRTHLK-FPEEAKL 384
G I+ E+ + P F D I R ++K P
Sbjct: 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAA 269
Query: 385 SI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+ + DL+ ++L + +R+ AK A E HP+
Sbjct: 270 PLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE---HPYLQT 311
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-24
Identities = 90/484 (18%), Positives = 171/484 (35%), Gaps = 141/484 (29%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
++ L IG GA G V + A+KKL + ++ + RA R L+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK------RAYRELVLM 115
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYV 222
V+ I+ L + ++ + +YL+ME M L + + L + + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLL 170
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + I+ +H IHRD+KP N+++ L++ DFGL +
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------------- 215
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ M Y V T Y APEV+L GY D WS
Sbjct: 216 -------------------------TSFMMTPY--VVTRYYRAPEVILGMGYKENVDIWS 248
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIV----------------NWRTHLK--------- 377
+G IM EM+ F D + K++ R +++
Sbjct: 249 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT 308
Query: 378 ----FPEEAKLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423
FP+ + +A+DL+SK+L + +R+ A + HP+ +
Sbjct: 309 FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ---HPYINV---- 361
Query: 424 RIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNF 483
+ E++ + +++ ++ + + + W++++ +
Sbjct: 362 --WYDP--------AEVEAPPPQIYDKQLDEREHTIEE--WKELI--------------Y 395
Query: 484 EIVNDYQVPGMAELKKTNNKPKRPSVKTLFESESETSESSDTPASDQPSQGSFTSLAPNQ 543
+ V + + + K P +V SES SS S + + S +
Sbjct: 396 KEVMNSEEKTKNGVVKGQPSPSGAAVN---SSESLPPSSSVNDISSMSTDQTLASDTDSS 452
Query: 544 LDRS 547
L+ S
Sbjct: 453 LEAS 456
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 60/255 (23%), Positives = 114/255 (44%), Gaps = 31/255 (12%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
D++ + +IG+G++G V + +K T A+KK+ + M ++ R R +L +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFED-LIDCKRILREITILNRL 82
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
S+ I++LY + LY+++E D+ L LTE+ + + +L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
IH+ IHRD+KP N LL++ +++ DFGL + ++ S ++
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN-----------------SEKD 184
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
+ ++ + +++ ++ V T Y APE++L + Y D WS G I
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSH--VVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 348 YEMLVGYPPFYSDDP 362
E+L +D
Sbjct: 243 AELLNMLQSHINDPT 257
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 90/417 (21%), Positives = 154/417 (36%), Gaps = 122/417 (29%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS--------------EMLRRGQVE 161
+EL+ +GKGA+G V ++ TG V A+KK+ + +L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT----- 63
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEF--LYLIMEYLPGGDMMTLL---MRKDTLTED 216
+ N IV L + D +YL+ +Y M T L +R + L
Sbjct: 64 ELSGHEN---------IVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPV 109
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
++ V + + I+ +H +HRD+KP N+LL+ H++++DFGL + +
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYG 335
+ N N + ++++P + Y V T Y APE+LL Y
Sbjct: 170 PLSINENTENFDDDQPI------------------LTDY--VATRWYRAPEILLGSTKYT 209
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN------------------------ 371
D WSLG I+ E+L G P F M+ +I+
Sbjct: 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
Query: 372 --WRTHLKFPE-----------------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
+ ++ +A + EA DL+ KLL N N+R+ A A +
Sbjct: 270 LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK- 328
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML 468
HP+ N+E + + +DN + +R ++
Sbjct: 329 --HPFVSIFH-------------NPNEEPNCDHIITIPINDNVKHSIDD---YRNLV 367
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 78/346 (22%), Positives = 132/346 (38%), Gaps = 101/346 (29%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ ++ L+ +G GA+G V + TG A+KKL + S + + R R LL
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK------RTYRELRLL 82
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFY 221
+ ++ L S ++ +YL+ M L ++ LT+D +F
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFL 137
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ IH IHRD+KP NL +++ L++ DFGL
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------------------ 179
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
R A + T Y V T Y APE++L Y D
Sbjct: 180 ---------RHTADEMTG---------------Y--VATRWYRAPEIMLNWMHYNQTVDI 213
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW-----------------RTHLK-FPEEA 382
WS+G IM E+L G F D + + I+ R +++ +
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 273
Query: 383 KLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
K++ A DL+ K+L + ++R+ A A H +F
Sbjct: 274 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA---HAYFA 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 81/344 (23%), Positives = 138/344 (40%), Gaps = 96/344 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ T +G GA+G V +K +G A+KKL + SE+ + RA R LL
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK------RAYRELLLL 77
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAE 224
+ ++ L S ++ YL+M ++ D+ ++ +E++ ++ V +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ ++ IH +HRD+KP NL +++ L++ DFGL
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA--------------------- 173
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
R A + T Y V T Y APEV+L Y D WS+
Sbjct: 174 ------RHADAEMTG---------------Y--VVTRWYRAPEVILSWMHYNQTVDIWSV 210
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIV-----------------NWRTHLK-FPEEAKLS 385
G IM EML G F D + +I+ +++++ P+ +
Sbjct: 211 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD 270
Query: 386 I---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+A DL+ K+L +V++RL A A HP+F+
Sbjct: 271 FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT---HPFFEP 311
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 66/351 (18%), Positives = 118/351 (33%), Gaps = 97/351 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV--EHV----RAER-- 167
+ + I G++G V + V A+K++ + R R R
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 168 NLLAEVDSNCIVKLY---CSFQDDEF--LYLIMEYLPGGDMMTLL-MRKDTLTEDEARFY 221
LL I+ L F++ LYL+ E + D+ ++ ++ ++ +++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ +L + +H+ +HRD+ P N+LL + + DF L
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA------------------ 181
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
R + Y V Y APE++++ KG+ D
Sbjct: 182 ---------REDTA-------------DANKTHY--VTHRWYRAPELVMQFKGFTKLVDM 217
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW-----------------RTHLK------ 377
WS G +M EM F + KIV R +L+
Sbjct: 218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277
Query: 378 --------FPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
P A DLI+K+L N +R+ ++ HP+F+
Sbjct: 278 PARAWTAVVP---TADPVALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 76/343 (22%), Positives = 128/343 (37%), Gaps = 89/343 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
+ L+ IG+GA+G V + A+KK+ E Q R R +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRF 82
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAET 225
I+ + + + + +Y++ + M T L ++ L+ D +++ +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQI 137
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ ++ IH + +HRD+KP NLLL+ L++ DFGL
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA---------------------- 175
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344
R H + Y V T Y APE++L KGY D WS+G
Sbjct: 176 -----------RVADPDHDHTGF---LTEY--VATRWYRAPEIMLNSKGYTKSIDIWSVG 219
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNW-----------------RTHLK-FPEEAKLSI 386
I+ EML P F + I+ R +L P + K+
Sbjct: 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279
Query: 387 ---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+A DL+ K+L N ++R+ + A HP+ +
Sbjct: 280 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA---HPYLEQ 319
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 68/353 (19%), Positives = 120/353 (33%), Gaps = 105/353 (29%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKL---KKSEMLR--RGQVEHVRAERNLLAE 172
+ L +G G G V + A+KK+ + R E ++
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR--------EIKIIRR 64
Query: 173 VDSNCIVKLY------------CSFQDDEF--LYLIMEYLPGGDMMTLL---MRKDTLTE 215
+D + IVK++ E +Y++ EY M T L + + L E
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLE 119
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQEQ 274
+ AR ++ + + ++ IH + +HRD+KP NL ++ L++ DFGL + +D
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------- 172
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KG 333
H+ + + T Y +P +LL
Sbjct: 173 -----------------------------PHYSHKGHLSEG--LVTKWYRSPRLLLSPNN 201
Query: 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV----------------NWRTHLK 377
Y D W+ G I EML G F + + I+ +++
Sbjct: 202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIR 261
Query: 378 -FPEEAKLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
E + EA D + ++L + RL A+ A HP+
Sbjct: 262 NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS---HPYMSI 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 89/350 (25%), Positives = 132/350 (37%), Gaps = 107/350 (30%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ L +G GA+G V + TG A+KKL + SE+ + RA R LL
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK------RAYRELRLL 78
Query: 171 AEVDSNCIVKLY---------CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEA 218
+ ++ L F D YL+M + M T L M+ + L ED
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTD---FYLVMPF-----MGTDLGKLMKHEKLGEDRI 130
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
+F V + + + IH IHRD+KP NL +++ L++ DFGL
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA--------------- 175
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 337
R A + T Y V T Y APEV+L Y
Sbjct: 176 ------------RQADSEMTG---------------Y--VVTRWYRAPEVILNWMRYTQT 206
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV-----------------NWRTHLK-FP 379
D WS+G IM EM+ G F D + ++I+ + ++K P
Sbjct: 207 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 266
Query: 380 EEAKLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
E K A +L+ K+L + QR+ A A HP+F+
Sbjct: 267 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA---HPYFES 313
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 77/357 (21%), Positives = 133/357 (37%), Gaps = 110/357 (30%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
++ L IG GA G V + A+KKL + ++ + RA R L+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK------RAYRELVLM 78
Query: 171 AEVDSNCIVKLY---------CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
V+ I+ L FQD +Y++ME + ++ ++ + L + +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQD---VYIVMELM-DANLCQVI--QMELDHERMSYL 132
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + I+ +H IHRD+KP N+++ L++ DFGL +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------------- 178
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ M Y V T Y APEV+L GY D W
Sbjct: 179 --------------------------TSFMMTPY--VVTRYYRAPEVILGMGYKENVDIW 210
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIV----------------NWRTHLK-------- 377
S+G IM EM+ G F D + K++ RT+++
Sbjct: 211 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGY 270
Query: 378 -----FP---------EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
FP + +A+DL+SK+L + ++R+ A + HP+ +
Sbjct: 271 SFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ---HPYINV 324
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 61/254 (24%), Positives = 110/254 (43%), Gaps = 59/254 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAE--VD 174
+E+L +IGKG+FG+V + A+K ++ + R+ E +R +L + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDN 157
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLAI 229
+ ++ + +F + + E L M L L++K+ + R + + +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+++HK+ IH D+KP+N+LL + G +++ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS----------------------SCY 251
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
++R Y+ + + Y APEV+L YGM D WSLG I+
Sbjct: 252 EHQRV----------------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
Query: 348 YEMLVGYPPFYSDD 361
E+L GYP +D
Sbjct: 290 AELLTGYPLLPGED 303
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 67/367 (18%), Positives = 124/367 (33%), Gaps = 110/367 (29%)
Query: 115 ADDFELLTM-IGKGAFGEV--RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
D FE +G+G +G V ++ YA+K+++ + + E LL
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI-----ALLR 73
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL---------MRKDTLTEDEARF 220
E+ ++ L D ++L+ +Y D+ ++ + L +
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + + I +H + +HRD+KP N+L+ + G ++++D G + F
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL----------F 182
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYG 335
P + L V T Y APE+LL + Y
Sbjct: 183 NS----------------PLKP----LADLDPV--------VVTFWYRAPELLLGARHYT 214
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCR---------KIV---------NWRTHLK 377
D W++G I E+L P F+ +I +W K
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKK 274
Query: 378 FPE-------------------------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
PE + K +A L+ KLL + +R+ ++ A +
Sbjct: 275 MPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ- 333
Query: 412 KVHPWFD 418
P+F
Sbjct: 334 --DPYFL 338
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 51/272 (18%), Positives = 96/272 (35%), Gaps = 67/272 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEV 173
D+ +LL +IG+G +G V + A+K + ++ E+N + +
Sbjct: 13 DNLKLLELIGRGRYGAV--YKGSLDERPVAVKVFSFANR------QNFINEKNIYRVPLM 64
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-- 226
+ + I + + L+MEY P G + L ++ + +A +V
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTR 122
Query: 227 --------LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
L +K HRD+ N+L+ G +SDFGL S + +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL------SMRLTGNRLV 176
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-------LK 331
++ +E VGT Y+APEVL
Sbjct: 177 RPGEEDNAAISE---------------------------VGTIRYMAPEVLEGAVNLRDX 209
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ + D ++LG I +E+ + + + +
Sbjct: 210 ESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 16/157 (10%), Positives = 49/157 (31%), Gaps = 2/157 (1%)
Query: 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
++ + LL G + + A+ + +L ++ + L
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+ +D + ++ ++ E++ GG + + + + A + A +
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAAD 143
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ H+ P + + G + L+ +
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN 180
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 57/266 (21%), Positives = 85/266 (31%), Gaps = 62/266 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A L IGKG FGEV R K G A+K E + AE +
Sbjct: 41 ARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLR 94
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + D L+L+ +Y G + L + T+T + T +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 153
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL D +T I N
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT---DTIDIAPN- 209
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------YGM 336
VGT Y+APEVL
Sbjct: 210 ---------------------------------HRVGTKRYMAPEVLDDSINMKHFESFK 236
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G + +E+ +
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 52/268 (19%), Positives = 81/268 (30%), Gaps = 64/268 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A D LL +GKG +GEV R G A+K + + E +
Sbjct: 7 ARDITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDE----KSWFRETELYNTVMLR 60
Query: 175 SNCIVKLY----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV---- 226
I+ S L+LI Y G + L + TL + ++
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVS-CLRIVLSIASGL 118
Query: 227 -----LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ K HRD+K N+L+ K G ++D GL + + Q +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL------AVMHSQSTNQLDV 172
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYG 335
N VGT Y+APEVL
Sbjct: 173 GN-------------------------------NPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPM 363
D W+ G +++E+ +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 7e-20
Identities = 52/266 (19%), Positives = 80/266 (30%), Gaps = 62/266 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A +++ IGKG +GEV K G A+K +E E +
Sbjct: 36 AKQIQMVKQIGKGRYGEV--WMGKWRGEKVAVKVFFTTEE----ASWFRETEIYQTVLMR 89
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + LYLI +Y G + L + TL +V +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLC 148
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL T +
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-- 206
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGM 336
VGT Y+ PEVL +
Sbjct: 207 -----------------------------------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +S G I++E+ +
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEE 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 64/265 (24%), Positives = 102/265 (38%), Gaps = 61/265 (23%)
Query: 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHV 163
++ + D +E+ ++IGKG+FG+V ++ A+K +K K L + Q+E V
Sbjct: 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-V 101
Query: 164 RAERNLLAE--VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTED 216
R + IV L F L L+ E L L L+R ++ +
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS----YNLYDLLRNTNFRGVSLN 157
Query: 217 EARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCSTLQ 272
R + + A+ + + IH D+KP+N+LL +++ DFG
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------- 206
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
S Q +R Y + + Y +PEVLL
Sbjct: 207 -----------SSCQLGQRI----------------------YQYIQSRFYRSPEVLLGM 233
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPF 357
Y + D WSLG I+ EM G P F
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 49/270 (18%), Positives = 103/270 (38%), Gaps = 65/270 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVE-----HVR-AERNLL 170
+ L+ +G G F V + ++ AMK ++ + E V A+
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 171 AEVDSNCIVKLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAE 224
+ +N I+KL F + + ++ E L G +++ L+ + + + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 225 TVLAIESIHKH-HYIHRDIKPDNLLLD------KYGHLRLSDFGLCKPLDCSTLQEQDFT 277
+L ++ +H+ IH DIKP+N+L++ ++++D G
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG---------------- 183
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
+ +E +++ T +Y +PEVLL +G
Sbjct: 184 ------NACWYDEH----------------------YTNSIQTREYRSPEVLLGAPWGCG 215
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCR 367
D WS +++E++ G F D+ S +
Sbjct: 216 ADIWSTACLIFELITGDFLFEPDEGHSYTK 245
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 53/257 (20%), Positives = 99/257 (38%), Gaps = 51/257 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNL-LAEVDS 175
F ++ +G G FG V +C+ YA+K ++ + R ++E + + ++++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINN 95
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLAIE 230
N IVK + F + + LI E L +L ++ ++ ++ + Y E + A+
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLG----PSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ---------DFTIGNN 281
+ K H D+KP+N+LLD + + DF
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF----- 206
Query: 282 LNGSS-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
G + ++ S + T Y APEV+L G+ + D
Sbjct: 207 --GCATFKSDYH----------------------GSIINTRQYRAPEVILNLGWDVSSDM 242
Query: 341 WSLGAIMYEMLVGYPPF 357
WS G ++ E+ G F
Sbjct: 243 WSFGCVLAELYTGSLLF 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 51/266 (19%), Positives = 89/266 (33%), Gaps = 65/266 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+LL + +G FG V + A+K + Q E L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKH 77
Query: 176 NCIVKL--YC--SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE--------AR--FY 221
I++ D L+LI + G + L + + ++ +E AR Y
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAY 136
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ E + ++ HK HRDIK N+LL ++DFGL + E + G+
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL------ALKFEAGKSAGDT 190
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGM 336
VGT Y+APEVL ++ +
Sbjct: 191 H---------------------------------GQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G +++E+
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVD 243
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 52/253 (20%), Positives = 102/253 (40%), Gaps = 47/253 (18%)
Query: 118 FELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAE--V 173
+E++ +G+GAFG+V C K G A+K +K + E ++ +L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-IQVLEHLNTTDPN 74
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLA 228
+ V++ F+ + ++ E L ++ ++++ D R + +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLG----LSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL---CKPLDCSTLQEQDFTIGNNLNGS 285
+ +H + H D+KP+N+L + + + + + L ++ DF GS
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF-------GS 183
Query: 286 S-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+ ++E + V T Y APEV+L G+ CD WS+G
Sbjct: 184 ATYDDEHH----------------------STLVSTRHYRAPEVILALGWSQPCDVWSIG 221
Query: 345 AIMYEMLVGYPPF 357
I+ E +G+ F
Sbjct: 222 CILIEYYLGFTVF 234
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 48/253 (18%), Positives = 98/253 (38%), Gaps = 47/253 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVY-AMKKLK-KSEMLRRGQVEHVRAERNLLAE--V 173
+E++ +G+G FG+V C + G A+K ++ + ++E + + + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-INVLKKIKEKDKE 79
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLA 228
+ V + F + + E L ++++ R + A
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLG----KNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG---LCKPLDCSTLQEQDFTIGNNLNGS 285
+ +H++ H D+KP+N+L L + K + ++++ DF GS
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF-------GS 188
Query: 286 S-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+ ++E + V T Y PEV+L+ G+ CD WS+G
Sbjct: 189 ATFDHEHH----------------------TTIVATRHYRPPEVILELGWAQPCDVWSIG 226
Query: 345 AIMYEMLVGYPPF 357
I++E G+ F
Sbjct: 227 CILFEYYRGFTLF 239
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ + +G+G FG+V + TG + A+K LK + + E ++L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ I+K C L L+MEY+P G + L + ++ + + + +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGM 147
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+H HYIHRD+ N+LLD +++ DFGL K +
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 63/244 (25%), Positives = 99/244 (40%), Gaps = 50/244 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L +GKG FG V +CR + T V A+KKL+ S + E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHSTE---EHLRDFEREIEIL 65
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVL 227
+ + IVK C L LIMEYLP G + L + K+ + + Y ++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+E + YIHRD+ N+L++ +++ DFGL K L Q+++F +
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFK------VKE 175
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
E P W APE L + + + D WS G ++
Sbjct: 176 PGESPIF-----------W-----------------YAPESLTESKFSVASDVWSFGVVL 207
Query: 348 YEML 351
YE+
Sbjct: 208 YELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 62/249 (24%), Positives = 96/249 (38%), Gaps = 60/249 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L +GKG FG V +CR + T V A+KKL+ S + E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHSTE---EHLRDFEREIEIL 96
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+ + IVK C L LIMEYLP G + L K+ + + Y ++
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+E + YIHRD+ N+L++ +++ DFGL K L Q+++
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP----QDKE------------ 200
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI-----APEVLLKKGYGMECDWWS 342
Y V P APE L + + + D WS
Sbjct: 201 ---------------------------YYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233
Query: 343 LGAIMYEML 351
G ++YE+
Sbjct: 234 FGVVLYELF 242
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 3e-18
Identities = 48/268 (17%), Positives = 91/268 (33%), Gaps = 31/268 (11%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVD 174
+ ++ +G G F V + + AMK +K +E E E LL D
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT----ETALDEIRLLKSVRNSD 94
Query: 175 SN-----CIVKLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVA 223
N +V+L F+ + + ++ E L G ++ +++ + L + +
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 224 ETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ +H IH DIKP+N+LL S + +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 283 NGSSQNNERPAAPKRTQQEQLQH--------WQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334
++ N + ++ W + T Y + EVL+ GY
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGSGY 270
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDP 362
D WS + +E+ G F
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSG 298
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 43/194 (22%), Positives = 77/194 (39%), Gaps = 48/194 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE----- 172
+++ IG+G+FG + A+K E R++ L +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTY 59
Query: 173 ---VDSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I +Y Q+ L+++ L G D++ L RK ++ +TV
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV----------KTV 108
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKP-LDCSTLQ 272
++SIH+ ++RDIKPDN L+ + + + DFG+ K D T Q
Sbjct: 109 AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168
Query: 273 EQDFTIGNNLNGSS 286
+ NL+G++
Sbjct: 169 HIPYREKKNLSGTA 182
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 45/169 (26%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER-NLLAEV--- 173
+ L IG G+FG++ + + G A+K E V+ + L E
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIY 58
Query: 174 ----DSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I + + ++ ++ME L G D+ RK +L +TV
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL----------KTV 107
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCK 264
L IE IH ++IHRD+KPDN L+ + + DFGL K
Sbjct: 108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKK--SEMLRRGQVEHVRAERN 168
+ + +G+G FG+V +CR + T V A+K LK + E
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQV-AVKSLKPESGGNHIADLKK----EIE 75
Query: 169 LLAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAET 225
+L + IVK C+ + LIME+LP G + L K+ + + Y +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
++ + Y+HRD+ N+L++ +++ DFGL K ++
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 49/172 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE----- 172
F + IG G FGE+R+ + T A+K +E +++ L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFY 58
Query: 173 ---VDSNCIVKLYCSFQDDEFLYLIMEYLPGG----DMMTLLMRKDTLTEDEARFYVAET 225
+ I ++Y ++ +++E L G D+ L R +L +T
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL----------KT 106
Query: 226 VL--------AIESIHKHHYIHRDIKPDNLLLDKYGHLR-----LSDFGLCK 264
VL +E +H + I+RD+KP+N L+ + G+ + DF L K
Sbjct: 107 VLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ ++ +GKG FG V +CR + T V A+K+L+ S Q + E +L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALV-AVKQLQHSGPD---QQRDFQREIQIL 78
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+ S+ IVK + L L+MEYLP G + L + L Y ++
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+E + +HRD+ N+L++ H++++DFGL K L
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 7/155 (4%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D L IG+G FGEV R + + A+K +++ E +L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
IV+L C+ + +Y++ME + GGD +T L L V + +E +
Sbjct: 172 PNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
IHRD+ N L+ + L++SDFG+ +
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 43/193 (22%), Positives = 71/193 (36%), Gaps = 35/193 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---------KSEM--LRRGQVEHVRAE 166
+ L IG G FG + + A +K SE+ +R + +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 167 RNLLAEVDSNCIVKLYCS----FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
++D I Y S F+ + +++ME L G D+ + + T +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKK------- 150
Query: 223 AETVL--------AIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKP-LDCSTL 271
TVL +E IH++ Y+H DIK NLLL + L+D+GL
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 272 QEQDFTIGNNLNG 284
++ NG
Sbjct: 210 KQYQENPRKGHNG 222
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 9/158 (5%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
D LL +G G+FG VR + V A+K LK + + ++ E N +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
+D +++LY + ++ E P G ++ L + Y + +
Sbjct: 78 LDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ +IHRD+ NLLL +++ DFGL + L
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 51/190 (26%), Positives = 75/190 (39%), Gaps = 46/190 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAE-RNLLAEV--- 173
F L IG G+FGE+ + T A+K E+V+ + LL E
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIY 56
Query: 174 ----DSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I + + ++ L+M+ L G D+ RK +L +TV
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL----------KTV 105
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKP-LDCSTLQEQ 274
L +E +H ++HRDIKPDN L+ + + DFGL K D ST Q
Sbjct: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
Query: 275 DFTIGNNLNG 284
+ NL G
Sbjct: 166 PYRENKNLTG 175
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 35/198 (17%), Positives = 69/198 (34%), Gaps = 42/198 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHV-----YAMKKLKK--------SEMLRRGQVEHVR 164
+++ IG+G FG + + ++ V +K + +R
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 165 AERNLLAEVDSNCIVKLYCS----FQDDEFLYLIMEYLPGGDMMTLLM---RKDTLTEDE 217
+ ++ + K + S + ++IM+ G D+ + ++ +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR---- 151
Query: 218 ARFYVAETVL--------AIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKP-L 266
+TVL +E IH+H Y+H DIK NLLL+ + L D+GL
Sbjct: 152 ------KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 267 DCSTLQEQDFTIGNNLNG 284
+ +G
Sbjct: 206 PEGVHKAYAADPKRCHDG 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 52/256 (20%), Positives = 98/256 (38%), Gaps = 64/256 (25%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+F+ + ++G GAFG V EK V A+K+L+++ + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATS--PKANKEILDEAYVM 71
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
A VD+ + +L C + LI + +P G ++ + KD + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ + +HRD+ N+L+ H++++DFGL K L ++
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----LLGAEEKE---------- 173
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT--PDYI---APEVLLKKGYGMECDWWS 342
Y G P I A E +L + Y + D WS
Sbjct: 174 ---------------------------YHAEGGKVP--IKWMALESILHRIYTHQSDVWS 204
Query: 343 LGAIMYEML-VGYPPF 357
G ++E++ G P+
Sbjct: 205 YGVTVWELMTFGSKPY 220
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 27/173 (15%), Positives = 59/173 (34%), Gaps = 33/173 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHV--------YAMKKLKKSEMLRRGQVEHVRAERNL 169
++L + + G + +T +++K K L Q RA + L
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 170 -------LAEVDSNCIVKLYCS-FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
L I D++ +L++ L G + + L
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK------HVL 156
Query: 222 VAETVL--------AIESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCK 264
+VL A+E +H++ Y+H ++ +N+ + + + L+ +G
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 37/148 (25%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG V+ + K A+K LK + E + E N++ ++D+ IV++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 83
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
C E L+ME G + L + + + V + + ++ + + +++H
Sbjct: 84 IGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
RD+ N+LL + ++SDFGL K L
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALR 168
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIES 231
+V+LY S +E +Y++ EY+ G ++ L + L + A+ +
Sbjct: 322 EKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ + +Y+HRD++ N+L+ + +++DFGL + +++ ++T + Q +
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYT-------ARQGAKF 426
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
P K T APE L + ++ D WS G ++ E+
Sbjct: 427 PI--KWT--------------------------APEAALYGRFTIKSDVWSFGILLTELT 458
Query: 352 -VGYPPF 357
G P+
Sbjct: 459 TKGRVPY 465
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 4e-14
Identities = 30/150 (20%), Positives = 63/150 (42%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + IG G FG V + V A+K +++ M E E ++ ++
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESI 232
+V+LY C + + L+ E++ G + L ++ + + + +
Sbjct: 63 PKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ IHRD+ N L+ + +++SDFG+
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGM 150
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIES 231
+V+LY S +E +Y++ EY+ G ++ L + L + A+ +
Sbjct: 239 EKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ + +Y+HRD++ N+L+ + +++DFGL + +++ ++T + Q +
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYT-------ARQGAKF 343
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
P K T APE L + ++ D WS G ++ E+
Sbjct: 344 PI--KWT--------------------------APEAALYGRFTIKSDVWSFGILLTELT 375
Query: 352 -VGYPPF 357
G P+
Sbjct: 376 TKGRVPY 382
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 5e-14
Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+L C+ + Y+I E++ G+++ L + ++ + + A+E
Sbjct: 276 PNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ K ++IHR++ N L+ + ++++DFGL
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGL 364
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 53/249 (21%), Positives = 93/249 (37%), Gaps = 52/249 (20%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ EL IG+G FG+V + + A+K K E E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQ 447
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
D IVKL + + +++IME G++ + L +RK +L Y + A+
Sbjct: 448 FDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ ++HRDI N+L+ ++L DFGL + +++ +
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKA---------- 549
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ P + W +APE + + + D W G M+E
Sbjct: 550 SKGKLPIK--------W-----------------MAPESINFRRFTSASDVWMFGVCMWE 584
Query: 350 ML-VGYPPF 357
+L G PF
Sbjct: 585 ILMHGVKPF 593
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+F+ + ++G GAFG V EK V A+K+L+++ + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATS--PKANKEILDEAYVM 71
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
A VD+ + +L C + LI + +P G ++ + KD + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +HRD+ N+L+ H++++DFGL K L
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 55/253 (21%), Positives = 92/253 (36%), Gaps = 55/253 (21%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ +IG G GEV R V A+K LK R Q +E +++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQ 106
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAI 229
D I++L + ++ EY+ G + T L T + + +
Sbjct: 107 FDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ Y+HRD+ N+L+D ++SDFGL + L+ + D
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE----DDPDA------------- 207
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLGAI 346
AY+T G I APE + + + D WS G +
Sbjct: 208 ------------------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243
Query: 347 MYEML-VGYPPFY 358
M+E+L G P++
Sbjct: 244 MWEVLAYGERPYW 256
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+D L ++G+G FGEV V + A+K KK L E +E ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKN 69
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAI 229
+D IVKL +E ++IME P G++ L R K++L Y + A+
Sbjct: 70 LDHPHIVKLIGIIE---EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + +HRDI N+L+ ++L DFGL
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGL 159
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 11/158 (6%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ EL IG+G FG+V + + A+K K E E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 72
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
D IVKL + + +++IME G++ + L +RK +L Y + A+
Sbjct: 73 FDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++HRDI N+L+ ++L DFGL + ++
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++ LL +G G FG V++ + K V A+K +K+ M + E + ++
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
+VK Y CS + +Y++ EY+ G ++ L L + + + +
Sbjct: 63 PKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
H +IHRD+ N L+D+ +++SDFG+
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGM 150
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+L C+ + Y+I E++ G+++ L + ++ + + A+E
Sbjct: 69 PNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ K ++IHRD+ N L+ + ++++DFGL
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGL 157
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D L +G G FG V+ + + V A+K +K+ M + E ++ +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
+V+LY C+ +++I EY+ G ++ L + + + A+E +
Sbjct: 79 EKLVQLYGVCT--KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N L++ G +++SDFGL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+LY + E +Y+I EY+ G ++ L LT ++ A+ +
Sbjct: 68 QRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
I + +YIHRD++ N+L+ +++DFGL
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGL 155
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 47/254 (18%), Positives = 97/254 (38%), Gaps = 55/254 (21%)
Query: 115 ADDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLA 171
A + + ++G G FGEV + + + A+K LK + Q E +++
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMG 101
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLA 228
+ D I++L + + + ++ EY+ G + + L T + +
Sbjct: 102 QFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + Y+HRD+ N+L++ ++SDFGL + L+
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--------------------- 198
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLGA 345
+ AY+T G I +PE + + + D WS G
Sbjct: 199 --------------------DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 346 IMYEML-VGYPPFY 358
+++E++ G P++
Sbjct: 239 VLWEVMSYGERPYW 252
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 50/255 (19%), Positives = 93/255 (36%), Gaps = 58/255 (22%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+IG G FGEV + K V A+K LK + Q E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV-AIKTLKAGYTEK--QRVDFLGEAGIM 100
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVL 227
+ + I++L S + + +I EY+ G + L + + + +
Sbjct: 101 GQFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ + +Y+HRD+ N+L++ ++SDFGL + L
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--------------------- 197
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLG 344
++ Y+T G I APE + + + D WS G
Sbjct: 198 --------------------EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 237
Query: 345 AIMYEML-VGYPPFY 358
+M+E++ G P++
Sbjct: 238 IVMWEVMTYGERPYW 252
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 36/151 (23%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V G+ A+K +K + + E +++ ++
Sbjct: 21 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ----AFLA-EASVMTQLRH 73
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E
Sbjct: 74 SNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++++HRD+ N+L+ + ++SDFGL
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L +G G FGEV + V A+K +K M VE AE N++ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +VKL+ + E +Y+I E++ G ++ L + + A+ +
Sbjct: 243 DKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
I + +YIHRD++ N+L+ +++DFGL
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGL 330
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 37/151 (24%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V G+ A+K +K + AE +++ ++
Sbjct: 193 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 245
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E
Sbjct: 246 SNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++++HRD+ N+L+ + ++SDFGL
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 14/160 (8%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L ++G G FG V E V +K ++ + + V +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPV-CIKVIEDKSGRQ--SFQAVTDHMLAI 69
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+D IV+L C L L+ +YLP G ++ + + L + +
Sbjct: 70 GSLDHAHIVRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +H +HR++ N+LL ++++DFG+ L
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 41/263 (15%), Positives = 83/263 (31%), Gaps = 70/263 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY-------AMKKLKKSEMLRRGQVEHVRAERN 168
+D +G+G F ++ + G +K L K+ E +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64
Query: 169 LLAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAET 225
+++++ +V Y C + L+ E++ G + T L + K+ + +
Sbjct: 65 MMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL 122
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLR--------LSDFGLCKPLDCSTLQEQDFT 277
A+ + ++ IH ++ N+LL + + LSD G+ T+ +D
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI-----TVLPKDIL 177
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGM 336
W + PE + K +
Sbjct: 178 ---------------QERIP--------W-----------------VPPECIENPKNLNL 197
Query: 337 ECDWWSLGAIMYEML-VGYPPFY 358
D WS G ++E+ G P
Sbjct: 198 ATDKWSFGTTLWEICSGGDKPLS 220
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 4e-12
Identities = 56/261 (21%), Positives = 100/261 (38%), Gaps = 63/261 (24%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH-VRAERNLLAEVDSNCIVKL 181
+G+G FG V + A+KKL + +++ E ++A+ +V+L
Sbjct: 38 KMGEGGFG--VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 182 Y-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTED-EARFYVAE-TVLAIESIHKHHY 237
S D+ L+ Y+P G ++ L T R +A+ I +H++H+
Sbjct: 96 LGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LLD+ ++SDFGL + +
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASE------------------------------ 184
Query: 298 TQQEQLQHWQKNRRMLAYST--VGTPDYIAPE----VLLKKGYGMECDWWSLGAIMYEML 351
+ ++ VGT Y+APE + K D +S G ++ E++
Sbjct: 185 --KFAQTV---------MTSRIVGTTAYMAPEALRGEITPK-----SDIYSFGVVLLEII 228
Query: 352 VGYPPFYSDDPMSTCRKIVNW 372
G P D + +++
Sbjct: 229 TGLPAV---DEHREPQLLLDI 246
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 20/164 (12%)
Query: 116 DDFELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
F L M+GKG FG VR + + V A+K LK + +E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKV-AVKMLKADIIASS-DIEEFLREAACMK 80
Query: 172 EVDSNCIVKLY-CSFQDD-----EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E D + KL S + +I+ ++ GD+ L + E+ +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTL 139
Query: 226 VLAIESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
V + I ++IHRD+ N +L + + ++DFGL
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG VR V R + A+K LK+ E + E ++ ++D+ IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 401
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
C E L L+ME GG + L+ +++ + + + + ++ + + +++
Sbjct: 402 IGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
HR++ N+LL + ++SDFGL K L
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALG 487
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 31/150 (20%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IGKG FG V + + + A+K L + ++ QVE E L+ ++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQ--QVEAFLREGLLMRGLN 80
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESI 232
++ L + ++++ Y+ GD++ + + T + + + +E +
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++HRD+ N +LD+ ++++DFGL
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGL 170
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 39/171 (22%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D +L +G+GAFG+V + + T V A+K LK+ + + +E +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHS--EHRALMSELKI 83
Query: 170 LAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
L + + +V L + L +I+E+ G++ T L R + + A + +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L +E + IHRD+ N+LL + +++ DFGL
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 27/150 (18%), Positives = 63/150 (42%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IG+G FG V + + H A+K L + + +V E ++ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIG--EVSQFLTEGIIMKDFS 84
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESI 232
++ L + + +++ Y+ GD+ + T + + + ++ +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N +LD+ ++++DFGL
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGL 174
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 9e-12
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 30/171 (17%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ + +G GAFG+V + +E V A+K LK + + E + +E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHAD--EKEALMSELKI 102
Query: 170 LAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
++ + N IV L C+ + +I EY GD++ L RK + E + F +A +
Sbjct: 103 MSHLGQHEN-IVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + + IHRD+ N+LL ++ DFGL
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 1e-11
Identities = 48/341 (14%), Positives = 103/341 (30%), Gaps = 93/341 (27%)
Query: 5 RSWLQKLQPRDK-----MRGSGK--------------KKEAGG----NGSNEESTDE--E 39
R L +L+P + GSGK K N N S + E
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 40 ALSNVTKQKVAAAKQYIENHY---------KEQMKNLQERRERRN---IL----EKKLAD 83
L + Q ++ + +++ L + + N +L K +
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 84 A-D------VSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVC- 135
A + ++ + + FL T ++ L H M E+ +++ K + + R
Sbjct: 261 AFNLSCKILLTTRFK-QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK--YLDCRPQD 317
Query: 136 --REKTTGHVYAMK---KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL--------Y 182
RE T + + + + + +HV ++ L + + + L +
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMF 375
Query: 183 --CS-FQDD--------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
S F ++ + ++ L + + + + S
Sbjct: 376 DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--------S 427
Query: 232 IHKHHYIHRDIKPDNL------LLDKYGHLRLSDFGLCKPL 266
I Y+ +K +N ++D Y + D P
Sbjct: 428 IP-SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP 467
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 1e-05
Identities = 82/563 (14%), Positives = 157/563 (27%), Gaps = 153/563 (27%)
Query: 15 DKMRGSGKKKEAG---GNGSNEESTDEEALSNVTKQKVAAAKQYIEN----HYKEQMKNL 67
D + K+E + T + ++KQ+ ++++E +YK M +
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE-EMVQKFVEEVLRINYKFLMSPI 98
Query: 68 Q-ERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGK 126
+ E+R+ + + D D K+ + Y++L++ + + + + G
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 127 GAFGE----VRVCREKTT-----GHVY--AMKKLKKSE-MLRRGQVEHVRAERNLLAEVD 174
G+ + VC ++ +K E +L Q + + N + D
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218
Query: 175 SNCIVKLYCSFQDDEFLYLIME--YLPGGDMMTLLMRKD---------------TL--TE 215
+ +KL E L+ Y LL+ + L T
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPY-----ENCLLVLLNVQNAKAWNAFNLSCKILLTTR 273
Query: 216 DE--ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL----CK--PLD 267
+ F A T I H + D + +LLL KY R D L P
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPD-EVKSLLL-KYLDCRPQD--LPREVLTTNPRR 329
Query: 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ-EQLQHWQKNRRMLAYSTVGTPDYIAP 326
S I ++ ++ + + + + + V P
Sbjct: 330 LS-------IIAESI----RDG-----LATWDNWKHVNCDKLTTIIESSLNVLEPA---- 369
Query: 327 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPEEAK 383
+K M++ L +P P I W +
Sbjct: 370 --EYRK--------------MFDRLSVFP----PSAHIPTILLSLI--W---FDVIKSDV 404
Query: 384 LSIEAKDLISKLLCN------------VNQRLGAKGADEIKVHPWFDGVDWARI---YQM 428
+ + L L + L K +E +H I Y +
Sbjct: 405 MVV-VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH--------RSIVDHYNI 455
Query: 429 EAAF-----IPEVNDE----------LDTQNFEKFEESDN--------QTKTSSKTGPWR 465
F IP D+ + ++ E+ + K + W
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWN 515
Query: 466 KMLSSKDINFVGYTYKNFEIVND 488
S + YK + ND
Sbjct: 516 ASGSILNTLQQLKFYKPYICDND 538
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 6e-04
Identities = 50/360 (13%), Positives = 91/360 (25%), Gaps = 100/360 (27%)
Query: 233 HKHH---------YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
H HH Y ++DI F DC + QD ++
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVF----------EDAF--VDNFDCKDV--QDMP--KSIL 46
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+ + + W +L+ ++ E +L+ Y + +
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWT----LLSKQEEMVQKFV--EEVLRINYK-----FLM 95
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKL---LCNVN 400
I E P R + + + F K ++ KL L +
Sbjct: 96 SPIKTEQR---QPSMMTRMYIEQRDRL-YNDNQVFA---KYNVSRLQPYLKLRQALLELR 148
Query: 401 ---------------QRLGAKGADEIKVHPWFD-GVDWARI-YQMEAAFIPEVNDELDTQ 443
+ KV D + W + + E+ +L Q
Sbjct: 149 PAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 444 NFEKF-EESDNQTKTSSKTGPW----RKMLSSKDINFVGYTYKN---------------- 482
+ SD+ + + R++L SK Y+N
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------YENCLLVLLNVQNAKAWNA 261
Query: 483 FEI-------VNDYQVPGMAELKKTNNKPKRPSVKTLFESESET--SESSDTPASDQPSQ 533
F + QV T + TL E ++ + D D P +
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE 321
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG VR V R + A+K LK+ E + E ++ ++D+ IV+L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 75
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYI 238
C E L L+ME GG + L+ +++ + + + + ++ + + +++
Sbjct: 76 IGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
HRD+ N+LL + ++SDFGL K L
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALG 161
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 29/165 (17%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ + +G+G+FG V V +++ V A+K + ++ +R + E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMR--ERIEFLNEASV 81
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
+ E + + +V+L S + +IME + GD+ + L R
Sbjct: 82 MKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 226 VLAI--------ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++ + ++ + ++HRD+ N ++ + +++ DFG+
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 27/150 (18%), Positives = 63/150 (42%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IG+G FG V + + H A+K L + + +V E ++ +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIG--EVSQFLTEGIIMKDFS 148
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
++ L + + +++ Y+ GD+ + T + + + ++ +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N +LD+ ++++DFGL
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGL 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 48/267 (17%), Positives = 94/267 (35%), Gaps = 73/267 (27%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G GAFGEV + + + V A+K L + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQ--DELDFLMEALI 86
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV- 226
+++ + IV+ +++ME + GGD+ + L + + + +
Sbjct: 87 ISKFNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 227 LAI------ESIHKHHYIHRDIKPDNLLLDKYGHLRL---SDFGLCKPLDCSTLQEQDFT 277
+A + + ++H+IHRDI N LL G R+ DFG+ + +
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD-----IYRAS-- 197
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI-----APEVLLKK 332
Y G + PE ++
Sbjct: 198 -------------------------------------YYRKGGCAMLPVKWMPPEAFMEG 220
Query: 333 GYGMECDWWSLGAIMYEML-VGYPPFY 358
+ + D WS G +++E+ +GY P+
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGYMPYP 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 31/163 (19%), Positives = 63/163 (38%), Gaps = 19/163 (11%)
Query: 116 DDFELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ L ++G+G FG V + T+ V A+K +K +R E + E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLS-EAACMK 91
Query: 172 EVDSNCIVKLY-CSFQDD----EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ +++L + +I+ ++ GD+ T L L + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLL 150
Query: 227 LAIESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ I +++HRD+ N +L + ++DFGL
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 30/173 (17%)
Query: 116 DDFELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER 167
D L +G+GAFG+V + K V A+K LK + + + +E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEK--DLSDLVSEM 91
Query: 168 NLLAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVA 223
++ + + I+ L QD LY+I+EY G++ L R + V
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 224 ETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E + + + IHRD+ N+L+ + ++++DFGL
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 47/267 (17%), Positives = 90/267 (33%), Gaps = 73/267 (27%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G GAFGEV + + + V A+K L + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQ--DELDFLMEALI 127
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+++ + IV+ ++++E + GGD+ + L + + + +
Sbjct: 128 ISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 228 AIESIHK-------HHYIHRDIKPDNLLLDKYGHLRL---SDFGLCKPLDCSTLQEQDFT 277
I +H+IHRDI N LL G R+ DFG+ + +
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD-----IYRAG-- 238
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI-----APEVLLKK 332
Y G + PE ++
Sbjct: 239 -------------------------------------YYRKGGCAMLPVKWMPPEAFMEG 261
Query: 333 GYGMECDWWSLGAIMYEML-VGYPPFY 358
+ + D WS G +++E+ +GY P+
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGYMPYP 288
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-11
Identities = 38/173 (21%), Positives = 68/173 (39%), Gaps = 30/173 (17%)
Query: 116 DDFELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER 167
D L +G+G FG+V + K V A+K LK + + + +E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEK--DLSDLVSEM 137
Query: 168 NLLAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVA 223
++ + + I+ L QD LY+I+EY G++ L R + V
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 224 ETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E + + + IHRD+ N+L+ + ++++DFGL
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 38/168 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKS------------EMLRRGQVEH 162
++F+ +IG G FG +V + G A+K+ E L H
Sbjct: 39 NNFDHKFLIGHGVFG--KVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL--SFCRH 94
Query: 163 VRAERNLLAEVDSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED---E 217
+L V L +C + + LI +Y+ G++ L D T E
Sbjct: 95 ----PHL---------VSLIGFC--DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 218 ARFYVA-ETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
R + + +H IHRD+K N+LLD+ +++DFG+ K
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 34/175 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ +G GAFG+V + + V A+K LK S L + E + +E +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTV-AVKMLKPSAHLT--EREALMSELKV 79
Query: 170 LAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVA 223
L+ + + N IV L C+ +I EY GD++ L R + + +
Sbjct: 80 LSYLGNHMN-IVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 224 ETVLAIES----------------IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ LA++ + + IHRD+ N+LL ++ DFGL
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 30/171 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + K V A+K LK + R + + E L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLV-AVKALKDPTLAAR---KDFQREAEL 70
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
L + IVK Y C D + L ++ EY+ GD+ L D + + + A+
Sbjct: 71 LTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L + + H++HRD+ N L+ +++ DFG+
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 35/171 (20%), Positives = 59/171 (34%), Gaps = 29/171 (16%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ +G+ FG+V + T V A+K LK E R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGP--LREEFRHEAML 65
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAET 225
A + +V L + D+ L +I Y GD+ L + ++
Sbjct: 66 RARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L HH +H+D+ N+L+ ++++SD GL
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 38/175 (21%), Positives = 73/175 (41%), Gaps = 29/175 (16%)
Query: 116 DDFELLTMIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+D + +IG+G FG+V R+ ++ A+K++K+ E +L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKD--DHRDFAGELEVLCK 81
Query: 173 VDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETV 226
+ N I+ L C +LYL +EY P G+++ L R A +
Sbjct: 82 LGHHPN-IINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 227 LAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
L+ + + +IHRD+ N+L+ + +++DFGL + +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 4e-10
Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 35/178 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L +G+G FG+V + V A+K LK++ ++ + +E N+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPS--ELRDLLSEFNV 79
Query: 170 LAEVDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L +V+ ++KLY QD L LI+EY G + L + + +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 229 IESIHK------------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++ + +HRD+ N+L+ + +++SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 29/170 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + E+ V A+K LK++ R + + E L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLV-AVKALKEASESAR---QDFQREAEL 96
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
L + IV+ + C+ + L ++ EY+ GD+ L VA
Sbjct: 97 LTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 227 LAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L + + H++HRD+ N L+ + +++ DFG+
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 39/178 (21%), Positives = 70/178 (39%), Gaps = 35/178 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ E ++G GAFG+V + + + V A+K LK+ + E + +E +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSS--EREALMSELKM 101
Query: 170 LAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+ ++ S+ IV L +YLI EY GD++ L K ++ Y + L
Sbjct: 102 MTQLGSHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 228 AIESIHK-----------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E +HRD+ N+L+ +++ DFGL
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 44/233 (18%), Positives = 83/233 (35%), Gaps = 53/233 (22%)
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
+H+ + +++ ++ E+ E R D
Sbjct: 30 HHHHHDYDIPTTENLYFQGMLAGVSEYELPEDP-----------RWELPR--------DR 70
Query: 118 FELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
L +G+GAFG+V + V A+K LK + + + +E +
Sbjct: 71 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV-AVKMLKSDATEK--DLSDLISEMEM 127
Query: 170 LAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVA 223
+ + N I+ L C+ D LY+I+EY G++ L R L +
Sbjct: 128 MKMIGKHKN-IINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 224 ETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E L+ + + IHRD+ N+L+ + ++++DFGL
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 42/179 (23%), Positives = 68/179 (37%), Gaps = 37/179 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ E + IG+GAFG V R + V A+K LK+ + E L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMV-AVKMLKEEASAD--MQADFQREAAL 103
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+AE D+ IVKL C+ + + L+ EY+ GD+ L T T
Sbjct: 104 MAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 228 AIESIHK------------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ S ++HRD+ N L+ + ++++DFGL
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 6e-09
Identities = 32/200 (16%), Positives = 61/200 (30%), Gaps = 48/200 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL-----KKSEMLRRGQVEHVRAERNLL 170
+ + IG+G FGEV + A+K + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 171 AEVD-----------------SNCIVKLYC----------------------SFQDDEFL 191
E+ S V+ F D+ L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLD 250
++++E+ GG + MR + A+ + + ++ + HRD+ N+LL
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 251 KYGHLRLSDFGLCKPLDCST 270
K +L K +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPS 216
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 47/177 (26%), Positives = 74/177 (41%), Gaps = 46/177 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKS-------------EMLRRGQ 159
D+F ++G+G FG+V K G + A+K+LK+ EM+
Sbjct: 30 DNFSNKNILGRGGFGKVY----KGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI--SM 83
Query: 160 VEHVRAERNLLAEVDSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTE 215
H RNL ++L +C E L L+ Y+ G + + L +
Sbjct: 84 AVH----RNL---------LRLRGFCM-TPTERL-LVYPYMANGSVASCLRERPESQPPL 128
Query: 216 D-EARFYVAE-TVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
D R +A + + +H H IHRD+K N+LLD+ + DFGL K +D
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 13/173 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +L +G+GAFG+V + T A+K LK+ + + +E +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79
Query: 171 AEVDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+ N + L + L +I+E+ G++ T L K Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP----YKTKGARF 135
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ I D+K + S F K L +E + +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 23/150 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKK-LKKS-------EMLRRGQVEHVRAERNLLAEVD 174
+IGKGA E + R+ +K+ +KK E +R+ E LA V
Sbjct: 343 LIGKGA--EADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVK 397
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I Y D + ++M Y+ G KD + ++ Y ++ +HK
Sbjct: 398 DFGIPAPYIFDVDLDNKRIMMSYINGKLA------KDVIEDNLDIAYKIGEIVG--KLHK 449
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ IH D+ N + D L + DFGL K
Sbjct: 450 NDVIHNDLTTSNFIFD--KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 552 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.64 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.49 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.4 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.17 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.81 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.79 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.48 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.48 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.43 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.34 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.05 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.98 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.86 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.83 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.71 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.5 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 80.29 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-73 Score=583.71 Aligned_cols=279 Identities=36% Similarity=0.674 Sum_probs=254.8
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
+...+||+++++||+|+||+||+|+++.+|+.||||++.+..+......+.+.+|+++|+.++|||||++|++|++++++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34568999999999999999999999999999999999998877777888999999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|||||||+||+|.++|.+.+.|+|.++++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997643211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
...+.+.||||.|||||++.+.+|+.++||||||||+|||+
T Consensus 188 ---------------------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 228 (311)
T 4aw0_A 188 ---------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228 (311)
T ss_dssp ---------------------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 01234689999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC---ChhhhhcCCCcCCCChhhhhh
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~---~a~eil~HpfF~~i~w~~l~~ 427 (552)
+|++||.+.+..+++.+|++ ..+.+|. .+|++++|||.+||+ ||.+|+++. +..+|++||||+++||+.|.+
T Consensus 229 ~G~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 229 AGLPPFRAGNEGLIFAKIIK--LEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 304 (311)
T ss_dssp HSSCSSCCSSHHHHHHHHHH--TCCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred hCCCCCCCCCHHHHHHHHHc--CCCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence 99999999999999999997 4566775 799999999999999 999999943 234589999999999999998
Q ss_pred cCCCCc
Q 008810 428 MEAAFI 433 (552)
Q Consensus 428 ~~~pf~ 433 (552)
..||.+
T Consensus 305 ~~pP~l 310 (311)
T 4aw0_A 305 QTPPKL 310 (311)
T ss_dssp SCCCCC
T ss_pred CCCCCC
Confidence 888764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-71 Score=611.74 Aligned_cols=290 Identities=34% Similarity=0.642 Sum_probs=258.2
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH---HhcCCCceEEEeeeecC
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL---~~l~hp~Iv~l~~~f~d 187 (552)
..++.+||+++++||+|+||+||+|+++.+|+.||||++.+..+.......++.+|+.++ ..++|||||+|+++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 468899999999999999999999999999999999999998877777777777776655 45689999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+++|||||||+||+|..+|.+.+.|+|..+++|++||+.||+|||++|||||||||+||||+.+|||||+|||+|+.+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998754
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvi 346 (552)
.. ...+.||||.|||||++.+ .+|+.++||||||||
T Consensus 344 ~~-------------------------------------------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvi 380 (689)
T 3v5w_A 344 KK-------------------------------------------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380 (689)
T ss_dssp SC-------------------------------------------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHH
T ss_pred CC-------------------------------------------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 22 1236799999999999974 689999999999999
Q ss_pred HHHHhhCCCCCCCCC---hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCC
Q 008810 347 MYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGV 420 (552)
Q Consensus 347 lyEmltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i 420 (552)
|||||+|++||.+.+ ..+++..+.. ..+.+|. .+|+++++||.+||+ ||.+|+|+ .|++||++||||++|
T Consensus 381 lYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 381 LFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 999999999998753 3345556665 4566665 799999999999999 99999995 579999999999999
Q ss_pred Chhhhh--hcCCCCccccCCcccCcCccc
Q 008810 421 DWARIY--QMEAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 421 ~w~~l~--~~~~pf~P~~~~~~d~~~f~~ 447 (552)
||+.|. +++|||+|.+.+..++++||.
T Consensus 457 dW~~l~~~~~~pP~~P~~~~~~~~~~fD~ 485 (689)
T 3v5w_A 457 DWQMVFLQKYPPPLIPPRGEVNAADAFDI 485 (689)
T ss_dssp CHHHHHTTCSCCSCCCCTTCSSTTBCCC-
T ss_pred CHHHHHcCCCCcCccCCCCCCCcCCCCCC
Confidence 999997 488999999988877777763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-72 Score=569.77 Aligned_cols=280 Identities=41% Similarity=0.740 Sum_probs=244.7
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
...++..++|++++.||+|+||+||+|++. .+++.||||++++...... ....+.+|+.+|+.++|||||+++++|
T Consensus 17 ~~~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 17 GHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp TCCCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEE
T ss_pred ccccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 345567789999999999999999999984 4788999999987654322 234678899999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
++++.+|||||||+||+|.++|.+.+.|++.++++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
..... ....+.|||+.|||||++.+.+|+.++|||||||
T Consensus 176 ~~~~~-----------------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGv 214 (304)
T 3ubd_A 176 SIDHE-----------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGV 214 (304)
T ss_dssp ----------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHH
T ss_pred ccCCC-----------------------------------------ccccccccCcccCCHHHhccCCCCCCCcccchHH
Confidence 43211 1123679999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCCh
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDW 422 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w 422 (552)
++|||++|.+||.+.+..+++.+|.+ ..+.+|. .+|+++++||.+||+ ||.+||++. +++||++||||+++||
T Consensus 215 ilyemltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw 290 (304)
T 3ubd_A 215 LMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDW 290 (304)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HHHHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCH
Confidence 99999999999999999999999987 4566675 799999999999999 999999963 5789999999999999
Q ss_pred hhhh--hcCCCCcc
Q 008810 423 ARIY--QMEAAFIP 434 (552)
Q Consensus 423 ~~l~--~~~~pf~P 434 (552)
+.+. +++|||+|
T Consensus 291 ~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 291 NKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHTTCSCCSSCC
T ss_pred HHHHhCCCCcCcCC
Confidence 9997 47899998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-68 Score=565.87 Aligned_cols=350 Identities=43% Similarity=0.810 Sum_probs=287.3
Q ss_pred hhhhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEee
Q 008810 104 EYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (552)
Q Consensus 104 ~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 183 (552)
...++.+.++..++|+++++||+|+||+||+|+++.+|+.||||++++.......+.+++++|+.+|..++|||||++++
T Consensus 49 ~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 49 IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 34556777888999999999999999999999999999999999999887766777788999999999999999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
+|++.+.+|||||||+||+|.++|.+. ..+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+
T Consensus 129 ~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGl 208 (412)
T 2vd5_A 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208 (412)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechh
Confidence 999999999999999999999999875 4899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-------CCCC
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-------KGYG 335 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-------~~y~ 335 (552)
|+.+..... ......+||+.|+|||++.. ..|+
T Consensus 209 a~~~~~~~~----------------------------------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~ 248 (412)
T 2vd5_A 209 CLKLRADGT----------------------------------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248 (412)
T ss_dssp CEECCTTSC----------------------------------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEEC
T ss_pred heeccCCCc----------------------------------------cccceeccccCcCCHHHHhhcccCcCCCCCC
Confidence 987643210 01124689999999999983 5689
Q ss_pred CccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCc-ccccChhHHHHHHHHhhCccccCCCCChhhhhcC
Q 008810 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVH 414 (552)
Q Consensus 336 ~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~H 414 (552)
.++|||||||++|||++|++||.+.+..+++.+|+++...+.+|. ...+|+++++||.+||++|.+|+|+.+++||++|
T Consensus 249 ~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 249 PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHTS
T ss_pred hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhcC
Confidence 999999999999999999999999999999999998766666664 2479999999999999999999988889999999
Q ss_pred CCcCCCChhhhhhcCCCCccccCCcccCcCccccccccccccCCC---CCCcccccccccCCcccCceecCcccccCCCC
Q 008810 415 PWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSS---KTGPWRKMLSSKDINFVGYTYKNFEIVNDYQV 491 (552)
Q Consensus 415 pfF~~i~w~~l~~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~f~g~~~~~~~~~~~~~~ 491 (552)
|||+++||+.+....|||+|.+.++.|++||+.+.+......... ............+..|.||||.+.. +.+...
T Consensus 329 pff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~-~~~~~~ 407 (412)
T 2vd5_A 329 PFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMA-LRDSEV 407 (412)
T ss_dssp GGGTTCCSTTSTTSCCSCCCC-----CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCCC-CCGGGC
T ss_pred CCcCCCCHHHHhhcCCCCCCcCCCcccccccCcccccccccccccCCCcccccCCCccccCCCCCCCcccCcc-cccccC
Confidence 999999999999999999999999999999998644322110000 0000001112346789999998854 344445
Q ss_pred Cch
Q 008810 492 PGM 494 (552)
Q Consensus 492 ~~~ 494 (552)
||+
T Consensus 408 ~~~ 410 (412)
T 2vd5_A 408 PGP 410 (412)
T ss_dssp C--
T ss_pred CCC
Confidence 543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-67 Score=561.58 Aligned_cols=335 Identities=44% Similarity=0.834 Sum_probs=289.2
Q ss_pred hhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 106 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
..+...++..++|+++++||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|+.++|||||+++++|
T Consensus 59 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 138 (410)
T 3v8s_A 59 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 138 (410)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34556678899999999999999999999999999999999999987776666777899999999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
++...+|||||||+||+|.+++.. ..+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 139 ~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 139 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999999999999999999864 5799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC----CCCccchh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWW 341 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~----y~~~~DiW 341 (552)
+..... ....+.+||+.|+|||++.+.+ |+.++|||
T Consensus 218 ~~~~~~----------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~Diw 257 (410)
T 3v8s_A 218 MNKEGM----------------------------------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWW 257 (410)
T ss_dssp CCTTSE----------------------------------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHH
T ss_pred eccCCc----------------------------------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEe
Confidence 643211 0123578999999999999766 88999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCCCC
Q 008810 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 342 SlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
||||++|||++|++||.+.+...++.+|+.+...+.+|....+|+++++||.+||+++.+|+++.+++||++||||++++
T Consensus 258 SlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 258 SVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred cchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 99999999999999999999999999999877778888777899999999999999666666666699999999999999
Q ss_pred hhhhh--hcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCccc
Q 008810 422 WARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEI 485 (552)
Q Consensus 422 w~~l~--~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~ 485 (552)
|+.+. ++.|||+|.+.++.|++||+++.+......+.. ........+..|.||||.+...
T Consensus 338 w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~----~~~~~~~~~~~f~~f~~~~~~~ 399 (410)
T 3v8s_A 338 WAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFP----IPKAFVGNQLPFVGFTYYSNRR 399 (410)
T ss_dssp CCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCCC----CCSSCCCTTGGGTTCCEECC--
T ss_pred HHHHhhcccCCCCCCcCCCccchhhcCCccccccccccCC----CchhhcccccccccceEeCccc
Confidence 97654 689999999999999999998765543222211 1112223567899999987543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-67 Score=560.65 Aligned_cols=340 Identities=46% Similarity=0.852 Sum_probs=287.1
Q ss_pred hhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
.+...++..++|+++++||+|+||+||+|+++.+|+.||||++.+..........++++|+.+|..++|||||+++++|+
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556778899999999999999999999999999999999999877766666777999999999999999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
+...+|||||||+||+|.++|.+ .+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999987 57899999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccch
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 340 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Di 340 (552)
+..... ......+||+.|+|||++. ...|+.++||
T Consensus 225 ~~~~~~----------------------------------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~Dv 264 (437)
T 4aw2_A 225 LMEDGT----------------------------------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264 (437)
T ss_dssp CCTTSC----------------------------------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHH
T ss_pred cccCCC----------------------------------------cccccccCCcCeeChHHHhhcccCCCCCCCcCee
Confidence 543210 0112468999999999998 4569999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcc-cccChhHHHHHHHHhhCccccCCCCChhhhhcCCCcCC
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~e~~dLI~~lL~dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||||++|||++|++||.+.+..+++.+|+.+...+.+|.. ..+|+++++||++||+.+.+|+++.+++||++||||++
T Consensus 265 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 265 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred HHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 99999999999999999999999999999987667777764 46899999999999995566766667999999999999
Q ss_pred CChhhhhhcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCcccccC
Q 008810 420 VDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVND 488 (552)
Q Consensus 420 i~w~~l~~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~ 488 (552)
+||+.+.+++|||+|.+.++.|++||+..........+.. .+........+..|.||||+.+..+.+
T Consensus 345 i~w~~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~~--~~~~~~~~~~~~~f~~~~~~~~~~~~~ 411 (437)
T 4aw2_A 345 IDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMP--PPTHTAFSGHHLPFVGFTYTSSCVLSD 411 (437)
T ss_dssp CCTTTGGGSCCSCCCCCSSTTCCTTSCCC--------------------CCTTGGGTTCCEESSCTTST
T ss_pred CCHHHHhhCCCCCCCcCCCccchhhcCCcccccccccCCC--CCccccccccCccccCCCcCCchhhcc
Confidence 9999999999999999999999999987543322111111 111112334567899999998765543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-65 Score=536.30 Aligned_cols=326 Identities=35% Similarity=0.685 Sum_probs=275.8
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
.++..++|+++++||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|..+ +|||||+++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 456789999999999999999999999999999999999988777777888899999999988 7999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|||||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999853221
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 178 ~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 216 (353)
T 3txo_A 178 G-----------------------------------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216 (353)
T ss_dssp -------------------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHH
Confidence 1 01235789999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC---CChhhhhcCCCcCCCChhhh
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~---~~a~eil~HpfF~~i~w~~l 425 (552)
|++|.+||.+.+..+++.+|.. ..+.+|. .+++++++||.+||+ ||.+||++ .+++||++||||++++|+.+
T Consensus 217 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l 292 (353)
T 3txo_A 217 MLCGHAPFEAENEDDLFEAILN--DEVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292 (353)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence 9999999999999999999987 4556665 689999999999999 99999996 45699999999999999998
Q ss_pred h--hcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCcc
Q 008810 426 Y--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484 (552)
Q Consensus 426 ~--~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 484 (552)
. +++|||+|.+.+..|++||+.......+..+...... ........|.||+|.+..
T Consensus 293 ~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~---~~~~~~~~f~~f~~~~~~ 350 (353)
T 3txo_A 293 NHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGH---LPMINQDEFRNFEYVSPE 350 (353)
T ss_dssp HTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTS---GGGSCGGGGTTCCEECC-
T ss_pred hcCcCCCCccCCCCCcccccccCcccccCCCcCCCccccc---cCcccccccCCceeeCcc
Confidence 7 4889999999999999999963322222222111111 111134579999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-65 Score=530.55 Aligned_cols=326 Identities=37% Similarity=0.662 Sum_probs=278.0
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|+.++|||||+++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 56789999999999999999999999999999999999887667777889999999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
+||||++||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999985421110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
...+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 161 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 200 (337)
T 1o6l_A 161 ----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200 (337)
T ss_dssp ----------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc
Confidence 1235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh--
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ-- 427 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~-- 427 (552)
|.+||.+.+....+..|.. ..+.+|. .+|+++++||.+||. ||.+|||+ .+++||++||||++++|+.+.+
T Consensus 201 g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~ 276 (337)
T 1o6l_A 201 GRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 276 (337)
T ss_dssp SSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 9999999999888888886 4566775 789999999999999 99999964 3699999999999999999974
Q ss_pred cCCCCccccCCcccCcCccc-cccccccccCCCCCCcccccc---cccCCcccCceecCc
Q 008810 428 MEAAFIPEVNDELDTQNFEK-FEESDNQTKTSSKTGPWRKML---SSKDINFVGYTYKNF 483 (552)
Q Consensus 428 ~~~pf~P~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~f~g~~~~~~ 483 (552)
+.|||+|.+.++.|++||+. |+.............+...+. ...+..|.||+|.+.
T Consensus 277 ~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 277 LLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp SCCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECC
T ss_pred CCCCCCCCCCCcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCC
Confidence 78999999999999999985 443322111111011111111 113468999999763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-66 Score=521.13 Aligned_cols=254 Identities=31% Similarity=0.587 Sum_probs=217.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999987766666677899999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||| +|+|.+++.+.+.|++.+++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---- 166 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence 9999 78999999999999999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEmltG 353 (552)
...+.+||+.|||||++.+..| +.++|||||||++|||++|
T Consensus 167 --------------------------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg 208 (275)
T 3hyh_A 167 --------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 208 (275)
T ss_dssp ----------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence 1225799999999999999886 6899999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
++||.+.+..+++.+|.+ ....+|. .+|+++++||.+||+ ||.+||+ ++||++||||+
T Consensus 209 ~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~s---~~eil~hpw~k 267 (275)
T 3hyh_A 209 RLPFDDESIPVLFKNISN--GVYTLPK--FLSPGAAGLIKRMLIVNPLNRIS---IHEIMQDDWFK 267 (275)
T ss_dssp SCSSCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC---HHHHHHCHHHH
T ss_pred CCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCChhHCcC---HHHHHcCcccc
Confidence 999999999999998887 4456664 799999999999999 9999998 99999999996
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-66 Score=534.35 Aligned_cols=256 Identities=29% Similarity=0.530 Sum_probs=229.9
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++|++|++++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999987643 23345889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||+||+|.+++.+ ..|++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---- 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC----
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC----
Confidence 99999999998865 6799999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
...+.|||+.|||||++.+.+|+.++||||||||+|||++|++
T Consensus 226 -------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 226 -------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp -------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 1236799999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
||.+.+..+.+..|... ....++....+|++++|||.+||+ ||.+||+ ++||++||||+..
T Consensus 269 PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 269 PYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 330 (346)
T ss_dssp TTTTSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred CCCCcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhcCC
Confidence 99999999998888763 233444446899999999999999 9999999 9999999999753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-65 Score=541.51 Aligned_cols=327 Identities=33% Similarity=0.651 Sum_probs=271.9
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
..+..++|+++++||+|+||+||+|+++.+|+.||||++++.........+++..|+.+|..+ +|||||+++++|++..
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 346788999999999999999999999999999999999988766666777899999999887 8999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|||||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 207 ~-----------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllye 245 (396)
T 4dc2_A 207 G-----------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 245 (396)
T ss_dssp T-----------------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHH
Confidence 0 01235799999999999999999999999999999999
Q ss_pred HhhCCCCCCCCC---------hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC---ChhhhhcCCC
Q 008810 350 MLVGYPPFYSDD---------PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIKVHPW 416 (552)
Q Consensus 350 mltG~~PF~~~~---------~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~---~a~eil~Hpf 416 (552)
|++|.+||.+.. ....+..|.. ..+.+|. .+|+++++||.+||+ ||.+||++. +++||++|||
T Consensus 246 ll~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 246 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp HHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred HHhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 999999996432 2334555655 4566775 699999999999999 999999963 5799999999
Q ss_pred cCCCChhhhhh--cCCCCccccCCcccCcCccccccccccccCCCCCCccccccc-ccCCcccCceecCcccc
Q 008810 417 FDGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLS-SKDINFVGYTYKNFEIV 486 (552)
Q Consensus 417 F~~i~w~~l~~--~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~~~~~ 486 (552)
|+++||+.+.+ +.|||+|.+.++.|++||+.....+....+... ...+. ..+..|.||+|.+....
T Consensus 322 f~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~~~~~~----~~~~~~~~~~~f~~f~~~~~~~~ 390 (396)
T 4dc2_A 322 FRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDD----DDIVRKIDQSEFEGFEYINPLLM 390 (396)
T ss_dssp TTTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCCCCCCC----HHHHTTSCGGGGTTCCEECC---
T ss_pred ccCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCccCCCc----chhhccccccccCCcEeECcccc
Confidence 99999999974 789999999999999999963322222111111 11111 23457999999987554
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-65 Score=532.68 Aligned_cols=326 Identities=32% Similarity=0.631 Sum_probs=278.4
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
.++..++|+++++||+|+||+||+|+++.+|+.||||++++.........+++..|+.+|..+ +||||++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 456789999999999999999999999999999999999988776777788899999999887 8999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|||||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ....+.+||+.|+|||++.+.+|+.++|||||||++||
T Consensus 175 ~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (353)
T 2i0e_A 175 G-----------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213 (353)
T ss_dssp T-----------------------------------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHH
Confidence 1 01235789999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhh
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~ 426 (552)
|++|.+||.+.+..+++.+|+. ..+.+|. .+|+++++||.+||+ ||.+||++ .++++|+.||||+++||+.+.
T Consensus 214 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~ 289 (353)
T 2i0e_A 214 MLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 289 (353)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHH
T ss_pred HHcCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 9999999999999999999987 4556665 799999999999999 99999986 358999999999999999996
Q ss_pred --hcCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCccc
Q 008810 427 --QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEI 485 (552)
Q Consensus 427 --~~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~ 485 (552)
++.|||+|.+.+. |++||+.+........+... . .......+..|.||+|.+.+.
T Consensus 290 ~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~--~-~~~~~~~~~~f~~f~~~~~~~ 346 (353)
T 2i0e_A 290 RKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPD--Q-EVIRNIDQSEFEGFSFVNSEF 346 (353)
T ss_dssp TTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCC--H-HHHHHSCTTTTCSCCEECTTC
T ss_pred hCCCCCCcCCCCCCc-chhhccchhccCCcccCCcc--c-cccccccccccCCCeeeCccc
Confidence 4889999999998 99999975433322211111 0 001112346899999998654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-65 Score=532.76 Aligned_cols=257 Identities=28% Similarity=0.506 Sum_probs=225.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..+ .....+.+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 5789999999999999999999999999999999987654 344567899999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 195 MEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||+||+|.++|... ..++|.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-- 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc--
Confidence 9999999999999654 457999999999999999999999999999999999999999999999999998653110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
....+.|||+.|||||++.+.+|+.++||||||||+|||++
T Consensus 180 ---------------------------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt 220 (350)
T 4b9d_A 180 ---------------------------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220 (350)
T ss_dssp ---------------------------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 01235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|++||.+.+..+++.+|++... ..++ ..+|+++++||.+||+ ||.+||+ ++||++||||+.
T Consensus 221 G~~PF~~~~~~~~~~~i~~~~~-~~~~--~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~ 282 (350)
T 4b9d_A 221 LKHAFEAGSMKNLVLKIISGSF-PPVS--LHYSYDLRSLVSQLFKRNPRDRPS---VNSILEKGFIAK 282 (350)
T ss_dssp SSCSCCCSSHHHHHHHHHHTCC-CCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHT
T ss_pred CCCCCCCcCHHHHHHHHHcCCC-CCCC--ccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHHhhc
Confidence 9999999999999999987432 1233 4799999999999999 9999998 999999999964
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-64 Score=525.49 Aligned_cols=321 Identities=35% Similarity=0.663 Sum_probs=253.3
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
.++..++|+++++||+|+||.||+|+++.+|+.||||++++.........+++..|+.+|..+ +|||||+++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999999999999999999988766667788899999999887 9999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+|||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999854221
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 172 ~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (345)
T 1xjd_A 172 D-----------------------------------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210 (345)
T ss_dssp T-----------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHH
Confidence 1 01235789999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChh-hhhcCCCcCCCChhhhhh
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD-EIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~-eil~HpfF~~i~w~~l~~ 427 (552)
|++|.+||.+.+..+++.+|... ...+|. .+|+++++||.+||+ ||.+||+ +. +|++||||++++|+.+..
T Consensus 211 ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dp~~R~~---~~~~i~~hp~f~~~~w~~l~~ 283 (345)
T 1xjd_A 211 MLIGQSPFHGQDEEELFHSIRMD--NPFYPR--WLEKEAKDLLVKLFVREPEKRLG---VRGDIRQHPLFREINWEELER 283 (345)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHSCSSGGGSBT---TBSCGGGSGGGTTCCHHHHHT
T ss_pred HhcCCCCCCCCCHHHHHHHHHhC--CCCCCc--ccCHHHHHHHHHHhcCCHhHcCC---ChHHHHcCccccCCCHHHHhh
Confidence 99999999999999999998873 455664 689999999999999 9999999 55 899999999999999964
Q ss_pred --cCCCCccccCCcccCcCccc-cccccccccCCCCCCccccccc-ccCCcccCceecCcc
Q 008810 428 --MEAAFIPEVNDELDTQNFEK-FEESDNQTKTSSKTGPWRKMLS-SKDINFVGYTYKNFE 484 (552)
Q Consensus 428 --~~~pf~P~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~~~ 484 (552)
+.|||+|.+.++.|++||+. |..... ..+... ...+. ..+..|.||+|.+..
T Consensus 284 ~~~~~p~~p~~~~~~d~~~f~~~~~~~~~-~~~~~~----~~~~~~~~~~~f~~f~~~~~~ 339 (345)
T 1xjd_A 284 KEIDPPFRPKVKSPFDCSNFDKEFLNEKP-RLSFAD----RALINSMDQNMFRNFSFMNPG 339 (345)
T ss_dssp TCSCC-------------------------------------------CCTTTTCCC----
T ss_pred CCCCCCcCCCCCCcchhhhcchhhcccCc-cCCccc----ccccccccccccCCCeeeChh
Confidence 78999999999999999996 543321 111111 01111 234689999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-64 Score=531.01 Aligned_cols=330 Identities=35% Similarity=0.647 Sum_probs=247.5
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHH-HHhcCCCceEEEeeeecCC
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~i-L~~l~hp~Iv~l~~~f~d~ 188 (552)
...+..++|+++++||+|+||+||+|+++.+++.||||++++..........++..|+.+ ++.++|||||+++++|++.
T Consensus 32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~ 111 (373)
T 2r5t_A 32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA 111 (373)
T ss_dssp CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence 345678899999999999999999999999999999999998877666777788888887 5778999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+.+|+|||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999985321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. ....+.+||+.|+|||++.+..|+.++|||||||++|
T Consensus 192 ~~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 230 (373)
T 2r5t_A 192 HN-----------------------------------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLY 230 (373)
T ss_dssp CC-----------------------------------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CC-----------------------------------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHH
Confidence 11 0123578999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC-ChhhhhcCCCcCCCChhhhh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~-~a~eil~HpfF~~i~w~~l~ 426 (552)
||++|.+||.+.+..+++.+|+.. .+.+|. .++.++++||.+||+ ||.+|+++. ++++|+.||||+++||+.+.
T Consensus 231 ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~ 306 (373)
T 2r5t_A 231 EMLYGLPPFYSRNTAEMYDNILNK--PLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLI 306 (373)
T ss_dssp HHHHSSCTTCCSBHHHHHHHHHHS--CCCCCS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHH
T ss_pred HHHcCCCCCCCCCHHHHHHHHHhc--ccCCCC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHH
Confidence 999999999999999999999874 455664 689999999999999 999999963 57899999999999999996
Q ss_pred h--cCCCCccccCCcccCcCccc-cccccccccCC--CCCCcccccccccCCcccCceecCcc
Q 008810 427 Q--MEAAFIPEVNDELDTQNFEK-FEESDNQTKTS--SKTGPWRKMLSSKDINFVGYTYKNFE 484 (552)
Q Consensus 427 ~--~~~pf~P~~~~~~d~~~f~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~f~g~~~~~~~ 484 (552)
. +.|||+|.+.++.|++||+. |++........ .........+...+..|.||||.+..
T Consensus 307 ~~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 369 (373)
T 2r5t_A 307 NKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPT 369 (373)
T ss_dssp TTCSCCSCCCSCCC-------------------------------------------------
T ss_pred hCCCCCCCCCCCCCcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCch
Confidence 4 78999999999999999995 54433211100 00000001112234679999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-64 Score=535.51 Aligned_cols=255 Identities=29% Similarity=0.532 Sum_probs=229.1
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+.|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++|++|++.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999986543 23345889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||+||+|.+++. ...|++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 228 Ey~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~---- 302 (423)
T 4fie_A 228 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 302 (423)
T ss_dssp ECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC----
T ss_pred eCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc----
Confidence 9999999999885 46799999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
...+.|||+.|||||++.+..|+.++||||||||+|||++|++
T Consensus 303 -------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 303 -------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp -------------------------------------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 1236799999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||.+.+..+.+..|... ....++....+|+++++||.+||+ ||.+|++ ++||++||||+.
T Consensus 346 PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~ell~Hp~~~~ 406 (423)
T 4fie_A 346 PYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAK 406 (423)
T ss_dssp TTTTSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGG
T ss_pred CCCCcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHHhcC
Confidence 99999999998888763 223334445799999999999999 9999999 999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-63 Score=514.79 Aligned_cols=323 Identities=34% Similarity=0.676 Sum_probs=274.1
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
..+..++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|..+ +|||||+++++|++..
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 346778999999999999999999999999999999999988766677788899999999987 8999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+|||||+||+|..++.+.+.+++..+++|++||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ....+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 164 ~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 202 (345)
T 3a8x_A 164 G-----------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202 (345)
T ss_dssp T-----------------------------------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred C-----------------------------------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHH
Confidence 0 01225789999999999999999999999999999999
Q ss_pred HhhCCCCCCC---------CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC---ChhhhhcCCC
Q 008810 350 MLVGYPPFYS---------DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIKVHPW 416 (552)
Q Consensus 350 mltG~~PF~~---------~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~---~a~eil~Hpf 416 (552)
|++|.+||.. ......+..|.. ..+.+|. .+|+++++||.+||+ ||.+||++. +++||++|||
T Consensus 203 ll~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 203 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp HHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred HHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 9999999975 233345556665 4556665 789999999999999 999999963 5689999999
Q ss_pred cCCCChhhhhh--cCCCCccccCCcccCcCccc-cccccccccCCCCCCcccccc-cccCCcccCceecCc
Q 008810 417 FDGVDWARIYQ--MEAAFIPEVNDELDTQNFEK-FEESDNQTKTSSKTGPWRKML-SSKDINFVGYTYKNF 483 (552)
Q Consensus 417 F~~i~w~~l~~--~~~pf~P~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~g~~~~~~ 483 (552)
|++++|+.+.+ +.|||+|.+.++.|++||+. |...... .+.. .+ .+. ...+..|.||+|.+.
T Consensus 279 f~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~-~~~~--~~--~~~~~~~~~~f~~f~~~~~ 344 (345)
T 3a8x_A 279 FRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQ-LTPD--DD--DIVRKIDQSEFEGFEYINP 344 (345)
T ss_dssp GTTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSS-CCCC--CH--HHHTTSCGGGGTTCCEECC
T ss_pred cCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCccc-CCCc--cc--cccccccccccCCCEeeCC
Confidence 99999999974 78999999999999999996 4433211 1111 00 111 123457999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=506.99 Aligned_cols=292 Identities=42% Similarity=0.838 Sum_probs=255.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|+.++|||||+++++|++...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 56789999999999999999999999999999999999887666677888999999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
+||||++||+|.+++.+...+++..+++|+.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999999998899999999999999999999999999999999999999999999999999999865321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
..+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 160 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 198 (318)
T 1fot_A 160 -----------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198 (318)
T ss_dssp -----------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh
Confidence 125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh--
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ-- 427 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~-- 427 (552)
|.+||.+.+...++.+|+.. .+.+|. .+++++++||.+||+ ||.+|++.. ++++|++||||++++|+.+..
T Consensus 199 g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~ 274 (318)
T 1fot_A 199 GYTPFYDSNTMKTYEKILNA--ELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 274 (318)
T ss_dssp SSCTTCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCC
Confidence 99999999999999999874 456664 789999999999999 999999642 599999999999999999974
Q ss_pred cCCCCccccC-CcccCcCcccccccc
Q 008810 428 MEAAFIPEVN-DELDTQNFEKFEESD 452 (552)
Q Consensus 428 ~~~pf~P~~~-~~~d~~~f~~~~~~~ 452 (552)
++|||+|.+. ++.|++||+.+.+..
T Consensus 275 ~~~p~~p~~~~~~~d~~~f~~~~~~~ 300 (318)
T 1fot_A 275 IETPYEPPIQQGQGDTSQFDKYPEED 300 (318)
T ss_dssp SCCSCCCCC----------------C
T ss_pred CCCCCCCCcCCCccchhhcCCCCccc
Confidence 7899999998 589999999986554
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-63 Score=502.36 Aligned_cols=254 Identities=23% Similarity=0.409 Sum_probs=219.1
Q ss_pred CCe-eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC----Cce
Q 008810 116 DDF-ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEF 190 (552)
Q Consensus 116 ~~f-~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~~ 190 (552)
.+| ++.+.||+|+||+||+|+++.+|..||||++.+... .....+.+.+|+.+|+.++|||||++|++|++ +..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 777889999999999999999999999999987654 34456779999999999999999999999875 467
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCccccC-CCcEEEcccccccccC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLD 267 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~~-~g~iKL~DFGlak~~~ 267 (552)
+|||||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999999999999999999999999999999998 999999999999984 8999999999998532
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
.. ...+.||||.|||||++.+ +|+.++|||||||++
T Consensus 184 ~~-------------------------------------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvil 219 (290)
T 3fpq_A 184 AS-------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM 219 (290)
T ss_dssp TT-------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred CC-------------------------------------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHH
Confidence 11 1236799999999999864 699999999999999
Q ss_pred HHHhhCCCCCCCCCh-hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 348 YEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 348 yEmltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||++|.+||.+.+. ...+..+........++ ..+++++++||.+||. ||.+||+ ++||++||||++
T Consensus 220 yelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~s---~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred HHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC--ccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccC
Confidence 999999999987554 44555555432222333 4688999999999999 9999998 999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-62 Score=511.42 Aligned_cols=294 Identities=41% Similarity=0.826 Sum_probs=271.0
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
.....++|++++.||+|+||.||+|+++.+|+.||||++.+.........+++.+|+.+|+.++|||||+++++|++...
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 44667899999999999999999999999999999999998877667778889999999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|+||||++||+|.+++.+.+.+++..+++|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
..+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 195 -------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 231 (350)
T 1rdq_E 195 -------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp -------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred -------------------------------------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHH
Confidence 1256899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhh-
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY- 426 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~- 426 (552)
++|.+||.+.+..+++.+|... .+.+|. .+++++++||.+||+ ||.+||++ .++++|++||||+++||..+.
T Consensus 232 l~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~ 307 (350)
T 1rdq_E 232 AAGYPPFFADQPIQIYEKIVSG--KVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307 (350)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHT
T ss_pred hhCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhh
Confidence 9999999999999999999874 456664 789999999999999 99999984 469999999999999999997
Q ss_pred -hcCCCCccccCCcccCcCcccccccc
Q 008810 427 -QMEAAFIPEVNDELDTQNFEKFEESD 452 (552)
Q Consensus 427 -~~~~pf~P~~~~~~d~~~f~~~~~~~ 452 (552)
.++|||+|.+.++.|++||+.|++..
T Consensus 308 ~~~~~p~~p~~~~~~~~~~f~~~~~~~ 334 (350)
T 1rdq_E 308 RKVEAPFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp TCSCCSCCCCCCSTTCCTTSCCCCCCC
T ss_pred ccCCCCCCCCCCCcccccccccccccc
Confidence 48899999999999999999876544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-63 Score=516.01 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=218.8
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++.+.||+|+||+||+|+++.+|+.||||++++... ..+|+.+|+.++|||||++|++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999987543 2369999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~~~~~~~ 272 (552)
|||||+||+|.++|.+.+.|++.++++|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999999999999999999999999999999999999999999999988 7999999999976432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.. .....++|||+.|||||++.+.+|+.++|||||||++|||++
T Consensus 208 ~~------------------------------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt 251 (336)
T 4g3f_A 208 KS------------------------------------LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251 (336)
T ss_dssp ------------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cc------------------------------------eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 00 001235789999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccc-cCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHL-KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~-~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
|++||.+.+..+++.+|......+ .+| ..+|+++++||.+||+ ||.+||+ +.||+
T Consensus 252 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s---a~el~ 308 (336)
T 4g3f_A 252 GCHPWTQYFRGPLCLKIASEPPPIREIP--PSCAPLTAQAIQEGLRKEPVHRAS---AMELR 308 (336)
T ss_dssp SSCSSTTTCCSCCHHHHHHSCCGGGGSC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred CcCCCCCCCHHHHHHHHHcCCCCchhcC--ccCCHHHHHHHHHHccCCHhHCcC---HHHHH
Confidence 999999999888899998754322 244 3799999999999999 9999998 88874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-63 Score=558.64 Aligned_cols=328 Identities=32% Similarity=0.634 Sum_probs=283.1
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCC
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD 188 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~ 188 (552)
+..+..++|+++++||+|+||+||+|+++.+|+.||||++++.........+.+..|+.+|..+ +||+|++++++|++.
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456788999999999999999999999999999999999988776777788899999999887 799999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+.+||||||++||+|..+|...+.|++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 99999999999999999999989999999999999999999999999999999999999999999999999999985422
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
... ...+.+||+.|+|||++.+..|+.++||||||||||
T Consensus 495 ~~~-----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvily 533 (674)
T 3pfq_A 495 DGV-----------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLY 533 (674)
T ss_dssp TTC-----------------------------------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHH
T ss_pred CCc-----------------------------------------ccccccCCCcccCHhhhcCCCCCccceEechHHHHH
Confidence 110 123578999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l 425 (552)
||++|.+||.+.+..+++.+|+. ..+.+|. .+|+++++||.+||. ||.+||++ .+++||++||||+++||+.+
T Consensus 534 elltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 534 EMLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHS--SCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred HHHcCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 99999999999999999999987 4566775 799999999999999 99999995 35799999999999999999
Q ss_pred hh--cCCCCccccCCcccCcCccccccccccccCCCCCCcccccccccCCcccCceecCcccc
Q 008810 426 YQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIV 486 (552)
Q Consensus 426 ~~--~~~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~ 486 (552)
.. +.|||+|.+.+ .|++||+.+........+.... ..+....+..|.||+|.+...+
T Consensus 610 ~~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~~---~~~~~~~~~~f~~f~~~~~~~~ 668 (674)
T 3pfq_A 610 ERKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPDQ---EVIRNIDQSEFEGFSFVNSEFL 668 (674)
T ss_dssp TTTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCCH---HHHTTCCGGGGTTCCEECSSCC
T ss_pred HhCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCch---hhhhcccccccCCCcccChhhh
Confidence 74 88999999998 9999999865544332222111 0111223468999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-61 Score=511.41 Aligned_cols=266 Identities=24% Similarity=0.416 Sum_probs=226.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC------C
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------D 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------~ 188 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|.+ .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3679999999999999999999999999999999976542 33455678899999999999999999998753 4
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+.+|||||||+ |+|..++.+.+.|++.+++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 68999999995 78999999999999999999999999999999999999999999999999999999999999986643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil 347 (552)
.... ......+.|||+.|||||++.+. .|+.++||||||||+
T Consensus 211 ~~~~-------------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il 253 (398)
T 4b99_A 211 SPAE-------------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253 (398)
T ss_dssp ------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred Cccc-------------------------------------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHH
Confidence 2110 01123468999999999999875 579999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhcccccc------------------CCc---------ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLK------------------FPE---------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~------------------~p~---------~~~~s~e~~dLI~~lL~-dp 399 (552)
|||++|++||.+.+..+.+.+|+....... +|. .+.+|++++|||.+||+ ||
T Consensus 254 ~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 333 (398)
T 4b99_A 254 GEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEP 333 (398)
T ss_dssp HHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSST
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCCh
Confidence 999999999999999999888875322211 111 02478999999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCCCh
Q 008810 400 NQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
.+|++ |+|+|+||||+....
T Consensus 334 ~~R~t---a~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 334 SARIS---AAAALRHPFLAKYHD 353 (398)
T ss_dssp TTSCC---HHHHTTSGGGTTTCC
T ss_pred hHCcC---HHHHhcCHhhCcCCC
Confidence 99999 999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-61 Score=494.44 Aligned_cols=268 Identities=25% Similarity=0.427 Sum_probs=205.7
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc------
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------ 189 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~------ 189 (552)
+||++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+.+|+.+|+.++|||||++|++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 47999999999999999999999999999999997653 2334567899999999999999999999997543
Q ss_pred ------eEEEEEecCCCCchhhHHhhcCCC---CHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccc
Q 008810 190 ------FLYLIMEYLPGGDMMTLLMRKDTL---TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (552)
Q Consensus 190 ------~lylVmEy~~gG~L~~~L~~~~~l---~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DF 260 (552)
++|||||||+||+|.+++.....+ ++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 489999999999999999876554 45678999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccch
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 340 (552)
|+|+.+........... + ........+.|||+.|||||++.+..|+.++||
T Consensus 163 Gla~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 213 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLT-----------------P------------MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213 (299)
T ss_dssp CCC-------------------------------------------------------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred ccceecCCCcccccccc-----------------c------------cccccccCCcccCccccCHHHHcCCCCCCHHHH
Confidence 99997754321100000 0 000011236799999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCCh-hhHHHHHhhccccccCCc-ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
||||||+|||++ ||.+... ...+..+. ...+|. ....++++++||.+||+ ||.+||+ +.||++||||
T Consensus 214 wSlGvilyell~---Pf~~~~~~~~~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~h~~~ 283 (299)
T 4g31_A 214 FSLGLILFELLY---PFSTQMERVRTLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE---AINIIENAVF 283 (299)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGG
T ss_pred HHHHHHHHHHcc---CCCCccHHHHHHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhh
Confidence 999999999996 8865432 22333333 234443 24578889999999999 9999999 9999999999
Q ss_pred CCCChhh
Q 008810 418 DGVDWAR 424 (552)
Q Consensus 418 ~~i~w~~ 424 (552)
+++||..
T Consensus 284 ~~~~~p~ 290 (299)
T 4g31_A 284 EDLDFPG 290 (299)
T ss_dssp CCC----
T ss_pred CCCCCCC
Confidence 9999843
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=525.98 Aligned_cols=264 Identities=29% Similarity=0.504 Sum_probs=237.7
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+|+++|++...+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4789999999999999999999999999999999987542 3346788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC--CcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY--GHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~--g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.++|.. .+.|++.++++|++||+.||.|||++|||||||||+|||++.+ |++||+|||+|+.+....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999999864 4689999999999999999999999999999999999999854 899999999999764321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
...+.|||+.|||||++.+.+|+.++|||||||||||||
T Consensus 312 -----------------------------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 312 -----------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp -----------------------------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 123579999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~ 426 (552)
+|.+||.+.+..+++.+|......+..+....+|++++|||.+||+ ||.+||+ ++|+++||||+..+|....
T Consensus 351 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t---~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 351 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTSCCCCTTTT
T ss_pred HCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcCcCCCCCCCch
Confidence 9999999999999999998754444444445799999999999999 9999999 9999999999999986543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-60 Score=496.90 Aligned_cols=283 Identities=27% Similarity=0.448 Sum_probs=215.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCce
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 190 (552)
.++|++++.||+|+||+||+|+++ .+++.||||++.+.. ....+.+|+.+|..+ +|||||+++++|++.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 467999999999999999999885 468899999987543 234578899999988 79999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC-CcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~-g~iKL~DFGlak~~~~~ 269 (552)
+|||||||+||+|.+++ +.+++.+++.|+.||+.||.|||++|||||||||+||||+.+ |++||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999998 359999999999999999999999999999999999999876 89999999999976544
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvily 348 (552)
......+.............. ...-..++....+.|||+.|||||++.+. .|+.++||||+|||+|
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNK-------------CSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp SCGGGGGC---------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccc-------------ccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 322111110000000000000 00000112234467999999999999875 5999999999999999
Q ss_pred HHhhCCCCCCCC-ChhhHHHHHhhcccc--------------------------------------------------cc
Q 008810 349 EMLVGYPPFYSD-DPMSTCRKIVNWRTH--------------------------------------------------LK 377 (552)
Q Consensus 349 EmltG~~PF~~~-~~~~~~~~i~~~~~~--------------------------------------------------~~ 377 (552)
||++|++||.+. +..+.+.+|....+. ..
T Consensus 239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 318 (361)
T 4f9c_A 239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN 318 (361)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence 999999999654 444454444321000 00
Q ss_pred CCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 378 FPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 378 ~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
.+....+|++++|||.+||+ ||.+|++ |+|+++||||++++
T Consensus 319 ~~~~~~is~~a~DLl~~lL~~dP~~R~t---a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 319 LEGWNEVPDEAYDLLDKLLDLNPASRIT---AEEALLHPFFKDMS 360 (361)
T ss_dssp ---CTTCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGTTC-
T ss_pred ccccccCCHHHHHHHHHHCcCChhHCcC---HHHHhcCcccCCCC
Confidence 11123589999999999999 9999999 99999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-60 Score=520.19 Aligned_cols=294 Identities=34% Similarity=0.658 Sum_probs=252.7
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+.+..+..++|+++++||+|+||.||+|+++.+|+.||||++.+..+.......++.+|+.+|..++|||||+++++|++
T Consensus 176 l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp HHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 34567889999999999999999999999999999999999998877777778889999999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+.+|||||||+||+|..++...+ .+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999999997654 499999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
+.... ...+.+||+.|+|||++.+..|+.++|||||||
T Consensus 336 ~~~~~------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGv 373 (576)
T 2acx_A 336 VPEGQ------------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 373 (576)
T ss_dssp CCTTC------------------------------------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHH
T ss_pred cccCc------------------------------------------cccccCCCccccCHHHHcCCCCCccchHHHHHH
Confidence 54221 012468999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCC----hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcC
Q 008810 346 IMYEMLVGYPPFYSDD----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFD 418 (552)
Q Consensus 346 ilyEmltG~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~ 418 (552)
++|||++|.+||.+.+ ...+...+.. ....+|. .+|+++++||.+||+ ||.+|||+. +++||++||||+
T Consensus 374 ilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~--~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 374 LLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp HHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred HHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCc--cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 9999999999998864 3445555554 3445553 799999999999999 999999754 589999999999
Q ss_pred CCChhhhhh--cCCCCccccC-----CcccCcCccc
Q 008810 419 GVDWARIYQ--MEAAFIPEVN-----DELDTQNFEK 447 (552)
Q Consensus 419 ~i~w~~l~~--~~~pf~P~~~-----~~~d~~~f~~ 447 (552)
+++|+.+.. +.|||+|.+. +..|+.+|..
T Consensus 450 ~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~~ 485 (576)
T 2acx_A 450 KLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFST 485 (576)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCCCCC-----------
T ss_pred cCCHHHHhcCCCCCCCCCCccccccCCcccHhhccc
Confidence 999999984 7899999864 3456666654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=506.47 Aligned_cols=294 Identities=33% Similarity=0.620 Sum_probs=255.9
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
....+..++|+++++||+|+||+||+|+++.+|+.||||++.+..........++.+|+.+|+.++|||||+++++|++.
T Consensus 178 ~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~ 257 (543)
T 3c4z_A 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK 257 (543)
T ss_dssp HTSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC
Confidence 34668889999999999999999999999999999999999988776667788899999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
..+|+|||||+||+|..++... ..+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceee
Confidence 9999999999999999999763 469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
.+..... ...+.+||+.|+|||++.+.+|+.++||||||
T Consensus 338 ~~~~~~~-----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlG 376 (543)
T 3c4z_A 338 ELKAGQT-----------------------------------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALG 376 (543)
T ss_dssp ECCTTCC-----------------------------------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHH
T ss_pred eccCCCc-----------------------------------------ccccccCCccccChhhhcCCCCChHHhcCcch
Confidence 7542210 11246899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCC----hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCc
Q 008810 345 AIMYEMLVGYPPFYSDD----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWF 417 (552)
Q Consensus 345 vilyEmltG~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF 417 (552)
||+|||++|.+||.+.+ ..+....|.. ....+|. .+|+++++||.+||+ ||.+||+.. ++++|+.||||
T Consensus 377 vilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 377 VTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPD--KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp HHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred HHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCc--ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 99999999999998763 3556666665 3455664 789999999999999 999999863 58999999999
Q ss_pred CCCChhhhhh--cCCCCccccC-----CcccCcCccc
Q 008810 418 DGVDWARIYQ--MEAAFIPEVN-----DELDTQNFEK 447 (552)
Q Consensus 418 ~~i~w~~l~~--~~~pf~P~~~-----~~~d~~~f~~ 447 (552)
++++|..+.. +.|||+|... +..|+.+|+.
T Consensus 453 ~~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~~ 489 (543)
T 3c4z_A 453 RDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFST 489 (543)
T ss_dssp TTCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC-
T ss_pred cCCCHHHHHcCCCCCCCCCCccccccCCchhhhhccc
Confidence 9999999984 7899999874 3445555543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=486.69 Aligned_cols=280 Identities=32% Similarity=0.658 Sum_probs=249.3
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|++..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45677899999999999999999999999999999999999887777778889999999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+|||||+||+|..++.....+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhhHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAI 346 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvi 346 (552)
. ...+.+||+.|+|||++.+ .+|+.++|||||||+
T Consensus 169 ~------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i 206 (384)
T 4fr4_A 169 T------------------------------------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206 (384)
T ss_dssp C------------------------------------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred C------------------------------------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence 1 1225789999999999974 569999999999999
Q ss_pred HHHHhhCCCCCCCCCh---hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 347 MYEMLVGYPPFYSDDP---MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 347 lyEmltG~~PF~~~~~---~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
+|||++|.+||.+.+. ......+.. ....+|. .+|+++.+||.+||. ||.+||++ +++|+.||||++++|
T Consensus 207 l~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~s~--~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 207 AYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPS--AWSQEMVSLLKKLLEPNPDQRFSQ--LSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCS--HHHHHTSGGGTTCCH
T ss_pred HHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCC--cCCHHHHHHHHHHhcCCHhHhccc--HHHHHcChhhhcCCH
Confidence 9999999999986433 334444443 3455664 789999999999999 99999984 899999999999999
Q ss_pred hhhhh--cCCCCccccC
Q 008810 423 ARIYQ--MEAAFIPEVN 437 (552)
Q Consensus 423 ~~l~~--~~~pf~P~~~ 437 (552)
+.+.+ +.|||+|...
T Consensus 281 ~~~~~~~~~p~~~p~~~ 297 (384)
T 4fr4_A 281 DAVFQKRLIPGFIPNKG 297 (384)
T ss_dssp HHHHTTCSCCCCCCSCC
T ss_pred HHHHhCCCCCCCCCCCC
Confidence 99974 7899999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-59 Score=499.49 Aligned_cols=294 Identities=40% Similarity=0.738 Sum_probs=251.6
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|+.++|||||+++++|.+.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 44567789999999999999999999999999999999999876656666778889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|||||||+||+|..++.+...+++..++.++.||+.||.|||+ .|||||||||+||||+.+|++||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999988999999999999999999999998 9999999999999999999999999999985321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
... .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 302 ~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 340 (446)
T 4ejn_A 302 DGA-----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340 (446)
T ss_dssp ----------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred CCc-----------------------------------------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHH
Confidence 110 112578999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l 425 (552)
||++|.+||.+.+....+..|.. ..+.+|. .+++++++||.+||. ||.+||+.. +++||++||||++++|+.+
T Consensus 341 ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 341 EMMCGRLPFYNQDHEKLFELILM--EEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHhhCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence 99999999999999888888886 4556664 689999999999999 999999432 4999999999999999998
Q ss_pred hh--cCCCCccccCCcccCcCcccc
Q 008810 426 YQ--MEAAFIPEVNDELDTQNFEKF 448 (552)
Q Consensus 426 ~~--~~~pf~P~~~~~~d~~~f~~~ 448 (552)
.+ +.|||+|.+.++.|+++|++.
T Consensus 417 ~~~~~~pp~~p~~~~~~~~~~~~~~ 441 (446)
T 4ejn_A 417 YEKKLSPPFKPQVTSETDTRYFDEE 441 (446)
T ss_dssp HTTCSCCSCCCSCSSTTCCTTC---
T ss_pred hhCcCCCCccCCCCCccchhhcchh
Confidence 74 789999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-58 Score=474.14 Aligned_cols=292 Identities=42% Similarity=0.773 Sum_probs=239.7
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
.++..++|++++.||+|+||.||+|++. .+|+.||||++++..... ......+.+|+.+|+.++|||||+++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4567889999999999999999999985 689999999998765432 234566889999999999999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
+.+.+|+|||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999999754
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
.... ......+||+.|+|||++.+..|+.++|||||||+
T Consensus 172 ~~~~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 210 (327)
T 3a62_A 172 IHDG-----------------------------------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210 (327)
T ss_dssp ------------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHH
T ss_pred ccCC-----------------------------------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHH
Confidence 2110 01124689999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChh
Q 008810 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWA 423 (552)
Q Consensus 347 lyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~ 423 (552)
+|||++|.+||.+.+....+.+|.. ..+.+|. .+++++++||.+||. ||.+||++. +++|+++||||++++|+
T Consensus 211 l~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 211 MYDMLTGAPPFTGENRKKTIDKILK--CKLNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 9999999999999999888888886 3455664 789999999999999 999999764 69999999999999999
Q ss_pred hhhh--cCCCCccccCCcccCcCccc
Q 008810 424 RIYQ--MEAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 424 ~l~~--~~~pf~P~~~~~~d~~~f~~ 447 (552)
.+.. +.|||+|.+....|+++|+.
T Consensus 287 ~~~~~~~~~p~~p~~~~~~~~~~~~~ 312 (327)
T 3a62_A 287 ELLARKVEPPFKPLLQSEEDVSQFDS 312 (327)
T ss_dssp HHHTTCSCCSCCCC------------
T ss_pred HHhhccCCCCCCCCcCChhhhhhcch
Confidence 9874 78999999999999999985
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=469.21 Aligned_cols=257 Identities=22% Similarity=0.394 Sum_probs=221.4
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
.+..++|.+.+.||+|+||+||+|+++ .+|..||||+++... ....+.+.+|+.+|++++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 466789999999999999999999875 368899999997643 344567999999999999999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRK-------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~-------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g 253 (552)
+.+.+|||||||+||+|.++|... ..|++.++..++.||+.||.|||+++||||||||+||||+.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3699999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC
Q 008810 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (552)
Q Consensus 254 ~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~ 333 (552)
++||+|||+|+........ ......+||+.|||||++.+..
T Consensus 166 ~~Ki~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~~~~~~ 206 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYY---------------------------------------RVGGHTMLPIRWMPPESIMYRK 206 (299)
T ss_dssp CEEECCCSCHHHHTGGGCE---------------------------------------EETTTEEECGGGCCHHHHHHCC
T ss_pred cEEECCcccceecCCCCce---------------------------------------eecCceecChhhcCHHHHcCCC
Confidence 9999999999865322110 0122467999999999999999
Q ss_pred CCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 334 y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
|+.++|||||||++|||+| |.+||.+.+..+....|.... .+..|. .+|+++.+||.+||. ||.+||+ +.+|
T Consensus 207 ~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~--~~~~~~~~li~~cl~~dP~~RPs---~~~i 280 (299)
T 4asz_A 207 FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPR--TCPQEVYELMLGCWQREPHMRKN---IKGI 280 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCc--cchHHHHHHHHHHcCCChhHCcC---HHHH
Confidence 9999999999999999998 999999999999988887642 345554 799999999999999 9999999 8888
Q ss_pred hcCCCcC
Q 008810 412 KVHPWFD 418 (552)
Q Consensus 412 l~HpfF~ 418 (552)
|+|++
T Consensus 281 --~~~L~ 285 (299)
T 4asz_A 281 --HTLLQ 285 (299)
T ss_dssp --HHHHH
T ss_pred --HHHHH
Confidence 44553
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-57 Score=469.32 Aligned_cols=256 Identities=21% Similarity=0.372 Sum_probs=216.8
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
..+..++|.+.+.||+|+||+||+|+++ .++..||||+++... ....+.+.+|+.+|++++|||||+++++|
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3466789999999999999999999875 368899999997643 34456799999999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRK---------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD 250 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~ 250 (552)
.+...+|||||||+||+|.++|... ..|++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999999653 3599999999999999999999999999999999999999
Q ss_pred CCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh
Q 008810 251 KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (552)
Q Consensus 251 ~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~ 330 (552)
.++++||+|||+|+.+...... ......+||+.|||||++.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~~~ 233 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY---------------------------------------RVGGRTMLPIRWMPPESIL 233 (329)
T ss_dssp TTTEEEECCCC-------------------------------------------------------CCCCGGGCCHHHHT
T ss_pred CCCcEEEcccccceeccCCCcc---------------------------------------eecCcccccccccChhhhc
Confidence 9999999999999865322100 0112468999999999999
Q ss_pred cCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCCh
Q 008810 331 KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (552)
Q Consensus 331 ~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a 408 (552)
+..|+.++|||||||+||||+| |++||.+.+..+.+..|... ..+..|. .+++++.+||.+||. ||.+||+ +
T Consensus 234 ~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs---~ 307 (329)
T 4aoj_A 234 YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELERPR--ACPPEVYAIMRGCWQREPQQRHS---I 307 (329)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CCCCCCT--TCCHHHHHHHHHHCCSSTTTSCC---H
T ss_pred CCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCcc--cccHHHHHHHHHHcCcChhHCcC---H
Confidence 9999999999999999999999 99999999998888888764 3455554 799999999999999 9999999 8
Q ss_pred hhhhcC
Q 008810 409 DEIKVH 414 (552)
Q Consensus 409 ~eil~H 414 (552)
.||+.|
T Consensus 308 ~ei~~~ 313 (329)
T 4aoj_A 308 KDVHAR 313 (329)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-57 Score=460.45 Aligned_cols=257 Identities=20% Similarity=0.261 Sum_probs=209.8
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
.+++..++|++.+.||+|+||+||+|+++. .||||+++... ......+.+.+|+.+|++++|||||++++++.+ +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 356788999999999999999999998643 58999997543 234556789999999999999999999998754 5
Q ss_pred eEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|||||||+||+|.++|.. ...+++.++..|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 68999999999999999965 46799999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhhH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 345 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGv 345 (552)
.... ....+.+||+.|||||++.+ ..|+.++|||||||
T Consensus 185 ~~~~---------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv 225 (307)
T 3omv_A 185 WSGS---------------------------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI 225 (307)
T ss_dssp ------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred CCcc---------------------------------------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence 1100 01235789999999999975 35999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccc-cccCCc-ccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRT-HLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~-~~~~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+||||+||++||.+.+.......++.... ....+. ...+++++++||.+||. ||.+||+ +.||+.
T Consensus 226 vl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ei~~ 293 (307)
T 3omv_A 226 VLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPL---FPQILS 293 (307)
T ss_dssp HHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCC---HHHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcC---HHHHHH
Confidence 99999999999998776666555554221 111111 24689999999999999 9999999 766543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-57 Score=461.95 Aligned_cols=257 Identities=21% Similarity=0.344 Sum_probs=220.9
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
.++...++++++.||+|+||+||+|+.. .+++.||||+++... .....+.+++|+.+|++++|||||+++++|
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 3466788999999999999999999864 467899999997542 233456799999999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL 249 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl 249 (552)
.++..+|||||||+||+|.++|... ..|++..+..++.||+.||.|||+++||||||||+||||
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999642 469999999999999999999999999999999999999
Q ss_pred cCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhh
Q 008810 250 DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329 (552)
Q Consensus 250 ~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl 329 (552)
+.++++||+|||+|+.+...... ....+.+||+.|||||++
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~l 219 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYY---------------------------------------KLLGNSLLPIRWMAPEAI 219 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCB---------------------------------------CSSSSSCBCGGGCCHHHH
T ss_pred CCCCCEEECCcccceeccCCCce---------------------------------------eEecccccCCcccCHHHH
Confidence 99999999999999865322100 012246899999999999
Q ss_pred hcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 330 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 330 ~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
.+..|+.++|||||||+||||+| |.+||.+.+..+....|.+. ..++.|. .+++++.+||.+||. ||.+||+
T Consensus 220 ~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~~~~li~~C~~~dP~~RPs--- 293 (308)
T 4gt4_A 220 MYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLPCPD--DCPAWVYALMIECWNEFPSRRPR--- 293 (308)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---
T ss_pred hCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCcc--cchHHHHHHHHHHcCCChhHCcC---
Confidence 99999999999999999999998 99999999998888888763 3344454 799999999999999 9999999
Q ss_pred hhhhhcC
Q 008810 408 ADEIKVH 414 (552)
Q Consensus 408 a~eil~H 414 (552)
+.||+.+
T Consensus 294 ~~ei~~~ 300 (308)
T 4gt4_A 294 FKDIHSR 300 (308)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8888764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-56 Score=464.79 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=221.2
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CceEEEe
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLY 182 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~ 182 (552)
.++++..++|++.+.||+|+||+||+|+++.+ ++.||||+++.... ....+.+.+|+.+|.++.| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34567789999999999999999999998654 46899999976532 3445678999999999966 8999999
Q ss_pred eeecC-CceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 008810 183 CSFQD-DEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (552)
Q Consensus 183 ~~f~d-~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPe 245 (552)
++|.+ ...+|||||||+||+|.++|... ..|++..+..|+.||+.||.|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 99865 46799999999999999999652 35899999999999999999999999999999999
Q ss_pred CccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 246 NILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
||||+.++++||+|||+|+.+...... ....+.+||+.|||
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~---------------------------------------~~~~~~~gt~~ymA 255 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMA 255 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTS---------------------------------------EEETTEEECGGGCC
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCc---------------------------------------eeeccccccccccC
Confidence 999999999999999999866432110 01225689999999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccC
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
||++.+..|+.++|||||||+||||+| |.+||.+.+..+.+.+++.....+..|. .+++++.+||.+||. ||.+||
T Consensus 256 PE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~--~~~~~~~~li~~c~~~dP~~RP 333 (353)
T 4ase_A 256 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRP 333 (353)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc--cCCHHHHHHHHHHcCcChhHCc
Confidence 999999999999999999999999998 9999998776665555554344556664 789999999999999 999999
Q ss_pred CCCChhhhhcC
Q 008810 404 GAKGADEIKVH 414 (552)
Q Consensus 404 ~~~~a~eil~H 414 (552)
+ +.||+.|
T Consensus 334 t---~~eil~~ 341 (353)
T 4ase_A 334 T---FSELVEH 341 (353)
T ss_dssp C---HHHHHHH
T ss_pred C---HHHHHHH
Confidence 9 9999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-56 Score=463.97 Aligned_cols=281 Identities=31% Similarity=0.530 Sum_probs=245.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++++...... ...+.+.+|+.+|..++|||||+++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 5679999999999999999999999999999999987653321 1356789999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC----cEEEcccccccccC
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g----~iKL~DFGlak~~~ 267 (552)
|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.+.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888999999999999999999999999999999999999998877 89999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
... .....+||+.|+|||++.+..|+.++||||||||+
T Consensus 171 ~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 208 (361)
T 2yab_A 171 DGV------------------------------------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (361)
T ss_dssp TTC------------------------------------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCC------------------------------------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHH
Confidence 221 01246899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
|+|++|.+||.+.+..+.+.+|.... ..++. ...+|+++++||.+||+ ||.+||+ ++|+++||||++++|..
T Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 209 YILLSGASPFLGDTKQETLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDTQQ 283 (361)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSTTTSCSSHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcCcCCCchhh
Confidence 99999999999999999999988743 34443 35789999999999999 9999999 99999999999999987
Q ss_pred hhhcCCCCccccCCcccCcCccccc
Q 008810 425 IYQMEAAFIPEVNDELDTQNFEKFE 449 (552)
Q Consensus 425 l~~~~~pf~P~~~~~~d~~~f~~~~ 449 (552)
..... ....+..+|+++.
T Consensus 284 ~~~~~-------~~~~~~~~~~~~~ 301 (361)
T 2yab_A 284 AMVRR-------ESVVNLENFKKQY 301 (361)
T ss_dssp HHHHH-------TCBCCHHHHHHHT
T ss_pred hhhcc-------cchhhHHHHHHHH
Confidence 65422 2334566776654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=455.26 Aligned_cols=291 Identities=42% Similarity=0.756 Sum_probs=242.4
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhh-hhhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEML-RRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~-~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f 185 (552)
..+..++|++++.||+|+||.||+|++. .+|+.||||++++.... .....+.+.+|+.+|..+ +||||++++++|
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 4566789999999999999999999984 58999999999865432 122344577899999999 799999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+...+|||||||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSL 343 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSl 343 (552)
+..... ......+||+.|+|||++.+ ..++.++|||||
T Consensus 209 ~~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvwsl 248 (355)
T 1vzo_A 209 FVADET----------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 248 (355)
T ss_dssp CCGGGG----------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred cccCCC----------------------------------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHH
Confidence 532110 01235689999999999986 458899999999
Q ss_pred hHHHHHHhhCCCCCCCCCh----hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCC
Q 008810 344 GAIMYEMLVGYPPFYSDDP----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPW 416 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~Hpf 416 (552)
||++|||++|..||...+. ......+.. ....+|. .++..+++||.+||. ||.+||++. +++|+++|||
T Consensus 249 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 249 GVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp HHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred HHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCc--ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 9999999999999976543 233344443 2334443 689999999999999 999999543 5999999999
Q ss_pred cCCCChhhhhh--cCCCCccccCCcccCcCc
Q 008810 417 FDGVDWARIYQ--MEAAFIPEVNDELDTQNF 445 (552)
Q Consensus 417 F~~i~w~~l~~--~~~pf~P~~~~~~d~~~f 445 (552)
|+.++|..+.. +++||.|.+.++.|++||
T Consensus 325 f~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 325 FQKINWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp GTTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred hhcCChhHhhhccCCCCCCCccccccccccC
Confidence 99999999885 679999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-54 Score=443.50 Aligned_cols=261 Identities=29% Similarity=0.526 Sum_probs=234.7
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
....++|++++.||+|+||.||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 3456789999999999999999999999999999999987643 344566788999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 168 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG- 168 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999998654221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCC-CccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvilyEm 350 (552)
.....+||+.|+|||++.+..|. .++|||||||++|+|
T Consensus 169 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 169 -----------------------------------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp -----------------------------------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHH
Confidence 01246899999999999988875 799999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
++|.+||.+.+..+...++... ...+|. .+|+++.+||.+||. ||.+||+ ++||++||||+...+
T Consensus 208 l~g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 208 VSGSLPFDGQNLKELRERVLRG--KYRIPF--YMSTDCENLLKRFLVLNPIKRGT---LEQIMKDRWINAGHE 273 (328)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHCCSSTTTSCC---HHHHTTCTTTTTTCT
T ss_pred HhCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHCCCChhHCcC---HHHHhcCHhhcCCCc
Confidence 9999999999998888888863 445554 689999999999999 9999999 999999999987543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=434.39 Aligned_cols=265 Identities=29% Similarity=0.538 Sum_probs=234.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+.|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|+.++|||||+++++|.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3569999999999999999999999999999999987643221 1356789999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC----cEEEcccccccccC
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g----~iKL~DFGlak~~~ 267 (552)
|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.+.
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888999999999999999999999999999999999999999888 89999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
.... ....+||+.|+|||++.+..|+.++|||||||++
T Consensus 170 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 207 (326)
T 2y0a_A 170 FGNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207 (326)
T ss_dssp TTSC------------------------------------------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCc------------------------------------------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHH
Confidence 2210 1246799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
|+|++|.+||.+.+..+....+.... ..++. ...+++++++||.+||. ||.+||+ +.|+++||||++.+|..
T Consensus 208 ~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~~ 282 (326)
T 2y0a_A 208 YILLSGASPFLGDTKQETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQ 282 (326)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTSCCSHHH
T ss_pred HHHHHCcCCCCCCCHHHHHHHHHhcC--CCcCccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcCCCccCCcchh
Confidence 99999999999999888888877633 33332 24689999999999999 9999999 99999999999999876
Q ss_pred hh
Q 008810 425 IY 426 (552)
Q Consensus 425 l~ 426 (552)
..
T Consensus 283 ~~ 284 (326)
T 2y0a_A 283 AL 284 (326)
T ss_dssp HH
T ss_pred hh
Confidence 54
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=440.68 Aligned_cols=259 Identities=32% Similarity=0.582 Sum_probs=232.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3579999999999999999999999999999999987643 334567789999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC---CcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~---g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~- 185 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-
Confidence 9999999999999888899999999999999999999999999999999999999865 459999999998654221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.....+||+.|+|||++.+..|+.++||||||||+|+|+
T Consensus 186 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 224 (362)
T 2bdw_A 186 -----------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224 (362)
T ss_dssp -----------------------------------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|.+||.+.+....+..|......+..+....+++++++||.+||. ||.+||+ +.+++.||||..
T Consensus 225 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~ 290 (362)
T 2bdw_A 225 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICN 290 (362)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSHHHHT
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCcccCC
Confidence 9999999999988888888754444445556789999999999999 9999999 999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=447.18 Aligned_cols=280 Identities=30% Similarity=0.552 Sum_probs=234.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lyl 193 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... ...+|+++|..+ +|||||+++++|++...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 3569999999999999999999999999999999987542 134677888777 89999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-C---CcEEEcccccccccCCC
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-Y---GHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-~---g~iKL~DFGlak~~~~~ 269 (552)
|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||+.. + +++||+|||+|+.+...
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 9999999999999998899999999999999999999999999999999999999843 3 35999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.. ...+.+||+.|+|||++.+.+|+.++|||||||++||
T Consensus 174 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 212 (342)
T 2qr7_A 174 NG-----------------------------------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYT 212 (342)
T ss_dssp TC-----------------------------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHH
Confidence 10 1125689999999999999889999999999999999
Q ss_pred HhhCCCCCCC---CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 350 MLVGYPPFYS---DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 350 mltG~~PF~~---~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
|++|.+||.+ .+..+.+..|......+..+....+|+++++||.+||. ||.+||+ +.++++|||| .+|+.+
T Consensus 213 ll~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~--~~~~~~ 287 (342)
T 2qr7_A 213 MLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT---AALVLRHPWI--VHWDQL 287 (342)
T ss_dssp HHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHH--HTGGGS
T ss_pred HhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCCee--cCcccc
Confidence 9999999986 35566677777643333322335799999999999999 9999999 9999999999 458777
Q ss_pred hh--cCCCCccccCCcccCcCccc
Q 008810 426 YQ--MEAAFIPEVNDELDTQNFEK 447 (552)
Q Consensus 426 ~~--~~~pf~P~~~~~~d~~~f~~ 447 (552)
.. +.+|+.|......+..+|..
T Consensus 288 ~~~~~~~~~~p~~~~~~~~~~~~~ 311 (342)
T 2qr7_A 288 PQYQLNRQDAPHLVKGAMAATYSA 311 (342)
T ss_dssp CCSCCCCCCCHHHHHHHHHHHHHH
T ss_pred ccccCCCccchhhhhhHHHHHHhh
Confidence 53 66778776544434444443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=449.12 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=231.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3579999999999999999999999999999999987653 334456789999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc---CCCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~---~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.+.+...+.+++..+..++.||+.||.|||++|||||||||+|||++ .++.+||+|||+++.......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999999999999999999999999999999999999999999999998 568899999999986542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.....+||+.|+|||++.+..|+.++||||||||+|+|+
T Consensus 169 -----------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell 207 (444)
T 3soa_A 169 -----------------------------------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207 (444)
T ss_dssp -----------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHH
Confidence 112468999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|.+||.+.+..+.+..+......+..|....+|+++++||.+||. ||.+||+ +.|+++||||.+
T Consensus 208 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~L~hp~~~~ 273 (444)
T 3soa_A 208 VGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT---AAEALKHPWISH 273 (444)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSCTTHH
T ss_pred hCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC---HHHHhcCccccC
Confidence 9999999999999999998755555555556899999999999999 9999999 999999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=432.10 Aligned_cols=254 Identities=28% Similarity=0.478 Sum_probs=227.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|+++.+|+.||+|++.... .....+.+|+.+|..++|||||+++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 578999999999999999999999999999999997542 3345688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC--CCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~--~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++++||+|||+++.+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~- 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence 9999999999999765 47999999999999999999999999999999999999997 7999999999998764321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 159 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 159 -----------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp -----------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 012468999999999999988999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|.+||.+.+..+...++.... ..++. ...+|+++++||.+||. ||.+||+ +.|+++||||+.
T Consensus 198 ~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~ 263 (321)
T 1tki_A 198 SGINPFLAETNQQIIENIMNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred hCCCCCcCCCHHHHHHHHHcCC--CCCChhhhccCCHHHHHHHHHHcCCChhHCcC---HHHHhcChhhcc
Confidence 9999999999988888888743 33332 34789999999999999 9999999 999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=422.31 Aligned_cols=257 Identities=30% Similarity=0.515 Sum_probs=226.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.+++.++|||||+++++|.+.+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 467999999999999999999999999999999997654 23345688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||||+||+|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (297)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---
T ss_pred EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc---
Confidence 999999999999865 4799999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 172 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 172 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp --------------------------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 012468999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+||.+.+.......+... ....++....+++++++||.+||. ||.+||+ +.|+++||||+..
T Consensus 214 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~ 276 (297)
T 3fxz_A 214 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHQFLKIA 276 (297)
T ss_dssp CTTTTSCHHHHHHHHHHH-CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred CCCCCCCHHHHHHHHHhC-CCCCCCCccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhccc
Confidence 999998887776666542 222333334799999999999999 9999999 9999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=437.47 Aligned_cols=257 Identities=31% Similarity=0.559 Sum_probs=226.8
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
...++|.+++.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34678999999999999999999999999999999998765544455567899999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 86 lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-- 162 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-- 162 (336)
T ss_dssp EEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--
T ss_pred EEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--
Confidence 999999 78999999888999999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHHHh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEML 351 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEml 351 (552)
...+.+||+.|+|||++.+..| +.++|||||||++|+|+
T Consensus 163 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 202 (336)
T 3h4j_B 163 ----------------------------------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVML 202 (336)
T ss_dssp ----------------------------------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHH
Confidence 1124689999999999998876 78999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|.+||.+......+.++.. ....+|. .+|+++++||.+||. ||.+||+ ++||++||||+.
T Consensus 203 ~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 264 (336)
T 3h4j_B 203 VGRLPFDDEFIPNLFKKVNS--CVYVMPD--FLSPGAQSLIRRMIVADPMQRIT---IQEIRRDPWFNV 264 (336)
T ss_dssp HSSCSSBCSSSTTCBCCCCS--SCCCCCT--TSCHHHHHHHHTTSCSSGGGSCC---HHHHTTCHHHHT
T ss_pred hCCCCCCCccHHHHHHHHHc--CCCCCcc--cCCHHHHHHHHHHcCCChhHCcC---HHHHHhChhhcc
Confidence 99999988766555444433 2334453 689999999999999 9999999 999999999974
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-52 Score=438.26 Aligned_cols=278 Identities=29% Similarity=0.496 Sum_probs=213.7
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCc--eE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE--FL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~--~l 191 (552)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|..+. |||||+++++|.+.+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 468999999999999999999999999999999997542 23445567889999999997 999999999997544 79
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+|||||+ |+|..++.. ..+++..++.++.||+.||.|||+.|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999996 689888865 6899999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHH
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEm 350 (552)
.........+.. . ... ..........+||+.|+|||++.+ ..|+.++||||||||+|||
T Consensus 165 ~~~~~~~~~~~~------~-------------~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 224 (388)
T 3oz6_A 165 VTNNIPLSINEN------T-------------ENF-DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224 (388)
T ss_dssp CCCCGGGCCC-----------------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccc------c-------------ccc-ccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence 110000000000 0 000 000011235799999999999987 6799999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCc----------------------------------------------cccc
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPE----------------------------------------------EAKL 384 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~----------------------------------------------~~~~ 384 (552)
++|.+||.+.+....+.+|+.. +.+|. ...+
T Consensus 225 l~g~~pf~~~~~~~~~~~i~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (388)
T 3oz6_A 225 LCGKPIFPGSSTMNQLERIIGV---IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301 (388)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHH---HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHh---cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence 9999999999988888777642 11111 1157
Q ss_pred ChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 385 SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 385 s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
++++++||.+||+ ||.+||+ ++|+++||||+.+.
T Consensus 302 ~~~~~dll~~~L~~dP~~R~t---~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 302 NEEALDLLDKLLQFNPNKRIS---ANDALKHPFVSIFH 336 (388)
T ss_dssp CHHHHHHHHHHCCSSGGGSCC---HHHHTTSTTTTTTC
T ss_pred CHHHHHHHHHhhccCcccCCC---HHHHhCCHHHHHhc
Confidence 8999999999999 9999999 99999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=422.41 Aligned_cols=265 Identities=28% Similarity=0.501 Sum_probs=220.3
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
....++|++++.||+|+||.||+|++. +|+.||+|++.... ........+.+|+.+|+.++|||||+++++|.+...+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence 345688999999999999999999985 58999999997653 2334456788999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|+|||||+| +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 999999975 777777554 569999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 349 (552)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+
T Consensus 174 ~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 212 (311)
T 3niz_A 174 R-----------------------------------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAE 212 (311)
T ss_dssp C--------------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHH
Confidence 0 0113579999999999987 568999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhcccccc---CCc-----------------------ccccChhHHHHHHHHhh-Ccccc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLK---FPE-----------------------EAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~---~p~-----------------------~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|++|.+||.+.+..+...++........ ++. ...+++++++||.+||+ ||.+|
T Consensus 213 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 292 (311)
T 3niz_A 213 MITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKR 292 (311)
T ss_dssp HHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHC
Confidence 9999999998887777766654211100 000 12468899999999999 99999
Q ss_pred CCCCChhhhhcCCCcCCCChh
Q 008810 403 LGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 403 l~~~~a~eil~HpfF~~i~w~ 423 (552)
|+ ++|+++||||++++++
T Consensus 293 pt---~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 293 IS---ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CC---HHHHHTSGGGTTSCTT
T ss_pred CC---HHHHhcCcccccCCcc
Confidence 99 9999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=434.82 Aligned_cols=263 Identities=30% Similarity=0.547 Sum_probs=224.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh--hHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3569999999999999999999999999999999987654322 23567899999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc---EEEcccccccc
Q 008810 193 LIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKP 265 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~---iKL~DFGlak~ 265 (552)
+|||||+||+|..++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999887543 35999999999999999999999999999999999999987654 99999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
+..... .....+||+.|+|||++.+..|+.++|||||||
T Consensus 183 ~~~~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 221 (351)
T 3c0i_A 183 LGESGL-----------------------------------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGV 221 (351)
T ss_dssp CCTTSC-----------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHH
T ss_pred ecCCCe-----------------------------------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHH
Confidence 643210 012468999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
|+|+|++|.+||.+. ....+..+.........+....+++++++||.+||. ||.+||+ +.|+++||||++.++
T Consensus 222 il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 222 ILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT---VYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTHHH
T ss_pred HHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcChhhcCCcc
Confidence 999999999999875 345666666533222222234689999999999999 9999999 999999999987654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=445.12 Aligned_cols=292 Identities=26% Similarity=0.399 Sum_probs=209.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec-----CCc
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-----DDE 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-----d~~ 189 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|. +..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 578999999999999999999999999999999997642 23445677899999999999999999999994 346
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||+ +|+|..++.....+++..++.++.||+.||.|||+.|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 799999998 6899999988889999999999999999999999999999999999999999999999999999976533
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHH--HhhhccccccccccCCCCCChhhhh-cCCCCCccchhhhhHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQH--WQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~r~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvi 346 (552)
......... .+ +........ .....+......+||++|+|||++. +..|+.++||||||||
T Consensus 210 ~~~~~~~~~---------------~~-~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~i 273 (458)
T 3rp9_A 210 ENGNSQLPI---------------SP-REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273 (458)
T ss_dssp TTCCCCCC-------------------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred ccccccccc---------------Cc-cccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHH
Confidence 211000000 00 000000000 0001111234679999999999875 5679999999999999
Q ss_pred HHHHhh-----------CCCCCCCCCh--------------------hhHHHHHhhcccc------------------cc
Q 008810 347 MYEMLV-----------GYPPFYSDDP--------------------MSTCRKIVNWRTH------------------LK 377 (552)
Q Consensus 347 lyEmlt-----------G~~PF~~~~~--------------------~~~~~~i~~~~~~------------------~~ 377 (552)
+|||++ |.+||.+.+. ...+..|.+.-+. ..
T Consensus 274 l~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 353 (458)
T 3rp9_A 274 FAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353 (458)
T ss_dssp HHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTT
T ss_pred HHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHh
Confidence 999999 7888876542 1222222210000 00
Q ss_pred CC---------cccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhh
Q 008810 378 FP---------EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 378 ~p---------~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~ 427 (552)
+| ....+++++++||.+||+ ||.+||+ ++|+++||||++++|..+..
T Consensus 354 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---~~e~L~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT---INECLAHPFFKEVRIAEVET 410 (458)
T ss_dssp SCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGTTTCCGGGCC
T ss_pred cCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC---HHHHhcCHhhhhcCCCccCC
Confidence 00 012569999999999999 9999999 99999999999999988753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=427.61 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=193.9
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc----eE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----FL 191 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----~l 191 (552)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+.++..++|||||+++++|.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999986 588999999975431 1122334555567889999999999997653 68
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccccCCCCccccCCCcEEEcccccc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------HYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
|||||||+||+|.++|.+ ..+++..+..++.|++.||.|||++ |||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999965 5799999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC------CCCCc
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK------GYGME 337 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~------~y~~~ 337 (552)
+......... .....+.+||+.|||||++.+. .|+.+
T Consensus 156 ~~~~~~~~~~-------------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k 198 (303)
T 3hmm_A 156 VRHDSATDTI-------------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp EEEETTTTEE-------------------------------------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred ccccCCCCce-------------------------------------eeecccccccccccCHHHhcccccccCCccChh
Confidence 8764321100 0011246899999999999764 36789
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCC---------------hhhHHHHHhhccccccCCcc---cccChhHHHHHHHHhh-C
Q 008810 338 CDWWSLGAIMYEMLVGYPPFYSDD---------------PMSTCRKIVNWRTHLKFPEE---AKLSIEAKDLISKLLC-N 398 (552)
Q Consensus 338 ~DiWSlGvilyEmltG~~PF~~~~---------------~~~~~~~i~~~~~~~~~p~~---~~~s~e~~dLI~~lL~-d 398 (552)
+|||||||+||||+||.+||.... .......+........+|.. ..++..+.+||.+||. |
T Consensus 199 ~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~d 278 (303)
T 3hmm_A 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSS
T ss_pred HhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccC
Confidence 999999999999999988764321 12223333332233344432 1234578899999998 9
Q ss_pred ccccCCCCChhhhhcC
Q 008810 399 VNQRLGAKGADEIKVH 414 (552)
Q Consensus 399 p~~Rl~~~~a~eil~H 414 (552)
|.+||+ +.||+.+
T Consensus 279 P~~RPt---~~ei~~~ 291 (303)
T 3hmm_A 279 GAARLT---ALRIKKT 291 (303)
T ss_dssp GGGSCC---HHHHHHH
T ss_pred HhHCcC---HHHHHHH
Confidence 999999 8887753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=451.53 Aligned_cols=265 Identities=34% Similarity=0.603 Sum_probs=238.2
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999987765555567789999999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc---cCCCcEEEcccccccccCCCC
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl---~~~g~iKL~DFGlak~~~~~~ 270 (552)
|||||.||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||+ +.++++||+|||+|+.+....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 183 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence 99999999999999988999999999999999999999999999999999999999 567899999999998664321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
. ....+||+.|+|||++.+ .|+.++|||||||++|+|
T Consensus 184 ~------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 220 (484)
T 3nyv_A 184 K------------------------------------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYIL 220 (484)
T ss_dssp S------------------------------------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHH
T ss_pred c------------------------------------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHH
Confidence 0 124589999999999976 699999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
++|.+||.+.+..+...++......+..|....+|+++++||.+||. ||.+||+ +.|++.||||+...+..
T Consensus 221 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 221 LSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS---ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHHHTC--
T ss_pred HHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhhChhhccccccc
Confidence 99999999999999999998866666666667899999999999999 9999999 99999999998765543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=447.64 Aligned_cols=261 Identities=30% Similarity=0.547 Sum_probs=236.1
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|.+++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||++++++.+..
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 44567789999999999999999999999999999999998876555566778999999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvily 348 (552)
. ...+.+||+.|+|||++.+..| +.++|||||||++|
T Consensus 170 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 170 E------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207 (476)
T ss_dssp C------------------------------------------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred c------------------------------------------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHH
Confidence 1 1124689999999999998776 78999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|++|.+||.+.+....+.+|... ....|. .+++++++||.+||. ||.+||+ +.||+.||||+.
T Consensus 208 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~~Rpt---~~eil~hp~~~~ 272 (476)
T 2y94_A 208 ALLCGTLPFDDDHVPTLFKKICDG--IFYTPQ--YLNPSVISLLKHMLQVDPMKRAT---IKDIREHEWFKQ 272 (476)
T ss_dssp HHHHSSCSSCCSSSHHHHHHHHTT--CCCCCT--TCCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHT
T ss_pred HHhhCCCCCCCCCHHHHHHHHhcC--CcCCCc--cCCHHHHHHHHHHcCCCchhCcC---HHHHHhCHHhhh
Confidence 999999999999888888888763 344553 689999999999999 9999999 999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=414.64 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=217.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999986542 3444567889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++|+.+..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS----
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc----
Confidence 9997654444444467899999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-CCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+||+.|+|||++.+.. |+.++|||||||++|||++|.
T Consensus 157 -------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~ 199 (292)
T 3o0g_A 157 -------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp -------------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred -------------------------------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcC
Confidence 012457999999999998765 899999999999999999877
Q ss_pred CC-CCCCChhhHHHHHhhccccc---------------cCC----------cccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 355 PP-FYSDDPMSTCRKIVNWRTHL---------------KFP----------EEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 355 ~P-F~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
.| |.+.+..+....+....... .++ ....+++++++||.+||+ ||.+||+
T Consensus 200 ~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t--- 276 (292)
T 3o0g_A 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS--- 276 (292)
T ss_dssp CCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC---
Confidence 66 55666666666665311110 000 012578999999999999 9999999
Q ss_pred hhhhhcCCCcCCC
Q 008810 408 ADEIKVHPWFDGV 420 (552)
Q Consensus 408 a~eil~HpfF~~i 420 (552)
++|+++||||+++
T Consensus 277 ~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 277 AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHhcCcccccC
Confidence 9999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=434.37 Aligned_cols=260 Identities=28% Similarity=0.531 Sum_probs=228.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+|+.+|..++|||||+++++|.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999986532 2345688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC--CCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~--~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.+++...+ .+++..+..++.||+.||.|||++|||||||||+|||++. ++++||+|||+++.+.....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999999997654 7999999999999999999999999999999999999974 57899999999987643210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 207 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 207 ------------------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp ------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 12458999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
+|.+||.+.+..+...++......+..+....+++++++||.+||+ ||.+||+ +.|+++||||++..+
T Consensus 245 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 245 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGDHS 313 (387)
T ss_dssp HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSCCT
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhhCccccCCcc
Confidence 9999999999888888887643333322334789999999999999 9999999 999999999987654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=435.01 Aligned_cols=275 Identities=21% Similarity=0.328 Sum_probs=225.7
Q ss_pred cCCCCeeEEeeeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 113 MGADDFELLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G--~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
...++|++++.||+| +||.||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456789999999999 999999999999999999999987643 34556778999999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999765 7799999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAI 346 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvi 346 (552)
....... ........+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 181 ~~~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 181 HGQRQRV----------------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226 (389)
T ss_dssp TTEECSC----------------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHH
T ss_pred ccccccc----------------------------------cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHH
Confidence 2110000 0001123589999999999987 689999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHhhcccc------------------------------------------ccCCccccc
Q 008810 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTH------------------------------------------LKFPEEAKL 384 (552)
Q Consensus 347 lyEmltG~~PF~~~~~~~~~~~i~~~~~~------------------------------------------~~~p~~~~~ 384 (552)
+|||++|.+||.+.+.......++..... ...+....+
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 99999999999987776665554431110 001112357
Q ss_pred ChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 385 SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 385 s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
++++++||.+||. ||.+||+ ++|+++||||+.+.|...
T Consensus 307 s~~~~~li~~~L~~dP~~Rpt---a~ell~hp~f~~~~~~~~ 345 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARPS---ASTLLNHSFFKQIKRRAS 345 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGGGC---CC
T ss_pred CHHHHHHHHHHhhcCcccCCC---HHHHhcCHHHHHHhhcch
Confidence 8999999999999 9999999 999999999999887543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=407.66 Aligned_cols=264 Identities=31% Similarity=0.571 Sum_probs=235.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|.+....|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 5789999999999999999999999999999999987653 344557788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc---EEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~---iKL~DFGlak~~~~~~~ 271 (552)
|||++||+|...+.....+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999998899999999999999999999999999999999999999987665 99999999976542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 164 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 201 (284)
T 3kk8_A 164 ------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201 (284)
T ss_dssp ------------------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHH
Confidence 11467999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
+|.+||.+.+.......+.........+....+++++++||.+||. ||.+||+ ++|+++||||++..+..
T Consensus 202 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 202 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICNRERVA 272 (284)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSHHHHSCCCGG
T ss_pred HCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC---HHHHhcCccccCChhHH
Confidence 9999999999888888887654444444445789999999999999 9999999 99999999998876544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=420.88 Aligned_cols=266 Identities=32% Similarity=0.549 Sum_probs=235.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 4569999999999999999999999999999999987543221 1356789999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC----cEEEcccccccccC
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g----~iKL~DFGlak~~~ 267 (552)
|+||||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ ++||+|||+++...
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999999999999998888999999999999999999999999999999999999999888 89999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
.... ....+||+.|+|||++.+..++.++|||||||++
T Consensus 171 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 208 (321)
T 2a2a_A 171 DGVE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (321)
T ss_dssp TTCC------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred cccc------------------------------------------ccccCCCCCccCcccccCCCCCCccccHHHHHHH
Confidence 2210 1145799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
|+|++|..||.+.+..+....+.... ..++. ...+++++++||.+||. ||.+||+ ++|+++||||.+++|..
T Consensus 209 ~~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~hp~~~~~~~~~ 283 (321)
T 2a2a_A 209 YILLSGASPFLGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDNQQ 283 (321)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC---HHHHHHSTTTSCSSHHH
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHhcc--cccChhhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhcCccccCCCccc
Confidence 99999999999998888888877632 33332 24689999999999999 9999999 99999999999999977
Q ss_pred hhh
Q 008810 425 IYQ 427 (552)
Q Consensus 425 l~~ 427 (552)
...
T Consensus 284 ~~~ 286 (321)
T 2a2a_A 284 AMV 286 (321)
T ss_dssp HHH
T ss_pred ccc
Confidence 653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-51 Score=409.82 Aligned_cols=259 Identities=35% Similarity=0.601 Sum_probs=232.0
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..+..++|++++.||+|+||.||+|+++.++..||+|++.+...........+.+|+.+++.++||||++++++|.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 45678899999999999999999999999999999999987765555556778999999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|+||||++||+|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999986432110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
....+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 164 -------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 200 (279)
T 3fdn_A 164 -------------------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200 (279)
T ss_dssp -----------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred -------------------------------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHH
Confidence 1245799999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
++|.+||.+.+..+....+.. ....+|. .+++++++||.+||. ||.+||+ +.||++||||++
T Consensus 201 ~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~e~l~h~~~~~ 263 (279)
T 3fdn_A 201 LVGKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 263 (279)
T ss_dssp HHSSCTTCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHCCSSGGGSCC---HHHHHHCHHHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHhccChhhCCC---HHHHhhCccccC
Confidence 999999999988888877765 3445554 689999999999999 9999999 999999999965
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=424.35 Aligned_cols=267 Identities=27% Similarity=0.428 Sum_probs=217.9
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
.....++|++++.||+|+||.||+|+++.+|+.||||+++.... .......+.+|+.+|+.++|||||+++++|.+...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 34456789999999999999999999999999999999976532 23334567889999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc-----cCCCcEEEcccccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL-----DKYGHLRLSDFGLCKP 265 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl-----~~~g~iKL~DFGlak~ 265 (552)
+|+||||++ |+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999999997 5999999988899999999999999999999999999999999999999 4555699999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 344 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlG 344 (552)
+..... .....+||+.|+|||++.+. .|+.++||||||
T Consensus 187 ~~~~~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 225 (329)
T 3gbz_A 187 FGIPIR-----------------------------------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA 225 (329)
T ss_dssp HC----------------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHH
T ss_pred cCCccc-----------------------------------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHH
Confidence 532210 01245789999999999874 589999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhcccccc----------------CCc----------ccccChhHHHHHHHHhh-
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK----------------FPE----------EAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~----------------~p~----------~~~~s~e~~dLI~~lL~- 397 (552)
|++|||++|.+||.+.+..+...++........ +|. ...+++++++||.+||.
T Consensus 226 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 305 (329)
T 3gbz_A 226 CIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEM 305 (329)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCS
T ss_pred HHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccC
Confidence 999999999999999988888777764211100 000 01278999999999999
Q ss_pred CccccCCCCChhhhhcCCCcCCCChh
Q 008810 398 NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
||.+||+ ++|+++||||++++|+
T Consensus 306 dP~~R~t---~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 306 DPVKRIS---AKNALEHPYFSHNDFD 328 (329)
T ss_dssp SGGGSCC---HHHHHTSGGGSSSCSC
T ss_pred ChhhCCC---HHHHhCCcccCCCCCC
Confidence 9999999 9999999999999996
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=421.99 Aligned_cols=260 Identities=26% Similarity=0.473 Sum_probs=220.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++...... ...+.+.+|+.+++.++|||||++++++.+.+.+|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 57899999999999999999999999999999999755322 2235588999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999986532210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEmltG 353 (552)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus 161 ------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 161 ------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp ------------------------------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 011225689999999999998775 7899999999999999999
Q ss_pred CCCCCCCChhh-HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 354 YPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 354 ~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+||.+.+... .+..+.. .....+....+++++.+||.+||. ||.+||+ ++||++||||+..
T Consensus 205 ~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~ 268 (323)
T 3tki_A 205 ELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (323)
T ss_dssp SCSCSSSCTTSHHHHHHHT--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred CCCCCCCchHHHHHHHHhc--ccccCCccccCCHHHHHHHHHHccCChhhCcC---HHHHhhChhhccc
Confidence 99998766543 2333332 222333345799999999999999 9999999 9999999999753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-51 Score=409.41 Aligned_cols=260 Identities=36% Similarity=0.619 Sum_probs=233.6
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++.+.||+|+||.||+|++..++..||||++.+...........+.+|+.+++.++||||++++++|.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 45567889999999999999999999999999999999998776554555667899999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. ....+||+.|+|||++.+..++.++|+|||||++|+
T Consensus 168 ~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 204 (284)
T 2vgo_A 168 R-------------------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204 (284)
T ss_dssp C-------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHH
T ss_pred c-------------------------------------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHH
Confidence 0 114579999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|++|.+||.+.+..+....+.. ....+|. .++.++++||.+||. ||.+||+ +++|++||||+.
T Consensus 205 l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~ll~h~~~~~ 268 (284)
T 2vgo_A 205 FLVGMPPFDSPSHTETHRRIVN--VDLKFPP--FLSDGSKDLISKLLRYHPPQRLP---LKGVMEHPWVKA 268 (284)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC---HHHHHTCHHHHH
T ss_pred HHHCCCCCCCCCHhHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhhcCHhhCCC---HHHHhhCHHHHh
Confidence 9999999999888888877776 3445554 689999999999999 9999999 999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=416.14 Aligned_cols=259 Identities=36% Similarity=0.670 Sum_probs=220.5
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh-----------------------hhHHHHHHHHHHH
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----------------------RGQVEHVRAERNL 169 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~-----------------------~~~~~~~~~E~~i 169 (552)
+..++|++.+.||+|+||.||+|+++.+|+.||||++.+..... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 45688999999999999999999999999999999998754322 1224568899999
Q ss_pred HHhcCCCceEEEeeeecC--CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCc
Q 008810 170 LAEVDSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (552)
Q Consensus 170 L~~l~hp~Iv~l~~~f~d--~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNI 247 (552)
|+.++|||||+++++|.+ ...+|+||||++||+|..++ ....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999986 67899999999999999876 456899999999999999999999999999999999999
Q ss_pred cccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChh
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APE 327 (552)
|++.+|++||+|||+++.+..... .....+||+.|+|||
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------~~~~~~gt~~y~aPE 207 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-----------------------------------------LLSNTVGTPAFMAPE 207 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-----------------------------------------EECCCCSCGGGCCGG
T ss_pred EECCCCCEEEecCCCccccccccc-----------------------------------------cccCCcCCccccChh
Confidence 999999999999999986542210 012468999999999
Q ss_pred hhhcCC---CCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccC
Q 008810 328 VLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 328 vl~~~~---y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.. ..+.+|....+++++++||.+||. ||.+||
T Consensus 208 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~ 285 (298)
T 2zv2_A 208 SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS--QALEFPDQPDIAEDLKDLITRMLDKNPESRI 285 (298)
T ss_dssp GCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC
T ss_pred hhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc--ccCCCCCccccCHHHHHHHHHHhhcChhhCC
Confidence 998765 47889999999999999999999999888777777765 345556556799999999999999 999999
Q ss_pred CCCChhhhhcCCCcC
Q 008810 404 GAKGADEIKVHPWFD 418 (552)
Q Consensus 404 ~~~~a~eil~HpfF~ 418 (552)
+ +.||++||||.
T Consensus 286 s---~~e~l~hp~~~ 297 (298)
T 2zv2_A 286 V---VPEIKLHPWVT 297 (298)
T ss_dssp C---HHHHTTCHHHH
T ss_pred C---HHHHhcCcccc
Confidence 9 99999999995
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=446.29 Aligned_cols=260 Identities=32% Similarity=0.635 Sum_probs=232.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3579999999999999999999999999999999987643 233456789999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc---CCCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~---~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++ .++++||+|||+++.+....
T Consensus 100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~- 178 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178 (486)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-
Confidence 99999999999998889999999999999999999999999999999999999995 55689999999998653221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.....+||+.|+|||++.+ .|+.++||||||||+|+|+
T Consensus 179 -----------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 216 (486)
T 3mwu_A 179 -----------------------------------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (486)
T ss_dssp --------------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHH
Confidence 0124689999999999975 5999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
+|.+||.+.+..+.+.++......+..|....+|+++++||.+||+ ||.+||+ +.+++.||||+...
T Consensus 217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYS 284 (486)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHHHCHHHHHTC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCHhhccCc
Confidence 9999999999999999998866666677667899999999999999 9999999 99999999997654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=424.93 Aligned_cols=260 Identities=34% Similarity=0.558 Sum_probs=213.9
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
...++|++.+.||+|+||.||+|+++.+++.||||++++.. ..+.+.+|+.+|..++|||||+++++|.+...+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34577999999999999999999999999999999998643 2345788999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEcccccccccCCC
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGlak~~~~~ 269 (552)
+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999975 899999999999864321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. .....+||+.|+|||++.+..|+.++|||||||++||
T Consensus 205 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 242 (349)
T 2w4o_A 205 V------------------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242 (349)
T ss_dssp --------------------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHH
Confidence 0 0124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhh-HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 350 MLVGYPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 350 mltG~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
|++|..||.+..... .+..+.........|....++.++++||.+||+ ||.+||+ +.|+++||||.+..+
T Consensus 243 ll~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 243 LLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT---TFQALQHPWVTGKAA 314 (349)
T ss_dssp HHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTTSTTC
T ss_pred HHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCcc
Confidence 999999998766544 666676644333333345789999999999999 9999999 999999999987653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=427.65 Aligned_cols=255 Identities=33% Similarity=0.563 Sum_probs=212.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
...++|++++.||+|+||.||+|+++.+|+.||||++.+.... .+.+.+|+.+++.++|||||+++++|.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4567899999999999999999999999999999999865422 245789999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc--EEEcccccccccCCCC
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCST 270 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~--iKL~DFGlak~~~~~~ 270 (552)
+|||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999988889999999999999999999999999999999999999987765 9999999987432110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCc-cchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME-CDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvilyE 349 (552)
.....+||+.|+|||++.+..|+.+ +|||||||++|+
T Consensus 173 ------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 210 (361)
T 3uc3_A 173 ------------------------------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210 (361)
T ss_dssp --------------------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHH
Confidence 0124689999999999998888655 899999999999
Q ss_pred HhhCCCCCCCCChhh----HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 350 MLVGYPPFYSDDPMS----TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 350 mltG~~PF~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
|++|.+||.+.+... ....+.. ....+|....+++++++||.+||. ||.+||+ +.||++||||.
T Consensus 211 ll~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~ 279 (361)
T 3uc3_A 211 MLVGAYPFEDPEEPRDYRKTIQRILS--VKYSIPDDIRISPECCHLISRIFVADPATRIS---IPEIKTHSWFL 279 (361)
T ss_dssp HHHSSCSCC----CCCHHHHHHHHHT--TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSHHHH
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhc--CCCCCCCcCCCCHHHHHHHHHHccCChhHCcC---HHHHHhCcchh
Confidence 999999998865433 3344443 344566656789999999999999 9999999 99999999994
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=410.55 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=215.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|++ .+|+.||+|++..... .......+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 6789999999976532 2233456889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||++| +|..++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--- 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc---
Confidence 99975 898888654 7799999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG 353 (552)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 156 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (288)
T 1ob3_A 156 --------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (288)
T ss_dssp --------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 0113579999999999986 4589999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccc---------c-------CC---------cccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHL---------K-------FP---------EEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~---------~-------~p---------~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
.+||.+.+..+....+....... . ++ ....+++++++||.+||. ||.+||+
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt--- 274 (288)
T 1ob3_A 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT--- 274 (288)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC---
Confidence 99999988877776665421100 0 00 002478999999999999 9999999
Q ss_pred hhhhhcCCCcCCCC
Q 008810 408 ADEIKVHPWFDGVD 421 (552)
Q Consensus 408 a~eil~HpfF~~i~ 421 (552)
++|+++||||++.|
T Consensus 275 ~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 275 AKQALEHAYFKENN 288 (288)
T ss_dssp HHHHHTSGGGGC--
T ss_pred HHHHhcCcchhhcC
Confidence 99999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=418.12 Aligned_cols=263 Identities=29% Similarity=0.476 Sum_probs=208.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|+++.+|+.||||+++... .......+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999997653 223345678899999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 195 MEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
|||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999988654 3699999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
... .....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 161 ~~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 199 (317)
T 2pmi_A 161 PVN-----------------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199 (317)
T ss_dssp CCC-----------------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred Ccc-----------------------------------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHH
Confidence 210 0114579999999999987 4689999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccc---------cCC---------------------cccccChhHHHHHHHHhh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------KFP---------------------EEAKLSIEAKDLISKLLC 397 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~---------~~p---------------------~~~~~s~e~~dLI~~lL~ 397 (552)
|||++|.+||.+.+..+....|....... ..| ....++.++++||.+||+
T Consensus 200 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 279 (317)
T 2pmi_A 200 AEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279 (317)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSC
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCC
Confidence 99999999999998888777775421110 000 012578899999999999
Q ss_pred -CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 398 -NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 398 -dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
||.+||+ ++|+++||||++..|..
T Consensus 280 ~dP~~Rpt---~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 280 LNPDMRLS---AKQALHHPWFAEYYHHA 304 (317)
T ss_dssp SSGGGSCC---HHHHTTSGGGGGGCC--
T ss_pred CCcccCCC---HHHHhCChhhhcccchh
Confidence 9999999 99999999999876643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-51 Score=439.59 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=212.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 188 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 578999999999999999999999999999999998653 3344566788999999999999999999999755
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|||||||+|+ |...+. ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 4679999999764 666664 3599999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. .....+||+.|+|||++.+.+|+.++||||||||+|
T Consensus 217 ~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 217 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp CC------------------------------------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred Cc------------------------------------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 21 112468999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccc-------------------------c----CCcc---------cccChhHHH
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHL-------------------------K----FPEE---------AKLSIEAKD 390 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~-------------------------~----~p~~---------~~~s~e~~d 390 (552)
||++|++||.+.+..+.+.+|+...+.. . +|.. ...++++++
T Consensus 255 ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 9999999999999888887776521110 0 0100 012678999
Q ss_pred HHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 391 LI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||.+||+ ||.+||+ ++|+++||||+.
T Consensus 335 Ll~~mL~~dP~~R~t---a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 335 LLSKMLVIDPAKRIS---VDDALQHPYINV 361 (464)
T ss_dssp HHHHHSCSSTTTSCC---HHHHHTSTTTGG
T ss_pred HHHHHcCCChhhCCC---HHHHhcChhhhh
Confidence 9999999 9999999 999999999984
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=445.79 Aligned_cols=261 Identities=33% Similarity=0.594 Sum_probs=226.7
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.++..||||++.+.... ......+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999999999999999999876532 223466889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEcccccccccCCCCcc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGlak~~~~~~~~ 272 (552)
|||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+.+....
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 99999999999998899999999999999999999999999999999999999976 4569999999998654221
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 194 ----------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 194 ----------------------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp ----------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh
Confidence 012468999999999986 569999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
|.+||.+.+..+.+.++......+..|....+|+++++||.+||+ ||.+||+ +.|+++||||+...+.
T Consensus 233 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS---AQQALEHPWIKEMCSK 301 (494)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc---HHHHhcCcccccCccc
Confidence 999999999999999988765555555556799999999999999 9999999 9999999999875443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=444.17 Aligned_cols=261 Identities=33% Similarity=0.591 Sum_probs=227.9
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh----------hHHHHHHHHHHHHHhcCCCceEEEee
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR----------GQVEHVRAERNLLAEVDSNCIVKLYC 183 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~----------~~~~~~~~E~~iL~~l~hp~Iv~l~~ 183 (552)
..++|++++.||+|+||.||+|+++.+++.||||++.+...... ...+.+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999999999999999987653321 33567899999999999999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cEEEccc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDF 260 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~iKL~DF 260 (552)
+|.+...+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.+| ++||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999999889999999999999999999999999999999999999999876 6999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccch
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 340 (552)
|+|+.+.... .....+||+.|+|||++. ..|+.++||
T Consensus 194 g~a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~-~~~~~~~Di 230 (504)
T 3q5i_A 194 GLSSFFSKDY------------------------------------------KLRDRLGTAYYIAPEVLK-KKYNEKCDV 230 (504)
T ss_dssp TTCEECCTTS------------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHH
T ss_pred CCCEEcCCCC------------------------------------------ccccccCCcCCCCHHHhc-cCCCchHHH
Confidence 9998654321 012468999999999986 569999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||||++|+|++|.+||.+.+..+.+.+|......+..+....+|+++++||.+||+ ||.+||+ ++|+++||||+.
T Consensus 231 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 307 (504)
T 3q5i_A 231 WSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT---AEEALNSRWIKK 307 (504)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC---HHHHhcCHhhhh
Confidence 999999999999999999999999999988754444444446799999999999999 9999999 999999999975
Q ss_pred C
Q 008810 420 V 420 (552)
Q Consensus 420 i 420 (552)
.
T Consensus 308 ~ 308 (504)
T 3q5i_A 308 Y 308 (504)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=416.82 Aligned_cols=266 Identities=26% Similarity=0.486 Sum_probs=230.2
Q ss_pred CCCeeEE-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEE
Q 008810 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 115 ~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ly 192 (552)
.+.|.+. +.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|..+ .||||++++++|.+...+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 4567777 899999999999999999999999999987543 223356788999999998 5699999999999999999
Q ss_pred EEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEcccccccccC
Q 008810 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLD 267 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGlak~~~ 267 (552)
+||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||+++.+.
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999999998553 67999999999999999999999999999999999999997 7999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
... .....+||+.|+|||++.+..|+.++|||||||++
T Consensus 186 ~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 223 (327)
T 3lm5_A 186 HAC------------------------------------------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIA 223 (327)
T ss_dssp --------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred Ccc------------------------------------------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHH
Confidence 221 01246799999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~ 426 (552)
|+|++|.+||.+.+..+.+..+.........+....+++++++||.+||. ||.+||+ +++|++||||++++|+.+.
T Consensus 224 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 224 YMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT---AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTCGGGCCCCTTCC-
T ss_pred HHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhCCHhhccccccccc
Confidence 99999999999999888888877644444333345789999999999999 9999999 9999999999999998764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=405.69 Aligned_cols=268 Identities=32% Similarity=0.541 Sum_probs=232.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh------hhhhHHHHHHHHHHHHHhcC-CCceEEEeeeec
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM------LRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQ 186 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~------~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~ 186 (552)
..++|++.+.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+|..+. ||||++++++|.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 36789999999999999999999999999999999976431 11233456889999999995 999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
+...+|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh------cCCCCCccch
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDW 340 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~------~~~y~~~~Di 340 (552)
..... ....+||+.|+|||++. ...++.++||
T Consensus 175 ~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di 212 (298)
T 1phk_A 175 DPGEK------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212 (298)
T ss_dssp CTTCC------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHH
T ss_pred CCCcc------------------------------------------cccccCCccccCHHHhccccccccccCCccccc
Confidence 42210 12457999999999996 3568999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||||++|+|++|..||.+.+.......+.........|....++.++.+||.+||. ||.+||+ +.|+++||||++
T Consensus 213 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~ 289 (298)
T 1phk_A 213 WSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQ 289 (298)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCT
T ss_pred HhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC---HHHHHhChHhhh
Confidence 999999999999999999998888888887754444445456789999999999999 9999999 999999999999
Q ss_pred CChhhhh
Q 008810 420 VDWARIY 426 (552)
Q Consensus 420 i~w~~l~ 426 (552)
..|+.+.
T Consensus 290 ~~~~~~~ 296 (298)
T 1phk_A 290 YVVEEVR 296 (298)
T ss_dssp TC-----
T ss_pred ccchhhc
Confidence 9887764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=431.78 Aligned_cols=289 Identities=27% Similarity=0.409 Sum_probs=218.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----c
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 189 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 578999999999999999999999999999999997642 2344556789999999999999999999999876 5
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||+. |+|..++.....+++..++.++.||+.||.|||+.|||||||||+||||+.+|++||+|||+|+.....
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 7999999995 699999988888999999999999999999999999999999999999999999999999999976433
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-cCCCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-~~~y~~~~DiWSlGvily 348 (552)
.......... ....+. ...+..+....+.+||+.|+|||++. +..|+.++||||||||+|
T Consensus 183 ~~~~~~~~~~--------~~~~~~-----------~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ 243 (432)
T 3n9x_A 183 KDTNIVNDLE--------ENEEPG-----------PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFA 243 (432)
T ss_dssp -----------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred cccccccccc--------cccccc-----------ccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHH
Confidence 1110000000 000000 00011112234679999999999975 567999999999999999
Q ss_pred HHhh-----------CCCCCCCCCh-----------------hhHHHHHhhccc----------------------cccC
Q 008810 349 EMLV-----------GYPPFYSDDP-----------------MSTCRKIVNWRT----------------------HLKF 378 (552)
Q Consensus 349 Emlt-----------G~~PF~~~~~-----------------~~~~~~i~~~~~----------------------~~~~ 378 (552)
||++ |+++|.+.+. ...+..|+..-+ ....
T Consensus 244 ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 323 (432)
T 3n9x_A 244 ELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRK 323 (432)
T ss_dssp HHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCC
T ss_pred HHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCC
Confidence 9998 5566655431 122222221000 0000
Q ss_pred Cc-----ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhh
Q 008810 379 PE-----EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 379 p~-----~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~ 427 (552)
+. .+.+++++++||.+||+ ||.+||+ ++|+++||||++++|.....
T Consensus 324 ~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 324 PINLKQKYPSISDDGINLLESMLKFNPNKRIT---IDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp CCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTCGGGTTTCCTTTC-
T ss_pred CCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcChhhhhccCcccCc
Confidence 00 13589999999999999 9999999 99999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=419.87 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=199.6
Q ss_pred CeeEE---eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEE
Q 008810 117 DFELL---TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 117 ~f~~~---~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~ly 192 (552)
+|++. +.||+|+||.||+|+++.+|+.||||++.+. ....+.+|+.+|..+. |||||+++++|.+...+|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 35554 7899999999999999999999999999754 2345778999999996 999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cEEEcccccccccCCC
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLDCS 269 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~iKL~DFGlak~~~~~ 269 (552)
+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999999989999999999999999999999999999999999999998766 8999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.. ...+.+||+.|+|||++.+..|+.++|||||||++|+
T Consensus 163 ~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ 201 (325)
T 3kn6_A 163 NQ-----------------------------------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYT 201 (325)
T ss_dssp --------------------------------------------------------------CCCCHHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHH
Confidence 10 0124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCCh-------hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 350 MLVGYPPFYSDDP-------MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 350 mltG~~PF~~~~~-------~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|++|.+||.+.+. .+...++......+..+....+|+++++||.+||. ||.+||+ +.||+.||||++.
T Consensus 202 ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~h~w~~~~ 277 (325)
T 3kn6_A 202 MLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK---MSGLRYNEWLQDG 277 (325)
T ss_dssp HHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC---TTTSTTCGGGCTT
T ss_pred HHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC---HHHHhcChhhccC
Confidence 9999999987543 45556666533222222234689999999999999 9999999 9999999999863
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=410.51 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=214.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhc---CCCceEEEeeeecC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQD 187 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~d 187 (552)
+..++|++++.||+|+||.||+|+++.+|+.||||++...... .......+.+|+.+++.+ +|||||+++++|.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567899999999999999999999999999999999754321 111123456677777665 59999999999976
Q ss_pred Cc-----eEEEEEecCCCCchhhHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccc
Q 008810 188 DE-----FLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (552)
Q Consensus 188 ~~-----~lylVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DF 260 (552)
.. .+|+||||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.+|++||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 6899999996 599999977654 999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccch
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~Di 340 (552)
|+|+...... .....+||+.|+|||++.+..|+.++||
T Consensus 165 g~a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di 202 (308)
T 3g33_A 165 GLARIYSYQM------------------------------------------ALTPVVVTLWYRAPEVLLQSTYATPVDM 202 (308)
T ss_dssp SCTTTSTTCC------------------------------------------CSGGGGCCCSSCCHHHHHTSCCCSTHHH
T ss_pred ccccccCCCc------------------------------------------ccCCccccccccCchHHcCCCCCchHHH
Confidence 9998653221 0124689999999999999999999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccc---------cccCCc--------------ccccChhHHHHHHHHhh
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT---------HLKFPE--------------EAKLSIEAKDLISKLLC 397 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~---------~~~~p~--------------~~~~s~e~~dLI~~lL~ 397 (552)
|||||++|||++|.+||.+.+..+...++..... ...++. ...+++++.+||.+||.
T Consensus 203 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 282 (308)
T 3g33_A 203 WSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLT 282 (308)
T ss_dssp HHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhc
Confidence 9999999999999999999998888877764211 111110 12578899999999999
Q ss_pred -CccccCCCCChhhhhcCCCcCCC
Q 008810 398 -NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 398 -dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
||.+||+ +.|+++||||+..
T Consensus 283 ~dP~~R~t---~~e~l~h~~~~~~ 303 (308)
T 3g33_A 283 FNPHKRIS---AFRALQHSYLHKD 303 (308)
T ss_dssp SSTTTSCC---HHHHHTSTTC---
T ss_pred CCCccCCC---HHHHhcCccccCC
Confidence 9999999 9999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=421.13 Aligned_cols=268 Identities=31% Similarity=0.510 Sum_probs=228.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~--~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
.++|++++.||+|+||.||+|+++.+++.||+|++.+.... .....+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 35699999999999999999999999999999999876542 3455678999999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 008810 193 LIMEYLPGGDMMTLLMR----------------------------------------KDTLTEDEARFYVAETVLAIESI 232 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~----------------------------------------~~~l~e~~~~~~~~qi~~aL~~L 232 (552)
+|||||+||+|.+++.. ...+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999842 11246788999999999999999
Q ss_pred HhCCCcccccCCCCccccCCC--cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 008810 233 HKHHYIHRDIKPDNLLLDKYG--HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNR 310 (552)
Q Consensus 233 H~~giiHrDLKPeNILl~~~g--~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r 310 (552)
|+.||+||||||+|||++.++ ++||+|||+++.+.......
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~------------------------------------- 227 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE------------------------------------- 227 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------------------------------------
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc-------------------------------------
Confidence 999999999999999998777 89999999998653211000
Q ss_pred cccccccccCCCCCChhhhhc--CCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhH
Q 008810 311 RMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388 (552)
Q Consensus 311 ~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~ 388 (552)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+......+..|....+++++
T Consensus 228 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (345)
T 3hko_A 228 YYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLA 307 (345)
T ss_dssp -------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHH
T ss_pred cccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHH
Confidence 000124679999999999976 678999999999999999999999999999988888888765555555555689999
Q ss_pred HHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 389 ~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
++||.+||. ||.+||+ +.++++||||+++.|
T Consensus 308 ~~li~~~l~~~p~~Rps---~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 308 RDLLSNLLNRNVDERFD---AMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHHSCSCTTTSCC---HHHHHHSHHHHTTSS
T ss_pred HHHHHHHcCCChhHCCC---HHHHhcChhhccChH
Confidence 999999999 9999999 999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=432.12 Aligned_cols=253 Identities=34% Similarity=0.537 Sum_probs=210.8
Q ss_pred CCCCeeEE-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH-hcCCCceEEEeeeecC----
Q 008810 114 GADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKLYCSFQD---- 187 (552)
Q Consensus 114 ~~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~d---- 187 (552)
..++|.++ ++||+|+||+||+|+++.+|+.||||++... ..+.+|+.++. ..+|||||+++++|.+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 35678887 7999999999999999999999999999743 23567888874 4589999999998865
Q ss_pred CceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGL 262 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGl 262 (552)
..++|||||||+||+|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++. +|++||+|||+
T Consensus 131 ~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 131 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred CcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccc
Confidence 678999999999999999997653 5999999999999999999999999999999999999997 78999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
++...... ...+.+||+.|+|||++.+..|+.++||||
T Consensus 211 a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 248 (400)
T 1nxk_A 211 AKETTSHN------------------------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248 (400)
T ss_dssp CEECC-----------------------------------------------------CTTCCGGGSCCCCSSSHHHHHH
T ss_pred ccccCCCC------------------------------------------ccccCCCCCCccCHhhcCCCCCCCcccHHH
Confidence 98653211 012468999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhh----HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMS----TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
||||+|||++|.+||.+.+... ...++......+..+....+|+++++||.+||+ ||.+||+ +.||++||||
T Consensus 249 lG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~ 325 (400)
T 1nxk_A 249 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWI 325 (400)
T ss_dssp HHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHH
T ss_pred HHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccc
Confidence 9999999999999998765432 445565544444444445799999999999999 9999999 9999999999
Q ss_pred CC
Q 008810 418 DG 419 (552)
Q Consensus 418 ~~ 419 (552)
..
T Consensus 326 ~~ 327 (400)
T 1nxk_A 326 MQ 327 (400)
T ss_dssp HT
T ss_pred cC
Confidence 65
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=427.72 Aligned_cols=260 Identities=30% Similarity=0.545 Sum_probs=222.5
Q ss_pred CeeE--EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 117 DFEL--LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 117 ~f~~--~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.|.+ .++||+|+||.||+|+++.+|+.||+|+++.... ...+.+.+|+.+|..++|||||+++++|.+.+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 6789999999999999999999999999987542 3446788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc--cCCCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl--~~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++++||+|||+++.+.....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 9999999999988654 579999999999999999999999999999999999999 5678999999999987643210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+||+.|+|||++.+..++.++||||||||+|||+
T Consensus 245 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 282 (373)
T 2x4f_A 245 ------------------------------------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282 (373)
T ss_dssp ------------------------------------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH
Confidence 11357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
+|.+||.+.+..+.+.+|+.....+..+....+++++++||.+||+ ||.+||+ +.|+++||||.+..|..
T Consensus 283 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 283 SGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS---ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHCHHHHH
T ss_pred hCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC---HHHHhcCcCcCCCchhh
Confidence 9999999999988888888744333333335789999999999999 9999999 99999999999887654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=421.19 Aligned_cols=274 Identities=27% Similarity=0.414 Sum_probs=219.7
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 578999999999999999999999999999999998643 23445567889999999999999999999998665
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|+|||||+ |+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 7899999996 47888774 4699999999999999999999999999999999999999999999999999985432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 180 ~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 217 (371)
T 2xrw_A 180 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217 (371)
T ss_dssp ----------------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cc------------------------------------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHH
Confidence 10 012468999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccc----------------------------------cCCcc----cccChhHHH
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHL----------------------------------KFPEE----AKLSIEAKD 390 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~----~~~s~e~~d 390 (552)
||++|.+||.+.+....+.+++...... .+|.. ...++++++
T Consensus 218 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (371)
T 2xrw_A 218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297 (371)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHH
Confidence 9999999999998888777776421100 01100 123678999
Q ss_pred HHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccccC
Q 008810 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVN 437 (552)
Q Consensus 391 LI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~~~ 437 (552)
||.+||+ ||.+||+ ++|+++||||+...........+|++|...
T Consensus 298 li~~mL~~dP~~R~t---~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 342 (371)
T 2xrw_A 298 LLSKMLVIDASKRIS---VDEALQHPYINVWYDPSEAEAPPPKIPDKQ 342 (371)
T ss_dssp HHHHHSCSSGGGSCC---HHHHHHSHHHHTTCCHHHHTCCCCCCCTTT
T ss_pred HHHHHCcCChhhCCC---HHHHhCCcchhhhcCccccCCCCCCCCChh
Confidence 9999999 9999999 999999999986443333345677777543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=413.20 Aligned_cols=268 Identities=30% Similarity=0.548 Sum_probs=215.8
Q ss_pred CCCeeEE-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEE
Q 008810 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 115 ~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ly 192 (552)
.+.|++. +.||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.+|..+ +||||++++++|.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4678885 78999999999999999999999999997653 23456688999999884 7999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc---EEEcccccccccCCC
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCS 269 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~---iKL~DFGlak~~~~~ 269 (552)
+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.+...
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999998889999999999999999999999999999999999999998776 999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----CCCCCccchhhhh
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLG 344 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----~~y~~~~DiWSlG 344 (552)
..... .........+||+.|+|||++.+ ..|+.++||||||
T Consensus 168 ~~~~~----------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 213 (316)
T 2ac3_A 168 GDCSP----------------------------------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213 (316)
T ss_dssp ------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHH
T ss_pred Ccccc----------------------------------ccccccccccCCcCccChHHhhcccccccCCCcccccHhHH
Confidence 10000 00001124679999999999986 5689999999999
Q ss_pred HHHHHHhhCCCCCCCCCh---------------hhHHHHHhhccccccCCcc--cccChhHHHHHHHHhh-CccccCCCC
Q 008810 345 AIMYEMLVGYPPFYSDDP---------------MSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~---------------~~~~~~i~~~~~~~~~p~~--~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
|++|||++|.+||.+... ......+.. ....+|.. ..+++++++||.+||. ||.+||+
T Consensus 214 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-- 289 (316)
T 2ac3_A 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS-- 289 (316)
T ss_dssp HHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC--
T ss_pred HHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCCC--
Confidence 999999999999987642 234455554 33445532 4689999999999999 9999999
Q ss_pred ChhhhhcCCCcCCCChhh
Q 008810 407 GADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 407 ~a~eil~HpfF~~i~w~~ 424 (552)
+.|+++||||++..|..
T Consensus 290 -~~e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 290 -AAQVLQHPWVQGCAPEN 306 (316)
T ss_dssp -HHHHHHSTTCC------
T ss_pred -HHHHhcChhhcCCCCcc
Confidence 99999999999887654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=408.86 Aligned_cols=265 Identities=27% Similarity=0.434 Sum_probs=220.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.... ......+.+.+|+.+++.++||||++++++|.+...+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999997653 2233456688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++|++|..++.....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--- 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG 353 (552)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 199 (311)
T 4agu_A 158 --------------------------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199 (311)
T ss_dssp ----------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 0124579999999999987 6789999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccc-----------------cccCCc----------ccccChhHHHHHHHHhh-CccccCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRT-----------------HLKFPE----------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~----------~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
.+||.+.+..+....+..... ....|. ...+++++.+||.+||. ||.+||+
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt- 278 (311)
T 4agu_A 200 VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT- 278 (311)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC-
T ss_pred CCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC-
Confidence 999999887776655543111 111111 13578899999999999 9999999
Q ss_pred CChhhhhcCCCcCCCChhh
Q 008810 406 KGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 406 ~~a~eil~HpfF~~i~w~~ 424 (552)
++||++||||+++.|..
T Consensus 279 --~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 279 --CEQLLHHPYFENIREIE 295 (311)
T ss_dssp --HHHHHTSGGGTTCC---
T ss_pred --HHHHhcChHHHhccCHH
Confidence 99999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=402.80 Aligned_cols=253 Identities=34% Similarity=0.607 Sum_probs=226.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++.+.||+|+||.||+|.++.++..||+|++.+... ...+.+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 469999999999999999999999999999999987542 33567889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc---cCCCcEEEcccccccccCCCCcc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl---~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~- 164 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM- 164 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC-
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc-
Confidence 999999999999888999999999999999999999999999999999999999 7889999999999986543210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
....+||+.|+|||++.+. ++.++|||||||++|+|++
T Consensus 165 -----------------------------------------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~ 202 (277)
T 3f3z_A 165 -----------------------------------------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLC 202 (277)
T ss_dssp -----------------------------------------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHH
Confidence 1245799999999998654 9999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|.+||.+.+..+...++... ...+|. ...+++++++||.+||. ||.+||+ +.+++.||||+.
T Consensus 203 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~ 267 (277)
T 3f3z_A 203 GYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT---SLQALEHEWFEK 267 (277)
T ss_dssp SSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhc
Confidence 99999999888888888763 344443 23689999999999999 9999999 999999999964
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=421.09 Aligned_cols=290 Identities=29% Similarity=0.449 Sum_probs=238.2
Q ss_pred HhhccCCCHHHHHHHHHHHHhhhhhhhhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhH
Q 008810 80 KLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ 159 (552)
Q Consensus 80 ~l~~~~~~~e~~~~~~~~~~~~e~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~ 159 (552)
+++..++.++.......++... .....+..++|++++.||+|+||.||+|+++.+|+.||+|++.... ....
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~ 74 (360)
T 3eqc_A 3 KLEELELDEQQRKRLEAFLTQK------QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAI 74 (360)
T ss_dssp ---CCCCCHHHHHHHHHHHHHH------HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHH
T ss_pred chhhhhhhhhhhhhHHHHhhhh------hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHH
Confidence 4555666666665555544322 2345677889999999999999999999999999999999998652 2344
Q ss_pred HHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCc
Q 008810 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYI 238 (552)
Q Consensus 160 ~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gii 238 (552)
.+.+.+|+.+|+.++|||||+++++|.+.+.+|+||||++||+|.+++...+.+++..+..++.+++.||.|||+. ||+
T Consensus 75 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~ 154 (360)
T 3eqc_A 75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154 (360)
T ss_dssp HHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 5678999999999999999999999999999999999999999999999888999999999999999999999995 999
Q ss_pred ccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccc
Q 008810 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (552)
Q Consensus 239 HrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~ 318 (552)
||||||+|||++.+|++||+|||+++.+... .....+
T Consensus 155 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------~~~~~~ 191 (360)
T 3eqc_A 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------------------------------------MANSFV 191 (360)
T ss_dssp CSCCSGGGEEECTTCCEEECCCCCCHHHHHH-------------------------------------------C----C
T ss_pred cCCccHHHEEECCCCCEEEEECCCCcccccc-------------------------------------------cccCCC
Confidence 9999999999999999999999998754211 112468
Q ss_pred cCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHH------------------------------
Q 008810 319 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRK------------------------------ 368 (552)
Q Consensus 319 GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~------------------------------ 368 (552)
||+.|+|||++.+..|+.++|||||||++|+|++|..||...+..+....
T Consensus 192 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (360)
T 3eqc_A 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271 (360)
T ss_dssp CCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------------
T ss_pred CCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCC
Confidence 99999999999999999999999999999999999999987765443221
Q ss_pred ------------HhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 369 ------------IVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 369 ------------i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
+... .....| ...++.++++||.+||. ||.+||+ ++|+++||||++.+|+.+
T Consensus 272 ~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 272 RPPMAIFELLDYIVNE-PPPKLP-SGVFSLEFQDFVNKCLIKNPAERAD---LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp --CCCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHHHHHSCC
T ss_pred CCcccchhhhhHHhcc-CCCCCC-cccccHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhcchHhhh
Confidence 1111 111122 13578999999999999 9999999 999999999988776554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=402.45 Aligned_cols=258 Identities=34% Similarity=0.634 Sum_probs=203.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.++..++||||++++++|.+.+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46899999999999999999999999999999999877655555567899999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 9999999999999765 6799999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 168 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (278)
T 3cok_A 168 ---------------------------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208 (278)
T ss_dssp ---------------------------------------------------------------CTHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 01246799999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+||...+......++.. ....+|. .++.++++||.+||. ||.+||+ +++++.||||...
T Consensus 209 ~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 269 (278)
T 3cok_A 209 RPPFDTDTVKNTLNKVVL--ADYEMPS--FLSIEAKDLIHQLLRRNPADRLS---LSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSCCCSCC-----CCS--SCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSTTTC--
T ss_pred CCCCCChhHHHHHHHHhh--cccCCcc--ccCHHHHHHHHHHcccCHhhCCC---HHHHhcCccccCC
Confidence 999998776666665553 2334443 689999999999999 9999999 9999999999764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=419.14 Aligned_cols=258 Identities=33% Similarity=0.596 Sum_probs=226.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-----hhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-----LRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~-----~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
++|++.+.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+|..+ +||||++++++|.+..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 569999999999999999999999999999999976431 1112245688999999999 8999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999866432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc------CCCCCccchhhh
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWWSL 343 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~------~~y~~~~DiWSl 343 (552)
. .....+||+.|+|||++.+ ..|+.++|||||
T Consensus 254 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 291 (365)
T 2y7j_A 254 E------------------------------------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291 (365)
T ss_dssp C------------------------------------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHH
T ss_pred c------------------------------------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhH
Confidence 1 0124689999999999974 368999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
||++|||++|.+||.+.+.......+.........|....+++++.+||.+||. ||.+||+ +++|++||||+
T Consensus 292 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~ 364 (365)
T 2y7j_A 292 GVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT---AEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGC
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCcccC
Confidence 999999999999999988888888887754444444445789999999999999 9999999 99999999996
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=420.65 Aligned_cols=260 Identities=31% Similarity=0.473 Sum_probs=216.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 468999999999999999999999999999999997543 23344567889999999999999999999998763
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8999999865 6799999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
. ....+||+.|+|||++.+ ..|+.++||||||||+
T Consensus 181 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 181 E--------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216 (367)
T ss_dssp S--------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence 1 114689999999999987 7899999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccc--------------------------cCCc-ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL--------------------------KFPE-EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~--------------------------~~p~-~~~~s~e~~dLI~~lL~-dp 399 (552)
|||++|.+||.+.+....+.+|+...... .++. ...+++++.+||.+||+ ||
T Consensus 217 ~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP 296 (367)
T 1cm8_A 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296 (367)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCCh
Confidence 99999999999998888777776421110 0000 12568999999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCCChhh
Q 008810 400 NQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
.+|++ ++|+++||||+.+.+..
T Consensus 297 ~~R~t---~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 297 EQRVT---AGEALAHPYFESLHDTE 318 (367)
T ss_dssp TTSCC---HHHHHHSGGGTTTC---
T ss_pred hHCCC---HHHHhcChHHHhhcCCc
Confidence 99999 99999999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=402.05 Aligned_cols=260 Identities=31% Similarity=0.518 Sum_probs=233.5
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
...++|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34678999999999999999999999999999999998876555666778999999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
+||||++|++|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999986532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 171 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 210 (294)
T 2rku_A 171 ----------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210 (294)
T ss_dssp ----------------------------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh
Confidence 0123579999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|..||.+....+.+..+.. ....+|. .+++++.+||.+||. ||.+||+ ++|+++||||.+.
T Consensus 211 g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~~~~~~~ 272 (294)
T 2rku_A 211 GKPPFETSCLKETYLRIKK--NEYSIPK--HINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 272 (294)
T ss_dssp SSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHhh--ccCCCcc--ccCHHHHHHHHHHcccChhhCcC---HHHHhhChheecC
Confidence 9999999888887777765 3444554 789999999999999 9999999 9999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=416.56 Aligned_cols=264 Identities=24% Similarity=0.425 Sum_probs=223.9
Q ss_pred hhhhhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-----CCc
Q 008810 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----SNC 177 (552)
Q Consensus 103 ~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----hp~ 177 (552)
...+.++...+..++|++++.||+|+||.||+|++..+|+.||||++++.. .....+..|..+|+.+. |||
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCC
Confidence 334456667777899999999999999999999999999999999997532 33455778999999986 999
Q ss_pred eEEEeeeecCCceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC----
Q 008810 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---- 251 (552)
Q Consensus 178 Iv~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---- 251 (552)
||+++++|.+.+.+|+||||+ ||+|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||++.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999999 999999997654 5999999999999999999999999999999999999975
Q ss_pred ---------------------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 008810 252 ---------------------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNR 310 (552)
Q Consensus 252 ---------------------~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r 310 (552)
++.+||+|||+|+.....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------------------------------------- 215 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------------------------------------- 215 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----------------------------------------
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----------------------------------------
Confidence 889999999999854211
Q ss_pred cccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccccc-------------
Q 008810 311 RMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK------------- 377 (552)
Q Consensus 311 ~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~------------- 377 (552)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+......++
T Consensus 216 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 292 (360)
T 3llt_A 216 ---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGS 292 (360)
T ss_dssp ---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGG
T ss_pred ---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCc
Confidence 1146899999999999999999999999999999999999999999887777666654211110
Q ss_pred -----------CCcc------------------cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 378 -----------FPEE------------------AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 378 -----------~p~~------------------~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
+|.. ...++++.+||.+||+ ||.+||+ +.|+++||||+
T Consensus 293 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~ 360 (360)
T 3llt_A 293 KYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS---PAELLKHKFLE 360 (360)
T ss_dssp GGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGC
T ss_pred cccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC---HHHHhcCcccC
Confidence 1110 1124678899999999 9999999 99999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=407.32 Aligned_cols=257 Identities=32% Similarity=0.609 Sum_probs=225.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|.+++.||+|+||.||+|+++.+|+.||+|++..... .....+.+|+.+|..++||||++++++|.+...+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 3569999999999999999999999999999999986532 2234578999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc---cCCCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl---~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~- 163 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI- 163 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT-
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc-
Confidence 9999999999999888899999999999999999999999999999999999999 788999999999987532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 164 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 201 (304)
T 2jam_A 164 ------------------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201 (304)
T ss_dssp ------------------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHH
Confidence 11357999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+|.+||.+.+.......+......+..+....+++++++||.+||. ||.+||+ +++++.||||.+.
T Consensus 202 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 268 (304)
T 2jam_A 202 CGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT---CEKALSHPWIDGN 268 (304)
T ss_dssp HSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHSS
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCccccCC
Confidence 9999999998888888887644333333335789999999999999 9999999 9999999999763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=410.76 Aligned_cols=260 Identities=31% Similarity=0.518 Sum_probs=233.9
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
....+|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34678999999999999999999999999999999998876555666778999999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~- 196 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 196 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999986542210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 197 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 236 (335)
T 2owb_A 197 ----------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236 (335)
T ss_dssp ----------------------------------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 0124679999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|..||.+....+.+..+.. ....+|. .+++++.+||.+||. ||.+||+ ++||++||||...
T Consensus 237 g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps---~~ell~~~~~~~~ 298 (335)
T 2owb_A 237 GKPPFETSCLKETYLRIKK--NEYSIPK--HINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 298 (335)
T ss_dssp SSCTTCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred CcCCCCCCCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccCC
Confidence 9999999888887777765 3444554 689999999999999 9999999 9999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=430.98 Aligned_cols=263 Identities=32% Similarity=0.603 Sum_probs=215.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh-----hhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
.++|.+.+.||+|+||.||+|.++.+++.||||++.+..... ......+.+|+.+|+.++|||||+++++|.+.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 468999999999999999999999999999999998764321 12223478999999999999999999998654
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cEEEccccccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPL 266 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~iKL~DFGlak~~ 266 (552)
.+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5799999999999999998889999999999999999999999999999999999999997554 5999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhh
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSL 343 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSl 343 (552)
.... .....+||+.|+|||++.+ ..|+.++|||||
T Consensus 293 ~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 330 (419)
T 3i6u_A 293 GETS------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330 (419)
T ss_dssp C-----------------------------------------------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred CCCc------------------------------------------cccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence 3211 0124689999999999864 678899999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHH-HHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTC-RKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~-~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||++|+|++|.+||.+....... ..+.. ....++. ...+++++++||.+||. ||.+||+ ++|+++||||++
T Consensus 331 G~il~~lltg~~pf~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~ 405 (419)
T 3i6u_A 331 GVILFICLSGYPPFSEHRTQVSLKDQITS--GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQD 405 (419)
T ss_dssp HHHHHHHHHSSCSSCCCSSSCCHHHHHHT--TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCC
T ss_pred HHHHHHHHHCCCCCCCCcchHHHHHHHhc--CCCCCCchhhcccCHHHHHHHHHHccCChhHCcC---HHHHhCCcccCC
Confidence 99999999999999876554333 33443 2223322 24689999999999999 9999999 999999999999
Q ss_pred CChhhh
Q 008810 420 VDWARI 425 (552)
Q Consensus 420 i~w~~l 425 (552)
.+|...
T Consensus 406 ~~~~~~ 411 (419)
T 3i6u_A 406 EDMKRK 411 (419)
T ss_dssp HHHHHH
T ss_pred hhHHHH
Confidence 888664
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=404.63 Aligned_cols=264 Identities=30% Similarity=0.533 Sum_probs=228.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
++|++++.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 569999999999999999999999999999999987643322 13567899999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC----cEEEcccccccccCC
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDC 268 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g----~iKL~DFGlak~~~~ 268 (552)
+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ ++||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999999877 899999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
... ....+||+.|+|||++.+..++.++|||||||++|
T Consensus 165 ~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 202 (283)
T 3bhy_A 165 GNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202 (283)
T ss_dssp -------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCc------------------------------------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHH
Confidence 110 11357999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
+|++|..||.+.+..+....+.........+....+++++++||.+||. ||.+||+ +.++++||||+.+.|..
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 203 ILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT---IAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC---HHHHHHCHHHHHHHHCC
T ss_pred HHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC---HHHHHhCHHHHHHHHHh
Confidence 9999999999998888887776533222211124688999999999999 9999999 99999999998876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=398.37 Aligned_cols=260 Identities=29% Similarity=0.542 Sum_probs=224.1
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..+..++|++.+.||+|+||.||+|+++.+|+.||||++...........+.+.+|+.+++.++||||+++++++.+...
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 45667899999999999999999999999999999999987665555566789999999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyE 349 (552)
.....+||+.|+|||++.+..+ +.++|+|||||++|+
T Consensus 166 ------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 203 (276)
T 2h6d_A 166 ------------------------------------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203 (276)
T ss_dssp -----------------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHH
Confidence 0113579999999999988776 689999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|++|..||...+.......+.. ....+|. .++.++.+||.+||. ||.+||+ +.+|++||||+.
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~~~l~h~~~~~ 267 (276)
T 2h6d_A 204 LLCGTLPFDDEHVPTLFKKIRG--GVFYIPE--YLNRSVATLLMHMLQVDPLKRAT---IKDIREHEWFKQ 267 (276)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHT
T ss_pred HHhCCCCCCCCcHHHHHHHhhc--CcccCch--hcCHHHHHHHHHHccCChhhCCC---HHHHHhChhhcc
Confidence 9999999998888777777765 3334453 689999999999999 9999999 999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=417.81 Aligned_cols=260 Identities=28% Similarity=0.505 Sum_probs=221.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh-----hHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-----GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~-----~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
++|++++.||+|+||.||+|+++.+|+.||||++.+...... .....+.+|+.+|+.++|||||+++++|.+...
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 579999999999999999999999999999999987653222 133457789999999999999999999999999
Q ss_pred EEEEEecCCCC-chhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGG-DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG-~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
+|+||||+.+| +|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.+...
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999777 99999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvily 348 (552)
. ...+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 184 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 221 (335)
T 3dls_A 184 K------------------------------------------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLY 221 (335)
T ss_dssp C------------------------------------------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred C------------------------------------------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHH
Confidence 1 1125689999999999998877 88999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC------CC
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG------VD 421 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~------i~ 421 (552)
+|++|..||..... +.. .....| ..+++++++||.+||. ||.+||+ +++|+.||||+. .+
T Consensus 222 el~~g~~pf~~~~~------~~~--~~~~~~--~~~~~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~~~~~~~~~ 288 (335)
T 3dls_A 222 TLVFEENPFCELEE------TVE--AAIHPP--YLVSKELMSLVSGLLQPVPERRTT---LEKLVTDPWVTQPVNLADYT 288 (335)
T ss_dssp HHHHSSCSCSSGGG------GTT--TCCCCS--SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHHCTTTTCCCCGGGCC
T ss_pred HHHhCCCchhhHHH------HHh--hccCCC--cccCHHHHHHHHHHccCChhhCcC---HHHHhcCccccCCccccccC
Confidence 99999999976322 111 222333 3689999999999999 9999999 999999999965 56
Q ss_pred hhhhhhcCC
Q 008810 422 WARIYQMEA 430 (552)
Q Consensus 422 w~~l~~~~~ 430 (552)
|+.+..+..
T Consensus 289 ~~~~~~~~~ 297 (335)
T 3dls_A 289 WEEVFRVNK 297 (335)
T ss_dssp HHHHC----
T ss_pred HHHHhhhcC
Confidence 766655443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=407.75 Aligned_cols=255 Identities=30% Similarity=0.528 Sum_probs=223.9
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|...+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 3788889999999999999999999999999997543 3345668899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
|++||+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~----- 196 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 196 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-----
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-----
Confidence 9999999998854 5799999999999999999999999999999999999999999999999999986542210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~P 356 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+|
T Consensus 197 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 240 (321)
T 2c30_A 197 ------------------------------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240 (321)
T ss_dssp ------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ------------------------------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 01246899999999999999999999999999999999999999
Q ss_pred CCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|.+.+.......+.... ...++....+++++++||.+||. ||.+||+ +.+|+.||||...
T Consensus 241 f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~ 301 (321)
T 2c30_A 241 YFSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELLDHPFLLQT 301 (321)
T ss_dssp TTTSCHHHHHHHHHHSS-CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGGGC
T ss_pred CCCCCHHHHHHHHhcCC-CCCcCccccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhccC
Confidence 99988888777776532 22233334789999999999999 9999999 9999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=400.72 Aligned_cols=256 Identities=28% Similarity=0.530 Sum_probs=218.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|.+.+.||+|+||.||+|+++.+|..||+|++.+... ....+.+.+|+.+|+.++||||++++++|.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 3679999999999999999999999999999999987642 33456789999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc---cCCCcEEEcccccccccC
Q 008810 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 195 mEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl---~~~g~iKL~DFGlak~~~ 267 (552)
|||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999999854 3689999999999999999999999999999999999999 556899999999997653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
... .....+||+.|+|||++. ..++.++|||||||++
T Consensus 179 ~~~------------------------------------------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il 215 (285)
T 3is5_A 179 SDE------------------------------------------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215 (285)
T ss_dssp --------------------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHH
T ss_pred Ccc------------------------------------------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHH
Confidence 211 012467999999999985 5789999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||++|..||.+.+..+....+......... ....+++++.+||.+||. ||.+||+ +.||++||||+.
T Consensus 216 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~f~~ 284 (285)
T 3is5_A 216 YFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPS---AAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGGC
T ss_pred HHHHhCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHhhc
Confidence 9999999999998887777666543222222 123579999999999999 9999999 999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=413.89 Aligned_cols=264 Identities=24% Similarity=0.379 Sum_probs=220.5
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc----
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE---- 189 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~---- 189 (552)
..++|++++.||+|+||.||+|+++.+|+.||||++.............+.+|+.++..++|||||++++++.+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4678999999999999999999999999999999998765555556677899999999999999999999987654
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 45999999999999999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.... ......+||+.|+|||++.+..|+.++|||||||++||
T Consensus 170 ~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 211 (311)
T 3ork_A 170 GNSV--------------------------------------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211 (311)
T ss_dssp --------------------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred cccc--------------------------------------ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 1000 01124679999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
|++|.+||.+.+.......+..............+++++.+||.+||. ||.+||+ +.+++.|+|++
T Consensus 212 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 278 (311)
T 3ork_A 212 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ---TAAEMRADLVR 278 (311)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh---hHHHHHHHHHH
Confidence 999999999998887776666532211111123589999999999999 9999999 88899999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=413.76 Aligned_cols=260 Identities=27% Similarity=0.457 Sum_probs=213.6
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+|+.||||++..... ......+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999999999999999975432 111123457999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||++ |+|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--- 155 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--- 155 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---
Confidence 9997 5888888664 4699999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG 353 (552)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|
T Consensus 156 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (324)
T 3mtl_A 156 --------------------------------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197 (324)
T ss_dssp ---------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 0124579999999999987 6789999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccc---cCC-----------------------cccccChhHHHHHHHHhh-CccccCCCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHL---KFP-----------------------EEAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~---~~p-----------------------~~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
.+||.+.+..+....+....... .+| ....+++++++||.+||. ||.+||+
T Consensus 198 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-- 275 (324)
T 3mtl_A 198 RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS-- 275 (324)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC--
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC--
Confidence 99999998888777765421111 011 012578899999999999 9999999
Q ss_pred ChhhhhcCCCcCCCCh
Q 008810 407 GADEIKVHPWFDGVDW 422 (552)
Q Consensus 407 ~a~eil~HpfF~~i~w 422 (552)
++|+++||||.++.+
T Consensus 276 -~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 276 -AEDAMKHPFFLSLGE 290 (324)
T ss_dssp -HHHHTTSGGGGGGCS
T ss_pred -HHHHhcChhhhhccc
Confidence 999999999987653
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=396.43 Aligned_cols=256 Identities=22% Similarity=0.389 Sum_probs=218.6
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC----Cc
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DE 189 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~ 189 (552)
....|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|..+|+.++|||||+++++|.+ ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 44568999999999999999999999999999999986543 34456778999999999999999999998864 46
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCcccc-CCCcEEEccccccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLD-KYGHLRLSDFGLCKPL 266 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~-~~g~iKL~DFGlak~~ 266 (552)
.+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.| |+||||||+|||++ .+|.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999988899999999999999999999999999 99999999999998 8899999999999754
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
.... ....+||+.|+|||++. ..++.++|||||||+
T Consensus 183 ~~~~-------------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~ 218 (290)
T 1t4h_A 183 RASF-------------------------------------------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMC 218 (290)
T ss_dssp CTTS-------------------------------------------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHH
T ss_pred cccc-------------------------------------------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHH
Confidence 3211 12467999999999886 459999999999999
Q ss_pred HHHHhhCCCCCCCCChh-hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 347 MYEMLVGYPPFYSDDPM-STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 347 lyEmltG~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|+|++|..||.+.... .....+........++ ...++++.+||.+||. ||.+||+ +.||++||||++
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~f~~ 288 (290)
T 1t4h_A 219 MLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred HHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC--CCCCHHHHHHHHHHccCChhhCCC---HHHHhhCccccc
Confidence 99999999999885444 4444444322222222 3678899999999999 9999999 999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=410.31 Aligned_cols=265 Identities=24% Similarity=0.423 Sum_probs=211.4
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc------
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------ 189 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~------ 189 (552)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 56999999999999999999999999999999998653 2345577999999999999999999999985432
Q ss_pred ---------------------------------------------------eEEEEEecCCCCchhhHHhhcCC---CCH
Q 008810 190 ---------------------------------------------------FLYLIMEYLPGGDMMTLLMRKDT---LTE 215 (552)
Q Consensus 190 ---------------------------------------------------~lylVmEy~~gG~L~~~L~~~~~---l~e 215 (552)
++|+|||||+||+|.+++.+... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 48999999999999999977543 566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCC
Q 008810 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295 (552)
Q Consensus 216 ~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (552)
..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+........... +
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~--------------~--- 226 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT--------------P--- 226 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc--------------c---
Confidence 67899999999999999999999999999999999999999999999987654321100000 0
Q ss_pred ccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccc
Q 008810 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH 375 (552)
Q Consensus 296 ~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~ 375 (552)
..........+||+.|+|||++.+..|+.++|||||||++|||++|..|+.. .......+. .
T Consensus 227 ------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~----~ 288 (332)
T 3qd2_B 227 ------------MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVR----N 288 (332)
T ss_dssp -----------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHH----T
T ss_pred ------------ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhh----c
Confidence 0000112356899999999999999999999999999999999999887632 122222222 2
Q ss_pred ccCCc-ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 376 LKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 376 ~~~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
..+|. ....++++++||.+||. ||.+||+ +.||++||||+++
T Consensus 289 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 289 LKFPLLFTQKYPQEHMMVQDMLSPSPTERPE---ATDIIENAIFENL 332 (332)
T ss_dssp TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC---HHHHHHSTTCCCC
T ss_pred cCCCcccccCChhHHHHHHHHccCCCCcCCC---HHHHhhchhhhcC
Confidence 23332 23678899999999999 9999999 9999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=411.67 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=222.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+.|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998664444555677899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||+. |+|.+++. ....+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9997 57777774 4578999999999999999999999999999999999999999999999999999754311
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhhhHHHHHHh
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlGvilyEml 351 (552)
...+||+.|+|||++. +..|+.++|||||||++|||+
T Consensus 208 ----------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 208 ----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp ----------------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence 1467999999999996 467899999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+|.+||.+.+.......+......... ...+++++++||.+||. ||.+||+ +++|++||||...
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 312 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSC
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcccChhhCcC---HHHHhhChhhhcc
Confidence 999999998887777777654322222 23689999999999999 9999999 9999999999653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=421.51 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=212.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec------CC
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ------DD 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------d~ 188 (552)
..+|+++++||+|+||.||+|+++.+|+.||||++.+... ...+|+.+|+.++|||||+++++|. +.
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3469999999999999999999999999999999976431 1346999999999999999998884 33
Q ss_pred ceEEEEEecCCCCchhhHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC-CcEEEcccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLC 263 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~----~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~-g~iKL~DFGla 263 (552)
.++++||||+++ +|..++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.+ +.+||+|||+|
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 468899999976 5655553 35789999999999999999999999999999999999999965 67899999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWS 342 (552)
+.+..... ..+.+||+.|+|||++.+. .|+.++||||
T Consensus 205 ~~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS 242 (420)
T 1j1b_A 205 KQLVRGEP------------------------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWS 242 (420)
T ss_dssp EECCTTCC------------------------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHH
T ss_pred hhcccCCC------------------------------------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHH
Confidence 86532210 1246899999999999874 7999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHHHHhhcc---------------ccccCCc----------ccccChhHHHHHHHHhh
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWR---------------THLKFPE----------EAKLSIEAKDLISKLLC 397 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~e~~dLI~~lL~ 397 (552)
||||+|||++|++||.+.+..+.+.+|+... ..+.+|. ...+++++++||.+||+
T Consensus 243 lG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~ 322 (420)
T 1j1b_A 243 AGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 322 (420)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSC
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhcc
Confidence 9999999999999999998877777766421 1122221 12468999999999999
Q ss_pred -CccccCCCCChhhhhcCCCcCCCChh
Q 008810 398 -NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 398 -dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
||.+|++ +.|+++||||+++.+.
T Consensus 323 ~dP~~R~t---~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 323 YTPTARLT---PLEACAHSFFDELRDP 346 (420)
T ss_dssp SSGGGSCC---HHHHHTSGGGGGGGCT
T ss_pred CChhHCCC---HHHHhCCHhhcccccc
Confidence 9999999 9999999999876554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=418.91 Aligned_cols=258 Identities=31% Similarity=0.448 Sum_probs=212.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec------CC
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ------DD 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------d~ 188 (552)
..+|+++++||+|+||.||+|+++.+++ ||+|++.+.... ..+|+.+|+.++|||||+++++|. +.
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 4579999999999999999999987776 788877654321 236999999999999999999984 34
Q ss_pred ceEEEEEecCCCCchhhHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc-CCCcEEEccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCK 264 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L---~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~-~~g~iKL~DFGlak 264 (552)
.++|+|||||+++.+..+. .....+++..++.|+.||+.||.|||++||+||||||+||||+ .+|++||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 4589999999876444333 2357899999999999999999999999999999999999999 89999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSL 343 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSl 343 (552)
.+..... ..+.+||+.|+|||++.+. .|+.++|||||
T Consensus 191 ~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 228 (394)
T 4e7w_A 191 ILIAGEP------------------------------------------NVSYICSRYYRAPELIFGATNYTTNIDIWST 228 (394)
T ss_dssp ECCTTCC------------------------------------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred cccCCCC------------------------------------------CcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence 7532210 1246899999999999874 59999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhcccc---------------ccCCc----------ccccChhHHHHHHHHhh-
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH---------------LKFPE----------EAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~e~~dLI~~lL~- 397 (552)
||++|||++|.+||.+.+..+.+..|+..... ..+|. ...+++++++||.+||+
T Consensus 229 G~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (394)
T 4e7w_A 229 GCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY 308 (394)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCC
Confidence 99999999999999999888777776642110 11111 12478999999999999
Q ss_pred CccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 398 NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
||.+||+ +.|++.||||+++.|...
T Consensus 309 dP~~R~t---~~e~l~hp~f~~~~~~~~ 333 (394)
T 4e7w_A 309 TPSARLT---AIEALCHPFFDELRTGEA 333 (394)
T ss_dssp SGGGSCC---HHHHHTSGGGSTTTSSCC
T ss_pred ChhhCCC---HHHHhcChhhhhhccccc
Confidence 9999999 999999999999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-49 Score=404.06 Aligned_cols=255 Identities=28% Similarity=0.437 Sum_probs=212.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecC--CceE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD--DEFL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d--~~~l 191 (552)
.++|++++.||+|+||.||+|+++.+|+.||||+++... ...+.+|+.+|..+. ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 578999999999999999999999999999999997432 356889999999997 9999999999987 6789
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~~~~~ 270 (552)
|+||||++|++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999884 489999999999999999999999999999999999999777 89999999998654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 349 (552)
. ....+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 186 ~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 223 (330)
T 3nsz_A 186 E------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223 (330)
T ss_dssp C------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHH
Confidence 0 124579999999999987 679999999999999999
Q ss_pred HhhCCCCCCCC-ChhhHHHHHhhcc-----------cc----------------------ccCCcccccChhHHHHHHHH
Q 008810 350 MLVGYPPFYSD-DPMSTCRKIVNWR-----------TH----------------------LKFPEEAKLSIEAKDLISKL 395 (552)
Q Consensus 350 mltG~~PF~~~-~~~~~~~~i~~~~-----------~~----------------------~~~p~~~~~s~e~~dLI~~l 395 (552)
|++|..||... +..+....+.... .. ........+++++++||.+|
T Consensus 224 ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 303 (330)
T 3nsz_A 224 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303 (330)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTT
T ss_pred HHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHH
Confidence 99999999643 3333322222100 00 11111224799999999999
Q ss_pred hh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 396 LC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 396 L~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
|. ||.+||+ ++||++||||+++.|+
T Consensus 304 L~~dP~~Rpt---a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 304 LRYDHQSRLT---AREAMEHPYFYTVVKD 329 (330)
T ss_dssp SCSSGGGSCC---HHHHHTSGGGTTCC--
T ss_pred hcCCcccCCC---HHHHhcCccHhhhccC
Confidence 99 9999999 9999999999999876
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=414.23 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=205.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~------ 188 (552)
.++|++++.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+|+.++|||||+++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 478999999999999999999999999999999997542 2334556788999999999999999999998754
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 8999998865 6799999999999999999999999999999999999999999999999999975421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
. ....+||+.|+|||++.+ ..|+.++||||||||+
T Consensus 185 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (367)
T 2fst_X 185 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220 (367)
T ss_dssp --------------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHH
Confidence 1 114689999999999987 7799999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccc---------------------cCCc------ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~e~~dLI~~lL~-dp 399 (552)
|||++|.+||.+.+....+..|+...+.. ..|. ...+++++++||.+||+ ||
T Consensus 221 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 300 (367)
T 2fst_X 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 300 (367)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCc
Confidence 99999999999998887777765421110 0010 02468899999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCCChh
Q 008810 400 NQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
.+||+ ++|++.||||+.+...
T Consensus 301 ~~R~t---~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 301 DKRIT---AAQALAHAYFAQYHDP 321 (367)
T ss_dssp GGSCC---HHHHHTSGGGTTTCCG
T ss_pred ccCcC---HHHHhcChhhhhccCC
Confidence 99999 9999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=411.51 Aligned_cols=266 Identities=27% Similarity=0.396 Sum_probs=218.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 187 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||+++++|.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 5789999999999999999999999999999999976542 22334457789999999999999999999986
Q ss_pred -CceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 188 -DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 188 -~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+.+|+||||++| +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4578999999975 66666654 46799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlG 344 (552)
+....... .......+||+.|+|||++.+ ..|+.++||||||
T Consensus 174 ~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 216 (351)
T 3mi9_A 174 FSLAKNSQ-------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216 (351)
T ss_dssp CCCCSSSS-------------------------------------CCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred cccccccc-------------------------------------ccccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence 64321100 001124689999999999986 5689999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhcccccc---CCccc-------------------------ccChhHHHHHHHHh
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK---FPEEA-------------------------KLSIEAKDLISKLL 396 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~---~p~~~-------------------------~~s~e~~dLI~~lL 396 (552)
|++|||++|.+||.+.+.......+......+. +|... ..++++++||.+||
T Consensus 217 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 296 (351)
T 3mi9_A 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296 (351)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHh
Confidence 999999999999999988877777664322221 11100 12788999999999
Q ss_pred h-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 397 C-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 397 ~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
+ ||.+||+ ++|+++||||.+..+
T Consensus 297 ~~dP~~R~t---~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 297 VLDPAQRID---SDDALNHDFFWSDPM 320 (351)
T ss_dssp CSSGGGSCC---HHHHHTSGGGGSSSC
T ss_pred cCChhhCCC---HHHHhCCCCcCCCCC
Confidence 9 9999999 999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=417.10 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=212.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec------
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ------ 186 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------ 186 (552)
...++|++++.||+|+||.||+|+++.+|+.||||++...... ..+|+.+|+.++|||||+++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4567899999999999999999999999999999999755321 236999999999999999999983
Q ss_pred --------------------------------CCceEEEEEecCCCCchhhHHh----hcCCCCHHHHHHHHHHHHHHHH
Q 008810 187 --------------------------------DDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIE 230 (552)
Q Consensus 187 --------------------------------d~~~lylVmEy~~gG~L~~~L~----~~~~l~e~~~~~~~~qi~~aL~ 230 (552)
+..++|+|||||+| +|...+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 44569999999984 7666654 4578999999999999999999
Q ss_pred HHHhCCCcccccCCCCcccc-CCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhh
Q 008810 231 SIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKN 309 (552)
Q Consensus 231 ~LH~~giiHrDLKPeNILl~-~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (552)
|||++||+||||||+|||++ .+|++||+|||+|+.+.....
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-------------------------------------- 197 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-------------------------------------- 197 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--------------------------------------
Confidence 99999999999999999998 689999999999986543210
Q ss_pred ccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccc--------------
Q 008810 310 RRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT-------------- 374 (552)
Q Consensus 310 r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~-------------- 374 (552)
....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+.+..|+....
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 273 (383)
T 3eb0_A 198 ----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY 273 (383)
T ss_dssp ----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC
T ss_pred ----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccc
Confidence 1246789999999999875 599999999999999999999999999988888777764211
Q ss_pred -cccCCc----------ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 375 -HLKFPE----------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 375 -~~~~p~----------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
...+|. ...+++++++||.+||. ||.+||+ +.|+++||||+++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 274 TEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN---PYEAMAHPFFDHLR 329 (383)
T ss_dssp --CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSGGGHHHH
T ss_pred ccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcCHHHHHHH
Confidence 111111 12478899999999999 9999999 99999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=398.37 Aligned_cols=271 Identities=29% Similarity=0.473 Sum_probs=227.1
Q ss_pred hhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
...+.....++|++++.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|+.+|+.++||||++++++|.
T Consensus 10 ~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp CCBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 33444445678999999999999999999999999999999997543 344567889999999999999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
+...+|+||||++||+|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999999998865 46799999999999999999999999999999999999999999999999999763
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccch
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 340 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~Di 340 (552)
..... ......+||+.|+|||++. +..++.++||
T Consensus 167 ~~~~~-----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 205 (302)
T 2j7t_A 167 NLKTL-----------------------------------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 205 (302)
T ss_dssp HHHHH-----------------------------------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHH
T ss_pred ccccc-----------------------------------------cccccccCChhhcCCeeeccccCCCCCCchhhhH
Confidence 21000 0012457999999999994 5678999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||||++|+|++|.+||...+.......+..... ...+....++.++.+||.+||. ||.+||+ +.+|++||||.+
T Consensus 206 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~ 281 (302)
T 2j7t_A 206 WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLEHPFVSS 281 (302)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSCTTTSCC---HHHHTTSTTTTT
T ss_pred HHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-cccCCccccCHHHHHHHHHHcccChhhCCC---HHHHhcChHHhh
Confidence 9999999999999999999888877777665322 2222234789999999999999 9999999 999999999999
Q ss_pred CChhhh
Q 008810 420 VDWARI 425 (552)
Q Consensus 420 i~w~~l 425 (552)
+.|...
T Consensus 282 ~~~~~~ 287 (302)
T 2j7t_A 282 ITSNKA 287 (302)
T ss_dssp CCCCHH
T ss_pred hccchh
Confidence 988654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=405.02 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=205.7
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCceEEEeeeecCCceEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d~~~lylV 194 (552)
++|++++.||+|+||+||+|+++.+|+.||||++......... ......|...+.. .+|||||+++++|.+...+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 6799999999999999999999999999999998764322222 2334445545544 4999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||+ +|+|..++... ..+++..++.++.||+.||.|||+.|||||||||+|||++.+|++||+|||+++......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~--- 211 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG--- 211 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC---
Confidence 9999 77888887654 569999999999999999999999999999999999999999999999999988653221
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
.....+||+.|+|||++.+ .|+.++|||||||++|||++|
T Consensus 212 ---------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g 251 (311)
T 3p1a_A 212 ---------------------------------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACN 251 (311)
T ss_dssp ------------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHT
T ss_pred ---------------------------------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhC
Confidence 0124579999999999876 799999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
..||.+... ...+........+ ...+++++.+||.+||+ ||.+||+ ++||++||||+.
T Consensus 252 ~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 310 (311)
T 3p1a_A 252 MELPHGGEG---WQQLRQGYLPPEF--TAGLSSELRSVLVMMLEPDPKLRAT---AEALLALPVLRQ 310 (311)
T ss_dssp CCCCSSHHH---HHHHTTTCCCHHH--HTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGSC
T ss_pred CCCCCCccH---HHHHhccCCCccc--ccCCCHHHHHHHHHHcCCChhhCcC---HHHHHhCccccC
Confidence 877765432 3334332111112 23689999999999999 9999999 999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=399.44 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=219.2
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+..++|++++.||+|+||.||+|++..++..||+|++...........+.+.+|..++..++|||||++++++.+.+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34567899999999999999999999999999999999766544555667899999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
. .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 167 ~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 206 (294)
T 4eqm_A 167 T----------------------------------------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206 (294)
T ss_dssp ------------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH
T ss_pred c----------------------------------------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 0 012467999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccc-cCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHL-KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~-~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
+|.+||.+.+......+++...... .......+++.+.++|.+||. ||.+||+ ..+.+.+.|.
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~---~~~~l~~~l~ 271 (294)
T 4eqm_A 207 VGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK---TIQEMKDDLS 271 (294)
T ss_dssp HSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS---SHHHHHHHHH
T ss_pred hCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc---cHHHHHHHHH
Confidence 9999999988877666655421110 001123689999999999999 9999996 3344444443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=408.48 Aligned_cols=267 Identities=29% Similarity=0.464 Sum_probs=224.5
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 46789999999999999999999999999999999976532 23334567899999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||||++|++|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence 999999999999888888999999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 180 ---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 180 ---------------------------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp -------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 01245799999999999875 78999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhcccc-----------------ccCCc----------ccccChhHHHHHHHHhh-CccccCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTH-----------------LKFPE----------EAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~----------~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
|.+||.+.+..+....++..... ..+|. ...+++++.+||.+||. ||.+||+
T Consensus 221 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 300 (331)
T 4aaa_A 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300 (331)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC
Confidence 99999998887776665532111 11111 12578999999999999 9999999
Q ss_pred CCChhhhhcCCCcCCCChhhh
Q 008810 405 AKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 405 ~~~a~eil~HpfF~~i~w~~l 425 (552)
+.||++||||+..+|...
T Consensus 301 ---~~ell~hp~f~~~~~~~~ 318 (331)
T 4aaa_A 301 ---CAELLHHDFFQMDGFAER 318 (331)
T ss_dssp ---GGGGGGSHHHHGGGHHHH
T ss_pred ---HHHHhcCchhccCChhhh
Confidence 999999999998777543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=392.46 Aligned_cols=259 Identities=26% Similarity=0.466 Sum_probs=222.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||.||+|+++.+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 579999999999999999999999999999999976542 234567899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||++||+|.+++.....+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++..+......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch---
Confidence 99999999999988888999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEmltG~ 354 (552)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 162 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 205 (276)
T 2yex_A 162 ------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205 (276)
T ss_dssp ------------------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred ------------------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCC
Confidence 01124679999999999988775 78999999999999999999
Q ss_pred CCCCCCChhh-HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 355 PPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 355 ~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
.||.+.+... .+..+... ....+....+++++++||.+||. ||.+||+ ++||++||||+..
T Consensus 206 ~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 268 (276)
T 2yex_A 206 LPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (276)
T ss_dssp CCCSCSCTTSHHHHHHHTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred CCCCCCchHHHHHHHhhhc--ccccCchhhcCHHHHHHHHHHCCCCchhCCC---HHHHhcCccccCh
Confidence 9998765432 33333331 22233345789999999999999 9999999 9999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=407.46 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=216.5
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--CceEEEeeeecCCc
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDE 189 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~~ 189 (552)
.+..++|++++.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|+.+|..+.| |||+++++++.+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 35677899999999999999999987 4689999999986542 33445678999999999976 99999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+||||| +.+|+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++ +|.+||+|||+++.+...
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999999 56899999999989999999999999999999999999999999999999997 689999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----------CCCCCcc
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----------KGYGMEC 338 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----------~~y~~~~ 338 (552)
... ......+||+.|+|||++.+ ..|+.++
T Consensus 161 ~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 161 TTS---------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp ------------------------------------------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred ccc---------------------------------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 100 01124689999999999976 6789999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCC-hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 339 DWWSLGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 339 DiWSlGvilyEmltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
|||||||++|||++|.+||.... .......++.......+|. ..+.++.+||.+||. ||.+||+ +.|+++|||
T Consensus 202 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rpt---~~e~l~hp~ 276 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPY 276 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHH
T ss_pred hHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCCC---HHHHHhCcc
Confidence 99999999999999999998753 3344555554344455554 578899999999999 9999999 999999999
Q ss_pred cCC
Q 008810 417 FDG 419 (552)
Q Consensus 417 F~~ 419 (552)
|+.
T Consensus 277 ~~~ 279 (343)
T 3dbq_A 277 VQI 279 (343)
T ss_dssp HHS
T ss_pred ccc
Confidence 963
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=410.61 Aligned_cols=268 Identities=22% Similarity=0.453 Sum_probs=232.1
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhH--------------HHHHHHHHHHHHhcCC
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--------------VEHVRAERNLLAEVDS 175 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~--------------~~~~~~E~~iL~~l~h 175 (552)
...+..++|++++.||+|+||.||+|++ +|+.||||++.......... .+.+.+|+.+|..++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3445578999999999999999999998 89999999998765432221 2678999999999999
Q ss_pred CceEEEeeeecCCceEEEEEecCCCCchhhH------Hhh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCC
Q 008810 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL------LMR--KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDN 246 (552)
Q Consensus 176 p~Iv~l~~~f~d~~~lylVmEy~~gG~L~~~------L~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeN 246 (552)
|||++++++|.+.+.+|+||||++||+|.++ +.. ...+++..+..++.||+.||.|||+ .||+||||||+|
T Consensus 103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 9999999999999999999999999999998 665 5789999999999999999999999 999999999999
Q ss_pred ccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCCh
Q 008810 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (552)
Q Consensus 247 ILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~AP 326 (552)
||++.+|++||+|||++....... ....+||+.|+||
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~y~aP 219 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDKK-------------------------------------------IKGSRGTYEFMPP 219 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTTE-------------------------------------------ECSSCSCGGGCCG
T ss_pred EEEcCCCcEEEecccccccccccc-------------------------------------------ccCCCCCcCccCc
Confidence 999999999999999998653210 1245799999999
Q ss_pred hhhhcC-CCCC-ccchhhhhHHHHHHhhCCCCCCCCCh-hhHHHHHhhccccccCCcc-----------------cccCh
Q 008810 327 EVLLKK-GYGM-ECDWWSLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEE-----------------AKLSI 386 (552)
Q Consensus 327 Evl~~~-~y~~-~~DiWSlGvilyEmltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~~-----------------~~~s~ 386 (552)
|++.+. .|+. ++|||||||++|||++|.+||.+.+. .+....+... ...+|.. ..+++
T Consensus 220 E~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (348)
T 2pml_X 220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSN 297 (348)
T ss_dssp GGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC--CCCCCCSSSSSTTTTCC--------CCCH
T ss_pred hhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CcCCccchhhhhccccccccccchhhcCH
Confidence 999887 6766 99999999999999999999998776 6677777653 3344421 46899
Q ss_pred hHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhh
Q 008810 387 EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 387 e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~ 427 (552)
++.+||.+||+ ||.+||+ +.|+++||||++++|..+..
T Consensus 298 ~l~~li~~~L~~dP~~Rps---~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 298 EDIDFLKLFLRKNPAERIT---SEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp HHHHHHHHHCCSSGGGSCC---HHHHHTSGGGTTCCHHHHHH
T ss_pred HHHHHHHHHccCChhhCCC---HHHHhcCccccCCCHHHHHH
Confidence 99999999999 9999999 99999999999999988764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=397.51 Aligned_cols=262 Identities=32% Similarity=0.623 Sum_probs=230.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3579999999999999999999999999999999986543 234466788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC---CcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~---g~iKL~DFGlak~~~~~~~ 271 (552)
|||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++........
T Consensus 100 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 9999999999999888899999999999999999999999999999999999999754 4799999999986532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 180 ------------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~ 216 (287)
T 2wei_A 180 ------------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILL 216 (287)
T ss_dssp ------------------------------------------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHH
Confidence 113468999999999875 4999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
+|.+||.+.+..+....+.........|....+++++.+||.+||. ||.+||+ +.+++.||||+..+|+
T Consensus 217 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 217 SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHHHCCC
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC---HHHHhcCHHHhccccC
Confidence 9999999998888888887755555555556789999999999999 9999999 9999999999876653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=409.48 Aligned_cols=265 Identities=29% Similarity=0.456 Sum_probs=216.3
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh--hhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR--RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~--~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
..++|++++.||+|+||.||+|+++.+|+.||||++....... ......+.+|+.+|..++|||||+++++|.+...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3578999999999999999999999999999999997643221 11224578899999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|+||||++| +|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999976 888887654 469999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 349 (552)
. .....+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 167 ~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 205 (346)
T 1ua2_A 167 R-----------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 205 (346)
T ss_dssp C-----------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHH
Confidence 0 0124689999999999976 458999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccc---------cCCc---------------ccccChhHHHHHHHHhh-CccccCC
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHL---------KFPE---------------EAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~---------~~p~---------------~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
|++|.+||.+.+..+.+.+|....... ..|. ...+++++++||.+||. ||.+||+
T Consensus 206 ll~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 285 (346)
T 1ua2_A 206 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285 (346)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC
Confidence 999999999999888888776521111 0110 03567899999999999 9999999
Q ss_pred CCChhhhhcCCCcCCCChh
Q 008810 405 AKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 405 ~~~a~eil~HpfF~~i~w~ 423 (552)
++|+++||||.+..|.
T Consensus 286 ---~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 286 ---ATQALKMKYFSNRPGP 301 (346)
T ss_dssp ---HHHHHTSGGGTSSSCC
T ss_pred ---HHHHhcChhhhcCCCC
Confidence 9999999999886553
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=423.62 Aligned_cols=263 Identities=18% Similarity=0.185 Sum_probs=203.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc--CCCceEEEeeeec------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV--DSNCIVKLYCSFQ------ 186 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~------ 186 (552)
..+|.+++.||+|+||.||+|+++.+|+.||||++.+.........+.+++|..++..+ +|||||+++..|.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999987655566677888886555544 6999988764442
Q ss_pred -CC-----------------ceEEEEEecCCCCchhhHHhhcC-CCCHHHH------HHHHHHHHHHHHHHHhCCCcccc
Q 008810 187 -DD-----------------EFLYLIMEYLPGGDMMTLLMRKD-TLTEDEA------RFYVAETVLAIESIHKHHYIHRD 241 (552)
Q Consensus 187 -d~-----------------~~lylVmEy~~gG~L~~~L~~~~-~l~e~~~------~~~~~qi~~aL~~LH~~giiHrD 241 (552)
.. ..+|||||||+ |+|.+++...+ .+++... ..++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 11 45899999998 89999997643 3443333 45569999999999999999999
Q ss_pred cCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCC
Q 008810 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321 (552)
Q Consensus 242 LKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~ 321 (552)
|||+||||+.+|++||+|||+|+..... .....||+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~~t~ 255 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--------------------------------------------GPASSVPV 255 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE--------------------------------------------EEGGGSCG
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC--------------------------------------------ccCccCCc
Confidence 9999999999999999999999865311 11356789
Q ss_pred CCCChhhhhc--CCCCCccchhhhhHHHHHHhhCCCCCCCCChhhH--HHH---HhhccccccCCcccccChhHHHHHHH
Q 008810 322 DYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST--CRK---IVNWRTHLKFPEEAKLSIEAKDLISK 394 (552)
Q Consensus 322 ~Y~APEvl~~--~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~--~~~---i~~~~~~~~~p~~~~~s~e~~dLI~~ 394 (552)
.|+|||++.+ ..|+.++|||||||++|||++|.+||.+..+... +.. +......+.+|....+++++++||.+
T Consensus 256 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp GGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHH
T ss_pred CCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHH
Confidence 9999999987 7899999999999999999999999988754321 111 11112344455445889999999999
Q ss_pred Hhh-CccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 395 LLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 395 lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
||. ||.+||+ +.++++||||+++.|..-
T Consensus 336 ~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 336 FLNFDRRRRLL---PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp HTCSSTTTCCC---HHHHTTSHHHHHHHHHHH
T ss_pred HcCCChhhCCC---HHHHhcCHHHHHHHHHHh
Confidence 999 9999999 999999999999888643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=406.44 Aligned_cols=262 Identities=32% Similarity=0.613 Sum_probs=217.1
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
++|++++.||+|+||.||+|+++.+|+.||||++.+.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 5699999999999999999999999999999999765421 1223345889999999999999999999998765
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc---EEEcccccccccC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLD 267 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~---iKL~DFGlak~~~ 267 (552)
+|+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987665 9999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhhh
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLG 344 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSlG 344 (552)
... .....+||+.|+|||++. ...|+.++||||||
T Consensus 169 ~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 206 (322)
T 2ycf_A 169 ETS------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206 (322)
T ss_dssp CCH------------------------------------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHH
T ss_pred ccc------------------------------------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHH
Confidence 210 011357999999999985 46789999999999
Q ss_pred HHHHHHhhCCCCCCCCChhh-HHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 345 AIMYEMLVGYPPFYSDDPMS-TCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~-~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|++|+|++|.+||....... ....+... ...++. ...++.++.+||.+||. ||.+||+ ++++++||||++.
T Consensus 207 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 207 VILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHHHSSCSSCSTTCSSCHHHHHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGCCH
T ss_pred HHHHHHHhCCCCCcccchHHHHHHHHHhC--ccccCchhhhhcCHHHHHHHHHHcccCHhhCCC---HHHHhhCcCcCCH
Confidence 99999999999998765443 33334332 222221 24689999999999999 9999999 9999999999998
Q ss_pred Chhhh
Q 008810 421 DWARI 425 (552)
Q Consensus 421 ~w~~l 425 (552)
+|...
T Consensus 282 ~~~~~ 286 (322)
T 2ycf_A 282 DMKRK 286 (322)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 87543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=415.59 Aligned_cols=260 Identities=27% Similarity=0.469 Sum_probs=218.5
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC--CCceEEEeeeecCCc
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--SNCIVKLYCSFQDDE 189 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~~f~d~~ 189 (552)
.+...+|++++.||+|+||.||+|.+.. |+.||||++.+... .....+.+.+|+.+|..+. |||||++++++.+.+
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 3445679999999999999999998765 89999999987543 3445677999999999996 599999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+||||| +.+|+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||++ +|.+||+|||+++.+...
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred EEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9999999 56899999999888999999999999999999999999999999999999996 589999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----------CCCCCcc
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----------KGYGMEC 338 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----------~~y~~~~ 338 (552)
... ......+||+.|+|||++.+ ..|+.++
T Consensus 208 ~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 208 TTS---------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp ---------------------------------------------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred Ccc---------------------------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 100 01124689999999999975 3689999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCC-hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 339 DWWSLGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 339 DiWSlGvilyEmltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
||||||||+|||++|.+||.+.. ....+..++.....+.+|. ..+.++++||.+||. ||.+||+ +.||++|||
T Consensus 249 DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~ 323 (390)
T 2zmd_A 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPY 323 (390)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHH
T ss_pred hHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc--cchHHHHHHHHHHcccChhhCCC---HHHHhhCcC
Confidence 99999999999999999998754 3455666665444455554 568899999999999 9999999 999999999
Q ss_pred cCC
Q 008810 417 FDG 419 (552)
Q Consensus 417 F~~ 419 (552)
|+.
T Consensus 324 ~~~ 326 (390)
T 2zmd_A 324 VQI 326 (390)
T ss_dssp HHS
T ss_pred ccc
Confidence 974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=408.08 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=219.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----c
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 189 (552)
.++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|..++|||||+++++|.+. .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 368999999999999999999999999999999997543 233456788999999999999999999999755 4
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||+. |+|..++.. ..+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++.....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 7999999996 599998854 57999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvily 348 (552)
... .......+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 182 ~~~--------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 223 (364)
T 3qyz_A 182 HDH--------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223 (364)
T ss_dssp GCB--------------------------------------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHH
T ss_pred CCc--------------------------------------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHH
Confidence 100 001124689999999999775 55899999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccc------------------cCCc---------ccccChhHHHHHHHHhh-Ccc
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHL------------------KFPE---------EAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~------------------~~p~---------~~~~s~e~~dLI~~lL~-dp~ 400 (552)
+|++|.+||.+.+..+.+..|+...... .+|. ...+++++.+||.+||. ||.
T Consensus 224 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 303 (364)
T 3qyz_A 224 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 303 (364)
T ss_dssp HHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTT
T ss_pred HHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999998888777775321110 0000 02578999999999999 999
Q ss_pred ccCCCCChhhhhcCCCcCCC
Q 008810 401 QRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF~~i 420 (552)
+||+ +.|+++||||+..
T Consensus 304 ~R~t---~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 304 KRIE---VEQALAHPYLEQY 320 (364)
T ss_dssp TSCC---HHHHHTSGGGTTT
T ss_pred hCCC---HHHHhcCcchhhc
Confidence 9999 9999999999876
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=392.88 Aligned_cols=259 Identities=28% Similarity=0.461 Sum_probs=205.0
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
++..++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+..+..+++.++||||++++++|.+...+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4667899999999999999999999999999999999976532 223334455566668888999999999999999999
Q ss_pred EEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCccccCCCcEEEccccccccc
Q 008810 192 YLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
|+||||++ |+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++++||+|||+++..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999997 577776643 56899999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhh----hcCCCCCccchhh
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGMECDWWS 342 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl----~~~~y~~~~DiWS 342 (552)
..... ....+||+.|+|||++ .+..++.++||||
T Consensus 161 ~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~s 198 (290)
T 3fme_A 161 VDDVA------------------------------------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198 (290)
T ss_dssp ---------------------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHH
T ss_pred ccccc------------------------------------------ccccCCCccccChhhcChhhcCcCCCcHHHHHH
Confidence 32210 1134799999999997 4567899999999
Q ss_pred hhHHHHHHhhCCCCCCC-CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 343 LGAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 343 lGvilyEmltG~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||++|+|++|..||.. .........+... .....+ ...+++++.+||.+||. ||.+||+ +.|+++||||+.
T Consensus 199 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt---~~e~l~hp~f~~ 272 (290)
T 3fme_A 199 LGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQLP-ADKFSAEFVDFTSQCLKKNSKERPT---YPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHH
T ss_pred HHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCCCcc-cccCCHHHHHHHHHHhhcChhhCcC---HHHHHhCccccc
Confidence 99999999999999986 3444444444442 222222 23689999999999999 9999999 999999999964
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=416.59 Aligned_cols=263 Identities=25% Similarity=0.393 Sum_probs=197.7
Q ss_pred CCeeE-EeeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee--cCCce
Q 008810 116 DDFEL-LTMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF--QDDEF 190 (552)
Q Consensus 116 ~~f~~-~~~IG~G~fG~V~l~~~k--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f--~d~~~ 190 (552)
+.|++ .++||+|+||.||+|+++ .+++.||||++..... ...+.+|+.+|+.++|||||+++++| .+...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34665 457999999999999976 4789999999975432 23577899999999999999999999 56789
Q ss_pred EEEEEecCCCCchhhHHhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc----cCCCcEEE
Q 008810 191 LYLIMEYLPGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRL 257 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl----~~~g~iKL 257 (552)
+||||||+. |+|..++... ..+++..++.++.||+.||.|||++|||||||||+|||| +.+|++||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 5888877532 249999999999999999999999999999999999999 77899999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCC
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGM 336 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~ 336 (552)
+|||+|+.+....... ......+||+.|+|||++.+. .|+.
T Consensus 174 ~Dfg~a~~~~~~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 215 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTK 215 (405)
T ss_dssp CCTTCCC------------------------------------------------------CCCTTCCHHHHTTCCSCCH
T ss_pred EECCCceecCCCCccc--------------------------------------ccCCCceecCcccCchhhcCCCcccc
Confidence 9999998654221000 011256899999999999874 5999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChh---------hHHHHHhhccccc---------cCCcc-----------------
Q 008810 337 ECDWWSLGAIMYEMLVGYPPFYSDDPM---------STCRKIVNWRTHL---------KFPEE----------------- 381 (552)
Q Consensus 337 ~~DiWSlGvilyEmltG~~PF~~~~~~---------~~~~~i~~~~~~~---------~~p~~----------------- 381 (552)
++||||||||+|||++|.+||.+.... +.+..|+..-... .+|..
T Consensus 216 ~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (405)
T 3rgf_A 216 AIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 295 (405)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCH
T ss_pred hhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchh
Confidence 999999999999999999999876542 3444443311100 01100
Q ss_pred --------cccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 382 --------AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 382 --------~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
...++++.+||.+||+ ||.+||+ ++||++||||.+..|...
T Consensus 296 ~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t---a~e~L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT---SEQAMQDPYFLEDPLPTS 345 (405)
T ss_dssp HHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGTSSSCCCS
T ss_pred hhhHhhcCCCCCHHHHHHHHHHccCCcccCCC---HHHHhcChhhccCCCCcc
Confidence 0127899999999999 9999999 999999999998766443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=407.85 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=218.2
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE---
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL--- 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l--- 191 (552)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 468999999999999999999999999999999997643 2334456788999999999999999999999887755
Q ss_pred ---EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 192 ---YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 192 ---ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
|+||||+. |+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999996 68888773 4599999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
. ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 197 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (371)
T 4exu_A 197 E--------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232 (371)
T ss_dssp -----------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred C--------------------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHH
Confidence 1 114679999999999987 7899999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccc---------------------cCCc------ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~e~~dLI~~lL~-dp 399 (552)
|+|++|.+||.+.+..+.+..++...... ..+. ...+++++++||.+||+ ||
T Consensus 233 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (371)
T 4exu_A 233 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 312 (371)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCCh
Confidence 99999999999998887777765421110 0000 12568999999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCCChhh
Q 008810 400 NQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
.+||+ +.|+++||||+.+....
T Consensus 313 ~~Rpt---~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 313 DKRLT---AAQALTHPFFEPFRDPE 334 (371)
T ss_dssp TTSCC---HHHHHTSGGGTTTCCGG
T ss_pred hhcCC---HHHHhcCcccccCCCcc
Confidence 99999 99999999999876544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=424.64 Aligned_cols=249 Identities=15% Similarity=0.204 Sum_probs=206.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHH---HHHhcCCCceEEEe-------ee
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN---LLAEVDSNCIVKLY-------CS 184 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~---iL~~l~hp~Iv~l~-------~~ 184 (552)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999998765555667788999994 55566899999998 55
Q ss_pred ecCCc-----------------eEEEEEecCCCCchhhHHhhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCccc
Q 008810 185 FQDDE-----------------FLYLIMEYLPGGDMMTLLMRKDTLTE-------DEARFYVAETVLAIESIHKHHYIHR 240 (552)
Q Consensus 185 f~d~~-----------------~lylVmEy~~gG~L~~~L~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~giiHr 240 (552)
+.+.+ ..||||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++|||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 55443 389999999 7899999987666666 7777899999999999999999999
Q ss_pred ccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccC
Q 008810 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (552)
Q Consensus 241 DLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT 320 (552)
||||+||||+.+|++||+|||+|+..... ..+.+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~g- 265 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGAR--------------------------------------------VVSSVS- 265 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCE--------------------------------------------EECCCC-
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCc--------------------------------------------ccCCCC-
Confidence 99999999999999999999999853210 124678
Q ss_pred CCCCChhhhhcC-----------CCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHH
Q 008810 321 PDYIAPEVLLKK-----------GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAK 389 (552)
Q Consensus 321 ~~Y~APEvl~~~-----------~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~ 389 (552)
+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.......+.. . ...++++++
T Consensus 266 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~------~--~~~~~~~~~ 337 (377)
T 3byv_A 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR------S--CKNIPQPVR 337 (377)
T ss_dssp TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS------S--CCCCCHHHH
T ss_pred cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh------h--ccCCCHHHH
Confidence 999999999988 899999999999999999999999987765554433332 1 136899999
Q ss_pred HHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 390 dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+||.+||. ||.+||+ +.|+++||||+++
T Consensus 338 ~li~~~L~~dp~~Rpt---~~e~l~hp~f~~~ 366 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLL---PLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHTCSSGGGCCC---HHHHHTSHHHHHH
T ss_pred HHHHHHcCCCchhCCC---HHHHhhChHHHHH
Confidence 99999999 9999999 9999999999765
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=416.87 Aligned_cols=256 Identities=24% Similarity=0.435 Sum_probs=215.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc------CCCceEEEeeeec
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV------DSNCIVKLYCSFQ 186 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l------~hp~Iv~l~~~f~ 186 (552)
....+|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+|..+ +|+||++++++|.
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 34567999999999999999999999999999999997643 2334577788888877 6779999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc--EEEccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGL 262 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~--iKL~DFGl 262 (552)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++|||||||||+||||+.+|. +||+|||+
T Consensus 170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999995 68999887653 5999999999999999999999999999999999999999987 99999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
|+..... ..+.+||+.|+|||++.+..|+.++||||
T Consensus 249 a~~~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 284 (429)
T 3kvw_A 249 SCYEHQR--------------------------------------------VYTYIQSRFYRAPEVILGARYGMPIDMWS 284 (429)
T ss_dssp CEETTCC--------------------------------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHH
T ss_pred ceecCCc--------------------------------------------ccccCCCCCccChHHHhCCCCCchHHHHh
Confidence 9754321 12468999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHHHHhhccccc------------------cCC-------------------------
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL------------------KFP------------------------- 379 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~------------------~~p------------------------- 379 (552)
||||+|||++|.+||.+.+..+.+..++...... .+|
T Consensus 285 lG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (429)
T 3kvw_A 285 LGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKL 364 (429)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCE
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhc
Confidence 9999999999999999998887776665321000 000
Q ss_pred ---c---------ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 380 ---E---------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 380 ---~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
. ....++++++||.+||+ ||.+||+ ++|+++||||+..
T Consensus 365 ~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt---a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 365 RGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT---PGQALRHPWLRRR 415 (429)
T ss_dssp ECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSTTTC--
T ss_pred cCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC---HHHHhCChhhccC
Confidence 0 01237889999999999 9999999 9999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=400.79 Aligned_cols=274 Identities=26% Similarity=0.437 Sum_probs=221.2
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD----- 188 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~----- 188 (552)
..++|++.+.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4678999999999999999999999999999999996432 233455688999999999999999999887654
Q ss_pred ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
..+|+||||+. |+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+..
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 68999999996 689988865 6799999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
........ ..........+||+.|+|||++.+ ..++.++|||||||++
T Consensus 165 ~~~~~~~~-------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 213 (353)
T 2b9h_A 165 SAADNSEP-------------------------------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213 (353)
T ss_dssp ----------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHH
T ss_pred ccccccCc-------------------------------cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHH
Confidence 21100000 000001224689999999999875 7799999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccc----------------------cCCc------ccccChhHHHHHHHHhh-C
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL----------------------KFPE------EAKLSIEAKDLISKLLC-N 398 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~----------------------~~p~------~~~~s~e~~dLI~~lL~-d 398 (552)
|+|++|.+||.+.+.......+....... .++. ...+++++++||.+||. |
T Consensus 214 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 99999999999988766655554311110 0110 13688999999999999 9
Q ss_pred ccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 399 VNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 399 p~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
|.+||+ +.||++||||+.+.|...
T Consensus 294 P~~Rpt---~~ell~hp~~~~~~~~~~ 317 (353)
T 2b9h_A 294 PAKRIT---AKEALEHPYLQTYHDPND 317 (353)
T ss_dssp GGGSCC---HHHHHTSGGGTTTCCTTS
T ss_pred cccCCC---HHHHhcCccccccCCccc
Confidence 999999 999999999999877553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=390.27 Aligned_cols=251 Identities=21% Similarity=0.338 Sum_probs=211.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lyl 193 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|..++..+ +|||||+++++|.+.+.+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3579999999999999999999999999999999986532 233455678899999988 99999999999999999999
Q ss_pred EEecCCCCchhhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC----------------
Q 008810 194 IMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---------------- 253 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---------------- 253 (552)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999765 6799999999999999999999999999999999999998544
Q ss_pred ---cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh
Q 008810 254 ---HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (552)
Q Consensus 254 ---~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~ 330 (552)
.+||+|||++...... ...+||+.|+|||++.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~---------------------------------------------~~~~gt~~y~aPE~~~ 203 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRISSP---------------------------------------------QVEEGDSRFLANEVLQ 203 (289)
T ss_dssp -CCCEEECCCTTCEETTCS---------------------------------------------CCCCCCGGGCCHHHHT
T ss_pred CceEEEEcccccccccCCc---------------------------------------------cccCCCccccChhHhc
Confidence 7999999999865321 1346999999999998
Q ss_pred cC-CCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCCh
Q 008810 331 KK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (552)
Q Consensus 331 ~~-~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a 408 (552)
+. .++.++|||||||++|+|++|.+||..... ...+... ....+| ..+++++.+||.+||. ||.+||+ +
T Consensus 204 ~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~ 274 (289)
T 1x8b_A 204 ENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQG-RLPRIP--QVLSQEFTELLKVMIHPDPERRPS---A 274 (289)
T ss_dssp TCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTT-CCCCCS--SCCCHHHHHHHHHHTCSSGGGSCC---H
T ss_pred CCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcC-CCCCCC--cccCHHHHHHHHHHhCCCcccCCC---H
Confidence 75 667899999999999999999998865432 3334432 122333 3689999999999999 9999999 9
Q ss_pred hhhhcCCCcCCC
Q 008810 409 DEIKVHPWFDGV 420 (552)
Q Consensus 409 ~eil~HpfF~~i 420 (552)
.++++||||.+.
T Consensus 275 ~~ll~h~~~~~~ 286 (289)
T 1x8b_A 275 MALVKHSVLLSA 286 (289)
T ss_dssp HHHHTCTTC---
T ss_pred HHHhhChHhhhh
Confidence 999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=397.13 Aligned_cols=268 Identities=30% Similarity=0.490 Sum_probs=221.8
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeec
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ 186 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 186 (552)
+.......++|++++.||+|+||.||+|++..+|+.||||++.... ...+.+.+|+.++..+ +||||++++++|.
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3344556789999999999999999999999999999999997542 2345688999999998 8999999999997
Q ss_pred C------CceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEc
Q 008810 187 D------DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (552)
Q Consensus 187 d------~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~ 258 (552)
+ ...+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 6 56899999999999999999764 579999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCC
Q 008810 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKG 333 (552)
Q Consensus 259 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~ 333 (552)
|||++..+..... .....+||+.|+|||++. +..
T Consensus 172 Dfg~~~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 210 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDAT 210 (326)
T ss_dssp CCTTTC------------------------------------------------------CCGGGCCHHHHC--------
T ss_pred eCcCceecCcCcc-----------------------------------------ccccccCCccccChhhhccccccCcC
Confidence 9999876532100 012457999999999997 567
Q ss_pred CCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 334 y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
++.++|||||||++|+|++|.+||.+.+.......+...... ......++.++++||.+||. ||.+||+ +.+|+
T Consensus 211 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll 285 (326)
T 2x7f_A 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPA---TEQLM 285 (326)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCC---HHHHH
T ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--cCCccccCHHHHHHHHHHhccChhhCCC---HHHHh
Confidence 899999999999999999999999988877776666543221 11224689999999999999 9999999 99999
Q ss_pred cCCCcCCCChhhh
Q 008810 413 VHPWFDGVDWARI 425 (552)
Q Consensus 413 ~HpfF~~i~w~~l 425 (552)
+||||++..+...
T Consensus 286 ~hp~~~~~~~~~~ 298 (326)
T 2x7f_A 286 KHPFIRDQPNERQ 298 (326)
T ss_dssp TSHHHHCCTTHHH
T ss_pred hChHHhhCccccc
Confidence 9999998876553
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=394.80 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=215.0
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
....+..++|++.+.||+|+||.||+|++ +|..||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34557788999999999999999999976 588999999976542 344566789999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCccccCCCcEEEcccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~~---l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
..+|+||||++||+|.+++..... +++..+..++.||+.||.|||+.| ||||||||+|||++.+|.+||+|||++
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999976553 999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+....... .....+||+.|+|||++.+..++.++|||||
T Consensus 187 ~~~~~~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (309)
T 3p86_A 187 RLKASTFL-----------------------------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225 (309)
T ss_dssp --------------------------------------------------------CCTTSCHHHHTTCCCCTTHHHHHH
T ss_pred cccccccc-----------------------------------------ccccCCCCccccChhhhcCCCCCchhhHHHH
Confidence 75422110 0124689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||++|||++|..||.+.+..+....+........+|. .+++++.+||.+||. ||.+||+ +.+|++
T Consensus 226 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps---~~~ll~ 291 (309)
T 3p86_A 226 GVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR--NLNPQVAAIIEGCWTNEPWKRPS---FATIMD 291 (309)
T ss_dssp HHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 9999999999999999988888777765444555554 799999999999999 9999999 888875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=409.80 Aligned_cols=261 Identities=21% Similarity=0.358 Sum_probs=212.8
Q ss_pred hhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC--------CCce
Q 008810 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--------SNCI 178 (552)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--------hp~I 178 (552)
.+....+..++|++++.||+|+||.||+|++..+|+.||||++.+.. ...+.+.+|+.+|+.+. ||||
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 34444555689999999999999999999999999999999997542 34456888999999885 7889
Q ss_pred EEEeeeec----CCceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCccccC
Q 008810 179 VKLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDK 251 (552)
Q Consensus 179 v~l~~~f~----d~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~~ 251 (552)
++++++|. +...+||||||+ +|+|...+... ..+++..++.++.||+.||.|||++ |||||||||+||||+.
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 99999998 677899999999 66666666544 5799999999999999999999998 9999999999999998
Q ss_pred CC-------------------------------------------------cEEEcccccccccCCCCcccccccccCCC
Q 008810 252 YG-------------------------------------------------HLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282 (552)
Q Consensus 252 ~g-------------------------------------------------~iKL~DFGlak~~~~~~~~~~~~~~~~~~ 282 (552)
+| .+||+|||+++.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------------- 249 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------------- 249 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-------------
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-------------
Confidence 76 7999999999865321
Q ss_pred CCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCCh
Q 008810 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362 (552)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~ 362 (552)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 250 -------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 250 -------------------------------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298 (397)
T ss_dssp -------------------------------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred -------------------------------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcc
Confidence 1145799999999999999999999999999999999999999987552
Q ss_pred ------hhHHHHHhhcccccc--------------------------------------CCcccccChhHHHHHHHHhh-
Q 008810 363 ------MSTCRKIVNWRTHLK--------------------------------------FPEEAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 363 ------~~~~~~i~~~~~~~~--------------------------------------~p~~~~~s~e~~dLI~~lL~- 397 (552)
......+.......+ ++....+++++++||.+||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 378 (397)
T 1wak_A 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLEL 378 (397)
T ss_dssp SSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhcc
Confidence 222222222111100 00012456789999999999
Q ss_pred CccccCCCCChhhhhcCCCcCC
Q 008810 398 NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||.+||+ +.||++||||++
T Consensus 379 dP~~Rpt---~~e~l~hp~~~~ 397 (397)
T 1wak_A 379 IPEKRAT---AAECLRHPWLNS 397 (397)
T ss_dssp SGGGSCC---HHHHHTSGGGGC
T ss_pred ChhhcCC---HHHHhhCccccC
Confidence 9999999 999999999974
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=401.18 Aligned_cols=281 Identities=19% Similarity=0.290 Sum_probs=215.0
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHV----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~----~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
..+..++|++++.||+|+||.||+|+++.+|+. ||+|++.... .......+.+|+.++..++|||||+++++|.
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP 85 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence 446778999999999999999999999988887 5666654332 1222345678999999999999999999886
Q ss_pred CCceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 86 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp -BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred -CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45689999999999999999764 6899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
+...... .......||+.|+|||++.+..|+.++|||||||
T Consensus 165 ~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (325)
T 3kex_A 165 LPPDDKQ---------------------------------------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205 (325)
T ss_dssp SCCCTTC---------------------------------------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCccccc---------------------------------------ccccCCCCcccccChHHhccCCCChhhHhHHhHH
Confidence 6432110 0012457889999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc----------
Q 008810 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV---------- 413 (552)
Q Consensus 346 ilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~---------- 413 (552)
++|||++ |.+||.+....+....+... .....|. .+++++.+||.+||. ||.+||+ +.+|++
T Consensus 206 ~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps---~~el~~~l~~~~~~~~ 279 (325)
T 3kex_A 206 TVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQ--ICTIDVYMVMVKCWMIDENIRPT---FKELANEFTRMARDPP 279 (325)
T ss_dssp HHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCCT--TBCTTTTHHHHHHTCSCTTTSCC---HHHHHHHHHHHTTSHH
T ss_pred HHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCCC--cCcHHHHHHHHHHcCCChhhCcC---HHHHHHHHHHHHhcch
Confidence 9999999 99999998877776666542 2334443 689999999999999 9999998 666654
Q ss_pred ---------------CCCcCCCChhhhhh--cCCCCccccCCc
Q 008810 414 ---------------HPWFDGVDWARIYQ--MEAAFIPEVNDE 439 (552)
Q Consensus 414 ---------------HpfF~~i~w~~l~~--~~~pf~P~~~~~ 439 (552)
+|.+.+++|..+.. +++||.|..+.+
T Consensus 280 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~d~e 322 (325)
T 3kex_A 280 RYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLE 322 (325)
T ss_dssp HHBCCCSSSSCCCBCCCCCCC----------------------
T ss_pred hhhccccCCCCCCCCCCccccchhhcccccccchhccCCcccc
Confidence 56677777766653 456666655443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=393.79 Aligned_cols=261 Identities=25% Similarity=0.440 Sum_probs=221.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcCCCceEEEeeee--cCCceE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSF--QDDEFL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f--~d~~~l 191 (552)
.++|++++.||+|+||.||+|.++.+|+.||+|++.+..... ......+.+|+.+|+.++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999998765432 34567799999999999999999999998 455689
Q ss_pred EEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 192 YLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
|+||||+++| |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999877 6666654 467999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC--CCCccchhhhhHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIM 347 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~--y~~~~DiWSlGvil 347 (552)
... .......||+.|+|||++.+.. ++.++|||||||++
T Consensus 163 ~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 163 AAD---------------------------------------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp CSS---------------------------------------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred ccc---------------------------------------cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 100 0112457999999999998754 37899999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
|||++|..||.+.+..+....+... ...+|. .+++++.+||.+||. ||.+||+ +.||++||||+....
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~--~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 204 YNITTGLYPFEGDNIYKLFENIGKG--SYAIPG--DCGPPLSDLLKGMLEYEPAKRFS---IRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCS--SSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSHHHHSCCC
T ss_pred HHHHhCCCCCCCchHHHHHHHHhcC--CCCCCC--ccCHHHHHHHHHHccCChhhCCC---HHHHhcCcccccCCC
Confidence 9999999999998888888877763 344553 689999999999999 9999999 999999999987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=399.44 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=217.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF---- 190 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~---- 190 (552)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 468999999999999999999999999999999997643 233445678899999999999999999999987654
Q ss_pred --EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 191 --LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 191 --lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+|+||||+. |+|..++. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 599999996 68888874 3599999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil 347 (552)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 179 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il 214 (353)
T 3coi_A 179 E--------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214 (353)
T ss_dssp -------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred C--------------------------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHH
Confidence 1 113579999999999987 7799999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhcccc--------------------------ccCCc-ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTH--------------------------LKFPE-EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~--------------------------~~~p~-~~~~s~e~~dLI~~lL~-dp 399 (552)
|+|++|.+||.+.+..+.+..++..... ..++. ...+++++++||.+||+ ||
T Consensus 215 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 294 (353)
T 3coi_A 215 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 294 (353)
T ss_dssp HHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCc
Confidence 9999999999998877776666532110 00110 13578999999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCCChhh
Q 008810 400 NQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
.+||+ +.+++.||||+.+.+..
T Consensus 295 ~~Rpt---~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 295 DKRLT---AAQALTHPFFEPFRDPE 316 (353)
T ss_dssp TTSCC---HHHHHTSGGGTTTCCGG
T ss_pred ccCCC---HHHHhcCcchhhccCcc
Confidence 99999 99999999999876543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=393.28 Aligned_cols=263 Identities=31% Similarity=0.508 Sum_probs=222.5
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||+|+||.||+|.++.+|+.||||++.... ....+.+|+.+|..++||||+++++++.+...+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4578999999999999999999999999999999997643 23568889999999999999999999999999999
Q ss_pred EEecCCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||++||+|.+++. ....+++..+..++.+|+.||.|||+.||+||||||+|||++.+|++||+|||++..+.....
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 999999999999986 457899999999999999999999999999999999999999999999999999986532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 181 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 220 (314)
T 3com_A 181 ----------------------------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220 (314)
T ss_dssp ----------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh
Confidence 0124579999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~ 426 (552)
|.+||...+.......+... ....+.....++.++.+||.+||. ||.+||+ +.+++.||||++..+....
T Consensus 221 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 221 GKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp SSCTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHTCCCGGGG
T ss_pred CCCCCCCCChHHHHHHHhcC-CCcccCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhcCCcchHH
Confidence 99999988776665554432 222233334689999999999999 9999999 9999999999988766544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=405.73 Aligned_cols=259 Identities=31% Similarity=0.452 Sum_probs=202.5
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.... ......+...+..++|||||+++++|.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 57899999999999999999999999999999998765322 224566777888899999999999986432
Q ss_pred --eEEEEEecCCCCchh---hHHhhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCcccccCCCCccccC-CCcEEEcccc
Q 008810 190 --FLYLIMEYLPGGDMM---TLLMRKDTLTEDEARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLDK-YGHLRLSDFG 261 (552)
Q Consensus 190 --~lylVmEy~~gG~L~---~~L~~~~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKPeNILl~~-~g~iKL~DFG 261 (552)
++|+||||++|+.+. .++.....+++..++.++.|++.||.||| +.|||||||||+|||++. +|++||+|||
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 98 DIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp CEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred ceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 489999999875332 23345678999999999999999999999 999999999999999996 8999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-CCCccch
Q 008810 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDW 340 (552)
Q Consensus 262 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-y~~~~Di 340 (552)
+++.+..... ....+||+.|+|||++.+.. |+.++||
T Consensus 178 ~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di 215 (360)
T 3e3p_A 178 SAKKLSPSEP------------------------------------------NVAYICSRYYRAPELIFGNQHYTTAVDI 215 (360)
T ss_dssp TCBCCCTTSC------------------------------------------CCSTTSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred CceecCCCCC------------------------------------------cccccCCcceeCHHHHcCCCCCCcHHHH
Confidence 9986542210 12457999999999997654 8999999
Q ss_pred hhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccc---------------c------------CCc-ccccChhHHHHH
Q 008810 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------K------------FPE-EAKLSIEAKDLI 392 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~---------------~------------~p~-~~~~s~e~~dLI 392 (552)
|||||++|||++|.+||.+.+....+..++...... . ++. ....++++++||
T Consensus 216 ~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (360)
T 3e3p_A 216 WSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLL 295 (360)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHH
Confidence 999999999999999999998888777776421100 0 000 012577999999
Q ss_pred HHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 393 SKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 393 ~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
.+||+ ||.+||+ +.|+++||||+++.+
T Consensus 296 ~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 296 SALLQYLPEERMK---PYEALCHPYFDELHD 323 (360)
T ss_dssp HHHTCSSGGGSCC---HHHHTTSGGGGGGGC
T ss_pred HHHhccCccccCC---HHHHhcCccccccCC
Confidence 99999 9999999 999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=394.55 Aligned_cols=263 Identities=27% Similarity=0.453 Sum_probs=219.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCceEEEeeeec----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQ---- 186 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k-~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~---- 186 (552)
.++|++++.||+|+||.||+|++. .+|+.||||++...... ......+.+|+.+++.+ +||||++++++|.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 478999999999999999999995 67899999999765321 11222456677777666 8999999999987
Q ss_pred -CCceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 187 -DDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 187 -d~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
+...+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 6678999999997 6999998764 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+...... .....+||+.|+|||++.+..|+.++|||||
T Consensus 168 ~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (326)
T 1blx_A 168 RIYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 205 (326)
T ss_dssp CCCCGGG------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccCCC------------------------------------------CccccccccceeCHHHHhcCCCCcchhHHHH
Confidence 7543110 0124679999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhcc---------ccccCCc--------------ccccChhHHHHHHHHhh-Cc
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWR---------THLKFPE--------------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~---------~~~~~p~--------------~~~~s~e~~dLI~~lL~-dp 399 (552)
||++|+|++|.+||.+.+......+++... .....+. ...++.++++||.+||. ||
T Consensus 206 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (326)
T 1blx_A 206 GCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285 (326)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSST
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCc
Confidence 999999999999999998888777776421 1111000 13578999999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCCChhh
Q 008810 400 NQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
.+||+ +.|++.||||++++|..
T Consensus 286 ~~Rpt---~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 286 AKRIS---AYSALSHPYFQDLERCK 307 (326)
T ss_dssp TTSCC---HHHHHTSGGGTTCCCCC
T ss_pred ccCCC---HHHHhcCccccccchhh
Confidence 99999 99999999999987643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=395.85 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=217.6
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEE-cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC------ceEEE
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN------CIVKL 181 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~-k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp------~Iv~l 181 (552)
+...+..++|++++.||+|+||.||+|.+ +.+|+.||||+++... ...+.+.+|+.+++.++|+ +|+++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 34455678999999999999999999998 5689999999997542 3345688899999888665 59999
Q ss_pred eeeecCCceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC--------
Q 008810 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------- 251 (552)
Q Consensus 182 ~~~f~d~~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-------- 251 (552)
+++|.+.+.+|+||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 899999997765 6899999999999999999999999999999999999987
Q ss_pred -----------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccC
Q 008810 252 -----------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (552)
Q Consensus 252 -----------~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT 320 (552)
++++||+|||+++..... ....+||
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~gt 197 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH--------------------------------------------HSTLVST 197 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC--------------------------------------------CCSSCSC
T ss_pred CccccccccccCCCceEeeCcccccCccc--------------------------------------------cccccCC
Confidence 678999999999754321 1146899
Q ss_pred CCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccccc-------------------C---
Q 008810 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK-------------------F--- 378 (552)
Q Consensus 321 ~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~-------------------~--- 378 (552)
+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+......++ +
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
T 1z57_A 198 RHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277 (339)
T ss_dssp GGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTT
T ss_pred ccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccccccc
Confidence 999999999999999999999999999999999999998887665544432111000 0
Q ss_pred ------------------CcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 379 ------------------PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 379 ------------------p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
......++++.+||.+||. ||.+||+ +.||++||||+.+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 335 (339)
T 1z57_A 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT---LREALKHPFFDLL 335 (339)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGG
T ss_pred ccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC---HHHHhcCHHHHHH
Confidence 0011346789999999999 9999999 9999999999865
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=394.01 Aligned_cols=274 Identities=26% Similarity=0.430 Sum_probs=201.5
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..+..++|++++.||+|+||.||+|++..+|+.||||++..... ....+.+.+|+.++..++||||++++++|.+.+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 45678899999999999999999999999999999999875432 2345568889999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMR--------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 341 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiW 341 (552)
+..+....... +.......+||+.|+|||++.+ ..++.++|||
T Consensus 168 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 211 (303)
T 2vwi_A 168 SAFLATGGDIT------------------------------------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211 (303)
T ss_dssp HHHCC---------------------------------------------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred hheeccCCCcc------------------------------------chhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence 98654221000 0001124689999999999986 6799999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccc-ccC-----CcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH-LKF-----PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 342 SlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~-~~~-----p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
||||++|||++|..||.+.+.............. +.. .....++.++++||.+||. ||.+||+ +.+|++|
T Consensus 212 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h 288 (303)
T 2vwi_A 212 SFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRH 288 (303)
T ss_dssp HHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC---HHHHHTS
T ss_pred HHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC---HHHHhhC
Confidence 9999999999999999988777666555432111 100 0113578899999999999 9999999 9999999
Q ss_pred CCcCCCChhhh
Q 008810 415 PWFDGVDWARI 425 (552)
Q Consensus 415 pfF~~i~w~~l 425 (552)
|||+...+..+
T Consensus 289 ~~~~~~~~~~~ 299 (303)
T 2vwi_A 289 KFFQKAKNKEF 299 (303)
T ss_dssp TTC--------
T ss_pred hhhhcCCCCcc
Confidence 99998776544
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=396.93 Aligned_cols=276 Identities=22% Similarity=0.337 Sum_probs=206.8
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeee
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 184 (552)
+....+..++|++++.||+|+||.||+|+++.++. .||||+++.... .....+.+.+|+.+++.++|||||+++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 34556778899999999999999999999887765 899999976532 34456789999999999999999999999
Q ss_pred ecCCceE------EEEEecCCCCchhhHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC
Q 008810 185 FQDDEFL------YLIMEYLPGGDMMTLLMRKD------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (552)
Q Consensus 185 f~d~~~l------ylVmEy~~gG~L~~~L~~~~------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~ 252 (552)
+.+.... |+||||++||+|..++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9887655 99999999999999996543 69999999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC
Q 008810 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (552)
Q Consensus 253 g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~ 332 (552)
|.+||+|||+++......... ......||+.|+|||++.+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 214 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYR---------------------------------------QGCASKLPVKWLALESLADN 214 (323)
T ss_dssp SCEEECCCCC--------------------------------------------------------CCGGGCCHHHHHHC
T ss_pred CCEEEeecccccccccccccc---------------------------------------ccccccCcccccCchhhcCC
Confidence 999999999998653321100 01134678899999999999
Q ss_pred CCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC----
Q 008810 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---- 406 (552)
Q Consensus 333 ~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~---- 406 (552)
.|+.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||+..
T Consensus 215 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 215 LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQP--PECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCCC--CccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999 999999998888888777532 23333 3789999999999999 999999843
Q ss_pred ChhhhhcCCCcCCCChhhhh
Q 008810 407 GADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 407 ~a~eil~HpfF~~i~w~~l~ 426 (552)
.+++++.|||+....++.|.
T Consensus 292 ~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 292 ELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp HHHHHHHC------------
T ss_pred HHHHHHHHhhhcCCCCCCCC
Confidence 26778999999887766554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=395.74 Aligned_cols=256 Identities=25% Similarity=0.425 Sum_probs=213.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc--e
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--F 190 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~--~ 190 (552)
+..++|++.+.||+|+||.||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||++++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 456789999999999999999999999999999999986543 233566789999999999999999999988655 8
Q ss_pred EEEEEecCCCCchhhHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc----cCCCcEEEcccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~---l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl----~~~g~iKL~DFGla 263 (552)
+|+||||++||+|.+++..... +++..+..++.||+.||.|||+.|||||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999976433 9999999999999999999999999999999999999 88889999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh--------cCCCC
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--------KKGYG 335 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~--------~~~y~ 335 (552)
+.+..... ..+.+||+.|+|||++. +..|+
T Consensus 164 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 201 (319)
T 4euu_A 164 RELEDDEQ------------------------------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201 (319)
T ss_dssp EECCTTCC------------------------------------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBC
T ss_pred eecCCCCc------------------------------------------eeecccCCCccCHHHhhhccccccccCCCC
Confidence 87643210 12467999999999997 47789
Q ss_pred CccchhhhhHHHHHHhhCCCCCCCCC----hhhHHHHHhhccccc-----------------cCCc----ccccChhHHH
Q 008810 336 MECDWWSLGAIMYEMLVGYPPFYSDD----PMSTCRKIVNWRTHL-----------------KFPE----EAKLSIEAKD 390 (552)
Q Consensus 336 ~~~DiWSlGvilyEmltG~~PF~~~~----~~~~~~~i~~~~~~~-----------------~~p~----~~~~s~e~~d 390 (552)
.++|||||||++|||++|.+||.... ..+...+++...... .+|. ...++..+.+
T Consensus 202 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 281 (319)
T 4euu_A 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281 (319)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHH
Confidence 99999999999999999999997543 234444554322100 1111 1346678999
Q ss_pred HHHHHhh-CccccCCCCChhhhhcCC
Q 008810 391 LISKLLC-NVNQRLGAKGADEIKVHP 415 (552)
Q Consensus 391 LI~~lL~-dp~~Rl~~~~a~eil~Hp 415 (552)
||.+||. ||.+|++ ++|+++||
T Consensus 282 ll~~~L~~dP~~R~s---~~ell~h~ 304 (319)
T 4euu_A 282 VLANILEADQEKCWG---FDQFFAET 304 (319)
T ss_dssp HHHHHSCCCTTTSCC---HHHHHHHH
T ss_pred HHHHhccCChhhhcc---HHHhhhcc
Confidence 9999999 9999999 99999996
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=394.03 Aligned_cols=264 Identities=25% Similarity=0.412 Sum_probs=214.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec--------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-------- 186 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-------- 186 (552)
.++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 578999999999999999999999999999999997543 345667889999999999999999998874
Q ss_pred ------CCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc-CCCcEEEcc
Q 008810 187 ------DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSD 259 (552)
Q Consensus 187 ------d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~-~~g~iKL~D 259 (552)
+...+|+||||++ |+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4478999999997 69999885 46799999999999999999999999999999999999997 567999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCcc
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 338 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~ 338 (552)
||+++......... .......||+.|+|||++.+ ..++.++
T Consensus 165 fg~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 206 (320)
T 2i6l_A 165 FGLARIMDPHYSHK--------------------------------------GHLSEGLVTKWYRSPRLLLSPNNYTKAI 206 (320)
T ss_dssp CTTCBCC----------------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHH
T ss_pred CccccccCCCcccc--------------------------------------cccccccccccccCcHHhcCcccCCchh
Confidence 99998653221000 01124578999999999976 7799999
Q ss_pred chhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccc--------------------cCCc------ccccChhHHHHH
Q 008810 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL--------------------KFPE------EAKLSIEAKDLI 392 (552)
Q Consensus 339 DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~--------------------~~p~------~~~~s~e~~dLI 392 (552)
|||||||++|||++|.+||.+.+..+....++...... ..+. ...++.++++||
T Consensus 207 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 286 (320)
T 2i6l_A 207 DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFL 286 (320)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHH
T ss_pred hhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHH
Confidence 99999999999999999999998877777766421100 0000 125799999999
Q ss_pred HHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 393 SKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 393 ~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
.+||. ||.+||+ ++|+++||||+.++|..
T Consensus 287 ~~~L~~dP~~Rpt---~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 287 EQILTFSPMDRLT---AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HTTSCSSGGGSCC---HHHHHTSHHHHTTCC--
T ss_pred HHHcCCCccccCC---HHHHhCCcccccccCcc
Confidence 99999 9999999 99999999999888754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=399.21 Aligned_cols=266 Identities=23% Similarity=0.409 Sum_probs=219.7
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc------eEEE
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC------IVKL 181 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~------Iv~l 181 (552)
....+..++|++++.||+|+||.||+|+++.++ ..||+|++++.. ...+.+.+|+.+|+.+.|++ |+.+
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 344555789999999999999999999998877 689999997542 23456788999999887655 9999
Q ss_pred eeeecCCceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc----------
Q 008810 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---------- 249 (552)
Q Consensus 182 ~~~f~d~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl---------- 249 (552)
+++|.....+|+||||+ +|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 66777777654 479999999999999999999999999999999999999
Q ss_pred ---------cCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccC
Q 008810 250 ---------DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (552)
Q Consensus 250 ---------~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT 320 (552)
+.++.+||+|||+++..... ....+||
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~gt 202 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDHEH--------------------------------------------HTTIVAT 202 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETTSC--------------------------------------------CCSSCSC
T ss_pred ccccccccccCCCcEEEeecCcccccccc--------------------------------------------ccCCcCC
Confidence 66889999999999754211 1146899
Q ss_pred CCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccccc-----------------------
Q 008810 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK----------------------- 377 (552)
Q Consensus 321 ~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~----------------------- 377 (552)
+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+......++
T Consensus 203 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 2eu9_A 203 RHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDEN 282 (355)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTT
T ss_pred CcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccc
Confidence 999999999999999999999999999999999999998877665544432111100
Q ss_pred -----------------CCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh
Q 008810 378 -----------------FPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 378 -----------------~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~ 426 (552)
.......+.++.+||.+||. ||.+||+ +.|+++||||.+++|+...
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 283 SSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGCCHHHHC
T ss_pred cchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcCCChhhcc
Confidence 00011235689999999999 9999999 9999999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=385.06 Aligned_cols=258 Identities=31% Similarity=0.550 Sum_probs=222.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec--CCceE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFL 191 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~--d~~~l 191 (552)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|. +...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 35789999999999999999999999999999999986543 2345667899999999999999999999874 56789
Q ss_pred EEEEecCCCCchhhHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCCCccccCCCcEEEccccc
Q 008810 192 YLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHH-----YIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+|||++.+|++||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999653 34999999999999999999999999 99999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
++....... .....+||+.|+|||++.+..++.++||||
T Consensus 163 ~~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 201 (279)
T 2w5a_A 163 ARILNHDTS-----------------------------------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201 (279)
T ss_dssp HHHC---CH-----------------------------------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred heeeccccc-----------------------------------------cccccCCCccccChHHhccCCCCchhhHHH
Confidence 986532110 011357999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|||++|+|++|.+||.+.+..+....+.... ...+|. .+++++.+||.+||. ||.+||+ +.||+.||||.+
T Consensus 202 lG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~~~~~~ 273 (279)
T 2w5a_A 202 LGCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPY--RYSDELNEIITRMLNLKDYHRPS---VEEILENPLILE 273 (279)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTCCG
T ss_pred HHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cccCCc--ccCHHHHHHHHHHcCCCcccCCC---HHHHHhChhhhh
Confidence 9999999999999999988877777776532 223443 689999999999999 9999999 999999999965
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=402.41 Aligned_cols=257 Identities=20% Similarity=0.343 Sum_probs=220.0
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEe
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k-------~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 182 (552)
..+..++|++.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+|+.+ +|||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3466789999999999999999999975 345689999997652 344567799999999999 899999999
Q ss_pred eeecCCceEEEEEecCCCCchhhHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCC
Q 008810 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (552)
Q Consensus 183 ~~f~d~~~lylVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeN 246 (552)
++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 48999999999999999999999999999999999
Q ss_pred ccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCCh
Q 008810 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (552)
Q Consensus 247 ILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~AP 326 (552)
||++.+|++||+|||+|+.+....... ......||+.|+||
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~aP 274 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYK---------------------------------------KTTNGRLPVKWMAP 274 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTC---------------------------------------TTTTTTSCGGGCCH
T ss_pred EEECCCCCEEEccccCCcccCccccee---------------------------------------cccCCCcccceECH
Confidence 999999999999999998654321100 01134688999999
Q ss_pred hhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCC
Q 008810 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 327 Evl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
|++.+..|+.++|||||||++|||++ |.+||.+.+..+....+... .....| ..++.++.+||.+||. ||.+||+
T Consensus 275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt 351 (370)
T 2psq_A 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHAVPSQRPT 351 (370)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCcC
Confidence 99999999999999999999999999 99999998887777766643 233344 3789999999999999 9999999
Q ss_pred CCChhhhhcC
Q 008810 405 AKGADEIKVH 414 (552)
Q Consensus 405 ~~~a~eil~H 414 (552)
+.||+.+
T Consensus 352 ---~~ell~~ 358 (370)
T 2psq_A 352 ---FKQLVED 358 (370)
T ss_dssp ---HHHHHHH
T ss_pred ---HHHHHHH
Confidence 8888764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=405.00 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=216.0
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CC-----ceEEEe
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SN-----CIVKLY 182 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp-----~Iv~l~ 182 (552)
.......++|++++.||+|+||.||+|+++.+|+.||||+++... .....+..|+.++..+. |+ +|++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 334445689999999999999999999999999999999997542 23455778888888874 44 599999
Q ss_pred eeecCCceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCcccccCCCCcccc--CCCcEE
Q 008810 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLD--KYGHLR 256 (552)
Q Consensus 183 ~~f~d~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH--~~giiHrDLKPeNILl~--~~g~iK 256 (552)
++|.+.+.+||||||++ |+|.+++... ..+++..++.++.||+.||.||| ..|||||||||+||||+ .++.+|
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEE
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEE
Confidence 99999999999999995 5999999765 46999999999999999999999 57999999999999995 578899
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCC
Q 008810 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (552)
Q Consensus 257 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~ 336 (552)
|+|||+|+..... ....+||+.|+|||++.+..|+.
T Consensus 202 L~DFG~a~~~~~~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~ 237 (382)
T 2vx3_A 202 IVDFGSSCQLGQR--------------------------------------------IYQYIQSRFYRSPEVLLGMPYDL 237 (382)
T ss_dssp ECCCTTCEETTCC--------------------------------------------CCSSCSCGGGCCHHHHTTCCCCT
T ss_pred EEeccCceecccc--------------------------------------------cccccCCccccChHHHcCCCCCc
Confidence 9999999865321 12468999999999999999999
Q ss_pred ccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcccccc----------------CCcc-------------------
Q 008810 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK----------------FPEE------------------- 381 (552)
Q Consensus 337 ~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~----------------~p~~------------------- 381 (552)
++|||||||++|||++|.+||.+.+..+.+.+|+....... +|..
T Consensus 238 ~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (382)
T 2vx3_A 238 AIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGT 317 (382)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTC
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcch
Confidence 99999999999999999999999988888777764211000 0000
Q ss_pred c-------------------------ccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCCh
Q 008810 382 A-------------------------KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (552)
Q Consensus 382 ~-------------------------~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w 422 (552)
. ..++++++||.+||+ ||.+||+ ++|+++||||++..|
T Consensus 318 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt---a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 318 RKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ---PYYALQHSFFKKTAD 381 (382)
T ss_dssp SCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGCC---
T ss_pred hhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC---HHHHhcCcccccCCC
Confidence 0 001378999999999 9999999 999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=387.81 Aligned_cols=255 Identities=32% Similarity=0.491 Sum_probs=223.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.+.|++++.||+|+||.||+|+++.+|+.||||++..... ....+.+.+|+.+|..++||||++++++|.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4569999999999999999999999999999999986542 34467789999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++||+|.+++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+.....
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 174 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--- 174 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC---
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc---
Confidence 999999999999854 6799999999999999999999999999999999999999999999999999986542210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 175 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (303)
T 3a7i_A 175 --------------------------------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216 (303)
T ss_dssp --------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCC
Confidence 012467999999999999999999999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+||...+.......+... ....++ ..++.++.+||.+||. ||.+||+ +.+|++||||..
T Consensus 217 ~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~ 276 (303)
T 3a7i_A 217 PPHSELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFILR 276 (303)
T ss_dssp CTTTTSCHHHHHHHHHHS-CCCCCC--SSCCHHHHHHHHHHCCSSGGGSCC---HHHHTTCHHHHH
T ss_pred CCCCCcCHHHHHHHhhcC-CCCCCc--cccCHHHHHHHHHHcCCChhhCcC---HHHHhhChhhhc
Confidence 999988877766665542 222233 3689999999999999 9999999 999999999953
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=407.52 Aligned_cols=265 Identities=18% Similarity=0.285 Sum_probs=223.1
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~-----~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
..+..++|++++.||+|+||.||+|+ ...++..||||+++... .......+.+|+.+|..++|||||+++++|
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 45667899999999999999999999 44578899999997532 234455688899999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC---cE
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HL 255 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g---~i 255 (552)
.+....|+|||||+||+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999997653 599999999999999999999999999999999999999665 49
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCC
Q 008810 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (552)
Q Consensus 256 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~ 335 (552)
||+|||+|+.+...... ......+||+.|+|||++.+..|+
T Consensus 224 kL~DFG~a~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 264 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY---------------------------------------RKGGCAMLPVKWMPPEAFMEGIFT 264 (367)
T ss_dssp EECCCHHHHHHHHHSSC---------------------------------------TTCCGGGSCGGGCCHHHHHHCCCC
T ss_pred EECCCcccccccccccc---------------------------------------ccCCCcCCcccEECHHHhcCCCCC
Confidence 99999999854211100 011246789999999999999999
Q ss_pred CccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 336 MECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 336 ~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||+ +.+|++
T Consensus 265 ~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~eil~ 338 (367)
T 3l9p_A 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRPN---FAIILE 338 (367)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCCHhHCcC---HHHHHH
Confidence 99999999999999998 999999999888887777532 23333 3789999999999999 9999999 999999
Q ss_pred CCCcCCCCh
Q 008810 414 HPWFDGVDW 422 (552)
Q Consensus 414 HpfF~~i~w 422 (552)
|.++-.-+.
T Consensus 339 ~l~~~~~~~ 347 (367)
T 3l9p_A 339 RIEYCTQDP 347 (367)
T ss_dssp HHHHHHHCH
T ss_pred HHHHHhhCh
Confidence 988744333
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=395.42 Aligned_cols=273 Identities=20% Similarity=0.267 Sum_probs=219.7
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ly 192 (552)
..++|++++.||+|+||.||+|+++.+|+.||||++..... ...+.+|+.+|+.+ +||||+++++++.+...+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 45789999999999999999999999999999999976532 22478899999999 9999999999999999999
Q ss_pred EEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc-----EEEccccccccc
Q 008810 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPL 266 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~-----iKL~DFGlak~~ 266 (552)
+||||+ ||+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.+|+ +||+|||+|+.+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999976 478999999999999999999999999999999999999999888 999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
........ .+ .......+||+.|+|||++.+..|+.++|||||||+
T Consensus 161 ~~~~~~~~-------------------~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 206 (330)
T 2izr_A 161 IDPETKKH-------------------IP---------------YREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHM 206 (330)
T ss_dssp BCTTTCCB-------------------CC---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred ecCCCCcc-------------------cc---------------ccccCCcCCCccccChHHHcCCCCCchhHHHHHHHH
Confidence 43211000 00 001125789999999999999999999999999999
Q ss_pred HHHHhhCCCCCCCCC---hhhHHHHHhhccccccCCcc--cccChhHHHHHHHHhh-CccccCCCCChhhhhc-------
Q 008810 347 MYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV------- 413 (552)
Q Consensus 347 lyEmltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~~--~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~------- 413 (552)
+|||++|.+||.+.+ ..+.+.++.... ...|.. ....+++.+||.+||. ||.+||+ +++|+.
T Consensus 207 l~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~---~~~l~~~l~~~~~ 281 (330)
T 2izr_A 207 FMYFLRGSLPWQGLKADTLKERYQKIGDTK--RATPIEVLCENFPEMATYLRYVRRLDFFEKPD---YDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHHSSCTTTTCCCSSHHHHHHHHHHHH--HHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCC---HHHHHHHHHHHHH
T ss_pred HHHHhcCCCCccccccccHHHHHHHHHhhh--ccCCHHHHhccChHHHHHHHHHHhCCCCCCCC---HHHHHHHHHHHHH
Confidence 999999999998844 344455554422 222221 1123399999999999 9999999 555443
Q ss_pred ---CCCcCCCChhhhhhcCCCC
Q 008810 414 ---HPWFDGVDWARIYQMEAAF 432 (552)
Q Consensus 414 ---HpfF~~i~w~~l~~~~~pf 432 (552)
.++...+||.. ..+.+|+
T Consensus 282 ~~~~~~~~~~dw~~-~~~~~p~ 302 (330)
T 2izr_A 282 RKGYMFDYEYDWIG-KQLPTPV 302 (330)
T ss_dssp HTTCCCSCCCTTTT-SCCCCCC
T ss_pred HcCCCCCCCccCCC-CCcCCCC
Confidence 45566788973 2344554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=399.87 Aligned_cols=261 Identities=23% Similarity=0.376 Sum_probs=211.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh--------hhhhHHHHHHHHHHHHHhcCCCceEEEeee
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--------LRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~--------~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 184 (552)
...++|++++.||+|+||.||+|.+.. |..||||++.+... ......+.+.+|+.+|+.++|||||+++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 346789999999999999999998755 89999999965422 122334679999999999999999999999
Q ss_pred e-----cCCceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEc
Q 008810 185 F-----QDDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (552)
Q Consensus 185 f-----~d~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~ 258 (552)
| .....+|+||||++ |+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 8 44457999999997 5777777554 479999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCc
Q 008810 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 337 (552)
Q Consensus 259 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~ 337 (552)
|||+++...... .....+||+.|+|||++.+ ..++.+
T Consensus 177 Dfg~~~~~~~~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~ 214 (362)
T 3pg1_A 177 DFNLAREDTADA------------------------------------------NKTHYVTHRWYRAPELVMQFKGFTKL 214 (362)
T ss_dssp CTTC---------------------------------------------------------CGGGCCHHHHTTCTTCCTH
T ss_pred ecCccccccccc------------------------------------------ccceecccceecCcHHhcCCCCCCcH
Confidence 999997432211 0124579999999999987 779999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccc----------------------cCCc------ccccChhHH
Q 008810 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL----------------------KFPE------EAKLSIEAK 389 (552)
Q Consensus 338 ~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~----------------------~~p~------~~~~s~e~~ 389 (552)
+|||||||++|+|++|.+||.+.+..+...+++...... ..|. ...+++++.
T Consensus 215 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (362)
T 3pg1_A 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL 294 (362)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHH
T ss_pred hHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHH
Confidence 999999999999999999999988877777765421111 0110 124688999
Q ss_pred HHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 390 dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+||.+||. ||.+||+ +.|+++||||+++
T Consensus 295 ~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 323 (362)
T 3pg1_A 295 DLIAKMLEFNPQRRIS---TEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHTCSSGGGSCC---HHHHHTSGGGTTT
T ss_pred HHHHHHhcCChhhCCC---HHHHHcCchhhhc
Confidence 99999999 9999999 9999999999986
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=399.64 Aligned_cols=260 Identities=22% Similarity=0.342 Sum_probs=219.5
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEe
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~-----~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~ 182 (552)
....+..++|++.+.||+|+||.||+|+ ...+++.||||++++.. .....+.+.+|+.+|..+ +|||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3456778899999999999999999999 45677899999997643 234456789999999999 889999999
Q ss_pred eeecCCc-eEEEEEecCCCCchhhHHhhcCC-------------------------------------------------
Q 008810 183 CSFQDDE-FLYLIMEYLPGGDMMTLLMRKDT------------------------------------------------- 212 (552)
Q Consensus 183 ~~f~d~~-~lylVmEy~~gG~L~~~L~~~~~------------------------------------------------- 212 (552)
++|.+.+ .+|+|||||+||+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998755 49999999999999999976433
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 213 -----------------LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 213 -----------------l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.+......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~--- 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY--- 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC---
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc---
Confidence 999999999999999999999999999999999999999999999999999865322100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~ 354 (552)
.......||+.|+|||++.+..|+.++|||||||++|||++ |.
T Consensus 250 ------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 293 (359)
T 3vhe_A 250 ------------------------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293 (359)
T ss_dssp ------------------------------------EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred ------------------------------------hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCC
Confidence 01124678999999999999999999999999999999998 99
Q ss_pred CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+||.+..........+........|. .+++++.+||.+||. ||.+||+ +.||+.|
T Consensus 294 ~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 349 (359)
T 3vhe_A 294 SPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 349 (359)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CCCCccchhHHHHHHHHcCCCCCCCC--CCCHHHHHHHHHHccCChhhCCC---HHHHHHH
Confidence 99998876665555554334444553 789999999999999 9999999 8898876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=392.62 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=218.7
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
..+..++|++.+.||+|+||.||+|+++.+|+ .||||+++... .....+.+.+|+.+|..++|||||+++++|.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45678899999999999999999999986655 59999997542 23445678999999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.|||||||||+|||++.+|.+||+|||+++.+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999654 68999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
....... .......||+.|+|||++.+..|+.++|||||||+
T Consensus 202 ~~~~~~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 243 (325)
T 3kul_A 202 EDDPDAA--------------------------------------YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243 (325)
T ss_dssp C----CC--------------------------------------EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHH
T ss_pred ccCccce--------------------------------------eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHH
Confidence 4321100 00113457889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 347 lyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+|||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 244 l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~ 306 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRDVISSVEEG---YRLPAPMGCPHALHQLMLDCWHKDRAQRPR---FSQIVS 306 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcC---CCCCCCCCcCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 999999 99999999888888777653 2233334789999999999999 9999999 777765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=377.98 Aligned_cols=253 Identities=18% Similarity=0.294 Sum_probs=219.1
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..+..++|++++.||+|+||.||+|++. +++.||+|++.+... ..+.+.+|+.+|+.++||||++++++|.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3567789999999999999999999986 577899999986542 23468899999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 9999999999999999965 456999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.. .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 160 ~~----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 199 (269)
T 4hcu_A 160 QY----------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 199 (269)
T ss_dssp HH----------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cc----------------------------------------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHH
Confidence 10 01124567889999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +.++++|
T Consensus 200 ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~ 260 (269)
T 4hcu_A 200 VFSEGKIPYENRSNSEVVEDISTG-FRLYKP--RLASTHVYQIMNHCWRERPEDRPA---FSRLLRQ 260 (269)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HhcCCCCCCCCCCHHHHHHHHhcC-ccCCCC--CcCCHHHHHHHHHHccCCcccCcC---HHHHHHH
Confidence 999 99999999888888777653 222333 3689999999999999 9999999 8888875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=382.10 Aligned_cols=272 Identities=28% Similarity=0.489 Sum_probs=211.3
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--------
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-------- 187 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-------- 187 (552)
++|++++.||+|+||.||+|++..+|+.||||++... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4699999999999999999999999999999999754 2345678899999999999999999998754
Q ss_pred -----CceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccc
Q 008810 188 -----DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (552)
Q Consensus 188 -----~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFG 261 (552)
...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 46789999999999999999754 468899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccch
Q 008810 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDW 340 (552)
Q Consensus 262 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~Di 340 (552)
+++.......... . . .. ..+ .........+||+.|+|||++.+. .++.++||
T Consensus 162 ~~~~~~~~~~~~~-~------~------~~-~~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 214 (303)
T 1zy4_A 162 LAKNVHRSLDILK-L------D------SQ-NLP-------------GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214 (303)
T ss_dssp CCSCTTC----------------------------------------------------CTTSCHHHHTSCSCCCTHHHH
T ss_pred chhhcccccchhc-c------c------cc-ccc-------------ccccccccCCCcccccCcccccCCCCCcchhhH
Confidence 9986543210000 0 0 00 000 000012256899999999999865 68999999
Q ss_pred hhhhHHHHHHhhCCCCCCCC-ChhhHHHHHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 341 WSLGAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
|||||++|||++ ||... +.......+.. ....+|. ...+++.+++||.+||. ||.+||+ +.+|++|||
T Consensus 215 ~slG~il~~l~~---p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~ 286 (303)
T 1zy4_A 215 YSLGIIFFEMIY---PFSTGMERVNILKKLRS--VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNSGW 286 (303)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHS--TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC---HHHHHHSSC
T ss_pred HHHHHHHHHHHh---ccCCchhHHHHHHhccc--cccccCccccccchHHHHHHHHHHHhcCcccCcC---HHHHhCCCC
Confidence 999999999998 55432 33344444443 2233332 23567889999999999 9999999 999999999
Q ss_pred cCCCChhhhh
Q 008810 417 FDGVDWARIY 426 (552)
Q Consensus 417 F~~i~w~~l~ 426 (552)
|....++...
T Consensus 287 ~~~~~~~~~~ 296 (303)
T 1zy4_A 287 LPVKHQDEVI 296 (303)
T ss_dssp SCCCCHHHHH
T ss_pred cCCCChHHHH
Confidence 9988876653
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=396.37 Aligned_cols=257 Identities=24% Similarity=0.432 Sum_probs=210.7
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-----------CCce
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----------SNCI 178 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~I 178 (552)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+.. ...+.+.+|+.++..+. ||||
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i 88 (373)
T 1q8y_A 13 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHI 88 (373)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTB
T ss_pred CCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchH
Confidence 34456789999999999999999999999999999999997543 23456788999988876 8999
Q ss_pred EEEeeeecCCc----eEEEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCcccc-
Q 008810 179 VKLYCSFQDDE----FLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLD- 250 (552)
Q Consensus 179 v~l~~~f~d~~----~lylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~- 250 (552)
++++++|.+.. .+|+||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++ |||||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 89 LKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp CCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred HHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEec
Confidence 99999998654 899999999 9999999976 35699999999999999999999998 999999999999994
Q ss_pred -----CCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 251 -----KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 251 -----~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
..+.+||+|||+++..... ....+||+.|+|
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------~~~~~~t~~y~a 203 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH--------------------------------------------YTNSIQTREYRS 203 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC--------------------------------------------CCSCCSCGGGCC
T ss_pred cCCCcCcceEEEcccccccccCCC--------------------------------------------CCCCCCCccccC
Confidence 4458999999999865321 113579999999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCCh------hhHHHHHhhccc-------------------------
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP------MSTCRKIVNWRT------------------------- 374 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~------~~~~~~i~~~~~------------------------- 374 (552)
||++.+..|+.++|||||||++|||++|.+||.+.+. ......++....
T Consensus 204 PE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 283 (373)
T 1q8y_A 204 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283 (373)
T ss_dssp HHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSS
T ss_pred cHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcc
Confidence 9999999999999999999999999999999986542 222223322100
Q ss_pred ---------------cccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 375 ---------------HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 375 ---------------~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
...+| ..++.++++||.+||+ ||.+||+ ++||++||||++.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 340 (373)
T 1q8y_A 284 ISKLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDT 340 (373)
T ss_dssp CCCCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTC
T ss_pred cccccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccCC---HHHHhhChhhhcc
Confidence 11122 2567889999999999 9999999 9999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=375.22 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=207.2
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
.+..++|++.+.||+|+||.||+|++. |..||||+++...... ....+.+.+|..+++.++||||++++++|.+...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 356789999999999999999999874 8899999997654322 2335678999999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CcccccCCCCccccC--------CCcEEEcc
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH---YIHRDIKPDNLLLDK--------YGHLRLSD 259 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKPeNILl~~--------~g~iKL~D 259 (552)
+|+||||++||+|..++. ...+++..+..++.|++.||.|||++| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999884 568999999999999999999999999 999999999999986 78899999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccc
Q 008810 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (552)
Q Consensus 260 FGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~D 339 (552)
||+++...... .....||+.|+|||++.+..++.++|
T Consensus 160 fg~~~~~~~~~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~D 196 (271)
T 3dtc_A 160 FGLAREWHRTT-------------------------------------------KMSAAGAYAWMAPEVIRASMFSKGSD 196 (271)
T ss_dssp CCC--------------------------------------------------------CCGGGSCHHHHHHCCCSHHHH
T ss_pred CCccccccccc-------------------------------------------ccCCCCccceeCHHHhccCCCCchhh
Confidence 99997543211 11357999999999999999999999
Q ss_pred hhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 340 iWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
||||||++|+|++|..||.+.+.......+........+| ..+++++.+||.+||. ||.+||+ +.|+++|
T Consensus 197 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~ 267 (271)
T 3dtc_A 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP--STCPEPFAKLMEDCWNPDPHSRPS---FTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC--cccCHHHHHHHHHHhcCCcccCcC---HHHHHHH
Confidence 9999999999999999999988877777766543334444 4789999999999999 9999999 8888765
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=396.31 Aligned_cols=253 Identities=34% Similarity=0.555 Sum_probs=186.5
Q ss_pred CCCCeeEEe-eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC----C
Q 008810 114 GADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----D 188 (552)
Q Consensus 114 ~~~~f~~~~-~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~ 188 (552)
..++|++++ +||+|+||.||+|+++.+|+.||||++..... ........+..+.||||++++++|.+ .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 467899965 69999999999999999999999999976421 12223334567799999999999876 5
Q ss_pred ceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEcccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGla 263 (552)
..+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 66999999999999999997653 6999999999999999999999999999999999999986 456999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+...... ....+||+.|+|||++.+..|+.++|||||
T Consensus 179 ~~~~~~~-------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 215 (336)
T 3fhr_A 179 KETTQNA-------------------------------------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215 (336)
T ss_dssp EEC-----------------------------------------------------------------CHHHHHHHHHHH
T ss_pred eeccccc-------------------------------------------cccCCCCcCccChhhhCCCCCCchhhHHHH
Confidence 8543211 114578999999999998899999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhH----HHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMST----CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
||++|+|++|.+||.+...... ...+......+..+....+++++++||.+||. ||.+||+ +.|+++||||+
T Consensus 216 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~ 292 (336)
T 3fhr_A 216 GVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT---ITQFMNHPWIN 292 (336)
T ss_dssp HHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHHSHHHH
T ss_pred HHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccc
Confidence 9999999999999987765443 22232222233334445789999999999999 9999999 99999999997
Q ss_pred C
Q 008810 419 G 419 (552)
Q Consensus 419 ~ 419 (552)
.
T Consensus 293 ~ 293 (336)
T 3fhr_A 293 Q 293 (336)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=387.54 Aligned_cols=263 Identities=19% Similarity=0.321 Sum_probs=213.8
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+..++|++.+.||+|+||.||+|.++.+|+.||+|++... .....+.+.+|+.+|+.++|||||+++++|.+...+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 35678999999999999999999999999999999998653 244566789999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.+....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999977 5789999999999999999999999999999999999999999999999999998764332
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
...... ..............+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 163 ~~~~~~---------------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 215 (310)
T 3s95_A 163 TQPEGL---------------------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215 (310)
T ss_dssp --------------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred cccccc---------------------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 110000 00000111123367899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhH-----HHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 351 LVGYPPFYSDDPMST-----CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 351 ltG~~PF~~~~~~~~-----~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++|.+||........ ...... ...| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 216 ~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~~l~~ 275 (310)
T 3s95_A 216 IGRVNADPDYLPRTMDFGLNVRGFLD----RYCP--PNCPPSFFPITVRCCDLDPEKRPS---FVKLEH 275 (310)
T ss_dssp HHTCCSSTTTSCBCTTSSBCHHHHHH----HTCC--TTCCTTHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred hcCCCCCcchhhhHHHHhhhhhcccc----ccCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 999999976433211 111111 1123 3688999999999999 9999999 888876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=390.77 Aligned_cols=259 Identities=20% Similarity=0.337 Sum_probs=218.2
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 183 (552)
...+..++|++.+.||+|+||.||+|++. .++..||||++.... .....+.+.+|+.+|..+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34567789999999999999999999973 466789999997543 233456789999999999 9999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------------------TLTEDEARFYVAETVLAIESIHKHHYIHR 240 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~~-----------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHr 240 (552)
+|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 38999999999999999999999999999
Q ss_pred ccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccC
Q 008810 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (552)
Q Consensus 241 DLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT 320 (552)
||||+|||++.+|++||+|||+++.+...... .......||
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~t 237 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY---------------------------------------VVRGNARLP 237 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---------------------------------------EEETTEEEC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc---------------------------------------eeccCccCc
Confidence 99999999999999999999999865322100 011245789
Q ss_pred CCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-C
Q 008810 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398 (552)
Q Consensus 321 ~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-d 398 (552)
+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.........++........| ..+++++.+||.+||. |
T Consensus 238 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~d 315 (344)
T 1rjb_A 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFD 315 (344)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSS
T ss_pred cCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999998 999999887766666666533333344 4789999999999999 9
Q ss_pred ccccCCCCChhhhhcC
Q 008810 399 VNQRLGAKGADEIKVH 414 (552)
Q Consensus 399 p~~Rl~~~~a~eil~H 414 (552)
|.+||+ +.+|+.|
T Consensus 316 p~~Rps---~~~l~~~ 328 (344)
T 1rjb_A 316 SRKRPS---FPNLTSF 328 (344)
T ss_dssp GGGSCC---HHHHHHH
T ss_pred chhCcC---HHHHHHH
Confidence 999999 8888876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=374.48 Aligned_cols=252 Identities=21% Similarity=0.315 Sum_probs=218.0
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+..++|++++.||+|+||.||+|+++ ++..||+|+++.... ..+.+.+|+.+|..++||||++++++|.+...+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 466789999999999999999999876 567899999986542 234588999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|+||||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999997654 59999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.. ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 159 ~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 198 (268)
T 3sxs_A 159 YV----------------------------------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198 (268)
T ss_dssp EE----------------------------------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHH
T ss_pred hh----------------------------------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHH
Confidence 10 01234678889999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
++ |.+||...+.......+... .....| ..+++++.+||.+||. ||.+||+ +.+|++|
T Consensus 199 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 258 (268)
T 3sxs_A 199 FSLGKMPYDLYTNSEVVLKVSQG-HRLYRP--HLASDTIYQIMYSCWHELPEKRPT---FQQLLSS 258 (268)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HcCCCCCccccChHHHHHHHHcC-CCCCCC--CcChHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99 99999998888877777653 222333 3679999999999999 9999999 8888875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=389.18 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=221.5
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 184 (552)
...+..++|++++.||+|+||.||+|++. .+++.||||++++.. .....+.+.+|+.+|+.++||||++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 45677889999999999999999999987 456899999998653 23445678999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMRK------------------------DTLTEDEARFYVAETVLAIESIHKHHYIHR 240 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHr 240 (552)
|.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus 119 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 119 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 99999999999999999999999763 579999999999999999999999999999
Q ss_pred ccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccC
Q 008810 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (552)
Q Consensus 241 DLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT 320 (552)
||||+|||++.+|++||+|||+++.+...... .......||
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~t 239 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY---------------------------------------KADGNDAIP 239 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---------------------------------------C----CCBC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc---------------------------------------cccCCCccc
Confidence 99999999999999999999999865322100 001235789
Q ss_pred CCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-C
Q 008810 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398 (552)
Q Consensus 321 ~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-d 398 (552)
+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..+....+.... ...+| ..+++++.+||.+||. |
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~ 316 (343)
T 1luf_A 240 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWSKL 316 (343)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSS
T ss_pred ceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-cCCCC--CCCCHHHHHHHHHHcccC
Confidence 99999999999999999999999999999999 999999998888877776532 23344 3789999999999999 9
Q ss_pred ccccCCCCChhhhhcC
Q 008810 399 VNQRLGAKGADEIKVH 414 (552)
Q Consensus 399 p~~Rl~~~~a~eil~H 414 (552)
|.+||+ +.+|+.+
T Consensus 317 p~~Rps---~~~~~~~ 329 (343)
T 1luf_A 317 PADRPS---FCSIHRI 329 (343)
T ss_dssp GGGSCC---HHHHHHH
T ss_pred cccCCC---HHHHHHH
Confidence 999999 8887753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=378.32 Aligned_cols=256 Identities=20% Similarity=0.348 Sum_probs=218.6
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
.....+..++|++++.||+|+||.||+|++. ++..||||++..... ..+.+.+|+.+|..++||||++++++|.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3455678889999999999999999999876 677899999986532 23458899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
...+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999976 567999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
..... .......||+.|+|||++.+..++.++|||||||+
T Consensus 171 ~~~~~----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 210 (283)
T 3gen_A 171 LDDEY----------------------------------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210 (283)
T ss_dssp CCHHH----------------------------------------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred ccccc----------------------------------------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHH
Confidence 32110 00123467889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 347 lyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+|+|++ |.+||...+.......+.... ....| ..+++++.+||.+||. ||.+||+ +.+|+.|
T Consensus 211 l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 274 (283)
T 3gen_A 211 MWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRP--HLASEKVYTIMYSCWHEKADERPT---FKILLSN 274 (283)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhCCCCCccccChhHHHHHHhccc-CCCCC--CcCCHHHHHHHHHHccCChhHCcC---HHHHHHH
Confidence 999998 999999998888887777531 22233 3679999999999999 9999999 8888875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=384.32 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=221.8
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEee
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 183 (552)
....+..++|.+.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+|+.++|||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 345567889999999999999999999983 456899999997543 3445677899999999999999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT------------------------LTEDEARFYVAETVLAIESIHKHHYIH 239 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~~~------------------------l~e~~~~~~~~qi~~aL~~LH~~giiH 239 (552)
+|.+...+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999976543 899999999999999999999999999
Q ss_pred cccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccc
Q 008810 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (552)
Q Consensus 240 rDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~G 319 (552)
|||||+|||++.+|++||+|||+++......... ......|
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~ 214 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV---------------------------------------KRSQGRI 214 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE---------------------------------------CSSCCCS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccce---------------------------------------eccCCCC
Confidence 9999999999999999999999998654321100 0113468
Q ss_pred CCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-
Q 008810 320 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 320 T~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~- 397 (552)
|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+.......+... .....| ..+++++.+||.+||.
T Consensus 215 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~ 291 (314)
T 2ivs_A 215 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG-HRMERP--DNCSEEMYRLMLQCWKQ 291 (314)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCS
T ss_pred cccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC-CcCCCC--ccCCHHHHHHHHHHccC
Confidence 899999999999999999999999999999999 99999998887777666543 223333 3789999999999999
Q ss_pred CccccCCCCChhhhhcC
Q 008810 398 NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~H 414 (552)
||.+||+ +.+|+.|
T Consensus 292 dp~~Rps---~~~l~~~ 305 (314)
T 2ivs_A 292 EPDKRPV---FADISKD 305 (314)
T ss_dssp SGGGSCC---HHHHHHH
T ss_pred ChhhCcC---HHHHHHH
Confidence 9999999 8888765
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=381.14 Aligned_cols=262 Identities=30% Similarity=0.496 Sum_probs=215.2
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..+..++|....+||+|+||.||+|++..++..||||++.... ....+.+.+|+.+++.++|||||+++++|.+.+.
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3345566666779999999999999999999999999997653 3345668899999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-CCcEEEccccccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPL 266 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~---~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-~g~iKL~DFGlak~~ 266 (552)
+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++. +|.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999999999999764 25679999999999999999999999999999999999987 899999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC--CCCCccchhhhh
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLG 344 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~--~y~~~~DiWSlG 344 (552)
..... .....+||+.|+|||++.+. .++.++||||||
T Consensus 174 ~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 212 (295)
T 2clq_A 174 AGINP-----------------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLG 212 (295)
T ss_dssp CC----------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHH
T ss_pred CCCCC-----------------------------------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHH
Confidence 32110 01145799999999999874 489999999999
Q ss_pred HHHHHHhhCCCCCCCCChhh-HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 345 AIMYEMLVGYPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
|++|+|++|..||....... .............+|. .+++++.+||.+||. ||.+||+ +++++.||||+...
T Consensus 213 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 213 CTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE--SMSAEAKAFILKCFEPDPDKRAC---ANDLLVDEFLKVSS 286 (295)
T ss_dssp HHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT--TSCHHHHHHHHHTTCSSTTTSCC---HHHHHTSGGGCC--
T ss_pred HHHHHHHHCCCCccCCCchhHHHHhhccccccccccc--cCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhhcc
Confidence 99999999999997644322 2222222222334443 789999999999999 9999999 99999999998643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=389.84 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=220.0
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcC--CCceEEEeee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVD--SNCIVKLYCS 184 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~--hp~Iv~l~~~ 184 (552)
......++|++.+.||+|+||.||+|+++.+|+.||||++.+...... .....+.+|+.+|+.+. ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 344567889999999999999999999999999999999987653321 11234677999999996 5999999999
Q ss_pred ecCCceEEEEEecCCC-CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc-CCCcEEEccccc
Q 008810 185 FQDDEFLYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGL 262 (552)
Q Consensus 185 f~d~~~lylVmEy~~g-G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~-~~g~iKL~DFGl 262 (552)
|.+.+.+|+||||+.+ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ .+|.+||+|||+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999999999976 99999999889999999999999999999999999999999999999999 789999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWW 341 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiW 341 (552)
++...... ....+||+.|+|||++.+..+ +.++|||
T Consensus 197 ~~~~~~~~-------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~ 233 (320)
T 3a99_A 197 GALLKDTV-------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVW 233 (320)
T ss_dssp CEECCSSC-------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHH
T ss_pred cccccccc-------------------------------------------ccCCCCCccCCChHHhccCCCCCccchHH
Confidence 98654221 114579999999999988776 7889999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 342 SlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
||||++|||++|..||...+ .+.. ....++. .+++++.+||.+||. ||.+||+ +++|++||||+++
T Consensus 234 slG~il~el~~g~~pf~~~~------~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~ 300 (320)
T 3a99_A 234 SLGILLYDMVCGDIPFEHDE------EIIR--GQVFFRQ--RVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDV 300 (320)
T ss_dssp HHHHHHHHHHHSSCSCCSHH------HHHH--CCCCCSS--CCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSC
T ss_pred hHHHHHHHHHHCCCCCCChh------hhhc--ccccccc--cCCHHHHHHHHHHccCChhhCcC---HHHHhcCHhhcCc
Confidence 99999999999999997542 2232 2333443 689999999999999 9999999 9999999999988
Q ss_pred Chhh
Q 008810 421 DWAR 424 (552)
Q Consensus 421 ~w~~ 424 (552)
.+..
T Consensus 301 ~~~~ 304 (320)
T 3a99_A 301 LLPQ 304 (320)
T ss_dssp CCHH
T ss_pred cCcc
Confidence 6543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=379.47 Aligned_cols=247 Identities=18% Similarity=0.265 Sum_probs=209.9
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCC-------cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeee
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTG-------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 184 (552)
++..++|++.+.||+|+||.||+|+++.++ ..||+|++.+.. ....+.+.+|+.+|+.++|||||+++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 466789999999999999999999998877 479999997643 3445678999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc--------E
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--------L 255 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~~~~-l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~--------i 255 (552)
|.+.+..|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999977654 999999999999999999999999999999999999998887 9
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCC
Q 008810 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGY 334 (552)
Q Consensus 256 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y 334 (552)
||+|||++...... ....||+.|+|||++.+ ..+
T Consensus 161 kl~Dfg~~~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~ 195 (289)
T 4fvq_A 161 KLSDPGISITVLPK---------------------------------------------DILQERIPWVPPECIENPKNL 195 (289)
T ss_dssp EECCCCSCTTTSCH---------------------------------------------HHHHHTTTTSCHHHHHCGGGC
T ss_pred eeccCcccccccCc---------------------------------------------cccCCcCcccCHHHhCCCCCC
Confidence 99999998754211 13468999999999997 779
Q ss_pred CCccchhhhhHHHHHHhhCC-CCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 335 GMECDWWSLGAIMYEMLVGY-PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmltG~-~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
+.++|||||||++|||++|. +||...+.... ..+.. ....+|. .+++++.+||.+||. ||.+||+ +.+|+
T Consensus 196 ~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~--~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps---~~~ll 267 (289)
T 4fvq_A 196 NLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYE--DRHQLPA--PKAAELANLINNCMDYEPDHRPS---FRAII 267 (289)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHH--TTCCCCC--CSSCTTHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred CchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhh--ccCCCCC--CCCHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 99999999999999999954 55554444333 33333 2333443 568899999999999 9999999 88888
Q ss_pred cC
Q 008810 413 VH 414 (552)
Q Consensus 413 ~H 414 (552)
+|
T Consensus 268 ~~ 269 (289)
T 4fvq_A 268 RD 269 (289)
T ss_dssp HH
T ss_pred HH
Confidence 75
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=386.12 Aligned_cols=269 Identities=17% Similarity=0.252 Sum_probs=227.0
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEee
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 183 (552)
....+..++|++.+.||+|+||.||+|+++ .+++.||||++.... .......+.+|+.+|+.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 345677789999999999999999999887 467899999997543 2334456889999999999999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g 253 (552)
++.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999999653 4679999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC
Q 008810 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (552)
Q Consensus 254 ~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~ 333 (552)
++||+|||+++........ ......+||+.|+|||++.+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~ 216 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYY---------------------------------------RKGGKGLLPVRWMSPESLKDGV 216 (322)
T ss_dssp CEEECCTTCCCGGGGGGCE---------------------------------------EGGGSSEECGGGCCHHHHHHCC
T ss_pred eEEECcCcccccccccccc---------------------------------------ccccCCCCCCCccChhhhccCC
Confidence 9999999999865321100 0112457899999999999999
Q ss_pred CCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 334 y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
++.++|||||||++|+|++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||+ +.||
T Consensus 217 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~e~ 290 (322)
T 1p4o_A 217 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRPS---FLEI 290 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCCcccCcC---HHHH
Confidence 9999999999999999999 899999988888777776532 22333 3789999999999999 9999999 8888
Q ss_pred hcC------CCcCCCChhh
Q 008810 412 KVH------PWFDGVDWAR 424 (552)
Q Consensus 412 l~H------pfF~~i~w~~ 424 (552)
+.| |+|..++|..
T Consensus 291 l~~L~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 291 ISSIKEEMEPGFREVSFYY 309 (322)
T ss_dssp HHHHGGGSCTTHHHHCSTT
T ss_pred HHHHHHhhccCCccccccc
Confidence 876 6666655543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=377.48 Aligned_cols=256 Identities=21% Similarity=0.346 Sum_probs=223.1
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
+....+..++|++.+.||+|+||.||+|.++.++..||+|++... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345667889999999999999999999999999999999999754 2345678899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999999763 4599999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
....... ......||+.|+|||++.+..++.++|||||||
T Consensus 161 ~~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 200 (288)
T 3kfa_A 161 MTGDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 200 (288)
T ss_dssp SCSSSSE----------------------------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred ccCCccc----------------------------------------cccCCccccCcCChhhhccCCCCchhhHHHHHH
Confidence 5432110 012456889999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 346 ilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++|+|++ |.+||.+.+.......+... .....| ..+++++.+||.+||. ||.+||+ +.+|++
T Consensus 201 il~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~~~~ 264 (288)
T 3kfa_A 201 LLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERP--EGCPEKVYELMRACWQWNPSDRPS---FAEIHQ 264 (288)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHhCCChhhCcC---HHHHHH
Confidence 9999999 99999998887777666542 223333 4789999999999999 9999999 777764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=381.03 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=220.0
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 183 (552)
...+..++|++.+.||+|+||.||+|++ ..+++.||||++..... ....+.+.+|+.+|..+ +||||+++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 3456678999999999999999999985 45788999999986532 23456789999999999 9999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPe 245 (552)
+|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999999999999999999999997654 4999999999999999999999999999999999
Q ss_pred CccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 246 NILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
|||++.+|.+||+|||+++........ .......||+.|+|
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~a 215 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNY---------------------------------------VVKGNARLPVKWMA 215 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTS---------------------------------------EECSSSEECGGGCC
T ss_pred eEEEcCCCCEEEccccccccccccccc---------------------------------------eeccCCCCcceeeC
Confidence 999999999999999999865432110 01123568899999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccC
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
||++.+..++.++|||||||++|||++ |.+||.+.........++........| ..+++++.+||.+||. ||.+||
T Consensus 216 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rp 293 (313)
T 1t46_A 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRP 293 (313)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc--ccCCHHHHHHHHHHcCCCchhCc
Confidence 999999999999999999999999998 999999877666665555433233333 4789999999999999 999999
Q ss_pred CCCChhhhhcC
Q 008810 404 GAKGADEIKVH 414 (552)
Q Consensus 404 ~~~~a~eil~H 414 (552)
+ +.+|+++
T Consensus 294 s---~~ell~~ 301 (313)
T 1t46_A 294 T---FKQIVQL 301 (313)
T ss_dssp C---HHHHHHH
T ss_pred C---HHHHHHH
Confidence 9 8888764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=382.68 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=204.4
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
+..+..++|++++.||+|+||.||+|+++.+|+.||||++..... .....+.+..+..+++.++||||++++++|.+.+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~ 97 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT 97 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence 345667899999999999999999999999999999999986542 1222334555566788889999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|+||||+ ++.+..++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.+|++||+|||+++.+.
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred cEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999999999 6666655543 57899999999999999999999995 99999999999999999999999999987553
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccchhh
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWS 342 (552)
.... ....+||+.|+|||++. +..|+.++||||
T Consensus 177 ~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 214 (318)
T 2dyl_A 177 DDKA------------------------------------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS 214 (318)
T ss_dssp ----------------------------------------------------CCTTCCHHHHC--------CCTHHHHHH
T ss_pred CCcc------------------------------------------ccccCCCccccChhhcccccccccCCccccchhh
Confidence 2110 11357999999999995 567899999999
Q ss_pred hhHHHHHHhhCCCCCCCC-ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 343 LGAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
|||++|||++|..||... ...+....+... ....+|....+++++.+||.+||. ||.+||+ +++|++||||++.
T Consensus 215 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 215 LGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK---YNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCcC---HHHHhhCHHHHhc
Confidence 999999999999999874 445555566543 233344445689999999999999 9999999 9999999999754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=376.78 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=208.1
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
...+..++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|..+|+.++|||||++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3456778999999999999999999998654 4579999987542 2344567889999999999999999999985
Q ss_pred CCceEEEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
++.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 457899999999999999997654 799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
....... ......||+.|+|||++.+..|+.++|||||||
T Consensus 166 ~~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (281)
T 1mp8_A 166 MEDSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205 (281)
T ss_dssp -----------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred cCccccc----------------------------------------ccccCCCcccccChhhcccCCCCCccCchHHHH
Confidence 5422100 011346788999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 346 ilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
++|||++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+||+ +.+|+.+
T Consensus 206 ~l~ell~~g~~pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~~ 270 (281)
T 1mp8_A 206 CMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSRRPR---FTELKAQ 270 (281)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHhcCCCCCCcCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 9999997 99999998888887777653 223344 4789999999999999 9999999 8887754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=391.77 Aligned_cols=259 Identities=20% Similarity=0.337 Sum_probs=222.1
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEE
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVK 180 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t-------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~ 180 (552)
.+..+..++|.+.+.||+|+||.||+|++..+ +..||||+++... .......+.+|+.+++.+ +|||||+
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 44567788999999999999999999997543 3579999997652 344557789999999999 9999999
Q ss_pred EeeeecCCceEEEEEecCCCCchhhHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCC
Q 008810 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244 (552)
Q Consensus 181 l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKP 244 (552)
++++|.+.+.+|+||||++||+|.+++.... .+++..++.++.||+.||.|||+.|||||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999997653 499999999999999999999999999999999
Q ss_pred CCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCC
Q 008810 245 DNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324 (552)
Q Consensus 245 eNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~ 324 (552)
+||||+.+|.+||+|||+|+.+....... ......||+.|+
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~ 260 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWM 260 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTC---------------------------------------CCTTCCCGGGGS
T ss_pred ceEEEcCCCcEEEcccCcccccccccccc---------------------------------------cccCCCCCccee
Confidence 99999999999999999998654321100 011346889999
Q ss_pred ChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-Ccccc
Q 008810 325 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 325 APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|||++.+..++.++|||||||++|||++ |..||.+.+..+....+... .....| ..+++++.+||.+||. ||.+|
T Consensus 261 aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~R 337 (382)
T 3tt0_A 261 APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDCWHAVPSQR 337 (382)
T ss_dssp CHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--SSCCHHHHHHHHHHTCSSGGGS
T ss_pred CHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999999999999999999 99999998888777766643 233334 3789999999999999 99999
Q ss_pred CCCCChhhhhcC
Q 008810 403 LGAKGADEIKVH 414 (552)
Q Consensus 403 l~~~~a~eil~H 414 (552)
|+ +.||++|
T Consensus 338 ps---~~ell~~ 346 (382)
T 3tt0_A 338 PT---FKQLVED 346 (382)
T ss_dssp CC---HHHHHHH
T ss_pred cC---HHHHHHH
Confidence 99 8888875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=383.64 Aligned_cols=267 Identities=27% Similarity=0.466 Sum_probs=218.2
Q ss_pred hhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC--CCceEEEee
Q 008810 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--SNCIVKLYC 183 (552)
Q Consensus 106 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~--hp~Iv~l~~ 183 (552)
+.++...+..++|++++.||+|+||.||+|++. +|+.||||++..... .....+.+.+|+.+|..+. ||||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 345556677889999999999999999999875 588999999976532 3345677899999999997 599999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
++.+...+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. |.+||+|||++
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccc
Confidence 9999999999999 568999999998889999999999999999999999999999999999999964 99999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----------C
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----------K 332 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-----------~ 332 (552)
+.+...... ......+||+.|+|||++.+ .
T Consensus 174 ~~~~~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (313)
T 3cek_A 174 NQMQPDTTS---------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214 (313)
T ss_dssp CC-----------------------------------------------------CCGGGCCHHHHTTCC----------
T ss_pred ccccCcccc---------------------------------------ccccCCCCCCCcCCHHHHhhcccccccccccc
Confidence 865322100 01124579999999999976 4
Q ss_pred CCCCccchhhhhHHHHHHhhCCCCCCCCCh-hhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhh
Q 008810 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (552)
Q Consensus 333 ~y~~~~DiWSlGvilyEmltG~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~e 410 (552)
.++.++|||||||++|||++|..||..... ......++.......+|. ..+.++.+||.+||. ||.+||+ +.|
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps---~~e 289 (313)
T 3cek_A 215 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRIS---IPE 289 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCC---HHH
T ss_pred cCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc--cchHHHHHHHHHHccCCcccCcC---HHH
Confidence 789999999999999999999999987543 344445554333444553 568899999999999 9999999 999
Q ss_pred hhcCCCcCCC
Q 008810 411 IKVHPWFDGV 420 (552)
Q Consensus 411 il~HpfF~~i 420 (552)
|++||||+..
T Consensus 290 ll~h~~~~~~ 299 (313)
T 3cek_A 290 LLAHPYVQIQ 299 (313)
T ss_dssp HHTSHHHHCC
T ss_pred HhcCccccCC
Confidence 9999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=397.02 Aligned_cols=257 Identities=23% Similarity=0.330 Sum_probs=219.3
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++.+.||+|+||.||+|+++.+|+.||||+++... .....+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34566789999999999999999999999999999999997542 2334456889999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999999765 4699999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
..... ......+|+.|+|||++.+..|+.++|||||||++|
T Consensus 266 ~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 306 (377)
T 3cbl_A 266 GVYAA---------------------------------------SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306 (377)
T ss_dssp SEEEC---------------------------------------CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred Cceee---------------------------------------cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHH
Confidence 21000 001234678899999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||++ |.+||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 307 el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps---~~~i~~ 367 (377)
T 3cbl_A 307 ETFSLGASPYPNLSNQQTREFVEKG-GRLPCP--ELCPDAVFRLMEQCWAYEPGQRPS---FSTIYQ 367 (377)
T ss_dssp HHHTTSCCSSTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCchhCcC---HHHHHH
Confidence 9998 99999998887776666542 334444 3689999999999999 9999999 777764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=375.67 Aligned_cols=270 Identities=19% Similarity=0.230 Sum_probs=217.7
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCce
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~ 190 (552)
.+..++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|..++..+ +|++|+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4557889999999999999999999999999999999875432 23477899999999 89999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc-----EEEccccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCK 264 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~-----iKL~DFGlak 264 (552)
.|+||||+ ||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|. +||+|||+++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 99999999765 46999999999999999999999999999999999999988776 9999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
.+........ .+ .......+||+.|+|||++.+..++.++||||||
T Consensus 160 ~~~~~~~~~~-------------------~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 205 (298)
T 1csn_A 160 FYRDPVTKQH-------------------IP---------------YREKKNLSGTARYMSINTHLGREQSRRDDLEALG 205 (298)
T ss_dssp ESBCTTTCCB-------------------CC---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred cccccccccc-------------------cc---------------ccCccCCCCCcccCCchhhcCCCCChHHHHHHHH
Confidence 7643311100 00 0012256899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCC---hhhHHHHHhhccccccCCc-ccccChhHHHHHHHHhh-CccccCCCCChhhhh-------
Q 008810 345 AIMYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK------- 412 (552)
Q Consensus 345 vilyEmltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil------- 412 (552)
|++|||++|.+||.+.+ ....+..+.........+. ...+++++.+||.+||. ||.+||+ +++|+
T Consensus 206 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~---~~~l~~~l~~~~ 282 (298)
T 1csn_A 206 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD---YDYLQGLFSKVL 282 (298)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC---HHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCC---HHHHHHHHHHHH
Confidence 99999999999998853 3444444443222121111 13688999999999999 9999999 65554
Q ss_pred ---cCCCcCCCChhh
Q 008810 413 ---VHPWFDGVDWAR 424 (552)
Q Consensus 413 ---~HpfF~~i~w~~ 424 (552)
.......+||+.
T Consensus 283 ~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 283 ERLNTTEDENFDWNL 297 (298)
T ss_dssp HHTTCCSCSCCGGGC
T ss_pred HhcCCCCCCccccCC
Confidence 334455566653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=371.24 Aligned_cols=249 Identities=17% Similarity=0.239 Sum_probs=216.2
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC--
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-- 188 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-- 188 (552)
..+..++|++++.||+|+||.||+|++. |..||||+++.... .....+.+.+|+.+|..++|||||+++++|.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 4567789999999999999999999975 88999999986542 234456789999999999999999999999887
Q ss_pred ceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCccccCCCcEEEccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
..+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998765 5999999999999999999999999 9999999999999999999999999865
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCC---ccchh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM---ECDWW 341 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~---~~DiW 341 (552)
.... ...+||+.|+|||++.+..++. ++|||
T Consensus 162 ~~~~----------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~ 195 (271)
T 3kmu_A 162 SFQS----------------------------------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMW 195 (271)
T ss_dssp TTSC----------------------------------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHH
T ss_pred eecc----------------------------------------------cCccCCccccChhhhccCCCCCCCchhhHH
Confidence 3211 1357899999999999766554 79999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 342 SlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||||++|||++|..||.+.+.......+........+|. .+++++.+||.+||. ||.+||+ +++|++
T Consensus 196 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 263 (271)
T 3kmu_A 196 SFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP--GISPHVSKLMKICMNEDPAKRPK---FDMIVP 263 (271)
T ss_dssp HHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999999999999999999888888777776444445553 789999999999999 9999999 888764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=385.68 Aligned_cols=254 Identities=20% Similarity=0.344 Sum_probs=208.0
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEE----EEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVY----AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~----AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
+..++|++++.||+|+||.||+|++..+|+.+ |+|.+.... .......+.+|+.+|+.++|||||+++++|.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 56788999999999999999999998888765 666664332 233456789999999999999999999999876
Q ss_pred ceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
. .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999976 4679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... ......||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3poz_A 169 AEEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp TTCC----------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcccc---------------------------------------cccCCCccccccChHHhccCCCCchhhhhhhHHHH
Confidence 321100 01134678899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++ |.+||.+.+.......+... .....| ..++.++.+||.+||. ||.+||+ +.+|+.|
T Consensus 210 ~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~ 272 (327)
T 3poz_A 210 WELMTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMVKCWMIDADSRPK---FRELIIE 272 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCC--TTBCHHHHHHHHHHTCSCGGGSCC---HHHHHHH
T ss_pred HHHHhcCCCCccCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcCCChhhCCC---HHHHHHH
Confidence 99999 99999988877766555432 233333 4789999999999999 9999999 8888875
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=380.60 Aligned_cols=258 Identities=21% Similarity=0.314 Sum_probs=207.3
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
...++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.++..++||||++++++|.+.+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 34678999999999999999999999999999999998765444555677999999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 190 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190 (309)
T ss_dssp EEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999998765322100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 191 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 230 (309)
T 2h34_A 191 ----------------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLT 230 (309)
T ss_dssp ----------------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHH
Confidence 0124579999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|.+||.+.+.......+.. ...........+++++.+||.+||. ||.+||+. +++++.
T Consensus 231 g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s--~~~l~~ 289 (309)
T 2h34_A 231 GSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVT--CGDLSA 289 (309)
T ss_dssp SSCSSCSCHHHHHHHHHHS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSS--HHHHHH
T ss_pred CCCCCCCchHHHHHHHhcc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHh--HHHHHH
Confidence 9999988766544333332 1111111124689999999999999 99999942 666553
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=406.90 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=205.5
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
..+...+|.+.++||+|+||+|+. +...+|+.||||++.+... ..+.+|+.+|+.+ +|||||++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 345667799999999999999764 4567899999999976432 1256799999999 8999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CC--cEEEcccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YG--HLRLSDFGLC 263 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g--~iKL~DFGla 263 (552)
.+|||||||. |+|.+++.... .+++..+..++.||+.||.|||++|||||||||+||||+. +| .+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999995 69999987653 5667778899999999999999999999999999999953 33 5789999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccch
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDW 340 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~Di 340 (552)
+.+....... ......+||+.|+|||++. ...++.++||
T Consensus 171 ~~~~~~~~~~--------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Di 212 (432)
T 3p23_A 171 KKLAVGRHSF--------------------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI 212 (432)
T ss_dssp ECC--------------------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHH
T ss_pred eeccCCCcce--------------------------------------eeccccCCCcCccChhhhhcccccCCCcHHHH
Confidence 8764221000 0112468999999999998 4667889999
Q ss_pred hhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 341 WSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
|||||++|||++ |.+||...........+.... ....+.....+..+++||.+||. ||.+||+ +++|++||||.
T Consensus 213 wSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~evl~hp~f~ 288 (432)
T 3p23_A 213 FSAGCVFYYVISEGSHPFGKSLQRQANILLGACS-LDCLHPEKHEDVIARELIEKMIAMDPQKRPS---AKHVLKHPFFW 288 (432)
T ss_dssp HHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC-CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC---HHHHHTSTTTC
T ss_pred HHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC-ccccCccccccHHHHHHHHHHHhCCHhhCCC---HHHHHhCcccc
Confidence 999999999999 999997655444332222111 11112223567789999999999 9999999 99999999999
Q ss_pred CCChh
Q 008810 419 GVDWA 423 (552)
Q Consensus 419 ~i~w~ 423 (552)
+++|.
T Consensus 289 ~~~~~ 293 (432)
T 3p23_A 289 SLEKQ 293 (432)
T ss_dssp CHHHH
T ss_pred ChHHH
Confidence 99883
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=388.33 Aligned_cols=266 Identities=26% Similarity=0.440 Sum_probs=197.3
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHH-HHHhcCCCceEEEeeeecC
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~-iL~~l~hp~Iv~l~~~f~d 187 (552)
....+..++|++++.||+|+||.||+|.++.+|+.||||++..... ......+..|.. +++.++||||++++++|.+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4456788999999999999999999999999999999999976531 223334445555 6777899999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCcccccCCCCccccCCCcEEEcccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFG 261 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKPeNILl~~~g~iKL~DFG 261 (552)
.+.+|+||||++| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|++||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 77777753 57899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhh----hcCCCCCc
Q 008810 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGME 337 (552)
Q Consensus 262 lak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl----~~~~y~~~ 337 (552)
+++.+..... ....+||+.|+|||++ .+..|+.+
T Consensus 172 ~~~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 209 (327)
T 3aln_A 172 ISGQLVDSIA------------------------------------------KTRDAGCRPYMAPERIDPSASRQGYDVR 209 (327)
T ss_dssp SSCC------------------------------------------------------------------------CCSH
T ss_pred Cceecccccc------------------------------------------cccCCCCccccCceeeccccCcCCCCch
Confidence 9976532110 1134799999999999 45679999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChh-hHHHHHhhccccccCC--cccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 338 CDWWSLGAIMYEMLVGYPPFYSDDPM-STCRKIVNWRTHLKFP--EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 338 ~DiWSlGvilyEmltG~~PF~~~~~~-~~~~~i~~~~~~~~~p--~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+|||||||++|+|++|..||.+.+.. +....+... ....++ ....+++++.+||.+||. ||.+||+ +.+|++
T Consensus 210 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~ 285 (327)
T 3aln_A 210 SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK---YKELLK 285 (327)
T ss_dssp HHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC---HHHHTT
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC---HHHHHh
Confidence 99999999999999999999875432 222222221 111222 123689999999999999 9999999 999999
Q ss_pred CCCcCCCChh
Q 008810 414 HPWFDGVDWA 423 (552)
Q Consensus 414 HpfF~~i~w~ 423 (552)
||||...++.
T Consensus 286 hp~~~~~~~~ 295 (327)
T 3aln_A 286 HPFILMYEER 295 (327)
T ss_dssp SHHHHHHHHS
T ss_pred ChHHHHhHhh
Confidence 9999766544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=380.76 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=217.6
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~-----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 183 (552)
...+..++|++.+.||+|+||.||+|++ ..+++.||||++.+.. .....+.+.+|+.+|..+ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3456778999999999999999999985 3577899999997653 233456788999999999 7899999999
Q ss_pred eecCCc-eEEEEEecCCCCchhhHHhhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCC
Q 008810 184 SFQDDE-FLYLIMEYLPGGDMMTLLMRKDT----------------LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (552)
Q Consensus 184 ~f~d~~-~lylVmEy~~gG~L~~~L~~~~~----------------l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeN 246 (552)
+|.+.+ .+|+||||++||+|.+++..... +++..+..++.||+.||.|||+.||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988654 59999999999999999976543 8999999999999999999999999999999999
Q ss_pred ccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCCh
Q 008810 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (552)
Q Consensus 247 ILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~AP 326 (552)
||++.+|++||+|||+++.+...... .......||+.|+||
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aP 219 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMAP 219 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTS---------------------------------------EEETTEEECGGGCCH
T ss_pred EEECCCCCEEECCCccccccccCccc---------------------------------------eeccCCCcceeecCc
Confidence 99999999999999999865322100 011245789999999
Q ss_pred hhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCC
Q 008810 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 327 Evl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
|++.+..++.++|||||||++|||++ |.+||.+..........+........| ..+++++.+||.+||. ||.+||+
T Consensus 220 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps 297 (316)
T 2xir_A 220 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPT 297 (316)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC--CCCCHHHHHHHHHHcCCChhhCcC
Confidence 99999999999999999999999998 999998877555544444333334444 3689999999999999 9999999
Q ss_pred CCChhhhhcC
Q 008810 405 AKGADEIKVH 414 (552)
Q Consensus 405 ~~~a~eil~H 414 (552)
+.+|+.|
T Consensus 298 ---~~ell~~ 304 (316)
T 2xir_A 298 ---FSELVEH 304 (316)
T ss_dssp ---HHHHHHH
T ss_pred ---HHHHHHH
Confidence 8998876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=382.34 Aligned_cols=259 Identities=21% Similarity=0.333 Sum_probs=220.3
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCc-----EEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 183 (552)
...+..++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+|..+ +|||||++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 456778899999999999999999999977664 79999997653 234456789999999999 8999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK--------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL 249 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl 249 (552)
+|.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999999653 468999999999999999999999999999999999999
Q ss_pred cCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhh
Q 008810 250 DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329 (552)
Q Consensus 250 ~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl 329 (552)
+.+|++||+|||+++.+...... .......||+.|+|||++
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY---------------------------------------IVKGNARLPVKWMAPESI 238 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS---------------------------------------EECSSCEECGGGSCHHHH
T ss_pred CCCCeEEECccccccccccccce---------------------------------------eecCCCCCCccccCHHHh
Confidence 99999999999999865322100 011245688999999999
Q ss_pred hcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 330 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 330 ~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
.+..|+.++|||||||++|||++ |.+||.+.........++........| ..+++++.+||.+||. ||.+||+
T Consensus 239 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps--- 313 (333)
T 2i1m_A 239 FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP--AFAPKNIYSIMQACWALEPTHRPT--- 313 (333)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---
T ss_pred ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCcC---
Confidence 99999999999999999999998 999999887766666666543333334 3689999999999999 9999999
Q ss_pred hhhhhcC
Q 008810 408 ADEIKVH 414 (552)
Q Consensus 408 a~eil~H 414 (552)
+.+|+.+
T Consensus 314 ~~~l~~~ 320 (333)
T 2i1m_A 314 FQQICSF 320 (333)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8888763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=372.87 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=211.6
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhH----HHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ----VEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~----~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
...+..++|++.+.||+|+||.||+|+++.+++.||+|++.......... .+.+.+|+.++..++||||++++++|
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 92 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence 34567889999999999999999999999999999999997654322222 26788999999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCccccCCCc-----EEE
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGH-----LRL 257 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~~~g~-----iKL 257 (552)
.+.. ++||||++||+|.+++... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++. +||
T Consensus 93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 8776 6999999999998888654 57999999999999999999999999 999999999999998887 999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh--cCCCC
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYG 335 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~--~~~y~ 335 (552)
+|||+++..... ....+||+.|+|||++. ...|+
T Consensus 171 ~Dfg~~~~~~~~--------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~ 206 (287)
T 4f0f_A 171 ADFGLSQQSVHS--------------------------------------------VSGLLGNFQWMAPETIGAEEESYT 206 (287)
T ss_dssp CCCTTCBCCSSC--------------------------------------------EECCCCCCTTSCGGGSSCSSCEEC
T ss_pred CCCCcccccccc--------------------------------------------ccccCCCccccCchhhccCCCCcC
Confidence 999999743211 12467999999999994 45678
Q ss_pred CccchhhhhHHHHHHhhCCCCCCCCChhhH--HHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMST--CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 336 ~~~DiWSlGvilyEmltG~~PF~~~~~~~~--~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
.++|||||||++|||++|..||...+.... ...+........+| ..+++++.+||.+||. ||.+||+ +.+|+
T Consensus 207 ~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll 281 (287)
T 4f0f_A 207 EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP--EDCPPRLRNVIELCWSGDPKKRPH---FSYIV 281 (287)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred chhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHhcCChhhCcC---HHHHH
Confidence 999999999999999999999987654433 33444322333444 3789999999999999 9999999 88876
Q ss_pred c
Q 008810 413 V 413 (552)
Q Consensus 413 ~ 413 (552)
+
T Consensus 282 ~ 282 (287)
T 4f0f_A 282 K 282 (287)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=377.28 Aligned_cols=255 Identities=26% Similarity=0.406 Sum_probs=206.4
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~----~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
.+..++|++++.||+|+||.||+|+ +..+|+.||||++.... ....+.+.+|+.+|..++|||||+++++|.+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4667899999999999999999998 56689999999997543 3445678999999999999999999999864
Q ss_pred --CceEEEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccc
Q 008810 188 --DEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 188 --~~~lylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
...+|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999997654 59999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
.+....... .......||+.|+|||++.+..|+.++||||||
T Consensus 163 ~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 204 (295)
T 3ugc_A 163 VLPQDKEFF--------------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFG 204 (295)
T ss_dssp ---------------------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred cccCCccee--------------------------------------eeccCCCCccceeCcHHhcCCCCChHHHHHHHH
Confidence 654221000 001134578889999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChh----------------hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 345 AIMYEMLVGYPPFYSDDPM----------------STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
|++|||++|..||...... .....+ ........| ..+++++.+||.+||. ||.+||+
T Consensus 205 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps--- 278 (295)
T 3ugc_A 205 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL-KNNGRLPRP--DGCPDEIYMIMTECWNNNVNQRPS--- 278 (295)
T ss_dssp HHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH-HTTCCCCCC--TTCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred HHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH-hccCcCCCC--cCcCHHHHHHHHHHcCCChhhCCC---
Confidence 9999999999998653211 111111 111223333 4789999999999999 9999999
Q ss_pred hhhhhc
Q 008810 408 ADEIKV 413 (552)
Q Consensus 408 a~eil~ 413 (552)
+.||+.
T Consensus 279 ~~el~~ 284 (295)
T 3ugc_A 279 FRDLAL 284 (295)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=381.86 Aligned_cols=253 Identities=29% Similarity=0.491 Sum_probs=207.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhc----CCCceEEEeeee
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEV----DSNCIVKLYCSF 185 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l----~hp~Iv~l~~~f 185 (552)
...++|++.+.||+|+||.||+|+++.+|+.||||++........ .....+.+|+.++..+ +||||++++++|
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 346789999999999999999999999999999999976543221 1223356789999888 899999999999
Q ss_pred cCCceEEEEEec-CCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc-CCCcEEEcccccc
Q 008810 186 QDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLC 263 (552)
Q Consensus 186 ~d~~~lylVmEy-~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~-~~g~iKL~DFGla 263 (552)
.+.+..|+|||| +.|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++ .+|.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 79999999999888999999999999999999999999999999999999999 8999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWS 342 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWS 342 (552)
+...... ....+||+.|+|||++.+..+ +.++||||
T Consensus 188 ~~~~~~~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 224 (312)
T 2iwi_A 188 ALLHDEP-------------------------------------------YTDFDGTRVYSPPEWISRHQYHALPATVWS 224 (312)
T ss_dssp EECCSSC-------------------------------------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHH
T ss_pred hhcccCc-------------------------------------------ccccCCcccccCceeeecCCCCCccchHHH
Confidence 8654221 114579999999999988776 45899999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
|||++|||++|..||.+.. .+.. ....+|. .++.++++||.+||. ||.+||+ ++|++.||||+...
T Consensus 225 lG~il~~l~~g~~pf~~~~------~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 225 LGILLYDMVCGDIPFERDQ------EILE--AELHFPA--HVSPDCCALIRRCLAPKPSSRPS---LEEILLDPWMQTPA 291 (312)
T ss_dssp HHHHHHHHHHSSCSCCSHH------HHHH--TCCCCCT--TSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSTTTCC--
T ss_pred HHHHHHHHHHCCCCCCChH------HHhh--hccCCcc--cCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhcCch
Confidence 9999999999999997532 2332 2344553 689999999999999 9999999 99999999998753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=367.52 Aligned_cols=253 Identities=18% Similarity=0.288 Sum_probs=218.3
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
..+..++|++++.||+|+||.||+|.+. ++..||+|++.+... ..+.+.+|+.+++.++||||++++++|.+.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3466789999999999999999999986 677899999986542 23568899999999999999999999999999
Q ss_pred EEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999764 56999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.. .......||+.|+|||++.+..++.++|+|||||++|+
T Consensus 158 ~~----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 197 (267)
T 3t9t_A 158 QY----------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 197 (267)
T ss_dssp HH----------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cc----------------------------------------cccccccccccccChhhhcCCCccchhchhhhHHHHHH
Confidence 00 00123568889999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||+ +.+++.+
T Consensus 198 l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 258 (267)
T 3t9t_A 198 VFSEGKIPYENRSNSEVVEDISTGF-RLYKP--RLASTHVYQIMNHCWRERPEDRPA---FSRLLRQ 258 (267)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HhccCCCCCCCCCHHHHHHHHhcCC-cCCCC--ccCcHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 999 999999988888877776531 22233 3689999999999999 9999999 8888764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=391.42 Aligned_cols=257 Identities=19% Similarity=0.320 Sum_probs=208.1
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k---~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
..+..++|++.+.||+|+||.||+|+++ .++..||||+++... .....+.+.+|+.+|..++|||||+++++|.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 4567789999999999999999999987 467789999997542 23455678999999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999999999765 47999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
....... .......||+.|+|||++.+..|+.++|||||||+
T Consensus 198 ~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~i 239 (373)
T 2qol_A 198 EDDPEAA--------------------------------------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239 (373)
T ss_dssp ------------------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred ccCCccc--------------------------------------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHH
Confidence 4221000 00112356889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 347 lyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+|||++ |..||.+.+..+....+... ...|....++.++.+||.+||. ||.+||+ +.+|+.
T Consensus 240 l~ellt~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~~i~~ 302 (373)
T 2qol_A 240 LWEVMSYGERPYWEMSNQDVIKAVDEG---YRLPPPMDCPAALYQLMLDCWQKDRNNRPK---FEQIVS 302 (373)
T ss_dssp HHHHHTTC-CTTTTCCHHHHHHHHHTT---EECCCCTTCBHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccccHHHHHHHHHHhCcChhhCcC---HHHHHH
Confidence 999998 99999998888777776542 2333334789999999999999 9999999 777765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=382.53 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=214.7
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEE--EEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~--AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
+..++|++.+.||+|+||.||+|+++.+|..+ |+|++.... .....+.+.+|+.+|..+ +||||++++++|.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 56689999999999999999999999999866 999987532 233455688999999999 9999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g 253 (552)
.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 799999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC
Q 008810 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (552)
Q Consensus 254 ~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~ 333 (552)
.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp CEEECCTTCEESSCEEC------------------------------------------CC----CCTTTCCHHHHHHCE
T ss_pred eEEEcccCcCccccccc------------------------------------------cccCCCCCccccChhhhcccc
Confidence 99999999987432110 011346789999999999999
Q ss_pred CCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 334 y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
|+.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++++||.+||. ||.+||+ ++++
T Consensus 218 ~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~el 291 (327)
T 1fvr_A 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERPS---FAQI 291 (327)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-CCCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHH
Confidence 9999999999999999998 99999999888877777642 222333 4789999999999999 9999999 8898
Q ss_pred hcC
Q 008810 412 KVH 414 (552)
Q Consensus 412 l~H 414 (552)
+.|
T Consensus 292 l~~ 294 (327)
T 1fvr_A 292 LVS 294 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=380.96 Aligned_cols=257 Identities=19% Similarity=0.311 Sum_probs=209.2
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechh--hhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~--~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
.+..++|++++.||+|+||.||+|+++.+|+.||+|+..|.. .........+.+|+.+|+.++|||||+++++|.+..
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 356789999999999999999999999888876444433221 112345567899999999999999999999998765
Q ss_pred eEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.+..
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 7899999999999999976 46799999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
.... .......||+.|+|||++.+..|+.++|||||||++|
T Consensus 170 ~~~~---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (327)
T 3lzb_A 170 EEKE---------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVW 210 (327)
T ss_dssp -------------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred cccc---------------------------------------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHH
Confidence 2100 0011346788999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
||++ |.+||.+.+..+....+... .....| ..++.++.+||.+||. ||.+||+ +.||+..
T Consensus 211 ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~ell~~ 272 (327)
T 3lzb_A 211 ELMTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMRKCWMIDADSRPK---FRELIIE 272 (327)
T ss_dssp HHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 9999 99999998887776666542 233333 4789999999999999 9999999 8888863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=380.04 Aligned_cols=259 Identities=20% Similarity=0.346 Sum_probs=219.7
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEE
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVK 180 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-------~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~ 180 (552)
....+..++|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+|+.+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 345567789999999999999999999975 467789999997643 234566789999999999 9999999
Q ss_pred EeeeecCCceEEEEEecCCCCchhhHHhhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCC
Q 008810 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244 (552)
Q Consensus 181 l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKP 244 (552)
++++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999997654 389999999999999999999999999999999
Q ss_pred CCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCC
Q 008810 245 DNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324 (552)
Q Consensus 245 eNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~ 324 (552)
+|||++.+|++||+|||+++......... ......||+.|+
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~ 226 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYK---------------------------------------KTTNGRLPVKWM 226 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEE---------------------------------------CCSCCCCCGGGC
T ss_pred ceEEEcCCCCEEEcccccccccccccccc---------------------------------------ccCCCCccccee
Confidence 99999999999999999998654321100 011346789999
Q ss_pred ChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-Ccccc
Q 008810 325 APEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 325 APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|||++.+..++.++|||||||++|||++ |.+||.+.+..+....+... .....| ..++.++.+||.+||. ||.+|
T Consensus 227 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~R 303 (334)
T 2pvf_A 227 APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHAVPSQR 303 (334)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGS
T ss_pred ChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC-CCCCCC--ccCCHHHHHHHHHHccCChhhC
Confidence 9999999999999999999999999999 99999998887777766653 223333 3789999999999999 99999
Q ss_pred CCCCChhhhhcC
Q 008810 403 LGAKGADEIKVH 414 (552)
Q Consensus 403 l~~~~a~eil~H 414 (552)
|+ +.+|+.+
T Consensus 304 ps---~~ell~~ 312 (334)
T 2pvf_A 304 PT---FKQLVED 312 (334)
T ss_dssp CC---HHHHHHH
T ss_pred cC---HHHHHHH
Confidence 99 8888865
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=390.26 Aligned_cols=275 Identities=17% Similarity=0.190 Sum_probs=207.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhhhhH--------HHHHHHHHHHHHhcCCCceE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQ--------VEHVRAERNLLAEVDSNCIV 179 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~t-----g~~~AiK~l~k~~~~~~~~--------~~~~~~E~~iL~~l~hp~Iv 179 (552)
+..++|++++.||+|+||.||+|.++.+ ++.||||++.......... ...+..|...+..++|||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4556899999999999999999998765 5889999997653211111 12234455667778899999
Q ss_pred EEeeeecCC----ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc--CC
Q 008810 180 KLYCSFQDD----EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KY 252 (552)
Q Consensus 180 ~l~~~f~d~----~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~--~~ 252 (552)
++++++.+. .++||||||| ||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5689999999 99999999765 6899999999999999999999999999999999999999 88
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC
Q 008810 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (552)
Q Consensus 253 g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~ 332 (552)
+++||+|||+|+.+......... ........+||+.|+|||++.+.
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 236 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAY----------------------------------AADPKRCHDGTIEFTSIDAHNGV 236 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCS----------------------------------SCCSSCCCCCCTTTCCHHHHTTC
T ss_pred CeEEEEECCcceecccCCccccc----------------------------------ccCcccccCCCCCccCHHHhCCC
Confidence 99999999999876432110000 00011246799999999999999
Q ss_pred CCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhcc--ccc------cCCcccccChhHHHHHHHHhh-CccccC
Q 008810 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWR--THL------KFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 333 ~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~--~~~------~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
.|+.++|||||||++|||++|..||.+.............. ..+ .++ ...+++++.+||..||. ||.+||
T Consensus 237 ~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP 315 (364)
T 3op5_A 237 APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKP 315 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999999998644333322221110 010 011 13578999999999999 999999
Q ss_pred CCCChhhhhc----------CCCcCCCChhhhh
Q 008810 404 GAKGADEIKV----------HPWFDGVDWARIY 426 (552)
Q Consensus 404 ~~~~a~eil~----------HpfF~~i~w~~l~ 426 (552)
+ +.+|+. .++...+||..+.
T Consensus 316 ~---~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 316 L---YENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp C---HHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred C---HHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 9 555543 3455556666544
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=381.82 Aligned_cols=261 Identities=18% Similarity=0.290 Sum_probs=216.9
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~-----~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
..+..++|++++.||+|+||.||+|+ ...++..||||++.... .......+.+|+.+|+.++||||+++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 102 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence 34677899999999999999999999 55688899999996432 234455788999999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC---CcE
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHL 255 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~---g~i 255 (552)
.+...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+ +.+
T Consensus 103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 9999999999999999999999765 349999999999999999999999999999999999999944 469
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCC
Q 008810 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (552)
Q Consensus 256 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~ 335 (552)
||+|||+++........ .......||+.|+|||++.+..|+
T Consensus 183 kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~ 223 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYY---------------------------------------RKGGCAMLPVKWMPPEAFMEGIFT 223 (327)
T ss_dssp EECCCHHHHHHHC---------------------------------------------CCGGGSCGGGCCHHHHHHCCCC
T ss_pred EECcccccccccccccc---------------------------------------ccCCCcCCCcceeCHhHhcCCCCC
Confidence 99999999855322100 001245789999999999999999
Q ss_pred CccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 336 MECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 336 ~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.++|||||||++|+|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 224 ~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~ 297 (327)
T 2yfx_A 224 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRPN---FAIILE 297 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 99999999999999998 999999988877777766532 22333 3789999999999999 9999999 999999
Q ss_pred CCCcC
Q 008810 414 HPWFD 418 (552)
Q Consensus 414 HpfF~ 418 (552)
|+|+-
T Consensus 298 ~l~~~ 302 (327)
T 2yfx_A 298 RIEYC 302 (327)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=372.80 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=205.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
...++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+|+.++||||++++++|.+.+.+|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 45678999999999999999999999999999999998755445556677899999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 193 LIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
+||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 46799999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
... ......||+.|+|||++.+..++.++|+|||||++|
T Consensus 189 ~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 227 (310)
T 2wqm_A 189 KTT-----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227 (310)
T ss_dssp ---------------------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CCc-----------------------------------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHH
Confidence 110 012457999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCC--hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 349 EMLVGYPPFYSDD--PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 349 EmltG~~PF~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+|++|..||.+.. .......+.... ....+ ...+++++.+||.+||. ||.+||+ +.+|+.+
T Consensus 228 ~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps---~~~il~~ 291 (310)
T 2wqm_A 228 EMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLP-SDHYSEELRQLVNMCINPDPEKRPD---VTYVYDV 291 (310)
T ss_dssp HHHHSSCTTC---CCHHHHHHHHHTTC-SCCCC-TTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHhCCCCCcccchhHHHHHHHhhccc-CCCCc-ccccCHHHHHHHHHHcCCChhhCCC---HHHHHHH
Confidence 9999999998753 233444444321 11122 24689999999999999 9999999 8888763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=403.20 Aligned_cols=254 Identities=21% Similarity=0.351 Sum_probs=220.3
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++.+.||+|+||.||+|+++.++..||||+++... ...+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34566788999999999999999999999999999999997653 23567899999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+++.+.
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999763 469999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... ......||+.|+|||++.+..|+.++|||||||++
T Consensus 370 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l 409 (495)
T 1opk_A 370 GDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409 (495)
T ss_dssp TCCEE----------------------------------------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHH
Confidence 32110 01134578899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++ |.+||.+.+..+....+.. ......| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 410 ~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~el~~ 471 (495)
T 1opk_A 410 WEIATYGMSPYPGIDLSQVYELLEK-DYRMERP--EGCPEKVYELMRACWQWNPSDRPS---FAEIHQ 471 (495)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHT-TCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCC--CCCCHHHHHHHHHHcCcChhHCcC---HHHHHH
Confidence 99999 9999999888777766654 2233344 4789999999999999 9999999 777764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=381.13 Aligned_cols=254 Identities=19% Similarity=0.228 Sum_probs=202.3
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE- 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~- 189 (552)
..+..++|++++.||+|+||.||+|++. |+.||||++.... ........|+.+|..++|||||+++++|.+..
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3466788999999999999999999875 7899999997543 23334566888899999999999999998643
Q ss_pred ---eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCcccccCCCCccccCCCcEE
Q 008810 190 ---FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH----------HYIHRDIKPDNLLLDKYGHLR 256 (552)
Q Consensus 190 ---~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------giiHrDLKPeNILl~~~g~iK 256 (552)
.+|+|||||+||+|.+++.. ..+++..+..++.|++.||.|||+. |||||||||+|||++.+|++|
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 58999999999999999965 5699999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-----
Q 008810 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----- 331 (552)
Q Consensus 257 L~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~----- 331 (552)
|+|||+|+.+....... .....+||+.|+|||++.+
T Consensus 172 L~DFg~a~~~~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 212 (322)
T 3soc_A 172 IADFGLALKFEAGKSAG---------------------------------------DTHGQVGTRRYMAPEVLEGAINFQ 212 (322)
T ss_dssp ECCCTTCEEECTTSCCC---------------------------------------CCTTCCCCGGGCCHHHHTTCCCCC
T ss_pred EccCCcccccccccCcc---------------------------------------ccccCccCccccCHhhcccccccC
Confidence 99999998764321100 0124689999999999987
Q ss_pred CCCCCccchhhhhHHHHHHhhCCCCCCCCCh----------------hhHHHHHhhccccccCCc---ccccChhHHHHH
Q 008810 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDP----------------MSTCRKIVNWRTHLKFPE---EAKLSIEAKDLI 392 (552)
Q Consensus 332 ~~y~~~~DiWSlGvilyEmltG~~PF~~~~~----------------~~~~~~i~~~~~~~~~p~---~~~~s~e~~dLI 392 (552)
..++.++|||||||++|||++|.+||.+... ......+........++. ....++++.+||
T Consensus 213 ~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (322)
T 3soc_A 213 RDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHH
T ss_pred cCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHH
Confidence 3566789999999999999999999976432 112222222211222221 113345699999
Q ss_pred HHHhh-CccccCCCCChhhhhc
Q 008810 393 SKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 393 ~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.+||. ||.+||+ +.||++
T Consensus 293 ~~cl~~dP~~Rps---~~ell~ 311 (322)
T 3soc_A 293 EECWDHDAEARLS---AGCVGE 311 (322)
T ss_dssp HHHTCSSGGGSCC---HHHHHH
T ss_pred HHHccCChhhCcC---HHHHHH
Confidence 99999 9999999 777764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=371.04 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=215.2
Q ss_pred ccccCCCCeeEEe-eeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 110 RHKMGADDFELLT-MIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 110 ~~~~~~~~f~~~~-~IG~G~fG~V~l~~~--k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
...+..++|.+.+ .||+|+||.||+|.+ +.+++.||||+++... ......+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 3456677899998 999999999999954 5678899999997653 2334466799999999999999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
+.+.+|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 56678999999999999999998888999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
....... .......||+.|+|||++.+..++.++|||||||+
T Consensus 168 ~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 209 (291)
T 1xbb_A 168 RADENYY--------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209 (291)
T ss_dssp CTTCSEE--------------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred ccCCCcc--------------------------------------cccccCCCCceeeChHHhccCCCChhhhHHHHHHH
Confidence 4321100 00112457899999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 347 lyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+|+|++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 210 l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~l~~ 272 (291)
T 1xbb_A 210 MWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRPG---FAAVEL 272 (291)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSCC---HHHHHH
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999999 99999998887777666643 233444 3789999999999999 9999999 777764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=368.14 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=213.9
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
..+..++|++.+.||+|+||.||+|++.. ++..||+|++.+.. .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 35667899999999999999999998754 34569999998653 23345678999999999999999999999876
Q ss_pred CceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
. ..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 5 468999999999999999765 46999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 164 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 203 (281)
T 3cc6_A 164 EDEDYY----------------------------------------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVC 203 (281)
T ss_dssp -------------------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cccccc----------------------------------------ccccCCCCcceeCchhhccCCCCchhccHHHHHH
Confidence 322100 0113467889999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 347 lyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+|||++ |.+||...+.......+... .....| ..+++++.+||.+||. ||.+||+ +.+|+.|
T Consensus 204 l~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~ell~~ 267 (281)
T 3cc6_A 204 MWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKP--DLCPPVLYTLMTRCWDYDPSDRPR---FTELVCS 267 (281)
T ss_dssp HHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHccCCchhCcC---HHHHHHH
Confidence 999998 99999988777776666542 233333 3689999999999999 9999999 8888765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=376.80 Aligned_cols=258 Identities=20% Similarity=0.298 Sum_probs=213.1
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
..+..++|.+.+.||+|+||.||+|+++.++ ..||||+++... .......+.+|+.++..++|||||++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3567889999999999999999999987653 459999997543 2334556889999999999999999999999
Q ss_pred CCceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999764 6799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
+....... .......||+.|+|||++.+..++.++|||||||
T Consensus 197 ~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 238 (333)
T 1mqb_A 197 LEDDPEAT--------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238 (333)
T ss_dssp ----------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred hccccccc--------------------------------------cccCCCCccccccCchhcccCCCCchhhhHHHHH
Confidence 53221000 0011245788999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 346 ilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
++|||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+||+ +.+|+.+
T Consensus 239 il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~~ 303 (333)
T 1mqb_A 239 VMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRPK---FADIVSI 303 (333)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCC---HHHHHHH
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHCC---CcCCCcccCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 9999998 99999998888877777653 2233334789999999999999 9999999 8887764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=369.08 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=217.1
Q ss_pred ccCCCCeeEEe-eeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 112 KMGADDFELLT-MIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 112 ~~~~~~f~~~~-~IG~G~fG~V~l~~~k--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
.+..++|.++. .||+|+||.||+|.++ .++..||+|+++... .....+.+.+|+.+|..++||||+++++++. .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence 45667888887 9999999999999864 468899999998652 2345677899999999999999999999995 4
Q ss_pred ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 5689999999999999999654 569999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... .......||+.|+|||++.+..++.++|||||||++
T Consensus 162 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 203 (287)
T 1u59_A 162 ADDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203 (287)
T ss_dssp TCSCEE--------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred cCccee--------------------------------------eccccccccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 321100 001134678999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+||+ +.+|+.|
T Consensus 204 ~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~~ 266 (287)
T 1u59_A 204 WEALSYGQKPYKKMKGPEVMAFIEQG-KRMECP--PECPPELYALMSDCWIYKWEDRPD---FLTVEQR 266 (287)
T ss_dssp HHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCC--CCcCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99998 99999998887777776653 233444 3789999999999999 9999999 8888876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=393.10 Aligned_cols=247 Identities=21% Similarity=0.389 Sum_probs=213.2
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++++.||+|+||.||+|.++ |+.||||+++... ..+.+.+|+.+|+.++|||||++++++.+..
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 45677889999999999999999999875 7799999997643 3456889999999999999999999976554
Q ss_pred -eEEEEEecCCCCchhhHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
.+|+|||||+||+|.++|...+. +++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999987543 899999999999999999999999999999999999999999999999999854
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
... .....+|+.|+|||++.+..|+.++|||||||+
T Consensus 340 ~~~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~ 375 (450)
T 1k9a_A 340 SST--------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375 (450)
T ss_dssp C--------------------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHH
T ss_pred ccc--------------------------------------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHH
Confidence 211 012367899999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 347 lyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+|||++ |.+||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 376 l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dp~~Rpt---~~~l~~ 438 (450)
T 1k9a_A 376 LWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYDVMKNCWHLDAATRPT---FLQLRE 438 (450)
T ss_dssp HHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 999998 99999998887777777643 233444 4789999999999999 9999999 777653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=371.62 Aligned_cols=258 Identities=22% Similarity=0.366 Sum_probs=208.9
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~----~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
..+....|++++.||+|+||.||+|+ +..+|+.||||++.... .....+.+.+|+.+|..++||||++++++|.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34556779999999999999999999 46789999999997653 2345577899999999999999999999998
Q ss_pred CC--ceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 187 DD--EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 187 d~--~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
+. ..+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 77 679999999999999999954 467999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+.+....... .......||+.|+|||++.+..++.++|||||
T Consensus 174 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 215 (302)
T 4e5w_A 174 KAIETDKEYY--------------------------------------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215 (302)
T ss_dssp EECCTTCCEE--------------------------------------ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred ccccCCCcce--------------------------------------eccCCCCCCccccCCeeecCCCCCcchhHHHH
Confidence 8764321100 01124578999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCC--------------ChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCCh
Q 008810 344 GAIMYEMLVGYPPFYSD--------------DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (552)
Q Consensus 344 GvilyEmltG~~PF~~~--------------~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a 408 (552)
||++|+|++|..||... .........+........| ..+++++.+||.+||. ||.+||+ +
T Consensus 216 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~ 290 (302)
T 4e5w_A 216 GVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP--PNCPDEVYQLMRKCWEFQPSNRTS---F 290 (302)
T ss_dssp HHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHTTCSSGGGSCC---H
T ss_pred HHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHcCCCCCCCCC---H
Confidence 99999999999986422 1112222222222233333 4789999999999999 9999999 7
Q ss_pred hhhhc
Q 008810 409 DEIKV 413 (552)
Q Consensus 409 ~eil~ 413 (552)
.++++
T Consensus 291 ~~ll~ 295 (302)
T 4e5w_A 291 QNLIE 295 (302)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=371.64 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=209.2
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKT-TGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-tg~--~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
.+..++|++++.||+|+||.||+|++.. +++ .||||+++..........+.+.+|+.++..++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4567789999999999999999998653 333 6999999876544555677899999999999999999999999876
Q ss_pred ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
. .|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 88999999999999999764 679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... .......||+.|+|||++.+..++.++|||||||++
T Consensus 173 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (291)
T 1u46_A 173 QNDDHY--------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214 (291)
T ss_dssp C-CCEE--------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred ccccch--------------------------------------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHH
Confidence 321100 011235688899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|+|++ |.+||.+.+..+....+......... ...++.++++||.+||. ||.+||+ +.+|+.
T Consensus 215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 277 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPT---FVALRD 277 (291)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcCcCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 99999 99999999988888887764333333 34789999999999999 9999999 888876
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=395.16 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=215.9
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++.+.||+|+||.||+|.++ ++..||||+++... ...+.+.+|+.+|+.++|||||++++++. .+
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 45677789999999999999999999986 46789999998643 23567899999999999999999999986 56
Q ss_pred eEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|+|||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+++.+.
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 789999999999999999754 378999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... ......+|+.|+|||++....|+.++|||||||++
T Consensus 336 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 375 (454)
T 1qcf_A 336 DNEYT----------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375 (454)
T ss_dssp CHHHH----------------------------------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHH
Confidence 21100 01134578899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +++|+.
T Consensus 376 ~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt---~~~i~~ 437 (454)
T 1qcf_A 376 MEIVTYGRIPYPGMSNPEVIRALERG-YRMPRP--ENCPEELYNIMMRCWKNRPEERPT---FEYIQS 437 (454)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHccCChhHCcC---HHHHHH
Confidence 99999 99999998888887777652 223333 4789999999999999 9999999 777764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=391.56 Aligned_cols=254 Identities=26% Similarity=0.424 Sum_probs=210.0
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc--e
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--F 190 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~--~ 190 (552)
...++|++.++||+|+||.||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||++++++.+.. .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 456789999999999999999999999999999999986543 233566789999999999999999999998655 7
Q ss_pred EEEEEecCCCCchhhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc----cCCCcEEEcccccc
Q 008810 191 LYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl----~~~g~iKL~DFGla 263 (552)
+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997643 39999999999999999999999999999999999999 78889999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--------CCCC
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--------KGYG 335 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--------~~y~ 335 (552)
+.+.... ...+.+||+.|+|||++.+ ..|+
T Consensus 164 ~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 201 (396)
T 4eut_A 164 RELEDDE------------------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201 (396)
T ss_dssp EECCCGG------------------------------------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHH
T ss_pred eEccCCC------------------------------------------ccccccCCccccCHHHhhccccccccccCCC
Confidence 8654221 0124679999999999975 5688
Q ss_pred CccchhhhhHHHHHHhhCCCCCCCC----ChhhHHHHHhhccccc-----------------cCCc----ccccChhHHH
Q 008810 336 MECDWWSLGAIMYEMLVGYPPFYSD----DPMSTCRKIVNWRTHL-----------------KFPE----EAKLSIEAKD 390 (552)
Q Consensus 336 ~~~DiWSlGvilyEmltG~~PF~~~----~~~~~~~~i~~~~~~~-----------------~~p~----~~~~s~e~~d 390 (552)
.++|||||||++|||++|.+||... ...+...+++...... .+|. ...++..+.+
T Consensus 202 ~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 281 (396)
T 4eut_A 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281 (396)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchH
Confidence 9999999999999999999999753 3344555555422110 1111 1246678999
Q ss_pred HHHHHhh-CccccCCCCChhhhhc
Q 008810 391 LISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 391 LI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||.+||. ||.+|++ +.+++.
T Consensus 282 ll~~~L~~dP~~R~s---~~e~l~ 302 (396)
T 4eut_A 282 VLANILEADQEKCWG---FDQFFA 302 (396)
T ss_dssp HHHHHSCCCTTTSCC---HHHHHH
T ss_pred HHHHhhccChhhhcc---HHHHHH
Confidence 9999999 9999999 887754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=372.96 Aligned_cols=261 Identities=19% Similarity=0.298 Sum_probs=211.0
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeee
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~---tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 184 (552)
+....+..++|.+.+.||+|+||.||+|+... ++..||+|+++.... .....+.+.+|+.+|+.++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34556778899999999999999999998765 566899999976532 23455678999999999999999999999
Q ss_pred ecCCc-----eEEEEEecCCCCchhhHHh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC
Q 008810 185 FQDDE-----FLYLIMEYLPGGDMMTLLM------RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (552)
Q Consensus 185 f~d~~-----~lylVmEy~~gG~L~~~L~------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g 253 (552)
+.+.. ..|+||||+++|+|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 98765 4599999999999999984 345799999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC
Q 008810 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (552)
Q Consensus 254 ~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~ 333 (552)
++||+|||+++.+....... ......||+.|+|||++.+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~ 225 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRV 225 (313)
T ss_dssp CEEECSCSCC-------------------------------------------------------CCGGGSCHHHHHSSC
T ss_pred cEEEeecCcceecccccccC---------------------------------------cccccCCCccccCchhhcCCC
Confidence 99999999998653221000 011346788999999999999
Q ss_pred CCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 334 y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
|+.++|||||||++|+|++ |.+||.+.+.......+.... ...+| ..+++++.+||.+||. ||.+||+ +.+|
T Consensus 226 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~l 299 (313)
T 3brb_A 226 YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQP--EDCLDELYEIMYSCWRTDPLDRPT---FSVL 299 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCB--TTCCHHHHHHHHHTTCSSGGGSCC---HHHH
T ss_pred ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhhCcC---HHHH
Confidence 9999999999999999999 999999988888887776532 23333 4789999999999999 9999999 8888
Q ss_pred hcC
Q 008810 412 KVH 414 (552)
Q Consensus 412 l~H 414 (552)
+.|
T Consensus 300 ~~~ 302 (313)
T 3brb_A 300 RLQ 302 (313)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=377.88 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=211.3
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec--
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-- 186 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~----~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-- 186 (552)
+..++|++++.||+|+||.||+|+ ...+++.||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 556889999999999999999999 46789999999997653 344567899999999999999999999886
Q ss_pred CCceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
+...+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 56679999999999999999976 45699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
........ .......||+.|+|||++.+..++.++|||||||
T Consensus 177 ~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 218 (327)
T 3lxl_A 177 LPLDKDYY--------------------------------------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218 (327)
T ss_dssp CCTTCSEE--------------------------------------ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHH
T ss_pred cccCCccc--------------------------------------eeeccCCccccccCHHHhccCCCChHHhHHHHHH
Confidence 64321100 0112356899999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChh--------------hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhh
Q 008810 346 IMYEMLVGYPPFYSDDPM--------------STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~--------------~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~e 410 (552)
++|+|++|..||...... ......+........ ...+++++.+||.+||. ||.+||+ +.+
T Consensus 219 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps---~~e 293 (327)
T 3lxl_A 219 VLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA--PPACPAEVHELMKLCWAPSPQDRPS---FSA 293 (327)
T ss_dssp HHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCC---HHH
T ss_pred HHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC--CCcccHHHHHHHHHHcCCChhhCcC---HHH
Confidence 999999999999754322 111122221222233 34789999999999999 9999999 777
Q ss_pred hhcC
Q 008810 411 IKVH 414 (552)
Q Consensus 411 il~H 414 (552)
|+.|
T Consensus 294 ll~~ 297 (327)
T 3lxl_A 294 LGPQ 297 (327)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=363.91 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=214.6
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++++.||+|+||.||+|++. ++..||+|++..... ..+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 34567789999999999999999999865 567899999976532 24568899999999999999999999874 4
Q ss_pred eEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 5899999999999999997543 79999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 200 (279)
T 1qpc_A 161 DNEYT----------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (279)
T ss_dssp SSCEE----------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred Ccccc----------------------------------------cccCCCCccCccChhhhccCCCCchhhhHHHHHHH
Confidence 32110 01134678999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 201 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 262 (279)
T 1qpc_A 201 TEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRP--DNCPEELYQLMRLCWKERPEDRPT---FDYLRS 262 (279)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCc--ccccHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 99999 99999998888777777642 222333 4789999999999999 9999999 777764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=378.71 Aligned_cols=259 Identities=21% Similarity=0.289 Sum_probs=211.8
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
......++|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 34456789999999999999999999864 68999999987542 344667899999999999999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~----~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999996543 599999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
....... ......+||+.|+|||++.+..|+.++|||||||
T Consensus 189 ~~~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 229 (321)
T 2qkw_B 189 GTELDQT---------------------------------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229 (321)
T ss_dssp CSSSSCC---------------------------------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHH
T ss_pred ccccccc---------------------------------------ccccccCCCccccCHHHhcCCCCCcccchHhHHH
Confidence 4321100 0112457999999999999999999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHH-------hhcc------ccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKI-------VNWR------THLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i-------~~~~------~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
++|||++|.+||.+..+.+....+ .... ..+.......++.++.+||.+||. ||.+||+ +.||
T Consensus 230 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~el 306 (321)
T 2qkw_B 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS---MGDV 306 (321)
T ss_dssp HHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred HHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcC---HHHH
Confidence 999999999999876543321111 0000 000111123567789999999999 9999999 8888
Q ss_pred hcC
Q 008810 412 KVH 414 (552)
Q Consensus 412 l~H 414 (552)
+.|
T Consensus 307 l~~ 309 (321)
T 2qkw_B 307 LWK 309 (321)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=391.86 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=197.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylV 194 (552)
+.|.+.++||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.+...+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 44566789999999999875 45689999999987542 24567899999876 899999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC-------------Cc
Q 008810 195 MEYLPGGDMMTLLMRKDTL-------TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-------------GH 254 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l-------~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~-------------g~ 254 (552)
||||. |+|.+++...... ++..+..++.||+.||.|||++|||||||||+|||++.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 6999999765433 333567799999999999999999999999999999754 48
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---
Q 008810 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--- 331 (552)
Q Consensus 255 iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--- 331 (552)
+||+|||+|+.+....... .......+||+.|+|||++.+
T Consensus 167 ~kL~DFG~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~ 209 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSF-------------------------------------RTNLNNPSGTSGWRAPELLEESNN 209 (434)
T ss_dssp EEECCCTTCEECCC---------------------------------------------------CCTTSCHHHHSCCCT
T ss_pred EEEcccccceecCCCCccc-------------------------------------eeeecCCCCCCCccCHHHhccccc
Confidence 9999999998764321000 000124689999999999976
Q ss_pred ----CCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhcccccc---CCcccccChhHHHHHHHHhh-Ccccc
Q 008810 332 ----KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLK---FPEEAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 332 ----~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~---~p~~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
..++.++|||||||++|||++ |.+||.+..... ..++.....+. ......+++++++||.+||+ ||.+|
T Consensus 210 ~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (434)
T 2rio_A 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287 (434)
T ss_dssp TSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred cccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhC
Confidence 678999999999999999999 999997665433 33443222211 11123567899999999999 99999
Q ss_pred CCCCChhhhhcCCCcCCC
Q 008810 403 LGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 403 l~~~~a~eil~HpfF~~i 420 (552)
|+ +.+|++||||.+.
T Consensus 288 ps---~~eil~hp~f~~~ 302 (434)
T 2rio_A 288 PT---AMKVLRHPLFWPK 302 (434)
T ss_dssp CC---HHHHHTSGGGSCH
T ss_pred CC---HHHHHhCCccCCc
Confidence 99 9999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=383.24 Aligned_cols=261 Identities=20% Similarity=0.219 Sum_probs=203.0
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhh--------hhHHHHHHHHHHHHHhcCCCceEEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLR--------RGQVEHVRAERNLLAEVDSNCIVKL 181 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~---tg~~~AiK~l~k~~~~~--------~~~~~~~~~E~~iL~~l~hp~Iv~l 181 (552)
+..++|++.+.||+|+||.||+|+++. ++..||||++.+..... ......+.+|..++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456789999999999999999999987 88899999998653211 1112336678888999999999999
Q ss_pred eeeecC----CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC--cE
Q 008810 182 YCSFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG--HL 255 (552)
Q Consensus 182 ~~~f~d----~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g--~i 255 (552)
++++.+ ...+|+||||+ ||+|.+++...+.+++..+..++.||+.||.|||++|||||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999887 78999999999 999999998888999999999999999999999999999999999999999887 99
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCC
Q 008810 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (552)
Q Consensus 256 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~ 335 (552)
||+|||+|+.+........ .........+||+.|+|||++.+..|+
T Consensus 193 kL~Dfg~a~~~~~~~~~~~----------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~ 238 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQ----------------------------------YQENPRKGHNGTIEFTSLDAHKGVALS 238 (345)
T ss_dssp EECCCTTCEESSGGGCCCC----------------------------------CCCCGGGCSCSCTTTCCHHHHHTCCCC
T ss_pred EEEeCCCceeccccccccc----------------------------------chhccccccCCCccccCHHHhcCCCCC
Confidence 9999999987643210000 000011356899999999999999999
Q ss_pred CccchhhhhHHHHHHhhCCCCCCCC--ChhhHHHHHhhccccccCCcc-------cccChhHHHHHHHHhh-CccccCCC
Q 008810 336 MECDWWSLGAIMYEMLVGYPPFYSD--DPMSTCRKIVNWRTHLKFPEE-------AKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 336 ~~~DiWSlGvilyEmltG~~PF~~~--~~~~~~~~i~~~~~~~~~p~~-------~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
.++|||||||++|||++|..||.+. +.......... ....+|.. ..+++++++||.+||. ||.+||+
T Consensus 239 ~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps- 315 (345)
T 2v62_A 239 RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN--LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN- 315 (345)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHH--HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC-
T ss_pred chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHh--hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC-
Confidence 9999999999999999999999653 22222221111 11122221 1688899999999999 9999999
Q ss_pred CChhhhhc
Q 008810 406 KGADEIKV 413 (552)
Q Consensus 406 ~~a~eil~ 413 (552)
+++|+.
T Consensus 316 --~~~l~~ 321 (345)
T 2v62_A 316 --YQALKK 321 (345)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 777765
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.45 Aligned_cols=266 Identities=19% Similarity=0.283 Sum_probs=209.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEe-eeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY-CSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~-~~f~d~~~lyl 193 (552)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|..++..+.|++++..+ .++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 46899999999999999999999999999999997655322 2377899999999887765555 45567888999
Q ss_pred EEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc---cCCCcEEEcccccccccCCC
Q 008810 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl---~~~g~iKL~DFGlak~~~~~ 269 (552)
||||+ ||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999974 5679999999999999999999999999999999999999 78999999999999876433
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
..... . +. ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 162 ~~~~~----------------~---~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 4hgt_A 162 RTHQH----------------I---PY---------------RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp TTCCB----------------C---CC---------------CCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCcc----------------C---CC---------------CcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHH
Confidence 21000 0 00 01124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChh---hHHHHHhhccccccCCcc---cccChhHHHHHHHHhh-CccccCCCCChhhhhc---------
Q 008810 350 MLVGYPPFYSDDPM---STCRKIVNWRTHLKFPEE---AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV--------- 413 (552)
Q Consensus 350 mltG~~PF~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~--------- 413 (552)
|++|.+||.+.+.. ..+..+... ....|.. ..+++++.+||.+||. ||.+||+ +.+|++
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 208 FNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD---YSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC---HHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcccchhhhhhhhhhhhcc--cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCC---HHHHHHHHHHHHHHh
Confidence 99999999875432 334444332 2222211 3578999999999999 9999999 666554
Q ss_pred -CCCcCCCChhhh
Q 008810 414 -HPWFDGVDWARI 425 (552)
Q Consensus 414 -HpfF~~i~w~~l 425 (552)
.+|-..+||+.+
T Consensus 283 ~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 283 GFSYDYVFDWNML 295 (296)
T ss_dssp TCCTTCCCGGGGC
T ss_pred CCCccCccchhhc
Confidence 466666777765
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=392.17 Aligned_cols=248 Identities=17% Similarity=0.242 Sum_probs=196.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----hhhHHHHHHHHHHHHHhcC---------C---
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVD---------S--- 175 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~---------h--- 175 (552)
+..++|++++.||+|+||+||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++ |
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3456799999999999999999987 7899999999876421 2334467889999998886 4
Q ss_pred --------------CceEEEeeeecC-------------CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHH
Q 008810 176 --------------NCIVKLYCSFQD-------------DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228 (552)
Q Consensus 176 --------------p~Iv~l~~~f~d-------------~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~a 228 (552)
||||+++++|.+ ...+|||||||+||++...+.+ ..+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 455555555554 7899999999999988777754 679999999999999999
Q ss_pred HHHHH-hCCCcccccCCCCccccCCC--------------------cEEEcccccccccCCCCcccccccccCCCCCCCC
Q 008810 229 IESIH-KHHYIHRDIKPDNLLLDKYG--------------------HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287 (552)
Q Consensus 229 L~~LH-~~giiHrDLKPeNILl~~~g--------------------~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~ 287 (552)
|.||| ++|||||||||+||||+.+| ++||+|||+|+.....
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------ 235 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------ 235 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------------
Confidence 99999 99999999999999999887 9999999999865311
Q ss_pred CCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH-HHHHhhCCCCCCCCCh-hhH
Q 008810 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI-MYEMLVGYPPFYSDDP-MST 365 (552)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi-lyEmltG~~PF~~~~~-~~~ 365 (552)
..+||+.|+|||++.+.. +.++||||||++ .++++.|..||.+... ...
T Consensus 236 ----------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~ 286 (336)
T 2vuw_A 236 ----------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYL 286 (336)
T ss_dssp ----------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHH
T ss_pred ----------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHH
Confidence 358999999999998766 899999998776 8889999999954211 112
Q ss_pred HHHHhh---ccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh-cCCCcC
Q 008810 366 CRKIVN---WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK-VHPWFD 418 (552)
Q Consensus 366 ~~~i~~---~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil-~HpfF~ 418 (552)
...+.. .......+....+|+++++||.+||+ | + |+|++ +||||+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s---a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 287 TDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S---ATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S---HHHHHHHCGGGC
T ss_pred HHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C---HHHHHhcCCCcC
Confidence 233332 11111111134689999999999998 5 4 99999 999995
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=367.54 Aligned_cols=253 Identities=28% Similarity=0.370 Sum_probs=201.2
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh--cCCCceEEEeeeec---
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQ--- 186 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~--- 186 (552)
.+..++|++++.||+|+||.||+|++ +|+.||||++.... ...+..|.+++.. ++||||+++++++.
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 35578899999999999999999986 68899999997542 3445667778777 79999999998854
Q ss_pred -CCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccccCCCCccccCCCcEEE
Q 008810 187 -DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH--------KHHYIHRDIKPDNLLLDKYGHLRL 257 (552)
Q Consensus 187 -d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~giiHrDLKPeNILl~~~g~iKL 257 (552)
+...+|+||||++||+|.+++. ...+++..+..++.||+.||.||| +.|||||||||+|||++.+|++||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3467999999999999999994 467999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-----
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK----- 332 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~----- 332 (552)
+|||+|+......... .......+||+.|+|||++.+.
T Consensus 155 ~Dfg~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 197 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQL-------------------------------------DVGNNPRVGTKRYMAPEVLDETIQVDC 197 (301)
T ss_dssp CCCTTCEEEETTTTEE-------------------------------------ECCCCCCCCCGGGCCHHHHTTCCCTTC
T ss_pred eeCCCeeecccccccc-------------------------------------cccccccccccceeChhhhcCcCCCCc
Confidence 9999998654321110 0011245899999999999876
Q ss_pred -CCCCccchhhhhHHHHHHhhC----------CCCCCCCCh----hhHHHHHhh-ccccccCCcc---cccChhHHHHHH
Q 008810 333 -GYGMECDWWSLGAIMYEMLVG----------YPPFYSDDP----MSTCRKIVN-WRTHLKFPEE---AKLSIEAKDLIS 393 (552)
Q Consensus 333 -~y~~~~DiWSlGvilyEmltG----------~~PF~~~~~----~~~~~~i~~-~~~~~~~p~~---~~~s~e~~dLI~ 393 (552)
.++.++|||||||++|||++| .+||..... .....++.. ......+|.. ..+++++.+||.
T Consensus 198 ~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 277 (301)
T 3q4u_A 198 FDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHH
T ss_pred ccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHH
Confidence 455799999999999999999 899976432 223333332 1222233321 235678999999
Q ss_pred HHhh-CccccCCCCChhhhhc
Q 008810 394 KLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 394 ~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+||. ||.+||+ +.+|++
T Consensus 278 ~cl~~dP~~Rps---~~~i~~ 295 (301)
T 3q4u_A 278 ECWYQNPSARLT---ALRIKK 295 (301)
T ss_dssp HHCCSSGGGSCC---HHHHHH
T ss_pred HHhhcChhhCCC---HHHHHH
Confidence 9999 9999999 888765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=363.76 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=209.4
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE-E
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL-Y 192 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l-y 192 (552)
.|.+.+.||+|+||.||+|++..++. .||+|++.... .....+.+.+|+.+|+.++|||||+++++|.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46778999999999999999866554 79999987532 344567789999999999999999999999877665 9
Q ss_pred EEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
+||||+.||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+.....
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 46799999999999999999999999999999999999999999999999999986533211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.. ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 180 ~~-------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 222 (298)
T 3pls_A 180 YS-------------------------------------VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222 (298)
T ss_dssp GC-------------------------------------SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred cc-------------------------------------cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHh
Confidence 00 00112457899999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 352 t-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+ |.+||...+.......+... .....| ..+++++.+||.+||. ||.+||+ +.+++.
T Consensus 223 ~g~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 280 (298)
T 3pls_A 223 TRGAPPYRHIDPFDLTHFLAQG-RRLPQP--EYCPDSLYQVMQQCWEADPAVRPT---FRVLVG 280 (298)
T ss_dssp HTSCCTTTTSCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred hCCCCCCccCCHHHHHHHhhcC-CCCCCC--ccchHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 9 56666666766666666542 223333 4789999999999999 9999999 887765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=365.08 Aligned_cols=242 Identities=25% Similarity=0.424 Sum_probs=207.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--------
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-------- 187 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-------- 187 (552)
.+|++++.||+|+||.||+|+++.+|+.||+|++.... +.+.+|+.++..++||||++++++|.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 56999999999999999999999999999999997643 236689999999999999999998864
Q ss_pred --------CceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEE
Q 008810 188 --------DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (552)
Q Consensus 188 --------~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL 257 (552)
...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|++||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45689999999999999999654 67999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCc
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~ 337 (552)
+|||+++.+..... ....+||+.|+|||++.+..++.+
T Consensus 164 ~Dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 201 (284)
T 2a19_B 164 GDFGLVTSLKNDGK------------------------------------------RTRSKGTLRYMSPEQISSQDYGKE 201 (284)
T ss_dssp CCCTTCEESSCCSC------------------------------------------CCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred Ccchhheecccccc------------------------------------------ccccCCcccccChhhhccCCCcch
Confidence 99999986543210 113579999999999999999999
Q ss_pred cchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 338 ~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
+|+|||||++|+|++|..||... ......+.. ..++ ..++.++++||.+||. ||.+||+ +.|++.|++
T Consensus 202 ~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~~l~ 270 (284)
T 2a19_B 202 VDLYALGLILAELLHVCDTAFET--SKFFTDLRD----GIIS--DIFDKKEKTLLQKLLSKKPEDRPN---TSEILRTLT 270 (284)
T ss_dssp HHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT----TCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc----cccc--ccCCHHHHHHHHHHccCChhhCcC---HHHHHHHHH
Confidence 99999999999999999998532 222223322 1233 2678999999999999 9999999 999999977
Q ss_pred c
Q 008810 417 F 417 (552)
Q Consensus 417 F 417 (552)
+
T Consensus 271 ~ 271 (284)
T 2a19_B 271 V 271 (284)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=382.01 Aligned_cols=242 Identities=18% Similarity=0.256 Sum_probs=198.4
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEE-----EEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCceEEE
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVC-----REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKL 181 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~-----~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l 181 (552)
...+..++|.+.+.||+|+||.||+| .+..+++.||||++.... ...+..|..++..+. |+||+++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 34567788999999999999999999 467789999999997542 335677888888886 8999999
Q ss_pred eeeecCCceEEEEEecCCCCchhhHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-----
Q 008810 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK----- 251 (552)
Q Consensus 182 ~~~f~d~~~lylVmEy~~gG~L~~~L~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~----- 251 (552)
++++.+.+..|||||||+||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC
T ss_pred heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCc
Confidence 9999999999999999999999999974 467999999999999999999999999999999999999998
Q ss_pred ------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 252 ------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 252 ------~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
++++||+|||+|+.+...... ......+||+.|+|
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~---------------------------------------~~~~~~~gt~~y~a 253 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKG---------------------------------------TIFTAKCETSGFQC 253 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTT---------------------------------------EEECCSSCTTSCCC
T ss_pred cccccccCCEEEeeCchhhhhhccCCC---------------------------------------ceeeeecCCCCCCC
Confidence 899999999999765311100 01235689999999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCC
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
||++.+..|+.++|||||||++|||++|.+||....... +.....++. ...++...++|.+||. +|.+|+.
T Consensus 254 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 254 VEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------CKPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------EEECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred hHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------eeechhccc-cCcHHHHHHHHHHHcCCCCCCcch
Confidence 999999999999999999999999999999997543321 111111211 1346788999999999 9999976
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=365.32 Aligned_cols=259 Identities=18% Similarity=0.279 Sum_probs=201.4
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
....++..++|++.+.||+|+||.||+|++.. .||+|+++... ......+.+.+|+.+|+.++||||+++++++ .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 34567888999999999999999999997543 59999997553 2345567799999999999999999999955 5
Q ss_pred CceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
...+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 5678999999999999999954 467999999999999999999999999999999999999999999999999999754
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh---cCCCCCccchhhh
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSL 343 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~---~~~y~~~~DiWSl 343 (552)
...... ......+||+.|+|||++. +..|+.++|||||
T Consensus 171 ~~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~sl 211 (289)
T 3og7_A 171 SRWSGS---------------------------------------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAF 211 (289)
T ss_dssp ----------------------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHH
T ss_pred cccccc---------------------------------------ccccccCCCccccCchhhcccCCCCCCcccchHHH
Confidence 321100 0012457999999999997 5678999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhcc-ccccCCc-ccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWR-THLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~-~~~~~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
||++|+|++|..||.+.+.......++... .....+. ...+++++++||.+||. ||.+||+ +.+|+.
T Consensus 212 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 281 (289)
T 3og7_A 212 GIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS---FPRILA 281 (289)
T ss_dssp HHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCC---HHHHHH
Confidence 999999999999998876655554444321 1111111 13688999999999999 9999999 887764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=380.47 Aligned_cols=265 Identities=21% Similarity=0.270 Sum_probs=210.9
Q ss_pred hhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 106 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
+.+....+..++|++.+.||+|+||.||+|+. .+|+.||||++....... ....+.+|+.++..++|||||+++++|
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEE
Confidence 34455667789999999999999999999974 468999999998654221 222588999999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCcccccCCCCccccCCCcEEEc
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLS 258 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~~----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKPeNILl~~~g~iKL~ 258 (552)
.+....|+||||++||+|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.+|++||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997543 499999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCcc
Q 008810 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338 (552)
Q Consensus 259 DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~ 338 (552)
|||+++........ .....+||+.|+|||++.+..++.++
T Consensus 177 Dfg~~~~~~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 216 (326)
T 3uim_A 177 DFGLAKLMDYKDTH----------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKT 216 (326)
T ss_dssp CCSSCEECCSSSSC----------------------------------------EECCCCSCGGGCCHHHHHHSEECHHH
T ss_pred cCccccccCccccc----------------------------------------ccccccCCcCccCHHHhccCCCCccc
Confidence 99999876432110 11245699999999999999999999
Q ss_pred chhhhhHHHHHHhhCCCCCCC----CChhhHHHHHhh-cccc----------ccCCcccccChhHHHHHHHHhh-Ccccc
Q 008810 339 DWWSLGAIMYEMLVGYPPFYS----DDPMSTCRKIVN-WRTH----------LKFPEEAKLSIEAKDLISKLLC-NVNQR 402 (552)
Q Consensus 339 DiWSlGvilyEmltG~~PF~~----~~~~~~~~~i~~-~~~~----------~~~p~~~~~s~e~~dLI~~lL~-dp~~R 402 (552)
|||||||++|+|++|.+||.. ..........+. .... +..+.....+.++.+||.+||. ||.+|
T Consensus 217 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 296 (326)
T 3uim_A 217 DVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMER 296 (326)
T ss_dssp HHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGS
T ss_pred cchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccC
Confidence 999999999999999999952 111111111111 0000 0001112456789999999999 99999
Q ss_pred CCCCChhhhhcCCC
Q 008810 403 LGAKGADEIKVHPW 416 (552)
Q Consensus 403 l~~~~a~eil~Hpf 416 (552)
|+ +.||++|-.
T Consensus 297 ps---~~ell~~L~ 307 (326)
T 3uim_A 297 PK---MSEVVRMLE 307 (326)
T ss_dssp CC---HHHHHHHHH
T ss_pred CC---HHHHHHHhc
Confidence 99 899988744
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.82 Aligned_cols=246 Identities=21% Similarity=0.387 Sum_probs=205.9
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-c
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-E 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-~ 189 (552)
..+..++|++++.||+|+||.||+|++. |+.||||+++... ..+.+.+|+.+++.++||||+++++++.+. .
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 4567789999999999999999999864 8899999997542 345688999999999999999999987544 5
Q ss_pred eEEEEEecCCCCchhhHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~--l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|+||||++||+|.+++..... +++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 79999999999999999976543 8999999999999999999999999999999999999999999999999987542
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
.. .....||+.|+|||++.+..++.++|||||||++
T Consensus 169 ~~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 204 (278)
T 1byg_A 169 ST--------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 204 (278)
T ss_dssp ---------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred cc--------------------------------------------ccCCCccccccCHHHhCCCCCCchhcHHHHHHHH
Confidence 11 0124678999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|+|++ |.+||...+..+....+... .....| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 205 ~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 266 (278)
T 1byg_A 205 WEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYEVMKNCWHLDAAMRPS---FLQLRE 266 (278)
T ss_dssp HHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCc--ccCCHHHHHHHHHHhcCChhhCCC---HHHHHH
Confidence 99998 99999988877777776642 223333 4789999999999999 9999999 777764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=364.17 Aligned_cols=254 Identities=17% Similarity=0.282 Sum_probs=209.7
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee-cCCce
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF-QDDEF 190 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f-~d~~~ 190 (552)
..+|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|..+|+.++||||+++++++ .++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 45699999999999999999997543 3468999987532 344567789999999999999999999985 56678
Q ss_pred EEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|++||+|||+++.+...
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999975 456899999999999999999999999999999999999999999999999999865432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.... ........||+.|+|||++.+..++.++|||||||++|+
T Consensus 182 ~~~~-------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 224 (298)
T 3f66_A 182 EYYS-------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224 (298)
T ss_dssp GGCB-------------------------------------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred chhc-------------------------------------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHH
Confidence 1100 000124578999999999999999999999999999999
Q ss_pred Hhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 350 mlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||+ +.+|++
T Consensus 225 l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 284 (298)
T 3f66_A 225 LMTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRPS---FSELVS 284 (298)
T ss_dssp HHTTSCCSSTTSCTTTHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHhCCCCCCccCCHHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999 778888877777777766532 22223 3689999999999999 9999999 777765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=372.03 Aligned_cols=262 Identities=23% Similarity=0.366 Sum_probs=209.6
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec----C
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ----D 187 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~----d 187 (552)
.+..++|++++.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 456778999999999999999999999999999999987642 345567889999999999999999999986 4
Q ss_pred CceEEEEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
...+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 5689999999999999999875 467999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC---CCCccch
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDW 340 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~---y~~~~Di 340 (552)
+......... ........ .....||+.|+|||++.+.. ++.++||
T Consensus 182 ~~~~~~~~~~------------------------~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 229 (317)
T 2buj_A 182 NQACIHVEGS------------------------RQALTLQD--------WAAQRCTISYRAPELFSVQSHCVIDERTDV 229 (317)
T ss_dssp EESCEEEESH------------------------HHHHHHHH--------HHHHHSCGGGCCGGGSSCCSEEEECTHHHH
T ss_pred hhcccccccc------------------------cccccccc--------cccccCCcccCCHhHhccCCCcCCCchhhH
Confidence 7653210000 00000001 12357899999999998654 7899999
Q ss_pred hhhhHHHHHHhhCCCCCCCCC--hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 341 WSLGAIMYEMLVGYPPFYSDD--PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 341 WSlGvilyEmltG~~PF~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||||++|||++|..||.... .......+. ....+|....+++++.+||.+||. ||.+||+ +.+|++|
T Consensus 230 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 300 (317)
T 2buj_A 230 WSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ---NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH---IPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH---CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHHHhCCCChhhhhcccchhhHHhh---ccCCCCccccCCHHHHHHHHHHhhcChhhCCC---HHHHHHH
Confidence 999999999999999995421 111222222 233445445789999999999999 9999999 8998875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=370.43 Aligned_cols=263 Identities=22% Similarity=0.362 Sum_probs=193.1
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeee---
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSF--- 185 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f--- 185 (552)
...+...+|++.+.||+|+||.||+|+++.+|+.||||++.+.. ......+.+|+.+|..+. |||||+++++|
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 44566678999999999999999999999999999999986553 334556889999999995 99999999998
Q ss_pred -----cCCceEEEEEecCCCCchhhHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCccccCCCcE
Q 008810 186 -----QDDEFLYLIMEYLPGGDMMTLLMR---KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHL 255 (552)
Q Consensus 186 -----~d~~~lylVmEy~~gG~L~~~L~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~~~g~i 255 (552)
.+...+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.| |+||||||+|||++.+|++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 45567999999995 789888864 467999999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhh---hcC
Q 008810 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKK 332 (552)
Q Consensus 256 KL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl---~~~ 332 (552)
||+|||+++.+........ . . ............+||+.|+|||++ .+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~--~------------~---------------~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSW--S------------A---------------QRRALVEEEITRNTTPMYRTPEIIDLYSNF 228 (337)
T ss_dssp EBCCCTTCBCCSSCC------------------------------------------------------------CCTTS
T ss_pred EEecCccceeccccCcccc--c------------c---------------cccccchhhccccCCCCcCChhhhhccccC
Confidence 9999999987643211000 0 0 000000011246799999999999 567
Q ss_pred CCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 333 ~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
.++.++|||||||++|||++|..||........... ....+....++..+.+||.+||. ||.+||+ +.|+
T Consensus 229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~ 299 (337)
T 3ll6_A 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLS---IAEV 299 (337)
T ss_dssp CSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCC---HHHH
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC------cccCCcccccchHHHHHHHHHccCChhhCcC---HHHH
Confidence 789999999999999999999999976554433222 22333344678899999999999 9999998 9999
Q ss_pred hcC
Q 008810 412 KVH 414 (552)
Q Consensus 412 l~H 414 (552)
+.|
T Consensus 300 l~~ 302 (337)
T 3ll6_A 300 VHQ 302 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=364.14 Aligned_cols=244 Identities=26% Similarity=0.421 Sum_probs=198.9
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.+..++|++.+.||+|+||.||+|++. ++.||||++... ...+.+.+|+.+|+.++|||||++++++.+. .
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~ 74 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNP--V 74 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--T
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--c
Confidence 356678999999999999999999874 789999998643 2346688999999999999999999998854 7
Q ss_pred EEEEecCCCCchhhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCcccccCCCCccccCCCc-EEEccccccc
Q 008810 192 YLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHK---HHYIHRDIKPDNLLLDKYGH-LRLSDFGLCK 264 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKPeNILl~~~g~-iKL~DFGlak 264 (552)
|+||||++||+|.+++.... .+++..+..++.|++.||.|||+ +||+||||||+|||++.+|. +||+|||++.
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 75 CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 89999999999999997654 47899999999999999999999 89999999999999998887 7999999987
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
..... .....||+.|+|||++.+..++.++||||||
T Consensus 155 ~~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 190 (307)
T 2eva_A 155 DIQTH--------------------------------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWG 190 (307)
T ss_dssp ------------------------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHH
T ss_pred ccccc--------------------------------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHH
Confidence 54211 0134699999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChh--hHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 345 AIMYEMLVGYPPFYSDDPM--STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|++|||++|..||...... .....+... ....+ ...+++++.+||.+||. ||.+||+ +++|+.+
T Consensus 191 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~~ 257 (307)
T 2eva_A 191 IILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPL--IKNLPKPIESLMTRCWSKDPSQRPS---MEEIVKI 257 (307)
T ss_dssp HHHHHHHHTCCTTTTTCSSHHHHHHHHHTT-CCCCC--BTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHCCCCchhhCccHHHHHHHHhcC-CCCCc--ccccCHHHHHHHHHHhcCChhhCcC---HHHHHHH
Confidence 9999999999999864322 222233221 12222 24789999999999999 9999999 8888763
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=387.81 Aligned_cols=252 Identities=20% Similarity=0.353 Sum_probs=211.4
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++.+.||+|+||.||+|.++. +..||||+++.... ..+.+.+|+.+|+.++|||||++++++.+ +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345677889999999999999999999875 45799999986532 23568899999999999999999999876 6
Q ss_pred eEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|+|||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+++.+.
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 789999999999999999743 569999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... ......||+.|+|||++.+..|+.++|||||||++
T Consensus 332 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l 371 (452)
T 1fmk_A 332 DNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371 (452)
T ss_dssp ---------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------cccCCcccccccCHhHHhcCCCCccccHHhHHHHH
Confidence 21100 01134578899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +++|+.
T Consensus 372 ~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt---~~~l~~ 433 (452)
T 1fmk_A 372 TELTTKGRVPYPGMVNREVLDQVERG-YRMPCP--PECPESLHDLMCQCWRKEPEERPT---FEYLQA 433 (452)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 99999 99999998888887777642 233334 4789999999999999 9999999 777765
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=389.72 Aligned_cols=274 Identities=19% Similarity=0.234 Sum_probs=218.9
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CceEEEeeeecCCceEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~ly 192 (552)
..++|++++.||+|+||.||+|++..+|+.||||++...... ..+..|..++..+.| ++|+.+..++.+....|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 457899999999999999999999999999999998765322 237789999999977 56667777777888999
Q ss_pred EEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc---cCCCcEEEcccccccccCC
Q 008810 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl---~~~g~iKL~DFGlak~~~~ 268 (552)
|||||+ ||+|.+++.. ...|++..++.++.||+.||.|||++|||||||||+|||| +.++++||+|||+|+.+..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 5689999999999999999999999999999999999999 6889999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
...... .+ -......+||+.|+|||++.+..|+.++||||||||||
T Consensus 159 ~~~~~~-------------------~~---------------~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ 204 (483)
T 3sv0_A 159 TSTHQH-------------------IP---------------YRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204 (483)
T ss_dssp TTTCCB-------------------CC---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred Cccccc-------------------cc---------------cccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHH
Confidence 311100 00 00112568999999999999999999999999999999
Q ss_pred HHhhCCCCCCCCCh---hhHHHHHhhccccccCCc-ccccChhHHHHHHHHhh-CccccCCCCCh-------hhhhcCCC
Q 008810 349 EMLVGYPPFYSDDP---MSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGA-------DEIKVHPW 416 (552)
Q Consensus 349 EmltG~~PF~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a-------~eil~Hpf 416 (552)
||++|..||.+... ...+.++.........+. ...++.++.+||.+||. ||.+||+...+ -..+.|+|
T Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~ 284 (483)
T 3sv0_A 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284 (483)
T ss_dssp HHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence 99999999987543 334444443211111110 13678999999999999 99999993221 12235899
Q ss_pred cCCCChhhhhh
Q 008810 417 FDGVDWARIYQ 427 (552)
Q Consensus 417 F~~i~w~~l~~ 427 (552)
+..+||+.+..
T Consensus 285 ~~~~dW~~~~~ 295 (483)
T 3sv0_A 285 DYVFDWTILKY 295 (483)
T ss_dssp SSCCHHHHHTC
T ss_pred cCCcCchhhcc
Confidence 99999998864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=401.65 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=209.6
Q ss_pred CeeEE-eeeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 117 DFELL-TMIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 117 ~f~~~-~~IG~G~fG~V~l~~~--k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
.+.+. +.||+|+||.||+|.+ +.+++.||||+++... ......+.+.+|+.+|..++|||||++++++.++ .+||
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEE
Confidence 34443 4899999999999955 4677899999998653 3344567799999999999999999999999754 5889
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||||+||+|.++|.....+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999998764321000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt- 352 (552)
.......||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 527 --------------------------------------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~ 568 (635)
T 4fl3_A 527 --------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 568 (635)
T ss_dssp ----------------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --------------------------------------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 00113467899999999999999999999999999999998
Q ss_pred CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|.+||.+.+..+....+... .....|. .+++++.+||.+||. ||.+||+ +++|+.
T Consensus 569 G~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs---~~~l~~ 624 (635)
T 4fl3_A 569 GQKPYRGMKGSEVTAMLEKG-ERMGCPA--GCPREMYDLMNLCWTYDVENRPG---FAAVEL 624 (635)
T ss_dssp TCCSSTTCCHHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHHTCSSTTTSCC---HHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHHcCCCHhHCcC---HHHHHH
Confidence 99999999888887777653 2344443 789999999999999 9999999 777653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=361.07 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=205.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEe-eeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY-CSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~-~~f~d~~~lyl 193 (552)
.++|++.+.||+|+||.||+|+++.+|+.||||++..... ...+.+|..++..+.|++++..+ .++.+...+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 5789999999999999999999999999999999876432 23478899999999887755544 44567788999
Q ss_pred EEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccc---cCCCcEEEcccccccccCCC
Q 008810 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl---~~~g~iKL~DFGlak~~~~~ 269 (552)
||||+ ||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999973 5679999999999999999999999999999999999999 48899999999999876433
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
..... . +. ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 162 ~~~~~----------------~---~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 162 RTHQH----------------I---PY---------------RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp TTCCB----------------C---CC---------------CCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccc----------------c---cc---------------ccccccccccccCChhhhcCCCCCcchhhHHHHHHHHH
Confidence 21000 0 00 00124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCC---hhhHHHHHhhccccccCCc---ccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 350 MLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPE---EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 350 mltG~~PF~~~~---~~~~~~~i~~~~~~~~~p~---~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|++|..||.+.+ ....+..+... ....|. ...+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~l~~ 273 (296)
T 3uzp_A 208 FNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD---YSYLRQ 273 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC---HHHHHH
T ss_pred HHhCCCCCCCcCchhhhhhhhhhccc--ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCC---HHHHHH
Confidence 999999998743 33445555432 222221 13678999999999999 9999999 666654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=399.21 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=210.9
Q ss_pred ccCCCCeeEEe-eeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 112 KMGADDFELLT-MIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 112 ~~~~~~f~~~~-~IG~G~fG~V~l~~~k--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
.+..+++.+.+ .||+|+||.||+|.++ .++..||||++++.. .....+.+.+|+.+|+.++|||||+++++|.+
T Consensus 331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~- 407 (613)
T 2ozo_A 331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 407 (613)
T ss_dssp BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-
T ss_pred eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-
Confidence 34556777777 8999999999999876 356679999998652 23456779999999999999999999999987
Q ss_pred ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
+.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 5699999999999999999654 569999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
...... .......||+.|+|||++.+..|+.++|||||||+|
T Consensus 488 ~~~~~~--------------------------------------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l 529 (613)
T 2ozo_A 488 ADDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 529 (613)
T ss_dssp ----------------------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCcee--------------------------------------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHH
Confidence 221000 001123567999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
|||++ |.+||.+.+..+....|... ..+.+|. .+++++.+||.+||. ||.+||+ +.+|+
T Consensus 530 ~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs---~~~l~ 590 (613)
T 2ozo_A 530 WEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPP--ECPPELYALMSDCWIYKWEDRPD---FLTVE 590 (613)
T ss_dssp HHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHTTCSSTTTSCC---HHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--cCCHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 99998 99999999888888777653 2344553 789999999999999 9999999 66654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=365.93 Aligned_cols=232 Identities=33% Similarity=0.566 Sum_probs=191.6
Q ss_pred CCCeeEE-eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH-HhcCCCceEEEeeeecC----C
Q 008810 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQD----D 188 (552)
Q Consensus 115 ~~~f~~~-~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL-~~l~hp~Iv~l~~~f~d----~ 188 (552)
.++|.++ ++||+|+||.||+|.++.+|+.||||++... ..+.+|+.++ +..+||||++++++|.+ .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4678887 8899999999999999999999999999753 2356788887 66699999999999876 7
Q ss_pred ceEEEEEecCCCCchhhHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEcccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~--~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGla 263 (552)
..+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999997754 6999999999999999999999999999999999999998 789999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+... +..|+.++|||||
T Consensus 168 ~~~~---------------------------------------------------------------~~~~~~~~Diwsl 184 (299)
T 3m2w_A 168 KETT---------------------------------------------------------------GEKYDKSCDMWSL 184 (299)
T ss_dssp EECT---------------------------------------------------------------TCGGGGHHHHHHH
T ss_pred cccc---------------------------------------------------------------cccCCchhhHHHH
Confidence 7431 1346778999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhc--cccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNW--RTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
||++|||++|.+||.+.+.......+... .....+|. ...+++++++||.+||. ||.+||+ +.|+++||||.
T Consensus 185 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~e~l~hp~~~ 261 (299)
T 3m2w_A 185 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIM 261 (299)
T ss_dssp HHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHH
T ss_pred HHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCC---HHHHhcChhhc
Confidence 99999999999999876654432222111 11223332 24689999999999999 9999999 99999999997
Q ss_pred CC
Q 008810 419 GV 420 (552)
Q Consensus 419 ~i 420 (552)
+.
T Consensus 262 ~~ 263 (299)
T 3m2w_A 262 QS 263 (299)
T ss_dssp TG
T ss_pred cc
Confidence 53
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=374.21 Aligned_cols=253 Identities=15% Similarity=0.207 Sum_probs=201.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCC--------CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEE------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTT--------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK------ 180 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~t--------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~------ 180 (552)
.++|++.+.||+|+||.||+|+++.+ ++.||||++.+. +.+.+|+.+|..++|||||+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 57899999999999999999999874 889999999764 24778999999999999988
Q ss_pred ---------EeeeecC-CceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcc
Q 008810 181 ---------LYCSFQD-DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLL 248 (552)
Q Consensus 181 ---------l~~~f~d-~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNIL 248 (552)
+++++.. ...+|+||||+ ||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 4555543 77899999999 99999999875 78999999999999999999999999999999999999
Q ss_pred ccCCC--cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCCh
Q 008810 249 LDKYG--HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (552)
Q Consensus 249 l~~~g--~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~AP 326 (552)
++.++ .+||+|||+++.+........ . ........+||+.|+||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~-~---------------------------------~~~~~~~~~gt~~y~aP 237 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVA-Y---------------------------------VEGSRSPHEGDLEFISM 237 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCC-C---------------------------------CTTSSCTTCSCTTTCCH
T ss_pred EcCCCCceEEEecCcceeeccCCCcccc-c---------------------------------cccccccccCCccccCH
Confidence 99998 999999999987643211000 0 00011245899999999
Q ss_pred hhhhcCCCCCccchhhhhHHHHHHhhCCCCCCCCC--hhhHHHHHhhcc-ccccCC----cccccChhHHHHHHHHhh-C
Q 008810 327 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD--PMSTCRKIVNWR-THLKFP----EEAKLSIEAKDLISKLLC-N 398 (552)
Q Consensus 327 Evl~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~--~~~~~~~i~~~~-~~~~~p----~~~~~s~e~~dLI~~lL~-d 398 (552)
|++.+..|+.++|||||||++|||++|..||.+.. .......+.... ....++ ....+++++.+||.+||. |
T Consensus 238 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 238 DLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCC
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCC
Confidence 99999999999999999999999999999998764 222322222111 111111 113578999999999999 9
Q ss_pred ccccCCCCChhhhhc
Q 008810 399 VNQRLGAKGADEIKV 413 (552)
Q Consensus 399 p~~Rl~~~~a~eil~ 413 (552)
|.+||+ +++|+.
T Consensus 318 p~~Rps---~~~l~~ 329 (352)
T 2jii_A 318 YEEKPP---YAMLRN 329 (352)
T ss_dssp TTCCCC---HHHHHH
T ss_pred hhhCCC---HHHHHH
Confidence 999999 777654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=377.83 Aligned_cols=254 Identities=17% Similarity=0.283 Sum_probs=203.2
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec-CCceE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFL 191 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-d~~~l 191 (552)
..|.+.+.||+|+||.||+|+...++ ..||+|+++.. ......+.+.+|..+|+.++|||||++++++. +++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999986443 46899998753 23455678999999999999999999999864 55688
Q ss_pred EEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.+....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 468999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
... ........||+.|+|||++.+..|+.++|||||||++|||
T Consensus 247 ~~~-------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 289 (373)
T 3c1x_A 247 FDS-------------------------------------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289 (373)
T ss_dssp ------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ccc-------------------------------------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 000 0001135688999999999999999999999999999999
Q ss_pred hh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 351 lt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||+ +.+|+.+
T Consensus 290 lt~~~~p~~~~~~~~~~~~~~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~RPs---~~ell~~ 349 (373)
T 3c1x_A 290 MTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRPS---FSELVSR 349 (373)
T ss_dssp HTTSCCSCTTSCSSCHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HhCcCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99 789998887777776666532 23333 3689999999999999 9999999 8888764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=366.61 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=205.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--Cc
Q 008810 116 DDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DE 189 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~ 189 (552)
..|++++.||+|+||.||+|.. ..+|+.||||++++.. .....+.+.+|+.+|+.++|||||+++++|.+ ..
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3359999999999999988865 3478999999998652 23445678999999999999999999999986 46
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|+||||++||+|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 899999999999999999654 5999999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
.... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 188 ~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 229 (318)
T 3lxp_A 188 HEYY--------------------------------------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229 (318)
T ss_dssp CSEE--------------------------------------EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred cccc--------------------------------------ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHH
Confidence 1100 00123568899999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhh--------------HHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 350 MLVGYPPFYSDDPMS--------------TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 350 mltG~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|++|..||....... .....+........| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 230 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~ell~ 303 (318)
T 3lxp_A 230 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRP--DKCPAEVYHLMKNCWETEASFRPT---FENLIP 303 (318)
T ss_dssp HHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCC--ccccHHHHHHHHHHcCCCcccCcC---HHHHHH
Confidence 999999997543210 111222212222333 4789999999999999 9999999 888774
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=363.35 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=199.6
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc--CCCceEEEeeeecCC-
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV--DSNCIVKLYCSFQDD- 188 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l--~hp~Iv~l~~~f~d~- 188 (552)
....++|++++.||+|+||.||+|+++ |+.||||++.... ......|.+++... +||||+++++++.+.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344578999999999999999999875 8899999996543 22345566666554 999999999999877
Q ss_pred ---ceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcccccCCCCccccCCCcEEE
Q 008810 189 ---EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------HYIHRDIKPDNLLLDKYGHLRL 257 (552)
Q Consensus 189 ---~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------giiHrDLKPeNILl~~~g~iKL 257 (552)
..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+. |||||||||+|||++.+|++||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 789999999999999999955 5799999999999999999999998 9999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCc
Q 008810 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (552)
Q Consensus 258 ~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~ 337 (552)
+|||+|+.+....... .......+||+.|+|||++.+..++..
T Consensus 184 ~Dfg~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 226 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEV-------------------------------------DIPPNTRVGTKRYMPPEVLDESLNRNH 226 (337)
T ss_dssp CCCTTCEECC----------------------------------------------CCSSCSCGGGCCHHHHTTCCCTTC
T ss_pred EeCCCceeeccccccc-------------------------------------cCCCCCCccCcceeChhhcccccCCcc
Confidence 9999998654321100 001124689999999999998777665
Q ss_pred ------cchhhhhHHHHHHhhC----------CCCCCCCCh----hhHHHHHh-hccccccCCc---ccccChhHHHHHH
Q 008810 338 ------CDWWSLGAIMYEMLVG----------YPPFYSDDP----MSTCRKIV-NWRTHLKFPE---EAKLSIEAKDLIS 393 (552)
Q Consensus 338 ------~DiWSlGvilyEmltG----------~~PF~~~~~----~~~~~~i~-~~~~~~~~p~---~~~~s~e~~dLI~ 393 (552)
+|||||||++|||++| ..||..... ......++ .......+|. ...+++++.+||.
T Consensus 227 ~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 306 (337)
T 3mdy_A 227 FQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT 306 (337)
T ss_dssp THHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHH
T ss_pred ccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHH
Confidence 9999999999999999 777765322 12222222 2122233332 1256778999999
Q ss_pred HHhh-CccccCCCCChhhhhcC
Q 008810 394 KLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 394 ~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+||. ||.+||+ +.+|++|
T Consensus 307 ~~l~~dP~~Rps---~~ell~~ 325 (337)
T 3mdy_A 307 ECWAHNPASRLT---ALRVKKT 325 (337)
T ss_dssp HHSCSSGGGSCC---HHHHHHH
T ss_pred HhhhhChhhCCC---HHHHHHH
Confidence 9999 9999999 8888875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=391.37 Aligned_cols=252 Identities=20% Similarity=0.353 Sum_probs=215.2
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
...+..++|++.+.||+|+||.||+|.++. +..||||+++.... ..+.+.+|+.+|+.++|||||++++++.+ .
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 455677889999999999999999999875 45799999986542 23568899999999999999999999876 6
Q ss_pred eEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+++.+.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 789999999999999999753 569999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... ......||+.|+|||++.+..|+.++|||||||+|
T Consensus 415 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l 454 (535)
T 2h8h_A 415 DNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454 (535)
T ss_dssp CHHHH----------------------------------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHH
Confidence 21000 01134578899999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|||++ |..||.+....+....+... ..+..| ..++.++.+||.+||. ||.+||+ +++|+.
T Consensus 455 ~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~~l~~ 516 (535)
T 2h8h_A 455 TELTTKGRVPYPGMVNREVLDQVERG-YRMPCP--PECPESLHDLMCQCWRKEPEERPT---FEYLQA 516 (535)
T ss_dssp HHHTTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 99999 99999998888887777642 223333 4789999999999999 9999999 777765
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=366.28 Aligned_cols=257 Identities=23% Similarity=0.352 Sum_probs=193.8
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHH--HhcCCCceEEEeeee---
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL--AEVDSNCIVKLYCSF--- 185 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL--~~l~hp~Iv~l~~~f--- 185 (552)
..+..++|++++.||+|+||.||+|+. +|+.||||++.... ...+..|..++ ..++||||+++++.+
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 356789999999999999999999975 68899999997543 22344455554 458999999998743
Q ss_pred --cCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCcccccCCCCccccCCCc
Q 008810 186 --QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---------HYIHRDIKPDNLLLDKYGH 254 (552)
Q Consensus 186 --~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------giiHrDLKPeNILl~~~g~ 254 (552)
.+...+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||+. |||||||||+|||++.+|+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 344578999999999999999955 4569999999999999999999999 9999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---
Q 008810 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--- 331 (552)
Q Consensus 255 iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--- 331 (552)
+||+|||+|+.+......... .........+||+.|+|||++.+
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~---------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPG---------------------------------EEDNAAISEVGTIRYMAPEVLEGAVN 205 (336)
T ss_dssp EEECCCTTCEECSSSSCC------------------------------------------CCTTSCGGGCCHHHHTTCCC
T ss_pred EEEeeccceeecccccccCcc---------------------------------ccccccccCCCccceeCchhhcCCcc
Confidence 999999999876533211000 00001225689999999999987
Q ss_pred ----CCCCCccchhhhhHHHHHHhhCCCCCCCCChh-----------------hHHHH-HhhccccccCCc----ccccC
Q 008810 332 ----KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM-----------------STCRK-IVNWRTHLKFPE----EAKLS 385 (552)
Q Consensus 332 ----~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~-----------------~~~~~-i~~~~~~~~~p~----~~~~s 385 (552)
..++.++|||||||++|||++|..||...... ..... +........+|. ...++
T Consensus 206 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
T 3g2f_A 206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285 (336)
T ss_dssp GGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHH
T ss_pred cccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchH
Confidence 45678999999999999999997776443211 11111 111112223332 22356
Q ss_pred hhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 386 IEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 386 ~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
+++.+||.+||. ||.+||+ +.||+
T Consensus 286 ~~l~~li~~cl~~dP~~Rps---~~e~l 310 (336)
T 3g2f_A 286 RSLKETIEDCWDQDAEARLT---AQXAE 310 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred HHHHHHHHHHhcCChhhCcc---hHHHH
Confidence 689999999999 9999999 88874
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=407.24 Aligned_cols=264 Identities=26% Similarity=0.424 Sum_probs=211.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC------C
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------D 188 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------~ 188 (552)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... .....+.+.+|+.+|..++|||||++++++.+ .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478999999999999999999999999999999987642 34456678999999999999999999998876 6
Q ss_pred ceEEEEEecCCCCchhhHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc---EEEccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGL 262 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~---iKL~DFGl 262 (552)
+..|+|||||+||+|.+++.... .+++..++.++.+++.||.|||+.|||||||||+|||++.+|. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999997644 6999999999999999999999999999999999999997775 99999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhh
Q 008810 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (552)
Q Consensus 263 ak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWS 342 (552)
++....... ....+||+.|+|||++.+..|+.++||||
T Consensus 171 a~~~~~~~~------------------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwS 208 (676)
T 3qa8_A 171 AKELDQGEL------------------------------------------CTEFVGTLQYLAPELLEQKKYTVTVDYWS 208 (676)
T ss_dssp CCBTTSCCC------------------------------------------CCCCCSCCTTCSSCSSCCSCCSTTHHHHH
T ss_pred ccccccccc------------------------------------------cccccCCcccCChHHhccCCCCchhHHHH
Confidence 986543210 12468999999999999999999999999
Q ss_pred hhHHHHHHhhCCCCCCCCChhhHHH---------HHh---------hccccccCCc--ccccChhHHHHHHHHhh-Cccc
Q 008810 343 LGAIMYEMLVGYPPFYSDDPMSTCR---------KIV---------NWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQ 401 (552)
Q Consensus 343 lGvilyEmltG~~PF~~~~~~~~~~---------~i~---------~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~ 401 (552)
|||++|+|++|..||.+......+. .+. .+...++.|. ...+++++.+||.+||. ||.+
T Consensus 209 LGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~k 288 (676)
T 3qa8_A 209 FGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ 288 (676)
T ss_dssp HHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC-
T ss_pred HHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhh
Confidence 9999999999999997654322110 000 0111111111 13477899999999999 9999
Q ss_pred cCCCCChhhhhcCCCcCCCChhhhhh
Q 008810 402 RLGAKGADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 402 Rl~~~~a~eil~HpfF~~i~w~~l~~ 427 (552)
||+ +.+++.||||+.+ +.+..
T Consensus 289 RPT---a~elL~hp~F~~l--~~iL~ 309 (676)
T 3qa8_A 289 RGT---DPQNPNVGCFQAL--DSILS 309 (676)
T ss_dssp --C---CTTCCCCTTHHHH--HHHHC
T ss_pred CcC---HHHHhcCHHHHHH--HHHHh
Confidence 999 8899999999873 45443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=363.11 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=208.3
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~----k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
..+..++|++++.||+|+||.||+|+. ..+|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 345677899999999999999999984 5689999999997642 345567899999999999999999999987
Q ss_pred CCc--eEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccc
Q 008810 187 DDE--FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 187 d~~--~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
+.. .+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 654 789999999999999999775 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+......... .......||+.|+|||++.+..++.++|||||
T Consensus 193 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (326)
T 2w1i_A 193 KVLPQDKEYY--------------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSF 234 (326)
T ss_dssp EECCSSCSEE--------------------------------------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred hhcccccccc--------------------------------------ccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence 8764321100 00113467888999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChh------------hH---HHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 344 GAIMYEMLVGYPPFYSDDPM------------ST---CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~------------~~---~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
||++|||++|..||...... .. ....+.....+..| ..+++++.+||.+||. ||.+||+
T Consensus 235 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps--- 309 (326)
T 2w1i_A 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP--DGCPDEIYMIMTECWNNNVNQRPS--- 309 (326)
T ss_dssp HHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred HHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCC--CcccHHHHHHHHHHcCCChhhCcC---
Confidence 99999999999998643110 00 11122211223333 4789999999999999 9999999
Q ss_pred hhhhhc
Q 008810 408 ADEIKV 413 (552)
Q Consensus 408 a~eil~ 413 (552)
+.+|+.
T Consensus 310 ~~el~~ 315 (326)
T 2w1i_A 310 FRDLAL 315 (326)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=359.04 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=202.6
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-hhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~-~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
|...+.||+|+||.||+|.. +++.||+|++..... ......+.+.+|+.+|+.++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 34458999999999999975 688999999976432 223445678999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 197 YLPGGDMMTLLMR---KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 197 y~~gG~L~~~L~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT- 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-
Confidence 9999999999864 346999999999999999999999999999999999999999999999999999865422100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
......+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 190 --------------------------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 190 --------------------------------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp --------------------------------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred --------------------------------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence 01123579999999999865 589999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhh----cccc------ccCC-cccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 354 YPPFYSDDPMSTCRKIVN----WRTH------LKFP-EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~----~~~~------~~~p-~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
.+||.+.........+.. .... ..++ .....+..+.+||.+||. ||.+||+ +.+|++|
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~l~~~ 300 (307)
T 2nru_A 231 LPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD---IKKVQQL 300 (307)
T ss_dssp CCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCC---HHHHHHH
T ss_pred CCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 999987654333222211 0000 0011 123466789999999999 9999999 8888754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=365.13 Aligned_cols=262 Identities=19% Similarity=0.250 Sum_probs=212.6
Q ss_pred hhhhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 008810 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (552)
Q Consensus 106 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f 185 (552)
..++...+..++|++.+.||+|+||.||+|+++. .||+|+++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 3456777889999999999999999999998754 499999976432 223334577899999999999999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccc
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
.+...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ +|.+||+|||+++
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 99999999999999999999997654 799999999999999999999999999999999999998 6899999999987
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---------CCCC
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---------KGYG 335 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---------~~y~ 335 (552)
......... .........||+.|+|||++.+ ..|+
T Consensus 178 ~~~~~~~~~------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~ 221 (319)
T 2y4i_B 178 ISGVLQAGR------------------------------------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221 (319)
T ss_dssp ----------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCC
T ss_pred ccccccccc------------------------------------cccccccCCCcccccChHHhhhccccccccccCCC
Confidence 543211000 0001124579999999999975 4578
Q ss_pred CccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 336 ~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
.++|||||||++|||++|..||.+.+.......+...... ......++.++.+||.+||. ||.+||+ +.+|+.
T Consensus 222 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~l~~ 295 (319)
T 2y4i_B 222 KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP--NLSQIGMGKEISDILLFCWAFEQEERPT---FTKLMD 295 (319)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCC--CCCCSSCCTTHHHHHHHHHCSSTTTSCC---HHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCC--CCCcCCCCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 9999999999999999999999998888777777653221 11123688999999999999 9999998 888776
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=393.40 Aligned_cols=255 Identities=24% Similarity=0.353 Sum_probs=214.5
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~t---g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~ 186 (552)
...+..++|++.+.||+|+||.||+|.++.+ +..||||+++... .....+.+.+|+.+|+.++|||||++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3456678899999999999999999998654 4579999987542 2344567899999999999999999999985
Q ss_pred CCceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 187 DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
++.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+++.
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 45689999999999999999765 3799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
+...... ......||+.|+|||++.+..|+.++|||||||
T Consensus 541 ~~~~~~~----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 580 (656)
T 2j0j_A 541 MEDSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580 (656)
T ss_dssp CCC--------------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCCcce----------------------------------------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHH
Confidence 5322100 011346788999999999999999999999999
Q ss_pred HHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 346 ilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++|||++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+||+ +.+|+.
T Consensus 581 il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~RPs---~~el~~ 644 (656)
T 2j0j_A 581 CMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSRRPR---FTELKA 644 (656)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccccHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 9999997 99999999888888877753 233444 3789999999999999 9999999 888765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=383.66 Aligned_cols=250 Identities=16% Similarity=0.205 Sum_probs=197.4
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-Cc----------e----
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NC----------I---- 178 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~----------I---- 178 (552)
....|.+.++||+|+||.||+|++..+|+.||||++...........+.+++|..++..+.| ++ +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34458899999999999999999999999999999985443333445678899999998876 21 1
Q ss_pred -EE------EeeeecC-----CceEEEEEecCCCCchhhHHhh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 008810 179 -VK------LYCSFQD-----DEFLYLIMEYLPGGDMMTLLMR-------KDTLTEDEARFYVAETVLAIESIHKHHYIH 239 (552)
Q Consensus 179 -v~------l~~~f~d-----~~~lylVmEy~~gG~L~~~L~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~giiH 239 (552)
+. ++..+.. ...+|++|+++ +|+|.+++.. ...+++..+..++.||+.||.|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 11 1111221 22467888876 7899998841 345788888999999999999999999999
Q ss_pred cccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccc
Q 008810 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (552)
Q Consensus 240 rDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~G 319 (552)
|||||+||||+.+|++||+|||+++..... ..+.+|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~g 270 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------------------------------------------AVSPIG 270 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--------------------------------------------ECCCCC
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--------------------------------------------cccCCC
Confidence 999999999999999999999998864311 124678
Q ss_pred CCCCCChhhh----------hcCCCCCccchhhhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHH
Q 008810 320 TPDYIAPEVL----------LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAK 389 (552)
Q Consensus 320 T~~Y~APEvl----------~~~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~ 389 (552)
+.|+|||++ .+..|+.++|||||||++|||++|+.||.+.+.......++. ....++++++
T Consensus 271 -~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~ 341 (413)
T 3dzo_A 271 -RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVR 341 (413)
T ss_dssp -TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHH
T ss_pred -CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHH
Confidence 999999999 445588899999999999999999999988776554444432 2236789999
Q ss_pred HHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 390 dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+||.+||. ||.+||+ +.+++.||||+.+
T Consensus 342 ~li~~~l~~dP~~Rpt---~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 342 ALLEGFLRYPKEDRLL---PLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHTCSSGGGSCC---HHHHTTSHHHHHH
T ss_pred HHHHHHccCChhhCcC---HHHHHhCHHHHHH
Confidence 99999999 9999999 9999999999865
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=359.88 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=203.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh--cCCCceEEEeeeecCCc---
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQDDE--- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~--l~hp~Iv~l~~~f~d~~--- 189 (552)
.++|++.+.||+|+||.||+|++ +|+.||||++.... ...+.+|.+++.. ++||||+++++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 46799999999999999999987 58899999997542 3457788899887 79999999999998776
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCcccccCCCCccccCCCcEEEccc
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~giiHrDLKPeNILl~~~g~iKL~DF 260 (552)
.+|+||||++||+|.+++.+ ..+++..+..++.|++.||.||| +.||+||||||+|||++.+|++||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999965 57999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC------C
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------Y 334 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~------y 334 (552)
|+++......... .......+||+.|+|||++.+.. +
T Consensus 192 g~~~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 234 (342)
T 1b6c_B 192 GLAVRHDSATDTI-------------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFES 234 (342)
T ss_dssp TTCEEEETTTTEE-------------------------------------EECCCSCCCCGGGCCHHHHTSCCCTTCHHH
T ss_pred CCceecccccccc-------------------------------------ccccccCCcCcccCCHhhhccccccccccc
Confidence 9998654321100 00112458999999999998752 3
Q ss_pred CCccchhhhhHHHHHHhhC----------CCCCCCCCh-----hhHHHHHhhccccccCCcc---cccChhHHHHHHHHh
Q 008810 335 GMECDWWSLGAIMYEMLVG----------YPPFYSDDP-----MSTCRKIVNWRTHLKFPEE---AKLSIEAKDLISKLL 396 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmltG----------~~PF~~~~~-----~~~~~~i~~~~~~~~~p~~---~~~s~e~~dLI~~lL 396 (552)
+.++|||||||++|||++| ..||..... ......+........+|.. ..++..+.+||.+||
T Consensus 235 ~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (342)
T 1b6c_B 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 314 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHC
T ss_pred CCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHh
Confidence 4689999999999999999 789976532 2333334332223334431 245568999999999
Q ss_pred h-CccccCCCCChhhhhcC
Q 008810 397 C-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 397 ~-dp~~Rl~~~~a~eil~H 414 (552)
. ||.+||+ +.+|+.|
T Consensus 315 ~~dp~~Rps---~~~i~~~ 330 (342)
T 1b6c_B 315 YANGAARLT---ALRIKKT 330 (342)
T ss_dssp CSSGGGSCC---HHHHHHH
T ss_pred ccChhhCCC---HHHHHHH
Confidence 8 9999999 8888875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=348.07 Aligned_cols=225 Identities=12% Similarity=0.117 Sum_probs=189.6
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|..++..++|||||++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 55678999999999999999999999999999999998765444555678899999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
+||||++||+|.+++.+ + ....++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999954 3 4666788899999999999999999999999999999999999998554
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
|++ .++.++|||||||++|||++
T Consensus 175 --------------------------------------------------~~~-------~~~~~~Di~slG~il~ellt 197 (286)
T 3uqc_A 175 --------------------------------------------------TMP-------DANPQDDIRGIGASLYALLV 197 (286)
T ss_dssp --------------------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------------------------ccC-------CCCchhHHHHHHHHHHHHHH
Confidence 223 37889999999999999999
Q ss_pred CCCCCCCCChhhHHH---HHhhccccccCCc--ccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 353 GYPPFYSDDPMSTCR---KIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 353 G~~PF~~~~~~~~~~---~i~~~~~~~~~p~--~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
|..||.+.+...... +++. .....+. ...+++++++||.+||. ||.+| + +.|++.
T Consensus 198 g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s---~~el~~ 258 (286)
T 3uqc_A 198 NRWPLPEAGVRSGLAPAERDTA--GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-S---ASTLLN 258 (286)
T ss_dssp SEECSCCCSBCCCSEECCBCTT--SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-C---HHHHHH
T ss_pred CCCCCCcCCcchhhHHHHHHhc--cCCCChhhcccCCCHHHHHHHHHHcccCCccC-C---HHHHHH
Confidence 999999876543221 1111 1111111 14689999999999999 99999 7 888776
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=388.82 Aligned_cols=243 Identities=22% Similarity=0.300 Sum_probs=201.7
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~-tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
.+..++|++++.||+|+||.||+|.++. +|+.||||++.... .......+.+|+.+|..++|||||+++++|.+.+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 4456899999999999999999999976 79999999987542 23445678899999999999999999999987655
Q ss_pred -----EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 191 -----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 191 -----lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
+|||||||+||+|..++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ ++||+|||+++.
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 79999999999999999999999999999999999999985 999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
+... ...+||+.|+|||++.+. ++.++|||||||
T Consensus 231 ~~~~---------------------------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~ 264 (681)
T 2pzi_A 231 INSF---------------------------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGR 264 (681)
T ss_dssp TTCC---------------------------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHH
T ss_pred cccC---------------------------------------------CccCCCccccCHHHHcCC-CCCceehhhhHH
Confidence 5321 145799999999999764 589999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
++|+|++|.+||.+...... ........+++.+.+||.+||. ||.+||+ ..+++.|+|+.
T Consensus 265 ~l~~l~~g~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 325 (681)
T 2pzi_A 265 TLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFT---TAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHSCCCEETTEECSSC----------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred HHHHHHhCCCCCcccccccc----------cccccccccCHHHHHHHhhhccCChhhCCC---HHHHHHHHHHH
Confidence 99999999999976321100 0111112467899999999999 9999998 77888888874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.15 Aligned_cols=190 Identities=16% Similarity=0.178 Sum_probs=140.3
Q ss_pred eeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------hhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCceEEEE
Q 008810 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 123 ~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-------~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++.|++|.+..++....|+.||||++.+.... .....+.+.+|+++|+++ .|+||++++++|+++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 356788888888888889999999999875321 223345699999999999 799999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||||+||+|.++|.+.+.+++. .|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~---- 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC---- 393 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-------
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC----
Confidence 9999999999999998899875 478999999999999999999999999999999999999999998653221
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
....+.|||+.|||||++.+ .+..++|+||+|+++|+|++|.
T Consensus 394 -------------------------------------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 394 -------------------------------------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred -------------------------------------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence 01235799999999999975 4677899999999999998876
Q ss_pred CCC
Q 008810 355 PPF 357 (552)
Q Consensus 355 ~PF 357 (552)
.||
T Consensus 436 ~~~ 438 (569)
T 4azs_A 436 SNW 438 (569)
T ss_dssp HHH
T ss_pred chh
Confidence 665
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=285.16 Aligned_cols=193 Identities=19% Similarity=0.192 Sum_probs=147.9
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----hhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
..++||+|+||.||+| ...+..+|+|+....... .....+.+.+|+.+|+.++|||||++..++.+.+..|||
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999999 456789999987543221 122345689999999999999999544444456667999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||||+||+|.+++.. +..++.|++.||.|||++|||||||||+|||++. ++||+|||+|+.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~--- 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED--- 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH---
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc---
Confidence 999999999999865 6689999999999999999999999999999999 999999999997642210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc--CCCCCccchhhhhHHHHHHhh
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvilyEmlt 352 (552)
.... ......+.+||+.|||||++.. .+|+..+|+||.++-..+.+.
T Consensus 485 ---------------------------~~~~----~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~ 533 (540)
T 3en9_A 485 ---------------------------KAVD----LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE 533 (540)
T ss_dssp ---------------------------HHHH----HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH
T ss_pred ---------------------------cccc----hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 0000 0011236789999999999987 789999999999999999888
Q ss_pred CCCCCC
Q 008810 353 GYPPFY 358 (552)
Q Consensus 353 G~~PF~ 358 (552)
++.+|.
T Consensus 534 ~r~rY~ 539 (540)
T 3en9_A 534 RRARYV 539 (540)
T ss_dssp TCSCCC
T ss_pred hccccC
Confidence 877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-28 Score=243.75 Aligned_cols=134 Identities=13% Similarity=0.124 Sum_probs=109.5
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---------------hHHHHHHHHHHHHHhcCCCceEEEe
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---------------GQVEHVRAERNLLAEVDSNCIVKLY 182 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---------------~~~~~~~~E~~iL~~l~hp~Iv~l~ 182 (552)
|.+.+.||+|+||.||+|++ .+|+.||||+++....... .....+.+|..+|+.++ | ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 34449999999999999999 8899999999975432111 23456889999999998 4 5666
Q ss_pred eeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 183 ~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
.++.. +.+|+|||||+||+|.. +. ...+..++.|++.||.|||++|||||||||+|||++ +|++||+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 65543 56699999999999988 42 134567999999999999999999999999999999 99999999999
Q ss_pred cc
Q 008810 263 CK 264 (552)
Q Consensus 263 ak 264 (552)
|+
T Consensus 239 a~ 240 (282)
T 1zar_A 239 SV 240 (282)
T ss_dssp CE
T ss_pred Ce
Confidence 86
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.2e-22 Score=202.24 Aligned_cols=142 Identities=15% Similarity=0.133 Sum_probs=110.4
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhh---------------------hhHHHHHHHHHHHHHhc
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLR---------------------RGQVEHVRAERNLLAEV 173 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~--~AiK~l~k~~~~~---------------------~~~~~~~~~E~~iL~~l 173 (552)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|..+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998788999 9999986542110 01123578899999999
Q ss_pred CCCce--EEEeeeecCCceEEEEEecCCC-C----chhhHHhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccccCCC
Q 008810 174 DSNCI--VKLYCSFQDDEFLYLIMEYLPG-G----DMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPD 245 (552)
Q Consensus 174 ~hp~I--v~l~~~f~d~~~lylVmEy~~g-G----~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKPe 245 (552)
.|++| +.++.. ...||||||+.+ | .|..++.. +++..+..++.|++.||.||| +.|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 87753 334432 356899999942 4 55554422 346678899999999999999 999999999999
Q ss_pred CccccCCCcEEEcccccccccC
Q 008810 246 NLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 246 NILl~~~g~iKL~DFGlak~~~ 267 (552)
|||++. +++|+|||+|....
T Consensus 201 NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SEEESS--SEEECCCTTCEETT
T ss_pred HEEEcC--cEEEEECcccccCC
Confidence 999998 99999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.7e-20 Score=192.30 Aligned_cols=139 Identities=14% Similarity=0.155 Sum_probs=100.8
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----------hhhHHH--------HHHHHHHHHHhcCCCc
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----------RRGQVE--------HVRAERNLLAEVDSNC 177 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~-----------~~~~~~--------~~~~E~~iL~~l~hp~ 177 (552)
-|++...||.|+||.||+|.+. +|+.||||+++..... ...... ....|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3899999999999999999874 6999999998643210 000001 1234556666664433
Q ss_pred eE--EEeeeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC--
Q 008810 178 IV--KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-- 253 (552)
Q Consensus 178 Iv--~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-- 253 (552)
+. ..+.. ...+|||||++|+.|..++. ...+..++.||+.||.+||+.|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 21 12221 12369999999999876542 234567889999999999999999999999999999877
Q ss_pred --------cEEEccccccccc
Q 008810 254 --------HLRLSDFGLCKPL 266 (552)
Q Consensus 254 --------~iKL~DFGlak~~ 266 (552)
.+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 4899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5e-13 Score=131.99 Aligned_cols=140 Identities=13% Similarity=0.089 Sum_probs=111.6
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylV 194 (552)
+.|++...+|.|+++.||++.. .|..|++|+...... .....+.+|..+|+.+. +..+.++++++.+....|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~---~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC---CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 4688999999999999999864 367999999875321 11234788999999884 56788899888888899999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------------------------------------- 234 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 234 (552)
|||++|.+|...+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876531 223345778899999999998
Q ss_pred -------------------CCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 235 -------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 235 -------------------~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+++|+|++|.|||++.++.+.|+||+.|..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998765667999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.3e-12 Score=125.03 Aligned_cols=136 Identities=13% Similarity=0.084 Sum_probs=100.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc--eEEEeeeecCCceEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSFQDDEFLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f~d~~~ly 192 (552)
..++.+..+.+.|+.+.||++.. .+|..|++|+..... ...+..|..+|+.+.+.. +.++++++.+.+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34566654445666799999853 567789999976431 134678888988885433 566888888888899
Q ss_pred EEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 008810 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH------------------------------------ 236 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~g------------------------------------ 236 (552)
+||||++|.+|. .. ..+ ...++.+++.+|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999999884 21 122 2356677777788888643
Q ss_pred ----------------------CcccccCCCCccccCCCcEEEcccccccc
Q 008810 237 ----------------------YIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 237 ----------------------iiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2e-11 Score=123.59 Aligned_cols=135 Identities=19% Similarity=0.229 Sum_probs=100.1
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCc--eEEEeeeecCCc---eEEEE
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNC--IVKLYCSFQDDE---FLYLI 194 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~--Iv~l~~~f~d~~---~lylV 194 (552)
++.|+.|..+.||++. ..+++|+.... .....+.+|..+|..+ .+.. +.+.+....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999863 46889986533 2345688899999887 3322 344555444333 34899
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------------------------------------- 234 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 234 (552)
|++++|..|..... ..++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999998875433 357788888888888888888886
Q ss_pred ------------------CCCcccccCCCCccccC--CCcEEEcccccccccC
Q 008810 235 ------------------HHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLD 267 (552)
Q Consensus 235 ------------------~giiHrDLKPeNILl~~--~g~iKL~DFGlak~~~ 267 (552)
..++|+|++|.|||++. .+.+.|+||+.+...+
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 13699999999999998 4567899999987543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.9e-11 Score=124.22 Aligned_cols=142 Identities=19% Similarity=0.267 Sum_probs=107.3
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEee--chhhhhhhHHHHHHHHHHHHHhcCC--CceEEEeeeecCC---ceE
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDD---EFL 191 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~--k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~---~~l 191 (552)
..++.|+.|.++.||++... +..|++|+.. ..... .....+.+|..+|+.+.. ..+++++..+.+. ...
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34678999999999998753 4688899876 33211 112357789999998863 4578888888776 458
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK------------------------------------- 234 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------- 234 (552)
|+||||++|..+.+.. ...+++.....++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 9999999998885422 2357888889999999999999997
Q ss_pred ---------------------CCCcccccCCCCccccCCCc--EEEccccccccc
Q 008810 235 ---------------------HHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPL 266 (552)
Q Consensus 235 ---------------------~giiHrDLKPeNILl~~~g~--iKL~DFGlak~~ 266 (552)
.++||+|++|.|||++.++. +.|+||+.|...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36899999999999997763 699999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=2.7e-07 Score=93.39 Aligned_cols=134 Identities=16% Similarity=0.163 Sum_probs=93.5
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC---ceEEEeeeec-CCceEEEEEe
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN---CIVKLYCSFQ-DDEFLYLIME 196 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp---~Iv~l~~~f~-d~~~lylVmE 196 (552)
++.++.|....||++ |..|++|+-... .....+..|..+|..+.+. -|.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 556899999999987 567889985322 2345688999999998642 2445555543 4556789999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH----------------------------------------- 235 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------------------------------------- 235 (552)
|++|..|..... ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876321 2344555555555555555555532
Q ss_pred -------------------CCcccccCCCCccccC---CCcE-EEccccccccc
Q 008810 236 -------------------HYIHRDIKPDNLLLDK---YGHL-RLSDFGLCKPL 266 (552)
Q Consensus 236 -------------------giiHrDLKPeNILl~~---~g~i-KL~DFGlak~~ 266 (552)
.++|+|++|.|||++. +|.+ .|+||+.+...
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999997 4665 89999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=6.6e-07 Score=88.09 Aligned_cols=133 Identities=18% Similarity=0.158 Sum_probs=92.8
Q ss_pred eeeecCCe-EEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CceEEEeeeecCCceEEEEEecCCC
Q 008810 123 MIGKGAFG-EVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLYLIMEYLPG 200 (552)
Q Consensus 123 ~IG~G~fG-~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lylVmEy~~g 200 (552)
.+..|..| .||+......+..+.+|+-... ....+.+|..+|..+.. --|.++++++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 44556555 6998877777788999986533 23457789999887742 2256778888888899999999999
Q ss_pred CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 008810 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------------------------------------------- 235 (552)
Q Consensus 201 G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------------------------------------------- 235 (552)
..+....... ......++.++...|..||..
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8876654321 112223344444444444421
Q ss_pred -------------CCcccccCCCCccccCCCcEEEcccccccc
Q 008810 236 -------------HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 236 -------------giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999999877778999998874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=3.2e-07 Score=96.00 Aligned_cols=81 Identities=16% Similarity=0.163 Sum_probs=50.7
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhh-hhh---hHHHHHHHHHHHHHhcCC--C-ceEEEeeeecCCceEE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRR---GQVEHVRAERNLLAEVDS--N-CIVKLYCSFQDDEFLY 192 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~-~~~---~~~~~~~~E~~iL~~l~h--p-~Iv~l~~~f~d~~~ly 192 (552)
.++.||.|.++.||++....+++.|++|....... ... .....+..|..+|..+.. | .+.+++++. .+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccE
Confidence 46789999999999997666678899998653211 000 123456778888887632 3 344555542 34457
Q ss_pred EEEecCCCCc
Q 008810 193 LIMEYLPGGD 202 (552)
Q Consensus 193 lVmEy~~gG~ 202 (552)
+||||++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998753
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.24 E-value=6e-06 Score=83.70 Aligned_cols=137 Identities=9% Similarity=0.140 Sum_probs=78.1
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--CceEEEeee------ecCCceE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCS------FQDDEFL 191 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~------f~d~~~l 191 (552)
-++.|+.|..+.||++... +..|++|+..... ..+..|..++..+.. -.+++++.. ..+.+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456777889999998753 3359999987521 223344444444321 123333321 1345678
Q ss_pred EEEEecCCCCchh--------------hHHhh-cCCC-------------CHHH--------------------------
Q 008810 192 YLIMEYLPGGDMM--------------TLLMR-KDTL-------------TEDE-------------------------- 217 (552)
Q Consensus 192 ylVmEy~~gG~L~--------------~~L~~-~~~l-------------~e~~-------------------------- 217 (552)
|+||+|++|..+. ..|.. ...+ .+..
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 11111 0111 1100
Q ss_pred -----HHHHHHHHHHHHHHHH-------------hCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 218 -----ARFYVAETVLAIESIH-------------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 218 -----~~~~~~qi~~aL~~LH-------------~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...++..+..++.+|+ ..++||+|+.|.|||++.++.+.|+||+.|..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1112222334566665 25799999999999998888999999998863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=5.4e-06 Score=85.12 Aligned_cols=84 Identities=8% Similarity=0.097 Sum_probs=55.7
Q ss_pred eeEEeee-eecCCeEEEEEEEc--C----CCcEEEEEEeechh---hhhhhHHHHHHHHHHHHHhcCC---CceEEEeee
Q 008810 118 FELLTMI-GKGAFGEVRVCREK--T----TGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAEVDS---NCIVKLYCS 184 (552)
Q Consensus 118 f~~~~~I-G~G~fG~V~l~~~k--~----tg~~~AiK~l~k~~---~~~~~~~~~~~~E~~iL~~l~h---p~Iv~l~~~ 184 (552)
...++.| +.|..+.||++... . ++..|++|+..... .... ..+.+|..+|+.+.. -.+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~---~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT---YRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC---CCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch---hHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3446778 88999999988653 1 25678999865432 1111 236678888777632 246677777
Q ss_pred ecCC---ceEEEEEecCCCCchh
Q 008810 185 FQDD---EFLYLIMEYLPGGDMM 204 (552)
Q Consensus 185 f~d~---~~lylVmEy~~gG~L~ 204 (552)
+.+. ...|+||||++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 6655 3568999999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.81 E-value=4.2e-05 Score=80.61 Aligned_cols=33 Identities=12% Similarity=0.163 Sum_probs=28.8
Q ss_pred HhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 233 H~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
+...++|+|++|.|||++.++ ++|+||+.|..-
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456899999999999999877 999999988753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.79 E-value=0.00014 Score=73.81 Aligned_cols=76 Identities=18% Similarity=0.157 Sum_probs=59.0
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCceEEEeeeecCCceEEEEEe
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~~~f~d~~~lylVmE 196 (552)
-++.|+.|....||++.. ++..|++|+.... ....+..|...|+.+. ...+++.+....+.+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 466799999999999863 5678899987643 2445788888887763 3567788888777788999999
Q ss_pred cCCCCch
Q 008810 197 YLPGGDM 203 (552)
Q Consensus 197 y~~gG~L 203 (552)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9999764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00015 Score=72.58 Aligned_cols=132 Identities=11% Similarity=-0.021 Sum_probs=74.2
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEEEecC-
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYL- 198 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylVmEy~- 198 (552)
++.|+.|....+|++ ..|++|+....... .....+|..++..+. +....++++.+.+. -++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~--~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVDPAT--GVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECTTT--CCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEECCC--CEEEEeecC
Confidence 778999999999998 46888987643110 011245666666552 22224566654433 36899999
Q ss_pred CCCchhhHH------------------hhcC-CCC-----HHHHHHHHHH--------------HHHHHHHHH-------
Q 008810 199 PGGDMMTLL------------------MRKD-TLT-----EDEARFYVAE--------------TVLAIESIH------- 233 (552)
Q Consensus 199 ~gG~L~~~L------------------~~~~-~l~-----e~~~~~~~~q--------------i~~aL~~LH------- 233 (552)
+|-.|.... .... .+. ......+... +...+..|.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 665443210 0000 011 1111122111 111111111
Q ss_pred -hCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 234 -KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 234 -~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
...++|+|+.|.||| ..+|.+.|+||..|..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 124899999999999 6677899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00017 Score=72.71 Aligned_cols=142 Identities=11% Similarity=0.023 Sum_probs=79.1
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc--eEEEeeee------cCC
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSF------QDD 188 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~--Iv~l~~~f------~d~ 188 (552)
...-++.|+.|....||++... +| .|++|+..... .. +.+..|..++..+.... +.+++... ...
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 4445678888999999998753 33 68899987531 11 23455777766553111 33333221 123
Q ss_pred ceEEEEEecCCCCchhh--------------HHhhc-CCC--------C---HHHH-H-----------HHHHHHHHHHH
Q 008810 189 EFLYLIMEYLPGGDMMT--------------LLMRK-DTL--------T---EDEA-R-----------FYVAETVLAIE 230 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~--------------~L~~~-~~l--------~---e~~~-~-----------~~~~qi~~aL~ 230 (552)
+..++||+|++|..+.. .|... ..+ . +... . .+...+...+.
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 56789999999865321 01110 011 1 1100 0 00112334455
Q ss_pred HHHh-------CCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 231 SIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 231 ~LH~-------~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.++. .++||+|+.|.|||++.++.+.|+||+.|..
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5552 4699999999999999876668999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.0002 Score=75.77 Aligned_cols=75 Identities=20% Similarity=0.270 Sum_probs=50.9
Q ss_pred EEeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceE
Q 008810 120 LLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~l 191 (552)
-++.|+.|-...||++.... .+..|.+|+..... ..+++..|..++..+. +...+++++.|.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889999999998643 35789999984311 1134456888887763 3334677777754
Q ss_pred EEEEecCCCCch
Q 008810 192 YLIMEYLPGGDM 203 (552)
Q Consensus 192 ylVmEy~~gG~L 203 (552)
.+||||++|-.|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00025 Score=73.85 Aligned_cols=141 Identities=16% Similarity=0.207 Sum_probs=85.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecC
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD 187 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d 187 (552)
+.++ ++.|..|-...+|++.... ++..|.+|+.-.. ......+.+|..+++.+ .+....++++.|.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 3444 3467778889999987642 3578999986331 11234456788888776 33444677887765
Q ss_pred CceEEEEEecCCCCchhhH--------------H---hhc-----CCC--CHHHHHHHHHHHHH----------------
Q 008810 188 DEFLYLIMEYLPGGDMMTL--------------L---MRK-----DTL--TEDEARFYVAETVL---------------- 227 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~--------------L---~~~-----~~l--~e~~~~~~~~qi~~---------------- 227 (552)
. +||||++|..|..- | ... ... -+.++..|..++-.
T Consensus 126 g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 G----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp E----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred c----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 2 99999998655311 1 011 011 13455555544322
Q ss_pred ---HHHHHH----h----CCCcccccCCCCccccCC----CcEEEcccccccc
Q 008810 228 ---AIESIH----K----HHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKP 265 (552)
Q Consensus 228 ---aL~~LH----~----~giiHrDLKPeNILl~~~----g~iKL~DFGlak~ 265 (552)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 233332 2 258999999999999876 7899999998874
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0004 Score=71.59 Aligned_cols=75 Identities=15% Similarity=0.095 Sum_probs=44.4
Q ss_pred EeeeeecCCeEEEEEEEcC--------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceE
Q 008810 121 LTMIGKGAFGEVRVCREKT--------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~--------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~l 191 (552)
++.|+.|....||++.... .+..|++|+.....- .......|..+|..+. +..+.++++.+. +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN--G-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC--C--
Confidence 5578888889999997643 136888998754311 1111356777777663 323446666653 2
Q ss_pred EEEEecCCCCch
Q 008810 192 YLIMEYLPGGDM 203 (552)
Q Consensus 192 ylVmEy~~gG~L 203 (552)
++||||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999998543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00064 Score=68.53 Aligned_cols=136 Identities=13% Similarity=0.174 Sum_probs=77.2
Q ss_pred eeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC--ceEEEeee-----ecCCceEEEE
Q 008810 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCS-----FQDDEFLYLI 194 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp--~Iv~l~~~-----f~d~~~lylV 194 (552)
..|+ |....||++.. .+|+.|++|+...... ....+..|..++..+... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998753 3466799999863311 123456677777666321 13444443 1123466899
Q ss_pred EecCCCCchhh-----------H---Hhh---c------CCCCHHHH----HH------------------HHHHHHHHH
Q 008810 195 MEYLPGGDMMT-----------L---LMR---K------DTLTEDEA----RF------------------YVAETVLAI 229 (552)
Q Consensus 195 mEy~~gG~L~~-----------~---L~~---~------~~l~e~~~----~~------------------~~~qi~~aL 229 (552)
|+|++|..+.. . |.. . ..++.... +. .+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 99998854321 0 110 0 01111110 11 111222222
Q ss_pred HHH----HhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 230 ESI----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 230 ~~L----H~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
..+ +...+||+|++|.|||++ + .+.|+||+.|..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 234689999999999999 4 899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00067 Score=68.72 Aligned_cols=32 Identities=28% Similarity=0.340 Sum_probs=27.9
Q ss_pred CCCcccccCCCCccccCC----CcEEEccccccccc
Q 008810 235 HHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPL 266 (552)
Q Consensus 235 ~giiHrDLKPeNILl~~~----g~iKL~DFGlak~~ 266 (552)
..+||+|+.|.|||++.+ +.+.|+||+.|..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999875 78999999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0017 Score=66.35 Aligned_cols=32 Identities=19% Similarity=0.193 Sum_probs=28.4
Q ss_pred CCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 235 ~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
.+++|+|+.|.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998889999999987653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0019 Score=68.94 Aligned_cols=76 Identities=13% Similarity=0.211 Sum_probs=49.2
Q ss_pred EEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCC-ceEEEeeeecCCceEEEEEecC
Q 008810 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIMEYL 198 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~f~d~~~lylVmEy~ 198 (552)
-++.|+.|-...||++.....+..|++|+..... ...+ ...+|..+|..+... ...++++.|.. .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 3567888999999999875445789999875421 1111 125788888888543 34678887742 2599999
Q ss_pred CCCch
Q 008810 199 PGGDM 203 (552)
Q Consensus 199 ~gG~L 203 (552)
+|-.|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 98544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0052 Score=60.77 Aligned_cols=81 Identities=16% Similarity=0.028 Sum_probs=54.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-C-C-ceEEEeeeecCCceE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-S-N-CIVKLYCSFQDDEFL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-h-p-~Iv~l~~~f~d~~~l 191 (552)
.....-+..+|.|..+.||+++. .+|+.|.+|+-..... .....+..|...|+.+. . + -+++.++.. . -
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~ 85 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--R 85 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--T
T ss_pred CCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEecc--C--c
Confidence 34566678899999999999874 5788999998654321 11234678988888773 2 1 244455442 2 2
Q ss_pred EEEEecCCCCch
Q 008810 192 YLIMEYLPGGDM 203 (552)
Q Consensus 192 ylVmEy~~gG~L 203 (552)
++||||+.++..
T Consensus 86 ~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 TLAMEWVDERPP 97 (288)
T ss_dssp EEEEECCCCCCC
T ss_pred eEEEEeecccCC
Confidence 689999987643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0068 Score=57.77 Aligned_cols=120 Identities=20% Similarity=0.178 Sum_probs=78.2
Q ss_pred chhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccccc
Q 008810 202 DMMTLLMR-KDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (552)
Q Consensus 202 ~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~ 279 (552)
+|.++|.. ..+|+|+++..++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 78888865 578999999999999999988762 11112333456888899999887774 2111
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCCCCCC
Q 008810 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (552)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~PF~~ 359 (552)
.....+.|||.+. .+.+.+.=|||||+++|.-|--
T Consensus 98 --------------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy------ 132 (229)
T 2yle_A 98 --------------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY------ 132 (229)
T ss_dssp -----------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTT------
T ss_pred --------------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc------
Confidence 0122355777652 3445677899999999988731
Q ss_pred CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh
Q 008810 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397 (552)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~ 397 (552)
.++-..+..+|+++..||..|..
T Consensus 133 ---------------gL~e~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 133 ---------------GLKENEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ---------------TCCTTEEECCCHHHHHHHHHHTT
T ss_pred ---------------CCCcccchhhCHHHHHHHHHHHh
Confidence 11112235799999999999985
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.23 E-value=0.0083 Score=63.24 Aligned_cols=76 Identities=13% Similarity=0.128 Sum_probs=48.4
Q ss_pred EEeeeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceE
Q 008810 120 LLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~t-------g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~l 191 (552)
-++.|..|--..+|++..... +..|++++..... . ..-...+|..+++.+. +....++++.+..
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~~---- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFPE---- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEETT----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcCC----
Confidence 345677788899999986521 5789999864321 0 0111346777776663 3345666665542
Q ss_pred EEEEecCCCCch
Q 008810 192 YLIMEYLPGGDM 203 (552)
Q Consensus 192 ylVmEy~~gG~L 203 (552)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.50 E-value=0.19 Score=52.13 Aligned_cols=30 Identities=30% Similarity=0.438 Sum_probs=25.7
Q ss_pred CCcccccCCCCccc------cCCCcEEEcccccccc
Q 008810 236 HYIHRDIKPDNLLL------DKYGHLRLSDFGLCKP 265 (552)
Q Consensus 236 giiHrDLKPeNILl------~~~g~iKL~DFGlak~ 265 (552)
.++|+|+.+.|||+ +.++.+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36899999999999 4567899999999874
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=80.29 E-value=18 Score=39.32 Aligned_cols=81 Identities=23% Similarity=0.279 Sum_probs=48.6
Q ss_pred EEEeeeecCCceEEEEEecCCCCchhhHHhhcCCC-----------------CHHHHHHHHHHHH--HHHHHHHhCCCcc
Q 008810 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTL-----------------TEDEARFYVAETV--LAIESIHKHHYIH 239 (552)
Q Consensus 179 v~l~~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l-----------------~e~~~~~~~~qi~--~aL~~LH~~giiH 239 (552)
+..|.+.......- ++|++++.++.+.+...+.+ .+.....|+..++ +.+.|+ .||
T Consensus 402 i~~Y~Vipls~~~G-lIE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YI--LGi-- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHG-FMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYI--LGV-- 476 (614)
T ss_dssp CCCCCEEESSSSEE-EEECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred eeccEEEEecCCCc-eEEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhhee--eec--
Confidence 44555555554443 46788876666655432211 1223334444433 234444 343
Q ss_pred cccCCCCccccCCCcEEEccccccc
Q 008810 240 RDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 240 rDLKPeNILl~~~g~iKL~DFGlak 264 (552)
+|=.++||||+.+||+.=+|||.+-
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 4778999999999999999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 552 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-90 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-86 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-85 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-83 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-78 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-75 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-75 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-73 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-73 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-72 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-72 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-72 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-70 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-69 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-69 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-66 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-66 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-60 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-59 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-54 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-52 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-51 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-49 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-49 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-48 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-47 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-46 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-46 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-46 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-37 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-15 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 278 bits (711), Expect = 1e-90
Identities = 101/330 (30%), Positives = 168/330 (50%), Gaps = 47/330 (14%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q K +DF+ ++G+G+F V + RE T YA+K L+K +++ +V +V ER+
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+++ +D VKLY +FQDDE LY + Y G+++ + + + E RFY AE V A
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+E +H IHRD+KP+N+LL++ H++++DFG K
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK------------------------ 156
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
++++ A S VGT Y++PE+L +K D W+LG I+Y
Sbjct: 157 ---------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 201
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK- 406
+++ G PPF + + +KI+ FPE K +A+DL+ KLL + +RLG +
Sbjct: 202 QLVAGLPPFRAGNEYLIFQKIIKLE--YDFPE--KFFPKARDLVEKLLVLDATKRLGCEE 257
Query: 407 --GADEIKVHPWFDGVDWARIYQMEAAFIP 434
G +K HP+F+ V W ++Q +
Sbjct: 258 MEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 268 bits (685), Expect = 2e-86
Identities = 114/370 (30%), Positives = 177/370 (47%), Gaps = 56/370 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
+DF L M+GKG+FG+V + K T +A+K LKK +L VE E+ +L+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ ++C+FQ E L+ +MEYL GGD+M + A FY AE +L ++ +H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
++RD+K DN+LLDK GH++++DFG+CK + F
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------------------ 163
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
GTPDYIAPE+LL + Y DWWS G ++YEML+G
Sbjct: 164 -----------------------CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413
PF+ D I +P L EAKDL+ KL +RLG +I+
Sbjct: 201 SPFHGQDEEELFHSIRMDN--PFYPR--WLEKEAKDLLVKLFVREPEKRLGV--RGDIRQ 254
Query: 414 HPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSK 471
HP F ++W + +++ F P+V D NF+K ++ + + R +++S
Sbjct: 255 HPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFAD----RALINSM 310
Query: 472 DIN-FVGYTY 480
D N F +++
Sbjct: 311 DQNMFRNFSF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (678), Expect = 5e-85
Identities = 122/387 (31%), Positives = 180/387 (46%), Gaps = 59/387 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K+ +DF+ L ++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ L +FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H ++RDIK +NL+LDK GH++++DFGLCK
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------------------- 159
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GTP+Y+APEVL YG DWW LG +MYEM+
Sbjct: 160 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GA 408
G PFY+ D I+ ++FP LS EAK L++ LL + QRLG A
Sbjct: 200 CGRLPFYNQDHERLFELILMEE--IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 409 DEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEES----DNQTKTSSKTG 462
E+ H +F ++W + Q + F P+V E+DT+ F+ + G
Sbjct: 256 KEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLG 315
Query: 463 PWRKMLSSKDINFVGYTYKNFEIVNDY 489
+ F + Y + D+
Sbjct: 316 LLELDQREEQEMFEDFDY-----IADW 337
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 260 bits (666), Expect = 1e-83
Identities = 123/343 (35%), Positives = 186/343 (54%), Gaps = 54/343 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DF++L +G G+FG V + R + G YAMK LKK ++R QVEH ER +L+ V
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++++ +FQD + +++IM+Y+ GG++ +LL + A+FY AE LA+E +H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+KP+N+LLDK GH++++DFG K + T
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------------------------- 158
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
Y+ GTPDYIAPEV+ K Y DWWS G ++YEML GY
Sbjct: 159 -------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIK 412
PFY + M T KI+N L+FP + + KDL+S+L+ +++QRLG G +++K
Sbjct: 200 PFYDSNTMKTYEKILNAE--LRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255
Query: 413 VHPWFDGVDWARIY--QMEAAFIPEV-NDELDTQNFEKFEESD 452
HPWF V W ++ +E + P + + DT F+K+ E D
Sbjct: 256 NHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 249 bits (636), Expect = 1e-78
Identities = 129/390 (33%), Positives = 206/390 (52%), Gaps = 57/390 (14%)
Query: 82 ADADVSEEDQNNLLKFLEKKETEYMR----LQRHKMGADDFELLTMIGKGAFGEVRVCRE 137
A A +Q ++ +FL K + ++++ ++ D F+ + +G G+FG V + +
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 138 KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197
K +G+ YAMK L K ++++ Q+EH E+ +L V+ +VKL SF+D+ LY++MEY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257
+ GG+M + L R +E ARFY A+ VL E +H I+RD+KP+NLL+D+ G++++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST 317
+DFG K + T ++
Sbjct: 183 TDFGFAKRVKGRT--------------------------------------------WTL 198
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK 377
GTP+ +APE++L KGY DWW+LG ++YEM GYPPF++D P+ KI ++
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVR 256
Query: 378 FPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEAAF 432
FP S + KDL+ LL ++ +R G G ++IK H WF DW IYQ +EA F
Sbjct: 257 FPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314
Query: 433 IPEVNDELDTQNFEKFEESDNQTKTSSKTG 462
IP+ DT NF+ +EE + + + K G
Sbjct: 315 IPKFKGPGDTSNFDDYEEEEIRVSINEKCG 344
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 2e-78
Identities = 91/303 (30%), Positives = 138/303 (45%), Gaps = 51/303 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE+ +GKG FG V + REK + + A+K L K+++ + G +R E + + +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++LY F D +YLI+EY P G + L + E Y+ E A+ H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIKP+NLLL G L+++DFG S
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------------------------ 161
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ GT DY+ PE++ + + + D WSLG + YE LVG P
Sbjct: 162 -------------------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
PF ++ T ++I FP+ ++ A+DLIS+LL N +QR + E+ H
Sbjct: 203 PFEANTYQETYKRISRVE--FTFPD--FVTEGARDLISRLLKHNPSQRPMLR---EVLEH 255
Query: 415 PWF 417
PW
Sbjct: 256 PWI 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 240 bits (613), Expect = 3e-75
Identities = 86/362 (23%), Positives = 155/362 (42%), Gaps = 54/362 (14%)
Query: 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+H D +++ +G GAFG V E+ TG+ +A K + E VR E
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
++ + +V L+ +F+DD + +I E++ GG++ + + ++EDEA Y+ +
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 229 IESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ +H+++Y+H D+KP+N++ + L+L DFGL LD
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD------------------- 177
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ T GT ++ APEV K G D WS+G +
Sbjct: 178 -----------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405
Y +L G PF ++ T R + + ++ + +S + KD I KLL + N R+
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM-- 272
Query: 406 KGADEIKVHPWFDGVDW-ARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPW 464
+ HPW + R Q+ ++ ++ D + T+ ++ + E S
Sbjct: 273 -TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTK-YDAWPEPLPPLGRISNYSSL 330
Query: 465 RK 466
RK
Sbjct: 331 RK 332
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 240 bits (612), Expect = 7e-75
Identities = 105/380 (27%), Positives = 166/380 (43%), Gaps = 64/380 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN---LLAE 172
+DF + +IG+G FGEV CR+ TG +YAMK L K + + ER L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
D IV + +F + L I++ + GGD+ L + +E + RFY AE +L +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H ++RD+KP N+LLD++GH+R+SD GL
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---------------------- 161
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351
+++VGT Y+APEVL K Y DW+SLG +++++L
Sbjct: 162 ---------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGA 408
G+ PF +I + S E + L+ LL +VN+RLG +GA
Sbjct: 201 RGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259
Query: 409 DEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNF--EKFEESDNQTKTSSKTGPW 464
E+K P+F +DW ++ + IP + F F+E D +
Sbjct: 260 QEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI-------- 311
Query: 465 RKMLSSKDINFVGYTYKNFE 484
K+L S + + E
Sbjct: 312 -KLLDSDQELYRNFPLTISE 330
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 233 bits (594), Expect = 2e-73
Identities = 85/316 (26%), Positives = 137/316 (43%), Gaps = 59/316 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR------RGQVEHVRAERNL 169
+++E ++G+G VR C K T YA+K + + + E E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 170 LAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L +V + I++L +++ + F +L+ + + G++ L K TL+E E R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
I ++HK + +HRD+KP+N+LLD +++L+DFG LD
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE------------------ 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWS 342
GTP Y+APE++ GYG E D WS
Sbjct: 165 ------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 200
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
G IMY +L G PPF+ M R I++ PE S KDL+S+ L +
Sbjct: 201 TGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260
Query: 402 RLGAKGADEIKVHPWF 417
R A+E HP+F
Sbjct: 261 RY---TAEEALAHPFF 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 233 bits (595), Expect = 4e-73
Identities = 86/336 (25%), Positives = 146/336 (43%), Gaps = 52/336 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D ++ ++G GAF EV + +K T + A+K + K + G+ + E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV L ++ LYLIM+ + GG++ ++ K TE +A + + + A++ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL D+ + +SDFGL K D +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y+APEVL +K Y D WS+G I Y +L
Sbjct: 165 --------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
GYPPFY ++ +I+ P +S AKD I L+ + +R ++
Sbjct: 205 GYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQA 261
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEK 447
HPW G D A + + ++ +++
Sbjct: 262 LQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 3e-72
Identities = 119/355 (33%), Positives = 188/355 (52%), Gaps = 52/355 (14%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEML 155
+ T + K+G ++FELL ++G GA+G+V + R+ TG +YAMK LKK+ ++
Sbjct: 7 HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 156 RRGQ-VEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTL 213
++ + EH R ER +L + S +V L+ +FQ + L+LI++Y+ GG++ T L +++
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126
Query: 214 TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273
TE E + YV E VLA+E +HK I+RDIK +N+LLD GH+ L+DFGL
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS---------- 176
Query: 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--K 331
+ + + AY GT +Y+AP+++
Sbjct: 177 ------------------------------KEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDL 391
G+ DWWSLG +MYE+L G PF D ++ +I + P ++S AKDL
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDL 266
Query: 392 ISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELD 441
I +LL + +RLG + ADEIK H +F ++W + ++ A F P + DELD
Sbjct: 267 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 4e-72
Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 47/305 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 62
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFR---------------------------- 154
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
NR L GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 155 -----------YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413
P+ K+ L+ K+L N + R+ +IK
Sbjct: 204 LPWDQPSDSCQEYSDWK-EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKK 259
Query: 414 HPWFD 418
W++
Sbjct: 260 DRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 7e-72
Identities = 76/309 (24%), Positives = 131/309 (42%), Gaps = 55/309 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E++ +G GAFG+V + K T + A K + ++E E ++LA D
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
IVKL +F + L++++E+ GG + +++ + LTE + + +T+ A+ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ IHRD+K N+L G ++L+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------------------------- 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
S +GTP ++APEV++ + Y + D WSLG + E
Sbjct: 162 --------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
M PP + +PM KI + ++ S KD + K L NV+ R
Sbjct: 208 MAEIEPPHHELNPMRVLLKIAKSEPP-TLAQPSRWSSNFKDFLKKCLEKNVDARW---TT 263
Query: 409 DEIKVHPWF 417
++ HP+
Sbjct: 264 SQLLQHPFV 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 231 bits (590), Expect = 7e-72
Identities = 77/356 (21%), Positives = 150/356 (42%), Gaps = 53/356 (14%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +++L +G GAFG V C EK TG V+ K + L + V+ E +++ ++
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
++ L+ +F+D + LI+E+L GG++ + +D ++E E Y+ + ++ +H+
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 235 HHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +H DIKP+N++ + K +++ DFGL L+
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---------------------- 183
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ T T ++ APE++ ++ G D W++G + Y +L
Sbjct: 184 --------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
G PF +D + T + + + +S EAKD I LL +RL +
Sbjct: 224 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDA 280
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKM 467
HPW G ++ ++ ++ ++ + + + + RK
Sbjct: 281 LEHPWLKGDHSNLTSRIPSSRYNKIRQKIK-EKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 2e-70
Identities = 77/352 (21%), Positives = 130/352 (36%), Gaps = 90/352 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE ++ +G G G V K +G V A K + ++ + E +L E +S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-K 234
IV Y +F D + + ME++ GG + +L + + E + + + K
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------------------- 158
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
+A S VGT Y++PE L Y ++ D WS+G + EM VG
Sbjct: 159 ------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
Query: 355 PPFYSDD--------------------------------------PMSTCRKIVNWRTHL 376
P D P +++++ +
Sbjct: 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE 260
Query: 377 KFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425
P+ S+E +D ++K L N +R K ++ VH + D +
Sbjct: 261 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK---QLMVHAFIKRSDAEEV 309
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 1e-69
Identities = 80/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+GA G V + TG A++++ + ++ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV S+ + L+++MEYL GG + ++ E + E + A+E +H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK DN+LL G ++L+DFG C +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-------------------------- 169
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ + VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 170 ---------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 356 PFYSDDPMSTCRKIV-NWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413
P+ +++P+ I N L+ PE KLS +D +++ L +V +R A E+
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRG---SAKELLQ 269
Query: 414 HPWF 417
H +
Sbjct: 270 HQFL 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 3e-69
Identities = 81/314 (25%), Positives = 140/314 (44%), Gaps = 60/314 (19%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A+D+E+L IG G++G + R K+ G + K+L M + + + +E NLL E+
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK 61
Query: 175 SNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLA 228
IV+ Y D + LY++MEY GGD+ +++ + + L E+ + + LA
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 229 IESIHK-----HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
++ H+ H +HRD+KP N+ LD +++L DFGL + L+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN---------------- 165
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+ A + VGTP Y++PE + + Y + D WSL
Sbjct: 166 -------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
G ++YE+ PPF + KI + + P + S E ++I+++L R
Sbjct: 201 GCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPY--RYSDELNEIITRMLNLKDYHR 257
Query: 403 LGAKGADEIKVHPW 416
+ EI +P
Sbjct: 258 PSVE---EILENPL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 222 bits (566), Expect = 7e-69
Identities = 71/339 (20%), Positives = 121/339 (35%), Gaps = 54/339 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
++ + + +L+MEY G L + K L E E + + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ IHRD+K N+LL + G ++L DFG + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------------------- 169
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLV 352
S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 170 --------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
PP ++ + MS I + + S ++ + L R ++ +
Sbjct: 210 RKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSE---VL 264
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
H + + + ELD + K ++
Sbjct: 265 LKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-66
Identities = 78/320 (24%), Positives = 136/320 (42%), Gaps = 53/320 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEHVRAERNLLAE 172
D ++ +G G F V+ CREK+TG YA K +KK R E + E ++L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ ++ L+ +++ + LI+E + GG++ L K++LTE+EA ++ + + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 233 HKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L +++ DFGL +D
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---------------- 173
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 174 --------------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407
+L G PF D T + + + S AKD I +LL + +R+ +
Sbjct: 208 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ- 266
Query: 408 ADEIKVHPWFDGVDWARIYQ 427
+ HPW D +
Sbjct: 267 --DSLQHPWIKPKDTQQALS 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 5e-66
Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 53/306 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + + +G+G FG V C E ++ Y K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHK 234
I+ L+ SF+ E L +I E++ G D+ + L E E YV + A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 235 HHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ H DI+P+N++ + +++ +FG + L
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
P+Y APEV D WSLG ++Y +L
Sbjct: 159 --------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
G PF ++ I+N ++SIEA D + +LL R+ A E
Sbjct: 199 GINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEA 255
Query: 412 KVHPWF 417
HPW
Sbjct: 256 LQHPWL 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 205 bits (523), Expect = 7e-63
Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 45/303 (14%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+D +EL ++G G EV + R+ A+K L+ R E A ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 175 SNCIVKLYCSFQDDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
IV +Y + + + Y++MEY+ G + ++ + +T A +A+ A+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
H++ IHRD+KP N+++ +++ DFG+ + +
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI------------------------ 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
N + +GT Y++PE D +SLG ++YE+
Sbjct: 162 --------------ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207
Query: 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
L G PPF D P+S + V LS + ++ K L N R A
Sbjct: 208 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AA 265
Query: 410 EIK 412
E++
Sbjct: 266 EMR 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-62
Identities = 58/309 (18%), Positives = 117/309 (37%), Gaps = 59/309 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ IG+G+F V + T A +L+ ++ + + + + E +L +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPN 69
Query: 178 IVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IV+ Y S++ + + L+ E + G + T L R + R + + + ++ +H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 234 KHHY--IHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IHRD+K DN+ + G +++ D GL S
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--------------------- 168
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
A + +GTP+++APE+ ++ Y D ++ G M EM
Sbjct: 169 ----------------------FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEM 205
Query: 351 LVGYPPFYSDDPMST-CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
P+ + R++ + F + E K++I + N ++R K
Sbjct: 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQNKDERYSIK-- 261
Query: 409 DEIKVHPWF 417
++ H +F
Sbjct: 262 -DLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-60
Identities = 93/377 (24%), Positives = 153/377 (40%), Gaps = 77/377 (20%)
Query: 106 MRLQRHKMGADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVR 164
++++++ + DD+++ + ++G G G+V K T +A+K L+ RR H R
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 60
Query: 165 AERNLLAEVDSNCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEA 218
A + IV++ +++ + L ++ME L GG++ + + + TE EA
Sbjct: 61 ASQ-------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTLQEQD 275
+ AI+ +H + HRD+KP+NLL L+L+DFG K
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--- 170
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335
+ TP Y+APEVL + Y
Sbjct: 171 ---------------------------------------TTPCYTPYYVAPEVLGPEKYD 191
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTC----RKIVNWRTHLKFPEEAKLSIEAKDL 391
CD WSLG IMY +L GYPPFYS+ ++ +I + PE +++S E K L
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 251
Query: 392 ISKLLC-NVNQRLGAKGADEIKVHPWFDG--------VDWARIYQMEAAFIPEVNDELDT 442
I LL QR+ E HPW + +R+ + + +V +E+ T
Sbjct: 252 IRNLLKTEPTQRM---TITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEM-T 307
Query: 443 QNFEKFEESDNQTKTSS 459
Q K
Sbjct: 308 SALATMRVDYEQIKIKK 324
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 7e-59
Identities = 74/315 (23%), Positives = 123/315 (39%), Gaps = 65/315 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH---VRAERNLLA 171
+++ ++G G FG V + A+K ++K + G++ + V E LL
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 172 EVDSNC--IVKLYCSFQDDEFLYLIMEYL-PGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+V S +++L F+ + LI+E P D+ + + L E+ AR + + + A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 229 IESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ H +HRDIK +N+L+D G L+L DFG L +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---------------- 166
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 346
GT Y PE + Y G WSLG +
Sbjct: 167 ---------------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405
+Y+M+ G PF D+ + R + F + ++S E + LI L + R
Sbjct: 200 LYDMVCGDIPFEHDEEII--------RGQVFFRQ--RVSSECQHLIRWCLALRPSDRP-- 247
Query: 406 KGADEIKVHPWFDGV 420
+EI+ HPW V
Sbjct: 248 -TFEEIQNHPWMQDV 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 3e-57
Identities = 75/327 (22%), Positives = 120/327 (36%), Gaps = 72/327 (22%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSN 176
E L +G+G F V R+K T + A+KK+K + G E LL E+
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
I+ L +F + L+ +++ + + LT + Y+ T+ +E +H+H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+KP+NLLLD+ G L+L+DFGL K
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----------------------------- 151
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYP 355
+ V T Y APE+L + YG+ D W++G I+ E+L+ P
Sbjct: 152 ------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199
Query: 356 PFYSDDPMSTCRKIVN---------WRTHLKFPEEA---------------KLSIEAKDL 391
D + +I W P+ + DL
Sbjct: 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
Query: 392 ISKLLC-NVNQRLGAKGADEIKVHPWF 417
I L N R+ A + +F
Sbjct: 260 IQGLFLFNPCARI---TATQALKMKYF 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-56
Identities = 61/314 (19%), Positives = 116/314 (36%), Gaps = 51/314 (16%)
Query: 117 DFELLTM----IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +LLT+ +G G FG V+ + K A+K LK E + + AE N++
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVM 62
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
++D+ IV++ + + + L+ME G + L + + + V + + ++
Sbjct: 63 QQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ + +++HRD+ N+LL + ++SDFGL K L
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--------------------- 160
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+N + APE + + + D WS G +M+E
Sbjct: 161 -----------------ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 203
Query: 351 L-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
G P+ + + P E DL++ +V R G
Sbjct: 204 FSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAG--CPREMYDLMNLCWTYDVENRPGFAAV 260
Query: 409 DEIKVHPWFDGVDW 422
+ + ++D V+
Sbjct: 261 ELRLRNYYYDVVNE 274
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-54
Identities = 49/298 (16%), Positives = 104/298 (34%), Gaps = 51/298 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG G+FG V + A+K L + + Q++ + E +L +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
I+ + L ++ ++ G + L +T + +T ++ +H
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+K +N+ L + +++ DFGL + Q +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL---------------- 166
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351
G+ ++APEV+ K Y + D ++ G ++YE++
Sbjct: 167 -----------------------SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAK 406
G P+ + + +V + + K L+++ L ++R
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP 261
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-54
Identities = 80/333 (24%), Positives = 125/333 (37%), Gaps = 73/333 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++F+ + IG+G +G V R K TG V A+KK++ + G E +LL E++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
IVKL + LYL+ E+L + T + + Y+ + + + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+KP NLL++ G ++L+DFGL +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--------------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353
V T Y APE+LL Y D WSLG I EM+
Sbjct: 160 --------------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 354 YPPFYSDDPMSTCRKIVN---------WRTHLKFPEE----------------AKLSIEA 388
F D + +I W P+ L +
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420
+ L+S++L + N+R+ AK HP+F V
Sbjct: 260 RSLLSQMLHYDPNKRISAK---AALAHPFFQDV 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-54
Identities = 71/340 (20%), Positives = 114/340 (33%), Gaps = 79/340 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E L IG+G FGEV R + TG A+KK+ + G E +L +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKH 68
Query: 176 NCIVKLYCSFQDDEF--------LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+V L + +YL+ ++ L T E + + +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ IH++ +HRD+K N+L+ + G L+L+DFGL + +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA------------------ 170
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
+ ++ + V T Y PE+LL ++ YG D W G I
Sbjct: 171 -------------------KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVN----------------------------WRTHLKF 378
M EM P + I R
Sbjct: 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271
Query: 379 PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+ A DLI KLL + QR+ +D+ H +F
Sbjct: 272 LKAYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFF 308
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-54
Identities = 85/380 (22%), Positives = 133/380 (35%), Gaps = 95/380 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + +G + A+KK+ + + + E ++ ++D
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDH 72
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETV 226
IV+L F +D+ +L L+++Y+P K TL + Y+ +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
++ IH HRDIKP NLLLD L+L DFG K L
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN------------- 179
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 344
S + + Y APE++ Y D WS G
Sbjct: 180 -----------------------------VSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVN---------------WRTHLKFPE--------- 380
++ E+L+G P F D + +I+ T KFP+
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 270
Query: 381 -EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVND 438
+ EA L S+LL RL E H +FD + + +P D
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNV------KLPNGRD 321
Query: 439 ELDTQNFEKFEESDNQTKTS 458
NF E S N +
Sbjct: 322 TPALFNFTTQELSSNPPLAT 341
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 77/369 (20%), Positives = 133/369 (36%), Gaps = 78/369 (21%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ L+ IG+GA+G V + A+KK+ E + + E +L
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFR 64
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + + ++ +L G D+ LL + L+ D +++ + + ++
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLK 123
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH + +HRD+KP NLLL+ L++ DFGL + D
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD--------------------- 162
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 349
+ V T Y APE++L GY D WS+G I+ E
Sbjct: 163 -----------------HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 350 MLVGYPPFYSDDPMSTCRKIVN------------------WRTHLKFPEEAK-------- 383
ML P F + I+ L P + K
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 384 -LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441
+A DL+ K+L N ++R+ ++ HP+ + + + A + + ELD
Sbjct: 266 NADSKALDLLDKMLTFNPHKRI---EVEQALAHPYLEQ-YYDPSDEPIAEAPFKFDMELD 321
Query: 442 TQNFEKFEE 450
EK +E
Sbjct: 322 DLPKEKLKE 330
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 1e-53
Identities = 62/318 (19%), Positives = 116/318 (36%), Gaps = 53/318 (16%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHV 163
+ L+R + D E +G G FG VR V R + A+K LK+ + E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 164 RAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYV 222
E ++ ++D+ IV+L Q + L L+ME GG + L+ +++ + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ + + +++HRD+ N+LL + ++SDFGL K L +
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS----- 170
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ + APE + + + D WS
Sbjct: 171 ---------------------------------AGKWPLKWYAPECINFRKFSSRSDVWS 197
Query: 343 LGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVN 400
G M+E L G P+ I + ++ P E E L+S
Sbjct: 198 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPE--CPPELYALMSDCWIYKWE 254
Query: 401 QRLGAKGADEIKVHPWFD 418
R ++ ++
Sbjct: 255 DRPDFLTVEQRMRACYYS 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-53
Identities = 54/296 (18%), Positives = 99/296 (33%), Gaps = 47/296 (15%)
Query: 113 MGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+G D LL +G G+FG VR A+K LK + + ++ E N
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
+ +D +++LY + ++ E P G ++ L + Y +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ + +IHRD+ NLLL +++ DFGL + L +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN------------------- 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ ++ + APE L + + D W G ++
Sbjct: 165 -------------------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205
Query: 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
EM G P+ + KI L PE+ + +++ + R
Sbjct: 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED--CPQDIYNVMVQCWAHKPEDR 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (450), Expect = 3e-52
Identities = 60/328 (18%), Positives = 122/328 (37%), Gaps = 60/328 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 72
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+V+L + Y+I E++ G+++ L + ++ + + A+E +
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
K ++IHRD+ N L+ + ++++DFGL + + T
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA------------------ 174
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ APE L + ++ D W+ G +++E+
Sbjct: 175 ----------------------GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
Y +S +++ ++ PE + +L+ N + R +
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEG--CPEKVYELMRACWQWNPSDRPSFA-----E 265
Query: 413 VHPWFDGVDWARIYQMEAAFIPEVNDEL 440
+H F+ ++Q E++ EV EL
Sbjct: 266 IHQAFE-----TMFQ-ESSISDEVEKEL 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 177 bits (449), Expect = 4e-52
Identities = 77/330 (23%), Positives = 124/330 (37%), Gaps = 73/330 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + L IG+G +G V + G +A+KK++ E G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ IVKLY + L L+ E+L L + + L A+ ++ + + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP NLL+++ G L+++DFGL + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK----------------------- 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354
+ T Y AP+VL+ Y D WS+G I EM+ G
Sbjct: 157 ------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 355 PPFYSDDPMSTCRKIV---------NWRTHLKFPEE----------------AKLSIEAK 389
P F +I NW + P+ L
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258
Query: 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
DL+SK+L + NQR+ AK + H +F
Sbjct: 259 DLLSKMLKLDPNQRITAK---QALEHAYFK 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 8e-52
Identities = 73/342 (21%), Positives = 127/342 (37%), Gaps = 78/342 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVR--AERNLLAE 172
+E + IG+GA+G+V R+ K G A+K+++ + +R A L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 173 VDSNCIVKLYCSFQDDEF-----LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETV 226
+ +V+L+ L L+ E++ L + + + + + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ +H H +HRD+KP N+L+ G ++L+DFGL +
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---------------------- 164
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ +M S V T Y APEVLL+ Y D WS+G I
Sbjct: 165 --------------------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 204
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVN---------WRTHLKFPEEA--------------K 383
EM P F + KI++ W + P +A
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 384 LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424
+ KDL+ K L N +R+ A HP+F ++ +
Sbjct: 265 IDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLERCK 303
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-51
Identities = 55/308 (17%), Positives = 112/308 (36%), Gaps = 63/308 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V + + G+ A+K +K + AE +++ ++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 59
Query: 176 NCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESI 232
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
++++HRD+ N+L+ + ++SDFGL K +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------------------- 157
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML- 351
+ + APE L +K + + D WS G +++E+
Sbjct: 158 ----------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-- 408
G P+ ++ K +++ + R
Sbjct: 196 FGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
Query: 409 --DEIKVH 414
+ IK H
Sbjct: 253 QLEHIKTH 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-51
Identities = 50/294 (17%), Positives = 104/294 (35%), Gaps = 51/294 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D L +G G FG V+ + + + A+K +K+ M + E ++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHK 234
+V+LY +++I EY+ G ++ L + + + A+E +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
++HRD+ N L++ G +++SDFGL +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR------------------------------ 148
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VG 353
+ + + + + PEVL+ + + D W+ G +M+E+ +G
Sbjct: 149 ----------YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
P+ T I L+ S + ++ ++R K
Sbjct: 199 KMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 8e-50
Identities = 59/353 (16%), Positives = 123/353 (34%), Gaps = 82/353 (23%)
Query: 89 EDQNNLLKFLEKKETEYMRLQRHKMGAD--------DFELLTMIGKGAFGEVRVCREKTT 140
E Q +++ + EY + + D + E ++G GAFG+V
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 141 GH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLI 194
A+K LK+ + E + +E ++ ++ S+ IV L + +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 195 MEYLPGGDMMTLLMRK-----------------------DTLTEDEARFYVAETVLAIES 231
EY GD++ L K + LT ++ + + +E
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ +HRD+ N+L+ +++ DFGL + +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM------------------------ 215
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ ++ + ++APE L + Y ++ D WS G +++E+
Sbjct: 216 ---------------SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 352 -VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
+G P+ + K++ + P + E ++ + +R
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPF--YATEEIYIIMQSCWAFDSRKR 311
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 1e-49
Identities = 53/348 (15%), Positives = 110/348 (31%), Gaps = 47/348 (13%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK--SEMLRRGQVEHVRAERNLLAE 172
+F+ + ++G GAFG V G + K E + + E ++A
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
VD+ + +L + G + + KD + + + + +
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+ N+L+ H++++DFGL K L
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ A ++A E +L + Y + D WS G ++E++
Sbjct: 165 ----------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
Y P S I+ L P +I+ ++ K + + R + E+
Sbjct: 209 FGSKPYDGIPASEISSILEKGERLPQPPI--CTIDVYMIMVKCWMIDADSRPKFR---EL 263
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSS 459
+ D R ++ + D+ + + ++
Sbjct: 264 IIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 170 bits (432), Expect = 2e-49
Identities = 51/313 (16%), Positives = 103/313 (32%), Gaps = 47/313 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLL 170
++ ++ +IG G FGEV K G +K Q +E +++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAI 229
+ D ++ L + +I E++ G + + L + D T + + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ + +Y+HRD+ N+L++ ++SDFGL + L+ T +
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG-------- 193
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ APE + + + D WS G +M+E
Sbjct: 194 ----------------------------KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
Query: 350 ML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407
++ G P++ I + P L+ + N R
Sbjct: 226 VMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 408 A----DEIKVHPW 416
D++ +P
Sbjct: 283 IVNTLDKMIRNPN 295
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 89/395 (22%), Positives = 142/395 (35%), Gaps = 103/395 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G GA+G V + TG A+KKL + + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 176 NCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
++ L F DE L YL+M ++ G + LM+ + L ED +F V + + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------------------- 175
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
V T Y APEV+L Y D WS+G IM
Sbjct: 176 -------------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 349 EMLVGYPPFYSDDPMSTCRKIVN------------------WRTHLKFPEEAK------- 383
EM+ G F D + ++I+ PE K
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 270
Query: 384 --LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDEL 440
S A +L+ K+L + QR+ A E HP+F+ + DE
Sbjct: 271 TNASPLAVNLLEKMLVLDAEQRVTAG---EALAHPYFESLHDT-------------EDEP 314
Query: 441 DTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
Q ++ + ++T W+++ + ++F
Sbjct: 315 QVQKYDDSFDDVDRTLD-----EWKRVTYKEVLSF 344
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 170 bits (432), Expect = 4e-49
Identities = 75/367 (20%), Positives = 128/367 (34%), Gaps = 97/367 (26%)
Query: 99 EKKETEYMRLQRHKM---GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML 155
+ EY + H + DD++L+ +G+G + EV T +K LK
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--- 71
Query: 156 RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDT 212
+ + ++ E +L + I+ L +D L+ E++ D L
Sbjct: 72 ---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--- 125
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTL 271
LT+ + RFY+ E + A++ H +HRD+KP N+++D ++ LRL D+GL +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
V + + PE+L+
Sbjct: 186 Y------------------------------------------NVRVASRYFKGPELLVD 203
Query: 332 -KGYGMECDWWSLGAIMYEMLVGYPPFY-SDDPMSTCRKIVN------------------ 371
+ Y D WSLG ++ M+ PF+ D +I
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 372 ---------------WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
W + + +S EA D + KLL + RL A+ E HP
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR---EAMEHP 320
Query: 416 WFDGVDW 422
+F V
Sbjct: 321 YFYTVVK 327
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 8e-49
Identities = 48/293 (16%), Positives = 96/293 (32%), Gaps = 49/293 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + IG G FG V + A+K +++ M E E ++ ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHK 234
+V+LY + + L+ E++ G + L + L E + V + + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+ N L+ + +++SDFG+ +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTR------------------------------ 149
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
++ + T + +PEV Y + D WS G +M+E+
Sbjct: 150 ----------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
Y + S + ++ L P S +++ R
Sbjct: 200 KIPYENRSNSEVVEDISTGFRLYKPRL--ASTHVYQIMNHCWKERPEDRPAFS 250
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 8e-49
Identities = 54/305 (17%), Positives = 106/305 (34%), Gaps = 52/305 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 71
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+V+LY ++ +Y++ EY+ G ++ L + L + A+ + +
Sbjct: 72 EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +Y+HRD++ N+L+ + +++DFGL + ++
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-------------------------- 164
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
N + APE L + ++ D WS G ++ E+
Sbjct: 165 --------------DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
Y V + P E DL+ + +R +
Sbjct: 211 GRVPYPGMVNREVLDQVERGYRMPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAF- 267
Query: 413 VHPWF 417
+ +F
Sbjct: 268 LEDYF 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-48
Identities = 55/290 (18%), Positives = 104/290 (35%), Gaps = 51/290 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+V+LY + +Y+I EY+ G ++ L LT ++ A+ + I
Sbjct: 68 QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +YIHRD++ N+L+ +++DFGL + ++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-------------------------- 160
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
N + APE + + ++ D WS G ++ E++
Sbjct: 161 --------------DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
Y + + + P+ E L+ R
Sbjct: 207 GRIPYPGMTNPEVIQNLERGYRMVRPD--NCPEELYQLMRLCWKERPEDR 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 5e-48
Identities = 49/326 (15%), Positives = 97/326 (29%), Gaps = 49/326 (15%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ + L IG G+FG++ + + G A+K + + E + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQ 60
Query: 175 S-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
I + + ++ ++ME L + + + IE IH
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 234 KHHYIHRDIKPDNLL---LDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
++IHRD+KPDN L K + + DFGL K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA--------------------- 159
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+ Q + GT Y + L D SLG ++
Sbjct: 160 -------------RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206
Query: 351 LVGYPPFYSDDPMSTCRKIVNW-RTHLKFPEEA---KLSIEAKDLISKLLC-NVNQRLGA 405
+G P+ + +K + P E E ++ + +
Sbjct: 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266
Query: 406 KGADEIKVHPWF-DGVDWARIYQMEA 430
++ + + G + ++
Sbjct: 267 SYLRQLFRNLFHRQGFSYDYVFDWNM 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 5e-47
Identities = 58/297 (19%), Positives = 102/297 (34%), Gaps = 52/297 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ EL IG+G FG+V + A+K K E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQ 64
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIES 231
D IVKL ++ +++IME G++ + L + +L Y + A+
Sbjct: 65 FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ ++HRDI N+L+ ++L DFGL + ++ ST
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--------------------- 162
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
A ++APE + + + D W G M+E+L
Sbjct: 163 -------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203
Query: 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
+ G PF +I N + P L++K + ++R
Sbjct: 204 MHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 257
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-47
Identities = 72/331 (21%), Positives = 120/331 (36%), Gaps = 73/331 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E L IG+G +G V + + T + A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ D+ L L+ E+ L + + ++ + + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ +HRD+KP NLL+++ G L+L++FGL +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV------------------------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG- 353
+ V T Y P+VL Y D WS G I E+
Sbjct: 156 ----------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
Query: 354 YPPFYSDDPMSTCRKIVN---------WRTHLKFPEEA----------------KLSIEA 388
P F +D ++I W + K P+ KL+
Sbjct: 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
Query: 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
+DL+ LL N QR+ A+E HP+F
Sbjct: 260 RDLLQNLLKCNPVQRI---SAEEALQHPYFS 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (412), Expect = 1e-46
Identities = 57/318 (17%), Positives = 104/318 (32%), Gaps = 75/318 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
++ E + IG+GAFG V R + A+K LK+ + E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 70
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------- 211
AE D+ IVKL + + L+ EY+ GD+ L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 212 -----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
L+ E + + + + ++HRD+ N L+ + ++++DFGL + +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
+ + D ++ P
Sbjct: 191 YSADYYKADGND---------------------------------------AIPIRWMPP 211
Query: 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLS 385
E + Y E D W+ G +++E+ G P+Y + + L PE
Sbjct: 212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPEN--CP 268
Query: 386 IEAKDLISKLLC-NVNQR 402
+E +L+ R
Sbjct: 269 LELYNLMRLCWSKLPADR 286
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (406), Expect = 8e-46
Identities = 44/289 (15%), Positives = 87/289 (30%), Gaps = 49/289 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-N 176
+++ IG+G+FG + A+K + R +R E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
I +Y Q+ L+++ L L + + + + ++SIH+
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 237 YIHRDIKPDNLLLDKY-----GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
++RDIKPDN L+ + + + DFG+ K ++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY-------------- 167
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GT Y++ L + D +LG + L
Sbjct: 168 --------------------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 207
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL----SIEAKDLISKLL 396
G P+ + +K + +L E +
Sbjct: 208 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 256
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 9e-46
Identities = 52/310 (16%), Positives = 104/310 (33%), Gaps = 64/310 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
+D + +IG+G FG+V R K G + E + E +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEA 218
I+ L + + +LYL +EY P G+++ L + TL+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ A+ ++ + + +IHRD+ N+L+ + +++DFGL + + +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK------ 183
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
++A E L Y
Sbjct: 184 ------------------------------------TMGRLPVRWMAIESLNYSVYTTNS 207
Query: 339 DWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397
D WS G +++E++ G P+ K+ + + E DL+ +
Sbjct: 208 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWR 264
Query: 398 -NVNQRLGAK 406
+R
Sbjct: 265 EKPYERPSFA 274
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 9e-46
Identities = 79/395 (20%), Positives = 143/395 (36%), Gaps = 101/395 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++ L+ +G GA+G V + TG A+KKL + + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 176 NCIVKLYCSFQDDEFL-----YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
++ L F L ++ +L G D+ + ++ LT+D +F + + + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------------------- 175
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYE 349
V T Y APE++L Y D WS+G IM E
Sbjct: 176 ------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 350 MLVGYPPFYSDDPMSTCRKIVN---------------------WRTHLKFPEE------A 382
+L G F D + + I+ ++ + P+
Sbjct: 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 271
Query: 383 KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441
+ A DL+ K+L + ++R+ A + H +F + +DE
Sbjct: 272 GANPLAVDLLEKMLVLDSDKRITAA---QALAHAYFAQY-------------HDPDDEPV 315
Query: 442 TQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
+++ ES + W+ + + I+FV
Sbjct: 316 ADPYDQSFESRDLLIDE-----WKSLTYDEVISFV 345
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 3e-45
Identities = 77/377 (20%), Positives = 132/377 (35%), Gaps = 96/377 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++ L IG GA G V + A+KKL + + + E L+ V+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F ++ + +YL+ME + + M D + + + + + I
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGI 132
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL + S
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF------------------- 173
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ V T Y APEV+L GY D WS+G IM E
Sbjct: 174 -----------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 350 MLVGYPPFYSDDPMSTCRKIVNW-------------------------RTHLKFPE---- 380
M+ F D + K++ L FP+
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 381 ---------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEA 430
+ +A+DL+SK+L + +R+ D+ HP+ + W ++EA
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN--VWYDPAEVEA 325
Query: 431 AFIPEVNDELDTQNFEK 447
+ +LD +
Sbjct: 326 PPPQIYDKQLDEREHTI 342
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-44
Identities = 58/317 (18%), Positives = 107/317 (33%), Gaps = 69/317 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ +G GAFG+V + A+K LK S L + E + +E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVL 80
Query: 171 AEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------ 211
+ + ++ IV L + +I EY GD++ L RK
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
L ++ + + + + + IHRD+ N+LL ++ DFGL + +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK---- 196
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
+ ++ + ++APE +
Sbjct: 197 -----------------------------------NDSNYVVKGNARLPVKWMAPESIFN 221
Query: 332 KGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
Y E D WS G ++E+ +G P+ S K++ + PE E D
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH--APAEMYD 279
Query: 391 LISKLLC-NVNQRLGAK 406
++ + +R K
Sbjct: 280 IMKTCWDADPLKRPTFK 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-44
Identities = 52/293 (17%), Positives = 96/293 (32%), Gaps = 48/293 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+IG G FGEV KT+ A+K LK Q E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMG 64
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIE 230
+ + I++L + + +I EY+ G + L KD + + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ +Y+HRD+ N+L++ ++SDFGL + L+
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----------------------- 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+ APE + + + D WS G +M+E+
Sbjct: 162 ---------------DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206
Query: 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
+ Y + K +N L P + L+ + +R
Sbjct: 207 MTYGERPYWELSNHEVMKAINDGFRLPTPMD--CPSAIYQLMMQCWQQERARR 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 8e-43
Identities = 42/287 (14%), Positives = 97/287 (33%), Gaps = 49/287 (17%)
Query: 123 MIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+IG+G FG V + A+K L + G+V E ++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 180 KLY-CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHY 237
L + + +++ Y+ GD+ + T + + + ++ + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+ N +LD+ ++++DFGL + + G
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG------------------ 193
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPP 356
++A E L + + + D WS G +++E++ G PP
Sbjct: 194 -------------------AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
+ + ++ R + + +++ K R
Sbjct: 235 YPDVNTFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-41
Identities = 54/315 (17%), Positives = 105/315 (33%), Gaps = 66/315 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +L +G+GAFG+V + T A+K LK+ + + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI 71
Query: 171 AEVDSNCIVKL-YCSFQDDEFLYLIMEYLPGGDMMTLL----------------MRKDTL 213
+V L + L +I+E+ G++ T L + KD L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 214 TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273
T + Y + +E + IHRD+ N+LL + +++ DFGL + +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY------ 185
Query: 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333
+ + ++APE + +
Sbjct: 186 ---------------------------------KDPDYVRKGDARLPLKWMAPETIFDRV 212
Query: 334 YGMECDWWSLGAIMYEMLVGY-PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLI 392
Y ++ D WS G +++E+ P+ + + T ++ P+ + E +
Sbjct: 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTM 270
Query: 393 SKLLC-NVNQRLGAK 406
+QR
Sbjct: 271 LDCWHGEPSQRPTFS 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 44/322 (13%), Positives = 107/322 (33%), Gaps = 64/322 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ + +G+G+FG V K A+K + ++ +R + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------TLTEDEARF 220
E + + +V+L + +IME + GD+ + L + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
E + ++ + ++HRD+ N ++ + +++ DFG+ + + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG-- 195
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ +++PE L + D
Sbjct: 196 -------------------------------------LLPVRWMSPESLKDGVFTTYSDV 218
Query: 341 WSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398
WS G +++E+ + P+ R ++ L P+ +L+ N
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDN--CPDMLFELMRMCWQYN 275
Query: 399 VNQRLGAK---GADEIKVHPWF 417
R + + ++ P F
Sbjct: 276 PKMRPSFLEIISSIKEEMEPGF 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-41
Identities = 53/316 (16%), Positives = 106/316 (33%), Gaps = 68/316 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERN 168
D L +G+GAFG+V + A+K LK + + +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEME 70
Query: 169 LLAEVDS-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------D 211
++ + I+ L + D LY+I+EY G++ L + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
L+ + + +E + IHRD+ N+L+ + ++++DFGL + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
++ + ++APE L
Sbjct: 191 YKK---------------------------------------TTNGRLPVKWMAPEALFD 211
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDL 391
+ Y + D WS G +++E+ Y P+ K++ + P + E +
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN--CTNELYMM 269
Query: 392 ISKLLC-NVNQRLGAK 406
+ +QR K
Sbjct: 270 MRDCWHAVPSQRPTFK 285
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 2e-37
Identities = 55/278 (19%), Positives = 85/278 (30%), Gaps = 62/278 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A L IGKG FGEV R K G A+K E + AE +
Sbjct: 2 ARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLR 55
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + D L+L+ +Y G + L + T+T + T +
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 114
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL D +T
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGM 336
+ VGT Y+APEVL
Sbjct: 163 -------------------------DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT 374
D +++G + +E+ + +
Sbjct: 198 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (328), Expect = 3e-34
Identities = 63/392 (16%), Positives = 127/392 (32%), Gaps = 105/392 (26%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-------L 170
+ L+ +G G F V + ++ AMK ++ ++ + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 171 AEVDSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAET 225
+ +N I+KL F ++++M + G+ + L++K + + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 226 VLAIESIHKHHYI-HRDIKPDNLLLDKYGHLR-LSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+L ++ +H+ I H DIKP+N+L++ L + + E
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-------- 186
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+++ T +Y +PEVLL +G D WS
Sbjct: 187 -------------------------------TNSIQTREYRSPEVLLGAPWGCGADIWST 215
Query: 344 GAIMYEMLVGYPPFYSDD---------------------PMSTCRKIVNWRTHL------ 376
+++E++ G F D+ P R RT
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 377 -----------------KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
K+ + E D +S +L + +R A + HPW
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG---GLVNHPWLK 332
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
D + ++ D + FEE
Sbjct: 333 --DTLGMEEIRVPDRELYGSGSDIPGW--FEE 360
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.4 bits (174), Expect = 5e-15
Identities = 20/160 (12%), Positives = 50/160 (31%), Gaps = 28/160 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKS---------------EMLRRGQVEHVRAER 167
++G+G V C + +K K + R E
Sbjct: 7 LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
L ++ + K+Y + ++ME + ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILE 114
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +H D+ N+L+ + G + + DF +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 552 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.04 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.56 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-72 Score=580.86 Aligned_cols=292 Identities=40% Similarity=0.725 Sum_probs=270.1
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
+++.++|++++.||+|+||+||+|+++.+|+.||||++++..+......+++.+|+.+|+.++|||||+++++|++.+++
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 46788999999999999999999999999999999999998877777888999999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+|||||+||+|..++.+.+.++|..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~- 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG- 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998653221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+.+||+.|||||++.+.+|+.++|||||||++|||+
T Consensus 160 ----------------------------------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml 199 (337)
T d1o6la_ 160 ----------------------------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp ----------------------------------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHH
Confidence 0123679999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhhhhh-
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ- 427 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~l~~- 427 (552)
+|++||.+.+..+++.++.. ..+.+|. .+|+++++||.+||+ ||.+|++.. +++||++||||++++|+.+..
T Consensus 200 ~G~~pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~ 275 (337)
T d1o6la_ 200 CGRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 275 (337)
T ss_dssp HSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred HCCCCCCCcCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhC
Confidence 99999999999999998887 4567775 799999999999999 999999743 589999999999999999974
Q ss_pred -cCCCCccccCCcccCcCcccc
Q 008810 428 -MEAAFIPEVNDELDTQNFEKF 448 (552)
Q Consensus 428 -~~~pf~P~~~~~~d~~~f~~~ 448 (552)
+.|||+|.+..+.|+++|++.
T Consensus 276 ~~~~p~~P~~~~~~~~~~f~~~ 297 (337)
T d1o6la_ 276 KLLPPFKPQVTSEVDTRYFDDE 297 (337)
T ss_dssp CSCCSCCCCCSSTTCCTTSCHH
T ss_pred CCCCCCCCCCCChhhhhhcCch
Confidence 789999999999999999863
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-68 Score=548.05 Aligned_cols=291 Identities=42% Similarity=0.845 Sum_probs=255.0
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..+||++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|+.++|||||+++++|++.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 45789999999999999999999999999999999998877677778899999999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||||+||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999875421
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
..+.+||+.|||||++.+..|+.++|||||||++|||++|
T Consensus 158 ----------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG 197 (316)
T d1fota_ 158 ----------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197 (316)
T ss_dssp ----------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ----------------------------------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC
Confidence 1257899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhh--hc
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QM 428 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~--~~ 428 (552)
.+||.+.+..+.+.+|.+. ...+|. .+|+++++||.+||. ||.+|++. .++++|++||||++++|+.+. .+
T Consensus 198 ~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~ 273 (316)
T d1fota_ 198 YTPFYDSNTMKTYEKILNA--ELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273 (316)
T ss_dssp SCTTCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred CCCCCCcCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCC
Confidence 9999999999999999874 455664 799999999999998 99999863 369999999999999999986 47
Q ss_pred CCCCccccC-CcccCcCcccccccc
Q 008810 429 EAAFIPEVN-DELDTQNFEKFEESD 452 (552)
Q Consensus 429 ~~pf~P~~~-~~~d~~~f~~~~~~~ 452 (552)
++||+|.+. ...|+++|+++.+++
T Consensus 274 ~~p~~p~~~~~~~d~~~f~~~~~~~ 298 (316)
T d1fota_ 274 ETPYEPPIQQGQGDTSQFDKYPEED 298 (316)
T ss_dssp CCSCCCCC----------------C
T ss_pred CcCCCCCcCCCcchhhhcCCCcccc
Confidence 899999864 456999999877654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-68 Score=553.68 Aligned_cols=293 Identities=41% Similarity=0.832 Sum_probs=269.2
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
....++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 116 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence 34568999999999999999999999999999999999988777777788899999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|+||||+.||+|..++.+.+.|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999876421
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
..+.+||+.|||||++.+.+|+.++|||||||++|||+
T Consensus 195 ------------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 195 ------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp ------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHH
Confidence 12578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC--CChhhhhcCCCcCCCChhhhhh-
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ- 427 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~--~~a~eil~HpfF~~i~w~~l~~- 427 (552)
+|++||.+.+....+.+|.. ..+.+|. .+|+++++||.+||+ ||.+|+.. .++++|++||||+++||+.+.+
T Consensus 233 tG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~ 308 (350)
T d1rdqe_ 233 AGYPPFFADQPIQIYEKIVS--GKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHH--CCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTT
T ss_pred hCCCCCCCcCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhc
Confidence 99999999999999999987 3455554 799999999999999 99999742 3599999999999999999874
Q ss_pred -cCCCCccccCCcccCcCcccccccc
Q 008810 428 -MEAAFIPEVNDELDTQNFEKFEESD 452 (552)
Q Consensus 428 -~~~pf~P~~~~~~d~~~f~~~~~~~ 452 (552)
++|||+|.+.++.|++||+.+++.+
T Consensus 309 ~~~~p~~p~~~~~~d~s~~~~~~~~~ 334 (350)
T d1rdqe_ 309 KVEAPFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp CSCCSCCCCCCSTTCCTTSCCCCCCC
T ss_pred CCCcCccCCCCCcchhhhcCCCCccc
Confidence 7899999999999999999876544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-68 Score=548.03 Aligned_cols=314 Identities=35% Similarity=0.668 Sum_probs=250.7
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHH-hcCCCceEEEeeeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++++.........+++..|..++. .++|||||+++++|++++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 378999999999999999999999999999999999887766777788888888775 6899999999999999999999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
|||||+||+|..++.....+++.+++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-- 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-- 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG 353 (552)
.....+||+.|+|||++.+.+|+.++|||||||++|||++|
T Consensus 159 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG 199 (320)
T d1xjda_ 159 ---------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199 (320)
T ss_dssp ---------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC
Confidence 11246899999999999999999999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChh-hhhcCCCcCCCChhhhh--hcC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD-EIKVHPWFDGVDWARIY--QME 429 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~-eil~HpfF~~i~w~~l~--~~~ 429 (552)
++||.+.+..+++.+|.. ....+|. .+|+++++||.+||+ ||.+||+ +. +|++||||++++|+.+. +++
T Consensus 200 ~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~s---~~~~l~~hpff~~~~~~~l~~~~~~ 272 (320)
T d1xjda_ 200 QSPFHGQDEEELFHSIRM--DNPFYPR--WLEKEAKDLLVKLFVREPEKRLG---VRGDIRQHPLFREINWEELERKEID 272 (320)
T ss_dssp SCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSBT---TBSCGGGSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHhcccCCCCCcC---HHHHHHhCchhccCCHHHHHhcCCC
Confidence 999999999999999886 3456664 789999999999999 9999999 64 79999999999999986 478
Q ss_pred CCCccccCCcccCcCccccccccccccCCCCCCcccccccc-cCCcccCcee
Q 008810 430 AAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTY 480 (552)
Q Consensus 430 ~pf~P~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~ 480 (552)
|||+|.+.++.|++||+.....+.+..+.. .+.++.+ .+..|.||+|
T Consensus 273 pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~----~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 273 PPFRPKVKSPFDCSNFDKEFLNEKPRLSFA----DRALINSMDQNMFRNFSF 320 (320)
T ss_dssp C------------------------------------------CCTTTTCCC
T ss_pred CCCCCCCCCccchhhcChHhhhCCccCCCC----cccccCchhhcccCcCcC
Confidence 999999999999999986432222111111 1122333 3456999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-68 Score=541.33 Aligned_cols=280 Identities=36% Similarity=0.671 Sum_probs=251.2
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||+++++|++++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 44568999999999999999999999999999999999988777777788899999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|||||||+||+|.+++...+.+++..++.++.|++.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997643210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
. ....+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 164 ~---------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell 204 (288)
T d1uu3a_ 164 Q---------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204 (288)
T ss_dssp ---------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHh
Confidence 0 0123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCC---hhhhhcCCCcCCCChhhhhh
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG---ADEIKVHPWFDGVDWARIYQ 427 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~---a~eil~HpfF~~i~w~~l~~ 427 (552)
+|.+||.+.+..+++.+|.+. .+.+|. .+|+++++||.+||+ ||.+||++.. ...|++||||+++||++|.+
T Consensus 205 ~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 205 AGLPPFRAGNEYLIFQKIIKL--EYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280 (288)
T ss_dssp HSSCSSCCSSHHHHHHHHHTT--CCCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred hCCCCCCCcCHHHHHHHHHcC--CCCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence 999999999999999999874 456665 799999999999999 9999999422 23479999999999999999
Q ss_pred cCCCCcc
Q 008810 428 MEAAFIP 434 (552)
Q Consensus 428 ~~~pf~P 434 (552)
..||-+|
T Consensus 281 ~~pP~l~ 287 (288)
T d1uu3a_ 281 QTPPKLT 287 (288)
T ss_dssp SCCCCCC
T ss_pred CCCCCCC
Confidence 8888766
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.9e-65 Score=531.78 Aligned_cols=289 Identities=34% Similarity=0.626 Sum_probs=240.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHH---HHHHHhcCCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAE---RNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E---~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
++.++|+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+| +.+++.++|||||+++++|.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 457899999999999999999999999999999999988765544444445555 55566678999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
.+|||||||+||+|..+|.+...+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvily 348 (552)
. ....+||+.|||||++.+ ..|+.++|||||||++|
T Consensus 161 ~-------------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvily 197 (364)
T d1omwa3 161 K-------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197 (364)
T ss_dssp C-------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHH
T ss_pred c-------------------------------------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHH
Confidence 1 124689999999999974 67999999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHh-hccccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcCCCChhh
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIV-NWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~-~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~~i~w~~ 424 (552)
||++|++||.+.+.......+. .......+|. .+|+++++||.+||+ ||.+||+.. +|+||++||||+++||..
T Consensus 198 emltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~ 275 (364)
T d1omwa3 198 KLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 275 (364)
T ss_dssp HHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS--SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC--CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHH
Confidence 9999999998765443322111 1123344443 799999999999999 999999953 489999999999999999
Q ss_pred hhh--cCCCCccccCCcccCcCcc
Q 008810 425 IYQ--MEAAFIPEVNDELDTQNFE 446 (552)
Q Consensus 425 l~~--~~~pf~P~~~~~~d~~~f~ 446 (552)
+.. ++|||+|......+.+.|+
T Consensus 276 ~~~~~~~~p~~p~~~~~~~~~~~d 299 (364)
T d1omwa3 276 VFLQKYPPPLIPPRGEVNAADAFD 299 (364)
T ss_dssp HHTTCSCCSCCCCCC---------
T ss_pred HhcCCCCcCcCCCCCCCCcCCccc
Confidence 874 7899999876555444443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-65 Score=507.38 Aligned_cols=257 Identities=35% Similarity=0.605 Sum_probs=237.5
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
++..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 81 (263)
T d2j4za1 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 81 (263)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence 34578999999999999999999999999999999999988776667778899999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
|||||||+||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 9999999999999999998999999999999999999999999999999999999999999999999999998653221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
....+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 161 ------------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell 198 (263)
T d2j4za1 161 ------------------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198 (263)
T ss_dssp ------------------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHh
Confidence 12568999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
+|.+||.+.+..+++.+|.. ..+.+|. .+|+++++||.+||+ ||.+||+ ++||++||||.
T Consensus 199 ~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~ 259 (263)
T d2j4za1 199 VGKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRPM---LREVLEHPWIT 259 (263)
T ss_dssp HSSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHHccCCHhHCcC---HHHHHcCcCcC
Confidence 99999999999999988876 4556665 799999999999999 9999998 99999999995
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-63 Score=499.27 Aligned_cols=260 Identities=26% Similarity=0.455 Sum_probs=222.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5789999999999999999999999999999999987543 22345688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
||||+||+|.++|.+...+++.+++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987642210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHHHHHHhhC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvilyEmltG 353 (552)
.....+.+||+.|||||++.+..| +.++|||||||++|||++|
T Consensus 159 ------------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G 202 (271)
T d1nvra_ 159 ------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202 (271)
T ss_dssp ------------------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence 011235789999999999998876 6789999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
.+||.+.+.......+... .....+....+|+++++||.+||+ ||.+||+ ++||++||||+.
T Consensus 203 ~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~ 265 (271)
T d1nvra_ 203 ELPWDQPSDSCQEYSDWKE-KKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNK 265 (271)
T ss_dssp SCSCSSSSTTSHHHHHHHT-TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTC
T ss_pred CCCCCCCChHHHHHHHHhc-CCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCc
Confidence 9999876554433333322 222333345799999999999999 9999998 999999999963
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-63 Score=500.60 Aligned_cols=267 Identities=29% Similarity=0.514 Sum_probs=233.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh---hHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~---~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|+.++|||||+++++|.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4679999999999999999999999999999999987654322 2356799999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC----cEEEcccccccccC
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g----~iKL~DFGlak~~~ 267 (552)
|||||||+||+|.++|...+.+++..++.++.||+.||.|||++|||||||||+|||++.+| ++||+|||+|+.+.
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999889999999999999999999999999999999999999998777 59999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
.... ..+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~------------------------------------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 169 FGNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206 (293)
T ss_dssp TSCB------------------------------------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CCcc------------------------------------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHH
Confidence 3211 1246899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhh
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~ 426 (552)
|||++|.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+||+ ++||++||||++++|....
T Consensus 207 yell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 207 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC-------
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCChhHhh
Confidence 99999999999999999999988743333222235789999999999999 9999999 9999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-63 Score=505.42 Aligned_cols=258 Identities=32% Similarity=0.581 Sum_probs=218.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||+++++|++++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46699999999999999999999999999999999876542 2345688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc---CCCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~---~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.++|...+.|++.+++.|+.||+.||.|||++|||||||||+|||+. .+|++||+|||+|+..+...
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99999999999999999999999999999999999999999999999999999995 57999999999998653221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
...+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 165 -----------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 165 -----------------------------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp -------------------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH
Confidence 112568999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|.+||.+.+..++..+|......+..|....+|+++++||.+||. ||.+||+ ++||++||||++
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 269 (307)
T d1a06a_ 204 CGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAG 269 (307)
T ss_dssp HSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTS
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCC
Confidence 9999999999999999999866555555556899999999999999 9999998 999999999976
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-62 Score=496.35 Aligned_cols=255 Identities=30% Similarity=0.516 Sum_probs=226.8
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||+||+|+++.+|+.||||++++... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 479999999999999999999999999999999987643 23467899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
|||+||+|..++.+ ..+++.+++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---- 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc----
Confidence 99999999988754 6799999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
.....+||+.|||||++.+..|+.++|||||||++|||++|.+
T Consensus 172 -------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 172 -------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp -------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 1125689999999999999999999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||.+.+......++.... ...++....+|+++++||.+||. ||.+||+ ++||++||||+.
T Consensus 215 Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 215 PYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp TTTTSCHHHHHHHHHHHC-SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred CCCCCCHHHHHHHHHhCC-CCCCCCcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCC
Confidence 999998888777776532 22333335799999999999999 9999998 999999999963
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.6e-62 Score=504.86 Aligned_cols=262 Identities=29% Similarity=0.518 Sum_probs=234.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976542 3456789999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc--CCCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~--~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+.+....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 180 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 180 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence 999999999999854 56799999999999999999999999999999999999996 46899999999998764321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
...+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 181 -----------------------------------------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 181 -----------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp -----------------------------------------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 122578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhh
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~ 424 (552)
+|.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+||+ ++||++||||...+|..
T Consensus 220 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 220 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPG 290 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTCCS
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCCCCC
Confidence 9999999999999999998755444433345799999999999999 9999999 99999999999887754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-62 Score=505.94 Aligned_cols=264 Identities=30% Similarity=0.462 Sum_probs=225.3
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceE
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~l 191 (552)
++..++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+.+|+.+|+.++|||||+++++|.++..+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356789999999999999999999999999999999998652 234456789999999999999999999999999999
Q ss_pred EEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 192 ylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999999999999999999999999999997 59999999999999999999999999999854211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
...+.+||+.|||||++.+..|+.++|||||||++|||
T Consensus 159 ------------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~el 196 (322)
T d1s9ja_ 159 ------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196 (322)
T ss_dssp ------------------------------------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHH
Confidence 12357999999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHH------------------------------------------HhhccccccCCcccccChhH
Q 008810 351 LVGYPPFYSDDPMSTCRK------------------------------------------IVNWRTHLKFPEEAKLSIEA 388 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~------------------------------------------i~~~~~~~~~p~~~~~s~e~ 388 (552)
++|++||.+.+....... +.. .....+|. ..+|.++
T Consensus 197 l~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~s~~~ 274 (322)
T d1s9ja_ 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLPS-GVFSLEF 274 (322)
T ss_dssp HHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHT-SCCCCCCB-TTBCHHH
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhc-cCCccCcc-ccCCHHH
Confidence 999999987654322110 000 01111221 2478999
Q ss_pred HHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhh
Q 008810 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (552)
Q Consensus 389 ~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l 425 (552)
+|||.+||+ ||.+||+ |+|+++||||+..+|+.+
T Consensus 275 ~dli~~~L~~dP~~R~t---a~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 275 QDFVNKCLIKNPAERAD---LKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp HHHHHHHTCSSTTTSCC---HHHHHTSHHHHHHHHSCC
T ss_pred HHHHHHHcCCChhHCcC---HHHHhhCHhhCcCCcccc
Confidence 999999999 9999999 999999999988777543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-61 Score=489.49 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=226.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46899999999999999999999999999999998653 344567889999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||+||+|..++.+ ...|++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999765 4679999999999999999999999999999999999999999999999999997542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhh-----cCCCCCccchhhhhHHHHH
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~-----~~~y~~~~DiWSlGvilyE 349 (552)
....+.+||+.|||||++. +..|+.++|||||||++||
T Consensus 165 -------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 165 -------------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp -------------------------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred -------------------------------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence 0122578999999999995 4668999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|++|.+||.+.++.+.+.+|..... ..++....+|+++++||.+||+ ||.+||+ ++||++||||+.
T Consensus 208 mltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~ 274 (288)
T d2jfla1 208 MAEIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTV 274 (288)
T ss_dssp HHHSSCTTTTSCGGGHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCC
T ss_pred HhhCCCCCCCCCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCC
Confidence 9999999999999999988887432 2233335899999999999999 9999999 999999999974
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-61 Score=492.76 Aligned_cols=253 Identities=27% Similarity=0.393 Sum_probs=228.7
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 39999999999999999999999999999999988766566667789999999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
||+||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-------- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------- 167 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------
Confidence 999999988888888999999999999999999999999999999999999999999999999999985431
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhhHHHHHHhhC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVG 353 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvilyEmltG 353 (552)
..+.+||+.|||||++.+ ..|+.++|||||||++|||++|
T Consensus 168 -------------------------------------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g 210 (309)
T d1u5ra_ 168 -------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (309)
T ss_dssp -------------------------------------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred -------------------------------------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence 124689999999999974 4589999999999999999999
Q ss_pred CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
.+||.+.+..+.+.++...... .+....+|+++++||.+||+ ||.+||+ ++||++||||..
T Consensus 211 ~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 211 KPPLFNMNAMSALYHIAQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLR 272 (309)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCC--CCSCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHS
T ss_pred CCCCCCCCHHHHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHCcCChhHCcC---HHHHHhCHHhcC
Confidence 9999999988888888864322 22234789999999999999 9999999 999999999953
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-61 Score=481.89 Aligned_cols=255 Identities=32% Similarity=0.571 Sum_probs=216.8
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC--CceEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLY 192 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d--~~~ly 192 (552)
.+||++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4789999999999999999999999999999999987654 34556779999999999999999999999865 46799
Q ss_pred EEEecCCCCchhhHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----CcccccCCCCccccCCCcEEEcccccc
Q 008810 193 LIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHH-----YIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g-----iiHrDLKPeNILl~~~g~iKL~DFGla 263 (552)
||||||+||+|.+++.+ ...+++..++.++.||+.||.|||+.| ||||||||+||||+.+|++||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 467999999999999999999999976 999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+.+..... ...+.+||+.|||||++.+..|+.++|||||
T Consensus 162 ~~~~~~~~-----------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 200 (269)
T d2java1 162 RILNHDTS-----------------------------------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200 (269)
T ss_dssp HHC----------------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred eecccCCC-----------------------------------------ccccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence 87642210 1225789999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
||++|||++|.+||.+.+..++..+|..... ..+|. .+|+++++||.+||. ||.+||+ ++||++|||.
T Consensus 201 Gvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~~--~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 201 GCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIPY--RYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCCc--ccCHHHHHHHHHHcCCChhHCcC---HHHHHhCCcC
Confidence 9999999999999999999988888876432 23443 789999999999999 9999999 9999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.3e-61 Score=497.82 Aligned_cols=258 Identities=29% Similarity=0.544 Sum_probs=230.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++++.... ....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999876432 335688999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc--CCCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~--~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.+++... ..|++.+++.++.||+.||.|||++|||||||||+||||+ .+|++||+|||+|+.+....
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999999887655 4699999999999999999999999999999999999998 67899999999998764321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
...+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 184 -----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 222 (352)
T d1koba_ 184 -----------------------------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222 (352)
T ss_dssp -----------------------------------------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH
Confidence 123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i 420 (552)
+|.+||.+.+..+.+.+|......+..+....+|+++++||.+||+ ||.+||+ ++||++||||++.
T Consensus 223 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~ 289 (352)
T d1koba_ 223 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGD 289 (352)
T ss_dssp HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCCC
Confidence 9999999999999999988744333333335799999999999999 9999999 9999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-60 Score=477.63 Aligned_cols=260 Identities=33% Similarity=0.566 Sum_probs=233.6
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhh------hhHHHHHHHHHHHHHhcC-CCceEEEeeeecC
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR------RGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD 187 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~------~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d 187 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 378999999999999999999999999999999998764322 223456889999999997 9999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
++++|||||||+||+|.++|...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc------CCCCCccchh
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWW 341 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~------~~y~~~~DiW 341 (552)
.... ....+||+.|+|||++.+ ..|+.++|||
T Consensus 162 ~~~~------------------------------------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diw 199 (277)
T d1phka_ 162 PGEK------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199 (277)
T ss_dssp TTCC------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred CCCc------------------------------------------eeeeeccCCCCCHHHhhccccccCCCCCchheEc
Confidence 3210 124689999999999974 4578999999
Q ss_pred hhhHHHHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 342 SlGvilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
|+||++|||++|.+||.+.+......+|++....+..|....+|+++++||.+||. ||.+||+ ++||++||||+.
T Consensus 200 slGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~ 275 (277)
T d1phka_ 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCT
T ss_pred ccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHHHH
Confidence 99999999999999999999999999999866555666666899999999999999 9999999 999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-61 Score=492.06 Aligned_cols=290 Identities=41% Similarity=0.732 Sum_probs=248.2
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhh-hhHHHHHHHHHHHHHhcCC-CceEEEeeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDS-NCIVKLYCSF 185 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~---k~tg~~~AiK~l~k~~~~~-~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f 185 (552)
.++..++|++++.||+|+||+||+|++ +.+|+.||||++++..... ....+.+.+|+.+|++++| |||++++++|
T Consensus 19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 446779999999999999999999997 4479999999998754332 2334568899999999976 8999999999
Q ss_pred cCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 186 QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 186 ~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+...+|+||||+.||+|..++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC--CCCCccchhhh
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSL 343 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~--~y~~~~DiWSl 343 (552)
+..... ....+.+||+.|+|||++.+. .|+.++|||||
T Consensus 179 ~~~~~~----------------------------------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSl 218 (322)
T d1vzoa_ 179 FVADET----------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218 (322)
T ss_dssp CCGGGG----------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHH
T ss_pred hccccc----------------------------------------ccccccccccccchhHHhhcCCcCCCchhhhHHH
Confidence 643211 012356899999999999864 47889999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHhhc--cccccCCcccccChhHHHHHHHHhh-CccccCCCC--ChhhhhcCCCcC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFD 418 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~--~a~eil~HpfF~ 418 (552)
||+||||++|.+||.+.+.......+... .....+|. .+|+++++||.+||. ||.+|++.. +++||++||||+
T Consensus 219 G~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~ 296 (322)
T d1vzoa_ 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296 (322)
T ss_dssp HHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence 99999999999999987766665555542 23344443 799999999999999 999999853 589999999999
Q ss_pred CCChhhhhh--cCCCCccccCCcccC
Q 008810 419 GVDWARIYQ--MEAAFIPEVNDELDT 442 (552)
Q Consensus 419 ~i~w~~l~~--~~~pf~P~~~~~~d~ 442 (552)
+++|+.+.. ++|||+|.+.++.|.
T Consensus 297 ~i~~~~l~~~~~~~p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 297 KINWDDLAAKKVPAPFKPVIRDELDV 322 (322)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCC-CCC
T ss_pred CCCHHHHHhCCCCcCCCCCCCCCCCC
Confidence 999999984 899999999998874
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-60 Score=474.11 Aligned_cols=251 Identities=23% Similarity=0.411 Sum_probs=217.8
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC----CceEEE
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEFLYL 193 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d----~~~lyl 193 (552)
|++.+.||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+++|+.++|||||++|++|.+ ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4677889999999999999999999999999987654 34456779999999999999999999999864 467999
Q ss_pred EEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CcccccCCCCcccc-CCCcEEEcccccccccCCCC
Q 008810 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKPeNILl~-~~g~iKL~DFGlak~~~~~~ 270 (552)
|||||+||+|.+++.+...+++..++.++.||+.||.|||++| ||||||||+||||+ .+|++||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999999899999999999999999999999998 99999999999996 5899999999999854321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
...+.+||+.|||||++.+ +|+.++|||||||++|||
T Consensus 169 ------------------------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 169 ------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp ------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHH
Confidence 1235789999999999865 699999999999999999
Q ss_pred hhCCCCCCCCC-hhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 351 LVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 351 ltG~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
++|.+||.+.. ...++.++........++ ..+++++++||.+||. ||.+||+ ++||++||||+
T Consensus 206 ~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred HHCCCCCCCcccHHHHHHHHHcCCCCcccC--ccCCHHHHHHHHHHccCCHhHCcC---HHHHhCCcccC
Confidence 99999998754 445556666533333333 3689999999999999 9999998 99999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-60 Score=485.35 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=228.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+|+.++|||||+++++|++++++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999998653 2234588999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCC--CcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY--GHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~-~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~--g~iKL~DFGlak~~~~~~~ 271 (552)
||||+||+|.++|...+ .+++.+++.|+.||+.||.|||++|||||||||+|||++.+ +.+||+|||+++......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 99999999999997665 79999999999999999999999999999999999999854 489999999998654221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
...+.+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 159 -----------------------------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll 197 (321)
T d1tkia_ 159 -----------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp -----------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHH
Confidence 123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCC
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
+|.+||.+.+..+.+.+|.+....+..+....+|+++++||.+||+ ||.+||+ ++||++||||+.
T Consensus 198 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~ 263 (321)
T d1tkia_ 198 SGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhcc
Confidence 9999999999999999998754333222234789999999999999 9999999 999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-59 Score=471.86 Aligned_cols=259 Identities=29% Similarity=0.442 Sum_probs=218.1
Q ss_pred eEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhh--hHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEe
Q 008810 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (552)
Q Consensus 119 ~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~--~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmE 196 (552)
+.+++||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|+.++|||||+++++|.+++++|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 457899999999999999999999999999976543222 123468899999999999999999999999999999999
Q ss_pred cCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccccc
Q 008810 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (552)
Q Consensus 197 y~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~ 276 (552)
||.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~----- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-----
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-----
Confidence 999999888887788999999999999999999999999999999999999999999999999999986543210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHHHhhCCC
Q 008810 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYP 355 (552)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyEmltG~~ 355 (552)
...+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+
T Consensus 156 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 156 ------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp ------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence 1125689999999999975 568999999999999999999999
Q ss_pred CCCCCChhhHHHHHhhccccc------------------cCCc------ccccChhHHHHHHHHhh-CccccCCCCChhh
Q 008810 356 PFYSDDPMSTCRKIVNWRTHL------------------KFPE------EAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (552)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~------------------~~p~------~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~e 410 (552)
||.+.+..+++.+|....... .+|. ...+|++++|||.+||+ ||.+||+ |+|
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e 276 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQ 276 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC---HHH
Confidence 999999988888876421110 0010 02568999999999999 9999999 999
Q ss_pred hhcCCCcCCCC
Q 008810 411 IKVHPWFDGVD 421 (552)
Q Consensus 411 il~HpfF~~i~ 421 (552)
+++||||++..
T Consensus 277 ~L~Hp~f~~~p 287 (299)
T d1ua2a_ 277 ALKMKYFSNRP 287 (299)
T ss_dssp HHTSGGGTSSS
T ss_pred HhCCHhhCCCC
Confidence 99999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-59 Score=479.44 Aligned_cols=252 Identities=33% Similarity=0.545 Sum_probs=212.3
Q ss_pred CCCeeEEe-eeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHh-cCCCceEEEeeeecC----C
Q 008810 115 ADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQD----D 188 (552)
Q Consensus 115 ~~~f~~~~-~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~-l~hp~Iv~l~~~f~d----~ 188 (552)
.++|+++. +||+|+||+||+|+++.+|+.||||++++.. .+.+|+.++.+ .+|||||+++++|++ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 57899885 6999999999999999999999999997543 36678888755 589999999999975 5
Q ss_pred ceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC---CCcEEEcccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~---~g~iKL~DFGla 263 (552)
.++|||||||+||+|.++|.+. ..|++.+++.|+.||+.||.|||++|||||||||+|||++. .+++||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6899999999999999999764 47999999999999999999999999999999999999985 568999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhh
Q 008810 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (552)
Q Consensus 264 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSl 343 (552)
+....... ..+.+||+.|||||++.+..|+.++|||||
T Consensus 162 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl 199 (335)
T d2ozaa1 162 KETTSHNS------------------------------------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199 (335)
T ss_dssp EECCCCCC------------------------------------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred eeccCCCc------------------------------------------cccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence 87643211 125689999999999999999999999999
Q ss_pred hHHHHHHhhCCCCCCCCChhhHHHHHh----hccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcC
Q 008810 344 GAIMYEMLVGYPPFYSDDPMSTCRKIV----NWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (552)
Q Consensus 344 GvilyEmltG~~PF~~~~~~~~~~~i~----~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~ 418 (552)
|||+|+|++|++||.+.+.......+. .....++.+....+|+++++||.+||+ ||.+||+ +.||++||||.
T Consensus 200 Gvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~ 276 (335)
T d2ozaa1 200 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIM 276 (335)
T ss_dssp HHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHH
T ss_pred chhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHhh
Confidence 999999999999998877655544433 222223333345799999999999999 9999999 99999999995
Q ss_pred C
Q 008810 419 G 419 (552)
Q Consensus 419 ~ 419 (552)
.
T Consensus 277 ~ 277 (335)
T d2ozaa1 277 Q 277 (335)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=461.41 Aligned_cols=262 Identities=30% Similarity=0.468 Sum_probs=218.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylV 194 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+++|+.++|||||+++++|++...+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 378999999999999999999999999999999997653 2233456788999999999999999999999999999999
Q ss_pred EecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccc
Q 008810 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (552)
Q Consensus 195 mEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~ 273 (552)
||||.|+.+..+... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++++||+|||+|+.......
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-- 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc--
Confidence 999976544444333 46799999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-CCCccchhhhhHHHHHHhh
Q 008810 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.... ++.++|+|||||++|+|++
T Consensus 158 ---------------------------------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~ 198 (298)
T d1gz8a_ 158 ---------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198 (298)
T ss_dssp ---------------------------------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------cceeecccceeeehhhhccccCCCccccccccchhhhHHhh
Confidence 122468999999999998766 4899999999999999999
Q ss_pred CCCCCCCCChhhHHHHHhhcccc----------------ccCCc---------ccccChhHHHHHHHHhh-CccccCCCC
Q 008810 353 GYPPFYSDDPMSTCRKIVNWRTH----------------LKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (552)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~----------------~~~p~---------~~~~s~e~~dLI~~lL~-dp~~Rl~~~ 406 (552)
|++||.+.+..+...++...... ..+|. ...+|++++|||.+||+ ||.+||+
T Consensus 199 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t-- 276 (298)
T d1gz8a_ 199 RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS-- 276 (298)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC--
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC--
Confidence 99999999888777766531110 00110 12568899999999999 9999999
Q ss_pred ChhhhhcCCCcCCCC
Q 008810 407 GADEIKVHPWFDGVD 421 (552)
Q Consensus 407 ~a~eil~HpfF~~i~ 421 (552)
++||++||||++++
T Consensus 277 -~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 277 -AKAALAHPFFQDVT 290 (298)
T ss_dssp -HHHHHTSGGGTTCC
T ss_pred -HHHHhCCHhhccCC
Confidence 99999999998873
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-58 Score=459.09 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=217.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhH---HHHHHHHHHHHHhcC--CCceEEEeeeecCCc
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAEVD--SNCIVKLYCSFQDDE 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~---~~~~~~E~~iL~~l~--hp~Iv~l~~~f~d~~ 189 (552)
.++|++.++||+|+||+||+|+++.+|+.||||++.+........ ...+.+|+.+|+.++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999999999999999998765433222 233668999999986 899999999999999
Q ss_pred eEEEEEecCCC-CchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-CCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~g-G~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-~g~iKL~DFGlak~~~ 267 (552)
.+|+||||+.| +++..++.....+++.+++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 688888888899999999999999999999999999999999999999985 5799999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC-CCccchhhhhHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 346 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvi 346 (552)
... ..+.+||+.|+|||++.+..| +.++|||||||+
T Consensus 163 ~~~-------------------------------------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvi 199 (273)
T d1xwsa_ 163 DTV-------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199 (273)
T ss_dssp SSC-------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHH
T ss_pred ccc-------------------------------------------ccccccCCCcCCHHHHcCCCCCCcccccccceee
Confidence 211 125689999999999998765 678999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCC
Q 008810 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (552)
Q Consensus 347 lyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~ 421 (552)
+|||++|.+||.+.+ .+.. ....+|. .+|+++++||.+||. ||.+||+ ++||++||||+++-
T Consensus 200 lyell~g~~Pf~~~~------~i~~--~~~~~~~--~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 200 LYDMVCGDIPFEHDE------EIIR--GQVFFRQ--RVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHSSCSCCSHH------HHHH--CCCCCSS--CCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCC
T ss_pred ehhHhhCCCCCCCch------HHhh--cccCCCC--CCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCCC
Confidence 999999999997642 3443 3445554 799999999999999 9999998 99999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=460.60 Aligned_cols=263 Identities=26% Similarity=0.420 Sum_probs=218.0
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCC-CcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc---CCCceEEEeeeec----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTT-GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQ---- 186 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~t-g~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l---~hp~Iv~l~~~f~---- 186 (552)
.++|++++.||+|+||+||+|+++.+ ++.||||++++.... ......+.+|+.+|+.+ +|||||+++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 46899999999999999999999765 678999999765322 22223356677777665 8999999999985
Q ss_pred -CCceEEEEEecCCCCchhhHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccc
Q 008810 187 -DDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 187 -d~~~lylVmEy~~gG~L~~~L~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
....+|+|||||.||++..... ....+++..++.++.|++.||.|||++|||||||||+|||++.+|++||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3457999999999988765543 45679999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhh
Q 008810 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (552)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlG 344 (552)
...... ...+.+||+.|+|||++.+..|+.++||||||
T Consensus 165 ~~~~~~------------------------------------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG 202 (305)
T d1blxa_ 165 IYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 202 (305)
T ss_dssp CCCGGG------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHH
T ss_pred hhcccc------------------------------------------cCCCcccChhhcCcchhcCCCCChhehhhchH
Confidence 543211 12357899999999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChhhHHHHHhhccc---------cccCC--------------cccccChhHHHHHHHHhh-Ccc
Q 008810 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRT---------HLKFP--------------EEAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 345 vilyEmltG~~PF~~~~~~~~~~~i~~~~~---------~~~~p--------------~~~~~s~e~~dLI~~lL~-dp~ 400 (552)
|++|||++|.+||.+.+..+++.+|+.... ....+ ....+|++++|||.+||+ ||.
T Consensus 203 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 282 (305)
T d1blxa_ 203 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282 (305)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChh
Confidence 999999999999999998888888764211 00000 013578999999999999 999
Q ss_pred ccCCCCChhhhhcCCCcCCCChh
Q 008810 401 QRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
+||+ |+|+++||||+++++.
T Consensus 283 ~R~s---a~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 283 KRIS---AYSALSHPYFQDLERC 302 (305)
T ss_dssp TSCC---HHHHHTSGGGTTCCCC
T ss_pred HCcC---HHHHhcChhhcCchhh
Confidence 9999 9999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-57 Score=455.11 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=219.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc----e
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----F 190 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----~ 190 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|+.++|||||++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998876655666778999999999999999999999997643 4
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|||||||+||+|..++...+.+++.+++.++.||+.||.|||++|||||||||+||||+.++.++|+|||+++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEm 350 (552)
.. .....+.+||+.|||||++.+..|+.++|||||||++|||
T Consensus 166 ~~--------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyel 207 (277)
T d1o6ya_ 166 NS--------------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207 (277)
T ss_dssp ---------------------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cc--------------------------------------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHH
Confidence 00 0112357899999999999999999999999999999999
Q ss_pred hhCCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCC
Q 008810 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (552)
Q Consensus 351 ltG~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~Hpf 416 (552)
++|.+||.+.++.+...+++.............+|+++++||.+||. ||.+||++ +++++ |+|
T Consensus 208 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~s--a~~l~-~~l 271 (277)
T d1o6ya_ 208 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMR-ADL 271 (277)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSS--HHHHH-HHH
T ss_pred HhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhH--HHHHH-HHH
Confidence 99999999999998888888643332222235799999999999999 99999952 55554 444
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-56 Score=449.90 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=219.6
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||+||+|+++ +|+.||||++++... .....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999986 789999999976543 3444567899999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||+.|+.+..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~---- 155 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR---- 155 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc----
Confidence 9999988888888889999999999999999999999999999999999999999999999999999987542211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+||+.|+|||++.+. .|+.++|||||||++|||++|+
T Consensus 156 -------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 156 -------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp -------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred -------------------------------------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 01245799999999999864 5799999999999999999999
Q ss_pred CCCCCCChhhHHHHHhhccccc---------cC-------------Cc---ccccChhHHHHHHHHhh-CccccCCCCCh
Q 008810 355 PPFYSDDPMSTCRKIVNWRTHL---------KF-------------PE---EAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (552)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~---------~~-------------p~---~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a 408 (552)
+||.+.+..+.+.++....... .. |. ...+|++++|||++||. ||++||+ +
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~ 275 (286)
T d1ob3a_ 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---A 275 (286)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---H
T ss_pred CCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC---H
Confidence 9999988888777765311110 00 00 12578899999999999 9999999 9
Q ss_pred hhhhcCCCcCC
Q 008810 409 DEIKVHPWFDG 419 (552)
Q Consensus 409 ~eil~HpfF~~ 419 (552)
+||++||||+.
T Consensus 276 ~ell~Hp~f~~ 286 (286)
T d1ob3a_ 276 KQALEHAYFKE 286 (286)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhcCcccCc
Confidence 99999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-56 Score=450.78 Aligned_cols=256 Identities=21% Similarity=0.331 Sum_probs=219.5
Q ss_pred hhccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
..+.++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++|||||+++++|.+
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 3456778899999999999999999999999999999999997653 235678999999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+.+|||||||++|+|..+|... ..+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999999654 6799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhH
Q 008810 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (552)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGv 345 (552)
....... ......||+.|+|||++.+..|+.++|||||||
T Consensus 165 ~~~~~~~----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv 204 (287)
T d1opja_ 165 MTGDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204 (287)
T ss_dssp CCSSSSE----------------------------------------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred cCCCCce----------------------------------------eeccccccccccChHHHcCCCCCchhhhhhHHH
Confidence 6432111 112456899999999999999999999999999
Q ss_pred HHHHHhhCCCCCC-CCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 346 IMYEMLVGYPPFY-SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 346 ilyEmltG~~PF~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
++|||++|..||. +.+...... ++.....+.+|. .+|+++++||.+||. ||.+||+ ++||++
T Consensus 205 ~l~ell~~~~p~~~~~~~~~~~~-~i~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps---~~ei~~ 268 (287)
T d1opja_ 205 LLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPE--GCPEKVYELMRACWQWNPSDRPS---FAEIHQ 268 (287)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHH-HHHTTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHhCCCCCCCcchHHHHHH-HHhcCCCCCCCc--cchHHHHHHHHHHcCCCHhHCcC---HHHHHH
Confidence 9999999665554 455544444 444333445554 799999999999999 9999999 888865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-56 Score=457.54 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=219.8
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCc-----EEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~-----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 184 (552)
.++..++|++.++||+|+||+||+|+++.+++ .||+|++.+.. .......+.+|+.+|.++ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 34667899999999999999999999876654 69999987543 233445688999999998 89999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMRK-----------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRD 241 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~~-----------------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrD 241 (552)
|.+.+.+|||||||+||+|.++|... ..+++..++.|+.||+.||.|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999654 3589999999999999999999999999999
Q ss_pred cCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCC
Q 008810 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321 (552)
Q Consensus 242 LKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~ 321 (552)
|||+|||++.+|++||+|||+|+....... .....+.+||+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~---------------------------------------~~~~~~~~gt~ 230 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSN---------------------------------------YVVRGNARLPV 230 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT---------------------------------------SEEETTEEECG
T ss_pred CchhccccccCCeEEEeeccccccccCCCc---------------------------------------eeeeccccCCC
Confidence 999999999999999999999986532210 01122567999
Q ss_pred CCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-Cc
Q 008810 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 322 ~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp 399 (552)
.|||||++.+..|+.++|||||||++|||++ |.+||.+.+....+.+++.....+..| ..+|+++++||.+||. ||
T Consensus 231 ~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP 308 (325)
T d1rjba_ 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDS 308 (325)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSG
T ss_pred ccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999997 899999988777777777654455555 4799999999999999 99
Q ss_pred cccCCCCChhhhhcC
Q 008810 400 NQRLGAKGADEIKVH 414 (552)
Q Consensus 400 ~~Rl~~~~a~eil~H 414 (552)
.+||+ ++||++|
T Consensus 309 ~~RPt---~~ei~~~ 320 (325)
T d1rjba_ 309 RKRPS---FPNLTSF 320 (325)
T ss_dssp GGSCC---HHHHHHH
T ss_pred hHCcC---HHHHHHH
Confidence 99999 9999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-55 Score=450.98 Aligned_cols=256 Identities=28% Similarity=0.430 Sum_probs=213.4
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecC--Cce
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD--DEF 190 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d--~~~ 190 (552)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. .+.+.+|+.+|+.+. ||||++++++|.+ ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3478999999999999999999999999999999997543 346889999999995 9999999999974 467
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~~~~ 269 (552)
+|+|||||.+|+|..+. +.|++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999999999998764 5699999999999999999999999999999999999998655 6999999999866432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvily 348 (552)
.. ....+||+.|+|||++.+. .|+.++|+|||||++|
T Consensus 184 ~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 221 (328)
T d3bqca1 184 QE------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221 (328)
T ss_dssp CC------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred Cc------------------------------------------ccccccCccccCcccccCCCCCCcccchhhhhhhhH
Confidence 10 1246899999999999874 5899999999999999
Q ss_pred HHhhCCCCCCCCChh-hHHHHHhhc---------------------------------cccccCCcccccChhHHHHHHH
Q 008810 349 EMLVGYPPFYSDDPM-STCRKIVNW---------------------------------RTHLKFPEEAKLSIEAKDLISK 394 (552)
Q Consensus 349 EmltG~~PF~~~~~~-~~~~~i~~~---------------------------------~~~~~~p~~~~~s~e~~dLI~~ 394 (552)
||++|..||...... .....+... ......+....+|++++|||++
T Consensus 222 e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 301 (328)
T d3bqca1 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301 (328)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHH
T ss_pred HhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHH
Confidence 999999999765432 222222110 0001111224589999999999
Q ss_pred Hhh-CccccCCCCChhhhhcCCCcCCCChh
Q 008810 395 LLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 395 lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
||+ ||.+||+ |+|||+||||+++.|+
T Consensus 302 mL~~dP~~R~t---a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 302 LLRYDHQSRLT---AREAMEHPYFYTVVKD 328 (328)
T ss_dssp HSCSSGGGSCC---HHHHHTSGGGTTSCCC
T ss_pred HccCChhHCcC---HHHHhcCcccCCCCCC
Confidence 999 9999999 9999999999999995
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-55 Score=455.07 Aligned_cols=259 Identities=31% Similarity=0.471 Sum_probs=214.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~----- 189 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 578999999999999999999999999999999998653 34455678999999999999999999999998665
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+||||||| |++|..++ +...|++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+..+.
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 66776665 567899999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 347 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil 347 (552)
. ....+||+.|+|||++.+. .++.++|||||||++
T Consensus 174 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 174 E--------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209 (346)
T ss_dssp S--------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------cccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence 2 1246899999999999874 579999999999999
Q ss_pred HHHhhCCCCCCCCChhhHHHHHhhccccc---------------------cC-----Cc-ccccChhHHHHHHHHhh-Cc
Q 008810 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KF-----PE-EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 348 yEmltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~-----p~-~~~~s~e~~dLI~~lL~-dp 399 (552)
|||++|.+||.+.+....+..+....... .. +. ...+|++++|||.+||+ ||
T Consensus 210 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 289 (346)
T d1cm8a_ 210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289 (346)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCCh
Confidence 99999999999988776665554311110 00 00 12578999999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCCChh
Q 008810 400 NQRLGAKGADEIKVHPWFDGVDWA 423 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i~w~ 423 (552)
.+||+ |+||++||||+++.+.
T Consensus 290 ~~R~t---a~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 290 EQRVT---AGEALAHPYFESLHDT 310 (346)
T ss_dssp TTSCC---HHHHHHSGGGTTTC--
T ss_pred hHCcC---HHHHhcChhhCcCCCc
Confidence 99999 9999999999988653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=454.18 Aligned_cols=252 Identities=31% Similarity=0.467 Sum_probs=211.9
Q ss_pred CeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec------CCce
Q 008810 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ------DDEF 190 (552)
Q Consensus 117 ~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~------d~~~ 190 (552)
+|..+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+.+|++++|||||+++++|. +..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999865421 346999999999999999999984 3457
Q ss_pred EEEEEecCCCCchhhHH---hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC-cEEEccccccccc
Q 008810 191 LYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPL 266 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L---~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g-~iKL~DFGlak~~ 266 (552)
+|||||||++|.+..+. .....|++.+++.++.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999877544433 3456899999999999999999999999999999999999999876 8999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGv 345 (552)
.... ...+.+||+.|+|||++.+ ..|+.++|||||||
T Consensus 174 ~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~ 211 (350)
T d1q5ka_ 174 VRGE------------------------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211 (350)
T ss_dssp CTTS------------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cCCc------------------------------------------ccccccccccccChHHhhcccCCCcceeecccce
Confidence 4221 1225689999999999886 57999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccc---------------cccCCc----------ccccChhHHHHHHHHhh-Cc
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRT---------------HLKFPE----------EAKLSIEAKDLISKLLC-NV 399 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~e~~dLI~~lL~-dp 399 (552)
++|||++|.+||.+.+..+.+.+|+...+ ...+|. ...++++++|||.+||+ ||
T Consensus 212 il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 291 (350)
T d1q5ka_ 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291 (350)
T ss_dssp HHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSG
T ss_pred EEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCCh
Confidence 99999999999999988887777653110 111111 13578999999999999 99
Q ss_pred cccCCCCChhhhhcCCCcCCC
Q 008810 400 NQRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 400 ~~Rl~~~~a~eil~HpfF~~i 420 (552)
.+||+ |.|+++||||+++
T Consensus 292 ~~R~t---a~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 292 TARLT---PLEACAHSFFDEL 309 (350)
T ss_dssp GGSCC---HHHHHTSGGGGGG
T ss_pred hHCcC---HHHHhcCHhhccc
Confidence 99999 9999999999765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=447.93 Aligned_cols=264 Identities=27% Similarity=0.349 Sum_probs=217.9
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-------
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------- 187 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 5789999999999999999999999999999999977643 33445668899999999999999999999865
Q ss_pred -CceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 188 -DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 188 -~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
...+|+|||||.++.+.........+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999998888777777789999999999999999999999999999999999999999999999999999866
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcC-CCCCccchhhhhH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 345 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~-~y~~~~DiWSlGv 345 (552)
....... .....+.+||+.|+|||++.+. .|+.++|||||||
T Consensus 168 ~~~~~~~-------------------------------------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGv 210 (318)
T d3blha1 168 SLAKNSQ-------------------------------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210 (318)
T ss_dssp CC------------------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred ccccccc-------------------------------------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCc
Confidence 4321110 0112356899999999999864 7999999999999
Q ss_pred HHHHHhhCCCCCCCCChhhHHHHHhhccccccCCc----------------------------ccccChhHHHHHHHHhh
Q 008810 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE----------------------------EAKLSIEAKDLISKLLC 397 (552)
Q Consensus 346 ilyEmltG~~PF~~~~~~~~~~~i~~~~~~~~~p~----------------------------~~~~s~e~~dLI~~lL~ 397 (552)
++|||++|++||.+.+.......+........... ....+++++|||.+||.
T Consensus 211 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~ 290 (318)
T d3blha1 211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290 (318)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSC
T ss_pred eeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCc
Confidence 99999999999999888877766654222111000 01247889999999999
Q ss_pred -CccccCCCCChhhhhcCCCcCC
Q 008810 398 -NVNQRLGAKGADEIKVHPWFDG 419 (552)
Q Consensus 398 -dp~~Rl~~~~a~eil~HpfF~~ 419 (552)
||++|++ |+||+.||||+.
T Consensus 291 ~dP~~R~s---a~elL~Hpff~~ 310 (318)
T d3blha1 291 LDPAQRID---SDDALNHDFFWS 310 (318)
T ss_dssp SSTTTSCC---HHHHHHSGGGSS
T ss_pred CChhHCcC---HHHHHcChhhcc
Confidence 9999999 999999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-56 Score=444.79 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=213.3
Q ss_pred eeeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEEecCC
Q 008810 122 TMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 122 ~~IG~G~fG~V~l~~~k--~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
+.||+|+||+||+|.++ .+++.||||+++... ......+.+.+|+.+|++++|||||+++++|.++ .+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999865 456789999997653 3344567799999999999999999999999765 5789999999
Q ss_pred CCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccccccc
Q 008810 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (552)
Q Consensus 200 gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~ 279 (552)
||+|.+++.+...+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 164 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence 99999999998999999999999999999999999999999999999999999999999999998764321100
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCC
Q 008810 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 358 (552)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~ 358 (552)
.......||+.|||||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 165 --------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 165 --------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp --------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred --------------------------------ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 01124579999999999999999999999999999999997 999999
Q ss_pred CCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh---hcCCCcCCCC
Q 008810 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI---KVHPWFDGVD 421 (552)
Q Consensus 359 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei---l~HpfF~~i~ 421 (552)
+.+..+....|... ..+.+|. .+|+++++||.+||. ||.+||+ +++| |+|+||+-++
T Consensus 213 ~~~~~~~~~~i~~~-~~~~~p~--~~~~~~~~li~~cl~~dp~~RPs---~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 213 GMKGSEVTAMLEKG-ERMGCPA--GCPREMYDLMNLCWTYDVENRPG---FAAVELRLRNYYYDVVN 273 (277)
T ss_dssp TCCHHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHHTCSSTTTSCC---HHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHcC-CCCCCCc--ccCHHHHHHHHHHcCCCHhHCcC---HHHHHHHhhCHHhhcCC
Confidence 99888887777653 3445554 799999999999999 9999999 6665 6787775443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=438.89 Aligned_cols=257 Identities=22% Similarity=0.367 Sum_probs=219.0
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
..++..++|++++.||+|+||+||+|+++ ++..||||++++... ..+.+.+|+.+|.+++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 34567789999999999999999999975 577899999976532 33568999999999999999999998765 5
Q ss_pred eEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+|||||||++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 679999999999999977543 369999999999999999999999999999999999999999999999999999764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... ......||+.|||||++.+..|+.++|||||||++
T Consensus 161 ~~~~~----------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl 200 (272)
T d1qpca_ 161 DNEYT----------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (272)
T ss_dssp SSCEE----------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCccc----------------------------------------cccccCCcccccChHHHhCCCCCchhhhhhhHHHH
Confidence 32111 11246799999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc--CCCcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV--HPWFD 418 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~--HpfF~ 418 (552)
|||+| |.+||...+..+....+..+ ..+..| ..+++++++||.+||. ||.+||+ +++|++ |+||.
T Consensus 201 ~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~P~~Rpt---~~ei~~~L~~~ft 269 (272)
T d1qpca_ 201 TEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRP--DNCPEELYQLMRLCWKERPEDRPT---FDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCc--ccChHHHHHHHHHHcCCCHhHCcC---HHHHHHHhhhhhh
Confidence 99999 56677777777777777653 233444 3799999999999999 9999999 899987 78874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-55 Score=434.07 Aligned_cols=251 Identities=18% Similarity=0.298 Sum_probs=209.4
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEE
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ly 192 (552)
+..++|++++.||+|+||+||+|+++ ++..||||++++... ..+.+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 45679999999999999999999976 567899999986432 2356889999999999999999999999999999
Q ss_pred EEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCc
Q 008810 193 LIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 193 lVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~ 271 (552)
+|||||++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.+.....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999998654 6789999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
. .....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 157 ~----------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 157 T----------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196 (263)
T ss_dssp ------------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred e----------------------------------------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHH
Confidence 0 012457999999999999999999999999999999999
Q ss_pred h-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 352 t-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+ |.+||...+..+....+... .....| ..+++++.+||.+||. ||.+||+ ++||++|
T Consensus 197 t~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~p~~Rps---~~~il~~ 255 (263)
T d1sm2a_ 197 SEGKIPYENRSNSEVVEDISTG-FRLYKP--RLASTHVYQIMNHCWKERPEDRPA---FSRLLRQ 255 (263)
T ss_dssp TTSCCTTCSCCHHHHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHhc-CCCCCc--cccCHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 9 67888888887888877763 233444 3789999999999999 9999999 9999876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=442.64 Aligned_cols=261 Identities=21% Similarity=0.341 Sum_probs=220.4
Q ss_pred cCCCCeeEEee-eeecCCeEEEEEEEcC--CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTM-IGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~-IG~G~fG~V~l~~~k~--tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
+..++|.+.+. ||+|+||+||+|.++. ++..||||++++.. .....+.+.+|+.+|..++|||||++++++.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 45577888885 9999999999998764 45589999997643 344567799999999999999999999999764
Q ss_pred eEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|||||||+||+|.+++.. +..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 58999999999999998765 46799999999999999999999999999999999999999999999999999997643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
..... ......+||+.|||||++.+..|+.++|||||||++|
T Consensus 162 ~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 162 DDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp CSCEE--------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred ccccc--------------------------------------ccccccccCccccChHHHhCCCCCccchhhcchHHHH
Confidence 21110 0112457999999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
||++ |.+||.+.+..++...|... ..+.+|. .+|+++.+||.+||. ||.+||+..++.+.++|+|+
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQG-KRMECPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 9998 99999998888888877753 3345554 799999999999999 99999994444555788876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-55 Score=443.14 Aligned_cols=259 Identities=21% Similarity=0.310 Sum_probs=209.4
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~---~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
.+..++|++.++||+|+||+||+|+++.+|+ .||||++.... .....+.+.+|+.+|+.++|||||+++++|.+.
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4667889999999999999999999987765 58899886543 234556799999999999999999999999999
Q ss_pred ceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
+.+|+|||||+||+|..++... +.+++.++..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988764 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
....... ........||+.|||||++.+..|+.++|||||||++
T Consensus 180 ~~~~~~~------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 180 DDTSDPT------------------------------------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp ----------------------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CCCCcce------------------------------------eeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 3211000 0001135689999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++ |.+||.+.+..+....|... ..++.| ..+++++++||.+||. ||.+||+ +.||+++
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~~P~~RPs---~~ei~~~ 286 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQD-YRLPPP--MDCPSALHQLMLDCWQKDRNHRPK---FGQIVNT 286 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSCC---HHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccchHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 99998 89999999988888887653 233334 4799999999999998 9999998 7777653
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=439.53 Aligned_cols=257 Identities=18% Similarity=0.242 Sum_probs=210.3
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCce
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~ 190 (552)
+++..++|++++.||+|+||+||+|+.+ ..||||+++.... .....+.+.+|+.+|.+++|||||++++++. +..
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4577889999999999999999999753 3599999976543 3456678999999999999999999999765 456
Q ss_pred EEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
+|||||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999654 57999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc---CCCCCccchhhhhHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAI 346 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~---~~y~~~~DiWSlGvi 346 (552)
... ....+.+||+.|||||++.+ ..|+.++|||||||+
T Consensus 158 ~~~---------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~ 198 (276)
T d1uwha_ 158 SGS---------------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198 (276)
T ss_dssp -----------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHH
T ss_pred CCc---------------------------------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHH
Confidence 100 01125689999999999975 358999999999999
Q ss_pred HHHHhhCCCCCCCCChhhHHHHHhhccccc-cCC-cccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHL-KFP-EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 347 lyEmltG~~PF~~~~~~~~~~~i~~~~~~~-~~p-~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
+|||++|..||.+.+.......++...... ..+ ....+++++++||.+||. ||.+||+ +.||+.|
T Consensus 199 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~~il~~ 266 (276)
T d1uwha_ 199 LYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL---FPQILAS 266 (276)
T ss_dssp HHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 999999999999877666555554322111 111 123689999999999999 9999999 8999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=429.14 Aligned_cols=250 Identities=20% Similarity=0.356 Sum_probs=221.1
Q ss_pred CCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEE
Q 008810 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lyl 193 (552)
..++|++++.||+|+||+||+|+++ +++.||||++++... ..+.+.+|+.++..++|||||+++++|.+++.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 4689999999999999999999985 778999999987643 23468899999999999999999999999999999
Q ss_pred EEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcc
Q 008810 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~ 272 (552)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999999654 567999999999999999999999999999999999999999999999999999865432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhh
Q 008810 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (552)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmlt 352 (552)
.....+||+.|+|||++.+..|+.++|||||||++|||+|
T Consensus 157 ----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 157 ----------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp ----------------------------------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ----------------------------------------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence 0113579999999999999999999999999999999998
Q ss_pred -CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|+.||.+.+..++..+|.+. ..+..| ..+++++++||.+||. ||.+||+ +++|++|
T Consensus 197 ~g~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 254 (258)
T d1k2pa_ 197 LGKMPYERFTNSETAEHIAQG-LRLYRP--HLASEKVYTIMYSCWHEKADERPT---FKILLSN 254 (258)
T ss_dssp TSCCTTTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHhC-CCCCCc--ccccHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 89999999999998888763 234445 3789999999999999 9999999 9999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=448.31 Aligned_cols=271 Identities=26% Similarity=0.382 Sum_probs=214.3
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC------Cc
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------DE 189 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d------~~ 189 (552)
++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 679999999999999999999999999999999987643 44556678999999999999999999999963 47
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
++|+|||||.||.+ ..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 89999999976544 444 357999999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyE 349 (552)
. .....+||+.|+|||++.+..|+.++||||+||++||
T Consensus 173 ~------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e 210 (355)
T d2b1pa1 173 F------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_dssp --------------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence 1 1124689999999999999999999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhcccc--------------------c---------cCC---------cccccChhHHHH
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTH--------------------L---------KFP---------EEAKLSIEAKDL 391 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~--------------------~---------~~p---------~~~~~s~e~~dL 391 (552)
|++|++||.+.+......+++..... . .++ ....+|++++||
T Consensus 211 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHH
Confidence 99999999998877776666431100 0 000 012357889999
Q ss_pred HHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccc
Q 008810 392 ISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (552)
Q Consensus 392 I~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~ 435 (552)
|++||+ ||.+||+ |+|||+||||+..-|.......+|.++.
T Consensus 291 l~~mL~~dP~~R~t---a~elL~Hpw~~~~~~~~~~~~~~~~~~~ 332 (355)
T d2b1pa1 291 LSKMLVIDPAKRIS---VDDALQHPYINVWYDPAEVEAPPPQIYD 332 (355)
T ss_dssp HHHHSCSSTTTSCC---HHHHHTSTTTGGGCCHHHHTCCCC----
T ss_pred HHHHCcCChhHCcC---HHHHhcCcccCCCCCcccccCCCCCCCC
Confidence 999999 9999999 9999999999876555555555665443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-54 Score=431.57 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=223.0
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCceEEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~~lylVm 195 (552)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+...+++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 68999999999999999999999999999999997654 34456778999999999999999999999999999999999
Q ss_pred ecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCccccc
Q 008810 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~ 275 (552)
||+.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||+|+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--- 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--- 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc---
Confidence 99999999999988899999999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-CCCccchhhhhHHHHHHhhCC
Q 008810 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvilyEmltG~ 354 (552)
.....+++.|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 158 --------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~ 199 (292)
T d1unla_ 158 --------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp --------------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred --------------------------------------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence 11346889999999998765 699999999999999999999
Q ss_pred CCC-CCCChhhHHHHHhhccccc---------cCC----------------cccccChhHHHHHHHHhh-CccccCCCCC
Q 008810 355 PPF-YSDDPMSTCRKIVNWRTHL---------KFP----------------EEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (552)
Q Consensus 355 ~PF-~~~~~~~~~~~i~~~~~~~---------~~p----------------~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~ 407 (552)
.|| .+.+..+.+.++....... ..+ ....+|++++|||.+||+ ||.+||+
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s--- 276 (292)
T d1unla_ 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS--- 276 (292)
T ss_dssp CCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred CCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC---
Confidence 885 4556666666654321110 000 013578899999999999 9999999
Q ss_pred hhhhhcCCCcCCC
Q 008810 408 ADEIKVHPWFDGV 420 (552)
Q Consensus 408 a~eil~HpfF~~i 420 (552)
|+||++||||+++
T Consensus 277 a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 277 AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHTTSGGGSSC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=443.01 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=212.1
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc-----e
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----F 190 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~-----~ 190 (552)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++|||||++++++.... +
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 56999999999999999999999999999999997653 2445567899999999999999999999987653 3
Q ss_pred EEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCC
Q 008810 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (552)
Q Consensus 191 lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~ 270 (552)
+|+| +|+.||+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||+|+......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 4554 55679999999864 579999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc-CCCCCccchhhhhHHHHH
Q 008810 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (552)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvilyE 349 (552)
.. .......+||+.|+|||++.. ..|+.++||||+||++||
T Consensus 164 ~~--------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~e 205 (345)
T d1pmea_ 164 DH--------------------------------------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205 (345)
T ss_dssp CB--------------------------------------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHH
T ss_pred cc--------------------------------------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehH
Confidence 10 011235689999999999854 678999999999999999
Q ss_pred HhhCCCCCCCCChhhHHHHHhhcccc------------------ccCCc---------ccccChhHHHHHHHHhh-Cccc
Q 008810 350 MLVGYPPFYSDDPMSTCRKIVNWRTH------------------LKFPE---------EAKLSIEAKDLISKLLC-NVNQ 401 (552)
Q Consensus 350 mltG~~PF~~~~~~~~~~~i~~~~~~------------------~~~p~---------~~~~s~e~~dLI~~lL~-dp~~ 401 (552)
|++|.+||.+.+...+...+...... ...|. ...+|+++++||.+||+ ||.+
T Consensus 206 ml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 285 (345)
T d1pmea_ 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285 (345)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTT
T ss_pred HhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhH
Confidence 99999999988876665554321000 00110 13578899999999999 9999
Q ss_pred cCCCCChhhhhcCCCcCCC
Q 008810 402 RLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 402 Rl~~~~a~eil~HpfF~~i 420 (552)
||+ |+|+++||||+..
T Consensus 286 R~t---a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 286 RIE---VEQALAHPYLEQY 301 (345)
T ss_dssp SCC---HHHHHTSGGGTTT
T ss_pred CcC---HHHHhcCHhhccC
Confidence 999 9999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-54 Score=429.53 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=209.4
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
++..++|++.+.||+|+||+||+|++..++ ..||||+++... .....+.+.+|+.+|+.++|||||+++++|. +
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 466789999999999999999999987543 468888886432 3444567999999999999999999999996 4
Q ss_pred ceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
+.+|+|||||+||+|..++.. ...+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.+.
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 678999999999999998755 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... .....+||+.|+|||++.+..|+.++|||||||++
T Consensus 160 ~~~~~----------------------------------------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil 199 (273)
T d1mp8a_ 160 DSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 199 (273)
T ss_dssp ---------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHH
T ss_pred CCcce----------------------------------------eccceecCcccchhhHhccCCCCCccccccchHHH
Confidence 22110 11245789999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++ |.+||.+.+..+.+.+|.+. ..+++| ..+|+++++||.+||. ||.+||+ +.||+.|
T Consensus 200 ~e~lt~g~~P~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dp~~Rps---~~ei~~~ 262 (273)
T d1mp8a_ 200 WEILMHGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSRRPR---FTELKAQ 262 (273)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 99998 99999999999999888764 233444 4799999999999999 9999999 9999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=431.30 Aligned_cols=267 Identities=20% Similarity=0.367 Sum_probs=219.8
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
....+..++|++.+.||+|+||+||+|+++.+ ..||||++++... ..+.+.+|+.+|+.++|||||++|++|.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 34567778999999999999999999998765 5699999976532 23568999999999999999999999965
Q ss_pred ceEEEEEecCCCCchhhHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 189 EFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~--~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
+.+|+|||||++|+|..++.. ...+++.++..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 457899999999999988864 357999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
...... .....+||+.|+|||++.+..|+.++|||||||+
T Consensus 164 ~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Gii 203 (285)
T d1fmka3 164 EDNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 203 (285)
T ss_dssp ----------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cCCCce----------------------------------------eeccccccccccChHHHhCCCCCcHHhhhcchHH
Confidence 322110 0124579999999999999999999999999999
Q ss_pred HHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc--CCCcCCCCh
Q 008810 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV--HPWFDGVDW 422 (552)
Q Consensus 347 lyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~--HpfF~~i~w 422 (552)
+|||++ |.+||.+....+.+..+... ...+.| ..+|+++++||.+||. ||++||+ +++|+. |+||...
T Consensus 204 l~el~t~~~p~~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps---~~~i~~~L~~~~~~~-- 275 (285)
T d1fmka3 204 LTELTTKGRVPYPGMVNREVLDQVERG-YRMPCP--PECPESLHDLMCQCWRKEPEERPT---FEYLQAFLEDYFTST-- 275 (285)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHTTTSCS--
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCC--cccCHHHHHHHHHHcccCHhHCcC---HHHHHHHHhhhhcCC--
Confidence 999999 46666677777777776642 333444 4799999999999999 9999999 999887 8899764
Q ss_pred hhhhhcCCCCccc
Q 008810 423 ARIYQMEAAFIPE 435 (552)
Q Consensus 423 ~~l~~~~~pf~P~ 435 (552)
.|++.|.
T Consensus 276 ------~p~~~p~ 282 (285)
T d1fmka3 276 ------EPQYQPG 282 (285)
T ss_dssp ------CCCCCCS
T ss_pred ------CCCCCCC
Confidence 4666664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=445.38 Aligned_cols=257 Identities=27% Similarity=0.419 Sum_probs=215.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC-----c
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~-----~ 189 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 468999999999999999999999999999999998654 2344556788999999999999999999999643 3
Q ss_pred eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~ 269 (552)
..++||+|+.||+|.+++.. +.|++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 44666778889999998854 57999999999999999999999999999999999999999999999999998754211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC-CCCccchhhhhHHHH
Q 008810 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMY 348 (552)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvily 348 (552)
..+.+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 175 --------------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~ 210 (348)
T d2gfsa1 175 --------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210 (348)
T ss_dssp --------------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHH
T ss_pred --------------------------------------------cccccccccccCchhhcCCccCCcccchhhhhHHHH
Confidence 12568999999999988754 689999999999999
Q ss_pred HHhhCCCCCCCCChhhHHHHHhhccccc---------------------cCCc------ccccChhHHHHHHHHhh-Ccc
Q 008810 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE------EAKLSIEAKDLISKLLC-NVN 400 (552)
Q Consensus 349 EmltG~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~e~~dLI~~lL~-dp~ 400 (552)
+|++|.+||.+.+.......|....... ..+. ...+|++++|||.+||+ ||.
T Consensus 211 ~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 290 (348)
T d2gfsa1 211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290 (348)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChh
Confidence 9999999999998888777776432111 0010 12578999999999999 999
Q ss_pred ccCCCCChhhhhcCCCcCCC
Q 008810 401 QRLGAKGADEIKVHPWFDGV 420 (552)
Q Consensus 401 ~Rl~~~~a~eil~HpfF~~i 420 (552)
+|++ |+||++||||+.+
T Consensus 291 ~R~t---a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 291 KRIT---AAQALAHAYFAQY 307 (348)
T ss_dssp GSCC---HHHHHTSGGGTTT
T ss_pred hCcC---HHHHhcCHhhCCC
Confidence 9999 9999999999865
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=436.07 Aligned_cols=254 Identities=20% Similarity=0.344 Sum_probs=211.1
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCC
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~----~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~ 188 (552)
+..+||+++++||+|+||+||+|+++.+|+ .||+|+++... .....+.+.+|+.+|++++|||||+++++|.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345789999999999999999999988887 47777776432 234466799999999999999999999999875
Q ss_pred ceEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 189 ~~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
..++||||+.+|+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 56788999999999988765 4689999999999999999999999999999999999999999999999999999764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
..... ......+||+.|||||++.+..|+.++|||||||++
T Consensus 163 ~~~~~---------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 163 AEEKE---------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203 (317)
T ss_dssp TTCC-----------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccccc---------------------------------------ccccccccCccccChHHHhcCCCChhhhhhhHHHHH
Confidence 32110 011245799999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||+| |.+||.+.+..+....+... ..+..| ..+++++++||.+||. ||.+||+ +.||+.|
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 266 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMVKCWMIDADSRPK---FRELIIE 266 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHhCCCChhhCcC---HHHHHHH
Confidence 99998 89999988887777666542 334455 4799999999999999 9999999 9999988
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-53 Score=431.13 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=207.1
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~ 184 (552)
.++..++|++++.||+|+||+||+|+++. +++.||||+++.... ....+.+..|..++.++ +|||||.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 35667899999999999999999999754 457899999975432 33445677777777776 68999999988
Q ss_pred ecC-CceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCc
Q 008810 185 FQD-DEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (552)
Q Consensus 185 f~d-~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNI 247 (552)
+.+ +..+|+|||||+||+|.++|... ..+++.++..|+.||+.||.|||++|||||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 765 45789999999999999999643 3589999999999999999999999999999999999
Q ss_pred cccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChh
Q 008810 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (552)
Q Consensus 248 Ll~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APE 327 (552)
||+.+|++||+|||+|+........ ....+.+||+.|||||
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~y~APE 206 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMAPE 206 (299)
T ss_dssp EECGGGCEEECC------CCSCTTS---------------------------------------CCTTSCCCGGGGCCHH
T ss_pred eECCCCcEEEccCcchhhccccccc---------------------------------------cccCceeeCccccchh
Confidence 9999999999999999865422110 0112468999999999
Q ss_pred hhhcCCCCCccchhhhhHHHHHHhhC-CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCC
Q 008810 328 VLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (552)
Q Consensus 328 vl~~~~y~~~~DiWSlGvilyEmltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~ 405 (552)
++.+..|+.++|||||||++|||++| .+||.+.+..+.+.+++.....+..|. .+++++++||.+||+ ||.+||+
T Consensus 207 ~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt- 283 (299)
T d1ywna1 207 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPT- 283 (299)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC-
T ss_pred HhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHHcCCChhHCcC-
Confidence 99999999999999999999999986 678888776666666665444555554 789999999999999 9999999
Q ss_pred CChhhhhcC
Q 008810 406 KGADEIKVH 414 (552)
Q Consensus 406 ~~a~eil~H 414 (552)
++||++|
T Consensus 284 --~~eil~~ 290 (299)
T d1ywna1 284 --FSELVEH 290 (299)
T ss_dssp --HHHHHHH
T ss_pred --HHHHHHH
Confidence 9999887
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-53 Score=423.89 Aligned_cols=256 Identities=20% Similarity=0.285 Sum_probs=209.1
Q ss_pred ccCCCCeeEEeeeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC
Q 008810 112 KMGADDFELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (552)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg----~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d 187 (552)
++..+.|++.++||+|+||+||+|.++.++ ..||||+++... .......+.+|+.+|..++|||||+++++|.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 466788999999999999999999987665 479999997543 23445568899999999999999999999999
Q ss_pred CceEEEEEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccccccc
Q 008810 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (552)
Q Consensus 188 ~~~lylVmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~ 266 (552)
...+|+|||||.+|++..++... ..+++..+..++.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999999988654 67999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHH
Q 008810 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (552)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvi 346 (552)
....... .......||+.|||||++.+..|+.++|||||||+
T Consensus 161 ~~~~~~~--------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 161 EDDPEAT--------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 202 (283)
T ss_dssp ---------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred cCCCccc--------------------------------------eEeccCCCCccccCHHHHccCCCCCcccccccHHH
Confidence 4321000 00123578999999999999999999999999999
Q ss_pred HHHHhhC-CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhc
Q 008810 347 MYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (552)
Q Consensus 347 lyEmltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~ 413 (552)
+|||++| .+||.+.+..+.+..+.. ...++.| ..++.++++||.+||. ||.+||+ +.||+.
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~-~~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt---~~eil~ 265 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAIND-GFRLPTP--MDCPSAIYQLMMQCWQQERARRPK---FADIVS 265 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCC--TTCBHHHHHHHHHHTCSSTTTSCC---HHHHHH
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhc-cCCCCCc--hhhHHHHHHHHHHHCcCCHhHCcC---HHHHHH
Confidence 9999995 556666666667666654 2334444 4789999999999998 9999999 888865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=424.16 Aligned_cols=256 Identities=21% Similarity=0.353 Sum_probs=208.8
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcC-CC--cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKT-TG--HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~-tg--~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d~~ 189 (552)
+..+||++++.||+|+||+||+|+... ++ ..||||++++.........+.+.+|+.+|+.++|||||++|++|.+.
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 456789999999999999999998754 33 36899999887666666677899999999999999999999999764
Q ss_pred eEEEEEecCCCCchhhHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~ 268 (552)
.+|+|||||++|+|.+++.. .+.|++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999988755 45799999999999999999999999999999999999999999999999999997643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHH
Q 008810 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (552)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvily 348 (552)
..... ......+||+.|+|||++.+..|+.++|||||||++|
T Consensus 164 ~~~~~--------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 164 NDDHY--------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp -CCEE--------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred CCCcc--------------------------------------eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHH
Confidence 31110 1112456888999999999999999999999999999
Q ss_pred HHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 349 Emlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
||++ |.+||.+.+..+...+|......++.| ..+|+++++||.+||. ||++||+ +.+|+
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt---~~ei~ 266 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--EDCPQDIYNVMVQCWAHKPEDRPT---FVALR 266 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred HHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc--ccccHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 9998 899999999999999988754444444 4789999999999999 9999999 77775
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-52 Score=424.19 Aligned_cols=258 Identities=21% Similarity=0.325 Sum_probs=220.6
Q ss_pred hccccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEee
Q 008810 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (552)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 183 (552)
...++..++|++++.||+|+||+||+|+.+ .+++.||||++++.. .....+.+.+|+.+|+.++||||+++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCccccee
Confidence 344566789999999999999999999976 356799999997543 2344667999999999999999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------------TLTEDEARFYVAETVLAIESIHKHHYIH 239 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~~------------------------~l~e~~~~~~~~qi~~aL~~LH~~giiH 239 (552)
+|.+...+++||||+++|+|.++|.... .|++..+..++.||+.||.|||++||||
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 9999999999999999999999996532 4899999999999999999999999999
Q ss_pred cccCCCCccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccc
Q 008810 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (552)
Q Consensus 240 rDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~G 319 (552)
|||||+||||+.++++||+|||+|+.+...... ....+.+|
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~---------------------------------------~~~~~~~~ 204 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYY---------------------------------------KADGNDAI 204 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---------------------------------------C----CCB
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccc---------------------------------------cccCCCCc
Confidence 999999999999999999999999865432110 11225689
Q ss_pred CCCCCChhhhhcCCCCCccchhhhhHHHHHHhhC-CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-
Q 008810 320 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC- 397 (552)
Q Consensus 320 T~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~- 397 (552)
|+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+..+...++.... ....| ..+++++.+||.+||+
T Consensus 205 ~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p--~~~~~~~~~li~~cl~~ 281 (301)
T d1lufa_ 205 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWSK 281 (301)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCS
T ss_pred CcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHcCC
Confidence 9999999999999999999999999999999998 57899999999888887643 33444 3789999999999999
Q ss_pred CccccCCCCChhhhhc
Q 008810 398 NVNQRLGAKGADEIKV 413 (552)
Q Consensus 398 dp~~Rl~~~~a~eil~ 413 (552)
||.+||+ +.||.+
T Consensus 282 ~P~~RPt---~~ev~~ 294 (301)
T d1lufa_ 282 LPADRPS---FCSIHR 294 (301)
T ss_dssp SGGGSCC---HHHHHH
T ss_pred ChhHCcC---HHHHHH
Confidence 9999999 888753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=427.75 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=215.2
Q ss_pred cCCCCeeEEeeeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeecCCc
Q 008810 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (552)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~--~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~d~~ 189 (552)
+..++|++.++||+|+||+||+|+++.+|.. ||||++++.. .....+.+.+|+.+|.++ +|||||+++++|.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5668999999999999999999999998875 6677765432 234456789999999998 7999999999999999
Q ss_pred eEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g 253 (552)
.+|+|||||+||+|.++|... ..|++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999654 5799999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC
Q 008810 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (552)
Q Consensus 254 ~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~ 333 (552)
.+||+|||+|+...... .....+||+.|+|||++.+..
T Consensus 165 ~~kl~DfG~a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~l~~~~ 202 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 202 (309)
T ss_dssp CEEECCTTCEESSCEEC------------------------------------------CC----CCTTTCCHHHHHHCE
T ss_pred ceEEccccccccccccc------------------------------------------cccceecCCcccchHHhccCC
Confidence 99999999998543211 011357999999999999999
Q ss_pred CCCccchhhhhHHHHHHhhC-CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhh
Q 008810 334 YGMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (552)
Q Consensus 334 y~~~~DiWSlGvilyEmltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~ei 411 (552)
|+.++|||||||++|||++| .+||.+.+..+.+.+|..+ ..+.+| ..+++++++||.+||. ||++||+ +.||
T Consensus 203 ~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs---~~ei 276 (309)
T d1fvra_ 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERPS---FAQI 276 (309)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCCCCC--ccCCHHHHHHHHHHcCCChhHCcC---HHHH
Confidence 99999999999999999996 5689888988888888764 234444 4799999999999999 9999999 9999
Q ss_pred hcC
Q 008810 412 KVH 414 (552)
Q Consensus 412 l~H 414 (552)
+.|
T Consensus 277 l~~ 279 (309)
T d1fvra_ 277 LVS 279 (309)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=416.02 Aligned_cols=247 Identities=21% Similarity=0.389 Sum_probs=209.1
Q ss_pred cccCCCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeecC-Cc
Q 008810 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DE 189 (552)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~d-~~ 189 (552)
+.+..++|++++.||+|+||.||+|+++ |..||||++++.. ..+.+.+|+.+|++++|||||+++++|.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4567889999999999999999999974 7799999997643 34568899999999999999999998854 56
Q ss_pred eEEEEEecCCCCchhhHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccC
Q 008810 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (552)
Q Consensus 190 ~lylVmEy~~gG~L~~~L~~~--~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~ 267 (552)
.+||||||+++|+|.++|... ..+++..++.++.||+.||.|||+.+||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 789999999999999999654 359999999999999999999999999999999999999999999999999998543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
.. .....||+.|+|||++.+..|+.++|||||||++
T Consensus 155 ~~--------------------------------------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il 190 (262)
T d1byga_ 155 ST--------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190 (262)
T ss_dssp ---------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CC--------------------------------------------CccccccccCCChHHHhCCCCChHHHHHhHHHHH
Confidence 21 1135689999999999999999999999999999
Q ss_pred HHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 348 yEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
|||++ |.+||...+..+...+|.+. ....+|. .+++++++||.+||. ||.+||+ +.+|++|
T Consensus 191 ~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~~--~~~~~~~~li~~cl~~dP~~Rps---~~~l~~~ 253 (262)
T d1byga_ 191 WEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD--GCPPAVYEVMKNCWHLDAAMRPS---FLQLREQ 253 (262)
T ss_dssp HHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCc--cCCHHHHHHHHHHcccCHhHCcC---HHHHHHH
Confidence 99998 89999999888888888753 3445554 789999999999999 9999999 8777653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=418.95 Aligned_cols=257 Identities=20% Similarity=0.347 Sum_probs=215.8
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcCCC-------cEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEE
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTG-------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~tg-------~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l 181 (552)
+..+..++|++++.||+|+||.||+|++..++ ..||||++++.. .......+.+|..++..+ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 35567899999999999999999999987654 479999997653 234456788888888887 89999999
Q ss_pred eeeecCCceEEEEEecCCCCchhhHHhhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 008810 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (552)
Q Consensus 182 ~~~f~d~~~lylVmEy~~gG~L~~~L~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPe 245 (552)
+++|.++..+|+|||||.||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999654 35899999999999999999999999999999999
Q ss_pred CccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 246 NILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
|||++.+|.+||+|||+++........ ......+||+.|+|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~a 205 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYY---------------------------------------KKTTNGRLPVKWMA 205 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTT---------------------------------------CCCTTSCCGGGGSC
T ss_pred ceeecCCCCeEeccchhhccccccccc---------------------------------------cccccCCCChhhhh
Confidence 999999999999999999866432111 01124689999999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccC
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+..+.+ ...+.+|. .+|+++++||.+||. ||.+||
T Consensus 206 PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~p~--~~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1fgka_ 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GHRMDKPS--NCTNELYMMMRDCWHAVPSQRP 282 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-TCCCCCCS--SCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHc-CCCCCCCc--cchHHHHHHHHHHccCCHhHCc
Confidence 999999999999999999999999998 7999998888887777665 34455554 799999999999999 999999
Q ss_pred CCCChhhhhc
Q 008810 404 GAKGADEIKV 413 (552)
Q Consensus 404 ~~~~a~eil~ 413 (552)
+ +.||++
T Consensus 283 s---~~eil~ 289 (299)
T d1fgka_ 283 T---FKQLVE 289 (299)
T ss_dssp C---HHHHHH
T ss_pred C---HHHHHH
Confidence 9 888875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=419.01 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=222.8
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k-----~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~ 183 (552)
..++..++|++.+.||+|+||.||+|+++ .+++.||||++++.. .......+.+|..+++.+ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 34567789999999999999999999864 467799999998653 234556789999999998 7999999999
Q ss_pred eecCCceEEEEEecCCCCchhhHHhhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCC
Q 008810 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (552)
Q Consensus 184 ~f~d~~~lylVmEy~~gG~L~~~L~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPe 245 (552)
+|.+...+|||||||+||+|..+|.+.. .+++..+..|+.||+.||.|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999997543 5899999999999999999999999999999999
Q ss_pred CccccCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCC
Q 008810 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (552)
Q Consensus 246 NILl~~~g~iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~A 325 (552)
|||++.++++||+|||+++........ ......+||+.|+|
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~---------------------------------------~~~~~~~gt~~y~a 215 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNY---------------------------------------VVKGNARLPVKWMA 215 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTS---------------------------------------EECSSSEECGGGCC
T ss_pred cccccccCcccccccchheeccCCCcc---------------------------------------eEeeecccChHHcC
Confidence 999999999999999999866432110 01124689999999
Q ss_pred hhhhhcCCCCCccchhhhhHHHHHHhh-CCCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccC
Q 008810 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (552)
Q Consensus 326 PEvl~~~~y~~~~DiWSlGvilyEmlt-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl 403 (552)
||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+.+++........|. .+|+++++||.+||. ||.+||
T Consensus 216 PE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~l~~Li~~cl~~dP~~RP 293 (311)
T d1t46a_ 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPE--HAPAEMYDIMKTCWDADPLKRP 293 (311)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCT--TSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcc--cccHHHHHHHHHHcCCChhHCc
Confidence 999999999999999999999999998 7888888887777778877555555553 789999999999999 999999
Q ss_pred CCCChhhhhc
Q 008810 404 GAKGADEIKV 413 (552)
Q Consensus 404 ~~~~a~eil~ 413 (552)
+ +++|+.
T Consensus 294 s---~~~il~ 300 (311)
T d1t46a_ 294 T---FKQIVQ 300 (311)
T ss_dssp C---HHHHHH
T ss_pred C---HHHHHH
Confidence 9 888775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=419.49 Aligned_cols=263 Identities=17% Similarity=0.246 Sum_probs=225.2
Q ss_pred ccccCCCCeeEEeeeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeee
Q 008810 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (552)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~l~~~k~-----tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~ 184 (552)
..++..++|++++.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.+|++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 456778999999999999999999998863 35789999997653 33455678999999999999999999999
Q ss_pred ecCCceEEEEEecCCCCchhhHHhhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCc
Q 008810 185 FQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (552)
Q Consensus 185 f~d~~~lylVmEy~~gG~L~~~L~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~ 254 (552)
|..+..+|+|||||++|+|.+++... ..+++..+..|+.|++.||.|||+++||||||||+||||+.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998643 34789999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCC
Q 008810 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (552)
Q Consensus 255 iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y 334 (552)
+||+|||+|+.+...... ......+||+.|+|||++.+..|
T Consensus 172 ~Kl~DFGla~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aPe~l~~~~~ 212 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYY---------------------------------------RKGGKGLLPVRWMSPESLKDGVF 212 (308)
T ss_dssp EEECCTTCCCGGGGGGCE---------------------------------------EGGGSSEECGGGCCHHHHHHCCC
T ss_pred EEEeecccceeccCCcce---------------------------------------eeccceecccccCCHHHHccCCC
Confidence 999999999865422110 11224579999999999999999
Q ss_pred CCccchhhhhHHHHHHhhC-CCCCCCCChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhh
Q 008810 335 GMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmltG-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil 412 (552)
+.++|||||||++|||++| .+||.+.+..+.+..+.+.. .+..| ..+++++.+||.+||. ||.+||+ +++|+
T Consensus 213 ~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RPs---~~~il 286 (308)
T d1p4oa_ 213 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRPS---FLEII 286 (308)
T ss_dssp CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccchHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 9999999999999999998 58899999989888887642 33444 3789999999999999 9999999 88887
Q ss_pred c------CCCcCC
Q 008810 413 V------HPWFDG 419 (552)
Q Consensus 413 ~------HpfF~~ 419 (552)
+ +|+|+.
T Consensus 287 ~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 287 SSIKEEMEPGFRE 299 (308)
T ss_dssp HHHGGGSCTTHHH
T ss_pred HHHHHhcCCCCcC
Confidence 6 666654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-50 Score=407.36 Aligned_cols=263 Identities=18% Similarity=0.229 Sum_probs=203.5
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCc-eEEEeeeecCCceEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~-Iv~l~~~f~d~~~lylV 194 (552)
++|++++.||+|+||+||+|+++.+|+.||||++...... ..+..|..+++.++|++ |+.+++++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5699999999999999999999999999999998765321 23678999999997665 55666777888899999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCcccc---CCCcEEEcccccccccCCCCc
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTL 271 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~---~~g~iKL~DFGlak~~~~~~~ 271 (552)
||||.|+.+..+......+++..+..++.|++.||+|||++|||||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 82 me~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 82 MELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 99995544444445567899999999999999999999999999999999999875 455799999999997753321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHh
Q 008810 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (552)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEml 351 (552)
.... + .....+.+||+.|||||++.+.+|+.++|||||||++|||+
T Consensus 162 ~~~~-------------------~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 162 HQHI-------------------P---------------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp CCBC-------------------C---------------CCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH
T ss_pred ccce-------------------e---------------ccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHH
Confidence 1000 0 00123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChhhHHHHHhhcc-ccccCCc---ccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCc
Q 008810 352 VGYPPFYSDDPMSTCRKIVNWR-THLKFPE---EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (552)
Q Consensus 352 tG~~PF~~~~~~~~~~~i~~~~-~~~~~p~---~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF 417 (552)
+|.+||.+.........+.... .....|. ...+|+++.+||.+||. ||.+||+...+.+++.|+|.
T Consensus 208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 208 LGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 9999998866555443332211 1112221 13689999999999999 99999985445567788765
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=400.08 Aligned_cols=250 Identities=17% Similarity=0.279 Sum_probs=204.2
Q ss_pred EEeeeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCCCceEEEeeeec-CCceEEEEE
Q 008810 120 LLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFLYLIM 195 (552)
Q Consensus 120 ~~~~IG~G~fG~V~l~~~k~tg---~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~f~-d~~~lylVm 195 (552)
+-++||+|+||+||+|++..++ ..||||++++. ......+.+.+|+++|.+++|||||++++++. .+..+|+||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999986643 36999999753 24556678999999999999999999999876 456899999
Q ss_pred ecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEcccccccccCCCCcccc
Q 008810 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (552)
Q Consensus 196 Ey~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGlak~~~~~~~~~~ 274 (552)
|||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||+.++++||+|||+++.+........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999988654 4678889999999999999999999999999999999999999999999999987643321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHHHHHhhCC
Q 008810 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (552)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvilyEmltG~ 354 (552)
.......||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 189 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~ 231 (311)
T d1r0pa_ 189 -------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231 (311)
T ss_dssp -------------------------------------TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -------------------------------------eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCC
Confidence 0012357999999999999999999999999999999999976
Q ss_pred CCCCC-CChhhHHHHHhhccccccCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcC
Q 008810 355 PPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 355 ~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~H 414 (552)
.||.. .+..+....+.... .+..| ..+++++.+||.+||. ||.+||+ +.||+.|
T Consensus 232 ~p~~~~~~~~~~~~~i~~g~-~~~~p--~~~~~~l~~li~~cl~~dP~~RPs---~~ei~~~ 287 (311)
T d1r0pa_ 232 APPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRPS---FSELVSR 287 (311)
T ss_dssp CCSCC------CHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCC-CCCCc--ccCcHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 66654 44455566666532 33444 3789999999999999 9999999 9999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-48 Score=393.01 Aligned_cols=250 Identities=19% Similarity=0.234 Sum_probs=204.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-CceEEEeeeecCCceEEE
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~f~d~~~lyl 193 (552)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+++|..+++.+.| ++|+.+++++.+....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 5789999999999999999999999999999999875432 1236778899999865 899999999999999999
Q ss_pred EEecCCCCchhhHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccC-----CCcEEEcccccccccC
Q 008810 194 IMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-----YGHLRLSDFGLCKPLD 267 (552)
Q Consensus 194 VmEy~~gG~L~~~L~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~-----~g~iKL~DFGlak~~~ 267 (552)
||||| ||+|..++... ..+++..+..++.|++.||+|||++|||||||||+|||++. ++++||+|||+|+.+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999888664 47999999999999999999999999999999999999974 6789999999999764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCCCCCccchhhhhHHH
Q 008810 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (552)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil 347 (552)
....... .+ .....+.+||+.|||||++.+..|+.++|||||||++
T Consensus 158 ~~~~~~~-------------------~~---------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (293)
T d1csna_ 158 DPVTKQH-------------------IP---------------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203 (293)
T ss_dssp CTTTCCB-------------------CC---------------CCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cCccccc-------------------ee---------------ecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHH
Confidence 3311100 00 0012357899999999999999999999999999999
Q ss_pred HHHhhCCCCCCCCCh---hhHHHHHhhccccccCCc-ccccChhHHHHHHHHhh-CccccCC
Q 008810 348 YEMLVGYPPFYSDDP---MSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLG 404 (552)
Q Consensus 348 yEmltG~~PF~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~e~~dLI~~lL~-dp~~Rl~ 404 (552)
|||++|.+||.+... ...+.++...+.....+. ...+|+++.+||..|+. +|.+||.
T Consensus 204 ~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~ 265 (293)
T d1csna_ 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265 (293)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred HHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 999999999986543 334444444322221111 13688999999999998 9999997
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=392.13 Aligned_cols=251 Identities=25% Similarity=0.302 Sum_probs=192.7
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHH--HHHhcCCCceEEEeeeecCCc---
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDSNCIVKLYCSFQDDE--- 189 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~--iL~~l~hp~Iv~l~~~f~d~~--- 189 (552)
..+|.+.+.||+|+||.||+|++ +|+.||||+++... ......|++ .+..++|||||++++++.+.+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 35789999999999999999985 68899999997543 122334444 456789999999999997553
Q ss_pred -eEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCcccccCCCCccccCCCcEEEccc
Q 008810 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK--------HHYIHRDIKPDNLLLDKYGHLRLSDF 260 (552)
Q Consensus 190 -~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~--------~giiHrDLKPeNILl~~~g~iKL~DF 260 (552)
.+|||||||++|+|..+|.+ ..+++..+..++.+++.||.|||. +|||||||||+||||+.+|++||+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 68999999999999999965 479999999999999999999996 59999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhcCC------C
Q 008810 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------Y 334 (552)
Q Consensus 261 Glak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~~~------y 334 (552)
|+|+......... .......+||+.|||||++.+.. |
T Consensus 153 Gl~~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 195 (303)
T d1vjya_ 153 GLAVRHDSATDTI-------------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFES 195 (303)
T ss_dssp TTCEEEETTTTEE-------------------------------------CC----CCSCGGGCCHHHHTTCSCTTCHHH
T ss_pred CccccccCCCcce-------------------------------------eccccceecccCcCChhhccccccccCCCc
Confidence 9999764321100 00112468999999999997643 6
Q ss_pred CCccchhhhhHHHHHHhhCCCCCCCCC--------------hhhHHHHHh-hccccccCCcc---cccChhHHHHHHHHh
Q 008810 335 GMECDWWSLGAIMYEMLVGYPPFYSDD--------------PMSTCRKIV-NWRTHLKFPEE---AKLSIEAKDLISKLL 396 (552)
Q Consensus 335 ~~~~DiWSlGvilyEmltG~~PF~~~~--------------~~~~~~~i~-~~~~~~~~p~~---~~~s~e~~dLI~~lL 396 (552)
+.++|||||||+||||++|.+||.... ......+.+ .......+|.. .....++.+||.+||
T Consensus 196 ~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl 275 (303)
T d1vjya_ 196 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 275 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTC
T ss_pred CcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHc
Confidence 778999999999999999998874322 112222222 21222233331 123456899999999
Q ss_pred h-CccccCCCCChhhhhcC
Q 008810 397 C-NVNQRLGAKGADEIKVH 414 (552)
Q Consensus 397 ~-dp~~Rl~~~~a~eil~H 414 (552)
. ||.+||+ +.||+.+
T Consensus 276 ~~dp~~Rps---~~ei~~~ 291 (303)
T d1vjya_ 276 YANGAARLT---ALRIKKT 291 (303)
T ss_dssp CSSGGGSCC---HHHHHHH
T ss_pred ccCHhHCcC---HHHHHHH
Confidence 9 9999999 8888763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-47 Score=394.63 Aligned_cols=274 Identities=23% Similarity=0.362 Sum_probs=208.1
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-----------CCceEEEee
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----------SNCIVKLYC 183 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-----------hp~Iv~l~~ 183 (552)
..+|+++++||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+|+.++ |+|||+++.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3569999999999999999999999999999999987643 2345677888887764 578999988
Q ss_pred eec--CCceEEEEEecCCCCchhhHHh---hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCcccccCCCCccccCCCc---
Q 008810 184 SFQ--DDEFLYLIMEYLPGGDMMTLLM---RKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGH--- 254 (552)
Q Consensus 184 ~f~--d~~~lylVmEy~~gG~L~~~L~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKPeNILl~~~g~--- 254 (552)
++. .....++||+++.++....... ....+++..++.++.||+.||.|||+ .|||||||||+||||+.+|.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 875 4457778888877665444432 34689999999999999999999998 89999999999999987664
Q ss_pred ---EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccccCCCCCChhhhhc
Q 008810 255 ---LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (552)
Q Consensus 255 ---iKL~DFGlak~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s~~GT~~Y~APEvl~~ 331 (552)
+||+|||.++..... ....+||+.|+|||++.+
T Consensus 168 ~~~~kl~dfg~s~~~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH--------------------------------------------YTNSIQTREYRSPEVLLG 203 (362)
T ss_dssp EEEEEECCCTTCEETTBC--------------------------------------------CCSCCSCGGGCCHHHHHT
T ss_pred cceeeEeecccccccccc--------------------------------------------cccccccccccChhhccc
Confidence 999999998754321 125689999999999999
Q ss_pred CCCCCccchhhhhHHHHHHhhCCCCCCCCChh------hHHHHHhhccc---------------------------cc--
Q 008810 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM------STCRKIVNWRT---------------------------HL-- 376 (552)
Q Consensus 332 ~~y~~~~DiWSlGvilyEmltG~~PF~~~~~~------~~~~~i~~~~~---------------------------~~-- 376 (552)
.+|+.++|+|||||++++|++|++||...+.. .....++..-+ ..
T Consensus 204 ~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
T d1q8ya_ 204 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 283 (362)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB
T ss_pred cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccC
Confidence 99999999999999999999999999764321 11111110000 00
Q ss_pred ---------cCCcccccChhHHHHHHHHhh-CccccCCCCChhhhhcCCCcCCCChhhhhhcCCCCccccCCccc
Q 008810 377 ---------KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441 (552)
Q Consensus 377 ---------~~p~~~~~s~e~~dLI~~lL~-dp~~Rl~~~~a~eil~HpfF~~i~w~~l~~~~~pf~P~~~~~~d 441 (552)
.+......+++++|||.+||+ ||.+||+ |+|||+||||+++.+. ..+..|..|...+..|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~~~~--~~~~~p~~~~~~~~~~ 353 (362)
T d1q8ya_ 284 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTLGM--EEIRVPDRELYGSGSD 353 (362)
T ss_dssp CCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCTTC--TTCCCTTSCTTCBSTT
T ss_pred CchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccCCCCCc--ccCCCCCcccCCCCCC
Confidence 000112467889999999999 9999999 9999999999976533 2355555555544333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.7e-26 Score=217.37 Aligned_cols=137 Identities=14% Similarity=0.161 Sum_probs=108.7
Q ss_pred eeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhh---------------hhhHHHHHHHHHHHHHhcCCCceEEEe
Q 008810 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---------------RRGQVEHVRAERNLLAEVDSNCIVKLY 182 (552)
Q Consensus 118 f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~---------------~~~~~~~~~~E~~iL~~l~hp~Iv~l~ 182 (552)
+.+.+.||+|+||+||+|++. +|+.||||+++..... ..........|...|..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457899999999999999874 7899999997642110 011123356688889999999999888
Q ss_pred eeecCCceEEEEEecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccccCCCCccccCCCcEEEccccc
Q 008810 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (552)
Q Consensus 183 ~~f~d~~~lylVmEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKPeNILl~~~g~iKL~DFGl 262 (552)
+... .++||||++++.+.. +++..+..++.|++.||.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 7643 279999998876543 4566678899999999999999999999999999999965 489999999
Q ss_pred ccccC
Q 008810 263 CKPLD 267 (552)
Q Consensus 263 ak~~~ 267 (552)
|+...
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 98653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=2.8e-07 Score=87.92 Aligned_cols=140 Identities=12% Similarity=0.082 Sum_probs=90.3
Q ss_pred CCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC-CCceEEEeeeecCCceEEEE
Q 008810 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (552)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~f~d~~~lylV 194 (552)
+.|+..+..+.|+.+.||++. ..+..+.+|+...... .....+.+|..+|..+. +--+.++++++.+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 356666666556668999875 4566788888765432 22234677888877663 32356677777788899999
Q ss_pred EecCCCCchhhHHhhcCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 008810 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH----------------------------------------- 233 (552)
Q Consensus 195 mEy~~gG~L~~~L~~~~~l~e~~~~~~~~qi~~aL~~LH----------------------------------------- 233 (552)
|++++|..+........ ....++.++...|..||
T Consensus 89 ~~~l~G~~~~~~~~~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccccc-----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 99999987755432110 11111222222222222
Q ss_pred ------------h------CCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 234 ------------K------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 234 ------------~------~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
. ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 2 1378999999999999876677999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.06 E-value=3.1e-06 Score=86.22 Aligned_cols=81 Identities=16% Similarity=0.192 Sum_probs=49.7
Q ss_pred EeeeeecCCeEEEEEEEcCCCcEEEEEEeechh-hhh---hhHHHHHHHHHHHHHhcC-C--CceEEEeeeecCCceEEE
Q 008810 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-MLR---RGQVEHVRAERNLLAEVD-S--NCIVKLYCSFQDDEFLYL 193 (552)
Q Consensus 121 ~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~-~~~---~~~~~~~~~E~~iL~~l~-h--p~Iv~l~~~f~d~~~lyl 193 (552)
.+.||.|....||++....+|+.|++|.-.... ... .....+...|..+|..+. + ..++++|++. ....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 567899999999999887778889999643211 100 112344566887877652 2 3466666553 334468
Q ss_pred EEecCCCCch
Q 008810 194 IMEYLPGGDM 203 (552)
Q Consensus 194 VmEy~~gG~L 203 (552)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=4.3e-05 Score=71.81 Aligned_cols=136 Identities=12% Similarity=0.073 Sum_probs=81.4
Q ss_pred eeeecCC-eEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC--CceEEEeeeecCCceEEEEEecCC
Q 008810 123 MIGKGAF-GEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDEFLYLIMEYLP 199 (552)
Q Consensus 123 ~IG~G~f-G~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h--p~Iv~l~~~f~d~~~lylVmEy~~ 199 (552)
.+..|.. +.||++.. .++..+.+|.-.... ...+..|..+|+.+.. --+.++++...+.+..|+||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455553 68898863 456678888765432 1235667777766532 226677888888889999999999
Q ss_pred CCchhhHH--------------hhcC-------CCC--HHH-----HHHHH---------------HHHHHHHHHHHhC-
Q 008810 200 GGDMMTLL--------------MRKD-------TLT--EDE-----ARFYV---------------AETVLAIESIHKH- 235 (552)
Q Consensus 200 gG~L~~~L--------------~~~~-------~l~--e~~-----~~~~~---------------~qi~~aL~~LH~~- 235 (552)
|-++.... .+-. .+. ... ...+. ......+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 87654311 0000 000 000 00000 0011123333321
Q ss_pred ------CCcccccCCCCccccCCCcEEEcccccccc
Q 008810 236 ------HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 236 ------giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.+||+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999876778999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.04 E-value=0.00059 Score=66.83 Aligned_cols=130 Identities=10% Similarity=0.160 Sum_probs=73.5
Q ss_pred CeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcC---CCceEEEe----eeecCCceEEEEEecCCCC
Q 008810 129 FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLY----CSFQDDEFLYLIMEYLPGG 201 (552)
Q Consensus 129 fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~---hp~Iv~l~----~~f~d~~~lylVmEy~~gG 201 (552)
--.||+++. .+|..|++|+.+... ...+.+..|..+|..+. -|-...+. ..+......+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 368999875 568889999986532 12344667877776653 22111111 2223456788999999874
Q ss_pred chhh--------------HHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHh-----
Q 008810 202 DMMT--------------LLMR----------------------------KDTLTEDEARFYVAETVLAIESIHK----- 234 (552)
Q Consensus 202 ~L~~--------------~L~~----------------------------~~~l~e~~~~~~~~qi~~aL~~LH~----- 234 (552)
.+.. .+.. ...++......+...+-..+..+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 3211 0000 0011111222222223333333332
Q ss_pred --CCCcccccCCCCccccCCCcEEEcccccccc
Q 008810 235 --HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (552)
Q Consensus 235 --~giiHrDLKPeNILl~~~g~iKL~DFGlak~ 265 (552)
.++||+|+.|.|||++. | ..++||+-|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999974 4 45899998874
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.02 E-value=0.0011 Score=66.76 Aligned_cols=80 Identities=19% Similarity=0.294 Sum_probs=53.4
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhc-CCCceEEEeeeec
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ 186 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~-------tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~f~ 186 (552)
.+++++ +.|+.|---.+|++.... .++.|.+++.-... .. ....+|..+++.+ .+....+++++|.
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 344544 578889999999998653 34567777765321 12 2345688888776 3555568888886
Q ss_pred CCceEEEEEecCCCCchh
Q 008810 187 DDEFLYLIMEYLPGGDMM 204 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~ 204 (552)
+ .+||||++|..|.
T Consensus 116 ~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPLS 129 (395)
T ss_dssp T----EEEECCCCEEECC
T ss_pred C----ceEEEEeccccCC
Confidence 4 5899999885443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.56 E-value=0.0089 Score=57.38 Aligned_cols=143 Identities=12% Similarity=0.042 Sum_probs=75.3
Q ss_pred CCCeeEEeeeeecCCeEEEEEEEcCCCcEEEEEEeechhhhhhhHHHHHHHHHHHHHhcCC-----CceEEEe-e--eec
Q 008810 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-----NCIVKLY-C--SFQ 186 (552)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~l~~~k~tg~~~AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-----p~Iv~l~-~--~f~ 186 (552)
.+...-++.|..|---+.|++... .| .|++|+..+.. ... .+..|..+|..+.. |..+... + ...
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~--~~~---~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKN---DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CC---HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC--CHH---HHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 445555667778888899998743 33 58999986542 222 24445556655522 2222110 0 111
Q ss_pred CCceEEEEEecCCCCchhhH--------------Hhh---c------CCCC------------------HHHHHHHHHHH
Q 008810 187 DDEFLYLIMEYLPGGDMMTL--------------LMR---K------DTLT------------------EDEARFYVAET 225 (552)
Q Consensus 187 d~~~lylVmEy~~gG~L~~~--------------L~~---~------~~l~------------------e~~~~~~~~qi 225 (552)
-....+.++.++.|...... +.. . .... .......+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 13455667777766433211 000 0 0000 11112223333
Q ss_pred HHHHHHHHh----CCCcccccCCCCccccCCCcEEEccccccc
Q 008810 226 VLAIESIHK----HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (552)
Q Consensus 226 ~~aL~~LH~----~giiHrDLKPeNILl~~~g~iKL~DFGlak 264 (552)
...+...+. .|+||+|+.++|||++.++..-|+||+.|.
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 333333332 479999999999999988777899999986
|